PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shiozaki, K; Takahashi, K; Hosono, M; Yamaguchi, K; Hata, K; Shiozaki, M; Bassi, R; Prinetti, A; Sonnino, S; Nitta, K; Miyagi, T				Shiozaki, Kazuhiro; Takahashi, Kohta; Hosono, Masahiro; Yamaguchi, Kazunori; Hata, Keiko; Shiozaki, Momo; Bassi, Rosaria; Prinetti, Alessandro; Sonnino, Sandro; Nitta, Kazuo; Miyagi, Taeko			Phosphatidic acid-mediated activation and translocation to the cell surface of sialidase NEU3, promoting signaling for cell migration	FASEB JOURNAL			English	Article						sialic acid; phospholipids; gangliosides; PLD1; cancer	MEMBRANE-ASSOCIATED SIALIDASE; SITE-DIRECTED MUTAGENESIS; GANGLIOSIDE SIALIDASE; PHOSPHOLIPASE D1; APOPTOSIS SUPPRESSION; MOLECULAR-CLONING; TYROSINE KINASE; GROWTH; EXPRESSION; BINDING	The plasma membrane-associated sialidase NEU3 plays crucial roles in regulation of transmembrane signaling, and its aberrant up-regulation in various cancers contributes to malignancy. However, it remains uncertain how NEU3 is naturally activated and locates to plasma membranes, because of its Triton X-100 requirement for the sialidase activity in vitro and its often changing subcellular location. Among phospholipids examined, we demonstrate that phosphatidic acid (PA) elevates its sialidase activity 4 to 5 times at 50 M in vitro at neutral pH and promotes translocation to the cell surface and cell migration through Ras-signaling in HeLa and COS-1 cells. NEU3 was found to interact selectively with PA as assessed by phospholipid array, liposome coprecipitation, and ELISA assays and to colocalize with phospholipase D (PLD) 1 in response to epidermal growth factor (EGF) or serum stimulation. Studies using tagged NEU3 fragments with point mutations identified PA- and calmodulin (CaM)-binding sites around the N terminus and confirmed its participation in translocation and catalytic activity. EGF induced PLD1 activation concomitantly with enhanced NEU3 translocation to the cell surface, as assessed by confocal microscopy. These results suggest that interactions of NEU3 with PA produced by PLD1 are important for regulation of transmembrane signaling, this aberrant acceleration probably promoting malignancy in cancers.	[Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Takahashi, Kohta; Hata, Keiko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Div Canc Glycosylat Res, Sendai, Miyagi 9818558, Japan; [Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Div Cell Recognit Study, Sendai, Miyagi 9818558, Japan; [Yamaguchi, Kazunori; Shiozaki, Momo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Bassi, Rosaria; Prinetti, Alessandro; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	Kagoshima University; Kagoshima University; Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Miyagi Cancer Center; University of Milan	Miyagi, T (corresponding author), Tohoku Pharmaceut Univ, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp	Sonnino, Sandro/R-4154-2017; Prinetti, Alessandro/R-4206-2017	Sonnino, Sandro/0000-0001-8180-5908; Prinetti, Alessandro/0000-0003-0252-2593; Shiozaki, Kazuhiro/0000-0002-0523-838X; BASSI, ROSARIA/0000-0001-7409-4730	Ministry of Education, Culture, Sports, Science and Technology of Japan [23110002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to Dr. M. A. Frohman, Stony Brook University, for a kind gift of PLD1 expression vector, pCGN-hPLD1b, and also to Mr. T. Wada and Ms. S. Moriya, Tohoku Pharmaceutical University, for their valuable technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Albohy A, 2010, GLYCOBIOLOGY, V20, P1127, DOI 10.1093/glycob/cwq077; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; KASZKIN M, 1992, BIOCHEM J, V287, P51, DOI 10.1042/bj2870051; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Magesh S, 2006, J MOL GRAPH MODEL, V25, P196, DOI 10.1016/j.jmgm.2005.12.006; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Zhang Y, 2014, J BIOL CHEM, V289, P22567, DOI 10.1074/jbc.R114.576876; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	39	17	17	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2099	2111		10.1096/fj.14-262543	http://dx.doi.org/10.1096/fj.14-262543			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25678627				2022-12-26	WOS:000354114600041
J	Drobnak, I; Braselmann, E; Clark, PL				Drobnak, Igor; Braselmann, Esther; Clark, Patricia L.			Multiple Driving Forces Required for Efficient Secretion of Autotransporter Virulence Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Kinetics; Outer Membrane; Protein Folding; Protein Secretion; Thermodynamics; Translocation; Virulence Factor; Autotransporter; Periplasm	BACTERIAL OUTER MEMBRANES; GRAM-NEGATIVE BACTERIA; TOXIN-B-SUBUNIT; BORDETELLA-PERTUSSIS; PASSENGER DOMAIN; ESCHERICHIA-COLI; EXTRACELLULAR TRANSPORT; STOCHASTIC SIMULATION; RECOMBINANT PROTEINS; FOLDING MECHANISM	Autotransporter (AT) proteins are a broad class of virulence proteins from Gram-negative bacterial pathogens that require their own C-terminal transmembrane domain to translocate their N-terminal passenger across the bacterial outer membrane (OM). But given the unavailability of ATP or a proton gradient across the OM, it is unknown what energy source(s) drives this process. Here we used a combination of computational and experimental approaches to quantitatively compare proposed AT OM translocation mechanisms. We show directly for the first time that when translocation was blocked an AT passenger remained unfolded in the periplasm. We demonstrate that AT secretion is a kinetically controlled, non-equilibrium process coupled to folding of the passenger and propose a model connecting passenger conformation to secretion kinetics. These results reconcile seemingly contradictory reports regarding the importance of passenger folding as a driving force for OM translocation but also reveal that another energy source is required to initiate translocation.	[Drobnak, Igor; Braselmann, Esther; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Clark, PL (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	pclark1@nd.edu		Clark, Patricia/0000-0001-5462-8248	National Institutes of Health, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship [R01 GM097573, T32 GM075762]; College of Science at the University of Notre Dame; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097573, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Science at the University of Notre Dame; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097573 (to P. L. C.) and T32 GM075762, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship (to E. B.).; Recipient of an Entrepreneurial Innovation postdoctoral fellowship from the College of Science at the University of Notre Dame. Present address: Department of Biotechnology, National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.	Besingi RN, 2013, MOL MICROBIOL, V90, P1028, DOI 10.1111/mmi.12414; Braselmann E, 2012, J PHYS CHEM LETT, V3, P1063, DOI 10.1021/jz201654k; Celik N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043245; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; CHARLES IG, 1989, P NATL ACAD SCI USA, V86, P3554, DOI 10.1073/pnas.86.10.3554; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Drobnak I, 2015, MOL MICROBIOL, V95, P1, DOI 10.1111/mmi.12838; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jong WSP, 2010, CURR OPIN BIOTECH, V21, P646, DOI 10.1016/j.copbio.2010.07.009; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kang'ethe W, 2013, J BIOL CHEM, V288, P35028, DOI 10.1074/jbc.M113.515635; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; KLAUSER T, 1990, EMBO J, V9, P1991, DOI 10.1002/j.1460-2075.1990.tb08327.x; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Li H, 2008, BIOTECHNOL PROGR, V24, P56, DOI 10.1021/bp070255h; MAKOFF AJ, 1990, BIO-TECHNOL, V8, P1030, DOI 10.1038/nbt1190-1030; Mansell TJ, 2010, PROTEIN SCI, V19, P1079, DOI 10.1002/pro.388; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Shen HH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6078; Shi LX, 2013, P NATL ACAD SCI USA, V110, P930, DOI 10.1073/pnas.1115886110; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Zhai YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548	54	18	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10104	10116		10.1074/jbc.M114.629170	http://dx.doi.org/10.1074/jbc.M114.629170			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670852	Green Published, hybrid			2022-12-26	WOS:000353241100017
J	Brown, RL; Xiong, WH; Peters, JH; Tekmen-Clark, M; Strycharska-Orczyk, I; Reed, BT; Morgans, CW; Duvoisin, RM				Brown, R. Lane; Xiong, Wei-Hong; Peters, James H.; Tekmen-Clark, Merve; Strycharska-Orczyk, Iwona; Reed, Brian T.; Morgans, Catherine W.; Duvoisin, Robert M.			TRPM3 Expression in Mouse Retina	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; NEIBANK PROJECT; GANGLION-CELLS; CHANNEL; RECEPTOR; LIGHT; IDENTIFICATION; RESPONSES; PATHWAY; IRIS	Transient receptor potential (TRP) channels constitute a large family of cation permeable ion channels that serve crucial functions in sensory systems by transducing environmental changes into cellular voltage and calcium signals. Within the retina, two closely related members of the melastatin TRP family, TRPM1 and TRPM3, are highly expressed. TRPM1 has been shown to be required for the depolarizing response to light of ON-bipolar cells, but the role of TRPM3 in the retina is unknown. Immunohistochemical staining of mouse retina with an antibody directed against the C-terminus of TRPM3 labeled the inner plexiform layer (IPL) and a subset of cells in the ganglion cell layer. Within the IPL, TRPM3 immunofluorescence was markedly stronger in the OFF sublamina than in the ON sublamina. Electroretinogram recordings showed that the scotopic and photopic a- and b-waves of TRPM3(-/-) mice are normal indicating that TRPM3 does not play a major role in visual processing in the outer retina. TRPM3 activity was measured by calcium imaging and patch-clamp recording of immunopurified retinal ganglion cells. Application of the TRPM3 agonist, pregnenolone sulfate (PS), stimulated increases in intracellular calcium in similar to 40% of cells from wild type and TRPM1(-/-) mice, and the PS-stimulated increases in calcium were blocked by co-application of mefenamic acid, a TRPM3 antagonist. No PS-stimulated changes in fluorescence were observed in ganglion cells from TRPM3(-/-) mice. Similarly, PS-stimulated currents that could be blocked by mefenamic acid were recorded from wild type retinal ganglion cells but were absent in ganglion cells from TRPM3(-/-) mice.	[Brown, R. Lane; Peters, James H.; Reed, Brian T.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Brown, R. Lane] Washington State Univ, WWAMI Med Educ Program, Pullman, WA 99164 USA; [Xiong, Wei-Hong; Tekmen-Clark, Merve; Strycharska-Orczyk, Iwona; Reed, Brian T.; Morgans, Catherine W.; Duvoisin, Robert M.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Washington State University; Washington State University; Oregon Health & Science University	Brown, RL (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA.	brownla@vetmed.wsu.edu; duvoisin@ohsu.edu		Morgans, Catherine/0000-0002-7287-3447	National Eye Institute [EY019907, EY018625, EY009534]; NATIONAL EYE INSTITUTE [R01EY022369, P30EY010572, R01EY018625, R01EY019907, R01EY009534] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute: EY019907, EY018625, EY009534, http://www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hoffmann A, 2010, J NEUROCHEM, V114, P654, DOI 10.1111/j.1471-4159.2010.06644.x; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Klose C, 2011, BRIT J PHARMACOL, V162, P1757, DOI 10.1111/j.1476-5381.2010.01186.x; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Nilius B, 2008, NAT CELL BIOL, V10, P1383, DOI 10.1038/ncb1208-1383; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SPENCE KT, 1991, LIFE SCI, V49, pPL235, DOI 10.1016/0024-3205(91)90649-V; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Vriens J, 2014, NATURE CHEMICAL BIOL, DOI [10.1038/nchembio.1731, DOI 10.1038/NCHEMBIO.1731]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wistow G, 2002, MOL VIS, V8, P205; Wistow G, 2002, MOL VIS, V8, P185; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	34	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117615	10.1371/journal.pone.0117615	http://dx.doi.org/10.1371/journal.pone.0117615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679224	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600077
J	Hu, HT; Yu, DH; Liu, H				Hu, Hongtao; Yu, Dazhao; Liu, Hong			Bioinformatics Analysis of Small RNAs in Pima (Gossypium barbadense L.)	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; DIRECTED DNA METHYLATION; DOUBLE-STRANDED-RNA; PLANT MICRORNAS; ARABIDOPSIS; SIRNA; POLYMERASE; COTTON; BIOGENESIS; MIRNAS	Small RNAs (sRNAs) are similar to 20 to 24 nucleotide single-stranded RNAs that play crucial roles in regulation of gene expression. In plants, sRNAs are classified into microRNAs (miRNAs), repeat-associated siRNAs (ra-siRNAs), phased siRNAs (pha-siRNAs), cis and trans natural antisense transcript siRNAs (cis- and trans-nat siRNAs). Pima (Gossypium barbadense L.) is one of the most economically important fiber crops, producing the best and longest spinnable fiber. Although some miRNAs are profiled in Pima, little is known about siRNAs, the largest subclass of plant sRNAs. In order to profile these gene regulators in Pima, a comprehensive analysis of sRNAs was conducted by mining publicly available sRNA data, leading to identification of 678 miRNAs, 3,559,126 ra-siRNAs, 627 pha-siRNAs, 136,600 cis-nat siRNAs and 79,994 trans-nat siRNAs. The 678 miRNAs, belonging to 98 conserved and 402 lineage-specific families, were produced from 2,138 precursors, of which 297 arose from introns, exons, or intron/UTR-exon junctions of protein-coding genes. Ra-siRNAs were produced from various repeat loci, while most (97%) were yielded from retrotransposons, especially LTRs (long terminal repeats). The genes encoding auxin-signaling-related proteins, NBS-LRRs and transcription factors were major sources of pha-siRNAs, while two conserved TAS3 homologs were found as well. Most cis-NATs in Pima overlapped in enclosed and convergent orientations, while a few hybridized in divergent and coincided orientations. Most cis- and trans-nat siRNAs were produced from overlapping regions. Additionally, characteristics of length and the 5'-first nucleotide of each sRNA class were analyzed as well. Results in this study created a valuable molecular resource that would facilitate studies on mechanism of controlling gene expression.	[Hu, Hongtao] Hubei Acad Agr Sci, Ctr Biopesticide Res, Wuhan, Hubei, Peoples R China; [Hu, Hongtao] Hubei Vocat Coll Biol Sci & Technol, Dept Biol Engn, Wuhan, Hubei, Peoples R China; [Yu, Dazhao] Hubei Acad Agr Sci, Inst Plant Protect & Soil Fertilizer, Wuhan, Hubei, Peoples R China; [Liu, Hong] Hunan Univ Arts & Sci, Coll Life Sci, Changde, Hunan, Peoples R China; [Liu, Hong] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Hubei Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences; Hunan University of Arts & Science; Huazhong Agricultural University	Liu, H (corresponding author), Hunan Univ Arts & Sci, Coll Life Sci, Changde, Hunan, Peoples R China.	liuhong59@mail.hzau.edu.cn			Fundamental Research Funds for the Central University [2014PY042]	Fundamental Research Funds for the Central University	This project was supported by a grant from Fundamental Research Funds for the Central University (No. 2014PY042). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen DJ, 2012, NUCLEIC ACIDS RES, V40, pD1187, DOI 10.1093/nar/gkr823; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2008, NUCLEIC ACIDS RES, V36, pW114, DOI 10.1093/nar/gkn297; Eun C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025730; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guan XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4050; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jia X, 2011, FRONT BIOL, V6, P133; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim JJ, 2012, PLANT PHYSIOL, V159, P461, DOI 10.1104/pp.111.192369; Koster T, 2014, NUCLEIC ACIDS RES, V42, P9925, DOI 10.1093/nar/gku716; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Melamed Z, 2013, MOL CELL, V50, P869, DOI 10.1016/j.molcel.2013.05.007; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Ramalingam P, 2014, RNA, V20, P76, DOI 10.1261/rna.041814.113; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Tong YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063938; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Visser M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095782; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2014, J EXP BOT, V65, P4723, DOI 10.1093/jxb/eru246; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xu C, 2013, PROTEIN CELL, V4, P656, DOI 10.1007/s13238-013-3052-7; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yan K, 2012, MOL CELL, V48, P521, DOI 10.1016/j.molcel.2012.08.032; Yang GD, 2012, J GENET, V91, P313, DOI 10.1007/s12041-012-0199-6; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang H, 2013, P NATL ACAD SCI USA, V110, P8290, DOI 10.1073/pnas.1300585110; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069743; Zhang XM, 2013, MOL PLANT, V6, P704, DOI 10.1093/mp/sst051; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108	81	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116826	10.1371/journal.pone.0116826	http://dx.doi.org/10.1371/journal.pone.0116826			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679373	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600036
J	Nagasawa, S; Sedukhina, AS; Nakagawa, Y; Maeda, I; Kubota, M; Ohnuma, S; Tsugawa, K; Ohta, T; Roche-Molina, M; Bernal, JA; Narvaez, AJ; Jeyasekharan, AD; Sato, K				Nagasawa, Satoi; Sedukhina, Anna S.; Nakagawa, Yuko; Maeda, Ichiro; Kubota, Manabu; Ohnuma, Shigeko; Tsugawa, Koichiro; Ohta, Tomohiko; Roche-Molina, Marta; Bernal, Juan A.; Narvaez, Ana J.; Jeyasekharan, Anand D.; Sato, Ko			LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MOLECULAR PORTRAITS; DNA-REPAIR; CARCINOMA; ACTIVATION; REPRESSION; TUMORS	LSD1, a lysine-specific histone demethylase, is overexpressed in several types of cancers and linked to poor outcomes. In breast cancer, the significance of LSD1 overexpression is not clear. We have performed an in silico analysis to assess the relationship of LSD1 expression to clinical outcome. We demonstrate that LSD1 overexpression is a poor prognostic factor in breast cancer, especially in basal-like breast cancer, a subtype of breast cancer with aggressive clinical features. This link is also observed in samples of triple negative breast cancer. Interestingly, we note that overexpression of LSD1 correlates with down-regulation of BRCA1 in triple negative breast cancer. This phenomenon is also observed in in vitro models of basal-like breast cancer, and is associated with an increased sensitivity to PARP inhibitors. We propose therefore that high expression levels of the demethylase LSD1 is a potential prognostic factor of poor outcome in basal-like breast cancer, and that PARP inhibition may be a therapeutic strategy of interest in this poor prognostic subtype with overexpression of LSD1.	[Nagasawa, Satoi; Sedukhina, Anna S.; Nakagawa, Yuko; Ohta, Tomohiko; Sato, Ko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Nagasawa, Satoi; Tsugawa, Koichiro] St Marianna Univ, Sch Med, Div Breast & Endocrine Surg, Dept Surg, Kawasaki, Kanagawa 2168511, Japan; [Nakagawa, Yuko] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa 2168511, Japan; [Maeda, Ichiro; Kubota, Manabu; Ohnuma, Shigeko] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa 2168511, Japan; [Roche-Molina, Marta; Bernal, Juan A.] CNIC, Dept Cardiovasc Dev & Repair, Madrid 28029, Spain; [Narvaez, Ana J.] Univ Cambridge, MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge CB2 OXZ, England; [Jeyasekharan, Anand D.] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, Singapore 117599, Singapore	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Cambridge; National University of Singapore	Sato, K (corresponding author), St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan.	kosato@marianna-u.ac.jp	Roche-Molina, Marta/G-2731-2016; Jeyasekharan, Anand/O-3398-2019; Nagasawa, Satoi/GSJ-2420-2022; Bernal, Juan A/N-4544-2014	Bernal, Juan A/0000-0002-9933-5550; Roche-Molina, Marta/0000-0002-9487-6980; Jeyasekharan, Anand/0000-0001-9816-6137; Nagasawa, Satoi/0000-0003-3967-7644; Ohta, Tomohiko/0000-0002-9700-7342	St. Marianna University; Grants-in-Aid for Scientific Research [26290042, 26670730] Funding Source: KAKEN	St. Marianna University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KS received a grant of St. Marianna University and ASS received a grant of St. Marianna University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Ding J, 2013, DIGEST DIS SCI, V58, P1581, DOI 10.1007/s10620-012-2552-2; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; REMMELE W, 1986, VIRCHOWS ARCH A, V409, P127, DOI 10.1007/BF00708323; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Yokoyama A, 2014, J BIOL CHEM; Yu YY, 2013, BIOCHEM BIOPH RES CO, V437, P192, DOI 10.1016/j.bbrc.2013.05.123; Zhao ZK, 2012, WORLD J GASTROENTERO, V18, P6651, DOI 10.3748/wjg.v18.i45.6651	27	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118002	10.1371/journal.pone.0118002	http://dx.doi.org/10.1371/journal.pone.0118002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679396	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600099
J	Chowdhury, PR; Charles, IG; Djordjevic, SP				Chowdhury, Piklu Roy; Charles, Ian G.; Djordjevic, Steven P.			A Role for Tn6029 in the Evolution of the Complex Antibiotic Resistance Gene Loci in Genomic Island 3 in Enteroaggregative Hemorrhagic Escherichia coli O104:H4	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PLASMIDS; TRANSPOSONS; INTEGRONS; TN1696	In enteroaggregative hemorrhagic Escherichia coli (EAHEC) O104 the complex antibiotic resistance gene loci (CRL) found in the region of divergence 1 (RD1) within E. coli genomic island 3 (GI3) contains bla(TEM-1), strAB, sul2, tet(A) A, and dfrA7 genes encoding resistance to ampicillin, streptomycin, sulfamethoxazole, tetracycline and trimethoprim respectively. The precise arrangement of antibiotic resistance genes and the role of mobile elements that drove the evolutionary events and created the CRL have not been investigated. We used a combination of bioinformatics and iterative BLASTn searches to determine the micro-evolutionary events that likely led to the formation of the CRL in GI3 using the closed genome sequences of EAHEC O104:H4 strains 2011C-3493 and 2009EL-2050 and high quality draft genomes of EAHEC E. coli O104:H4 isolates from sporadic cases not associated with the initial outbreak. Our analyses indicate that the CRL in GI3 evolved from a progenitor structure that contained an In2-derived class 1 integron in a Tn21/Tn1721 hybrid backbone. Within the hybrid backbone, a Tn6029-family transposon, identified here as Tn6029C abuts the sul1 gene in the 3'-Conserved Segment (-CS) of a class 1 integron generating a unique molecular signature that has only previously been observed in pASL01a, a small plasmid found in commensal E. coli in West Africa. From this common progenitor, independent IS26-mediated events created two novel transposons identified here as Tn6029D and Tn6222 in 2011C-3493 and 2009EL-2050 respectively. Analysis of RD1 within GI3 reveals IS26 has played a crucial role in the assembly of regions within the CRL.	[Chowdhury, Piklu Roy; Charles, Ian G.; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Chowdhury, Piklu Roy] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Narellan, NSW 2567, Australia	University of Technology Sydney; NSW Department of Primary Industries	Djordjevic, SP (corresponding author), Univ Technol Sydney, Ithree Inst, POB 123 Broadway, Sydney, NSW 2007, Australia.	Steven.Djordjevic@uts.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Charles, Ian/0000-0002-2423-1167; Roy Chowdhury, Piklu/0000-0003-4352-603X	NSW Department of Primary Industries; ithree Institute	NSW Department of Primary Industries; ithree Institute	This work was supported by a joint collaboration between the NSW Department of Primary Industries and the ithree Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Baquero F, 2013, MBIO, V4, DOI 10.1128/mBio.00066-13; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Cain AK, 2012, J ANTIMICROB CHEMOTH, V67, P2848, DOI 10.1093/jac/dks317; Cain AK, 2010, MICROB DRUG RESIST, V16, P197, DOI 10.1089/mdr.2010.0042; Chouikha I, 2006, J BACTERIOL, V188, P977, DOI 10.1128/JB.188.3.977-987.2006; Chowdhury PR, 2011, ANTIMICROB AGENTS CH, V55, P3140, DOI 10.1128/AAC.01529-10; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; Dionisi AM, 2009, ANTIMICROB AGENTS CH, V53, P4019, DOI 10.1128/AAC.00294-09; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Guy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063027; Harmer CJ, 2014, MBIO, V5, DOI 10.1128/mBio.01801-14; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Jourdan-da Silva N, 2012, EUROSURVEILLANCE, V17, P10; Kunne C, 2012, J BACTERIOL, V194, P532, DOI 10.1128/JB.06368-11; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; LEE KY, 1990, J BACTERIOL, V172, P3229, DOI 10.1128/jb.172.6.3229-3236.1990; Mariani-Kurkdjian P, 2011, LANCET INFECT DIS, V11, P732, DOI 10.1016/S1473-3099(11)70266-3; MOLLET B, 1985, MOL GEN GENET, V201, P198, DOI 10.1007/BF00425660; Naas T, 2001, J BACTERIOL, V183, P235, DOI 10.1128/JB.183.1.235-249.2001; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Partridge SR, 2001, ANTIMICROB AGENTS CH, V45, P1263, DOI 10.1128/AAC.45.4.1263-1270.2001; Post V, 2010, J ANTIMICROB CHEMOTH, V65, P1162, DOI 10.1093/jac/dkq095; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Ruiz E, 2010, INT J MED MICROBIOL, V300, P464, DOI 10.1016/j.ijmm.2010.04.014; Siebor E, 2013, J ANTIMICROB CHEMOTH, V68, P1750, DOI 10.1093/jac/dkt100; Sjostrand J, 2014, SYST BIOL, V63, P409, DOI 10.1093/sysbio/syu007; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Tamamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077644; Vejborg RM, 2009, MICROBIOL-SGM, V155, P1407, DOI 10.1099/mic.0.026419-0; Venturini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078862; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; Yau S, 2010, MICROB DRUG RESIST, V16, P249, DOI 10.1089/mdr.2010.0033	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115781	10.1371/journal.pone.0115781	http://dx.doi.org/10.1371/journal.pone.0115781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675217	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000004
J	Huang, PT; Chen, CH; Hsu, IU; Salim, SA; Kao, SH; Cheng, CW; Lai, CH; Lee, CF; Lin, YF				Huang, Pai-Tsang; Chen, Chien-Ho; Hsu, I-Uen; Salim, Shaima'a Ahmad; Kao, Shu-Huei; Cheng, Chao-Wen; Lai, Chang-Hao; Lee, Cheng-Fan; Lin, Yung-Feng			Huntingtin-Associated Protein 1 Interacts with Breakpoint Cluster Region Protein to Regulate Neuronal Differentiation	PLOS ONE			English	Article							BCR-ABL; INTRACELLULAR TRAFFICKING; FEEDING-BEHAVIOR; DOMAIN; ACTIVATION; EXPRESSION; TRANSPORT; PATHWAYS; BRAIN; DEATH	Alterations in microtubule-dependent trafficking and certain signaling pathways in neuronal cells represent critical pathogenesis in neurodegenerative diseases. Huntingtin (Htt)-associated protein-1 (Hap1) is a brain-enriched protein and plays a key role in the trafficking of neuronal surviving and differentiating cargos. Lack of Hap1 reduces signaling through tropomyosin-related kinases including extracellular signal regulated kinase (ERK), resulting in inhibition of neurite outgrowth, hypothalamic dysfunction and postnatal lethality in mice. To examine how Hap1 is involved in microtubule-dependent trafficking and neuronal differentiation, we performed a proteomic analysis using taxol-precipitated microtubules from Hap1-null and wild-type mouse brains. Breakpoint cluster region protein (Bcr), a Rho GTPase regulator, was identified as a Hap1-interacting partner. Bcr was co-immunoprecipitated with Hap1 from transfected neuro-2a cells and co-localized with Hap1A isoform more in the differentiated than in the nondifferentiated cells. The Bcr downstream effectors, namely ERK and p38, were significantly less activated in Hap1-null than in wildtype mouse hypothalamus. In conclusion, Hap1 interacts with Bcr on microtubules to regulate neuronal differentiation.	[Huang, Pai-Tsang] Taipei Med Univ, Wan Fang Hosp, Dept Occupat Med, Taipei, Taiwan; [Chen, Chien-Ho; Hsu, I-Uen; Salim, Shaima'a Ahmad; Kao, Shu-Huei; Lee, Cheng-Fan; Lin, Yung-Feng] Taipei Med Univ, Coll Med Sci & Technol, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan; [Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lai, Chang-Hao] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, YF (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan.	yflin@tmu.edu.tw	Lin, Yung-Feng/H-3289-2019	Kao, Shu-Huei/0000-0003-4618-0898	Grants of Taipei Medical University-Wan Fang Hospital [100TMU-WFH-05]; Ministry of Science and Technology in Taiwan [NSC 101-2320-B-038-028, 102-2320-B-038-033]	Grants of Taipei Medical University-Wan Fang Hospital; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Grants of Taipei Medical University-Wan Fang Hospital (100TMU-WFH-05 to PTH) and the Ministry of Science and Technology in Taiwan (NSC 101-2320-B-038-028 and 102-2320-B-038-033 to YFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Dubash AD, 2013, J CELL BIOL, V202, P653, DOI 10.1083/jcb.201304133; Ehrnhoefer DE, 2011, NAT REV DRUG DISCOV, V10, P853, DOI 10.1038/nrd3556; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROCHEM, V71, P2178; Li SH, 1998, J BIOL CHEM, V273, P19220, DOI 10.1074/jbc.273.30.19220; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lin YF, 2010, J BIOL CHEM, V285, P15941, DOI 10.1074/jbc.M110.107318; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; PASCHAL BM, 1991, METHOD ENZYMOL, V196, P181; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Redig AJ, 2011, LEUKEMIA LYMPHOMA, V52, P45, DOI 10.3109/10428194.2010.546919; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xiang JX, 2014, J CLIN INVEST, V124, P85, DOI 10.1172/JCI69206; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang GZ, 2012, J NEUROCHEM, V122, P1010, DOI 10.1111/j.1471-4159.2012.07845.x; Yi SJ, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-8; Yi SJ, 2009, J BIOL CHEM, V284, P35645, DOI 10.1074/jbc.M109.062240; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhou LL, 2008, J EXP MED, V205, P2657, DOI 10.1084/jem.20072316	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116372	10.1371/journal.pone.0116372	http://dx.doi.org/10.1371/journal.pone.0116372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671650	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300020
J	Roy, V; Girondot, M; Harry, M				Roy, Virginie; Girondot, Marc; Harry, Myriam			The Distribution of Wolbachia in Cubitermes (Termitidae, Termitinae) Castes and Colonies: A Modelling Approach	PLOS ONE			English	Article							SP AFFINIS-SUBARQUATUS; INTRODUCED POPULATIONS; EVOLUTIONARY HISTORY; DROSOPHILA-SIMULANS; BEES ANTHOPHILA; INFECTION; DIVERSITY; STRAINS; PCR; ENDOSYMBIONT	Wolbachia are endosymbiotic bacteria of arthropods and nematodes that are able to manipulate host reproduction. Although vertically transmitted via the cytoplasm in eggs, horizontal transmission of Wolbachia among and within arthropod species has been shown to be common. Eusocial insects represent interesting models for studying Wolbachia transmission due to colonial organization and close interaction between nestmates. Here we conducted a detailed screening of Wolbachia infection for 15 colonies of the very common soil-feeding termites Cubitermes spp. affinis subarquatus (Termitidae, Termitinae) that consist of four distinct phylogenetic species in the Lope forest Reserve, Gabon. Infection tests showed that 50% of the individuals were Wolbachia positive (N = 555) with 90% of reproductives and 48% of offspring infected. White soldiers, which are transitional stages preceding mature soldiers, had a significantly higher mean infection rate (74%) than the other castes and stages (63%, 33% and 39% for larvae, workers and mature soldiers, respectively). We used a maximum likelihood method and Akaike's Information Criterion in order to explain the non-expected high rate of Wolbachia infection in white soldiers. The best model included a species effect for the stochastic loss of Wolbachia and a caste effect for the rate of gain. After fitting, the best model selected was for a species-specific rate of loss with a null rate of new gain for larvae, workers and soldiers and a probability of 0.72 whatever the species, that a white soldier becomes newly contaminated during that stage. The mean expected infection rate in white soldiers without a new gain was estimated to 17% instead of the 74% observed. Here we discuss the possible explanations to the high infection rate observed in white soldiers.	[Roy, Virginie] Univ Paris Est Creteil, Fac Sci & Technol, iEES Inst Ecol & Sci Environnement Paris, Dept SOLeO, F-94010 Creteil, France; [Girondot, Marc] Univ Paris 11, Dept Ecol Populat & Communautes, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Harry, Myriam] Univ Paris 11, CNRS, UR IRD 072, Lab Evolut Genomes & Speciat,UPR 9034, F-91198 Gif Sur Yvette, France; [Harry, Myriam] Univ Paris 11, UFR Sci, F-91400 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Harry, M (corresponding author), Univ Paris 11, CNRS, UR IRD 072, Lab Evolut Genomes & Speciat,UPR 9034, Ave Terrasse,Batiment 13, F-91198 Gif Sur Yvette, France.	myriam.harry@u-psud.fr	HARRY, Myriam/AAF-1530-2019	Roy, Virginie/0000-0003-1908-0074	University of Paris-Est Creteil	University of Paris-Est Creteil	MH and VR thank the University of Paris-Est Creteil for the financing of the ABI Prism automated sequencer (Bonus Qualite Recherche Grant and recurring budgets). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ME, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-35; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alibert J., 1963, Insectes Sociaux Paris, V10, P1, DOI 10.1007/BF02223519; Andersen SB, 2012, J EVOLUTION BIOL, V25, P1340, DOI 10.1111/j.1420-9101.2012.02521.x; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; BODOT P, 1970, CR ACAD SCI D NAT, V271, P327; Bordenstein S, 2005, CURR MICROBIOL, V51, P393, DOI 10.1007/s00284-005-0084-0; Bouillon Antoine, 1964, ETUDES TERMITES AFRI, P197; Bouwma AM, 2006, INSECT MOL BIOL, V15, P89, DOI 10.1111/j.1365-2583.2006.00614.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charlat S, 2002, SYMBIOSIS, P624; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; DEJEAN A, 1995, INSECT SOC, V42, P129, DOI 10.1007/BF01242449; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Eggleton P, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P1, DOI 10.1007/978-90-481-3977-4_1; Espino CI, 2009, APPL ENVIRON MICROB, V75, P547, DOI 10.1128/AEM.01665-08; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Frost CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095122; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Gerth M, 2013, MOL ECOL, V22, P6149, DOI 10.1111/mec.12549; Gerth M, 2011, SYST BIODIVERS, V9, P319, DOI 10.1080/14772000.2011.627953; Grasse PP, 1982, TERMITOLOGIA, V1; Guruprasad N. M., 2012, Journal of Entomological Research (New Delhi), V36, P119; HAN SH, 1983, ANN SOC ENTOMOL FR, V19, P413; Han SH, 1987, THESIS DIJON; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hughes GL, 2011, APPL ENVIRON MICROB, V77, P2165, DOI 10.1128/AEM.02878-10; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 2000, GENETICS, V156, P699; Kautz S., 2013, Psyche: A Journal of Entomology, V2013, P936341, DOI 10.1155/2013/936341; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; Keller L, 2001, HEREDITY, V87, P227, DOI 10.1046/j.1365-2540.2001.00918.x; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lo N, 2007, MOL PHYLOGENET EVOL, V44, P461, DOI 10.1016/j.ympev.2006.10.028; Mikac KM, 2007, J STORED PROD RES, V43, P594, DOI 10.1016/j.jspr.2007.01.005; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; Noirot C., 1969, BIOL TERMITES, VI, P311; Noirot C, 1955, RECHERCHES POLYMORPH, V11; Oster G.F., 1978, Monographs in Population Biology, pi; Pattabhiramaiah M., 2011, World Applied Sciences Journal, V15, P1503; Pfarr KM, 2007, TRENDS PARASITOL, V23, P5, DOI 10.1016/j.pt.2006.11.002; Plantard O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030692; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; ROUSSET F, 1995, P NATL ACAD SCI USA, V92, P6389, DOI 10.1073/pnas.92.14.6389; Roy V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-102; Roy V, 2007, FEMS MICROBIOL LETT, V274, P102, DOI 10.1111/j.1574-6968.2007.00815.x; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Salunke BK, 2010, J BIOSCIENCES, V35, P171, DOI 10.1007/s12038-010-0020-8; Salunke BK, 2010, FEMS MICROBIOL LETT, V307, P55, DOI 10.1111/j.1574-6968.2010.01960.x; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Snook RR, 2000, GENETICS, V155, P167; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Tsutsui ND, 2003, MOL ECOL, V12, P3057, DOI 10.1046/j.1365-294X.2003.01979.x; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WILLIAMS R. M. C., 1959, INSECTES SOCIAUX, V6, P291, DOI 10.1007/BF02224412; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	81	10	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116070	10.1371/journal.pone.0116070	http://dx.doi.org/10.1371/journal.pone.0116070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671520	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300016
J	Eschbach, RS; Fendler, WP; Kazmierczak, PM; Hacker, M; Rominger, A; Carlsen, J; Hirner-Eppeneder, H; Schuster, J; Moser, M; Havla, L; Schneider, MJ; Ingrisch, M; Spaeth, L; Reiser, MF; Nikolaou, K; Cyran, CC				Eschbach, Ralf S.; Fendler, Wolfgang P.; Kazmierczak, Philipp M.; Hacker, Marcus; Rominger, Axel; Carlsen, Janette; Hirner-Eppeneder, Heidrun; Schuster, Jessica; Moser, Matthias; Havla, Lukas; Schneider, Moritz J.; Ingrisch, Michael; Spaeth, Lukas; Reiser, Maximilian F.; Nikolaou, Konstantin; Cyran, Clemens C.			Correlation of Perfusion MRI and F-18-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; ANTI-ANGIOGENIC THERAPY; PHASE-II; UNCONTROLLED TRIAL; BREAST-CANCER; NUDE-MICE; SORAFENIB; MULTICENTER; GROWTH; CHEMOTHERAPY	Objectives To investigate a multimodal, multiparametric perfusion MRI/F-18-fluoro-deoxyglucose (F-18-FDG)-PET imaging protocol for monitoring regorafenib therapy effects on experimental colorectal adenocarcinomas in rats with immunohistochemical validation. Materials and Methods Human colorectal adenocarcinoma xenografts (HT-29) were implanted subcutaneously in n = 17 (n = 10 therapy group; n = 7 control group) female athymic nude rats (Hsd: RH-Foxn1(mu)). Animals were imaged at baseline and after a one-week daily treatment protocol with regorafenib (10 mg/kg bodyweight) using a multimodal, multiparametric perfusion MRI/F-18-FDG-PET imaging protocol. In perfusion MRI, quantitative parameters of plasma flow (PF, mL/100 mL/min), plasma volume (PV, %) and endothelial permeability-surface area product (PS, mL/100 mL/min) were calculated. In F-18-FDG-PET, tumor-to-background-ratio (TTB) was calculated. Perfusion MRI parameters were correlated with TTB and immunohistochemical assessments of tumor microvascular density (CD-31) and cell proliferation (Ki-67). Results Regorafenib significantly (p<0.01) suppressed PF (81.1 +/- 7.5 to 50.6 +/- 16.0 mL/100mL/min), PV (12.1 +/- 3.6 to 7.5 +/- 1.6%) and PS (13.6 +/- 3.2 to 7.9 +/- 2.3 mL/100mL/min) as well as TTB (3.4 +/- 0.6 to 1.9 +/- 1.1) between baseline and day 7. Immunohistochemistry revealed significantly (p<0.03) lower tumor microvascular density (CD-31, 7.0 +/- 2.4 vs. 16.1 +/- 5.9) and tumor cell proliferation (Ki-67, 434.0 +/- 62.9 vs. 663.0 +/- 98.3) in the therapy group. Perfusion MRI parameters Delta PF, Delta PV and Delta PS showed strong and significant (r = 0.67-0.78; p<0.01) correlations to the PET parameter Delta TTB and significant correlations (r = 0.57-0.67; p<0.03) to immunohistochemical Ki-67 as well as to CD-31-stainings (r = 0.49-0.55; p<0.05). Conclusions A multimodal, multiparametric perfusion MRI/PET imaging protocol allowed for non-invasive monitoring of regorafenib therapy effects on experimental colorectal adenocarcinomas in vivo with significant correlations between perfusion MRI parameters and F-18-FDG-PET validated by immunohistochemistry.	[Eschbach, Ralf S.; Kazmierczak, Philipp M.; Hirner-Eppeneder, Heidrun; Schuster, Jessica; Moser, Matthias; Spaeth, Lukas; Reiser, Maximilian F.; Cyran, Clemens C.] Univ Munich, Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, D-81377 Munich, Germany; [Fendler, Wolfgang P.; Rominger, Axel; Carlsen, Janette] Univ Munich, Univ Hosp Munich, Dept Nucl Med, D-81377 Munich, Germany; [Hacker, Marcus] Med Univ Vienna, Univ Hosp Vienna, Dept Nucl Med, A-1090 Vienna, Austria; [Havla, Lukas; Schneider, Moritz J.; Ingrisch, Michael] Univ Munich, Univ Hosp Munich, Dept Clin Radiol, Josef Lissner Lab Biomed Imaging, D-81377 Munich, Germany; [Nikolaou, Konstantin] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany	University of Munich; University of Munich; Medical University of Vienna; University Hospital Vienna; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Cyran, CC (corresponding author), Univ Munich, Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, Marchioninistr 15, D-81377 Munich, Germany.	Clemens.Cyran@med.lmu.de	Rominger, Axel/K-5891-2019; Ingrisch, Michael/T-3408-2017; Hacker, Marcus/GRJ-2825-2022; Fendler, Wolfgang/AAH-1611-2021	Ingrisch, Michael/0000-0003-0268-9078; Fendler, Wolfgang/0000-0002-5106-3584; Rominger, Axel/0000-0002-1954-736X	Bayer Healthcare; German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 [01EX1021X]	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4(Federal Ministry of Education & Research (BMBF))	This study was supported by a research grant (research material only) of Bayer Healthcare (www.bayer.com) and by the German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 (www.m4.de; Grant No. 01EX1021X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Aragon-Ching JB, 2009, BJU INT, V103, P1636, DOI 10.1111/j.1464-410X.2008.08327.x; Atkin G, 2006, BRIT J SURG, V93, P992, DOI 10.1002/bjs.5352; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Blumenschein GR, 2009, J CLIN ONCOL, V27, P4274, DOI 10.1200/JCO.2009.22.0541; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Calcagno C, 2013, EUR J NUCL MED MOL I, V40, P1884, DOI 10.1007/s00259-013-2518-4; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cyran CC, 2008, J MAGN RESON IMAGING, V27, P581, DOI 10.1002/jmri.21245; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Cyran CC, 2012, AM J ROENTGENOL, V198, P384, DOI 10.2214/AJR.11.6951; Daldrup-Link HE, 2006, CURR PHARM DESIGN, V12, P2661, DOI 10.2174/138161206777698774; De Visschere P, 2010, JBR-BTR, V93, P62, DOI 10.5334/jbr-btr.121; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Fan XB, 2004, MAGNET RESON MED, V51, P487, DOI 10.1002/mrm.10737; Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Gatidis S, 2013, RADIOLOGE, V53, P669, DOI 10.1007/s00117-013-2496-3; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Holubec L, 2012, ANTICANCER RES, V32, P4007; Huellner MW, 2012, CANCER IMAGING, V12, P212, DOI 10.1102/1470-7330.2012.0021; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Kiessling F, 2004, NEOPLASIA, V6, P213, DOI 10.1593/neo.03394; Komatsu Yoshito, 2014, Nihon Rinsho, V72, P120; Kristian A, 2013, ACTA ONCOL, V52, P1566, DOI 10.3109/0284186X.2013.813634; Kwee RM, 2014, WORLD J GASTROENTERO, V20, P1650, DOI 10.3748/wjg.v20.i7.1650; Lam ET, 2010, J CLIN ONCOL, V28, P2323, DOI 10.1200/JCO.2009.25.0068; Marques I, 2013, WORLD J GASTROENTERO, V19, P7955, DOI 10.3748/wjg.v19.i44.7955; Meier R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094972; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Miles KA, 2010, CLIN RADIOL, V65, P549, DOI 10.1016/j.crad.2010.04.007; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Ng TSC, 2012, J NUCL MED, V53, P1102, DOI 10.2967/jnumed.111.099861; Nikolaou K, 2012, RADIOLOGE, V52, P252, DOI 10.1007/s00117-011-2194-y; Padhani Anwar R, 2004, Top Magn Reson Imaging, V15, P41, DOI 10.1097/00002142-200402000-00005; Preda A, 2005, INVEST RADIOL, V40, P349, DOI 10.1097/01.rli.0000163740.40474.48; Pujol JL, 2007, J CLIN ONCOL, V25, P3945, DOI 10.1200/JCO.2007.11.8109; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Smeets Peter, 2009, Surg Technol Int, V18, P93; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Song T, 2009, MAGN RESON MED, V61, P1242, DOI 10.1002/mrm.21901; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Sterzik A, 2014, ACTA RADIOL; Vriens Dennis, 2011, Clin Colorectal Cancer, V10, pE1, DOI 10.3816/CCC.2011.n.010; Weber WA, 2006, EUR J NUCL MED MOL I, V33, pS27, DOI 10.1007/s00259-006-0133-3; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Zagouri F, 2012, GYNECOL ONCOL, V127, P662, DOI 10.1016/j.ygyno.2012.08.040	49	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0115543	10.1371/journal.pone.0115543	http://dx.doi.org/10.1371/journal.pone.0115543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668193	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000003
J	Roesch, SL; Styer, AM; Wood, GC; Kosak, Z; Seiler, J; Benotti, P; Petrick, AT; Gabrielsen, J; Strodel, WE; Gerhard, GS; Still, CD; Argyropoulos, G				Roesch, Stephen L.; Styer, Amanda M.; Wood, G. Craig; Kosak, Zachary; Seiler, Jamie; Benotti, Peter; Petrick, Anthony T.; Gabrielsen, Jon; Strodel, William E.; Gerhard, Glenn S.; Still, Christopher D.; Argyropoulos, George			Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes	PLOS ONE			English	Article							BILE-ACIDS; EXPRESSION; REMISSION	Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each other or whether the associated hepatic signaling mechanisms that play a role in glucose metabolism are dysregulated in diabetes. We used a cross-sectional, case/control, experimental design involving Class III obese patients undergoing Roux-en-Y bariatric surgery (RYGB), and measured FGF19 and FGF21 serum levels and hepatic gene expression (mRNA) in perioperative liver wedge biopsies. We found that T2D patients had lower FGF19 and higher FGF21 serum levels. The latter was corroborated transcriptionally, whereby, FGF21, as well as CYP7A1, beta-Klotho, FGFR4, HNF4 alpha, and glycogen synthase, but not of SHP or FXR mRNA levels in liver biopsies were higher in T2D patients that did not remit diabetes after RYGB surgery, compared to T2D patients that remitted diabetes after RYGB surgery or did not have diabetes. In a Phenome-wide association analysis using 205 clinical variables, higher FGF21 serum levels were associated with higher glucose levels and various cardiometabolic disease phenotypes. When serum levels of FGF19 were < 200 mg/mL and FGF21 > 500 mg/mL, 91% of patients had diabetes. These data suggest that FGF19/FGF21 circulating levels and hepatic gene expression of the associated signaling pathway are significantly dysregulated in type 2 diabetes.	[Roesch, Stephen L.; Styer, Amanda M.; Wood, G. Craig; Kosak, Zachary; Seiler, Jamie; Benotti, Peter; Gerhard, Glenn S.; Still, Christopher D.; Argyropoulos, George] Geisinger Hlth Syst, Inst Obes, Danville, PA 17822 USA; [Petrick, Anthony T.; Gabrielsen, Jon; Strodel, William E.] Geisinger Hlth Syst, Dept Surg, Danville, PA USA; [Gerhard, Glenn S.] Penn State Univ, Dept Biochem & Mol Biol, Hershey, PA USA; [Gerhard, Glenn S.] Penn State Univ, Dept Pathol & Lab Med, Hershey, PA USA	Geisinger Health System; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Argyropoulos, G (corresponding author), Geisinger Hlth Syst, Inst Obes, Danville, PA 17822 USA.	gargyropoulos1@geisinger.edu			Geisinger Health System; National Institute of Health [DK072488, DK088231, DK091601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091601, R01DK088231, P30DK072488] Funding Source: NIH RePORTER	Geisinger Health System; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by research funds from the Geisinger Health System and the National Institute of Health grants DK072488 (GSG, CDS, GA) and DK088231 (GSG) and DK091601 (GSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cicione C, 2012, HEPATOLOGY, V56, P2404, DOI 10.1002/hep.25929; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gallego-Escuredo JM, 2014, INT J OBES LOND; Gerhard GS, 2014, INT J OBESITY, V38, P371, DOI 10.1038/ijo.2013.152; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jansen PLM, 2011, DIGEST DIS, V29, P48, DOI 10.1159/000324128; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; LIPS MA, 2014, CLIN ENDOCRINOL OXF, P87044; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Still CD, 2014, LANCET DIABETES ENDO, V2, P38, DOI 10.1016/S2213-8587(13)70070-6; Stutz AM, 2007, OBESITY, V15, P607, DOI 10.1038/oby.2007.564; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wood GC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-45; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	25	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116928	10.1371/journal.pone.0116928	http://dx.doi.org/10.1371/journal.pone.0116928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664662	gold, Green Published, Green Submitted			2022-12-26	WOS:000349123100015
J	Hakuno, D; Hamba, Y; Toya, T; Adachi, T				Hakuno, Daihiko; Hamba, Yasuhito; Toya, Takumi; Adachi, Takeshi			Plasma Amino Acid Profiling Identifies Specific Amino Acid Associations with Cardiovascular Function in Patients with Systolic Heart Failure	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; RISK; EXERCISE; SURVIVAL; DISEASE; STRESS	Background The heart has close interactions with other organs' functions and concomitant systemic factors such as oxidative stress, nitric oxide (NO), inflammation, and nutrition in systolic heart failure (HF). Recently, plasma amino acid (AA) profiling as a systemic metabolic indicator has attracted considerable attention in predicting the future risk of human cardiometabolic diseases, but it has been scarcely studied in HF. Methods Thirty-eight stable but greater than New York Heart Association class II symptomatic patients with left ventricular (LV) ejection fraction <45% and 33 asymptomatic individuals with normal B-type natriuretic peptide (BNP) value were registered as the HF and control groups, respectively. We analyzed fasting plasma concentrations of 41 AAs using high-performance liquid chromatography, serum NO metabolite concentration, hydroperoxide and high-sensitivity C-reactive protein measurements, echocardiography, and flow-mediated dilatation. Results We found that 17 AAs and two ratios significantly changed in the HF group compared with those in the control group (p < 0.05). In the HF group, subsequent univariate and stepwise multivariate analyses with clinical variables revealed that Fischer ratio and five specific AAs, ie, monoethanolamine, methionine, tyrosine, 1-methylhistidine, and histidine have significant correlation with BNP, LV ejection fraction, LV end-diastolic volume index, inferior vena cava diameter, the ratio of early diastolic velocity of the mitral inflow to mitral annulus, and BNP, respectively (p < 0.05). Interestingly, further exploratory factor analysis categorized these AAs into hepatic-related (monoethanolamine, tyrosine, and Fischer ratio) and skeletal muscle-related (histidine, methionine, and 1-methylhistidine) components. Some categorized AAs showed unique correlations with concomitant factors: monoethanolamine, tyrosine, and Fischer ratio with serum NO concentration; histidine with serum albumin; and 1-methylhistidine with flow-mediated dilatation (p < 0.05). Conclusions Plasma AA profiling identified correlations of specific AAs with cardiac function and concomitant factors, highlighting the cardio-hepatic-skeletal muscle axis in patients with systolic HF.	[Hakuno, Daihiko; Toya, Takumi; Adachi, Takeshi] Natl Def Med Coll, Dept Internal Med, Div Cardiol, Tokorozawa, Saitama 359, Japan; [Hamba, Yasuhito] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Hakuno, D (corresponding author), Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan.	hakuno@kuhp.kyoto-u.ac.jp		Toya, Takumi/0000-0002-4681-2798	National Defense Medical College; Japan Heart Foundation Research Grant (Tokyo); Takeda Science Foundation (Osaka)	National Defense Medical College; Japan Heart Foundation Research Grant (Tokyo); Takeda Science Foundation (Osaka)(Takeda Science Foundation (TSF))	This work was supported by the National Defense Medical College Grants-in-Aid for Encouragement of Scientists (Saitama); Japan Heart Foundation Research Grant (Tokyo); and a grant from Takeda Science Foundation (Osaka) to D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Anker SD, 1997, EUR HEART J, V18, P259; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Diercks DB, 2012, ACAD EMERG MED, V19, P18, DOI 10.1111/j.1553-2712.2011.01239.x; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Givertz MM, 2014, CIRC-HEART FAIL, V7, P59, DOI 10.1161/CIRCHEARTFAILURE.113.000556; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Heuman DM, 2007, LIVER TRANSPLANT, V13, P30, DOI 10.1002/lt.20906; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Indik JH, 2001, AM J PHYSIOL-HEART C, V281, pH1767, DOI 10.1152/ajpheart.2001.281.4.H1767; Kalantar-Zadeh K, 2008, AM J CARDIOL, V101, p89E, DOI 10.1016/j.amjcard.2008.03.007; Kim MS, 2013, J AM COLL CARDIOL, V61, P2253, DOI 10.1016/j.jacc.2012.12.056; Lin D, 2011, J CARD FAIL, V17, P867, DOI 10.1016/j.cardfail.2011.07.001; Melenovsky V, 2013, J AM COLL CARDIOL, V62, P1660, DOI 10.1016/j.jacc.2013.06.046; Okita K, 2013, CIRC J, V77, P293, DOI 10.1253/circj.CJ-12-1235; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Pitkanen HT, 2003, MED SCI SPORT EXER, V35, P784, DOI 10.1249/01.MSS.0000064934.51751.F9; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Samsky MD, 2013, J AM COLL CARDIOL, V61, P2397, DOI 10.1016/j.jacc.2013.03.042; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Vesali RF, 2004, METABOLISM, V53, P1076, DOI 10.1016/j.metabol.2004.02.017; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076538	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117325	10.1371/journal.pone.0117325	http://dx.doi.org/10.1371/journal.pone.0117325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658112	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900133
J	Lutken, SC; Frokiaer, J; Nielsen, S				Lutken, Sophie Constantin; Frokiaer, Jorgen; Nielsen, Soren			AVP-Induced Increase in AQP2 and p-AQP2 Is Blunted in Heart Failure during Cardiac Remodeling and Is Associated with Decreased AT1R Abundance in Rat Kidney	PLOS ONE			English	Article							MEDULLARY COLLECTING DUCT; AQUAPORIN-2 WATER CHANNEL; RENIN-ANGIOTENSIN SYSTEM; HYPERTONICITY-INDUCED AQUAPORIN-1; INDUCED NEPHROTIC SYNDROME; THICK ASCENDING LIMB; LIVER-CIRRHOSIS; ARGININE-VASOPRESSIN; (PRO)RENIN RECEPTOR; CARDIOMYOPATHIC HAMSTERS	Aim The objective was to examine the renal effects of long-term increased angiotensin II and vasopressin plasma levels in early-stage heart failure (HF). We investigated the regulations of the V2 vasopressin receptor, the type 1A angiotensin II receptor, the (pro) renin receptor, and the water channels AQP2, AQP1, AQP3, and AQP4 in the inner medulla of rat kidney. Methods HF was induced by coronary artery ligation. Sixty-eight rats were allocated to six groups: Sham (N = 11), HF (N = 11), sodium restricted sham (N = 11), sodiumrestricted HF (N = 11), sodium restricted sham + DDAVP (N = 12), and sodium restricted HF + DDAVP (N = 12). 1-desamino-8-D-arginine vasopressin (0.5 ng h-1 for 7 days) or vehicle was administered. Pre-and post-treatment echocardiographic evaluation was performed. The rats were sacrificed at day 17 after surgery, before cardiac remodeling in rat is known to be completed. Results HF rats on standard sodium diet and sodium restriction displayed biochemical markers of HF. These rats developed hyponatremia, hypo-osmolality, and decreased fractional excretion of sodium. Increase of AQP2 and p(Ser256)-AQP2 abundance in all HF groups was blunted compared with control groups even when infused with DDAVP and despite increased vasopressin V2 receptor and Gs alpha abundance. This was associated with decreased protein abundance of the AT1A receptor in HF groups vs. controls. Conclusion Early-stage HF is associated with blunted increase in AQP2 and p(Ser256)-AQP2 despite of hyponatremia, hypo-osmolality, and increased inner medullary vasopressin V2 receptor expression. Decreased type 1A angiotensin II receptor abundance likely plays a role in the transduction of these effects.	[Lutken, Sophie Constantin; Nielsen, Soren] Univ Aarhus, Dept Biomed Anat, DK-8000 Aarhus C, Denmark; [Lutken, Sophie Constantin; Frokiaer, Jorgen] Aarhus Univ Hosp, Inst Clin Med, DK-8200 Aarhus N, Denmark; [Nielsen, Soren] Aalborg Univ, Dept Hlth Sci & Technol, DK-9220 Aalborg O, Denmark	Aarhus University; Aarhus University; Aalborg University	Lutken, SC (corresponding author), Univ Aarhus, Dept Biomed Anat, DK-8000 Aarhus C, Denmark.	sche@ana.au.dk			Karen Elise Jensen Foundation; Aase and Ejnar Danielsen Foundation; Danish Heart Foundation; Carl and Ellen Hertz Foundation; A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion; Human Frontier Science Program; European Commission [QRLT 2000 00778, QRLT 2000 00987]; intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health	Karen Elise Jensen Foundation; Aase and Ejnar Danielsen Foundation; Danish Heart Foundation; Carl and Ellen Hertz Foundation; A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion; Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study was provided by the Karen Elise Jensen Foundation (www.kejfond.dk), Aase and Ejnar Danielsen Foundation (www.danielsensfond.dk), The Danish Heart Foundation (www.hjerteforeningen.dk), Carl and Ellen Hertz Foundation (poulroepstorff@mail.dk), The A.P. Mc-Kinney Moller Foundation for Medical Scientific Promotion (www.apmollerfonde.dk), Human Frontier Science Program, the European Commission (QRLT 2000 00778 and QRLT 2000 00987) (www.hfsp.org), and the intramural budget of the National Heart, Lung, and Blood Institute, National Institutes of Health (www.nhlbi.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that there are no restrictions on sharing of data and/or materials from any funders or organisations listed above.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Biner HL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134836; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bouby N, 1997, J AM SOC NEPHROL, V8, P1658; Brond L, 2013, AM J PHYSIOL-RENAL, V305, pF1547, DOI 10.1152/ajprenal.00461.2012; Brooks HL, 2001, J PHYSIOL-LONDON, V530, P359, DOI 10.1111/j.1469-7793.2001.0359k.x; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Christensen BM, 2003, AM J PHYSIOL-RENAL, V284, pF701, DOI 10.1152/ajprenal.00234.2002; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V270, pF623, DOI 10.1152/ajprenal.1996.270.4.F623; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fenton RA, 2009, PFLUG ARCH EUR J PHY, V458, P169, DOI 10.1007/s00424-008-0612-4; Fernandez-Llama P, 1999, J AM SOC NEPHROL, V10, P1950; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Funayama H, 2004, KIDNEY INT, V66, P1387, DOI 10.1111/j.1523-1755.2004.00902.x; Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5; GOLDBERG M, 1981, MED CLIN N AM, V65, P251, DOI 10.1016/S0025-7125(16)31523-1; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; ICHIKAWA I, 1984, CIRC RES, V55, P669, DOI 10.1161/01.RES.55.5.669; Jensen AM, 2009, AM J PHYSIOL-RENAL, V296, pF127, DOI 10.1152/ajprenal.90479.2008; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Jonassen TEN, 1998, AM J PHYSIOL-RENAL, V275, pF216, DOI 10.1152/ajprenal.1998.275.2.F216; Jonassen TEN, 2000, AM J PHYSIOL-RENAL, V279, pF1101, DOI 10.1152/ajprenal.2000.279.6.F1101; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; KIM JK, 1990, KIDNEY INT, V38, P818, DOI 10.1038/ki.1990.276; Kim SW, 2005, BIOL CELL, V97, P765, DOI 10.1042/BC20040148; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kim SW, 2001, J AM SOC NEPHROL, V12, P2019, DOI 10.1681/ASN.V12102019; Kishore BK, 1995, AM J PHYSIOL-RENAL, V269, pF863, DOI 10.1152/ajprenal.1995.269.6.F863; Klingler C, 1998, CELL SIGNAL, V10, P65, DOI 10.1016/S0898-6568(97)00077-6; Kwon TH, 2005, AM J PHYSIOL-RENAL, V288, pF673, DOI 10.1152/ajprenal.00304.2004; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Kwon TH, 2002, AM J PHYSIOL-RENAL, V283, pF1403, DOI 10.1152/ajprenal.00059.2002; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee YJ, 2007, AM J PHYSIOL-RENAL, V292, pF340, DOI 10.1152/ajprenal.00090.2006; LUK JKH, 1993, CARDIOLOGY, V83, P49, DOI 10.1159/000175947; Lutken SC, 2009, AM J PHYSIOL-RENAL, V297, pF1678, DOI 10.1152/ajprenal.00010.2009; MA TH, 1994, J BIOL CHEM, V269, P21845; MAEDA Y, 1993, AM J PHYSIOL, V265, pF15, DOI 10.1152/ajprenal.1993.265.1.F15; Marples D, 1998, AM J PHYSIOL-RENAL, V275, pF400, DOI 10.1152/ajprenal.1998.275.3.F400; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; NADLER SP, 1992, J CLIN INVEST, V90, P1458, DOI 10.1172/JCI116013; Nguyen G, 2006, KIDNEY INT, V69, P1503, DOI 10.1038/sj.ki.5000265; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Nielsen J, 2003, AM J PHYSIOL-RENAL, V285, pF1198, DOI 10.1152/ajprenal.00118.2003; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; O'Neill H, 2008, NEPHROL DIAL TRANSPL, V23, P1546, DOI 10.1093/ndt/gfm814; Oren RM, 2005, AM J CARDIOL, V95, p2B; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pedersen RS, 2003, KIDNEY INT, V63, P1417, DOI 10.1046/j.1523-1755.2003.00858.x; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; POGGIOLI J, 1992, AM J PHYSIOL, V263, pC750, DOI 10.1152/ajpcell.1992.263.4.C750; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Qin YW, 2012, INVEST OPHTH VIS SCI, V53, P3047, DOI 10.1167/iovs.11-9154; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; SANDS JM, 1987, AM J PHYSIOL, V253, pF823, DOI 10.1152/ajprenal.1987.253.5.F823; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao WJ, 2013, AM J PHYSIOL-RENAL, V304, pF505, DOI 10.1152/ajprenal.00587.2012; Staahltoft D, 2002, AM J PHYSIOL-RENAL, V282, pF307, DOI 10.1152/ajprenal.00132.2001; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Stegbauer J, 2011, J AM SOC NEPHROL, V22, P2237, DOI 10.1681/ASN.2010101095; Takahashi K, 2010, J NEUROENDOCRINOL, V22, P453, DOI 10.1111/j.1365-2826.2010.01980.x; Takahashi K, 2013, ACTA HISTOCHEM CYTOC, V46, P47, DOI 10.1267/ahc.12030; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Torp M, 2007, ACTA PHYSIOL, V190, P339, DOI 10.1111/j.1748-1716.2007.01722.x; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Umenishi F, 2005, J AM SOC NEPHROL, V16, P600, DOI 10.1681/ASN.2004030241; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; van Balkom BWM, 2003, J BIOL CHEM, V278, P1101, DOI 10.1074/jbc.M207339200; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Van Hoek AN, 2009, AM J PHYSIOL-RENAL, V296, pF1396, DOI 10.1152/ajprenal.00018.2009; Veeraveedu PT, 2007, BIOCHEM PHARMACOL, V74, P1466, DOI 10.1016/j.bcp.2007.07.027; Wasmeier GH, 2007, CORONARY ARTERY DIS, V18, P283, DOI 10.1097/MCA.0b013e3280d5a7e3; Wong NLM, 2002, METABOLISM, V51, P970, DOI 10.1053/meta.2002.34015; WYATT HL, 1980, AM HEART J, V100, P821, DOI 10.1016/0002-8703(80)90062-9; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yamazaki T, 1999, AM J CARDIOL, V83, p53H; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yu CM, 2004, J MOL CELL CARDIOL, V36, P445, DOI 10.1016/j.yjmcc.2004.01.002; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	96	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116501	10.1371/journal.pone.0116501	http://dx.doi.org/10.1371/journal.pone.0116501			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658446	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900045
J	Ndlovu, T; Le Roux, M; Khan, W; Khan, S				Ndlovu, Thando; Le Roux, Marcellous; Khan, Wesaal; Khan, Sehaam			Co-Detection of Virulent Escherichia coli Genes in Surface Water Sources	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MULTIPLEX PCR; RAPID DETECTION; SOUTH-AFRICA; WESTERN-CAPE; ASSAY; IDENTIFICATION; SEQUENCE; STRAINS	McNemar's test and the Pearson Chi-square were used to assess the co-detection and observed frequency, respectively, for potentially virulent E. coli genes in river water. Conventional multiplex Polymerase Chain Reaction (PCR) assays confirmed the presence of the aggR gene (69%), ipaH gene (23%) and the stx gene (15%) carried by Enteroaggregative E. coli (EAEC), Enteroinvasive E. coli (EIEC) and Enterohermorrhagic E. coli (EHEC), respectively, in river water samples collected from the Berg River (Paarl, South Africa). Only the aggR gene was present in 23% of samples collected from the Plankenburg River system (Stellenbosch, South Africa). In a comparative study, real-time multiplex PCR assays confirmed the presence of aggR (EAEC) in 69%, stx (EHEC) in 15%, ipaH (EIEC) in 31% and eae (EPEC) in 8% of the river water samples collected from the Berg River. In the Plankenburg River, aggR (EAEC) was detected in 46% of the samples, while eae (EPEC) was present in 15% of the water samples analyzed using real-time multiplex PCR in the Plankenburg River. Pearson Chi-square showed that there was no statistical difference (p > 0.05) between the conventional and real-time multiplex PCRs for the detection of virulent E. coli genes in water samples. However, the McNemar's test showed some variation in the co-detection of virulent E. coli genes, for example, there was no statistical difference in the misclassification of the discordant results for stx versus ipaH, which implies that the ipaH gene was frequently detected with the stx gene. This study thus highlights the presence of virulent E. coli genes in river water and while early detection is crucial, quantitative microbial risk analysis has to be performed to identify and estimate the risk to human health.	[Ndlovu, Thando; Le Roux, Marcellous; Khan, Sehaam] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, ZA-7535 Bellville, South Africa; [Khan, Wesaal] Univ Stellenbosch, Fac Sci, Dept Microbiol, ZA-7602 Stellenbosch, South Africa	Cape Peninsula University of Technology; Stellenbosch University	Khan, S (corresponding author), Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, POB 1906, ZA-7535 Bellville, South Africa.	khans@cput.ac.za	Ndlovu, Thando/L-3694-2018	Ndlovu, Thando/0000-0002-5624-8975; Khan, Sehaam/0000-0002-6030-6058	National Research Foundation; Cape Peninsula University of Technology	National Research Foundation; Cape Peninsula University of Technology	The authors would like to thank the National Research Foundation and Cape Peninsula University of Technology for financial support.	Ackermann A, 2010, THESIS U STELLENBOSC; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1997, B DEP MED SCI; Aranda KRS, 2007, FEMS MICROBIOL LETT, V267, P145, DOI 10.1111/j.1574-6968.2006.00580.x; Barnes JM, 2003, THESIS U STELLENBOSC; Ken BTT, 2007, J MED MICROBIOL, V56, P1086, DOI 10.1099/jmm.0.47093-0; Buckalew DW, 2006, J ENVIRON MANAGE, V80, P191, DOI 10.1016/j.jenvman.2005.08.024; BURGART LJ, 1992, MODERN PATHOL, V5, P320; Department of Water Affairs and Forestry, 1996, BACT GUID S AFR WAT, V1-8; Doughari HJ, 2012, J MICROBIOL BIOTECHN, V22, P25, DOI 10.4014/jmb.1107.07029; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; European Centre for Disease Prevention and Control, 2011, SHIG TOX VER PROD ES; Gemmell ME., 2010, CURRENT RES, P1190; Gizinger DG, 2003, EXP HEMATOL, V30, P503; Gomez-Duarte OG, 2010, FOODBORNE PATHOG DIS, V7, P199, DOI 10.1089/fpd.2009.0355; Hsu BM, 2010, WATER RES, V44, P949, DOI 10.1016/j.watres.2009.10.004; Hsu WB, 2007, FEMS MICROBIOL LETT, V270, P291, DOI 10.1111/j.1574-6968.2007.00686.x; Hunter Paul R., 2003, Journal of Water and Health, V1, P65; Kong RYC, 1999, MAR POLLUT BULL, V38, P1207, DOI 10.1016/S0025-326X(99)00164-2; Lorusso V, 2011, J FOOD PROTECT, V74, P13, DOI 10.4315/0362-028X.JFP-10-201; Lu YQ, 2010, COMMUN STAT-THEOR M, V39, P3525, DOI 10.1080/03610920903289218; Mgese S, 2010, THESIS U CAPE TOWN; O'Sullivan J, 2007, METHODS DETECTION MO, P6; Omar KB, 2010, WATER SA, V36, P172; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Paulse AN, 2007, WATER SA, V33, P165; Paulse AN, 2009, WATER SA, V35, P469; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Phantouamath B, 2003, JPN J INFECT DIS, V56, P103; Reischl U, 2004, J CLIN MICROBIOL, V42, P4092, DOI 10.1128/JCM.42.9.4092-4100.2004; Salem Imen Ben, 2011, BMC Res Notes, V4, P144, DOI 10.1186/1756-0500-4-144; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Sidhu JPS, 2013, APPL ENVIRON MICROB, V79, P328, DOI 10.1128/AEM.02888-12; Sooka A., 2004, Southern African Journal of Epidemiology & Infection, V19, P23; Tobias J, 2012, MICROBIOL RES, V167, P564, DOI 10.1016/j.micres.2011.11.006; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Watterworth L, 2005, J MICROBIOL METH, V60, P93, DOI 10.1016/j.mimet.2004.08.016; Weggerhof FO, 1987, THESIS U WITWATERSRA; Wiley JM, 2014, PRESCOTTS MICROBIOLO, P920, DOI [10.1152/jn.00982.2014, DOI 10.1152/JN.00982.2014]; Yamasaki S, 1996, MICROBIOL IMMUNOL, V40, P345, DOI 10.1111/j.1348-0421.1996.tb01078.x	42	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116808	10.1371/journal.pone.0116808	http://dx.doi.org/10.1371/journal.pone.0116808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659126	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900069
J	Prykhodko, O; Pierzynowski, SG; Nikpey, E; Sureda, EA; Fedkiv, O; Westrom, BR				Prykhodko, Olena; Pierzynowski, Stefan G.; Nikpey, Elham; Sureda, Ester Arevalo; Fedkiv, Olexandr; Westrom, Bjorn R.			Pancreatic and Pancreatic-Like Microbial Proteases Accelerate Gut Maturation in Neonatal Rats	PLOS ONE			English	Article							SUCKLING RATS; GASTROINTESTINAL-TRACT; POSTNATAL-DEVELOPMENT; SMALL-INTESTINE; YOUNG; TRYPSIN; TRANSMISSION; INHIBITORS; DIGESTION; RECEPTOR	Objectives Postnatal gut maturation in neonatal mammals, either at natural weaning or after precocious inducement, is coinciding with enhanced enzymes production by exocrine pancreas. Since the involvement of enzymes in gut functional maturation was overlooked, the present study aimed to investigate the role of enzymes in gut functional maturation using neonatal rats. Methods Suckling rats (Rattus norvegicus) were instagastrically gavaged with porcine pancreatic enzymes (Creon), microbial-derived amylase, protease, lipase and mixture thereof, while controls received a-lactalbumin or water once per day during 14-16 d of age. At 17 d of age the animals were euthanized and visceral organs were dissected, weighed and analyzed for structural and functional properties. For some of the rats, gavage with the macromolecular markers such as bovine serum albumin and bovine IgG was performed 3 hours prior to blood collection to assess the intestinal permeability. Results Gavage with the pancreatic or pancreatic-like enzymes resulted in stimulated gut growth, increased gastric acid secretion and switched intestinal disaccharidases, with decreased lactase and increased maltase and sucrase activities. The fetal-type vacuolated enterocytes were replaced by the adult-type in the distal intestine, and macromolecular transfer to the blood was declined. Enzyme exposure also promoted pancreas growth with increased amylase and trypsin production. These effects were confined to the proteases in a dose-dependent manner. Conclusion Feeding exogenous enzymes, containing proteases, induced precocious gut maturation in suckling rats. This suggests that luminal exposure to proteases by oral loading or, possibly, via enhanced pancreatic secretion involves in the gut maturation of young mammals.	[Prykhodko, Olena; Pierzynowski, Stefan G.; Nikpey, Elham; Sureda, Ester Arevalo; Fedkiv, Olexandr; Westrom, Bjorn R.] Lund Univ, Dept Biol, Lund, Sweden; [Pierzynowski, Stefan G.] Inst Rural Hlth, Dept Med Biol, Lublin, Poland	Lund University; Institute of Rural Health in Lublin, Poland	Prykhodko, O (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Olena.Prykhodko@biol.lu.se	Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Prykhodko, Olena/D-4224-2014; Weström, Björn R/N-2232-2016; Sureda, Ester Arévalo/AAN-2171-2020	Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Prykhodko, Olena/0000-0002-5788-9176; Weström, Björn R/0000-0001-9296-2845; Sureda, Ester Arévalo/0000-0002-3299-1510	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [229-2010-1674]; Royal Physiographic Society of Lund; Albert Pahlsson's Foundation	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Royal Physiographic Society of Lund; Albert Pahlsson's Foundation	This work was funded through Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, no 229-2010-1674), the Royal Physiographic Society of Lund (www.fysiografen.se) and Director Albert Pahlsson's Foundation (www.pahlssonsstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbemafle BM, 2005, AM J PHYSIOL-GASTR L, V288, pG897, DOI 10.1152/ajpgi.00454.2004; ALTMANN GG, 1971, AM J ANAT, V132, P167, DOI 10.1002/aja.1001320204; ALTMANN GG, 1970, AM J ANAT, V127, P15, DOI 10.1002/aja.1001270104; Baintner K, 2002, BIOL GROW ANIM, V1, P55, DOI 10.1016/S1877-1823(09)70118-3; Cranwell P. D., 1995, P99; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; FRITZ H, 1966, H-S Z PHYSIOL CHEM, V345, P150, DOI 10.1515/bchm2.1966.345.1.150; HARADA E, 1991, COMP BIOCHEM PHYS A, V100, P467, DOI 10.1016/0300-9629(91)90501-3; HARADA E, 1992, AM J PHYSIOL, V263, pR996, DOI 10.1152/ajpregu.1992.263.5.R996; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HENNING SJ, 1979, ENVIRON HEALTH PERSP, V33, P9, DOI 10.2307/3429067; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; KISFALVI K, 1993, J DEV PHYSIOL, V19, P149; KLEIN RM, 1983, J PEDIATR GASTR NUTR, V2, P204, DOI 10.1097/00005176-198305000-00002; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; Linderoth A, 2006, BRIT J NUTR, V95, P105, DOI 10.1079/BJN20051612; Linderoth A, 2005, J PEDIATR GASTR NUTR, V41, P195, DOI 10.1097/01.mpg.0000172262.05297.98; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Peulen O, 2000, LIVEST PROD SCI, V66, P109, DOI 10.1016/S0301-6226(00)00218-9; PIERZYNOWSKI SG, 1993, J PEDIATR GASTR NUTR, V16, P287, DOI 10.1097/00005176-199304000-00012; PIERZYNOWSKI SG, 1990, J PEDIATR GASTR NUTR, V10, P206, DOI 10.1097/00005176-199002000-00011; Rakhimov K R, 2002, Zh Evol Biokhim Fiziol, V38, P142; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Slupecka M, 2012, J ANIM SCI, V90, P311, DOI [10.2527/jas.53921, 10.2527/jas53921]; TELEMO E, 1987, BIOL NEONATE, V52, P141, DOI 10.1159/000242703; Walthall K, 2005, BIRTH DEFECTS RES B, V74, P132, DOI 10.1002/bdrb.20040; WESTROM BR, 1985, BIOL NEONATE, V47, P359, DOI 10.1159/000242140; WILSON JM, 1991, J CELL SCI, V100, P133	30	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116947	10.1371/journal.pone.0116947	http://dx.doi.org/10.1371/journal.pone.0116947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658606	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900082
J	Xu, JL; Zhao, QZ; Wei, L; Yang, Y; Xu, R; Yu, NJ; Zhao, YM				Xu, Jinlong; Zhao, Qizhi; Wei, Lei; Yang, Yu; Xu, Rui; Yu, Nengjiang; Zhao, Yimin			Phytochemical Composition and Antinociceptive Activity of Bauhinia glauca subsp hupehana in Rats	PLOS ONE			English	Article							ACUTE TOXICITY; EXTRACTS; PAIN	In traditional medicine, Bauhinia glauca subsp. hupehana has long been used as an analgesic agent in China. The aim of this study was to evaluate the antinociceptive activity of the ethanol extract of the aerial parts of Bauhinia glauca subsp. hupehana (BHE) in rats and its chemical fingerprint. The antinociceptive activity of BHE was assessed in mice using chemically and heat-induced pain models, such as the acetic acid-induced writhing, hot plate, tail-flick and glutamate tests. Naltrexone hydrochloride, a non-selective opioid receptor antagonist, was utilized to determine the involvement of the opioid system. In addition to this, the involvements of the cGMP and ATP-sensitive K+ channel pathways were also detected using methylene blue and glibenclamide. The oral administration of BHE (at doses of 50, 100 and 200 mg/kg) produced significant and dose-related inhibitions in both the chemically and heat-induced pain models. Interestingly, in the abdominal constriction test, when the dose of BHE was increased to 800 mg/kg (p.o., n = 10), the inhibition rate was 100%. The antinociceptive mechanism may involve the cGMP pathway and ATP-sensitive K+ channel pathway. The central antinociceptive effect was not antagonized by naltrexone. One phenolic acid, one lignin and five flavonoids were isolated from BHE. The antinociceptive activity of BHE was most likely due to the presence of the flavonoids. The acute toxicity results showed that BHE was safe at a high dose (2 g/kg, p.o.). The current investigation demonstrates that Bauhinia glauca subsp. hupehana is a potential candidate for the development of novel, non-opioid, analgesic phytomedicines.	[Xu, Jinlong; Zhao, Qizhi; Wei, Lei; Yang, Yu; Xu, Rui; Yu, Nengjiang; Zhao, Yimin] Beijing Inst Pharmacol & Toxicol, Dept Nat Prod Chem, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zhao, YM (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Nat Prod Chem, Beijing, Peoples R China.	zhaoyimin1960@163.com			National Twelfth-Five Year Research Program of China; National S...T Major Special Project on Major New Drug Innovation [2012ZX09301003-001, 2013ZX09102-018]	National Twelfth-Five Year Research Program of China; National S...T Major Special Project on Major New Drug Innovation	This research was supported by National Twelfth-Five Year Research Program of China and National S...T Major Special Project on Major New Drug Innovation (No. 2012ZX09301003-001; No. 2013ZX09102-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacioglu N, 2000, LIFE SCI, V67, P1127, DOI 10.1016/S0024-3205(00)00711-6; Annegowda H. V., 2010, Asian Journal of Plant Sciences, V9, P479; Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1; BENTLEY GA, 1983, BRIT J PHARMACOL, V79, P125, DOI 10.1111/j.1476-5381.1983.tb10504.x; BRUCE RD, 1985, FUND APPL TOXICOL, V5, P151, DOI 10.1016/0272-0590(85)90059-4; Calixto JB, 2000, PHYTOTHER RES, V14, P401, DOI 10.1002/1099-1573(200009)14:6&lt;401::AID-PTR762&gt;3.0.CO;2-H; Cechinel V, 2009, PHYTOTHER RES, V23, P1347, DOI 10.1002/ptr.2756; Chen YF, 2008, PHYTOMEDICINE, V15, P427, DOI 10.1016/j.phymed.2007.09.023; Franzotti EM, 2000, J ETHNOPHARMACOL, V72, P273, DOI 10.1016/S0378-8741(00)00205-1; Garcia MD, 2004, J ETHNOPHARMACOL, V91, P69, DOI 10.1016/j.jep.2003.11.018; Khan H, 2011, PHYTOTHER RES, V25, P1024, DOI 10.1002/ptr.3369; Lawson K, 1996, PHARMACOL THERAPEUT, V70, P39, DOI 10.1016/0163-7258(96)00003-4; Lu TC, 2007, J ETHNOPHARMACOL, V113, P142, DOI 10.1016/j.jep.2007.05.024; Neugebauer V, 2001, Expert Rev Neurother, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.0.CO;2-3; Ramesh M, 1998, J ETHNOPHARMACOL, V62, P63, DOI 10.1016/S0378-8741(98)00048-8; Sanchez-Mateo CC, 2006, J ETHNOPHARMACOL, V107, P1, DOI 10.1016/j.jep.2006.01.032; Srinivasan K, 2003, PHYTOTHER RES, V17, P259, DOI 10.1002/ptr.1126; Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003; Wibool R, 2008, J ETHNOPHARMACOL, V118, P225, DOI 10.1016/j.jep.2008.04.002; Wu Z., 1995, FLORA CHINA; [颜玲娣 Yan lingdi], 2003, [药学学报, Acta Pharmaceutica Sinica], V38, P578; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	23	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117801	10.1371/journal.pone.0117801	http://dx.doi.org/10.1371/journal.pone.0117801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658740	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900227
J	Brito, JA; Denkmann, K; Pereira, IAC; Archer, M; Dahl, C				Brito, Jose A.; Denkmann, Kevin; Pereira, Ines A. C.; Archer, Margarida; Dahl, Christiane			Thiosulfate Dehydrogenase (TsdA) from Allochromatium vinosum STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THIOSULFATE OXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME COMPLEX SOXXA; C NITRITE REDUCTASE; SULFUR-OXIDATION; HEME PROTEIN; PARACOCCUS-PANTOTROPHUS; STRUCTURE REFINEMENT; STRUCTURE VALIDATION; DENSITY MODIFICATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE	Although the oxidative condensation of two thiosulfate anions to tetrathionate constitutes a well documented and significant part of the natural sulfur cycle, little is known about the enzymes catalyzing this reaction. In the purple sulfur bacterium Allochromatium vinosum, the reaction is catalyzed by the periplasmic diheme c-type cytochrome thiosulfate dehydrogenase (TsdA). Here, we report the crystal structure of the "as isolated" form of A. vinosum TsdA to 1.98 angstrom resolution and those of several redox states of the enzyme to different resolutions. The protein contains two typical class I c-type cytochrome domains wrapped around two hemes axially coordinated by His(53)/Cys(96) and His(164)/Lys(208). These domains are very similar, suggesting a gene duplication event during evolution. A ligand switch from Lys(208) to Met(209) is observed upon reduction of the enzyme. Cys(96) is an essential residue for catalysis, with the specific activity of the enzyme being completely abolished in several TsdA-Cys(96) variants. TsdA-K208N, K208G, and M209G variants were catalytically active in thiosulfate oxidation as well as in tetrathionate reduction, pointing to heme 2 as the electron exit point. In this study, we provide spectroscopic and structural evidence that the TsdA reaction cycle involves the transient presence of heme 1 in the high-spin state caused by movement of the S gamma atom of Cys(96) out of the iron coordination sphere. Based on the presented data, we draw important conclusions about the enzyme and propose a possible reaction mechanism for TsdA.	Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Denkmann, Kevin; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany	Universidade Nova de Lisboa; University of Bonn		archer@itqb.unl.pt; ChDahl@uni-bonn.de	Brito, Jose A./A-5605-2011; Pereira, Inês/C-2748-2009; Dahl, Christiane/H-4786-2019	Brito, Jose A./0000-0002-8307-2282; Pereira, Inês/0000-0003-3283-4520; Dahl, Christiane/0000-0001-8288-7546; Archer, Margarida/0000-0001-8419-5420	Deutsche Forschungsgemeinschaft [DA351/7-1]; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BBB-BQB/0684/2012, PTDC/BIA-PRO/118535/2010, PEst-OE/EQB/LA0004/2011]; German Academic Exchange Service; Conselho de Reitores das Universidades Portuguesas; BioStruct-X [1493]; FCT [SFRH/BPD/79224/2011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Conselho de Reitores das Universidades Portuguesas; BioStruct-X; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant DA351/7-1; Fundacao para a Ciencia e a Tecnologia (FCT) Grants PTDC/BBB-BQB/0684/2012, PTDC/BIA-PRO/118535/2010, and PEst-OE/EQB/LA0004/2011; the German Academic Exchange Service; Conselho de Reitores das Universidades Portuguesas; and BioStruct-X (Proposal 1493).; Recipient of FCT Fellowship SFRH/BPD/79224/2011.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bamford VA, 2002, BIOCHEM SOC T, V30, P638, DOI 10.1042/bst0300638; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; Bradley JM, 2012, J BIOL CHEM, V287, P40350, DOI 10.1074/jbc.M112.396192; Brito JA, 2014, ACTA CRYSTALLOGR F, V70, P1424, DOI 10.1107/S2053230X14019384; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, ACTA CRYSTALLOGR D, V58, P341, DOI 10.1107/S090744490102039X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; FUKUMORI Y, 1979, CURR MICROBIOL, V3, P117, DOI 10.1007/BF02602443; Girvan HM, 2007, J BIOL CHEM, V282, P564, DOI 10.1074/jbc.M607949200; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Lemberg R., 1973, CYTOCHROMES; Leys D, 2000, J BIOL CHEM, V275, P16050, DOI 10.1074/jbc.275.21.16050; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marques MC, 2013, INT J HYDROGEN ENERG, V38, P8664, DOI 10.1016/j.ijhydene.2013.04.132; Martinez SE, 1996, PROTEIN SCI, V5, P1081; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MILES CS, 1993, BIOCHIM BIOPHYS ACTA, V1202, P82, DOI 10.1016/0167-4838(93)90066-Z; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pereira I. A., 2005, ENCY INORGANIC CHEM, V5, P3360; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Rother D, 2002, BBA-PROTEINS PROTEOM, V1598, P65, DOI 10.1016/S0167-4838(02)00332-1; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1688, DOI 10.1107/S0907444903015142; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; WOOD PM, 1983, FEBS LETT, V164, P223, DOI 10.1016/0014-5793(83)80289-0; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	67	28	29	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9222	9238		10.1074/jbc.M114.623397	http://dx.doi.org/10.1074/jbc.M114.623397			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673691	Green Published, hybrid			2022-12-26	WOS:000352207100044
J	Hellmuth, S; Pohlmann, C; Brown, A; Bottger, F; Sprinzl, M; Stemmann, O				Hellmuth, Susanne; Poehlmann, Christopher; Brown, Andreas; Boettger, Franziska; Sprinzl, Mathias; Stemmann, Olaf			Positive and Negative Regulation of Vertebrate Separase by Cdk1-Cyclin B1 May Explain Why Securin Is Dispensable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; Cyclin-dependent Kinase (CDK); Cysteine Protease; Mitosis; Phosphorylation; Cdk1-Cyclin B1; Centriole Disengagement; Securin; Separase; Sister Chromatid Separation	SISTER-CHROMATID SEPARATION; CASPASE-ACTIVATED DNASE; CENTRIOLE DUPLICATION; HUMAN-CELLS; COHESIN; CLEAVAGE; PHOSPHORYLATION; INHIBITION; YEAST; OVEREXPRESSION	Background: Separase, the trigger protease of eukaryotic anaphase, remains regulated in the absence of its inhibitor, securin. Results: Cdk1-cyclin B1 triggers precipitation of separase by phosphorylation but stabilizes it by inhibitory binding. Conclusion: Only separase that is first complexed by Cdk1-cyclin B1 can later be activated by cyclin B1 degradation. Significance: These minimal requirements of separase regulation could explain the faithful execution of anaphase in the absence of securin. Sister chromatid cohesion is established during replication by entrapment of both dsDNAs within the cohesin ring complex. It is dissolved in anaphase when separase, a giant cysteine endopeptidase, cleaves the Scc1/Rad21 subunit of cohesin, thereby triggering chromosome segregation. Separase is held inactive by association with securin until this anaphase inhibitor is destroyed at the metaphase-to-anaphase transition by ubiquitin-dependent degradation. The relevant ubiquitin ligase, the anaphase-promoting complex/cyclosome, also targets cyclin B1, thereby causing inactivation of Cdk1 and mitotic exit. Although separase is essential, securin knock-out mice are surprisingly viable and fertile. Capitalizing on our previous finding that Cdk1-cyclin B1 can also bind and inhibit separase, we investigated whether this kinase might be suitable to maintain faithful timing and execution of anaphase in the absence of securin. We found that, similar to securin, Cdk1-cyclin B1 regulates separase in both a positive and negative manner. Although securin associates with nascent separase to co-translationally assist proper folding, Cdk1-cyclin B1 acts on native state separase. Upon entry into mitosis, Cdk1-cyclin B1-dependent phosphorylation of Ser-1126 renders separase prone to inactivation by aggregation/precipitation. Stable association of Cdk1-cyclin B1 with phosphorylated separase counteracts this tendency and stabilizes separase in an inhibited yet activatable state. These opposing effects are suited to prevent premature cleavage of cohesin in early mitosis while ensuring timely activation of separase by anaphase-promoting complex/cyclosome-dependent degradation of cyclin B1. Coupling sister chromatid separation with subsequent exit from mitosis by this simplified mode might have been the common scheme of mitotic control prior to the evolution of securin.	[Hellmuth, Susanne; Brown, Andreas; Boettger, Franziska; Stemmann, Olaf] Univ Bayreuth, Chair Genet, D-95440 Bayreuth, Germany; [Poehlmann, Christopher; Sprinzl, Mathias] Univ Bayreuth, Chair Biochem, D-95440 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Stemmann, O (corresponding author), Univ Bayreuth, Dept Genet, Univ Str 30, D-95440 Bayreuth, Germany.	olaf.stemmann@uni-bayreuth.de	Pöhlmann, Christopher/ABC-9093-2020	Stemmann, Olaf/0000-0003-3044-2515; Brown, Andreas/0000-0002-1249-1316; Pohlmann, Christopher/0000-0001-9797-8643	Deutsche Forschungsgemeinschaft (DFG) [STE 997/3-2, STE 997/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants STE 997/3-2 (within the priority program SPP1384) and STE 997/4-1 (to O. S.).	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Boos D, 2008, J BIOL CHEM, V283, P816, DOI 10.1074/jbc.M706748200; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hamid T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-18; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hellmuth S, 2014, EMBO J, V33, P1134, DOI 10.1002/embj.201488098; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2008, PLOS BIOL, V6, P52, DOI 10.1371/journal.pbio.0060015; Huang XX, 2009, MOL CELL BIOL, V29, P1498, DOI 10.1128/MCB.01778-08; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Jager H, 2001, GENE DEV, V15, P2572, DOI 10.1101/gad.207301; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Mukherjee M, 2014, J NEURO-ONCOL, V119, P27, DOI 10.1007/s11060-014-1458-6; Mukherjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022167; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 2002, J BIOL CHEM, V277, P3364, DOI 10.1074/jbc.M110071200; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang YR, 2007, BIOSENS BIOELECTRON, V22, P1798, DOI 10.1016/j.bios.2006.08.046; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	41	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					8002	8010		10.1074/jbc.M114.615310	http://dx.doi.org/10.1074/jbc.M114.615310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25659430	Green Published, hybrid			2022-12-26	WOS:000351613600057
J	Luu, BE; Tessier, SN; Duford, DL; Storey, KB				Luu, Bryan E.; Tessier, Shannon N.; Duford, Dianna L.; Storey, Kenneth B.			The Regulation of Troponins I, C and ANP by GATA4 and Nkx2-5 in Heart of Hibernating Thirteen-Lined Ground Squirrels, Ictidomys tridecemlineatus	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; TRANSCRIPTION FACTOR GATA-4; MYOCYTE ENHANCER FACTOR-2; METABOLIC-RATE DEPRESSION; DEPENDENT ACTIVATION; ADAPTIVE-MECHANISMS; GENE-EXPRESSION; TEMPERATURE; PHOSPHORYLATION; MUSCLE	Hibernation is an adaptive strategy used by various mammals to survive the winter under situations of low ambient temperatures and limited or no food availability. The heart of hibernating thirteen-lined ground squirrels (Ictidomys tridecemlineatus) has the remarkable ability to descend to low, near 0 degrees C temperatures without falling into cardiac arrest. We hypothesized that the transcription factors GATA4 and Nkx2-5 may play a role in cardioprotection by facilitating the expression of key downstream targets such as troponin I, troponin C, and ANP (atrial natriuretic peptide). This study measured relative changes in transcript levels, protein levels, protein post-translational modifications, and transcription factor binding over six stages: euthermic control (EC), entrance into torpor (EN), early torpor (ET), late torpor (LT), early arousal (EA), and interbout arousal (IA). We found differential regulation of GATA4 whereby transcript/protein expression, post-translational modification (phosphorylation of serine 261), and DNA binding were enhanced during the transitory phases (entrance and arousal) of hibernation. Activation of GATA4 was paired with increases in cardiac troponin I, troponin C and ANP protein levels during entrance, while increases in p-GATA4 DNA binding during early arousal was paired with decreases in troponin I and no changes in troponin C and ANP protein levels. Unlike its binding partner, the relative mRNA/protein expression and DNA binding of Nkx2-5 did not change during hibernation. This suggests that either Nkx2-5 does not play a substantial role or other regulatory mechanisms not presently studied (e.g. posttranslational modifications) are important during hibernation. The data suggest a significant role for GATA4-mediated gene transcription in the differential regulation of genes which aid cardiac-specific challenges associated with torpor-arousal.	[Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Storey, KB (corresponding author), Carleton Univ, Inst Biochem, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	kenneth_storey@carleton.ca		Luu, Bryan/0000-0002-9271-9324; Tessier, Shannon/0000-0003-2373-232X	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant [6793]; Heart and Stroke Foundation of Canada [G-14-0005874]; NSERC scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (#6793) (www.nserc-crsng.gc.ca) and a grant-in-aid from the Heart and Stroke Foundation of Canada (#G-14-0005874) (http://www.hsf.ca/research/en/grants-aid) to KBS. BEL and SNT were funded by undergraduate and postgraduate NSERC scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Alderman SL, 2012, AM J PHYSIOL-REG I, V303, pR168, DOI 10.1152/ajpregu.00127.2012; Arjamaa Olli, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P191; Armaly Z, 2013, CURR OPIN NEPHROL HY, V22, P713, DOI 10.1097/01.mnh.0000435609.35789.32; Bratincsak A, 2007, J COMP NEUROL, V505, P443, DOI 10.1002/cne.21507; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Chen YF, 2006, LIFE SCI, V79, P1357, DOI 10.1016/j.lfs.2006.03.051; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Engel PL, 2007, J BIOL CHEM, V282, P183, DOI 10.1074/jbc.M512337200; Engel PL, 2009, J MOL CELL CARDIOL, V47, P359, DOI 10.1016/j.yjmcc.2009.04.016; Fahlman A, 2000, CRYOBIOLOGY, V40, P332, DOI 10.1006/cryo.2000.2254; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gallagher JM, 2012, MOL CELL BIOL, V32, P2214, DOI 10.1128/MCB.00218-12; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Genge CE, 2013, PHYSIOL GENOMICS, V45, P866, DOI 10.1152/physiolgenomics.00074.2013; Hasan MK, 2010, GENES CELLS, V15, P439, DOI 10.1111/j.1365-2443.2010.01394.x; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Horio T, 2000, HYPERTENSION, V35, P19, DOI 10.1161/01.HYP.35.1.19; Huang RT, 2013, INT J MOL MED, V31, P1119, DOI 10.3892/ijmm.2013.1316; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Jun JH, 2013, J CELL PHYSIOL, V228, P190, DOI 10.1002/jcp.24121; Klaiman JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024464; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kuzman JA, 2005, J APPL PHYSIOL, V99, P1428, DOI 10.1152/japplphysiol.00515.2005; Li XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024787; Lien CL, 1999, DEVELOPMENT, V126, P75; LIU B, 1993, AM J PHYSIOL, V264, pR104, DOI 10.1152/ajpregu.1993.264.1.R104; Liu BY, 2012, INT SYM COMPUT INTEL, P7, DOI 10.1109/ISCID.2012.10; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; McMullen DC, 2010, J COMP PHYSIOL B, V180, P927, DOI 10.1007/s00360-010-0468-8; MORANO I, 1992, J MUSCLE RES CELL M, V13, P64, DOI 10.1007/BF01738429; Murphy AM, 1997, BIOCHEM J, V322, P393, DOI 10.1042/bj3220393; Nakipova OV, 2007, CRYOBIOLOGY, V55, P173, DOI 10.1016/j.cryobiol.2007.07.001; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shan XH, 2009, INT J CARDIOL, V134, P384, DOI 10.1016/j.ijcard.2008.03.043; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Suzuki YJ, 2004, LIFE SCI, V74, P1829, DOI 10.1016/j.lfs.2003.10.002; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tervonen V, 2001, J PHYSIOL-LONDON, V536, P199, DOI 10.1111/j.1469-7793.2001.00199.x; Tessier SN, 2012, GENE, V501, P8, DOI 10.1016/j.gene.2012.04.004; Tessier SN, 2010, MOL CELL BIOCHEM, V344, P151, DOI 10.1007/s11010-010-0538-y; Thielmann M, 2006, CIRCULATION, V114, pI448, DOI 10.1161/CIRCULATIONAHA.105.001057; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; Wang L.C.H., 1996, HDB PHYSL ENV PHYSL, P507, DOI [10.1002/CPHY.CP040122, DOI 10.1002/CPHY.CP040122]; Wang SQ, 2002, J EXP BIOL, V205, P2957; WICKLER SJ, 1991, AM J PHYSIOL, V261, pR1214, DOI 10.1152/ajpregu.1991.261.5.R1214; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; ZHOU ZQ, 1991, AM J PHYSIOL, V260, pR353, DOI 10.1152/ajpregu.1991.260.2.R353	64	15	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117747	10.1371/journal.pone.0117747	http://dx.doi.org/10.1371/journal.pone.0117747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679215	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600084
J	Niranjan, TS; Skinner, C; May, M; Turner, T; Rose, R; Stevenson, R; Schwartz, CE; Wang, T				Niranjan, Tejasvi S.; Skinner, Cindy; May, Melanie; Turner, Tychele; Rose, Rebecca; Stevenson, Roger; Schwartz, Charles E.; Wang, Tao			Affected Kindred Analysis of Human X Chromosome Exomes to Identify Novel X-Linked Intellectual Disability Genes	PLOS ONE			English	Article							FRAGILE-X; RARE VARIANTS; MUTATIONS; FRAMEWORK; CHROMATIN; AUTISM	X-linked Intellectual Disability (XLID) is a group of genetically heterogeneous disorders caused by mutations in genes on the X chromosome. Deleterious mutations in similar to 10% of X chromosome genes are implicated in causing XLID disorders in similar to 50% of known and suspected XLID families. The remaining XLID genes are expected to be rare and even private to individual families. To systematically identify these XLID genes, we sequenced the X chromosome exome (X-exome) in 56 well-established XLID families (a single affected male from 30 families and two affected males from 26 families) using an Agilent SureSelect X-exome kit and the Illumina HiSeq 2000 platform. To enrich for disease-causing mutations, we first utilized variant filters based on dbSNP, the male-restricted portions of the 1000 Genomes Project, or the Exome Variant Server datasets. However, these databases present limitations as automatic filters for enrichment of XLID genes. We therefore developed and optimized a strategy that uses a cohort of affected male kindred pairs and an additional small cohort of affected unrelated males to enrich for potentially pathological variants and to remove neutral variants. This strategy, which we refer to as Affected Kindred/Cross-Cohort Analysis, achieves a substantial enrichment for potentially pathological variants in known XLID genes compared to variant filters from public reference databases, and it has identified novel XLID candidate genes. We conclude that Affected Kindred/Cross-Cohort Analysis can effectively enrich for disease-causing genes in rare, Mendelian disorders, and that public reference databases can be used effectively, but cautiously, as automatic filters for X-linked disorders.	[Niranjan, Tejasvi S.; Turner, Tychele; Rose, Rebecca; Wang, Tao] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Niranjan, Tejasvi S.; Turner, Tychele] Johns Hopkins Univ, Predoctoral Training Program Human Genet, Sch Med, Baltimore, MD 21205 USA; [Skinner, Cindy; May, Melanie; Stevenson, Roger; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Turner, Tychele] Univ Washington, Dept Genom Sci, Seattle, WA 98195 USA; [Wang, Tao] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Greenwood Genetic Center; University of Washington; University of Washington Seattle; Johns Hopkins University	Wang, T (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	twang9@jhmi.edu	Niranjan, Tejasvi/ABD-2892-2020	Niranjan, Tejasvi/0000-0002-6458-2017; Turner, Tychele/0000-0001-8246-6477	National Institutes of Health [R01 HD056780, R01 NS073854]; South Carolina Department of Disabilities and Special Needs (SCDDSN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs (SCDDSN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health, R01 HD056780 (to TW) and R01 NS073854 (to CES and TW), and a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN; http://ddsn.sc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arvanitis DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088325; Athanasakis E, 2014, AM J MED GENET A, V164, P170, DOI 10.1002/ajmg.a.36274; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Caramins M, 2013, HUM MOL GENET, DOI [10.1093/hmg/ddt644, DOI 10.1093/HMG/DDT644]; Chung BHY, 2011, EUR J MED GENET, V54, pE516, DOI 10.1016/j.ejmg.2011.05.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edens AC, 2011, DEV MED CHILD NEUROL, V53, P463, DOI 10.1111/j.1469-8749.2010.03909.x; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gilissen C, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-12-r127, DOI 10.1186/GB-2011-12-12-R127]; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hirata H, 2013, AM J HUM GENET, V92, P681, DOI 10.1016/j.ajhg.2013.03.021; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Piton A, 2013, AM J HUM GENET, DOI [10.1016/j.ajhg.2013.10.002, DOI 10.1016/J.AJHG.2013.10.002]; Purcell S, 2007, PLINK TOOLSET WHOLEG, V81; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simmons AD, 1998, BIOCHEM BIOPH RES CO, V242, P685, DOI 10.1006/bbrc.1997.8027; Twigg SRF, 2013, HUM MOL GENET, V22, P1654, DOI 10.1093/hmg/ddt015; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409	47	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116454	10.1371/journal.pone.0116454	http://dx.doi.org/10.1371/journal.pone.0116454			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679214	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600021
J	Wang, ZM; Yang, WL; Jacob, A; Aziz, M; Wang, P				Wang, Zhimin; Yang, Weng Lang; Jacob, Asha; Aziz, Monowar; Wang, Ping			Human Ghrelin Mitigates Intestinal Injury and Mortality after Whole Body Irradiation in Rats	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SECRETAGOGUE RECEPTOR; MESENTERIC ISCHEMIA; ACYLATED PEPTIDE; HORMONE; SECRETION; SEPSIS; REPERFUSION; STOMACH; GH	Widespread use of ionizing radiation has led to the realization of the danger associated with radiation exposure. Although studies in radiation countermeasures were initiated a half century ago, an effective therapy for a radiomitigator has not been identified. Ghrelin is a gastrointestinal hormone, and administration of ghrelin is protective in animal models of injuries including radiation combined injury. To test whether ghrelin can be protective in whole body irradiaton (WBI) alone, male Sprague Dawley (SD) rats were treated with human ghrelin (20 nmol/rat) daily for 6 days starting at either 24 h or 48 h after 10 Gray (Gy) WBI and survival outcome was examined. The 10 Gy WBI produced a LD70/30 model in SD rats (30% survival in 30 days). The survival rate in rats treated with ghrelin starting at 24 h was significantly improved to 63% and when treatment was initiated at 48 h, the survival remained at 61%. At 7 days post WBI, plasma ghrelin was significantly reduced from the control value. Ghrelin treatment starting at 24 h after WBI daily for 6 days improved histological appearance of the intestine, reduced gut permeability, serum endotoxin levels and bacterial translocation to the liver by 38%, 42% and 61%, respectively at day 7 post WBI. Serum glucose and albumin were restored to near control levels with treatment. Ghrelin treatment also attenuated WBI-induced intestinal apoptosis by 62% as evidenced by TUNEL staining. The expression of anti-apoptotic cell regulator Bcl-xl was decreased by 38% in the vehicle and restored to 75% of the control with ghrelin treatment. Increased expression of intestinal CD73 and pAkt were observed with ghrelin treatment, indicating protection of the intestinal epithelium after WBI. These results indicate that human ghrelin attenuates intestinal injury and mortality after WBI. Thus, human ghrelin can be developed as a novel mitigator for radiation injury.	[Yang, Weng Lang; Jacob, Asha; Aziz, Monowar; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA; [Wang, Zhimin; Yang, Weng Lang; Jacob, Asha] TheraSource LLC, Manhasset, NY USA	Northwell Health	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R43A10696777, R33A1080536]; TheraSource LLC	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TheraSource LLC	This work was supported by the National Institutes of Health (NIH) grants R43A10696777 (W.L.Y.) and R33A1080536 (P. W.). PW is a co-founder of TheraSource LLC, and other authors (Z.W., W.L.Y., A.J.) are employed by TheraSource LLC and received salary from TheraSource LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046540; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Cowley MA, 2004, ENDOCRINOLOGY, V145, P2604, DOI 10.1210/en.2004-0346; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Hauer-Jensen Martin, 2007, Curr Opin Support Palliat Care, V1, P23, DOI 10.1097/SPC.0b013e3281108014; Higuchi S, 2008, INT J CLIN EXP PATHO, V1, P409; Khayyal MT, 2014, PHYTOMEDICINE, V21, P1390, DOI 10.1016/j.phymed.2014.04.030; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Liaudet L, 2000, SHOCK, V14, P134, DOI 10.1097/00024382-200014020-00010; MacVittie TJ, 1996, BLOOD, V87, P4129, DOI 10.1182/blood.V87.10.4129.bloodjournal87104129; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Nass R, 2000, J NEUROENDOCRINOL, V12, P1194, DOI 10.1046/j.1365-2826.2000.00586.x; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; PATCHEN ML, 1992, INT J RADIAT ONCOL, V22, P773, DOI 10.1016/0360-3016(92)90522-J; Patchen ML, 1995, EJC SUPPL, V31A, pS17; Petrovic-Djergovic D, 2012, J IMMUNOL, V188, P2387, DOI 10.4049/jimmunol.1003671; Saito T, 2006, SHOCK, V26, P620, DOI 10.1097/01.shk.0000230297.93762.a8; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Singh VK, 2012, INT J RADIAT BIOL, V88, P296, DOI 10.3109/09553002.2012.652726; SUREDA A, 1993, EXP HEMATOL, V21, P1605; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wattanasirichaigoon S, 1999, SHOCK, V12, P127, DOI 10.1097/00024382-199908000-00006; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	35	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118213	10.1371/journal.pone.0118213	http://dx.doi.org/10.1371/journal.pone.0118213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671547	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300088
J	Betzer, C; Movius, AJ; Shi, M; Gai, WP; Zhang, J; Jensen, PH				Betzer, Cristine; Movius, A. James; Shi, Min; Gai, Wei-Ping; Zhang, Jing; Jensen, Poul Henning			Identification of Synaptosomal Proteins Binding to Monomeric and Oligomeric alpha-Synuclein	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; FAMILIAL PARKINSON DISEASE; LEWY BODY DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; HUMAN BRAIN; PROTEOMICS; DEMENTIA; MUTATION; BODIES	Monomeric alpha-synuclein (alpha SN) species are abundant in nerve terminals where they are hypothesized to play a physiological role related to synaptic vesicle turn-over. In Parkinson's disease (PD) and dementia with Lewy body (DLB), alpha SN accumulates as aggregated soluble oligomers in terminals, axons and the somatodendritic compartment and insoluble filaments in Lewy inclusions and Lewy neurites. The autosomal dominant heritability associated to mutations in the alpha SN gene suggest a gain of function associated to aggregated alpha SN. We have conducted a proteomic screen to identify the alpha SN interactome in brain synaptosomes. Porcine brain synaptosomes were fractionated, solubilized in non-denaturing detergent and subjected to co-immunoprecipitation using purified recombinant human aSN monomers or oligomers as bait. The isolated alpha SN binding proteins were identified with LC-LTQ-orbitrap tandem mass spectrometry and quantified by peak area using Windows client application, Skyline Targeted Proteomic Environment. Data are available via ProteomeXchange with identifier PXD001462. To quantify the preferential binding an average fold increase was calculated by comparing binding to monomer and oligomer. We identified 10 proteins preferentially binding monomer, and 76 binding preferentially to oligomer and a group of 92 proteins not displaying any preferred conformation of alpha SN. The proteomic data were validated by immunoprecipitation in both human and porcine brain extracts using antibodies against monomer alpha SN interactors: Abl interactor 1, and myelin proteolipid protein, and oligomer interactors: glutamate decarboxylase 2, synapsin 1, glial fibrillary acidic protein, and VAMP-2. We demonstrate the existence of alpha SN conformation selective ligands and present lists of proteins, whose identity and functions will be useful for modeling normal and pathological alpha SN dependent processes.	[Betzer, Cristine; Jensen, Poul Henning] Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark; [Betzer, Cristine; Jensen, Poul Henning] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Movius, A. James; Shi, Min; Zhang, Jing] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Bedford Pk, SA 5042, Australia; [Movius, A. James; Shi, Min; Zhang, Jing] Flinders Univ S Australia, Sch Med, Ctr Neurosci, Bedford Pk, SA 5042, Australia; [Gai, Wei-Ping] Washington Sch Med, Dept Pathol, Seattle, WA USA	Aarhus University; Aarhus University; Flinders University South Australia; Flinders University South Australia; University of Washington	Jensen, PH (corresponding author), Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark.	phj@biomed.au.dk	Gai, Wei-Ping/A-3700-2008; Shi, Min/G-6165-2012	Shi, Min/0000-0002-6901-2558; Jensen, Poul Henning/0000-0002-4439-9020; Betzer, Cristine/0000-0001-5429-3548	European Community's Seventh Framework Programme (FP7) [241791]; Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA); Lundbeck Foundation	European Community's Seventh Framework Programme (FP7)(European Commission); Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241791 (MEFOPA), cordis.europa.eu/fp7/home_en.html; the Michael J. Fox Foundation with a Rapid Response Innovation Award (RRIA), www.michaeljfox.org; and The Lundbeck Foundation, www.lundbeckfonden.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Gai WP, 2003, EXP NEUROL, V181, P68, DOI 10.1016/S0014-4886(03)00004-9; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Hansson O, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt255; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hoffman-Zacharska D, 2013, PARKINSONISM RELAT D, V19, P1057, DOI 10.1016/j.parkreldis.2013.07.011; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kim SS, 2011, ARCH PHARM RES, V34, P837, DOI 10.1007/s12272-011-0518-0; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu L, 2012, J BIOL CHEM, V287, P32307, DOI 10.1074/jbc.C112.403048; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nuytemans K, 2013, NEUROLOGY, V80, P982, DOI 10.1212/WNL.0b013e31828727d4; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Otzen DE, 2005, PROTEIN SCI, V14, P1396, DOI 10.1110/ps.041285605; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Pennington K, 2010, J PROTEOME RES, V9, P2390, DOI 10.1021/pr901102d; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Sarafian TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063557; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharrad DF, 2013, J COMP NEUROL, V521, P2523, DOI 10.1002/cne.23296; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Xilouri M, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001803; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	72	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116473	10.1371/journal.pone.0116473	http://dx.doi.org/10.1371/journal.pone.0116473			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659148	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900042
J	Breslin, JW; Zhang, XE; Worthylake, RA; Souza-Smith, FM				Breslin, Jerome W.; Zhang, Xun E.; Worthylake, Rebecca A.; Souza-Smith, Flavia M.			Involvement of Local Lamellipodia in Endothelial Barrier Function	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; SPHINGOSINE 1-PHOSPHATE; STRESS FIBERS; RHO-KINASE; MYOSIN-II; IN-VIVO; MICROVASCULAR HYPERPERMEABILITY; MONOLAYER INTEGRITY; MESENTERIC VENULES; MAMMALIAN-CELLS	Recently we observed that endothelial cells cultured in tightly confluent monolayers display frequent local lamellipodia, and that thrombin, an agent that increases endothelial permeability, reduces lamellipodia protrusions. This led us to test the hypothesis that local lamellipodia contribute to endothelial barrier function. Movements of subcellular structures containing GFP-actin or VE-cadherin-GFP expressed in endothelial cells were recorded using time-lapse microscopy. Transendothelial electrical resistance (TER) served as an index of endothelial barrier function. Changes in both lamellipodia dynamics and TER were assessed during baseline and after cells were treated with either the barrier-disrupting agent thrombin, or the barrier-stabilizing agent sphingosine-1-phosphate (S1P). The myosin II inhibitor blebbistatin was used to selectively block lamellipodia formation, and was used to test their role in the barrier function of endothelial cell monolayers and isolated, perfused rat mesenteric venules. Myosin light chain (MLC) phosphorylation was assessed by immunofluorescence microscopy. Rac1 and RhoA activation were evaluated using G-LISA assays. The role of Rac1 was tested with the specific inhibitor NSC23766 or by expressing wild-type or dominant negative GFP-Rac1. The results show that thrombin rapidly decreased both TER and the lamellipodia protrusion frequency. S1P rapidly increased TER in association with increased protrusion frequency. Blebbistatin nearly abolished local lamellipodia protrusions while cortical actin fibers and stress fibers remained intact. Blebbistatin also significantly decreased TER of cultured endothelial cells and increased permeability of isolated rat mesenteric venules. Both thrombin and S1P increased MLC phosphorylation and activation of RhoA. However, thrombin and S1P had differential impacts on Rac1, correlating with the changes in TER and lamellipodia protrusion frequency. Overexpression of Rac1 elevated, while NSC23766 and dominant negative Rac1 reduced barrier function and lamellipodia activity. Combined, these data suggest that local lamellipodia, driven by myosin II and Rac1, are important for dynamic changes in endothelial barrier integrity.	[Breslin, Jerome W.; Zhang, Xun E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA; [Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol, New Orleans, LA USA; [Souza-Smith, Flavia M.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA USA	State University System of Florida; University of South Florida; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Breslin, JW (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA.	jbreslin@health.usf.edu			U.S. National Institutes of Health [R01HL098215, P20RR018766, F32AA021049]; American Heart Association [0835388N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021049] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health grants R01HL098215, P20RR018766, and F32AA021049, and American Heart Association grant 0835388N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 2010, CARDIOVASC RES, V88, P344, DOI 10.1093/cvr/cvq184; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BALDWIN AL, 1995, AM J PHYSIOL-HEART C, V269, pH1528, DOI 10.1152/ajpheart.1995.269.5.H1528; Ballestrem C, 1998, J CELL SCI, V111, P1649; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2013, MOL BIOL CELL; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Breslin JW, 2011, LYMPHAT RES BIOL, V9, P3, DOI 10.1089/lrb.2010.0016; Breslin Jerome W., 2009, Lymphatic Research and Biology, V7, P229, DOI 10.1089/lrb.2009.0015; Breslin JW, 2006, AM J PHYSIOL-HEART C, V290, pH741, DOI 10.1152/ajpheart.00238.2005; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Curry FRE, 2013, ACTA PHYSIOL, V207, P628, DOI 10.1111/apha.12076; Dejana E, 2000, INT J DEV BIOL, V44, P743; Delanoe-Ayari H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108102; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; Doggett TM, 2011, JOVE-J VIS EXP, V57, P3187, DOI [10.3791/3187, DOI 10.3791/3187]; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Duran WN, 2008, HANDBOOK OF PHYSIOLOGY: MICROCIRCULATION, 2ND EDITION, P81; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jonas O, 2010, CYTOSKELETON, V67, P555, DOI 10.1002/cm.20466; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; Minnear FL, 2005, AM J PHYSIOL-HEART C, V289, pH840, DOI 10.1152/ajpheart.00026.2005; MOY AB, 1993, J CLIN INVEST, V92, P1198, DOI 10.1172/JCI116690; Moy AB, 2002, AM J PHYSIOL-HEART C, V282, pH21, DOI 10.1152/ajpheart.2002.282.1.H21; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Spindler V, 2011, AM J PATHOL, V178, P2424, DOI 10.1016/j.ajpath.2011.01.014; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Srinivas SP, 2006, INVEST OPHTH VIS SCI, V47, P4011, DOI 10.1167/iovs.05-1127; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Walsh TG, 2011, J CELL PHYSIOL, V226, P3053, DOI 10.1002/jcp.22655; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wong RK, 1999, AM J PHYSIOL-HEART C, V276, pH736; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Yuan Y, 1997, AM J PHYSIOL-HEART C, V272, pH1437, DOI 10.1152/ajpheart.1997.272.3.H1437; YUAN Y, 1993, AM J PHYSIOL, V265, pH543, DOI 10.1152/ajpheart.1993.265.2.H543	72	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117970	10.1371/journal.pone.0117970	http://dx.doi.org/10.1371/journal.pone.0117970			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658915	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900247
J	Greenhill, AR; Tsuji, H; Ogata, K; Natsuhara, K; Morita, A; Soli, K; Larkins, JA; Tadokoro, K; Odani, S; Baba, J; Naito, Y; Tomitsuka, E; Nomoto, K; Siba, PM; Horwood, PF; Umezaki, M				Greenhill, Andrew R.; Tsuji, Hirokazu; Ogata, Kiyohito; Natsuhara, Kazumi; Morita, Ayako; Soli, Kevin; Larkins, Jo-Ann; Tadokoro, Kiyoshi; Odani, Shingo; Baba, Jun; Naito, Yuichi; Tomitsuka, Eriko; Nomoto, Koji; Siba, Peter M.; Horwood, Paul F.; Umezaki, Masahiro			Characterization of the Gut Microbiota of Papua New Guineans Using Reverse Transcription Quantitative PCR	PLOS ONE			English	Article							GROUP-SPECIFIC PRIMERS; PREDOMINANT BACTERIA; FECAL MICROBIOTA; HUMAN FECES; OBESITY; ENERGY; DIET; ENTEROTYPES; POPULATIONS; MICROFLORA	There has been considerable interest in composition of gut microbiota in recent years, leading to a better understanding of the role the gut microbiota plays in health and disease. Most studies have been limited in their geographical and socioeconomic diversity to high-income settings, and have been conducted using small sample sizes. To date, few analyses have been conducted in low-income settings, where a better understanding of the gut microbiome could lead to the greatest return in terms of health benefits. Here, we have used quantitative real-time polymerase chain reaction targeting dominant and sub-dominant groups of microorganisms associated with human gut microbiome in 115 people living a subsistence lifestyle in rural areas of Papua New Guinea. Quantification of Clostridium coccoides group, C. leptum subgroup, C. perfringens, Bacteroides fragilis group, Bifidobacterium, Atopobium cluster, Prevotella, Enterobacteriaceae, Enterococcus, Staphylococcus, and Lactobacillus spp. was conducted. Principle coordinates analysis (PCoA) revealed two dimensions with Prevotella, clostridia, Atopobium, Enterobacteriaceae, Enterococcus and Staphylococcus grouping in one dimension, while B. fragilis, Bifidobacterium and Lactobacillus grouping in the second dimension. Highland people had higher numbers of most groups of bacteria detected, and this is likely a key factor for the differences revealed by PCoA between highland and lowland study participants. Age and sex were not major determinants in microbial population composition. The study demonstrates a gut microbial composition with some similarities to those observed in other low-income settings where traditional diets are consumed, which have previously been suggested to favor energy extraction from a carbohydrate rich diet.	[Greenhill, Andrew R.; Larkins, Jo-Ann] Federat Univ, Sch Appl & Biomed Sci, Churchill, Australia; [Greenhill, Andrew R.; Soli, Kevin; Siba, Peter M.; Horwood, Paul F.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Tsuji, Hirokazu; Ogata, Kiyohito; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Natsuhara, Kazumi] Japanese Red Cross Akita Coll Nursing, Fac Nursing, Akita, Japan; [Morita, Ayako; Tadokoro, Kiyoshi; Tomitsuka, Eriko; Umezaki, Masahiro] Univ Tokyo, Dept Human Ecol, Tokyo, Japan; [Odani, Shingo] Chiba Univ, Fac Letter, Chiba, Japan; [Baba, Jun] Tokyo Univ Foreign Studies, Res Inst Languages & Cultures Asia & Africa, Tokyo, Japan; [Naito, Yuichi] Univ Tubingen, Tubingen, Germany	Federation University Australia; PNG Institute Of Medical Research; Yakult Honsha Company, Limited; University of Tokyo; Chiba University; Tokyo University of Foreign Studies; Eberhard Karls University of Tubingen	Greenhill, AR (corresponding author), Federat Univ, Sch Appl & Biomed Sci, Churchill, Australia.	andrew.greenhill@federation.edu.au	Larkins, Jo-ann/Q-9858-2019	Hirokazu, Tsuji/0000-0003-2856-6447; Horwood, Paul/0000-0001-9622-0742; Greenhill, Andrew/0000-0001-5831-8714; Larkins, Jo-ann/0000-0002-3436-9362	Funding Program for Next Generation World-Leading Researchers (NEXT program) [LS024]; Grants-in-Aid for Scientific Research [26560137, 26360004] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (NEXT program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Funding Program for Next Generation World-Leading Researchers (NEXT program): LS024 (Masahiro UMEZAKI, the University of Tokyo), http://www.jsps.go.jp/j-jisedai/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Grzeskowiak L, 2012, J PEDIATR GASTR NUTR, V54, P812, DOI 10.1097/MPG.0b013e318249039c; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mendez FL, 2012, MOL BIOL EVOL, V29, P1513, DOI 10.1093/molbev/msr301; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Morita A, 2015, AM J HUM BIOL, V27, P349, DOI 10.1002/ajhb.22647; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Natsuhara K, 1999, MAN CUL OCEANIA, V15, P91; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Serjeanston SW, 1992, HUMAN BIOL PAPUA NEW; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Temu P. I., 2001, Food security for Papua New Guinea. Proceedings of the Papua New Guinea Food and Nutrition 2000 Conference, PNG University of Technology, Lae, Papua New Guinea, 26-30 June 2000, P395; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Umezaki M, 1999, ECOL FOOD NUTR, V37, P409, DOI 10.1080/03670244.1998.9991558; Umezaki M, 2003, HUM ECOL, V31, P3, DOI 10.1023/A:1022881506510; Umezaki M, 1998, J BIOSOC SCI, V30, P411, DOI 10.1017/S0021932098004118; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu PR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-283; Yamauchi T, 2001, BRIT J NUTR, V85, P65, DOI 10.1079/BJN2000208; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	40	15	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117427	10.1371/journal.pone.0117427	http://dx.doi.org/10.1371/journal.pone.0117427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658868	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900147
J	Humphreys, AF; Tan, J; Peng, RS; Benton, SM; Qin, X; Worley, KC; Mikulski, RL; Chow, DC; Palzkill, TG; Ling, PD				Humphreys, Alan F.; Tan, Jie; Peng, RongSheng; Benton, Susan M.; Qin, Xiang; Worley, Kim C.; Mikulski, Rose L.; Chow, Dar-Chone; Palzkill, Timothy G.; Ling, Paul D.			Generation and Characterization of Antibodies against Asian Elephant (Elephas maximus) IgG, IgM, and IgA	PLOS ONE			English	Article							NEWLY RECOGNIZED DISEASE; ENDOTHELIOTROPIC HERPESVIRUS; INFECTION	Asian elephant (Elephas maximus) immunity is poorly characterized and understood. This gap in knowledge is particularly concerning as Asian elephants are an endangered species threatened by a newly discovered herpesvirus known as elephant endotheliotropic herpesvirus (EEHV), which is the leading cause of death for captive Asian elephants born after 1980 in North America. While reliable diagnostic assays have been developed to detect EEHV DNA, serological assays to evaluate elephant anti-EEHV antibody responses are lacking and will be needed for surveillance and epidemiological studies and also for evaluating potential treatments or vaccines against lethal EEHV infection. Previous studies have shown that Asian elephants produce IgG in serum, but they failed to detect IgM and IgA, further hampering development of informative serological assays for this species. To begin to address this issue, we determined the constant region genomic sequence of Asian elephant IgM and obtained some limited protein sequence information for putative serum IgA. The information was used to generate or identify specific commercial antisera reactive against IgM and IgA isotypes. In addition, we generated a monoclonal antibody against Asian elephant IgG. These three reagents were used to demonstrate that all three immunoglobulin isotypes are found in Asian elephant serum and milk and to detect antibody responses following tetanus toxoid booster vaccination or antibodies against a putative EEHV structural protein. The results indicate that these new reagents will be useful for developing sensitive and specific assays to detect and characterize elephant antibody responses for any pathogen or vaccine, including EEHV.	[Humphreys, Alan F.] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; [Tan, Jie; Peng, RongSheng; Ling, Paul D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Benton, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Qin, Xiang; Worley, Kim C.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mikulski, Rose L.; Chow, Dar-Chone; Palzkill, Timothy G.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Ling, PD (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	pling@bcm.edu		Benton, Susan/0000-0002-7694-2091; Worley, Kim/0000-0002-0282-1000	NIH [P30 CA125123]; Houston zoo; Institute of Museum and Library Services [MG-30-13-0086-13]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston zoo; Institute of Museum and Library Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for these services was provided by NIH grant P30 CA125123. Support for these studies was also provided by a grant from the Houston zoo to PDL and in part by the Institute of Museum and Library Services grant MG-30-13-0086-13.	Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Fickel J, 2001, VET MICROBIOL, V82, P103, DOI 10.1016/S0378-1135(01)00363-7; Fowler, 2011, FOWLERS ZOO WILD ANI, P496; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Guo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016889; Kania S. A., 1997, Journal of Veterinary Allergy and Clinical Immunology, V5, P125; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; Lam FW, 2013, THROMB RES, V132, P69, DOI 10.1016/j.thromres.2013.04.018; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Lindsay WA, 2010, VET IMMUNOL IMMUNOP, V133, P287, DOI 10.1016/j.vetimm.2009.08.005; Ling PD, 2008, J VIROL, V82, P8000, DOI 10.1128/JVI.02752-07; Ling PD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-13; Nofs SA, 2013, VET IMMUNOL IMMUNOP, V153, P308, DOI 10.1016/j.vetimm.2013.03.008; Pretorius A, 1997, ONDERSTEPOORT J VET, V64, P201; Reid CE, 2006, VET QUART, V28, P61, DOI 10.1080/01652176.2006.9695209; Richman LK, 2000, ZOO BIOL, V19, P383, DOI 10.1002/1098-2361(2000)19:5&lt;383::AID-ZOO8&gt;3.0.CO;2-X; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Sripiboon S, 2013, J ZOO WILDLIFE MED, V44, P100, DOI 10.1638/1042-7260-44.1.100; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Zechariah A, 2013, J WILDLIFE DIS, V49, P381, DOI 10.7589/2012-07-193	20	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116318	10.1371/journal.pone.0116318	http://dx.doi.org/10.1371/journal.pone.0116318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658336	Green Published, gold			2022-12-26	WOS:000349444900035
J	Lei, Y; Li, B; Tong, SY; Qi, L; Hu, XH; Cui, YB; Li, ZB; He, W; Zu, XB; Wang, Z; Chen, MF				Lei, Ye; Li, Bin; Tong, Shiyu; Qi, Lin; Hu, Xiheng; Cui, Yunbo; Li, Zengbo; He, Wei; Zu, Xiongbing; Wang, Zhi; Chen, Minfeng			miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-C; HEPATOCELLULAR-CARCINOMA; RADICAL CYSTECTOMY; GASTRIC-CANCER; MOLECULAR-MECHANISMS; PROSTATE-CANCER; DOWN-REGULATION; IN-VIVO; EXPRESSION	Background The microRNA miR-101 is downregulated in several cancers, including bladder cancer. However, miR-101's role in the invasion, metastasis, and chemosensitivity of bladder cancer cells remains unclear. This study was conducted to determine miR-101's role on the lymphangiogenic molecule vascular endothelial growth factor C (VEGF-C) and their effects upon bladder cancer cell migration, invasion, and chemosensitivity to cisplatin. Methods Two bladder cancer cell lines (T24 and 5637) and the tool cell line 293T were employed here. Bladder cancer cells were transfected with either a miR-101 overexpression vector or a scrambled-sequence lentivirus, both of which exhibited a high transfection efficiency. Non-transfection was used as a mock negative control. Wound healing and Transwell assays were performed to measure cell migration and invasiveness. A luciferase reporter assay was performed to validate miR-101's interaction with VEGF-C's 3' untranslated region followed by RT-PCR and Western blot confirmation. An MTS assay was used to evaluate the cisplatin sensitivity of the cell lines. Results miR-101 overexpression significantly inhibited the migration and invasiveness while significantly enhancing cisplatin sensitivity. miR-101 negatively regulated VEGF-C protein expression, and VEGF-C overexpression rescued the effects of miR-101 overexpression, indicating that miR-101 negatively regulates VEGF-C protein expression post-transcriptionally. miR-101 and VEGF-C interference independently enhanced cisplatin cytotoxicity in bladder cancer cells. Conclusions miR-101 suppresses VEGF-C expression, inhibits cell migration and invasion, and increases cisplatin sensitivity in bladder cancer cells. This study provides new insight into miR-101's role in bladder cancer and shows miR-101's promise as a potential molecular target for bladder cancer.	[Lei, Ye; Tong, Shiyu; Qi, Lin; Hu, Xiheng; He, Wei; Zu, Xiongbing; Wang, Zhi; Chen, Minfeng] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Li, Bin] Hebei Med Univ, Dept Biochem & Mol Biol, Coll Basic Med, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Hebei, Peoples R China; [Li, Zengbo] Cent S Univ, Dept Gen Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cui, Yunbo] Cent S Univ, Sch Life Sci, Changsha 410008, Hunan, Peoples R China	Central South University; Hebei Medical University; Central South University; Central South University	Chen, MF (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	chenminfeng1999@tom.com	He, Wei/GQO-8968-2022	He, Wei/0000-0001-8909-9008; Hu, Xiheng/0000-0002-0454-8060	National Nature Science Foundation for the Youth of China [81202005]; Technology Plan Fund of Hunan Science [2013FJ4109]; Central South University Innovation Fund for Independent Graduate Exploration [72150050587]	National Nature Science Foundation for the Youth of China; Technology Plan Fund of Hunan Science; Central South University Innovation Fund for Independent Graduate Exploration	This work was supported by the National Nature Science Foundation for the Youth of China (No. 81202005), the Technology Plan Fund of Hunan Science (No. 2013FJ4109), and the Central South University Innovation Fund for Independent Graduate Exploration (No. 72150050587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Canter D, 2008, BJU INT, V102, P952, DOI 10.1111/j.1464-410X.2008.07732.x; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cho HJ, 2014, INT J CANCER, V135, P1553, DOI 10.1002/ijc.28801; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Drayton RM, 2012, EXPERT REV ANTICANC, V12, P271, DOI [10.1586/era.11.201, 10.1586/ERA.11.201]; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fellmer PT, 1999, SURGERY, V126, P1056, DOI 10.1067/msy.2099.101432; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frank I, 2003, CANCER, V97, P2425, DOI 10.1002/cncr.11370; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Guo F, 2014, ONCOL REP, V31, P2021, DOI 10.3892/or.2014.3106; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; Herr HW, 2001, J CLIN ONCOL, V19, P89, DOI 10.1200/JCO.2001.19.1.89; Hu ZH, 2013, BIOCHEM BIOPH RES CO, V435, P82, DOI 10.1016/j.bbrc.2013.04.042; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1996, EMBO J, V15, P290; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Leissner J, 2003, J UROLOGY, V169, P955, DOI 10.1097/01.ju.0000043639.55877.17; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Li D, 2014, CANCER LETT, V346, P45, DOI 10.1016/j.canlet.2013.12.004; Lim JJ, 2014, NEOPLASIA, V16, P343, DOI 10.1016/j.neo.2014.04.003; Lin XJ, 2014, BIOMED REP, V2, P122, DOI 10.3892/br.2013.192; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo CL, 2013, CANCER LETT, V341, P240, DOI 10.1016/j.canlet.2013.08.021; Luo L, 2012, MED ONCOL, V29, P1681, DOI 10.1007/s12032-011-0085-8; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Rosenberg JE, 2005, J UROLOGY, V174, P14, DOI 10.1097/01.ju.0000162039.38023.5f; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Sonpavde G, 2010, LANCET ONCOL, V11, P861, DOI 10.1016/S1470-2045(10)70086-3; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Suzuki K, 2005, INT J UROL, V12, P152, DOI 10.1111/j.1442-2042.2005.01010.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tanji N, 2010, INT J CLIN ONCOL, V15, P369, DOI 10.1007/s10147-010-0069-2; Trojan L, 2006, BJU INT, V98, P903, DOI 10.1111/j.1464-410X.2006.06403.x; Tsurusaki T, 1999, BRIT J CANCER, V80, P309, DOI 10.1038/sj.bjc.6690356; Walz J, 2008, BJU INT, V101, P1356, DOI 10.1111/j.1464-410X.2008.07524.x; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Xu LB, 2014, J HEPATOL, V60, P590, DOI 10.1016/j.jhep.2013.10.028; Xu YH, 2013, ONCOL REP, V29, P2019, DOI 10.3892/or.2013.2338; Yafi Faysal A, 2009, Can Urol Assoc J, V3, pS206; Yonemura Y, 1999, CLIN CANCER RES, V5, P1823	49	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117809	10.1371/journal.pone.0117809	http://dx.doi.org/10.1371/journal.pone.0117809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658842	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900228
J	Rabes, A; Zimmermann, S; Reppe, K; Lang, R; Seeberger, PH; Suttorp, N; Witzenrath, M; Lepenies, B; Opitz, B				Rabes, Anne; Zimmermann, Stephanie; Reppe, Katrin; Lang, Roland; Seeberger, Peter H.; Suttorp, Norbert; Witzenrath, Martin; Lepenies, Bernd; Opitz, Bastian			The C-Type Lectin Receptor Mincle Binds to Streptococcus pneumoniae but Plays a Limited Role in the Anti-Pneumococcal Innate Immune Response	PLOS ONE			English	Article							ACTIVATING RECEPTOR; LIPOTEICHOIC ACID; VIRULENCE FACTORS; MARGINAL ZONE; HOST-DEFENSE; RECOGNITION; CAPSULE; CELLS; IDENTIFICATION; COLONIZATION	The innate immune system employs C-type lectin receptors (CLRs) to recognize carbohydrate structures on pathogens and self-antigens. The Macrophage-inducible C-type lectin (Mincle) is a FcR gamma-coupled CLR that was shown to bind to mycobacterial cord factor as well as certain fungal species. However, since CLR functions during bacterial infections have not yet been investigated thoroughly, we aimed to examine their function in Streptococcus pneumonia infection. Binding studies using a library of recombinantly expressed CLR-Fc fusion proteins indicated a specific, Ca2+-dependent, and serotype-specific binding of Mincle to Streptococcus pneumonia. Subsequent experiments with different Mincle-expressing cells as well as Mincle-deficient mice, however, revealed a limited role of this receptor in bacterial phagocytosis, neutrophil-mediated killing, cytokine production, and antibacterial immune response during pneumonia. Collectively, our results indicate that Mincle is able to recognize Streptococcus pneumonia but is not required for the anti-pneumococcal innate immune response.	[Rabes, Anne; Reppe, Katrin; Suttorp, Norbert; Witzenrath, Martin; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Zimmermann, Stephanie; Seeberger, Peter H.; Lepenies, Bernd] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Zimmermann, Stephanie; Lepenies, Bernd] Free Univ Berlin, Inst Chem & Biochem, Dept Biol Chem & Pharm, Berlin, Germany; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; University of Erlangen Nuremberg	Lepenies, B (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany.	bernd.lepenies@mpikg.mpg.de; bastian.opitz@charite.de	Lepenies, Bernd/C-6509-2009	Suttorp, Norbert/0000-0002-3958-1151; Lepenies, Bernd/0000-0001-9033-5522; Rabes, Anne/0000-0003-0495-5931; Lang, Roland/0000-0003-0502-3677; Opitz, Bastian/0000-0003-1276-836X	Deutsche Forschungsgemeinschaft [GRK1673/B5, OP 86/7-2, SFB/TR84, C3/6, B1, A1/A5, SFB765, B8, SFB796, B6]; IMPRS on Multiscale Bio-Systems; German Federal Ministry of Education and Research (BMBF) [Fkz. 0315446, 01ZX1304B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IMPRS on Multiscale Bio-Systems; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK1673/B5 to A.R., M.W. and B.O., OP 86/7-2 to M.W. and B.O., SFB/TR84 project C3/6 to M.W., project B1 to N.S., and project A1/A5 to B.O., SFB765 project B8 to P.H.S. and B.L., and SFB796 project B6 to R. L.). S.Z. and B.L. acknowledge funding by the IMPRS on Multiscale Bio-Systems. Funding by the German Federal Ministry of Education and Research (BMBF, Fkz. 0315446 to B.L. and 01ZX1304B to M.W.) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Balch SG, 2002, EUR J IMMUNOGENET, V29, P61, DOI 10.1046/j.1365-2370.2002.00266.x; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Eriksson M, 2014, CHEMBIOCHEM, V15, P844, DOI 10.1002/cbic.201300764; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; Hutter J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103281; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Lepenies B, 2013, ADV DRUG DELIVER REV, V65, P1271, DOI 10.1016/j.addr.2013.05.007; Maglinao M, 2014, J CONTROL RELEASE, V175, P36, DOI 10.1016/j.jconrel.2013.12.011; Maglinao M, 2013, J IMMUNOL, V191, P2551, DOI 10.4049/jimmunol.1203451; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schlegel MK, 2011, CHEMBIOCHEM, V12, P2791, DOI 10.1002/cbic.201100511; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wevers BA, 2014, CELL HOST MICROBE, V15, P494, DOI 10.1016/j.chom.2014.03.008; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yoshimura A, 1999, J IMMUNOL, V163, P1	50	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117022	10.1371/journal.pone.0117022	http://dx.doi.org/10.1371/journal.pone.0117022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658823	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900093
J	Sekandi, JN; Dobbin, K; Oloya, J; Okwera, A; Whalen, CC; Corso, PS				Sekandi, Juliet N.; Dobbin, Kevin; Oloya, James; Okwera, Alphonse; Whalen, Christopher C.; Corso, Phaedra S.			Cost-Effectiveness Analysis of Community Active Case Finding and Household Contact Investigation for Tuberculosis Case Detection in Urban Africa	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; MIDDLE-INCOME COUNTRIES; GAMMA RELEASE ASSAY; CHEST-X-RAY; PULMONARY TUBERCULOSIS; SOUTHERN ETHIOPIA; CLASSIC SYMPTOMS; CLOSE CONTACTS; STRATEGIES; KAMPALA	Introduction Case detection by passive case finding (PCF) strategy alone is inadequate for detecting all tuberculosis (TB) cases in high burden settings especially Sub-Saharan Africa. Alternative case detection strategies such as community Active Case Finding (ACF) and Household Contact Investigations (HCI) are effective but empirical evidence of their cost-effectiveness is sparse. The objective of this study was to determine whether adding ACF or HCI compared with standard PCF alone represent cost-effective alternative TB case detection strategies in urban Africa. Methods A static decision modeling framework was used to examine the costs and effectiveness of three TB case detection strategies: PCF alone, PCF+ACF, and PCF+HCI. Probability and cost estimates were obtained from National TB program data, primary studies conducted in Uganda, published literature and expert opinions. The analysis was performed from the societal and provider perspectives over a 1.5 year time-frame. The main effectiveness measure was the number of true TB cases detected and the outcome was incremental cost-effectiveness ratios (ICERs) expressed as cost in 2013 US$ per additional true TB case detected. Results Compared to PCF alone, the PCF+HCI strategy was cost-effective at US$443.62 per additional TB case detected. However, PCF+ACF was not cost-effective at US$1492.95 per additional TB case detected. Sensitivity analyses showed that PCF+ACF would be cost-effective if the prevalence of chronic cough in the population screened by ACF increased 10-fold from 4% to 40% and if the program costs for ACF were reduced by 50%. Conclusions Under our baseline assumptions, the addition of HCI to an existing PCF program presented a more cost-effective strategy than the addition of ACF in the context of an African city. Therefore, implementation of household contact investigations as a part of the recommended TB control strategy should be prioritized.	[Sekandi, Juliet N.; Dobbin, Kevin; Oloya, James; Whalen, Christopher C.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Corso, Phaedra S.] Univ Georgia, Coll Publ Hlth, Dept Hlth Policy & Management, Athens, GA 30602 USA; [Sekandi, Juliet N.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Okwera, Alphonse] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Makerere University; Makerere University	Sekandi, JN (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	Juliet.Sekandi@gmail.com	Sekandi, Juliet/AAO-4212-2020	Sekandi, Juliet/0000-0003-2430-1396	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093856] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research Partial funding support for primary data was obtained from the Operations Research on AIDS Care and Tuberculosis in Africa (ORACTA) grant, Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER VR, 1980, TUBERCLE, V61, P123, DOI 10.1016/0041-3879(80)90001-X; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; Ayles H, 2013, LANCET; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Cohen R, 1996, CHEST, V109, P420, DOI 10.1378/chest.109.2.420; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Drummond MF, 2015, METHODS EC EVALUATIO; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Gold MR, 1996, COST EFFECTIVENESS H; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Government of Uganda, 2010, HLTH SECT STRAT PLAN; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Khan MA, 2002, HEALTH POLICY PLANN, V17, P178, DOI 10.1093/heapol/17.2.178; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Kowada A, 2008, MOL DIAGN THER, V12, P235, DOI 10.1007/BF03256289; Kowada A, 2010, MOL DIAGN THER, V14, P229, DOI 10.2165/11538610-000000000-00000; Laxminarayan R, 2007, EC BENEFIT TUBERCULO; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; Lodi S, 2012, THORAX, DOI [10.1136/thoraxjnl-2012-202544, DOI 10.1136/THORAXJNL-2012-202544]; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039187; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Ministry of Health, 2010, MIN HLTH MAN NAT TB; Moalosi G, 2003, INT J TUBERC LUNG D, V7, pS80; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Nakiyingi Lydia, 2012, BMC Res Notes, V5, P487, DOI 10.1186/1756-0500-5-487; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Sekandi JN, 2014, INT J TUBERC LUNG D, V18, P13, DOI 10.5588/ijtld.13.0129; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro A E, 2012, SYSTEMATIC REV ACTIV; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Shrestha RK, 2006, INT J TUBERC LUNG D, V10, P656; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Uganda Bureau of Statistics (UBOS) and ICF, 2011, UG DEM HLTH SURV 201; Uganda Ministry of Health, 2010, NAT TB LEPR PROGR AN; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Bank, 2013, GDP PER CAP UG CURR; World Health Organization, 2011, GLOB TUB REP; World Health Organization, 2013, TUBERCULOSIS; Zarocostas J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6396	67	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117009	10.1371/journal.pone.0117009	http://dx.doi.org/10.1371/journal.pone.0117009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658592	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900091
J	Skhosana, L; Steegen, K; Bronze, M; Lukhwareni, A; Letsoalo, E; Papathanasopoulos, MA; Carmona, SC; Stevens, WS				Skhosana, Lindiwe; Steegen, Kim; Bronze, Michelle; Lukhwareni, Azwidowi; Letsoalo, Esrom; Papathanasopoulos, Maria A.; Carmona, Sergio C.; Stevens, Wendy S.			High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; DISOPROXIL FUMARATE; NAIVE PATIENTS; STAVUDINE; FAILURE; ACCUMULATION; GENOTYPE; ABACAVIR	Background Tenofovir (TDF) has replaced stavudine (d4T) as the preferred nucleoside reverse transcriptase inhibitor (NRTI) in first-line regimens in South Africa, but limited information is available on the resistance patterns that develop after the introduction of TDF. This study investigated the antiretroviral drug resistance patterns in South African HIV-1 subtype C-infected patients failing stavudine-(d4T) and tenofovir-(TDF) based first-line regimens and assess the suitability of TDF as the preferred first-line nucleotide reverse transcriptase inhibitor (NRTI). Methods Resistance patterns of HIV-1 from 160 adult patients virologically failing TDF- (n = 80) and d4T- (n = 80) based first-line regimens were retrospectively analyzed. The pol gene was sequenced using an in-house protocol and mutations were analysed using the IAS-USA 2014 Drug Resistance Mutation list. Results Compared to d4T-exposed patients (n = 7), patients failing on a TDF-containing regimen (n = 43) were almost 5 times more likely to present with a K65R mutation (aRR 4.86 95% CI 2.29 - 10.34). Y115F was absent in the d4T group, and detected in 13.8% (n = 11) of TDF-exposed patients, p = 0.0007. Virus from 9 of the 11 patients (82.0%) who developed the Y115F mutation also developed K65R. Intermediate or high-level resistance to most NRTIs was common in the TDF-treatment group, but these patients twice more likely to remain susceptible to AZT as compared to those exposed to d4T (aRR 2.09 95% CI 1.13 - 3.90). Conclusion The frequency of the TDF induced K65R mutation was higher in our setting compared to non-subtype C dominated countries. However, despite the higher frequency of cross-resistance to NRTIs, most patients remained susceptible to AZT, which is reflected in the South African treatment guidelines that recommend AZT as an essential component of second-line regimens.	[Skhosana, Lindiwe; Steegen, Kim; Bronze, Michelle; Letsoalo, Esrom; Papathanasopoulos, Maria A.; Carmona, Sergio C.; Stevens, Wendy S.] Univ Witwatersrand, Fac Hlth Sci, Dept Haematol & Mol Med, Johannesburg, South Africa; [Lukhwareni, Azwidowi; Carmona, Sergio C.; Stevens, Wendy S.] Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Steegen, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Haematol & Mol Med, Johannesburg, South Africa.	kim.steegen@nhls.ac.za	Lukhwareni, Azwidowi/AAZ-8649-2021; Steegen, Kim/ABH-4471-2020; Steegen, K/AAF-6512-2020	Steegen, Kim/0000-0003-3226-7685; Lukhwareni, Azwidowi/0000-0002-4456-2270; Carmona, Sergio/0000-0002-6792-4748				Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Coutsinos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020208; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Etiebet MAA, 2013, AIDS, V27, P553, DOI 10.1097/QAD.0b013e32835b0f59; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hoffmann CJ, 2013, ANTIVIR THER, V18, P915, DOI 10.3851/IMP2652; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kuritzkes DR, 2004, JAIDS-J ACQ IMM DEF, V36, P600, DOI 10.1097/00126334-200405010-00008; Lukhwareni A, 2012, VALIDATION ROBUST IN; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; National Department of Health (NDOH), 2010, S AFR ANT TREATM GUI; NDoH, 2013, S AFR ANT TREATM GUI; NDoH, 2004, S AFR ANT TREATM GUI; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Parikh UM, 2006, J INFECT DIS, V194, P651, DOI 10.1086/505711; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Stone C, 2004, ANTIMICROB AGENTS CH, V48, P1413, DOI 10.1128/AAC.48.4.1413-1415.2004; Sunpath H, 2012, AIDS, V26, P1679, DOI 10.1097/QAD.0b013e328356886d; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang MW, 2013, J INFECT DIS, V207, pS70, DOI 10.1093/infdis/jit114; Theys K, 2013, ANTIMICROB AGENTS CH, V57, P1053, DOI 10.1128/AAC.01668-12; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Wallis C, 2009, AFFORDABLE IN HOUSE; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; WHO, 2013, GLOB UPD HIV TREATM	31	28	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118145	10.1371/journal.pone.0118145	http://dx.doi.org/10.1371/journal.pone.0118145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659108	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900266
J	Szulzewsky, F; Pelz, A; Feng, X; Synowitz, M; Markovic, D; Langmann, T; Holtman, IR; Wang, X; Eggen, BJL; Boddeke, HWGM; Hambardzumyan, D; Wolf, SA; Kettenmann, H				Szulzewsky, Frank; Pelz, Andreas; Feng, Xi; Synowitz, Michael; Markovic, Darko; Langmann, Thomas; Holtman, Inge R.; Wang, Xi; Eggen, Bart J. L.; Boddeke, Hendrikus W. G. M.; Hambardzumyan, Dolores; Wolf, Susanne A.; Kettenmann, Helmut			Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1	PLOS ONE			English	Article							MELANOMA PROTEIN-B; MT1-MMP EXPRESSION; MALIGNANT GLIOMAS; AURISTATIN-E; IFN-GAMMA; DC-HIL; MACROPHAGES; GLIOBLASTOMA; GLYCOPROTEIN; MICROGLIA	Malignant glioma belong to the most aggressive neoplasms in humans with no successful treatment available. Patients suffering from glioblastoma multiforme (GBM), the highest-grade glioma, have an average survival time of only around one year after diagnosis. Both microglia and peripheral macrophages/monocytes accumulate within and around glioma, but fail to exert effective anti-tumor activity and even support tumor growth. Here we use microarray analysis to compare the expression profiles of glioma-associated microglia/macrophages and naive control cells. Samples were generated from CD11b(+) MACS-isolated cells from naive and GL261-implanted C57BL/6 mouse brains. Around 1000 genes were more than 2-fold up-or downregulated in glioma-associated microglia/macrophages when compared to control cells. A comparison with published data sets of M1, M2a,b,c-polarized macrophages revealed a gene expression pattern that has only partial overlap with any of the M1 or M2 gene expression patterns. Samples for the qRT-PCR validation of selected M1 and M2a,b,c-specific genes were generated from two different glioma mouse models and isolated by flow cytometry to distinguish between resident microglia and invading macrophages. We confirmed in both models the unique glioma-associated microglia/macrophage phenotype including a mixture of M1 and M2a,b,c-specific genes. To validate the expression of these genes in human we MACS-isolated CD11b(+) microglia/macrophages from GBM, lower grade brain tumors and control specimens. Apart from the M1/M2 gene analysis, we demonstrate that the expression of Gpnmb and Spp1 is highly upregulated in both murine and human glioma-associated microglia/macrophages. High expression of these genes has been associated with poor prognosis in human GBM, as indicated by patient survival data linked to gene expression data. We also show that microglia/macrophages are the predominant source of these transcripts in murine and human GBM. Our findings provide new potential targets for future anti-glioma therapy.	[Szulzewsky, Frank; Pelz, Andreas; Synowitz, Michael; Markovic, Darko; Wang, Xi; Wolf, Susanne A.; Kettenmann, Helmut] Max Delbruck Ctr Mol Med, Berlin, Germany; [Pelz, Andreas] Charite, Dept Expt Neurol, D-13353 Berlin, Germany; [Feng, Xi; Hambardzumyan, Dolores] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Hambardzumyan, Dolores] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Synowitz, Michael] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Markovic, Darko] Helios Clin, Dept Neurosurg, Berlin, Germany; [Langmann, Thomas] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Holtman, Inge R.; Eggen, Bart J. L.; Boddeke, Hendrikus W. G. M.] Univ Groningen, Univ Med Ctr Groningen, Sect Med Physiol, Dept Neurosci, Groningen, Netherlands	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Groningen	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	Kettenmann@mdc-berlin.de	Langmann, Thomas/HHZ-9814-2022; Synowitz, Michael/G-2596-2012; Kettenmann, Helmut/AAJ-5142-2021; Feng, Xi/N-7160-2016; Szulzewsky, Frank/AAF-3906-2020; Wolf, Susanne/AAA-6598-2022; Holtman, Inge R./AAE-8655-2020; Wang, Xi/N-9527-2014	Langmann, Thomas/0000-0001-6826-529X; Feng, Xi/0000-0002-6920-1519; Wang, Xi/0000-0002-7572-6354; Kettenmann, Helmut/0000-0001-8208-0291; Holtman, Inge R./0000-0001-9752-4756; Szulzewsky, Frank/0000-0001-5710-9590; Pelz, Andreas/0000-0002-7111-6970; Wolf, Susanne/0000-0003-0922-8418	Deutsche Forschungsgemeinschaft [SFB-TRR43, KE 329/301]; NeuroCure; NIC [U01CA160882-01A1]; NATIONAL CANCER INSTITUTE [U01CA160882] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure; NIC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TRR43, KE 329/301), NeuroCure and NIC Grant (U01CA160882-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; BROWN LF, 1994, AM J PATHOL, V145, P610; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Huang YJ, 2014, CANCER RES, V74, P1011, DOI 10.1158/0008-5472.CAN-13-1072; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kuan CT, 2011, INT J CANCER, V129, P111, DOI 10.1002/ijc.25645; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li A, 2013, MOGENE 10STTRANSCURP; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Markovic DS, 2011, BRAIN BEHAV IMMUN, V25, P624, DOI 10.1016/j.bbi.2011.01.015; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251; Patel AP, 2014, SCIENCE; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Vinnakota K, 2013, NEURO-ONCOLOGY, V15, P1457, DOI 10.1093/neuonc/not115; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhou LT, 2012, NEOPLASMA, V59, P1, DOI 10.4149/neo_2012_001	65	244	247	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116644	10.1371/journal.pone.0116644	http://dx.doi.org/10.1371/journal.pone.0116644			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658639	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000349444900055
J	Tracy, CM; Kolesnikov, AV; Blake, DR; Chen, CK; Baehr, W; Kefalov, VJ; Willardson, BM				Tracy, Christopher M.; Kolesnikov, Alexander V.; Blake, Devon R.; Chen, Ching-Kang; Baehr, Wolfgang; Kefalov, Vladimir J.; Willardson, Barry M.			Retinal Cone Photoreceptors Require Phosducin-Like Protein 1 for G Protein Complex Assembly and Signaling	PLOS ONE			English	Article							GTPASE ACCELERATING PROTEIN; BETA-SUBUNIT; EXPRESSION LEVELS; GAMMA-SUBUNIT; RGS PROTEINS; MICE LACKING; MOUSE MODEL; ROD; TRANSDUCIN; LIGHT	G protein beta subunits (G beta) play essential roles in phototransduction as part of G protein beta gamma. (G beta gamma) and regulator of G protein signaling 9 (RGS9)-G beta(5) heterodimers. Both are obligate dimers that rely on the cytosolic chaperone CCT and its co-chaperone PhLP1 to form complexes from their nascent polypeptides. The importance of PhLP1 in the assembly process was recently demonstrated in vivo in a retinal rod-specific deletion of the Phlp1 gene. To test whether this is a general mechanism that also applies to other cell types, we disrupted the Phlp1 gene specifically in mouse cones and measured the effects on G protein expression and cone visual signal transduction. In PhLP1-deficient cones, expression of cone transducin (G(t2)) and RGS9-G beta(5) subunits was dramatically reduced, resulting in a 27-fold decrease in sensitivity and a 38-fold delay in cone photoresponse recovery. These results demonstrate the essential role of PhLP1 in cone G protein complex formation. Our findings reveal a common mechanism of G beta gamma and RGS9-G beta(5) assembly in rods and cones, highlighting the importance of PhLP1 and CCT-mediated G beta complex formation in G protein signaling.	[Tracy, Christopher M.; Blake, Devon R.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Ching-Kang] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Chen, Ching-Kang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Brigham Young University; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	kefalov@vision.wustl.edu; bmwillardson@chem.byu.edu	Kolesnikov, Alexander V/O-1840-2016	Kefalov, Vladimir/0000-0002-1659-008X; Willardson, Barry/0000-0002-8503-2268	United States National Institutes of Health [EY012287, EY019312, EY021126, EY08123, EY019298, EY014800-039003, EY013811, EY02228]; NATIONAL EYE INSTITUTE [R01EY019298, R01EY013811, R01EY019312, R24EY021126, R56EY013811, P30EY014800, R01EY008123, R01EY012287] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by United States National Institutes of Health (www.nih.gov) grants EY012287 to BMW; EY019312 and EY021126 to VJK; EY08123, EY019298 and EY014800-039003 to WB; and EY013811 and EY02228 to CKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky VY, 2013, INVEST OPHTH VIS SCI, V54, P7725, DOI 10.1167/iovs.13-13281; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Garzon J, 2002, NEUROPHARMACOLOGY, V42, P813, DOI 10.1016/S0028-3908(02)00027-8; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; Lai CWJ, 2013, J NEUROSCI, V33, P7941, DOI 10.1523/JNEUROSCI.5001-12.2013; Le YZ, 2006, ADV EXP MED BIOL, V572, P173; Le YZ, 2004, MOL VIS, V10, P1011; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lyubarsky A, 2001, MOL VIS, V7, P71; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Thulin CD, 1999, MOL VIS, V5, pU13; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson Barry M, 2012, Subcell Biochem, V63, P131, DOI 10.1007/978-94-007-4765-4_8; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117129	10.1371/journal.pone.0117129	http://dx.doi.org/10.1371/journal.pone.0117129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659125	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900105
J	Zhou, ZY; Zhou, XX; Li, J; Zhong, ZJ; Li, W; Liu, XH; Liu, FR; Su, HY; Luo, YJ; Gu, WY; Wang, CD; Zhang, HM; Li, DS; He, TM; Fu, HL; Cao, SZ; Shi, JJ; Peng, GN				Zhou, Ziyao; Zhou, Xiaoxiao; Li, Jin; Zhong, Zhijun; Li, Wei; Liu, Xuehan; Liu, Furui; Su, Huaiyi; Luo, Yongjiu; Gu, Wuyang; Wang, Chengdong; Zhang, Hemin; Li, Desheng; He, Tingmei; Fu, Hualin; Cao, Suizhong; Shi, Jinjiang; Peng, Guangneng			Transcriptional Regulation and Adaptation to a High-Fiber Environment in Bacillus subtilis HH2 Isolated from Feces of the Giant Panda	PLOS ONE			English	Article							GENOME SEQUENCE; BACTERIA; SPORULATION; DIVERSITY; IDENTIFICATION; 2-COMPONENT; ARCHAEA; SYSTEMS; RNAS	In the giant panda, adaptation to a high-fiber environment is a first step for the adequate functioning of intestinal bacteria, as the high cellulose content of the gut due to the panda's vegetarian appetite results in a harsh environment. As an excellent producer of several enzymes and vitamins, Bacillus subtilis imparts various advantages to animals. In our previous study, we determined that several strains of B. subtilis isolated from pandas exhibited good cellulose decomposition ability, and we hypothesized that this bacterial species can survive in and adapt well to a high-fiber environment. To evaluate this hypothesis, we employed RNA-Seq technology to analyze the differentially expressed genes of the selected strain B. subtilis HH2, which demonstrates significant cellulose hydrolysis of different carbon sources (cellulose and glucose). In addition, we used bioinformatics software and resources to analyze the functions and pathways of differentially expressed genes. Interestingly, comparison of the cellulose and glucose groups revealed that the up-regulated genes were involved in amino acid and lipid metabolism or transmembrane transport, both of which are involved in cellulose utilization. Conversely, the down-regulated genes were involved in non-essential functions for bacterial life, such as toxin and bacteriocin secretion, possibly to conserve energy for environmental adaptation. The results indicate that B. subtilis HH2 triggered a series of adaptive mechanisms at the transcriptional level, which suggests that this bacterium could act as a probiotic for pandas fed a high-fiber diet, despite the fact that cellulose is not a very suitable carbon source for this bacterial species. In this study, we present a model to understand the dynamic organization of and interactions between various functional and regulatory networks for unicellular organisms in a high-fiber environment.	[Zhou, Ziyao; Li, Jin; Zhong, Zhijun; Li, Wei; Liu, Xuehan; Liu, Furui; Su, Huaiyi; Luo, Yongjiu; Gu, Wuyang; Fu, Hualin; Cao, Suizhong; Shi, Jinjiang; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan 625014, Peoples R China; [Zhou, Xiaoxiao] Chengdu Ctr Anim Dis Prevent & Control, Chengdu 610041, Peoples R China; [Wang, Chengdong; Zhang, Hemin; Li, Desheng; He, Tingmei] China Conservat & Res Ctr Giant Panda, Yaan Bifengxia Base, Yaan 625007, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan 625014, Peoples R China.	pgn.sicau@163.com			National Natural Science Foundation of China [31272620]; Sichuan Provincial Department of Science and Technology Support Program [2011NZ0060]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0848]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of Science and Technology Support Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (number 31272620), Sichuan Provincial Department of Science and Technology Support Program (number 2011NZ0060) and the Program for Changjiang Scholars and Innovative Research Team in University (number IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chen ZT, 2011, METHODS MOL BIOL, V733, P93, DOI 10.1007/978-1-61779-089-8_7; COHEN SS, 1951, J BIOL CHEM, V189, P617; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Higgins CF, 1992, ANN REV CELL BIOL, V8, P67; Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Jin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022602; Joseph P, 2002, J MOL MICROB BIOTECH, V4, P503; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Konings WN, 2002, ANTON LEEUW INT J G, V81, P61, DOI 10.1023/A:1020573408652; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Meyer M, 2010, COLD SPRING HARBOR P; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadaie Y, 2008, FEMS MICROBIOL LETT, V279, P103, DOI 10.1111/j.1574-6968.2007.01018.x; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Stephens C, 1998, CURR BIOL, V8, pR45, DOI 10.1016/S0960-9822(98)70031-4; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079902; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yano K, 2013, MICROBIOL-SGM, V159, P2225, DOI 10.1099/mic.0.067025-0; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhou Xiao-xiao, 2013, Zhongguo Shouyi Kexue, V43, P1115; Zhou ZY, 2014, WORLD J MICROB BIOT, V30, P3129, DOI 10.1007/s11274-014-1740-y; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	42	9	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116935	10.1371/journal.pone.0116935	http://dx.doi.org/10.1371/journal.pone.0116935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658435	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900081
J	Frances, D; Sharma, N; Pofahl, R; Maneck, M; Behrendt, K; Reuter, K; Krieg, T; Klein, CA; Haase, I; Niemann, C				Frances, D.; Sharma, N.; Pofahl, R.; Maneck, M.; Behrendt, K.; Reuter, K.; Krieg, T.; Klein, C. A.; Haase, I.; Niemann, C.			A role for Rac1 activity in malignant progression of sebaceous skin tumors	ONCOGENE			English	Article							PROSTATE-CANCER; HAIR; DIFFERENTIATION; EXPRESSION; EPIDERMIS; CELLS; MORPHOGENESIS; MUTATIONS; LEF1	The small GTPase Rac1 is crucial for maintaining stem cells (SCs) in mammalian epidermis, and Rac1 activation leads to SC expansion. Loss or inhibition of Rac1 correlates with decreased frequency of skin cancer formation in a chemical carcinogenesis model. Here, we have addressed whether Rac1 activation would enhance carcinogenesis and result in tumor progression. We used K14 Delta NLef1 mice, a model for differentiated sebaceous adenomas (SAs), and activated Rac1 in an epidermis-specific manner (K14L61Rac1). Surprisingly, Rac1 activation did not change the incidence and frequency of sebaceous tumors. However, tumors, which occurred exclusively in K14 Delta NLef1/K14L61Rac1 double-transgenic mice, were poorly differentiated resembling malignant sebaceous tumors and were termed sebaceous carcinoma-like tumors (SCLTs). Compared with SAs, SCLTs showed an aberrant pattern of cell proliferation, invasive growth and less abundant expression of sebocyte differentiation markers, including stearoyl-CoA desaturase-1 and adipophilin. Interestingly, the adnexal SC marker Lrig1 was upregulated in SCLTs, showing that active Rac1 leads to the accumulation of sebocyte precursors in the context of K14 Delta NLef1-induced skin tumors. In a search for targets of Rac1, we found cancer progression-related proteins, Dhcr24/Seladin1 and Nuclear protein 1/P8, to be strongly regulated in SCLTs. At last, Rac1 and Dhcr24/Seladin1 were detected in human sebaceous tumors demonstrating a potential high impact of our findings for human skin disease. This is the first study showing that Rac1 activity can lead to malignant progression of skin tumors.	[Frances, D.; Sharma, N.; Reuter, K.; Niemann, C.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Pofahl, R.; Behrendt, K.; Krieg, T.; Haase, I.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Maneck, M.; Klein, C. A.] Univ Regensburg, Expt Med & Therapy Res, Cologne, Germany; [Niemann, C.] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Regensburg; University of Cologne	Niemann, C (corresponding author), Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany.	cnieman1@uni-koeln.de		S, Neha/0000-0002-4287-5994; Klein, Christoph A./0000-0001-7128-1725	Deutsche Krebshilfe;  [SFB 829];  [A3];  [B10]	Deutsche Krebshilfe(Deutsche Krebshilfe); ; ; 	We thank Vera Czichowski, Dagmar Fehrenschild, Peter Schettina, Margot Junker and Michael Tscharntke for expert technical support and are grateful for technical support by Wilhelm Bloch and Cornelia Mauch (SFB 829, Z2). This work was funded by the Deutsche Krebshilfe (to CN and CK) and the SFB 829 (A3 to CN, B10 to IH).	Battista MC, 2010, PROSTATE, V70, P921, DOI 10.1002/pros.21126; Behrendt K, 2012, J CELL SCI, V125, P896, DOI 10.1242/jcs.091868; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Calonje J. E., 2011, MCKEES PATHOLOGY SKI; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Fehrenschild D, 2012, J INVEST DERMATOL, V132, P337, DOI 10.1038/jid.2011.301; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Gu LH, 2008, AM J PATHOL, V173, P752, DOI 10.2353/ajpath.2008.071089; Hartmann CH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl740; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jiang WG, 2006, INT J MOL MED, V18, P981; Kakanj P, 2013, CELL REP, V4, P340, DOI 10.1016/j.celrep.2013.06.037; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Niemann C, 2002, DEVELOPMENT, V129, P95; Niemann C, 2007, CANCER RES, V67, P2916, DOI 10.1158/0008-5472.CAN-06-3427; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ree AH, 1999, CANCER RES, V59, P4675; Scheid S, 2005, BIOINFORMATICS, V21, P2921, DOI 10.1093/bioinformatics/bti436; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95	26	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5505	5512		10.1038/onc.2014.471	http://dx.doi.org/10.1038/onc.2014.471			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25659584				2022-12-26	WOS:000363479700010
J	Gong, J; Weng, D; Eguchi, T; Murshid, A; Sherman, MY; Song, B; Calderwood, SK				Gong, J.; Weng, D.; Eguchi, T.; Murshid, A.; Sherman, M. Y.; Song, B.; Calderwood, S. K.			Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis	ONCOGENE			English	Article							HEAT-SHOCK-PROTEIN; BREAST-CANCER; C-MET; PROGNOSTIC-SIGNIFICANCE; TANESPIMYCIN 17-AAG; MOUSE MODEL; EXPRESSION; HEAT-SHOCK-PROTEIN-70; ACTIVATION; HSP90	Elevated levels of the inducible heat-shock protein 70 (Hsp72) have been implicated in mammary tumorigenesis in histological investigations of human breast cancer. We therefore examined the role of Hsp72 in mice, using animals in which the hsp70 gene was inactivated. We used a spontaneous tumor system with mice expressing the polyomavirus middle T (PyMT) oncogene under control of the mouse mammary tumor virus (MMTV) long-terminal repeat (MMT mice). These mice developed spontaneous, metastatic mammary cancer. We then showed Hsp72 to be upregulated in a fraction of mammary cancer initiating cells (CIC) within the MMT tumor cell population. These cells were characterized by elevated surface levels of stem cell markers CD44 and Sca1 and by rapid metastasis. Inactivation of the hsp70 gene delayed the initiation of mammary tumors. This delay in tumor initiation imposed by loss of hsp70 was correlated with a decreased pool of CIC. Interestingly, hsp70 knockout significantly reduced invasion and metastasis by mammary tumor cells and implicated its product Hsp72 in cell migration and formation of secondary neoplasms. Impaired tumorigenesis and metastasis in hsp70-knockout MMT mice was associated with downregulation of the met gene and reduced activition of the oncogenic c-Met protein. These experiments therefore showed Hsp72 to be involved in the growth and progression of mammary carcinoma and highlighted this protein as a potential target for anticancer drug development.	[Gong, J.; Weng, D.; Song, B.] Boston Univ, Dept Med, Med Ctr, Boston, MA 02118 USA; [Eguchi, T.; Murshid, A.; Calderwood, S. K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mol & Cellular Radiat Oncol, Boston, MA 02215 USA; [Sherman, M. Y.] Boston Univ, Med Ctr, Dept Biochem, Boston, MA 02118 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Gong, J (corresponding author), Boston Univ, Dept Med, Sch Med, 650 Albany St,Room 309, Boston, MA 02118 USA.	jgong@bu.edu; scalderw@bidmc.harvard.edu		Eguchi, Takanori/0000-0002-3297-6126	Department of Radiation Oncology, Beth Israel Deaconess Medical Center; NIH [R01CA119045, RO1CA47407, RO1CA176326]; Harvard JCRT Foundation; NATIONAL CANCER INSTITUTE [R01CA176326, R01CA047407, R01CA119045] Funding Source: NIH RePORTER	Department of Radiation Oncology, Beth Israel Deaconess Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard JCRT Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the support of the Department of Radiation Oncology, Beth Israel Deaconess Medical Center. This work was supported by NIH research grants R01CA119045, RO1CA47407 and RO1CA176326 as well as the Harvard JCRT Foundation. We are grateful to Buzz Hunt for the kind gift of the hsp70 knockout mice.	Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boroughs LK, 2011, J BIOL CHEM, V286, P37094, DOI 10.1074/jbc.M111.242438; Calderwood SK, 2012, CURR MOL MED, V12, P1102, DOI 10.2174/156652412803306675; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; CARDIFF RD, 1993, CANCER SURV, V16, P97; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Gallego MI, 2003, ONCOGENE, V22, P8498, DOI 10.1038/sj.onc.1207063; Galluzzi L, 2009, MOL CELL, V36, P176, DOI 10.1016/j.molcel.2009.10.003; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jiang YF, 2001, CANCER RES, V61, P2365; Kalogeraki A, 2007, J EXP CLIN CANC RES, V26, P367; Kang Y, 2013, KOREAN J PATHOL, V47, P219, DOI 10.4132/KoreanJPathol.2013.47.3.219; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Kouspou MM, 2011, METHODS MOL BIOL, V787, P303, DOI 10.1007/978-1-61779-295-3_23; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu FF, 1996, INT J HYPERTHER, V12, P197, DOI 10.3109/02656739609022508; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Meng L, 2011, ONCOGENE, V30, P2836, DOI 10.1038/onc.2011.5; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Nakajima M, 2002, CANCER LETT, V178, P99, DOI 10.1016/S0304-3835(01)00825-4; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Otsuka T, 1998, CANCER RES, V58, P5157; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Rodriguez Luis G., 2004, V294, P23; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SCHLESINGER MJ, 1994, PEDIATR RES, V36, P1; Slattery ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063165; STEVENSON MA, 1990, MOL CELL BIOL, V10, P1234, DOI 10.1128/MCB.10.3.1234; Sun BC, 2008, CLIN CANCER RES, V14, P7050, DOI 10.1158/1078-0432.CCR-08-0520; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Thanner F, 2003, ANTICANCER RES, V23, P1057; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Weng DS, 2013, J IMMUNOL, V191, P755, DOI 10.4049/jimmunol.1203286; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Xia JC, 2003, J IMMUNOL, V170, P1980, DOI 10.4049/jimmunol.170.4.1980	67	42	44	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5460	5471		10.1038/onc.2015.1	http://dx.doi.org/10.1038/onc.2015.1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25659585	Green Accepted			2022-12-26	WOS:000363479700006
J	Lozupone, F; Borghi, M; Marzoli, F; Azzarito, T; Matarrese, P; Iessi, E; Venturi, G; Meschini, S; Canitano, A; Bona, R; Cara, A; Fais, S				Lozupone, F.; Borghi, M.; Marzoli, F.; Azzarito, T.; Matarrese, P.; Iessi, E.; Venturi, G.; Meschini, S.; Canitano, A.; Bona, R.; Cara, A.; Fais, S.			TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells	ONCOGENE			English	Article							PROTON PUMP INHIBITORS; VACUOLAR H+-ATPASE; MULTIDRUG-RESISTANCE; INTRACELLULAR PH; MELANOMA-CELLS; ENERGY-METABOLISM; SUBUNIT ISOFORMS; IN-VITRO; INVASION; METASTASIS	An inverted pH gradient across the cell membranes is a typical feature of malignant cancer cells that are characterized by extracellular acidosis and cytosol alkalization. These dysregulations are able to create a unique milieu that favors tumor progression, metastasis and chemo/immune-resistance traits of solid tumors. A key event mediating tumor cell pH alterations is an aberrant activation of ion channels and proton pumps such as (H+)-vacuolar-ATPase (V-ATPase). TM9SF4 is a poorly characterized transmembrane protein that we have recently shown to be related to cannibal behavior of metastatic melanoma cells. Here, we demonstrate that TM9SF4 represents a novel V-ATPase-associated protein involved in V-ATPase activation. We have observed in HCT116 and SW480 colon cancer cell lines that TM9SF4 interacts with the ATP6V1H subunit of the V-ATPase V1 sector. Suppression of TM9SF4 with small interfering RNAs strongly reduces assembly of V-ATPase V0/V1 sectors, thus reversing tumor pH gradient with a decrease of cytosolic pH, alkalization of intracellular vesicles and a reduction of extracellular acidity. Such effects are associated with a significant inhibition of the invasive behavior of colon cancer cells and with an increased sensitivity to the cytotoxic effects of 5-fluorouracil. Our study shows for the first time the important role of TM9SF4 in the aberrant constitutive activation of the V-ATPase, and the development of a malignant phenotype, supporting the potential use of TM9SF4 as a target for future anticancer therapies.	[Lozupone, F.; Marzoli, F.; Azzarito, T.; Matarrese, P.; Iessi, E.; Venturi, G.; Canitano, A.; Bona, R.; Cara, A.; Fais, S.] Ist Super Sanita, Therapeut Res & Med Evaluat Dept, I-00161 Rome, Italy; [Borghi, M.] Ist Super Sanita, Infect Parasit & Immune Mediated Dis Dept, I-00161 Rome, Italy; [Meschini, S.] Ist Super Sanita, Technol & Hlth Dept, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Lozupone, F (corresponding author), Ist Super Sanita, Dept Drug Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	francesco.lozupone@iss.it	Lozupone, Francesco/H-2998-2016; Cara, Andrea/M-4865-2015; CANITANO, ANDREA/O-1907-2017; Matarrese, Paola/A-4369-2014; VENTURI, GIULIETTA/O-8123-2015; Cara, Andrea/AAA-4238-2021; BORGHI, MARTINA/M-4355-2015; Iessi, Elisabetta/O-2460-2017; Fais, Stefano/J-8638-2016; Bona, Roberta/O-1730-2017; MESCHINI, STEFANIA/E-9091-2015	Lozupone, Francesco/0000-0002-4959-9400; Cara, Andrea/0000-0003-4967-1895; CANITANO, ANDREA/0000-0002-1494-1237; VENTURI, GIULIETTA/0000-0002-9078-8350; Cara, Andrea/0000-0003-4967-1895; BORGHI, MARTINA/0000-0001-6313-0273; Iessi, Elisabetta/0000-0001-7221-9173; Fais, Stefano/0000-0001-9060-2766; Bona, Roberta/0000-0002-9226-3734; MESCHINI, STEFANIA/0000-0001-9079-1181; matarrese, paola/0000-0001-5477-3752; marzoli, francesca/0000-0002-1353-527X	AIRC Associazione Italiana per la Ricerca sul Cancro; Airc Grant [10602, IG 11505n]	AIRC Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Airc Grant(Fondazione AIRC per la ricerca sul cancro)	We thank Dr Angelo De Milito for helpful discussion, Pasqualina Leone for her contribution in plasmid cloning and Dr Tonino Sofia for his suggestions. This study was supported by AIRC Associazione Italiana per la Ricerca sul Cancro. Airc Grant '10602' and 'IG 11505n'. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chang H, 2011, BREAST CANCER RES TR, V125, P55, DOI 10.1007/s10549-010-0825-z; Chen M, 2012, J CELL BIOCHEM, V113, P2474, DOI 10.1002/jcb.24122; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; Daniel C, 2013, BBA-MOL BASIS DIS, V1832, P606, DOI 10.1016/j.bbadis.2013.01.020; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Graham RM, 2014, ONCOTARGET, V5, P1162, DOI 10.18632/oncotarget.1699; He PF, 2009, AUTOPHAGY, V5, P52, DOI 10.4161/auto.5.1.7247; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Lozupone F, 2009, EMBO REP, V10, P1348, DOI 10.1038/embor.2009.236; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; MacKinnon RN, 2010, GENE CHROMOSOME CANC, V49, P998, DOI 10.1002/gcc.20806; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Niikura K, 2006, DRUG NEWS PERSPECT, V19, P139, DOI 10.1358/dnp.2006.19.3.977442; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Oo HZ, 2014, PATHOBIOLOGY, V81, P138, DOI 10.1159/000357821; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Perez-Sayans M, 2010, CANCER LETT, V295, P135, DOI 10.1016/j.canlet.2010.03.019; Perrin J, 2015, J INNATE IMMUN, V7, P37, DOI 10.1159/000365112; Qi J, 2007, J BIOENERG BIOMEMBR, V39, P423, DOI 10.1007/s10863-007-9116-8; Raghunand N, 2000, DRUG RESIST UPDATE, V3, P39, DOI 10.1054/drup.2000.0119; Riemann D, 2005, BIOCHEM BIOPH RES CO, V331, P1408, DOI 10.1016/j.bbrc.2005.04.061; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; de Souza ACS, 2011, CELL PHYSIOL BIOCHEM, V28, P771, DOI 10.1159/000335792; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SEO JT, 1994, PFLUG ARCH EUR J PHY, V426, P75, DOI 10.1007/BF00374673; SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128; Spugnini EP, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-221; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Supino R, 2009, ANN NY ACAD SCI, V1171, P606, DOI 10.1111/j.1749-6632.2009.04705.x; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958	52	61	67	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5163	5174		10.1038/onc.2014.437	http://dx.doi.org/10.1038/onc.2014.437			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25659576				2022-12-26	WOS:000362233400006
J	Koeberle, A; Pergola, C; Shindou, H; Koeberle, SC; Shimizu, T; Laufer, SA; Werz, O				Koeberle, Andreas; Pergola, Carlo; Shindou, Hideo; Koeberle, Solveigh C.; Shimizu, Takao; Laufer, Stefan A.; Werz, Oliver			Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasis	FASEB JOURNAL			English	Article						bioactive lipid; fatty acid; lipidomics; phospholipid; unfolded protein response	POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; ACYLTRANSFERASE 3; CELL-CYCLE; STRESS; MEMBRANE; MUSCLE; PHOSPHOLIPIDS; PROGRESSION; SENSITIVITY	Endoplasmic reticulum (ER) homeostasis is regulated by a network of signaling pathways to which stearoyl-CoA desaturase (SCD)-1, p38 mitogen-activated protein kinase (MAPK) and the unfolded protein response (UPR) belong. Because all these pathways are located at the interface of cell cycle control and cell stress, we hypothesized a cross-regulation. Interference with SCD-1, either by small interfering (si) RNA or the specific SCD-1 inhibitor CAY10566 (EC50 1 mu M; >= 24 h), specifically induced phosphorylation and thus activation of p38 MAPK in NIH-3T3 mouse fibroblasts (1.5- to 2-fold; 48 hours). During lipotoxic and cell cycle stress, prolonged activation of p38 MAPK due to SCD-1 inhibition induced ER stress, the UPR, and ER/Golgi remodeling as shown by Western blot and immunofluorescence microscopy (1.2- to 3.5-fold). Specific inhibition of p38 MAPK by Skepinone-L [half maximal inhibitory concentration (IC50) 25-50 nM] reversed these effects (at 1 mu M; 48 hours). The specificity by which SCD-1 modulates the phospholipid composition and inhibits p38 MAPK signaling (among survival/stress pathways), thereby preventing ER stress (but not other SCD-1-dependent responses), suggests selective protein-lipid interactions. Palmitoleoyl/oleoyl-phosphatidylinositol (PI) was accordingly identified as potential lipid mediator using chromatography-coupled ESI tandem mass spectrometry. We conclude that the negative regulation of p38 MAPK mediates the protective effects of SCD-1 on ER homeostasis under distinct stress conditions.	[Koeberle, Andreas; Pergola, Carlo; Werz, Oliver] Univ Jena, Inst Pharm, D-07743 Jena, Germany; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo, Japan; [Koeberle, Solveigh C.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Laufer, Stefan A.] Univ Tubingen, Dept Pharmaceut Chem, Inst Pharmaceut, Tubingen, Germany	Friedrich Schiller University of Jena; National Center for Global Health & Medicine - Japan; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Tokyo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Koeberle, A (corresponding author), Univ Jena, Inst Pharm, Chair Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	andreas.koeberle@uni-jena.de	Koeberle, Andreas/ABB-2356-2020; Shimizu, Takao/AAV-7052-2021	Koeberle, Andreas/0000-0001-6269-5088; Koeberle, Solveigh/0000-0002-8008-494X; Laufer, Stefan/0000-0001-6952-1486	Deutsche Forschungsgemeinschaft [KO 4589/4-1]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cell Science Research Foundation; Takeda Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank Kevin Schomburg and Christoph Seidel for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (KO 4589/4-1 to A.K.); Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T.S.); Grant-in-Aid for Young Scientists (B) from the MEXT of Japan (to H.S.); the Cell Science Research Foundation (to H.S.); and Takeda Science Foundation (to A.K.).	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bolognesi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055537; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BROTHERUS J, 1977, BIOCHIM BIOPHYS ACTA, V486, P243, DOI 10.1016/0005-2760(77)90020-0; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koeberle A, 2009, BRIT J PHARMACOL, V156, P952, DOI 10.1111/j.1476-5381.2009.00070.x; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Koeberle A, 2012, J BIOL CHEM, V287, P27244, DOI 10.1074/jbc.M111.274829; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Doria ML, 2013, J CELL PHYSIOL, V228, P457, DOI 10.1002/jcp.24152; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Pinnamaneni SK, 2006, DIABETOLOGIA, V49, P3027, DOI 10.1007/s00125-006-0427-9; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Vessby B, 2012, NUTR METAB CARDIOVAS, V22, P176, DOI 10.1016/j.numecd.2010.07.011; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang YQ, 2009, J NUTR BIOCHEM, V20, P982, DOI 10.1016/j.jnutbio.2008.09.002	38	22	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2439	2449		10.1096/fj.14-268474	http://dx.doi.org/10.1096/fj.14-268474			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25678624	Bronze			2022-12-26	WOS:000355209500021
J	Kunikata, H; Aizawa, N; Kudo, M; Mugikura, S; Nitta, F; Morimoto, R; Iwakura, Y; Ono, Y; Satoh, F; Takahashi, H; Ito, S; Takahashi, S; Nakazawa, T				Kunikata, Hiroshi; Aizawa, Naoko; Kudo, Masataka; Mugikura, Shunji; Nitta, Fumihiko; Morimoto, Ryo; Iwakura, Yoshitsugu; Ono, Yoshikiyo; Satoh, Fumitoshi; Takahashi, Hidetoshi; Ito, Sadayoshi; Takahashi, Shoki; Nakazawa, Toru			Relationship of Ocular Microcirculation, Measured by Laser Speckle Flowgraphy, and Silent Brain Infarction in Primary Aldosteronism	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; HEAD BLOOD-FLOW; PULSE-WAVE ANALYSIS; ATHEROSCLEROSIS RISK; FLUORESCEIN ANGIOGRAPHY; CEREBRAL INFARCTION; GLAUCOMA PATIENTS; CIRCULATION; STROKE; DIAGNOSIS	Purpose Recent studies have shown that the risk of cerebro- and cardiovascular events (CVEs) is higher in patients with primary aldosteronism (PA) than in those with essential hypertension (EH), and that silent brain infarction (SBI) is a risk factor and predictor of CVEs. Here, we evaluated the relationship between findings from laser speckle flowgraphy (LSFG), a recently introduced non-invasive means of measuring mean blur rate (MBR), an important biomarker of ocular blood flow, and the occurrence of SBI in patients with PA. Methods 87 PA patients without symptomatic cerebral events (mean 55.1 +/- 11.2 years old, 48 male and 39 female) were enrolled in this study. We measured MBR in the optic nerve head (ONH) with LSFG and checked the occurrence of SBI with magnetic resonance imaging. We examined three MBR waveform variables: skew, blowout score (BOS) and blowout time (BOT). We also recorded clinical findings, including age, blood pressure, and plasma aldosterone concentration. Results PA patients with SBI (15 of 87 patients; 17%) were significantly older and had significantly lower BOT in the capillary area of the ONH than the patients without SBI (P = 0.02 and P = 0.03, respectively). Multiple logistic regression analysis revealed that age and BOT were independent factors for the presence of SBI in PA patients (OR, 1.15, 95% CI 1.01-1.38; P = .03 and OR, 0.73, 95% CI 0.45-0.99; P = .04, respectively). Conclusion PA patients with SBI were older and had lower MBR BOT than those without SBI. Our analysis showed that age was a risk factor for SBI, and that BOT was a protective factor, in patients with PA. This suggests that BOT, a non-invasive and objective biomarker, may be a useful predictor of SBI and form part of future PA evaluations and clinical decision-making.	[Kunikata, Hiroshi; Aizawa, Naoko; Nitta, Fumihiko; Takahashi, Hidetoshi; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan; [Kudo, Masataka; Morimoto, Ryo; Iwakura, Yoshitsugu; Ono, Yoshikiyo; Satoh, Fumitoshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Dept Med, Sendai, Miyagi 980, Japan; [Mugikura, Shunji; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; [Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kunikata, H (corresponding author), Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan.	kunikata@oph.med.tohoku.ac.jp	Ito, Sadayoshi/A-3933-2015	Ito, Sadayoshi/0000-0002-5092-3626; MUGIKURA, SHUNJI/0000-0002-9138-610X	JST grant; JSPS KAKENHI [26293372, 26462629, 26670751]	JST grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper was supported in part by JST grant, JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (T.N. 26293372), for Scientific Research (C) (H.K. 26462629), and for Exploratory Research (T.N. 26670751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2013, CLIN EXPERIMENT OPHT, DOI [10.1111/ceo.12150, DOI 10.1111/CEO.12150]; Aizawa N, INVEST OPHTH VIS SCI, DOI [10.1167/iovs.14-15725, DOI 10.1167/IOVS.14-15725]; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Asumi M, 2010, ATHEROSCLEROSIS, V210, P674, DOI 10.1016/j.atherosclerosis.2010.01.008; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; CONN JW, 1955, T ASSOC AM PHYSICIAN, V68, P215; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Kawasaki R, 2010, STROKE, V41, P1826, DOI 10.1161/STROKEAHA.110.585042; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; Milan A, 2012, HIGH BLOOD PRESS CAR, V19, P11, DOI 10.2165/11593690-000000000-00000; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Miwa K, 2010, INTERNAL MED, V49, P817, DOI 10.2169/internalmedicine.49.3211; Mulatero P, 2013, J CLIN ENDOCR METAB, V98, P4826, DOI 10.1210/jc.2013-2805; Musa F, 2006, ACTA OPHTHALMOL SCAN, V84, P740, DOI 10.1111/j.1600-0420.2006.00728.x; Nishikawa T, 2011, ENDOCR J, V58, P711, DOI 10.1507/endocrj.EJ11-0133; Orth D, 1984, COLOR AND FLUORESCEI, P1; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; Satoh F, 2007, HYPERTENS RES, V30, P1083, DOI 10.1291/hypres.30.1083; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; Sharrett AR, 2007, OPHTHAL EPIDEMIOL, V14, P238, DOI 10.1080/09286580701396712; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tsuda S, 2014, CURR EYE RES, DOI [10.3109/02713683.2014.986333, DOI 10.3109/02713683.2014.986333]; Turchi F, 2014, NUTR METAB CARDIOVAS, V24, P476, DOI 10.1016/j.numecd.2013.09.009; VANBUCHEM FSP, 1956, LANCET, V271, P335; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2004, LANCET NEUROL, V3, P179, DOI 10.1016/S1474-4422(04)00682-9; Yatsuya H, 2010, STROKE, V41, P1349, DOI 10.1161/STROKEAHA.110.580837; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204; Yoshida Y, 2010, J OCUL PHARMACOL TH, V26, P187, DOI 10.1089/jop.2009.0117; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114	46	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117452	10.1371/journal.pone.0117452	http://dx.doi.org/10.1371/journal.pone.0117452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675373	gold, Green Published, Green Submitted			2022-12-26	WOS:000349914000023
J	Ocwieja, KE; Sherrill-Mix, S; Liu, CC; Song, JZ; Bau, H; Bushman, FD				Ocwieja, Karen E.; Sherrill-Mix, Scott; Liu, Changchun; Song, Jinzhao; Bau, Haim; Bushman, Frederic D.			A Reverse Transcription Loop-Mediated Isothermal Amplification Assay Optimized to Detect Multiple HIV Subtypes	PLOS ONE			English	Article							RAPID DETECTION	Diagnostic methods for detecting and quantifying HIV RNA have been improving, but efficient methods for point-of-care analysis are still needed, particularly for applications in resource-limited settings. Detection based on reverse-transcription loop-mediated isothermal amplification (RT-LAMP) is particularly useful for this, because when combined with fluorescence- based DNA detection, RT-LAMP can be implemented with minimal equipment and expense. Assays have been developed to detect HIV RNA with RT-LAMP, but existing methods detect only a limited subset of HIV subtypes. Here we report a bioinformatic study to develop optimized primers, followed by empirical testing of 44 new primer designs. One primer set (ACeIN-26), targeting the HIV integrase coding region, consistently detected subtypes A, B, C, D, and G. The assay was sensitive to at least 5000 copies per reaction for subtypes A, B, C, D, and G, with Z-factors of above 0.69 (detection of the minor subtype F was found to be unreliable). There are already rapid and efficient assays available for detecting HIV infection in a binary yes/no format, but the rapid RT-LAMP assay described here has additional uses, including 1) tracking response to medication by comparing longitudinal values for a subject, 2) detecting of infection in neonates unimpeded by the presence of maternal antibody, and 3) detecting infection prior to seroconversion.	[Ocwieja, Karen E.; Sherrill-Mix, Scott; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Changchun; Song, Jinzhao; Bau, Haim] Univ Penn, Dept Mech Engn & Appl Mech, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bushman, FD (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Bau, Haim H/D-1161-2009; Song, Jinzhao/Q-7866-2016	Sherrill-Mix, Scott/0000-0002-8955-8072; Ocwieja, Karen/0000-0002-1738-1634	National Institutes of Health [R01 AI052845, 1R41AI104418-01A1, K25AI099160, 5T32HG000046, T32 AI007324]; University of Pennsylvania Center for AIDS Research [P30 AI045008]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, P30AI045008, T32AI007632, R41AI104418, T32AI007324, K25AI099160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 AI052845 to F.D.B and the University of Pennsylvania Center for AIDS Research P30 AI045008. FDB, HHB and CK were supported, in part, by National Institutes of Health 1R41AI104418-01A1. CL was supported by National Institutes of Health K25AI099160. SS-M was supported in part by National Institutes of Health 5T32HG000046. K.E.O. was supported by National Institutes of Health T32 AI007324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2014, J CLIN MICROBIOL, V52, P2674, DOI 10.1128/JCM.00935-14; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Hosaka N, 2009, J VIROL METHODS, V157, P195, DOI 10.1016/j.jviromet.2009.01.004; Kuiken Carla, 2013, Methods Mol Biol, V939, P253, DOI 10.1007/978-1-62703-107-3_16; Liu CC, 2013, ANAL CHEM, V85, P10463, DOI 10.1021/ac402459h; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Murray CJ, 2014, LANCET, DOI [10.1016/S0140-6736(14)62428-4, DOI 10.1016/S0140-6736(14)62428-4]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; Zeng YL, 2014, GENE, V541, P123, DOI 10.1016/j.gene.2014.03.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	18	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117852	10.1371/journal.pone.0117852	http://dx.doi.org/10.1371/journal.pone.0117852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675344	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000035
J	Rohde, J; Pedersen, HR; Bjerring, PN; Larsen, FS				Rohde, Johan; Pedersen, Hans R.; Bjerring, Peter N.; Larsen, Fin Stolze			Effects of Dexamethasone and Cox Inhibitors on Intracranial Pressure and Cerebral Perfusion in the Lipopolysaccharide Treated Rats with Hyperammonemia	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; BLOOD-BRAIN-BARRIER; HEPATIC-ENCEPHALOPATHY; ENDOTHELIAL-CELLS; FLOW; INDOMETHACIN; RELEASE; EDEMA; AMMONIA; PERMEABILITY	Introduction Systemic inflammation may affect the brain by aggravating the stage of encephalopathy and increasing intracranial pressure (ICP) especially if liver insufficiency with hyperammonemia is present. The aim of this study was to determine if the influence of concomitant hyperammonemia and lipopolysaccharide (LPS) on the brain can be prevented by dexamethasone and cyclooxygenase (COX) inhibitors. Method Fifty-four male Wistar rats, 6 in each group, were divided into the following groups: Saline+saline; LPS (2mg/kg)+saline; LPS+indomethacin (10mg/kg); LPS+diclofenac (10mg/kg); LPS+dexamethasone (2mg/kg) in experiment A. Experiment-B included the following groups: LPS+NH3 (140 mu mol/kg/min)+saline; LPS+NH3+indomethacin; LPS+NH3+diclofenac and LPS+NH3+dexamethasone. ICP was monitored via a catheter placed in cisterna magna and changes in CBF were recorded by laser Doppler flowmetry. Results LPS with and without NH3 induced a similar increase in plasma 6-keto-prostaglandin-F-1 alpha (6-keto-PGF(1 alpha)) concentration together with a concomitant rise in CBF and ICP. Indomethacin and diclofenac prevented the increase in ICP by LPS alone, and with the addition of NH3 the increase in both CBF and ICP, which was associated with a decrease in 6-keto-PGF(1 alpha). Dexamethasone only reduced the LPS induced increase in ICP but not CBF, and partly the 6-keto-PGF(1 alpha) plasma concentration in the combined setup. Conclusion These data indicate that activation of cycloooxygenases is of central importance for development of cerebral hyperemia and high ICP during concomitant systemic inflammation and hyperammonemia.	[Rohde, Johan; Pedersen, Hans R.; Bjerring, Peter N.; Larsen, Fin Stolze] Univ Copenhagen, Dept Hepatol, Rigshosp A2121, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Rohde, J (corresponding author), Univ Copenhagen, Dept Hepatol, Rigshosp A2121, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	doktorrohde@gmail.com	Bjerring, Peter/AAB-7322-2020; Bjerring, Peter Nissen/Q-5089-2019	Larsen, Fin Stolze/0000-0003-2205-8265; Bjerring, Peter Nissen/0000-0001-8636-0709				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Godoy DA, 2014, NEUROCRIT CARE, V20, P230, DOI 10.1007/s12028-013-9924-0; Andresen J, 2006, J APPL PHYSIOL, V100, P318, DOI 10.1152/japplphysiol.00937.2005; Bemeur C, 2013, METAB BRAIN DIS, V28, P145, DOI 10.1007/s11011-012-9361-3; Blei AT, 2005, NEUROCHEM INT, V47, P71, DOI 10.1016/j.neuint.2005.04.009; Chastre A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049670; Chung CH, 2001, HEPATOLOGY, V34, P249, DOI 10.1053/jhep.2001.26383; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Farkas E, 2006, MICROVASC RES, V72, P113, DOI 10.1016/j.mvr.2006.05.007; Hribar M, 1999, EUR J IMMUNOL, V29, P3105; Jalan R, 2004, J HEPATOL, V41, P613, DOI 10.1016/j.jhep.2004.06.011; Jalan R, 2003, SEMIN LIVER DIS, V23, P271; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; MASFERRER JL, 1994, RECEPTOR, V4, P25; Mastronardi CA, 2001, NEUROIMMUNOMODULAT, V9, P148, DOI 10.1159/000049019; MOZES T, 1991, PROSTAG LEUKOTR ESS, V42, P209, DOI 10.1016/0952-3278(91)90085-J; Pedersen HR, 2007, J HEPATOL, V47, P245, DOI 10.1016/j.jhep.2007.03.026; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Possamai LA, 2014, J HEPATOL, V61, P439, DOI 10.1016/j.jhep.2014.03.031; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; SAIJA A, 1995, LIFE SCI, V56, P775, DOI 10.1016/0024-3205(95)00008-T; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028; Van Damme E, 2015, J GEN VIROL, V96, P131, DOI 10.1099/vir.0.069872-0; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; WANG Q, 1993, J CEREBR BLOOD F MET, V13, P724, DOI 10.1038/jcbfm.1993.92; Wright G, 2007, HEPATOLOGY, V45, P1517, DOI 10.1002/hep.21599; ZAKI AEO, 1983, EXPERIENTIA, V39, P988, DOI 10.1007/BF01989765	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117416	10.1371/journal.pone.0117416	http://dx.doi.org/10.1371/journal.pone.0117416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675251	gold, Green Submitted, Green Published			2022-12-26	WOS:000349914000022
J	Shin, HS; Han, DH; Shin, MS; Lee, HJ; Kim, MS; Kim, HD				Shin, Hye-Sun; Han, Dong-Hun; Shin, Myung-Seop; Lee, Hyun-Jin; Kim, Mi-Sun; Kim, Hyun-Duck			Korean Version of Child Perceptions Questionnaire and Dental Caries among Korean Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH IMPACT PROFILE; ORAL-HEALTH; VALIDATION; VALIDITY; RELIABILITY; ADOLESCENTS; TRANSLATION; CPQ(11-14)	Although dental caries has been a major oral health problem for children, the association between dental caries and oral health related quality of life has been still controversial. This study aims to evaluate the association between the Korean version of the Child Perceptions Questionnaire (K-CPQ) and dental caries among Korean children. Eight hundred one school children aged 8 to 14 years participated in this study. After the K-CPQ was validated we performed an association study. The K-CPQ was self-reported. Dental caries were evaluated by dentists using the World Health Organization Index. Correlation analyses (intraclass correlation coefficient, Cronbach's alpha and Pearson's correlation coefficient [r]) and linear regression models (partial r) including age, gender and type of school were applied. Untreated deciduous dental caries was associated with the K-CPQ8-10 overall score (partial r = 0.15, P < 0.05). The link was highlighted in the domains of functional limitation and emotional wellbeing. Filled teeth due to caries (FT) was associated with the K-CPQ11-14 overall domain (partial r = 0.14, P = 0.002) as well as with the oral symptoms domain (partial r = 0.16, P = 0.001). This association was highlighted among public school children. Our data indicate that K-CPQ was independently associated with dental caries. The K-CPQ could be a practical tool to evaluate the subjective oral health among Korean children aged 8 to 14.	[Shin, Hye-Sun; Han, Dong-Hun; Shin, Myung-Seop; Lee, Hyun-Jin; Kim, Mi-Sun; Kim, Hyun-Duck] Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea; [Han, Dong-Hun; Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HD (corresponding author), Seoul Natl Univ, Dept Prevent & Social Dent, Sch Dent, Seoul, South Korea.	hyundkim@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013-062881]; NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2013-070465]; Brain Korea 21 at Seoul National University School of Dentistry in Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea; Brain Korea 21 at Seoul National University School of Dentistry in Korea	This work was supported by the grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2013-062881) and the NRF Grant, through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2013-070465) at Seoul National University in Korea. Ms. Shin was supported by grants from Brain Korea 21 at Seoul National University School of Dentistry in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz FD, 2011, MED ORAL PATOL ORAL, V16, pE430, DOI 10.4317/medoral.16.e430; Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301; Bae KH, 2007, COMMUNITY DENT ORAL, V35, P73, DOI 10.1111/j.1600-0528.2007.00331.x; Barbosa Tais S, 2009, BMC Oral Health, V9, P13, DOI 10.1186/1472-6831-9-13; Barbosa TS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-32; Bekes K, 2012, CLIN ORAL INVEST, V16, P165, DOI 10.1007/s00784-010-0496-5; Bendo CB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-114; Brown A, 2006, INT J PAEDIATR DENT, V16, P405, DOI 10.1111/j.1365-263X.2006.00775.x; Costa AA, 2011, J ORTHOD, V38, P275, DOI 10.1179/14653121141632; Do LG, 2008, COMMUNITY DENT HLTH, V25, P205, DOI 10.1922/CDH_2241Do06; Gherunpong Sudaduang, 2004, Community Dent Health, V21, P161; Goursand D, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-2; Gururatana O, 2011, COMMUNITY DENT HLTH, V28, P232, DOI 10.1922/CDH_2588Gururatana06; Jokovic A, 2004, PEDIATR DENT, V26, P512; Jokovic A, 2002, J DENT RES, V81, P459, DOI 10.1177/154405910208100705; Kolawole KA, 2011, EUR J PAEDIATR DENT, V12, P55; Kushnir D, 2004, J PUBLIC HEALTH DENT, V64, P71, DOI 10.1111/j.1752-7325.2004.tb02730.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larsson P, 2004, ACTA ODONTOL SCAND, V62, P147, DOI 10.1080/00016350410001496; Lawrence H P, 2001, Community Dent Health, V18, P207; Marshman Z, 2005, COMMUNITY DENT HLTH, V22, P151; McGrath C, 2008, INT J PAEDIATR DENT, V18, P267, DOI [10.1111/j.1365-263X.2007.00877.x, 10.1111/j.1365-263X.2007.00878.x]; Olivieri A, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-55; Oscarson N, 2007, CARIES RES, V41, P85, DOI 10.1159/000098040; Page LAF, 2005, J DENT RES, V84, P649, DOI 10.1177/154405910508400713; Page LAF, 2013, INT J PAEDIATR DENT, V23, P415, DOI 10.1111/ipd.12011; Page LAF, 2013, EUR J ORAL SCI, V121, P182, DOI 10.1111/eos.12034; Page LAF, 2012, J PUBLIC HEALTH DENT, V72, P287, DOI 10.1111/j.1752-7325.2012.00336.x; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Robinson PG, 2003, COMMUNITY DENT ORAL, V31, P90, DOI 10.1034/j.1600-0528.2003.00051.x; Sheiham A, 2005, B WORLD HEALTH ORGAN, V83, P644; Slade G D, 1994, Community Dent Health, V11, P3; Slade GD, 1998, COMMUNITY DENT ORAL, V26, P52; Torres CS, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-43; Vargas-Ferreira F, 2011, BRAZ ORAL RES, V25, P531, DOI 10.1590/S1806-83242011000600010; Wogelius P., 2009, BMC ORAL HEALTH, V9, P11, DOI DOI 10.1186/1472-6831-9-11; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116011	10.1371/journal.pone.0116011	http://dx.doi.org/10.1371/journal.pone.0116011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675410	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000006
J	Doldan-Martelli, V; Miguez, DG				Doldan-Martelli, Victoria; Miguez, David G.			Synergistic Interaction between Selective Drugs in Cell Populations Models	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-I TRIAL; FUSION PROTEIN; APOPTOSIS INDUCTION; MEDIATED APOPTOSIS; SPECIFICITY; LYMPHOMA; TARGET; LIGAND; CANCER	The design of selective drugs and combinatorial drug treatments are two of the main focuses in modern pharmacology. In this study we use a mathematical model of chimeric ligand-receptor interaction to show that the combination of selective drugs is synergistic in nature, providing a way to gain optimal selective potential at reduced doses compared to the same drugs when applied individually. We use a cell population model of proliferating cells expressing two different amounts of a target protein to show that both selectivity and synergism are robust against variability and heritability in the cell population. The reduction in the total drug administered due to the synergistic performance of the selective drugs can potentially result in reduced toxicity and off-target interactions, providing a mechanism to improve the treatment of cell-based diseases caused by aberrant gene overexpression, such as cancer and diabetes.	[Miguez, David G.] Univ Autonoma Madrid, Dept Fis Mat Condensada, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid	Miguez, DG (corresponding author), Univ Autonoma Madrid, Dept Fis Mat Condensada, Condensed Matter Phys Ctr IFIMAC, Cantoblanco, E-28049 Madrid, Spain.	david.gomez.miguez@uam.es	Míguez Gómez, David/K-4519-2014; Gómez, David Míguez/P-2889-2019	Míguez Gómez, David/0000-0001-8065-1142; Gómez, David Míguez/0000-0001-8065-1142; DOLDAN MARTELLI, Victoria Lucia/0000-0002-6895-8376	Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship [RYC-2010-07450]; Plan Nacional framework [BFU2011-30303]; Ministerio de Educacion y Ciencia of Spain	Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship; Plan Nacional framework; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	The authors thank the Instituto Nicolas Cabrera of the Universidad Autonoma de Madrid (Spain). This work has been supported by the Ministry of Science and Technology of Spain via a Ramon Y Cajal Fellowship (Ref. RYC-2010-07450) and a Project from Plan Nacional framework (Ref. BFU2011-30303). VDM acknowledges financial support from the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Bremer E, 2005, J BIOL CHEM, V280, P10025, DOI 10.1074/jbc.M413673200; Bremer E, 2005, CANCER RES, V65, P3380, DOI 10.1158/0008-5472.CAN-04-2756; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cironi P, 2008, J BIOL CHEM, V283, P8469, DOI 10.1074/jbc.M708502200; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Doldan-Martelli V, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.2; Dowling MR, 2005, J R SOC INTERFACE, V2, P517, DOI 10.1098/rsif.2005.0069; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GEWERT DR, 1981, EUR J BIOCHEM, V116, P487, DOI 10.1111/j.1432-1033.1981.tb05362.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kioi M, 2006, TECHNOL CANCER RES T, V5, P239, DOI 10.1177/153303460600500307; KLEIN E, 1968, CANCER RES, V28, P1300; Kreitman RJ, 2000, J CLIN ONCOL, V18, P1622, DOI 10.1200/JCO.2000.18.8.1622; Kreitman RJ, 2005, J CLIN ONCOL, V23, P6719, DOI 10.1200/JCO.2005.11.437; Lauffenburger DA, 1993, RECEPTORS MODELS BIN, V365; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Miguez DG, 2010, BIOPHYS CHEM, V148, P74, DOI 10.1016/j.bpc.2010.02.012; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Ruiz-Herrero T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003274; SCHWARZ MA, 1995, CANCER RES, V55, P3692; Stieglmaier J, 2008, CANCER IMMUNOL IMMUN, V57, P233, DOI 10.1007/s00262-007-0370-8; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; Taylor ND, 2010, PROTEIN ENG DES SEL, V23, P251, DOI 10.1093/protein/gzp085; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Weddell JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097271; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zhang BL, 2011, REGUL TOXICOL PHARM, V60, P73, DOI 10.1016/j.yrtph.2011.02.007; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117558	10.1371/journal.pone.0117558	http://dx.doi.org/10.1371/journal.pone.0117558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671700	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300060
J	Naleway, AL; Weinmann, S; Krishnarajah, G; Arondekar, B; Fernandez, J; Swamy, G; Myers, E				Naleway, Allison L.; Weinmann, Sheila; Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle; Swamy, Geeta; Myers, Evan			Pregnancy after Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; FOLLOW-UP; FERTILITY; CONIZATION; EXCISION; OUTCOMES; WOMEN	Objective To determine whether treatments for precancerous cervical lesions were associated with lower pregnancy rates compared to rates in unexposed women and women who had a diagnostic cervical biopsy or colposcopy. Design Matched, retrospective cohort study. Setting Kaiser Permanente Northwest (KPNW), an integrated healthcare delivery system in Oregon and Washington. Patients Women 14 to 53 years old with KPNW enrollment during the period 1998 through 2009. Main Outcome Measure Pregnancy after exposure or index date. Pregnancy was defined using a validated algorithm and electronic medical records data. Results We observed 570 pregnancies following cervical treatment in 4,137 women, 1,533 pregnancies following a diagnostic procedure in 13,767 women, and 7,436 pregnancies in a frequency- matched sample of 81,435 women unexposed to treatment or diagnostic procedures. After adjusting for age and contraceptive use, we observed a higher rate of pregnancies in the treatment group compared to unexposed women (hazard ratio (HR) = 1.42, 95% confidence interval (CI): 1.30-1.55), but no difference in pregnancy rates between the treatment and diagnostic procedure groups (HR = 1.03, 95% CI: 0.93-1.13). Conclusions No adverse effects of cervical procedures on subsequent rates of pregnancy were observed in this cohort with up to twelve years of follow-up time.	[Naleway, Allison L.; Weinmann, Sheila] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97232 USA; [Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle] GlaxoSmithKline, North Amer Vaccine Dev, Philadelphia, PA USA; [Krishnarajah, Girishanthy; Arondekar, Bhakti; Fernandez, Jovelle] GlaxoSmithKline, North Amer Vaccine Dev, King Of Prussia, PA USA; [Swamy, Geeta; Myers, Evan] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Kaiser Permanente; GlaxoSmithKline; GlaxoSmithKline; Duke University	Naleway, AL (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97232 USA.	allison.naleway@kpchr.org			GlaxoSmithKline Biologicals SA; GlaxoSmithKline	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA (www.gsk.com) funded this study and was involved in all stages of study conduct, including analysis and interpretation of the data and development of this manuscript. SW and AN received grants from GlaxoSmithKline to conduct the study.	Arybn M, 2008, BMJ-BRIT MED J, V337, pa1284, DOI [10.1136/bmj.a1284, DOI 10.1136/BMJ.A1284]; BIGRIGG A, 1994, LANCET, V343, P32, DOI 10.1016/S0140-6736(94)90881-8; Chew GK, 1999, INT J GYNECOL CANCER, V9, P487, DOI 10.1046/j.1525-1438.1999.99066.x; Coppleson M, 1992, GYNECOL ONCOL, P590; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; International Agency for Research on Cancer, 2005, IARC HDB CANC PREV, V10; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Luhn P, 2013, GYNECOL ONCOL, V128, P265, DOI 10.1016/j.ygyno.2012.11.003; Martin-Hirsch P, 2000, COCHRANE DB SYST REV, V2; McLaren J, 1967, J OBSTET GYNAECOL CO, V74, P487; Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; SPITZER M, 1995, OBSTET GYNECOL, V86, P504, DOI 10.1016/0029-7844(95)00237-L; Turlington WT, 1996, J REPROD MED, V41, P815; WEBER T, 1979, ACTA OBSTET GYN SCAN, V58, P347, DOI 10.3109/00016347909154594; WEED JC, 1978, OBSTET GYNECOL, V52, P245	18	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117525	10.1371/journal.pone.0117525	http://dx.doi.org/10.1371/journal.pone.0117525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671561	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300057
J	Rao, MS; Swathi, P; Rao, CAR; Rao, KV; Raju, BMK; Srinivas, K; Manimanjari, D; Maheswari, M				Rao, Mathukumalli Srinivasa; Swathi, Pettem; Rao, Chitiprolu Anantha Rama; Rao, K. V.; Raju, B. M. K.; Srinivas, Karlapudi; Manimanjari, Dammu; Maheswari, Mandapaka			Model and Scenario Variations in Predicted Number of Generations of Spodoptera litura Fab. on Peanut during Future Climate Change Scenario	PLOS ONE			English	Article							ELEVATED CO2; TEMPERATURE; LEPIDOPTERA; INDIA	The present study features the estimation of number of generations of tobacco caterpillar, Spodoptera litura. Fab. on peanut crop at six locations in India using MarkSim, which provides General Circulation Model (GCM) of future data on daily maximum (T.max), minimum (T.min) air temperatures from six models viz., BCCR-BCM2.0, CNRM-CM3, CSIRO-Mk3.5, ECHams5, INCM-CM3.0 and MIROC3.2 along with an ensemble of the six from three emission scenarios (A2, A1B and B1). This data was used to predict the future pest scenarios following the growing degree days approach in four different climate periods viz., Baseline-1975, Near future (NF) -2020, Distant future (DF)-2050 and Very Distant future (VDF)-2080. It is predicted that more generations would occur during the three future climate periods with significant variation among scenarios and models. Among the seven models, 1-2 additional generations were predicted during DF and VDF due to higher future temperatures in CNRM-CM3, ECHams5 & CSIRO-Mk3.5 models. The temperature projections of these models indicated that the generation time would decrease by 18-22% over baseline. Analysis of variance (ANOVA) was used to partition the variation in the predicted number of generations and generation time of S. litura on peanut during crop season. Geographical location explained 34% of the total variation in number of generations, followed by time period (26%), model (1.74%) and scenario (0.74%). The remaining 14% of the variation was explained by interactions. Increased number of generations and reduction of generation time across the six peanut growing locations of India suggest that the incidence of S. litura may increase due to projected increase in temperatures in future climate change periods.	[Rao, Mathukumalli Srinivasa; Swathi, Pettem; Rao, Chitiprolu Anantha Rama; Rao, K. V.; Raju, B. M. K.; Srinivas, Karlapudi; Manimanjari, Dammu; Maheswari, Mandapaka] Cent Res Inst Dryland Agr CRIDA, Hyderabad, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Research Institute of Dryland Agriculture	Rao, MS (corresponding author), Cent Res Inst Dryland Agr CRIDA, Hyderabad, Andhra Pradesh, India.	msrao909@gmail.com			Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA)	Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA)	The work was supported by grants from the Indian Council of Agricultural Research (ICAR) in the form of National Initiative on Climate Resilient Agriculture (NICRA), http://nicra-icar.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal PK, 2008, INDIAN J AGR SCI, V78, P911; Arora M, 2005, HYDROLOG SCI J, V50, P81, DOI 10.1623/hysj.50.1.81.56330; Bannayan M, 2009, CLIMATIC CHANGE, V93, P389, DOI 10.1007/s10584-008-9510-1; Cline W., 2007, GLOBAL WARMING AGR I; Das DK., 2011, AGROPHYSICS, V11, P13; Elsaadany G.B., 2000, ANN AGR SCI, P1469; IPCC 2007 Climate Change, 2007, IMP AD VULN; IPCC Climate Change, 2013, PHYS SCI BAS SUMM PO, P3; Jones P. G., 2011, GENERATING CHARACTER; Jones PG, 2011, MARKSIMGCM WEATHER S; Krishna Kumar K., 2011, CURR SCI, V3, P312; Lastuka Z., 2008, PLANT PROTECT SCI, V45, pS53; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; POLLARD E, 1994, MONITORING BUTTERFLI; Rajib MA, 2011, P GLOB C GLOB WARM 2; RAO GVR, 1989, ENVIRON ENTOMOL, V18, P548, DOI 10.1093/ee/18.4.548; Rao M. Srinivasa, 2014, Scientific Research and Essays, V9, P195; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; Some L, 2012, W AFRICAN AGR CLIMAT; Srinivasa Rao M, 2012, S MAN STRESS DRYL CL, P12; Srinivasa Rao M, 2014, SOFTWARE ESTIMATING; Stern Nicholas, 2006, STERN REV EC CLIMATE; Wightman J. A., 1994, GROUNDNUT CROP SCI B, P395, DOI DOI 10.1007/978-94-011-0733-4_11; Zhai F., 2009, 131 ADBI; Ziter C, 2012, GLOBAL CHANGE BIOL, V18, P2771, DOI 10.1111/j.1365-2486.2012.02748.x	26	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116762	10.1371/journal.pone.0116762	http://dx.doi.org/10.1371/journal.pone.0116762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671564	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300025
J	Djami-Tchatchou, AT; Maake, MP; Piater, LA; Dubery, IA				Djami-Tchatchou, Arnaud T.; Maake, Mmapula P.; Piater, Lizelle A.; Dubery, Ian A.			Isonitrosoacetophenone Drives Transcriptional Reprogramming in Nicotiana tabacum Cells in Support of Innate Immunity and Defense	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; DISEASE RESISTANCE; LIGNIN BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; RESPONSES; EXPRESSION; TOBACCO; GENES; TRANSPORT	Plants respond to various stress stimuli by activating broad-spectrum defense responses both locally as well as systemically. As such, identification of expressed genes represents an important step towards understanding inducible defense responses and assists in designing appropriate intervention strategies for disease management. Genes differentially expressed in tobacco cell suspensions following elicitation with isonitrosoacetophenone (INAP) were identified using mRNA differential display and pyro-sequencing. Sequencing data produced 14579 reads, which resulted in 198 contigs and 1758 singletons. Following BLAST analyses, several inducible plant defense genes of interest were identified and classified into functional categories including signal transduction, transcription activation, transcription and protein synthesis, protein degradation and ubiquitination, stress-responsive, defense-related, metabolism and energy, regulation, transportation, cytoskeleton and cell wall-related. Quantitative PCR was used to investigate the expression of 17 selected target genes within these categories. Results indicate that INAP has a sensitising or priming effect through activation of salicylic acid-, jasmonic acid- and ethylene pathways that result in an altered transcriptome, with the expression of genes involved in perception of pathogens and associated cellular re-programming in support of defense. Furthermore, infection assays with the pathogen Pseudomonas syringae pv. tabaci confirmed the establishment of a functional anti-microbial environment in planta.	[Djami-Tchatchou, Arnaud T.; Maake, Mmapula P.; Piater, Lizelle A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, Auckland Pk, South Africa	University of Johannesburg	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, Auckland Pk, South Africa.	idubery@uj.ac.za	Dubery, Ian/A-6346-2013; TCHATCHOU, ARNAUD THIERRY DJAMI/S-2039-2019	Dubery, Ian/0000-0002-9079-4769; TCHATCHOU, ARNAUD THIERRY DJAMI/0000-0002-7496-449X; Piater, Lizelle/0000-0002-9526-0109	National Research Foundation, South Africa [76523]; University of Johannesburg, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Johannesburg, South Africa	The authors acknowledge fellowship support (MM and AD) and financial support (ID, grant number 76523) from the National Research Foundation (www.nrf.ac.za), South Africa and the University of Johannesburg, South Africa (www.uj.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Briceno Z, 2012, J PLANT PHYSIOL, V169, P1050, DOI 10.1016/j.jplph.2012.03.008; CASSAB GI, 1988, ANNU REV PLANT PHYS, V39, P321, DOI 10.1146/annurev.pp.39.060188.001541; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; Dubery IA, 2007, BIOL PLANTARUM, V51, P327, DOI 10.1007/s10535-007-0063-3; Dubery IA, 1999, PHYTOCHEMISTRY, V50, P983, DOI 10.1016/S0031-9422(98)00247-7; Gerber IB, 2006, PLANT PHYSIOL BIOCH, V44, P369, DOI 10.1016/j.plaphy.2006.06.015; Gerber IB, 2008, BBA-PROTEINS PROTEOM, V1784, P1750, DOI 10.1016/j.bbapap.2008.06.012; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gust AA, 2010, CURR OPIN BIOTECH, V21, P204, DOI 10.1016/j.copbio.2010.02.004; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Kullertz G, 1999, PLANTA, V208, P599, DOI 10.1007/s004250050598; Kwon SI, 2013, PLANT PHYSIOL, V161, P1722, DOI 10.1104/pp.112.208108; Liu F, 2010, PHYSIOL MOL PLANT P, V74, P330, DOI 10.1016/j.pmpp.2010.05.002; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Madala NE, 2013, PHYTOCHEMISTRY, V94, P82, DOI 10.1016/j.phytochem.2013.05.010; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; MARIVET J, 1994, PLANT MOL BIOL, V26, P1181, DOI 10.1007/BF00040698; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mashayekhi F, 2007, ANAL BIOCHEM, V363, P275, DOI 10.1016/j.ab.2007.02.002; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Moeder W, 2005, MOL PLANT MICROBE IN, V18, P116, DOI 10.1094/MPMI-18-0116; Monaghan J, 2009, SIGNAL COMMUN PLANTS, P119, DOI 10.1007/978-3-540-89230-4_7; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Nakayama A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-150; New SA, 2015, BIOL PLANT IN PRESS; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Ogawa T, 2005, PLANT PHYSIOL, V138, P1436, DOI 10.1104/pp.105.063586; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Piater LA, 2004, MOL PLANT PATHOL, V5, P331, DOI 10.1111/j.1364-3703.2004.00234.x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Qiu YJ, 2012, PLANT J, V69, P489, DOI 10.1111/j.1365-313X.2011.04807.x; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Sambrook J, 2000, MOL CLONING LAB MANU; Sanabria N, 2008, NEW PHYTOL, V178, P503, DOI 10.1111/j.1469-8137.2008.02403.x; Sanabria NM, 2006, BIOCHEM BIOPH RES CO, V344, P1001, DOI 10.1016/j.bbrc.2006.03.216; Sanabria Natasha M, 2010, Self Nonself, V1, P40; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Schreiber K, 2008, PLANT PATHOLOGY J, V24, P245, DOI 10.5423/PPJ.2008.24.3.245; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seo NS, 2008, J PLANT BIOL, V51, P1; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Thomas CM, 2000, MOL PLANT MICROBE IN, V13, P465, DOI 10.1094/MPMI.2000.13.4.465; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Tronchet M, 2010, MOL PLANT PATHOL, P1183; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Unver T, 2013, PLANT MOL BIOL REP, V31, P323, DOI 10.1007/s11105-012-0502-y; van der Merwe JA, 2006, J PLANT PHYSIOL, V163, P877, DOI 10.1016/j.jplph.2005.08.016; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vidhyasekaran P, 2014, SIGNALING COMMUNICAT, P1; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Widjaja I, 2010, PLANT J, V61, P249, DOI 10.1111/j.1365-313X.2009.04047.x; Zheng HY, 1999, MOL BIOL CELL, V10, P2251, DOI 10.1091/mbc.10.7.2251; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	86	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117377	10.1371/journal.pone.0117377	http://dx.doi.org/10.1371/journal.pone.0117377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658943	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900139
J	Gisder, S; Genersch, E				Gisder, Sebastian; Genersch, Elke			Identification of Candidate Agents Active against N. ceranae Infection in Honey Bees: Establishment of a Medium Throughput Screening Assay Based on N. ceranae Infected Cultured Cells	PLOS ONE			English	Article							ENCEPHALITOZOON SP MICROSPORIDIA; APIS-MELLIFERA-IBERIENSIS; NOSEMA-CERANAE; PARASITE; HYMENOPTERA; SURFACTIN; PATHOGEN; GERMINATION; POLLINATORS; VENTRICULUS	Many flowering plants in both natural ecosytems and agriculture are dependent on insect pollination for fruit set and seed production. Managed honey bees (Apis mellifera) and wild bees are key pollinators providing this indispensable eco- and agrosystem service. Like all other organisms, bees are attacked by numerous pathogens and parasites. Nosema apis is a honey bee pathogenic microsporidium which is widely distributed in honey bee populations without causing much harm. Its congener Nosema ceranae was originally described as pathogen of the Eastern honey bee (Apis cerana) but jumped host from A. cerana to A. mellifera about 20 years ago and spilled over from A. mellifera to Bombus spp. quite recently. N. ceranae is now considered a deadly emerging parasite of both Western honey bees and bumblebees. Hence, novel and sustainable treatment strategies against N. ceranae are urgently needed to protect honey and wild bees. We here present the development of an in vitro medium throughput screening assay for the identification of candidate agents active against N. ceranae infections. This novel assay is based on our recently developed cell culture model for N. ceranae and coupled with an RT-PCR-ELISA protocol for quantification of N. ceranae in infected cells. The assay has been adapted to the 96-well microplate format to allow automated analysis. Several substances with known (fumagillin) or presumed (surfactin) or no (paromomycin) activity against N. ceranae were tested as well as substances for which no data concerning N. ceranae inhibition existed. While fumagillin and two nitroimidazoles (metronidazole, tinidazole) totally inhibited N. ceranae proliferation, all other test substances were inactive. In summary, the assay proved suitable for substance screening and demonstrated the activity of two synthetic antibiotics against N. ceranae.	[Gisder, Sebastian; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany		Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.	elke.genersch@rz.hu-berlin.de	Gisder, Sebastian/AAF-2586-2021	Genersch, Elke/0000-0001-7906-4530	Ministries for Agriculture from the Federal States of Brandenburg (MIL), Germany; Ministries for Agriculture from the Federal States of Sachsen-Anhalt (MLU), Germany; German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV) [511-06.01-28-1-34.007-07]	Ministries for Agriculture from the Federal States of Brandenburg (MIL), Germany; Ministries for Agriculture from the Federal States of Sachsen-Anhalt (MLU), Germany; German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV)	This work was supported by grants from the Ministries for Agriculture from the Federal States of Brandenburg (MIL) and Sachsen-Anhalt (MLU), Germany. S.G. was supported by a grant (511-06.01-28-1-34.007-07) from the German Ministry of Nutrition, Agriculture and Consumer Protection (BMELV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; BAILEY L, 1953, NATURE, V171, P212, DOI 10.1038/171212a0; BAILEY L, 1955, PARASITOLOGY, V45, P86, DOI 10.1017/S0031182000027451; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; BEAUVAIS B, 1994, ANTIMICROB AGENTS CH, V38, P2440, DOI 10.1128/AAC.38.10.2440; BHAT SA, 2012, J ENTOMOL NEMATOL, V4, P12, DOI DOI 10.5897/JEN11.021; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; Botias C, 2013, RES VET SCI, V95, P1041, DOI 10.1016/j.rvsc.2013.09.012; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Cali Ann, 1999, P85; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Ferroglio E, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.11; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2006, J APICULT RES, V45, P230; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1984, J APICULT RES, V23, P102, DOI 10.1080/00218839.1984.11100617; FRIES I, 1992, APIDOLOGIE, V23, P61, DOI 10.1051/apido:19920107; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; FRIES I, 1989, J APICULT RES, V28, P107; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Grangemard I, 1997, J PEPT SCI, V3, P145, DOI 10.1002/(SICI)1099-1387(199703)3:2<145::AID-PSC96>3.0.CO;2-Y; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; HAQUE MA, 1993, J INVERTEBR PATHOL, V62, P171, DOI 10.1006/jipa.1993.1092; He Q, 1996, ANTIMICROB AGENTS CH, V40, P179, DOI 10.1128/AAC.40.1.179; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; Johny S, 2009, PARASITOL RES, V104, P419, DOI 10.1007/s00436-008-1214-y; Johny S, 2008, PARASITOL INT, V57, P362, DOI 10.1016/j.parint.2008.03.002; Katiyar SK, 1997, ANTIMICROB AGENTS CH, V41, P2729, DOI 10.1128/AAC.41.12.2729; KATIYAR SK, 1995, GENE, V152, P27, DOI 10.1016/0378-1119(94)00677-K; KATZNELSON H, 1952, SCIENCE, V115, P70, DOI 10.1126/science.115.2977.70; Kim SD, 2006, J MICROBIOL BIOTECHN, V16, P1656; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kobets T, 2010, NAT PROTOC, V5, P1074, DOI 10.1038/nprot.2010.68; Kowall M, 1998, J COLLOID INTERF SCI, V204, P1, DOI 10.1006/jcis.1998.5558; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Maistrello L, 2008, APIDOLOGIE, V39, P436, DOI 10.1051/apido:2008022; Fernandez JM, 2012, J INVERTEBR PATHOL, V111, P106, DOI 10.1016/j.jip.2012.06.008; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; MOFFETT JO, 1969, J ECON ENTOMOL, V62, P886, DOI 10.1093/jee/62.4.886; OLSEN PE, 1986, J INVERTEBR PATHOL, V47, P65, DOI 10.1016/0022-2011(86)90164-3; Pajuelo AG, 2008, J APICULT RES, V47, P84, DOI 10.1080/00218839.2008.11101429; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Payne MA, 1999, J AM VET MED ASSOC, V215, P28; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Porrini MP, 2010, PARASITOL RES, V107, P381, DOI 10.1007/s00436-010-1875-1; Seydlova G, 2008, CENT EUR J MED, V3, P123, DOI 10.2478/s11536-008-0002-5; Stevanovic J, 2013, APIDOLOGIE, V44, P522, DOI 10.1007/s13592-013-0203-z; Stevanovic J, 2011, APIDOLOGIE, V42, P49, DOI 10.1051/apido/2010034; Teixeira EW, 2013, J INVERTEBR PATHOL, V114, P250, DOI 10.1016/j.jip.2013.09.002; Underwood RM, 2004, J ECON ENTOMOL, V97, P177, DOI 10.1603/0022-0493-97.2.177; Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; WANG DI, 1969, J INVERTEBR PATHOL, V14, P135, DOI 10.1016/0022-2011(69)90098-6; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099465; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Yoder JA, 2014, APIDOLOGIE, V45, P568, DOI 10.1007/s13592-014-0274-5; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	80	20	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117200	10.1371/journal.pone.0117200	http://dx.doi.org/10.1371/journal.pone.0117200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658121	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900115
J	Huang, SL; Zhou, SQ; Zhang, YW; Lv, ZQ; Li, SS; Xie, CH; Ke, YB; Deng, PJ; Geng, YJ; Zhang, Q; Chu, XF; Yi, ZH; Zhang, Y; Wu, TC; Cheng, JQ				Huang, Suli; Zhou, Shiquan; Zhang, Yanwei; Lv, Ziquan; Li, Shanshan; Xie, Changhui; Ke, Yuebin; Deng, Pingjian; Geng, Yijie; Zhang, Qian; Chu, Xiaofan; Yi, Zhaohui; Zhang, Ying; Wu, Tangchun; Cheng, Jinquan			Association of the Genetic Polymorphisms in Pre-MicroRNAs with Risk of Ischemic Stroke in a Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; EXPRESSION PROFILE; CANCER; VARIANT; MIRNA; MIR-146A; BURDEN; CARE	microRNA (miRNA) plays a role in the pathogenesis of ischemic stroke, and single nucleotide polymorphisms in miRNA genes may contribute to disease susceptibility. However, the effect of miR-146a, miR-196a2, and miR-499 polymorphisms on ischemic stroke susceptibility has been rarely reported. Using the TaqMan assay, we evaluated the association of hsa-miR-146a/rs2910164, hsa-miR-196a2/rs11614913, and hsa-miR-499/rs3746444 polymorphisms with the risk of ischemic stroke in a Chinese population with 531 ischemic stroke patients and 531 control subjects. Rs2910164 C/G genotypes were significantly associated with increased risk of ischemic stroke in different genetic model (homozygote comparison: OR = 2.00, 95% CI, 1.29-3.12, P = 0.002; additive model: OR = 1.35, 95% CI, 1.10-1.65, P = 0.004; dominant model: OR = 1.33, 95% CI, 1.00-1.75, P = 0.049; recessive model: OR = 1.82, 95% CI, 1.20-2.74, P = 0.004). Subjects with allele G of hsa-miR-146a/rs2910164 also showed increased risk of ischemic stroke (OR = 1.33, 95% CI, 1.09-1.62, P = 0.005). Stratification analysis showed that the association between rs2910164 and the risk of ischemic stroke was more pronounced in subjects over 60 years old, females, non-drinkers, subjects without hypertension or diabetes mellitus. There were significant combined effects between miR-146a/rs2910164 and fasting glucose/low-density lipoprotein cholesterol levels on ischemic stroke susceptibility. However, we failed to find any association between the alleles/genotypes of rs11614913 T/C and ischemic stroke, respectively (P > 0.05). In summary, this study provides evidence that miR-146a/rs2910164 might be associated with a significantly increased risk of ischemic stroke in a Chinese population, and the combined effects between miRNA polymorphism and fasting glucose /blood lipid levels may contribute to stroke pathogenesis.	[Huang, Suli; Zhang, Yanwei; Lv, Ziquan; Li, Shanshan; Xie, Changhui; Ke, Yuebin; Deng, Pingjian; Geng, Yijie; Zhang, Qian; Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol, Shenzhen, Peoples R China; [Zhou, Shiquan] LongHua New Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Chu, Xiaofan; Yi, Zhaohui; Zhang, Ying] Peoples Hosp Shenzhen, Dept Neurol, Shenzhen, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Environm Protect, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Wuhan 430074, Hubei, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol, Shenzhen, Peoples R China.	cjinquan@szcdc.net			National Natural Science Foundation of China [30771852, 81402754]; China Postdoctoral Scientific Foundation [2014M562031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Scientific Foundation(China Postdoctoral Science Foundation)	This work was supported by the following sources: National Natural Science Foundation of China (no: 30771852, JQC), for study design, China Postdoctoral Scientific Foundation (no: 2014M562031, SLH) for data collection and analysis, and National Natural Science Foundation of China (no: 81402754, SLH) for preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cui GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-235; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu Y, 2013, JIMD REP, V7, P89, DOI 10.1007/8904_2012_153; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Solito E, 2008, TRENDS PHARMACOL SCI, V29, P135, DOI 10.1016/j.tips.2007.12.003; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tsai NW, 2012, CLIN CHIM ACTA, V413, P1861, DOI 10.1016/j.cca.2012.07.021; Wessel J, 2007, J HYPERTENS, V25, P329, DOI 10.1097/HJH.0b013e328011753e; Xiong XD, 2014, MUTAT RES-FUND MOL M, V761, P15, DOI 10.1016/j.mrfmmm.2014.01.001; Xu J, 2009, HUM MUTAT, V30, P1231, DOI 10.1002/humu.21044; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	31	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117007	10.1371/journal.pone.0117007	http://dx.doi.org/10.1371/journal.pone.0117007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658319	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900089
J	Jacomet, C; Allavena, C; Peyrol, F; Pereira, B; Joubert, LM; Bagheri, H; Cotte, L; Garaffo, R; Gerbaud, L; Dellamonica, P				Jacomet, Christine; Allavena, Clotilde; Peyrol, Fleur; Pereira, Bruno; Joubert, Laurence Morand; Bagheri, Haleh; Cotte, Laurent; Garaffo, Rodolphe; Gerbaud, Laurent; Dellamonica, Pierre			Perception of Antiretroviral Generic Medicines: One-Day Survey of HIV-Infected Patients and Their Physicians in France	PLOS ONE			English	Article							PATIENTS ATTITUDES; DRUG SUBSTITUTION; PRESCRIPTION; EXPERIENCES; VIEWS	Background In the interest of cost effectiveness, switching antiretroviral brand name medications to generics is recommended in France since 2013. The study objective was to evaluate the perception of generics per se and antiretroviral generics in HIV-infected patients and their hospital physicians Methods and Findings 556 out of 703 (79%) adult HIV+ outpatients and 116 physicians in 33 clinics were included in a multicentric cross-sectional survey performed in September 2013. Patients completed a self-questionnaire on their perception and acceptability of generics. Physicians completed a questionnaire on their acceptability of switching antiretroviral to generic. Socio-demographic data, medical history and HIV history were collected. Among the 556 patients with a median HIV duration of 13 years, 77% were France native, 59% in active employment, 100% covered by social insurance, 95% on antiretroviral therapy. Seventy-six percent of the patients accepted generics and 55% trusted them overall. Antiretroviral generics were accepted by 44% of them but only by 17% if the pill burden was going to increase. The factor significantly associated with acceptability of antiretroviral generics was acceptance of generics per se (p<0.001). Among the 116 physicians following a median of 100 HIV-patients/year, 75% would prescribe generics, dropping to 26% if the combo had to be broken. Factors significantly associated with willingness to prescribe antiretroviral generics were the absence of concern regarding the chemical entity (OR = 0.33), being aware that the patient would accept generics for other pathologies (OR = 2.04) and would accept antiretroviral generics (OR = 1.94). No factor related to sociodemographic conditions, HIV status or comorbidities was associated with the acceptability of antiretroviral generics. Conclusions Acceptability of antiretroviral generics in this French population was mostly dictated by the patient's and physician's knowledge and use of generics overall. It should be improved with an efficient information of both patients and physicians.	[Jacomet, Christine] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Malad Infect & Trop, Clermont Ferrand, France; [Allavena, Clotilde] CHU Hotel Dieu, Serv Malad Infect & Trop, Nantes, France; [Peyrol, Fleur; Gerbaud, Laurent] CHU Clermont Ferrand, EA PEPRADE 4681, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Serv Biostat, Clermont Ferrand, France; [Joubert, Laurence Morand] CHU St Antoine, INSERM, UMR S 1136, Virol Lab, Paris, France; [Bagheri, Haleh] CHU Toulouse, INSERM, U1027, Toulouse, France; [Cotte, Laurent] Hosp Civils Lyon, INSERM, U1052, Serv Malad Infect & Trop, Lyon, France; [Garaffo, Rodolphe] CHU Pasteur, Nice, France; [Dellamonica, Pierre] CHU Archet, Serv Malad Infect & Trop, Nice, France	CHU Clermont Ferrand; Nantes Universite; CHU de Nantes; CHU Clermont Ferrand; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; CHU Nice	Jacomet, C (corresponding author), CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Malad Infect & Trop, Clermont Ferrand, France.	cjacomet@chu-clermontferrand.fr	Allavena, Clotilde/AAH-4310-2019; GERBAUD, Laurent/ABY-4952-2022	Pereira, Bruno/0000-0003-3778-7161	Mylan	Mylan	This paper presents independent research by CHU Clermont-Ferrand, the promoter of the survey. Mylan provided funding for data capture. Funding sources were not involved in study design, data collection, analysis, interpretation, medical writing or submission, decision to publish, or preparation of the manuscript.	Agence Nationale de Securite du Medicament et des produits de sante (ANSM), 2012, MED GEN MED PART ENT; Allenet B, 1999, J EC MED, V17, P301; Allenet B, 2013, REV MED SUISSE, V9, P1005; [Anonymous], 2012, ACAD NATL PHARM RAPP; Barrett LL, 2005, PHYS ATTITUDES PRACT; Baudrant-Boga M, 2011, MED MALADIES METABOL, V5, pS73, DOI [10.1038/nutd.2014.45, DOI 10.1038/NUTD.2014.45]; Chong CP, 2011, HEALTH POLICY, V99, P139, DOI 10.1016/j.healthpol.2010.08.002; Collet JP, 2010, LETT CARDIOLOGUE, V341, P16; De Plazaola JP, 2014, TABLEAU EC FRANCAISE; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Figueiras MJ, 2008, PHARM WORLD SCI, V30, P590, DOI 10.1007/s11096-008-9247-y; Granlund D, 2009, SOC SCI MED, V69, P1643, DOI 10.1016/j.socscimed.2009.09.016; Hakonsen H, 2009, CURR MED RES OPIN, V25, P2515, DOI 10.1185/03007990903192223; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Kjoenniksen I, 2006, PHARM WORLD SCI, V28, P284, DOI 10.1007/s11096-006-9043-5; Lagarce L, 2005, THERAPIE, V60, P67, DOI 10.2515/therapie:2005009; Menkes CJ, 2012, B ACAD NAT MED PARIS, V196, P521, DOI 10.1016/S0001-4079(19)31843-6; Ringuier R, 2008, THERAPIE, V63, P11, DOI 10.2515/therapie:2008006; Roos J., 2005, Journal de Pharmacie Clinique, V24, P217; Sarradon-Eck A, 2007, REV EPIDEMIOL SANTE, V55, P179, DOI 10.1016/j.respe.2007.01.026; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Valles JA, 2003, HEALTH POLICY, V65, P269, DOI 10.1016/S0168-8510(03)00018-6; WHO, 2010, WOR HEALT REP, P1; Zucman D, 2014, AIDS, V28, P607, DOI 10.1097/QAD.0000000000000170	26	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117214	10.1371/journal.pone.0117214	http://dx.doi.org/10.1371/journal.pone.0117214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658627	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900118
J	Kim, H; Cha, GW; Jeong, YE; Lee, WG; Chang, KS; Roh, JY; Yang, SC; Park, MY; Park, C; Shin, EH				Kim, Hyunwoo; Cha, Go-Woon; Jeong, Young Eui; Lee, Wook-Gyo; Chang, Kyu Sik; Roh, Jong Yul; Yang, Sung Chan; Park, Mi Yeoun; Park, Chan; Shin, E-Hyun			Detection of Japanese Encephalitis Virus Genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea	PLOS ONE			English	Article							WEST-NILE-VIRUS; SOUTH-KOREA; TRANSMISSION; MOSQUITOS	Japanese encephalitis virus (JEV) causes significant viral encephalitis and is distributed throughout the Asian countries. The virus is known to be transmitted by Culex tritaeniorhynchus, which mainly breeds in rice paddies in Korea. In this study, we investigated the presence of other mosquito species that can transmit JEV as a second or regional vector. We selected five cities where patients have experienced JE in the last 5 years as mosquito-collecting locations and subdivided them into four collection sites according to the mosquito habitats (cowshed, downtown area, forest, and swamp). Mosquitoes were caught using the BG-Sentinel trap, CDC black-light trap, Fay-Prince trap, and Gravid trap. A total of 993 pools from 22,774 mosquitoes were prepared according to their species, collection date, and site. We performed a SYBR Green 1-based real-time RT-PCR assay to detect JEV from the mosquito pools. A total of six JEV-positive pools were detected from Culex orientalis and Culex pipiens caught in the Gangwon-do and Gyeonngi-do provinces. All the detected JEVs were revealed as genotype V by phylogenetic analysis of the envelope gene. Our findings confirm that a new genotype of JEV was introduced in Korea and suggest that two mosquito species may play a role in JEV transmission.	[Kim, Hyunwoo; Lee, Wook-Gyo; Chang, Kyu Sik; Roh, Jong Yul; Yang, Sung Chan; Park, Mi Yeoun; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea; [Cha, Go-Woon; Jeong, Young Eui; Park, Chan] Korea Natl Inst Hlth, Div Arboviruses, Ctr Immunol & Pathol, Cheongju, South Korea; [Kim, Hyunwoo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jeong, Young Eui] Hallym Univ, Grad Sch, Dept Biomed Sci, Chunchon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Seoul National University (SNU); Hallym University	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019		Research of Korea Center for Disease Control and Prevention [2012-N55001-00]	Research of Korea Center for Disease Control and Prevention	This research was supported by funding (2012-N55001-00) from Research of Korea Center for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen WJ, 2000, J MED ENTOMOL, V37, P108, DOI 10.1603/0022-2585-37.1.108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Johansen CA, 2002, AM J TROP MED HYG, V67, P656, DOI 10.4269/ajtmh.2002.67.656; Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; Ravanini P, 2012, EUROSURVEILLANCE, V17, P2; Ree Han-Il, 2003, Korean Journal of Entomology, V33, P39; Seo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055165; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 1974, REVISION ADULT LARVA; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127	21	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116547	10.1371/journal.pone.0116547	http://dx.doi.org/10.1371/journal.pone.0116547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658839	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900048
J	Sarkar, S; Pires, MM				Sarkar, Sourav; Pires, Marcos M.			d-Amino Acids Do Not Inhibit Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; MECHANISMS	Bacteria can either exist in the planktonic (free floating) state or in the biofilm (encased within an organic framework) state. Bacteria biofilms cause industrial concerns and medical complications and there has been a great deal of interest in the discovery of small molecule agents that can inhibit the formation of biofilms or disperse existing structures. Herein we show that, contrary to previously published reports, d-amino acids do not inhibit biofilm formation of Bacillus subtilis (B. subtilis), Staphylococcus aureus (S. aureus), and Staphylococcus epidermis (S. epidermis) at millimolar concentrations. We evaluated a diverse set of natural and unnatural d-amino acids and observed no activity from these compounds in inhibiting biofilm formation.	[Sarkar, Sourav; Pires, Marcos M.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA	Lehigh University	Pires, MM (corresponding author), Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA.	map311@lehigh.edu			Lehigh University start up	Lehigh University start up	This work was supported by: Lehigh University start up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Burt SA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; Huigens RW, 2007, J AM CHEM SOC, V129, P6966, DOI 10.1021/ja069017t; Kadam RU, 2011, ANGEW CHEM INT EDIT, V50, P10631, DOI 10.1002/anie.201104342; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Petrelli D, 2008, J MED MICROBIOL, V57, P364, DOI 10.1099/jmm.0.47621-0; Ramon-Perez ML, 2014, J MED MICROBIOLOGY; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Sanchez CJ, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-611, DOI 10.1186/1471-2334-13-611]; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960	32	32	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117613	10.1371/journal.pone.0117613	http://dx.doi.org/10.1371/journal.pone.0117613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658642	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900190
J	Sun, HW; Wu, XL; Wu, F; Li, Y; Yu, ZP; Chen, XR; Chen, YZ; Yang, WJ				Sun, Hongwei; Wu, Xiaoli; Wu, Fang; Li, Ying; Yu, Zhengping; Chen, Xiangrong; Chen, Yunzhi; Yang, Wenjun			Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population	PLOS ONE			English	Article							STEM-CELL ANTIGEN; GENOME-WIDE ASSOCIATION; PHOSPHOLIPASE-C EPSILON; GASTRIC-CANCER; RISK; POLYMORPHISMS; ESOPHAGEAL; CARCINOMA; LOCI; 10Q23	Background Several genetic variants including PSCA rs2294008 C>T and rs2976392 G>A, MUC1 rs4072037 T>C, and PLCE1 rs2274223 A>G have shown significant association with stomach cancer risk in the previous genome-wide association studies (GWASs). Methods To evaluate associations of these SNPs in the Han Chinese, an independent hospital based case-control study was performed by genotyping these four polymorphisms in a total of 692 stomach cancer cases and 774 healthy controls acquired by using frequency matching for age and gender. False-positive report probability (FPRP) analysis was also performed to validate all statistically significant findings. Results In the current study, significant association with stomach cancer susceptibility was observed for all the four polymorphisms of interest. Specifically, a significant increased stomach cancer risk was associated with PSCA rs2294008 (CT vs. CC: adjusted OR = 1.37, 95% CI = 1.07-1.74, and CT/TT vs. CC: adjusted OR = 1.30, 95% CI = 1.03-1.63), PSCA rs2976392 (AG vs. GG: adjusted OR = 1.30, 95% CI = 1.02-1.65, and AG/AA vs. GG: adjusted OR = 1.26, 95% CI = 1.00-1.59), or PLCE1 rs2274223 (AG vs. AA: adjusted OR = 1.48, 95% CI = 1.15-1.90, and AG/GG vs. AA: adjusted OR = 1.45, 95% CI = 1.14-1.84), respectively. In contrast, MUC1 rs4072037 was shown to decrease the cancer risk (CT vs. TT: adjusted OR = 0.77, 95% CI = 0.60-0.98). Patients with more than one risk genotypes had significant increased risk to develop stomach cancer (adjusted OR = 1.30, 95% CI = 1.03-1.64), when compared with those having 0-1 risk genotypes. Stratified analysis indicated that the increased risk was more pronounced in younger subjects, men, ever smokers, smokers with pack years <= 27, patients with high BMI, or non-cardia stomach cancer. Conclusions This study substantiated the associations between four previous reported genetic variants and stomach cancer susceptibility in an independent Han Chinese population. Further studies with larger sample size and different ethnicities are warranted to validate our findings.	[Sun, Hongwei; Yu, Zhengping; Chen, Yunzhi; Yang, Wenjun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Zhejiang, Peoples R China; [Wu, Xiaoli; Wu, Fang; Chen, Xiangrong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Ying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Operating Room, Wenzhou 325000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Yang, WJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Zhejiang, Peoples R China.	mdyangwenjun@126.com			China National Natural Science Foundation [81370563]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China [2011ZA072]; ministry of health of China-the major medicine science and technology project in Zhejiang province [WKJ2012-2-033]; science technology department of Zhejiang province [2012C23108]; Excellent Youth Foundation of Zhejiang Provincial Natural Science [LR14H030001]; science and technology of Wencheng county	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China; ministry of health of China-the major medicine science and technology project in Zhejiang province; science technology department of Zhejiang province; Excellent Youth Foundation of Zhejiang Provincial Natural Science; science and technology of Wencheng county	The study was supported by China National Natural Science Foundation (No. 81370563) grant and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China (No. 2011ZA072) and Project supported by ministry of health of China-the major medicine science and technology project in Zhejiang province (No. WKJ2012-2-033) and Public welfare technology application research project supported by science technology department of Zhejiang province (No. 2012C23108) and Excellent Youth Foundation of Zhejiang Provincial Natural Science (No. LR14H030001) and project of science and technology of Wencheng county. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bye H, 2012, CARCINOGENESIS, V33, P2155, DOI 10.1093/carcin/bgs262; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Dura P, 2013, EUR J CANCER PREV, V22, P417, DOI 10.1097/CEJ.0b013e32835c7f53; Eshel R, 2002, INT J CANCER, V98, P803, DOI 10.1002/ijc.10301; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Gu XX, 2014, TUMOR BIOL, V35, P2167, DOI 10.1007/s13277-013-1287-9; Hao NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067229; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hu HC, 2012, ANN SURG ONCOL, V19, P2403, DOI 10.1245/s10434-011-2160-y; Hu Zhibin, 2007, Gastrointest Cancer Res, V1, P12; Hwang JY, 2013, J HUM GENET, V58, P233, DOI 10.1038/jhg.2012.158; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Li F, 2012, ASIAN PAC J CANCER P, V13, P2593, DOI 10.7314/APJCP.2012.13.6.2593; Li FX, 2012, MOL BIOL REP, V39, P9557, DOI 10.1007/s11033-012-1820-8; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Ma HX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-258; Mai RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069214; Malik MA, 2014, ASIAN PAC J CANCER P, V15, P4319, DOI 10.7314/APJCP.2014.15.10.4319; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Ou JF, 2010, DNA CELL BIOL, V29, P319, DOI 10.1089/dna.2009.0960; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Qiao L, 2012, GENE, V493, P83, DOI 10.1016/j.gene.2011.11.017; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Rouissi K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-101; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Sharma Kiran Lata, 2013, J Gastrointest Cancer, V44, P436, DOI 10.1007/s12029-013-9537-z; Shi DN, 2012, J CANCER RES CLIN, V138, P1339, DOI 10.1007/s00432-012-1210-6; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Umar M, 2014, TUMOR BIOL, V35, P11667, DOI 10.1007/s13277-014-2458-z; Umar M, 2013, TUMOR BIOL, V34, P3537, DOI 10.1007/s13277-013-0932-7; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wang T, 2012, CANCER EPIDEM BIOMAR, V21, P843, DOI 10.1158/1055-9965.EPI-11-1176; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; Zhang QH, 2012, ASIAN PAC J CANCER P, V13, P2867, DOI 10.7314/APJCP.2012.13.6.2867; Zhang T, 2012, EXP THER MED, V4, P158, DOI 10.3892/etm.2012.563; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076425; Zheng LZ, 2013, MOL BIOL REP, V40, P5791, DOI 10.1007/s11033-013-2682-4; Zhou RM, 2012, ARCH MED RES, V43, P578, DOI 10.1016/j.arcmed.2012.09.006	61	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117576	10.1371/journal.pone.0117576	http://dx.doi.org/10.1371/journal.pone.0117576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658482	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900180
J	Tulapurkar, ME; Ramarathnam, A; Hasday, JD; Singh, IS				Tulapurkar, Mohan E.; Ramarathnam, Aparna; Hasday, Jeffrey D.; Singh, Ishwar S.			Bacterial Lipopolysaccharide Augments Febrile-Range Hyperthermia-Induced Heat Shock Protein 70 Expression and Extracellular Release in Human THP1 Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NECROSIS-FACTOR-ALPHA; LPS-STIMULATED MACROPHAGES; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; FACTOR-I; STRESS; HSP70	Sepsis, a devastating and often lethal complication of severe infection, is characterized by fever and dysregulated inflammation. While infections activate the inflammatory response in part through Toll-like receptors (TLRs), fever can partially activate the heat shock response with generation of heat shock proteins (HSPs). Since extracellular HSPs, especially HSP70 (eHSP70), are proinflammatory TLR agonists, we investigated how exposure to the TLR4 agonist, bacterial lipopolysaccharide (LPS) and febrile range hyperthermia (FRH; 39.5 degrees C) modify HSP70 expression and extracellular release. Using differentiated THP1 cells, we found that concurrent exposure to FRH and LPS as well as TLR2 and TLR3 agonists synergized to activate expression of inducible HSP72 (HSPA1A) mRNA and protein via a p38 MAP kinase-requiring mechanism. Treatment with LPS for 6 h stimulated eHSP70 release; levels of eHSP70 released at 39.5 degrees C were higher than at 37 degrees C roughly paralleling the increase in intracellular HSP72 in the 39.5 degrees C cells. By contrast, 6 h exposure to FRH in the absence of LPS failed to promote eHSP70 release. Release of eHSP70 by LPS-treated THP1 cells was inhibited by glibenclamide, but not brefeldin, indicating that eHSP70 secretion occurred via a non-classical protein secretory mechanism. Analysis of eHSP70 levels in exosomes and exosome-depleted culture supernatants from LPS-treated THP1 cells using ELISA demonstrated similar eHSP70 levels in unfractionated and exosome-depleted culture supernatants, indicating that LPS-stimulated eHSP70 release did not occur via the exosome pathway. Immunoblot analysis of the exosome fraction of culture supernatants from these cells showed constitutive HSC70 (HSPA8) to be the predominant HSP70 family member present in exosomes. In summary, we have shown that LPS stimulates macrophages to secrete inducible HSP72 via a non-classical non-exosomal pathway while synergizing with FRH exposure to increase both intracellular and secreted levels of inducible HSP72. The impact of increased macrophage intracellular HSP70 levels and augmented secretion of proinflammatory eHSP70 in the febrile, infected patient remains to be elucidated.	[Tulapurkar, Mohan E.; Ramarathnam, Aparna; Hasday, Jeffrey D.; Singh, Ishwar S.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.] Univ Maryland, Sch Med, Cytokine Core Lab, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.; Singh, Ishwar S.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Singh, IS (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA.	isingh@medicine.umaryland.edu	tulapurkar, mohan/F-1926-2015	tulapurkar, mohan/0000-0002-2476-5417	Department of Veteran Affairs Merit Review [IBX002143A]; National Institutes of Health [HL69057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002143] Funding Source: NIH RePORTER	Department of Veteran Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Supported by Department of Veteran Affairs Merit Review award IBX002143A and National Institutes of Health grant HL69057 (JDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Aneja R, 2006, J IMMUNOL, V177, P7184, DOI 10.4049/jimmunol.177.10.7184; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BAUMGARTNER RA, 1994, J IMMUNOL, V153, P2609; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Cooper ZA, 2010, CELL STRESS CHAPERON, V15, P665, DOI 10.1007/s12192-010-0179-9; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Edelman DA, 2007, J SURG RES, V140, P171, DOI 10.1016/j.jss.2006.12.560; Evdonin AL, 2006, EUR J CELL BIOL, V85, P443, DOI 10.1016/j.ejcb.2006.02.008; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Ganter MT, 2006, AM J PHYSIOL-LUNG C, V291, pL354, DOI 10.1152/ajplung.00405.2005; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gupta A, 2013, J BIOL CHEM, V288, P2756, DOI 10.1074/jbc.M112.427336; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Hasday JD, 2001, J APPL PHYSIOL, V90, P90, DOI 10.1152/jappl.2001.90.1.90; Hasday Jeffrey D, 2011, Trans Am Clin Climatol Assoc, V122, P34; Hashiguchi N, 2001, J TRAUMA, V51, P1104, DOI 10.1097/00005373-200112000-00015; Hopkins PM, 2011, BRIT J ANAESTH, V107, P48, DOI 10.1093/bja/aer132; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Mambula SS, 2006, INT J HYPERTHER, V22, P575, DOI 10.1080/02656730600976042; McClung JP, 2008, AM J PHYSIOL-REG I, V294, pR185, DOI 10.1152/ajpregu.00532.2007; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nagarsekar A, 2008, J IMMUNOL, V181, P2636, DOI 10.4049/jimmunol.181.4.2636; Nagarsekar A, 2012, AM J RESP CELL MOL, V47, P824, DOI 10.1165/rcmb.2012-0105OC; Nakano M, 1996, AM J PHYSIOL-HEART C, V270, pH1231, DOI 10.1152/ajpheart.1996.270.4.H1231; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; Njemini R, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-24; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Shah NG, 2012, INT J HYPERTHER, V28, P627, DOI 10.3109/02656736.2012.690547; Shah NG, 2010, PROSTAG OTH LIPID M, V93, P1, DOI 10.1016/j.prostaglandins.2010.03.006; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2004, J ENDOTOXIN RES, V10, P175, DOI 10.1179/096805104225004851; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh IS, 2008, AM J RESP CELL MOL, V39, P235, DOI 10.1165/rcmb.2007-0294OC; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Stephanou A, 1997, BIOCHEM J, V321, P103, DOI 10.1042/bj3210103; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Tulapurkar ME, 2012, AM J RESP CELL MOL, V46, P807, DOI 10.1165/rcmb.2011-0378OC; Tulapurkar ME, 2009, CELL STRESS CHAPERON, V14, P499, DOI 10.1007/s12192-009-0103-3; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Zhan R, 2009, BIOCHEM BIOPH RES CO, V387, P229, DOI 10.1016/j.bbrc.2009.06.095	60	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118010	10.1371/journal.pone.0118010	http://dx.doi.org/10.1371/journal.pone.0118010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659128	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900249
J	Dengl, S; Hoffmann, E; Grote, M; Wagner, C; Mundigl, O; Georges, G; Thorey, I; Stubenrauch, KG; Bujotzek, A; Josel, HP; Dziadek, S; Benz, J; Brinkmann, U				Dengl, Stefan; Hoffmann, Eike; Grote, Michael; Wagner, Cornelia; Mundigl, Olaf; Georges, Guy; Thorey, Irmgard; Stubenrauch, Kay-Gunnar; Bujotzek, Alexander; Josel, Hans-Peter; Dziadek, Sebastian; Benz, Joerg; Brinkmann, Ulrich			Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies	FASEB JOURNAL			English	Article						targeted delivery; biotin; X-ray structure; protein engineering; pharmacokinetics	NEUROPEPTIDE-Y; HALF-LIFE; BINDING; DRUG; CONJUGATION; PEPTIDES	Humanized hapten-binding IgGs were designed with an accessible cysteine close to their binding pockets, for specific covalent payload attachment. Individual analyses of known structures of digoxigenin (Dig)- and fluorescein (Fluo) binding antibodies and a new structure of a biotin (Biot)-binder, revealed a universal coupling position (52(+2)) in proximity to binding pockets but without contributing to hapten interactions. Payloads that carry a free thiol are positioned on the antibody and covalently linked to it via disulfides. Covalent coupling is achieved and driven toward complete (95-100%) payload occupancy by spontaneous redox shuffling between antibody and payload. Attachment at the universal position works with different haptens, antibodies, and payloads. Examples are the haptens Fluo, Dig, and Biot combined with various fluorescent or peptidic payloads. Disulfide-bonded covalent antibody-payload complexes do not dissociate in vitro and in vivo. Coupling requires the designed cysteine and matching payload thiol because payload or antibody without the Cys/thiol are not linked (<5% nonspecific coupling). Hapten-mediated positioning is necessary as hapten-thiol-payload is only coupled to antibodies that bind matching haptens. Covalent complexes are more stable in vivo than noncovalent counterparts because digoxigeninylated or biotinylated fluorescent payloads without disulfide-linkage are cleared more rapidly in mice (approximately 50% reduced 48 hour serum levels) compared with their covalently linked counterparts. The coupling technology is applicable to many haptens and hapten binding antibodies (confirmed by automated analyses of the structures of 140 additional hapten binding antibodies) and can be applied to modulate the pharmacokinetics of small compounds or peptides. It is also suitable to link payloads in a reduction-releasable manner to tumor- or tissue-targeting delivery vehicles.-Dengl, S., Hoffmann, E., Grote, M., Wagner, C., Mundigl, O., Georges, G., Thorey, I., Stubenrauch, K.-G., Bujotzek, A., Josel, H.-P., Dziadek, S., Benz, J., Brinkmann, U. Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.	[Dengl, Stefan; Hoffmann, Eike; Grote, Michael; Wagner, Cornelia; Mundigl, Olaf; Georges, Guy; Thorey, Irmgard; Stubenrauch, Kay-Gunnar; Bujotzek, Alexander; Brinkmann, Ulrich] Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev, Large Mol Res, D-82377 Penzberg, Germany; [Josel, Hans-Peter; Dziadek, Sebastian] Roche Diagnost GmbH, Penzberg, Germany; [Benz, Joerg] Roche Discovery Technol, Roche Innovat Ctr Basel, Basel, Switzerland	Roche Holding; Roche Holding	Dengl, S (corresponding author), Roche Innovat Ctr Penzberg, Nonnenwald 2, D-82377 Penzberg, Germany.	ulrich.brinkmann@roche.com	Brinkmann, Ulrich/AAF-8216-2019	Brinkmann, Ulrich/0000-0002-5558-0212	Roche Postdoc Fund	Roche Postdoc Fund	The authors thank Klaus Mayer, Daniela Matscheko, Cornelius Gati, Elisabeth Graeber, Stephan Nothjunge, Michael Tischler, Helga Becker, Fabian Rodewald, and Ranjan Sircar for excellent technical and operative support. A.B. is supported by the Roche Postdoc Fund. The authors are employed by Roche. Roche has an interest in and patent applications for payload coupling and PK modulation technologies.	Ahrens VM, 2012, FUTURE MED CHEM, V4, P1567, DOI [10.4155/FMC.12.76, 10.4155/fmc.12.76]; Amiri-Kordestani L, 2014, CLIN CANCER RES, V20, P4436, DOI 10.1158/1078-0432.CCR-14-0012; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Behrens CR, 2014, MABS-AUSTIN, V6, P46, DOI 10.4161/mabs.26632; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Danho W, 2009, ADV EXP MED BIOL, V611, P467, DOI 10.1007/978-0-387-73657-0_201; Dautzenberg FM, 2005, PHARMACOLOGY, V75, P21, DOI 10.1159/000085897; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Doppalapudi VR, 2007, BIOORG MED CHEM LETT, V17, P501, DOI 10.1016/j.bmcl.2006.10.009; Doppalapudi VR, 2010, P NATL ACAD SCI USA, V107, P22611, DOI 10.1073/pnas.1016478108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hoffmann E, 2013, J CONTROL RELEASE, V171, P48, DOI 10.1016/j.jconrel.2013.06.021; Horwitz SM, 2014, BLOOD, V123, P3095, DOI 10.1182/blood-2013-12-542142; Hutt M, 2012, J BIOL CHEM, V287, P4462, DOI 10.1074/jbc.M111.311522; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kabat EA, 1991, NIH PUBL; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kornberger P, 2014, MABS-AUSTIN, V6, P354, DOI 10.4161/mabs.27444; KRANZ DM, 1982, J BIOL CHEM, V257, P6987; Metz S, 2011, P NATL ACAD SCI USA, V108, P8194, DOI 10.1073/pnas.1018565108; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen AD, 2011, CURR OPIN ENDOCRINOL, V18, P56, DOI 10.1097/MED.0b013e3283422f0a; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Paterson BM, 2014, ANGEW CHEM INT EDIT, V53, P6115, DOI 10.1002/anie.201402613; Reiter Y, 1995, PROTEIN ENG, V8, P1323, DOI 10.1093/protein/8.12.1323; Sassoon I, 2013, METHODS MOL BIOL, V1045, P1, DOI 10.1007/978-1-62703-541-5_1; Syed S, 1997, BLOOD, V89, P3243, DOI 10.1182/blood.V89.9.3243; Zac-Varghese S, 2011, CURR OPIN PHARMACOL, V11, P582, DOI 10.1016/j.coph.2011.10.001	31	10	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1763	1779		10.1096/fj.14-263665	http://dx.doi.org/10.1096/fj.14-263665			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25670234	Green Published, hybrid			2022-12-26	WOS:000354114600014
J	Ma, SK; Wang, YQ; Chen, JC; Zhang, MZ; Harris, RC; Chen, JK				Ma, Seong Kwon; Wang, Yinqiu; Chen, Jianchun; Zhang, Ming-Zhi; Harris, Raymond C.; Chen, Jian-Kang			Overexpression of G-Protein-Coupled Receptor 40 Enhances the Mitogenic Response to Epoxyeicosatrienoic Acids	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SODIUM-CHANNEL ACTIVITY; FREE FATTY-ACIDS; ARACHIDONIC-ACID; EPITHELIAL-CELLS; TYROSINE PHOSPHORYLATION; EPOXYGENASE METABOLITES; SRC KINASE; GPR40; CYTOCHROME-P450	The cytochrome P450 epoxygenase-dependent arachidonic acid metabolites, epoxyeicosatrienoic acids (EETs), are potent survival factors and mitogens for renal epithelial cells, but the molecular identity in the cells that initiates the mitogenic signaling of EETs has remained elusive. We screened kidney cell lines for the expression of G-protein-coupled receptor 40 (GPR40) and found that the porcine renal tubular epithelial cell line LLCPKcl4, which has been previously demonstrated to be sensitive to the mitogenic effect of EETs, expresses higher levels of GPR40 mRNA and protein than the human embryonic kidney cell line HEK293. EETs induced only a weak mitogenic EGFR signaling and mild cell proliferation in HEK293 cells. To determine whether GPR40 expression level is what mediates the mitogenic sensitivity of cells to EETs, we created a human GPR40 (hGPR40) cDNA construct and transfected it into HEK293 cells and picked up a number of stable transfectants. We found that GPR40 overexpression in HEK293 cells indeed significantly enhanced EETinduced cell proliferation and markedly augmented EGFR phosphorylation ERK activation, which were inhibited by the EGFR tyrosine kinase inhibitor, AG1478, or the HB-EGF inhibitor, CRM197. EETs significantly enhanced release of soluble HB-EGF, a natural ligand of EGFR, into the culture medium of hGPR40-transfected HEK293 cells, compared to empty vector-transfected cells. In mouse kidneys, markedly higher level of GPR40 protein was found in the cortex and outer stripe of outer medulla compared to the inner stripe of outer medulla and inner medulla. In situ hybridization confirmed that GPR40 mRNA was localized to a subset of renal tubules in the kidney, including the cortical collecting duct. Thus, this study provides the first demonstration that upregulation of GPR40 expression enhances the mitogenic response to EETs and a relatively high expression level of GPR40 is detected in a subset of tubules including cortical collecting ducts in the mammalian kidney.	[Ma, Seong Kwon; Wang, Yinqiu; Chen, Jianchun; Zhang, Ming-Zhi; Harris, Raymond C.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ma, Seong Kwon] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Chen, Jian-Kang] Georgia Regents Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA; [Chen, Jian-Kang] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA USA	Vanderbilt University; Chonnam National University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Harris, RC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	ray.harris@vanderbilt.edu			Department of Veterans Affairs; National Institutes of Health [DK38226, DK51265, DK62794, DK95785, DK83575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095785, P01DK038226, R01DK062794, R01DK051265, R01DK083575] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Department of Veterans Affairs (RCH) and National Institutes of Health Grant No. DK38226, DK51265, DK62794, and DK95785 (to R.C.H.) and funds from National Institutes of Health Grant No. DK83575 (to J.K.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; BURNS KD, 1995, AM J PHYSIOL-CELL PH, V269, pC831, DOI 10.1152/ajpcell.1995.269.4.C831; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Chen JR, 2000, J BIOL CHEM, V275, P13789, DOI 10.1074/jbc.275.18.13789; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; ENDOU H, 1983, JPN J PHARMACOL, V33, P423, DOI 10.1254/jjp.33.423; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; FITZPATRICK FA, 1986, J BIOL CHEM, V261, P5334; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Graber MN, 1997, J BIOL CHEM, V272, P29546, DOI 10.1074/jbc.272.47.29546; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Makita K, 1996, FASEB J, V10, P1456, DOI 10.1096/fasebj.10.13.8940291; Medhora M, 1998, INT J MOL MED, V2, P661; MORRISON AR, 1981, P NATL ACAD SCI-BIOL, V78, P7375, DOI 10.1073/pnas.78.12.7375; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Ou HY, 2013, AM J PHYSIOL-ENDOC M, V304, pE668, DOI 10.1152/ajpendo.00419.2012; Palop JJ, 2011, METHODS MOL BIOL, V670, P207, DOI 10.1007/978-1-60761-744-0_15; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Poitout V, 2013, DRUG DISCOV TODAY, V18, P1301, DOI 10.1016/j.drudis.2013.09.003; Rahman M, 1997, AM J HYPERTENS, V10, P356, DOI 10.1016/S0895-7061(96)00381-0; Roman RJ, 2000, CLIN EXP PHARMACOL P, V27, P855, DOI 10.1046/j.1440-1681.2000.03349.x; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140	40	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0113130	10.1371/journal.pone.0113130	http://dx.doi.org/10.1371/journal.pone.0113130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679385	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600001
J	Rebello, MR; Kandukuru, P; Verhagen, JV				Rebello, Michelle R.; Kandukuru, Padma; Verhagen, Justus V.			Direct Behavioral and Neurophysiological Evidence for Retronasal Olfaction in Mice	PLOS ONE			English	Article							MULTIMODAL FOOD PERCEPTION; NEUROCOGNITIVE BASES; NEURAL ACTIVITY; ORTHONASAL; TASTE; STIMULI; FLAVOR; INPUT; BULB; REPRESENTATION	The neuroscience of flavor perception is hence becoming increasingly important to understand food flavor perception that guides food selection, ingestion and appreciation. We recently provided evidence that rats can use the retronasal mode of olfaction, an essential element of human flavor perception. We showed that in rats, like humans, odors can acquire a taste. We and others also defined how the input of the olfactory bulb (OB) -not functionally imageable in humans-codes retronasal smell in anesthetized rat. The powerful awake transgenic mouse, however, would be a valuable additional model in the study of flavor neuroscience. We used a go/no-go behavioral task to test the mouse's ability to detect and discriminate the retronasal odor amyl acetate. In this paradigm a tasteless aqueous odor solution was licked by water-restricted head-fixed mice from a lick spout. Orthonasal contamination was avoided. The retronasal odor was successfully discriminated by mice against pure distilled water in a concentration-dependent manner. Bulbectomy removed the mice's ability to discriminate the retronasal odor but not tastants. The OB showed robust optical calcium responses to retronasal odorants in these awake mice. These results suggest that mice, like rats, are capable of smelling retronasally. This direct neuro-behavioral evidence establishes the mouse as a useful additional animal model for flavor research.	[Verhagen, Justus V.] Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University	Verhagen, JV (corresponding author), Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA.	jverhagen@jbpierce.org			U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC009994, R01DC011286]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009994, R01DC011286] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders, Grants R01DC009994 and R01DC011286 to JVV. http://www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Croy I, 2014, EUR ARCH OTO-RHINO-L, V271, P1087, DOI 10.1007/s00405-013-2684-9; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Furudono Y, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-45; Gautam H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044781; Gautam SH, 2012, J NEUROSCI, V32, P7949, DOI 10.1523/JNEUROSCI.1413-12.2012; Gautam SH, 2010, CHEM SENSES, V35, P767, DOI 10.1093/chemse/bjq075; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Heilmann S, 2004, BEHAV NEUROSCI, V118, P412, DOI 10.1037/0735-7044.118.2.412; Hong Jae Hee, 2009, J Support Oncol, V7, P58; Hummel T, 2006, FLAVOUR FRAG J, V21, P42, DOI 10.1002/ffj.1700; Iannilli E, 2014, BRAIN RES; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; MURPHY C, 1977, SENS PROCESS, V1, P204; MURPHY C, 1980, PHYSIOL BEHAV, V24, P601, DOI 10.1016/0031-9384(80)90257-7; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Ramaekers MG, 2014, BRIT J NUTR, V111, P554, DOI 10.1017/S0007114513002729; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; ROBERTS DD, 1995, J AGR FOOD CHEM, V43, P2179, DOI 10.1021/jf00056a041; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Ruijschop RMAJ, 2008, BRIT J NUTR, V99, P1140, DOI 10.1017/S0007114507837482; Ruijschop RMAJ, 2009, J AGR FOOD CHEM, V57, P9888, DOI 10.1021/jf901445z; Shepherd GM, 2011, NEUROGASTRONOMY HOW, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Stein BE, 1993, MERGING OF THE SENSE; Veldhuizen MG, 2010, FRONTIERS IN HUMAN N, V4, DOI [10.3389/fnhum.2010.00228, DOI 10.3389/FNHUM.2010.00228]; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Verhagen JV, 2007, BRAIN RES REV, V53, P271, DOI 10.1016/j.brainresrev.2006.09.002; Verhagen JV, 2006, NEUROSCI BIOBEHAV R, V30, P613, DOI 10.1016/j.neubiorev.2005.11.003; Wachowiak M, 2013, J NEUROSCI, V33, P5285, DOI 10.1523/JNEUROSCI.4824-12.2013; Welge-Lussen A, 2009, NEUROSCI LETT, V454, P124, DOI 10.1016/j.neulet.2009.03.002; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zijlstra N, 2011, BRIT J NUTR, V106, P297, DOI 10.1017/S0007114511000146	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117218	10.1371/journal.pone.0117218	http://dx.doi.org/10.1371/journal.pone.0117218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675095	gold, Green Published, Green Submitted			2022-12-26	WOS:000349914000015
J	Tanaka, S; Tanaka, J; Miwa, Y; Horikawa, DD; Katayama, T; Arakawa, K; Toyoda, A; Kubo, T; Kunieda, T				Tanaka, Sae; Tanaka, Junko; Miwa, Yoshihiro; Horikawa, Daiki D.; Katayama, Toshiaki; Arakawa, Kazuharu; Toyoda, Atsushi; Kubo, Takeo; Kunieda, Takekazu			Novel Mitochondria-Targeted Heat-Soluble Proteins Identified in the Anhydrobiotic Tardigrade Improve Osmotic Tolerance of Human Cells	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; LOW-EARTH-ORBIT; LEA PROTEINS; WATER-STRESS; MODEL PEPTIDES; DESICCATION; DEHYDRATION; TREHALOSE; DEATH; LOCALIZATION	Tardigrades are able to tolerate almost complete dehydration through transition to a metabolically inactive state, called "anhydrobiosis". Late Embryogenesis Abundant (LEA) proteins are heat-soluble proteins involved in the desiccation tolerance of many anhydrobiotic organisms. Tardigrades, Ramazzottius varieornatus, however, express predominantly tardigrade- unique heat-soluble proteins: CAHS (Cytoplasmic Abundant Heat Soluble) and SAHS (Secretory Abundant Heat Soluble) proteins, which are secreted or localized in most intracellular compartments, except the mitochondria. Although mitochondrial integrity is crucial to ensure cellular survival, protective molecules for mitochondria have remained elusive. Here, we identified two novel mitochondrial heat-soluble proteins, RvLEAM and MAHS (Mitochondrial Abundant Heat Soluble), as potent mitochondrial protectants from Ramazzottius varieornatus. RvLEAM is a group3 LEA protein and immunohistochemistry confirmed its mitochondrial localization in tardigrade cells. MAHS-green fluorescent protein fusion protein localized in human mitochondria and was heat-soluble in vitro, though no sequence similarity with other known proteins was found, and one region was conserved among tardigrades. Furthermore, we demonstrated that RvLEAM protein as well as MAHS protein improved the hyperosmotic tolerance of human cells. The findings of the present study revealed that tardigrade mitochondria contain at least two types of heat-soluble proteins that might have protective roles in water-deficient environments.	[Tanaka, Sae; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Tanaka, Junko; Miwa, Yoshihiro] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Horikawa, Daiki D.; Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Katayama, Toshiaki] Database Ctr Life Sci, Kashiwa, Chiba, Japan; [Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Toyoda, Atsushi] Natl Inst Genet, Adv Genom Ctr, Mishima, Shizuoka 411, Japan	University of Tokyo; University of Tsukuba; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kunieda, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.	kunieda@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; Mondragon, Angel/F-3972-2017; KUBO, TAKEO/G-4951-2014	Mondragon, Angel/0000-0002-6721-2054; Arakawa, Kazuharu/0000-0002-2893-4919; Tanaka, Sae/0000-0002-3460-2777; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Japan Society for the Promotion of Science [26660288, 24657069, 25-10474]; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Exploratory Research (Nos. 26660288, 24657069) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research on Innovative Areas, Genome Science (No. 221S0002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. ST received a Grant-in-Aid for JSPS Fellows (No. 25-10474) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Contreras-Porcia L, 2011, J EXP BOT, V62, P1815, DOI 10.1093/jxb/erq364; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Carvalho RC, 2012, ANN BOT-LONDON, V110, P1007, DOI 10.1093/aob/mcs180; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Furuki T, 2014, BBA-BIOMEMBRANES, V1838, P2757, DOI 10.1016/j.bbamem.2014.07.009; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iturriaga Gabriel, 2008, Biochem J, V410, pe1, DOI 10.1042/BJ20071633; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; Marunde MR, 2013, J INSECT PHYSIOL, V59, P377, DOI 10.1016/j.jinsphys.2013.01.004; Mobjerg N, 2011, ACTA PHYSL OXFORD EN, V202, P1748; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Tanaka J, 1999, BIOCHEM BIOPH RES CO, V264, P938, DOI 10.1006/bbrc.1999.1617; Tripathi R, 2012, J EXP BIOL, V215, P2786, DOI 10.1242/jeb.071647; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	45	46	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118272	10.1371/journal.pone.0118272	http://dx.doi.org/10.1371/journal.pone.0118272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675104	gold, Green Submitted, Green Published			2022-12-26	WOS:000349914000045
J	Hoffmann, CJ; Hoffmann, JD; Kensler, C; van der Watt, M; Omar, T; Chaisson, RE; Martinson, NA; Variava, E				Hoffmann, Christopher J.; Hoffmann, Jennifer D.; Kensler, Caroline; van der Watt, Martin; Omar, Tanvier; Chaisson, Richard E.; Martinson, Neil A.; Variava, Ebrahim			Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEPATOTOXICITY; DISEASE; BURDEN; ANTITUBERCULOSIS; INJURY; ADULTS; RISK	Liver disease epidemiology in sub-Saharan Africa has shifted as a result of HIV and the increased use of antiretroviral therapy leading to a need for updated data on common causes of liver disease. We retrospectively reviewed records from all hospitalized patients who had liver biopsy at a single hospital in South Africa from 2001 to 2009 and compared diagnosis by HIV status. During the period of study 262 patients had liver biopsy, 108 (41%) were HIV-infected, 25 (10%) were HIV-sero-negative, and 129 (49%) had unknown or unrecorded HIV status. Overall 81% of biopsies provided additional diagnostic data. Malignancy was the most common finding reported on 56 (21%) biopsies followed by granuloma or TB, hepatic steatosis, and fibrosis or cirrhosis. HIV-infected patients were more likely to have granulomas and steatosis. Half of patients with granulomas were already on TB treatment, suggesting paradoxical reactions or drug induced liver injury may have been important causes of liver inflammation among these patients. We note that TB, paradoxical reactions during TB treatment, possible drug induced liver injury, and hepatic steatosis are important causes of liver pathology among HIV-infected hospitalized patients with unclear etiology of liver disease after initial assessment. Among HIV sero-negative patients, malignancy was the major cause of liver disease. Our findings re-enforce the importance of TB as a diagnosis among HIV-infected individuals.	[Hoffmann, Christopher J.; Hoffmann, Jennifer D.; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kensler, Caroline] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [van der Watt, Martin; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Omar, Tanvier] Univ Witwatersrand, Dept Anat Pathol, Johannesburg, South Africa; [Omar, Tanvier] Natl Hlth Lab Serv, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp Complex, Dept Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp, South Africa	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020	Variava, Ebrahim/0000-0003-2888-789X; Hoffmann, Christopher/0000-0002-9422-0519	National Institutes of Health [AI083099]; SATBAT a Fogarty International Center [5U2RTW007370/3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083099, P30AI094189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SATBAT a Fogarty International Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CJH is supported by a National Institutes of Health research grant [AI083099]. EV received research training from SATBAT a Fogarty International Center funded program [5U2RTW007370/3]. The funders had no role in study design, data collection, analysis, or manuscript preparation.	Alvarez SZ, 1998, J GASTROEN HEPATOL, V13, P833, DOI 10.1111/j.1440-1746.1998.tb00743.x; Barr DA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-257; Cho HJ, 2013, PEDIATR GASTROENTERO, V16, P273, DOI 10.5223/pghn.2013.16.4.273; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; O'Brien CB, 2009, CLIN LIVER DIS, V13, P179, DOI 10.1016/j.cld.2009.02.010; Ouyang DW, 2009, AIDS, V23, P2425, DOI 10.1097/QAD.0b013e32832e34b1; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Reddy SP, 2012, AM J PUBLIC HEALTH, V102, P262, DOI 10.2105/AJPH.2011.300222; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schneider M, 2007, SAMJ S AFR MED J, V97, P664; Schutz C, 2012, SAMJ S AFR MED J, V102, P506, DOI 10.7196/SAMJ.5650; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Yao F, 1997, AM J GASTROENTEROL, V92, P167	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117813	10.1371/journal.pone.0117813	http://dx.doi.org/10.1371/journal.pone.0117813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668620	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000349493000026
J	Lazzarotto, V; Corraze, G; Leprevost, A; Quillet, E; Dupont-Nivet, M; Medale, F				Lazzarotto, Viviana; Corraze, Genevieve; Leprevost, Amandine; Quillet, Edwige; Dupont-Nivet, Mathilde; Medale, Francoise			Three-Year Breeding Cycle of Rainbow Trout (Oncorhynchus mykiss) Fed a Plant-Based Diet, Totally Free of Marine Resources: Consequences for Reproduction, Fatty Acid Composition and Progeny Survival	PLOS ONE			English	Article							BREAM SPARUS-AURATA; SALMON SALMO-SALAR; EUROPEAN SEA-BASS; BODY/FILLET QUALITY TRAITS; FISH-MEAL REPLACEMENT; EGG QUALITY; VEGETABLE-OILS; DICENTRARCHUS-LABRAX; GROWTH-PERFORMANCE; GILTHEAD SEABREAM	Terrestrial plant resources are increasingly used as substitutes for fish meal and fish oil in fish feed in order to reduce the reliance of aquaculture on marine fishery resources. Although many studies have been conducted to assess the effects of such nutritional transition, no whole breeding cycles of fish fed diets free from marine resources has been reported to date. We therefore studied the reproductive performance of trout after a complete cycle of breeding while consuming a diet totally devoid of marine ingredients and thus of n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFAs) that play a major role in the formation of ova. Two groups of female rainbow trout were fed from first feeding either a commercial diet (C, marine and plant ingredients), or a 100% plant-based diet (V, blend of plant proteins and vegetable oils). Livers, viscera, carcasses and ova were sampled at spawning and analyzed for lipids and fatty acids. Although the V-diet was devoid of n-3 LCPUFAs, significant amounts of EPA and DHA were found in livers and ova, demonstrating efficient bioconversion of linolenic acid and selective orientation towards the ova. Some ova were fertilized to assess the reproductive performance and offspring survival. We observed for the first time that trout fed a 100% plant-based diet over a 3-year breeding cycle were able to produce ova and viable alevins, although the ova were smaller. The survival of offspring from V-fed females was lower (-22%) at first spawning, but not at the second. Our study showed that, in addition to being able to grow on a plant-based diet, rainbow trout reared entirely on such a diet can successfully produce ova in which neo-synthesized n-3 LC-PUFAs are accumulated, leading to viable offspring. However, further adjustment of the feed formula is still needed to optimize reproductive performance.	[Lazzarotto, Viviana; Corraze, Genevieve; Leprevost, Amandine; Medale, Francoise] INRA, UR Nutr Metab Aquaculture 1067, F-64310 St Pee Sur Nivelle, France; [Quillet, Edwige; Dupont-Nivet, Mathilde; Medale, Francoise] INRA, UMR Genet Anim & Biol Integrat 1313, F-78352 Jouy En Josas, France	INRAE; Universite de Pau et des Pays de l'Adour; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Medale, F (corresponding author), INRA, UR Nutr Metab Aquaculture 1067, F-64310 St Pee Sur Nivelle, France.	medale@st-pee.inra.fr	, Dupont-Nivet/J-2850-2019	Medale, Francoise/0000-0002-8083-1298; Dupont-Nivet, Mathilde/0000-0002-9299-0560	FP7 European project ARRAINA [288925]; FUI progect VegeAqua	FP7 European project ARRAINA; FUI progect VegeAqua	This work was supported by the FP7 European project ARRAINA (no 288925) and by the FUI progect VegeAqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ayad A, 1997, AQUACULT INT, V5; BELL JG, 1994, BBA-LIPID LIPID MET, V1211, P335, DOI 10.1016/0005-2760(94)90158-9; Bell JG, 2003, AQUACULTURE, V218, P515, DOI 10.1016/S0044-8486(02)00462-3; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; BROMAGE N, 1992, AQUACULTURE, V100, P141, DOI 10.1016/0044-8486(92)90355-O; Bromage NR., 1995, BROODSTOCK MANAGEMEN; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Cerda J, 1995, ENDOCRINOLOGY, V111, P83; Corraze G, 1999, OCL-OL CORPS GRAS LI, V6, P111; Corraze G, 2009, CAH AGRIC, V18, P112, DOI 10.1684/agr.2009.0276; De Francesco M, 2007, AQUACULT NUTR, V13, P361, DOI 10.1111/j.1365-2095.2007.00485.x; de Francesco M, 2004, AQUACULTURE, V236, P413, DOI 10.1016/j.aquaculture.2004.01.006; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; FAO, 2009, STAT WORLD FISH AQ 2; FAO Aquaculture Department, 2013, GLOB AQ PROD STAT YE; FERNANDEZPALACIOS H, 1995, AQUACULTURE, V132, P325, DOI 10.1016/0044-8486(94)00345-O; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Furuita H, 2002, AQUACULTURE, V210, P323, DOI 10.1016/S0044-8486(01)00855-9; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; HARDY RW, 1987, AQUACULTURE, V65, P267, DOI 10.1016/0044-8486(87)90240-7; HAREL M, 1994, BRIT J NUTR, V72, P45, DOI 10.1079/BJN19940008; Izquierdo MS, 1996, AQUACULT NUTR, V2, P183, DOI 10.1111/j.1365-2095.1996.tb00058.x; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kaushik SJ, 2004, AQUACULTURE, V230, P391, DOI 10.1016/S0044-8486(03)00422-8; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; LERAY C, 1985, REPROD NUTR DEV, V25, P567, DOI 10.1051/rnd:19850409; Lim C., 2008, ALTERNATIVE PROTEIN; Manor ML, 2014, AQUACULTURE, V418, P17, DOI 10.1016/j.aquaculture.2013.09.023; Manor ML, 2012, AQUACULTURE, V364, P312, DOI 10.1016/j.aquaculture.2012.08.012; Matos E, 2012, AQUACULTURE, V358, P205, DOI 10.1016/j.aquaculture.2012.07.009; Medale F, 2009, CAH AGRIC, V18, P103, DOI 10.1684/agr.2009.0279; Mustafa T., 1989, ADV COMP ENV PHYSL, P157, DOI [10.1007/978-3-642-74510-2_6, DOI 10.1007/978-3-642-74510-2_6]; Nassour I, 1988, THESIS U PARIS DIDER; Nassour I., 1989, AQUAT LIVING RESOUR, V2, P153, DOI [10.1051/alr:1989018, DOI 10.1051/ALR:1989018, DOI 10.1016/j.ygcen.2009.05.004]; Navas JM, 1997, J FISH BIOL, V51, P760, DOI 10.1006/jfbi.1997.0484; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Peragen J, 2000, MOL CELL BIOCHEM, V209, P97, DOI 10.1023/A:1007130906365; Pereira JOB, 1998, AQUAC RES, V29, P751, DOI 10.1046/j.1365-2109.1998.29100751.x; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Rodriguez C, 1998, FISH PHYSIOL BIOCHEM, V18, P177, DOI 10.1023/A:1007750218840; Ronnestad I, 1998, AQUACULTURE, V162, P157, DOI 10.1016/S0044-8486(98)00203-8; Rosenlund G., 2011, FISH OIL REPLACEMENT, P487; Salze G, 2005, AQUAC RES, V36, P1488, DOI 10.1111/j.1365-2109.2005.01367.x; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Sargent John R., 2002, P181; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Spoden K, 2013, AQUACULTURE TRIES FI, P57; Stottrup JG, 2013, AQUACULT NUTR, V19, P172, DOI 10.1111/j.1365-2095.2012.00967.x; Takeuchi Toshio, 1997, Reviews in Fisheries Science, V5, P1; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tocher DR, 1997, LIPIDS, V32, P1237, DOI 10.1007/s11745-006-0159-0; TOCHER DR, 1984, LIPIDS, V19, P492, DOI 10.1007/BF02534481; Torstensen BE, 2011, BRIT J NUTR, V106, P633, DOI 10.1017/S0007114511000729; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Watanabe T., 1985, P395	69	58	58	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117609	10.1371/journal.pone.0117609	http://dx.doi.org/10.1371/journal.pone.0117609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658483	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900189
J	Lin, CJ; Lin, HJ; Chen, TH; Hsu, YA; Liu, CS; Hwang, GY; Wan, L				Lin, Chao-Jen; Lin, Hui-Ju; Chen, Ter-Hsin; Hsu, Yu-An; Liu, Chin-San; Hwang, Guang-Yuh; Wan, Lei			Polygonum cuspidatum and Its Active Components Inhibit Replication of the Influenza Virus through Toll-Like Receptor 9-Induced Interferon Beta Expression	PLOS ONE			English	Article							A VIRUS; H1N1 VIRUS; ACTIVATION; HEMAGGLUTININ; INDUCTION; LACKING; HUMANS; DNA	Influenza virus infection is a global public health issue. The effectiveness of antiviral therapies for influenza has been limited by the emergence of drug-resistant viral strains. Therefore, there is an urgent need to identify novel antiviral therapies. Here we tested the effects of 300 traditional Chinese medicines on the replication of various influenza virus strains in a lung cell line, A549, using an influenza-specific luciferase reporter assay. Of the traditional medicines tested, Polygonum cuspidatum (PC) and its active components, resveratrol and emodin, were found to attenuate influenza viral replication in A549 cells. Furthermore, they preferentially inhibited the replication of influenza A virus, including clinical strains isolated in 2009 and 2011 in Taiwan and the laboratory strain A/WSN/33 (H1N1). In addition to inhibiting the expression of hemagglutinin and neuraminidase, PC, emodin, and resveratrol also increased the expression of interferon beta (IFN-beta) through Toll-like receptor 9 (TLR9). Moreover, the anti-viral activity of IFN-beta or resveratrol was reduced when the A549 cells were treated with neutralizing anti-IFN-beta antibodies or a TLR9 inhibitor, suggesting that IFN-beta likely acts synergistically with resveratrol to inhibit H1N1 replication. This potential antiviral mechanism, involving direct inhibition of virus replication and simultaneous activation of the host immune response, has not been previously described for a single antiviral molecule. In conclusion, our data support the use of PC, resveratrol or emodin for inhibiting influenza virus replication directly and via TLR-9-induced IFN-beta production.	[Lin, Chao-Jen] Changhua Christian Childrens Hosp, Dept Pediat, Changhua, Taiwan; [Lin, Chao-Jen; Hwang, Guang-Yuh] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Lin, Chao-Jen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Hui-Ju] China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Lin, Hui-Ju; Wan, Lei] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Ter-Hsin] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan; [Hsu, Yu-An] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wan, Lei] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Wan, Lei] China Med Univ Hosp, Dept Gynecol, Taichung, Taiwan	Tunghai University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; National Tsing Hua University; Changhua Christian Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hwang, GY (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	gyhwang@thu.edu.tw; leiwan@mail.cmu.edu.tw	Wan, Lei/F-4719-2010	Wan, Lei/0000-0002-9525-3232	Ministry of Science and Technology, Taiwan, R.O.C. (MOST) [101-2320-B-039-038, 102-2320-B-039-043-MY3, 102-2632-B-039-001-MY3]; China Medical University Hospital, Taichung, Taiwan [DMR-103-064]; Changhua Christian Children's Hospital, Changhua, Taiwan [103-CCH-IRP-081]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TDB-111004]	Ministry of Science and Technology, Taiwan, R.O.C. (MOST); China Medical University Hospital, Taichung, Taiwan; Changhua Christian Children's Hospital, Changhua, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by Ministry of Science and Technology, Taiwan, R.O.C. (MOST 101-2320-B-039-038, 102-2320-B-039-043-MY3 and 102-2632-B-039-001-MY3), China Medical University Hospital, Taichung, Taiwan (DMR-103-064), Changhua Christian Children's Hospital, Changhua, Taiwan (103-CCH-IRP-081) and in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TDB-111004). The funders had no role in study design, data	Aluyen Julia Khristine, 2012, Journal of Dietary Supplements, V9, P45, DOI 10.3109/19390211.2011.650842; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Dapat C, 2013, ANTIVIR RES, V99, P261, DOI 10.1016/j.antiviral.2013.06.003; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Han JH, 2012, IMMUNOPHARM IMMUNOT, V34, P191, DOI 10.3109/08923973.2011.590499; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jackson RJ, 2011, J INFECTION, V62, P14, DOI 10.1016/j.jinf.2010.10.003; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Naikin A. N., 2013, Voprosy Virusologii, V58, P38; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Sohail MN, 2011, ASIAN J ANIM VET ADV, V6, P1125, DOI 10.3923/ajava.2011.1125.1152; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Trost BM, 2011, CHEM-EUR J, V17, P3630, DOI 10.1002/chem.201003454; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	32	59	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117602	10.1371/journal.pone.0117602	http://dx.doi.org/10.1371/journal.pone.0117602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658356	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900188
J	Moretti, D; Del Bello, B; Allavena, G; Corti, A; Signorini, C; Maellaro, E				Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Corti, Alessandro; Signorini, Cinzia; Maellaro, Emilia			Calpain-3 Impairs Cell Proliferation and Stimulates Oxidative Stress-Mediated Cell Death in Melanoma Cells	PLOS ONE			English	Article							MUSCLE-SPECIFIC CALPAIN; DYSTROPHY TYPE 2A; GLUTATHIONE TRANSFERASES; REDOX REGULATION; COMET ASSAY; DNA-DAMAGE; P53; EXPRESSION; GENE; IDENTIFICATION	Calpain-3 is an intracellular cysteine protease, belonging to Calpain superfamily and predominantly expressed in skeletal muscle. In human melanoma cell lines and biopsies, we previously identified two novel splicing variants (hMp78 and hMp84) of Calpain-3 gene (CAPN3), which have a significant lower expression in vertical growth phase melanomas and, even lower, in metastases, compared to benign nevi. In the present study, in order to investigate the pathophysiological role played by the longer Calpain-3 variant, hMp84, in melanoma cells, we over-expressed it in A375 and HT-144 cells. In A375 cells, the enforced expression of hMp84 induces p53 stabilization, and modulates the expression of a few p53-and oxidative stress-related genes. Consistently, hMp84 increases the intracellular production of ROS (Reactive Oxygen Species), which lead to oxidative modification of phospholipids (formation of F-2-isoprostanes) and DNA damage. Such events culminate in an adverse cell fate, as indicated by the decrease of cell proliferation and by cell death. To a different extent, either the antioxidant N-acetyl-cysteine or the p53 inhibitor, Pifithrin-alpha, recover cell viability and decrease ROS formation. Similarly to A375 cells, hMp84 over-expression causes inhibition of cell proliferation, cell death, and increase of both ROS levels and F-2-iso-prostanes also in HT-144 cells. However, in these cells no p53 accumulation occurs. In both cell lines, no significant change of cell proliferation and cell damage is observed in cells over-expressing the mutant hMp84(C42S) devoid of its enzymatic activity, suggesting that the catalytic activity of hMp84 is required for its detrimental effects. Since a more aggressive phenotype is expected to benefit from down-regulation of mechanisms impairing cell growth and survival, we envisage that Calpain-3 down-regulation can be regarded as a novel mechanism contributing to melanoma progression.	[Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Signorini, Cinzia; Maellaro, Emilia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Corti, Alessandro] Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, I-56100 Pisa, Italy; [Moretti, Daniele; Del Bello, Barbara; Allavena, Giulia; Corti, Alessandro; Maellaro, Emilia] ITT, Florence, Italy	University of Siena; University of Pisa	Maellaro, E (corresponding author), Univ Siena, Dept Mol & Dev Med, Via Laterina 8, I-53100 Siena, Italy.	emilia.maellaro@unisi.it		Allavena, Giulia/0000-0003-3267-175X	Istituto Toscano Tumori (ITT)	Istituto Toscano Tumori (ITT)	This work was supported by the Istituto Toscano Tumori (ITT) (grant Research Project to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Blackburn AC, 2006, MOL PHARMACOL, V69, P650, DOI 10.1124/mol.105.018911; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Comporti M, 2008, FREE RADICAL BIO MED, V44, P247, DOI 10.1016/j.freeradbiomed.2007.10.004; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Del Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057236; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Gollob JA, 2005, CANCER RES, V65, P8869, DOI 10.1158/0008-5472.CAN-05-1387; GOPALAKRISHNA P, 1995, J BIOCHEM BIOPH METH, V30, P69, DOI 10.1016/0165-022X(94)00056-J; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Italiano D, 2012, CELL CYCLE, V11, P4589, DOI 10.4161/cc.22853; Kawabata Y, 2003, FEBS LETT, V555, P623, DOI 10.1016/S0014-5793(03)01324-3; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Ramsay J, 1998, BRIT J CANCER, V77, P11, DOI 10.1038/bjc.1998.2; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Ruffini F, 2013, ONCOL REP, V30, P2887, DOI 10.3892/or.2013.2791; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Signorini C, 2003, J MASS SPECTROM, V38, P1067, DOI 10.1002/jms.520; Soengas MS, 2012, PIGM CELL MELANOMA R, V25, P721, DOI 10.1111/pcmr.12021; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200; Wittgen HGM, 2007, MELANOMA RES, V17, P400, DOI 10.1097/CMR.0b013e3282f1d312; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745	55	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117258	10.1371/journal.pone.0117258	http://dx.doi.org/10.1371/journal.pone.0117258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658320	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900125
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang			The Risk of Asthma in Patients with Ankylosing Spondylitis: A Population-Based Cohort Study	PLOS ONE			English	Article							COLLAGEN VASCULAR DISEASES; RHEUMATOID-ARTHRITIS; PULMONARY INVOLVEMENT; PERIPHERAL SPONDYLOARTHRITIS; CLASSIFICATION CRITERIA; RETROSPECTIVE COHORT; PREVALENCE; MANIFESTATIONS; COMORBIDITIES; ATOPY	Background The relationship between asthma and ankylosing spondylitis (AS) is controversial. We examined the risk of asthma among AS patients in a nationwide population. Methods We conducted a retrospective cohort study using data from the National Health Insurance (NHI) system of Taiwan. The cohort included 5,974 patients newly diagnosed with AS from 2000 to 2010. The date of diagnosis was defined as the index date. A 4-fold of general population without AS was randomly selected frequency matched by age, gender and the index year. The occurrence and hazard ratio (HR) of asthma were estimated by the end of 2011. Results The overall incidence of asthma was 1.74 folds greater in the AS cohort than in the non-AS cohort (8.26 versus 4.74 per 1000 person-years) with a multivariable Cox method measured adjusted HR of 1.54 (95% confidence interval (CI), 1.34-1.76). The adjusted HR of asthma associated with AS was higher in women (1.59; 95% CI, 1.33-1.90), those aged 50-64 years (1.66; 95% CI, 1.31-2.09), or those without comorbidities (1.82; 95% CI, 1.54-2.13). Conclusion Patients with AS are at a higher risk of developing asthma than the general population, regardless of gender and age. The pathophysiology needs further investigation.	[Shen, Te-Chun; Chen, Chia-Hung; Sung, Fung-Chang] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ, China Med Univ Hosp, Dept Pediat, Div Nephrol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tu, CY (corresponding author), China Med Univ, China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan.	chesttu@gmail.com; fcsung.tw@gmail.com		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM103010096]; NRPB Stroke Clinical Trial Consortium (MOST) [103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium (MOST); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM103010096), NRPB Stroke Clinical Trial Consortium (MOST w103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulet LP, 2011, EXPERT REV RESP MED, V5, P377, DOI [10.1586/ERS.11.34, 10.1586/ers.11.34]; Bulwark DW, 1985, CLIN REV ALLERG, V3, P249; Chou CH, 2014, SCAND J RHEUMATOL, V43, P132, DOI 10.3109/03009742.2013.822097; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Dean LE, 2014, RHEUMATOLOGY, V53, P650, DOI 10.1093/rheumatology/ket387; Dincer U, 2007, TOHOKU J EXP MED, V212, P423, DOI 10.1620/tjem.212.423; GUPTA SM, 1978, NEW ZEAL MED J, V88, P186; Hajdarbegovic E, 2014, RHEUMATOL INT, V34, P847, DOI 10.1007/s00296-013-2785-1; HUNNINGHAKE GW, 1979, AM REV RESPIR DIS, V119, P471; Kaptanoglu E, 2004, RHEUMATOL INT, V24, P267, DOI 10.1007/s00296-003-0369-1; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Mercieca C, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0434-7; Papaiwannou A, 2014, J THORAC DIS, V6, pS146, DOI 10.3978/j.issn.2072-1439.2014.03.04; Perez-Fernandez OM, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/736384; Pham T, 2008, JOINT BONE SPINE, V75, P656, DOI 10.1016/j.jbspin.2008.09.003; Reveille JD, 2005, AM J MED, V118, P592, DOI 10.1016/j.amjmed.2005.01.001; Reveille JD, 2012, ARTHRIT CARE RES, V64, P905, DOI 10.1002/acr.21621; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; RUMANCIK WM, 1984, CT-J COMPUT TOMOGR, V8, P225, DOI 10.1016/0149-936X(84)90066-3; Shen TC, 2014, QJM-INT J MED, V107, P435, DOI 10.1093/qjmed/hcu008; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Sun LM, 2014, SCAND J RHEUMATOL, V43, P301, DOI 10.3109/03009742.2013.863969; TANOUE LT, 1992, J THORAC IMAG, V7, P62, DOI 10.1097/00005382-199203000-00008; WIEDEMANN HP, 1989, CLIN CHEST MED, V10, P677; WOLSON AH, 1975, AM J ROENTGENOL, V124, P466, DOI 10.2214/ajr.124.3.466; Yuksekkaya R, 2014, POL J RADIOL, V79, P156, DOI 10.12659/PJR.889850; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116608	10.1371/journal.pone.0116608	http://dx.doi.org/10.1371/journal.pone.0116608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658339	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900053
J	Solc, P; Kitajima, TS; Yoshida, S; Brzakova, A; Kaido, M; Baran, V; Mayer, A; Samalova, P; Motlik, J; Ellenberg, J				Solc, Petr; Kitajima, Tomoya S.; Yoshida, Shuhei; Brzakova, Adela; Kaido, Masako; Baran, Vladimir; Mayer, Alexandra; Samalova, Pavlina; Motlik, Jan; Ellenberg, Jan			Multiple Requirements of PLK1 during Mouse Oocyte Maturation	PLOS ONE			English	Article							POLO-LIKE KINASE-1; ANAPHASE-PROMOTING COMPLEX; NUCLEAR-ENVELOPE BREAKDOWN; PROPHASE-I ARREST; SCF-BETA-TRCP; MEIOSIS-I; CHROMOSOME BIORIENTATION; MITOTIC CENTROSOMES; SPINDLE CHECKPOINT; MEIOTIC MATURATION	Polo-like kinase 1 (PLK1) orchestrates multiple events of cell division. Although PLK1 function has been intensively studied in centriole-containing and rapidly cycling somatic cells, much less is known about its function in the meiotic divisions of mammalian oocytes, which arrest for a long period of time in prophase before meiotic resumption and lack centrioles for spindle assembly. Here, using specific small molecule inhibition combined with live mouse oocyte imaging, we comprehensively characterize meiotic PLK1's functions. We show that PLK1 becomes activated at meiotic resumption on microtubule organizing centers (MTOCs) and later at kinetochores. PLK1 is required for efficient meiotic resumption by promoting nuclear envelope breakdown. PLK1 is also needed to recruit centrosomal proteins to acentriolar MTOCs to promote normal spindle formation, as well as for stable kineto-chore-microtubule attachment. Consequently, PLK1 inhibition leads to metaphase I arrest with misaligned chromosomes activating the spindle assembly checkpoint (SAC). Unlike in mitosis, the metaphase I arrest is not bypassed by the inactivation of the SAC. We show that PLK1 is required for the full activation of the anaphase promoting complex/cyclosome (APC/C) by promoting the degradation of the APC/C inhibitor EMI1 and is therefore essential for entry into anaphase I. Moreover, our data suggest that PLK1 is required for proper chromosome segregation and the maintenance of chromosome condensation during the meiosis I-II transition, independently of the APC/C. Thus, our results define the meiotic roles of PLK1 in oocytes and reveal interesting differential requirements of PLK1 between mitosis and oocyte meiosis in mammals.	[Solc, Petr; Brzakova, Adela; Mayer, Alexandra; Samalova, Pavlina; Motlik, Jan] Inst Anim Physiol & Genet, Libechov, Czech Republic; [Kitajima, Tomoya S.; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69012 Heidelberg, Germany; [Baran, Vladimir] Inst Anim Physiol, Kosice, Slovakia; [Kitajima, Tomoya S.; Yoshida, Shuhei; Kaido, Masako] RIKEN Ctr Dev Biol, Lab Chromosome Segregat, Kobe, Hyogo, Japan	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; European Molecular Biology Laboratory (EMBL); Slovak Academy of Sciences; RIKEN	Solc, P (corresponding author), Inst Anim Physiol & Genet, Libechov, Czech Republic.	solc@iapg.cas.cz; tkitajima@cdb.riken.jp	Šolc, Petr/G-7154-2014; Ellenberg, Jan/I-4688-2014; Kitajima, Tomoya/A-7049-2016; Baran, Vladimír/GXM-7406-2022	Šolc, Petr/0000-0003-4571-3891; Ellenberg, Jan/0000-0001-5909-701X; Kitajima, Tomoya/0000-0002-6486-7143; Baran, Vladimír/0000-0002-1686-2145; Yoshida, Shuhei/0000-0002-5640-6128	Ministry of Education, Youth and Sports of the Czech Republic [LH12057]; Grant Agency of the Czech Republic [P301-11-P081, 301-09-J036, P502/11/0593]; Japan Society for the Promotion of Science KAKENH [00376641]; Nakajima Foundation; Uehara Memorial Foundation; European Community [241548]; German Research Foundation DFG [EL246/4-1, EL246/4-2]; Human Frontier Science Program; Slovak Research and Development Agency [APVV-0237-10]; Institutional Research Concept [67985904]; European Regional Development Fund [CZ.1.05/2.1.00/03.0124]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Japan Society for the Promotion of Science KAKENH; Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); European Community(European Commission); German Research Foundation DFG(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Slovak Research and Development Agency(Slovak Research and Development Agency); Institutional Research Concept; European Regional Development Fund(European Commission)	This work was supported by the research grants from Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz, LH12057) and from Grant Agency of the Czech Republic (http://www.gacr.cz, P301-11-P081) to P. S.; Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp, 00376641), Nakajima Foundation (http://www.nakajimafound.or.jp), Uehara Memorial Foundation (http://www.ueharazaidan.or.jp) to T. S. K.; Grant Agency of the Czech Republic (http://www.gacr.cz, 301-09-J036) to J. M.; European Community's Seventh Framework Programme [FP7/2007-2013] (http://cordis.europa.eu/fp7/home_en.html) under grant agreement no [241548] "Mitosys" and the German Research Foundation DFG (http://www.dfg.de/en/, EL246/4-1,2) within the SPP 1384 "Mechanisms of Genome Haploidization" to J. E. T. S. K. was partly supported by the long-term fellowship from Human Frontier Science Program (http://www.hfsp.org/). A. B. and A. M. were partly supported by Grant Agency of the Czech Republic (http://www.gacr.cz, P502/11/0593). V. B. was supported by Slovak Research and Development Agency (http://www.apvv.sk, APVV-0237-10). Work at IAPG was supported by Institutional Research Concept 67985904 (IAPG AS CR, v.v.i.,http://www.iapg.cas.cz/). This work significantly benefited from European Regional Development Fund (http://ec.europa.eu/regional policy/thefunds/regional/index_en.cfm, ExAM CZ.1.05/2.1.00/03.0124) to J. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Anger M, 2004, MOL REPROD DEV, V69, P11, DOI 10.1002/mrd.20151; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Ito J, 2008, DEV BIOL, V320, P402, DOI 10.1016/j.ydbio.2008.05.548; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lenart P, 2003, CURR OPIN CELL BIOL, V15, P88, DOI 10.1016/S0955-0674(02)00011-X; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu JJ, 2004, J BIOL CHEM, V279, P21367, DOI 10.1074/jbc.M400482200; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Pomerantz Y, 2012, FASEB J, V26, P4495, DOI 10.1096/fj.12-209866; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Solc P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101014; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Swain JE, 2008, MOL HUM REPROD, V14, P291, DOI 10.1093/molehr/gan015; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vanderheyden V, 2009, CELL CALCIUM, V46, P56, DOI 10.1016/j.ceca.2009.04.004; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wianny F, 1998, CHROMOSOMA, V107, P430, DOI 10.1007/s004120050327; Xiong B, 2008, CELL CYCLE, V7, P1804, DOI 10.4161/cc.7.12.6019; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068964	76	55	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116783	10.1371/journal.pone.0116783	http://dx.doi.org/10.1371/journal.pone.0116783			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658810	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900066
J	Wilson, MM; Anderson, DE; Bernstein, HD				Wilson, Marlena M.; Anderson, D. Eric; Bernstein, Harris D.			Analysis of the Outer Membrane Proteome and Secretome of Bacteroides fragilis Reveals a Multiplicity of Secretion Mechanisms	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; BINDING-PROTEIN; DEMYELINATING DISEASE; SURFACE-PROTEINS; SIGNAL PEPTIDES; DNA INVERSIONS; GENE SEQUENCE; CELL-ENVELOPE; IDENTIFICATION; EXPRESSION	Bacteroides fragilis is a widely distributed member of the human gut microbiome and an opportunistic pathogen. Cell surface molecules produced by this organism likely play important roles in colonization, communication with other microbes, and pathogenicity, but the protein composition of the outer membrane (OM) and the mechanisms used to transport polypeptides into the extracellular space are poorly characterized. Here we used LC-MS/MS to analyze the OM proteome and secretome of B. fragilis NCTC 9343 grown under laboratory conditions. Of the 229 OM proteins that we identified, 108 are predicted to be lipoproteins, and 61 are predicted to be TonB-dependent transporters. Based on their proximity to genes encoding TonB-dependent transporters, many of the lipoprotein genes likely encode proteins involved in nutrient or small molecule uptake. Interestingly, protease accessibility and biotinylation experiments indicated that an unusually large fraction of the lipoproteins are cell-surface exposed. We also identified three proteins that are members of a novel family of autotransporters, multiple potential type I protein secretion systems, and proteins that appear to be components of a type VI secretion apparatus. The secretome consisted of lipoproteins and other proteins that might be substrates of the putative type I or type VI secretion systems. Our proteomic studies show that B. fragilis differs considerably from well-studied Gram-negative bacteria such as Escherichia coli in both the spectrum of OM proteins that it produces and the range of secretion strategies that it utilizes.	[Wilson, Marlena M.; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Anderson, D. Eric] NIDDK, Adv Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK062009, ZIADK075086] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambula D, 2013, P NATL ACAD SCI USA, V110, P8212, DOI 10.1073/pnas.1301366110; Avelar KES, 1999, LETT APPL MICROBIOL, V29, P264, DOI 10.1046/j.1365-2672.1999.00603.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bacic MK, 2008, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MC13C01S9; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bendtsen JD, 2005, MICROBIOL-SGM, V151, P1725, DOI 10.1099/mic.0.28029-0; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14; Ferreira ED, 2006, RES MICROBIOL, V157, P960, DOI 10.1016/j.resmic.2006.09.005; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DeRocco AJ, 2007, INFECT IMMUN, V75, P3220, DOI 10.1128/IAI.00072-07; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Ferreira ED, 2011, ANAEROBE, V17, P4, DOI 10.1016/j.anaerobe.2010.09.004; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Flores-Ramirez G, 2014, PROTEOMICS, V14, P1868, DOI 10.1002/pmic.201300338; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; GUZMAN CA, 1990, FEMS MICROBIOL LETT, V71, P187; Houston S, 2010, MICROBIOL-SGM, V156, P2516, DOI 10.1099/mic.0.038588-0; Huang JY, 2011, ANAEROBE, V17, P137, DOI 10.1016/j.anaerobe.2011.05.017; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; KOTARSKI SF, 1984, J BACTERIOL, V158, P102, DOI 10.1128/JB.158.1.102-109.1984; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; ONDERDONK AB, 1978, INFECT IMMUN, V19, P1083, DOI 10.1128/IAI.19.3.1083-1087.1978; OTTO BR, 1988, MICROB PATHOGENESIS, V4, P279, DOI 10.1016/0882-4010(88)90088-5; Papastathopoulou A, 1997, ANAEROBE, V3, P203, DOI 10.1006/anae.1997.0106; Patrick S, 2011, MICROBIOL-SGM, V157, P3071, DOI 10.1099/mic.0.049940-0; Pauer H, 2009, FEMS IMMUNOL MED MIC, V55, P388, DOI 10.1111/j.1574-695X.2009.00532.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Phansopa C, 2014, BIOCHEM J, V458, P499, DOI 10.1042/BJ20131415; Pumbwe L, 2006, ANAEROBE, V12, P211, DOI 10.1016/j.anaerobe.2006.09.004; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; ROGEMOND V, 1986, INFECT IMMUN, V53, P99, DOI 10.1128/IAI.53.1.99-102.1986; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sijbrandi R, 2008, MICROBES INFECT, V10, P514, DOI 10.1016/j.micinf.2008.01.015; Ueda O, 2005, ANTIMICROB AGENTS CH, V49, P2807, DOI 10.1128/AAC.49.7.2807-2815.2005; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wexler HM, 2012, ANAEROBE, V18, P200, DOI 10.1016/j.anaerobe.2011.12.017; Wexler HM, 2009, MICROBIOL-SGM, V155, P2694, DOI 10.1099/mic.0.025858-0; Wexler HM, 2002, ANAEROBE, V8, P180, DOI 10.1006/anae.2002.0427; Wexler HM, 2002, GENE, V283, P95, DOI 10.1016/S0378-1119(01)00835-6; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zischka H, 2004, PROTEOMICS, V4, P3776, DOI 10.1002/pmic.200400851	81	50	50	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117732	10.1371/journal.pone.0117732	http://dx.doi.org/10.1371/journal.pone.0117732			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658944	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900211
J	Silva, LFCE; Valadares, SD; Engle, TE; Rotta, PP; Marcondes, MI; Silva, FAS; Martins, EC; Tokunaga, AT				Costa e Silva, Luiz Fernando; Valadares Filho, Sebastiao de Campos; Engle, Terry Eugene; Rotta, Polyana Pizzi; Marcondes, Marcos Inacio; Sales Silva, Flavia Adriane; Martins, Edilane Costa; Tokunaga, Arnaldo Taishi			Macrominerals and Trace Element Requirements for Beef Cattle	PLOS ONE			English	Article							BIOLOGICAL AVAILABILITY; GLUTATHIONE-PEROXIDASE; ZINC SUPPLEMENTATION; CORN-SILAGE; COPPER; METABOLISM; MANGANESE; SELENIUM; CALCIUM; PERFORMANCE	Eighty-seven Nellore animals were utilized in this study to estimate net requirements for the maintenance and growth of beef cattle as well as the retention coefficients of 13 minerals: macrominerals (Ca, P, Mg, K, Na, and S) and trace elements (Cu, Fe, Mn, Se, Zn, Co, and Cr). The net requirements for maintenance and the true retention coefficient were estimated by using the regression between apparent retention and intake for each mineral. The net requirement for maintenance (mu g/kg BW) and retention coefficients (%) were 163 and 85 for Cu, 2,097 and 53 for Fe, 32.3 and 24 for Mn, 3.72 and 48 for Se, 669 and 0.80 for Zn, 18.4 and 86 for Co, and 22.9 and 78 for Cr. The dietary requirements of macrominerals (g/kg DMI) were 5.12 for Ca, 2.38 for P, 0.96 for Mg, 2.40 for K, 0.79 for Na, and 1.47 for S. This is the first study using Nellore cattle to estimate mineral requirements; considering that Nellore cattle are the most common breed in Brazil and that Brazil is a major beef producer globally, this knowledge can help producers to improve animal performance by supplying the correct amount of minerals.	[Costa e Silva, Luiz Fernando; Valadares Filho, Sebastiao de Campos; Rotta, Polyana Pizzi; Marcondes, Marcos Inacio; Sales Silva, Flavia Adriane; Martins, Edilane Costa; Tokunaga, Arnaldo Taishi] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Engle, Terry Eugene] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	Universidade Federal de Vicosa; Colorado State University	Silva, LFCE (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	lfcostasilva@yahoo.com.br	Hasui, Erica/AAF-5580-2019; Rotta, Polyana P/L-4722-2016; Rotta, Polyana/AAT-8719-2020; da Cunha, Rogério Grassetto Teixeira/AAS-6530-2020; Costa e Silva, Luiz Fernando/T-6073-2019; Silva, Flávia/AAQ-6163-2021; da Cunha, Rogério Grassetto Teixeira/J-1738-2012; Marcondes, Marcos/AAH-7553-2020	Hasui, Erica/0000-0002-9938-9284; Rotta, Polyana/0000-0002-1185-8120; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Silva, Flávia/0000-0001-5819-5638; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Marcondes, Marcos/0000-0003-4843-2809	FAPEMIG (BRAZIL) [CVZ-APQ-00655-12]	FAPEMIG (BRAZIL)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by FAPEMIG (BRAZIL) - CVZ-APQ-00655-12.	AFRC, 1993, ENERGY PROTEIN REQUI; Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; BENTLEY OG, 1951, J DAIRY SCI, V34, P396, DOI 10.3168/jds.S0022-0302(51)91727-4; Bernhard BC, 2012, J ANIM SCI, V90, P3879, DOI 10.2527/jas.2011-4981; BERNIER JF, 1984, J DAIRY SCI, V67, P2369, DOI 10.3168/jds.S0022-0302(84)81585-4; Bodansky M, 1920, J BIOL CHEM, V44, P399; BOUCHARD R, 1973, J DAIRY SCI, V56, P1276, DOI 10.3168/jds.S0022-0302(73)85347-0; Braselton WE, 1997, J VET DIAGN INVEST, V9, P395, DOI 10.1177/104063879700900409; BREMNER I, 1973, BRIT J NUTR, V30, P61, DOI 10.1079/BJN19730008; Brody S., 1945, BIOENERGETICS GROWTH; BUNTING LD, 1994, J ANIM SCI, V72, P1591, DOI 10.2527/1994.7261591x; CLAWSON WJ, 1972, J ANIM SCI, V34, P516; Commonwealth Scientific and Industrial Research Organization (CSIRO), 2007, NUTR REQUIREMENTS DO; COTZIAS GC, 1958, PHYSIOL REV, V38, P503, DOI 10.1152/physrev.1958.38.3.503; Delezenne C, 1919, ANN I PASTEUR, V33, P68; DOWE TW, 1957, J ANIM SCI, V16, P811, DOI 10.2527/jas1957.164811x; Erickson GE, 2002, J ANIM SCI, V80, P1690; Hambridge KM., 1986, TRACE ELEMENTS HUM A, P1; HANSARD SL, 1968, J ANIM SCI, V27, P1097, DOI 10.2527/jas1968.2741097x; HANSARD SL, 1968, J NUTR, V96, P247, DOI 10.1093/jn/96.2.247; Hartmans J., 1974, Trace element metabolism in animals-2,, P261; Hurley L., 1987, TRACE ELEMENTS HUMAN, V11, P185, DOI DOI 10.1016/B978-0-08-092468-7.50010-7; KEGLEY EB, 1995, J ANIM SCI, V73, P2721; Korn KT, 2013, J ANIM SCI, V91, P3332, DOI 10.2527/jas.2012-5962; LOONEY JW, 1976, J ANIM SCI, V42, P693, DOI 10.2527/jas1976.423693x; MILLER JK, 1965, J DAIRY SCI, V48, P370, DOI 10.3168/jds.S0022-0302(65)88231-5; MILLER WJ, 1966, J DAIRY SCI, V49, P1012, DOI 10.3168/jds.S0022-0302(66)88003-7; MILLS CF, 1976, BRIT J NUTR, V35, P309, DOI 10.1079/BJN19760039; MONROE RA, 1952, P SOC EXP BIOL MED, V80, P250, DOI 10.3181/00379727-80-19586; Mullis LA, 2003, J ANIM SCI, V81, P865; National Research Council (NRC), 2001, NUTR REQ DAIR CATTL; NRC, 1970, NUTR REQ BEEF CATTL, DOI DOI 10.17226/9791; OH SH, 1976, J ANIM SCI, V42, P977, DOI 10.2527/jas1976.424977x; PEELER HT, 1972, J ANIM SCI, V35, P695; PERRY TW, 1968, J ANIM SCI, V27, P1674; POND WG, 1988, NUTR REP INT, V38, P737; Rotta PP, 2014, J ANIM SCI, V92, P2996, DOI 10.2527/jas.2013-7364; SANSOM BF, 1978, RES VET SCI, V24, P366, DOI 10.1016/S0034-5288(18)33049-2; SCHROEDER HA, 1966, J CHRON DIS, V19, P545, DOI 10.1016/0021-9681(66)90094-4; Schwarz W A, 1975, Arch Tierernahr, V25, P597; Smith RM, 1987, TRACE ELEMENTS HUMAN, P185; Standing Committee on Agriculture (SCA), 1990, FEED STAND AUSTR LIV; STOMER VVE, 1967, CAN J ANIM SCI, V47, P39, DOI 10.4141/cjas67-006; SULLIVAN JF, 1979, J NUTR, V109, P1432, DOI 10.1093/jn/109.8.1432; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; SUTTLE NF, 1974, BRIT J NUTR, V32, P395, DOI 10.1079/BJN19740091; Teixeira IAMA, 2015, J ANIM SCI, V93, P2349, DOI 10.2527/jas.2014-8588; THOMAS JW, 1970, J DAIRY SCI, V53, P1107, DOI 10.3168/jds.S0022-0302(70)86354-8; Valadares S.C., 2010, NUTR REQUIREMENTS ZE, V2nd; VANBRUWAENE R, 1984, HEALTH PHYS, V46, P1069, DOI 10.1097/00004032-198405000-00007; WARD GM, 1966, J DAIRY SCI, V49, P268, DOI 10.3168/jds.S0022-0302(66)87848-7; WEIGAND E, 1982, Z TIERPHYSIOL TIERER, V47, P1, DOI 10.1111/j.1439-0396.1982.tb01228.x; WEITZEL G, 1954, H-S Z PHYSIOL CHEM, V296, P19, DOI 10.1515/bchm2.1954.296.1.19; WISE MB, 1963, J NUTR, V79, P79, DOI 10.1093/jn/79.1.79; WRIGHT PL, 1966, AM J PHYSIOL, V211, P6, DOI 10.1152/ajplegacy.1966.211.1.6	57	47	49	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144464	10.1371/journal.pone.0144464	http://dx.doi.org/10.1371/journal.pone.0144464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	25658108	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900053
J	Kommaddi, RP; Jean-Charles, PY; Shenoy, SK				Kommaddi, Reddy Peera; Jean-Charles, Pierre-Yves; Shenoy, Sudha K.			Phosphorylation of the Deubiquitinase USP20 by Protein Kinase A Regulates Post-endocytic Trafficking of beta(2) Adrenergic Receptors to Autophagosomes during Physiological Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; SELECTIVE AUTOPHAGY; MEMBRANE-PROTEINS; UBIQUITIN; ARRESTIN; ENZYMES; HEART; ROLES	Ubiquitination by the E3 ligase Nedd4 and deubiquitination by the deubiquitinases USP20 and USP33 have been shown to regulate the lysosomal trafficking and recycling of agonist-activated beta(2) adrenergic receptors (beta(2)ARs). In this work, we demonstrate that, in cells subjected to physiological stress by nutrient starvation, agonist-activated ubiquitinated beta(2)ARs traffic to autophagosomes to colocalize with the autophagy marker protein LC3-II. Furthermore, this trafficking is synchronized by dynamic posttranslational modifications of USP20 that, in turn, are induced in a beta(2)AR-dependent manner. Upon beta(2)AR activation, a specific isoform of the second messenger cAMP-dependent protein kinaseA(PKA alpha) rapidly phosphorylates USP20 on serine 333 located in its unique insertion domain. This phosphorylation of USP20 correlates with a characteristic SDS-PAGE mobility shift of the protein, blocks its deubiquitinase activity, promotes its dissociation from the activated beta(2)AR complex, and facilitates trafficking of the ubiquitinated beta(2)AR to autophagosomes, which fuse with lysosomes to form autolysosomes where receptors are degraded. Dephosphorylation of USP20 has reciprocal effects and blocks trafficking of the beta(2)AR to autophagosomes while promoting plasma membrane recycling of internalized beta(2)ARs. Our findings reveal a dynamic regulation of USP20 by site-specific phosphorylation as well as the interdependence of signal transduction and trafficking pathways in balancing adrenergic stimulation and maintaining cellular homeostasis.	[Kommaddi, Reddy Peera; Jean-Charles, Pierre-Yves; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Shenoy, SK (corresponding author), 412 SANDS Bldg,303 Res Dr, Durham, NC 27710 USA.	skshenoy@dm.duke.edu	Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	National Institutes of Health [HL080525, T32 HL00710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118369, R01HL080525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080525 (to S. K. S.).; Supported by National Institutes of Health Training Grant T32 HL00710.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferrara N, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00396; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gottlieb RA, 2013, HEART FAIL REV, V18, P575, DOI 10.1007/s10741-012-9367-2; Guo YR, 2012, BIOCHEMISTRY-US, V51, P9323, DOI 10.1021/bi301282k; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hiebel C, 2014, J NEUROCHEM, V131, P484, DOI 10.1111/jnc.12839; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Luttrell LM, 2002, J CELL SCI, V115, P455; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Xie M, 2011, CURR OPIN CARDIOL, V26, P216, DOI 10.1097/HCO.0b013e328345980a; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102	60	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8888	8903		10.1074/jbc.M114.630541	http://dx.doi.org/10.1074/jbc.M114.630541			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666616	Green Published, hybrid			2022-12-26	WOS:000352207100017
J	Dai, XY; Jin, X; Chen, XW; He, JY; Yin, Z				Dai, Xiangyan; Jin, Xia; Chen, Xiaowen; He, Jiangyan; Yin, Zhan			Sufficient Numbers of Early Germ Cells Are Essential for Female Sex Development in Zebrafish	PLOS ONE			English	Article							DEAD-END; GENE-EXPRESSION; LINE; DIFFERENTIATION; PROMOTER; DIMORPHISM; ABLATION; TOOL	The sex determination for zebrafish is controlled by a combination of genetic and environmental factors. The determination of sex in zebrafish has been suggested to rely on a mechanism that is affected by germ cell-derived signals. To begin our current study, a simplified and efficient germ cell-specific promoter of the dead end (dnd) gene was identified. Utilizing the metrodinazole (MTZ)/bacterial nitroreductase (NTR) system for inducible germ cell ablation, several stable Tg (dnd:NTR-EGFP(-3'UTR)) and Tg (dnd:NTR-EGFP(+3'UTR)) zebrafish lines were then generated with the identified promoter. A thorough comparison of the expression patterns and tissue distributions of endogenous dnd and ntr-egfp transcripts in vivo revealed that the identified 2032-bp zebrafish dnd promoter can recapitulate dnd expression faithfully in stable transgenic zebrafish. The correlation between the levels of the germ cell-derived signals and requirement for maintaining the female fate has been also explored with different durations of the MTZ treatments. Our results revealed the decreasing ratios of female presented in the treated transgenic group are fairly associated with the reducing levels of the early germ cell-derived signals. After the juvenile transgenic fish treated with 5 mM MTZ for 20 days, all MTZ-treated transgenic fish exclusively developed into males with subfertilities. Taken together, our results identified here a simplified and efficient dnd promoter, and provide clear evidence indicating that it was not the presence but the sufficiency of signals derived from germ cells that is essential for female sex development in zebrafish. Our model also provides a unique system for sex control in zebrafish studies.	[Dai, Xiangyan; Jin, Xia; Chen, Xiaowen; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Dai, Xiangyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yin, Z (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zyin@ihb.ac.cn		, Dai/0000-0003-0275-6840	National Basic Research Program of China (973 Program) [2014CB138602]; National Natural Science Foundation of China [31172390]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by funds obtained from the National Basic Research Program of China (973 Program, 2014CB138602) to ZY, and National Natural Science Foundation of China (No. 31172390) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya C, 2007, BIOCHEM BIOPH RES CO, V355, P194, DOI 10.1016/j.bbrc.2007.01.138; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Hsiao CD, 2003, DEV BIOL, V262, P313, DOI 10.1016/S0012-1606(03)00402-0; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Jiang N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099689; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Leu DH, 2010, DEV DYNAM, V239, P2714, DOI 10.1002/dvdy.22404; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Moss JB, 2009, DIABETES, V58, P1844, DOI 10.2337/db08-0628; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Sfakianakis DG, 2012, J BIOL RES-THESSALON, V17, P68; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wong TT, 2013, INT J DEV BIOL, V57, P767, DOI 10.1387/ijdb.120234tw; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427	32	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117824	10.1371/journal.pone.0117824	http://dx.doi.org/10.1371/journal.pone.0117824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679390	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600092
J	Zhu, D; Yang, DY; Guo, YY; Zheng, YF; Li, JL; Wang, B; Tao, Y; Jonas, JB				Zhu, Dan; Yang, Da-Yong; Guo, Yuan-Yuan; Zheng, Yan-Fei; Li, Jun-Lian; Wang, Bin; Tao, Yong; Jonas, Jost B.			Intracameral Interleukin 1 beta, 6, 8, 10, 12p, Tumor Necrosis Factor alpha and Vascular Endothelial Growth Factor and Axial Length in Patients with Cataract	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; AGE-RELATED MACULOPATHY; AQUEOUS-HUMOR LEVELS; DIABETIC-RETINOPATHY; MACULAR DEGENERATION; CYTOKINE CONCENTRATION; EYES; PHARMACOKINETICS; PATHOGENESIS; EXPRESSION	Objective To assess associations between the aqueous humour concentration of interleukin IL-1 beta, IL-6, IL-8, IL-10 and IL-12p, tumor necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) and axial length in eyes with cataract. Methods The hospital-based investigation included patients who underwent cataract surgery between March 2014 and April 2014. Using aqueous humour collected at the start of cataract surgery, the interleukins IL-1 beta, IL- 6, IL- 8, IL- 10 and IL- 12p, TNF-alpha and VEGF were examined using a cytometric bead array. Axial length was determined by partial coherence laser interferometry (IOL Master). Results The study included 33 patients with cataract (33 eyes) with a mean age of 69.2 +/- 10.8 years (range:50-87 years) and a mean axial length of 24.7 +/- 1.9 mm (range:22.6-31.5 mm). Lower aqueous concentration of VEGF was significantly associated with longer axial length (VEGF concentration (pg/mL) = -5.12 x Axial Length (mm) + 163; correlation coefficient r = -0.41; P<0.001) and more myopic refractive error (VEGF concentration (pg/mL) = 1.27xspherical equivalent (diopters)+44.8; r = 0.383; P = 0.002). The aqueous concentrations of all other substances were not significantly (all P>0.10) associated with axial length or refractive error. Conclusions Higher intravitreal concentrations of VEGF were measured in eyes with a longer axial length, while the intraocular concentrations of IL-1 beta, IL-6, IL-8, IL-10, IL-12p and TNF-alpha were not correlated with axial length. The lower concentration of VEGF in axially elongated eyes may be one of the reasons for the lower prevalence of age-related macular degeneration and diabetic retinopathy in myopic eyes.	[Zhu, Dan; Yang, Da-Yong; Guo, Yuan-Yuan; Zheng, Yan-Fei; Li, Jun-Lian] Inner Mongolia Med Univ, Affiliated Hosp, Dept Ophthalmol, Hohhot, Inner Mongolia, Peoples R China; [Wang, Bin; Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Inner Mongolia Medical University; Peking University; Ruprecht Karls University Heidelberg	Tao, Y (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drtaoyong@163.com		Tao, Yong/0000-0003-1443-2667	Program for New Century Excellent Talents in University [NCET-12-0010]; FOK YING TONG education foundation; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); FOK YING TONG education foundation(Fok Ying Tung Education Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	This study was supported by Program for New Century Excellent Talents in University (No: NCET-12-0010) and FOK YING TONG education foundation. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Carmi Y, 2013, J IMMUNOL, V190, P3500, DOI 10.4049/jimmunol.1202769; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Hu Q, 2014, RETINA; Ikram MK, 2003, INVEST OPHTH VIS SCI, V44, P3778, DOI 10.1167/iovs.03-0120; Jain I S, 1965, J All India Ophthalmol Soc, V13, P88; JAIN IS, 1967, ARCH OPHTHALMOL-CHIC, V77, P59; Jia Y, 2014, INVEST OPHTH VIS SCI, V55, P3922, DOI 10.1167/iovs.14-13983; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe381, DOI 10.1111/j.1755-3768.2012.02414.x; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Kon CH, 1999, INVEST OPHTH VIS SCI, V40, P705; Krohne TU, 2015, RETINA-J RET VIT DIS, V35, P69, DOI 10.1097/IAE.0000000000000265; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Limb GA, 1999, INVEST OPHTH VIS SCI, V40, P2453; Meyer CH, 2011, RETINA-J RET VIT DIS, V31, P1877, DOI 10.1097/IAE.0b013e318217373c; Miao H, 2012, MOL VIS, V18, P574; Missotten GSO, 2006, ARCH OPHTHALMOL-CHIC, V124, P1428, DOI 10.1001/archopht.124.10.1428; MOSS SE, 1994, OPHTHALMOLOGY, V101, P77; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005; Salom D, 2008, INVEST OPHTH VIS SCI, V49, P3499, DOI 10.1167/iovs.07-1168; Sawada O, 2011, JPN J OPHTHALMOL, V55, P401, DOI 10.1007/s10384-011-0027-1; Shin YJ, 2012, MOL VIS, V18, P2265; Tao Y, 2010, EYE, V24, P648, DOI 10.1038/eye.2009.160; Teichmann KD, 2002, J CATARACT REFR SURG, V28, P1886, DOI 10.1016/S0886-3350(02)01671-1; Tong JP, 2006, AM J OPHTHALMOL, V141, P456, DOI 10.1016/j.ajo.2005.10.012; Wakabayashi T, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/257381; Wang B, 2014, J OCUL PHARMACOL TH, V30, P587, DOI 10.1089/jop.2013.0241; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123	37	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117777	10.1371/journal.pone.0117777	http://dx.doi.org/10.1371/journal.pone.0117777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679504	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600086
J	Awad, AI; Aboud, EA				Awad, Abdelmoneim Ismail; Aboud, Esraa Abdulwahid			Knowledge, Attitude and Practice towards Antibiotic Use among the Public in Kuwait	PLOS ONE			English	Article							UPPER RESPIRATORY-INFECTIONS; SELF-MEDICATION; ANTIMICROBIAL RESISTANCE; GENERAL-PRACTITIONERS; COMMUNITY; CARE; EXPECTATIONS; PREVALENCE; BEHAVIOR	Background The emergence and spread of bacterial resistance to antibiotics is a growing problem worldwide, which presents a significant threat to public health globally in the 21st century. A substantial evidence has shown that the general community plays a role in the increase and spread of antibiotic resistance. The present study was designed to determine knowledge, attitude and practice towards antibiotic use. Methods A cross-sectional survey was performed using a pretested self-administered questionnaire on a sample of 770 randomly selected Kuwaiti individuals. Descriptive and multivariate logistic regression analysis were used in data analysis. Results The response rate was 88.3%. Nearly three-quarters (72.8%) of respondents had been prescribed antibiotics within 12 months prior to the study period, and 36% of them had not finished the course of treatment. Over one-quarter (27.5%) were self-medicated with antibiotics to treat mainly common cold, sore throat and cough. Self-medication was more prevalent among those who were prescribed antibiotics and those who had attitudes towards using and accessing antibiotic inappropriately. Almost 47% of participants had low knowledge regarding action, use, safety and resistance of antibiotics. Forty one percent of respondents had attitudes towards using and accessing antibiotic inappropriately. Better knowledge was found to be a predictor for positive attitude. Respondents level of agreement that doctors often prescribe antibiotics to meet the patient's expectation, and that doctors often take time to consider carefully the need for an antibiotic were 52.7% and 35.3%, respectively. Conclusions These findings will aid in the assessment of the adequacy of present public educational campaigns. Also, it will provide further insight in designing future multifaceted interventions to promote specific messages to rationalize antibiotic use, and compensate for knowledge and attitude gaps as an effort towards preventing development of antibiotic resistance.	[Awad, Abdelmoneim Ismail] Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait; [Aboud, Esraa Abdulwahid] Minist Hlth, Kuwait, Kuwait	Kuwait University	Awad, AI (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait.	amoneim@hsc.edu.kw	Awad, Abdelmoneim Ismail/AAU-1963-2020	Awad, Abdelmoneim Ismail/0000-0002-2266-3687				Abasaeed A, 2009, J INFECT DEV COUNTR, V3, P491, DOI 10.3855/jidc.466; Al-Mousa HH, 2011, MED PRIN PRACT, V21, P97, DOI 10.1159/000331903; Al-Ramahi R, 2013, INT J CLIN PHARM TH, V51, P562, DOI 10.5414/CP201814; Aly M, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-26; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; Awad A, 2010, EUR J CLIN PHARMACOL, V66, P1247, DOI 10.1007/s00228-010-0872-8; Barah F., 2010, Eastern Mediterranean Health Journal, V16, P516; Belongia EA, 2002, PREV MED, V34, P346, DOI 10.1006/pmed.2001.0992; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; European Commission, 2013, SPEC EURB 407 ANT RE; Franco Beatriz Espinosa, 2009, Infect Drug Resist, V2, P1; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hawkings NJ, 2008, PATIENT EDUC COUNS, V73, P146, DOI 10.1016/j.pec.2008.05.025; Hulscher MEJL, 2010, INT J MED MICROBIOL, V300, P351, DOI 10.1016/j.ijmm.2010.04.003; Jassim Abdul-Mohsin, 2010, Oman Med J, V25, P79, DOI 10.5001/omj.2010.25; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Kuwait Central Statistical Bureau, 2011, GEN POP CENS; Lim Ka Keat, 2012, South Med Rev, V5, P26; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Memish Z A, 2007, J Chemother, V19 Suppl 1, P17; Mohanna Mabrook, 2010, Oman Med J, V25, P41, DOI 10.5001/omj.2010.10; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Ong S, 2007, ANN EMERG MED, V50, P213, DOI 10.1016/j.annemergmed.2007.03.026; Raosoft Inc., 2004, RAOS SAMPL SIZ CALC; Sawair FA, 2009, MED PRIN PRACT, V18, P21, DOI 10.1159/000163041; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Vaandnen MH, 2006, HEALTH POLICY, V77, P166, DOI 10.1016/j.healthpol.2005.07.001; WHO, 2001, WHOCDSCSRDRS20012; Widayati Aris, 2011, BMC Res Notes, V4, P491, DOI 10.1186/1756-0500-4-491; World Health Organization, 2007, WORLD HLTH REP 2007; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	41	134	135	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117910	10.1371/journal.pone.0117910	http://dx.doi.org/10.1371/journal.pone.0117910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675405	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000036
J	Bocherens, H; Hofman-Kaminska, E; Drucker, DG; Schmolcke, U; Kowalczyk, R				Bocherens, Herve; Hofman-Kaminska, Emilia; Drucker, Dorothee G.; Schmoelcke, Ulrich; Kowalczyk, Rafal			European Bison as a Refugee Species? Evidence from Isotopic Data on Early Holocene Bison and Other Large Herbivores in Northern Europe	PLOS ONE			English	Article							BOS-PRIMIGENIUS BOJANUS; N-15 NATURAL-ABUNDANCE; MOOSE ALCES-ALCES; LATE PLEISTOCENE; STABLE-ISOTOPES; BONE-COLLAGEN; MYCORRHIZAL FUNGI; GLOBAL PATTERNS; NITROGEN ISOTOPES; FORAGING ECOLOGY	According to the refugee species concept, increasing replacement of open steppe by forest cover after the last glacial period and human pressure had together forced European bison (Bison bonasus)-the largest extant terrestrial mammal of Europe-into forests as a refuge habitat. The consequent decreased fitness and population density led to the gradual extinction of the species. Understanding the pre-refugee ecology of the species may help its conservation management and ensure its long time survival. In view of this, we investigated the abundance of stable isotopes (delta C-13 and delta N-15) in radiocarbon dated skeletal remains of European bison and other large herbivores-aurochs (Bos primigenius), moose (Alces alces), and reindeer (Rangifer tarandus)-from the Early Holocene of northern Europe to reconstruct their dietary habits and pattern of habitat use in conditions of low human influence. Carbon and nitrogen isotopic compositions in collagen of the ungulate species in northern central Europe during the Early Holocene showed significant differences in the habitat use and the diet of these herbivores. The values of the delta C-13 and delta N-15 isotopes reflected the use of open habitats by bison, with their diet intermediate between that of aurochs (grazer) and of moose (browser). Our results show that, despite the partial overlap in carbon and nitrogen isotopic values of some species, Early Holocene large ungulates avoided competition by selection of different habitats or different food sources within similar environments. Although Early Holocene bison and Late Pleistocene steppe bison utilized open habitats, their diets were significantly different, as reflected by their delta N-15 values. Additional isotopic analyses show that modern populations of European bison utilize much more forested habitats than Early Holocene bison, which supports the refugee status of the species.	[Bocherens, Herve; Drucker, Dorothee G.] Univ Tubingen, Fachbereich Geowissensch, Forsch Bereich Palaobiol, D-72074 Tubingen, Germany; [Bocherens, Herve] Univ Tubingen, Senckenberg Ctr Human Evolut & Palaeoecol HEP, D-72074 Tubingen, Germany; [Hofman-Kaminska, Emilia; Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, Gen Waszkiewicza 1c, PL-17230 Bialowieza, Poland; [Schmoelcke, Ulrich] Ctr Baltic & Scandinavian Archaeol ZBSA, D-24837 Schleswig, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Hofman-Kaminska, E (corresponding author), Polish Acad Sci, Mammal Res Inst, Gen Waszkiewicza 1c, PL-17230 Bialowieza, Poland.	ehofman@ibs.bialowieza.pl	BOCHERENS, Hervé/F-3580-2011; Drucker, Dorothée G./E-8900-2011	BOCHERENS, Hervé/0000-0002-0494-0126; Drucker, Dorothée G./0000-0003-0854-4371; Hofman-Kaminska, Emilia/0000-0001-7924-5307; Kowalczyk, Rafal/0000-0001-7264-2158; Schmolcke, Ulrich/0000-0002-8974-449X	Polish National Science Centre [N N304 301940]; budget of the Mammal Research Institute PAS in Bialowieza	Polish National Science Centre; budget of the Mammal Research Institute PAS in Bialowieza	This study was financed by the Polish National Science Centre grant no. N N304 301940 (to RK) and the budget of the Mammal Research Institute PAS in Bialowieza (to RK and EHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaris-Sorensen K, 2007, J ARCHAEOL SCI, V34, P914, DOI 10.1016/j.jas.2006.09.014; Aaris-Sorensen K, 2009, FOSS STRATA, P1; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Asada T, 2005, AQUAT BOT, V82, P297, DOI 10.1016/j.aquabot.2005.05.005; Barnett B, 1994, THESIS; Ben-David M, 2001, ALCES-N AM MOOSE CON, V37, P421; Benecke N, 2003, ARCHEOZOOLOGIA, V21, P19; Benecke Norbert, 2006, Munibe (Antropologia - Arkeologia), V57, P421; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; Bjorck J, 2002, QUATERNARY SCI REV, V21, P1489, DOI 10.1016/S0277-3791(01)00115-9; Bocherens H, 1997, QUATERNARY RES, V48, P370, DOI 10.1006/qres.1997.1927; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2011, QUATERN INT, V245, P249, DOI 10.1016/j.quaint.2011.02.023; BOERTJE RD, 1984, ARCTIC, V37, P161; Bonafini M, 2013, J ARCHAEOL SCI, V40, P3926, DOI 10.1016/j.jas.2013.03.028; BOROWSKI S, 1972, Acta Theriologica, V17, P151, DOI 10.4098/AT.arch.72-13; Bos JAA, 2001, REV PALAEOBOT PALYNO, V115, P177, DOI 10.1016/S0034-6667(01)00069-0; Bratlund Bodil, 1999, P39; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Brooks JR, 1997, OECOLOGIA, V110, P301, DOI 10.1007/s004420050163; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Crowley BE, 2012, P ROY SOC B-BIOL SCI, V279, P3597, DOI 10.1098/rspb.2012.0727; Deinet S, 2013, WILDLIFE COMEBACK IN, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; Drucker DG, 2012, QUATERN INT, V272, P322, DOI 10.1016/j.quaint.2012.05.040; Drucker DG, 2011, QUATERN INT, V245, P218, DOI 10.1016/j.quaint.2011.05.007; Drucker DG, 2011, QUATERN INT, V245, P268, DOI 10.1016/j.quaint.2011.07.019; Drucker DG, 2003, EARTH PLANET SC LETT, V216, P163, DOI 10.1016/S0012-821X(03)00514-4; Drucker DG, 2009, FOREST CANOPIES FORE, P103; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Drucker DG, 2010, ISOT ENVIRON HEALT S, V46, P107, DOI 10.1080/10256010903388410; Emmerton KS, 2001, NEW PHYTOL, V151, P513, DOI 10.1046/j.1469-8137.2001.00179.x; Eriksen BV, 2002, JUT ARCH SOC PUBL, V39, P25; Feng XH, 1998, OECOLOGIA, V117, P19, DOI 10.1007/s004420050626; Feranec RS, 2007, PALAEOGEOGR PALAEOCL, V252, P575, DOI 10.1016/j.palaeo.2007.05.012; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fischer L.A, 2002, THESIS; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; FRETWELL S D, 1972, P217; GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257; GEBCZYNSKA Z, 1991, ACTA THERIOL, V36, P307; GEE H, 1993, J QUATERNARY SCI, V8, P79, DOI 10.1002/jqs.3390080107; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gross M, 2013, CURR BIOL, V23, pR939, DOI 10.1016/j.cub.2013.10.039; Guthrie RD, 1990, FROZEN FAUNA OF THE; HEDGES REM, 1993, ARCHAEOMETRY, V35, P147, DOI 10.1111/j.1475-4754.1993.tb01030.x; Hobbie JE, 2009, CAN J MICROBIOL, V55, P84, DOI 10.1139/W08-127; Hofman-Kaminska E, 2012, ENVIRON MANAGE, V50, P530, DOI 10.1007/s00267-012-9913-7; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Jensen J, 2003, THE PREHISTORY OF DE; Jessen CA, 2014, QUATERNARY INTERNATI; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Kowalczyk R, 2013, ACTA THERIOL, V58, P391, DOI 10.1007/s13364-013-0136-y; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Krasinski, 2013, THE NATURE MONOGRAPH; Kristensen DK, 2011, CAN J ZOOL, V89, P892, DOI [10.1139/Z11-073, 10.1139/z11-073]; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; LARTER NC, 1991, CAN J ZOOL, V69, P2677, DOI 10.1139/z91-376; Martin MLSt, 2012, THESIS; Martin T, 1987, SENCKENBERGISCHE NAT, V96; McLeman C. I. A., 2006, THESIS; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Merceron G, 2014, FOREST ECOL MANAG, V328, P262, DOI 10.1016/j.foreco.2014.05.041; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; MOROW K, 1976, Acta Theriologica, V21, P101; NIEMINEN M, 1989, Rangifer, V9, P17; Noe-Nygaard N, 2005, J ARCHAEOL SCI, V32, P855, DOI 10.1016/j.jas.2005.01.004; Olech W., 2004, STATUS SURVEY CONSER; Pape R, 2012, AMBIO, V41, P421, DOI 10.1007/s13280-012-0257-6; Perzanowski KA, 2011, ROCZNIKI BIESZCZADZK, V19, P191; Perzanowski KA, 2008, ANN ZOOL FENN, V45, P347, DOI 10.5735/086.045.0417; Pushkina D, 2014, QUATERN INT, V339, P164, DOI 10.1016/j.quaint.2013.12.033; Pushkina D, 2010, NATURWISSENSCHAFTEN, V97, P299, DOI 10.1007/s00114-009-0642-6; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rivals F, 2010, PALAEOGEOGR PALAEOCL, V286, P42, DOI 10.1016/j.palaeo.2009.12.002; Sala MTN, 2010, ANTROPOLOGIA ARKEOLO, V61, P43; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmolcke U, 2005, MAMM BIOL, V70, P329, DOI 10.1016/j.mambio.2005.08.001; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schulz E, 2007, COUR FOR SEKENBG, V259, P155; SCHULZE ED, 1994, OECOLOGIA, V100, P406, DOI 10.1007/BF00317862; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; Stewart KM, 2003, ECOSCIENCE, V10, P297, DOI 10.1080/11956860.2003.11682777; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart Anthony John, 1999, P257; TEERI JA, 1979, OECOLOGIA, V39, P197, DOI 10.1007/BF00348068; Theuerkauf M, 2014, QUATERNARY SCI REV, V90, P183, DOI 10.1016/j.quascirev.2014.03.002; Turvey Samuel T., 2009, P17; Usinger H, 2005, INTERNATIONALE ARCHA, V5, P1, DOI [10.1016/j.acvd.2014.03.005, DOI 10.1016/J.ACVD.2014.03.005]; van Vuure C, 2005, RETRACING AUROCHS HI; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Wam HK, 2010, EUR J WILDLIFE RES, V56, P745, DOI 10.1007/s10344-010-0370-4; Weniger G, 1999, ARCHAOLOGIE UND BIOL	110	87	91	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115090	10.1371/journal.pone.0115090	http://dx.doi.org/10.1371/journal.pone.0115090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671634	gold, Green Published, Green Submitted			2022-12-26	WOS:000349545300004
J	Symeon, GK; Goliomytis, M; Bizelis, I; Papadomichelakis, G; Pagonopoulou, O; Abas, Z; Deligeorgis, SG; Chadio, SE				Symeon, George K.; Goliomytis, Michael; Bizelis, Iosif; Papadomichelakis, George; Pagonopoulou, Olga; Abas, Zafeiris; Deligeorgis, Stelios G.; Chadio, Stella E.			Effects of Gestational Maternal Undernutrition on Growth, Carcass Composition and Meat Quality of Rabbit Offspring	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; FEED RESTRICTION; METABOLIC SYNDROME; BIRTH-WEIGHT; FETAL-GROWTH; MUSCLE; PREGNANCY; NUTRITION; ORGANOGENESIS; CONSEQUENCES	An experiment was conducted in order to evaluate the effects of gestational undernutrition of rabbit does on growth, carcass composition and meat quality of the offsprings. Thirty primiparous non lactating rabbit does were artificially inseminated and randomly divided in three treatment groups: Control (C; fed to 100% of maintenance requirements throughout gestation, n = 10), early undernourished (EU; fed to 50% of maintenance requirements during days 7-19 of gestation, n = 10) and late undernourished (LU; fed to 50% of maintenance requirements during days 20-27 of gestation, n = 10). During the 4th week of the gestation period, LU does significantly lost weight compared to C and EU groups (P<0.05). At kindling, C does produced litters with higher proportions of stillborn kits (P<0.05) while the total litter size (alive and stillborn kits) was not different among groups (10.7, 12.8 and 12.7 kits in C, EU and LU groups, respectively). Kit birth weight tended to be lower in the LU group. During fattening, body weight and feed intake were not different among offsprings of the three experimental groups. Moreover, the maternal undernutrition did not have any impact on carcass composition of the offsprings in terms of carcass parts and internal organs weights as well as meat quality of L. lumborum muscle (pH24, colour, water holding capacity and shear values) at slaughter (70 days of age). Therefore, it can be concluded that the gestational undernutrition of the mother does not have detrimental effects on the productive and quality traits of the offsprings.	[Symeon, George K.; Pagonopoulou, Olga] Democritus Univ Thrace, Sch Med, Dept Physiol, Alexandroupolis, Greece; [Abas, Zafeiris] Democritus Univ Thrace, Dept Agr Dev, Div Anim Prod, Nea Orestiada, Greece; [Goliomytis, Michael; Bizelis, Iosif; Deligeorgis, Stelios G.] Agr Univ Athens, Dept Anim Breeding & Husb, Fac Anim Sci & Aquaculture, GR-11855 Athens, Greece; [Chadio, Stella E.] Agr Univ Athens, Fac Anim Sci & Aquaculture, Dept Anat & Physiol Farm Anim, GR-11855 Athens, Greece; [Papadomichelakis, George] Agr Univ Athens, Dept Nutr Physiol & Feeding, Fac Anim Sci & Aquaculture, GR-11855 Athens, Greece	Democritus University of Thrace; Democritus University of Thrace; Agricultural University of Athens; Agricultural University of Athens; Agricultural University of Athens	Symeon, GK (corresponding author), Democritus Univ Thrace, Sch Med, Dept Physiol, Alexandroupolis, Greece.	gsymewn@yahoo.gr	Goliomytis, Michael/J-9625-2019; Papadomichelakis, George/AAM-5033-2021; Symeon, George/I-8567-2019; Pagonopoulou, Olga/AAH-9944-2021	Goliomytis, Michael/0000-0001-9606-9894; Symeon, George/0000-0002-3782-7031; Papadomichelakis, George/0000-0002-6774-2434; BIZELIS, IOSIF/0000-0002-9457-2696	European Social Fund (ESF); Greek State [LS9-1678]	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	This research project was implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and was co-financed by the European Social Fund (ESF) and the Greek State (grant number LS9-1678). Funder website: www.gsrt.gr. Authors who received the funding: GKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J., 1994, BIOL LAB RABBIT, P457; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bee G, 2004, J ANIM SCI, V82, P826; Blasco A., 1996, WORLD RABBIT SCI, V4, P93, DOI [DOI 10.4995/WRS.1996.278, DOI 10.4995/WRS.1993.189]; Cappon GD, 2005, BIRTH DEFECTS RES B, V74, P424, DOI 10.1002/bdrb.20058; Caton JS, 2009, J ANIM SCI, V87, P222, DOI 10.2527/jas.2008-1043; Chadio S, 2014, J DEV ORIG HLTH DIS, V5, P2, DOI 10.1017/S204017441300038X; CLARK RL, 1986, FUND APPL TOXICOL, V7, P272, DOI 10.1016/0272-0590(86)90157-0; Combes S, 2004, MEAT SCI, V66, P91, DOI 10.1016/S0309-1740(03)00019-6; COUDERT P, 1985, ANN ZOOTECH, V34, P31, DOI 10.1051/animres:19850104; Daniel ZCTR, 2007, J ANIM SCI, V85, P1565, DOI 10.2527/jas.2006-743; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORTUN L, 1994, ANN ZOOTECH, V43, P163, DOI 10.1051/animres:19940206; Fortun-Lamothe L, 2006, ANIM REPROD SCI, V93, P1, DOI 10.1016/j.anireprosci.2005.06.009; Fortun-Lamothe L, 1999, LIVEST PROD SCI, V60, P229, DOI 10.1016/S0301-6226(99)00096-2; Fortun-Lamothe L, 1999, ANIM REPROD SCI, V55, P289, DOI 10.1016/S0378-4320(99)00020-2; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gondret F., 2005, Archiv fur Tierzucht, V48, P68; Greenwood PL, 2000, J ANIM SCI, V78, P50; HASTINGSROBERTS MM, 1977, J NUTR, V107, P973, DOI 10.1093/jn/107.6.973; Hernandez P, 2004, J ANIM SCI, V82, P3138; Kind KL, 1999, AM J PHYSIOL-REG I, V277, pR1675, DOI 10.1152/ajpregu.1999.277.6.R1675; LEDIN I, 1984, ANN ZOOTECH, V33, P33, DOI 10.1051/animres:19840103; Manal AF, 2010, ANIM REPROD SCI, V120, P179, DOI 10.1016/j.anireprosci.2010.03.010; Martinez-Paredes E, 2012, ANIMAL, V6, P1086, DOI 10.1017/S1751731111002643; Matsuoka Tetsuya, 2006, Journal of Toxicological Sciences, V31, P169, DOI 10.2131/jts.31.169; MATSUZAWA T, 1981, TOXICOLOGY, V22, P255, DOI 10.1016/0300-483X(81)90088-3; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nafeaa Abeer, 2011, Vet Med Int, V2011, P839737, DOI 10.4061/2011/839737; Parigi-Bini R, 1990, P 5 JOURN RECH CUN F; PARIGIBINI R, 1992, ANIM PROD, V55, P153, DOI 10.1017/S0003356100037387; PETRERE JA, 1993, FUND APPL TOXICOL, V21, P517, DOI 10.1006/faat.1993.1128; Poigner J., 2000, World Rabbit Science, V8, P17; Ramirez JA, 2004, MEAT SCI, V67, P617, DOI 10.1016/j.meatsci.2003.12.012; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Robinson DL, 2013, J ANIM SCI, V91, P1428, DOI 10.2527/jas.2012-5799; Rommers JM, 2004, ANIM REPROD SCI, V81, P151, DOI 10.1016/j.anireprosci.2003.09.001; SAS Institute Inc., 2005, STAT AN SYST US GUID, DOI [10.4137/BBI.S19057, DOI 10.4137/BBI.S19057]; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Xiccato G, 2010, NUTRITION OF THE RABBIT, 2ND EDITION, P83, DOI 10.1079/9781845936693.0083	41	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118259	10.1371/journal.pone.0118259	http://dx.doi.org/10.1371/journal.pone.0118259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671602	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300091
J	Kuwabara, WMT; Zhang, L; Schuiki, I; Curi, R; Volchuk, A; Alba-Loureiro, TC				Tatagiba Kuwabara, Wilson Mitsuo; Zhang, Liling; Schuiki, Irmgard; Curi, Rui; Volchuk, Allen; Alba-Loureiro, Tatiana Carolina			NADPH Oxidase-Dependent Production of Reactive Oxygen Species Induces Endoplasmatic Reticulum Stress in Neutrophil-Like HL60 Cells	PLOS ONE			English	Article							BIOLOGICAL DEFENSE-MECHANISMS; RESPIRATORY BURST OXIDASE; MESSENGER-RNA; BIOCHEMICAL ASPECTS; ACTIVATION DOMAIN; OXIDATIVE STRESS; GENE-EXPRESSION; ER STRESS; PROTEIN; DIFFERENTIATION	Reactive oxygen species (ROS) primarily produced via NADPH oxidase play an important role for killing microorganisms in neutrophils. In this study we examined if ROS production in Human promyelocytic leukemia cells (HL60) differentiated into neutrophil-like cells (dHL60) induces ER stress and activates the unfolded protein response (UPR). To cause ROS production cells were treated with PMA or by chronic hyperglycemia. Chronic hyperglycemia failed to induce ROS production and did not cause activation of the UPR in dHL60 cells. PMA, a pharmacologic NADPH oxidase activator, induced ER stress in dHL60 cells as monitored by IRE-1 and PERK pathway activation, and this was independent of calcium signaling. The NADPH oxidase inhibitor, DPI, abolished both ROS production and UPR activation. These results show that ROS produced by NADPH oxidase induces ER stress and suggests a close association between the redox state of the cell and the activation of the UPR in neutrophil-like HL60 cells.	[Tatagiba Kuwabara, Wilson Mitsuo; Curi, Rui; Volchuk, Allen] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Zhang, Liling; Schuiki, Irmgard; Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Universidade de Sao Paulo; University of Toronto	Kuwabara, WMT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	wilsonk@icb.usp.br	Loureiro, Tatiana C Alba/U-9436-2018; Curi, Rui/C-9351-2012; Loureiro, Tatiana/C-6712-2012; Kuwabara, Wilson MT/H-9492-2017	Kuwabara, Wilson MT/0000-0001-5307-6218	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/05349-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)- 2012/05349-9, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agner K., 1972, STRUCTURE FUNCTION O, P329; Ahmed N, 1999, LEUKEMIA RES, V23, P395, DOI 10.1016/S0145-2126(98)00179-9; BABIOR BM, 1991, AM J HEMATOL, V37, P263, DOI 10.1002/ajh.2830370410; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BABIOR BM, 1975, J LAB CLIN MED, V85, P235; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brechard S, 2005, CELL CALCIUM, V37, P531, DOI 10.1016/j.ceca.2005.01.019; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; COLLINS SJ, 1987, BLOOD, V70, P1233; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; FANTONE JC, 1982, AM J PATHOL, V107, P397; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; IYER GY, 1961, NATURE, V192, P535, DOI 10.1038/192535a0; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; Klebanoff SJ, 1992, INFLAMMATION BASIC P, P451; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lakshmanan AP, 2013, INT J BIOCHEM CELL B, V45, P438, DOI 10.1016/j.biocel.2012.09.017; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lin CJ, 2012, CELL BIOL INT, V36, P391, DOI 10.1042/CBI20110290; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu W, 2013, EXP THER MED, V5, P1289, DOI 10.3892/etm.2013.978; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MACDOUGALL SL, 1988, J CLIN INVEST, V81, P449, DOI 10.1172/JCI113340; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Miyake H, 2000, J CELL BIOCHEM, V77, P396, DOI 10.1002/(SICI)1097-4644(20000601)77:3<396::AID-JCB5>3.0.CO;2-5; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSSI F, 1964, EXPERIENTIA, V20, P21, DOI 10.1007/BF02146019; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sage AT, 2012, OBESITY, V20, P748, DOI 10.1038/oby.2011.144; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CX, 2013, ANTIOXID RE IN PRESS; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuster DP, 2007, AM J PHYSIOL-LUNG C, V292, pL845, DOI 10.1152/ajplung.00350.2006; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shimizu Y, 2009, ANTIOXID REDOX SIGN, V11, P2317, DOI [10.1089/ars.2009.2501, 10.1089/ARS.2009.2501]; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Thorens B, 2010, AM J PHYSIOLENDOCRIN, V298; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhai YP, 2013, ACTA PHARMACOL SIN, V34, P507, DOI 10.1038/aps.2012.207	75	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116410	10.1371/journal.pone.0116410	http://dx.doi.org/10.1371/journal.pone.0116410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668518	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000007
J	Behar, RZ; Hua, M; Talbot, P				Behar, Rachel Z.; Hua, My; Talbot, Prue			Puffing Topography and Nicotine Intake of Electronic Cigarette Users	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; DELIVERY-SYSTEMS; IN-VITRO; YIELDS; CONSUMPTION; CARTRIDGES; EXPOSURE; TAR	Background Prior electronic cigarette (EC) topography data are based on two video analyses with limited parameters. Alternate methods for measuring topography are needed to understand EC use and nicotine intake. Objectives This study evaluated EC topography with a CReSS Pocket device and quantified nicotine intake. Methods Validation tests on pressure drop, flow rate, and volume confirmed reliable performance of the CReSS Pocket device. Twenty participants used Blu Cigs and V2 Cigs for 10 minute intervals with a 10-15 minute break between brands. Brand order was reversed and repeated within 7 days Data were analyzed to determine puff duration, puff count, volume, flow rate, peak flow, and inter-puff interval. Nicotine intake was estimated from cartomizer fluid consumption and topography data. Results Nine patterns of EC use were identified. The average puff count and inter-puff interval were 32 puffs and 17.9 seconds. All participants, except one, took more than 20 puffs/10 minutes. The averages for puff duration (2.65 seconds/puff), volume/puff (51ml/puff), total puff volume (1,579 ml), EC fluid consumption (79.6 mg), flow rate (20 ml/s), and peak flow rate (27 ml/s) were determined for 10-minute sessions. All parameters except total puff count were significantly different for Blu versus V2 EC. Total volume for Blu versus V2 was four-times higher than for conventional cigarettes. Average nicotine intake for Blu and V2 across both sessions was 1.2 +/- 0.5 mg and 1.4 +/- 0.7 mg, respectively, which is similar to conventional smokers. Conclusions EC puffing topography was variable among participants in the study, but often similar within an individual between brands or days. Puff duration, inter-puff interval, and puff volume varied from conventional cigarette standards. Data on total puff volume and nicotine intake are consistent with compensatory usage of EC. These data can contribute to the development of a standard protocol for laboratory testing of EC products.	[Behar, Rachel Z.] Univ Calif Riverside, Cell Mol & Dev Biol Grad Program, Riverside, CA 92521 USA; [Behar, Rachel Z.; Hua, My; Talbot, Prue] Univ Calif Riverside, Dept Neurosci & Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Neurosci & Cell Biol, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		University of California Tobacco-Related Disease Research Program [22RT-0127]; National Institutes of Health Predoctoral Fellowship [F32HL116121]; University of California Chancellors Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL116121] Funding Source: NIH RePORTER	University of California Tobacco-Related Disease Research Program(University of California System); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Chancellors Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the University of California Tobacco-Related Disease Research Program Grant #22RT-0127 awarded to PT; National Institutes of Health Predoctoral Fellowship grant #F32HL116121 awarded to RB; University of California Chancellors Research Fellowship awarded to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 1997, J ORAL PATHOL MED, V26, P117, DOI 10.1111/j.1600-0714.1997.tb00033.x; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; BRIDGES RB, 1990, PHARMACOL BIOCHEM BE, V37, P29, DOI 10.1016/0091-3057(90)90037-I; Cameron JM, 2014, TOB CONTROL, V23, P77, DOI 10.1136/tobaccocontrol-2012-050604; Chen IL, 2014, TOB CONTROL, V23, P1, DOI 10.1136/tobaccocontrol-2013-051504; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; De Jesus S, 2015, J SMOK CESS, V10, P12, DOI 10.1017/jsc.2013.31; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Grana RA, 2013, J ADOLESCENT HEALTH, V52, P135, DOI 10.1016/j.jadohealth.2012.11.007; Hammond D, 2005, CANCER EPIDEM BIOMAR, V14, P1370, DOI 10.1158/1055-9965.EPI-04-0498; Hammond D, 2006, CANCER EPIDEM BIOMAR, V15, P1495, DOI 10.1158/1055-9965.EPI-06-0047; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kozlowski LT, 2002, TOB CONTROL, V11, pI40, DOI 10.1136/tc.11.suppl_1.i40; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Lee EM, 2003, NICOTINE TOB RES, V5, P673, DOI 10.1080/1462220031000158645; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; SUTTON SR, 1982, BRIT MED J, V285, P600, DOI 10.1136/bmj.285.6342.600; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Uchiyama S, 2013, ANAL SCI, V29, P1219, DOI 10.2116/analsci.29.1219; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987	40	130	138	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117222	10.1371/journal.pone.0117222	http://dx.doi.org/10.1371/journal.pone.0117222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664463	gold, Green Published			2022-12-26	WOS:000349123100021
J	Malhotra, A; Gundel, M; Rajput, AM; Mevissen, HT; Saiz, A; Pastor, X; Lozano-Rubi, R; Martinez-Lapsicina, EH; Zubizarreta, I; Mueller, B; Kotelnikova, E; Toldo, L; Hofmann-Apitius, M; Villoslada, P				Malhotra, Ashutosh; Guendel, Michaela; Rajput, Abdul Mateen; Mevissen, Heinz-Theodor; Saiz, Albert; Pastor, Xavier; Lozano-Rubi, Raimundo; Martinez-Lapsicina, Elena H.; Zubizarreta, Irati; Mueller, Bernd; Kotelnikova, Ekaterina; Toldo, Luca; Hofmann-Apitius, Martin; Villoslada, Pablo			Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology	PLOS ONE			English	Article							HEALTH RECORDS; DECISION-SUPPORT; COMORBIDITIES; DIAGNOSIS; PATTERNS; THERAPY; MS	Background In order to retrieve useful information from scientific literature and electronic medical records (EMR) we developed an ontology specific for Multiple Sclerosis (MS). Methods The MS Ontology was created using scientific literature and expert review under the Protege OWL environment. We developed a dictionary with semantic synonyms and translations to different languages for mining EMR. The MS Ontology was integrated with other ontologies and dictionaries (diseases/comorbidities, gene/protein, pathways, drug) into the text-mining tool SCAIView. We analyzed the EMRs from 624 patients with MS using the MS ontology dictionary in order to identify drug usage and comorbidities in MS. Testing competency questions and functional evaluation using F statistics further validated the usefulness of MS ontology. Results Validation of the lexicalized ontology by means of named entity recognition-based methods showed an adequate performance (F score = 0.73). The MS Ontology retrieved 80% of the genes associated with MS from scientific abstracts and identified additional pathways targeted by approved disease-modifying drugs (e.g. apoptosis pathways associated with mitoxantrone, rituximab and fingolimod). The analysis of the EMR from patients with MS identified current usage of disease modifying drugs and symptomatic therapy as well as comorbidities, which are in agreement with recent reports. Conclusion The MS Ontology provides a semantic framework that is able to automatically extract information from both scientific literature and EMR from patients with MS, revealing new pathogenesis insights as well as new clinical information.	[Malhotra, Ashutosh; Guendel, Michaela; Mevissen, Heinz-Theodor; Mueller, Bernd; Hofmann-Apitius, Martin] Fraunhofer Inst Algorithms & Sci Comp, Dept Bioinformat, D-53754 St Augustin, Germany; [Rajput, Abdul Mateen; Toldo, Luca] Merck KGaA, Darmstadt, Germany; [Saiz, Albert] Hosp Clin Barcelona, Dept Neurol, MS Ctr, Barcelona, Spain; [Saiz, Albert; Martinez-Lapsicina, Elena H.; Zubizarreta, Irati; Kotelnikova, Ekaterina; Villoslada, Pablo] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain; [Pastor, Xavier; Lozano-Rubi, Raimundo] Univ Barcelona, Hosp Clin Barcelona, Dept Med Informat, Barcelona, Spain	Fraunhofer Gesellschaft; Merck KGaA; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Villoslada, P (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain.	pvilloslada@clinic.ub.es	Martínez-Lapiscina, Elena H/L-1161-2014; Müller, Bernd/AFE-4930-2022; Villoslada, Pablo/AAF-9547-2019; Kotelnikova, Elena/N-8496-2013; Hofmann-Apitius, Martin/E-6123-2018	Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Müller, Bernd/0000-0003-3062-8192; Zubizarreta Nafarrate, Irati/0000-0001-7637-7830; Hofmann-Apitius, Martin/0000-0001-9012-6720; Lozano-Rubi, Raimundo/0000-0002-7912-721X	Instituto de Salud Carlos III, Spain [PS09/00259, RD12/0032/0001]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	Funded by the Instituto de Salud Carlos III, Spain (FIS program PS09/00259 and RETICS program RD12/0032/0001), www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejarano B, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-67; Bodenreider O, 2008, Yearb Med Inform, P67; Davis MF, 2013, J AM MED INFORM ASSN, V20, pE334, DOI 10.1136/amiajnl-2013-001999; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Esposito M, 2011, ENG APPL ARTIF INTEL, V24, P1340, DOI 10.1016/j.engappai.2011.02.002; Frohman Teresa C, 2011, Ther Adv Neurol Disord, V4, P83, DOI 10.1177/1756285611400658; Fromont A, 2013, J NEUROL, V260, P2629, DOI 10.1007/s00415-013-7041-9; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kang JH, 2010, EUR J NEUROL, V17, P1215, DOI 10.1111/j.1468-1331.2010.02971.x; Katzan IL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004583; Lafata JE, 2008, J AM PHARM ASSOC, V48, P752, DOI 10.1331/JAPhA.2008.07116; LePendu P, 2013, CLIN PHARMACOL THER, V93, P547, DOI 10.1038/clpt.2013.47; Mahurkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057655; Malhotra A, 2013, ALZHEIMERS DEMENT, P238; Markowitz Clyde, 2010, Continuum (Minneap Minn), V16, P90, DOI 10.1212/01.CON.0000389936.61789.04; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Marriott JJ, 2013, CAN J NEUROL SCI, V40, P67, DOI 10.1017/S031716710001297X; Miller DM, 2011, TELEMED E-HEALTH, V17, P5, DOI 10.1089/tmj.2010.0133; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Obrst L, 2007, EVALUATION ONTOLOGIE, P139, DOI DOI 10.1007/978-0-387-48438-9_8; Oleen-Burkey MerriKay, 2013, J Med Econ, V16, P397, DOI 10.3111/13696998.2013.764309; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Rothman B, 2012, MT SINAI J MED, V79, P757, DOI 10.1002/msj.21351; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sethi NK, 2013, NEUROLOGY, V81, P1558, DOI 10.1212/WNL.0b013e3182a9f1ea; Solaro C, 2011, EUR J NEUROL, V18, P1113, DOI 10.1111/j.1468-1331.2011.03425.x; Torkildsen O, 2007, ACTA NEUROL SCAND, V115, P46, DOI 10.1111/j.1600-0404.2007.00846.x; Villoslada P, 2012, J NEUROIMMUNOL, V248, P58, DOI 10.1016/j.jneuroim.2012.01.001; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Wild F, 2013, NERVENARZT, V84, P202, DOI 10.1007/s00115-012-3683-6; Windt R, 2013, INT J CLIN PHARM-NET, V35, P1229, DOI 10.1007/s11096-013-9857-x; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548	35	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116718	10.1371/journal.pone.0116718	http://dx.doi.org/10.1371/journal.pone.0116718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665127	Green Published, gold, Green Submitted			2022-12-26	WOS:000349123100012
J	Cha, YL; Li, PD; Yuan, LJ; Zhang, MY; Zhang, YJ; Rao, HL; Zhang, HZ; Zheng, XFS; Wang, HY				Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Zhang, Yao-Jun; Rao, Hui-Lan; Zhang, Hui-Zhong; Zheng, X. F. Steven; Wang, Hui-Yun			EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; 4E-BINDING PROTEIN-1; INITIATION-FACTORS; TRANSLATION; MTOR; EXPRESSION; P150; PHENOTYPE; EFFECTORS; HALLMARK	Objective EIF4EBP1 acts as a crucial effector in mTOR signaling pathway. Studies have suggested that EIF4EBP1 plays a critical role in carcinogenesis. However, the clinical significance and biological role of EIF4EBP1 in hepatocellular carcinoma (HCC) have not been elucidated. Therefore, we aimed to investigate the clinical significance of EIF4EBP1 in HCC. Methods Total 128 cases of HCCs were included in this study. EIF4EBP1 expression in HCC tissues was detected by qRT-PCR, Western blot and immunohistochemistry, respectively. Then the relationships between EIF4EBP1 expression and clinical features as well as survival were analyzed. Results The expression level of EIF4EBP1 mRNA is significantly higher in 60% (24/40) of fresh HCC tissues than that in the matched adjacent nontumor liver (NCL) tissues (P = 0.044). Similarly, EIF4EBP1 protein is notably upregulated in 8 HCC tissues (randomly selected from the 40 HCCs) measured by Western blot and is significantly increased in another 88 paraffin-embedded HCCs (53%, 47/88) by immunohistochemistry compared with the matched NCLs (P < 0.001). EIF4EBP1 protein expression in HCC tissues is significantly correlated with serum AFP (P = 0.003) and marginally significantly associated with pathological grade (P = 0.085), tumor number (P = 0.084), tumor embolus (P = 0.084) and capsulation (P = 0.073). Patients with higher EIF4EBP1 protein expression have a much worse 5-year overall survival (40.3% vs 73.6%) and 5-year disease-free survival (33.0% vs 49.0%) than those with low expression. Furthermore, Cox regression analysis shows that EIF4EBP1 protein is an independent prognostic factor for overall survival (HR, 2.285; 95% CI, 1.154-4.527; P = 0.018) and disease-free survival (HR, 1.901; 95% CI, 1.067-3.386; P = 0.029) in HCC patients. Conclusions Our results demonstrate for the first time that EIF4EBP1 mRNA and protein are markedly up-regulated in HCC tissues, and the protein overexpression is significantly associated with poor survival and progression, which provide a potential new prognostic marker and therapeutic target for HCC patients.	[Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Natl Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yao-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan; Zhang, Hui-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, X. F. Steven] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Wang, HY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn	Zhang, Yaojun/U-2965-2019; YANG, YANG/U-3889-2017	Zhang, Yaojun/0000-0002-9752-4729	National Natural Science Foundation of China [81171891]; Research Fund of National Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of National Key Laboratory of Oncology in South China	This work was supported by a grant (No: 81171891) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) and partly supported by the Research Fund of National Key Laboratory of Oncology in South China (http://skl.sysucc.org.cn/). The grants were awarded to HYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi M, 2010, P NATL ACAD SCI USA, V107, P2640, DOI 10.1073/pnas.0914856107; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Cai WJ, 2014, ONCOTARGET, V5, P6015, DOI 10.18632/oncotarget.2109; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Haybaeck J, 2010, ANTICANCER RES, V30, P1047; Heikkinen T, 2013, BREAST CANCER RES TR, V141, P79, DOI 10.1007/s10549-013-2671-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karlsson E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3557; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086371; Li X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.331; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; Spilka R, 2014, CELL ONCOL, V37, P253, DOI 10.1007/s13402-014-0181-9; Spilka R, 2012, J ONCOL, V2012, DOI 10.1155/2012/901956; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Thoreen CC, 2013, BIOCHEM SOC T, V41, P913, DOI 10.1042/BST20130082; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang CM, 2013, CELL CYCLE, V12, P1999, DOI 10.4161/cc.25099; Weng QJ, 2011, INVEST NEW DRUG, V29, P1177, DOI 10.1007/s10637-010-9462-y; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034	31	19	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117493	10.1371/journal.pone.0117493	http://dx.doi.org/10.1371/journal.pone.0117493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658620	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900163
J	Hegde, A; Strachan, RT; Walker, JKL				Hegde, Akhil; Strachan, Ryan T.; Walker, Julia K. L.			Quantification of Beta Adrenergic Receptor Subtypes in Beta-Arrestin Knockout Mouse Airways	PLOS ONE			English	Article							SMOOTH-MUSCLE; GUINEA-PIG; AUTORADIOGRAPHIC LOCALIZATION; I-125 IODOCYANOPINDOLOL; ADRENOCEPTOR SUBTYPES; RADIOLIGAND BINDING; ASTHMA PHENOTYPE; ISOLATED TRACHEA; MURINE MODEL; HUMAN-LUNG	In allergic asthma Beta 2 adrenergic receptors (beta(2)ARs) are important mediators of bronch-orelaxation and, paradoxically, asthma development. This contradiction is likely due to the activation of dual signaling pathways that are downstream of G proteins or beta-arrestins. Our group has recently shown that beta-arrestin-2 acts in its classical role to desensitize and constrain beta(2)AR-induced relaxation of both human and murine airway smooth muscle. To assess the role of beta-arrestins in regulating beta(2)AR function in asthma, we and others have utilized beta-arrestin-1 and -2 knockout mice. However, it is unknown if genetic deletion of beta-arrestins in these mice influences beta(2)AR expression in the airways. Furthermore, there is lack of data on compensatory expression of beta AR subtypes when either of the beta-arrestins is genetically deleted, thus necessitating a detailed beta AR subtype expression study in these beta-arrestin knockout mice. Here we standardized a radioligand binding methodology to characterize and quantitate beta AR subtype distribution in the airway smooth muscle of wild-type C57BL/6J and beta-arrestin-1 and beta-arrestin-2 knockout mice. Using complementary competition and single-point saturation binding assays we found that beta(2)ARs predominate over beta(1)ARs in the whole lung and epithelium-denuded tracheobronchial smooth muscle of C57BL/6J mice. Quantification of beta AR subtypes in beta-arrestin-1 and beta-arrestin-2 knockout mouse lung and epithelium-denuded tracheobronchial tissue showed that, similar to the C57BL/6J mice, both knockouts display a predominance of beta(2)AR expression. These data provide further evidence that beta(2)ARs are expressed in greater abundance than beta(1)ARs in the tracheobronchial smooth muscle and that loss of either beta-arrestin does not significantly affect the expression or relative proportions of beta(2)AR subtypes. As beta-arrestins are known to modulate beta(2)AR function, our analysis of beta AR subtype expression in beta-arrestin knockout mice airways sets a reference point for future studies exploiting these knockout mice in various disease models including asthma.	[Hegde, Akhil; Walker, Julia K. L.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA; [Strachan, Ryan T.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Strachan, Ryan T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University	Walker, JKL (corresponding author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA.	walke082@mc.duke.edu			National Institutes of Health (NIH) [HL084123, HL093103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084123, R01HL093103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants HL084123 and HL093103 to JKLW. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisheganaden J, 1998, AM J MED, V104, P494; Abraham G, 2003, BIOCHEM PHARMACOL, V66, P1067, DOI 10.1016/S0006-2952(03)00460-X; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BARNES PJ, 1983, J PHARMACOL EXP THER, V225, P456; Black JL, 2009, CLIN EXP ALLERGY, V39, P962, DOI 10.1111/j.1365-2222.2009.03270.x; CARSTAIRS JR, 1985, AM REV RESPIR DIS, V132, P541; CARSWELL H, 1983, BRIT J PHARMACOL, V79, P965, DOI 10.1111/j.1476-5381.1983.tb10542.x; Davenport A.P., 1996, CURRENT DIRECTIONS R, P169, DOI DOI 10.1007/978-94-009-1768-2_11; DELEAN A, 1982, MOL PHARMACOL, V21, P5; Deng HY, 2012, PHARMACOLOGY, V89, P211, DOI 10.1159/000337184; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; ENGEL G, 1981, POSTGRAD MED J, V57, P77; FINKEL MS, 1984, PHARMACOLOGY, V29, P247, DOI 10.1159/000138020; GOLDIE RG, 1986, EUR J PHARMACOL, V124, P179, DOI 10.1016/0014-2999(86)90141-X; GOLDIE RG, 1986, BRIT J PHARMACOL, V87, P5, DOI 10.1111/j.1476-5381.1986.tb10150.x; GOLDIE RG, 1986, BRIT J PHARMACOL, V88, P621, DOI 10.1111/j.1476-5381.1986.tb10243.x; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P136, DOI 10.1111/j.1476-5381.1990.tb14667.x; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P131, DOI 10.1111/j.1476-5381.1990.tb14666.x; Ikeda T, 2012, BRIT J PHARMACOL, V166, P1804, DOI 10.1111/j.1476-5381.2012.01881.x; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, pXV, DOI 10.1016/B978-0-12-374585-9.00017-7; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Luttrell LM, 2002, J CELL SCI, V115, P455; MINNEMAN KP, 1979, MOL PHARMACOL, V16, P34; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; OTA A, 1993, NEUROSCI LETT, V160, P96, DOI 10.1016/0304-3940(93)90922-8; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spina D, 2014, CURR OPIN PULM MED, V20, P73, DOI 10.1097/MCP.0000000000000012; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	35	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116458	10.1371/journal.pone.0116458	http://dx.doi.org/10.1371/journal.pone.0116458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658948	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900040
J	Huang, MG; Sannaningaiah, D; Zhao, N; Gong, YQ; Grondolsky, J; Hoover-Plow, J				Huang, Menggui; Sannaningaiah, Devaraja; Zhao, Nan; Gong, Yanqing; Grondolsky, Jessica; Hoover-Plow, Jane			EMILIN2 Regulates Platelet Activation, Thrombus Formation, and Clot Retraction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ELASTIC FIBERS; BLOOD-PRESSURE; HEART-FAILURE; MOUSE MODELS; DOMAIN; INTEGRIN; MICE; ALPHA-IIB-BETA-3; HEMOSTASIS	Thrombosis, like other cardiovascular diseases, has a strong genetic component, with largely unknown determinants. EMILIN2, Elastin Microfibril Interface Located Protein2, was identified as a candidate gene for thrombosis in mouse and human quantitative trait loci studies. EMILIN2 is expressed during cardiovascular development, on cardiac stem cells, and in heart tissue in animal models of heart disease. In humans, the EMILIN2 gene is located on the short arm of Chromosome 18, and patients with partial and complete deletion of this chromosome region have cardiac malformations. To understand the basis for the thrombotic risk associated with EMILIN2, EMILIN2 deficient mice were generated. The findings of this study indicate that EMILIN2 influences platelet aggregation induced by adenosine diphosphate, collagen, and thrombin with both EMILIN2-deficient platelets and EMILIN2-deficient plasma contributing to the impaired aggregation response. Purified EMILIN2 added to platelets accelerated platelet aggregation and reduced clotting time when added to EMILIN2-deficient mouse and human plasma. Carotid occlusion time was 2-fold longer in mice with platelet-specific EMILIN2 deficiency, but stability of the clot was reduced in mice with both global EMILIN2 deficiency and with platelet-specific EMILIN2 deficiency. In vitro clot retraction was markedly decreased in EMILIN2 deficient mice, indicating that platelet outside-in signaling was dependent on EMILIN2. EMILIN1 deficient mice and EMILIN2: EMILIN1 double deficient mice had suppressed platelet aggregation and delayed clot retraction similar to EMILIN2 mice, but EMILIN2 and EMILIN1 had opposing affects on clot retraction, suggesting that EMILIN1 may attenuate the effects of EMILIN2 on platelet aggregation and thrombosis. In conclusion, these studies identify multiple influences of EMILIN2 in pathophysiology and suggest that its role as a prothrombotic risk factor may arise from its effects on platelet aggregation and platelet mediated clot retraction.	[Huang, Menggui; Sannaningaiah, Devaraja; Zhao, Nan; Gong, Yanqing; Grondolsky, Jessica; Hoover-Plow, Jane] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Hoover-Plow, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	hooverj@ccf.org		, Menggui/0000-0002-4942-5558	National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL065204, R01HL17964]; University Grants Commission, Bahadur Shah Zafar Marg, New Delhi, India; American Heart Association [09BGIA2050157, 12SDG9050018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL065204, R01HL017964] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University Grants Commission, Bahadur Shah Zafar Marg, New Delhi, India(University Grants Commission, India); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute, R01HL065204 and R01HL17964, (JHP), University Grants Commission, Bahadur Shah Zafar Marg, New Delhi-110 002, India, DS, and American Heart Association (09BGIA2050157 and 12SDG9050018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2014, THROMB RES, V133, pS3, DOI 10.1016/j.thromres.2014.03.002; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Flierl U, 2013, PHARMACOL RES, V74, P49, DOI 10.1016/j.phrs.2013.05.002; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Guthikonda S, 2008, THROMB HAEMOSTASIS, V100, P83, DOI 10.1160/TH07-10-0590; Hamirani YS, 2012, CIRCULATION, V126, P1121, DOI 10.1161/CIRCULATIONAHA.112.113993; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; Hildemann SK, 2014, THROMB HAEMOSTASIS, V111, P725, DOI 10.1160/TH13-08-0640; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Jug B, 2009, INT HEART J, V50, P591, DOI 10.1536/ihj.50.591; Kauskot A, 2012, BLOOD, V119, P4056, DOI 10.1182/blood-2011-11-392787; Kielty CM, 2002, J CELL SCI, V115, P2817; Litteri G, 2012, ARTERIOSCL THROM VAS, V32, P2178, DOI 10.1161/ATVBAHA.112.254664; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Ninivaggi M, 2014, THROMB HAEMOSTASIS, V111, P447, DOI 10.1160/TH13-06-0493; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sa Q, 2008, MAMM GENOME, V19, P406, DOI 10.1007/s00335-008-9122-0; Sa Q, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-9; Sa Q, 2010, MAMM GENOME, V21, P337, DOI 10.1007/s00335-010-9274-6; Soria JM, 2003, BLOOD, V101, P163, DOI 10.1182/blood-2002-06-1792; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Stissing T, 2011, CLIN APPL THROMB-HEM, V17, pE211, DOI 10.1177/1076029610397183; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tymvios C, 2008, THROMB HAEMOSTASIS, V99, P435, DOI 10.1160/TH07-07-0479; Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115284	10.1371/journal.pone.0115284	http://dx.doi.org/10.1371/journal.pone.0115284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658937	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900013
J	Li, GB; Shan, CY; Liu, L; Zhou, T; Zhou, J; Hu, XY; Chen, YB; Cui, HJ; Gao, N				Li, Guobing; Shan, Changyu; Liu, Lei; Zhou, Ting; Zhou, Jing; Hu, Xiaoye; Chen, Yibiao; Cui, Hongjuan; Gao, Ning			Tanshinone IIA Inhibits HIF-1 alpha and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; UNFAVORABLE PROGNOSIS; GENE-EXPRESSION; ANGIOGENESIS; OVEREXPRESSION; PROGRESSION; MECHANISMS; BIOLOGY; MTOR	Hypoxia-inducible factor 1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) play important roles in angiogenesis and tumor growth. Tanshinone IIA (T2A) is a novel antiangiogenic agent with promising antitumor effects; however, the molecular mechanism underlying the antiangiogenic effects of T2A remains unclear. In the present study, we provided evidence showing that T2A inhibited angiogenesis and breast cancer growth by down-regulating VEGF expression. Specifically, T2A repressed HIF-1 alpha expression at the translational level and inhibited the transcriptional activity of HIF-1 alpha, which led to the down-regulation of VEGF expression. Suppression of HIF-1 alpha synthesis by T2A correlated with strong dephosphorylation of mammalian target of rapamycin (mTOR) and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1), a pathway regulating HIF-1 alpha expression at the translational level. In addition, we also found that T2A inhibited the angiogenesis and growth of human breast cancer xenografts in nude mice through suppression of HIF-1 alpha and VEGF. Our study provides novel perspectives and potential targets for the treatment of human breast cancer.	[Li, Guobing; Shan, Changyu; Liu, Lei; Zhou, Ting; Zhou, Jing; Hu, Xiaoye; Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Chen, Yibiao; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Army Medical University; Southwest University - China	Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China.	gaoning59@163.com			Chongqing Natural Science Foundation [CSTC2013jjB10007]; National Natural Science Foundation of China [81402970]; State Key Laboratory of Silkworm Genome Biology, Southwest University [2013024]	Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Silkworm Genome Biology, Southwest University	This work was supported by Chongqing Natural Science Foundation (CSTC2013jjB10007), the National Natural Science Foundation of China (No. 81402970), and the Open Project Program of State Key Laboratory of Silkworm Genome Biology, Southwest University (2013024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Boudreau N, 2003, BREAST CANCER RES, V5, P140, DOI 10.1186/bcr589; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Chekhonin VP, 2013, CURR CANCER DRUG TAR, V13, P423, DOI 10.2174/15680096113139990074; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Duong MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002538; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033656; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kakeya Hideaki, 2004, Nihon Rinsho, V62, P1264; Li G, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.7; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Longo Flavia, 2006, Tumori, V92, P1; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Miller KD, 2004, HEMATOL ONCOL CLIN N, V18, P1071, DOI 10.1016/j.hoc.2004.06.010; Montero JC, 2014, ONCOGENE, V33, P148, DOI 10.1038/onc.2012.572; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwarzlose-Schwarck S, 2012, ANTICANCER RES, V32, P3435; Shibaji T, 2003, ANTICANCER RES, V23, P4721; Su CC, 2008, INT J MOL MED, V22, P357, DOI 10.3892/ijmm_00000030; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Tsai MY, 2011, CANCER LETT, V310, P198, DOI 10.1016/j.canlet.2011.06.031; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Van den Eynden GG, 2008, CLIN CANCER RES, V14, P2944, DOI 10.1158/1078-0432.CCR-07-4397; Vaupel P, 2005, ADV EXP MED BIOL, V566, P333; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wang XJ, 2005, INT J CANCER, V116, P799, DOI 10.1002/ijc.20880; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604	42	76	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117440	10.1371/journal.pone.0117440	http://dx.doi.org/10.1371/journal.pone.0117440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659153	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900150
J	Wu, HY; Han, Y; Yang, X; Chase, GG; Tang, Q; Lee, CJ; Cao, B; Zhe, J; Cheng, G				Wu, Haiyan; Han, Yu; Yang, Xi; Chase, George G.; Tang, Qiong; Lee, Chen-Jung; Cao, Bin; Zhe, Jiang; Cheng, Gang			A Versatile Microparticle-Based Immunoaggregation Assay for Macromolecular Biomarker Detection and Quantification	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY; BLOOD-PLASMA; BIOSENSOR; IMMUNOASSAY; PROTEIN; ENHANCEMENT; DISEASE; POINT	The rapid, sensitive and low-cost detection of macromolecular biomarkers is critical in clinical diagnostics, environmental monitoring, research, etc. Conventional assay methods usually require bulky, expensive and designated instruments and relative long assay time. For hospitals and laboratories that lack immediate access to analytical instruments, fast and low-cost assay methods for the detection of macromolecular biomarkers are urgently needed. In this work, we developed a versatile microparticle (MP)-based immunoaggregation method for the detection and quantification of macromolecular biomarkers. Antibodies (Abs) were firstly conjugated to MP through streptavidin-biotin interaction; the addition of macromolecular biomarkers caused the aggregation of Ab-MPs, which were subsequently detected by an optical microscope or optical particle sizer. The invisible nanometer-scale macromolecular biomarkers caused detectable change of micrometer-scale particle size distributions. Goat anti-rabbit immunoglobulin and human ferritin were used as model biomarkers to demonstrate MP-based immunoaggregation assay in PBS and 10% FBS to mimic real biomarker assay in the complex medium. It was found that both the number ratio and the volume ratio of Ab-MP aggregates caused by biomarker to all particles were directly correlated to the biomarker concentration. In addition, we found that the detection range could be tuned by adjusting the Ab-MP concentration. We envision that this novel MP-based immunoaggregation assay can be combined with multiple detection methods to detect and quantify macromolecular biomarkers at the nanogram per milliliter level.	[Wu, Haiyan; Yang, Xi; Chase, George G.; Tang, Qiong; Lee, Chen-Jung; Cao, Bin; Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Han, Yu; Zhe, Jiang] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Zhe, J (corresponding author), Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.	jzhe@uakron.edu; gc@uakron.edu			National Science Foundation (NSF) [CMMI-1129727]; Directorate For Engineering [1129727] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work was supported by the National Science Foundation (NSF CMMI-1129727).	Cao C, 2007, BIOSENS BIOELECTRON, V22, P1874, DOI 10.1016/j.bios.2006.07.021; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Cui XQ, 2003, TALANTA, V60, P53, DOI 10.1016/S0039-9140(03)00043-2; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Jebrail MJ, 2010, CURR OPIN CHEM BIOL, V14, P574, DOI 10.1016/j.cbpa.2010.06.187; Jokerst JV, 2009, BIOSENS BIOELECTRON, V24, P3622, DOI 10.1016/j.bios.2009.05.026; LEE MH, 1995, AM J MED, V98, P566, DOI 10.1016/S0002-9343(99)80015-1; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Moyo M, 2014, SENSOR ACTUAT B-CHEM, V193, P515, DOI 10.1016/j.snb.2013.11.086; Soper SA, 2006, BIOSENS BIOELECTRON, V21, P1932, DOI 10.1016/j.bios.2006.01.006; Su XD, 2001, CHEM COMMUN, P755, DOI 10.1039/b009768n; SUN S, 1992, J BIOL CHEM, V267, P25160; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888; Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P1924, DOI 10.1016/j.bios.2008.09.035; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031; Zhang WY, 2014, TRAC-TREND ANAL CHEM, V54, P1, DOI 10.1016/j.trac.2013.10.007	20	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115046	10.1371/journal.pone.0115046	http://dx.doi.org/10.1371/journal.pone.0115046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658837	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900012
J	Wu, ZQ; Tembrock, LR; Ge, S				Wu, Zhiqiang; Tembrock, Luke R.; Ge, Song			Are Differences in Genomic Data Sets due to True Biological Variants or Errors in Genome Assembly: An Example from Two Chloroplast Genomes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENE ORGANIZATION; DNA; SEQUENCE; INDELS; DIVERSIFICATION; IDENTIFICATION; TRANSFORMATION; CHALLENGES; EVOLUTION	DNA sequencing has been revolutionized by the development of high-throughput sequencing technologies. Plummeting costs and the massive throughput capacities of second and third generation sequencing platforms have transformed many fields of biological research. Concurrently, new data processing pipelines made rapid de novo genome assemblies possible. However, high quality data are critically important for all investigations in the genomic era. We used chloroplast genomes of one Oryza species (O. australiensis) to compare differences in sequence quality: one genome (GU592209) was obtained through Illumina sequencing and reference-guided assembly and the other genome (KJ830774) was obtained via target enrichment libraries and shotgun sequencing. Based on the whole genome alignment, GU592209 was more similar to the reference genome (O. sativa: AY522330) with 99.2% sequence identity (SI value) compared with the 98.8% SI values in the KJ830774 genome; whereas the opposite result was obtained when the SI values in coding and noncoding regions of GU592209 and KJ830774 were compared. Additionally, the junctions of two single copies and repeat copies in the chloroplast genome exhibited differences. Phylogenetic analyses were conducted using these sequences, and the different data sets yielded dissimilar topologies: phylogenetic replacements of the two individuals were remarkably different based on whole genome sequencing or SNP data and insertions and deletions (indels) data. Thus, we concluded that the genomic composition of GU592209 was heterogeneous in coding and non-coding regions. These findings should impel biologists to carefully consider the quality of sequencing and assembly when working with next-generation data.	[Wu, Zhiqiang; Ge, Song] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Wu, Zhiqiang; Tembrock, Luke R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Colorado State University	Wu, ZQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	wu.zhiqiang.1020@gmail.com	Wu, Zhiqiang/CAG-6688-2022; , wuzhiqiang/C-7843-2017	Wu, Zhiqiang/0000-0002-4238-7317; , wuzhiqiang/0000-0002-4238-7317	National Natural Science Foundation of China [30990240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30990240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bock R, 2007, CURR OPIN BIOTECH, V18, P100, DOI 10.1016/j.copbio.2006.12.001; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Cheng L, 2010, PLANT CELL REP, V29, P371, DOI 10.1007/s00299-010-0828-6; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cui CJ, 2011, ACTA BIOCH BIOPH SIN, V43, P284, DOI 10.1093/abbs/gmr008; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Grimm D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-132; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Ledford H, 2008, NATURE, V451, P616, DOI 10.1038/451616b; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mahmud MP, 2012, BIOINFORMATICS, V28, pI325, DOI 10.1093/bioinformatics/bts380; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Meyers B, 2010, BIOTECHNOL ADV, V28, P747, DOI 10.1016/j.biotechadv.2010.05.022; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Sugiura M, 2003, PHOTOSYNTH RES, V76, P371, DOI 10.1023/A:1024913304263; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang L, 2010, BOT J LINN SOC, V162, P28, DOI 10.1111/j.1095-8339.2009.01018.x; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Waters DLE, 2012, ECOL EVOL, V2, P211, DOI 10.1002/ece3.66; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P1062, DOI 10.3109/19401736.2014.928868; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835; Zou XH, 2013, NEW PHYTOL, V198, P1155, DOI 10.1111/nph.12230; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	72	39	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118019	10.1371/journal.pone.0118019	http://dx.doi.org/10.1371/journal.pone.0118019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658309	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900251
J	Maenpuen, S; Amornwatcharapong, W; Krasatong, P; Sucharitakul, J; Palfey, BA; Yuthavong, Y; Chitnumsub, P; Leartsakulpanich, U; Chaiyen, P				Maenpuen, Somchart; Amornwatcharapong, Watcharee; Krasatong, Pasupat; Sucharitakul, Jeerus; Palfey, Bruce A.; Yuthavong, Yongyuth; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree; Chaiyen, Pimchai			Kinetic Mechanism and the Rate-limiting Step of Plasmodium vivax Serine Hydroxymethyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL ANTIMALARIAL TARGET; BACILLUS-STEAROTHERMOPHILUS; METHYLENETETRAHYDROFOLATE REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME; BINDING; SPECIFICITY; COMPLEXES; SUBSTRATE	Serine hydroxymethyltransferase (SHMT) is a pyridoxal 5 '-phosphate (PLP)-dependent enzyme that catalyzes a hydroxymethyl group transfer from L-serine to tetrahydrofolate (H(4)folate) to yield glycine and 5,10-methylenetetrahydrofolate (CH2-H(4)folate). SHMT is crucial for deoxythymidylate biosynthesis and a target for antimalarial drug development. Our previous studies indicate that PvSHMT catalyzes the reaction via a ternary complex mechanism. To define the kinetic mechanism of this catalysis, we explored the PvSHMT reaction by employing various methodologies including ligand binding, transient, and steady-state kinetics as well as product analysis by rapid-quench and HPLC/MS techniques. The results indicate that PvSHMT can bind first to either L-serine or H(4)folate. The dissociation constants for the enzyme.L-serine and enzyme.H(4)folate complexes were determined as 0.18 +/- 0.08 and 0.35 +/- 0.06 mM, respectively. The amounts of glycine formed after single turnovers of different preformed binary complexes were similar, indicating that the reaction proceeds via a random-order binding mechanism. In addition, the rate constant of glycine formation measured by rapid-quench and HPLC/MS analysis is similar to the k(cat) value (1.09 +/- 0.05 s(-1)) obtained from the steady-state kinetics, indicating that glycine formation is the rate-limiting step of SHMT catalysis. This information will serve as a basis for future investigation on species-specific inhibition of SHMT for antimalarial drug development.	[Maenpuen, Somchart; Amornwatcharapong, Watcharee; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Maenpuen, Somchart; Amornwatcharapong, Watcharee; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Maenpuen, Somchart; Krasatong, Pasupat] Burapha Univ, Dept Biochem, Fac Sci, Chon Buri 20131, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10330, Thailand; [Palfey, Bruce A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Yuthavong, Yongyuth; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree] Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Pathum Thani 12120, Thailand	Mahidol University; Mahidol University; Burapha University; Chulalongkorn University; University of Michigan System; University of Michigan; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Leartsakulpanich, U (corresponding author), 113 Paholyothin Rd,Klong 1, Klongluang 12120, Pathumthani, Thailand.	ubolsree@biotec.or.th; pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Palfey, Bruce/0000-0001-5098-259X; Maenpuen, Somchart/0000-0001-7770-4178; Yuthavong, Yongyuth/0000-0002-3582-8401	Cluster and Program Management office, National Science and Technology Development Agency (NSTDA) [P-13-00835]; Thailand Research Fund [RTA5680001, MRG5580066]; Faculty of Science, Mahidol University; Faculty of Science, Burapha University	Cluster and Program Management office, National Science and Technology Development Agency (NSTDA); Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Faculty of Science, Burapha University	This work was supported by Cluster and Program Management office, National Science and Technology Development Agency (NSTDA) Grant P-13-00835 (to U. L., P. C., and P. C. C.), Thailand Research Fund Grant RTA5680001 and the Faculty of Science, Mahidol University (to P. C.), and Thailand Research Fund Grant MRG5580066 and the Faculty of Science, Burapha University (to S. M.).	Angelaccio S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/851428; Bhavani BS, 2008, FEBS J, V275, P4606, DOI 10.1111/j.1742-4658.2008.06603.x; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P1517, DOI 10.1107/S1399004714005598; Contestabile R, 2000, BIOCHEMISTRY-US, V39, P7492, DOI 10.1021/bi000032z; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Florio R, 2011, BBA-PROTEINS PROTEOM, V1814, P1489, DOI 10.1016/j.bbapap.2010.10.010; Harris E L, 1988, Methods Mol Biol, V3, P33, DOI 10.1385/0-89603-126-8:33; Hiromi K., 1979, KINETICS FAST ENZYME; Kappes B, 2011, BBA-PROTEINS PROTEOM, V1814, P1567, DOI 10.1016/j.bbapap.2011.07.018; Maenpuen S, 2009, MOL BIOCHEM PARASIT, V168, P63, DOI 10.1016/j.molbiopara.2009.06.010; MATTHEWS RG, 1982, BIOCHEMISTRY-US, V21, P1230, DOI 10.1021/bi00535a019; MATTHEWS RG, 1990, CHEM REV, V90, P1275, DOI 10.1021/cr00105a010; Pai VR, 2009, BIOCHEM J, V418, P635, DOI 10.1042/BJ20081739; Pang CKT, 2009, MOL BIOCHEM PARASIT, V168, P74, DOI 10.1016/j.molbiopara.2009.06.011; Pinthong C, 2014, FEBS J, V281, P2570, DOI 10.1111/febs.12803; Pornthanakasem W, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-387; Rajaram V, 2007, FEBS J, V274, P4148, DOI 10.1111/j.1742-4658.2007.05943.x; ROSENTHAL S, 1965, J BIOL CHEM, V240, P836; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; SCHIRCH L, 1977, BIOCHEMISTRY-US, V16, P410, DOI 10.1021/bi00622a011; SCHIRCH L, 1980, J BIOL CHEM, V255, P7801; SCHIRCH L, 1964, J BIOL CHEM, V239, P3801; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; Schirch V., 1998, COMPREHENSIVE BIOL C, P223; Scrimgeour K G, 1980, Methods Enzymol, V66, P517; Sopitthummakhun K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-194; Sopitthummakhun K, 2009, FEBS J, V276, P4023, DOI 10.1111/j.1742-4658.2009.07111.x; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P106, DOI 10.1021/bi00427a016; Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6205, DOI 10.1021/bi002789w; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wahba A. J., 1961, J BIOL CHEM, V236, P11	38	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8656	8665		10.1074/jbc.M114.612275	http://dx.doi.org/10.1074/jbc.M114.612275			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678710	Green Published, hybrid			2022-12-26	WOS:000351662600055
J	Boardman, AK; Campbell, J; Wirz, H; Sharon, A; Sauer-Budge, AF				Boardman, Anna K.; Campbell, Jennifer; Wirz, Holger; Sharon, Andre; Sauer-Budge, Alexis F.			Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device	PLOS ONE			English	Article							WHOLE-BLOOD; BACTEREMIA; PCR; IMPACT; TIME; CENTRIFUGATION; MORTALITY; DIAGNOSIS; THERAPY; CULTURE	Appropriate care for bacteremic patients is dictated by the amount of time needed for an accurate diagnosis. However, the concentration of microbes in the blood is extremely low in these patients (1-100 CFU/mL), traditionally requiring growth (blood culture) or amplification (e.g., PCR) for detection. Current culture-based methods can take a minimum of two days, while faster methods like PCR require a sample free of inhibitors (i.e., blood components). Though commercial kits exist for the removal of blood from these samples, they typically capture only DNA, thereby necessitating the use of blood culture for antimicrobial testing. Here, we report a novel, scaled-up sample preparation protocol carried out in a new microbial concentration device. The process can efficiently lyse 10 mL of bacteremic blood while maintaining the microorganisms' viability, giving a 30-mu L final output volume. A suite of six microorganisms (Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, and Candida albicans) at a range of clinically relevant concentrations was tested. All of the microorganisms had recoveries greater than 55% at the highest tested concentration of 100 CFU/mL, with three of them having over 70% recovery. At the lowest tested concentration of 3 CFU/mL, two microorganisms had recoveries of ca. 40-50% while the other four gave recoveries greater than 70%. Using a Taqman assay for methicillin-sensitive S. aureus (MSSA) to prove the feasibility of downstream analysis, we show that our microbial pellets are clean enough for PCR amplification. PCR testing of 56 spiked-positive and negative samples gave a specificity of 0.97 and a sensitivity of 0.96, showing that our sample preparation protocol holds great promise for the rapid diagnosis of bacteremia directly from a primary sample.	[Boardman, Anna K.; Campbell, Jennifer; Wirz, Holger; Sharon, Andre; Sauer-Budge, Alexis F.] Fraunhofer USA, Ctr Mfg Innovat, Brookline, MA 02446 USA; [Sharon, Andre] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Sauer-Budge, Alexis F.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Sauer-Budge, AF (corresponding author), Fraunhofer USA, Ctr Mfg Innovat, Brookline, MA 02446 USA.	asauerbudge@fraunhofer.org	Sauer-Budge, Alexis/L-2286-2019	Sauer-Budge, Alexis/0000-0001-5961-5286	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI090815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090815] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding from National Institute of Allergy and Infectious Diseases, National Institutes of Health R01AI090815, ( http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; BELDING ME, 1972, APPL MICROBIOL, V24, P691, DOI 10.1128/AEM.24.5.691-698.1972; BERNHARDT M, 1991, J CLIN MICROBIOL, V29, P422, DOI 10.1128/JCM.29.3.422-425.1991; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Boardman AK, 2013, ANAL METHODS-UK, V5, P273, DOI 10.1039/c2ay25662b; Bu Y, 2008, ANAL BIOCHEM, V375, P370, DOI 10.1016/j.ab.2008.01.010; BURCKHARDT J, 1994, PCR METH APPL, V3, P239; Cheah ALY, 2013, CLIN MICROBIOL INFEC, V19, pE181, DOI 10.1111/1469-0691.12132; Cheng IF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02365; Chu HY, 2007, OPT EXPRESS, V15, P12230, DOI 10.1364/OE.15.012230; de Vries JE, 2001, CLIN CHEM, V47, P1701; FARMER SG, 1972, APPL MICROBIOL, V23, P500, DOI 10.1128/AEM.23.3.500-504.1972; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; HERLICH MB, 1982, J CLIN MICROBIOL, V16, P99, DOI 10.1128/JCM.16.1.99-102.1982; Ho KM, 2009, ANAESTH INTENS CARE, V37, P457, DOI 10.1177/0310057X0903700320; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kim SH, 2013, J ANTIMICROB CHEMOTH, V68, P2890, DOI 10.1093/jac/dkt256; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAMBERG RE, 1983, J CLIN MICROBIOL, V17, P856, DOI 10.1128/JCM.17.5.856-859.1983; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; MARTIN E, 1992, J CLIN MICROBIOL, V30, P2246, DOI 10.1128/JCM.30.9.2246-2255.1992; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; Nejadnik MR, 2009, LANGMUIR, V25, P6245, DOI 10.1021/la9001169; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; PANACCIO M, 1993, BIOTECHNIQUES, V14, P238; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Pechorsky A, 2009, J MICROBIOL METH, V78, P325, DOI 10.1016/j.mimet.2009.07.008; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Rodriguez-Bano J, 2009, J INFECTION, V58, P131, DOI 10.1016/j.jinf.2008.11.003; Rothman RE, 2002, J INFECT DIS, V186, P1677, DOI 10.1086/345367; Ryding U, 2002, DIAGN MICR INFEC DIS, V42, P9, DOI 10.1016/S0732-8893(01)00311-X; Sharma R, 2012, GENE, V501, P85, DOI 10.1016/j.gene.2012.03.065; Shime N, 2010, EUR J CLIN MICROBIOL, V29, P1475, DOI 10.1007/s10096-010-1024-x; SULLIVAN NM, 1975, J CLIN MICROBIOL, V1, P30, DOI 10.1128/JCM.1.1.30-36.1975; Walter A, 2011, LAB CHIP, V11, P1013, DOI [10.1039/c0lc00536c, 10.1039/c01c00536c]; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wiesinger-Mayr H, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-78; Zhang JY, 2010, LAB CHIP, V10, P3265, DOI [10.1039/c0lc00051e, 10.1039/c0lcC0051e]; Zhang XY, 2005, J AM CHEM SOC, V127, P4484, DOI 10.1021/ja043623b	47	18	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116837	10.1371/journal.pone.0116837	http://dx.doi.org/10.1371/journal.pone.0116837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675242	gold, Green Published, Green Submitted			2022-12-26	WOS:000349914000010
J	Cleys, ER; Halleran, JL; Enriquez, VA; da Silveira, JC; West, RC; Winger, QA; Anthony, RV; Bruemmer, JE; Clay, CM; Bouma, GJ				Cleys, Ellane R.; Halleran, Jennifer L.; Enriquez, Vanessa A.; da Silveira, Juliano C.; West, Rachel C.; Winger, Quinton A.; Anthony, Russell V.; Bruemmer, Jason E.; Clay, Colin M.; Bouma, Gerrit J.			Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta	PLOS ONE			English	Article							GROWTH/PERMEABILITY FACTOR EXPRESSION; TROPHOBLAST INVASION; IMMUNOHISTOCHEMICAL LOCALIZATION; GROWTH-RETARDATION; DNA METHYLATION; GENE ACTIVATION; ESTROGEN; PREECLAMPSIA; PREGNANCY; DIFFERENTIATION	Sex steroid hormones regulate developmental programming in many tissues, including programming gene expression during prenatal development. While estradiol is known to regulate placentation, little is known about the role of testosterone and androgen signaling in placental development despite the fact that testosterone rises in maternal circulation during pregnancy and in placenta-induced pregnancy disorders. We investigated the role of testosterone in placental gene expression, and focused on androgen receptor (AR). Prenatal androgenization decreased global DNA methylation in gestational day 90 placentomes, and increased placental expression of AR as well as genes involved in epigenetic regulation, angiogenesis, and growth. As AR complexes with histone lysine demethylases (KDMs) to regulate AR target genes in human cancers, we also investigated if the same mechanism is present in the ovine placenta. AR co-immunoprecipitated with KDM1A and KDM4D in sheep placentomes, and AR-KDM1A complexes were recruited to a half-site for androgen response element (ARE) in the promoter region of VEGFA. Androgenized ewes also had increased cotyledonary VEGFA. Finally, in human first trimester placental samples KDM1A and KDM4D immunolocalized to the syncytiotrophoblast, with nuclear KDM1A and KDM4D immunostaining also present in the villous stroma. In conclusion, placental androgen signaling, possibly through AR-KDM complex recruitment to AREs, regulates placental VEGFA expression. AR and KDMs are also present in first trimester human placenta. Androgens appear to be an important regulator of trophoblast differentiation and placental development, and aberrant androgen signaling may contribute to the development of placental disorders.	[Cleys, Ellane R.; Halleran, Jennifer L.; Enriquez, Vanessa A.; da Silveira, Juliano C.; West, Rachel C.; Winger, Quinton A.; Anthony, Russell V.; Bruemmer, Jason E.; Clay, Colin M.; Bouma, Gerrit J.] Colorado State Univ, Anim Reprod & Biotechnol Lab, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Bruemmer, Jason E.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Bouma, GJ (corresponding author), Colorado State Univ, Anim Reprod & Biotechnol Lab, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Gerrit.Bouma@colostate.edu	Bouma, Gerrit/AAT-4644-2020; Da Silveira, Juliano/AAH-9784-2020; Silveira, Juliano C/B-3086-2013	Bouma, Gerrit/0000-0003-2433-5086; Da Silveira, Juliano/0000-0002-4796-6393; Silveira, Juliano C/0000-0002-4796-6393; Bruemmer, Jason/0000-0002-4236-756X	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture [2010-38420-20397]; Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture; Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council	This project was supported by Agriculture and Food Research Initiative competitive grant 2010-38420-20397 from the United States Department of Agriculture National Institute of Food and Agriculture, and by the Colorado State University College of Veterinary Medicine and Biomedical Sciences College Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acromite MT, 1999, AM J OBSTET GYNECOL, V180, P60, DOI 10.1016/S0002-9378(99)70150-X; Albrecht ED, 2006, PLACENTA, V27, P483, DOI 10.1016/j.placenta.2005.04.005; Albrecht ED, 2004, J CLIN ENDOCR METAB, V89, P5803, DOI 10.1210/jc.2004-0479; Albrecht ED, 1999, PLACENTA, V20, P129, DOI 10.1053/plac.1998.0359; Angiolini E, 2006, PLACENTA SA, V27; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Beckett EM, 2011, 44 ANN M SOC STUD RE, V85; BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728; BROSENS IA, 1988, TROPHOBLAST RES, V3, P61; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P36, DOI 10.1186/1477-7827-1-36; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P13, DOI 10.1186/1477-7827-1-13; Carlsen SM, 2005, ACTA OBSTET GYN SCAN, V84, P117, DOI 10.1111/j.0001-6349.2005.00493.x; Castracane VD, 1998, HUM REPROD, V13, P460, DOI 10.1093/humrep/13.2.460; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Comstock CES, 2008, CONTEMP ENDOCRINOL S, P83, DOI 10.1007/978-1-59745-309-7_5; Ford SP, 2004, BIOL REPROD S, V71; Ford SP, 2006, J SOC GYNECOL INVE S, V13; GAIANI R, 1984, J REPROD FERTIL, V70, P55, DOI 10.1530/jrf.0.0700055; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; HILL DJ, 1993, PLACENTA, V14, P1, DOI 10.1016/S0143-4004(05)80244-9; HORIE K, 1992, HUM REPROD, V7, P1461, DOI 10.1093/oxfordjournals.humrep.a137595; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Iavazzo C, 2010, ARCH GYNECOL OBSTET, V282, P235, DOI 10.1007/s00404-010-1495-0; IWAMURA M, 1994, J HISTOCHEM CYTOCHEM, V42, P783, DOI 10.1177/42.6.8189040; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Karjalainen MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051378; Karvela M, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.04.071; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Khatri P, 2013, PLACENTA, V34, P416, DOI 10.1016/j.placenta.2013.01.018; Lim JH, 2011, J ASSIST REPROD GEN, V28, P85, DOI 10.1007/s10815-010-9485-5; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milosevic M, 2007, CANCER RES, V67, P6022, DOI 10.1158/0008-5472.CAN-07-0561; MIZUNO M, 1968, J CLIN ENDOCR METAB, V28, P1133, DOI 10.1210/jcem-28-8-1133; Niklaus AL, 2003, BIOL REPROD, V68, P1997, DOI 10.1095/biolreprod.102.011288; Osgerby JC, 2004, J ENDOCRINOL, V182, P89, DOI 10.1677/joe.0.1820089; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rama S, 2004, MOL CELL ENDOCRINOL, V218, P79, DOI 10.1016/j.mce.2003.12.016; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Salamalekis E, 2006, EUR J OBSTET GYN R B, V126, P16, DOI 10.1016/j.ejogrb.2005.07.007; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shabisgh A, 1999, ENDOCRINOLOGY, V140, P1920, DOI 10.1210/en.140.4.1920; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Sun M, 2012, AM J PHYSIOL-ENDOC M, V303, pE1373, DOI 10.1152/ajpendo.00421.2012; van der Linden DS, 2013, J ANIM SCI, V91, P644, DOI 10.2527/jas.2012-5629; VATNICK I, 1991, J DEV PHYSIOL, V15, P351; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Verrier L, 2011, BIOL CELL, V103, P381, DOI 10.1042/BC20110028; Vonnahme KA, 2006, J ANIM SCI, V84, P3451, DOI 10.2527/jas.2006-132; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Wieciech I, 2013, ACTA HISTOCHEM, V115, P290, DOI 10.1016/j.acthis.2012.08.003; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9; ZHOU Y, 1993, AM J OBSTET GYNECOL, V169, P224, DOI 10.1016/0002-9378(93)90172-F	68	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117472	10.1371/journal.pone.0117472	http://dx.doi.org/10.1371/journal.pone.0117472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675430	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000024
J	Ericsson, AC; Davis, JW; Spollen, W; Bivens, N; Givan, S; Hagan, CE; McIntosh, M; Franklin, CL				Ericsson, Aaron C.; Davis, J. Wade; Spollen, William; Bivens, Nathan; Givan, Scott; Hagan, Catherine E.; McIntosh, Mark; Franklin, Craig L.			Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice	PLOS ONE			English	Article							T-CELL RESPONSES; GUT MICROBIOTA; INTESTINAL MICROBIOTA; MOUSE; STRAIN; DATABASE; DISEASE; HEALTH	The commensal gut microbiota has been implicated as a determinant in several human diseases and conditions. There is mounting evidence that the gut microbiota of laboratory mice (Mus musculus) similarly modulates the phenotype of mouse models used to study human disease and development. While differing model phenotypes have been reported using mice purchased from different vendors, the composition and uniformity of the fecal microbiota in mice of various genetic backgrounds from different vendors is unclear. Using culture-independent methods and robust statistical analysis, we demonstrate significant differences in the richness and diversity of fecal microbial populations in mice purchased from two large commercial vendors. Moreover, the abundance of many operational taxonomic units, often identified to the species level, as well as several higher taxa, differed in vendorand strain-dependent manners. Such differences were evident in the fecal microbiota of weanling mice and persisted throughout the study, to twenty-four weeks of age. These data provide the first in-depth analysis of the developmental trajectory of the fecal microbiota in mice from different vendors, and a starting point from which researchers may be able to refine animal models affected by differences in the gut microbiota and thus possibly reduce the number of animals required to perform studies with sufficient statistical power.	[Ericsson, Aaron C.; Hagan, Catherine E.; Franklin, Craig L.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Biostat, Columbia, MO USA; [Spollen, William; Givan, Scott] Univ Missouri, Informat Res Core Facil, Columbia, MO USA; [Bivens, Nathan; McIntosh, Mark] Univ Missouri, DNA Core Facil, Columbia, MO USA; [McIntosh, Mark] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269; Bivens, Nathan/0000-0002-6023-8729; Givan, Scott/0000-0002-0630-8589	National Institutes of Health [U42 OD010918-13]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Studies were funded by a grant from the National Institutes of Health (U42 OD010918-13) to the University of Missouri Mutant Mouse Resource and Research Center (www.mmrrc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ericsson AC, 2014, COMPARATIVE MEDICINE; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kuczynski J, 2011, USING QIIME TO ANALY, DOI [10.1002/0471250953.bi0801s36, DOI 10.1002/0471250953.BI0801S36]; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MOSCA A, 1995, ANAEROBE, V1, P21, DOI 10.1016/S1075-9964(95)80379-3; Paulson JN, METAGENOMESEQ STATIS, P160; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smyth G, 2005, LIMMA LINEAR MODELS; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	190	192	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116704	10.1371/journal.pone.0116704	http://dx.doi.org/10.1371/journal.pone.0116704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675094	Green Submitted, gold, Green Published			2022-12-26	WOS:000349914000009
J	Haigh, R; Ianson, D; Holt, CA; Neate, HE; Edwards, AM				Haigh, Rowan; Ianson, Debby; Holt, Carrie A.; Neate, Holly E.; Edwards, Andrew M.			Effects of Ocean Acidification on Temperate Coastal Marine Ecosystems and Fisheries in the Northeast Pacific	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; JUVENILE PINK SALMON; EARLY-LIFE STAGES; DISSOLVED INORGANIC CARBON; EGG-PRODUCTION RATE; SUB-ARCTIC PACIFIC; RED KING CRAB; HIGH CO2; PSEUDO-NITZSCHIA; BRITISH-COLUMBIA	As the oceans absorb anthropogenic CO2 they become more acidic, a problem termed ocean acidification (OA). Since this increase in CO2 is occurring rapidly, OA may have profound implications for marine ecosystems. In the temperate northeast Pacific, fisheries play key economic and cultural roles and provide significant employment, especially in rural areas. In British Columbia (BC), sport (recreational) fishing generates more income than commercial fishing (including the expanding aquaculture industry). Salmon (fished recreationally and farmed) and Pacific Halibut are responsible for the majority of fishery-related income. This region naturally has relatively acidic (low pH) waters due to ocean circulation, and so may be particularly vulnerable to OA. We have analyzed available data to provide a current description of the marine ecosystem, focusing on vertical distributions of commercially harvested groups in BC in the context of local carbon and pH conditions. We then evaluated the potential impact of OA on this temperate marine system using currently available studies. Our results highlight significant knowledge gaps. Above trophic levels 2-3 (where most local fishery-income is generated), little is known about the direct impact of OA, and more importantly about the combined impact of multi-stressors, like temperature, that are also changing as our climate changes. There is evidence that OA may have indirect negative impacts on finfish through changes at lower trophic levels and in habitats. In particular, OA may lead to increased fish-killing algal blooms that can affect the lucrative salmon aquaculture industry. On the other hand, some species of locally farmed shellfish have been well-studied and exhibit significant negative direct impacts associated with OA, especially at the larval stage. We summarize the direct and indirect impacts of OA on all groups of marine organisms in this region and provide conclusions, ordered by immediacy and certainty.	[Haigh, Rowan; Holt, Carrie A.; Neate, Holly E.; Edwards, Andrew M.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Ianson, Debby] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Neate, Holly E.; Edwards, Andrew M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada; University of Victoria	Ianson, D (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, 9860 West Saanich Rd, Sidney, BC V8L 4B2, Canada.	debby.ianson@dfo-mpo.gc.ca	/AAL-3738-2021	Holt, Carrie/0000-0002-4699-9978; Ianson, Debby/0000-0001-8317-5196	Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding	Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding	The authors were funded by Fisheries and Oceans Canada through the Inter-Governance Strategy (IGS) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; Allen SE, 2013, PROG OCEANOGR, V115, P6, DOI 10.1016/j.pocean.2013.05.026; [Anonymous], 2014, R LANG ENV STAT COMP; Arkhipkin AI, 2000, J ZOOL, V250, P31, DOI 10.1111/j.1469-7998.2000.tb00575.x; Armstrong JL, 2008, T AM FISH SOC, V137, P1299, DOI 10.1577/T07-196.1; Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Asnaghi V, 2014, MAR ENVIRON RES, V93, P78, DOI 10.1016/j.marenvres.2013.08.005; Asnaghi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061978; Aydin KY, 2005, DEEP-SEA RES PT II, V52, P757, DOI 10.1016/j.dsr2.2004.12.017; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Bacher C, 2003, AQUAT LIVING RESOUR, V16, P10, DOI 10.1016/S0990-7440(03)00003-2; Baker P, 1995, J SHELLFISH RES, V14, P501; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Baldwin A, 2011, E FAUNA BC ELECTRONI; Baldwin A, 2009, E FAUNA BC ELECTRONI; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bass C. L., 2006, SCIENTIFIC COMMITTEE; Bates C, 2004, E FLORA BC ATLAS OF; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bayer FM, 2001, P BIOL SOC WASH, V114, P309; BC Ministry of Agriculture, 2012, BRITISH COLUMBIA SEA; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; BEER S, 1989, AQUAT BOT, V34, P153, DOI 10.1016/0304-3770(89)90054-5; Bejarano AC, 2008, HUM ECOL RISK ASSESS, V14, P544, DOI 10.1080/10807030802074220; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Brewer PG, 2013, BIOGEOSCIENCES, V10, P7411, DOI 10.5194/bg-10-7411-2013; BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Bylhouwer B, 2013, J GEOPHYS RES-OCEANS, V118, P2565, DOI 10.1002/jgrc.20194; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; CAIRNS S D, 1992, Palaios, V7, P96, DOI 10.2307/3514799; Cairns SD, 2011, SMITHSON CONTRIB ZOO, V634, P55; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Conway K. W., 2007, GEOLOGICAL SURVEY CA; CONWAY KW, 1991, CONT SHELF RES, V11, P771, DOI 10.1016/0278-4343(91)90079-L; Conway KW, 2005, ERLANGEN EARTH CONF, P605, DOI 10.1007/3-540-27673-4_29; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Cosgrove J, 2009, E FAUNA BC ELECTRONI; Crim RN, 2011, J EXP MAR BIOL ECOL, V400, P272, DOI 10.1016/j.jembe.2011.02.002; CRIMS, 2013, SALTWATER FINFISH AN; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; CUSHING DH, 1969, J CONSEIL, V33, P81; Deeds JR, 2008, MAR DRUGS, V6, P308, DOI [10.3390/md6020308, 10.3390/md20080015]; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dineshram R, 2012, MAR POLLUT BULL, V64, P2160, DOI 10.1016/j.marpolbul.2012.07.043; Dixson D.L., 2014, GLOBAL CHANGE BIOL; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Druehl LD, 2000, PACIFIC SEAWEEDS A G; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; DUFFY JE, 1990, BIOSCIENCE, V40, P368, DOI 10.2307/1311214; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Egge JK, 2009, BIOGEOSCIENCES, V6, P877, DOI 10.5194/bg-6-877-2009; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Findlay HS, 2011, MAR BIOL RES, V7, P565, DOI 10.1080/17451000.2010.547200; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Finney JL, 2010, CAN SCI ADVIS SEC RE, V2010; Fisheries and Oceans Canada, 2014, PACIFIC REGION INTEG; Fisheries and Oceans Canada, 2013, PACIFIC REGION EXPLO; Fisheries and Oceans Canada, 2013, PACIFIC REGION INTEG; Ford JK, 2014, MARINE MAMMALS OF BR; Foreman MGG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006995; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Foster MS., 1985, US FISH WILDL SERV B, V85; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2010, BIOGEOSCIENCES, V7, P3915, DOI 10.5194/bg-7-3915-2010; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Fu FX, 2008, HARMFUL ALGAE, V7, P76, DOI 10.1016/j.hal.2007.05.006; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gardner G.A., 1982, Canadian Special Publication of Fisheries and Aquatic Sciences, V62, P1; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gillespie GE, 2012, CAN SCI ADVIS SEC RE; Gillespie GE, 1999, CAN STOCK ASSESS SEC, V99; Ginger KWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064147; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0448; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gower J, 2013, RESEARCH DOCUMENT 20, P60; Gravinese PM, 2014, OCEAN SCIENCES MEETI; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haigh N, 2013, WORKSHOP 6 ECONOMIC; HAIGH R, 1991, MAR BIOL, V110, P301, DOI 10.1007/BF01313717; HAIGH R, 1992, MAR ECOL PROG SER, V89, P117, DOI 10.3354/meps089117; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Harbo R, 1996, SHELLS AND SHELLFISH; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Harris SL, 2009, DEEP-SEA RES PT II, V56, P2487, DOI 10.1016/j.dsr2.2009.02.009; HARRISON PJ, 1983, CAN J FISH AQUAT SCI, V40, P1064, DOI 10.1139/f83-129; Hart J.L., 1973, Bulletin Fish Res Bd Canada, V180, P1; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hendriks IE, 2014, BIOGEOSCIENCES, V11, P333, DOI 10.5194/bg-11-333-2014; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Hettinger A, 2013, GLOBAL CHANGE BIOL, V19, P3317, DOI 10.1111/gcb.12307; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hickey BM, 2013, HARMFUL ALGAE, V25, P1, DOI 10.1016/j.hal.2013.01.006; Hickey BM, 2008, OCEANOGRAPHY, V21, P90, DOI 10.5670/oceanog.2008.07; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; Hofmann AF, 2013, BIOGEOSCIENCES, V10, P2409, DOI 10.5194/bg-10-2409-2013; Hofmann LC, 2012, MAR ECOL PROG SER, V464, P89, DOI 10.3354/meps09892; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Hwang DF, 2000, TOXICON, V38, P1491, DOI 10.1016/S0041-0101(00)00080-5; Ianson D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001451; Ianson D, 2003, DEEP-SEA RES PT I, V50, P1023, DOI 10.1016/S0967-0637(03)00114-6; Ianson D., 2001, J OCEANOGR, V57, P723, DOI DOI 10.1023/A:1021288510407; Ianson D, 2010, CAN SCI ADVIS SEC RE, P56; Ianson D, 2013, CAN TECH REP FISH AQ, V3032; Ianson D, 2009, J OCEANOGR, V65, P677, DOI 10.1007/s10872-009-0059-z; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Intergovernmental Panel on Climate Change, 2011, WORKSHOP REPORT OF T; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; International Hydrographic Organization Data Centre, 2014, IHO IOC GEBCO GAZETT; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Ishimatsu A, 2004, J OCEANOGR, V60, P731, DOI 10.1007/s10872-004-5765-y; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Jamieson GS, 2006, CAN SCI ADVIS SEC RE; JOHNSON AM, 1982, TRANS N AM WILDL NAT, V47, P293; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Joseph JE, 2010, J ACOUST SOC AM, V128, pEL144, DOI 10.1121/1.3425738; Jutfelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065825; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; Kaplan MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063714; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Kikkawa T, 2004, MAR POLLUT BULL, V48, P108, DOI 10.1016/S0025-326X(03)00367-9; Kim D, 1999, J PLANKTON RES, V21, P1017, DOI 10.1093/plankt/21.6.1017; Kim H, 2013, HARMFUL ALGAE, V26, P1, DOI 10.1016/j.hal.2013.03.004; Kim JM, 2010, ENVIRON SCI TECHNOL, V44, P8140, DOI 10.1021/es102028k; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kunkel JG, 2012, J SHELLFISH RES, V31, P515, DOI 10.2983/035.031.0211; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; Lalli CM., 1989, PELAGIC SNAILS THE B; Lambert P., 2011, Canadian Technical Report of Fisheries and Aquatic Sciences, V2929, P1; Lambert P, 2007, E FAUNA BC ELECTRONI; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lassiter AM, 2006, DEEP-SEA RES PT II, V53, P3063, DOI 10.1016/j.dsr2.2006.07.013; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Leduc AOHC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0447; Lessard J, 2007, J SHELLFISH RES, V26, P677, DOI 10.2983/0730-8000(2007)26[677:DNAHKH]2.0.CO;2; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Lindahl O, 2005, AMBIO, V34, P131, DOI 10.1639/0044-7447(2005)034[0131:IMWQBM]2.0.CO;2; Lipsen MS, 2007, PROG OCEANOGR, V75, P304, DOI 10.1016/j.pocean.2007.08.004; Lischka S, 2012, GLOBAL CHANGE BIOL, V18, P3517, DOI 10.1111/gcb.12020; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; Loomis J.B., 1994, MAR RESOUR ECON, V9, P3, DOI [10.1086/mre.9.3.42629085, DOI 10.1086/MRE.9.3.42629085]; Love ML., 2011, CERTAINLY MORE YOU W; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Lucas BG, 2007, CANADIAN TECHNICAL R, V2667; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Mackas D, 2013, PROG OCEANOGR, V115, P129, DOI 10.1016/j.pocean.2013.05.019; Mackas DL, 2012, ICES J MAR SCI, V69, P448, DOI 10.1093/icesjms/fsr163; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mackas DL, 2001, CAN J FISH AQUAT SCI, V58, P685, DOI 10.1139/cjfas-58-4-685; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Maneja RH, 2013, MAR ECOL PROG SER, V477, P251, DOI 10.3354/meps10146; Maneja RH, 2013, MAR BIOL, V160, P1963, DOI 10.1007/s00227-012-2054-y; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MARTIN AJ, 1993, J EUKARYOT MICROBIOL, V40, P535, DOI 10.1111/j.1550-7408.1993.tb06105.x; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; McFarlane GA, 1997, OCEANOL ACTA, V20, P191; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Merryfield WJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005123; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; Moroney JV, 1999, PLANT PHYSIOL, V119, P9, DOI 10.1104/pp.119.1.9; MORSE ANC, 1991, AM SCI, V79, P154; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Muzzarelli R. A., 1977, CHITIN; Nagorsen D, 2009, E FAUNA BC ELEC TRON; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakagawa Yoshizumi, 2001, Plankton Biology and Ecology, V48, P68; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nemcek N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002879; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Nimer NA, 1997, J PHYCOL, V33, P625, DOI 10.1111/j.0022-3646.1997.00625.x; O'Donnell MJ, 2013, NAT CLIM CHANGE, V3, P587, DOI 10.1038/NCLIMATE1846; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Olson MB, 2006, MAR ECOL PROG SER, V326, P207, DOI 10.3354/meps326207; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Peden A, 2002, E FAUNA BC ELECTRONI; Pedersen SA, 2013, BIOGEOSCIENCES, V10, P7481, DOI 10.5194/bg-10-7481-2013; PERRY RI, 1983, CAN J FISH AQUAT SCI, V40, P871, DOI 10.1139/f83-114; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Peterson TD, 2007, J PLANKTON RES, V29, P219, DOI 10.1093/plankt/fbm010; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Preikshot DB, 2007, THESIS; Punt AE, 2014, ECOL MODEL, V285, P39, DOI 10.1016/j.ecolmodel.2014.04.017; Raven J., 2005, OCEAN ACIDIFICATION; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Rensel J.E, 2007, FISH KILLS HARMFUL A; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2011, GUIDE TO BEST PRACTI; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts R, 2001, J SHELLFISH RES, V20, P571; Roger LM, 2012, ICES J MAR SCI, V69, P465, DOI 10.1093/icesjms/fsr171; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Rooper CN, 2007, ESTUAR COAST SHELF S, V75, P371, DOI 10.1016/j.ecss.2007.05.006; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Ryer CH, 1997, MAR ECOL PROG SER, V147, P77, DOI 10.3354/meps147077; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saba GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052224; Sanders MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074118; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Sato-Okoshi W, 2010, POLAR SCI, V4, P257, DOI 10.1016/j.polar.2010.05.006; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Shaffer J, 2004, P 2003 GEORG BAS PUG, P1; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; SMITH KL, 1983, MAR BIOL, V76, P325, DOI 10.1007/BF00393036; STENZEL HB, 1963, SCIENCE, V142, P232, DOI 10.1126/science.142.3589.232; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Stone RP, 2013, NOAA TECH MEM NMFS A; Stone RP, 2007, STATE DEEP CORAL ECO, P65; Stroomer C., 2013, BRIT COLUMBIAS FISHE; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Swanson AK, 2007, GLOBAL CHANGE BIOL, V13, P1696, DOI 10.1111/j.1365-2486.2007.01384.x; Talmage SC, 2012, MAR ECOL PROG SER, V464, P121, DOI 10.3354/meps09867; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tatters AO, 2013, HARMFUL ALGAE, V30, P37, DOI 10.1016/j.hal.2013.08.007; Tatters AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032116; Taylor F. J. R., 2002, HARMFUL ALGAL BLOOMS, P77; TAYLOR FJR, 1993, DEV MAR BIO, V3, P705; Timmins-Schiffman E, 2013, MAR BIOL, V160, P1973, DOI 10.1007/s00227-012-2055-x; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P1485, DOI 10.4319/lo.2000.45.7.1485; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Tortell PD, 2012, CONT SHELF RES, V47, P119, DOI 10.1016/j.csr.2012.07.007; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P1461, DOI 10.4319/lo.2009.54.5.1461; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; Twiner MJ, 2000, J PLANKTON RES, V22, P1961, DOI 10.1093/plankt/22.10.1961; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; WILSON JG, 1994, ESTUARIES, V17, P94, DOI 10.2307/1352337; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zhai WD, 2012, CHINESE SCI BULL, V57, P1062, DOI 10.1007/s11434-011-4949-2; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9; Zhang ML, 2011, J SHELLFISH RES, V30, P267, DOI 10.2983/035.030.0211; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; [No title captured]	345	67	74	1	236	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117533	10.1371/journal.pone.0117533	http://dx.doi.org/10.1371/journal.pone.0117533			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671596	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300059
J	Suzuki, T; Kikuchi, H; Ogura, M; Homma, MK; Oshima, Y; Homma, Y				Suzuki, Toshiyuki; Kikuchi, Haruhisa; Ogura, Masato; Homma, Miwako K.; Oshima, Yoshiteru; Homma, Yoshimi			Weight Loss by Ppc-1, a Novel Small Molecule Mitochondrial Uncoupler Derived from Slime Mold	PLOS ONE			English	Article							DIFFERENTIATION-INDUCING FACTOR; SUPPRESSES CELL-GROWTH; DICTYOSTELIUM-DISCOIDEUM; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; CYCLIN D1; C-SRC; PROLIFERATION; INHIBITION	Mitochondria play a key role in diverse processes including ATP synthesis and apoptosis. Mitochondrial function can be studied using inhibitors of respiration, and new agents are valuable for discovering novel mechanisms involved in mitochondrial regulation. Here, we screened small molecules derived from slime molds and other microorganisms for their effects on mitochondrial oxygen consumption. We identified Ppc-1 as a novel molecule which stimulates oxygen consumption without adverse effects on ATP production. The kinetic behavior of Ppc-1 suggests its function as a mitochondrial uncoupler. Serial administration of Ppc-1 into mice suppressed weight gain with no abnormal effects on liver or kidney tissues, and no evidence of tumor formation. Serum fatty acid levels were significantly elevated in mice treated with Ppc-1, while body fat content remained low. After a single administration, Ppc-1 distributes into various tissues of individual animals at low levels. Ppc-1 stimulates adipocytes in culture to release fatty acids, which might explain the elevated serum fatty acids in Ppc-1-treated mice. The results suggest that Ppc-1 is a unique mitochondrial regulator which will be a valuable tool for mitochondrial research as well as the development of new drugs to treat obesity.	[Suzuki, Toshiyuki; Ogura, Masato; Homma, Miwako K.; Homma, Yoshimi] Fukushima Med Univ, Sch Med, Fukushima 9601295, Japan; [Kikuchi, Haruhisa; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808678, Japan	Fukushima Medical University; Tohoku University	Homma, Y (corresponding author), Fukushima Med Univ, Sch Med, Fukushima 9601295, Japan.	yoshihom@fmu.ac.jp	Kikuchi, Haruhisa/AAC-3758-2019; Ogura, Masato/AAK-1619-2020	Kikuchi, Haruhisa/0000-0001-6938-0185; Ogura, Masato/0000-0001-9557-5023	Japan Society for the Promotion of Science [24590110, 23710247]; Fukushima Medical University [H2401]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukushima Medical University	Funding: This work was supported in part by a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to YO: No. 24590110, and to HK: No. 23710247) and a grant from Fukushima Medical University (to YH: No. H2401). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	ASAHI KI, 1995, BIOCHEM BIOPH RES CO, V208, P1036, DOI 10.1006/bbrc.1995.1438; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HEKMAN C, 1988, BIOCHEMISTRY-US, V27, P7559, DOI 10.1021/bi00419a057; Heytler P G, 1979, Methods Enzymol, V55, P462; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kanai M, 2003, ONCOGENE, V22, P548, DOI 10.1038/sj.onc.1206109; Katou Y, 2014, LIFE SCI, V103, P1, DOI 10.1016/j.lfs.2014.03.023; Kikuchi H, 2005, J ORG CHEM, V70, P8854, DOI 10.1021/jo051352x; Kikuchi H, 2002, TETRAHEDRON LETT, V43, P1477, DOI 10.1016/S0040-4039(02)00038-2; Kikuchi H, 2001, J ORG CHEM, V66, P6982, DOI 10.1021/jo015657x; Kikuchi H, 2007, TETRAHEDRON LETT, V48, P5905, DOI 10.1016/j.tetlet.2007.06.040; Kikuchi H, 2010, TETRAHEDRON, V66, P6000, DOI 10.1016/j.tet.2010.06.029; KUBOHARA Y, 1995, FEBS LETT, V359, P119, DOI 10.1016/0014-5793(95)00022-2; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1997, BIOCHEM BIOPH RES CO, V236, P418, DOI 10.1006/bbrc.1997.6964; Kubohara Y, 2014, BIOL OPEN, V3, P289, DOI 10.1242/bio.20146585; Kubohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072118; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; MATSUNOYAGI A, 1986, J BIOL CHEM, V261, P14031; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Ogura M, 2014, FEBS LETT, V588, P2837, DOI 10.1016/j.febslet.2014.06.044; Ogura M, 2012, BIOCHEM J, V447, P281, DOI 10.1042/BJ20120509; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Poole F, 1934, J AMER MED ASSOC, V102, P1141, DOI 10.1001/jama.1934.02750140027011; POTTER VR, 1952, J BIOL CHEM, V194, P287; Rigoulet M, 1996, EUR J BIOCHEM, V241, P280; Singer T P, 1979, Methods Enzymol, V55, P454; Tainter ML, 1934, J AMER MED ASSOC, V102, P1147, DOI 10.1001/jama.1934.02750140033012; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Takaya Y, 2000, J ORG CHEM, V65, P985, DOI 10.1021/jo991338i; Thrush AB, 2013, FEBS J, V280, P5015, DOI 10.1111/febs.12399; Worrall DS, 2002, MOL ENDOCRINOL, V16, P378, DOI 10.1210/me.16.2.378; Yamada T, 2013, J CHROMATOGR A, V1292, P211, DOI 10.1016/j.chroma.2013.01.078	45	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117088	10.1371/journal.pone.0117088	http://dx.doi.org/10.1371/journal.pone.0117088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668511	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000015
J	Chen, JH; Ke, KF; Lu, JH; Qiu, YH; Peng, YP				Chen, Jia-Hui; Ke, Kai-Fu; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping			Protection of TGF-beta 1 against Neuroinflammation and Neurodegeneration in A beta(1-42)-Induced Alzheimer's Disease Model Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BLOOD-BRAIN-BARRIER; T-CELLS; MOUSE MODEL; FACTOR-I; MICROGLIAL ACTIVATION; PLAQUE BURDEN; ANIMAL-MODEL; EXPRESSION; ALPHA	Neuroinflammation has been reported to be associated with Alzheimer's disease (AD) pathogenesis. Neuroinflammation is generally considered as an outcome of glial activation; however, we recently demonstrated that T helper (Th) 17 cells, a subpopulation of proinflammatory CD4+ T cells, are also involved in AD pathogenesis. Transforming growth factor (TGF)-beta 1, a cytokine that can be expressed in the brain, can be immunosuppressive, but its effects on lymphocyte-mediated neuroinflammation in AD pathogenesis have not been well addressed. In the current study we administered TGF-beta 1 via intracerebroventricle (ICV) and intranasal (IN) routes in AD model rats to investigate its antiinflammatory and neuroprotective effects. The AD rat model was prepared by bilateral hippocampal injection of amyloid- beta (A beta)(1-42). TGF-beta 1 was administered via ICV one hour prior to A beta(1-42) injection or via both nares seven days after A beta(1-42) injection. ICV administration of TGF-beta 1 before A beta(1-42) injection remarkably ameliorated A beta(1-42)-induced neurodegeneration and prevented A beta(1-42) induced increases in glia-derived proinflammatory mediators (TNF-alpha, IL-1 beta and iNOS), as well as T cell-derived proinflammatory cytokines (IFN-gamma, IL-2, IL-17 and IL-22), in the hypothalamus, serum or cerebrospinal fluid (CSF) in a concentration-dependent manner. TGF beta 1 pretreatment also prevented A beta(1-42)-induced decreases in the neurotrophic factors, IGF1, GDNF and BDNF, and in the antiinflammatory cytokine, IL-10. Similarly, IN administration of TGF-beta 1 after A beta(1-42) injection reduced neurodegeneration, elevation of proinflammatory mediators and cytokines, and reduction of neurotrophic and antiinflammatory factors, in the hypothalamus, serum or CSF. These findings suggest that TGF-beta 1 suppresses glial and T cell-mediated neuroinflammation and thereby alleviates AD-related neurodegeneration. The effectiveness of IN administered TGF-beta 1 in reducing A beta(1-42) neurotoxicity suggests a possible therapeutic approach in patients with AD.	[Chen, Jia-Hui; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Sch Med, Dept Physiol, Nantong, Peoples R China; [Chen, Jia-Hui; Lu, Jian-Hua; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Chen, Jia-Hui; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Qiu, YH (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Peoples R China.	yhqiu@ntu.edu.cn; yppeng@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [81271323, 31371182]; Natural Science Foundation of Jiangsu Province of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors wish to thank Dr. M. Kerry O'Banion, University of Rochester, for editing this manuscript. This work was supported by grants 81271323 and 31371182 from the National Natural Science Foundation of China, BK2011386 from the Natural Science Foundation of Jiangsu Province of China, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco P, 2013, CURR GENOMICS, V14, P147, DOI 10.2174/1389202911314020007; Browne TC, 2013, J IMMUNOL, V190, P2241, DOI 10.4049/jimmunol.1200947; Caraci F, 2008, NEUROBIOL DIS, V30, P234, DOI 10.1016/j.nbd.2008.01.007; Caraci F, 2012, CELL TISSUE RES, V347, P291, DOI 10.1007/s00441-011-1230-6; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; Carare RO, 2014, BRAIN BEHAV IMMUN, V36, P9, DOI 10.1016/j.bbi.2013.10.012; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Giuffrida ML, 2007, J NEUROSCI RES, V85, P623, DOI 10.1002/jnr.21135; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Jantaratnotai Nattinee, 2011, Int J Alzheimers Dis, V2011, P918280, DOI 10.4061/2011/918280; Juraskova B, 2010, J NUTR HEALTH AGING, V14, P758, DOI 10.1007/s12603-010-0325-1; Le YY, 2005, INT IMMUNOPHARMACOL, V5, P1771, DOI 10.1016/j.intimp.2005.07.006; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi VRM, 1999, J NEUROIMMUNOL, V97, P163, DOI 10.1016/S0165-5728(99)00046-6; Luppi C, 2009, ARCH GERONTOL GERIAT, V49, P173, DOI 10.1016/j.archger.2009.09.027; Lynch MA, 2014, IMMUNOLOGY, V141, P292, DOI 10.1111/imm.12156; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Ma YP, 2007, BRAIN RES BULL, V74, P271, DOI 10.1016/j.brainresbull.2007.06.021; McLarnon JG, 2008, CURR ALZHEIMER RES, V5, P475, DOI 10.2174/156720508785908874; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morales I, 2010, NEUROIMMUNOMODULAT, V17, P202, DOI 10.1159/000258724; Paxinos G, 2005, THE RAT BRAIN IN STE; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; Saresella M, 2011, BRAIN BEHAV IMMUN, V25, P539, DOI 10.1016/j.bbi.2010.12.004; Schindowski K, 2007, NEUROMOL MED, V9, P340, DOI 10.1007/s12017-007-8015-9; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Subramanian S, 2010, J ALZHEIMERS DIS, V22, P619, DOI 10.3233/JAD-2010-100852; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Vivien D, 2006, CYTOKINE GROWTH F R, V17, P121, DOI 10.1016/j.cytogfr.2005.09.011; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; Yang YM, 2013, NEUROCHEM RES, V38, P2295, DOI 10.1007/s11064-013-1138-5; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075786	53	153	159	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116549	10.1371/journal.pone.0116549	http://dx.doi.org/10.1371/journal.pone.0116549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658940	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900049
J	Wang, HN; Bai, YH; Chen, YC; Zhang, RG; Wang, HH; Zhang, YH; Gan, JL; Peng, ZW; Tan, QR				Wang, Hua-ning; Bai, Yuan-han; Chen, Yun-chun; Zhang, Rui-guo; Wang, Huai-hai; Zhang, Ya-hong; Gan, Jing-li; Peng, Zheng-wu; Tan, Qing-rong			Repetitive Transcranial Magnetic Stimulation Ameliorates Anxiety-Like Behavior and Impaired Sensorimotor Gating in a Rat Model of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ACOUSTIC STARTLE REFLEX; PREPULSE INHIBITION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; MESSENGER-RNA; DOUBLE-BLIND; PLACEBO; HIPPOCAMPAL; ATTENTION	Background Repetitive transcranial magnetic stimulation (rTMS) has been employed for decades as a non-pharmacologic treatment for post-traumatic stress disorder (PTSD). Although a link has been suggested between PTSD and impaired sensorimotor gating (SG), studies assessing the effects of rTMS against PTSD or PTSD with impaired SG are scarce. Aim To assess the benefit of rTMS in a rat model of PTSD. Methods Using a modified single prolonged stress (SPS&S) rat model of PTSD, behavioral parameters were acquired using open field test (OFT), elevated plus maze test (EPMT), and prepulse inhibition trial (PPI), with or without 7 days of high frequency (10Hz) rTMS treatment of SPS&S rats. Results Anxiety-like behavior, impaired SG and increased plasma level of cortisol were observed in SPS&S animals after stress for a prolonged time. Interestingly, rTMS administered immediately after stress prevented those impairment. Conclusion Stress-induced anxiety-like behavior, increased plasma level of cortisol and impaired PPI occur after stress and high-frequency rTMS has the potential to ameliorate this behavior, suggesting that high frequency rTMS should be further evaluated for its use as a method for preventing PTSD.	[Wang, Hua-ning; Bai, Yuan-han; Chen, Yun-chun; Zhang, Rui-guo; Wang, Huai-hai; Zhang, Ya-hong; Peng, Zheng-wu; Tan, Qing-rong] Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Peoples R China; [Gan, Jing-li] 91 Hosp PLA, Dept Psychiat, Jiaozuo 454150, Peoples R China	Air Force Military Medical University	Peng, ZW (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Peoples R China.	pengzhengwu1446@163.com; tanqingr@fmmu.edu.cn	Peng, Zheng-wu/ABA-5838-2021	Peng, Zheng-wu/0000-0002-8185-0538; Bai, Yuanhan/0000-0003-3574-1346; Wang, Hua-Ning/0000-0003-1981-4293	National Key Technology R & D Program of China [2009BA177B09]; Natural Science Foundation of China [81201041, 81371478, 81401109]	National Key Technology R & D Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Technology R & D Program of China (No. 2009BA177B09) and the Natural Science Foundation of China (No. 81201041, 81371478 and 81401109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Baek K, 2012, NEUROSCIENCE, V200, P159, DOI 10.1016/j.neuroscience.2011.09.050; Baisley SK, 2011, PHYSIOL BEHAV, V104, P796, DOI 10.1016/j.physbeh.2011.08.001; Bitsios P, 2005, INT J PSYCHOPHYSIOL, V55, P229, DOI 10.1016/j.ijpsycho.2004.08.002; Boggio PS, 2010, J CLIN PSYCHIAT, V71, P992, DOI 10.4088/JCP.08m04638blu; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; Conrad KL, 2011, PHYSIOL BEHAV, V104, P248, DOI 10.1016/j.physbeh.2011.03.001; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferguson SA, 2001, NEUROTOXICOL TERATOL, V23, P57, DOI 10.1016/S0892-0362(00)00115-X; Filion DL, 2003, BIOL PSYCHOL, V64, P283, DOI 10.1016/S0301-0511(03)00077-2; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; George MS, 1996, J NEUROPSYCH CLIN N, V8, P373; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Ghisolfi ES, 2004, INT J PSYCHOPHYSIOL, V51, P209, DOI 10.1016/j.ijpsycho.2003.09.002; Gillette GM, 1997, LIFE SCI, V61, P1421, DOI 10.1016/S0024-3205(97)00688-7; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Horger BA, 1996, CRIT REV NEUROBIOL, V10, P395; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Iwamoto Y, 2007, PROG NEURO-PSYCHOPH, V31, P642, DOI 10.1016/j.pnpbp.2006.12.010; JACKSON G, 1991, BRIT MED J, V303, P533, DOI 10.1136/bmj.303.6802.533; Jia M, 2012, JOVE-J VIS EXP, DOI 10.3791/3361; Kanno M, 2003, J NEUROL SCI, V211, P5, DOI 10.1016/S0022-510X(03)00030-3; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Li YN, 2013, J MOL NEUROSCI, V51, P127, DOI 10.1007/s12031-013-9965-z; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Marshall RD, 2001, AM J PSYCHIAT, V158, P1982, DOI 10.1176/appi.ajp.158.12.1982; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Meloni EG, 2000, J NEUROSCI, V20, P5374, DOI 10.1523/JNEUROSCI.20-14-05374.2000; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Sallinen J, 1998, J NEUROSCI, V18, P3035; Seo JH, 2013, MOL MED REP, V7, P389, DOI 10.3892/mmr.2012.1197; Stewart LP, 2008, DEPRESS ANXIETY, V25, P38, DOI 10.1002/da.20255; Swerdlow NR, 2013, NEUROPHARMACOLOGY, V75, P38, DOI 10.1016/j.neuropharm.2013.06.003; Swerdlow NR, 2013, BEHAV BRAIN RES, V257, P118, DOI 10.1016/j.bbr.2013.09.005; SWERDLOW NR, 1991, J PHARMACOL EXP THER, V256, P530; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Thorne GL, 2005, INT J PSYCHOPHYSIOL, V56, P121, DOI 10.1016/j.ijpsycho.2004.11.006; Tucker P, 2001, J CLIN PSYCHIAT, V62, P860, DOI 10.4088/JCP.v62n1105; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wang HN, 2010, PHYSIOL RES, V59, P263, DOI 10.33549/physiolres.931756; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wang HN, 2009, PROG NEURO-PSYCHOPH, V33, P1458, DOI 10.1016/j.pnpbp.2009.07.031; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Weiss SJ, 2007, PERSPECT PSYCHIATR C, V43, P114, DOI 10.1111/j.1744-6163.2007.00120.x; Wen L, 2014, J MOL NEUROSCI; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhao DM, 2014, J MOL NEUROSCI, V54, P147, DOI 10.1007/s12031-014-0263-1	61	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117189	10.1371/journal.pone.0117189	http://dx.doi.org/10.1371/journal.pone.0117189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659132	gold, Green Published			2022-12-26	WOS:000349444900114
J	Yamaji, M; Mahmoud, M; Evans, IM; Zachary, IC				Yamaji, Maiko; Mahmoud, Marwa; Evans, Ian M.; Zachary, Ian C.			Neuropilin 1 Is Essential for Gastrointestinal Smooth Muscle Contractility and Motility in Aged Mice	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; INTESTINAL PSEUDOOBSTRUCTION; URINARY-BLADDER; GENE-EXPRESSION; SEMAPHORIN-III; CELL MIGRATION; GROWTH-FACTOR; TUMOR-CELLS; MYOSIN; RECEPTOR	Background and Aims Neuropilin 1 (NRP1) is a non-tyrosine kinase receptor for vascular endothelial growth factor (VEGF) and class 3 semaphorins, playing a role in angiogenesis and neuronal axon guidance, respectively. NRP1 is expressed in smooth muscle cells (SMC) but the functional role of NRP1 in SMC has not been elucidated. We therefore investigated the biological relevance of NRP1 in SMC in vivo by generating mice with SMC-specific Nrp1 deficiency. Methods Conditional gene targeting generated SMC-specific Nrp1 knockout mice (Nrp1(SMKO)) in which Cre recombinase is driven by the smooth muscle-specific myosin heavy chain (smMHC) promoter. Results SMC-specific Nrp1 deficiency resulted in a significant reduction in intestinal length by 6 months, and, by 18 months, in severe constipation, and enlargement of the intestine consistent with chronic intestinal pseudo-obstruction. These effects were associated with significant thinning of the intestinal smooth muscle, and decreased intestinal contractility. Expression of contractile proteins was reduced in Nrp1(SMKO) mice, including the smMHC isoform, SMB, whereas we observed a significant increase in the expression of the small-conductance calcium-activated potassium channel 3 (SK3/KCa2.3), implicated in negative regulation of smooth muscle contraction. Conclusions Nrp1 deficiency in visceral SMC results in adult-onset defects in gastrointestinal contractility and motility and causes a shift to a less contractile SMC phenotype. These findings indicate a new role for Nrp1 in the maintenance of the visceral SMC contractile phenotype required for normal GI motility in aged mice.	[Yamaji, Maiko; Mahmoud, Marwa; Evans, Ian M.; Zachary, Ian C.] UCL, Div Med, Ctr Cardiovasc Biol & Med, London WC1E 6JJ, England	University of London; University College London	Zachary, IC (corresponding author), UCL, Div Med, Ctr Cardiovasc Biol & Med, Rayne Bldg, London WC1E 6JJ, England.	I.Zachary@ucl.ac.uk	Evans, Ian/C-8533-2009	Evans, Ian/0000-0002-0468-8274; Mahmoud, Marwa/0000-0003-4382-1725	British Heart Foundation [RG/06/003]; British Heart Foundation [RG/06/003/21131, RG/11/11/29050] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation programme grant RG/06/003 to I.Z. (M.Y., M.M., I.M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Bielenberg DR, 2012, AM J PATHOL, V181, P548, DOI 10.1016/j.ajpath.2012.04.013; Burn Sally F, 2012, Methods Mol Biol, V886, P241, DOI 10.1007/978-1-61779-851-1_21; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; Fujita A, 2001, AM J PHYSIOL-CELL PH, V281, pC1727, DOI 10.1152/ajpcell.2001.281.5.C1727; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; HAMADA Y, 1990, BIOCHEM BIOPH RES CO, V170, P53, DOI 10.1016/0006-291X(90)91239-O; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HENNING SJ, 1973, ENZYME, V15, P3, DOI 10.1159/000481051; Herrera GM, 2000, AM J PHYSIOL-REG I, V279, pR60, DOI 10.1152/ajpregu.2000.279.1.R60; Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KELLEY CA, 1993, J BIOL CHEM, V268, P12848; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KLEIN RM, 1983, J PEDIATR GASTR NUTR, V2, P204, DOI 10.1097/00005176-198305000-00002; Knowles CH, 2004, GUT, V53, P1583, DOI 10.1136/gut.2003.037275; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li F, 2008, BIOCHEM BIOPH RES CO, V370, P317, DOI 10.1016/j.bbrc.2008.03.096; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Liu WB, 2005, CYTOKINE, V32, P206, DOI 10.1016/j.cyto.2005.09.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann SD, 1997, GUT, V41, P675, DOI 10.1136/gut.41.5.675; McHugh KM, 1996, J PEDIATR GASTR NUTR, V23, P379, DOI 10.1097/00005176-199611000-00001; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Ro S, 2001, AM J PHYSIOL-GASTR L, V281, pG964, DOI 10.1152/ajpgi.2001.281.4.G964; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; SCHUFFLER MD, 1977, GASTROENTEROLOGY, V73, P327; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Siegman MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1571, DOI 10.1152/ajpgi.1997.272.6.G1571; Sjuve R, 1996, J CELL BIOCHEM, V63, P86; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wright-Jin EC, 2013, DEV BIOL, V381, P28, DOI 10.1016/j.ydbio.2013.06.021; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10	52	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115563	10.1371/journal.pone.0115563	http://dx.doi.org/10.1371/journal.pone.0115563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659123	Green Published, gold			2022-12-26	WOS:000349444900023
J	Papadopoulos, T; Schemm, R; Grubmuller, H; Brose, N				Papadopoulos, Theofilos; Schemm, Rudolf; Grubmueller, Helmut; Brose, Nils			Lipid Binding Defects and Perturbed Synaptogenic Activity of a Collybistin R290H Mutant That Causes Epilepsy and Intellectual Disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR COLLYBISTIN; LINKED MENTAL-RETARDATION; MOLECULAR SIMULATION; INHIBITORY SYNAPSES; GEPHYRIN; CDC42; ACTIVATION; ARHGEF9; IDENTIFICATION; TRAFFICKING	Signaling at nerve cell synapses is a key determinant of proper brain function, and synaptic defects-or synaptopathies-are at the basis of many neurological and psychiatric disorders. In key areas of the mammalian brain, such as the hippocampus or the basolateral amygdala, the clustering of the scaffolding protein Gephyrin and of gamma-aminobutyric acid type A receptors at inhibitory neuronal synapses is critically dependent upon the brainspecific guanine nucleotide exchange factor Collybistin (Cb). Accordingly, it was discovered recently that an R290H missense mutation in the diffuse B-cell lymphoma homology domain of Cb, which carries the guanine nucleotide exchange factor activity, leads to epilepsy and intellectual disability in human patients. In the present study, we determined the mechanism by which the CbR290H mutation perturbs inhibitory synapse formation and causes brain dysfunction. Based on a combination of biochemical, cell biological, and molecular dynamics simulation approaches, we demonstrate that the R290H mutation alters the strength of intramolecular interactions between the diffuse B-cell lymphoma homology domain and the pleckstrin homology domain of Cb. This defect reduces the phosphatidylinositol 3-phosphate binding affinity of Cb, which limits its normal synaptogenic activity. Our data indicate that impairment of the membrane lipid binding activity of Cb and a consequent defect in inhibitory synapse maturation represent a likely molecular pathomechanism of epilepsy and mental retardation in humans.	[Papadopoulos, Theofilos; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Schemm, Rudolf; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de		Papadopoulos, Theofilos/0000-0002-0684-2407	Max Planck Society; German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology) [PA2087/1-1]; European Commission Innovative Medicines Initiative [FP7-115300]	Max Planck Society(Max Planck Society); German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology); European Commission Innovative Medicines Initiative	This work was supported by the Max Planck Society (to N. B.), the German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant to N. B. and Grant PA2087/1-1 to T. P.) and European Commission Innovative Medicines Initiative FP7-115300 (to N. B.).	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grosskreutz Y, 2001, BIOL CHEM, V382, P1455, DOI 10.1515/BC.2001.179; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2011, AM J MED GENET A, V155A, P1706, DOI 10.1002/ajmg.a.34004; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marco EJ, 2008, J MED GENET, V45, P100, DOI 10.1136/jmg.2007.052324; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Smith KR, 2010, CURR OPIN NEUROBIOL, V20, P550, DOI 10.1016/j.conb.2010.06.001; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verpelli C, 2014, DEV NEUROBIOL, V74, P197, DOI 10.1002/dneu.22093; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019	42	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8256	8270		10.1074/jbc.M114.633024	http://dx.doi.org/10.1074/jbc.M114.633024			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678704	hybrid, Green Published			2022-12-26	WOS:000351662600022
J	Weiser, BP; Eckenhoff, RG				Weiser, Brian P.; Eckenhoff, Roderic G.			Propofol Inhibits SIRT2 Deacetylase through a Conformation-specific, Allosteric Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ANESTHETIC PROPOFOL; SWISS-MODEL; HISTONE DEACETYLASE; RAT-BRAIN; EMBL-EBI; PROTEIN; MECHANISM; ACETYLATION; INFORMATION; TUBULIN	meta-Azi-propofol (AziPm) is a photoactive analog of the general anesthetic propofol. We photolabeled a myelin-enriched fraction from rat brain with [H-3]AziPm and identified the sirtuin deacetylase SIRT2 as a target of the anesthetic. AziPm photolabeled three SIRT2 residues (Tyr(139), Phe(190), and Met(206)) that are located in a single allosteric protein site, and propofol inhibited [H-3]AziPm photolabeling of this site in myelin SIRT2. Structural modeling and in vitro experiments with recombinant human SIRT2 determined that propofol and [H-3]AziPm only bind specifically and competitively to the enzyme when co-equilibrated with other substrates, which suggests that the anesthetic site is either created or stabilized in enzymatic conformations that are induced by substrate binding. In contrast to SIRT2, specific binding of [H-3]AziPm or propofol to recombinant human SIRT1 was not observed. Residues that line the propofol binding site on SIRT2 contact the sirtuin co-substrate NAD(+) during enzymatic catalysis, and assays that measured SIRT2 deacetylation of acetylated alpha-tubulin revealed that propofol inhibits enzymatic function. We conclude that propofol inhibits the mammalian deacetylase SIRT2 through a conformation-specific, allosteric protein site that is unique from the previously described binding sites of other inhibitors. This suggests that propofol might influence cellular events that are regulated by protein acetylation state.	[Weiser, Brian P.; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weiser, Brian P.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Eckenhoff, RG (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health [P01-GM055876, F31-NS080519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-GM055876 (to R.G.E.) and F31-NS080519 (to B.P.W.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Ballatore C, 2012, J MED CHEM, V55, P8979, DOI 10.1021/jm301079z; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emerson DJ, 2013, J AM CHEM SOC, V135, P5389, DOI 10.1021/ja311171u; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Liu L, 2012, J BIOL CHEM, V287, P32307, DOI 10.1074/jbc.C112.403048; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Patel S, 2003, BRIT J PHARMACOL, V139, P1005, DOI 10.1038/sj.bjp.0705334; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Weiser BP, 2014, FEBS LETT, V588, P4398, DOI 10.1016/j.febslet.2014.10.009; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Weiser BP, 2013, J BIOL CHEM, V288, P1279, DOI 10.1074/jbc.M112.413989; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zhang XN, 2009, NEUROSCI LETT, V465, P165, DOI 10.1016/j.neulet.2009.08.025	46	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8559	8568		10.1074/jbc.M114.620732	http://dx.doi.org/10.1074/jbc.M114.620732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666612	hybrid, Green Published			2022-12-26	WOS:000351662600046
J	Holst, PJ; Jensen, BAH; Ragonnaud, E; Thomsen, AR; Christensen, JP				Holst, Peter J.; Jensen, Benjamin A. H.; Ragonnaud, Emeline; Thomsen, Allan R.; Christensen, Jan P.			Targeting of Non-Dominant Antigens as a Vaccine Strategy to Broaden T-Cell Responses during Chronic Viral Infection	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; EXHAUSTED PHENOTYPE; IN-VIVO; MEMORY; ADENOVIRUS; IMMUNITY; EFFECTOR; EXPRESSION; CHALLENGE; SIV	In this study, we compared adenoviral vaccine vectors with the capacity to induce equally potent immune responses against non-dominant and immunodominant epitopes of murine lymphocytic choriomeningitis virus (LCMV). Our results demonstrate that vaccination targeting non-dominant epitopes facilitates potent virus-induced T-cell responses against immunodominant epitopes during subsequent challenge with highly invasive virus. In contrast, when an immunodominant epitope was included in the vaccine, the T-cell response associated with viral challenge remained focussed on that epitope. Early after challenge with live virus, the CD8+ T cells specific for vaccine-encoded epitopes, displayed a phenotype typically associated with prolonged/persistent antigenic stimulation marked by high levels of KLRG-1, as compared to T cells reacting to epitopes not included in the vaccine. Notably, this association was lost over time in T cells specific for the dominant T cell epitopes, and these cells were fully capable of expanding in response to a new viral challenge. Overall, our data suggests a potential for broadening of the antiviral CD8+ T-cell response by selecting non-dominant antigens to be targeted by vaccination. In addition, our findings suggest that prior adenoviral vaccination is not likely to negatively impact the long-term and protective immune response induced and maintained by a vaccine-attenuated chronic viral infection.	[Holst, Peter J.; Jensen, Benjamin A. H.; Thomsen, Allan R.; Christensen, Jan P.] Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Holst, Peter J.; Ragonnaud, Emeline] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Holst, PJ (corresponding author), Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark.	pholst@sund.ku.dk	Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; ragonnaud, emeline/0000-0001-5460-7789; Holst, Peter Johannes/0000-0002-1279-304X; Thomsen, Allan Randrup/0000-0002-2392-9803	Danish Research Council; Novo Nordisk Foundation; Aase and Einar Danielsens Fond; Hede Nielsen Family Foundation; Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden [NNF14OC0011875] Funding Source: researchfish	Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase and Einar Danielsens Fond; Hede Nielsen Family Foundation; Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank The Danish Research Council, The Novo Nordisk Foundation, Aase and Einar Danielsens Fond, The Hede Nielsen Family Foundation and the Foundation for the Advancement of Medical Sciences for funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bannard O, 2010, J IMMUNOL, V185, P7141, DOI 10.4049/jimmunol.1002537; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bartholdy C, 2004, J IMMUNOL, V173, P6284, DOI 10.4049/jimmunol.173.10.6284; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Christensen JP, 2003, J IMMUNOL, V171, P4733, DOI 10.4049/jimmunol.171.9.4733; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hoegh-Petersen M, 2009, VACCINE, V27, P6723, DOI 10.1016/j.vaccine.2009.08.104; Holst PJ, 2007, J GEN VIROL, V88, P1708, DOI 10.1099/vir.0.82727-0; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Holst PJ, 2011, J IMMUNOL, V186, P3997, DOI 10.4049/jimmunol.1001251; Holst PJ, 2010, J IMMUNOL, V184, P4431, DOI 10.4049/jimmunol.0900537; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Lecuroux C, 2009, AIDS, V23, P1649, DOI 10.1097/QAD.0b013e32832e6634; Leligdowicz A, 2010, EUR J IMMUNOL, V40, P1963, DOI 10.1002/eji.200940295; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MK, 2012, J CLIN INVEST, DOI [10.1172/JCI64993, DOI 10.1172/JCI64993]; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mikkelsen M, 2011, J IMMUNOL, V186, P2355, DOI 10.4049/jimmunol.1001877; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Roshorm Y, 2012, EUR J IMMUNOL, V42, P3243, DOI 10.1002/eji.201242624; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Steffensen MA, 2013, J VIROL, V87, P6283, DOI 10.1128/JVI.00465-13; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tan WG, 2013, J VIROL, V87, P1359, DOI 10.1128/JVI.02055-12; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wiesel M, 2009, APMIS, V117, P356, DOI 10.1111/j.1600-0463.2009.02459.x; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117242	10.1371/journal.pone.0117242	http://dx.doi.org/10.1371/journal.pone.0117242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679375	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600057
J	Sarna, M; Wojcik, KA; Hermanowicz, P; Wnuk, D; Burda, K; Sanak, M; Czyz, J; Michalik, M				Sarna, Michal; Wojcik, Katarzyna A.; Hermanowicz, Pawel; Wnuk, Dawid; Burda, Kvetoslava; Sanak, Marek; Czyz, Jaroslaw; Michalik, Marta			Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts	PLOS ONE			English	Article							TO-MYOFIBROBLAST TRANSITION; NANOMECHANICAL ANALYSIS; ACTIN CYTOSKELETON; STRESS FIBERS; GROWTH-FACTOR; CELLS; DIFFERENTIATION; EXPRESSION; STIFFNESS; MECHANICS	During asthma development, differentiation of epithelial cells and fibroblasts towards the contractile phenotype is associated with bronchial wall remodeling and airway constriction. Pathological fibroblast-to-myofibroblast transition (FMT) can be triggered by local inflammation of bronchial walls. Recently, we have demonstrated that human bronchial fibroblasts (HBFs) derived from asthmatic patients display some inherent features which facilitate their FMT in vitro. In spite of intensive research efforts, these properties remain unknown. Importantly, the role of undifferentiated HBFs in the asthmatic process was systematically omitted. Specifically, biomechanical properties of undifferentiated HBFs have not been considered in either FMT or airway remodeling in vivo. Here, we combine atomic force spectroscopy with fluorescence microscopy to compare mechanical properties and actin cytoskeleton architecture of HBFs derived from asthmatic patients and non-asthmatic donors. Our results demonstrate that asthmatic HBFs form thick and aligned 'ventral' stress fibers accompanied by enlarged focal adhesions. The differences in cytoskeleton architecture between asthmatic and non-asthmatic cells correlate with higher elastic modulus of asthmatic HBFs and their increased predilection to TGF-beta-induced FMT. Due to the obvious links between cytoskeleton architecture and mechanical equilibrium, our observations indicate that HBFs derived from asthmatic bronchi can develop considerably higher static tension than non-asthmatic HBFs. This previously unexplored property of asthmatic HBFs may be potentially important for their myofibroblastic differentiation and bronchial wall remodeling during asthma development.	[Sarna, Michal; Burda, Kvetoslava] AGH Univ Sci & Technol, Dept Med Phys & Biophys, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland; [Wojcik, Katarzyna A.; Wnuk, Dawid; Czyz, Jaroslaw; Michalik, Marta] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wojcik, Katarzyna A.] Jagiellonian Univ, Fac Pharm, Dept Pharmaceut Biochem, Coll Med, Krakow, Poland; [Hermanowicz, Pawel] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sanak, Marek] Jagiellonian Univ, Coll Med, Lab Mol Biol & Clin Genet, Krakow, Poland	AGH University of Science & Technology; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Sarna, M (corresponding author), AGH Univ Sci & Technol, Dept Med Phys & Biophys, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland.	michal.sarna@fis.agh.edu.pl; marta.michalik@uj.edu.pl	Burda, Kvetoslava/AAW-2621-2021; Wnuk, Dawid/X-1664-2018; Sanak, Marek/AAV-1628-2021	Burda, Kvetoslava/0000-0001-5049-6217; Wnuk, Dawid/0000-0002-5807-2440; Sanak, Marek/0000-0001-7635-8103; Hermanowicz, Pawel/0000-0002-4708-442X; Wojcik-Pszczola, Katarzyna/0000-0002-2477-5607; Czyz, Jaroslaw/0000-0001-6779-7630	Polish National Science Centre [2011/01/B/NZ3/00004]; European Union [UDA-POIG.01.03.01-14-036/09-00, POIG.02.01.00-12-064/08, POIG 01.02-00-109/99]	Polish National Science Centre; European Union(European Commission)	This work was supported by the Polish National Science Centre (grant 2011/01/B/NZ3/00004). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (Grants No: UDA-POIG.01.03.01-14-036/09-00-"Application of polyisoprenoid derivatives as drug carriers and metabolism regulators"; POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"; POIG 01.02-00-109/99 "Innovative methods of stem cell applications in medicine"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Daniel-Wojcik A, 2008, INT J ONCOL, V33, P309, DOI 10.3892/ijo_00000010; Desideria D, 2007, RECENT PATENTS INFLA, V1, P237, DOI 10.2174/187221307782418847; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dufrene YF, 2003, CURR OPIN MICROBIOL, V6, P317, DOI 10.1016/S1369-5274(03)00058-4; Evans ND, 2009, EUR CELLS MATER, V18, P1; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/NNANO.2012.163, 10.1038/nnano.2012.163]; Hermanowicz P, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4881683; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Kliche K, 2011, PFLUG ARCH EUR J PHY, V462, P209, DOI 10.1007/s00424-011-0929-2; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Michalik Marta, 2012, J Allergy (Cairo), V2012, P206109, DOI 10.1155/2012/206109; Michalik M, 2013, EUR J PHARMACOL, V704, P23, DOI 10.1016/j.ejphar.2013.02.023; Michalik M, 2011, RESP MED, V105, P1467, DOI 10.1016/j.rmed.2011.04.009; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sandbo N, 2011, TRANSL RES, V158, P181, DOI 10.1016/j.trsl.2011.05.004; Sarna M, 2013, PIGM CELL MELANOMA R, V26, P727, DOI 10.1111/pcmr.12113; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; West AR, 2013, PULM PHARMACOL THER, V26, P3, DOI 10.1016/j.pupt.2012.08.009; Westergren-Thorsson G, 2010, CLIN RESPIR J, V4, P1, DOI 10.1111/j.1752-699X.2010.00190.x; Wojcik KA, 2013, PHARMACOL REP, V65, P164, DOI 10.1016/S1734-1140(13)70974-5; Wojcik KA, 2012, POL ARCH MED WEWN, V122, P326, DOI 10.20452/pamw.1343	43	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116840	10.1371/journal.pone.0116840	http://dx.doi.org/10.1371/journal.pone.0116840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679502	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600037
J	Wu, QH; Chen, YX; Zhou, SH; Fu, L; Chen, JJ; Xiao, Y; Zhang, D; Ouyang, SH; Zhao, XJ; Cui, Y; Zhang, DY; Liang, Y; Wang, ZZ; Xie, JZ; Qin, JX; Wang, GX; Li, DL; Huang, YL; Yu, MH; Lu, P; Wang, LL; Wang, L; Wang, H; Dang, C; Li, J; Zhang, Y; Peng, HR; Yuan, CG; You, MS; Sun, QX; Wang, JR; Wang, LX; Luo, MC; Han, J; Liu, ZY				Wu, Qiu-Hong; Chen, Yong-Xing; Zhou, Sheng-Hui; Fu, Lin; Chen, Jiao-Jiao; Xiao, Yao; Zhang, Dong; Ouyang, Shu-Hong; Zhao, Xiao-Jie; Cui, Yu; Zhang, De-Yun; Liang, Yong; Wang, Zhen-Zhong; Xie, Jing-Zhong; Qin, Jin-Xia; Wang, Guo-Xin; Li, De-Lin; Huang, Yin-Lian; Yu, Mei-Hua; Lu, Ping; Wang, Li-Li; Wang, Ling; Wang, Hao; Dang, Chen; Li, Jie; Zhang, Yan; Peng, Hui-Ru; Yuan, Cheng-Guo; You, Ming-Shan; Sun, Qi-Xin; Wang, Ji-Rui; Wang, Li-Xin; Luo, Ming-Cheng; Han, Jun; Liu, Zhi-Yong			High-Density Genetic Linkage Map Construction and QTL Mapping of Grain Shape and Size in the Wheat Population Yanda1817 x Beinong6	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L.; D-GENOME; AEGILOPS-TAUSCHII; AGRONOMIC TRAITS; MOLECULAR MARKER; POLYPLOID WHEAT; KERNEL WEIGHT; BREAD WHEAT; SEED SIZE	High-density genetic linkage maps are necessary for precisely mapping quantitative trait loci (QTLs) controlling grain shape and size in wheat. By applying the Infinium iSelect 9K SNP assay, we have constructed a high-density genetic linkage map with 269 F-8 recombinant inbred lines (RILs) developed between a Chinese cornerstone wheat breeding parental line Yanda1817 and a high-yielding line Beinong6. The map contains 2431 SNPs and 128 SSR & EST-SSR markers in a total coverage of 3213.2 cM with an average interval of 1.26 cM per marker. Eighty-eight QTLs for thousand-grain weight (TGW), grain length (GL), grain width (GW) and grain thickness (GT) were detected in nine ecological environments (Beijing, Shijiazhuang and Kaifeng) during five years between 2010-2014 by inclusive composite interval mapping (ICIM) (LOD >= 2.5). Among which, 17 QTLs for TGW were mapped on chromosomes 1A, 1B, 2A, 2B, 3A, 3B, 3D, 4A, 4D, 5A, 5B and 6B with phenotypic variations ranging from 2.62% to 12.08%. Four stable QTLs for TGW could be detected in five and seven environments, respectively. Thirty-two QTLs for GL were mapped on chromosomes 1B, 1D, 2A, 2B, 2D, 3B, 3D, 4A, 4B, 4D, 5A, 5B, 6B, 7A and 7B, with phenotypic variations ranging from 2.62% to 44.39%. QGl. cau-2A. 2 can be detected in all the environments with the largest phenotypic variations, indicating that it is a major and stable QTL. For GW, 12 QTLs were identified with phenotypic variations range from 3.69% to 12.30%. We found 27 QTLs for GT with phenotypic variations ranged from 2.55% to 36.42%. In particular, QTL QGt. cau-5A. 1 with phenotypic variations of 6.82-23.59% was detected in all the nine environments. Moreover, pleiotropic effects were detected for several QTL loci responsible for grain shape and size that could serve as target regions for fine mapping and marker assisted selection in wheat breeding programs.	[Wu, Qiu-Hong; Chen, Yong-Xing; Zhou, Sheng-Hui; Fu, Lin; Chen, Jiao-Jiao; Xiao, Yao; Zhang, Dong; Ouyang, Shu-Hong; Zhao, Xiao-Jie; Cui, Yu; Zhang, De-Yun; Liang, Yong; Wang, Zhen-Zhong; Xie, Jing-Zhong; Qin, Jin-Xia; Wang, Guo-Xin; Li, De-Lin; Huang, Yin-Lian; Yu, Mei-Hua; Lu, Ping; Wang, Li-Li; Wang, Ling; Wang, Hao; Dang, Chen; Li, Jie; Zhang, Yan; Peng, Hui-Ru; Yuan, Cheng-Guo; You, Ming-Shan; Sun, Qi-Xin; Liu, Zhi-Yong] China Agr Univ, State Key Lab Agrobiotechnol, Dept Plant Genet & Breeding, Beijing 100193, Peoples R China; [Wang, Ji-Rui; Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Ji-Rui] Sichuan Agr Univ, Triticeae Res Inst, Chengdu 611130, Sichuan, Peoples R China; [Wang, Li-Xin] Beijing Acad Agr & Forestry Sci, Beijing 100197, Peoples R China; [Han, Jun] Beijing Univ Agr, Beijing 102206, Peoples R China	China Agricultural University; University of California System; University of California Davis; Sichuan Agricultural University; Beijing Academy of Agriculture & Forestry; Beijing University of Agriculture	Han, J (corresponding author), Beijing Univ Agr, Beijing 102206, Peoples R China.	hanjun4226@163.com; zhiyongliu@cau.edu.cn	chen, JJ/HGB-6029-2022; Li, Delin/AAO-2275-2021; CHEN, JIAO/GZA-5784-2022; Xie, Jingzhong/AAF-5899-2020	Li, Delin/0000-0002-3689-3790; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233	973 project [2011CB100104]; National Natural Science Foundation of China [31030056, 31271710]; Ministry of Education of China [111-2-03]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by 973 project 2011CB100104; National Natural Science Foundation of China 31030056, 31271710; Ministry of Education of China 111-2-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Berard A, 2009, PLANT BIOTECHNOL J, V7, P364, DOI 10.1111/j.1467-7652.2009.00404.x; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chang JZ, 2013, PLANTA, V237, P1495, DOI 10.1007/s00425-013-1860-x; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Cui F, 2013, MOL BREEDING, V31, P265, DOI 10.1007/s11032-012-9786-8; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Giura A, 1996, EUPHYTICA, V89, P77, DOI 10.1007/BF00015722; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo Y, 2013, FIELD CROP RES, V154, P119, DOI 10.1016/j.fcr.2013.07.012; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kang GZ, 2013, PLANT PHYSIOL BIOCH, V73, P93, DOI 10.1016/j.plaphy.2013.09.003; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar N, 2006, EUPHYTICA, V151, P135, DOI 10.1007/s10681-006-9133-4; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Lincoln L, 1993, CONSTRUCTING GENETIC, P1; Liu Ren-Hu, 2003, Yichuan, V25, P317; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Paux E, 2012, BIOTECHNOL ADV, V30, P1071, DOI 10.1016/j.biotechadv.2011.09.015; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Pozzi C, 2004, CEREAL GENOMICS, P165; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rasheed A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-128; Roder MS, 1998, GENETICS, V149, P2007; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Varshney RK, 2000, THEOR APPL GENET, V100, P1290, DOI 10.1007/s001220051437; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; Williams K, 2013, EUPHYTICA, V190, P99, DOI 10.1007/s10681-012-0783-0; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhuang QS., 2003, CHINESE WHEAT IMPROV	58	87	96	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118144	10.1371/journal.pone.0118144	http://dx.doi.org/10.1371/journal.pone.0118144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675376	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000041
J	Aleman, Y; Vinken, L; Kour, V; Perez, L; Alvarez, A; Abrahantes, Y; Fonseca, C; Perez, J; Correa, C; Soto, Y; Schrooten, Y; Vandamme, AM; Van Laethem, K				Aleman, Yoan; Vinken, Lore; Kour, Vivian; Perez, Lissette; Alvarez, Alina; Abrahantes, Yeissel; Fonseca, Carlos; Perez, Jorge; Correa, Consuelo; Soto, Yudira; Schrooten, Yoeri; Vandamme, Anne-Mieke; Van Laethem, Kristel			Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SEQUENCE-BASED ANALYSIS; BLOOD SPOT SPECIMENS; FIELD-EVALUATION; VIROSEQ(TM) 2.0; HIV-1; ASSAY; MUTATIONS; STRAINS	As commercial human immunodeficiency virus type 1 drug resistance assays are expensive, they are not commonly used in resource-limited settings. Hence, a more affordable inhouse procedure was set up taking into account the specific epidemiological and economic circumstances of Cuba. The performance characteristics of the in-house assay were evaluated using clinical samples with various subtypes and resistance patterns. The lower limit of amplification was determined on dilutions series of 20 clinical isolates and ranged from 84 to 529 RNA copies/mL. For the assessment of trueness, 14 clinical samples were analyzed and the ViroSeq HIV-1 Genotyping System v2.0 was used as the reference standard. The mean nucleotide sequence identity between the two assays was 98.7% +/- 1.0. Additionally, 99.0% of the amino acids at drug resistance positions were identical. The sensitivity and specificity in detecting drug resistance mutations was respectively 94.1% and 99.5%. Only few discordances in drug resistance interpretation patterns were observed. The repeatability and reproducibility were evaluated using 10 clinical samples with 3 replicates per sample. The in-house test was very precise as nucleotide sequence identity among paired nucleotide sequences ranged from 98.7% to 99.9%. The acceptance criteria were met by the inhouse test for all performance characteristics, demonstrating a high degree of accuracy. Subsequently, the applicability in routine clinical practice was evaluated on 380 plasma samples. The amplification success rate was 91% and good quality consensus sequences encoding the entire protease and the first 335 codons in reverse transcriptase could be obtained for 99% of the successful amplicons. The reagent cost per sample using the inhouse procedure was around (sic) 80 per genotyping attempt. Overall, the in-house assay provided good results, was feasible with equipment and reagents available in Cuba and was half as expensive as commercial assays.	[Aleman, Yoan; Kour, Vivian; Perez, Lissette; Alvarez, Alina; Correa, Consuelo; Soto, Yudira] Inst Trop Med Pedro Kouri, Dept Virol, Havana, Cuba; [Vinken, Lore; Schrooten, Yoeri; Vandamme, Anne-Mieke; Van Laethem, Kristel] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium; [Abrahantes, Yeissel; Fonseca, Carlos; Perez, Jorge] Hosp Inst Trop Med Pedro Kouri, Havana, Cuba; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, P-1200 Lisbon, Portugal	KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Van Laethem, K (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.	kristel.vanlaethem@uzleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Van Laethem, Kristel/R-6282-2016	Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Laethem, Kristel/0000-0001-6036-2271; Correa Sierra, Consuelo B/0000-0003-2897-8388	Vlaamse Interuniversitaire Raad (VLIR) [ZEIN2008PR358]; Global Fund To Fight AIDS, Tuberculosis and Malaria; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0692.14N]; AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs	Vlaamse Interuniversitaire Raad (VLIR); Global Fund To Fight AIDS, Tuberculosis and Malaria; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs	This work was supported by grants from the Vlaamse Interuniversitaire Raad (VLIR) (ZEIN2008PR358), the Global Fund To Fight AIDS, Tuberculosis and Malaria, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0692.14N) and by the AIDS Reference Laboratory of Leuven that receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Aitken SC, 2012, J CLIN VIROL, V54, P21, DOI 10.1016/j.jcv.2012.01.010; Beddows S, 2003, J MED VIROL, V70, P337, DOI 10.1002/jmv.10401; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2012, ANTIVIR THER, V17, P941, DOI 10.3851/IMP2320; Bile EC, 2005, J CLIN VIROL, V32, P60, DOI 10.1016/j.jcv.2004.07.008; Chaturbhuj DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087441; Chaturbhuj DN, 2013, J VIROL METHODS, V189, P87, DOI 10.1016/j.jviromet.2013.01.001; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Chen JHK, 2012, HONG KONG MED J, V18, P20; Clinical and Laboratory Standards Institute (CLSI), 2006, MM10A CLSI; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; HHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES USE ANTIR; Huang DD, 2003, J CLIN MICROBIOL, V41, P3265, DOI 10.1128/JCM.41.7.3265-3272.2003; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Jagodzinski LL, 2003, J CLIN MICROBIOL, V41, P998, DOI 10.1128/JCM.41.3.998-1003.2003; Jennings L, 2009, ARCH PATHOL LAB MED, V133, P743, DOI 10.1043/1543-2165-133.5.743; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maes B, 2004, J VIROL METHODS, V119, P45, DOI 10.1016/j.jviromet.2004.02.005; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Mracna M, 2001, J CLIN MICROBIOL, V39, P4323, DOI 10.1128/JCM.39.12.4323-4327.2001; Parkin N, 2012, CLIN INFECT DIS, V54, pS273, DOI 10.1093/cid/cir982; Perez J, 2004, PERSPECTIVES PRACTIC; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thew KK, 2012, ANN ACAD MED SINGAP, V41, P553; Thiam M, 2013, J VIROL METHODS, V188, P97, DOI 10.1016/j.jviromet.2012.11.044; Vandamme AM, 2011, AIDS REV, V13, P77; Vinken L, 2013, J VIROL METHODS, V193, P135, DOI 10.1016/j.jviromet.2013.05.017; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; World Health Organization, 2010, WHO HIVRESNET HIV DR; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	40	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117176	10.1371/journal.pone.0117176	http://dx.doi.org/10.1371/journal.pone.0117176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671421	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300039
J	Ammann, RA; Teuffel, O; Agyeman, P; Amport, N; Leibundgut, K				Ammann, Roland A.; Teuffel, Oliver; Agyeman, Philipp; Amport, Nadine; Leibundgut, Kurt			The Influence of Different Fever Definitions on the Rate of Fever in Neutropenia Diagnosed in Children with Cancer	PLOS ONE			English	Article							PEDIATRIC FEBRILE NEUTROPENIA; MANAGEMENT; RISK; ONCOLOGY; ANTIBIOTICS; OUTPATIENT; GUIDELINE; CENTERS; TRIALS	Background The temperature limit defining fever (TLDF) is based on scarce evidence. This study aimed to determine the rate of fever in neutropenia (FN) episodes additionally diagnosed by lower versus standard TLDF. Methods In a single center using a high TLDF (39.0 degrees C tympanic temperature, Limit(Standard)), pediatric patients treated with chemotherapy for cancer were observed prospectively. Results of all temperature measurements and CBCs were recorded. The application of lower TLDFs (Limit(Low); range, 37.5 degrees C to 38.9 degrees C) versus Limit(Standard) was simulated in silicon, resulting in three types of FN: simultaneous FN, diagnosed at both limits within 1 hour; earlier FN, diagnosed > 1hour earlier at Limit(Low); and additional FN, not diagnosed at Limit(Standard). Results In 39 patients, 8896 temperature measurements and 1873 CBCs were recorded during 289 months of chemotherapy. Virtually applying Limit(Standard) resulted in 34 FN diagnoses. The predefined relevantly (>= 15%) increased FN rate was reached at Limit(Low) 38.4 degrees C, with total 44 FN, 23 simultaneous, 11 earlier, and 10 additional (Poisson rate ratio(Additional/Standard), 0.29; 95% lower confidence bound, 0.16). Virtually applying 37.5 degrees C as Limit(Low) led to earlier FN diagnosis (median, 4.5 hours; 95% CI, 1.0 to 20.8), and to 53 additional FN diagnosed. In 51 (96%) of them, spontaneous defervescence without specific therapy was observed in reality. Conclusion Lower TLDFs led to many additional FN diagnoses, implying overtreatment because spontaneous defervescence was observed in the vast majority. Lower TLDFs led as well to relevantly earlier diagnosis in a minority of FN episodes. The question if the high TLDF is not only efficacious but as well safe remains open.	[Ammann, Roland A.; Teuffel, Oliver; Agyeman, Philipp; Amport, Nadine; Leibundgut, Kurt] Univ Bern, Dept Pediat, Bern, Switzerland; [Teuffel, Oliver] Med Serv Statutory Hlth Insurance Baden Wurttemb, Div Oncol, Tubingen, Germany; [Agyeman, Philipp] Univ Bern, Inst Infect Dis, Bern, Switzerland	University of Bern; University of Bern	Ammann, RA (corresponding author), Univ Bern, Dept Pediat, Bern, Switzerland.	roland.ammann@insel.ch	Agyeman, Philipp/AAG-3510-2019; Ammann, Roland A/I-4716-2019	Ammann, Roland A/0000-0002-1902-2352; Leibundgut, Kurt/0000-0003-2514-6041; Agyeman, Philipp Kwame Abayie/0000-0002-8339-5444	Swiss Cancer League [KLS-2933-02-2012]	Swiss Cancer League	This study was supported by an unrestricted research grant from the Swiss Cancer League (Grant No. KLS-2933-02-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Ammann RA, 2012, CURR OPIN INFECT DIS, V25, P258, DOI 10.1097/QCO.0b013e328351d199; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; Bate J, 2013, ARCH DIS CHILD, V98, P315, DOI 10.1136/archdischild-2013-303810; Binz P, 2013, PEDIATR BLOOD CANCER, V60, P799, DOI 10.1002/pbc.24380; Cheng S, 2011, BRIT J CANCER, V105, P606, DOI 10.1038/bjc.2011.213; Fletcher M, 2013, PEDIATR BLOOD CANCER, V60, P1299, DOI 10.1002/pbc.24485; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gibson F, 2013, SUPPORT CARE CANCER, V21, P1241, DOI 10.1007/s00520-012-1653-y; Ichikawa M, 2011, PEDIATR BLOOD CANCER, V57, P1159, DOI 10.1002/pbc.23106; Kaz Europe SA, 2011, BRAUN THERM IRT 4520, P3; Klaassen RJ, 2000, J CLIN ONCOL, V18, P1012, DOI 10.1200/JCO.2000.18.5.1012; Koh A, 2011, PRINCIPLES PRACTICE, P1190; Lehrnbecher T, 2012, J CLIN ONCOL, V30, P4427, DOI 10.1200/JCO.2012.42.7161; Manji A, 2012, SUPPORT CARE CANCER, V20, P1135, DOI 10.1007/s00520-012-1425-8; Nijhuis CO, 2005, J CLIN ONCOL, V23, P7437, DOI 10.1200/JCO.2004.00.5264; Nimah MM, 2006, PEDIATR CRIT CARE ME, V7, P48, DOI 10.1097/01.PCC.0000185476.35550.B2; Phillips B, 2007, ARCH DIS CHILD, V92, P495, DOI 10.1136/adc.2006.102699; Phillips RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038300; Schlapbach LJ, 2007, PEDIATR BLOOD CANCER, V49, P11, DOI 10.1002/pbc.21097; Schoot RA, 2012, SUPPORT CARE CANCER, V20, P3149, DOI 10.1007/s00520-012-1447-2; Sung L, 2004, J CLIN ONCOL, V22, P3922, DOI 10.1200/JCO.2004.01.077; Teuffel O, 2012, CURR OPIN PEDIATR, V24, P40, DOI 10.1097/MOP.0b013e32834c4b12; Teuffel O, 2011, PEDIATRICS, V127, pE279, DOI 10.1542/peds.2010-0734	24	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117528	10.1371/journal.pone.0117528	http://dx.doi.org/10.1371/journal.pone.0117528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671574	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300058
J	Kim, ES; Shin, JH; Park, SJ; Jo, YK; Kim, JS; Kang, IH; Nam, JB; Chung, DY; Cho, Y; Lee, EH; Chang, JW; Cho, DH				Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Kim, Jae-Sung; Kang, Il-Hwan; Nam, Jung-Bum; Chung, Doo-Young; Cho, Yoonchul; Lee, EunJoo H.; Chang, Jong Wook; Cho, Dong-Hyung			Inhibition of Autophagy Suppresses Sertraline-Mediated Primary Ciliogenesis in Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							PRIMARY CILIA; ANTIDEPRESSANT SERTRALINE; CALCIUM; INTRAFLAGELLAR; HEDGEHOG; DISEASE; LINES; SIZE	Primary cilia are conserved cellular organelles that regulate diverse signaling pathways. Autophagy is a complex process of cellular degradation and recycling of cytoplasmic proteins and organelles, and plays an important role in cellular homeostasis. Despite its potential importance, the role of autophagy in ciliogenesis is largely unknown. In this study, we identified sertraline as a regulator of autophagy and ciliogenesis. Sertraline, a known antidepressant, induced the growth of cilia and blocked the disassembly of cilia in htRPE cells. Following treatment of sertraline, there was an increase in the number of cells with autophagic puncta and LC3 protein conversion. In addition, both a decrease of ATG5 expression and the treatment of an autophagy inhibitor resulted in the suppression of the sertraline-induced activation of autophagy in htRPE cells. Interestingly, we found that genetic and chemical inhibition of autophagy attenuated the growth of primary cilia in htRPE cells. Taken together, our results suggest that the inhibition of autophagy suppresses sertralineinduced ciliogenesis.	[Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Kang, Il-Hwan; Nam, Jung-Bum; Chung, Doo-Young; Cho, Yoonchul; Lee, EunJoo H.; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea; [Kim, Jae-Sung] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Chang, Jong Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Res Inst Future Med Stem Cell & Regenerat Med, Seoul, South Korea	Kyung Hee University; Korea Institute of Radiological & Medical Sciences; Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Res Inst Future Med Stem Cell & Regenerat Med, Seoul, South Korea.	jongwook.chang@samsung.com; dhcho@khu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1058361]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1058361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chien JM, 2011, HUM EXP TOXICOL, V30, P1635, DOI 10.1177/0960327110396523; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Daniel WA, 2006, EUR NEUROPSYCHOPHARM, V16, P580, DOI 10.1016/j.euroneuro.2006.01.004; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Grohol J., 2012, PSYCH CENTRAL; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang CJ, 2009, J RECEPT SIG TRANSD, V29, P342, DOI 10.3109/10799890903295135; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jo YK, 2011, BIOCHEM BIOPH RES CO, V404, P1039, DOI 10.1016/j.bbrc.2010.12.106; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kim ES, 2014, EXP DERMATOL, V23, P204, DOI 10.1111/exd.12337; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ohno Y, 2007, BRAIN RES, V1178, P44, DOI 10.1016/j.brainres.2007.08.018; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Reddy KK, 2008, PIGM CELL MELANOMA R, V21, P451, DOI 10.1111/j.1755-148X.2008.00481.x; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tang ZM, 2014, AUTOPHAGY, V10, P379, DOI 10.4161/auto.27346; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Taylor D, 2012, MAUDSLEY PRESCRIBING, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Wang GK, 2008, J MEMBRANE BIOL, V222, P79, DOI 10.1007/s00232-008-9103-y; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yuan SAL, 2012, P NATL ACAD SCI USA, V109, P2021, DOI 10.1073/pnas.1112834109	44	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118190	10.1371/journal.pone.0118190	http://dx.doi.org/10.1371/journal.pone.0118190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671433	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300087
J	Verissimo, P; Timenetsky, KT; Casalaspo, TJA; Goncalves, LHR; Yang, ASY; Eid, RC				Verissimo, Pedro; Timenetsky, Karina T.; Andre Casalaspo, Thaisa Juliana; Rodrigues Goncalves, Louise Helena; Yun Yang, Angela Shu; Eid, Raquel Caserta			High Prevalence of Respiratory Muscle Weakness in Hospitalized Acute Heart Failure Elderly Patients	PLOS ONE			English	Article							TASK-FORCE; DYSFUNCTION; EXERCISE; PRESSURES; STRENGTH; SOCIETY	Introduction Respiratory Muscle Weakness (RMW) has been defined when the maximum inspiratory pressure (MIP) is lower than 70% of the predictive value. The prevalence of RMW in chronic heart failure patients is 30 to 50%. So far there are no studies on the prevalence of RMW in acute heart failure (AHF) patients. Objectives Evaluate the prevalence of RMW in patients admitted because of AHF and the condition of respiratory muscle strength on discharge from the hospital. Methods Sixty-three patients had their MIP measured on two occasions: at the beginning of the hospital stay, after they had reached respiratory, hemodynamic and clinical stability and before discharge from the hospital. The apparatus and technique to measure MIP were adapted because of age-related limitations of the patients. Data on cardiac ejection fraction, ECG, brain natriuretic peptide (BNP) levels and on the use of noninvasive ventilation (NIV) were collected. Results The mean age of the 63 patients under study was 75 years. On admission the mean ejection fraction was 33% (95% CI: 31-35) and the BNP hormone median value was 726.5 pg/ml (range: 217 to 2283 pg/ml); 65% of the patients used NIV. The median value of MIP measured after clinical stabilization was -52.7 cmH2O (range: -20 to -120 cmH(2)O); 76% of the patients had MIP values below 70% of the predictive value. On discharge, after a median hospital stay of 11 days, the median MIP was -53.5 cmH(2)O (range:-20 to -150 cmH(2)O); 71% of the patients maintained their MIP values below 70% of the predictive value. The differences found were not statistically significant. Conclusion Elderly patients admitted with AHF may present a high prevalence of RMW on admission; this condition may be maintained at similar levels on discharge in a large percentage of these patients, even after clinical stabilization of the heart condition.	[Verissimo, Pedro] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; Hosp Israelita Albert Einstein, Coronary Care Unit, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Verissimo, P (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.	pedropbusp@yahoo.com.br						Bosnak-Guclu M, 2011, RESP MED, V105, P1671, DOI 10.1016/j.rmed.2011.05.001; Brower Roy G, 2009, Crit Care Med, V37, pS422, DOI 10.1097/CCM.0b013e3181b6e30a; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Callegaro CC, 2010, RESP PHYSIOL NEUROBI, V171, P31, DOI 10.1016/j.resp.2010.01.009; Caruso P, 1999, CHEST, V115, P1096, DOI 10.1378/chest.115.4.1096; Chiappa GR, 2008, J AM COLL CARDIOL, V51, P1663, DOI 10.1016/j.jacc.2007.12.045; Chung CJ, 2011, PHYSICIAN SPORTSMED, V39, P37, DOI 10.3810/psm.2011.11.1937; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Frankenstein L, 2009, EUR J CARDIOV PREV R, V16, P424, DOI 10.1097/HJR.0b013e3283030a7e; Gosker HR, 2000, AM J CLIN NUTR, V71, P1033; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Jonghe B, 2009, CRIT CARE MED, V37, P309; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; MARINI J J, 1986, Journal of Critical Care, V1, P32, DOI 10.1016/S0883-9441(86)80114-9; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Meyer FJ, 2001, CIRCULATION, V103, P2153; Montera MW, 2012, ARQ BRAS CARDIOL, V98; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; NISHIMURA Y, 1994, CHEST, V105, P355, DOI 10.1378/chest.105.2.355; OMLAND T, 2008, CRIT CARE MED, V36, P17; Ribeiro Jorge P, 2009, Curr Heart Fail Rep, V6, P95; RIBEIRO JP, 2012, REV BRAS FISIOTER, V16, P261, DOI DOI 10.1590/S1413-35552012005000034; Smart NA, 2013, INT J CARDIOL, V167, P1502, DOI 10.1016/j.ijcard.2012.04.029; Tzanis G, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-14; Winkelmann ER, 2009, AM HEART J, V158, DOI 10.1016/j.ahj.2009.09.005; Wohlgemuth M, 2003, EUR RESPIR J, V22, P1001, DOI 10.1183/09031936.03.00028103; Wong E, 2011, HEART LUNG CIRC, V20, P289, DOI 10.1016/j.hlc.2011.01.009; Yosef-Brauner O, 2015, CLIN RESPIR J, V9, P1, DOI 10.1111/crj.12091	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118218	10.1371/journal.pone.0118218	http://dx.doi.org/10.1371/journal.pone.0118218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671566	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300089
J	Barker, JW; Han, PK; Choi, SH; Bae, KT; Park, SH				Barker, Jeffrey W.; Han, Paul Kyu; Choi, Seung Hong; Bae, Kyongtae Ty; Park, Sung-Hong			Investigation of Inter-Slice Magnetization Transfer Effects as a New Method for MTR Imaging of the Human Brain	PLOS ONE			English	Article							TRANSFER CONTRAST; TRANSFER RATIO; TISSUE; RELAXATION; RESONANCE; CARTILAGE; TUMOR	We present a new method for magnetization transfer (MT) ratio imaging in the brain that requires no separate saturation pulse. Interslice MT effects that are inherent to multi-slice balanced steady-state free precession (bSSFP) imaging were controlled via an interslice delay time to generate MT-weighted (0 s delay) and reference images (5-8 s delay) for MT ratio (MTR) imaging of the brain. The effects of varying flip angle and phase encoding (PE) order were investigated experimentally in normal, healthy subjects. Values of up to similar to 50% and similar to 40% were observed for white and gray matter MTR. Centric PE showed larger MTR, higher SNR, and better contrast between white and gray matter than linear PE. Simulations of a two-pool model of MT agreed well with in vivo MTR values. Simulations were also used to investigate the effects of varying acquisition parameters, and the effects of varying flip angle, PE steps, and interslice delay are discussed. Lastly, we demonstrated reduced banding with a non-balanced SSFP-FID sequence and showed preliminary results of interslice MTR imaging of meningioma.	[Barker, Jeffrey W.; Bae, Kyongtae Ty; Park, Sung-Hong] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Barker, Jeffrey W.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Han, Paul Kyu; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU)	Park, SH (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668; Choi, Seung Hong/0000-0002-0412-2270	National Research Foundation of Korea [NRF-2013R1A1A1061759]; Competitive Medical Research Fund of the UPMC Health System	National Research Foundation of Korea(National Research Foundation of Korea); Competitive Medical Research Fund of the UPMC Health System	This study was supported by a grant from National Research Foundation of Korea (NRF-2013R1A1A1061759) and a grant from Competitive Medical Research Fund of the UPMC Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieri O, 2007, MAGN RESON MED, V58, P511, DOI 10.1002/mrm.21326; Bieri O, 2006, MAGN RESON MED, V56, P1067, DOI 10.1002/mrm.21056; Bieri O, 2008, MAGN RESON MED, V60, P1261, DOI 10.1002/mrm.21781; DIXON WT, 1990, MAGN RESON IMAGING, V8, P417, DOI 10.1016/0730-725X(90)90050-C; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Graham SJ, 1997, JMRI-J MAGN RESON IM, V7, P903, DOI 10.1002/jmri.1880070520; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Laurent D, 2001, MAGN RESON IMAGING, V19, P1279, DOI 10.1016/S0730-725X(01)00433-7; MELKI PS, 1992, MAGNET RESON MED, V24, P189, DOI 10.1002/mrm.1910240122; MORRISON C, 1995, J MAGN RESON SER B, V108, P103, DOI 10.1006/jmrb.1995.1111; Okumura A, 1999, NEUROL RES, V21, P250, DOI 10.1080/01616412.1999.11740927; Park SH, 2012, MAGN RESON MED, V68, P1600, DOI 10.1002/mrm.24169; Park SH, 2011, MAGN RESON MED, V65, P1578, DOI 10.1002/mrm.22580; Park SH, 2011, MAGN RESON MED, V65, P1702, DOI 10.1002/mrm.22568; Pui MH, 2000, J MAGN RESON IMAGING, V12, P395, DOI 10.1002/1522-2586(200009)12:3<395::AID-JMRI4>3.0.CO;2-L; SANTYR GE, 1993, MAGN RESON IMAGING, V11, P521, DOI 10.1016/0730-725X(93)90471-O; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Wang CY, 2010, MAGN RESON MED, V64, P1520, DOI 10.1002/mrm.22533; Weigel M, 2010, MAGN RESON MED, V63, P230, DOI 10.1002/mrm.22145; Welsch GH, 2008, J MAGN RESON IMAGING, V28, P979, DOI 10.1002/jmri.21516; WOLFF SD, 1991, RADIOLOGY, V179, P623, DOI 10.1148/radiology.179.3.2027963; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	25	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117101	10.1371/journal.pone.0117101	http://dx.doi.org/10.1371/journal.pone.0117101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664938	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000349123100018
J	Yao, FY; Chen, YH; Yan, ZB; Li, P; Han, WX; Fang, JY				Yao, Fanyun; Chen, Yahan; Yan, Zhengbing; Li, Peng; Han, Wenxuan; Fang, Jingyun			Biogeographic Patterns of Structural Traits and C:N:P Stoichiometry of Tree Twigs in China's Forests	PLOS ONE			English	Article							LEAF NITROGEN; PHOSPHORUS STOICHIOMETRY; FUNCTIONAL TRAITS; GROWTH FORM; SOIL; PLANTS; EVOLUTION; CLIMATE; BIOMASS; STRATEGIES	There have been a number of studies on biogeographic patterns of plant leaf functional traits; however, the variations in traits of other plant organs such as twigs are rarely investigated. In this study, we sampled current-year twigs of 335 tree species from 12 forest sites across a latitudinal span of 32 degrees in China, and measured twig specific density (TSD), twig dry matter content (TDMC), and carbon (C), nitrogen (N) and phosphorous (P) contents, to explore the latitudinal and environmental patterns of these twig traits. The overall mean of TSD and TDMC was 0.37 g cm(-3) and 41%, respectively; mean twig C, N and P was 472 mg g(-1), 9.8 mg g(-1) and 1.15 mg g(-1), respectively, and mean N:P mass ratio was 10.6. TSD was positively correlated with TDMC which was positively associated with twig C but negatively with twig N and P. There were no significant differences in TSD between conifer, deciduous-broadleaf and evergreen-broadleaf plants, but evergreen-broadleaf plants had the lowest and conifers the highest TDMC. Conifer twigs were lowest in C, N, P and N:P, whereas deciduous-plant twigs were highest in N and P and evergreen-plant twigs were highest in C and N:P. As latitude increased or temperature/precipitation dropped, TDMC and P increased, but N:P ratio decreased. Our results also showed that the patterns of twig P and N:P stoichiometry were consistent with those reported for leaves, but no significant trends in twig N were observed along the gradient of latitude, climate and soils. This study provides the first large-scale patterns of the twig traits and will improve our understanding of the biogeochemistry of carbon and other key nutrients in forest ecosystems.	[Yao, Fanyun; Chen, Yahan; Yan, Zhengbing; Li, Peng; Fang, Jingyun] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Key Lab Earth Surface Proc,Minist Educ, Beijing 100871, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	Peking University; China Agricultural University	Fang, JY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Key Lab Earth Surface Proc,Minist Educ, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Han, Wenxuan/B-8791-2016	Han, Wenxuan/0000-0001-8678-7147	National Natural Science Foundation of China [31321061, 31330012, 41173083]; National Basic Research Program of China on Global Change [2010CB950600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China on Global Change(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (# 31321061 and 31330012, 41173083) and the National Basic Research Program of China on Global Change (2010CB950600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bazzaz FA., 1997, PLANT RESOURCE ALLOC; Boerner R, 1984, J APPL ECOL, P1029; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; GROVE TS, 1990, PLANT SOIL, V126, P265, DOI 10.1007/BF00012829; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; HAUKIOJA E, 1991, PHILOS T R SOC B, V333, P241, DOI 10.1098/rstb.1991.0073; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; John A, 1950, GRASS FORAGE SCI, V5, P93; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Liu C, 2006, GLOBAL ECOL BIOGEOGR, V15, P438, DOI 10.1111/j.1466-822x.2006.00251.x; Ma SB, 2001, CHINESE J ECOL, V21, P65; Martin JG, 1998, CAN J FOREST RES, V28, P1648, DOI 10.1139/cjfr-28-11-1648; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Mooney H. A., 1972, Annual Review of Ecology and Systematics, V3, P315, DOI 10.1146/annurev.es.03.110172.001531; Osada N, 2006, NEW PHYTOL, V172, P667, DOI 10.1111/j.1469-8137.2006.01857.x; RADULOVICH R, 1991, BIOTROPICA, V23, P84, DOI 10.2307/2388691; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Ren Shu-jie, 2007, Huanjing Kexue, V28, P2665; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Santiago LS, 2007, ECOLOGY, V88, P1126, DOI 10.1890/06-1841; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2013, GLOBAL ECOL BIOGEOGR, V22, P494, DOI 10.1111/geb.12015; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun SC, 2000, ACTA PHYTO SINI, V25, P76; VANDENDRIESSCHE R, 1974, BOT REV, V40, P347, DOI 10.1007/BF02860066; WILSON BF, 1989, CAN J BOT, V67, P434, DOI 10.1139/b89-060; Xiang SA, 2009, TREES-STRUCT FUNCT, V23, P637, DOI 10.1007/s00468-008-0308-6; Yan En-Rong, 2010, Chinese Journal of Plant Ecology, V34, P48, DOI 10.3773/j.issn.1005-264x.2010.01.008; Yang X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05448; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zechmeister-Boltenstern S, 2002, SOIL BIOL BIOCHEM, V34, P823, DOI 10.1016/S0038-0717(02)00012-3	40	22	26	10	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116391	10.1371/journal.pone.0116391	http://dx.doi.org/10.1371/journal.pone.0116391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664764	Green Submitted, Green Published, gold			2022-12-26	WOS:000349123100008
J	Bannon, MJ; Savonen, CL; Hartley, ZJ; Johnson, MM; Schmidt, CJ				Bannon, Michael J.; Savonen, Candace L.; Hartley, Zachary J.; Johnson, Magen M.; Schmidt, Carl J.			Investigating the Potential Influence of Cause of Death and Cocaine Levels on the Differential Expression of Genes Associated with Cocaine Abuse	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; PROFILE; BRAINS	The development of new therapeutic strategies for the treatment of complex brain disorders such as drug addiction is likely to be advanced by a more complete understanding of the underlying molecular pathophysiology. Although the study of postmortem human brain represents a unique resource in this regard, it can be challenging to disentangle the relative contribution of chronic pathological processes versus perimortem events to the observed changes in gene expression. To begin to unravel this issue, we analyzed by quantitative PCR the midbrain expression of numerous candidate genes previously associated with cocaine abuse. Data obtained from chronic cocaine abusers (and matched control subjects) dying of gunshot wounds were compared with a prior study of subjects with deaths directly attributable to cocaine abuse. Most of the genes studied (i.e., tyrosine hydroxylase, dopamine transporter, forkhead box A2, histone variant H3 family 3B, nuclear factor kappa B inhibitor alpha, growth arrest and DNA damage-inducible beta) were found to be differentially expressed in chronic cocaine abusers irrespective of immediate cause of death or perimortem levels of cocaine, suggesting that these may represent core pathophysiological changes arising with chronic drug abuse. On the other hand, chemokine C-C motif ligand 2 and jun proto-oncogene expression were unaffected in cocaine-abusing subjects dying of gunshot wounds, in contrast to the differential expression previously reported in cocaine-related fatalities. The possible influence of cause of death and other factors on the cocaine-responsiveness of these genes is discussed.	[Bannon, Michael J.; Savonen, Candace L.; Hartley, Zachary J.; Johnson, Magen M.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Schmidt, Carl J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Wayne State University; University of Michigan System; University of Michigan	Bannon, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	mbannon@med.wayne.edu		Savonen, Candace/0000-0001-6331-7070	National Institutes of Health [DA006470, DA032222]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA032222, R01DA006470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA006470 (MJB) and DA032222 (MMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Albertson DN, 2006, NEUROPSYCHOPHARMACOL, V31, P2304, DOI 10.1038/sj.npp.1301089; Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Bannon MJ, 2014, NEUROPSYCHOPHARMACOL, V39, P2191, DOI 10.1038/npp.2014.70; Bannon MJ, 2005, ADDICT BIOL, V10, P119, DOI 10.1080/13556210412331308921; Bannon MJ, 2012, DOPAMINE; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Dowling GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P209, DOI 10.1038/sj.npp.1301412; Feng J, 2013, CURR OPIN NEUROBIOL, V23, P521, DOI 10.1016/j.conb.2013.01.001; Johnson MM, 2012, J FORENSIC SCI, V57, P1519, DOI 10.1111/j.1556-4029.2012.02212.x; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McCullumsmith RE, 2014, NEUROPSYCHOPHARMACOL, V39, P65, DOI 10.1038/npp.2013.239; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Zhou YH, 2014, ADDICT BIOL, V19, P122, DOI 10.1111/j.1369-1600.2011.00391.x	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117580	10.1371/journal.pone.0117580	http://dx.doi.org/10.1371/journal.pone.0117580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658879	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900183
J	Cui, DZ; Wu, DD; Liu, J; Li, DT; Xu, CY; Li, S; Li, P; Zhang, H; Liu, X; Jiang, C; Wang, LW; Chen, TT; Chen, HB; Zhao, L				Cui, Dezhou; Wu, Dandan; Liu, Jie; Li, Detao; Xu, Chunyan; Li, Song; Li, Peng; Zhang, Hua; Liu, Xu; Jiang, Chuan; Wang, Liwen; Chen, Tingting; Chen, Huabang; Zhao, Li			Proteomic Analysis of Seedling Roots of Two Maize Inbred Lines That Differ Significantly in the Salt Stress Response	PLOS ONE			English	Article							SALINITY TOLERANCE; ARABIDOPSIS ROOTS; PROTEINS; MECHANISMS; GENOTYPES; GROWTH; PLANTS; HOMEOSTASIS; ADJUSTMENT; DROUGHT	Salinity is a major abiotic stress that limits plant productivity and quality throughout the world. Roots are the sites of salt uptake. To better understand salt stress responses in maize, we performed a comparative proteomic analysis of seedling roots from the salt-tolerant genotype F63 and the salt-sensitive genotype F35 under 160 mM NaCl treatment for 2 days. Under salinity conditions, the shoot fresh weight and relative water content were significantly higher in F63 than in F35, while the osmotic potential was significantly lower and the reduction of the K+/Na+ ratio was significantly less pronounced in F63 than in F35. Using an iTRAQ approach, twenty-eight proteins showed more than 2.0-fold changes in abundance and were regarded as salt-responsive proteins. Among them, twenty-two were specifically regulated in F63 but remained constant in F35. These proteins were mainly involved in signal processing, water conservation, protein synthesis and biotic cross-tolerance, and could be the major contributors to the tolerant genotype of F63. Functional analysis of a salt-responsive protein was performed in yeast as a case study to confirm the salt-related functions of detected proteins. Taken together, the results of this study may be helpful for further elucidating salt tolerance mechanisms in maize.	[Cui, Dezhou; Liu, Jie; Zhang, Hua; Chen, Huabang; Zhao, Li] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Cui, Dezhou] Shandong Acad Agr Sci, Inst Crops Sci, Jinan, Shandong, Peoples R China; [Wu, Dandan] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Li, Detao; Xu, Chunyan; Li, Song; Li, Peng; Liu, Xu; Jiang, Chuan; Wang, Liwen; Chen, Tingting] Shandong Agr Univ, Coll Agr, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Shandong Academy of Agricultural Sciences; Shandong University; Shandong Agricultural University	Chen, HB (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	hbchen@genetics.ac.cn; zhaoli@genetics.ac.cn			China National Science Foundation [31201214]; National Sci-Tech Support program [2013BAD05B01]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); National Sci-Tech Support program	This work was funded by grant support from the China National Science Foundation (Grant No. 31201214, http://www.nsfc.gov.cn/publish/portal1/) and the National Sci-Tech Support program (Grant No. 2013BAD05B01, http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCI C P, P781; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; BLUM A, 1989, CROP SCI, V29, P230, DOI 10.2135/cropsci1989.0011183X002900010052x; Canovas FM, 2004, PROTEOMICS, V4, P285, DOI 10.1002/pmic.200300602; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Cheng YW, 2009, PROTEOMICS, V9, P3100, DOI 10.1002/pmic.200800340; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Khan MH, 2008, ACTA PHYSIOL PLANT, V30, P81, DOI 10.1007/s11738-007-0093-7; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu YM, 2012, J PLANT PHYSIOL, V169, P117, DOI 10.1016/j.jplph.2011.08.019; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Munns R, 2002, PLANT SOIL, V247, P93, DOI 10.1023/A:1021119414799; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schweppe RE, 2003, ACCOUNTS CHEM RES, V36, P453, DOI 10.1021/ar020143l; Shin D, 2004, BIOCHEM BIOPH RES CO, V323, P534, DOI 10.1016/j.bbrc.2004.08.127; Steppuhn H, 2005, CAN J PLANT SCI, V85, P863, DOI 10.4141/P04-014; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang L, 2012, J PLANT PHYSIOL, V169, P839, DOI 10.1016/j.jplph.2012.01.023; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zorb C, 2010, PROTEOMICS, V10, P4441, DOI 10.1002/pmic.201000231	36	38	42	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116697	10.1371/journal.pone.0116697	http://dx.doi.org/10.1371/journal.pone.0116697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659111	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900059
J	Hsu, WC; Nenov, MN; Shavkunov, A; Panova, N; Zhan, M; Laezza, F				Hsu, Wei-Chun; Nenov, Miroslav N.; Shavkunov, Alexander; Panova, Neli; Zhan, Ming; Laezza, Fernanda			Identifying a Kinase Network Regulating FGF14:Nav1.6 Complex Assembly Using Split-Luciferase Complementation	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; BIPOLAR AFFECTIVE-DISORDER; NERVOUS-SYSTEM DISEASE; AXON INITIAL SEGMENT; NA+ CHANNELS; C ACTIVITY; INHIBITORS; ACTIVATION; BRAIN; EXPRESSION	Kinases play fundamental roles in the brain. Through complex signaling pathways, kinases regulate the strength of protein: protein interactions (PPI) influencing cell cycle, signal transduction, and electrical activity of neurons. Changes induced by kinases on neuronal excitability, synaptic plasticity and brain connectivity are linked to complex brain disorders, but the molecular mechanisms underlying these cellular events remain for the most part elusive. To further our understanding of brain disease, new methods for rapidly surveying kinase pathways in the cellular context are needed. The bioluminescence-based luciferase complementation assay (LCA) is a powerful, versatile toolkit for the exploration of PPI. LCA relies on the complementation of two firefly luciferase protein fragments that are functionally reconstituted into the full luciferase enzyme by two interacting binding partners. Here, we applied LCA in live cells to assay 12 kinase pathways as regulators of the PPI complex formed by the voltage-gated sodium channel, Nav1.6, a transmembrane ion channel that elicits the action potential in neurons and mediates synaptic transmission, and its multivalent accessory protein, the fibroblast growth factor 14 (FGF14). Through extensive dose-dependent validations of structurally-diverse kinase inhibitors and hierarchical clustering, we identified the PI3K/Akt pathway, the cell-cycle regulator Wee1 kinase, and protein kinase C (PKC) as prospective regulatory nodes of neuronal excitability through modulation of the FGF14: Nav1.6 complex. Ingenuity Pathway Analysis shows convergence of these pathways on glycogen synthase kinase 3 (GSK3) and functional assays demonstrate that inhibition of GSK3 impairs excitability of hippocampal neurons. This combined approach provides a versatile toolkit for rapidly surveying PPI signaling, allowing the discovery of new modular pathways centered on GSK3 that might be the basis for functional alterations between the normal and diseased brain.	[Hsu, Wei-Chun; Nenov, Miroslav N.; Shavkunov, Alexander; Panova, Neli; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hsu, Wei-Chun] Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Zhan, Ming] Methodist Hosp, Res Inst, Weill Cornell Med Coll, Dept Syst Med & Bioengn, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/L-6019-2016; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/X-4076-2019	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852	Sealy Center for Molecular Medicine, University of Texas Medical Branch; National Institutes of Health [R01MH095995]; National Institute of Mental Health, Florida; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	Sealy Center for Molecular Medicine, University of Texas Medical Branch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health, Florida; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	WJH was supported by the Sealy Center for Molecular Medicine, University of Texas Medical Branch. FL received grant support from the National Institutes of Health (Grant R01MH095995) from the National Institute of Mental Health, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bandyopadhyay RS, 1997, ENDOTHELIUM-J ENDOTH, V5, P95, DOI 10.3109/10623329709079867; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Budni J, 2012, J PSYCHOPHARMACOL, V26, P714, DOI 10.1177/0269881111424456; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Clay JR, 2005, PROG BIOPHYS MOL BIO, V88, P59, DOI 10.1016/j.pbiomolbio.2003.12.004; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Gildish I, 2012, LEARN MEMORY, V19, P116, DOI 10.1101/lm.023937.111; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Hsu WCJ, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00109; Insel TR, 2013, NEUROSCI BIOBEHAV R, V37, P2438, DOI 10.1016/j.neubiorev.2013.03.022; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Insel TR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004873; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Karyo R, 2010, MOL CELL NEUROSCI, V45, P449, DOI 10.1016/j.mcn.2010.08.004; Konig HG, 2012, J CELL SCI, V125, P6058, DOI 10.1242/jcs.111880; Kramer T, 2012, ACS CHEM NEUROSCI, V3, P151, DOI 10.1021/cn200117j; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Malhi GS, 2013, CNS DRUGS, V27, P135, DOI 10.1007/s40263-013-0039-0; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Michnick SW, 2011, METHODS MOL BIOL, V756, P395, DOI 10.1007/978-1-61779-160-4_25; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Nakamura Y, 2003, NEUROSCIENCE, V116, P477, DOI 10.1016/S0306-4522(02)00658-9; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Rodriguez-Murillo L, 2014, NEUROPSYCHOPHARMACOL, V39, P934, DOI 10.1038/npp.2013.293; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Schultz C, 2006, MOL CELL NEUROSCI, V33, P68, DOI 10.1016/j.mcn.2006.06.008; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Tomashevski A, 2001, J ALZHEIMERS DIS, V3, P195; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang HY, 1996, BIOL PSYCHIAT, V40, P568, DOI 10.1016/0006-3223(95)00611-7; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wittmack EK, 2005, J NEUROSCI, V25, P6621, DOI 10.1523/JNEUROSCI.0541-05.2005; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060	72	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117246	10.1371/journal.pone.0117246	http://dx.doi.org/10.1371/journal.pone.0117246			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659151	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900123
J	Marshall, AT; Kirkpatrick, K				Marshall, Andrew T.; Kirkpatrick, Kimberly			Relative Gains, Losses, and Reference Points in Probabilistic Choice in Rats	PLOS ONE			English	Article							DECISION-MAKING; INDIVIDUAL-DIFFERENCES; IMPULSIVE CHOICE; FORAGING PREFERENCES; UNITED-STATES; RISK-TAKING; HOT HAND; BEHAVIOR; DOPAMINE; OUTCOMES	Theoretical reference points have been proposed to differentiate probabilistic gains from probabilistic losses in humans, but such a phenomenon in non-human animals has yet to be thoroughly elucidated. Three experiments evaluated the effect of reward magnitude on probabilistic choice in rats, seeking to determine reference point use by examining the effect of previous outcome magnitude(s) on subsequent choice behavior. Rats were trained to choose between an outcome that always delivered reward (low-uncertainty choice) and one that probabilistically delivered reward (high-uncertainty). The probability of high-uncertainty outcome receipt and the magnitudes of low-uncertainty and high-uncertainty outcomes were manipulated within and between experiments. Both the low- and high-uncertainty outcomes involved variable reward magnitudes, so that either a smaller or larger magnitude was probabilistically delivered, as well as reward omission following high-uncertainty choices. In Experiments 1 and 2, the between groups factor was the magnitude of the high-uncertainty-smaller (H-S) and high-uncertainty-larger (H-L) outcome, respectively. The H-S magnitude manipulation differentiated the groups, while the H-L magnitude manipulation did not. Experiment 3 showed that manipulating the probability of differential losses as well as the expected value of the low-uncertainty choice produced systematic effects on choice behavior. The results suggest that the reference point for probabilistic gains and losses was the expected value of the low-uncertainty choice. Current theories of probabilistic choice behavior have difficulty accounting for the present results, so an integrated theoretical framework is proposed. Overall, the present results have implications for understanding individual differences and corresponding underlying mechanisms of probabilistic choice behavior.	[Marshall, Andrew T.; Kirkpatrick, Kimberly] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Marshall, AT (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	atmarsh@ksu.edu		Marshall, Andrew/0000-0002-0068-8138	National Institute of Mental Health [085739]; Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085739] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health Grant 085739 awarded to Kimberly Kirkpatrick and Kansas State University (http://www.nimh.nih.gov). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL A, 1952, J EXP PSYCHOL, V43, P363, DOI 10.1037/h0059393; Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; BACOTTI AV, 1976, ANIM LEARN BEHAV, V4, P41, DOI 10.3758/BF03211983; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bhatti M, 2014, BEHAV BRAIN RES; BOLES TL, 1995, ORGAN BEHAV HUM DEC, V61, P262, DOI 10.1006/obhd.1995.1021; BRUE SL, 1993, J ECON PERSPECT, V7, P185, DOI 10.1257/jep.7.3.185; CARACO T, 1983, BEHAV ECOL SOCIOBIOL, V12, P63, DOI 10.1007/BF00296934; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Cardinal R.N., 2005, BIOMED CTR NEUROSCI, V28, P37; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Connolly T, 2002, CURR DIR PSYCHOL SCI, V11, P212, DOI 10.1111/1467-8721.00203; COWIE RJ, 1977, NATURE, V268, P137, DOI 10.1038/268137a0; Crossman E, 1983, Behav Anal, V6, P109; Dai ZJ, 2009, LEARN BEHAV, V37, P281, DOI 10.3758/LB.37.3.281; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Demaree HA, 2012, EMOTION, V12, P495, DOI 10.1037/a0025780; Dixon MJ, 2010, ADDICTION, V105, P1819, DOI 10.1111/j.1360-0443.2010.03050.x; Dixon MR, 1998, PSYCHOL REP, V82, P1047, DOI 10.2466/PR0.82.3.1047-1050; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; DUKAS R, 1993, OECOLOGIA, V94, P244, DOI 10.1007/BF00341323; EVENDEN JL, 1984, Q J EXP PSYCHOL-B, V36, P1, DOI 10.1080/14640748408402190; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Friedman M, 1948, J POLIT ECON, V56, P279, DOI 10.1086/256692; Fulop A, 2000, ANIM BEHAV, V60, P657, DOI 10.1006/anbe.2000.1492; Galtress T, 2012, J EXP ANAL BEHAV, V98, P65, DOI 10.1901/jeab.2012.98-65; Garcia A, 2013, BEHAV BRAIN RES, V238, P10, DOI 10.1016/j.bbr.2012.10.017; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HAMM SL, 1987, J EXP PSYCHOL-ANIM B, V13, P376, DOI 10.1037/0097-7403.13.4.376; Hastie R., 2010, RATIONAL CHOICE UNCE; Hayden BY, 2009, ANIM COGN, V12, P201, DOI 10.1007/s10071-008-0186-8; Heilbronner SR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00007; HOLLENBECK JR, 1994, J APPL PSYCHOL, V79, P592, DOI 10.1037/0021-9010.79.4.592; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; HOUSTON A, 1982, ANIM BEHAV, V30, P1260, DOI 10.1016/S0003-3472(82)80225-X; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00082; KEREN G, 1987, J EXP PSYCHOL LEARN, V13, P387, DOI 10.1037/0278-7393.13.3.387; Kirkpatrick K, 2014, BEHAV BRAIN RES, V269, P115, DOI 10.1016/j.bbr.2014.04.024; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Levin IP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00015; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Marshall AT, 2014, J EXP ANAL BEHAV, V102, P86, DOI 10.1002/jeab.88; Marshall AT, 2013, J EXP PSYCHOL-ANIM B, V39, P24, DOI 10.1037/a0030765; MAZUR JE, 1988, ANIM LEARN BEHAV, V16, P199, DOI 10.3758/BF03209066; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MCGLOTHLIN WH, 1956, AM J PSYCHOL, V69, P604, DOI 10.2307/1419083; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Potenza MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2623, DOI 10.1038/npp.2009.152; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2004, BEHAV PROCESS, V65, P35, DOI 10.1016/S0376-6357(03)00109-8; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Rode C, 1999, COGNITION, V72, P269, DOI 10.1016/S0010-0277(99)00041-4; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; Shaffer HJ, 2002, ANNU REV PUBL HEALTH, V23, P171, DOI 10.1146/annurev.publhealth.23.100901.140532; SHELLEY MK, 1993, MANAGE SCI, V39, P806, DOI 10.1287/mnsc.39.7.806; Slattery JP, 2002, J MANAGE, V28, P89, DOI 10.1177/014920630202800106; Smethells JR, 2012, J EXP ANAL BEHAV, V97, P203, DOI 10.1901/jeab.2012.97-203; St Onge JR, 2012, J NEUROSCI, V32, P2886, DOI 10.1523/JNEUROSCI.5625-11.2012; Staddon JER, 1966, PSYCHON SCI, V4, P287; Stauffer WR, 2014, CURR BIOL, V24, P2491, DOI 10.1016/j.cub.2014.08.064; Steiner AP, 2012, FRONTIERS NEUROSCIEN, V6, P1, DOI [10.3389/fnins.2012.00001, DOI 10.3389/FNINS.2012.00001]; Steiner AP, 2014, NATURE NEUROSCIENCE; Stephens D.W., 1986, pi; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Stopper CM, 2012, CEREBRAL CORTEX; Stopper CM, 2011, COGN AFFECT BEHAV NE, V11, P97, DOI 10.3758/s13415-010-0015-9; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TATHAM TA, 1989, BEHAV RES METH INSTR, V21, P294, DOI 10.3758/BF03205598; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Vasconcelos M, 2010, BEHAV PROCESS, V84, P435, DOI 10.1016/j.beproc.2009.11.010; Wang XT, 2012, J EXP PSYCHOL GEN, V141, P743, DOI 10.1037/a0027415; Weatherly JN, 2007, ANAL GAMBLING BEHAV, V1, P79; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430; Winstanley CA, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.136	95	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117697	10.1371/journal.pone.0117697	http://dx.doi.org/10.1371/journal.pone.0117697			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658448	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900207
J	Okuda, M; Hijikuro, I; Fujita, Y; Wu, XF; Nakayama, S; Sakata, Y; Noguchi, Y; Ogo, M; Akasofu, S; Ito, Y; Soeda, Y; Tsuchiya, N; Tanaka, N; Takahashi, T; Sugimoto, H				Okuda, Michiaki; Hijikuro, Ichiro; Fujita, Yuki; Wu, Xiaofeng; Nakayama, Shinichi; Sakata, Yoko; Noguchi, Yuji; Ogo, Makoto; Akasofu, Shigeru; Ito, Yoshimasa; Soeda, Yoshiyuki; Tsuchiya, Nobuhiko; Tanaka, Naoki; Takahashi, Takashi; Sugimoto, Hachiro			PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; PROTEIN-TAU; P301L TAU; OLIGOMERS; PATHOLOGY; BINDING; NEURODEGENERATION; PHOSPHORYLATION; DEGENERATION	In tauopathies, a neural microtubule-associated protein tau (MAPT) is abnormally aggregated and forms neurofibrillary tangle. Therefore, inhibition of the tau aggregation is one of the key approaches for the treatment of these diseases. Here, we have identified a novel tau aggregation inhibitor, PE859. An oral administration of PE859 resulted in the significant reduction of sarkosyl-insoluble aggregated tau along with the prevention of onset and progression of the motor dysfunction in JNPL3 P301L-mutated human tau transgenic mice. These results suggest that PE859 is useful for the treatment of tauopathies.	[Okuda, Michiaki; Wu, Xiaofeng; Nakayama, Shinichi; Sakata, Yoko; Noguchi, Yuji; Sugimoto, Hachiro] Pharma Eight Co Ltd, Kyoto, Japan; [Okuda, Michiaki; Fujita, Yuki; Sugimoto, Hachiro] Doshisha Univ, Grad Sch Brain Sci, Kyoto 602, Japan; [Hijikuro, Ichiro] ChemGenesis Inc, Tokyo, Japan; [Wu, Xiaofeng] Chinese Acad Sci, Key Lab Reprod Biol, Inst Zool, Beijing, Peoples R China; [Ogo, Makoto; Akasofu, Shigeru; Ito, Yoshimasa] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Soeda, Yoshiyuki] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Obu, Japan; [Tsuchiya, Nobuhiko; Tanaka, Naoki] Kyoto Inst Technol, Dept Biomol Engn, Kyoto 606, Japan; [Takahashi, Takashi] Yokohama Coll Pharm, Nat Prod Chem & Pharmaceut Res Ctr, Yokohama, Kanagawa, Japan	Doshisha University; Chinese Academy of Sciences; Institute of Zoology, CAS; Eisai Co Ltd; National Center for Geriatrics & Gerontology; Kyoto Institute of Technology	Okuda, M (corresponding author), Pharma Eight Co Ltd, Kyoto, Japan.	jt-liaay@mail.doshisha.ac.jp		Okuda, Michiaki/0000-0002-0211-7144	Pharma Eight Co., Ltd.; ChemGenesis Inc.; Eisai Co., Ltd.	Pharma Eight Co., Ltd.; ChemGenesis Inc.; Eisai Co., Ltd.(Eisai Co Ltd)	The authors received no specific funding for this work. Pharma Eight Co., Ltd., ChemGenesis Inc. and Eisai Co., Ltd. provided support in the form of salaries for authors M Okuda, YF, SN, YS, YN, HS, IH, M. Ogo, SA and YI but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Guzman-Martinez L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00167; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Okuyama K, 2008, FEBS J, V275, P1529, DOI 10.1111/j.1742-4658.2008.06312.x; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	46	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117511	10.1371/journal.pone.0117511	http://dx.doi.org/10.1371/journal.pone.0117511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659102	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900167
J	Toniolo, C; Balducci, E; Romano, MR; Proietti, D; Ferlenghi, I; Grandi, G; Berti, F; Ros, IMY; Janulczyk, R				Toniolo, Chiara; Balducci, Evita; Romano, Maria Rosaria; Proietti, Daniela; Ferlenghi, Ilaria; Grandi, Guido; Berti, Francesco; Ros, Immaculada Margarit Y.; Janulczyk, Robert			Streptococcus agalactiae Capsule Polymer Length and Attachment Is Determined by the Proteins CpsABCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; BACTERIAL-CELL WALL; POLYSACCHARIDE BIOSYNTHESIS; TYROSINE PHOSPHORYLATION; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; PNEUMONIAE; GENES; CPSD; PARADIGMS	The production of capsular polysaccharides ((PS) or secreted exopolysaccharides is ubiquitous in bacteria, and the Wzy pathway constitutes a prototypical mechanism to produce these structures. Despite the differences in polysaccharide composition among species, a group of proteins involved in this pathway is well conserved. Streptococcus agalactiae (group B Streptococcus; GBS) produces a CPS that represents the main virulence factor of the bacterium and is a prime target in current vaccine development. We used this human pathogen to investigate the roles and potential interdependencies of the conserved proteins CpsABCD encoded in the cps operon, by developing knock-out and functional mutant strains. The mutant strains were examined for CPS quantity, size, and attachment to the cell surface as well as CpsD phosphorylation. We observed that CpsB, -C, and -D compose a phosphoregulatory system where the CpsD autokinase phosphorylates its C-terminal tyrosines in a CpsC-dependent manner. These Tyr residues are also the target of the cognate CpsB phosphatase. An interaction between CpsD and CpsC was observed, and the phosphorylation state of CpsD influenced the subsequent action of CpsC. The CpsC extracellular domain appeared necessary for the production of high molecular weight polysaccharides by influencing CpsA-mediated attachment of the CPS to the bacterial cell surface. In conclusion, although having no impact on cps transcription or the synthesis of the basal repeating unit, we suggest that these proteins are fine-tuning the last steps of CPS biosynthesis (i.e. the balance between polymerization and attachment to the cell wall).	[Toniolo, Chiara; Balducci, Evita; Romano, Maria Rosaria; Proietti, Daniela; Ferlenghi, Ilaria; Grandi, Guido; Berti, Francesco; Ros, Immaculada Margarit Y.; Janulczyk, Robert] Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentino 1, I-53100 Siena, Italy	Novartis	Janulczyk, R (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentino 1, I-53100 Siena, Italy.	robert.janulczyk@novartis.com	Toniolo, Chiara/ABH-6697-2020	Toniolo, Chiara/0000-0002-2167-2936; Grandi, Guido/0000-0001-9724-2185				Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; BAKER CJ, 1973, J PEDIATR-US, V83, P919, DOI 10.1016/S0022-3476(73)80524-4; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; BARTON LL, 1973, J PEDIATR-US, V82, P719, DOI 10.1016/S0022-3476(73)80605-5; Berti F, 2014, J BIOL CHEM, V289, P23437, DOI 10.1074/jbc.M114.567974; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Deng LY, 2000, J BIOL CHEM, V275, P7497, DOI 10.1074/jbc.275.11.7497; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; FRANCIOSI RA, 1973, J PEDIATR-US, V82, P707, DOI 10.1016/S0022-3476(73)80604-3; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hanson BR, 2011, J BACTERIOL, V193, P411, DOI 10.1128/JB.01098-10; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tudela CM, 2012, OBSTET GYNECOL, V119, P626, DOI 10.1097/AOG.0b013e31824532f6; van den Biggelaar AHJ, 2013, VACCINE, V31, P2525, DOI 10.1016/j.vaccine.2012.06.019; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	38	30	33	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9521	9532		10.1074/jbc.M114.631499	http://dx.doi.org/10.1074/jbc.M114.631499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666613	hybrid, Green Published			2022-12-26	WOS:000352729400019
J	Abou-Hamdan, A; Ceccaldi, P; Lebrette, H; Gutierrez-Sanz, O; Richaud, P; Cournac, L; Guigliarelli, B; De Lacey, AL; Leger, C; Volbeda, A; Burlat, B; Dementin, S				Abou-Hamdan, Abbas; Ceccaldi, Pierre; Lebrette, Hugo; Gutierrez-Sanz, Oscar; Richaud, Pierre; Cournac, Laurent; Guigliarelli, Bruno; De lacey, Antonio L.; Leger, Christophe; Volbeda, Anne; Burlat, Benedicte; Dementin, Sebastien			A Threonine Stabilizes the NiC and NiR Catalytic Intermediates of [NiFe]-hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSPORT PATHWAYS; UNREADY OXIDIZED STATES; NIFE HYDROGENASE; ACTIVE-SITE; DESULFOVIBRIO-GIGAS; ELECTRON TRANSFERS; ESCHERICHIA-COLI; ACTIVATION; CLUSTER; CYCLE	The heterodimeric [NiFe] hydrogenase from Desulfovibrio fructosovorans catalyzes the reversible oxidation of H-2 into protons and electrons. The catalytic intermediates have been attributed to forms of the active site (NiSI, NiR, and NiC) detected using spectroscopic methods under potentiometric but noncatalytic conditions. Here, we produced variants by replacing the conserved Thr-18 residue in the small subunit with Ser, Val, Gln, Gly, or Asp, and we analyzed the effects of these mutations on the kinetic (H-2 oxidation, H-2 production, and H/D exchange), spectroscopic (IR, EPR), and structural properties of the enzyme. The mutations disrupt the H-bond network in the crystals and have a strong effect on H-2 oxidation and H-2 production turnover rates. However, the absence of correlation between activity and rate of H/D exchange in the series of variants suggests that the alcoholic group of Thr-18 is not necessarily a proton relay. Instead, the correlation between H-2 oxidation and production activity and the detection of the NiC species in reduced samples confirms that NiC is a catalytic intermediate and suggests that Thr-18 is important to stabilize the local protein structure of the active site ensuring fast NiSI-NiC-NiR interconversions during H-2 oxidation/production.	[Abou-Hamdan, Abbas; Ceccaldi, Pierre; Guigliarelli, Bruno; Leger, Christophe; Burlat, Benedicte; Dementin, Sebastien] Aix Marseille Univ, Lab Bioenergt & Ingn Proteines, Inst Microbiol Mediterranee, CNRS,UMR 7281, F-13402 Marseille 20, France; [Lebrette, Hugo; Volbeda, Anne] Univ Grenoble 1, Metalloproteins Unit, Inst Biol Struct, UMR Commissariat Energie Atom 5075,CNRS, F-38000 Grenoble, France; [Gutierrez-Sanz, Oscar; De lacey, Antonio L.] Inst Catalisis & Petroleoquim, Consejo Super Invest Cientif, Madrid 28049, Spain; [Richaud, Pierre; Cournac, Laurent] Inst Biol Environm & Biotechnol, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Commissariat Energie Atom, Direct Sci Vivant, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] CNRS, UMR Biol Vegetale & Microbiol Environm BVME 7265, F-13108 St Paul Les Durance, France; Aix Marseille Univ, BVME UMR7265, F-13284 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Dementin, S (corresponding author), Aix Marseille Univ, Lab Bioenergt & Ingn Proteines, Inst Microbiol Mediterranee, CNRS,UMR 7281, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	dementin@imm.cnrs.fr	HAMDAN, Abbas ABOU/N-6783-2014; Léger, Christophe/C-7230-2016; Ceccaldi, Pierre/AAH-3860-2020; Cournac, Laurent/G-2564-2010; De Lacey, Antonio L/H-3311-2015	HAMDAN, Abbas ABOU/0000-0001-6703-772X; Léger, Christophe/0000-0002-8871-6059; De Lacey, Antonio L/0000-0002-9347-0452; Ceccaldi, Pierre/0000-0001-8156-5035; Cournac, Laurent/0000-0003-0371-938X; Dementin, Sebastien/0000-0001-6168-5371; Volbeda, Anne/0000-0002-6038-0979; Gutierrez-Sanz, Oscar/0000-0001-7559-9204; Lebrette, Hugo/0000-0002-8081-181X	Pole de Competitivite Capenergies; FrenchBIC research network	Pole de Competitivite Capenergies; FrenchBIC research network	We thank the Pole de Competitivite Capenergies and the FrenchBIC research network for support. We thank the staff at the used SLS and ESRF beamlines for assistance with x-ray data collections. We acknowledge the Aix-Marseille EPR spectroscopy Facility Center (national TGE-RENARD network, FR3443) and the HelioBiotec platform (Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)).	Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Abou Hamdan A, 2012, J AM CHEM SOC, V134, P8368, DOI 10.1021/ja301802r; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Bruschi M, 2014, J AM CHEM SOC, V136, P1803, DOI 10.1021/ja408511y; Cammack R., 2001, HYDROGEN FUEL LEARNI, P77; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Dementin S, 2011, J AM CHEM SOC, V133, P10211, DOI 10.1021/ja202615a; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fourmond V, 2013, CHEM COMMUN, V49, P6840, DOI 10.1039/c3cc43297a; Galvan IF, 2008, PROTEINS, V73, P195, DOI 10.1002/prot.22045; Gebler A, 2007, FEBS J, V274, P74, DOI 10.1111/j.1742-4658.2006.05565.x; Ginovska-Pangovska B, 2014, BBA-BIOENERGETICS, V1837, P131, DOI 10.1016/j.bbabio.2013.08.004; Greco C, 2014, ENERG ENVIRON SCI, V7, P3543, DOI 10.1039/c4ee01848f; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; HATCHIKIAN CE, 1990, EUR J BIOCHEM, V187, P635, DOI 10.1111/j.1432-1033.1990.tb15347.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Pardo A, 2006, J BIOL INORG CHEM, V11, P286, DOI 10.1007/s00775-005-0076-3; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Sumner I, 2012, J PHYS CHEM B, V116, P2917, DOI 10.1021/jp208512y; Szori-Doroghazi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034666; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Vernede X, 1999, J APPL CRYSTALLOGR, V32, P505, DOI 10.1107/S0021889899002678; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2015, J BIOL INORG CHEM, V20, P11, DOI 10.1007/s00775-014-1203-9; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Yagi T, 2014, INT J HYDROGEN ENERG, V39, P18543, DOI 10.1016/j.ijhydene.2013.12.174; Yagi T, 2013, P JPN ACAD B-PHYS, V89, P16, DOI 10.2183/pjab.89.16	45	15	15	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8550	8558		10.1074/jbc.M114.630491	http://dx.doi.org/10.1074/jbc.M114.630491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666617	Green Published, hybrid			2022-12-26	WOS:000351662600045
J	Lu, SQ; Chen, SB; Mao, DB; Zhang, Y; Long, M				Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian			Contribution of the CR Domain to P-Selectin Lectin Domain Allostery by Regulating the Orientation of the EGF Domain	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CATCH BONDS; GLYCOPROTEIN LIGAND-1; MOLECULAR-DYNAMICS; CELL-ADHESION; FORCE; DISSOCIATION; FLOW; BINDING; PSGL-1	The allostery of P-selectin has been studied extensively with a focus on the Lec and EGF domains, whereas the contribution of the CR domain remains unclear. Here, molecular dynamics simulations (MDS) combined with homology modeling were preformed to investigate the impact of the CR domain on P-selectin allostery. The results indicated that the CR domain plays a role in the allosteric dynamics of P-selectin in two ways. First, the CR1 domain tends to stabilize the low affinity of P-selectin during the equilibration processes with the transition inhibition from the S1 to S1' state by restraining the extension of the bent EGF orientation, or with the relaxation acceleration of the S2 state by promoting the bending of the extended EGF orientation. Second, the existence of CR domain increases intramolecular extension prior to complex separation, increasing the time available for the allosteric shift during forced dissociation with a prolonged bond duration. These findings further our understanding of the structure-function relationship of P-selectin with the enriched microstructural bases of the CR domain.	[Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Lu, Shouqin; Chen, Shenbao; Mao, Debin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Lu, SQ (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China.	lsq@imech.ac.cn; mlong@imech.ac.cn			National Natural Science Foundation of China [31230027, 11372332]; National Key Basic Research Foundation of China [2011CB710904]; CAS Knowledge Innovation Program [KJCX2-YW-L08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); CAS Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China grants 31230027 and 11372332 http://www.nsfc.gov.cn/publish/portal1/); National Key Basic Research Foundation of China grant 2011CB710904 http://www.most.gov.cn/eng/); CAS Knowledge Innovation Program grant KJCX2-YW-L08 http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MOL OP ENV MOE; Chou KC, 1997, J PROTEIN CHEM, V16, P765, DOI 10.1023/A:1026363816730; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lu SQ, 2006, POLYMER, V47, P2539, DOI 10.1016/j.polymer.2005.11.095; Lue Shouqin, 2005, Molecular & Cellular Biomechanics, V2, P161; Lu SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015417; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Sun GY, 2009, EUR BIOPHYS J BIOPHY, V38, P701, DOI 10.1007/s00249-009-0428-y; Tu LL, 1996, J IMMUNOL, V157, P3995; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zhang Y, 2008, BIOPHYS J, V95, P5439, DOI 10.1529/biophysj.108.137141; Zhang Y, 2011, SCI CHINA PHYS MECH, V54, P923, DOI 10.1007/s11433-011-4302-4; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5; Zhu Cheng, 2005, Molecular & Cellular Biomechanics, V2, P91; Zhu C, 2014, ANN BIOMED ENG, V42, P388, DOI 10.1007/s10439-013-0904-5	37	4	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118083	10.1371/journal.pone.0118083	http://dx.doi.org/10.1371/journal.pone.0118083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675100	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000039
J	Breitburg, DL; Hondorp, D; Audemard, C; Carnegie, RB; Burrell, RB; Trice, M; Clark, V				Breitburg, Denise L.; Hondorp, Darryl; Audemard, Corinne; Carnegie, Ryan B.; Burrell, Rebecca B.; Trice, Mark; Clark, Virginia			Landscape-Level Variation in Disease Susceptibility Related to Shallow-Water Hypoxia	PLOS ONE			English	Article							REAL-TIME PCR; PARASITE PERKINSUS-MARINUS; HYPERCAPNIC HYPOXIA; OYSTER POPULATIONS; DISSOLVED-OXYGEN; IMMUNE-RESPONSE; CHESAPEAKE BAY; DYNAMICS; ECOLOGY; STRESS	Diel-cycling hypoxia is widespread in shallow portions of estuaries and lagoons, especially in systems with high nutrient loads resulting from human activities. Far less is known about the effects of this form of hypoxia than deeper-water seasonal or persistent low dissolved oxygen. We examined field patterns of diel-cycling hypoxia and used field and laboratory experiments to test its effects on acquisition and progression of Perkinsus marinus infections in the eastern oyster, Crassostrea virginica, as well as on oyster growth and filtration. P. marinus infections cause the disease known as Dermo, have been responsible for declines in oyster populations, and have limited success of oyster restoration efforts. The severity of diel-cycling hypoxia varied among shallow monitored sites in Chesapeake Bay, and average daily minimum dissolved oxygen was positively correlated with average daily minimum pH. In both field and laboratory experiments, diel-cycling hypoxia increased acquisition and progression of infections, with stronger results found for younger (1-year-old) than older (2-3-year-old) oysters, and more pronounced effects on both infections and growth found in the field than in the laboratory. Filtration by oysters was reduced during brief periods of exposure to severe hypoxia. This should have reduced exposure to waterborne P. marinus, and contributed to the negative relationship found between hypoxia frequency and oyster growth. Negative effects of hypoxia on the host immune response is, therefore, the likely mechanism leading to elevated infections in oysters exposed to hypoxia relative to control treatments. Because there is considerable spatial variation in the frequency and severity of hypoxia, diel-cycling hypoxia may contribute to landscape-level spatial variation in disease dynamics within and among estuarine systems.	[Breitburg, Denise L.; Hondorp, Darryl; Burrell, Rebecca B.; Clark, Virginia] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Hondorp, Darryl] USGS Great Lakes Sci Ctr, Ann Arbor, MI 48105 USA; [Audemard, Corinne; Carnegie, Ryan B.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Trice, Mark] Maryland Dept Nat Resources, Annapolis, MD 21401 USA	Smithsonian Institution; Smithsonian Environmental Research Center; United States Department of the Interior; United States Geological Survey; William & Mary; Virginia Institute of Marine Science	Breitburg, DL (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	breitburgd@si.edu			MD Sea Grant [SA7528085-CC]; Smithsonian Institution Johnson Fund; Smithsonian Women's Committee	MD Sea Grant; Smithsonian Institution Johnson Fund; Smithsonian Women's Committee	Research was funded by Award # SA7528085-CC from MD Sea Grant to DLB and CA, Smithsonian Institution Johnson Fund to DH, and Smithsonian Women's Committee funding to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RS, 1998, J FISH DIS, V21, P371, DOI 10.1046/j.1365-2761.1998.00128.x; Andrews J.D., 1988, American Fisheries Society Special Publication, V18, P47; Audemard C, 2006, PARASITOLOGY, V132, P827, DOI 10.1017/S0031182006009851; Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004; Baumann H, 2014, ESTUAR COAST, P1; Boyd JN, 1999, J EXP BIOL, V202, P3135; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; BREITBURG DL, 1995, MAR ECOL PROG SER, V125, P45, DOI 10.3354/meps125045; Burge CA, 2013, MICROB ECOL, V65, P869, DOI 10.1007/s00248-013-0190-7; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BURRESON E M, 1991, Journal of Shellfish Research, V10, P417; Burreson EM, 1996, J SHELLFISH RES, V15, P17; Bushek David, 1994, Annual Review of Fish Diseases, V4, P201, DOI 10.1016/0959-8030(94)90029-9; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Carnegie RB., 2013, STATUS MAJOR OYSTER; Cheng W, 2004, AQUACULTURE, V232, P103, DOI 10.1016/S0044-8486(03)00488-5; Clark V, 2014, CRASSOSTREA VIRGINIC; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; DAVANZO C, 1994, ESTUARIES, V17, P131, DOI 10.2307/1352562; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Elliot P, 2000, SPATIAL EPIDEMIOLOGY; Ford SE, 2012, J MAR RES, V70, P253, DOI 10.1357/002224012802851850; Gauthier JD, 2006, J SHELLFISH RES, V25, P619, DOI 10.2983/0730-8000(2006)25[619:TMRPAT]2.0.CO;2; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Holman JD, 2004, BIOL BULL-US, V206, P188, DOI 10.2307/1543642; Johnson PTJ, 2010, ECOL APPL, V20, P16, DOI 10.1890/08-0633.1; Johnson Pieter T. J., 2008, P71; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Kennedy VS, 2011, J SHELLFISH RES, V30, P719, DOI 10.2983/035.030.0312; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Le Moullac G, 1998, FISH SHELLFISH IMMUN, V8, P621, DOI 10.1006/fsim.1998.0166; Macey BM, 2008, APPL ENVIRON MICROB, V74, P6077, DOI 10.1128/AEM.00317-08; MACKIN JOHN G., 1961, PUBL INST MAR SCI [PORT ARANSAS TEXAS], V7, P132; McCallum Hamish, 2008, P100; McKenzie VJ, 2007, ECOHEALTH, V4, P384, DOI 10.1007/s10393-007-0131-3; Mikulski CM, 2000, J SHELLFISH RES, V19, P301; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Newell RIE, 2007, MAR ECOL PROG SER, V341, P293, DOI 10.3354/meps341293; PAYNTER K T, 1991, Journal of Shellfish Research, V10, P425; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Qiu RJ, 2011, AQUACULT INT, V19, P283, DOI 10.1007/s10499-010-9390-z; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Ray S.M., 1966, P NATL SHELLFISH ASS, V54, P55, DOI DOI 10.2983/0730-8000(2006)25; Reiskind MH, 2004, J MED ENTOMOL, V41, P650, DOI 10.1603/0022-2585-41.4.650; Robohm RA, 2005, J SHELLFISH RES, V24, P773; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Sanford E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2681; Scholnick DA, 2012, BIOL BULL-US, V222, P56, DOI 10.1086/BBLv222n1p56; Soniat TM, 2006, J SHELLFISH RES, V25, P83, DOI 10.2983/0730-8000(2006)25[83:UTSAFO]2.0.CO;2; Tarnowski M, 2007, MARYLAND OYSTER POPU; Tyler RM, 2009, ESTUAR COAST, V32, P123, DOI 10.1007/s12237-008-9108-x; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wang YJ, 2012, AQUACULTURE, V356, P22, DOI 10.1016/j.aquaculture.2012.06.001; Wenner E, 2004, J COASTAL RES, P17, DOI 10.2112/SI45-017.1; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161; Yarnall HA, 2009, QUANTITATIVE COMPETI; Zhang J, 2010, BIOGEOSCIENCES, V7, DOI [10.5194/bg-7-1413-2010, DOI 10.5194/BG-7-1413-2010]	62	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116223	10.1371/journal.pone.0116223	http://dx.doi.org/10.1371/journal.pone.0116223			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671595	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300018
J	Kramer, R; Sauer-Heilborn, A; Welte, T; Jauregui, R; Brettar, I; Guzman, CA; Hofle, MG				Kramer, Rolf; Sauer-Heilborn, Annette; Welte, Tobias; Jauregui, Ruy; Brettar, Ingrid; Guzman, Carlos A.; Hoefle, Manfred G.			High Individuality of Respiratory Bacterial Communities in a Large Cohort of Adult Cystic Fibrosis Patients under Continuous Antibiotic Treatment	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ANAEROBIC-BACTERIA; DIVERSITY; LUNG; INFECTIONS; DNA; IDENTIFICATION; PATHOGENESIS; ADAPTATION; STANDARDS	Background Routine clinical diagnostics of CF patients focus only on a restricted set of well-known pathogenic species. Recent molecular studies suggest that infections could be polymicrobial with many bacteria not detected by culture-based diagnostics. Methodology and Principal Findings A large cohort of 56 adults with continuous antibiotic treatment was studied and different microbial diagnostic methods were compared, including culture-independent and culture-based bacterial diagnostics. A total of 72 sputum samples including longitudinal observations was analysed by 16S rRNA gene sequence comparison. Prevalence of known pathogens was highly similar among all methods but the vast spectrum of bacteria associated with CF was only revealed by culture-independent techniques. The sequence comparison enabled confident determination of the bacterial community composition and revealed a high diversity and individuality in the communities across the cohort. Results of microbiological analyses were further compared with individual host factors, such as age, lung function and CFTR genotype. No statistical relationship between these factors and the diversity of the entire community or single bacterial species could be identified. However, patients with non-Delta F508 mutations in the CFTR gene often had low abundances of Pseudomonas aeruginosa. Persistence of specific bacteria in some communities was demonstrated by longitudinal analyses of 13 patients indicating a potential clinical relevance of anaerobic bacteria, such as Fusobacterium nucleatum and Streptococcus millerii. Conclusions The high individuality in community composition and the lack of correlation to clinical host factors might be due to the continuous treatment with antibiotics. Since this is current practice for adult CF patients, the life-long history of the patient and the varying selection pressure on the related microbial communities should be a focus of future studies and its relation to disease progression. These studies should be substantially larger, providing more molecular information on the microbial communities complemented by detailed genetic assessment of the host.	[Kramer, Rolf; Brettar, Ingrid; Guzman, Carlos A.; Hoefle, Manfred G.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Sauer-Heilborn, Annette; Welte, Tobias] Hannover Med Sch, Dept Pneumol, Hannover, Germany; [Jauregui, Ruy] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Welte, Tobias] German Ctr Infect Res, Hannover, Germany; [Welte, Tobias] German Ctr Lung Res, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research	Hofle, MG (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	manfred.hoefle@helmholtz-hzi.de		Jauregui, Ruy/0000-0002-3484-8937; Kramer, Rolf/0000-0002-6095-4338				Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Castellani C, 2014, J CYST FIBROS, V13, pS1, DOI 10.1016/j.jcf.2014.03.008; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cystic Fibrosis Foundation Patient Registry, 2012, 2011 ANN DAT REP; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hogardt M, 2006, MIQ 24 AT MUK QUAL M; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Jones AM, 2011, THORAX, V66, P558, DOI 10.1136/thx.2010.157875; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meyer M, 2010, COLD SPRING HARB PRO, DOI [DOI 10.1101/PDB.PR0T5448, 10.1101/pdb.prot5448]; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	50	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117436	10.1371/journal.pone.0117436	http://dx.doi.org/10.1371/journal.pone.0117436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671713	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300053
J	Ligasova, A; Strunin, D; Friedecky, D; Adam, T; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Friedecky, David; Adam, Tomas; Koberna, Karel			A Fatal Combination: A Thymidylate Synthase Inhibitor with DNA Damaging Activity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; IN-VIVO; 5-FLUOROURACIL; CANCER; EDU; QUANTITATION; REPLICATION; SYNTHETASE	2'-deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 mu M EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.	[Ligasova, Anna; Strunin, Dmytro; Friedecky, David; Adam, Tomas; Koberna, Karel] Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77900, Czech Republic	Palacky University Olomouc	Ligasova, A (corresponding author), Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77900, Czech Republic.	anna.ligasova@upol.cz	KOBERNA, Karel/G-5551-2019; Ligasová, Anna/P-5460-2015; FRIEDECKÝ, David/AAR-5649-2021	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768; Adam, Tomas/0000-0003-4317-4708; Friedecky, David/0000-0002-3448-9073	Technology Agency of the Czech Republic [TA03010598, TA03010719, TE02000058]; Ministry of Education, Youth and Sports [LO1304]	Technology Agency of the Czech Republic; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010598, TA03010719 and TE02000058] and the Ministry of Education, Youth and Sports [LO1304]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bradford JA., 2011, CURR PROTOC CYTOM; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; de Groot T, 2014, J AM SOC NEPHROL, V25, P501, DOI 10.1681/ASN.2013090988; Debiak M, 2011, TOXICOLOGY, V280, P53, DOI 10.1016/j.tox.2010.11.007; DECLERCQ E, 1978, MOL PHARMACOL, V14, P422; DECLERCQ E, 1980, J INFECT DIS, V141, P563, DOI 10.1093/infdis/141.5.563; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dornfeld K, 2005, NUCLEIC ACIDS RES, V33, P6644, DOI 10.1093/nar/gki975; Freshney RI, 2005, CULTURE ANIMAL CELLS, P365; Hua H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr063; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; MILANESI G, 1984, MOL CELL BIOL, V4, P1551, DOI 10.1128/MCB.4.8.1551; Palmeira CA, 2008, ANTICANCER RES, V28, P443; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; van Laar JAM, 1998, EUR J CANCER, V34, P296, DOI 10.1016/S0959-8049(97)00366-3; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	36	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117459	10.1371/journal.pone.0117459	http://dx.doi.org/10.1371/journal.pone.0117459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671308	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300054
J	Nogueira, NP; Saraiva, FMS; Sultano, PE; Cunha, PRBB; Laranja, GAT; Justo, GA; Sabino, KCC; Coelho, MGP; Rossini, A; Atella, GC; Paes, MC				Nogueira, Natalia P.; Saraiva, Francis M. S.; Sultano, Pedro E.; Cunha, Paula R. B. B.; Laranja, Gustavo A. T.; Justo, Graca A.; Sabino, Katia C. C.; Coelho, Marsen G. P.; Rossini, Ana; Atella, Georgia C.; Paes, Marcia C.			Proliferation and Differentiation of Trypanosoma cruzi inside Its Vector Have a New Trigger: Redox Status	PLOS ONE			English	Article							METACYCLIC TRYPOMASTIGOTES; BLOODSUCKING INSECT; XANTHURENIC ACID; GROWTH; BLOOD; IDENTIFICATION; AZADIRACHTIN; MECHANISM; CYCLE; DNA	Trypanosoma cruzi proliferate and differentiate inside different compartments of triatomines gut that is the first environment encountered by T. cruzi. Due to its complex life cycle, the parasite is constantly exposed to reactive oxygen species (ROS). We tested the influence of the pro-oxidant molecules H2O2 and the superoxide generator, Paraquat, as well as, metabolism products of the vector, with distinct redox status, in the proliferation and metacyclogenesis. These molecules are heme, hemozoin and urate. We also tested the antioxidants NAC and GSH. Heme induced the proliferation of epimastigotes and impaired the metacyclogenesis. beta-hematin, did not affect epimastigote proliferation but decreased parasite differentiation. Conversely, we show that urate, GSH and NAC dramatically impaired epimastigote proliferation and during metacyclogenesis, NAC and urate induced a significant increment of trypomastigotes and decreased the percentage of epimastigotes. We also quantified the parasite loads in the anterior and posterior midguts and in the rectum of the vector by qPCR. The treatment with the antioxidants increased the parasite loads in all midgut sections analyzed. In vivo, the group of vectors fed with reduced molecules showed an increment of trypomastigotes and decreased epimastigotes when analyzed by differential counting. Heme stimulated proliferation by increasing the cell number in the S and G2/M phases, whereas NAC arrested epimastigotes in G1 phase. NAC greatly increased the percentage of trypomastigotes. Taken together, these data show a shift in the triatomine gut microenvironment caused by the redox status may also influence T. cruzi biology inside the vector. In this scenario, oxidants act to turn on epimastigote proliferation while antioxidants seem to switch the cycle towards metacyclogenesis. This is a new insight that defines a key role for redox metabolism in governing the parasitic life cycle.	[Nogueira, Natalia P.; Saraiva, Francis M. S.; Sultano, Pedro E.; Laranja, Gustavo A. T.; Paes, Marcia C.] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Interacao Tripanossomatideos & Vetores, Rio De Janeiro, Brazil; [Atella, Georgia C.; Paes, Marcia C.] INCT EM, Rio De Janeiro, Brazil; [Cunha, Paula R. B. B.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis IBqM, Lab Bioquim Lipideos & Lipoprot, Rio de Janeiro, Brazil; [Justo, Graca A.; Sabino, Katia C. C.; Coelho, Marsen G. P.] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Imunol Aplicada Bioquim Prot & Prod Nat, Rio De Janeiro, Brazil; [Rossini, Ana] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Toxicol & Biol Mol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Paes, MC (corresponding author), Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Lab Interacao Tripanossomatideos & Vetores, Rio De Janeiro, Brazil.	mcpaes@uerj.br	Coelho, M.G.P./AAR-8546-2021; Atella, Georgia/AAK-7897-2020; PAES, MARCIA CRISTINA/AAL-9530-2021	Coelho, M.G.P./0000-0002-8945-7415; Saraiva, Francis/0000-0002-6744-3549; Bittencourt-Cunha, Paula/0000-0002-3913-1441; Pereira de Almeida Nogueira, Natalia/0000-0003-3258-607X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)	The funders, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular (INCT-EM), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROHER FJ, 1988, CELL DIFFER DEV, V22, P165, DOI 10.1016/0045-6039(88)90029-2; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Caldas S, 2012, ACTA TROP, V123, P170, DOI 10.1016/j.actatropica.2012.05.002; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cortez MR, 2012, EXP PARASITOL, V131, P363, DOI 10.1016/j.exppara.2012.05.005; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; Echevarria M, 2001, PFLUG ARCH EUR J PHY, V442, P27, DOI 10.1007/s004240000494; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Garcia E.S, 1975, ACAD BRAS CIENC, V47, P539; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GARCIA ES, 1982, AM J TROP MED HYG, V31, P259, DOI 10.4269/ajtmh.1982.31.259; GONZALEZ MS, 1992, J INVERTEBR PATHOL, V60, P201, DOI 10.1016/0022-2011(92)90098-O; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Kollien AH, 1997, PARASITOL RES, V83, P781, DOI 10.1007/s004360050339; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; KRASSNER SM, 1990, J PROTOZOOL, V37, P128, DOI 10.1111/j.1550-7408.1990.tb05882.x; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Martins C, 2008, MOL BIOCHEM PARASIT, V160, P60, DOI 10.1016/j.molbiopara.2008.03.004; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; OSUNA A, 1990, CELL DIFFER DEV, V30, P89, DOI 10.1016/0922-3371(90)90077-A; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SCHAUB GA, 1988, EXP PARASITOL, V65, P174, DOI 10.1016/0014-4894(88)90121-X; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Sekharam M, 1998, TOXICOL APPL PHARM, V149, P210, DOI 10.1006/taap.1997.8361; Souza CF, 2009, BIOCHEM BIOPH RES CO, V390, P541, DOI 10.1016/j.bbrc.2009.09.135; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; UCROS H, 1983, ACTA TROP, V40, P105; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907; Wigglesworth VB, 1931, J EXP BIOL, V8, P443	51	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116712	10.1371/journal.pone.0116712	http://dx.doi.org/10.1371/journal.pone.0116712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671543	Green Submitted, Green Published			2022-12-26	WOS:000349545300024
J	Shanmugam, M; Li, D; Gao, SM; Fefelova, N; Shah, V; Voit, A; Pachon, R; Yehia, G; Xie, LH; Babu, GJ				Shanmugam, Mayilvahanan; Li, Dan; Gao, Shumin; Fefelova, Nadezhda; Shah, Vikas; Voit, Antanina; Pachon, Ronald; Yehia, Ghassan; Xie, Lai-Hua; Babu, Gopal J.			Cardiac Specific Expression of Threonine 5 to Alanine Mutant Sarcolipin Results in Structural Remodeling and Diastolic Dysfunction	PLOS ONE			English	Article							RETICULUM CALCIUM-TRANSPORT; PROTEASOME INHIBITION; VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; PRESSURE-OVERLOAD; ATPASE SERCA; OVEREXPRESSION; PHOSPHOLAMBAN; CONTRACTILITY	The functional importance of threonine 5 (T5) in modulating the activity of sarcolipin (SLN), a key regulator of sarco/endoplasmic reticulum (SR) Ca2+ ATPase (SERCA) pump was studied using a transgenic mouse model with cardiac specific expression of threonine 5 to alanine mutant SLN (SLNT5A). In these transgenic mice, the SLNT5A protein replaces the endogenous SLN in atria, while maintaining the total SLN content. The cardiac specific expression of SLNT5A results in severe cardiac structural remodeling accompanied by bi-atrial enlargement. Biochemical analyses reveal a selective downregulation of SR Ca2+ handling proteins and a reduced SR Ca2+ uptake both in atria and in the ventricles. Optical mapping analysis shows slower action potential propagation in the transgenic mice atria. Doppler echocardiography and hemodynamic measurements demonstrate a reduced atrial contractility and an impaired diastolic function. Together, these findings suggest that threonine 5 plays an important role in modulating SLN function in the heart. Furthermore, our studies suggest that alteration in SLN function can cause abnormal Ca2+ handling and subsequent cardiac remodeling and dysfunction.	[Shanmugam, Mayilvahanan; Li, Dan; Gao, Shumin; Fefelova, Nadezhda; Shah, Vikas; Voit, Antanina; Pachon, Ronald; Yehia, Ghassan; Xie, Lai-Hua; Babu, Gopal J.] Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Babu, GJ (corresponding author), Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA.	babugo@njms.rutgers.edu	Babu, Gopal/AAB-7787-2021	Babu, Gopal/0000-0001-7833-5300	Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ	Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ	This work was supported by the funds from the Department of Cell Biology and Molecular Medicine and foundation grant, NJMS, Rutgers, Newark, NJ (to GJB).	Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Depre C, 2010, CARDIOVASC RES, V85, P251, DOI 10.1093/cvr/cvp362; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Gladden JD, 2013, AM J PHYSIOL-HEART C, V305, pH1440, DOI 10.1152/ajpheart.00007.2013; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; Hedhli N, 2010, CARDIOVASC RES, V85, P321, DOI 10.1093/cvr/cvp226; Hong CS, 2008, J MOL CELL CARDIOL, V44, P672, DOI 10.1016/j.yjmcc.2008.01.012; Huang SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1298, DOI 10.1152/ajpheart.00765.2007; Kadambi VJ, 1998, J MOL CELL CARDIOL, V30, P1275, DOI 10.1006/jmcc.1998.0688; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Stansfield WE, 2008, AM J PHYSIOL-HEART C, V294, pH645, DOI 10.1152/ajpheart.00196.2007; Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049; Uemura N, 2004, EUR J CLIN INVEST, V34, P723, DOI 10.1111/j.1365-2362.2004.01422.x; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Xie LH, 2012, AM J PHYSIOL-CELL PH, V302, pC1762, DOI 10.1152/ajpcell.00425.2011; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309; Yu XC, 2009, CURR OPIN PHARMACOL, V9, P167, DOI 10.1016/j.coph.2008.11.005; Zheng JY, 2014, CIRC-HEART FAIL, V7, P194, DOI 10.1161/CIRCHEARTFAILURE.113.000519; Zheng Q, 2010, PANMINERVA MED, V52, P9	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115822	10.1371/journal.pone.0115822	http://dx.doi.org/10.1371/journal.pone.0115822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671318	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300014
J	Bryan, BA; Huai, J; Connor, J; Gao, L; King, D; Kandulu, J; Zhao, G				Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang			What Actually Confers Adaptive Capacity? Insights from Agro-Climatic Vulnerability of Australian Wheat	PLOS ONE			English	Article							CLIMATE-CHANGE; LIVELIHOOD DIVERSIFICATION; EMPIRICAL-ANALYSIS; SPATIAL-ANALYSIS; LARGE-SCALE; MODEL; VARIABILITY; DROUGHT; STRATEGIES; IMPACT	Vulnerability assessments have often invoked sustainable livelihoods theory to support the quantification of adaptive capacity based on the availability of capital-social, human, physical, natural, and financial. However, the assumption that increased availability of these capitals confers greater adaptive capacity remains largely untested. We quantified the relationship between commonly used capital indicators and an empirical index of adaptive capacity (ACI) in the context of vulnerability of Australian wheat production to climate variability and change. We calculated ACI by comparing actual yields from farm survey data to climate-driven expected yields estimated by a crop model for 12 regions in Australia's wheat-sheep zone from 1991-2010. We then compiled data for 24 typical indicators used in vulnerability analyses, spanning the five capitals. We analyzed the ACI and used regression techniques to identify related capital indicators. Between regions, mean ACI was not significantly different but variance over time was. ACI was higher in dry years and lower in wet years suggesting that farm adaptive strategies are geared towards mitigating losses rather than capitalizing on opportunity. Only six of the 24 capital indicators were significantly related to adaptive capacity in a way predicted by theory. Another four indicators were significantly related to adaptive capacity but of the opposite sign, countering our theory-driven expectation. We conclude that the deductive, theory-based use of capitals to define adaptive capacity and vulnerability should be more circumspect. Assessments need to be more evidence-based, first testing the relevance and influence of capital metrics on adaptive capacity for the specific system of interest. This will more effectively direct policy and targeting of investment to mitigate agro-climatic vulnerability.	[Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang] CSIRO, Land & Water Flagship & Agr Flagship, Urrbrae, SA, Australia; [Bryan, Brett A.; Huai, Jianjun; Connor, Jeff; Gao, Lei; King, Darran; Kandulu, John; Zhao, Gang] Northwest A&F Univ, Coll Econ & Management, Yangling, Shaanxi, Peoples R China; [Zhao, Gang] Univ Bonn, Inst Crop Sci & Resource Conservat, Crop Sci Grp, Bonn, Germany	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China; University of Bonn	Bryan, BA (corresponding author), CSIRO, Land & Water Flagship & Agr Flagship, Waite Campus, Urrbrae, SA, Australia.	brett.bryan@csiro.au	King, Darran A/G-3996-2011; Gao, Lei/F-9698-2010; kandulu, john M/G-3521-2011; Bryan, Brett Anthony/F-8949-2010; Kandulu, John/AAC-6448-2020; Connor, Jeff/T-7345-2019; connor, jeffery/G-5466-2010; KANDULU, JOHN/AAL-6208-2020	Gao, Lei/0000-0003-4272-9417; kandulu, john M/0000-0002-1871-4429; Bryan, Brett Anthony/0000-0003-4834-5641; Kandulu, John/0000-0002-1871-4429; connor, jeffery/0000-0002-2313-8630; Huai, Jianjun/0000-0003-4175-2260	Social Science Special Program of Northwest AF University [2011RWZXX3]; CSIRO's Sustainable Agriculture Flagship; Australian National Outlook initiative; Chinese Scholarship Council; Program of the National Natural Science Foundation of China [71473196]	Social Science Special Program of Northwest AF University; CSIRO's Sustainable Agriculture Flagship; Australian National Outlook initiative; Chinese Scholarship Council(China Scholarship Council); Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Social Science Special Program of Northwest A&F University Grant No. 2011RWZXX3, CSIRO's Sustainable Agriculture Flagship and Australian National Outlook initiative, the Chinese Scholarship Council, and the Program of the National Natural Science Foundation of China Grant No. 71473196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, US GUID CAV LAND US; ABARES, 2011, SURV METH DEF; Adger WN., 2004, TYNDALL CTR CLIMATE; Antwi-Agyei P, 2012, APPL GEOGR, V32, P324, DOI 10.1016/j.apgeog.2011.06.010; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Asseng S, 2013, CLIMATIC CHANGE, V118, P167, DOI 10.1007/s10584-012-0623-1; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Babulo B, 2008, AGR SYST, V98, P147, DOI 10.1016/j.agsy.2008.06.001; Bartos S., 2006, GRAIN AWB SCANDAL WH; Bell LW, 2012, AGR SYST, V111, P1, DOI 10.1016/j.agsy.2012.04.003; Block S, 2001, FOOD POLICY, V26, P333, DOI 10.1016/S0306-9192(01)00015-X; Brenkert AL, 2005, CLIMATIC CHANGE, V72, P57, DOI 10.1007/s10584-005-5930-3; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Bryan BA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044005; Bryan BA, 2008, LAND USE POLICY, V25, P533, DOI 10.1016/j.landusepol.2007.11.003; Bryan BA, 2010, GCB BIOENERGY, V2, P330, DOI 10.1111/j.1757-1707.2010.01056.x; Bryan BA, 2010, LAND USE POLICY, V27, P713, DOI 10.1016/j.landusepol.2009.09.012; Challinor AJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034012; Chambers R., 1992, SUSTAINABLE RURAL LI; Chen CC, 2004, CLIMATIC CHANGE, V66, P239, DOI 10.1023/B:CLIM.0000043159.33816.e5; CSIRO, 2010, CLIM VAR CHANG SE AU; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dong ZQ, 2015, ECOL INDIC, V48, P49, DOI 10.1016/j.ecolind.2014.07.032; Dougill AJ, 2010, ECOL SOC, V15; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; Ellis Frank, 2000, RURAL LIVELIHOODS DI; Fang YP, 2014, ECOL INDIC, V38, P225, DOI 10.1016/j.ecolind.2013.11.007; Fraser EDG, 2008, CR GEOSCI, V340, P679, DOI 10.1016/j.crte.2008.07.004; Fraser EDG, 2013, AGR FOREST METEOROL, V170, P195, DOI 10.1016/j.agrformet.2012.04.008; Gbetibouo GA, 2010, NAT RESOUR FORUM, V34, P175, DOI 10.1111/j.1477-8947.2010.01302.x; Goklany I. M., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P755, DOI 10.1007/s11027-007-9098-1; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; HERBEL CH, 1972, ECOLOGY, V53, P1084, DOI 10.2307/1935420; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Kandulu JM, 2012, ECOL ECON, V79, P105, DOI 10.1016/j.ecolecon.2012.04.025; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kirono DGC, 2011, J ARID ENVIRON, V75, P566, DOI 10.1016/j.jaridenv.2010.12.012; Krishnamurthy PK, 2014, GLOBAL ENVIRON CHANG, V25, P121, DOI 10.1016/j.gloenvcha.2013.11.004; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Luo QY, 2005, AGR FOREST METEOROL, V132, P273, DOI 10.1016/j.agrformet.2005.08.003; Luo QY, 2005, CLIMATIC CHANGE, V72, P213, DOI 10.1007/s10584-005-5361-1; Marshall NA, 2014, AGR ECOSYST ENVIRON, V186, P86, DOI 10.1016/j.agee.2014.01.004; McCarl BA, 2008, AM J AGR ECON, V90, P1241, DOI 10.1111/j.1467-8276.2008.01211.x; McKernan M, 2005, DROUGHT RED MARAUDER; Meinke H, 1998, EUR J AGRON, V8, P101, DOI 10.1016/S1161-0301(97)00015-4; Monjardino M, 2013, AGR SYST, V116, P37, DOI 10.1016/j.agsy.2012.12.007; Moss R. H., 2001, PNNLSA33642 US DEP E; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Nelson R, 2010, ENVIRON SCI POLICY, V13, P8, DOI 10.1016/j.envsci.2009.09.006; Nelson R, 2010, ENVIRON SCI POLICY, V13, P18, DOI 10.1016/j.envsci.2009.09.007; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Potgieter A, 2013, CLIMATIC CHANGE, V117, P163, DOI 10.1007/s10584-012-0543-0; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Scoones I., 1998, SUSTAINABLE RURAL LI; Sheng Y., 2011, TURNING POINT AGR PR; Simelton E, 2012, FOOD SECUR, V4, P163, DOI 10.1007/s12571-012-0173-4; Simelton E, 2009, ENVIRON SCI POLICY, V12, P438, DOI 10.1016/j.envsci.2008.11.005; Solomon S., 2007, PHYS SCI BASIS WORKI; Thomas RJ, 2008, AGR ECOSYST ENVIRON, V126, P36, DOI 10.1016/j.agee.2008.01.011; Tukey JW, 1977, EXPLORATORY DATA ANA; Valdivia C, 2010, ANN ASSOC AM GEOGR, V100, P818, DOI 10.1080/00045608.2010.500198; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Zhang Y, 2012, CAN J PLANT SCI, V92, P937, DOI [10.4141/CJPS2011-266, 10.4141/cjps2011-266]; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145; Zhao G, 2013, ENVIRON MODELL SOFTW, V41, P231, DOI 10.1016/j.envsoft.2012.08.007; Zhao G, 2012, COMPUT ELECTRON AGR, V89, P94, DOI 10.1016/j.compag.2012.08.007	71	21	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117600	10.1371/journal.pone.0117600	http://dx.doi.org/10.1371/journal.pone.0117600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668192	Green Submitted, Green Published, gold			2022-12-26	WOS:000349493000021
J	Nguyen, DN; Jiang, PP; Jacobsen, S; Sangild, PT; Bendixen, E; Chatterton, DEW				Duc Ninh Nguyen; Jiang, Pingping; Jacobsen, Susanne; Sangild, Per T.; Bendixen, Emoke; Chatterton, Dereck E. W.			Protective Effects of Transforming Growth Factor beta 2 in Intestinal Epithelial Cells by Regulation of Proteins Associated with Stress and Endotoxin Responses	PLOS ONE			English	Article							IN-VITRO; BACTERIAL-COLONIZATION; TISSUE INHIBITOR; BREAST-MILK; EXPRESSION; APOPTOSIS; PROTEOME; HSP27; DEATH; FORMULA	Transforming growth factor (TGF)-beta 2 is an important anti-inflammatory protein in milk and colostrum. TGF-beta 2 supplementation appears to reduce gut inflammatory diseases in early life, such as necrotizing enterocolitis (NEC) in young mice. However, the molecular mechanisms by which TGF-beta 2 protects immature intestinal epithelial cells (IECs) remain to be more clearly elucidated before interventions in infants can be considered. Porcine IECs PsIc1 were treated with TGF-beta 2 and/or lipopolysaccharide (LPS), and changes in the cellular proteome were subsequently analyzed using two-dimensional gel electrophoresis-MS and LC-MS-based proteomics. TGF-beta 2 alone induced the differential expression of 13 proteins and the majority of the identified proteins were associated with stress responses, TGF-alpha and Toll-like receptor 4 signaling cascades. In particular, a series of heat shock proteins had similar differential trends as previously shown in the intestine of NEC-resistant preterm pigs and young mice. Furthermore, LC-MS-based proteomics and Western blot analyses revealed 20 differentially expressed proteins following treatment with TGF-beta 2 in LPS-challenged IECs. Thirteen of these proteins were associated with stress response pathways, among which five proteins were altered by LPS and restored by TGF-beta 2, whereas six were differentially expressed only by TGF-beta 2 in LPS-challenged IECs. Based on previously reported biological functions, these patterns indicate the anti-stress and anti-inflammatory effects of TGF-beta 2 in IECs. We conclude that TGF-beta 2 of dietary or endogenous origin may regulate the IEC responses against LPS stimuli, thereby supporting cellular homeostasis and innate immunity in response to bacterial colonization, and the first enteral feeding in early life.	[Duc Ninh Nguyen; Chatterton, Dereck E. W.] Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg, Denmark; [Jiang, Pingping; Sangild, Per T.; Chatterton, Dereck E. W.] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Jacobsen, Susanne] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Bendixen, Emoke] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Aarhus University	Chatterton, DEW (corresponding author), Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg, Denmark.	dcha@food.ku.dk	Nguyen, Duc Ninh/AAX-1131-2020; Chatterton, Dereck/G-6827-2015	Nguyen, Duc Ninh/0000-0002-4997-555X; Chatterton, Dereck/0000-0002-8417-3210; Jiang, Pingping/0000-0002-7393-9719; Nguyen, Duc Ninh/0000-0002-6296-8450	Danish Dairy Research Foundation	Danish Dairy Research Foundation	The study was supported by a grant from the Danish Dairy Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boyd CA, 2007, ARCH DIS CHILD-FETAL, V92, pF169, DOI 10.1136/adc.2005.089490; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chiang CW, 2011, BIOCHEM J, V433, P187, DOI 10.1042/BJ20100247; Danielsen M, 2007, J PROTEOME RES, V6, P2596, DOI 10.1021/pr070038b; Das A, 2013, BIOCHIP J, V7, P75, DOI 10.1007/s13206-013-7112-0; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Nguyen DN, 2014, AM J PHYSIOL-GASTR L, V307, pG689, DOI 10.1152/ajpgi.00193.2014; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Gauthier SF, 2006, LAIT, V86, P99, DOI 10.1051/lait:2005048; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu L, 2013, ONCOL LETT, V6, P49, DOI 10.3892/ol.2013.1318; Im E, 2009, J NUTR, V139, P1848, DOI 10.3945/jn.109.108613; Jiang PP, 2008, J NUTR, V138, P1895, DOI 10.1093/jn/138.10.1895; Jiang PP, 2014, PROTEOM CLIN APPL, V8, P700, DOI 10.1002/prca.201300097; Jiang PP, 2013, J PEDIATR GASTR NUTR, V56, P615, DOI 10.1097/MPG.0b013e318288cf71; Jiang PP, 2013, PEDIATR RES, V73, P268, DOI 10.1038/pr.2012.182; Jiang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044929; Jiang PP, 2011, NEONATOLOGY, V99, P280, DOI 10.1159/000317807; Jin YH, 2009, BIOSCI BIOTECH BIOCH, V73, P1318, DOI 10.1271/bbb.80841; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee JK, 2008, NEUROBIOL DIS, V30, P174, DOI 10.1016/j.nbd.2008.01.004; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Nunez MT, 2001, J CELL BIOCHEM, V82, P660, DOI 10.1002/jcb.1194; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Oz HS, 2004, J AM COLL NUTR, V23, P220, DOI 10.1080/07315724.2004.10719364; Paduch R, 2009, J BIOSCIENCES, V34, P927, DOI 10.1007/s12038-009-0107-2; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Quarmby L, 2000, J CELL SCI, V113, P2821; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; Sangild PT, 2009, AM J PHYSIOL-REG I, V296, pR1053, DOI 10.1152/ajpregu.90790.2008; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Somara S, 2004, AM J PHYSIOL-CELL PH, V286, pC1290, DOI 10.1152/ajpcell.00458.2003; TAKENAKA IM, 1993, J CELL PHYSIOL, V155, P54, DOI 10.1002/jcp.1041550108; TAKENAKA IM, 1992, J CELL PHYSIOL, V152, P568, DOI 10.1002/jcp.1041520317; Wang SA, 2011, J BIOL CHEM, V286, P43816, DOI 10.1074/jbc.M111.310979; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	59	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117608	10.1371/journal.pone.0117608	http://dx.doi.org/10.1371/journal.pone.0117608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668313	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000023
J	Bougerol, M; Aurade, F; Lambert, FM; Le Ray, D; Combes, D; Thoby-Brisson, M; Relaix, F; Pollet, N; Tostivint, H				Bougerol, Marion; Aurade, Frederic; Lambert, Francois M.; Le Ray, Didier; Combes, Denis; Thoby-Brisson, Muriel; Relaix, Frederic; Pollet, Nicolas; Tostivint, Herve			Generation of BAC Transgenic Tadpoles Enabling Live Imaging of Motoneurons by Using the Urotensin II-Related Peptide (ust2b) Gene as a Driver	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SPINAL-CORD; XENOPUS-LAEVIS; BRAIN-STEM; MESSENGER-RNAS; MOTOR-NEURONS; CLAWED FROG; RAT-BRAIN; ZEBRAFISH; MOUSE	Xenopus is an excellent tetrapod model for studying normal and pathological motoneuron ontogeny due to its developmental morpho-physiological advantages. In mammals, the urotensin II-related peptide (UTS2B) gene is primarily expressed in motoneurons of the brainstem and the spinal cord. Here, we show that this expression pattern was conserved in Xenopus and established during the early embryonic development, starting at the early tailbud stage. In late tadpole stage, uts2b mRNA was detected both in the hindbrain and in the spinal cord. Spinal uts2b(+) cells were identified as axial motoneurons. In adult, however, the uts2b expression was only detected in the hindbrain. We assessed the ability of the uts2b promoter to drive the expression of a fluorescent reporter in motoneurons by recombineering a green fluorescent protein (GFP) into a bacterial artificial chromosome (BAC) clone containing the entire X. tropicalis uts2b locus. After injection of this construction in one-cell stage embryos, a transient GFP expression was observed in the spinal cord of about a quarter of the resulting animals from the early tailbud stage and up to juveniles. The GFP expression pattern was globally consistent with that of the endogenous uts2b in the spinal cord but no fluorescence was observed in the brainstem. A combination of histological and electrophysiological approaches was employed to further characterize the GFP(+) cells in the larvae. More than 98% of the GFP(+) cells expressed choline acetyltransferase, while their projections were co-localized with alpha-bungarotoxin labeling. When tail myotomes were injected with rhodamine dextran amine crystals, numerous double-stained GFP(+) cells were observed. In addition, intracellular electrophysiological recordings of GFP(+) neurons revealed locomotion-related rhythmic discharge patterns during fictive swimming. Taken together our results provide evidence that uts2b is an appropriate driver to express reporter genes in larval motoneurons of the Xenopus spinal cord.	[Bougerol, Marion; Tostivint, Herve] Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France; [Aurade, Frederic; Relaix, Frederic] UPMC, INSERM, UMRS 974, CNRS,AIM,FRE 3617, Paris, France; [Aurade, Frederic; Relaix, Frederic] INSERM, Avenir Team, Paris, France; [Lambert, Francois M.; Le Ray, Didier; Combes, Denis; Thoby-Brisson, Muriel] Univ Bordeaux, CNRS, UMR 5287, INCIA, Bordeaux, France; [Pollet, Nicolas] Univ Evry Val dEssonne, CNRS, Inst Syst & Synthet Biol, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Tostivint, H (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France.	htostivi@mnhn.fr	Lambert, François/AAG-1626-2021; Tostivint, Hervé/P-8524-2019; Le Ray, Didier/C-2625-2008; Pollet, Nicolas/A-4746-2013; Thoby-Brisson, Muriel/E-1167-2014	Tostivint, Hervé/0000-0002-0719-0922; Le Ray, Didier/0000-0003-2089-9861; Pollet, Nicolas/0000-0002-9975-9644; Thoby-Brisson, Muriel/0000-0003-3214-1724; Relaix, Frederic/0000-0003-1270-1472	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre les Myopathies (AFM); AFM; Association Institut de Myologie (AIM); Labex REVIVE; Fondation pour la Recherche Medicale FRM [ARF20140128968]; PEPS IdEx de Bordeaux-CNRS [101SG/1024R]; Genopole; AFM (Amphigentools); French Ministry of Research and the Legs Prevost (MNHN)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); AFM(Association Francaise contre les Myopathies); Association Institut de Myologie (AIM); Labex REVIVE; Fondation pour la Recherche Medicale FRM(Fondation pour la Recherche Medicale); PEPS IdEx de Bordeaux-CNRS; Genopole; AFM (Amphigentools); French Ministry of Research and the Legs Prevost (MNHN)	This research was supported by funding obtained from the Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr), the Museum National d'Histoire Naturelle (MNHN; http://www.mnhn. fr) and the Association Francaise contre les Myopathies (AFM; http://www.afm-telethon.fr; Amphigentools) to HT, from the AFM, Association Institut de Myologie (AIM; http://www.institutmyologie.org/), and Labex REVIVE to FA and FR, from the Fondation pour la Recherche Medicale FRM ARF20140128968; http://www.frm.org) to FML, from the PEPS IdEx de Bordeaux-CNRS (101SG/1024R) to DLR, and from Genopole and the AFM (Amphigentools) to NP. MB was the recipient of Ph.D grants from the French Ministry of Research and the Legs Prevost (MNHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, DEV GROWTH DIFFER, V55, P390, DOI 10.1111/dgd.12062; Ampatzis K, 2013, J NEUROSCI, V33, P10875, DOI 10.1523/JNEUROSCI.0896-13.2013; Babin PJ, 2014, PROG NEUROBIOL, V118, P36, DOI 10.1016/j.pneurobio.2014.03.001; Becker TS, 2012, DEV NEUROBIOL, V72, P415, DOI 10.1002/dneu.20888; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Detrich HW, 2011, METHOD CELL BIOL, V104, P1; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Dubessy C, 2008, J NEUROCHEM, V107, P361, DOI 10.1111/j.1471-4159.2008.05624.x; Dun SL, 2001, NEUROSCI LETT, V305, P9, DOI 10.1016/S0304-3940(01)01804-3; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Farfsing A, 2009, LEUKEMIA, V23, P2018, DOI 10.1038/leu.2009.144; Fish MB, 2012, GENESIS, V50, P307, DOI 10.1002/dvg.20819; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FOREHAND CJ, 1982, J COMP NEUROL, V209, P386, DOI 10.1002/cne.902090408; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; HARTENSTEIN V, 1993, J COMP NEUROL, V328, P213, DOI 10.1002/cne.903280205; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; HUGHES A, 1961, J EMBRYOL EXP MORPH, V9, P269; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kelly LE, 2005, GENESIS, V41, P185, DOI 10.1002/gene.20113; Konno N, 2013, GEN COMP ENDOCR, V185, P44, DOI 10.1016/j.ygcen.2013.01.015; KORZH V, 1993, DEVELOPMENT, V118, P417; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Lihrmann I, 2013, HDB BIOL ACTIVE PEPT, P957; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; Lopez JM, 2002, J COMP NEUROL, V453, P418, DOI 10.1002/cne.10419; Marsh-Armstrong N, 2004, P NATL ACAD SCI USA, V101, P165, DOI 10.1073/pnas.2136755100; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Parmentier C, 2008, PEPTIDES, V29, P820, DOI 10.1016/j.peptides.2008.01.023; Pelletier G, 2005, NEUROSCIENCE, V132, P689, DOI 10.1016/j.neuroscience.2004.12.045; Pelletier G, 2002, NEUROSCIENCE, V115, P525, DOI 10.1016/S0306-4522(02)00413-X; Pelzer D, 2014, 15 INT XEN C PAC GRO; Pratt KG, 2013, DIS MODEL MECH, V6, P1057, DOI 10.1242/dmm.012138; PRESTIGE MC, 1967, J EMBRYOL EXP MORPH, V18, P359; Roberts A, 1999, J COMP NEUROL, V411, P472, DOI 10.1002/(SICI)1096-9861(19990830)411:3<472::AID-CNE9>3.0.CO;2-B; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlosser G, 2002, DEV DYNAM, V225, P485, DOI 10.1002/dvdy.10179; Schmitt SM, 2014, ADV DRUG DELIVER REV, V69, P225, DOI 10.1016/j.addr.2014.02.004; Seredick SD, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-35; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sive HL, 2007, INDUCING OVULATION X; Straka H, 1998, BIOL BULL, V195, P220, DOI 10.2307/1542849; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Tostivint H, 2014, J MOL ENDOCRINOL, V52, pT61, DOI 10.1530/JME-13-0274; Tostivint H, 2013, GEN COMP ENDOCR, V188, P110, DOI 10.1016/j.ygcen.2012.12.015; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VANMIER P, 1986, INT J DEV NEUROSCI, V4, P465, DOI 10.1016/0736-5748(86)90028-6; VANMIER P, 1985, ANAT EMBRYOL, V172, P311; Vaudry H, 2014, PHARMACOL REV IN PRE; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vouillot L, 2014, XENOPUS DEVELOPMENT, P383; Ymlahi-Ouazzani Q, 2010, NEUROGENETICS, V11, P27, DOI 10.1007/s10048-009-0200-6; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P11674, DOI 10.1073/pnas.1018512108	68	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117370	10.1371/journal.pone.0117370	http://dx.doi.org/10.1371/journal.pone.0117370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658845	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900138
J	Loh, PY; Muraki, S				Loh, Ping Yeap; Muraki, Satoshi			Effect of Wrist Angle on Median Nerve Appearance at the Proximal Carpal Tunnel	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; GENDER-DIFFERENCES; PATHOPHYSIOLOGY; DIAGNOSIS; WORK	This study investigated the effects of wrist angle, sex, and handedness on the changes in the median nerve cross-sectional area (MNCSA) and median nerve diameters, namely longitudinal diameter (D1) and vertical diameter (D2). Ultrasound examination was conducted to examine the median nerve at the proximal carpal tunnel in both dominant and nondominant hands of men (n = 27) and women (n = 26). A total of seven wrist angles were examined: neutral; 15 degrees, 30 degrees, and 45 degrees extension; and 15 degrees, 30 degrees, and 45 degrees flexion. Our results indicated sexual dimorphism and bilateral asymmetry of MNCSA, D1 and D2 measurements. MNCSA was significantly reduced when the wrist angle changed from neutral to flexion or extension positions. At flexion positions, D1 was significantly smaller than that at neutral. In contrast, at extension positions, D2 was significantly smaller than that at neutral. In conclusion, this study showed that MNCSA decreased as the wrist angle changed from neutral to flexion or extension positions in both dominant and nondominant hands of both sexes, whereas deformation of the median nerve differed between wrist flexion and extension.	[Loh, Ping Yeap] Kyushu Univ, Grad Sch Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan; [Muraki, Satoshi] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan	Kyushu University; Kyushu University	Loh, PY (corresponding author), Kyushu Univ, Grad Sch Design, Dept Human Sci, Minami Ku, Fukuoka 812, Japan.	lohpingyeap@gmail.com		Loh, Ping Yeap/0000-0003-3821-3039				[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Baker NA, 2007, CLIN BIOMECH, V22, P34, DOI 10.1016/j.clinbiomech.2006.08.008; Bakhsh H, 2012, Ortop Traumatol Rehabil, V14, P335, DOI 10.5604/15093492.1005085; Bonfiglioli R, 2007, INT ARCH OCC ENV HEA, V80, P248, DOI 10.1007/s00420-006-0129-0; Brasseur JL, 2004, EUR RADIOL, V14, P1770, DOI 10.1007/s00330-004-2401-6; Cramer D., 2004, SAGE DICT STAT; Cramer D., 1998, FUNDAMENTAL STAT SOC; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Donoghue MF, 2013, APPL ERGON, V44, P42, DOI 10.1016/j.apergo.2012.04.009; Duncan I, 1999, AM J ROENTGENOL, V173, P681, DOI 10.2214/ajr.173.3.10470903; Duymus M, 2013, J NEUROL SCI-TURK, V30, P59; Fragala MS, 2012, GENDER MED, V9, P445, DOI 10.1016/j.genm.2012.10.004; Jarvik JG, 2004, NEUROIMAG CLIN N AM, V14, P93, DOI 10.1016/j.nic.2004.02.002; Jarvik JG, 2002, NEUROLOGY, V58, P1597, DOI 10.1212/WNL.58.11.1597; Keir Peter J, 2005, J Hand Ther, V18, P259, DOI 10.1197/j.jht.2005.02.001; Kele H., 2012, PERSPECTIVES MED, V1, P417, DOI [DOI 10.1016/J.PERMED.2012.02.047, 10.1016/j.permed.2012.02.047.]; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; LaJoie AS, 2005, PLAST RECONSTR SURG, V116, P502, DOI 10.1097/01.prs.0000172894.21006.e2; Loh PY, 2015, BRIDGING RESEARCH AND GOOD PRACTICES TOWARDS PATIENT WELFARE: HEALTHCARE SYSTEMS ERGONOMICS AND PATIENT SAFETY 2014, P149; Lopes MM, 2011, CLIN BIOMECH, V26, P930, DOI 10.1016/j.clinbiomech.2011.03.014; MILLESI H, 1995, CLIN ORTHOP RELAT R, P76; Mogk JPM, 2007, J BIOMECH, V40, P2222, DOI 10.1016/j.jbiomech.2006.10.033; Mogk JPM, 2009, CLIN BIOMECH, V24, P708, DOI 10.1016/j.clinbiomech.2009.05.012; Lopez PM, 2011, J BIOSOC SCI, V43, P597, DOI 10.1017/S0021932011000228; Moriyama H, 2013, SEXUAL DIMORPHISM, DOI [10.5772/56080, DOI 10.5772/56080]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasternack II, 2003, SCAND J WORK ENV HEA, V29, P189, DOI 10.5271/sjweh.721; Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487; Pratt NE, 2011, REHABILITATION HAND; Presazzi A, 2011, J Ultrasound, V14, P40, DOI 10.1016/j.jus.2011.01.006; ROY TA, 1994, AM J PHYS ANTHROPOL, V94, P203, DOI 10.1002/ajpa.1330940205; Sakurai M, 2006, HYPERTENS RES, V29, P75, DOI 10.1291/hypres.29.75; Sambandam SN, 2008, INT ORTHOP, V32, P497, DOI 10.1007/s00264-007-0344-7; SARRAFIAN SK, 1977, CLIN ORTHOP RELAT R, P153; SAUTER SL, 1991, HUM FACTORS, V33, P151, DOI 10.1177/001872089103300203; SAVELBERG HHCM, 1991, J ORTHOPAED RES, V9, P693, DOI 10.1002/jor.1100090509; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Toosi KK, 2011, AM J IND MED, V54, P826, DOI 10.1002/ajim.20983; Topp KS, 2012, J HAND THER, V25, P142, DOI 10.1016/j.jht.2011.09.002; Topp KS, 2006, PHYS THER, V86, P92, DOI 10.1093/ptj/86.1.92; Uchiyama S, 2010, J ORTHOP SCI, V15, P1, DOI 10.1007/s00776-009-1416-x; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Viera AJ, 2003, AM FAM PHYSICIAN, V68, P265; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Yao L, 2009, SKELETAL RADIOL, V38, P355, DOI 10.1007/s00256-008-0626-1	46	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117930	10.1371/journal.pone.0117930	http://dx.doi.org/10.1371/journal.pone.0117930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658422	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900243
J	Pourhoseini, S; Seth, RK; Das, S; Dattaroy, D; Kadiiska, MB; Xie, G; Michelotti, GA; Nagarkatti, M; Diehl, AM; Chatterjee, S				Pourhoseini, Sahar; Seth, Ratanesh Kumar; Das, Suvarthi; Dattaroy, Diptadip; Kadiiska, Maria B.; Xie, Guanhua; Michelotti, Gregory A.; Nagarkatti, Mitzi; Diehl, Anna Mae; Chatterjee, Saurabh			Upregulation of miR21 and Repression of Grhl3 by Leptin Mediates Sinusoidal Endothelial Injury in Experimental Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							DISEASE PROGRESSION; STELLATE CELLS; MICRORNAS; DYSFUNCTION; EXPRESSION; MECHANISMS; FIBROSIS; MICROCIRCULATION; INFLAMMATION; METABOLISM	Sinusoidal endothelial dysfunction (SED) has been found to be an early event in nonalcoholic steatohepatitis (NASH) progression but the molecular mechanisms underlying its causation remains elusive. We hypothesized that adipokine leptin worsens sinusoidal injury by decreasing functionally active nitric oxide synthase 3 (NOS) 3 via miR21. Using rodent models of NASH, and transgenic mice lacking leptin and leptin receptor, results showed that hyperleptinemia caused a 4-5 fold upregulation of hepatic miR21 as assessed by qRTPCR. The upregulation of miR21 led to a time-dependent repression of its target protein Grhl3 levels as shown by western blot analyses. NOS3-p/NOS3 ratio which is controlled by Grhl3 was significantly decreased in NASH models. SED markers ICAM-1, VEGFR-2, and E-selectin as assessed by immunofluorescence microscopy were significantly up regulated in the progressive phases of NASH. Lack of leptin or its receptor in vivo, reversed the upregulation of miR21 and restored the levels of Grhl3 and NOS3-p/NOS3 ratio coupled with decreased SED dysfunction markers. Interestingly, leptin supplementation in mice lacking leptin, significantly enhanced miR21 levels, decreased Grhl3 repression and NOS3 phosphorylation. Leptin supplementation in isolated primary endothelial cells, Kupffer cells and stellate cells showed increased mir21 expression in stellate cells while sinusoidal injury was significantly higher in all cell types. Finally miR21 KO mice showed increased NOS3-p/NOS3 ratio and reversed SED markers in the rodent models of NASH. The experimental results described here show a close association of leptin-induced miR21 in aiding sinusoidal injury in NASH.	[Pourhoseini, Sahar; Seth, Ratanesh Kumar; Das, Suvarthi; Dattaroy, Diptadip; Chatterjee, Saurabh] Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA; [Kadiiska, Maria B.] Inst Environm Hlth Sci, Free Rad Metab Grp, Res Triangle Pk, NC 27709 USA; [Xie, Guanhua; Michelotti, Gregory A.; Diehl, Anna Mae] Duke Univ, Div Gastroenterol, Durham, NC 27707 USA; [Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chatterjee, S (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA.	schatt@mailbox.sc.edu	Das, Suvarthi/AAK-2589-2020; Das, Suvarthi/AAA-4364-2020; Kadiiska, Maria B./AAC-9981-2019; Seth, Ratanesh/M-3700-2016	Seth, Ratanesh/0000-0002-7078-0052; , Gregory/0000-0002-3936-4675; Nagarkatti, Mitzi/0000-0002-5977-5615	NIH [4R00ES019875-02, R01DK053792, P20GM103641, R01AT006888, R01ES019313]; Intramural Research Program of the National Institutes of Health; National Institute of Environmental Health Sciences; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053792, T32DK007568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES019875, R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH pathway to Independence Award (4R00ES019875-02 to Saurabh Chatterjee), NIH R01 (R01DK053792 to Anna Mae Diehl) NIH grants (P20GM103641, R01AT006888, R01ES019313 to Mitzi Nagarkatti) and the Intramural Research Program of the National Institutes of Health and the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021; Cayon A, 2006, LIVER INT, V26, P1065, DOI 10.1111/j.1478-3231.2006.01337.x; Ceccarelli S, 2013, INT J MOL SCI, V14, P8437, DOI 10.3390/ijms14048437; Chatterjee S, 2012, J HEPATOL; Cheung O, 2010, CURR PHARM DESIGN, V16, P1952, DOI 10.2174/138161210791208866; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Das S, 2013, TOXICOL APPL PHARM; De Minicis S, 2008, HEPATOLOGY, V48, P2016, DOI 10.1002/hep.22560; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; Ikejima K, 2001, HEPATOLOGY, V34, P288, DOI 10.1053/jhep.2001.26518; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kerr TA, 2011, TRANSL RES, V157, P241, DOI 10.1016/j.trsl.2011.01.008; Kida K, 2011, PHARM RES-DORDR, V28, P2467, DOI 10.1007/s11095-011-0473-y; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Krawczyk K, 2009, J PHYSIOL PHARMACOL, V60, P71; Lawrie CH, 2013, BLOOD REV, V27, P143, DOI 10.1016/j.blre.2013.04.002; Li ZP, 2002, GASTROENTEROLOGY, V123, P1304, DOI 10.1053/gast.2002.35997; Lukosz M, 2011, BIOCHEM BIOPH RES CO, V412, P648, DOI 10.1016/j.bbrc.2011.08.018; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Musso G, 2010, ANNU REV MED, V61, P375, DOI 10.1146/annurev.med.60.101107.134820; Nakagawa T, 2007, AM J PHYSIOL-RENAL, V292, pF1665, DOI 10.1152/ajprenal.00495.2006; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pogribny IP, 2013, EXPERT OPIN DRUG MET, V9, P713, DOI 10.1517/17425255.2013.783817; Procaccini C, 2010, CURR PHARM DESIGN, V16, P1902, DOI 10.2174/138161210791208884; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, pG167, DOI 10.1152/ajpgi.00385.2009; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Saxena NK, 2003, J CELL BIOCHEM, V89, P311, DOI 10.1002/jcb.10494; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Seth RK, 2014, TOXICOL APPL PHARM, V274, P42, DOI 10.1016/j.taap.2013.10.029; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zhang Y, 2006, PHYSIOL BEHAV, V88, P249, DOI 10.1016/j.physbeh.2006.05.038	55	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116780	10.1371/journal.pone.0116780	http://dx.doi.org/10.1371/journal.pone.0116780			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658689	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900065
J	Quintero-Hernandez, V; Ramirez-Carreto, S; Romero-Gutierrez, MT; Valdez-Velazquez, LL; Becerril, B; Possani, LD; Ortiz, E				Quintero-Hernandez, Veronica; Ramirez-Carreto, Santos; Romero-Gutierrez, Maria Teresa; Valdez-Velazquez, Laura L.; Becerril, Baltazar; Possani, Lourival D.; Ortiz, Ernesto			Transcriptome Analysis of Scorpion Species Belonging to the Vaejovis Genus	PLOS ONE			English	Article							KV1.3 POTASSIUM CHANNELS; VENOM PEPTIDES; FUNCTIONAL-CHARACTERIZATION; SARCOPLASMIC-RETICULUM; MOLECULAR DIVERSITY; RYANODINE RECEPTOR; CHEMICAL-SYNTHESIS; DISULFIDE BRIDGES; CDNA SEQUENCES; CLONING	Scorpions belonging to the Buthidae family have traditionally drawn much of the biochemist's attention due to the strong toxicity of their venoms. Scorpions not toxic to mammals, however, also have complex venoms. They have been shown to be an important source of bioactive peptides, some of them identified as potential drug candidates for the treatment of several emerging diseases and conditions. It is therefore important to characterize the large diversity of components found in the non-Buthidae venoms. As a contribution to this goal, this manuscript reports the construction and characterization of cDNA libraries from four scorpion species belonging to the Vaejovis genus of the Vaejovidae family: Vaejovis mexicanus, V. intrepidus, V. subcristatus and V. punctatus. Some sequences coding for channel-acting toxins were found, as expected, but the main transcribed genes in the glands actively producing venom were those coding for non disulfide-bridged peptides. The ESTs coding for putative channel-acting toxins, corresponded to sodium channel beta toxins, to members of the potassium channel-acting a or. families, and to calcium channel-acting toxins of the calcin family. Transcripts for scorpine-like peptides of two different lengths were found, with some of the species coding for the two kinds. One sequence coding for La1-like peptides, of yet unknown function, was found for each species. Finally, the most abundant transcripts corresponded to peptides belonging to the long chain multifunctional NDBP-2 family and to the short antimicrobials of the NDBP-4 family. This apparent venom composition is in correspondence with the data obtained to date for other non-Buthidae species. Our study constitutes the first approach to the characterization of the venom gland transcriptome for scorpion species belonging to the Vaejovidae family.	[Quintero-Hernandez, Veronica; Ramirez-Carreto, Santos; Romero-Gutierrez, Maria Teresa; Becerril, Baltazar; Possani, Lourival D.; Ortiz, Ernesto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Valdez-Velazquez, Laura L.] Univ Colima, Fac Ciencias Quim, Colima, Mexico; [Valdez-Velazquez, Laura L.] Univ Colima, Fac Med, Colima, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Colima; Universidad de Colima	Possani, LD (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	possani@ibt.unam.mx; erne@ibt.unam.mx	Valdez-Velazquez, Laura L/AAM-1280-2021; Ortiz, Ernesto/E-4592-2013	Valdez-Velazquez, Laura L/0000-0001-8474-1495; Romero-Gutierrez, Teresa/0000-0002-4882-7491; Quintero-Hernandez, Veronica/0000-0002-1856-8134; Ortiz, Ernesto/0000-0002-8713-0224; RAMIREZ-CARRETO, SANTOS/0000-0002-8052-9793	Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT) [153496)]; Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico [200113]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT); Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico	The work described here was partially financed by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) of the Mexican Government (SEP-CONACyT #153496) and Direccion General de Asuntos del Personal Academico (DGAPA) of the National Autonomous University of Mexico (grant #200113) to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; BECERRIL B, 1993, GENE, V128, P165, DOI 10.1016/0378-1119(93)90559-L; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Chen TB, 2005, PEPTIDES, V26, P731, DOI 10.1016/j.peptides.2004.12.002; Chen TB, 2003, REGUL PEPTIDES, V115, P115, DOI 10.1016/S0167-0115(03)00146-0; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chippaux JP, 2012, DRUG DES DEV THER, V6, P165, DOI 10.2147/DDDT.S24754; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Darbon H, 1999, J Soc Biol, V193, P445; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; FERREIRA LAF, 1993, TOXICON, V31, P941, DOI 10.1016/0041-0101(93)90253-F; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; Gao B, 2009, FASEB J, V23, P1230, DOI 10.1096/fj.08-122317; Garcia F, 2013, J ANTIBIOT, V66, P3, DOI 10.1038/ja.2012.87; Gurrola GB, 2012, BIOCHEMISTRY-US, V51, P4049, DOI 10.1021/bi300060n; Hernandez-Aponte CA, 2011, TOXICON, V57, P84, DOI 10.1016/j.toxicon.2010.10.008; Hoffmann CC, 1931, MONOGRAFIA ANAL I BI, V2, P117; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Ji YH, 1997, CHINESE SCI BULL, V42, P952, DOI 10.1007/BF02882556; Kamachi S, 2014, ACTA CRYSTALLOGR F, V70, P915, DOI 10.1107/S2053230X14010589; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Matsushita N, 2007, TOXICON, V50, P861, DOI 10.1016/j.toxicon.2007.06.014; Miyashita M, 2007, TOXICON, V50, P428, DOI 10.1016/j.toxicon.2007.04.012; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Morrissette J, 1996, BIOPHYS J, V71, P707, DOI 10.1016/S0006-3495(96)79270-6; Nascimento DG, 2006, TOXICON, V47, P628, DOI 10.1016/j.toxicon.2006.01.015; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Ortiz E, 2014, BBA-GEN SUBJECTS, V1840, P1738, DOI 10.1016/j.bbagen.2013.12.012; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; Ramirez-Carreto S, 2012, PEPTIDES, V34, P290, DOI 10.1016/j.peptides.2012.02.002; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Sambrook J., 2001, MOL CLONING LAB MANU; Lopez CS, 2010, ZOOTAXA, P49; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Schwartz EF, 2009, BRIT J PHARMACOL, V157, P392, DOI 10.1111/j.1476-5381.2009.00147.x; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Sissom WD, 2010, CATALOG SCORPIONS WO, P503; Smith JJ, 2013, P NATL ACAD SCI USA, V110, P8906, DOI 10.1073/pnas.1214062110; Smith Jennifer J, 2012, J Venom Res, V3, P7; Soleglad ME, 2003, EUSCORPIUS, V11, P1, DOI DOI 10.18590/euscorpius.2003.vol2003.iss11.1; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Soudani N, 2005, Arch Inst Pasteur Tunis, V82, P39; Stahnke HL, 1974, J ARACHNOL, V1, P35; Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Tuuri RE, 2011, PEDIATR EMERG CARE, V27, P667, DOI 10.1097/PEC.0b013e3182228dfa; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Uawonggul N, 2007, TOXICON, V49, P19, DOI 10.1016/j.toxicon.2006.09.003; Valdez-Velazquez LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066486; VALDIVIA HH, 1991, J BIOL CHEM, V266, P19135; VALDIVIA HH, 1992, P NATL ACAD SCI USA, V89, P12185, DOI 10.1073/pnas.89.24.12185; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zeng XC, 2000, IUBMB LIFE, V49, P207, DOI 10.1080/713803610; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1	82	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117188	10.1371/journal.pone.0117188	http://dx.doi.org/10.1371/journal.pone.0117188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659089	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900113
J	Yaya, I; Saka, B; Landoh, DE; Patchali, PM; Patassi, AA; Aboubakari, AS; Makawa, MS; N'Dri, MK; Senanou, S; Lamboni, B; Idrissou, D; Salaka, KT; Pitche, P				Yaya, Issifou; Saka, Bayaki; Landoh, Dadja Essoya; Patchali, P'Niwe Massoubayo; Patassi, Akouda Akessiwe; Aboubakari, Abdoul-Samadou; Makawa, Makawa-Sy; N'Dri, Mathias Kouame; Senanou, Sekande; Lamboni, Bassan; Idrissou, Daoudou; Salaka, Kao Tanang; Pitche, Palokinam			HIV Status Disclosure to Sexual Partners, among People Living with HIV and AIDS on Antiretroviral Therapy at Sokode Regional Hospital, Togo	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; HIV/AIDS; UGANDA; TANZANIA; PREDICTORS; WOMEN; RISK; CARE	Background Many studies have reported factors associated with HIV status disclosure among People Living With HIV and AIDS (PLWHA) but very few were conducted among PLWHA receiving ART. In Togo, no study on HIV status disclosure to sexual partners has been conducted among PLWHA on ART yet. We sought to document factors associated with HIV status disclosure among PLWHA receiving ART at Sokode regional hospital in Togo. Method This was a cross-sectional study conducted from May to July 2013 at the regional hospital of Sokode among 291 PLWHA who had been on ART for at least three months. Results A total of 291 PLWHA on ART were enrolled in this study. Their mean age (+/- SD) was 37.3 +/- 9.3 years and the sex ratio (Male/Female) was 0.4. Among them, 215 (74.6%) completed the questionnaire on HIV sero-status disclosure. We found that 131 PLWHA (60.9%) had disclosed their HIV sero-status to their sexual partners; 130 (60.5%) were aware of the HIV status of their sexual partners. In the multivariate analysis, the factors associated with HIV status disclosure to sexual partners were: adherence to ART (aOR = 4.89; 95%CI = [1.52; 15.78]), sexual partner awareness of HIV sero-status (aOR = 52.73; 95%CI = [14.76; 188.36]) and marital status of PLWHA (aOR = 6.10; 95%CI = [1.74; 21.37]). Conclusion This study allowed us to note that the disclosure of HIV status to sexual partners is relatively low and to document the associated factors such as adherence to ART, sexual partner awareness of HIV sero-status and marital status.	[Yaya, Issifou; N'Dri, Mathias Kouame] Aix Marseille Univ, Lab Sante Publ, EA 3279, Marseille, France; [Saka, Bayaki; Pitche, Palokinam] Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo; [Landoh, Dadja Essoya] Minist Sante, Div Epidemiol, Lome, Togo; [Patchali, P'Niwe Massoubayo; Senanou, Sekande] Ctr Hosp Reg CHR Sokode, Serv Dispensat Antiretroviraux ARV, Sokode, Togo; [Patassi, Akouda Akessiwe] Univ Lome, CHU Sylvanus Olympio, Serv Malad Infect, Lome, Togo; [Aboubakari, Abdoul-Samadou] CHU Kara, Serv Gynecoobstet, Kara, Togo; [Makawa, Makawa-Sy] Direct Prefectorale Sante Tone, Dapaong, Togo; [Lamboni, Bassan] Minist Sante, Programme Natl Lutte Malad Non Transmissibles, Lome, Togo; [Idrissou, Daoudou] Minist Sante, Div Sante Familiale, Lome, Togo; [Salaka, Kao Tanang] Minist Sante, Div Sante Communautaire, Lome, Togo; [Pitche, Palokinam] Conseil Natl Lutte IST VIH Sida, Lome, Togo	UDICE-French Research Universities; Aix-Marseille Universite	Saka, B (corresponding author), Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo.	barthelemysaka@yahoo.fr	YAYA, Issifou/J-3662-2017	YAYA, Issifou/0000-0002-2554-6515; N'DRI, KOUAME MATHIAS/0000-0001-8620-0457				Amoran OE, 2012, NIGER J CLIN PRACT, V15, P385, DOI 10.4103/1119-3077.104507; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Coutherut J, 2014, B SOC PATHOL EXOT; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Erku TA, 2012, PAN AFR MED J, V13, P87; Kangwende R A, 2009, Cent Afr J Med, V55, P1; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-433; Kouanda S, 2012, REV EPIDEMIOL SANTE, V60, P221, DOI 10.1016/j.respe.2011.12.135; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Ministere de la sante, 2012, PLAN NAT DEV SAN 201; Ndiaye C, 2008, World Health Popul, V10, P43; ONUSIDA, 2001, EP VIH SIDA PARL OUV, P43; Osinde MO, 2012, INT J GYNECOL OBSTET, V118, P61, DOI 10.1016/j.ijgo.2012.02.008; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Programme National de Lutte contre le Sida et les IST au Togo, 2013, RAPP ACT 2012; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Sow K, 2013, SAHARA J-J SOC ASP H, V10, pS28, DOI 10.1080/02664763.2012.755322; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Yonah G, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-5	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118157	10.1371/journal.pone.0118157	http://dx.doi.org/10.1371/journal.pone.0118157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658105	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900268
J	Chauvigne, F; Zapater, C; Stavang, JA; Taranger, GL; Cerda, J; Finn, RN				Chauvigne, Francois; Zapater, Cinta; Stavang, Jon Anders; Taranger, Geir Lasse; Cerda, Joan; Finn, Roderick Nigel			The pH sensitivity of Aqp0 channels in tetraploid and diploid teleosts	FASEB JOURNAL			English	Article						aquaporin; water transport; permeability lens; cataract	RAY-FINNED FISH; AQUAPORIN WATER PERMEABILITY; FIBER CELL-DIFFERENTIATION; MAJOR INTRINSIC PROTEIN; SALMO-SALAR L.; ATLANTIC SALMON; GENOME DUPLICATION; LENS DEVELOPMENT; EXPRESSION; EYE	Water homeostasis and the structural integrity of the vertebrate lens is partially mediated by AQP0 channels. Emerging evidence indicates that external pH may be involved in channel gating. Here we show that a tetraploid teleost, the Atlantic salmon, retains 4 aqp0 genes (aqp0a1, -0a2, -0b1, and -0b2), which are highly, but not exclusively, expressed in the lens. Functional characterization reveals that, although each paralog permeates water efficiently, the permeability is respectively shifted to the neutral, alkaline, or acidic pH in Aqp0a1, -0a2, and -0b1, whereas that of Aqp0b2 is not regulated by external pH. Mutagenesis studies demonstrate that Ser(38), His(39), and His(40) residues in the extracellular transmembrane domain of -helix 2 facing the water pore are critical for the pH modulation of water transport. To validate these findings, we show that both zebrafish Aqp0a and -0b are functional water channels with respective pH sensitivities toward alkaline or acid pH ranges and that an N-terminal allelic variant (Ser(19)) of Aqp0b exists that abolishes water transport in Xenopus laevis oocytes. The data suggest that the alkaline pH sensitivity is a conserved trait in teleost Aqp0 a-type channels, whereas mammalian AQP0 and some teleost Aqp0 b-type channels display an acidic pH permeation preference.	[Chauvigne, Francois; Stavang, Jon Anders; Finn, Roderick Nigel] Univ Bergen, Bergen High Technol Ctr, Dept Biol, N-5020 Bergen, Norway; [Chauvigne, Francois; Zapater, Cinta; Cerda, Joan] CSIC, Inst Ciencias Mar, IRTA, Barcelona, Spain; [Taranger, Geir Lasse; Finn, Roderick Nigel] Inst Marine Res, N-5024 Bergen, Norway	University of Bergen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; Institute of Marine Research - Norway	Finn, RN (corresponding author), Univ Bergen, Bergen High Technol Ctr, Dept Biol, N-5020 Bergen, Norway.	joan.cerda@irta.cat; nigel.finn@bio.uib.no	Finn, Roderick Nigel/Y-2916-2019; Zapater, Cinta/L-9406-2017; Chauvigne, Francois/D-6854-2017; Cerdà, Joan/M-1099-2016	Finn, Roderick Nigel/0000-0002-8776-3945; Zapater, Cinta/0000-0001-9326-7502; Chauvigne, Francois/0000-0001-5571-7517; Cerdà, Joan/0000-0003-2568-6398	Research Council of Norway (RCN) [224816/E40, 178837/40]; Spanish Ministry of Science and Innovation (MICINN) [AGL2010-15597]; RCN [224816/E40, 178837/40]; MICINN	Research Council of Norway (RCN)(Research Council of Norway); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RCN; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	The authors thank Per Gunnar Fjelldal (Institute of Marine Research, Norway) for assistance during the sampling of salmon. This work was supported by Research Council of Norway (RCN) Projects 224816/E40 and 178837/40 (to R.N.F.), and Spanish Ministry of Science and Innovation (MICINN) Grant AGL2010-15597 (to J.C.). F.C. and J.A.S. were supported by postdoctoral fellowships from the RCN (224816/E40 and 178837/40, respectively); C.Z. was supported by a predoctoral fellowship (FPI) from MICINN. The authors declare no conflicts of interest.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Ahmad N, 2013, INT J DEV BIOL, V57, P741, DOI 10.1387/ijdb.130193jg; Allendorf F.W., 1984, P1; Ball LE, 2003, INVEST OPHTH VIS SCI, V44, P4820, DOI 10.1167/iovs.02-1317; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; BASSNETT S, 1987, EXP EYE RES, V44, P143, DOI 10.1016/S0014-4835(87)80032-5; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chauvigne F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110783; Chauvigne F, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-34; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Clemens D. M., 2013, INVEST OPHTH VIS SCI, P5136; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Easter SS, 1996, DEV BIOL, V180, P646; Eckert R, 2002, PFLUG ARCH EUR J PHY, V443, P843, DOI 10.1007/s00424-001-0760-2; Engelund MB, 2013, J EXP BIOL, V216, P3873, DOI 10.1242/jeb.087890; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Fischbarg J, 2012, MOL ASPECTS MED, V33, P638, DOI 10.1016/j.mam.2012.07.016; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Froger A, 2010, INVEST OPHTH VIS SCI, V51, P6582, DOI 10.1167/iovs.10-5626; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Gustafsson OSE, 2010, J MORPHOL, V271, P980, DOI 10.1002/jmor.10849; Hall JE, 2014, BIOPHYS J, V107, P10, DOI 10.1016/j.bpj.2014.05.023; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Karasawa Kaoru, 2011, Vet J, V190, pe72, DOI 10.1016/j.tvjl.2010.12.027; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Kumari SS, 2014, BIOCHEM BIOPH RES CO, V452, P986, DOI 10.1016/j.bbrc.2014.09.032; Kumari SS, 2012, MOL VIS, V18, P957; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Madsen SS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00056; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; MICHEA LF, 1994, BIOCHEMISTRY-US, V33, P7663, DOI 10.1021/bi00190a021; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; Naran D, 2006, AFR ZOOL, V41, P178, DOI 10.3377/1562-7020(2006)41[178:KOTRMG]2.0.CO;2; Narumi Y, 2014, AM J MED GENET A, V164, P1272, DOI 10.1002/ajmg.a.36433; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nemeth-Cahalan KL, 2013, J GEN PHYSIOL, V141, P287, DOI 10.1085/jgp.201210884; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Ogino H, 2012, DEV BIOL, V363, P333, DOI 10.1016/j.ydbio.2012.01.006; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; SIVAK JG, 1991, VISION RES, V31, P373, DOI 10.1016/0042-6989(91)90090-R; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; UYENO T, 1972, SCIENCE, V175, P644, DOI 10.1126/science.175.4022.644; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Verkman AS, 2003, EXP EYE RES, V76, P137, DOI 10.1016/S0014-4835(02)00303-2; Virkki LV, 2001, AM J PHYSIOL-REG I, V281, pR1994, DOI 10.1152/ajpregu.2001.281.6.R1994; Waagbo R, 2003, J FISH DIS, V26, P213, DOI 10.1046/j.1365-2761.2003.00449.x; Waagbo R, 2010, BRIT J NUTR, V104, P1460, DOI 10.1017/S0007114510002485; WALL AE, 1992, VET REC, V131, P553; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wang XN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003645; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Zampighi GA, 2002, EXP EYE RES, V75, P505, DOI 10.1006/exer.2002.2041; Zapater C, 2013, GEN COMP ENDOCR, V182, P24, DOI 10.1016/j.ygcen.2012.11.015; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146	86	12	12	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2172	2184		10.1096/fj.14-267625	http://dx.doi.org/10.1096/fj.14-267625			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25667219	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000354114600047
J	Meabon, JS; De Laat, R; Leguchi, K; Wiley, JC; Hudson, MP; Bothwell, M				Meabon, James S.; De Laat, Rian; Leguchi, Katsuaki; Wiley, Jesse C.; Hudson, Mark P.; Bothwell, Mark			LINGO-1 Protein Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE DIFFERENTIATION; AXONAL REGENERATION; SURFACE EXPRESSION; FAMILY-MEMBER; NOGO RECEPTOR; INHIBITION; WNK4; COTRANSPORTER; RELEASE	Axon outgrowth inhibition in response to trauma is thought to be mediated via the binding of myelin-associated inhibitory factors (e.g. Nogo-66, myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, and myelin basic protein) to a putative tripartite LINGO-1-p75(NTR).Nogo-66 receptor (NgR) complex at the cell surface. We found that endogenous LINGO-1 expression in neurons in the cortex and cerebellum is intracellular. Mutation or truncation of the highly conserved LINGO-1 C terminus altered this intracellular localization, causing poor intracellular retention and increased plasma membrane expression. p75(NTR) associated predominantly with natively expressed LINGO-1 containing immature N-glycans, characteristic of protein that has not completed trans-Golgi-mediated processing, whereas mutant forms of LINGO-1 with enhanced plasma membrane expression did not associate with p75(NTR). Co-immunoprecipitation experiments demonstrated that LINGO-1 and NgR competed for binding to p75(NTR) a manner that is difficult to reconcile with the existence of a LINGO-1.p75(NTR).NgR ternary complex. These findings contradict models postulating functional LINGO-1.p75(NTR).NgR complexes in the plasma membrane.	[Meabon, James S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98109 USA; [Wiley, Jesse C.] Univ Washington, Dept Comparat Med, Seattle, WA 98109 USA; [Hudson, Mark P.; Bothwell, Mark] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98109 USA; [Meabon, James S.] Vet Affairs Med Ctr, Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA; [De Laat, Rian] Immusoft, Seattle, WA 98103 USA; [Leguchi, Katsuaki] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo 1628666, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tokyo Women's Medical University	Bothwell, M (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98109 USA.	mab@uw.edu			National Institutes of Health [NS47348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS47348 (to M. B.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Bandtlow Christine, 2004, Sci STKE, V2004, ppe24, DOI 10.1126/stke.2352004pe24; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Escudero CA, 2014, J CELL SCI, V127, P1966, DOI 10.1242/jcs.141754; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Jepson S, 2012, J BIOL CHEM, V287, P22184, DOI 10.1074/jbc.M112.366179; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029771; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhong XT, 2009, FEBS LETT, V583, P1034, DOI 10.1016/j.febslet.2009.02.034	32	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9511	9520		10.1074/jbc.M114.608018	http://dx.doi.org/10.1074/jbc.M114.608018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666623	Green Published, hybrid			2022-12-26	WOS:000352729400018
J	Ithychanda, SS; Fang, XY; Mohan, ML; Zhu, L; Tirupula, KC; Prasad, SVN; Wang, YX; Karnik, SS; Qin, J				Ithychanda, Sujay Subbayya; Fang, Xianyang; Mohan, Maradumane L.; Zhu, Liang; Tirupula, Kalyan C.; Prasad, Sathyamangla V. Naga; Wang, Yun-Xing; Karnik, Sadashiva S.; Qin, Jun			A Mechanism of Global Shape-dependent Recognition and Phosphorylation of Filamin by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; SMALL-ANGLE SCATTERING; POSTTRANSLATIONAL MODIFICATIONS; BIOLOGICAL MACROMOLECULES; SUBSTRATE-SPECIFICITY; CONSENSUS SEQUENCES; STRUCTURAL BASIS; LIGAND-BINDING; LINEAR MOTIFS; ACTIVATION	Protein phosphorylation mediates essentially all aspects of cellular life. In humans, this is achieved by similar to 500 kinases, each recognizing a specific consensus motif (CM) in the substrates. The majority of CMs are surface-exposed and are thought to be accessible to kinases for phosphorylation. Here we investigated the archetypical protein kinase A (PKA)-mediated phosphorylation of filamin, a major cytoskeletal protein that can adopt an autoinhibited conformation. Surprisingly, autoinhibited filamin is refractory to phosphorylation by PKA on a known Ser(2152) site despite itsCMbeing exposed and the corresponding isolated peptide being readily phosphorylated. Structural analysis revealed that although the CM fits into the PKA active site its surrounding regions sterically clash with the kinase. However, upon ligand binding, filamin undergoes a conformational adjustment, allowing rapid phosphorylation on Ser(2152). These data uncover a novel ligand-induced conformational switch to trigger filamin phosphorylation. They further suggest a substrate shape-dependent filtering mechanism that channels specific exposed CM/kinase recognition in diverse signaling responses.	[Ithychanda, Sujay Subbayya; Mohan, Maradumane L.; Zhu, Liang; Tirupula, Kalyan C.; Prasad, Sathyamangla V. Naga; Karnik, Sadashiva S.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Fang, Xianyang; Wang, Yun-Xing] NCI, NIH, Protein Nucle Acid Interact Sect, Struct Biophys Lab, Frederick, MD 21702 USA; [Zhu, Liang; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Mail Code NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Zhu, Liang/GMX-3125-2022; Ithychanda, Sujay Subbayya/C-7792-2011; Karnik, Sadashiva/Y-2477-2019	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Karnik, Sadashiva/0000-0003-0746-2753; Fang, Xianyang/0000-0001-9432-9736; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM062823, HL057470, HL089473]; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089473, R01HL115964, R01HL057470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM062823, HL057470, and HL089473 (to J.Q., S.S.K., and S.V.N.P.).	Aksaas Anne Kristin, 2011, Genes Cancer, V2, P841, DOI 10.1177/1947601911430226; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CARROLL RC, 1982, BLOOD, V59, P466; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Chen D., 1999, MOL CELL BIOL, V19, P1002; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenhaber B, 2007, CURR PROTEIN PEPT SC, V8, P197, DOI 10.2174/138920307780363424; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hastie LE, 1997, J CELL PHYSIOL, V172, P373, DOI 10.1002/(SICI)1097-4652(199709)172:3<373::AID-JCP11>3.0.CO;2-7; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jay D, 2004, MOL CELL BIOCHEM, V260, P49, DOI 10.1023/B:MCBI.0000026052.76418.55; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Levene PA, 1906, J BIOL CHEM, V2, P127; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marazita MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035638; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Simon EJ, 2010, NEUROCHEM RES, V35, P1859, DOI 10.1007/s11064-010-0261-9; SPARKS JW, 1986, INT J BIOCHEM, V18, P497, DOI 10.1016/0020-711X(86)90159-X; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyanova S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002842; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vandermarliere E, 2013, PROTEOMICS, V13, P1028, DOI 10.1002/pmic.201200232; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	77	13	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8527	8538		10.1074/jbc.M114.633446	http://dx.doi.org/10.1074/jbc.M114.633446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666618	hybrid, Green Published			2022-12-26	WOS:000351662600043
J	Ibrahim, SM; El-Denshary, ES; Abdallah, DM				Ibrahim, Sherehan M.; El-Denshary, Ezzedin S.; Abdallah, Dalaal M.			Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLYCATION END-PRODUCTS; INSULIN-RESISTANCE; PPAR-GAMMA; ADIPOSE-TISSUE; UP-REGULATION; NITRIC-OXIDE; URIC-ACID; RECEPTOR; ADIPONECTIN	Geraniol (GO) potent antitumor and chemopreventive effects are attributed to its antioxidant and anti-inflammatory properties. In the current study, the potential efficacy of GO (250 mg/kg) in ameliorating metabolic syndrome (MetS) induced by fructose in drinking water was elucidated. Moreover, the effect of pioglitazone (5 and 10 mg/kg; PIO) and the possible interaction of the co-treatment of GO with PIO5 were studied in the MetS model. After 4 weeks of treatment, GO and/or PIO reduced the fasting blood glucose and the glycemic excursion in the intraperitoneal glucose tolerance test. GO and PIO5/10 restrained visceral adiposity and partly the body weight gain. The decreased level of peroxisome proliferator activated receptor (PPAR)-gamma transcriptional activity in the visceral adipose tissue of MetS rats was increased by single treatment regimens. Though GO did not affect MetS-induced hyperinsulinemia, PIO5/10 lowered it. Additionally, GO and PIO5/10 suppressed glycated hemoglobin and the receptor for advanced glycated end products (RAGE). These single regimens also ameliorated hyperuricemia, the disrupted lipid profile, and the elevated systolic blood pressure evoked by MetS. The rise in serum transaminases, interleukin-1 beta, and tumor necrosis factor-alpha, as well as hepatic lipid peroxides and nitric oxide (NO) was lowered by the single treatments to different extents. Moreover, hepatic non-protein thiols, as well as serum NO and adiponectin were enhanced by single regimens. Similar effects were reached by the combination of GO with PIO5; however, a potentiative interaction was noted on fasting serum insulin level, while synergistic effects were reflected as improved insulin sensitivity, as well as reduced RAGE and triglycerides. Therefore, GO via the transcriptional activation of PPAR-gamma reduces inflammation and free radical injury produced by MetS. Thereby, these effects provide novel mechanistic insights on GO management of MetS associated critical risk factors. Moreover, the co-administration of GO to PIO5 exalted the antidiabetic drug anti-MetS efficacy.	[Ibrahim, Sherehan M.; El-Denshary, Ezzedin S.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Abdallah, DM (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	dalabdallah@staff.cu.edu.eg	Abdallah, Dalaal/GVT-0783-2022	, Sherehan/0000-0003-3495-3451				Abate N, 2000, J DIABETES COMPLICAT, V14, P154, DOI 10.1016/S1056-8727(00)00067-2; Abe S, 2003, MEDIAT INFLAMM, V12, P323, DOI 10.1080/09629350310001633342; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Albright A L, 1994, Obes Res, V2, P535; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Bartolome N, 2007, ANN NY ACAD SCI, V1096, P55, DOI 10.1196/annals.1397.070; Brunzell JD, 2003, AM J MED, V115, P24, DOI 10.1016/j.amjmed.2003.08.011; Carnesecchi S, 2002, J PHARMACOL EXP THER, V303, P711, DOI 10.1124/jpet.102.039263; CHADHA A, 1984, XENOBIOTICA, V14, P365, DOI 10.3109/00498258409151425; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Desai RV, 2010, AM J CARDIOL, V106, P1134, DOI 10.1016/j.amjcard.2010.06.023; Desiderio JG, 2005, 37 MIDDL ATL REG M; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; El-Abhar HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037757; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elmazar MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045638; Emanuelli B, 2004, DIABETES, V53, pS97, DOI 10.2337/diabetes.53.suppl_3.S97; Fried SK, 2003, AM J CLIN NUTR, V78, p873S, DOI 10.1093/ajcn/78.4.873S; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Grundy SM, 2006, AM J CLIN NUTR, V83, P1248, DOI 10.1093/ajcn/83.6.1248; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; HIRSCH J, 1995, AM J CLIN NUTR, V61, p996S, DOI 10.1093/ajcn/61.4.996S; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jack MM, 2012, EXP NEUROL, V234, P62, DOI 10.1016/j.expneurol.2011.12.015; Jayachandran M, 2015, MOL CELL BIOCHEM, V398, P39, DOI 10.1007/s11010-014-2203-3; Katsukawa M, 2011, BIOSCI BIOTECH BIOCH, V75, P1010, DOI 10.1271/bbb.110039; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Khan MA, 2002, DIABETES CARE, V25, P708, DOI 10.2337/diacare.25.4.708; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Liang HF, 2008, ENDOCRINOLOGY, V149, P2943, DOI 10.1210/en.2007-0978; Mahmoud AAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106993; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Marcuzzi A, 2011, IN VIVO, V25, P87; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Milan G, 2002, OBES RES, V10, P1095, DOI 10.1038/oby.2002.149; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; de Carvalho KIM, 2014, N-S ARCH PHARMACOL, V387, P355, DOI 10.1007/s00210-013-0947-z; Ong TP, 2006, CARCINOGENESIS, V27, P1194, DOI 10.1093/carcin/bgi291; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Psyrogiannis Agathoklis, 2003, Hormones (Athens), V2, P161; Qin BL, 2008, AM J PHYSIOL-GASTR L, V294, pG1120, DOI 10.1152/ajpgi.00407.2007; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Robins SJ, 2003, DIABETES CARE, V26, P1513, DOI 10.2337/diacare.26.5.1513; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Singh BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034200; Spruss A, 2011, ANTIOXID REDOX SIGN, V14, P2121, DOI 10.1089/ars.2010.3263; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Su YW, 2010, PLANTA MED, V76, P1666, DOI 10.1055/s-0030-1249947; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Tham DM, 2003, DRUG NEWS PERSPECT, V16, P109, DOI 10.1358/dnp.2003.16.2.740244; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Tjokroprawiro Askandar, 2006, Acta Med Indones, V38, P160; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vieira A, 2011, BRAZ J MED BIOL RES, V44, P538, DOI 10.1590/S0100-879X2011007500037; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang GZ, 2013, J THORAC DIS, V5, P706, DOI 10.3978/j.issn.2072-1439.2013.08.69; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yuan GJ, 2004, WORLD J GASTROENTERO, V10, P1047	75	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117516	10.1371/journal.pone.0117516	http://dx.doi.org/10.1371/journal.pone.0117516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679220	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600070
J	Chettier, R; Nelson, L; Ogilvie, JW; Albertsen, HM; Ward, K				Chettier, Rakesh; Nelson, Lesa; Ogilvie, James W.; Albertsen, Hans M.; Ward, Kenneth			Haplotypes at LBX1 Have Distinct Inheritance Patterns with Opposite Effects in Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-FUNCTION; VARIANTS; GENES	Adolescent idiopathic scoliosis (AIS) is a clinically significant disorder with high heritability that affects 2-4% of the population. Genome-wide association studies have identified LBX1 as a strong susceptibility locus for AIS in Asian and Caucasian populations. Here we further dissect the genetic association with AIS in a Caucasian population. To identify genetic markers associated with AIS we employed a genome-wide association study (GWAS) design comparing 620 female Caucasian patients who developed idiopathic scoliosis during adolescence with 1,287 ethnically matched females who had normal spinal curves by skeletal maturity. The genomic region around LBX1 was imputed and haplotypes investigated for genetic signals under different inheritance models. The strongest signal was identified upstream of LBX1 (rs11190878, P-trend = 4.18x10(-9), OR = 0.63[0.54-0.74]). None of the remaining SNPs pass the genome-wide significance threshold. We found rs11190870, downstream of LBX1 and previously associated with AIS in Asian populations, to be in modest linkage disequilibrium (LD) with rs11190878 (r(2) = 0.40, D' = 0.81). Haplotype analysis shows that rs11190870 and rs11190878 track a single risk factor that resides on the ancestral haplotype and is shared across ethnic groups. We identify six haplotypes at the LBX1 locus including two strongly associated haplotypes; a recessive risk haplotype (TTA, Control(freq) = 0.52, P = 1.25x10(-9), OR = 1.56), and a co-dominant protective haplotype (CCG, Control(freq) = 0.28, P = 2.75x10(-7), OR = 0.65). Together the association signals from LBX1 explain 1.4% of phenotypic variance. Our results identify two clinically relevant haplotypes in the LBX1-region with opposite effects on AIS risk. The study demonstrates the utility of haplotypes over un-phased SNPs for individualized risk assessment by more strongly delineating individuals at risk for AIS without compromising the effect size.	[Chettier, Rakesh; Nelson, Lesa; Ward, Kenneth] Affiliated Genet Inc, Salt Lake City, UT 84109 USA; [Ogilvie, James W.] Lucina Fdn, Salt Lake City, UT 84109 USA; [Albertsen, Hans M.; Ward, Kenneth] Juneau Biosci LLC, Salt Lake City, UT 84109 USA		Ward, K (corresponding author), Affiliated Genet Inc, Salt Lake City, UT 84109 USA.	kward@affiliatedgenetics.com			Affiliated Genetics, Inc.	Affiliated Genetics, Inc.	This study was funded by Affiliated Genetics, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Juneau Biosciences, LLC provided support in the form of salaries for authors HMA and KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barois A, 1999, B ACAD NAT MED PARIS, V183, P721; BENGTSSON G, 1974, ACTA PSYCHIAT SCAND, V50, P50, DOI 10.1111/j.1600-0447.1974.tb07656.x; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053234; Grauers A, 2012, EUR SPINE J, V21, P1069, DOI 10.1007/s00586-011-2074-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Kotwicki T, 2008, STUD HEALTH TECHNOL, V140, P44, DOI 10.3233/978-1-58603-888-5-44; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Lenke Lawrence G, 2005, Instr Course Lect, V54, P537; Lenke LG, 2003, SPINE, V28, pS199, DOI 10.1097/01.BRS.0000092216.16155.33; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Londono D, 2014, J MED GENET, V51, P401, DOI 10.1136/jmedgenet-2013-102067; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Miller NH, 2007, CLIN ORTHOP RELAT R, P6, DOI 10.1097/BLO.0b013e318126c062; Miller NH, 1999, ORTHOP CLIN N AM, V30, P343, DOI 10.1016/S0030-5898(05)70091-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; PEHRSSON K, 1991, THORAX, V46, P474, DOI 10.1136/thx.46.7.474; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu XS, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-38; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; RENSHAW TS, 1988, CLIN ORTHOP RELAT R, P26; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Tang NLS, 2012, J ORTHOP RES, V30, P1464, DOI 10.1002/jor.22090; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117708	10.1371/journal.pone.0117708	http://dx.doi.org/10.1371/journal.pone.0117708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675428	Green Submitted, gold, Green Published			2022-12-26	WOS:000349914000030
J	Chu, CHG; Kee, CS				Chu, Chin Hung Geoffrey; Kee, Chea Su			Effects of Optically Imposed Astigmatism on Early Eye Growth in Chicks	PLOS ONE			English	Article							TILTED-DISC SYNDROME; GANGLION-CELL LAYER; REFRACTIVE ERROR; CORNEAL ASTIGMATISM; FORM DEPRIVATION; EXPERIMENTAL MYOPIA; PRESCHOOL-CHILDREN; INFANT ASTIGMATISM; SPECTACLE LENSES; HIGH PREVALENCE	Purpose To determine the effects of optically imposed astigmatism on early eye growth in chicks. Methods 5-day-old (P5) White Leghorn chicks were randomly assigned to either wear, monocularly, a "high magnitude" (H: +4.00DS/-8.00DC) crossed-cylindrical lens oriented at one of four axes (45, 90, 135, and 180; n = 20 in each group), or were left untreated (controls; n = 8). Two additional groups wore a "low magnitude" (L: +2.00DS/-4.00DC) cylindrical lens orientated at either axis 90 or 180 (n = 20 and n = 18, respectively). Refractions were measured at P5 and after 7 days of treatment for all chicks (P12), whereas videokeratography and ex-vivo eyeshape analysis were performed at P12 for a subset of chicks in each group (n = 8). Results Compared to controls, chicks in the treatment groups developed significant amounts of refractive astigmatism (controls: 0.03 +/- 0.22DC; treatment groups: 1.34 +/- 0.22DC to 5.51 +/- 0.26DC, one-way ANOVAs, p <= 0.05) with axes compensatory to those imposed by the cylindrical lenses. H cylindrical lenses induced more refractive astigmatism than L lenses (H90 vs. L90: 5.51 +/- 0.26D vs. 4.10 +/- 0.16D; H180 vs. L180: 2.84 +/- 0.44D vs. 1.34 +/- 0.22D, unpaired two-sample t-tests, both p <= 0.01); and imposing with-the-rule (H90 and L90) and against-the- rule astigmatisms (H180 and L180) resulted in, respectively, steeper and flatter corneal shape. Both corneal and internal astigmatisms were moderately to strongly correlated with refractive astigmatisms (Pearson's r: +0.61 to +0.94, all p <= 0.001). In addition, the characteristics of astigmatism were significantly correlated with multiple eyeshape parameters at the posterior segments (Pearson's r: -0.27 to +0.45, all p <= 0.05). Conclusions Chicks showed compensatory ocular changes in response to the astigmatic magnitudes imposed in this study. The correlations of changes in refractive, corneal, and posterior eyeshape indicate the involvement of anterior and posterior ocular segments during the development of astigmatism.	[Chu, Chin Hung Geoffrey; Kee, Chea Su] Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Chu, CHG (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China.	geopicasso@yahoo.com		Kee, Chea-Su/0000-0002-5177-129X	RGC General Research Fund [561209]; Internal Competitive Research Grant [G-YK90]; Centre of Myopia Research; Niches Areas-Myopia Research Fund from The Hong Kong Polytechnic University [J-BB7P]	RGC General Research Fund; Internal Competitive Research Grant; Centre of Myopia Research; Niches Areas-Myopia Research Fund from The Hong Kong Polytechnic University	Grant support was provided by RGC General Research Fund #561209; Internal Competitive Research Grant G-YK90, The Centre of Myopia Research and The Niches Areas-Myopia Research Fund (J-BB7P) from The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JE, 1972, J AM OPTOM ASSOC, V43, P1257; Abrahamsson M, 2003, ACTA OPHTHALMOL SCAN, V81, P33, DOI 10.1034/j.1600-0420.2003.00022.x; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; ALPINS NA, 1993, J CATARACT REFR SURG, V19, P524, DOI 10.1016/S0886-3350(13)80617-7; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Avila NV, 2010, J COMP PHYSIOL A, V196, P825, DOI 10.1007/s00359-010-0562-0; Barutchu A, 2002, CLIN EXP OPHTHALMOL, V30, P217, DOI 10.1046/j.1442-9071.2002.00514.x; Batschelet E, 1981, CIRCULAR STAT BIOL; Benavente-Perez A, 2012, INVEST OPHTH VIS SCI, V53, P6479, DOI 10.1167/iovs.12-9822; Beresford JA, 2001, OPTOMETRY VISION SCI, V78, P40, DOI 10.1097/00006324-200101010-00013; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; Boote C, 2009, J STRUCT BIOL, V166, P195, DOI 10.1016/j.jsb.2009.01.009; Bozkurt B, 2002, CORNEA, V21, P458, DOI 10.1097/00003226-200207000-00005; Campbell M. C. W., 2008, J VISION, V8, P48; Chen Y, 2004, ANAT HISTOL EMBRYOL, V33, P161, DOI 10.1111/j.1439-0264.2004.00528.x; Chen YX, 2000, J VET MED SCI, V62, P53, DOI 10.1292/jvms.62.53; Chu CH, 2012, VISION RES, V55, P24, DOI 10.1016/j.visres.2011.12.011; Chu CHG, 2014, VISION RES, V98, P26, DOI 10.1016/j.visres.2014.03.002; Clementi M, 1998, AM J HUM GENET, V63, P825, DOI 10.1086/302014; COULOMBRE ALFRED J., 1964, ADVANCE MORPHOGENESIS, V4, P81; Cowen L, 2003, INVEST OPHTH VIS SCI, V44, P4593, DOI 10.1167/iovs.02-0730; Cox MJ, 2010, ENCY EYE, P135; DEQUEIROZ K, 1988, AUK, V105, P29; Dobson V, 2003, VISION RES, V43, P1081, DOI 10.1016/S0042-6989(03)00014-2; Dobson V, 2008, INVEST OPHTH VIS SCI, V49, P4427, DOI 10.1167/iovs.08-1985; Dobson V, 2007, OPTOMETRY VISION SCI, V84, P124, DOI 10.1097/OPX.0b013e318031b6ac; Duke-Elder S, 1993, DUKE ELDERS PRACTICE; Duke-Elder S., 1970, OPHTHALMIC OPT REFRA; EHRLICH DL, 1995, VISION RES, V35, P1313, DOI 10.1016/0042-6989(94)00228-E; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fischer AJ, 2008, DEV BIOL, V317, P196, DOI 10.1016/j.ydbio.2008.02.023; FLEDELIUS HC, 1986, ACTA OPHTHALMOL, V64, P487; Flitcroft DI, 2005, BRIT J OPHTHALMOL, V89, P484, DOI 10.1136/bjo.2004.045328; FULTON AB, 1982, OPHTHALMOLOGY, V89, P298, DOI 10.1016/s0161-6420(82)34788-0; Furtado KS, 2013, OA ANAESTHETICS, V1, P20, DOI DOI 10.13172/2052-7853-1-2-1006; GLASSER A, 1994, VISION RES, V34, P1549, DOI 10.1016/0042-6989(94)90112-0; Goss DA, 1999, OPHTHAL PHYSL OPT, V19, P438, DOI 10.1046/j.1475-1313.1999.00455.x; Gunduz A, 2002, J CATARACT REFR SURG, V28, P1836, DOI 10.1016/S0886-3350(02)01424-4; GWIAZDA J, 1985, VISION RES, V25, P1269, DOI 10.1016/0042-6989(85)90042-2; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Harvey EM, 2006, OPTOMETRY VISION SCI, V83, P206, DOI 10.1097/01.opx.0000214333.84822.71; Harvey EM, 2011, INVEST OPHTH VIS SCI, V52, P4350, DOI 10.1167/iovs.10-6061; HOWLAND HC, 1978, SCIENCE, V202, P331, DOI 10.1126/science.694540; Huang J, 1997, INVEST OPHTHALMOL  S, V38, pS546; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; IRVING EL, 1992, OPHTHAL PHYSL OPT, V12, P448, DOI 10.1111/j.1475-1313.1992.tb00315.x; IRVING EL, 1991, OPTOMETRY VISION SCI, V68, P364, DOI 10.1097/00006324-199105000-00007; IRVING EL, 1995, VISION RES, V35, P1165, DOI 10.1016/0042-6989(94)00235-E; Irving EL, 1996, J COMP PHYSIOL A, V179, P185; Johnson CA, 2004, INVEST OPHTH VIS SCI, V45, pU416; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; Kaye SB, 1997, J CATARACT REFR SURG, V23, P1496, DOI 10.1016/S0886-3350(97)80020-X; Kee CS, 2008, INVEST OPHTH VIS SCI, V49, P858, DOI 10.1167/iovs.06-1370; Kee CS, 2013, EXP EYE RES, V114, P89, DOI 10.1016/j.exer.2013.04.020; Kee CS, 2004, INVEST OPHTH VIS SCI, V45, P1647, DOI 10.1167/iovs.03-0841; Kisilak ML, 2008, J MOD OPTIC, V55, P611, DOI 10.1080/09500340701470003; Lansche R K, 1966, Headache, V6, P147, DOI 10.1111/j.1526-4610.1966.hed0603147.x; Laskowski F. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS687; LORD REXFORD D., 1956, AMER MIDLAND NAT, V56, P325, DOI 10.2307/2422424; LYLE WM, 1972, AMER J OPT ARCH AM A, V49, P517; Mahan RP, 1991, CIRCULAR STAT METHOD, V16; Mandalos AT, 2002, EUR J OPHTHALMOL, V12, P1; MANDELMAN T, 1983, VISION RES, V23, P1555, DOI 10.1016/0042-6989(83)90169-4; MARSHTOOTLE WL, 1989, INVEST OPHTH VIS SCI, V30, P2245; McLean RC, 2003, INVEST OPHTH VIS SCI, V44, P449, DOI 10.1167/iovs.01-0670; Miller J M, 2000, Ophthalmic Epidemiol, V7, P187, DOI 10.1076/0928-6586(200009)7:3;1-V;FT187; MOHINDRA I, 1978, SCIENCE, V202, P329, DOI 10.1126/science.694539; Montes-Mico R, 2000, J PEDIAT OPHTH STRAB, V37, P349; MURPHY CJ, 1995, INVEST OPHTH VIS SCI, V36, P889; Nalbach HO, 1993, VISION BRAIN BEHAV B; Nickla DL, 2006, J COMP PHYSIOL A, V192, P399, DOI 10.1007/s00359-005-0077-2; Nickla DL, 2005, OPTOMETRY VISION SCI, V82, P318, DOI 10.1097/01.OPX.0000159368.31481.DE; Norton TT, 2006, INVEST OPHTH VIS SCI, V47, P4687, DOI 10.1167/iovs.05-1369; Oh IK, 2014, INVEST OPHTH VIS SCI, V55, P4313, DOI 10.1167/iovs.14-14277; Phillips J, 2000, P 8 INT C MYOP, P162; Pinero DP, 2014, CONTACT LENS ANTERIO, V37, P49, DOI 10.1016/j.clae.2013.07.006; RAASCH TW, 1995, OPTOMETRY VISION SCI, V72, P272, DOI 10.1097/00006324-199504000-00008; Read SA, 2007, CLIN EXPT OPTOMETRY, V90; SAUNDERS H, 1981, OPHTHAL PHYSL OPT, V1, P159, DOI 10.1111/j.1475-1313.1981.tb00388.x; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; Schmid KL, 1997, EXP EYE RES, V64, P837, DOI 10.1006/exer.1997.0282; Shen W, 2007, INVEST OPHTH VIS SCI, V48, P4829, DOI 10.1167/iovs.06-1273; Shih YF, 2004, OPTOMETRY VISION SCI, V81, P94, DOI 10.1097/00006324-200402000-00007; SIVAK JG, 1990, CIBA F SYMP, V155, P160; Smith EL, 1998, OPTOMETRY VISION SCI, V75, P388, DOI 10.1097/00006324-199806000-00023; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; Smith EL, 1998, MYOPIA UPDATES, P336; Sokol Jason A, 2005, Eye Contact Lens, V31, P111, DOI 10.1097/01.ICL.0000140921.39111.47; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Thibos LN, 2001, INVEST OPHTH VIS SCI, V42, pS58; Thomas S, 2000, VISION RES, V40, P3553, DOI 10.1016/S0042-6989(00)00209-1; TRELSTAD RL, 1971, J CELL BIOL, V50, P840, DOI 10.1083/jcb.50.3.840; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Votaw JR, 2004, ANESTHESIOLOGY, V101, P1128, DOI 10.1097/00000542-200411000-00012; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WALLMAN J, 1987, VISION RES, V27, P1139, DOI 10.1016/0042-6989(87)90027-7; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1988, CLIN VISION SCI, V3, P99; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38	102	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117729	10.1371/journal.pone.0117729	http://dx.doi.org/10.1371/journal.pone.0117729			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675443	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000031
J	Gerber, M; Fischer, A; Jagannathan, V; Drogemuller, M; Drogemuller, C; Schmidt, MJ; Bernardino, F; Manz, E; Matiasek, K; Rentmeister, K; Leeb, T				Gerber, Martina; Fischer, Andrea; Jagannathan, Vidhya; Droegemueller, Michaela; Droegemueller, Cord; Schmidt, Martin J.; Bernardino, Filipa; Manz, Eberhard; Matiasek, Kaspar; Rentmeister, Kai; Leeb, Tosso			A Deletion in the VLDLR Gene in Eurasier Dogs with Cerebellar Hypoplasia Resembling a Dandy-Walker-Like Malformation (DWLM)	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; DYSEQUILIBRIUM SYNDROME; QUADRUPEDAL LOCOMOTION; MUTATIONS; GENOME; IDENTIFICATION; ASSOCIATION	Dandy-Walker-like malformation (DWLM) is the result of aberrant brain development and mainly characterized by cerebellar hypoplasia. DWLM affected dogs display a non-progressive cerebellar ataxia. Several DWLM cases were recently observed in the Eurasier dog breed, which strongly suggested a monogenic autosomal recessive inheritance in this breed. We performed a genome-wide association study (GWAS) with 9 cases and 11 controls and found the best association of DWLM with markers on chromosome 1. Subsequent homozygosity mapping confirmed that all 9 cases were homozygous for a shared haplotype in this region, which delineated a critical interval of 3.35 Mb. We sequenced the genome of an affected Eurasier and compared it with the Boxer reference genome and 47 control genomes of dogs from other breeds. This analysis revealed 4 private non-synonymous variants in the critical interval of the affected Eurasier. We genotyped these variants in additional dogs and found perfect association for only one of these variants, a single base deletion in the VLDLR gene encoding the very low density lipoprotein receptor. This variant, VLDLR:c.1713delC is predicted to cause a frameshift and premature stop codon (p.W572Gfs*10). Variants in the VLDLR gene have been shown to cause congenital cerebellar ataxia and mental retardation in human patients and Vldlr knockout mice also display an ataxia phenotype. Our combined genetic data together with the functional knowledge on the VLDLR gene from other species thus strongly suggest that VLDLR:c.1713delC is indeed causing DWLM in Eurasier dogs.	[Gerber, Martina; Jagannathan, Vidhya; Droegemueller, Michaela; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland; [Fischer, Andrea; Bernardino, Filipa] Univ Munich, Clin Small Anim Med, Neurol Sect, D-80539 Munich, Germany; [Schmidt, Martin J.] Univ Giessen, Small Anim Clin, Dept Vet Clin Sci, D-35392 Giessen, Germany; [Manz, Eberhard] Generatio Sol GmbH, D-69115 Heidelberg, Germany; [Matiasek, Kaspar] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Sect Clin & Comparat Neuropathol, D-80539 Munich, Germany; [Rentmeister, Kai] Tierarztliche Praxis Neurol, D-97337 Dettelbach, Germany	University of Bern; University of Munich; Justus Liebig University Giessen; University of Munich	Leeb, T (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Fischer, Andrea/AFV-0155-2022; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Matiasek, Kaspar/0000-0001-5021-3280; Fischer, Andrea/0000-0001-7094-1947; Drogemuller, Cord/0000-0001-9773-522X	Albert-Heim Foundation; Alexander von Humboldt Foundation	Albert-Heim Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This study was funded in part by a grant from the Albert-Heim Foundation. T. Leeb received a Humboldt Research Award from the Alexander von Humboldt Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-80; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bernardino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117670; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; KNECHT CD, 1979, J AM ANIM HOSP ASSOC, V15, P51; Kolb LE, 2010, NEUROGENETICS, V11, P319, DOI 10.1007/s10048-009-0232-y; KORNEGAY JN, 1986, VET PATHOL, V23, P374, DOI 10.1177/030098588602300405; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schlotawa L, 2013, J NEUROL, V260, P1678, DOI 10.1007/s00415-013-6941-z; SCHMID V, 1992, J AM ANIM HOSP ASSOC, V28, P355; Sonmez FM, 2013, J CHILD NEUROL, V28, P379, DOI 10.1177/0883073812441065; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0108917	10.1371/journal.pone.0108917	http://dx.doi.org/10.1371/journal.pone.0108917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668033	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000001
J	Lachmandas, E; Vrieling, F; Wilson, LG; Joosten, SA; Netea, MG; Ottenhoff, TH; Van Crevel, R				Lachmandas, Ekta; Vrieling, Frank; Wilson, Louis G.; Joosten, Simone A.; Netea, Mihai G.; Ottenhoff, Tom H.; Van Crevel, Reinout			The Effect of Hyperglycaemia on In Vitro Cytokine Production and Macrophage Infection with Mycobacterium tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; TYPE-2 MACROPHAGES; INTERFERON-GAMMA; SUSCEPTIBILITY; DEFICIENCY; MONOCYTES; RESPONSES; IMMUNITY; BLOOD; MICE	Type 2 diabetes mellitus is an established risk factor for tuberculosis but the underlying mechanisms are largely unknown. We examined the effects of hyperglycaemia, a hallmark of diabetes, on the cytokine response to and macrophage infection with Mycobacterium tuberculosis. Increasing in vitro glucose concentrations from 5 to 25 mmol/L had marginal effects on cytokine production following stimulation of peripheral blood mononuclear cells (PBMCs) with Mycobacterium. tuberculosis lysate, LPS or Candida albicans, while 40 mmol/L glucose increased production of TNF-alpha, IL-1 beta, IL-6 and IL-10, but not of IFN-gamma, IL-17A and IL-22. Macrophage differentiation under hyperglycaemic conditions of 25 mmol/L glucose was also associated with increased cytokine production upon stimulation with Mycobacterium. tuberculosis lysate and LPS but in infection experiments no differences in Mycobacterium. tuberculosis killing or outgrowth was observed. The phagocytic capacity of these hyperglycaemic macrophages also remained unaltered. The fact that only very high glucose concentrations were able to significantly influence cytokine production by macrophages suggests that hyperglycaemia alone cannot fully explain the increased susceptibility of diabetes mellitus patients to tuberculosis.	[Lachmandas, Ekta; Netea, Mihai G.; Van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Lachmandas, Ekta; Netea, Mihai G.; Van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Vrieling, Frank; Wilson, Louis G.; Joosten, Simone A.; Ottenhoff, Tom H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Van Crevel, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Ekta.Lachmandas@rabdboudumc.nl	Joosten, Simone/E-4731-2011; Vrieling, Frank/AAC-7489-2022; Joosten, Simone A/F-1357-2011; Netea, Mihai/N-5155-2014; Lachmandas, Ekta/G-6682-2016; van Crevel, reinout/A-6636-2010	Joosten, Simone A/0000-0002-9878-0863; van Crevel, reinout/0000-0002-6233-6410; Vrieling, Frank/0000-0002-8064-672X	TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme) [305279]; ERC (European Research Council) Starting Grant (ERC) [310372]; Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [91710310]; EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases) [2012.1 312661]; EC-FP7 ADITEC (Advanced Immunization Technologies) [280873]; LUMC (Leiden University Medical Center) Profiling area grant	TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme); ERC (European Research Council) Starting Grant (ERC); Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases); EC-FP7 ADITEC (Advanced Immunization Technologies); LUMC (Leiden University Medical Center) Profiling area grant	This study was supported by the TANDEM (Tuberculosis and Diabetes Mellitus) Grant of the EC-FP7 (European Union's Seventh Framework Programme) under Grant Agreement No. 305279. MGN was supported by an ERC (European Research Council) Starting Grant (ERC#310372). RvC was supported by a Vidi grant of NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) (No. 91710310). SAJ and THO were supported by EC-FP7 EURIPRED INFRASTRUCTURES (European Research Infrastructures for Poverty Related Diseases), contract no. 2012.1 312661, EC-FP7 ADITEC (Advanced Immunization Technologies) Grant agreement no. 280873 and LUMC (Leiden University Medical Center) Profiling area grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Devaraj S, 2005, DIABETES, V54, P85, DOI 10.2337/diabetes.54.1.85; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leclerc L, 2010, INHAL TOXICOL, V22, P1091, DOI 10.3109/08958378.2010.522781; Lecube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023366; Liu HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/867023; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mo YQ, 2009, TOXICOLOGY, V262, P130, DOI 10.1016/j.tox.2009.05.019; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092977; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Statistics Netherlands, 2010, HLTH LIF US MED FAC; Sugawara I, 2004, TOHOKU J EXP MED, V204, P135, DOI 10.1620/tjem.204.135; Sugawara I, 2008, TOHOKU J EXP MED, V216, P363, DOI 10.1620/tjem.216.363; Sun CM, 2012, J CELL PHYSIOL, V227, P1670, DOI 10.1002/jcp.22891; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van Crevel R, 2014, LANCET DIABETES ENDO, V2, P270, DOI 10.1016/S2213-8587(14)70011-7; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015	38	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117941	10.1371/journal.pone.0117941	http://dx.doi.org/10.1371/journal.pone.0117941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664765	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100024
J	Kitamura, J; Uemura, M; Kurozumi, M; Sonobe, M; Manabe, T; Hiai, H; Date, H; Kinoshita, K				Kitamura, Jiro; Uemura, Munehiro; Kurozumi, Mafumi; Sonobe, Makoto; Manabe, Toshiaki; Hiai, Hiroshi; Date, Hiroshi; Kinoshita, Kazuo			Chronic Lung Injury by Constitutive Expression of Activation-Induced Cytidine Deaminase Leads to Focal Mucous Cell Metaplasia and Cancer	PLOS ONE			English	Article							ATYPICAL ADENOMATOUS HYPERPLASIA; STEM-CELLS; BRONCHIOLOALVEOLAR CARCINOMA; EPITHELIAL-CELLS; GENE; DEDIFFERENTIATION; MUTATION; DNA	Activation-induced cytidine deaminase (AID) is an enzyme required for antibody diversification, and it causes DNA mutations and strand breaks. Constitutive AID expression in mice invariably caused lung lesions morphologically similar to human atypical adenomatous hyperplasia (AAH), which can be a precursor of bronchioloalveolar carcinoma. Similar to AAH, mouse AAH-like lesion (MALL) exhibited signs of alveolar differentiation, judging from the expression of alveolar type II (AT2) cell marker surfactant protein C (SP-C). However, electron microscopy indicated that MALL, which possessed certain features of a mucous cell, is distinct from an AAH or AT2 cell. Although MALL developed in all individuals within 30 weeks after birth, lung tumors occurred in only 10%; this suggests that the vast majority of MALLs fail to grow into visible tumors. MALL expressed several recently described markers of lung alveolar regeneration such as p63, keratin 5, keratin 14, leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5), and Lgr6. Increased cell death was observed in the lungs of AID transgenic mice compared with wild-type mice. Based on these observations, we speculate that MALL is a regenerating tissue compensating for cellular loss caused by AID cytotoxicity. AID expression in such regenerating tissue should predispose cells to malignant transformation via its mutagenic activity.	[Kitamura, Jiro; Sonobe, Makoto; Date, Hiroshi] Kyoto Univ, Fac Med, Dept Thorac Surg, Kyoto, Japan; [Kitamura, Jiro] Nagahama City Hosp, Dept Thorac Surg, Nagahama, Japan; [Uemura, Munehiro; Kurozumi, Mafumi; Manabe, Toshiaki; Kinoshita, Kazuo] Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan; [Hiai, Hiroshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University	Kinoshita, K (corresponding author), Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan.	kkinoshi.shigamed@mac.com			Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI) [23390097]	Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Scientific Research by Ministry of Education, Culture, Sports, Science and Technology in Japan (KAKENHI 23390097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Cooper CA, 1997, J PATHOL, V181, P401, DOI 10.1002/(SICI)1096-9896(199704)181:4<401::AID-PATH799>3.0.CO;2-Y; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fehrenbach H, 1999, EUR RESPIR J, V14, P534, DOI 10.1034/j.1399-3003.1999.14c10.x; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/IJH97.06011; Kitamura H, 1997, VIRCHOWS ARCH, V431, P415, DOI 10.1007/s004280050118; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Malvezzi M, 2011, ANN ONCOL, V22, P947, DOI 10.1093/annonc/mdq774; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; SHORTER RG, 1964, DIS CHEST, V46, P138; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slebos RJC, 1998, HUM PATHOL, V29, P801, DOI 10.1016/S0046-8177(98)90448-8; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Westra WH, 1996, CANCER RES, V56, P2224; Yamasaki M, 2000, PATHOL INT, V50, P778, DOI 10.1046/j.1440-1827.2000.01123.x; Yoo SB, 2010, J THORAC ONCOL, V5, P964, DOI 10.1097/JTO.0b013e3181dd15c0; Yoshida Y, 2005, LUNG CANCER, V50, P1, DOI 10.1016/j.lungcan.2005.04.012; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117986	10.1371/journal.pone.0117986	http://dx.doi.org/10.1371/journal.pone.0117986			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659078	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900248
J	Rezende, TJR; de Albuquerque, M; Lamas, GM; Martinez, ARM; Campos, BM; Casseb, RF; Silva, CB; Branco, LMT; D'Abreu, A; Lopes-Cendes, I; Cendes, F; Franca, MC				Rezende, Thiago J. R.; de Albuquerque, Milena; Lamas, Gustavo M.; Martinez, Alberto R. M.; Campos, Brunno M.; Casseb, Raphael F.; Silva, Cynthia B.; Branco, Lucas M. T.; D'Abreu, Anelyssa; Lopes-Cendes, Iscia; Cendes, Fernando; Franca, Marcondes C., Jr.			Multimodal MRI-Based Study in Patients with SPG4 Mutations	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPARESIS; HUMAN CEREBRAL-CORTEX; BRAIN; PURE; SEGMENTATION; ATROPHY	Mutations in the SPG4 gene (SPG4-HSP) are the most frequent cause of hereditary spastic paraplegia, but the extent of the neurodegeneration related to the disease is not yet known. Therefore, our objective is to identify regions of the central nervous system damaged in patients with SPG4-HSP using a multi-modal neuroimaging approach. In addition, we aimed to identify possible clinical correlates of such damage. Eleven patients (mean age 46.0 +/- 15.0 years, 8 men) with molecular confirmation of hereditary spastic paraplegia, and 23 matched healthy controls (mean age 51.4 +/- 14.1years, 17 men) underwent MRI scans in a 3T scanner. We used 3D T1 images to perform volumetric measurements of the brain and spinal cord. We then performed tract-based spatial statistics and tractography analyses of diffusion tensor images to assess microstructural integrity of white matter tracts. Disease severity was quantified with the Spastic Paraplegia Rating Scale. Correlations were then carried out between MRI metrics and clinical data. Volumetric analyses did not identify macroscopic abnormalities in the brain of hereditary spastic paraplegia patients. In contrast, we found extensive fractional anisotropy reduction in the corticospinal tracts, cingulate gyri and splenium of the corpus callosum. Spinal cord morphometry identified atrophy without flattening in the group of patients with hereditary spastic paraplegia. Fractional anisotropy of the corpus callosum and pyramidal tracts did correlate with disease severity. Hereditary spastic paraplegia is characterized by relative sparing of the cortical mantle and remarkable damage to the distal portions of the corticospinal tracts, extending into the spinal cord.	[Rezende, Thiago J. R.; de Albuquerque, Milena; Lamas, Gustavo M.; Martinez, Alberto R. M.; Campos, Brunno M.; Casseb, Raphael F.; Silva, Cynthia B.; Branco, Lucas M. T.; D'Abreu, Anelyssa; Cendes, Fernando; Franca, Marcondes C., Jr.] Univ Estadual Campinas, Dept Neurol, UNICAMP, Sao Paulo, Brazil; [Lopes-Cendes, Iscia] Univ Estadual Campinas, Dept Med Genet, UNICAMP, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Franca, MC (corresponding author), Univ Estadual Campinas, Dept Neurol, Sao Paulo, Brazil.	mcfrancajr@uol.com.br	Casseb, Raphael F/K-3731-2017; Rezende, Thiago/B-9673-2017; Lopes-Cendes, Iscia/B-9416-2013; de Campos, Brunno Machado/L-8423-2013; Cendes, Fernando/C-1301-2012; Abreu, Anelyssa D'/AAK-4535-2021	Casseb, Raphael F/0000-0002-0643-7110; Lopes-Cendes, Iscia/0000-0002-6221-6822; de Campos, Brunno Machado/0000-0003-1261-8257; Cendes, Fernando/0000-0001-9336-9568; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/21521-3]; CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant #2011/21521-3 for MCF Jr. Dr Albuquerque received a PhD scholarship from FAPESP and Dr Rezende received a Msc scholarship from CAPES (Coordenacao de Aperfeicoamento de Pessoal - Brazil). Both agencies are governmental institutions and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897; Bergo FPG, 2012, CISTI 2012 7 C IB SI, P400; Branco LMT, 2014, AMYOTROPH LAT SCL FR, V15, P93, DOI 10.3109/21678421.2013.852589; Charvin D, 2003, HUM MOL GENET, V12, P71, DOI 10.1093/hmg/ddg004; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Depienne C, 2007, J MED GENET, V44, P281, DOI 10.1136/jmg.2006.046425; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duning T, 2010, MOVEMENT DISORD, V25, P1986, DOI 10.1002/mds.23211; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Franca MC, 2014, CLIN GENET, V86, P194, DOI 10.1111/cge.12252; Franca MC, 2012, J NEUROL NEUROSUR PS, V83, P828, DOI 10.1136/jnnp-2011-300129; Garaci F, 2014, INT J NEUROSCI, V124, P261, DOI 10.3109/00207454.2013.836705; Hedera P, 2005, NEURORADIOLOGY, V47, P730, DOI 10.1007/s00234-005-1415-3; Karle KN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-158; Kassubek J, 2006, EUR J NEUROL, V13, P880, DOI 10.1111/j.1468-1331.2006.01380.x; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Murphy S, 2009, NEUROLOGY, V73, P378, DOI 10.1212/WNL.0b013e3181b04c6c; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Uttner I, 2007, NEUROSCI LETT, V419, P158, DOI 10.1016/j.neulet.2007.04.031; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; White KD, 2000, NEUROLOGY, V55, P89, DOI 10.1212/WNL.55.1.89	30	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117666	10.1371/journal.pone.0117666	http://dx.doi.org/10.1371/journal.pone.0117666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658484	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900198
J	Wang, Y; Barbeau, X; Bilimoria, A; Lague, P; Couture, M; Tang, JKH				Wang, Yaya; Barbeau, Xavier; Bilimoria, Astha; Laguee, Patrick; Couture, Manon; Tang, Joseph Kuo-Hsiang			Peroxidase Activity and Involvement in the Oxidative Stress Response of Roseobacter denitrificans Truncated Hemoglobin	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS HEMOGLOBIN; MULTIPLE SEQUENCE ALIGNMENT; NITRIC-OXIDE-REDUCTASE; HEME DISTAL SITE; FUNCTIONAL-PROPERTIES; LIGAND-BINDING; BACILLUS-SUBTILIS; SINGLE-DOMAIN; GEN. NOV.; BACTERIA	Roseobacter denitrificans is a member of the widespread marine Roseobacter genus. We report the first characterization of a truncated hemoglobin from R. denitrificans (Rd. trHb) that was purified in the heme-bound form from heterologous expression of the protein in Escherichia coli. Rd. trHb exhibits predominantly alpha-helical secondary structure and absorbs light at 412, 538 and 572 nm. The phylogenetic classification suggests that Rd. trHb falls into group II trHbs, whereas sequence alignments indicate that it shares certain important heme pocket residues with group I trHbs in addition to those of group II trHbs. The resonance Raman spectra indicate that the isolated Rd. trHb contains a ferric heme that is mostly 6-coordinate low-spin and that the heme of the ferrous form displays a mixture of 5- and 6-coordinate states. Two Fe-His stretching modes were detected, notably one at 248 cm(-1), which has been reported in peroxidases and some flavohemoglobins that contain an Fe-His-Asp (or Glu) catalytic triad, but was never reported before in a trHb. We show that Rd. trHb exhibits a significant peroxidase activity with a (k(cat)/K-m) value three orders of magnitude higher than that of bovine Hb and only one order lower than that of horseradish peroxidase. This enzymatic activity is pH-dependent with a pK(a) value similar to 6.8. Homology modeling suggests that residues known to be important for interactions with heme-bound ligands in group II trHbs from Mycobacterium tuberculosis and Bacillus subtilis are pointing toward to heme in Rd. trHb. Genomic organization and gene expression profiles imply possible functions for detoxification of reactive oxygen and nitrogen species in vivo. Altogether, Rd. trHb exhibits some distinctive features and appears equipped to help the bacterium to cope with reactive oxygen/nitrogen species and/or to operate redox biochemistry.	[Wang, Yaya; Bilimoria, Astha; Tang, Joseph Kuo-Hsiang] Clark Univ, Dept Chem & Biochem, Worcester, MA 01610 USA; [Barbeau, Xavier; Laguee, Patrick; Couture, Manon] Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada; [Barbeau, Xavier; Laguee, Patrick; Couture, Manon] Univ Laval, PROTEO, Quebec City, PQ, Canada	Clark University; Laval University; Laval University	Tang, JKH (corresponding author), Clark Univ, Dept Chem & Biochem, Worcester, MA 01610 USA.	manon.couture@bcm.ulaval.ca; jtang@clarku.edu	Couture, Manon/F-8326-2015	Couture, Manon/0000-0001-8296-8055; Lague, Patrick/0000-0002-5236-4979	Clark University; National Sciences and Engineering Research Council [250073]; Les Fonds de recherche du Quebec-Nature et technologies	Clark University; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds de recherche du Quebec-Nature et technologies	JKT is supported by the start-up funds from Clark University. MC acknowledges support by National Sciences and Engineering Research Council grant 250073. XB was supported from Les Fonds de recherche du Quebec-Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V373, P197, DOI 10.1016/j.bbrc.2008.05.168; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, J BIOL CHEM, V274, P6898, DOI 10.1074/jbc.274.11.6898; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Couture M, 2000, EUR J BIOCHEM, V267, P4770, DOI 10.1046/j.1432-1327.2000.01531.x; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dai X, 2006, INT J SYST EVOL MICR, V56, P529, DOI 10.1099/ijs.0.64013-0; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; DOI M, 1991, PLANT CELL PHYSIOL, V32, P365, DOI 10.1093/oxfordjournals.pcp.a078089; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; EVERSE J, 1994, METHOD ENZYMOL, V231, P547; Falzone CJ, 2002, J MOL BIOL, V324, P1015, DOI 10.1016/S0022-2836(02)01093-8; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; GARCIA D, 1994, BIOCHIMIE, V76, P666, DOI 10.1016/0300-9084(94)90143-0; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Haghighi AZ, 1996, J NEUROSCI RES, V43, P107, DOI 10.1002/jnr.490430114; Hemschemeier A, 2013, P NATL ACAD SCI USA, V110, P10854, DOI 10.1073/pnas.1302592110; Hill DR, 1996, J BACTERIOL, V178, P6587, DOI 10.1128/jb.178.22.6587-6598.1996; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; Igamberdiev A, 2006, PLANTA, V223, P1041, DOI 10.1007/s00425-005-0145-4; Johnson EA, 2014, BIOCHEMISTRY-US, V53, P4573, DOI 10.1021/bi5005206; Kimura M, 2012, BIOSCI BIOTECH BIOCH, V76, P1984, DOI 10.1271/bbb.120406; Kitagawa T, 1987, STRUCT BONDING BERLI, V64, P71, DOI DOI 10.1007/BFB0036788; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; LAFAY B, 1995, INT J SYST BACTERIOL, V45, P290, DOI 10.1099/00207713-45-2-290; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Manac'h-Little N, 2005, PLANT PHYSIOL BIOCH, V43, P485, DOI 10.1016/j.plaphy.2005.03.012; Matsuda Y, 2002, J BIOCHEM, V131, P791, DOI 10.1093/oxfordjournals.jbchem.a003167; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Nie XZ, 2006, PLANTA, V223, P542, DOI 10.1007/s00425-005-0094-y; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2001, J MOL BIOL, V309, P1153, DOI 10.1006/jmbi.2001.4731; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2011, BBA-PROTEINS PROTEOM, V1814, P810, DOI 10.1016/j.bbapap.2010.11.001; Ramond E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003893; Reeder BJ, 2014, ACTA CRYSTALLOGR D, V70, P1411, DOI 10.1107/S1399004714004878; ROUSSEAU DL, 1983, ANNU REV BIOPHYS BIO, V12, P357, DOI 10.1146/annurev.bb.12.060183.002041; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Saikin SK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05057; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Shapleigh JP, 2011, BIOCHEM SOC T, V39, P179, DOI 10.1042/BST0390179; SHIBA T, 1991, SYST APPL MICROBIOL, V14, P140, DOI 10.1016/S0723-2020(11)80292-4; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Spiro TG, 1988, BIOL APPL RAMAN SPEC, P39; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TAKAMIYA K, 1993, PLANT CELL PHYSIOL, V34, P985; TAKAMIYA K, 1993, ARCH MICROBIOL, V159, P51, DOI 10.1007/BF00244264; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang KH, 2002, BIOCHEMISTRY-US, V41, P8767, DOI 10.1021/bi020255k; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Torge R, 2009, J MOL CATAL B-ENZYM, V61, P303, DOI 10.1016/j.molcatb.2009.08.010; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2013, ADV MICROB PHYSIOL, V63, P391, DOI 10.1016/B978-0-12-407693-8.00009-1; Wagner-Dobler I, 2004, INT J SYST EVOL MICR, V54, P1177, DOI 10.1099/ijs.0.02850-0; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yeh SR, 2004, J PHYS CHEM B, V108, P1478, DOI 10.1021/jp037054q; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	99	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117768	10.1371/journal.pone.0117768	http://dx.doi.org/10.1371/journal.pone.0117768			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658318	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900215
J	Willet, CE; Makara, M; Reppas, G; Tsoukalas, G; Malik, R; Haase, B; Wade, CM				Willet, Cali E.; Makara, Mariano; Reppas, George; Tsoukalas, George; Malik, Richard; Haase, Bianca; Wade, Claire M.			Canine Disorder Mirrors Human Disease: Exonic Deletion in HES7 Causes Autosomal Recessive Spondylocostal Dysostosis in Miniature Schnauzer Dogs	PLOS ONE			English	Article							MYOTONIA-CONGENITA; NATURAL-HISTORY; MUTATION; GENE; SEGMENTATION; HAIRY-AND-ENHANCER-OF-SPLIT-7; CLASSIFICATION; HEMIVERTEBRA; MECHANISM; SEQUENCE	Spondylocostal dysostosis is a congenital disorder of the axial skeleton documented in human families from diverse racial backgrounds. The condition is characterised by truncal shortening, extensive hemivertebrae and rib anomalies including malalignment, fusion and reduction in number. Mutations in the Notch signalling pathway genes DLL3, MESP2, LFNG, HES7 and TBX6 have been associated with this defect. In this study, spondylocostal dysostosis in an outbred family of miniature schnauzer dogs is described. Computed tomography demonstrated that the condition mirrors the skeletal defects observed in human cases, but unlike most human cases, the affected dogs were stillborn or died shortly after birth. Through gene mapping and whole genome sequencing, we identified a single-base deletion in the coding region of HES7. The frameshift mutation causes loss of functional domains essential for the oscillatory transcriptional autorepression of HES7 during somitogenesis. A restriction fragment length polymorphism test was applied within the immediate family and supported a highly penetrant autosomal recessive mode of inheritance. The mutation was not observed in wider testing of 117 randomly sampled adult miniature schnauzer and six adult standard schnauzer dogs; providing a significance of association of P-raw = 4.759e(-36) (genome-wide significant). Despite this apparently low frequency in the Australian population, the allele may be globally distributed based on its presence in two unrelated sires from geographically distant locations. While isolated hemivertebrae have been observed in a small number of other dog breeds, this is the first clinical and genetic diagnosis of spontaneously occurring spondylocostal dysostosis in a non-human mammal and offers an excellent model in which to study this devastating human disorder. The genetic test can be utilized by dog breeders to select away from the disease and avoid unnecessary neonatal losses.	[Willet, Cali E.; Makara, Mariano; Tsoukalas, George; Haase, Bianca; Wade, Claire M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Reppas, George] Vetnostics, N Ryde, NSW, Australia; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Willet, CE (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	cali.willet@sydney.edu.au; claire.wade@sydney.edu.au	Malik, Richard/I-2009-2019	Willet, Cali/0000-0001-8449-1502; Waud, Bianca/0000-0001-6493-9808; Wade, Claire/0000-0003-3413-4771	Australian Postgraduate Award; Val Street Scholarship; National Institutes of Health [NIH/NIDCR1R01DE022532-01A1]; Vetnostics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022532] Funding Source: NIH RePORTER	Australian Postgraduate Award(Australian Government); Val Street Scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetnostics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research conducted by CEW was funded by the Australian Postgraduate Award and Val Street Scholarship. Four of the samples used in the authors' study were genotyped and sequenced as part of an unrelated project funded by the National Institutes of Health (http://www.nih.gov/) grant NIH/NIDCR1R01DE022532-01A1. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vetnostics provided support in the form of salaries for authors GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Australian National Kennel Council Ltd, 2012, NAT REG STAT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Besalti O, 2005, IRISH VET J, V58, P688, DOI 10.1186/2046-0481-58-12-688; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Bhalerao DR, 2002, AM J VET RES, V63, P1443, DOI 10.2460/ajvr.2002.63.1443; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Cornier AS, 2008, AM J HUM GENET, V82, P1334, DOI 10.1016/j.ajhg.2008.04.014; Cornier AS, 2004, AM J MED GENET A, V128A, P120, DOI 10.1002/ajmg.a.30011; Cornier AS, 2003, CURR OPIN PEDIATR, V15, P614, DOI 10.1097/00008480-200312000-00012; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Ghebranious N, 2006, AM J MED GENET A, V140A, P1346, DOI 10.1002/ajmg.a.31307; Gracis M, 2000, J VET DENT, V17, P119, DOI 10.1177/089875640001700301; Gutierrez-Quintana R, 2014, VET RADIOL ULTRASOUN, V55, P585, DOI 10.1111/vru.12172; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; KRAMER JW, 1982, J AM VET MED ASSOC, V181, P814; Lewis J, 2009, J BIOL, V8, pe44; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MARTINEZFRIAS ML, 1994, AM J MED GENET, V51, P203, DOI 10.1002/ajmg.1320510306; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez N, 2007, J BONE JOINT SURG AM, V89A, P2663, DOI 10.2106/JBJS.F.01085; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlensker E, 2013, EUR J COMP ANIM PRAC, V23, P119; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Sparrow DB, 2013, AM J MED GENET A, V161, P2244, DOI 10.1002/ajmg.a.36073; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sparrow DB, 2010, EUR J HUM GENET, V18, P674, DOI 10.1038/ejhg.2009.241; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tsai KL, 2007, MAMM GENOME, V18, P444, DOI 10.1007/s00335-007-9037-1; Turnpenny PD, 2007, DEV DYNAM, V236, P1456, DOI 10.1002/dvdy.21182; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053	38	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117055	10.1371/journal.pone.0117055	http://dx.doi.org/10.1371/journal.pone.0117055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659135	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900096
J	Jeffery, J; Neyt, C; Moore, W; Paterson, S; Bower, NI; Chenevix-Trench, G; Verkade, H; Hogan, BM; Khanna, KK				Jeffery, Jessie; Neyt, Christine; Moore, Wade; Paterson, Scott; Bower, Neil I.; Chenevix-Trench, Georgia; Verkade, Heather; Hogan, Benjamin M.; Khanna, Kum Kum			Cep55 regulates embryonic growth and development by promoting Akt stability in zebrafish	FASEB JOURNAL			English	Article						apoptosis; PI3K/AKT pathway; cytokinesis; multinucleation	S-PHASE ARREST; CELL-CYCLE; CANCER-CELLS; MIDBODY; PROTEIN; APOPTOSIS; ACTIVATION; AUTOPHAGY; KINASE; ESCRT	CEP55 was initially described as a centrosome- and midbody-associated protein and a key mediator of cytokinesis. More recently, it has been implicated in PI3K/AKT pathway activation via an interaction with the catalytic subunit of PI3K. However, its role in embryonic development is unknown. Here we describe a cep55 nonsense mutant zebrafish with which we can study the in vivo physiologic role of Cep55. Homozygous mutants underwent extensive apoptosis by 24 hours postfertilization (hpf) concomitant with cell cycle defects, and heterozygous carriers were indistinguishable from their wild-type siblings. A similar phenotype was also observed in zebrafish injected with a cep55 morpholino, suggesting the mutant is a cep55 loss-of-function model. Further analysis revealed that Akt was destabilized in the homozygous mutants, which partially phenocopied Akt1 and Akt2 knockdown. Expression of either constitutively activated PIK3CA or AKT1 could partially rescue the homozygous mutants. Consistent with a role for Cep55 in regulation of Akt stability, treatment with proteasome inhibitor, MG132, partially rescued the homozygous mutants. Taken together, these results provide the first description of Cep55 in development and underline the importance of Cep55 in the regulation of Pi3k/Akt pathway and in particular Akt stability.	[Jeffery, Jessie; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia; [Neyt, Christine; Paterson, Scott; Bower, Neil I.; Hogan, Benjamin M.] Univ Queensland, Inst Mol Biosci, Vasc Biol & Dev Lab, Brisbane, Qld, Australia; [Moore, Wade; Verkade, Heather] Monash Univ, Zebrafish Dev Genet Lab, Clayton, Vic, Australia; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Canc Genet Lab, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Monash University; QIMR Berghofer Medical Research Institute	Khanna, KK (corresponding author), QIMR Berghofer Med Res Inst, Signal Transduct Lab, 300 Herston Rd, Brisbane, Qld, Australia.	kumkum.khanna@qimrberghofer.edu.au	Hogan, Benjamin M/J-1807-2014; Hogan, Benjamin/AAD-7410-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Bower, Neil/K-1478-2014	Hogan, Benjamin M/0000-0002-0651-7065; Hogan, Benjamin/0000-0002-0651-7065; Chenevix-Trench, Georgia/0000-0002-1878-2587; Khanna, Kum Kum/0000-0001-8650-5381; Bower, Neil/0000-0002-6764-6063; Verkade, Heather/0000-0002-2817-0509	Australian Research Council [FT 011265]; National Health and Medical Research Council (NHMRC) (Australia) [ID: 613638]; Australian Zebrafish Phenomics Facility (NHMRC) [455871]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Zebrafish Phenomics Facility (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Xiao Qing Chen and Jonathan Beesley for technical assistance. B.M.H. was supported by an Australian Research Council Future Fellowship (FT 011265). K.K.K. was supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (ID: 613638; Australia). Part of the experiments were supported by the Australian Zebrafish Phenomics Facility (NHMRC Grant 455871).	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chang YC, 2012, J BIOL CHEM, V287, P4376, DOI 10.1074/jbc.M111.289108; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chen MC, 2002, PHYSIOL GENOMICS, V8, P51, DOI 10.1152/physiolgenomics.00042.2001; Cheng YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054262, 10.1371/journal.pone.0060503]; Cheng YC, 2013, CELL MOL LIFE SCI, V70, P935, DOI 10.1007/s00018-012-1178-z; Choorapoikayil S, 2014, BLOOD, V123, P184, DOI 10.1182/blood-2013-05-501544; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Ettinger AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1511; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jensen PJ, 2010, J BIOL CHEM, V285, P17673, DOI 10.1074/jbc.M109.079343; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Mondal G, 2012, DEV CELL, V23, P137, DOI 10.1016/j.devcel.2012.05.008; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Ornelas IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053517; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Shen XY, 2014, INT J ONCOL, V44, P791, DOI 10.3892/ijo.2014.2251; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; Shishodia S, 2007, BIOCHEM PHARMACOL, V74, P118, DOI 10.1016/j.bcp.2007.03.026; Shuang C., 2011, ACTA HYDROBIOL, V35, P717; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; van der Horst A, 2009, CANCER RES, V69, P6651, DOI 10.1158/0008-5472.CAN-09-0825; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yabe T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000518; Yeh CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018702; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	54	19	20	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1999	2009		10.1096/fj.14-265090	http://dx.doi.org/10.1096/fj.14-265090			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25667221				2022-12-26	WOS:000354114600033
J	Heim, KP; Sullan, RMA; Crowley, PJ; El-Kirat-Chatel, S; Beaussart, A; Tang, WX; Besingi, R; Dufrene, YF; Brady, LJ				Heim, Kyle P.; Sullan, Ruby May A.; Crowley, Paula J.; El-Kirat-Chatel, Sofiane; Beaussart, Audrey; Tang, Wenxing; Besingi, Richard; Dufrene, Yves F.; Brady, L. Jeannine			Identification of a Supramolecular Functional Architecture of Streptococcus mutans Adhesin P1 on the Bacterial Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; GRAM-POSITIVE BACTERIA; ANTIGEN-BINDING FORCES; RICH REPEAT DOMAIN; SALIVARY AGGLUTININ; PROTEIN ANTIGEN; SEROTYPE-C; MONOCLONAL-ANTIBODIES; DENTAL-CARIES; PORPHYROMONAS-GINGIVALIS	P1 (antigen I/II) is a sucrose-independent adhesin of Streptococcus mutans whose functional architecture on the cell surface is not fully understood. S. mutans cells subjected to mechanical extraction were significantly diminished in adherence to immobilized salivary agglutinin but remained immunoreactive and were readily aggregated by fluid-phase salivary agglutinin. Bacterial adherence was restored by incubation of postextracted cells with P1 fragments that contain each of the two known adhesive domains. In contrast to untreated cells, glutaraldehyde-treated bacteria gained reactivity with anti-C-terminal monoclonal antibodies (mAbs), whereas epitopes recognized by mAbs against other portions of the molecule were masked. Surface plasmon resonance experiments demonstrated the ability of apical and C-terminal fragments of P1 to interact. Binding of several different anti-P1 mAbs to unfixed cells triggered release of a C-terminal fragment from the bacterial surface, suggesting a novel mechanism of action of certain adherence-inhibiting antibodies. We also used atomic force microscopy-based single molecule force spectroscopy with tips bearing various mAbs to elucidate the spatial organization and orientation of P1 on living bacteria. The similar rupture lengths detected using mAbs against the head and C-terminal regions, which are widely separated in the tertiary structure, suggest a higher order architecture in which these domains are in close proximity on the cell surface. Taken together, our results suggest a supramolecular organization in which additional P1 polypeptides, including the C-terminal segment originally identified as antigen II, associate with covalently attached P1 to form the functional adhesive layer.	[Heim, Kyle P.; Crowley, Paula J.; Tang, Wenxing; Besingi, Richard; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Sullan, Ruby May A.; El-Kirat-Chatel, Sofiane; Beaussart, Audrey; Dufrene, Yves F.] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain La Neuve, Belgium	State University System of Florida; University of Florida; Universite Catholique Louvain	Dufrene, YF (corresponding author), Catholic Univ Louvain, Inst Life Sci, Croix Sud 1,Bte L7-04-01, B-1348 Louvain La Neuve, Belgium.	Yves.Dufrene@uclouvain.be; jbrady@dental.ufl.edu	Brady, L. Jeannine/P-5059-2019; Beaussart, Audrey/N-5645-2016; El-Kirat-Chatel, Sofiane/H-7728-2016; Sullan, Ruby May A./L-7511-2016	Beaussart, Audrey/0000-0002-4602-3019; El-Kirat-Chatel, Sofiane/0000-0001-5877-5640; Sullan, Ruby May A./0000-0002-8927-2605; Brady, Jeannine/0000-0001-8952-086X; Dufrene, Yves/0000-0002-7289-4248	National Institutes of Health from the NIDCR [R01DE08007, R01DE21789]; University of Florida Alumni; National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fondation Louvain-Prix De Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); Research Department of the Communaute francaise de Belgique (Concerted Research Action);  [T90 DE021990-03]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE008007, R01DE021789] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; University of Florida Alumni(University of Florida); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fondation Louvain-Prix De Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); Research Department of the Communaute francaise de Belgique (Concerted Research Action); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE08007 and R01DE21789 from the NIDCR and Predoctoral Fellowship T90 DE021990-03. This work was also supported by a University of Florida Alumni fellowship; the National Foundation for Scientific Research (FNRS); the Universite catholique de Louvain (Fondation Louvain-Prix De Merre); the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); and the Research Department of the Communaute francaise de Belgique (Concerted Research Action).	Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; AYAKAWA GY, 1987, INFECT IMMUN, V55, P2759, DOI 10.1128/IAI.55.11.2759-2767.1987; Beg AM, 2002, BIOCHEM BIOPH RES CO, V298, P75, DOI 10.1016/S0006-291X(02)02390-2; Berquand A, 2005, LANGMUIR, V21, P5517, DOI 10.1021/la050162e; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; BLEIWEIS AS, 1992, ADV EXP MED BIOL, V327, P229; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; BRADY LJ, 1991, INFECT IMMUN, V59, P4425, DOI 10.1128/IAI.59.12.4425-4435.1991; CRAIG RA, 1979, INFECT IMMUN, V26, P1177, DOI 10.1128/IAI.26.3.1177-1185.1979; Crowley PJ, 2008, INFECT IMMUN, V76, P2456, DOI 10.1128/IAI.01315-07; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Gauduchon V, 2001, CLIN MICROBIOL INFEC, V7, P36, DOI 10.1046/j.1469-0691.2001.00197.x; Gilbert Y, 2007, NANO LETT, V7, P796, DOI 10.1021/nl0700853; HAJISHENGALLIS G, 1992, INFECT IMMUN, V60, P5057, DOI 10.1128/IAI.60.12.5057-5064.1992; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; HARRINGTON DJ, 1993, J BACTERIOL, V175, P5925, DOI 10.1128/JB.175.18.5925-5933.1993; Heim KP, 2014, P NATL ACAD SCI USA, V111, P15746, DOI 10.1073/pnas.1413018111; Heim KP, 2013, J BIOL CHEM, V288, P13762, DOI 10.1074/jbc.M113.459974; Homonylo-McGavin MK, 1999, CAN J MICROBIOL, V45, P536, DOI 10.1139/cjm-45-6-536; HomonyloMcGavin MK, 1996, J BACTERIOL, V178, P801, DOI 10.1128/jb.178.3.801-807.1996; Hu P, 2008, ARCH ORAL BIOL, V53, P150, DOI 10.1016/j.archoralbio.2007.08.008; Isoda R, 2007, FEMS IMMUNOL MED MIC, V51, P102, DOI 10.1111/j.1574-695X.2007.00279.x; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; KELLY C, 1989, FEBS LETT, V258, P127, DOI 10.1016/0014-5793(89)81632-1; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; Knox K W, 1978, Adv Exp Med Biol, V107, P629; LAMONT RJ, 1992, ORAL MICROBIOL IMMUN, V7, P193, DOI 10.1111/j.1399-302X.1992.tb00024.x; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lee SF, 2000, CAN J MICROBIOL, V46, P584, DOI 10.1139/cjm-46-6-584; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; LEE SF, 1995, INFECT IMMUN, V63, P1940, DOI 10.1128/IAI.63.5.1940-1946.1995; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; LEHNER T, 1980, LANCET, V1, P995; Liu BH, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/27/275401; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; McArthur WP, 2007, FEMS IMMUNOL MED MIC, V50, P342, DOI 10.1111/j.1574-695X.2007.00260.x; MORO I, 1983, INFECT IMMUN, V41, P410, DOI 10.1128/IAI.41.1.410-413.1983; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; Murakami Y, 1997, INFECT IMMUN, V65, P794, DOI 10.1128/IAI.65.2.794-797.1997; Murakami Y, 1997, INFECT IMMUN, V65, P1531, DOI 10.1128/IAI.65.4.1531-1535.1997; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; OKAHASHI N, 1993, INFECT IMMUN, V61, P1301, DOI 10.1128/IAI.61.4.1301-1306.1993; OKAHASHI N, 1989, MOL MICROBIOL, V3, P673, DOI 10.1111/j.1365-2958.1989.tb00215.x; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; Petersen FC, 2002, INFECT IMMUN, V70, P249, DOI 10.1128/IAI.70.1.249-256.2002; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Purushotham S, 2014, J BIOL CHEM, V289, P21877, DOI 10.1074/jbc.M114.565507; Ray CA, 1999, CLIN DIAGN LAB IMMUN, V6, P400, DOI 10.1128/CDLI.6.3.400-404.1999; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rhodin NR, 2004, INFECT IMMUN, V72, P13, DOI 10.1128/IAI.72.1.13-21.2004; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Robinette RA, 2014, VACCINE, V32, P375, DOI 10.1016/j.vaccine.2013.11.023; Robinette RA, 2009, J IMMUNOL, V183, P4628, DOI 10.4049/jimmunol.0803300; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; RUSSELL MW, 1980, INFECT IMMUN, V29, P999; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1978, ARCH ORAL BIOL, V23, P7, DOI 10.1016/0003-9969(78)90047-X; RUSSELL MW, 1989, ORAL MICROBIOL IMMUN, V4, P106, DOI 10.1111/j.1399-302X.1989.tb00107.x; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; SCHOLLER M, 1981, INFECT IMMUN, V31, P52; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Seifert TB, 2004, INFECT IMMUN, V72, P4699, DOI 10.1128/IAI.72.8.4699-4706.2004; Shanmugam KT, 2013, J CLIN DIAGN RES, V7, P1250, DOI 10.7860/JCDR/2013/5246.3053; Sivanathan V, 2012, GENE DEV, V26, P2659, DOI 10.1101/gad.205310.112; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; ULLMAN RF, 1988, HEART LUNG, V17, P209; van Dolleweerd CJ, 2004, J BIOL CHEM, V279, P22198, DOI 10.1074/jbc.M400820200; Verbelen C, 2009, LANGMUIR, V25, P4324, DOI 10.1021/la900302a; Xu QA, 2011, INFECT IMMUN, V79, P3792, DOI 10.1128/IAI.05338-11; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06; Zhang S, 2013, CURR PHARM BIOTECHNO, V14, P960; Zhao WW, 2014, CLIN VACCINE IMMUNOL, V21, P74, DOI 10.1128/CVI.00452-13	96	26	28	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9002	9019		10.1074/jbc.M114.626663	http://dx.doi.org/10.1074/jbc.M114.626663			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666624	hybrid, Green Published			2022-12-26	WOS:000352207100026
J	Malhotra, V; Agrawal, R; Duncan, TR; Saini, DK; Clark-Curtiss, JE				Malhotra, Vandana; Agrawal, Ruchi; Duncan, Tammi R.; Saini, Deepak. K.; Clark-Curtiss, Josephine E.			Mycobacterium tuberculosis Response Regulators, DevR and NarL, Interact in Vivo and Co-regulate Gene Expression during Aerobic Nitrate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SYSTEM; NITRIC-OXIDE; HYPOXIC RESPONSE; CARBON-MONOXIDE; PROTEIN-KINASE; DOSR; ADAPTATION; TRANSDUCTION; OPERON; ACTIVATION	Mycobacterium tuberculosis genes Rv0844c/Rv0845 encoding the NarL response regulator and NarS histidine kinase are hypothesized to constitute a two-component system involved in the regulation of nitrate metabolism. However, there is no experimental evidence to support this. In this study, we established M. tuberculosis NarL/NarS as a functional two-component system and identified His(241) and Asp(61) as conserved phosphorylation sites in NarS and NarL, respectively. Transcriptional profiling between M. tuberculosis H37Rv and Delta narL mutant strain during exponential growth in broth cultures with or without nitrate defined an similar to 30-gene NarL regulon that exhibited significant overlap with DevR-regulated genes, thereby implicating a role for the DevR response regulator in the regulation of nitrate metabolism. Notably, expression analysis of a subset of genes common to NarL and DevR regulons in M. tuberculosis Delta devR, Delta devS Delta dosT, and Delta narL mutant strains revealed that in response to nitrite produced during aerobic nitrate metabolism, the DevRS/DosT regulatory system plays a primary role that is augmented by NarL. Specifically, NarL itself was unable to bind to the narK2, acg, and Rv3130c promoters in phosphorylated or unphosphorylated form; however, its interaction with DevR similar to P resulted in cooperative binding, thereby enabling co-regulation of these genes. These findings support the role of physiologically derived nitrite as a metabolic signal in mycobacteria. We propose NarL-DevR binding, possibly as a heterodimer, as a novel mechanism for co-regulation of gene expression by the DevRS/DosT and NarL/NarS regulatory systems.	[Malhotra, Vandana; Duncan, Tammi R.; Clark-Curtiss, Josephine E.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Duncan, Tammi R.; Clark-Curtiss, Josephine E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Agrawal, Ruchi; Saini, Deepak. K.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Indian Institute of Science (IISC) - Bangalore	Malhotra, V (corresponding author), Univ Delhi, Dept Biochem, Sri Venkateswara Coll, New Delhi 110021, India.	vmal71@gmail.com; deepak@mrdg.iisc.ernet.in	Agrawal, Ruchi/D-7230-2015; agrawal, ruchi/AAE-6860-2022	Agrawal, Ruchi/0000-0003-0168-6000; agrawal, ruchi/0000-0003-0168-6000	National Institutes of Health [AI46428]; Department of Biotechnology, India [BT/PR15001/BRB/10/897]; Council of Scientific and Industrial Research, India [37 (1435) 10-EMR-II]; Arizona State University; Arizona State University PREP program for Biomedical Research; National Institutes of Health Public Health Service [GM071798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM071798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Arizona State University; Arizona State University PREP program for Biomedical Research; National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46428. This research was also supported by Department of Biotechnology, India, Grant BT/PR15001/BRB/10/897; Council of Scientific and Industrial Research, India, Grant-in-aid 37 (1435) 10-EMR-II (to D. K. S.); and Arizona State University start-up funding (to J. E. C.-C.).; Supported by a research fellowship from the Council of Scientific and Industrial Research, India.; Supported by the Arizona State University PREP program for Biomedical Research and National Institutes of Health Public Health Service Grant GM071798.	Agrawal R., 2014, BIOCHEM BIOPH RES CO, V446, P1172; Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cho HY, 2014, BIOCHEM BIOPH RES CO, V444, P651, DOI 10.1016/j.bbrc.2014.01.128; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Haydel SE, 2004, FEMS MICROBIOL LETT, V236, P341, DOI 10.1016/j.femsle.2004.06.010; Haydel SE, 2012, J BACTERIOL, V194, P354, DOI 10.1128/JB.06258-11; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; HEDGECOCK LW, 1962, J BACTERIOL, V84, P195, DOI 10.1128/JB.84.2.195-205.1962; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Laub MT, 2007, METHOD ENZYMOL, V423, P531, DOI 10.1016/S0076-6879(07)23026-5; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; LI J, 1994, J MOL BIOL, V241, P150, DOI 10.1006/jmbi.1994.1485; Loebel RO, 1933, J BACTERIOL, V26, P167, DOI 10.1128/JB.26.2.167-200.1933; Malhotra V, 2012, J BACTERIOL, V194, P4184, DOI 10.1128/JB.00585-12; Malhotra V, 2009, TUBERCULOSIS, V89, P169, DOI 10.1016/j.tube.2008.12.003; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tan W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012924, 10.1371/journal.pone.0013356]; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226	62	23	25	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8294	8309		10.1074/jbc.M114.591800	http://dx.doi.org/10.1074/jbc.M114.591800			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659431	Green Published, hybrid			2022-12-26	WOS:000351662600025
J	Dorraki, M; Cambrell, GK; Abbott, D				Dorraki, Mohsen; Cambrell, Gregory K.; Abbott, Derek			Analysis of the Transient Response of a Dual-Fed RC Transmission Line	PLOS ONE			English	Article							DELAY ANALYSIS	The transient analysis of a uniform transmission line of finite length is considered in this paper. For the first time this paper provides an analytical expression for the time-domain response of an RC transmission line, which is stimulated by a step function that is fed into both ends of the transmission line. In particular, we find an analytical expression for the step response at the center of the transmission line, in order to determine the worst-case rise time. This is of interest, for example, in large charge-coupled device (CCD) arrays, where long polysilicon lines are dual-fed in order to mitigate degradation in rise time. The analytical expressions for the RC transmission line are supported by computer-simulated lumped RC models.	[Dorraki, Mohsen] Amirkabir Univ Technol, Dept Elect Engn, Tehran, Iran; [Cambrell, Gregory K.] Monash Univ, Fac Engn, Dept Elect & Comp Syst Engn, Clayton, Vic 3800, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia	Amirkabir University of Technology; Monash University; University of Adelaide	Dorraki, M (corresponding author), Amirkabir Univ Technol, Dept Elect Engn, Tehran, Iran.	dorraki@aut.ac.ir	Abbott, Derek/E-8352-2011; Dorraki, Mohsen/J-6393-2019	Abbott, Derek/0000-0002-0945-2674; Dorraki, Mohsen/0000-0002-6675-3393				Gupta S, 1999, TWELFTH INTERNATIONAL CONFERENCE ON VLSI DESIGN, PROCEEDINGS, P160, DOI 10.1109/ICVD.1999.745142; Kahng A. B., 1997, ACM Transactions on Design Automation of Electronic Systems, V2, P168, DOI 10.1145/253052.253137; KAHNG AB, 1994, ACM IEEE D, P563; KAMASZ SR, 1993, P SOC PHOTO-OPT INS, V1900, P147, DOI 10.1117/12.148593; Ng J, 2002, MICROELECTRON J, V33, P171, DOI 10.1016/S0026-2692(01)00116-1; PEIRSON RC, 1969, J APPL PHYS, V40, P118, DOI 10.1063/1.1657014; RAO VB, 1995, DES AUT CON, P370; SAKURAI T, 1983, IEEE J SOLID-ST CIRC, V18, P418, DOI 10.1109/JSSC.1983.1051966	8	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116993	10.1371/journal.pone.0116993	http://dx.doi.org/10.1371/journal.pone.0116993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679379	Green Published, gold			2022-12-26	WOS:000350682600043
J	Leong, SL; Hinds, MG; Connor, AR; Smith, DP; Illes-Toth, E; Pham, CLL; Barnham, KJ; Cappai, R				Leong, Su Ling; Hinds, Mark G.; Connor, Andrea R.; Smith, David P.; Illes-Toth, Eva; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto			The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated alpha-Synuclein Dimerisation	PLOS ONE			English	Article							SPECTROMETRY-MASS SPECTROMETRY; PARKINSONS-DISEASE; ELECTROSPRAY-IONIZATION; UNFOLDED PROTEINS; NMR-SPECTROSCOPY; AMYLOID FIBRILS; CONFORMATIONAL STATES; SECONDARY STRUCTURE; CHEMICAL-SHIFTS; BINDING	alpha-synuclein (alpha-syn) is a major component of the intracellular inclusions called Lewy bodies, which are a key pathological feature in the brains of Parkinson's disease patients. The neurotransmitter dopamine (DA) inhibits the fibrillisation of alpha-syn into amyloid, and promotes alpha-syn aggregation into SDS-stable soluble oligomers. While this inhibition of amyloid formation requires the oxidation of both DA and the methionines in alpha-syn, the molecular basis for these processes is still unclear. This study sought to define the protein sequences required for the generation of oligomers. We tested N-(alpha-syn residues 43-140) and C-terminally (1-95) truncated alpha-syn, and found that similar to full-length protein both truncated species formed soluble DA: alpha-syn oligomers, albeit 1-95 had a different profile. Using nuclear magnetic resonance (NMR), and the N- terminally truncated alpha-syn 43-140 protein, we analysed the structural characteristics of the DA: alpha-syn 43-140 dimer and alpha-syn 43-140 monomer and found the dimerisation interface encompassed residues 43 to 60. Narrowing the interface to this small region will help define the mechanism by which DA mediates the formation of SDS-stable soluble DA: alpha-syn oligomers.	[Leong, Su Ling; Connor, Andrea R.; Pham, Chi L. L.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Leong, Su Ling; Hinds, Mark G.; Connor, Andrea R.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hinds, Mark G.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Smith, David P.; Illes-Toth, Eva] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Barnham, Kevin J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Sheffield Hallam University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Cappai, R (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.	r.cappai@unimelb.edu.au	Hinds, Mark Gavin/AAD-3653-2020; Cappai, Roberto/B-3347-2010	Hinds, Mark Gavin/0000-0002-2856-5375; Wuthrich, Kurt/0000-0001-8739-6965; Illes-Toth, Eva/0000-0001-5232-8196; Smith, David/0000-0001-5177-8574; Cappai, Roberto/0000-0002-9505-8496	National Health and Medical Research Council of Australia [628946]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia, Program Grant 628946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Bae EJ, 2013, ANTIOXID REDOX SIGN, V18, P770, DOI 10.1089/ars.2011.4429; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hokenson MJ, 2004, BIOCHEMISTRY-US, V43, P4621, DOI 10.1021/bi049979h; Illes-Toth E, 2013, J AM SOC MASS SPECTR, V24, P1346, DOI 10.1007/s13361-013-0676-z; Ito S, 2010, NEUROSCI RES, V66, P124, DOI 10.1016/j.neures.2009.10.005; Jain MK, 2014, NEUROBIOL DIS, V63, P115, DOI 10.1016/j.nbd.2013.11.004; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kahle PJ, 2002, J NEUROCHEM, V82, P449, DOI 10.1046/j.1471-4159.2002.01020.x; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511+; Keller R., 2004, COMPUTER AIDED RESON, V1; Kjaergaard M, 2012, PROG NUCL MAG RES SP, V60, P42, DOI 10.1016/j.pnmrs.2011.10.001; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pham CLL, 2013, BIOSCIENCE REP, V33, P807, DOI 10.1042/BSR20130092; Pham CLL, 2014, PROTEINS, V82, P10, DOI 10.1002/prot.24332; Pham CLL, 2009, J MOL BIOL, V387, P771, DOI 10.1016/j.jmb.2009.02.007; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Planchard MS, 2014, PROTEIN SCI, V23, P1369, DOI 10.1002/pro.2521; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Yamaguchi Y, 2010, J MOL BIOL, V395, P445, DOI 10.1016/j.jmb.2009.10.068; Yamakawa K, 2010, BIOCHEM BIOPH RES CO, V391, P129, DOI 10.1016/j.bbrc.2009.11.015; Zijlstra N, 2014, BIOPHYS J, V106, P440, DOI 10.1016/j.bpj.2013.12.009	60	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116497	10.1371/journal.pone.0116497	http://dx.doi.org/10.1371/journal.pone.0116497			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679387	Green Published, gold, Green Accepted			2022-12-26	WOS:000350682600022
J	Sroga, GE; Siddula, A; Vashishth, D				Sroga, Grazyna E.; Siddula, Alankrita; Vashishth, Deepak			Glycation of Human Cortical and Cancellous Bone Captures Differences in the Formation of Maillard Reaction Products between Glucose and Ribose	PLOS ONE			English	Article							FRUCTOSE CORN SYRUP; INSULIN-RESISTANCE; NONENZYMATIC GLYCATION; SWEETENED BEVERAGES; CROSS-LINKS; BIOMECHANICAL PROPERTIES; MATRIX PROTEINS; TISSUE PROTEINS; END-PRODUCTS; COLLAGEN	To better understand some aspects of bone matrix glycation, we used an in vitro glycation approach. Within two weeks, our glycation procedures led to the formation of advanced glycation end products (AGEs) at the levels that corresponded to approx. 25-30 years of the natural in vivo glycation. Cortical and cancellous bones from human tibias were glycated in vitro using either glucose (glucosylation) or ribose (ribosylation). Both glucosylation and ribosylation led to the formation of higher levels of AGEs and pentosidine (PEN) in cancellous than cortical bone dissected from all tested donors (young, middle-age and elderly men and women). More efficient glycation of bone matrix proteins in cancellous bone most likely depended on the higher porosity of this tissue, which facilitated better accessibility of the sugars to the matrix proteins. Notably, glycation of cortical bone from older donors led to much higher AGEs levels as compared to young donors. Such efficient in vitro glycation of older cortical bone could result from aging-related increase in porosity caused by the loss of mineral content. In addition, more pronounced glycation in vivo would be driven by elevated oxidation processes. Interestingly, the levels of PEN formation differed pronouncedly between glucosylation and ribosylation. Ribosylation generated very high levels of PEN (approx. 6-vs. 2.5-fold higher PEN level than in glucosylated samples). Kinetic studies of AGEs and PEN formation in human cortical and cancellous bone matrix confirmed higher accumulation of fluorescent crosslinks for ribosylation. Our results suggest that in vitro glycation of bone using glucose leads to the formation of lower levels of AGEs including PEN, whereas ribosylation appears to support a pathway toward PEN formation. Our studies may help to understand differences in the progression of bone pathologies related to protein glycation by different sugars, and raise awareness for excessive sugar supplementation in food and drinks.	[Sroga, Grazyna E.; Siddula, Alankrita; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Vashishth, D (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	vashid@rpi.edu		Vashishth, Deepak/0000-0001-5712-0167	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [AG20618, AR49635]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020618, R56AG020618] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Numbers AG20618 and AR49635. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors acknowledge use of human bone tissues provided by the National Disease Research Interchange (NDRI) with support from NIH grant 5 U42 RR006042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTLE JP, 1983, NEW ENGL J MED, V309, P7, DOI 10.1056/NEJM198307073090102; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; BROOM AD, 1964, BIOCHEMISTRY-US, V3, P494, DOI 10.1021/bi00892a005; Cai WJ, 2014, P NATL ACAD SCI USA, V111, P4940, DOI 10.1073/pnas.1316013111; CHANG RS, 1960, J EXP MED, V111, P235, DOI 10.1084/jem.111.2.235; Clark PM, 2014, P NATL ACAD SCI USA, V111, pE2866, DOI 10.1073/pnas.1410326111; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Fayle S.E., 2002, MAILLARD REACTION, P1; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gross LS, 2004, AM J CLIN NUTR, V79, P774; GROSS M, 1991, KLIN WOCHENSCHR, V69, P31, DOI 10.1007/BF01649054; GUNDBERG CM, 1986, J BIOL CHEM, V261, P4557; Han CSA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024623; HANOVER LM, 1993, AM J CLIN NUTR, V58, P724, DOI 10.1093/ajcn/58.5.724S; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Jilka RL, 2014, J BONE MINER RES, V29, P103, DOI 10.1002/jbmr.2007; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; KATZ J., 1955, JOUR BIOL CHEM, V214, P853; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Laroque D, 2008, FOOD CHEM, V111, P1032, DOI 10.1016/j.foodchem.2008.05.033; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Lowndes J, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-55; MAHONEY JR, 1989, J SURG RES, V47, P530, DOI 10.1016/0022-4804(89)90131-5; Malerbi DA, 1996, DIABETES CARE, V19, P1249, DOI 10.2337/diacare.19.11.1249; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Nikel O, 2013, LANGMUIR, V29, P13873, DOI 10.1021/la403203w; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Nursten HE, 2005, MAILLARD REACTION: CHEMISTRY, BIOCHEMISTRY AND IMPLICATIONS, P1, DOI 10.1039/9781847552570; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223; RACKER E, 1961, ADV ENZYMOL REL S BI, V23, P323; RAHBAR S, 1969, BIOCHEM BIOPH RES CO, V36, P838, DOI 10.1016/0006-291X(69)90685-8; REITZER LJ, 1980, J BIOL CHEM, V255, P5616; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stanhope KL, 2008, AM J CLIN NUTR, V88, p1733S, DOI 10.3945/ajcn.2008.25825D; Su T, 2013, PROG BIOCHEM BIOPHYS, V40, P816, DOI 10.3724/SP.J.1206.2013.00341; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Teitelbaum JE, 2006, J ALTERN COMPLEM MED, V12, P857, DOI 10.1089/acm.2006.12.857; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viviani GL, 2008, METABOLISM, V57, P163, DOI 10.1016/j.metabol.2007.08.020; Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wei Y, 2012, BBA-GEN SUBJECTS, V1820, P488, DOI 10.1016/j.bbagen.2012.01.005; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7	63	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117240	10.1371/journal.pone.0117240	http://dx.doi.org/10.1371/journal.pone.0117240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679213	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600056
J	Caverly, LJ; Caceres, SM; Fratelli, C; Happoldt, C; Kidwell, KM; Malcolm, KC; Nick, JA; Nichols, DP				Caverly, Lindsay J.; Caceres, Silvia M.; Fratelli, Cori; Happoldt, Carrie; Kidwell, Kelley M.; Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.			Mycobacterium abscessus Morphotype Comparison in a Murine Model	PLOS ONE			English	Article							FIBROSIS LUNG-DISEASE; CYSTIC-FIBROSIS; NONTUBERCULOUS-MYCOBACTERIA; PSEUDOMONAS-AERUGINOSA; PULMONARY INFECTION; MICE; ROUGH; MASSILIENSE; PREVALENCE; INDUCTION	Pulmonary infections with Mycobacterium abscessus (M. abscessus) are increasingly prevalent in patients with lung diseases such as cystic fibrosis. M. abscessus exists in two morphotypes, smooth and rough, but the impact of morphotype on virulence is unclear. We developed an immune competent mouse model of pulmonary M. abscessus infection and tested the differences in host inflammatory response between the morphotypes of M. abscessus. Smooth and rough morphotypes of M. abscessus were isolated from the same American Type Culture Collection strain. Wild type and cystic fibrosis mice were intratracheally inoculated with known quantities of M. abscessus suspended in fibrin plugs. At the time of sacrifice lung and splenic tissues and bronchoalveolar lavage fluid were collected and cultured. Bronchoalveolar lavage fluid was analyzed for leukocyte count, differential and cytokine expression. Pulmonary infection with M. abscessus was present at both 3 days and 14 days post-inoculation in all groups at greater levels than systemic infection. Inoculation with M. abscessus rough morphotype resulted in more bronchoalveolar lavage fluid neutrophils compared to smooth morphotype at 14 days post-inoculation in both wild type (p = 0.01) and cystic fibrosis (p<0.01) mice. Spontaneous in vivo conversion from smooth to rough morphotype occurred in 12/57 (21%) of mice. These mice trended towards greater weight loss than mice in which morphotype conversion did not occur. In the described fibrin plug model of M. abscessus infection, pulmonary infection with minimal systemic dissemination is achieved with both smooth and rough morphotypes. In this model M. abscessus rough morphotype causes a greater host inflammatory response than the smooth based on bronchoalveolar lavage fluid neutrophil levels.	[Caverly, Lindsay J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Caceres, Silvia M.; Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Fratelli, Cori; Happoldt, Carrie; Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Kidwell, Kelley M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Malcolm, Kenneth C.; Nick, Jerry A.; Nichols, David P.] Univ Colorado Denver, Dept Med, Aurora, CO USA	University of Michigan System; University of Michigan; National Jewish Health; National Jewish Health; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Caverly, LJ (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	caverlyl@med.umich.edu		Kidwell, Kelley M/0000-0002-1717-4483; Nichols, David/0000-0001-8611-7960	Cystic fibrosis foundation [CAVERL13D0]; National Institute of Health [K12HD028820, T32HL007670, KL2 TR000156]; Charles Woodson Fund for Clinical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, KL2TR001080, KL2TR000156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007670] Funding Source: NIH RePORTER	Cystic fibrosis foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Woodson Fund for Clinical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by Cystic fibrosis foundation, www.cff.org: grant number CAVERL13D0 to author: LJC, National Institute of Health, www.nih.gov: grant numbers K12HD028820, T32HL007670 to author: LJC, grant number KL2 TR000156 to author: DPN and Charles Woodson Fund for Clinical Research, www.charleswoodsonfoundation.org to author: KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Ballarino GJ, 2009, RESP MED, V103, P1448, DOI 10.1016/j.rmed.2009.04.026; Bryant JM, 2013, LANCET, DOI [10.1016/S2214-109X(13)70180-3, DOI 10.1016/S2214-109X(13)70180-3]; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Cardona PJ, 1999, SCAND J IMMUNOL, V49, P362; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Caverly L F C, 2012, AJRCCM, P185; Chan ED, 2013, SEMIN RESP CRIT CARE, V34, P110, DOI 10.1055/s-0033-1333573; Chandler JD, 2013, BRIT J PHARMACOL, V169, P1166, DOI 10.1111/bph.12206; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Irvin Charles G, 2009, Proc Am Thorac Soc, V6, P306, DOI 10.1513/pats.200808-091RM; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; Jeon BY, 2009, J MICROBIOL, V47, P633, DOI 10.1007/s12275-009-0139-1; Jonsson B, 2013, APMIS, V121, P45, DOI 10.1111/j.1600-0463.2012.02932.x; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Leung JM, 2013, SEMIN RESP CRIT CARE, V34, P124, DOI 10.1055/s-0033-1333574; Madsen Priscilla, 2005, Paediatr Respir Rev, V6, P292; Malcolm KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057402; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Martiniano Stacey L, 2014, Ann Am Thorac Soc, V11, P36, DOI 10.1513/AnnalsATS.201309-310OC; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Pawlik A, 2013, MOL MICROBIOL, DOI [10.1111/mmi.12478, DOI 10.1111/MMI.12478]; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; POLLOCK HM, 1977, J CLIN MICROBIOL, V5, P329; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Ruger K, 2013, J CLIN MICROBIOL, DOI [10.1128/JCM.02925-13, DOI 10.1128/JCM.02925-13]; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Seear M, 1997, AM J RESP CRIT CARE, V155, P364, DOI 10.1164/ajrccm.155.1.9001337; SNOUWAERT JN, 1995, AM J RESP CRIT CARE, V151, pS59, DOI 10.1164/ajrccm/151.3_Pt_2.S59; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Tomashefski JF, 1996, AM J RESP CRIT CARE, V154, P523, DOI 10.1164/ajrccm.154.2.8756832; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9	44	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117657	10.1371/journal.pone.0117657	http://dx.doi.org/10.1371/journal.pone.0117657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675351	gold, Green Published, Green Submitted			2022-12-26	WOS:000349914000029
J	Ariani, A; Di Baccio, D; Romeo, S; Lombardi, L; Andreucci, A; Lux, A; Horner, DS; Sebastiani, L				Ariani, Andrea; Di Baccio, Daniela; Romeo, Stefania; Lombardi, Lara; Andreucci, Andrea; Lux, Alexander; Horner, David Stephen; Sebastiani, Luca			RNA Sequencing of Populus x canadensis Roots Identifies Key Molecular Mechanisms Underlying Physiological Adaption to Excess Zinc	PLOS ONE			English	Article							EURAMERICANA CLONE I-214; HEAVY-METAL ACCUMULATION; ARABIDOPSIS-THALIANA; NICOTIANAMINE-SYNTHASE; IRON HOMEOSTASIS; TRANSPORTER; POPLAR; RESPONSES; EXPRESSION; HALLERI	Populus x canadensis clone I-214 exhibits a general indicator phenotype in response to excess Zn, and a higher metal uptake in roots than in shoots with a reduced translocation to aerial parts under hydroponic conditions. This physiological adaptation seems mainly regulated by roots, although the molecular mechanisms that underlie these processes are still poorly understood. Here, differential expression analysis using RNA-sequencing technology was used to identify the molecular mechanisms involved in the response to excess Zn in root. In order to maximize specificity of detection of differentially expressed (DE) genes, we consider the intersection of genes identified by three distinct statistical approaches (61 up- and 19 down- regulated) and validate them by RT-qPCR, yielding an agreement of 93% between the two experimental techniques. Gene Ontology (GO) terms related to oxidationreduction processes, transport and cellular iron ion homeostasis were enriched among DE genes, highlighting the importance of metal homeostasis in adaptation to excess Zn by P. x canadensis clone I-214. We identified the up-regulation of two Populus metal transporters (ZIP2 and NRAMP1) probably involved in metal uptake, and the down-regulation of a NAS4 gene involved in metal translocation. We identified also four Fe-homeostasis transcription factors (two bHLH38 genes, FIT and BTS) that were differentially expressed, probably for reducing Zn-induced Fe-deficiency. In particular, we suggest that the down-regulation of FIT transcription factor could be a mechanism to cope with Zn-induced Fe-deficiency in Populus. These results provide insight into the molecular mechanisms involved in adaption to excess Zn in Populus spp., but could also constitute a starting point for the identification and characterization of molecular markers or biotechnological targets for possible improvement of phytoremediation performances of poplar trees.	[Ariani, Andrea; Di Baccio, Daniela; Romeo, Stefania; Sebastiani, Luca] Scuola Super Sant Anna, Inst Life Sci, BioLabs, I-56127 Pisa, Italy; [Lombardi, Lara; Andreucci, Andrea] Univ Pisa, Dept Biol, I-56126 Pisa, Italy; [Lux, Alexander] Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia; [Lux, Alexander] Slovak Acad Sci, Inst Chem, Bratislava, Slovakia; [Horner, David Stephen] Univ Milan, Dept Biosci, Milan, Italy	Scuola Superiore Sant'Anna; University of Pisa; Comenius University Bratislava; Slovak Academy of Sciences; University of Milan	Sebastiani, L (corresponding author), Scuola Super Sant Anna, Inst Life Sci, BioLabs, I-56127 Pisa, Italy.	sebastiani@sssup.it	Sebastiani, Luca/AAU-5989-2021; Sebastiani, Luca/B-1055-2008; Horner, David/AAC-2274-2022; Lux, Alexander/AAU-6675-2021; Di Baccio, Daniela/O-3452-2019	Sebastiani, Luca/0000-0002-8536-3569; Sebastiani, Luca/0000-0002-8536-3569; Lux, Alexander/0000-0001-8651-8166; Di Baccio, Daniela/0000-0001-6270-0270	Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale	Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was supported by the Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale (Significant bilateral project between Italy and Slovak) (http://www.esteri.it/MAE/IT/Politica_Estera/CooperScientificaTecnologica/Progetti_grande_rilevanza.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2011, J EXP BOT, V62, P3737, DOI 10.1093/jxb/err025; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; BAKER AJM, 1981, J PLANT NUTR, V3, P643, DOI 10.1080/01904168109362867; Berta M, 2010, PLANT BIOLOGY, V12, P341, DOI 10.1111/j.1438-8677.2009.00320.x; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Bluthgen Nils, 2005, Genome Inform, V16, P106; Brautigam A, 2010, PLANT BIOLOGY, V12, P831, DOI 10.1111/j.1438-8677.2010.00373.x; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craciun AR, 2012, J EXP BOT, V63, P4179, DOI 10.1093/jxb/ers104; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Deinlein U, 2012, PLANT CELL, V24, P708, DOI 10.1105/tpc.111.095000; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Di Baccio D, 2005, NEW PHYTOL, V167, P73, DOI 10.1111/j.1469-8137.2005.01462.x; Di Baccio D, 2003, NEW PHYTOL, V159, P443, DOI 10.1046/j.1469-8137.2003.00818.x; Di Baccio D, 2009, ENVIRON EXP BOT, V67, P153, DOI 10.1016/j.envexpbot.2009.05.014; Di Baccio D, 2011, TREE PHYSIOL, V31, P1293, DOI 10.1093/treephys/tpr106; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Erland S, 2002, ECOL STU AN, V157, P163; Frerot H, 2010, NEW PHYTOL, V187, P355, DOI 10.1111/j.1469-8137.2010.03295.x; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; He JL, 2013, PLANT PHYSIOL, V162, P424, DOI 10.1104/pp.113.215681; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kohler A, 2003, FEBS LETT, V542, P37, DOI 10.1016/S0014-5793(03)00334-X; Lado LR, 2008, GEODERMA, V148, P189, DOI 10.1016/j.geoderma.2008.09.020; Laureysens I, 2005, ENVIRON POLLUT, V133, P541, DOI 10.1016/j.envpol.2004.06.013; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; PULFORD ID, 2005, TRACE ELEMENTS ENV, P383; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sebastiani L, 2004, ENVIRON EXP BOT, V52, P79, DOI 10.1016/j.envexpbot.2004.01.003; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Shanmugam V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00281; Shanmugam V, 2011, NEW PHYTOL, V190, P125, DOI 10.1111/j.1469-8137.2010.03606.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Stolarikova M, 2012, BIOLOGIA, V67, P483, DOI 10.2478/s11756-012-0039-4; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vassilev Andon, 2004, ScientificWorldJournal, V4, P9; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wu HL, 2012, PLANT PHYSIOL, V158, P790, DOI 10.1104/pp.111.190983; Wu ZJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-564; Xiao HH, 2008, ANN BOT-LONDON, V102, P881, DOI 10.1093/aob/mcn178; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331	77	18	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117571	10.1371/journal.pone.0117571	http://dx.doi.org/10.1371/journal.pone.0117571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671786	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300061
J	Fuhr, MJ; Meyer, M; Fehr, E; Ponzio, G; Werner, S; Herrmann, HJ				Fuhr, Matthias Jorg; Meyer, Michael; Fehr, Eric; Ponzio, Gilles; Werner, Sabine; Herrmann, Hans Jurgen			A Modeling Approach to Study the Effect of Cell Polarization on Keratinocyte Migration	PLOS ONE			English	Article							WOUND REPAIR; RECEPTORS 1	The skin forms an efficient barrier against the environment, and rapid cutaneous wound healing after injury is therefore essential. Healing of the uppermost layer of the skin, the epidermis, involves collective migration of keratinocytes, which requires coordinated polarization of the cells. To study this process, we developed a model that allows analysis of live-cell images of migrating keratinocytes in culture based on a small number of parameters, including the radius of the cells, their mass and their polarization. This computational approach allowed the analysis of cell migration at the front of the wound and a reliable identification and quantification of the impaired polarization and migration of keratinocytes from mice lacking fibroblast growth factors 1 and 2 - an established model of impaired healing. Therefore, our modeling approach is suitable for large-scale analysis of migration phenotypes of cells with specific genetic defects or upon treatment with different pharmacological agents.	[Fuhr, Matthias Jorg; Fehr, Eric; Herrmann, Hans Jurgen] ETH, Inst Bldg Mat Computat Phys Engn Mat, Zurich, Switzerland; [Meyer, Michael; Werner, Sabine] ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Ponzio, Gilles] CNRS, UMR 7275, Valbonne, France; [Ponzio, Gilles] Univ Nice Sophia Antipolis, F-06189 Nice, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Werner, S (corresponding author), ETH, Inst Mol Hlth Sci, Zurich, Switzerland.	sabine.werner@biol.ethz.ch; hans@ifb.baug.ethz.ch	Ponzio, Gilles/Q-1256-2016	Ponzio, Gilles/0000-0003-2741-0248; Meyer, Michael/0000-0002-8238-0216; Werner, Sabine/0000-0001-7397-8710	Swiss National Foundation SNF [205321121701, 310030_132884]; European Research Council (ERC) [319968-FlowCCS]	Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC))	This work was supported by grants from the Swiss National Foundation SNF (No. 205321121701 to H.J.H. and 310030_132884 to S.W.) and the European Research Council (ERC) Advanced Grant 319968-FlowCCS (to H.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2011, BIOPHYS J, V100, P535, DOI 10.1016/j.bpj.2010.11.083; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Griebel M, 2007, NUMERICAL SIMULATION; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Iannaccone P, 1996, FRACTAL GEOMETRY BIO; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Losa GA, 2005, CELL TISSUE RES, V322, P257, DOI 10.1007/s00441-005-0030-2; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Muller AK, 2012, SEMIN CELL DEV BIOL, V23, P963, DOI 10.1016/j.semcdb.2012.09.015; Nuatro J, 2007, SUMM COMP SIM C 2007; Ouaknin GY, 2009, BIOPHYS J, V97, P1811, DOI 10.1016/j.bpj.2009.05.064; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Sullivan THR, 2008, WORLD ACAD SCI ENG T, V20, P1019; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Yuan CQ, 2003, WEAR, V255, P315, DOI 10.1016/S0043-1648(03)00206-0	30	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117676	10.1371/journal.pone.0117676	http://dx.doi.org/10.1371/journal.pone.0117676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671585	Green Published, gold			2022-12-26	WOS:000349545300066
J	Heblich, S; Lameli, A; Riener, G				Heblich, Stephan; Lameli, Alfred; Riener, Gerhard			The Effect of Perceived Regional Accents on Individual Economic Behavior: A Lab Experiment on Linguistic Performance, Cognitive Ratings and Economic Decisions	PLOS ONE			English	Article							JOB INTERVIEW; DISCRIMINATION; IDENTIFICATION; LANGUAGE; IDENTITY; DIALECT; MATTERS; BEAUTY	Does it matter if you speak with a regional accent? Speaking immediately reveals something of one's own social and cultural identity, be it consciously or unconsciously. Perceiving accents involves not only reconstructing such imprints but also augmenting them with particular attitudes and stereotypes. Even though we know much about attitudes and stereotypes that are transmitted by, e.g. skin color, names or physical attractiveness, we do not yet have satisfactory answers how accent perception affects human behavior. How do people act in economically relevant contexts when they are confronted with regional accents? This paper reports a laboratory experiment where we address this question. Participants in our experiment conduct cognitive tests where they can choose to either cooperate or compete with a randomly matched male opponent identified only via his rendering of a standardized text in either a regional accent or standard accent. We find a strong connection between the linguistic performance and the cognitive rating of the opponent. When matched with an opponent who speaks the accent of the participant's home region-the in-group opponent-, individuals tend to cooperate significantly more often. By contrast, they are more likely to compete when matched with an accent speaker from outside their home region, the out-group opponent. Our findings demonstrate, firstly, that the perception of an out-group accent leads not only to social discrimination but also influences economic decisions. Secondly, they suggest that this economic behavior is not necessarily attributable to the perception of a regional accent per se, but rather to the social rating of linguistic distance and the in-group/out-group perception it evokes.	[Heblich, Stephan] Univ Bristol, CESifo, IZA, Bristol, Avon, England; [Heblich, Stephan] Univ Bristol, SERC, Dept Econ, Bristol, Avon, England; [Lameli, Alfred] Res Ctr Deutsch Sprachatlas, Marburg, Germany; [Lameli, Alfred] ADW Mainz, Marburg, Germany; [Riener, Gerhard] Univ Mannheim, Dusseldorf Inst Competit Econ, D-68131 Mannheim, Germany; [Riener, Gerhard] Univ Gottingen, CRC PEG, Mannheim, Germany	University of Bristol; University of Bristol; University of Mannheim; University of Gottingen	Riener, G (corresponding author), Univ Mannheim, Dusseldorf Inst Competit Econ, D-68131 Mannheim, Germany.	riener@dice.hhu.de		Riener, Gerhard/0000-0003-1056-2034; Heblich, Stephan/0000-0001-6486-3727; Lameli, Alfred/0000-0003-1516-2224	Max Planck Society; Academy of Science and Literature Mainz [REDE 0404]; German Research Foundation (DFG) [RTG1411]; Research Center Deutscher Sprachatlas	Max Planck Society(Max Planck SocietyFoundation CELLEX); Academy of Science and Literature Mainz; German Research Foundation (DFG)(German Research Foundation (DFG)); Research Center Deutscher Sprachatlas	This research is supported by the Max Planck Society, the Academy of Science and Literature Mainz (grant REDE 0404), the German Research Foundation (DFG grant RTG1411) and the Research Center Deutscher Sprachatlas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer Peter, 2005, PERSPECTIVES VARIATI, P7, DOI DOI 10.1515/9783110909579.7; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; Chambers J. K., 1999, DIALECTOLOGY; Coupland N, 2007, J SOCIOLING, V11, P74, DOI 10.1111/j.1467-9841.2007.00311.x; De Fina A, 2007, LANG SOC, V36, P371, DOI 10.1017/S0047404507070182; Deprez-Sims AS, 2010, INT J PSYCHOL, V45, P417, DOI 10.1080/00207594.2010.499950; Dixon JA, 2002, J LANG SOC PSYCHOL, V21, P162, DOI 10.1177/02627X02021002004; Durante R, 2014, J EUROPEAN EC ASS; Eckert P, 2012, ANNU REV ANTHROPOL, V41, P87, DOI 10.1146/annurev-anthro-092611-145828; Falck O, 2012, J URBAN ECON, V72, P225, DOI 10.1016/j.jue.2012.05.007; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frumkin L, 2007, PSYCHOL CRIME LAW, V13, P317, DOI 10.1080/10683160600822246; Ginsburgh V., 2011, MANY LANGUAGES DO WE; Gluszek A, 2010, PERS SOC PSYCHOL REV, V14, P214, DOI 10.1177/1088868309359288; Greiner B., 2004, 13513 MPRA; Grosse N. D., 2010, EXPLAINING GENDER DI; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hanushek E. A., 2013, RETURNS SKILLS WORLD; Herrgen J, 1989, DIALEKTGEOGRAPHIE DI, P304; Holmes K, 2001, NEW ZEAL J PSYCHOL, V30, P79; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huesmann A, 1998, ZWISCHEN DIALEKT STA, pXV; Institut fur Demoskopie Allensbach, 2008, ALLENSBACH, DOI [10.1016/j.envpol.2015.01.010, DOI 10.1016/J.ENVPOL.2015.01.010]; Kehrein Roland., 2012, REGIONALSPRACHLICHE; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Krauss RM, 1997, HDB SOCIAL PSYCHOL, P41; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LAMBERT WE, 1960, J ABNORM SOC PSYCH, V60, P44, DOI 10.1037/h0044430; Lameli A, 2004, STANDARD SUBSTANDARD, DOI [10.1016/j.watres.2015.01.006, DOI 10.1016/J.WATRES.2015.01.006]; Lev-Ari S, 2010, J EXP SOC PSYCHOL, V46, P1093, DOI 10.1016/j.jesp.2010.05.025; Mai R, 2011, J SERV RES-US, V14, P460, DOI 10.1177/1094670511414551; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Preston D, 2010, LANGUAGE SPACE INT H; Purnell T, 1999, J LANG SOC PSYCHOL, V18, P10, DOI 10.1177/0261927X99018001002; Purschke C, 2011, REGIONALSPRACHE HORE, V347, pXVI; Rakic T, 2011, BRIT J PSYCHOL, V102, P868, DOI 10.1111/j.2044-8295.2011.02051.x; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; ROMAINE S, 1980, LANG SPEECH, V23, P213, DOI 10.1177/002383098002300301; Schmidt JE, TAAL TONGVAL, V63, P1, DOI [10.1002/acr.22531, DOI 10.1002/ACR.22531]; Schmitt EH, 1992, INTERDIALEKTALE VERS; Souza AL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00953; Thorne S., 2005, J QUANT LINGUIST, V12, P151; Tsalikis J., 1992, INT MARKET REV, V9, P57; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	48	13	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0113475	10.1371/journal.pone.0113475	http://dx.doi.org/10.1371/journal.pone.0113475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671607	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300003
J	Lindahl, E; Sattorov, N; Boqvist, S; Magnusson, U				Lindahl, Elisabeth; Sattorov, Nosirjon; Boqvist, Sofia; Magnusson, Ulf			A Study of Knowledge, Attitudes and Practices Relating to Brucellosis among Small-Scale Dairy Farmers in an Urban and Peri-Urban Area of Tajikistan	PLOS ONE			English	Article							RISK-FACTORS; RUMINANTS	Improvement of knowledge, attitudes and practices among urban livestock farmers could have a significant impact on the reduction of many zoonotic infections in urban farming. This study aimed to describe and evaluate weak areas in knowledge, attitudes and practices with regards to brucellosis among urban and peri-urban small-scale dairy farmers in a low income country to generate information essential for control programmes and public health interventions. The cross-sectional study was conducted during six weeks in 2011. The study subjects were small-scale dairy farmers living in the urban and peri-urban area of the capital Dushanbe in Tajikistan. In total, 441 farmers were interviewed using a questionnaire with questions about demographic characteristics, knowledge, attitudes and practices relating to brucellosis. Descriptive statistics were used and a logistic regression model applied to evaluate potential predictors to knowledge about brucellosis. The majority (85%) of the farmers had never heard of brucellosis. Low educational level was found to be associated with low awareness of brucellosis (P = < 0.001). Respondents who talked about animal health issues with family members or friends were less likely to have heard of brucellosis compared to those who often talked to veterinarians (P = 0.03). Sixty three per cent of the participants wanted more information about brucellosis. Seventeen per cent sold unpasteurized dairy products on a regular basis direct to consumers. Almost 30% of the households consumed unpasteurized dairy products on regular basis. A majority of the respondents did not use any protection when handling cows having an abortion or when dealing with aborted materials. Poor knowledge, high-risk behaviours and a willingness to learn more strengthens the logic for including health education as part of control programmes.	[Lindahl, Elisabeth; Magnusson, Ulf] Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, SE-75007 Uppsala, Sweden; [Sattorov, Nosirjon] Tajik Agrarian Univ, Dushanbe, Tajikistan; [Boqvist, Sofia] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Div Food Safety & Bacteriol, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Tajik Agrarian University Named Shirinsho Shotemur; Swedish University of Agricultural Sciences	Magnusson, U (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, POB 7054, SE-75007 Uppsala, Sweden.	ulf.magnusson@slu.se		Boqvist, Sofia/0000-0002-8072-7132; Magnusson, Ulf/0000-0002-7087-6820	Swedish Ministry of Foreign Affair's special investment in food security	Swedish Ministry of Foreign Affair's special investment in food security	This study was supported by the Swedish Ministry of Foreign Affair's special investment in food security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamahy HA, 2000, EPIDEMIOL INFECT, V125, P309, DOI 10.1017/S0950268899004458; Bonfoh B, 2012, ECOHEALTH, V9, P132, DOI 10.1007/s10393-011-0722-x; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Earhart K, 2009, INT J INFECT DIS, V13, P749, DOI 10.1016/j.ijid.2009.02.014; FAO, 2014, PATHW SUCC BRUC CONT; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Jackson R, 2007, VET REC, V161, P476, DOI 10.1136/vr.161.14.476; Kang'Ethe E.K., 2007, E AFR MED J, V84, P48, DOI [10.4314/eamj.v84i11.9576, DOI 10.4314/EAMJ.V84I11.9576]; Kangethe EK., 2007, E AFR MED J, V84, P45; Kangethe EK, 2007, E AFR MED J, V84, P96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; Kozukeev Turatbek B, 2006, MMWR Suppl, V55, P31; Lindahl E, 2014, TROP ANIM HEALTH PRO, V46, P563, DOI 10.1007/s11250-013-0534-9; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Smits HL, 2012, VET REC, V170, P97, DOI 10.1136/vr.e666; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; Solera J, 1999, CLIN INFECT DIS, V29, P1440, DOI 10.1086/313524; United Nations, 2012, SOC IND; Ward D, 2012, VET REC, V170, DOI 10.1136/vr.100012; WHO, 2014, NEGL ZOON DIS; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	22	60	64	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117318	10.1371/journal.pone.0117318	http://dx.doi.org/10.1371/journal.pone.0117318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668783	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000018
J	Steel, MM; Papsin, BC; Gordon, KA				Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.			Binaural Fusion and Listening Effort in Children Who Use Bilateral Cochlear Implants: A Psychoacoustic and Pupillometric Study	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; INTERAURAL TIME DIFFERENCES; CROSS-MODAL PLASTICITY; PLACE-OF-STIMULATION; SPEECH-PERCEPTION; PUPILLARY RESPONSES; SOUND LOCALIZATION; LEVEL DIFFERENCES; EVOKED-POTENTIALS; SPATIAL UNMASKING	Bilateral cochlear implants aim to provide hearing to both ears for children who are deaf and promote binaural/spatial hearing. Benefits are limited by mismatched devices and unilaterally-driven development which could compromise the normal integration of left and right ear input. We thus asked whether children hear a fused image (ie. 1 vs 2 sounds) from their bilateral implants and if this "binaural fusion" reduces listening effort. Binaural fusion was assessed by asking 25 deaf children with cochlear implants and 24 peers with normal hearing whether they heard one or two sounds when listening to bilaterally presented acoustic click-trains/electric pulses (250 Hz trains of 36 ms presented at 1 Hz). Reaction times and pupillary changes were recorded simultaneously to measure listening effort. Bilaterally implanted children heard one image of bilateral input less frequently than normal hearing peers, particularly when intensity levels on each side were balanced. Binaural fusion declined as brainstem asymmetries increased and age at implantation decreased. Children implanted later had access to acoustic input prior to implantation due to progressive deterioration of hearing. Increases in both pupil diameter and reaction time occurred as perception of binaural fusion decreased. Results indicate that, without binaural level cues, children have difficulty fusing input from their bilateral implants to perceive one sound which costs them increased listening effort. Brainstem asymmetries exacerbate this issue. By contrast, later implantation, reflecting longer access to bilateral acoustic hearing, may have supported development of auditory pathways underlying binaural fusion. Improved integration of bilateral cochlear implant signals for children is required to improve their binaural hearing.	[Steel, Morrison M.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Steel, Morrison M.; Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Dept Otolaryngol, Toronto, ON M5G 1X8, Canada; [Gordon, Karen A.] Hosp Sick Children, Dept Commun Disorders, Toronto, ON M5G 1X8, Canada	Central Michigan University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Steel, MM (corresponding author), Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.	mosteel47@gmail.com			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	K.A.G. received funding from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson V, 2001, J ACOUST SOC AM, V109, P2840, DOI 10.1121/1.1371756; Aronoff JM, 2010, J ACOUST SOC AM, V127, pEL87, DOI 10.1121/1.3298451; BABKOFF H, 1966, J ACOUST SOC AM, V39, P87, DOI 10.1121/1.1909878; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baskent D, 2012, JARO-J ASSOC RES OTO, V13, P683, DOI 10.1007/s10162-012-0334-3; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; BEATTY J, 1982, PSYCHOPHYSIOLOGY, V19, P167, DOI 10.1111/j.1469-8986.1982.tb02540.x; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Burkholder RA, 2003, J EXP CHILD PSYCHOL, V85, P63, DOI 10.1016/S0022-0965(03)00033-X; CARR CE, 1990, J NEUROSCI, V10, P3227; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Chadha NK, 2011, OTOL NEUROTOL, V32, P1057, DOI 10.1097/MAO.0b013e3182267de7; Cheng AK, 1999, ANN OTO RHINOL LARYN, V108, P124; Chermak Gail D, 2005, J Am Acad Audiol, V16, P554, DOI 10.3766/jaaa.16.8.4; Colburn HS, 2006, INT J AUDIOL, V45, pS34, DOI 10.1080/14992020600782642; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; D'Elia A, 2012, OTOL NEUROTOL, V33, P343, DOI 10.1097/MAO.0b013e3182487dbb; Darwin C., 1965, EXPRESS EMOT MAN; DOBIE RA, 1980, ELECTROEN CLIN NEURO, V49, P303, DOI 10.1016/0013-4694(80)90224-2; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Eisenberg LS, 2007, EAR HEARING, V28, P766, DOI 10.1097/AUD.0b013e318157f01f; Fiedler A, 2011, COGN AFFECT BEHAV NE, V11, P68, DOI 10.3758/s13415-010-0013-y; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; FURST M, 1985, J ACOUST SOC AM, V78, P1644, DOI 10.1121/1.392802; Galvin KL, 2007, EAR HEARING, V28, P470, DOI 10.1097/AUD.0b013e31806dc194; GIOLAS TG, 1967, J SPEECH HEAR DISORD, V32, P336, DOI 10.1044/jshd.3204.336; Gordon K A, 2011, Cochlear Implants Int, V12 Suppl 2, pS8, DOI 10.1179/146701011X13074645127199; Gordon KA, 2005, NEUROREPORT, V16, P2041, DOI 10.1097/00001756-200512190-00015; Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2004, EAR HEARING, V25, P447, DOI 10.1097/01.aud.0000146178.84065.b3; Gordon KA, 2001, J OTOLARYNGOL, V30, P216, DOI 10.2310/7070.2001.20157; Gordon KA, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0116463, DOI 10.1371/JOURNAL.PONE.0116463]; Gordon KA, 2008, OTOL NEUROTOL, V29, P193, DOI 10.1097/mao.0b013e318162514c; Gordon KA, 2007, NEUROREPORT, V18, P613, DOI 10.1097/WNR.0b013e3280b10c15; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gordon KA, 2010, OTOL NEUROTOL, V31, P1293, DOI 10.1097/MAO.0b013e3181e8f965; Gordon KA, 2009, OTOL NEUROTOL, V30, P319, DOI 10.1097/MAO.0b013e31819a8f4c; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Grieco-Calub TM, 2008, OTOL NEUROTOL, V29, P235, DOI 10.1097/mao.0b013e31816250fe; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Hancock KE, 2010, J NEUROSCI, V30, P14068, DOI 10.1523/JNEUROSCI.3213-10.2010; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Hartmann WM, 2002, J ACOUST SOC AM, V112, P1037, DOI 10.1121/1.1500759; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Hopyan T, 2011, Cochlear Implants Int, V12, P21, DOI 10.1179/146701010X12677899497399; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Hughes Kathryn C, 2013, Cochlear Implants Int, V14, P121, DOI 10.1179/1754762812Y.0000000009; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jiwani S, 2013, CLIN NEUROPHYSIOL, V124, P1868, DOI 10.1016/j.clinph.2013.03.023; Jung KH, 2012, AUDIOL NEURO-OTOL, V17, P189, DOI 10.1159/000336407; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P164, DOI 10.1037/h0026952; KAHNEMAN D, 1967, PERCEPT PSYCHOPHYS, V2, P101; Kan A, 2013, J ACOUST SOC AM, V134, P2923, DOI 10.1121/1.4820889; Kirk K I, 1985, Ear Hear, V6, p36S, DOI 10.1097/00003446-198505001-00008; Kral A, 2007, INT J AUDIOL, V46, P479, DOI 10.1080/14992020701383027; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krumbholz K, 2005, EUR J NEUROSCI, V21, P230, DOI 10.1111/j.1460-9568.2004.03836.x; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Limb CJ, 2010, JARO-J ASSOC RES OTO, V11, P133, DOI 10.1007/s10162-009-0184-9; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 2004, ARCH OTOLARYNGOL, V130, P648, DOI 10.1001/archotol.130.5.648; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Long CJ, 2003, J ACOUST SOC AM, V114, P1565, DOI 10.1121/1.1603765; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MCPHERSON DL, 1995, HEARING RES, V89, P162, DOI 10.1016/0378-5955(95)00134-1; Meredith MA, 2011, HEARING RES, V280, P38, DOI 10.1016/j.heares.2011.02.004; Mickey BJ, 2001, J NEUROPHYSIOL, V86, P1333, DOI 10.1152/jn.2001.86.3.1333; Miyamoto RT, 1996, ACTA OTO-LARYNGOL, V116, P240, DOI 10.3109/00016489609137832; Mok M, 2007, AUDIOL NEURO-OTOL, V12, P295, DOI 10.1159/000103210; MOORE MJ, 1983, J NEUROSCI, V3, P237; Nadol JB, 1997, OTOLARYNG HEAD NECK, V117, P220, DOI 10.1016/S0194-5998(97)70178-5; Naito Y, 2000, HEARING RES, V143, P139, DOI 10.1016/S0378-5955(00)00035-6; Pals C, 2013, J SPEECH LANG HEAR R, V56, P1075, DOI 10.1044/1092-4388(2012/12-0074); Papesh MH, 2012, INT J PSYCHOPHYSIOL, V83, P56, DOI 10.1016/j.ijpsycho.2011.10.002; Papsin BC, 2008, CURR OPIN OTOLARYNGO, V16, P69, DOI 10.1097/MOO.0b013e3282f5e97c; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Poon BB, 2009, J ACOUST SOC AM, V126, P806, DOI 10.1121/1.3158821; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Riedel H, 2006, HEARING RES, V218, P5, DOI 10.1016/j.heares.2006.03.018; Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0; Rubinstein JT, 2003, ANN OTO RHINOL LARYN, V112, P14; Rubinstein JT, 1999, AM J OTOL, V20, P445; Salloum CAM, 2010, EAR HEARING, V31, P441, DOI 10.1097/AUD.0b013e3181d4f228; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; SCHWARTZ IR, 1982, ACTA OTO-LARYNGOL, V93, P9, DOI 10.3109/00016488209130847; Seeber BU, 2008, J ACOUST SOC AM, V123, P1030, DOI 10.1121/1.2821965; Shepherd RK, 2001, AUDIOL NEURO-OTOL, V6, P305, DOI 10.1159/000046843; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Steel MM, EAR HEAR IN PRESS; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Takeuchi T, 2011, PLOS ONE, V6, P1; TERAYAMA Y, 1977, ACTA OTO-LARYNGOL, V83, P291, DOI 10.3109/00016487709128848; Tillein J, 2010, CEREB CORTEX, V20, P492, DOI 10.1093/cercor/bhp222; Tirko NN, 2012, J COMP NEUROL, V520, P2202, DOI 10.1002/cne.23038; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; Van Deun L, 2010, AUDIOL NEURO-OTOL, V15, P7, DOI 10.1159/000218358; Van Deun L, 2009, AUDIOL NEURO-OTOL, V14, P240, DOI 10.1159/000190402; Van Deun L, 2009, EAR HEARING, V30, P178, DOI 10.1097/AUD.0b013e318194256b; van Hoesel RJM, 2007, J ACOUST SOC AM, V121, P2192, DOI 10.1121/1.2537300; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; WADA SI, 1989, ELECTROEN CLIN NEURO, V72, P535, DOI 10.1016/0013-4694(89)90231-9; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Yulek F, 2008, CURR EYE RES, V33, P263, DOI 10.1080/02713680801915284; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251; Zhou JX, 2003, J ACOUST SOC AM, V114, P1508, DOI 10.1121/1.1600718	120	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117611	10.1371/journal.pone.0117611	http://dx.doi.org/10.1371/journal.pone.0117611			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668423	Green Published, gold			2022-12-26	WOS:000349493000024
J	Lerner, CA; Sundar, IK; Yao, HW; Gerloff, J; Ossip, DJ; McIntosh, S; Robinson, R; Rahman, I				Lerner, Chad A.; Sundar, Isaac K.; Yao, Hongwei; Gerloff, Janice; Ossip, Deborah J.; McIntosh, Scott; Robinson, Risa; Rahman, Irfan			Vapors Produced by Electronic Cigarettes and E-Juices with Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung Epithelial Cells and in Mouse Lung	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE RELEASE; NF-KAPPA-B; CARBONYL-COMPOUNDS; SMOKE EXTRACT; MAINSTREAM; EXPOSURE; COTININE; NICOTINE; ACTIVATION; EMPHYSEMA	Oxidative stress and inflammatory response are the key events in the pathogenesis of chronic airway diseases. The consumption of electronic cigarettes (e-cigs) with a variety of e-liquids/e-juices is alarmingly increasing without the unrealized potential harmful health effects. We hypothesized that electronic nicotine delivery systems (ENDS)/e-cigs pose health concerns due to oxidative toxicity and inflammatory response in lung cells exposed to their aerosols. The aerosols produced by vaporizing ENDS e-liquids exhibit oxidant reactivity suggesting oxidants or reactive oxygen species (OX/ROS) may be inhaled directly into the lung during a "vaping" session. These OX/ROS are generated through activation of the heating element which is affected by heating element status (new versus used), and occurs during the process of e-liquid vaporization. Unvaporized e-liquids were oxidative in a manner dependent on flavor additives, while flavors containing sweet or fruit flavors were stronger oxidizers than tobacco flavors. In light of OX/ROS generated in ENDS e-liquids and aerosols, the effects of ENDS aerosols on tissues and cells of the lung were measured. Exposure of human airway epithelial cells (H292) in an air-liquid interface to ENDS aerosols from a popular device resulted in increased secretion of inflammatory cytokines, such as IL-6 and IL-8. Furthermore, human lung fibroblasts exhibited stress and morphological change in response to treatment with ENDS/e-liquids. These cells also secrete increased IL-8 in response to a cinnamon flavored e-liquid and are susceptible to loss of cell viability by ENDS e-liquids. Finally, exposure of wild type C57BL/6J mice to aerosols produced from a popular e-cig increase pro-inflammatory cytokines and diminished lung glutathione levels which are critical in maintaining cellular redox balance. Thus, exposure to e-cig aerosols/juices incurs measurable oxidative and inflammatory responses in lung cells and tissues that could lead to unrealized health consequences.	[Lerner, Chad A.; Sundar, Isaac K.; Yao, Hongwei; Gerloff, Janice; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Ossip, Deborah J.; McIntosh, Scott] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA; [Robinson, Risa] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	University of Rochester; University of Rochester; Rochester Institute of Technology	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460; McIntosh, Scott/0000-0002-5776-9617	National Institute of Drug Abuse at the National Institutes of Health, NIH [R21DA036057, 2R01 HL085613, 1R01HL092842]; National Cancer Institute, NCI at the NIH [R01CA132950, R01CA152093]; University of Rochester Clinical Translational Research Institute, CTSI incubator project [5UL1RR024160];  [T32 HL066988]; NATIONAL CANCER INSTITUTE [R01CA152093, R01CA132950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, T32HL066988, R01HL092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036057] Funding Source: NIH RePORTER	National Institute of Drug Abuse at the National Institutes of Health, NIH; National Cancer Institute, NCI at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Rochester Clinical Translational Research Institute, CTSI incubator project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse at the National Institutes of Health, NIH (R21DA036057 to RR and IR), NIH 2R01 HL085613 (IR), 1R01HL092842 (IR), and by the National Cancer Institute, NCI at the NIH (R01CA132950 to DJO, and R01CA152093 to SM), pulmonary training grant T32 HL066988, and by the University of Rochester Clinical Translational Research Institute, CTSI 5UL1RR024160 incubator project (IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-50; Alpar B, 1998, Clin Oral Investig, V2, P40, DOI 10.1007/s007840050042; Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA244, DOI 10.1289/ehp.122-A244; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; BLACK MJ, 1974, ANAL BIOCHEM, V58, P246, DOI 10.1016/0003-2697(74)90464-3; Brown CJ, 2014, TOB CONTROL, V23, P4, DOI 10.1136/tobaccocontrol-2013-051476; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Fuoco FC, 2014, ENVIRON POLLUT, V184, P523, DOI 10.1016/j.envpol.2013.10.010; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2011, NICOTINE TOB RES, V13, P202, DOI 10.1093/ntr/ntq237; Horn KH, 2008, REPROD TOXICOL, V26, P203, DOI 10.1016/j.reprotox.2008.09.013; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Huang MF, 2005, INDOOR AIR, V15, P135, DOI 10.1111/j.1600-0668.2005.00330.x; Hung HF, 2001, J AEROSOL SCI, V32, P1201, DOI 10.1016/S0021-8502(01)00051-9; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Jarvis MJ, 2001, TOB CONTROL, V10, P368, DOI 10.1136/tc.10.4.368; Jiang J, 2008, NANOTOXICOLOGY, V2, P33, DOI 10.1080/17435390701882478; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kosno K, 2012, FREE RADICAL REACTIO, P20; Lane ME, 2013, INT J PHARMACEUT, V447, P12, DOI 10.1016/j.ijpharm.2013.02.040; Laytragoon-Lewin N, 2011, ANTICANCER RES, V31, P1527; Lim HH, 2013, B KOREAN CHEM SOC, V34, P2691, DOI 10.5012/bkcs.2013.34.9.2691; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nelson N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju101; Paschke A, 2002, TOBACCO RES, P20; Pepper JK, 2014, CHEM RES TOXICOL, V27, P1336, DOI 10.1021/tx500200j; Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239, DOI 10.1177/026119290503300310; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Ruprecht Ario Alberto, 2014, Tumori, V100, pe24, DOI 10.1700/1430.15833; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Schraufnagel DE, 2014, AM J RESP CRIT CARE, V190, P611, DOI 10.1164/rccm.201407-1198PP; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Uchiyama S, 2013, ANAL SCI, V29, P1219, DOI 10.2116/analsci.29.1219; Weaver M, 2014, J ADDICT MED, V8, P234, DOI 10.1097/ADM.0000000000000043; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Xu X, 2014, SCI REP-UK, V4, DOI 10.1038/srep03864; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022	59	393	402	6	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116732	10.1371/journal.pone.0116732	http://dx.doi.org/10.1371/journal.pone.0116732			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658421	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900063
J	Mao, LY; Zhang, Y; Mo, WJ; Yu, Y; Lu, H				Mao, Langyong; Zhang, Yan; Mo, Wenjuan; Yu, Yao; Lu, Hong			BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; HUMAN-PAPILLOMAVIRUS; MIR-203; EXPRESSION; PROTEIN; ROLES; IRF-1; EPIGENETICS; BIOGENESIS; MECHANISM	MicroRNAs (miRNAs) play important roles in various biological processes and are closely associated with the development of cancer. In fact, aberrant expression of miRNAs has been implicated in numerous cancers. In cervical cancer, miR-203 levels are decreased, although the cause of this aberrant expression remains unclear. In this study, we investigate the molecular mechanisms regulating miR-203 gene transcription. We identify the miR-203 transcription start site by 5' rapid amplification of cDNA ends and subsequently identify the miR-203 promoter region. Promoter analysis revealed that IRF1, a transcription factor, regulates miR-203 transcription by binding to the miR-203 promoter. We also demonstrate that miR-203 targets the 3' untranslated region of BANF1, thus downregulating its expression, whereas miR-203 expression is driven by IRF1. MiR-203 is involved in cell cycle regulation and overexpression of miR-203 suppresses cervical cancer cell proliferation, colony formation, migration and invasion. The inhibitory effect of miR-203 on the cancer cells is partially mediated by downregulating its target, BANF1, since knockdown of BANF1 also suppresses colony formation, migration and invasion.	[Mao, Langyong; Mo, Wenjuan; Yu, Yao; Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Yan] Changhai Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Yu, Yao; Lu, Hong] Shanghai Engn Res Ctr Ind Microorganisms, Shanghai, Peoples R China; [Lu, Hong] Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai, Peoples R China	Fudan University; Naval Medical University	Lu, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	honglu0211@yahoo.com		Yu, Yao/0000-0003-0090-8193				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Qian JJ, 2011, GENOMICS, V97, P294, DOI 10.1016/j.ygeno.2011.02.004; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Rouhi A, 2008, MAMM GENOME, V19, P517, DOI 10.1007/s00335-008-9133-x; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Takama H, 2013, J DERMATOL SCI, V71, P100, DOI 10.1016/j.jdermsci.2013.04.007; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Torres A, 2011, MED RES REV, V31, P895, DOI 10.1002/med.20205; Um SJ, 2002, CANCER LETT, V179, P205, DOI 10.1016/S0304-3835(01)00871-0; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Wang GZ, 2010, REPRODUCTIVE HEALTH AND GENDER EQUALITY: METHOD, MEASUREMENT, AND IMPLICATIONS, P1; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wiklund ED, 2010, EPIGENOMICS-UK, V2, P823, DOI 10.2217/EPI.10.51; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088745; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	43	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117035	10.1371/journal.pone.0117035	http://dx.doi.org/10.1371/journal.pone.0117035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658920	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900094
J	Yip, W; Sabanayagam, C; Teo, BW; Tay, WT; Ikram, MK; Tai, ES; Chow, KY; Wong, TY; Cheung, CY				Yip, WanFen; Sabanayagam, Charumathi; Teo, Boon Wee; Tay, Wan Ting; Ikram, M. Kamran; Tai, E. Shyong; Chow, Khuan Yew; Wong, Tien Y.; Cheung, Carol Y.			Retinal Microvascular Abnormalities and Risk of Renal Failure in Asian Populations	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; VESSEL DIAMETERS; FRACTAL ANALYSIS; SINGAPORE; PROGRESSION; PREVALENCE; NEPHROPATHY; METHODOLOGY	Background Retinal microvascular signs may provide insights into the structure and function of small vessels that are associated with renal disease. We examined the relationship of retinal microvascular signs with both prevalent and incident end-stage renal disease (ESRD) in a multi-ethnic Asian population. Methods A total of 5763 subjects (aged >= 40 years) from two prospective population-based studies (the Singapore Malay Eye Study and the Singapore Prospective Study) were included for the current analysis. Retinopathy was graded using the modified Airlie House classification system. Retinal vascular parameters were measured using computer-assisted programs to quantify the retinal vessel widths (arteriolar and venular caliber) and retinal vascular network (fractal dimension). Data on ESRD was obtained by record linkage with the ESRD cases registered by National Registry of Diseases Office, Singapore. Multi-variable adjusted regression analyses were performed to assess the associations of baseline retinal vascular parameters and prevalent and incident ESRD. Results At baseline, 21(0.36%) persons had prevalent ESRD. During a median follow-up of 4.3 years, 33 (0.57%) subjects developed ESRD. In our analyses, retinopathy was associated with prevalent ESRD (multi-variable adjusted odds ratio [OR], 3.21, 95% confidence interval [CI]: 1.28-8.05) and incident ESRD (multi-variable adjusted hazard ratio [HR], 2.51, 95% CI: 1.14-5.54). This association was largely seen in person with diabetes (HR, 2.60, 95% CI: 1.01-6.66) and not present in persons without diabetes (HR, 1.65, 95% CI: 0.14-18.98). Retinal arteriolar caliber, retinal venular caliber and retinal vascular fractal dimension were not associated with ESRD. Conclusion Retinopathy signs in persons with diabetes are related to an increased risk of ESRD; however, other microvascular changes in the retina are not associated with ESRD.	[Yip, WanFen; Sabanayagam, Charumathi; Tay, Wan Ting; Ikram, M. Kamran; Wong, Tien Y.; Cheung, Carol Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Yip, WanFen; Sabanayagam, Charumathi; Wong, Tien Y.; Cheung, Carol Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Yip, WanFen; Sabanayagam, Charumathi; Teo, Boon Wee; Tai, E. Shyong; Wong, Tien Y.; Cheung, Carol Y.] Natl Univ Hlth Syst, Singapore, Singapore; [Sabanayagam, Charumathi; Ikram, M. Kamran; Wong, Tien Y.; Cheung, Carol Y.] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Teo, Boon Wee; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Ikram, M. Kamran] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Chow, Khuan Yew] Natl Registry Dis Off, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Cheung, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	carol.cheung.y.l@seri.com.sg	Cheung, Carol Y./G-7895-2016; Cheung, Carol/AAF-1101-2020; Sabanayagam, Charumathi/C-1294-2011; Wong, Tien Yin/AAC-9724-2020	Cheung, Carol/0000-0002-9672-1819; Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; Tai, E Shyong/0000-0003-2929-8966; Ikram, Mohammad Kamran/0000-0003-0173-9571; Cheung, Carol/0000-0003-0869-859X	National Medical Research Council (NMRC) [R607/28/2008]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council (NMRC) R607/28/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexei V, 2002, J RENIN-ANGIO-ALDO S, V3, P16; Amann K, 2000, J AM SOC NEPHROL, V11, P1702, DOI 10.1681/ASN.V1191702; [Anonymous], 2013, SYST USRD USRDS 2013; Awua-Larbi S, 2011, NEPHROL DIAL TRANSPL, V26, P3523, DOI 10.1093/ndt/gfr095; Board HP, 2012, DROP; Board HP, 2012, 8 BOARD HP; Cheung CYL, 2012, HYPERTENSION, V60, P1094, DOI 10.1161/HYPERTENSIONAHA.111.189142; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; Earle KA, 2001, NEPHROL DIAL TRANSPL, V16, P286, DOI 10.1093/ndt/16.2.286; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; El-Asrar A M, 2001, Int Ophthalmol, V24, P1, DOI 10.1023/A:1014409829614; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P207, DOI 10.1016/0272-6386(95)90001-2; Grunwald JE, 2014, CLIN J AM SOC NEPHRO, V9, P1217, DOI 10.2215/CJN.11761113; He F, 2013, DIABETOLOGIA, V56, P457, DOI 10.1007/s00125-012-2796-6; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P29, DOI 10.1136/jech.44.1.29; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; JACOBSON HR, 1991, LANCET, V338, P419, DOI 10.1016/0140-6736(91)91042-S; Jennette JC OJ, 1998, DIABETES MELLITUS HE, P41, DOI [10.1148/radiol.14144045, DOI 10.1148/RADIOL.14144045]; JENSEN T, 1992, HORM METAB RES, V26, P68; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Klein R, 1999, DIABETES CARE, V22, P743, DOI 10.2337/diacare.22.5.743; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Lim LS, 2013, INVEST OPHTH VIS SCI, V54, P2970, DOI 10.1167/iovs.13-11941; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Roderick PJ, 1996, J EPIDEMIOL COMMUN H, V50, P334, DOI 10.1136/jech.50.3.334; Sabanayagam C, 2011, AM J KIDNEY DIS, V57, P682, DOI 10.1053/j.ajkd.2010.11.025; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Schwartz MM, 1998, NEPHROL DIAL TRANSPL, V13, P2547, DOI 10.1093/ndt/13.10.2547; Skyler JS, 2001, ENDOCRIN METAB CLIN, V30, P833, DOI 10.1016/S0889-8529(05)70218-8; Sng CCA, 2010, NEPHROL DIAL TRANSPL, V25, P2252, DOI 10.1093/ndt/gfq007; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Weiner DE, 2010, AM J KIDNEY DIS, V55, P5, DOI 10.1053/j.ajkd.2009.11.004; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Yau JWY, 2011, AM J KIDNEY DIS, V58, P39, DOI 10.1053/j.ajkd.2011.02.382	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118076	10.1371/journal.pone.0118076	http://dx.doi.org/10.1371/journal.pone.0118076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658337	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900260
J	Goka, ET; Lippman, ME				Goka, E. T.; Lippman, M. E.			Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression	ONCOGENE			English	Article							CARCINOMA IN-SITU; SMALL-MOLECULE INHIBITOR; FAMILY SMALL GTPASES; GROWTH-FACTOR-BETA; EPITHELIAL-CELLS; ACTIVE RAC1; OVEREXPRESSION; TUMOR; UBIQUITYLATION; METHYLATION	The transition from ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC) is a crucial step in breast cancer progression. The specific alterations that govern this transition have not been elucidated. HER2/neu is frequently overexpressed in DCIS but is less common in IBC, thereby suggesting additional requirements for transformation. To identify genes capable of cooperating with HER2/neu to fully transform mammary epithelial cells, we used an insertional mutagenesis screen on cells isolated from wild-type neu expressing mice and identified the E3 ligase HACE1 as HER2 cooperative tumor suppressor gene. Loss of HACE1 expression is commonly seen in clinical breast cancer data sets. HACE1 downregulation in normal human mammary epithelial cells (HMECs) results in the accumulation of the activated GTP-bound Rac1 partially transforming these cells. Overexpression of HER2 activates Rac1, which further accumulates upon HACE1 loss resulting in Rac1 hyperactivation. Although the knockdown of HACE1 or overexpression of HER2 alone in HMECs is not sufficient for tumorigenesis, HER2 overexpression combined with HACE1 downregulation fully transforms HMECs resulting in robust tumor formation. The pharmaceutical interference of Rac function abrogates the effects of HACE1 loss both in vitro and in vivo, resulting in marked reduction in tumor burden. Our work supports a critical role for HACE1 in breast cancer progression and identifies patients that may benefit from Rac-targeted therapies.	[Goka, E. T.] Univ Miami, Miller Sch Med, Shelia & David Fuente Grad Program Canc Biol, Miami, FL 33101 USA; [Lippman, M. E.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33101 USA	University of Miami; University of Miami	Lippman, ME (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Biomedical Res Bldg,1501 NW 10th Ave,POB 016960, Miami, FL 33101 USA.	mlippman@med.miami.edu						Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; BARNES DM, 1992, EUR J CANCER, V28A, P644, DOI 10.1016/S0959-8049(05)80117-0; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Castillo-Lluva S, 2012, ONCOGENE; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez E, 2010, P R HEALTH SCI J, V29, P348; Hibi K, 2008, ANTICANCER RES, V28, P1581; Hyytinen ER, 2002, GENE CHROMOSOME CANC, V34, P306, DOI 10.1002/gcc.10065; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Lachance V, 2014, J CELL SCI, V127, P111, DOI 10.1242/jcs.132944; Latta EK, 2002, MODERN PATHOL, V15, P1318, DOI 10.1097/01.MP.0000038462.62634.B1; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Marcotte R, 2008, J MAMMARY GLAND BIOL, V13, P323, DOI 10.1007/s10911-008-9087-3; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Porter D, 2003, MOL CANCER RES, V1, P362; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sakata M, 2013, HEPATO-GASTROENTEROL, V60, P781, DOI 10.5754/hge10439; Sakata M, 2009, ANTICANCER RES, V29, P2231; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Tang DM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1509; Tina E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-350; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Visvikis O, 2010, BIOL CELL, V102, P377, DOI 10.1042/BC20090151; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621	41	43	44	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5395	5405		10.1038/onc.2014.468	http://dx.doi.org/10.1038/onc.2014.468			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25659579	hybrid, Green Published			2022-12-26	WOS:000363479200009
J	Basudhar, D; Madrona, Y; Kandel, S; Lampe, JN; Nishida, CR; de Montellano, PRO				Basudhar, Debashree; Madrona, Yarrow; Kandel, Sylvie; Lampe, Jed N.; Nishida, Clinton R.; de Montellano, Paul R. Ortiz			Analysis of Cytochrome P450 CYP119 Ligand-dependent Conformational Dynamics by Two-dimensional NMR and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Conformational Change; Cytochrome P450; Molecular Dynamics; Nuclear Magnetic Resonance (NMR); X-ray Crystallography	CRYSTAL-STRUCTURE; THERMOPHILIC CYTOCHROME-P450; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE-SITE; SUBSTRATE; BINDING; COMPLEX; RESOLUTION; P450CAM; STATE	Defining the conformational states of cytochrome P450 active sites is critical for the design of agents that minimize drug-drug interactions, the development of isoform-specific P450 inhibitors, and the engineering of novel oxidative catalysts. We used two-dimensional H-1,N-15 HSQC chemical shift perturbation mapping of N-15-labeled Phe residues and x-ray crystallography to examine the ligand-dependent conformational dynamics of CYP119. Active site Phe residues were most affected by the binding of azole inhibitors and fatty acid substrates, in agreement with active site localization of the conformational changes. This was supported by crystallography, which revealed movement of the F-G loop with various azoles. Nevertheless, the NMR chemical shift perturbations caused by azoles and substrates were distinguishable. The absence of significant chemical shift perturbations with several azoles revealed binding of ligands to an open conformation similar to that of the ligand-free state. In contrast, 4-phenylimidazole caused pronounced NMR changes involving Phe-87, Phe-144, and Phe-153 that support the closed conformation found in the crystal structure. The same closed conformation is observed by NMR and crystallography with a para-fluoro substituent on the 4-phenylimidazole, but a para-chloro or bromo substituent engendered a second closed conformation. An open conformation is thus favored in solution with many azole ligands, but para-substituted phenylimidazoles give rise to two closed conformations that depend on the size of the para-substituent. The results suggest that ligands selectively stabilize discrete cytochrome P450 conformational states.	[Basudhar, Debashree; Madrona, Yarrow; Nishida, Clinton R.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kandel, Sylvie] XenoTech LLC, Lenexa, KS 66219 USA; [Lampe, Jed N.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of California System; University of California San Francisco; University of Kansas; University of Kansas Medical Center	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	Ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263; Kandel, Sylvie/0000-0002-8059-8035	United States Department of Energy [DE-ACO2-05CH11231, DE-ACO2-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM025515, R37GM025515] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Christopher Waddling, manager of the X-ray Structure Facility (University of California at San Francisco), and Dr. James Holton and George Meigs of the Advance Light Source beamline (8.3.1), for their help. The Advanced Light Source is supported by Contract DE-ACO2-05CH11231 and the Stanford Synchrotron Radiation Light Source by Contract DE-ACO2-76SF00515, both from the United States Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and National Institutes of Health Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; Ball A, 2013, ENVIRON SCI POLLUT R, V20, P4311, DOI 10.1007/s11356-013-1620-2; BANCI L, 1994, J AM CHEM SOC, V116, P4866, DOI 10.1021/ja00090a035; BANCI L, 1993, BIOPHYS J, V65, P806, DOI 10.1016/S0006-3495(93)81122-6; Benedetti MS, 1999, DRUG METAB REV, V31, P665, DOI 10.1081/DMR-100101941; Brandman R, 2011, ARCH BIOCHEM BIOPHYS, V509, P127, DOI 10.1016/j.abb.2011.02.020; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; Dunn AR, 2001, P NATL ACAD SCI USA, V98, P12420, DOI 10.1073/pnas.221297998; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jaudzems K, 2010, ACTA CRYSTALLOGR F, V66, P1367, DOI 10.1107/S1744309110005890; Jiang YY, 2009, ANGEW CHEM INT EDIT, V48, P7193, DOI 10.1002/anie.200901485; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating GM, 2005, DRUGS, V65, P1553, DOI 10.2165/00003495-200565110-00007; Koo LS, 2000, J BIOL CHEM, V275, P14112, DOI 10.1074/jbc.275.19.14112; Lacroix C, 2005, BRIT J DERMATOL, V152, P1067, DOI 10.1111/j.1365-2133.2005.06534.x; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Lee YT, 2011, BIOCHEMISTRY-US, V50, P693, DOI 10.1021/bi101726d; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LOOSE DS, 1983, J CLIN INVEST, V71, P1495, DOI 10.1172/JCI110903; Martinez CA, 2013, CURR TOP MED CHEM, V13, P1470; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; Mohanty B, 2010, ACTA CRYSTALLOGR F, V66, P1381, DOI 10.1107/S1744309110020956; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; MURRAY M, 1983, CHEM-BIOL INTERACT, V43, P341, DOI 10.1016/0009-2797(83)90117-5; Nazor J, 2008, PROTEIN ENG DES SEL, V21, P29, DOI 10.1093/protein/gzm074; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nishida CR, 2005, BIOCHEM BIOPH RES CO, V338, P437, DOI 10.1016/j.bbrc.2005.08.093; Olieric V, 2007, ACTA CRYSTALLOGR D, V63, P759, DOI 10.1107/S0907444907019580; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Park SY, 2000, ACTA CRYSTALLOGR D, V56, P1173, DOI 10.1107/S0907444900008234; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Shah MB, 2013, J PHARMACOL EXP THER, V346, P113, DOI 10.1124/jpet.113.204776; Stoll S, 2012, P NATL ACAD SCI USA, V109, P12888, DOI 10.1073/pnas.1207123109; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Venkatakrishnan K, 2000, CLIN PHARMACOKINET, V38, P111, DOI 10.2165/00003088-200038020-00002; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Wackett LP, 1998, ANN NY ACAD SCI, V864, P142, DOI 10.1111/j.1749-6632.1998.tb10297.x; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02538; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200	64	23	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10000	10017		10.1074/jbc.M114.627935	http://dx.doi.org/10.1074/jbc.M114.627935			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670859	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000353241100009
J	Bao, X; Johnson, JL; Rao, H				Bao, Xin; Johnson, Jill L.; Rao, Hai			Rad25 Protein Is Targeted for Degradation by the Ubc4-Ufd4 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN; REPLICATION; SUMO	Proteasome-mediated proteolysis provides dynamic spatial and temporal modulation of protein concentration in response to various intrinsic and extrinsic challenges. To gain a better understanding of the role of the proteasome in DNA repair, we systematically monitored the stability of 26 proteins involved in nucleotide excision repair (NER) under normal growth conditions. Among six NER factors found to be regulated by the proteasome, we further delineated the specific pathway involved in the degradation of Rad25, a subunit of TFIIH. We demonstrate that Rad25 turnover requires the ubiquitin-conjugating enzyme Ubc4 and the ubiquitin ligase Ufd4. Interestingly, the deletion of UFD4 specifically suppresses the rad25 mutant defective in transcription. Our results reveal a novel function of the Ufd4 pathway and another tie between the proteasome and NER regulators.	[Bao, Xin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	University of Texas System; University of Texas Health San Antonio; Idaho; University of Idaho	Bao, X (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	baox@livemail.uthscsa.edu; raoh@uthscsa.edu		RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM 078085]; Department of Defense [W911NF-11-10466]; Welch Foundation [AQ 1747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM 078085, by Department of Defense Grant W911NF-11-10466, and by Welch Foundation Grant AQ 1747. To whom correspondence may be addressed: Dept. of Molecular Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229. Tel.: 210-562-4149; Fax: 210-562-4161; E-mail: raoh@uthscsa.edu.	Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; den Dulk B, 2006, DNA REPAIR, V5, P683, DOI 10.1016/j.dnarep.2006.02.002; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Furuchi T, 2004, BIOCHEM BIOPH RES CO, V314, P844, DOI 10.1016/j.bbrc.2003.12.160; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krzeszinski JY, 2014, MOL BIOL CELL, V25, P213, DOI 10.1091/mbc.E13-05-0293; Li Y, 2010, MOL BIOL CELL, V21, P177, DOI 10.1091/mbc.E09-04-0305; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830	22	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8606	8612		10.1074/jbc.M114.618793	http://dx.doi.org/10.1074/jbc.M114.618793			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670855	Green Published, hybrid			2022-12-26	WOS:000351662600050
J	Huang, W; Shang, YF; Chen, PL; Cen, K; Wang, CS				Huang, Wei; Shang, Yanfang; Chen, Peilin; Cen, Kai; Wang, Chengshu			Basic Leucine Zipper (bZIP) Domain Transcription Factor MBZ1 Regulates Cell Wall Integrity, Spore Adherence, and Virulence in Metarhizium robertsii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL BIOCONTROL AGENTS; SACCHAROMYCES-CEREVISIAE; ENTOMOPATHOGENIC FUNGUS; CANDIDA-ALBICANS; STRESS RESPONSES; FULL VIRULENCE; GENE; PROTEINS; ADHESION; REVEALS	Transcription factors (TFs) containing the basic leucine zipper (bZIP) domain are widely distributed in eukaryotes and display an array of distinct functions. In this study, a bZIP-type TF gene (MBZ1) was deleted and functionally characterized in the insect pathogenic fungus Metarhizium robertsii. The deletion mutant (Delta MBZ1) showed defects in cell wall integrity, adhesion to hydrophobic surfaces, and topical infection of insects. Relative to the WT, Delta MBZ1 was also impaired in growth and conidiogenesis. Examination of putative target gene expression indicated that the genes involved in chitin biosynthesis were differentially transcribed in Delta MBZ1 compared with the WT, which led to the accumulation of a higher level of chitin in mutant cell walls. MBZ1 exhibited negative regulation of subtilisin proteases, but positive control of an adhesin gene, which is consistent with the observation of effects on cell autolysis and a reduction in spore adherence to hydrophobic surfaces in Delta MBZ1. Promoter binding assays indicated thatMBZ1can bind to different target genes and suggested the possibility of heterodimer formation to increase the diversity of the MBZ1 regulatory network. The results of this study advance our understanding of the divergence of bZIP-type TFs at both intra-and interspecific levels.	[Huang, Wei; Shang, Yanfang; Chen, Peilin; Cen, Kai; Wang, Chengshu] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CS (corresponding author), Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China.	cswang@sibs.ac.cn	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466	National Natural Science Foundation of China [31225023]; Chinese Academy of Sciences Strategic Priority Research Program [XDB11030100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program	This work was supported by National Natural Science Foundation of China Grant 31225023 and Chinese Academy of Sciences Strategic Priority Research Program Grant XDB11030100.	Alberti-Segui C, 2004, YEAST, V21, P285, DOI 10.1002/yea.1061; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Boomsma JJ, 2014, ANNU REV ENTOMOL, V59, P467, DOI 10.1146/annurev-ento-011613-162054; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Calderon J, 2010, MICROBIOL-SGM, V156, P2484, DOI 10.1099/mic.0.038000-0; Chen L, 2014, FUNGAL GENET BIOL, V63, P42, DOI 10.1016/j.fgb.2013.12.001; Chen YX, 2015, FUNGAL GENET BIOL, V81, P142, DOI 10.1016/j.fgb.2014.10.018; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Duan ZB, 2013, AUTOPHAGY, V9, P538, DOI 10.4161/auto.23575; Duan ZB, 2009, ENVIRON MICROBIOL, V11, P2351, DOI 10.1111/j.1462-2920.2009.01961.x; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gao Q, 2013, APPL ENVIRON MICROB, V79, P7646, DOI 10.1128/AEM.02905-13; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Hu X, 2014, P NATL ACAD SCI USA, V111, P16796, DOI 10.1073/pnas.1412662111; Huang W, 2015, ENVIRON MICROBIOL, V17, P994, DOI 10.1111/1462-2920.12451; Jiang C, 2015, ENVIRON MICROBIOL, V17, P1245, DOI 10.1111/1462-2920.12561; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llorca CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00169; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Montibus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083377; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Orlean P., 1997, MOL CELLULAR BIOL YE, V21, P229; Polley SD, 1996, FEBS LETT, V388, P200, DOI 10.1016/0014-5793(96)00541-8; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ramana KV, 2013, AM J INFECT DIS MICR, V1, P64, DOI DOI 10.12691/AJIDM-1-4-2; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Spode I, 2002, J MOL BIOL, V319, P407, DOI 10.1016/S0022-2836(02)00322-4; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; STLEGER RJ, 1994, ARCH BIOCHEM BIOPHYS, V313, P1, DOI 10.1006/abbi.1994.1350; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang W, 2015, ENVIRON MICROBIOL, V17, P1377, DOI 10.1111/1462-2920.12618; Tian CG, 2011, MICROBIOL-SGM, V157, P747, DOI 10.1099/mic.0.045468-0; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang CS, 2014, BIOL CONTROL, V68, P129, DOI 10.1016/j.biocontrol.2013.06.017; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang CS, 2004, J INVERTEBR PATHOL, V85, P168, DOI 10.1016/j.jip.2004.02.008; Wang CS, 2002, FEMS MICROBIOL LETT, V213, P251, DOI 10.1111/j.1574-6968.2002.tb11314.x; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Xiao Guohua, 2012, Sci Rep, V2, P483, DOI 10.1038/srep00483; Yago JI, 2011, MOL PLANT PATHOL, V12, P653, DOI [10.1111/j.1364-3703.2010.00701.x, 10.1111/J.1364-3703.2010.00701.X]; Yin WB, 2013, MICROBIOL-SGM, V159, P77, DOI 10.1099/mic.0.063370-0; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zheng P, 2013, APPL MICROBIOL BIOT, V97, P2797, DOI 10.1007/s00253-013-4771-7; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	56	31	36	2	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8218	8231		10.1074/jbc.M114.630939	http://dx.doi.org/10.1074/jbc.M114.630939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25673695	Green Published, hybrid			2022-12-26	WOS:000351662600019
J	Morais, MAB; Giuseppe, PO; Souza, TACB; Alegria, TGP; Oliveira, MA; Netto, LES; Murakami, MT				Morais, Mariana A. B.; Giuseppe, Priscila O.; Souza, Tatiana A. C. B.; Alegria, Thiago G. P.; Oliveira, Marcos A.; Netto, Luis E. S.; Murakami, Mario T.			How pH Modulates the Dimer-Decamer Interconversion of 2-Cys Peroxiredoxins from the Prx1 Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE FUNCTION; STABLE OXIDIZED DECAMER; OXIDATIVE STRESS; MITOCHONDRIAL PEROXIREDOXIN; PLASMODIUM-FALCIPARUM; STRUCTURE REFINEMENT; ANTIOXIDANT DEFENSE; LEISHMANIA-INFANTUM; CRYSTAL-STRUCTURE; OLIGOMERIC STATE	2-Cys peroxiredoxins belonging to the Prx1 subfamily are Cys-based peroxidases that control the intracellular levels of H2O2 and seem to assume a chaperone function under oxidative stress conditions. The regulation of their peroxidase activity as well as the observed functional switch from peroxidase to chaperone involves changes in their quaternary structure. Multiple factors can modulate the oligomeric transitions of 2-Cys peroxiredoxins such as redox state, post-translational modifications, and pH. However, the molecular basis for the pH influence on the oligomeric state of these enzymes is still elusive. Herein, we solved the crystal structure of a typical 2-Cys peroxiredoxin from Leishmania in the dimeric (pH 8.5) and decameric (pH 4.4) forms, showing that conformational changes in the catalytic loop are associated with the pH-induced decamerization. Mutagenesis and biophysical studies revealed that a highly conserved histidine (His(113)) functions as a pH sensor that, at acidic conditions, becomes protonated and forms an electrostatic pair with Asp(76) from the catalytic loop, triggering the decamerization. In these 2-Cys peroxiredoxins, decamer formation is important for the catalytic efficiency and has been associated with an enhanced sensitivity to oxidative inactivation by overoxidation of the peroxidatic cysteine. In eukaryotic cells, exposure to high levels of H2O2 can trigger intracellular pH variations, suggesting that pH changes might act cooperatively with H2O2 and other oligomerization-modulator factors to regulate the structure and function of typical 2-Cys peroxiredoxins in response to oxidative stress.	[Morais, Mariana A. B.; Giuseppe, Priscila O.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil; [Souza, Tatiana A. C. B.] Inst Carlos Chagas, Lab Proteom & Engn Proteinas, BR-81350010 Curitiba, Parana, Brazil; [Alegria, Thiago G. P.; Netto, Luis E. S.] Univ Sao Paulo, Dept Genet & Biol Evolutiva, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil; [Oliveira, Marcos A.] Univ Estadual Paulista, Dept Biol, BR-11330900 Sao Vicente, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Murakami, MT (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Murakami, Mario T/C-2087-2012; Oliveira de Giuseppe, Priscila/GLR-1319-2022; Murakami, Mario T/F-5640-2016; Netto, Luis/A-3783-2008; de Oliveira, Marcos A/K-5746-2015	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Murakami, Mario T/0000-0002-0405-8010; Netto, Luis/0000-0002-4250-9177; de Oliveira, Marcos A/0000-0002-1192-7296; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51730-0, 2011/10248-4, 2012/24134-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/51730-0, 2011/10248-4, and 2012/24134-3, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bernier-Villamor L, 2004, J EXP BOT, V55, P2191, DOI 10.1093/jxb/erh238; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; de Morais MAB, 2013, ACTA CRYSTALLOGR F, V69, P408, DOI 10.1107/S1744309113003989; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Nguyen JB, 2013, CHEM BIOL, V20, P991, DOI 10.1016/j.chembiol.2013.06.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	50	33	33	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8582	8590		10.1074/jbc.M114.619205	http://dx.doi.org/10.1074/jbc.M114.619205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666622	Green Published, hybrid			2022-12-26	WOS:000351662600048
J	Ding, G; Zou, WJ; Zhang, H; Xue, YD; Cai, Y; Huang, GF; Chen, LF; Duan, SM; Kang, LJ				Ding, Gang; Zou, Wenjuan; Zhang, Hu; Xue, Yadan; Cai, Yang; Huang, Guifang; Chen, Lufeng; Duan, Shumin; Kang, Lijun			In Vivo Tactile Stimulation-Evoked Responses in Caenorhabditis elegans Amphid Sheath Glia	PLOS ONE			English	Article							C-ELEGANS; MECHANOTRANSDUCTION CHANNEL; DEG/ENAC CHANNEL; TOUCH SENSATION; SUBUNIT; NEURONS	Glial cells are important components of the nervous system. However, how they respond to physiological stimuli in vivo remains largely unknown. In this study, we investigated the electrophysiological activities and Ca2+ responses of the C. elegans amphid sheath glia (AMsh glia) to tactile stimulation in vivo. We recorded robust inward currents and Ca2+ elevation in the AMsh cell with the delivery of tactile stimuli of varying displacements to the nose tip of the worm. Compared to the adjacent mechanoreceptor ASH neuron, the AMsh cell showed greater sensitivity to tactile stimulation. Amiloride, an epithelial Na+ channel blocker, blocked the touch-induced currents and Ca2+ signaling in the ASH neuron, but not those in the AMsh cell. Taken together, our results revealed that AMsh glial cells actively respond to in vivo tactile stimulation and likely function cell-autonomously as mechanoreceptors.	[Ding, Gang; Zou, Wenjuan; Zhang, Hu; Xue, Yadan; Cai, Yang; Huang, Guifang; Duan, Shumin; Kang, Lijun] Zhejiang Univ, Sch Med, Minist Hlth China, Dept Neurobiol,Key Lab Med Neurobiol,Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Yang; Chen, Lufeng] Xinjiang Med Univ, Basic Med Coll, Dept Pharmacol, Urumqi, Peoples R China	Zhejiang University; Xinjiang Medical University	Duan, SM (corresponding author), Zhejiang Univ, Sch Med, Minist Hlth China, Dept Neurobiol,Key Lab Med Neurobiol,Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China.	duanshumin@zjuem.zju.edu.cn; kanglijun@zju.edu.cn		KANG, Lijun/0000-0001-9939-5134	Major National Scientific Research Projects of the Ministry of Science and Technology of China [2013CB945603]; National Foundation of Natural Science of China [31271180]; Zhejiang Natural Science Funds for Distinguished Young Scholars of China [LR14C090001]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Major National Scientific Research Projects of the Ministry of Science and Technology of China; National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scholars of China; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Major National Scientific Research Projects of the Ministry of Science and Technology of China (2013CB945603, to LJK). http://www.most.gov.cn/; the National Foundation of Natural Science of China (31271180, to LJK). http://www.nsfc.gov.cn/; Zhejiang Natural Science Funds for Distinguished Young Scholars of China (LR14C090001, to LJK). http://www.zjnsf.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Brophy P, 2009, CURR OPIN NEUROBIOL, V19, P459, DOI 10.1016/j.conb.2009.10.013; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Davila D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00272; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Doroquez DB, 2014, ELIFE, V3, DOI 10.7554/eLife.01948; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Han L, 2013, J NEUROSCI, V33, P936, DOI 10.1523/JNEUROSCI.2749-12.2013; Heiman MG, 2009, CELL, V137, P344, DOI 10.1016/j.cell.2009.01.057; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Li ZY, 2014, CELL, V159, P751, DOI 10.1016/j.cell.2014.09.056; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Oikonomou G, 2011, GLIA, V59, P1253, DOI 10.1002/glia.21084; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Richmond J, 2009, J VIS EXP; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Stiernagle Theresa, 2006, WormBook, P1; Stout RF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00067; Stout RF, 2011, CELL CALCIUM, V50, P98, DOI 10.1016/j.ceca.2011.05.016; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zou Wen-juan, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P222	30	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117114	10.1371/journal.pone.0117114	http://dx.doi.org/10.1371/journal.pone.0117114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671616	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300035
J	Venn-Watson, S; Garrison, L; Litz, J; Fougeres, E; Mase, B; Rappucci, G; Stratton, E; Carmichael, R; Odell, D; Shannon, D; Shippee, S; Smith, S; Staggs, L; Tumlin, M; Whitehead, H; Rowles, T				Venn-Watson, Stephanie; Garrison, Lance; Litz, Jenny; Fougeres, Erin; Mase, Blair; Rappucci, Gina; Stratton, Elizabeth; Carmichael, Ruth; Odell, Daniel; Shannon, Delphine; Shippee, Steve; Smith, Suzanne; Staggs, Lydia; Tumlin, Mandy; Whitehead, Heidi; Rowles, Teri			Demographic Clusters Identified within the Northern Gulf of Mexico Common Bottlenose Dolphin (Tursiops truncates) Unusual Mortality Event: January 2010-June 2013	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; INFECTION	1 National Marine Mammal Foundation, San Diego, California, United States of America, 2 National Marine Fisheries Service, Southeast Fisheries Science Center, Miami, Florida, United States of America, 3 National Marine Fisheries Service, Southeast Regional Office, St. Petersburg, Florida, United States of America, 4 NOAA Affiliate, Southeast Fisheries Science Center, Miami, Florida, United States of America, 5 Dauphin Island Sea Lab and University of South Alabama, Dauphin Island, Alabama, United States of America, 6 Hubbs- SeaWorld Research Institute, Melbourne Beach, Florida, United States of America, 7 Institute for Marine Mammal Studies, Gulfport, Mississippi, United States of America, 8 Emerald Coast Wildlife Refuge, Fort Walton Beach, Florida, United States of America, 9 Marine Wildlife Response, Esther, Florida, United States of America, 10 Audubon Aquarium of the Americas, New Orleans, Louisiana, United States of America, 11 Gulf World Marine Park, Panama City Beach, Florida, United States of America, 12 Louisiana Department of Wildlife and Fisheries, Baton Rouge, Louisiana, United States of America, 13 Texas Marine Mammal Stranding Network, Galveston, Texas, United States of America, 14 National Marine Fisheries Service, Office of Protected Resources, Silver Spring, Maryland, United States of America	[Venn-Watson, Stephanie] Natl Marine Mammal Fdn, San Diego, CA 92106 USA; [Garrison, Lance; Litz, Jenny; Mase, Blair] Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Fougeres, Erin] Southeast Reg Off, Natl Marine Fisheries Serv, St Petersburg, FL USA; [Rappucci, Gina; Stratton, Elizabeth] NOAA Affiliate, Southeast Fisheries Sci Ctr, Miami, FL USA; [Carmichael, Ruth] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Carmichael, Ruth] Univ S Alabama, Dauphin Isl, AL USA; [Odell, Daniel] Hubbs SeaWorld Res Inst, Melbourne Beach, FL USA; [Shannon, Delphine] Inst Marine Mammal Studies, Gulfport, MS USA; [Shippee, Steve] Emerald Coast Wildlife Refuge, Ft Walton Beach, FL USA; [Shippee, Steve] Marine Wildlife Response, Esther, FL USA; [Smith, Suzanne] Audubon Aquarium Amer, New Orleans, LA USA; [Staggs, Lydia] Gulf World Marine Pk, Panama City Beach, FL USA; [Tumlin, Mandy] Louisiana Dept Wildlife & Fisheries, Baton Rouge, LA USA; [Whitehead, Heidi] Texas Marine Mammal Stranding Network, Galveston, TX USA; [Rowles, Teri] Off Protected Resources, Natl Marine Fisheries Serv, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Dauphin Island Sea Lab; University of South Alabama; National Oceanic Atmospheric Admin (NOAA) - USA	Venn-Watson, S (corresponding author), Natl Marine Mammal Fdn, San Diego, CA 92106 USA.	stephanie.venn-watson@nmmf.org		Carmichael, Ruth/0000-0002-6033-3777	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by the National Oceanic and Atmospheric Administration, in which represented co-authors from the National Marine Fisheries Service participated in the study design, data collection and analysis, and preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Antonio FJ, 2011, AQUAT TOXICOL, V105, P177, DOI 10.1016/j.aquatox.2011.05.022; Barry KP, 2008, LAKE PONTCHARTRAIN L; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Fernandez S, 1998, FISH B-NOAA, V96, P357; Fire SE, 2011, HARMFUL ALGAE, V10, P330, DOI 10.1016/j.hal.2010.12.001; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; GARROTT RA, 1993, MAR MAMMAL SCI, V9, P343, DOI 10.1111/j.1748-7692.1993.tb00468.x; KRAFFT A, 1995, J WILDLIFE DIS, V31, P410, DOI 10.7589/0090-3558-31.3.410; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Lipscomb TP, 1996, J VET DIAGN INVEST, V8, P283, DOI 10.1177/104063879600800302; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Mattson MC, 2006, MAR MAMMAL SCI, V22, P654, DOI 10.1111/j.1748-7692.2006.00057.x; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20222, DOI 10.1073/pnas.1214389109; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; National Response Team, 2011, SCEN COORD REP UNPUB; NOAA Fisheries, 2010 2014 CET UN MOR; NOAA Fisheries, 2011 2012 BOTTL DOLP; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; Twiner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042974	23	12	12	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117248	10.1371/journal.pone.0117248	http://dx.doi.org/10.1371/journal.pone.0117248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671657	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300044
J	Li, G; Hu, HH; Dong, Z; Xie, J; Zhou, Y				Li, Gang; Hu, Huanhuan; Dong, Zhong; Xie, Jin; Zhou, Ying			Urban and Suburban Differences in Hypertension Trends and Self-Care: Three Population-Based Cross-Sectional Studies from 2005-2011	PLOS ONE			English	Article							PREVALENCE; AWARENESS; ASSOCIATION; BEHAVIORS; ADULTS; RATES; CHINA	Objectives This study aimed to compare hypertension trends in the urban and suburban population, and to examine the use of several self-care behaviors among patients who were aware of their hypertension. Methods We examined the data from three cross-sectional adult populations obtained in 2005, 2008, and 2011, in Beijing. Results Our analyses indicated that from 2005 to 2011 the standardized rate of hypertension increased from 31.9% to 36.0% (P <0.001) among urban adults, and was relatively stable (40.8% -40.2%) among suburban adults (P = 0.02). About 10% of the patients reported having taken measures to control their weight for hypertension management. As compared to the other patients, the female patients in the urban areas reported the highest rate of regular BP measurement (52.6%). In addition, the patients who reported taking medication regularly increased among the males and females. Most of the women reported nonsmoking (>= 95%) and alcohol abstinence (>= 90%). The trend of nonsmoking decreased among the urban males. In contrast, the prevalence of nonsmoking increased among the suburban males, though the trend was not statistically significant (P = 0.055). Further, the patient-reported alcohol abstinence was found to exhibit a decreasing trend among the males. Conclusions We observed an increase in the hypertension prevalence from 2005 to 2011. The rates remained higher for suburban adults than for urban adults. Females generally had better self-care ability as compared to male patients. Further research is needed to promote self-care behaviors in hypertensive patients, especially for male patients.	[Li, Gang; Dong, Zhong; Xie, Jin; Zhou, Ying] Beijing Ctr Dis Control & Prevent, Inst Chron Dis Control & Prevent, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Grad Sch Sport Sci, Lab Exercise Epidemiol, Saitama, Japan	Waseda University	Li, G (corresponding author), Beijing Ctr Dis Control & Prevent, Inst Chron Dis Control & Prevent, Beijing, Peoples R China.	ligangcn@126.com			Beijing Health Bureau	Beijing Health Bureau	This work was supported by Beijing Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, FRONT PUBLIC HEALTH, DOI [10.3389/fpubh.2013.00074, DOI 10.3389/FPUBH.2013.00074]; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gupta R, 2010, INDIAN J MED RES, V132, P531; Hou XH, 2008, ASIA-PAC J PUBLIC HE, V20, P159, DOI 10.1177/1010539507312306; Hu HH, 2013, ISRN PUBLIC HLTH; Hu HH, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/526949; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Lee JE, 2010, INT J NURS STUD, V47, P411, DOI 10.1016/j.ijnurstu.2009.09.011; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; MarquesVidal P, 1997, J HUM HYPERTENS, V11, P213, DOI 10.1038/sj.jhh.1000426; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Modesti PA, 2014, J HYPERTENS, V32, P951, DOI 10.1097/HJH.0000000000000125; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Peters RM, 2008, RES NURS HEALTH, V31, P543, DOI 10.1002/nur.20287; Trivedi RB, 2008, J BEHAV MED, V31, P489, DOI 10.1007/s10865-008-9173-4; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; Wang X, 2014, J HYPERTENS, V32, P1919, DOI 10.1097/HJH.0000000000000252; Warren-Findlow J, 2012, J COMMUN HEALTH, V37, P15, DOI 10.1007/s10900-011-9410-6; Warren-Findlow J, 2011, J NATL MED ASSOC, V103, P503, DOI 10.1016/S0027-9684(15)30365-5; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yoon Sung Sug, 2012, NCHS Data Brief, P1	25	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117999	10.1371/journal.pone.0117999	http://dx.doi.org/10.1371/journal.pone.0117999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UO	25665069	Green Published, gold, Green Submitted			2022-12-26	WOS:000349123100027
J	Minami, H; Isomoto, H; Miuma, S; Kobayashi, Y; Yamaguchi, N; Urabe, S; Matsushima, K; Akazawa, Y; Ohnita, K; Takeshima, F; Inoue, H; Nakao, K				Minami, Hitomi; Isomoto, Hajime; Miuma, Satoshi; Kobayashi, Yasutoshi; Yamaguchi, Naoyuki; Urabe, Shigetoshi; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Inoue, Haruhiro; Nakao, Kazuhiko			New Endoscopic Indicator of Esophageal Achalasia: "Pinstripe Pattern"	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EOSINOPHILIC ESOPHAGITIS; PNEUMATIC DILATION; CANCER	Background and Study Aims Endoscopic diagnosis of esophageal achalasia lacking typical endoscopic features can be extremely difficult. The aim of this study was to identify simple and reliable early indicator of esophageal achalasia. Patients and Methods This single-center retrospective study included 56 cases of esophageal achalasia without previous treatment. As a control, 60 non-achalasia subjects including reflux esophagitis and superficial esophageal cancer were also included in this study. Endoscopic findings were evaluated according to Descriptive Rules for Achalasia of the Esophagus as follows: (1) esophageal dilatation, (2) abnormal retention of liquid and/or food, (3) whitish change of the mucosal surface, (4) functional stenosis of the esophago-gastric junction, and (5) abnormal contraction. Additionally, the presence of the longitudinal superficial wrinkles of esophageal mucosa, "pinstripe pattern (PSP)" was evaluated endoscopically. Then, inter-observer diagnostic agreement was assessed for each finding. Results The prevalence rates of the above-mentioned findings (1-5) were 41.1%, 41.1%, 16.1%, 94.6%, and 43.9%, respectively. PSP was observed in 60.7% of achalasia, while none of the control showed positivity for PSP. PSP was observed in 26 (62.5%) of 35 cases with shorter history < 10 years, which usually lacks typical findings such as severe esophageal dilation and tortuosity. Inter-observer agreement level was substantial for food/liquid remnant (k = 0.6861) and PSP (k = 0.6098), and was fair for abnormal contraction and white change. The accuracy, sensitivity, and specificity for achalasia were 83.8%, 64.7%, and 100%, respectively. Conclusion "Pinstripe pattern" could be a reliable indicator for early discrimination of primary esophageal achalasia.	[Minami, Hitomi; Isomoto, Hajime; Miuma, Satoshi; Yamaguchi, Naoyuki; Urabe, Shigetoshi; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan; [Kobayashi, Yasutoshi] Kobayashi Internal Med Clin, Kobe, Hyogo, Japan; [Inoue, Haruhiro] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan	Nagasaki University; Showa University	Isomoto, H (corresponding author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan.	hajimei2002@yahoo.co.jp						Bassett J, 2009, DIS ESOPHAGUS, V22, P543, DOI 10.1111/j.1442-2050.2009.00949.x; Dellon ES, 2013, GASTROENTEROL CLIN N, V42, P133, DOI 10.1016/j.gtc.2012.11.008; Dunaway Peter M., 2001, Curr Treat Options Gastroenterol, V4, P89, DOI 10.1007/s11938-001-0051-1; ECKARDT VF, 1992, GASTROENTEROLOGY, V103, P1732, DOI 10.1016/0016-5085(92)91428-7; Heller, 1913, MITT GRENZGEB MED CH, V27, P141; HOWARD PJ, 1992, GUT, V33, P1011, DOI 10.1136/gut.33.8.1011; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Iwakiri K, 2010, J GASTROENTEROL, V45, P422, DOI 10.1007/s00535-009-0179-7; Junginger T, 2002, LONG TERM OUTCOME MY; Leeuwenburgh I, 2010, AM J GASTROENTEROL, V105, P2144, DOI 10.1038/ajg.2010.263; Leeuwenburgh I, 2010, DIS ESOPHAGUS, V23, P506, DOI 10.1111/j.1442-2050.2009.01040.x; Loviscek L F, 1998, Dis Esophagus, V11, P239; PORSCHEN R, 1995, GASTROENTEROLOGY, V108, P545, DOI 10.1016/0016-5085(95)90084-5; Spiess AE, 1998, JAMA-J AM MED ASSOC, V280, P638, DOI 10.1001/jama.280.7.638; STREITZ JM, 1995, ANN THORAC SURG, V59, P1604, DOI 10.1016/0003-4975(94)00997-L; West RL, 2002, AM J GASTROENTEROL, V97, P1346, DOI 10.1016/S0002-9270(02)04127-8	16	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0101833	10.1371/journal.pone.0101833	http://dx.doi.org/10.1371/journal.pone.0101833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664812	gold, Green Published, Green Submitted			2022-12-26	WOS:000349123100001
J	Ardal, C; Rottingen, JA				Ardal, Christine; Rottingen, John-Arne			An Open Source Business Model for Malaria	PLOS ONE			English	Article							ERADICATION	Greater investment is required in developing new drugs and vaccines against malaria in order to eradicate malaria. These precious funds must be carefully managed to achieve the greatest impact. We evaluate existing efforts to discover and develop new drugs and vaccines for malaria to determine how best malaria R&D can benefit from an enhanced open source approach and how such a business model may operate. We assess research articles, patents, clinical trials and conducted a smaller survey among malaria researchers. Our results demonstrate that the public and philanthropic sectors are financing and performing the majority of malaria drug/vaccine discovery and development, but are then restricting access through patents, 'closed' publications and hidden away physical specimens. This makes little sense since it is also the public and philanthropic sector that purchases the drugs and vaccines. We recommend that a more "open source" approach is taken by making the entire value chain more efficient through greater transparency which may lead to more extensive collaborations. This can, for example, be achieved by empowering an existing organization like the Medicines for Malaria Venture (MMV) to act as a clearing house for malaria-related data. The malaria researchers that we surveyed indicated that they would utilize such registry data to increase collaboration. Finally, we question the utility of publicly or philanthropically funded patents for malaria medicines, where little to no profits are available. Malaria R&D benefits from a publicly and philanthropically funded architecture, which starts with academic research institutions, product development partnerships, commercialization assistance through UNITAID and finally procurement through mechanisms like The Global Fund to Fight AIDS, Tuberculosis and Malaria and the U.S.' President's Malaria Initiative. We believe that a fresh look should be taken at the cost/benefit of patents particularly related to new malaria medicines and consider alternative incentives, like WHO prequalification.	[Ardal, Christine] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Ardal, Christine] Norwegian Knowledge Ctr Hlth Serv, Sect Global Hlth, Oslo, Norway; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Rottingen, John-Arne] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Norwegian Institute of Public Health (NIPH); Norwegian Knowledge Centre for Health Services; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Ardal, C (corresponding author), Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway.	christine.ardal@fhi.no			Norwegian Research Council [192465]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was made possible through the generous financing of the Norwegian Research Council (grant number 192465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Barrett S, 2010, WHY COOPERATIVE INCE; Burrows J, 2013, GUARDIAN; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chesbrough H, 2002, IND CORP CHANGE, V11, P529, DOI 10.1093/icc/11.3.529; Dilaforette, 2012, AB US; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV; Kar S, 2010, NAT REV DRUG DISCOV, V9, P511, DOI 10.1038/nrd3207; Liu J, 2013, LANCET GLOB HEALTH, V1, pE2, DOI 10.1016/S2214-109X(13)70002-0; Malaria Vaccine Initiative, 2013, MAL VACC CAND RED DI; Masum H., 2011, OPEN SOURCE NEGLECTE; Maurer S, 2005, RIGHT TOOLS DESIGNIN; Medicines for Malaria Venture, 2013, MMV PROV PROM COMP S; Medicines for Malaria Venture, 2013, GLOB MAL PORTF; Medicines for Malaria Venture, 2013, ANN REP 2012; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Moran M, 2012, G FINDER NEGLECTED D; Moran M, 2013, G FINDER NEGLECTED D; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Patentstyret, 2013, KOSTN INT PAT, DOI [10.1016/j.mgene.2013.11.003, DOI 10.1016/J.MGENE.2013.11.003]; Pecoul B, 2011, COMMUNICATION; PLOS, 2014, PUBL FEES; Robertson M, 2013, PARASITOLOGY; The Global Fund to Fight AIDS TaM, 2013, ACT PRIC AFF MED FAC; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2012, ANN REP 2012; The President's Malaria Initiative, 2013, 7 PRES MAL IN; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, RES DEV MEET HLTH NE; Wikipedia, 2013, BUS MOD; World Health Organization, 2013, PUBL BRIEF HELD WHO; World Health Organization Roll Back Malaria Partnership, 2011, EL MAL LEARN LOOK AH; World Health Organization Roll Back Malaria Partnership, 2013, FOC S AFR	34	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117150	10.1371/journal.pone.0117150	http://dx.doi.org/10.1371/journal.pone.0117150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658590	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900109
J	Bao, LD; Fu, XD; Si, MW; Wang, Y; Ma, RL; Ren, XH; Lv, HJ				Bao, Lidao; Fu, Xudong; Si, Mingwen; Wang, Yi; Ma, Ruilian; Ren, Xianhua; Lv, Haijun			MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes	PLOS ONE			English	Article							LEPTIN RECEPTOR; EXPRESSION; GLUCOSE; PROGRESSION; SUPPRESSOR; COMPONENTS; MIR-185; CANCER	Diabetes is the most common and complex metabolic disorder, and one of the most important health threats now. MicroRNAs (miRNAs) are a group of small non-coding RNAs that have been suggested to play a vital role in a variety of physiological processes, including glucose homeostasis. In this study, we investigated the role of miR-185 in diabetes. MiR-85 was significantly downregulated in diabetic patients and mice, and the low level was correlated to blood glucose concentration. Overexpression of miR-185 enhanced insulin secretion of pancreatic beta-cells, promoted cell proliferation and protected cells from apoptosis. Further experiments using in silico prediction, luciferase reporter assay and western blot assay demonstrated that miR-185 directly targeted SOCS3 by binding to its 3'-UTR. On the contrary to miR-185's protective effects, SOCS3 significantly suppressed functions of beta-cell and inactivated Stat3 pathway. When treating cells with miR-185 mimics in combination with SOCS3 overexpression plasmid, the inhibitory effects of SOCS3 were reversed. While combined treatment of miR-185 mimics and SOCS3 siRNA induced synergistically promotive effects compared to either miR-185 mimics or SOCS3 siRNA treatment alone. Moreover, we observed that miR-185 level was inversely correlated with SOCS3 expression in diabetes patients. In conclusion, this study revealed a functional and mechanistic link between miR-185 and SOCS3 in the pathogenesis of diabetes. MIR-185 plays an important role in the regulation of insulin secretion and beta-cell growth in diabetes. Restoration of miR-185 expression may serve a potentially promising and efficient therapeutic approach for diabetes.	[Bao, Lidao; Wang, Yi; Ma, Ruilian; Ren, Xianhua] Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China; [Fu, Xudong] Liaocheng Peoples Hosp, Dept Endocrinol, Liaocheng, Shandong, Peoples R China; [Si, Mingwen] Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Shandong, Peoples R China; [Lv, Haijun] Inner Mongolia Med Univ, Affiliated Hosp, Res Dept, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University	Ren, XH (corresponding author), Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China.	xhr197702@126.com; haijun_lv13@126.com			Nature Science Foundation of Inner Mongolia Autonomous Region [2013MS1224]; Scientific Project of Affiliated Hospital of Inner Mongolia Medical University [NYFY2010YB006]; Youth Innovation Fund of Inner Mongolia Medical University [NY2010QN002]; Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University [NYFYZD20130158]	Nature Science Foundation of Inner Mongolia Autonomous Region; Scientific Project of Affiliated Hospital of Inner Mongolia Medical University; Youth Innovation Fund of Inner Mongolia Medical University; Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University	This study was financially supported by the Nature Science Foundation of Inner Mongolia Autonomous Region (2013MS1224, for LDB, http://nsbr.nmkjt.gov.cn/index.aspx), Scientific Project of Affiliated Hospital of Inner Mongolia Medical University (NYFY2010YB006, for LDB, http://www.nmgfy.com/), Youth Innovation Fund of Inner Mongolia Medical University (NY2010QN002, for LDB, http://www.nmgfy.com/), and Key Scientific Fund of Affiliated Hospital of Inner Mongolia Medical University (NYFYZD20130158, for LDB, http://www. nmgfy.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ilonen J, 1999, Diabetes Technol Ther, V1, P205, DOI 10.1089/152091599317440; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kato M, 2013, FREE RADICAL BIO MED, V64, P85, DOI 10.1016/j.freeradbiomed.2013.06.009; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Li Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.148; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Meyer JM, 2013, CURR OPIN LIPIDOL, V24, P386, DOI 10.1097/MOL.0b013e3283638042; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rochette L, 2014, BIOCHIM BIOPHYS ACTA; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tomita S, 2011, CANCER SCI, V102, P57, DOI 10.1111/j.1349-7006.2010.01751.x; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wang C, 2014, FEBS J, V281, P2136, DOI 10.1111/febs.12767; Wang J, 2014, J MOL MED BERL; Xie J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108559; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	36	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116067	10.1371/journal.pone.0116067	http://dx.doi.org/10.1371/journal.pone.0116067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658748	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900029
J	Castorina, A; Waschek, JA; Marzagalli, R; Cardile, V; Drago, F				Castorina, Alessandro; Waschek, James A.; Marzagalli, Rubina; Cardile, Venera; Drago, Filippo			PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; PERIPHERAL-NERVE INJURY; TUMOR MPNST CELLS; SIGNALING PATHWAYS; NEURITE OUTGROWTH; GENE-EXPRESSION; UP-REGULATION; VIP; NEURONS; MICE	Regeneration of peripheral nerves depends on the abilities of rejuvenating axons to migrate at the injury site through cellular debris and altered extracellular matrix, and then grow along the residual distal nerve sheath conduit and reinnervate synaptic targets. Considerable evidence suggest that glial cells participate in this process, although the mechanisms remain to be clarified. In cell culture, regenerating neurites secrete PACAP, a peptide shown to induce the expression of the protease tissue plasminogen activator (tPA) in neural cell types. In the present studies, we tested the hypothesis that PACAP can stimulate peripheral glial cells to produce tPA. More specifically, we addressed whether or not PACAP promoted the expression and activity of tPA in the Schwann cell line RT4-D6P2T, which shares biochemical and physical properties with Schwann cells. We found that PACAP dose- and time-dependently stimulated tPA expression both at the mRNA and protein level. Such effect was mimicked by maxadilan, a potent PAC1 receptor agonist, but not by the PACAP-related homolog VIP, suggesting a PAC1-mediated function. These actions appeared to be mediated at least in part by the Akt/CREB signaling cascade because wortmannin, a PI3K inhibitor, prevented peptide-driven CREB phosphorylation and tPA increase. Interestingly, treatment with BDNF mimicked PACAP actions on tPA, but acted through both the Akt and MAPK signaling pathways, while causing a robust increase in PACAP and PAC1 expression. PACAP6-38 totally blocked PACAP-driven tPA expression and in part hampered BDNF-mediated effects. We conclude that PACAP, acting through PAC1 receptors, stimulates tPA expression and activity in a Akt/CREB-dependent manner to promote proteolytic activity in Schwann-cell like cultures.	[Castorina, Alessandro; Marzagalli, Rubina] Univ Catania, Dept Biomed Sci & Biotechnol, Sect Human Anat & Histol, Catania, Italy; [Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst, Los Angeles, CA USA; [Cardile, Venera] Univ Catania, Dept Biomed Sci & Biotechnol, Physiol Sect, Catania, Italy; [Drago, Filippo] Univ Catania, Dept Biomed Sci & Biotechnol, Pharmacol Sect, Catania, Italy	University of Catania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Catania; University of Catania	Castorina, A (corresponding author), Univ Catania, Dept Biomed Sci & Biotechnol, Sect Human Anat & Histol, Catania, Italy.	alecasto@unict.it	Drago, Francesco/H-7563-2019; Drago, Filippo/AAC-5090-2022; loreto, carla/AAC-2711-2019; Castorina, Alessandro/C-5495-2013; Drago, Filippo/K-5619-2018	Castorina, Alessandro/0000-0001-7037-759X; Drago, Filippo/0000-0003-2887-5223; CARDILE, Venera/0000-0001-9902-3736; Marzagalli, Rubina/0000-0002-2165-8632	National grant [PON01-00110]	National grant	This work was supported by a National grant PON01-00110. Part of these experiments were accomplished using scientific equipment provided through a convention with Catania City Hall in the context of the ICT-E1 project. The authors would like to thank Mr P. Asero for his technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2006, CURR TOP MED CHEM, V6, P151, DOI 10.2174/156802606775270288; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Armstrong BD, 2004, NEUROREPORT, V15, P2647, DOI 10.1097/00001756-200412030-00018; Armstrong BD, 2003, J NEUROSCI RES, V74, P240, DOI 10.1002/jnr.10750; Castorina A, 2013, NEUROSCIENCE, V250, P546, DOI 10.1016/j.neuroscience.2013.07.053; Castorina A, 2014, EXP CELL RES, V322, P108, DOI 10.1016/j.yexcr.2013.11.003; Castorina A, 2012, J MOL NEUROSCI, V48, P674, DOI 10.1007/s12031-012-9755-z; Castorina A, 2010, PEPTIDES, V31, P2276, DOI 10.1016/j.peptides.2010.08.013; Castorina A, 2008, BRAIN RES, V1241, P29, DOI 10.1016/j.brainres.2008.09.035; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; CLARK MB, 1991, GLIA, V4, P514, DOI 10.1002/glia.440040511; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Endo A, 1998, NEUROSCI LETT, V246, P37, DOI 10.1016/S0304-3940(98)00204-3; Giunta S, 2012, PEPTIDES, V37, P32, DOI 10.1016/j.peptides.2012.06.004; Giunta S, 2010, NEUROPEPTIDES, V44, P45, DOI 10.1016/j.npep.2009.10.003; Godinho MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069987; GOLD LI, 1992, J CELL BIOCHEM, V50, P441, DOI 10.1002/jcb.240500412; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Jamen F, 2002, J NEUROCHEM, V82, P1199, DOI 10.1046/j.1471-4159.2002.01124.x; KRYSTOSEK A, 1984, J CELL BIOL, V98, P773, DOI 10.1083/jcb.98.2.773; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lee H, 2009, J NEUROSCI RES, V87, P171, DOI 10.1002/jnr.21820; MARS WM, 1993, AM J PATHOL, V143, P949; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Nakajima E, 2013, MOL VIS, V19, P174; OHLSSON M, 1993, MOL CELL BIOL, V13, P266, DOI 10.1128/MCB.13.1.266; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Pettersson LME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100730; Raoult E, 2011, J NEUROCHEM, V119, P920, DOI 10.1111/j.1471-4159.2011.07486.x; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Sasagasako N, 1996, J NEUROCHEM, V66, P1432; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scuderi S, 2013, PEPTIDES, V39, P119, DOI 10.1016/j.peptides.2012.11.015; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tan YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061200; Tan YV, 2011, ASN NEURO, V3, P195, DOI 10.1042/AN20110024; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Waschek JA, 1995, REGUL PEPTIDES, V60, P149, DOI 10.1016/0167-0115(95)00124-7; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhou CJ, 2002, CURR PROTEIN PEPT SC, V3, P423, DOI 10.2174/1389203023380576; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	51	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117799	10.1371/journal.pone.0117799	http://dx.doi.org/10.1371/journal.pone.0117799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658447	Green Published, gold			2022-12-26	WOS:000349444900225
J	Ding, F; Zhang, QR; Ung, COL; Wang, YT; Han, YF; Hu, YJ; Qi, J				Ding, Fan; Zhang, Qianru; Ung, Carolina Oi Lam; Wang, Yitao; Han, Yifan; Hu, Yuanjia; Qi, Jin			An Analysis of Chemical Ingredients Network of Chinese Herbal Formulae for the Treatment of Coronary Heart Disease	PLOS ONE			English	Article							MEDICINE; PHARMACOLOGY; TARGETS	As a complex system, the complicated interactions between chemical ingredients, as well as the potential rules of interactive associations among chemical ingredients of traditional Chinese herbal formulae are not yet fully understood by modern science. On the other hand, network analysis is emerging as a powerful approach focusing on processing complex interactive data. By employing network approach in selected Chinese herbal formulae for the treatment of coronary heart disease (CHD), this article aims to construct and analyze chemical ingredients network of herbal formulae, and provide candidate herbs, chemical constituents, and ingredient groups for further investigation. As a result, chemical ingredients network composed of 1588 ingredients from 36 herbs used in 8 core formulae for the treatment of CHD was produced based on combination associations in herbal formulae. In this network, 9 communities with relative dense internal connections are significantly associated with 14 kinds of chemical structures with P < 0.001. Moreover, chemical structural fingerprints of network communities were detected, while specific centralities of chemical ingredients indicating different levels of importance in the network were also measured. Finally, several distinct herbs, chemical ingredients, and ingredient groups with essential position in the network or high centrality value are recommended for further pharmacology study in the context of new drug development.	[Ding, Fan; Zhang, Qianru; Ung, Carolina Oi Lam; Wang, Yitao; Hu, Yuanjia] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Peoples R China; [Zhang, Qianru] Zunyi Med Univ, Sch Pharm, Zunyi 563003, Peoples R China; [Han, Yifan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon 999077, Hong Kong, Peoples R China; [Qi, Jin] China Pharmaceut Univ, Dept Complex Prescript Tradit Chinese Med, Nanjing 211198, Jiangsu, Peoples R China	University of Macau; Zunyi Medical University; Hong Kong Polytechnic University; China Pharmaceutical University	Hu, YJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Ave Padre Tomas Pereira SJ, Taipa 999078, Peoples R China.	yuanjiahu@umac.mo; yaoyuelingxing@163.com	Hu, Yuanjia/AAW-7721-2021; Ung, Carolina Oi Lam/AAR-2672-2020; Wang, Yitao/O-5184-2016	yuanjia, Hu/0000-0001-5244-8577; Han, Yifan/0000-0002-5833-069X; Ung, Carolina Oi Lam/0000-0003-1915-5099	University of Macau [MYRG119 (Y1-L3)-ICMS12-HYJ, MYRG208 (Y2-L4)-ICMS11-WYT]	University of Macau	The University of Macau provided financial support for this research by the projects MYRG119 (Y1-L3)-ICMS12-HYJ and MYRG208 (Y2-L4)-ICMS11-WYT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugessaisa I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104382; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bi YF, 2013, WORLD SCI TECHNOL MO, V15, P804; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cheng KF, 2011, J CANC THER, V2, P91; Chu Y, 2011, J ETHNOPHARMACOL, V137, P1457, DOI 10.1016/j.jep.2011.08.035; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077247; Janga SC, 2009, MOL BIOSYST, V5, P1536, DOI [10.1039/b908147j, 10.1039/B908147j]; Jiang M, 2011, PLANTA MED, V77, P873, DOI 10.1055/s-0030-1270983; Konkimalla VB, 2008, J ETHNOPHARMACOL, V116, P207, DOI 10.1016/j.jep.2007.12.009; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Li S, 2009, CURR BIOINFORM, V4, P188, DOI 10.2174/157489309789071129; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Li ZJ, 2011, MOD J INTEGR TRADIT, V20, P933; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noack A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026102; Owens J, 2006, NAT REV DRUG DISCOV, V5, P1474; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Qin LP, 2008, J ETHNOPHARMACOL, V118, P271, DOI 10.1016/j.jep.2008.04.009; Shi Q, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/697028; Smith Mary Elizabeth, 2012, Semin Oncol Nurs, V28, P64, DOI 10.1016/j.soncn.2011.11.007; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang P, 2010, FITOTERAPIA, V81, P793, DOI 10.1016/j.fitote.2010.04.007; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yang M, 2012, MOD TRADIT CHIN MED, V14, P1376; Yang M, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/971272; Zhang AH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-20; Zhang AH, 2011, FITOTERAPIA, V82, P1160, DOI 10.1016/j.fitote.2011.07.014; [张兰凤 Zhang Lanfeng], 2005, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V20, P8; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhou XZ, 2009, FIRST INTERNATIONAL WORKSHOP ON DATABASE TECHNOLOGY AND APPLICATIONS, PROCEEDINGS, P188, DOI 10.1109/DBTA.2009.65; Zhu Hui, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P474	42	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116441	10.1371/journal.pone.0116441	http://dx.doi.org/10.1371/journal.pone.0116441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658855	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900039
J	Gaudin, ACM; Tolhurst, TN; Ker, AP; Janovicek, K; Tortora, C; Martin, RC; Deen, W				Gaudin, Amelie C. M.; Tolhurst, Tor N.; Ker, Alan P.; Janovicek, Ken; Tortora, Cristina; Martin, Ralph C.; Deen, William			Increasing Crop Diversity Mitigates Weather Variations and Improves Yield Stability	PLOS ONE			English	Article							ORGANIC-MATTER; CORN YIELD; RED-CLOVER; SOIL-STRUCTURE; CLIMATE-CHANGE; HYDRAULIC CONDUCTIVITY; STRUCTURAL STABILITY; CONSERVATION TILLAGE; MIXTURE-MODELS; WATER-CONTENT	Cropping sequence diversification provides a systems approach to reduce yield variations and improve resilience to multiple environmental stresses. Yield advantages of more diverse crop rotations and their synergistic effects with reduced tillage are well documented, but few studies have quantified the impact of these management practices on yields and their stability when soil moisture is limiting or in excess. Using yield and weather data obtained from a 31-year long term rotation and tillage trial in Ontario, we tested whether crop rotation diversity is associated with greater yield stability when abnormal weather conditions occur. We used parametric and non-parametric approaches to quantify the impact of rotation diversity (monocrop, 2-crops, 3-crops without or with one or two legume cover crops) and tillage (conventional or reduced tillage) on yield probabilities and the benefits of crop diversity under different soil moisture and temperature scenarios. Although the magnitude of rotation benefits varied with crops, weather patterns and tillage, yield stability significantly increased when corn and soybean were integrated into more diverse rotations. Introducing small grains into short corn-soybean rotation was enough to provide substantial benefits on long-term soybean yields and their stability while the effects on corn were mostly associated with the temporal niche provided by small grains for underseeded red clover or alfalfa. Crop diversification strategies increased the probability of harnessing favorable growing conditions while decreasing the risk of crop failure. In hot and dry years, diversification of corn-soybean rotations and reduced tillage increased yield by 7% and 22% for corn and soybean respectively. Given the additional advantages associated with cropping system diversification, such a strategy provides a more comprehensive approach to lowering yield variability and improving the resilience of cropping systems to multiple environmental stresses. This could help to sustain future yield levels in challenging production environments.	[Gaudin, Amelie C. M.; Janovicek, Ken; Martin, Ralph C.; Deen, William] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Tolhurst, Tor N.; Ker, Alan P.] Univ Guelph, Dept Food Agr & Resources Econ, Guelph, ON N1G 2W1, Canada; [Tortora, Cristina] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4L8, Canada	University of Guelph; University of Guelph; McMaster University	Gaudin, ACM (corresponding author), Univ Guelph, Dept Plant Agr, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	agaudind@uoguelph.ca		Tortora, Cristina/0000-0001-8351-3730	Ontario Ministry of Agriculture and Food; Grain Farmers of Ontario	Ontario Ministry of Agriculture and Food; Grain Farmers of Ontario	Funding was provided by the Ontario Ministry of Agriculture and Food and Grain Farmers of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karaki GN, 1998, J PLANT NUTR, V21, P263, DOI 10.1080/01904169809365401; Almaraz JJ, 2008, CLIMATIC CHANGE, V88, P187, DOI 10.1007/s10584-008-9408-y; Altieri MA, 2017, CLIMATIC CHANGE, V140, P33, DOI 10.1007/s10584-013-0909-y; Angers D.A., 1993, SOIL SAMPLING METHOD, P651; Baxter S, 2007, WORLD SOIL RESOURCES, V43, P264, DOI [10.1017/s0014479706394902, DOI 10.1017/S0014479706394902]; Benson MH, 2014, SOC NATUR RESOUR, V27, P777, DOI 10.1080/08941920.2014.901467; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; BLEVINS RL, 1983, J SOIL WATER CONSERV, V38, P301; Bohning D, 2014, COMPUT STAT DATA AN, V71, P1, DOI 10.1016/j.csda.2013.10.010; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Canadian Agricultural Services Coordinating Committee, 1998, CAN SYST SOIL CLASS; Carpenter SR, 2012, SUSTAINABILITY-BASEL, V4, P3248, DOI 10.3390/su4123248; CARTER MR, 1993, AGR ECOSYST ENVIRON, V43, P245, DOI 10.1016/0167-8809(93)90089-8; Carter MR, 2002, AGRON J, V94, P38, DOI 10.2134/agronj2002.0038; Chen JH, 2009, ANN STAT, V37, P2523, DOI 10.1214/08-AOS651; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Dapaah HK, 1998, COMMUN SOIL SCI PLAN, V29, P2557, DOI 10.1080/00103629809370134; de Mendiburu F., 2014, STAT PROCEDURES AGR; DeFelice M. S., 2006, Crop Management, P1; Deguchi S, 2007, PLANT SOIL, V291, P291, DOI 10.1007/s11104-007-9194-8; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Di Falco S, 2008, LAND ECON, V84, P83, DOI 10.3368/le.84.1.83; Di Falco S, 2006, EUR REV AGRIC ECON, V33, P289, DOI 10.1093/eurrag/jbl016; DIXON BL, 1994, J AGR RESOUR ECON, V19, P58; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; Drury CF, 2003, SOIL SCI SOC AM J, V67, P867, DOI 10.2136/sssaj2003.0867; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Everitt B.S., 2011, CLUSTER ANAL, P71, DOI DOI 10.1002/9780470977811.CH4; FEDDES RA, 1978, J HYDROL, V37, P393, DOI 10.1016/0022-1694(78)90030-6; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Fujikoshi Y, 2010, WILEY SER PROBAB ST, P283; Gaudin ACM, 2013, AGRONOMY-BASEL, V3, P148, DOI 10.3390/agronomy3010148; Gentry LF, 2013, AGRON J, V105, P295, DOI 10.2134/agronj2012.0246; Givens GH, 2012, COMPUTATION STAT, P287; Goodwin BK, 2000, J AGR RESOUR ECON, V25, P195; GRIFFITH DR, 1988, AGRON J, V80, P599, DOI 10.2134/agronj1988.00021962008000040011x; Grover KK, 2009, AGRON J, V101, P940, DOI 10.2134/agronj2008.0221x; Harri A, 2011, AM J AGR ECON, V93, P703, DOI 10.1093/ajae/aar009; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Hatfield JL, 2013, MAR FRESHWATER RES, V64, P423, DOI 10.1071/MF12164; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; HAYNES RJ, 1991, SOIL TILL RES, V19, P77, DOI 10.1016/0167-1987(91)90111-A; Helmers GA, 2001, AGRON J, V93, P1337, DOI 10.2134/agronj2001.1337; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooyer M, 2012, THESIS U GUELPH; Horton R, 1996, THEOR APPL CLIMATOL, V54, P27, DOI 10.1007/BF00863556; Hu Q, 2003, J APPL METEOROL, V42, P1626, DOI 10.1175/1520-0450(2003)042&lt;1626:CEOCYI&gt;2.0.CO;2; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Intergovernmental Panel on Climate Change, 2013, WORKING GROUP 1 CONT; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JOHNSON MD, 1985, SOIL SCI SOC AM J, V49, P1547, DOI 10.2136/sssaj1985.03615995004900060043x; KARLEN DL, 1991, COMMUN SOIL SCI PLAN, V22, P1985, DOI 10.1080/00103629109368552; Katsvairo T, 2002, AGRON J, V94, P299, DOI 10.2134/agronj2002.0299; Katsvairo TW, 2000, AGRON J, V92, P493, DOI 10.2134/agronj2000.923493x; Kucharik CJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034003; Lazcano C, 2014, SOIL BIOL BIOCHEM, V74, P184, DOI 10.1016/j.soilbio.2014.03.010; Lehman R. M., 2012, Applied Soil Ecology, V61, P300, DOI 10.1016/j.apsoil.2011.11.008; Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; LOCKERETZ W, 1981, SCIENCE, V211, P540, DOI 10.1126/science.211.4482.540; Lotter DW, 2000, AM J ALTER AGR, V18, P1; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; Meyer-Aurich A, 2006, AGR ECOSYST ENVIRON, V117, P119, DOI 10.1016/j.agee.2006.03.023; Meyer-Aurich A, 2006, AGRON J, V98, P1204, DOI 10.2134/agronj2005.0262; Mitchell JP, 2012, CALIF AGR, V66, P55, DOI 10.3733/ca.v066n02p55; MORIN J, 1981, J HYDROL, V52, P321, DOI 10.1016/0022-1694(81)90178-5; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Mueller L, 2009, SOIL TILL RES, V103, P188, DOI 10.1016/j.still.2008.09.010; Munkholm LJ, 2013, SOIL TILL RES, V127, P85, DOI 10.1016/j.still.2012.02.007; Naeem S, 2002, NATURE, V416, P23, DOI 10.1038/416023a; OMAFRA, 2013, AGR GUID FIELD CROPS; OMAFRA, 2013, FIELD CROPS STAT; PETERSON TA, 1989, AGRON J, V81, P735, DOI 10.2134/agronj1989.00021962008100050007x; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Porter PM, 1997, AGRON J, V89, P442, DOI 10.2134/agronj1997.00021962008900030012x; RAIMBAULT BA, 1991, AGRON J, V83, P979, DOI 10.2134/agronj1991.00021962008300060011x; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; RUNGE ECA, 1960, AGRON J, V52, P245, DOI 10.2134/agronj1960.00021962005200050001x; RUNGE ECA, 1968, AGRON J, V60, P503, DOI 10.2134/agronj1968.00021962006000050018x; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; SETA AK, 1993, J ENVIRON QUAL, V22, P661, DOI 10.2134/jeq1993.00472425002200040004x; Singer JW, 1998, CROP SCI, V38, P996, DOI 10.2135/cropsci1998.0011183X003800040019x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Smolik J. D., 1995, American Journal of Alternative Agriculture, V10, P25, DOI 10.1017/S0889189300006081; Southworth J, 2000, AGR ECOSYST ENVIRON, V82, P139, DOI 10.1016/S0167-8809(00)00223-1; Stanger TF, 2008, AGRON J, V100, P643, DOI 10.2134/agronj2007.0280; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TISDALL JM, 1979, AUST J SOIL RES, V17, P429, DOI 10.1071/SR9790429; TOBAR RM, 1994, MYCORRHIZA, V4, P105, DOI 10.1007/BF00203769; Toliver DK, 2012, AGRON J, V104, P530, DOI 10.2134/agronj2011.0291; Urban D, 2012, CLIMATIC CHANGE, V112, P525, DOI 10.1007/s10584-012-0428-2; VandenBygaart AJ, 1999, CAN J SOIL SCI, V79, P149, DOI 10.4141/S98-034; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Varvel GE, 2000, AGRON J, V92, P938, DOI 10.2134/agronj2000.925938x; VARVEL GE, 1994, AGRON J, V86, P204, DOI 10.2134/agronj1994.00021962008600010036x; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wesseling J.G., 1991, SWATRE INSTRUCTIONS; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Woodard JD, 2011, AM J AGR ECON, V93, P968, DOI 10.1093/ajae/aar034; YAACOB O, 1981, PLANT SOIL, V60, P11, DOI 10.1007/BF02377108; Yamoah CF, 1998, J PROD AGRIC, V11, P219, DOI 10.2134/jpa1998.0219; Zentner RP, 2002, SOIL TILL RES, V67, P9, DOI 10.1016/S0167-1987(02)00028-4	106	208	211	13	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113261	10.1371/journal.pone.0113261	http://dx.doi.org/10.1371/journal.pone.0113261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658914	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900004
J	Kawano, M; Sawada, K; Shimodera, S; Ogawa, Y; Kariya, S; Lang, DJ; Inoue, S; Honer, WG				Kawano, Mitsuhiko; Sawada, Ken; Shimodera, Shinji; Ogawa, Yasuhiro; Kariya, Shinji; Lang, Donna J.; Inoue, Shimpei; Honer, William G.			Hippocampal Subfield Volumes in First Episode and Chronic Schizophrenia	PLOS ONE			English	Article							COGNITION RATING-SCALE; 1ST-EPISODE SCHIZOPHRENIA; ALZHEIMERS-DISEASE; WHITE-MATTER; 3 T; AMYGDALA; SEGMENTATION; METAANALYSIS; PLASTICITY; CIRCUITRY	Background Reduced hippocampal volume in schizophrenia is a well-replicated finding. New imaging techniques allow delineation of hippocampal subfield volumes. Studies including predominantly chronic patients demonstrate differences between subfields in sensitivity to illness, and in associations with clinical features. We carried out a cross-sectional and longitudinal study of first episode, sub-chronic, and chronic patients, using an imaging strategy that allows for the assessment of multiple hippocampal subfields. Methods Hippocampal subfield volumes were measured in 34 patients with schizophrenia (19 first episode, 6 sub-chronic, 9 chronic) and 15 healthy comparison participants. A subset of 10 first episode and 12 healthy participants were rescanned after six months. Results Total left hippocampal volume was smaller in sub-chronic (p = 0.04, effect size 1.12) and chronic (p = 0.009, effect size 1.42) patients compared with healthy volunteers. The CA2-3 subfield volume of chronic patients was significantly decreased (p = 0.009, effect size 1.42) compared to healthy volunteers. The CA4-DG volume was significantly reduced in all three patient groups compared to healthy group (all p < 0.005). The two affected subfield volumes were inversely correlated with severity of negative symptoms (p < 0.05). There was a small, but statistically significant decline in left CA4-DG volume over the first six months of illness (p = 0.01). Conclusions Imaging strategies defining the subfields of the hippocampus may be informative in linking symptoms and structural abnormalities, and in understanding more about progression during the early phases of illness in schizophrenia.	[Kawano, Mitsuhiko; Sawada, Ken; Shimodera, Shinji] Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan; [Sawada, Ken] Aki Gen Hosp, Dept Psychiat, Kochi, Japan; [Ogawa, Yasuhiro] Hyogo Prefectural Kakogawa Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Kariya, Shinji] Kochi Med Sch, Dept Diagnost Radiol & Radiat Oncol, Kochi, Japan; [Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Inoue, Shimpei] Fukushima Med Univ, Aizu Med Ctr, Dept Neuropsychiat, Fukushima, Japan; [Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	Kochi University; Kochi University; University of British Columbia; Fukushima Medical University; University of British Columbia	Sawada, K (corresponding author), Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan.	kensawadaster@gmail.com	Lang, Donna/GVR-9040-2022	Lang, Donna/0000-0001-9373-1555	Japan Society for the Promotion of Science [16790691]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science: Grant-in-Aid for Scientific Research (Grant Number 16790691 to KS, URL: http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, JPN J BIOL PSYCHIAT; Benes FM, 1999, BIOL PSYCHIAT, V46, P589, DOI 10.1016/S0006-3223(99)00136-5; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Brambilla P, 2013, BRIT J PSYCHIAT, V202, P50, DOI 10.1192/bjp.bp.111.105700; Csernansky JG, 1998, P NATL ACAD SCI USA, V95, P11406, DOI 10.1073/pnas.95.19.11406; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; Das SR, 2012, NEUROIMAGE, V60, P1266, DOI 10.1016/j.neuroimage.2012.01.098; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Francis AN, 2013, SCHIZOPHR RES, V151, P154, DOI 10.1016/j.schres.2013.10.002; Guy W, 2000, HANDBOOK OF PSYCHIAT; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Herz MI, 1997, AM J PSYCHIAT, V154, P1; Ho AJ, 2010, HUM BRAIN MAPP, V31, P499, DOI 10.1002/hbm.20882; Huang YF, 2007, BIOMETRIKA, V94, P965, DOI 10.1093/biomet/asm067; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; Kaneda Yasuhiro, 2011, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V31, P259; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2006, AM J PSYCHIAT, V163, P426, DOI 10.1176/appi.ajp.163.3.426; Kuhn S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.51; Li YD, 2013, AM J ALZHEIMERS DIS, V28, P627, DOI 10.1177/1533317513494452; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Mamah Daniel, 2012, Front Psychiatry, V3, P96, DOI 10.3389/fpsyt.2012.00096; Mathew I, 2014, JAMA PSYCHIATRY; Narr KL, 2004, NEUROIMAGE, V21, P1563, DOI 10.1016/j.neuroimage.2003.11.011; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; Panenka WJ, 2007, SCHIZOPHR RES, V94, P288, DOI 10.1016/j.schres.2007.05.002; Pereira JB, 2013, HIPPOCAMPUS, V23, P720, DOI 10.1002/hipo.22131; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Qiu AQ, 2010, NEUROIMAGE, V52, P1181, DOI 10.1016/j.neuroimage.2010.05.046; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sheng GQ, 2012, ARCH GEN PSYCHIAT, V69, P550, DOI 10.1001/archgenpsychiatry.2011.1882; Shenton ME, 2002, PSYCHIAT RES-NEUROIM, V115, P15, DOI 10.1016/S0925-4927(02)00025-2; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Tamminga CA, 2012, SCHIZOPHR BULL; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang L, 2008, BIOL PSYCHIAT, V64, P1060, DOI 10.1016/j.biopsych.2008.08.007; Winterburn JL, 2013, NEUROIMAGE, V74, P254, DOI 10.1016/j.neuroimage.2013.02.003; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335	47	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117785	10.1371/journal.pone.0117785	http://dx.doi.org/10.1371/journal.pone.0117785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658118	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900223
J	Rao, S; Larroque-Lombard, AL; Peyrard, L; Thauvin, C; Rachid, Z; Williams, C; Jean-Claude, BJ				Rao, Suman; Larroque-Lombard, Anne-Laure; Peyrard, Lisa; Thauvin, Cedric; Rachid, Zakaria; Williams, Christopher; Jean-Claude, Bertrand J.			Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-Targeting	PLOS ONE			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; ACTIVATION; EXPRESSION; POLYPHARMACOLOGY; MOLECULES; DISCOVERY; CARCINOMA; GEFITINIB; OVERCOME	Cancer cells are characterized by a complex network of interrelated and compensatory signaling driven by multiple kinases that reduce their sensitivity to targeted therapy. Therefore, strategies directed at inhibiting two or more kinases are required to robustly block the growth of refractory tumour cells. Here we report on a novel strategy to promote sustained inhibition of two oncogenic kinases (Kin-1 and Kin-2) by designing a molecule K1-K2, termed "combi-molecule", to induce a tandem blockade of Kin-1 and Kin-2, as an intact structure and to be further hydrolyzed to two inhibitors K1 and K2 directed at Kin-1 and Kin-2, respectively. We chose to target EGFR (Kin-1) and c-Src (Kin-2), two tyrosine kinases known to synergize to promote tumour growth and progression. Variation of K1-K2 linkers led to AL776, our first optimized EGFR-c-Src targeting prototype. Here we showed that: (a) AL776 blocked EGFR and c-Src as an intact structure using an in vitro kinase assay (IC50 EGFR = 0.12 mu M and IC50 c-Src = 3 nM), (b) it could release K1 (AL621, a nanomolar EGFR inhibitor) and K2 (dasatinib, a clinically approved Abl/c-Src inhibitor) by hydrolytic cleavage both in vitro and in vivo, (c) it could robustly inhibit phosphorylation of EGFR and c-Src (0.25-1 mu M) in cells, (d) it induced 2-4 fold stronger growth inhibition than gefitinib or dasatinib and apoptosis at concentrations as low as 1 mu M, and, (e) blocked motility and invasion at sub-micromolar doses in the highly invasive 4T1 and MDA-MB-231 cells. Despite its size (MW = 1032), AL776 blocked phosphorylation of EGFR and c-Src in 4T1 tumours in vivo. We now term this new targeting model consisting of designing a kinase inhibitor K1-K2 to target Kin-1 and Kin-2, and to further release two inhibitors K1 and K2 of the latter kinases, "type III combi-targeting".	[Rao, Suman; Larroque-Lombard, Anne-Laure; Peyrard, Lisa; Thauvin, Cedric; Rachid, Zakaria; Jean-Claude, Bertrand J.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Canc Drug Res Lab,Dept Med,Div Med Oncol, Montreal, PQ H3A 1A1, Canada; [Williams, Christopher] Chem Comp Grp Inc, Montreal, PQ H3A 2R7, Canada	McGill University; Royal Victoria Hospital; Chemical Computing Group	Jean-Claude, BJ (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Canc Drug Res Lab,Dept Med,Div Med Oncol, 687 Pine Ave West Rm M7-19, Montreal, PQ H3A 1A1, Canada.	bertrandj.jean-claude@mcgill.ca		Rao, Suman/0000-0002-5046-0852	Canadian Institutes of Health Research (CIHR) team grant; Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship); McGill-CIHR Drug Development Training Program [TGF-96110]; McGill University Health Center (MUHC) scholarship; postdoctoral fellowship-training award	Canadian Institutes of Health Research (CIHR) team grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship)(Canadian Institutes of Health Research (CIHR)); McGill-CIHR Drug Development Training Program(Canadian Institutes of Health Research (CIHR)); McGill University Health Center (MUHC) scholarship; postdoctoral fellowship-training award	This work was supported by the following sources of funding: Canadian Institutes of Health Research (CIHR) team grant (http://www.cihr-irsc.gc.ca/; BJC), Canadian Institutes of Health Research (CIHR)-Frederick Banting and Charles Best award (Canadian Graduate Scholarship; SR), McGill-CIHR Drug Development Training Program, TGF-96110 (http://www.medicine.mcgill.ca/trainingindrugdev/, postdoctoral fellowship-training award; SR ALL LP CT), and McGill University Health Center (MUHC) scholarship (http://muhc.ca/; SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Banerjee R, 2003, J MED CHEM, V46, P5546, DOI 10.1021/jm030423m; Banerjee R, 2011, CELL SIGNAL, V23, P630, DOI 10.1016/j.cellsig.2010.11.014; Banerjee R, 2010, J PHARMACOL EXP THER, V334, P9, DOI 10.1124/jpet.109.160085; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Barchechath S, 2009, CHEM BIOL DRUG DES, V73, P380, DOI 10.1111/j.1747-0285.2009.00786.x; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brahimi F, 2005, BIOCHEM PHARMACOL, V70, P511, DOI 10.1016/j.bcp.2005.04.037; Brahimi F, 2002, J PHARMACOL EXP THER, V303, P238, DOI 10.1124/jpet.102.039099; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Fortin S, 2013, EXPERT OPIN DRUG DIS, V8, P1029, DOI 10.1517/17460441.2013.798296; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HUNTER RL, 1961, ANN NY ACAD SCI, V94, P861; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irwin ME, 2011, CANCER BIOL THER, V12, P718, DOI 10.4161/cbt.12.8.16907; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Larroque AL, 2008, CHEM BIOL DRUG DES, V71, P374, DOI 10.1111/j.1747-0285.2008.00638.x; Larroque-Lombard AL, 2012, CHEM BIOL DRUG DES, V80, P981, DOI 10.1111/cbdd.12043; Larroque-Lombard AL, 2011, CHEM BIOL DRUG DES, V77, P309, DOI 10.1111/j.1747-0285.2011.01098.x; Larroque-Lombard AL, 2010, J MED CHEM, V53, P2104, DOI 10.1021/jm9016043; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; Nautiyal J, 2009, CANCER LETT, V283, P143, DOI 10.1016/j.canlet.2009.03.035; Neto C, 2012, NUCL MED BIOL, V39, P247, DOI 10.1016/j.nucmedbio.2011.09.001; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Rachid Z, 2005, BIOORG MED CHEM LETT, V15, P1135, DOI 10.1016/j.bmcl.2004.12.015; Reddy AS, 2013, EXPERT REV CLIN PHAR, V6, P41, DOI [10.1586/ECP.12.74, 10.1586/ecp.12.74]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; Todorova MI, 2010, MOL CANCER THER, V9, P869, DOI 10.1158/1535-7163.MCT-09-0673; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Walker I, 2009, NAT REV DRUG DISCOV, V8, P15, DOI 10.1038/nrd2758; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	47	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117215	10.1371/journal.pone.0117215	http://dx.doi.org/10.1371/journal.pone.0117215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658745	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900119
J	Xue, F; Li, X; Zhao, XQ; Wang, LQ; Liu, M; Shi, RF; Zheng, J				Xue, Feng; Li, Xia; Zhao, Xiaoqing; Wang, Lanqi; Liu, Min; Shi, Ruofei; Zheng, Jie			SRSF1 Facilitates Cytosolic DNA-Induced Production of Type I Interferons Recognized by RIG-I	PLOS ONE			English	Article							SPLICING FACTOR SF2/ASF; INNATE IMMUNE SENSOR; SR PROTEINS; RNA; EXPRESSION; PSORIASIS; HELICASE; PHOSPHORYLATION; PROLIFERATION; INFLAMMASOME	Background Evidence has shown that psoriasis is closely associated with infection; however, the mechanism of this association remains unclear. In mammalian cells, viral or bacterial infection is accompanied by the release of cytosolic DNA, which in turn triggers the production of type-I interferons (IFNs). Type I IFNs and their associated genes are significantly upregulated in psoriatic lesions. RIG-I is also highly upregulated in psoriatic lesions and is responsible for IFN production. However, RIG-I mediated regulatory signaling in psoriasis is poorly understood. Methods We screened a cDNA library and identified potential RIG-I interacting partners that may play a role in psoriasis. Results We found that serine/arginine-rich splicing factor 1 (SRSF1) could specifically interact with RIG-I to facilitate RIG-I mediated production of type-I IFN that is triggered by cytosolic DNA. We found SRSF1 associates with RNA polymerase III and RIG-I in a DNA-dependent manner. In addition, treatment with a TNF alpha inhibitor downregulated SRSF1 expression in peripheral blood mononuclear cells (PBMCs) from psoriasis vulgaris patients. Discussion Based on the abundance of pathogenic cytosolic DNA that is detected in psoriatic lesions, our finding that RIG-I interacts with SRSF1 to regulate type-I IFN production reveals acritical link regarding how cytosolic DNA specifically activates aberrant IFN expression. These data may provide new therapeutic targets for the treatment of psoriasis.	[Xue, Feng; Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dermatol Lab, Shanghai 200030, Peoples R China; [Li, Xia; Zhao, Xiaoqing; Wang, Lanqi; Liu, Min; Shi, Ruofei; Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, J (corresponding author), Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China.	jie-zheng2001@126.com			National Natural Science Foundation of China [81171500]; Science and Technology Commission Foundation of Shanghai [11JC1407500]; National Bureau of Health, China [2011Y076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Shanghai; National Bureau of Health, China	This work was supported by grants (81171500) from the National Natural Science Foundation of China, (11JC1407500) from the Science and Technology Commission Foundation of Shanghai, 2011 and (No. 2011Y076) from National Bureau of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Baran W, 2005, ACTA DERMATOVEN ALP, V14, P79; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Buerger C, 2013, THE BRITISH JOURNAL; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai YH, 2009, J INVEST DERMATOL, V129, P2653, DOI 10.1038/jid.2009.153; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fregoso OI, 2013, MOL CELL, V50, P56, DOI 10.1016/j.molcel.2013.02.001; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kitamura H, 2007, J DERMATOL SCI, V45, P127, DOI 10.1016/j.jdermsci.2006.11.003; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; SCHMID P, 1994, J INTERFERON RES, V14, P229, DOI 10.1089/jir.1994.14.229; Sun L, 2012, SCIENCE; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Wu J, 2012, SCIENCE; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, NAT IMMUNOL, V8, P907, DOI 10.1038/ni0907-907; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	57	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115354	10.1371/journal.pone.0115354	http://dx.doi.org/10.1371/journal.pone.0115354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658361	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900017
J	Greenall, SA; Donoghue, JF; Van Sinderen, M; Dubljevic, V; Budiman, S; Devlin, M; Street, I; Adams, TE; Johns, TG				Greenall, S. A.; Donoghue, J. F.; Van Sinderen, M.; Dubljevic, V.; Budiman, S.; Devlin, M.; Street, I.; Adams, T. E.; Johns, T. G.			EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; DOMAIN BINDING-SITE; CELLS; GLIOBLASTOMAS; AMPLIFICATION; ACTIVATION; RESISTANCE; INHIBITORS; MUTATIONS	A truncation mutant of the epidermal growth factor receptor, EGFRvIII, is commonly expressed in glioma, an incurable brain cancer. EGFRvIII is tumorigenic, in part, through its transactivation of other receptor tyrosine kinases (RTKs). Preventing the effects of this transactivation could form part of an effective therapy for glioma; however, the mechanism by which the transactivation occurs is unknown. Focusing on the RTK MET, we show that MET transactivation in U87MG human glioma cells in vitro is proportional to EGFRvIII activity and involves MET heterodimerization associated with a focal adhesion kinase (FAK) scaffold. The transactivation of certain other RTKs was, however, independent of FAK. Simultaneously targeting EGFRvIII (with panitumumab) and the transactivated RTKs themselves (with motesanib) in an intracranial mouse model of glioma resulted in significantly greater survival than with either agent alone, indicating that cotargeting these RTKs has potent antitumor efficacy and providing a strategy for treating EGFRvIII-expressing gliomas, which are usually refractory to treatment.	[Greenall, S. A.; Donoghue, J. F.; Van Sinderen, M.; Dubljevic, V.; Budiman, S.; Johns, T. G.] MIMR PHI Inst Med Res, Ctr Canc Res, Oncogen Signalling Lab, Clayton, Vic 3168, Australia; [Greenall, S. A.; Donoghue, J. F.; Van Sinderen, M.; Dubljevic, V.; Budiman, S.; Johns, T. G.] MIMR PHI Inst Med Res, Ctr Canc Res, Brain Canc Discovery Collaborat, Clayton, Vic 3168, Australia; [Greenall, S. A.; Donoghue, J. F.; Van Sinderen, M.; Dubljevic, V.; Budiman, S.; Johns, T. G.] Monash Univ, Clayton, Vic, Australia; [Greenall, S. A.; Adams, T. E.] CSIRO, Div Mat Sci & Engn, Parkville, Vic, Australia; [Devlin, M.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Street, I.] CRC Canc Therapeut, Bundoora, Vic, Australia; [Street, I.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Street, I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Prince Henry's Institute of Medical Research; Prince Henry's Institute of Medical Research; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Johns, TG (corresponding author), MIMR PHI Inst Med Res, Ctr Canc Res, Oncogen Signalling Lab, 27-31 Wright St, Clayton, Vic 3168, Australia.	terry.johns@monash.edu	Adams, Timothy E/I-6231-2012; Johns, Terrance/C-2441-2008; Street, Ian/GXG-9517-2022	Adams, Timothy E/0000-0003-3436-0066; Johns, Terrance/0000-0002-8874-4543; Dubljevic, Valentina/0000-0002-7944-8937; Greenall, Sameer/0000-0002-1461-7111; Street, Ian/0000-0003-2684-4239; Donoghue, Jacqueline/0000-0003-1370-2469	Commonwealth Scientific and Industrial Research Organisation (CSIRO) OCE Postdoctoral Fellowship; Cure Cancer Australia Foundation postdoctoral fellowship; Victorian Cancer Agency Early Career Seed Grant [ECSG1108]; National Health and Medical Research Council [1028552, 1012020]; Victorian Government's Operational and Infrastructure Support Program; Cure Brain Cancer Foundation; CRC for Cancer Therapeutics, an initiative of the Australian Government	Commonwealth Scientific and Industrial Research Organisation (CSIRO) OCE Postdoctoral Fellowship; Cure Cancer Australia Foundation postdoctoral fellowship; Victorian Cancer Agency Early Career Seed Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational and Infrastructure Support Program; Cure Brain Cancer Foundation; CRC for Cancer Therapeutics, an initiative of the Australian Government	We acknowledge the facilities and scientific and technical assistance of the Histology Facility, Microimaging facility and Monash Animal Services, at MIMR-PHI Institute of Medical Research. We thank Dr D Dadley-Moore for editing the manuscript. SAG is funded by a Commonwealth Scientific and Industrial Research Organisation (CSIRO) OCE Postdoctoral Fellowship. JFD is funded by a Cure Cancer Australia Foundation postdoctoral fellowship and a Victorian Cancer Agency Early Career Seed Grant (ECSG1108). TGJ is funded by National Health and Medical Research Council Project Grants 1028552 and 1012020, the Victorian Government's Operational and Infrastructure Support Program and the Cure Brain Cancer Foundation. This work was supported by the CRC for Cancer Therapeutics, an initiative of the Australian Government. Rilotumumab and motesanib must be obtained through an MTA. Rilotumumab, panitumumab and motesanib were provided by Amgen (rilotumumab and motesanib through an MTA); and dacomitinib was provided by Pfizer.	Akhavan D, 2013, CANCER DISCOV, V3, P534, DOI 10.1158/2159-8290.CD-12-0502; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Donoghue JF, 2011, JOVE-J VIS EXP, DOI 10.3791/3157; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Greenall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034658; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Johns TG, 2007, CLIN CANCER RES, V13, P1911, DOI 10.1158/1078-0432.CCR-06-1453; Johns TG, 2002, INT J CANCER, V98, P398, DOI 10.1002/ijc.10189; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Liu MZ, 2010, ARCH BIOCHEM BIOPHYS, V502, P89, DOI 10.1016/j.abb.2010.07.014; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Pillay V, 2009, NEOPLASIA, V11, P448, DOI 10.1593/neo.09230; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; Riemenschneider MJ, 2005, AM J PATHOL, V167, P1379, DOI 10.1016/S0002-9440(10)61225-4; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Street I, 2012, P 103 ANN M AM ASS C, P72; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wen PY, 2014, NEURO-ONCOLOGY, V16, P567, DOI 10.1093/neuonc/not247; Ymer Susie I, 2011, Cancers (Basel), V3, P2032, DOI 10.3390/cancers3022032	36	33	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5277	5287		10.1038/onc.2014.448	http://dx.doi.org/10.1038/onc.2014.448			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25659577				2022-12-26	WOS:000362575400007
J	Long, JS; Schoonen, PM; Graczyk, D; O'Prey, J; Ryan, KM				Long, J. S.; Schoonen, P. M.; Graczyk, D.; O'Prey, J.; Ryan, K. M.			p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death	ONCOGENE			English	Article							OUTER-MEMBRANE PERMEABILIZATION; KINASE C-ABL; DNA-DAMAGE; APOPTOTIC RESPONSE; P53; ADENOSINE; ACTIVATION; INDUCTION; AUTOPHAGY; PROTEINS	Tumour cells often acquire the ability to escape cell death, a key event leading to the development of cancer. In almost half of all human cancers, the capability to induce cell death is reduced by the mutation and inactivation of p53, a tumour suppressor protein that is a central regulator of apoptosis. As a result, there is a crucial need to identify different cell death pathways that could be targeted in malignancies lacking p53. p73, the closely related p53 family member, can regulate many p53 target genes and therefore some of the same cellular responses as p53. Unlike p53, however, p73 is seldom mutated in cancer, making it an attractive, alternative death effector to target. We report here the ability of p73 to upregulate the expression of the A2B receptor, a recently characterized p53 target that effectively promotes cell death in response to extracellular adenosine-a metabolite that accumulates during various forms of cellular stress. Importantly, we show that p73-dependent stimulation of A2B signalling markedly enhances apoptosis in cancer cells that are devoid of p53. This mode of death is caspase-and puma-dependent, and can be prevented by the overexpression of anti-apoptotic Bcl-XL. Moreover, treatment of p53-null cancer cells with the chemotherapeutic drug adriamycin (doxorubicin) induces A2B in a p73-dependent manner and, in combination with an A2B agonist, substantially enhances apoptotic death. We therefore propose an alternate and distinct p53-independent pathway to stimulate programmed cell death involving p73-mediated engagement of adenosine signalling.	[Long, J. S.; Schoonen, P. M.; Graczyk, D.; O'Prey, J.; Ryan, K. M.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Schoonen, P. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 AV Groningen, Netherlands	Beatson Institute; University of Groningen	Ryan, KM (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Graczyk, Damian/J-6494-2016	Graczyk, Damian/0000-0002-6006-647X; Ryan, Kevin M./0000-0002-1059-9681	Worldwide Cancer Research; Cancer Research UK; Cancer Research UK [15816] Funding Source: researchfish; Worldwide Cancer Research [09-0170, 11-0285] Funding Source: researchfish	Worldwide Cancer Research; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We thank members of the Tumour Cell Death laboratory for critical reading of the manuscript. Work in the Tumour Cell Death Laboratory is supported by Worldwide Cancer Research and Cancer Research UK.	Agami R, 1999, NATURE, V399, P809; Bell HS, 2007, J CLIN INVEST, V117, P1008, DOI 10.1172/JCI28920; Blay J, 1997, CANCER RES, V57, P2602; Borrmann T, 2009, J MED CHEM, V52, P3994, DOI 10.1021/jm900413e; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fricker M, 2010, J NEUROCHEM, V114, P772, DOI 10.1111/j.1471-4159.2010.06804.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gong JG, 1999, NATURE, V399, P806; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Klanrit P, 2008, CELL CYCLE, V7, P205, DOI 10.4161/cc.7.2.5361; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Levrero M, 2000, J CELL SCI, V113, P1661; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Long JS, 2013, MOL CELL, V50, P394, DOI 10.1016/j.molcel.2013.03.016; Lunghi P, 2004, BLOOD, V104, P519, DOI 10.1182/blood-2003-08-2743; Martin AG, 2009, AGING-US, V1, P335, DOI 10.18632/aging.100026; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; O'Prey J, 2009, CELL CYCLE, V8, P2260, DOI 10.4161/cc.8.14.9050; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; PELLICCIARI C, 1993, EUR J HISTOCHEM, V37, P381; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stiewe T, 2002, CANCER RES, V62, P3598; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2009, P NATL ACAD SCI USA, V106, P797, DOI 10.1073/pnas.0812096106; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wilkinson S, 2009, GENE DEV, V23, P1283, DOI 10.1101/gad.521709; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	49	15	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5152	5162		10.1038/onc.2014.436	http://dx.doi.org/10.1038/onc.2014.436			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25659586	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000362233400005
J	Takahashi, H; Jin, C; Rajabi, H; Pitroda, S; Alam, M; Ahmad, R; Raina, D; Hasegawa, M; Suzuki, Y; Tagde, A; Bronson, RT; Weichselbaum, R; Kufe, D				Takahashi, H.; Jin, C.; Rajabi, H.; Pitroda, S.; Alam, M.; Ahmad, R.; Raina, D.; Hasegawa, M.; Suzuki, Y.; Tagde, A.; Bronson, R. T.; Weichselbaum, R.; Kufe, D.			MUC1-C activates the TAK1 inflammatory pathway in colon cancer	ONCOGENE			English	Article							BOWEL-DISEASE; MONOCLONAL-ANTIBODY; COLORECTAL-CANCER; MOUSE MODEL; ONCOPROTEIN; KINASE; EXPRESSION; MUCIN; INHIBITION; BREAST	The mucin 1 (MUC1) oncoprotein has been linked to the inflammatory response by promoting cytokine-mediated activation of the NF-kappa B pathway. The TGF-beta-activated kinase 1 (TAK1) is an essential effector of proinflammatory NF-kappa B signaling that also regulates cancer cell survival. The present studies demonstrate that the MUC1-C transmembrane subunit induces TAK1 expression in colon cancer cells. MUC1 also induces TAK1 in a MUC1(+/-)/IL-10(-/-) mouse model of colitis and colon tumorigenesis. We show that MUC1C promotes NF-kappa B-mediated activation of TAK1 transcription and, in a positive regulatory loop, MUC1-C contributes to TAK1-induced NF-kappa B signaling. In this way, MUC1-C binds directly to TAK1 and confers the association of TAK1 with TRAF6, which is necessary for TAK1-mediated activation of NF-kappa B. Targeting MUC1-C thus suppresses the TAK1 -> NF-kappa B pathway, downregulates BCL-XL and in turn sensitizes colon cancer cells to MEK inhibition. Analysis of colon cancer databases further indicates that MUC1, TAK1 and TRAF6 are upregulated in tumors associated with decreased survival and that MUC1-C-induced gene expression patterns predict poor outcomes in patients. These results support a model in which MUC1-C-induced TAK1 -> NF-kappa B signaling contributes to intestinal inflammation and colon cancer progression.	[Takahashi, H.; Rajabi, H.; Alam, M.; Ahmad, R.; Hasegawa, M.; Suzuki, Y.; Tagde, A.; Kufe, D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Jin, C.; Raina, D.] Genus Oncol, Boston, MA USA; [Pitroda, S.; Weichselbaum, R.] Univ Chicago, Dept Radiat & Cellular Oncol, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Bronson, R. T.] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Harvard University; Harvard Medical School	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu	Tagde, Ashujit/M-9497-2014	Tagde, Ashujit/0000-0002-0770-097X; Hasegawa, Masanori/0000-0002-4354-6105; Ahmad, Rehan/0000-0003-2612-2818	Department of Defense; National Cancer Institute of the National Institutes of Health [CA97098, CA166480]; CDMRP [CA110495]; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA166480] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by Grant CDMRP CA110495 awarded by the Department of Defense and by the National Cancer Institute of the National Institutes of Health under award numbers CA97098 and CA166480.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Baldus SE, 2002, HISTOPATHOLOGY, V40, P440, DOI 10.1046/j.1365-2559.2002.01389.x; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Cai PCH, 2014, ONCOTARGET, V5, P7549, DOI 10.18632/oncotarget.2273; Campbell BJ, 2001, GLYCOCONJUGATE J, V18, P851, DOI 10.1023/A:1022240107040; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Duncan Timothy J, 2007, World J Surg Oncol, V5, P31, DOI 10.1186/1477-7819-5-31; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Furr AE, 2010, PEDIATR DEVEL PATHOL, V13, P24, DOI 10.2350/08-06-0479.1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Lugli A, 2007, J CLIN PATHOL, V60, P534, DOI 10.1136/jcp.2006.039552; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Niv Y, 2008, WORLD J GASTROENTERO, V14, P2139, DOI 10.3748/wjg.14.2139; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Omori E, 2010, CANCER RES, V70, P8417, DOI 10.1158/0008-5472.CAN-10-1227; Panchamoorthy G, 2011, HYBRIDOMA, V30, P531, DOI 10.1089/hyb.2011.0070; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Ray DM, 2012, BRIT J CANCER, V107, P129, DOI 10.1038/bjc.2012.214; Relic B, 2004, J BIOL CHEM, V279, P22399, DOI 10.1074/jbc.M314118200; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Rowse GJ, 1998, CANCER RES, V58, P315; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Suzuki H, 2004, CLIN EXP METASTAS, V21, P321, DOI 10.1023/B:CLIN.0000046133.35133.cc; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387	50	70	74	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5187	5197		10.1038/onc.2014.442	http://dx.doi.org/10.1038/onc.2014.442			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25659581	Green Accepted, Green Submitted			2022-12-26	WOS:000362233400008
J	Wang, W; Dai, HE; Zhang, Y; Chandrasekar, R; Luo, L; Hiromasa, Y; Sheng, CZ; Peng, GX; Chen, SL; Tomich, JM; Reese, J; Edwards, O; Kang, L; Reeck, G; Cui, F				Wang, Wei; Dai, Huaien; Zhang, Yi; Chandrasekar, Raman; Luo, Lan; Hiromasa, Yasuaki; Sheng, Changzhong; Peng, Gongxin; Chen, Shaoliang; Tomich, John M.; Reese, John; Edwards, Owain; Kang, Le; Reeck, Gerald; Cui, Feng			Armet is an effector protein mediating aphid-plant interactions	FASEB JOURNAL			English	Article						saliva protein; salivary gland; feeding behavior; MANF; calcium binding	ACYRTHOSIPHON-PISUM; NEUROTROPHIC FACTOR; PEA APHID; SALIVARY PROTEINS; MYZUS-PERSICAE; ARABIDOPSIS-THALIANA; DOPAMINERGIC-NEURONS; POTATO APHID; IN-VIVO; MANF	Aphid saliva is predicted to contain proteins that modulate plant defenses and facilitate feeding. Armet is a well-characterized bifunctional protein in mammalian systems. Here we report a new role of Armet, namely as an effector protein in the pea aphid, Acyrthosiphon pisum. Pea aphid Armet's physical and chemical properties and its intracellular role are comparable to those reported for mammalian Armets. Uniquely, we detected Armet in aphid watery saliva and in the phloem sap of fava beans fed on by aphids. Armet's transcript level is several times higher in the salivary gland when aphids feed on bean plants than when they feed on an artificial diet. Knockdown of the Armet transcript by RNA interference disturbs aphid feeding behavior on fava beans measured by the electrical penetration graph technique and leads to a shortened life span. Inoculation of pea aphid Armet protein into tobacco leaves induced a transcriptional response that included pathogen-responsive genes. The data suggest that Armet is an effector protein mediating aphid-plant interactions.	[Wang, Wei; Luo, Lan; Kang, Le; Cui, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Wang, Wei; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Dai, Huaien; Chandrasekar, Raman; Hiromasa, Yasuaki; Sheng, Changzhong; Tomich, John M.; Reeck, Gerald; Cui, Feng] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Zhang, Yi; Peng, Gongxin] Hebei Univ Sci & Technol, Dept Math, Hebei Lab Pharmaceut Mol Chem, Shijiazhuang, Hebei, Peoples R China; [Reese, John] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Edwards, Owain] CSIRO, Ecosyst Sci, Ctr Environm & Life Sci, Floreat, WA, Australia	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Forestry University; Kansas State University; Hebei University of Science & Technology; Kansas State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cui, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.	reeck@ksu.edu; cuif@ioz.ac.cn	Edwards, Owain Rhys/B-9707-2008; Peng, Gongxin/GYR-1891-2022; Kang, Le/ABD-1116-2022	Edwards, Owain Rhys/0000-0003-3861-7906; Kang, Le/0000-0003-4262-2329; Cui, Feng/0000-0001-6215-7159; TOMICH, JOHN/0000-0001-7848-8307	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11040200]; Major State Basic Research Development Program of China (973 Program) [2012CB114102]; Cooperative Research Centre for National Plant Biosecurity (Australia); Grains Research and Development Corporation (Australia); Kansas Agricultural Experiment Station [15-035-J]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Cooperative Research Centre for National Plant Biosecurity (Australia); Grains Research and Development Corporation (Australia); Kansas Agricultural Experiment Station	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDB11040200), the Major State Basic Research Development Program of China (973 Program; Grant 2012CB114102), the Cooperative Research Centre for National Plant Biosecurity (Australia), the Grains Research and Development Corporation (Australia), and the Kansas Agricultural Experiment Station (publication 15-035-J).	AKEY DH, 1971, ANN ENTOMOL SOC AM, V64, P353, DOI 10.1093/aesa/64.2.353; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Atamian HS, 2013, MOL PLANT MICROBE IN, V26, P67, DOI 10.1094/MPMI-06-12-0144-FI; BLACKMAN R.L., 1984, ORIENT INSECTS; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Cao HH, 2014, INSECT SCI, V21, P47, DOI 10.1111/1744-7917.12023; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Cooper WC, 2004, J CHEM ECOL, V30, P2527, DOI 10.1007/s10886-004-7948-9; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Gao LL, 2010, NEW PHYTOL, V186, P980, DOI 10.1111/j.1469-8137.2010.03229.x; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Guo K, 2014, BIOPHYS CHEM, V189, P25, DOI 10.1016/j.bpc.2014.03.006; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Louis J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00213; Medina-Ortega KJ, 2013, J EXP BOT, V64, P5525, DOI 10.1093/jxb/ert325; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Rao SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057413; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903; Will T, 2009, J EXP BIOL, V212, P3305, DOI 10.1242/jeb.028514; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	43	63	71	3	82	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2032	2045		10.1096/fj.14-266023	http://dx.doi.org/10.1096/fj.14-266023			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25678626				2022-12-26	WOS:000354114600036
J	Dhingra, N; Bruck, I; Smith, S; Ning, BT; Kaplan, DL				Dhingra, Nalini; Bruck, Irina; Smith, Skye; Ning, Boting; Kaplan, Daniel L.			Dpb11 Protein Helps Control Assembly of the Cdc45 center dot Mcm2-7 center dot GINS Replication Fork Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclin-dependent Kinase (CDK); DNA; DNA Helicase; DNA Replication	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; S-PHASE PROGRESSION; BUDDING YEAST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; ACTIVE-SITES; ORIGIN DNA; CDC45	Background: Dpb11 is required for the initiation of DNA replication. The replication fork helicase is composed of Cdc45, Mcm2-7, and GINS. Results: Dpb11 recruits Cdc45 to Mcm2-7, and Dpb11 blocks GINS interaction with Mcm2-7. Dpb11 also binds to ssDNA, and this interaction releases Dpb11 from Mcm2-7. Conclusion: Dpb11 helps control assembly of the replication fork helicase. Significance: A mechanism for Dpb11 function is described. Dpb11 is required for the initiation of DNA replication in budding yeast. Dpb11 binds to S-phase cyclin-dependent kinase-phosphorylated Sld2 and Sld3 to form a ternary complex during S phase. The replication fork helicase in eukaryotes is composed of Cdc45, Mcm2-7, and GINS. We show here, using purified proteins from budding yeast, that Dpb11 alone binds to Mcm2-7 and that Dpb11 also competes with GINS for binding to Mcm2-7. Furthermore, Dpb11 binds directly to single-stranded DNA (ssDNA), and ssDNA inhibits the Dpb11 interaction with Mcm2-7. We also found that Dpb11 can recruit Cdc45 to Mcm2-7. We identified a mutant of the BRCT4 motif of Dpb11 that remains bound to Mcm2-7 in the presence of ssDNA (dpb11-m1,m2,m3,m5), and this mutant exhibits a DNA replication defect when expressed in budding yeast cells. Expression of this mutant results in increased interaction between Dpb11 and Mcm2-7 during S phase, impaired GINS interaction with Mcm2-7 during S phase, and decreased replication protein A (RPA) interaction with origin DNA during S phase. We propose a model in which Dpb11 first recruits Cdc45 to Mcm2-7. Dpb11, although bound to Cdc45.Mcm2-7, can block the interaction between GINS and Mcm2-7. Upon extrusion of ssDNA from the central channel of Mcm2-7, Dpb11 dissociates from Mcm2-7, and Dpb11 binds to ssDNA, thereby allowing GINS to bind to Cdc45.Mcm2-7. Finally, we propose that Dpb11 functions with Sld2 and Sld3 to help control the assembly of the replication fork helicase.	[Dhingra, Nalini; Ning, Boting] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Bruck, Irina; Smith, Skye; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Vanderbilt University; State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu		Dhingra, Nalini/0000-0003-0949-883X; Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1265431]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 1265431 (to D. L. K.).	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	43	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7586	7601		10.1074/jbc.M115.640383	http://dx.doi.org/10.1074/jbc.M115.640383			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25659432	hybrid, Green Published			2022-12-26	WOS:000351613600023
J	Bao, PP; Zhao, ZG; Gao, YT; Zheng, Y; Zhang, B; Cai, H; Zheng, W; Shu, XO; Lu, W				Bao, Ping-Ping; Zhao, Zhi-Guo; Gao, Yu-Tang; Zheng, Ying; Zhang, Ben; Cai, Hui; Zheng, Wei; Shu, Xiao-Ou; Lu, Wei			Association of Type 2 Diabetes Genetic Variants with Breast Cancer Survival among Chinese Women	PLOS ONE			English	Article							COMORBIDITY; IMPACT; MORTALITY; MELLITUS; STAGE; MECHANISMS; RECEPTORS; METFORMIN; PROGNOSIS; OUTCOMES	Objective To evaluate whether the genetic susceptibility of T2D was associated with overall survival (OS) and disease-free survival (DFS) outcomes for breast cancer (BC). Methods Included in the study were 6346 BC patients who participated in three population-based epidemiological studies of BC and were genotyped with either GWAS or Exome-chip. We constructed a genetic risk score (GRS) for diabetes using risk variants identified from the GWAS catalog (http://genome.gov/gwastudies) that were associated with T2D risk at a minimum significance level of P <= 5.0E-8 among Asian population and evaluated its associations with BC outcomes with Cox proportional hazards models. Results During a median follow-up of 8.08 years (range, 0.01-16.95 years), 1208 deaths were documented in 6346 BC patients. Overall, the diabetes GRS was not associated with OS and DFS. Analyses stratified by estrogen receptor status (ER) showed that the diabetes GRS was inversely associated with OS among women with ER-but not in women with ER+ breast cancer; the multivariable adjusted HR was 1.38 (95% CI: 1.05-1.82) when comparing the highest to the lowest GRS quartiles. The association of diabetes GRS with OS varied by diabetes status (P for interaction < 0.01). In women with history of diabetes, higher diabetes GRS was significantly associated with worse OS, with HR of 2.22 (95% CI: 1.28-3.88) for the highest vs. lowest quartile, particularly among women with an ER-breast cancer, with corresponding HR being 4.59 (95% CI: 1.04-20.28). No significant association between the diabetes GRS and OS was observed across different BMI and PR groups. Conclusions Our study suggested that genetic susceptibility of T2D was positively associated with total mortality among women with ER-breast cancer, particularly among subjects with a history of diabetes. Additional studies are warranted to verify the associations and elucidate the underlying biological mechanism.	[Bao, Ping-Ping; Zheng, Ying; Lu, Wei] Shanghai Municipal Ctr Dis Prevent & Control, Shanghai, Peoples R China; [Zhao, Zhi-Guo; Zhang, Ben; Cai, Hui; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr,I, Nashville, TN 37235 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Vanderbilt University; Shanghai Jiao Tong University	Lu, W (corresponding author), Shanghai Municipal Ctr Dis Prevent & Control, 1380 Zhongshan Rd West, Shanghai, Peoples R China.	weiloo@msn.com	Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; gao, yi/HCI-8298-2022; Lu, Wei/AAE-2921-2022; Zhang, Ben/GQP-3420-2022; Gao, Yu/HGE-1937-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Lu, Wei/0000-0002-4150-8674; 	NATIONAL CANCER INSTITUTE [UM1CA182910] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen WW, 2012, ONCOLOGIST, V17, P485, DOI 10.1634/theoncologist.2011-0412; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hale PJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S16; Hindorff LA, CATALOG PUBLISHED GE; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Kaplan MA, 2012, MED ONCOL, V29, P1576, DOI 10.1007/s12032-011-0109-4; Land LH, 2012, CRIT REV ONCOL HEMAT, V81, P196, DOI 10.1016/j.critrevonc.2011.03.001; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nechuta S, 2013, BREAST CANCER RES TR, V139, P227, DOI 10.1007/s10549-013-2521-2; Papa V, 1996, J ENDOCRINOL INVEST, V19, P324, DOI 10.1007/BF03347871; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Sheppard AJ, 2011, CANCER EPIDEM BIOMAR, V20, P2160, DOI 10.1158/1055-9965.EPI-11-0459; Shu XO, 2009, JAMA-J AM MED ASSOC, V302, P2437, DOI 10.1001/jama.2009.1783; Singh SK, 2010, GROWTH HORM IGF RES, V20, P245, DOI 10.1016/j.ghir.2010.03.001; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang PP, 2013, CANCER EPIDEMIOL, V37, P207, DOI 10.1016/j.canep.2012.12.009; Zhang ZJ, 2014, DIABETES OBES METAB, V16, P707, DOI 10.1111/dom.12267; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	33	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117419	10.1371/journal.pone.0117419	http://dx.doi.org/10.1371/journal.pone.0117419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679392	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600064
J	Astarita, G; Avanesian, A; Grimaldi, B; Realini, N; Justinova, Z; Panlilio, LV; Basit, A; Goldberg, SR; Piomelli, D				Astarita, Giuseppe; Avanesian, Agnesa; Grimaldi, Benedetto; Realini, Natalia; Justinova, Zuzana; Panlilio, Leight V.; Basit, Abdul; Goldberg, Steven R.; Piomelli, Daniele			Methamphetamine Accelerates Cellular Senescence through Stimulation of De Novo Ceramide Biosynthesis	PLOS ONE			English	Article							KAPPA-B; SPHINGOLIPID METABOLISM; BETA-GALACTOSIDASE; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; MOUSE-BRAIN; DNA-BINDING; TNF-ALPHA; RAT; APOPTOSIS	Methamphetamine is a highly addictive psychostimulant that causes profound damage to the brain and other body organs. Post mortem studies of human tissues have linked the use of this drug to diseases associated with aging, such as coronary atherosclerosis and pulmonary fibrosis, but the molecular mechanism underlying these findings remains unknown. Here we used functional lipidomics and transcriptomics experiments to study abnormalities in lipid metabolism in select regions of the brain and, to a greater extent, peripheral organs and tissues of rats that self-administered methamphetamine. Experiments in various cellular models (primary mouse fibroblasts and myotubes) allowed us to investigate the molecular mechanisms of systemic inflammation and cellular aging related to methamphetamine abuse. We report now that methamphetamine accelerates cellular senescence and activates transcription of genes involved in cell-cycle control and inflammation by stimulating production of the sphingolipid messenger ceramide. This pathogenic cascade is triggered by reactive oxygen species, likely generated through methamphetamine metabolism via cytochrome P-450, and involves the recruitment of nuclear factor-kappa B (NF-kappa B) to induce expression of enzymes in the de novo pathway of ceramide biosynthesis. Inhibitors of NF-kappa B signaling and ceramide formation prevent methamphetamine-induced senescence and systemic inflammation in rats self-administering the drug, attenuating their health deterioration. The results suggest new therapeutic strategies to reduce the adverse consequences of methamphetamine abuse and improve effectiveness of abstinence treatments.	[Astarita, Giuseppe; Avanesian, Agnesa] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Grimaldi, Benedetto; Realini, Natalia; Basit, Abdul; Piomelli, Daniele] Italian Inst Technol, Genoa, Italy; [Justinova, Zuzana; Panlilio, Leight V.; Goldberg, Steven R.] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, Baltimore, MD USA; [Justinova, Zuzana] Univ Maryland, Sch Med, MPRC, Dept Psychiat, Baltimore, MD 21201 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University of California System; University of California Irvine	Piomelli, D (corresponding author), Italian Inst Technol, Genoa, Italy.	piomelli@uci.edu	Basit, Abdul/H-9903-2019; Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014; Justinova, Zuzana/A-9109-2011	Basit, Abdul/0000-0002-1164-5520; Grimaldi, Benedetto/0000-0002-2589-9302; Astarita, Giuseppe/0000-0001-6700-301X; Justinova, Zuzana/0000-0001-5793-7484	National Institute on Drug Abuse [RC2 DA028902]; National Institute on Drug Abuse, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000003, RC2DA028902] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Drug Abuse, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by the National Institute on Drug Abuse (RC2 DA028902 to D. P.) and by the Intramural Research Program of the National Institute on Drug Abuse, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz O, 1998, BRAIN RES, V813, P200, DOI 10.1016/S0006-8993(98)01020-8; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; ASTARITA G, 2009, METH MOL B 1, V579, P201, DOI DOI 10.1007/978-1-60761-322-0_; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carvalho F, 2009, ADICCIONES, V21, P99, DOI 10.20882/adicciones.236; Cherner M, 2010, J INT NEUROPSYCH SOC, V16, P890, DOI 10.1017/S1355617710000779; Conner DA, 2001, CURR PROTOC MOL BIOL; Curtis Eric K, 2006, Gen Dent, V54, P125; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gluck MR, 2001, J NEUROCHEM, V79, P152, DOI 10.1046/j.1471-4159.2001.00549.x; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Karch SB, 1999, J FORENSIC SCI, V44, P359; Kaye S, 2008, ADDICTION, V103, P1353, DOI 10.1111/j.1360-0443.2008.02231.x; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kuczenski R, 2007, EXP NEUROL, V207, P42, DOI 10.1016/j.expneurol.2007.05.023; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee YW, 2002, J NEUROSCI RES, V70, P82, DOI 10.1002/jnr.10370; Lee YW, 2001, J NEUROSCI RES, V66, P583, DOI 10.1002/jnr.1248; Lin LY, 1997, DRUG METAB DISPOS, V25, P1059; Melo P, 2012, NEUROTOXICOLOGY, V33, P491, DOI 10.1016/j.neuro.2012.03.002; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Miller CJ, 2001, J GERONTOL A-BIOL, V56, pB8, DOI 10.1093/gerona/56.1.B8; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Modrak DE, 2009, MOL CANCER RES, V7, P890, DOI 10.1158/1541-7786.MCR-08-0457; Mouton RE, 2000, MECH AGEING DEV, V113, P169, DOI 10.1016/S0047-6374(99)00105-0; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; PALESTINI P, 1993, J NEUROCHEM, V61, P955, DOI 10.1111/j.1471-4159.1993.tb03608.x; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; SUNDARAM KS, 1989, NEUROCHEM RES, V14, P245, DOI 10.1007/BF00971318; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wu DF, 1997, BIOCHEM PHARMACOL, V53, P1605, DOI 10.1016/S0006-2952(97)00014-2; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	52	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116961	10.1371/journal.pone.0116961	http://dx.doi.org/10.1371/journal.pone.0116961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671639	Green Published, gold			2022-12-26	WOS:000349545300028
J	Balcells, ME; Garcia, P; Meza, P; Pena, C; Cifuentes, M; Couvin, D; Rastogi, N				Elvira Balcells, Maria; Garcia, Patricia; Meza, Paulina; Pena, Carlos; Cifuentes, Marcela; Couvin, David; Rastogi, Nalin			A First Insight on the Population Structure of Mycobacterium tuberculosis Complex as Studied by Spoligotyping and MIRU-VNTRs in Santiago, Chile	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; DRUG-RESISTANCE; STRAINS; DIFFERENTIATION; GENOTYPE; LINEAGE; RISK; LIMA	Tuberculosis (TB) remains a significant public health problem worldwide, but the ecology of the prevalent mycobacterial strains, and their transmission, can vary depending on country and region. Chile is a country with low incidence of TB, that has a geographically isolated location in relation to the rest of South American countries due to the Andes Mountains, but recent migration from neighboring countries has changed this situation. We aimed to assess the genotypic diversity of Mycobacterium tuberculosis complex (MTBC) strains in Santiago, Chile, and compare with reports from other Latin-American countries. We analyzed MTBC isolates from pulmonary tuberculosis cases collected between years 2008 and 2013 in Central Santiago, using two genotyping methods: spoligotyping and 12-loci mycobacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTRs). Data obtained were analyzed and compared to the SITVIT2 database. Mean age of the patients was 47.5 years and 61% were male; 11.6% were migrants. Of 103 strains (1 isolate/patient) included, there were 56 distinct spoligotype patterns. Of these, 16 strains (15.5%) corresponded to orphan strains in the SITVIT2 database, not previously reported. Latin American and Mediterranean (LAM) (34%) and T (33%) lineages were the most prevalent strains, followed by Haarlem lineage (16.5%). Beijing family was scarcely represented with only two cases (1.9%), one of them isolated from a Peruvian migrant. The most frequent clustered spoligotypes were SIT33/LAM3 (10.7%), SIT53/T1 (8.7%), SIT50/H3 (7.8%), and SIT37/T3 (6.8%). We conclude that LAM and T genotypes are the most prevalent genotypes of MTBC in Santiago, Chile, and together correspond to almost two thirds of analyzed strains, which is similar to strain distribution reported from other countries of Latin America. Nevertheless, the high proportion of SIT37/T3, which was rarely found in other Latin American countries, may underline a specific history or demographics of Chile related to probable human migrations and evolutions.	[Elvira Balcells, Maria] Pontificia Univ Catolica Chile, Sch Med, Dept Infect Dis, Alameda 340, Santiago, Chile; [Garcia, Patricia; Meza, Paulina] Pontificia Univ Catolica Chile, Sch Med, Microbiol Lab, Clin Lab Dept, Santiago, Chile; [Pena, Carlos; Cifuentes, Marcela] Hosp San Borja Arriaran, Div Resp, Santiago, Chile; [Pena, Carlos; Cifuentes, Marcela] Hosp San Borja Arriaran, Microbiol Lab, Santiago, Chile; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile	Balcells, ME (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Infect Dis, Alameda 340, Santiago, Chile.	balcells@med.puc.cl	Balcells, Maria Elvira/GRR-9067-2022; RASTOGI, NALIN/AAP-1958-2020	Balcells, Maria Elvira/0000-0002-7223-9665; RASTOGI, NALIN/0000-0002-7199-7747	Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT [1130600]; Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT [1130600]	Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean National Funding Agency CONICYT; Chilean National Funding Agency, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by funding by Chilean National Funding Agency CONICYT, FONDECYT GRANT No 1130600 (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Barbosa CD, 2012, INT J TUBERC LUNG D, V16, P1377, DOI 10.5588/ijtld.11.0709; Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Cohen T, 2011, EMERG INFECT DIS, V17, P969, DOI [10.3201/eid1706.101471, 10.3201/eid/1706.101471]; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Couvin D, 2014, EUROREFERENCE J REFE, V12, P36, DOI [10.1186/1471-2407-14-960, DOI 10.1186/1471-2407-14-960]; Cowan LS, 2002, J CLIN MICROBIOL, V40, P1592, DOI 10.1128/JCM.40.5.1592-1602.2002; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Garzelli C, 2012, INFECT GENET EVOL, V12, P610, DOI 10.1016/j.meegid.2011.10.015; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Jagielski T, 2010, J CLIN MICROBIOL, V48, P3899, DOI 10.1128/JCM.00572-10; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kasai H, 2000, J CLIN MICROBIOL, V38, P301; Kato-Maeda M, 2010, INT J TUBERC LUNG D, V14, P538; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Mancilla E Marcos, 2006, Rev. chil. infectol., V23, P220; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Meza P, 2014, REV CHIL INFECTOL, V31, P21, DOI 10.4067/S0716-10182014000100003; MILLET J, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/689852; Monteserin J, 2013, INFECT GENET EVOL, V17, P195, DOI 10.1016/j.meegid.2013.04.010; Morcillo N., 2005, Rev. argent. microbiol., V37, P92; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Ritacco V, 2012, INFECT GENET EVOL, V12, P711, DOI 10.1016/j.meegid.2011.06.006; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tuberculosis Informe De Situacion Chile, 2012, PROGR NAC TUB; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, WHO REPORT	52	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118007	10.1371/journal.pone.0118007	http://dx.doi.org/10.1371/journal.pone.0118007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671320	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300078
J	Olsen, IH; Holt, N; Langer, SW; Hasselby, JP; Gronbaek, H; Hillingso, J; Mahmoud, M; Ladekarl, M; Iversen, LH; Kjaer, A; Federspiel, BH; Knigge, U				Olsen, Ingrid Holst; Holt, Nanna; Langer, Seppo W.; Hasselby, Jane P.; Gronbaek, Henning; Hillingso, Jens; Mahmoud, Masti; Ladekarl, Morten; Iversen, Lene H.; Kjaer, Andreas; Federspiel, Birgitte H.; Knigge, Ulrich			Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients	PLOS ONE			English	Article							APPENDIX; TUMORS; SURVIVIN; CHEMOTHERAPY; GUIDELINES; MANAGEMENT; DIAGNOSIS; NEOPLASMS; BEHAVIOR; MARKER	Background Appendiceal goblet cell carcinoids (GCCs) exhibit neuroendocrine and adenocarcinoma features. Patients and Methods Analysis of demography, pathology, prognostic markers, treatment and survival in 83 GCC patients (f/m: 56/27) diagnosed 1992-2013. Results Median age for f/m was 59/58 years, respectively, and similar for localized and disseminated disease. At diagnosis 54 patients had localized appendiceal disease (f/m: 29/25). According to TNM 24% had Stage I, 70% had Stage II and 6% had Stage III. Twenty-nine patients had disseminated disease (f/m: 27/2). Chromogranin A, synaptophysin and p53 were positive in >90%. Serotonin was positive in 70%. Median Ki67 index was 32% (6-75%) and higher in Tang group C (50%) compared to group A (30%; p< 0.0001), and group B (30%; p< 0.004). All patients had surgery. Sixty-three (76%) had radical resections including all patients with localized disease. Median OS was 83 months. The 1-, 5-and 10-year survival rates were 90%, 58%, and 38%, respectively. For localized disease OS was 164 months and 1-, 5-and 10-year survival rates were 100%, 80%, and 55%, respectively. For disseminated disease OS was 19 months and 1-, 5-and 10-year survival rates were 73%, 18% and 6%, respectively. The 1-, 5- and 10 year-survival rates for f/m were 87%/96%, 49%/76% and 31%/57%, respectively (p = 0.02). According to the Tang classification group A, B, and C OS was 118, 83 and 20 months, respectively (p = 0.0002). Conclusion The Tang classification was found to be a significant prognostic factor, while the Ki67 index was not. Localized GCCs occurred equally in males and females, while disseminated GCCs were mostly seen in females. Median age of patients with localized disease and disseminated disease was identical. Cox regression analysis found Stage IV, focally positive synaptophysin and non-radical surgery as strongest negative prognostic factors.	[Olsen, Ingrid Holst; Hillingso, Jens; Mahmoud, Masti; Knigge, Ulrich] Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol, European NET Ctr Excellence,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Langer, Seppo W.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Oncol, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Hasselby, Jane P.; Federspiel, Birgitte H.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Pathol, DK-2100 Copenhagen, Denmark; [Olsen, Ingrid Holst; Knigge, Ulrich] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence,Dept Endocrinol, Copenhagen, Denmark; [Olsen, Ingrid Holst; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Olsen, Ingrid Holst; Kjaer, Andreas] Univ Copenhagen, Rigshosp, Fac Hlth Sci, European NET Ctr Excellence, Copenhagen, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, European NET Ctr Excellence, Dept Oncol, DK-8000 Aarhus, Denmark; [Iversen, Lene H.] Aarhus Univ Hosp, European NET Ctr Excellence, Dept Surg, DK-8000 Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University	Olsen, IH (corresponding author), Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol, European NET Ctr Excellence,Fac Hlth Sci, DK-2100 Copenhagen, Denmark.	ingridho@sund.ku.dk	Gronbaek, Henning/AAJ-3202-2020; Ladekarl, Morten/AAQ-1702-2020; Kjaer, Andreas/E-8932-2015	Gronbaek, Henning/0000-0001-8998-7910; Iversen, Lene Hjerrild/0000-0002-2336-2923; Ladekarl, Morten/0000-0002-0182-1228; Hillingsoe, Jens G./0000-0002-2381-7836; /0000-0001-9732-9192; Holt Jessen, Nanna/0000-0002-2032-1691; Kjaer, Andreas/0000-0002-2706-5547	Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation; Research Foundation of the Capital Region; Arvid Nilssons Foundation; Internalization Foundation; Lundbeck Foundation; Svend Andersen Foundation; National Advanced Technology Foundation; NOVO Nordisk Foundation; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish; The Danish Cancer Society [R72-A4569] Funding Source: researchfish	Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation; Research Foundation of the Capital Region; Arvid Nilssons Foundation; Internalization Foundation; Lundbeck Foundation(Lundbeckfonden); Svend Andersen Foundation; National Advanced Technology Foundation; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by The Danish Research Council for Strategic Research, Rigshospitalet's Research Foundation, The Research Foundation of the Capital Region, Arvid Nilssons Foundation, Internalization Foundation, The Lundbeck Foundation, Svend Andersen Foundation, National Advanced Technology Foundation and The NOVO Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binderup T, 2010, J NUCL MED, V51, P704, DOI 10.2967/jnumed.109.069765; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Boudreaux JP, 2010, PANCREAS, V39, P753, DOI 10.1097/MPA.0b013e3181ebb2a5; Bucher P, 2005, WORLD J SURG, V29, P1436, DOI 10.1007/s00268-005-7958-y; BUTLER JA, 1994, AM J SURG, V168, P685, DOI 10.1016/S0002-9610(05)80145-X; Grabowski P, 2005, NEUROENDOCRINOLOGY, V81, P1, DOI 10.1159/000084892; Greene FL, 2002, AJCC CANC STAGING HD; Holt N, 2013, SCI WORLD J, DOI 10.1155/2013/543696; Hristov AC, 2007, AM J SURG PATHOL, V31, P1502, DOI 10.1097/PAS.0b013e31804f7aa1; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Kanthan R, 2001, ARCH PATHOL LAB MED, V125, P386; Koch CA, 2002, EUR J ENDOCRINOL, V146, P381, DOI 10.1530/eje.0.1460381; Landry CS, 2008, ARCH SURG-CHICAGO, V143, P664, DOI 10.1001/archsurg.143.7.664; Lee KS, 2013, EUR J RADIOL, V82, P85, DOI 10.1016/j.ejrad.2012.05.038; Liu E, 2011, AM J SURG, V202, P400, DOI 10.1016/j.amjsurg.2010.08.036; Mandai M, 2001, EUR J OBSTET GYN R B, V97, P90, DOI 10.1016/S0301-2115(00)00503-0; McConnell YJ, 2014, ANN SURG ONCOL, V21, P1975, DOI 10.1245/s10434-013-3469-5; McCusker ME, 2002, CANCER, V94, P3307, DOI 10.1002/cncr.10589; Pahlavan Payam S, 2005, World J Surg Oncol, V3, P36, DOI 10.1186/1477-7819-3-36; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; Pham TH, 2006, ANN SURG ONCOL, V13, P370, DOI 10.1245/ASO.2006.02.016; Plockinger U, 2008, NEUROENDOCRINOLOGY, V87, P20, DOI 10.1159/000109876; Ramnani DM, 2000, CANCER; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Roy P, 2010, WORLD J GASTRO ONCOL, V2, P251, DOI 10.4251/wjgo.v2.i6.251; Sobin LH, 2011, TNM CLASSIFICATION M; SUBBUSWAMY SG, 1974, CANCER-AM CANCER SOC, V34, P338, DOI 10.1002/1097-0142(197408)34:2<338::AID-CNCR2820340218>3.0.CO;2-W; Sukpan K, 2011, INT J GYNECOL CANCER, V21, P911, DOI 10.1097/IGC.0b013e31821a2567; Tang LH, 2008, AM J SURG PATHOL, V32, P1429, DOI 10.1097/PAS.0b013e31817f1816; Toumpanakis C, 2007, DIS COLON RECTUM, V50, P315, DOI 10.1007/s10350-006-0762-4; van Eeden S, 2007, HISTOPATHOLOGY, V51, P763, DOI 10.1111/j.1365-2559.2007.02883.x; Varisco B, 2004, AM SURGEON, V70, P593	32	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117627	10.1371/journal.pone.0117627	http://dx.doi.org/10.1371/journal.pone.0117627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671432	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300063
J	Salces-Ortiz, J; Ramon, M; Gonzalez, C; Perez-Guzman, MD; Garde, JJ; Garcia-Alvarez, O; Maroto-Morales, A; Calvo, JH; Serrano, MM				Salces-Ortiz, Judit; Ramon, Manuel; Gonzalez, Carmen; Perez-Guzman, M. Dolores; Garde, J. Julian; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Calvo, Jorge H.; Serrano, M. Magdalena			Differences in the Ovine HSP90AA1 Gene Expression Rates Caused by Two Linked Polymorphisms at Its Promoter Affect Rams Sperm DNA Fragmentation under Environmental Heat Stress Conditions	PLOS ONE			English	Article							SHOCK RESPONSE; CHAPERONE; CELLS; SHEEP; TRANSCRIPTION; MECHANISMS; FERTILITY; INTEGRITY; IMPACT; REPAIR	Heat shock (HS) is one of the best-studied exogenous cellular stresses. Almost all tissues, cell types, metabolic pathways and biochemical reactions are affected in greater or lesser extent by HS. However, there are some especially thermo sensible cellular types such as the mammalian male germ cells. The present study examined the role of three INDELs in conjunction with the -660G/C polymorphism located at the HSP90AA1 promoter region over the gene expression rate under HS. Specially, the -668insC INDEL, which is very close to the -660G/C transversion, is a good candidate to be implied in the transcriptional regulation of the gene by itself or in a cooperative way with this SNP. Animals carrying the genotype Il-668 showed higher transcription rates than those with ID-668 (FC = 3.07) and DD-668 (FC = 3.40) genotypes for samples collected under HS. A linkage between gene expression and sperm DNA fragmentation was also found. When HS conditions were present along or in some stages of the spermatogenesis, alternative genotypes of the -668insC and -660G/C mutations are involved in the effect of HS over sperm DNA fragmentation. Thus, unfavorable genotypes in terms of gene expression induction (ID(-668)GC(-660) and DD(-668)GG(-660)) do not produce enough mRNA (stored as messenger ribonucleoprotein particles) and Hsp90 alpha protein to cope with future thermal stress which might occur in posterior stages when transcriptional activity is reduced and cell types and molecular processes are more sensible to heat (spermatocytes in pachytene and spermatids protamination). This would result in the impairment of DNA packaging and the consequent commitment of the events occurring shortly after fertilization and during embryonic development. In the short-term, the assessment of the relationship between sperm DNA fragmentation sensitivity and ram's fertility will be of interest to a better understanding of the mechanisms of response to HS and its consequences on animal production and reproduction performance.	[Salces-Ortiz, Judit; Gonzalez, Carmen; Serrano, M. Magdalena] INIA, Madrid 28040, Spain; [Ramon, Manuel; Perez-Guzman, M. Dolores] CERSYRA, Valdepenas 13300, Spain; [Garde, J. Julian; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro] CSIC UCLM JCCM, SaBio IREC, Albacete, Spain; [Calvo, Jorge H.] CITA, Unidad Tecnol Prod Anim, Zaragoza 59059, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Ramon, M (corresponding author), CERSYRA, Av Vino 10, Valdepenas 13300, Spain.	m.ramon.fernandez@gmail.com	garcia-alvarez, olga/AAM-5128-2020; garcia-alvarez, olga/L-4424-2014; Fernandez, Manuel Ramon/B-5755-2014; Serrano, Malena/GXH-8219-2022; Serrano, Magdalena M/R-5716-2017; Calvo, Jorge H/E-5240-2016; López-Brea, José Julián Garde/AAE-5894-2019; Garde, Julian J/O-5607-2015	garcia-alvarez, olga/0000-0003-4310-0557; garcia-alvarez, olga/0000-0003-4310-0557; Fernandez, Manuel Ramon/0000-0003-4179-9894; Serrano, Magdalena M/0000-0002-1621-3102; Calvo, Jorge H/0000-0001-9513-0219; López-Brea, José Julián Garde/0000-0002-3667-6518; Garde, Julian J/0000-0002-3667-6518; Gonzalez Verdejo, Carmen/0000-0001-8757-9147; Salces-Ortiz, Judit/0000-0002-3572-4020	INIA projects [RTA2009-00098-00-00, RTA2012-00041-00-00]; INIA doctoral grant	INIA projects; INIA doctoral grant	This work was supported by RTA2009-00098-00-00 and RTA2012-00041-00-00 INIA projects. Judit Salces-Ortiz was supported by an INIA doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mahecha A, 2001, BIOL REPROD, V65, P119, DOI 10.1095/biolreprod65.1.119; Banks S, 2005, REPRODUCTION, V129, P505, DOI 10.1530/rep.1.00531; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de la Fuente M, 2012, FEBS LETT, V586, P4061, DOI 10.1016/j.febslet.2012.10.018; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; Dominguez K, 2011, SPERM CHROMATIN: BIOLOGICAL AND CLINICAL APPLICATIONS IN MALE INFERTILITY AND ASSISTED REPRODUCTION, P61, DOI 10.1007/978-1-4419-6857-9_4; Erlejman AG, 2014, BBA-GENE REGUL MECH, V1839, P71, DOI 10.1016/j.bbagrm.2013.12.006; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fleming JS, 2004, MOL REPROD DEV, V68, P103, DOI 10.1002/mrd.20049; Freeman BC, 2000, METH MOL B, V99, P393; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Hales Barbara F, 2005, Toxicol Appl Pharmacol, V207, P514, DOI 10.1016/j.taap.2004.12.021; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marcos-Carcavilla A, 2008, CELL STRESS CHAPERON, V13, P19, DOI 10.1007/s12192-007-0004-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P343, DOI 10.1007/s12192-009-0149-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Oner Y, 2013, TROP ANIM HEALTH PRO, V45, P947, DOI 10.1007/s11250-012-0313-z; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Paul C, 2008, MOL HUM REPROD, V14, P1, DOI 10.1093/molehr/gam089; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086107; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Sailer BL, 1997, J ANDROL, V18, P294; Salces-Ortiz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066641; Setchell B. P., 2006, Animal Reproduction, V3, P81; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; [Team RC Computing RFfS], 2013, COMPUTING RFFS; Ulberg LC, 1958, J HERED, V49; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	48	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116360	10.1371/journal.pone.0116360	http://dx.doi.org/10.1371/journal.pone.0116360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671615	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300019
J	Whalan, S; Abdul Wahab, MA; Sprungala, S; Poole, AJ; de Nys, R				Whalan, Steve; Abdul Wahab, Muhammad A.; Sprungala, Susanne; Poole, Andrew J.; de Nys, Rocky			Larval Settlement: The Role of Surface Topography for Sessile Coral Reef Invertebrates	PLOS ONE			English	Article							ATTACHMENT STRENGTH; METAMORPHOSIS; INDUCTION; SELECTION; ECOLOGY; SPONGES; CUES; RECRUITMENT; PATTERNS; BIOFILMS	For sessile marine invertebrates with complex life cycles, habitat choice is directed by the larval phase. Defining which habitat-linked cues are implicated in sessile invertebrate larval settlement has largely concentrated on chemical cues which are thought to signal optimal habitat. There has been less effort establishing physical settlement cues, including the role of surface microtopography. This laboratory based study tested whether surface microtopography alone (without chemical cues) plays an important contributing role in the settlement of larvae of coral reef sessile invertebrates. We measured settlement to tiles, engineered with surface microtopography (holes) that closely matched the sizes (width) of larvae of a range of corals and sponges, in addition to surfaces with holes that were markedly larger than larvae. Larvae from two species of scleractinian corals (Acropora millepora and Ctenactis crassa) and three species of coral reef sponges (Luffariella variabilis, Carteriospongia foliascens and Ircinia sp.,) were used in experiments. L. variabilis, A. millepora and C. crassa showed markedly higher settlement to surface microtopography that closely matched their larval width. C. foliascens and Ircinia sp., showed no specificity to surface microtopography, settling just as often to microtopography as to flat surfaces. The findings of this study question the sole reliance on chemical based larval settlement cues, previously established for some coral and sponge species, and demonstrate that specific physical cues (surface complexity) can also play an important role in larval settlement of coral reef sessile invertebrates.	[Whalan, Steve] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, POB 157, Lismore, NSW 2480, Australia; [Abdul Wahab, Muhammad A.; de Nys, Rocky] James Cook Univ, MACRO, Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; [Abdul Wahab, Muhammad A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Abdul Wahab, Muhammad A.] James Cook Univ, AIMS JCL, Townsville, Qld 4811, Australia; [Sprungala, Susanne] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Sprungala, Susanne] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Dept Mol Sci, Townsville, Qld 4811, Australia; [Poole, Andrew J.] CSIRO Mfg Flagship, Victoria 3216, Australia	Southern Cross University; James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Whalan, S (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, POB 157, Lismore, NSW 2480, Australia.	stephen.whalan@scu.edu.au	de Nys, Rocky/D-6741-2012	de Nys, Rocky/0000-0003-3869-4928; Abdul Wahab, Muhammad Azmi/0000-0003-4088-9652; Poole, Andrew/0000-0001-9584-6452; Whalan, Steve/0000-0001-6786-8945	Great Barrier Reef Foundation [G13/36138.1]	Great Barrier Reef Foundation	This work was undertaken with funding to SW through the Great Barrier Reef Foundation and under permit G13/36138.1, issued by the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2014, CORAL REEFS, V33, P381, DOI 10.1007/s00338-013-1119-9; Abdul Wahab MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098181; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Aldred N, 2010, BIOFOULING, V26, P287, DOI 10.1080/08927010903511626; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bishop CD, 2006, INTEGR COMP BIOL, V46, P662, DOI 10.1093/icb/icl043; Callow ME, 2002, BIOFOULING, V18, P237, DOI 10.1080/08927010290014917; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CRISP DJ, 1960, NATURE, V185, P119, DOI 10.1038/185119a0; CRISP DJ, 1954, J ANIM ECOL, V23, P142, DOI 10.2307/1664; Dixson DL, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.53; Duckworth AR, 2008, CONT SHELF RES, V28, P2168, DOI 10.1016/j.csr.2008.03.024; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hills JM, 1999, FUNCT ECOL, V13, P868, DOI 10.1046/j.1365-2435.1999.00377.x; Hodson J, 2010, OECOLOGIA, V164, P73, DOI 10.1007/s00442-010-1691-4; Hollander AF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Howdeshell KL, 2003, ENVIRON HEALTH PERSP, V111, P1180, DOI 10.1289/ehp.5993; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Keough MJ, 1996, J EXP MAR BIOL ECOL, V207, P59, DOI 10.1016/S0022-0981(96)02632-9; Kingsford MJ, 2002, B MAR SCI, V70, P309; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lau SCK, 2005, AQUAT MICROB ECOL, V38, P41, DOI 10.3354/ame038041; LETOURNEUX F, 1988, MAR BIOL, V97, P57, DOI 10.1007/BF00391245; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Myan FWY, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-30; Nozawa Y, 2012, J EXP MAR BIOL ECOL, V413, P145, DOI 10.1016/j.jembe.2011.12.008; Nozawa Y, 2011, ZOOL STUD, V50, P53; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Petersen D, 2005, MAR BIOL, V146, P937, DOI 10.1007/s00227-004-1503-7; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Resetarits WJ, 2005, ECOL LETT, V8, P480, DOI 10.1111/j.1461-0248.2005.00747.x; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scardino AJ, 2011, BIOFOULING, V27, P73, DOI 10.1080/08927014.2010.536837; SEBENS KP, 1983, BIOL BULL, V165, P286, DOI 10.2307/1541370; Siboni N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037774; SOLER M, 1994, BEHAV ECOL SOCIOBIOL, V35, P295, DOI 10.1007/s002650050100; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Tebben J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087545; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Toonen RJ, 2001, MAR ECOL PROG SER, V224, P115, DOI 10.3354/meps224115; Vucko MJ, 2014, BIOFOULING, V30, P1, DOI 10.1080/08927014.2013.836507; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; Whalan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030386	60	62	63	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117675	10.1371/journal.pone.0117675	http://dx.doi.org/10.1371/journal.pone.0117675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671562	Green Accepted, Green Published, gold			2022-12-26	WOS:000349545300065
J	Kumar, KJS; Vani, MG; Chueh, PJ; Mau, JL; Wang, SY				Kumar, K. J. Senthil; Vani, M. Gokila; Chueh, Pin-Ju; Mau, Jeng-Leun; Wang, Sheng-Yang			Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and beta-Catenin Signaling Pathways	PLOS ONE			English	Article							DERIVATIVES; ACTIVATION; CAMPHORATA	Epithelial-to-mesenchymal transition (EMT) is a crucial event involved metastasis of certain tumors. Thus, identifying chemical agents that can block EMT is highly warranted for the development of anti-cancer chemoprevention/chemotherapies. In this study, we found that Antrodin C (ADC), a maleimide derivative isolated from Antrodia cinnamomea health food product inhibits TGF-beta 1-induced EMT and breast cancer cell metastasis in vitro. Pretreatment of MCF-7 cells with ADC significantly blocked TGF-beta 1-induced phenotypic changes and actin cytoskeleton remodeling. In addition, ADC was able to up-regulate epithelial markers such as E-cadherin and occludin, whereas mesenchymal markers including N-cadherin and vimentin were significantly inhibited, possibly through the modulation of transcriptional regulators Smad/Smad3. ADC blocked TGF-beta 1-induced migration and invasion of MCF-7 cells through the down-regulation of matrix-metalloproteinases (MMP-2, -9) and urokinase plasminogen activator (uPA). The inhibition of MMPs and uPA activity by ADC was reasoned by suppression of its corresponding transcription factor beta-catenin. Taken together, our data suggested that ADC attenuates the TGF-beta 1-induced EMT, migration and invasion of human breast carcinoma through the suppression of Smad2/3 and beta-catenin signaling pathways.	[Kumar, K. J. Senthil; Vani, M. Gokila; Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Chueh, Pin-Ju] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chueh, Pin-Ju] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Mau, Jeng-Leun] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Mau, Jeng-Leun; Wang, Sheng-Yang] Natl Chung Hsing Univ, Univ Calif Davis, Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Wang, SY (corresponding author), Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan.	taiwanfir@dragon.nchu.edu.tw	Wang, Sheng-Yang/M-9656-2019; K.J., Senthil Kumar/F-5309-2011	Wang, Sheng-Yang/0000-0002-8579-3569; Chueh, Pin Ju/0000-0002-3200-7552; K.J., Senthil Kumar/0000-0002-8310-0546	National Science Council, Republic of China [NSC-102-2911-I-005-301, NSC-103-2911-I-005-301]; Ministry of Education, Taiwan, ROC, under the ATU plan	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC, under the ATU plan(Ministry of Education, Taiwan)	This study was supported by the National Science Council, Republic of China (NSC-102-2911-I-005-301, NSC-103-2911-I-005-301), and the Ministry of Education, Taiwan, ROC, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZH, 2009, J ETHNOPHARMACOL, V121, P194, DOI 10.1016/j.jep.2008.10.039; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chen Y, 2011, J BIOL CHEM, V286, P42575, DOI 10.1074/jbc.M111.294595; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Chien SC, 2008, J AGR FOOD CHEM, V56, P7017, DOI 10.1021/jf801171x; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Krstic Jelena, 2014, ScientificWorldJournal, V2014, P521754, DOI 10.1155/2014/521754; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Moustakas A, 2001, J CELL SCI, V114, P4359; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Nakamura N, 2004, J NAT PROD, V67, P46, DOI 10.1021/np030293k; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Tang LL, 2013, BIOMED PHARMACOTHER, V67, P179, DOI 10.1016/j.biopha.2012.10.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Walsh LA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-10; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wu MD, 2008, J NAT PROD, V71, P1258, DOI 10.1021/np070634k; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058719	33	38	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117111	10.1371/journal.pone.0117111	http://dx.doi.org/10.1371/journal.pone.0117111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658913	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900103
J	Peess, C; von Proff, L; Goller, S; Andersson, K; Gerg, M; Malmqvist, M; Bossenmaier, B; Schraml, M				Peess, Carmen; von Proff, Leopold; Goller, Sabine; Andersson, Karl; Gerg, Michael; Malmqvist, Magnus; Bossenmaier, Birgit; Schraeml, Michael			Deciphering the Stepwise Binding Mode of HRG1 beta to HER3 by Surface Plasmon Resonance and Interaction Map	PLOS ONE			English	Article							OPTICAL BIOSENSOR LITERATURE; EXTRACELLULAR REGION; TYROSINE KINASES; RECEPTOR; ERBB4; HEREGULIN; CONFORMATION; COMPLEX; ABSENCE; TETHER	For the development of efficient anti-cancer therapeutics against the HER receptor family it is indispensable to understand the mechanistic model of the HER receptor activation upon ligand binding. Due to its high complexity the binding mode of Heregulin 1 beta (HRG1 beta) with its receptor HER3 is so far not understood. Analysis of the interaction of HRG1 beta with surface immobilized HER3 extracellular domain by time-resolved Surface Plasmon Resonance (SPR) was so far not interpretable using any regular analysis method as the interaction was highly complex. Here, we show that Interaction Map (IM) made it possible to shed light on this interaction. IM allowed deciphering the rate limiting kinetic contributions from complex SPR sensorgrams and thereby enabling the extraction of discrete kinetic rate components from the apparently heterogeneous interactions. We could resolve details from the complex avidity-driven binding mode of HRG1 beta with HER3 by using a combination of SPR and IM data. Our findings contribute to the general understanding that a major conformational change of HER3 during its activation is induced by a complex sequential HRG1 beta docking mode.	[Peess, Carmen; von Proff, Leopold; Goller, Sabine; Gerg, Michael; Schraeml, Michael] Roche Diagnost GmbH, Penzberg, Germany; [Bossenmaier, Birgit] Roche Innovat Ctr, Penzberg, Germany; [Andersson, Karl; Malmqvist, Magnus] Ridgeview Diagnost AB, Uppsala, Sweden	Roche Holding	Peess, C (corresponding author), Roche Diagnost GmbH, Penzberg, Germany.	carmen.peess@roche.com	Bossenmaier, Birgit/AAN-7075-2020					Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Andersson K, 2010, GOOGLE PATENTS; BAUMGARTEN H, 1989, J IMMUNOL METHODS, V122, P1, DOI 10.1016/0022-1759(89)90327-X; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cooper MA, 2009, LABEL-FREE BIOSENSORS: TECHNIQUES AND APPLICATIONS, P1, DOI 10.1017/CBO9780511626531; Danielson UH, 2009, FUTURE MED CHEM, V1, P1399, DOI [10.4155/fmc.09.100, 10.4155/FMC.09.100]; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Du Y, 2012, J AM CHEM SOC, V134, P6720, DOI 10.1021/ja211941d; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; Liu P, 2012, PROTEIN SCI, V21, P152, DOI 10.1002/pro.753; Luo C, 2005, PROTEINS, V59, P742, DOI 10.1002/prot.20443; Nilvebrant J, 2012, BIOTECHNOL APPL BIOC, V59, P367, DOI 10.1002/bab.1033; Rich RL, 2011, J MOL RECOGNIT, V24, P892, DOI 10.1002/jmr.1138; Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Singer E, 2001, J BIOL CHEM, V276, P44266, DOI 10.1074/jbc.M105428200; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Zhang K, 1996, J BIOL CHEM, V271, P3884	26	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116870	10.1371/journal.pone.0116870	http://dx.doi.org/10.1371/journal.pone.0116870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658697	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900074
J	Tiezzi, F; Parker-Gaddis, KL; Cole, JB; Clay, JS; Maltecca, C				Tiezzi, Francesco; Parker-Gaddis, Kristen L.; Cole, John B.; Clay, John S.; Maltecca, Christian			A Genome-Wide Association Study for Clinical Mastitis in First Parity US Holstein Cows Using Single-Step Approach and Genomic Matrix Re-Weighting Procedure	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MAMMARY EPITHELIAL-CELLS; MAPPING INCLUDING PHENOTYPES; FACTOR-KAPPA-B; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; CANDIDATE GENES; DAIRY-CATTLE; TUMOR-SUPPRESSOR; MILK-PRODUCTION	Clinical mastitis (CM) is one of the health disorders with large impacts on dairy farming profitability and animal welfare. The objective of this study was to perform a genome-wide association study (GWAS) for CM in first-lactation Holstein. Producer-recorded mastitis event information for 103,585 first-lactation cows were used, together with genotype information on 1,361 bulls from the Illumina BovineSNP50 BeadChip. Single-step genomic-BLUP methodology was used to incorporate genomic data into a threshold-liability model. Association analysis confirmed that CM follows a highly polygenic mode of inheritance. However, 10-adjacent-SNP windows showed that regions on chromosomes 2, 14 and 20 have impacts on genetic variation for CM. Some of the genes located on chromosome 14 (LY6K, LY6D, LYNX1, LYPD2, SLURP1, PSCA) are part of the lymphocyte-antigen-6 complex (LY6) known for its neutrophil regulation function linked to the major histocompatibility complex. Other genes on chromosome 2 were also involved in regulating immune response (IFIH1, LY75, and DPP4), or are themselves regulated in the presence of specific pathogens (ITGB6, NR4A2). Other genes annotated on chromosome 20 are involved in mammary gland metabolism (GHR, OXCT1), antibody production and phagocytosis of bacterial cells (C6, C7, C9, C1QTNF3), tumor suppression (DAB2), involution of mammary epithelium (OSMR) and cytokine regulation (PRLR). DAVID enrichment analysis revealed 5 KEGG pathways. The JAK-STAT signaling pathway (cell proliferation and apoptosis) and the 'Cytokine-cytokine receptor interaction' (cytokine and interleukines response to infectious agents) are co-regulated and linked to the 'ABC transporters' pathway also found here. Gene network analysis performed using GeneMania revealed a co-expression network where 665 interactions existed among 145 of the genes reported above. Clinical mastitis is a complex trait and the different genes regulating immune response are known to be pathogen-specific. Despite the lack of information in this study, candidate QTL for CM were identified in the US Holstein population.	[Tiezzi, Francesco; Parker-Gaddis, Kristen L.; Maltecca, Christian] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [Parker-Gaddis, Kristen L.; Cole, John B.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA; [Clay, John S.] Dairy Records Management Syst, Raleigh, NC 27603 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Tiezzi, F (corresponding author), N Carolina State Univ, Dept Anim Sci, Box 7621, Raleigh, NC 27695 USA.	ftmaestr@ncsu.edu	Cole, John B./J-8571-2014; Tiezzi, Francesco/L-6411-2016	Cole, John B./0000-0003-1242-4401; Tiezzi, Francesco/0000-0002-4358-9236; maltecca, christian/0000-0002-9996-4680; Clay, John/0000-0001-7273-225X	Select Sires [2010-1714]; ARS [ARS-0423282] Funding Source: Federal RePORTER	Select Sires; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by project 2010-1714 from Select Sires - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Aguilar I., 2014, P 10 WORLD C GENETIC; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Beecher C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-99; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Bonnefont CMD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-208; Boutet P, 2004, J DAIRY SCI, V87, P4104, DOI 10.3168/jds.S0022-0302(04)73553-5; Boutet P, 2007, J DAIRY SCI, V90, P155, DOI 10.3168/jds.S0022-0302(07)72617-6; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; CDCB, 2014, TREND SOM CELL SCOR; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Connor EE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-362; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Detilleux JC, 2009, VET MICROBIOL, V134, P157, DOI 10.1016/j.vetmic.2008.09.023; DETILLEUX JC, 1994, J DAIRY SCI, V77, P2640, DOI 10.3168/jds.S0022-0302(94)77205-2; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Eshraghi HR, 1999, LIFE SCI, V64, P1675, DOI 10.1016/S0024-3205(99)00105-8; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gaddis KLP, 2014, J DAIRY SCI, V97, P3190, DOI 10.3168/jds.2013-7543; Gaddis KLP, 2012, J DAIRY SCI, V95, P5422, DOI 10.3168/jds.2012-5572; Galvao KN, 2011, J DAIRY SCI, V94, P2083, DOI 10.3168/jds.2010-3636; Glass EJ, 2007, VET IMMUNOL IMMUNOP, V120, P20, DOI 10.1016/j.vetimm.2007.07.013; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; Gutierrez-Barroso A, 2008, VET IMMUNOL IMMUNOP, V121, P113, DOI 10.1016/j.vetimm.2007.09.007; He YH, 2011, J DAIRY RES, V78, P242, DOI 10.1017/S0022029911000148; Heringstad B, 2003, J DAIRY SCI, V86, P369, DOI 10.3168/jds.S0022-0302(03)73615-7; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Holmberg M, 2004, J DAIRY SCI, V87, P2653, DOI 10.3168/jds.S0022-0302(04)73391-3; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang C, 2006, J ANIM SCI, V84, P275; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jiang L, 2012, PHYSIOL GENOMICS, V44, P305, DOI 10.1152/physiolgenomics.00047.2011; Jiang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-443; Kandasamy S, 2012, J DAIRY SCI, V95, P3852, DOI 10.3168/jds.2011-5251; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klungland H, 2001, MAMM GENOME, V12, P837, DOI 10.1007/s00335001-2081-3; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Lahouassa H, 2007, CYTOKINE, V38, P12, DOI 10.1016/j.cyto.2007.04.006; Lara-Zarate L, 2011, MICROB PATHOGENESIS, V51, P313, DOI 10.1016/j.micpath.2011.07.010; Lavon Y, 2011, THERIOGENOLOGY, V76, P942, DOI 10.1016/j.theriogenology.2011.05.001; Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051; Lee SU, 2001, INFECT IMMUN, V69, P7190, DOI 10.1128/IAI.69.11.7190-7193.2001; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Lund MS, 2008, J DAIRY SCI, V91, P4028, DOI 10.3168/jds.2007-0290; Mallya M, 2002, GENOMICS, V80, P113, DOI 10.1006/geno.2002.6794; Meredith Brian K., 2013, Frontiers in Genetics, V4, P229, DOI 10.3389/fgene.2013.00229; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Misztal I., 2002, Proceedings of the 7th World Congress on Genetics Applied to Livestock Production, Montpellier, France, August, 2002. Session 18, P1; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Mrode R, 2012, J DAIRY SCI, V95, P4618, DOI 10.3168/jds.2011-4971; Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173; Neerhof HJ, 2000, J DAIRY SCI, V83, P1064, DOI 10.3168/jds.S0022-0302(00)74970-8; Nguyen TTT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000229; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; PHILIPSSON J, 1995, LIVEST PROD SCI, V41, P195, DOI 10.1016/0301-6226(94)00067-H; Pighetti GM, 2011, J MAMMARY GLAND BIOL, V16, P421, DOI 10.1007/s10911-011-9238-9; Pimentel ECG, 2011, ANIM GENET, V42, P251, DOI 10.1111/j.1365-2052.2010.02148.x; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rainard P, 2003, VET RES, V34, P647, DOI 10.1051/vetres:2003025; Rambeaud M, 2003, VET IMMUNOL IMMUNOP, V96, P193, DOI 10.1016/j.vetimm.2003.08.008; Rinaldi M, 2010, VET IMMUNOL IMMUNOP, V138, P267, DOI 10.1016/j.vetimm.2010.10.005; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Schulman NF, 2004, J DAIRY SCI, V87, P443, DOI 10.3168/jds.S0022-0302(04)73183-5; Schwerin M, 2003, GENET SEL EVOL, V35, pS19, DOI 10.1051/gse:2003014; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; Sigl T, 2014, J ANIM PHYSIOL AN N, V98, P84, DOI 10.1111/jpn.12039; Sodeland M, 2011, ANIM GENET, V42, P457, DOI 10.1111/j.1365-2052.2010.02165.x; Sorensen LP, 2008, J DAIRY SCI, V91, P2493, DOI 10.3168/jds.2007-0583; Stanford JC, 2013, APOPTOSIS CLEARANCE; Swanson KM, 2009, J DAIRY SCI, V92, P117, DOI 10.3168/jds.2008-1382; Thacker JD, 2012, ANTIMICROB AGENTS CH, V56, P1921, DOI 10.1128/AAC.06372-11; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Youngerman SM, 2004, J DAIRY SCI, V87, P2442, DOI 10.3168/jds.S0022-0302(04)73367-6; Zarrin M, 2014, J DAIRY SCI, V97, P3531, DOI 10.3168/jds.2013-7480	87	61	65	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114919	10.1371/journal.pone.0114919	http://dx.doi.org/10.1371/journal.pone.0114919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658712	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900011
J	Whiteford, HA; Ferrari, AJ; Degenhardt, L; Feigin, V; Vos, T				Whiteford, Harvey A.; Ferrari, Alize J.; Degenhardt, Louisa; Feigin, Valery; Vos, Theo			The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SYSTEMATIC ANALYSIS; CONDUCT DISORDER; 187 COUNTRIES; 21 REGIONS; MORTALITY; INJURIES	Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. Method For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. Results In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. Conclusion Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.	[Whiteford, Harvey A.; Ferrari, Alize J.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.; Degenhardt, Louisa; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Degenhardt, Louisa] UNSW Australia, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Feigin, Valery] AUT Univ, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand	University of Queensland; Queensland Centre for Mental Health Research; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of New South Wales Sydney; University of Melbourne; Auckland University of Technology	Whiteford, HA (corresponding author), Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia.	h.whiteford@uq.edu.au	Degenhardt, Louisa J/D-4515-2012; Whiteford, Harvey A/A-4840-2009; Feigin, Valery/AAF-2313-2019; Ferrari, Alize J/G-1746-2011	Degenhardt, Louisa J/0000-0002-8513-2218; Whiteford, Harvey A/0000-0003-4667-6623; Ferrari, Alize J/0000-0002-7863-9117; Feigin, Valery L./0000-0002-6372-1740	Queensland Centre for Mental Health Research; Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship [1041742]; Australian National Health and Medical Research Council Principal Research Fellowship; Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund; Queensland Department of Health; Bill and Melinda Gates Foundation	Queensland Centre for Mental Health Research; Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund(Australian Government); Queensland Department of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	HAW and AJF are supported by the Queensland Centre for Mental Health Research which receives its funding from the Queensland Department of Health. LD is supported by an Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowship (#1041742). The National Drug and Alcohol Research Centre at UNSW Australia is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund and an Australian National Health and Medical Research Council Principal Research Fellowship. TV receives funding from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Cheng ATA, 2001, BRIT J PSYCHIAT, V179, P1, DOI 10.1192/bjp.179.1.1; Crump C, 2013, AM J PSYCHIAT, V170, P324, DOI 10.1176/appi.ajp.2012.12050599; Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551; Degenhardt L, 2014, DRUG ALCOHOL DEPEN, V137, P36, DOI 10.1016/j.drugalcdep.2013.12.025; Degenhardt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076635; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Diop AG, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00405.x; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637; Ferrari AJ, 2011, J AFFECT DISORDERS, V134, P1, DOI 10.1016/j.jad.2010.11.007; Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957; Lawrence D, 2013, BRIT MED J, V346, DOI [10.1136/bmj.f4242, DOI 10.1136/BMJ.F4242]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; United Nations, 2011, WORLD POP PROSP 2010, DOI [10.4414/smw.2014.14059, DOI 10.4414/SMW.2014.14059]; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whiteford HA, 2013, CURR OPIN PSYCHIATR, V26, P376, DOI 10.1097/YCO.0b013e328361e60f; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang LH, 2009, LANCET, V373, P2002, DOI 10.1016/S0140-6736(09)61091-6	35	669	680	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116820	10.1371/journal.pone.0116820	http://dx.doi.org/10.1371/journal.pone.0116820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658103	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900070
J	Yuasa, M; Yamada, T; Taniyama, T; Masaoka, T; Wei, XT; Yoshii, T; Horie, M; Yasuda, H; Uemura, T; Okawa, A; Sotome, S				Yuasa, Masato; Yamada, Tsuyoshi; Taniyama, Takashi; Masaoka, Tomokazu; Wei Xuetao; Yoshii, Toshitaka; Horie, Masaki; Yasuda, Hiroaki; Uemura, Toshimasa; Okawa, Atsushi; Sotome, Shinichi			Dexamethasone Enhances Osteogenic Differentiation of Bone Marrow- and Muscle-Derived Stromal Cells and Augments Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; EXPRESSION; CULTURES; MATRIX; COMPLICATIONS; C3H10T1/2; DELIVERY; SUBPOPULATION	We evaluated whether dexamethasone augments the osteogenic capability of bone marrow-derived stromal cells (BMSCs) and muscle tissue-derived stromal cells (MuSCs), both of which are thought to contribute to ectopic bone formation induced by bone morphogenetic protein-2 (BMP-2), and determined the underlying mechanisms. Rat BMSCs and MuSCs were cultured in growth media with or without 10-7 M dexamethasone and then differentiated under osteogenic conditions with dexamethasone and BMP-2. The effects of dexamethasone on cell proliferation and osteogenic differentiation, and also on ectopic bone formation induced by BMP-2, were analyzed. Dexamethasone affected not only the proliferation rate but also the subpopulation composition of BMSCs and MuSCs, and subsequently augmented their osteogenic capacity during osteogenic differentiation. During osteogenic induction by BMP-2, dexamethasone also markedly affected cell proliferation in both BMSCs and MuSCs. In an in vivo ectopic bone formation model, bone formation in muscle-implanted scaffolds containing dexamethasone and BMP-2 was more than two fold higher than that in scaffolds containing BMP-2 alone. Our results suggest that dexamethasone potently enhances the osteogenic capability of BMP-2 and may thus decrease the quantity of BMP-2 required for clinical application, thereby reducing the complications caused by excessive doses of BMP-2. Highlights: 1. Dexamethasone induced selective proliferation of bone marrow-and muscle- derived cells with higher differentiation potential. 2. Dexamethasone enhanced the osteogenic capability of bone marrow-and muscle-derived cells by altering the subpopulation composition. 3. Dexamethasone augmented ectopic bone formation induced by bone morphogenetic protein-2.	[Yuasa, Masato; Yamada, Tsuyoshi; Taniyama, Takashi; Masaoka, Tomokazu; Wei Xuetao; Yoshii, Toshitaka; Yasuda, Hiroaki; Okawa, Atsushi; Sotome, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Tokyo, Japan; [Yuasa, Masato; Yamada, Tsuyoshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Horie, Masaki] Tokyo Med & Dent Univ, Univ Hosp Med, Hyperbar Med Ctr, Tokyo, Japan; [Uemura, Toshimasa] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Sotome, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed Res & Dev, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Medical & Dental University (TMDU)	Sotome, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Tokyo, Japan.	sotome.orth@tmd.ac.jp			Japanese Ministry of Health, Labor and Welfare; Olympus Corporation	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Olympus Corporation	This study was partially supported by grants from the Japanese Ministry of Health, Labor and Welfare and by Olympus Corporation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahlstrom M, 2005, BIOCHEM PHARMACOL, V69, P267, DOI 10.1016/j.bcp.2004.09.012; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004; Alm JJ, 2012, TISSUE ENG PART C-ME, V18, P658, DOI [10.1089/ten.tec.2011.0675, 10.1089/ten.TEC.2011.0675]; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; BELLOWS CG, 1994, ENDOCRINOLOGY, V134, P2221, DOI 10.1210/en.134.5.2221; BELLOWS CG, 1989, CELL TISSUE RES, V256, P145; BELLOWS CG, 1990, DEV BIOL, V140, P132, DOI 10.1016/0012-1606(90)90060-V; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Cole BJ, 1997, CLIN ORTHOP RELAT R, P219; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Haramoto N, 2007, ORAL DIS, V13, P23, DOI 10.1111/j.1601-0825.2006.01234.x; Hayashi K, 2009, BIOCHEM BIOPH RES CO, V379, P261, DOI 10.1016/j.bbrc.2008.12.035; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HERBERTSON A, 1995, J BONE MINER RES, V10, P285; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Iu MF, 2005, J BONE MINER METAB, V23, P450, DOI 10.1007/s00774-005-0627-2; Iu MF, 2005, J ENDOCRINOL, V185, P131, DOI 10.1677/joe.1.05962; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151; Kandziora F, 2002, J NEUROSURG, V97, P40, DOI 10.3171/spi.2002.97.1.0040; Kaul Z, 2007, ANN NY ACAD SCI, V1100, P368, DOI 10.1196/annals.1395.040; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018; Lewandrowski KU, 2007, SPINE J, V7, P609, DOI 10.1016/j.spinee.2007.01.011; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b; McDonald MM, 2013, J BONE MINER RES, V28, P1550, DOI 10.1002/jbmr.1889; Mikami Y, 2007, BIOCHEM BIOPH RES CO, V362, P368, DOI 10.1016/j.bbrc.2007.07.192; Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017; Mindea SA, 2009, SPINE, V34, P1480, DOI 10.1097/BRS.0b013e3181a396a1; Nakagawa K, 2007, BONE, V41, P543, DOI 10.1016/j.bone.2007.06.013; Nottmeier EW, 2010, SPINE J, V10, P595, DOI [10.1016/j.spinee.2010.04.013, 10.1016/j.spinee.2010.03.023]; Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007; Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024; Oshina H, 2007, BONE, V41, P575, DOI 10.1016/j.bone.2007.06.022; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Robin BN, 2010, SPINE, V35, pE1350, DOI 10.1097/BRS.0b013e3181e85756; Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Yoshii T, 2009, J ORTHOP RES, V27, P1, DOI 10.1002/jor.20630; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002	64	52	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116462	10.1371/journal.pone.0116462	http://dx.doi.org/10.1371/journal.pone.0116462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659106	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900041
J	Kaur, PJ; Strawn, R; Bai, HY; Xu, K; Ordas, G; Matsui, H; Xu, YJ				Kaur, Parminder Jeet; Strawn, Rebecca; Bai, Hanying; Xu, Ke; Ordas, Gabriel; Matsui, Hiroshi; Xu, Yujia			The Self-assembly of a Mini-fibril with Axial Periodicity from a Designed Collagen-mimetic Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-AMPHIPHILE NANOFIBERS; HIGHER-ORDER STRUCTURES; AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; I COLLAGEN; HYDROXYPROLINE; STABILIZATION; TROPOCOLLAGEN; RECOGNITION; ASSOCIATION	In this work we describe the self-assembly of a collagen-like periodic mini-fibril from a recombinant triple helix. The triple helix, designated Col108, is expressed in Escherichia coli using an artificial gene and consists of a 378-residue triple helix domain organized into three pseudo-repeating sequence units. The peptide forms a stable triple helix with a melting temperature of 41 degrees C. Upon increases of pH and temperature, Col108 self-assembles in solution into smooth mini-fibrils with the cross-striated banding pattern typical of fibrillar collagens. The banding pattern is characterized by an axially repeating feature of similar to 35nmas observed by transmission electron microscopy and atomic force microscopy. Both the negatively stained and the positively stained transmission electron microscopy patterns of the Col108 mini-fibrils are consistent with a staggered arrangement of triple helices having a staggering value of 123 residues, a value closely connected to the size of one repeat sequence unit. A mechanism is proposed for the mini-fibril formation of Col108 in which the axial periodicity is instigated by the built-in sequence periodicity and stabilized by the optimized interactions between the triple helices in a 1-unit staggered arrangement. Lacking hydroxyproline residues and telopeptides, two factors implicated in the fibrillogenesis of native collagen, the Col108 mini-fibrils demonstrate that sequence features of the triple helical domain alone are sufficient to "code" for axially repeating periodicity of fibrils. To our knowledge, Col108 is the first designed triple helix to self-assemble into periodic fibrils and offers a unique opportunity to unravel the specific molecular interactions of collagen fibrillogenesis.	[Kaur, Parminder Jeet; Strawn, Rebecca; Bai, Hanying; Xu, Ke; Ordas, Gabriel; Matsui, Hiroshi; Xu, Yujia] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Xu, YJ (corresponding author), CUNY Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA.	Yujia.xu@hunter.cuny.edu			National Science Foundation [CHE 1022120]; National Institutes of Health [RR003037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Science Foundation Grant CHE 1022120 (to Y. X.). This work was also supported in part by National Institutes of Health Grant RR003037.	BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; DRAKE MP, 1966, BIOCHEMISTRY-US, V5, P301, DOI 10.1021/bi00865a039; Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; GHOSH SK, 1975, BIOCHIM BIOPHYS ACTA, V405, P340, DOI 10.1016/0005-2795(75)90099-9; GUSTAVSON KH, 1955, NATURE, V175, P70, DOI 10.1038/175070a0; HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; HULMES DJS, 1977, BIOCHEM BIOPH RES CO, V77, P574, DOI 10.1016/S0006-291X(77)80017-X; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; Kadler KE, 1996, BIOCHEM J, V316, P1; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m; Kielty Cay M., 1993, P103; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; LEIBOVICH SJ, 1970, BIOCHIM BIOPHYS ACTA, V214, P445, DOI 10.1016/0005-2795(70)90303-X; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Paramonov SE, 2006, BIOMACROMOLECULES, V7, P24, DOI 10.1021/bm050798k; Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; PIEZ K A, 1974, Journal of Supramolecular Structure, V2, P121, DOI 10.1002/jss.400020207; PROCKOP DJ, 1969, J BIOL CHEM, V244, P4838; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200; Xu YJ, 2004, BIOPHYS CHEM, V108, P141, DOI 10.1016/j.bpc.2003.10.015	41	13	13	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9251	9261		10.1074/jbc.M113.542241	http://dx.doi.org/10.1074/jbc.M113.542241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673694	Green Published, hybrid			2022-12-26	WOS:000352207100046
J	Tsai, YL; Zhang, Y; Tseng, CC; Stanciauskas, R; Pinaud, F; Lee, AS				Tsai, Yuan-Li; Zhang, Yi; Tseng, Chun-Chih; Stanciauskas, Ramunas; Pinaud, Fabien; Lee, Amy S.			Characterization and Mechanism of Stress-induced Translocation of 78-Kilodalton Glucose-regulated Protein (GRP78) to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; MONOCLONAL-ANTIBODY; MEMBRANE-PROTEIN; LIVING CELLS; CANCER-CELLS; ATP BINDING; BREFELDIN-A; ER; RECEPTOR; BIP	Glucose-regulated protein (GRP78)/BiP, a major chaperone in the endoplasmic reticulum, is recently discovered to be preferably expressed on the surface of stressed cancer cells, where it regulates critical oncogenic signaling pathways and is emerging as a target for anti-cancer therapy while sparing normal organs. However, because GRP78 does not contain classical transmembrane domains, its mechanism of transport and its anchoring at the cell surface are poorly understood. Using a combination of biochemical, mutational, FACS, and single molecule super-resolution imaging approaches, we discovered that GRP78 majorly exists as a peripheral protein on plasma membrane via interaction with other cell surface proteins including glycosylphosphatidylinositol-anchored proteins. Moreover, cell surface GRP78 expression requires its substrate binding activity but is independent of ATP binding or a membrane insertion motif conserved with HSP70. Unexpectedly, different cancer cell lines rely on different mechanisms for GRP78 cell surface translocation, implying that the process is cell context-dependent.	[Tsai, Yuan-Li; Zhang, Yi; Tseng, Chun-Chih; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Stanciauskas, Ramunas; Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Chem, Los Angeles, CA 90089 USA; [Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Phys & Astron, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lee, AS (corresponding author), USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1441 Eastlake Ave,Rm 5308, Los Angeles, CA 90089 USA.	amylee@usc.edu	Tseng, Chun-Chih/AAS-3712-2020	Tseng, Chun-Chih/0000-0001-9285-0712; Pinaud, Fabien/0000-0002-4272-3616; Lee, Amy/0000-0002-0378-5443	National Cancer Institute Cancer Center Shared Grant [P30 CA014089]; USC Provost Office, Dean's Development Funds, Keck School of Medicine; NATIONAL CANCER INSTITUTE [R21CA179273, P30CA014089, R01CA027607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Shared Grant; USC Provost Office, Dean's Development Funds, Keck School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Parkash Gill and Ren Liu for the gift of antibodies and reagents and James Ou, Tobias Ulmer, Erik Snapp, and Linda Hendershot for helpful discussions. Flow cytometry was performed in the USC Flow Cytometry Core Facility supported in part by the National Cancer Institute Cancer Center Shared Grant P30 CA014089 and the USC Provost Office, Dean's Development Funds, Keck School of Medicine.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Bellani S, 2014, CELL DEATH DIFFER, V21, P1971, DOI 10.1038/cdd.2014.111; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kepes F, 1996, J MOL BIOL, V262, P77, DOI 10.1006/jmbi.1996.0500; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; LIU ES, 1992, J BIOL CHEM, V267, P7128; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Okamoto T, 2001, Curr Protoc Cell Biol, VChapter 5, DOI 10.1002/0471143030.cb0101s05; Patlolla JMR, 2004, ONCOL REP, V11, P957; Pinaud F, 2011, P NATL ACAD SCI USA, V108, pE201, DOI 10.1073/pnas.1101929108; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rasche L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063414; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Spike BT, 2014, STEM CELL REP, V2, P427, DOI 10.1016/j.stemcr.2014.02.010; Tamilselvam B, 2008, J IMMUNOL, V180, P8262, DOI 10.4049/jimmunol.180.12.8262; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	56	105	108	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8049	8064		10.1074/jbc.M114.618736	http://dx.doi.org/10.1074/jbc.M114.618736			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25673690	hybrid, Green Published			2022-12-26	WOS:000351662600004
J	Laverty, AA; Elkin, SL; Watt, HC; Millett, C; Restrick, LJ; Williams, S; Bell, D; Hopkinson, NS				Laverty, Anthony A.; Elkin, Sarah L.; Watt, Hilary C.; Millett, Christopher; Restrick, Louise J.; Williams, Sian; Bell, Derek; Hopkinson, Nicholas S.			Impact of a COPD Discharge Care Bundle on Readmissions following Admission with Acute Exacerbation: Interrupted Time Series Analysis	PLOS ONE			English	Article							PULMONARY REHABILITATION; POPULATION; PREVALENCE	Objectives We evaluated the impact of a COPD discharge care bundle on readmission rates following hospitalisation with an acute exacerbation. Design Interrupted time series analysis, comparing readmission rates for COPD exacerbations at nine trusts that introduced the bundle, to two comparison groups; (1) other NHS trusts in London and (2) all other NHS trusts in England. Care bundles were implemented at different times for different NHS trusts, ranging from October 2009 to April 2011. Setting Nine NHS acute trusts in the London, England. Participants Patients aged 45 years and older admitted to an NHS acute hospital in England for acute exacerbation of COPD. Data come from Hospital Episode Statistics, April 2002 to March 2012. Main Outcome Measures Annual trend readmission rates (and in total bed days) within 7, 28 and 90 days, before and after implementation. Results In hospitals introducing the bundle readmission rates were rising before implementation and falling afterwards (e.g. readmissions within 28 days + 2.13% per annum (pa) pre and -5.32% pa post (p for difference in trends = 0.012)). Following implementation, readmission rates within 7 and 28 day were falling faster than among other trusts in London, although this was not statistically significant (e.g. readmissions within 28 days -4.6% pa vs. -3.2% pa, p = 0.44). Comparisons with a national control group were similar. Conclusions The COPD discharge care bundle appeared to be associated with a reduction in readmission rate among hospitals using it. The significance of this is unclear because of changes to background trends in London and nationally.	[Laverty, Anthony A.; Watt, Hilary C.; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Elkin, Sarah L.] Imperial Coll London NHS Trust, London, England; [Restrick, Louise J.; Williams, Sian] London Resp Team NHS London, London, England; [Bell, Derek] NIHR CLAHRC Northwest London, London, England; [Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	Laverty, AA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	a.laverty@imperial.ac.uk		Laverty, Anthony/0000-0003-1318-8439; Williams, Sian/0000-0002-0527-2254; Millett, Christopher/0000-0002-0793-9884	National Institute for Health Research (NIHR); Imperial Centre for Patient Safety and Service Quality	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the Collaborations for Leadership in Applied Health Research and Care (CLAHRC) programme for North West London. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Additional support was received from Imperial Centre for Patient Safety and Service Quality and the NIHR Biomedical Research Centre scheme. The funders had no role in the study design, interpretation, or the decision to publish.	[Anonymous], AN INTERNATIONAL COM; [Anonymous], 2014, ALL PARTY PARLIAMENT; Audit Commission, 2012, PAYMENT BY RESULTS D; Bolton CE, 2013, THORAX, V68, P887, DOI 10.1136/thoraxjnl-2013-203809; BTS Care Bundles for CAP and COPD, BTS CARE BUNDLES FOR; Buckingham RJ, 2008, REPORT NATL CHRONIC; Department of Health, CONSULTATION ON A ST; Falzon C, 2013, PRIM CARE RESP J, V22, P59, DOI 10.4104/pcrj.2013.00008; Falzon C, 2011, THORAX, V66, P630, DOI 10.1136/thx.2010.140913; Health and Social Care Information Centre, HOSPITAL EPISODE STA; Hopkinson NS, 2012, THORAX, V67, P90, DOI 10.1136/thoraxjnl-2011-200233; Jones SE, 2013, THORAX; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lennox L, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000035; London Respiratory Team, ANNUAL REPORT 2011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nacul L, 2011, J PUBLIC HEALTH-UK, V33, P108, DOI 10.1093/pubmed/fdq031; National Institute for Clinical Excellence, 2010, MANAGEMENT OF CHRONI; Pronovost P, 2014, NEW ENGL J MED, V371, P691, DOI 10.1056/NEJMp1405800; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Purdy S, 2011, J HEALTH SERV RES PO, V16, P133, DOI 10.1258/jhsrp.2010.010013; Robb E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1234; Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916; Royal College of Physicians (London) and British Lung Foundation, 2008, THE NATIONAL CHRONIC; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walker PP, 2013, THORAX, V68, P968, DOI 10.1136/thoraxjnl-2012-202365; Williams S, 2011, THE CASE FOR A COPD; Yohannes AM, 2011, CHRON RESP DIS, V8, P193, DOI 10.1177/1479972311413400; Zoumot Z, 2014, THORAX, V69, P973, DOI 10.1136/thoraxjnl-2014-205667	29	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116187	10.1371/journal.pone.0116187	http://dx.doi.org/10.1371/journal.pone.0116187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679218	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600014
J	Menze, ET; Esmat, A; Tadros, MG; Abdel-Naim, AB; Khalifa, AE				Menze, Esther T.; Esmat, Ahmed; Tadros, Mariane G.; Abdel-Naim, Ashraf B.; Khalifa, Amani E.			Genistein Improves 3-NPA-Induced Memory Impairment in Ovariectomized Rats: Impact of Its Antioxidant, Anti-Inflammatory and Acetylcholinesterase Modulatory Properties	PLOS ONE			English	Article							KAPPA-B ACTIVATION; 3-NITROPROPIONIC ACID; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; ANIMAL-MODEL; SUCCINATE-DEHYDROGENASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; BCL-2 EXPRESSION; ESTROGEN	Huntington's disease (HD) is a progressive neurodegenerative disorder. The pre-motor symptomatic stages of the disease are commonly characterized by cognitive problems including memory loss. 3-Nitropropionic acid (3-NPA) is a mitochondrial toxin that produces selective lesions in the brain similar to that of HD and was proven to cause memory impairment in rodents. Phytoestrogens have well-established neuroprotective and memory enhancing effects with fewer side effects in comparison to estrogens. This study investigated the potential neuroprotective and memory enhancing effect of genistein (5, 10 and 20 mg/kg), a phytoestrogen, in ovariectomized rats challenged with 3-NPA (20 mg/kg). These potential effects were compared to those of 17 beta-estradiol (2.5 mg/kg). Systemic administration of 3-NPA for 4 consecutive days impaired locomotor activity, decreased retention latencies in the passive avoidance task, decreased striatal, cortical and hippocampal ATP levels, increased oxidative stress, acetylcholinesterase (AChE) activity, cycloxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expressions. Pretreatment with genistein and 17 beta-estradiol attenuated locomotor hypoactivity, increased retention latencies in the passive avoidance task, increased ATP levels, improved the oxidative stress profile, attenuated the increase in AChE activity and decreased the expression of COX-2 and iNOS. Overall, the higher genistein dose (20 mg/kg) was the most effective. In conclusion, this study suggests neuroprotective and memory enhancing effects for genistein in a rat model of HD. These effects might be attributed to its antioxidant, anti-inflammatory and cholinesterase inhibitory activities.	[Menze, Esther T.; Esmat, Ahmed; Tadros, Mariane G.; Abdel-Naim, Ashraf B.; Khalifa, Amani E.] Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	Tadros, MG (corresponding author), Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	mirogeogo@yahoo.com	Esmat, Ahmed/R-4805-2016; Abdel-Naim, Ashraf B/J-3199-2012	Esmat, Ahmed/0000-0002-1937-9300; Abdel-Naim, Ashraf B/0000-0002-0400-9075; Menze, Esther/0000-0002-1819-9113; Khalifa, Amani/0000-0002-1627-7800				ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahuja M, 2008, TOXICOLOGY, V244, P111, DOI 10.1016/j.tox.2007.11.003; Al Mutairy A, 2010, NEUROTOXICOL TERATOL, V32, P226, DOI 10.1016/j.ntt.2009.09.003; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; Arce C, 2010, NEUROSCI MED, V1, P50, DOI [10.1155/2015/598496, DOI 10.1155/2015/598496]; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Banchroft J.D., 1996, THEORY PRACTICE HIST; Bang OY, 2004, NEUROBIOL DIS, V16, P21, DOI 10.1016/j.nbd.2003.12.017; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Barnes S, 2000, J NUTR, V130, p656S, DOI 10.1093/jn/130.3.656S; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1993, J NEUROSCI, V13, P4181; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; Bonelli RM, 2004, EXPERT OPIN PHARMACO, V5, P767, DOI 10.1517/14656566.5.4.767; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Brouillet E, 1998, J NEUROCHEM, V70, P794; Browne SE, 1999, BRAIN PATHOL, V9, P147; Castello-Ruiz M, 2011, PHYTOMEDICINE, V18, P513, DOI 10.1016/j.phymed.2011.02.001; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Curzon P, 2009, BEHAV ASSESSMENT SEN; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Diaz A, 2011, PHARMACOL BIOCHEM BE, V98, P67, DOI 10.1016/j.pbb.2010.12.005; Duan WZ, 2000, EXP NEUROL, V165, P1, DOI 10.1006/exnr.2000.7434; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; File SE, 2001, PSYCHOPHARMACOLOGY, V157, P430, DOI 10.1007/s002130100845; Folstein S.E., 1989, HUNTINGTONS DIS DISO; Gomez-Zubeldia MA, 2001, MENOPAUSE, V8, P274; Hahn-Barma V, 1998, J NEUROL NEUROSUR PS, V64, P172, DOI 10.1136/jnnp.64.2.172; Ho AK, 2003, NEUROLOGY, V61, P1702, DOI 10.1212/01.WNL.0000098878.47789.BD; Huang YH, 2010, BRIT J NUTR, V104, P1297, DOI 10.1017/S0007114510002291; JAMES LF, 1980, AM J VET RES, V41, P377; Jang M, 2014, BRAIN BEHAV IMMUN, V38, P151, DOI 10.1016/j.bbi.2014.01.015; Johansson AC, 2002, J NEUROIMMUNOL, V123, P135, DOI 10.1016/S0165-5728(01)00468-4; JONES DNC, 1995, J NEUROSCI, V15, P7282; Kalpana S, 2013, INT J SCI ENG RES, V4, P296; Kumar P, 2009, NEUROSCI RES, V63, P302, DOI 10.1016/j.neures.2009.01.005; Kyuhou SI, 2008, NEUROSCI LETT, V448, P10, DOI 10.1016/j.neulet.2008.10.045; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; Mandy HM, 2011, NEUROCHEM INT, V59, P770, DOI 10.1016/j.neuint.2011.07.012; Martins DB, 2012, LIFE SCI, V90, P351, DOI 10.1016/j.lfs.2011.12.006; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Miller PJ, 1997, EXP NEUROL, V146, P212, DOI 10.1006/exnr.1997.6522; MING L, 1995, J TOXICOL-CLIN TOXIC, V33, P363, DOI 10.3109/15563659509028924; Montoya A, 2006, J PSYCHIATR NEUROSCI, V31, P21; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Phillips W, 2008, MOVEMENT DISORD, V23, P1491, DOI 10.1002/mds.21971; Poumeau-Delille G, 1953, TECHNIQUES BIOL ENDO; Prokai L, 2005, DRUG DEVELOP RES, V66, P118, DOI 10.1002/ddr.20050; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Sato T, 2004, PHARMACOL RES, V49, P151, DOI 10.1016/j.phrs.2003.09.006; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Seaman RL, 2000, NEUROSCI LETT, V280, P183, DOI 10.1016/S0304-3940(00)00790-4; Sharma M, 2012, IOSR J PHARM, V2, P61; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silva RH, 2007, PROG NEURO-PSYCHOPH, V31, P65, DOI 10.1016/j.pnpbp.2006.06.019; SMETS LA, 1994, BLOOD, V84, P1613; SPOKES EGS, 1980, BRAIN, V103, P179, DOI 10.1093/brain/103.1.179; Tadros MG, 2005, PHARMACOL BIOCHEM BE, V82, P574, DOI 10.1016/j.pbb.2005.10.018; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; VILLA P, 1994, J NEUROCHEM, V62, P1468; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Xu J, 2007, J MOL NEUROSCI, V31, P101, DOI 10.1007/s12031-007-0010-y; Xu SZ, 2009, FREE RADICAL BIO MED, V47, P167, DOI 10.1016/j.freeradbiomed.2009.04.021; Yuan GJ, 2006, WORLD J GASTROENTERO, V12, P2375, DOI 10.3748/wjg.v12.i15.2375; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066	82	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117223	10.1371/journal.pone.0117223	http://dx.doi.org/10.1371/journal.pone.0117223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675218	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000016
J	Focaccetti, C; Bruno, A; Magnani, E; Bartolini, D; Principi, E; Dallaglio, K; Bucci, EO; Finzi, G; Sessa, F; Noonan, DM; Albini, A				Focaccetti, Chiara; Bruno, Antonino; Magnani, Elena; Bartolini, Desiree; Principi, Elisa; Dallaglio, Katiuscia; Bucci, Eraldo O.; Finzi, Giovanna; Sessa, Fausto; Noonan, Douglas M.; Albini, Adriana			Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes	PLOS ONE			English	Article							CANCER-PATIENTS; BREAST-CANCER; IN-VITRO; MOLECULAR-MECHANISMS; GROWTH-FACTOR; ANTICANCER DRUGS; CARDIO-ONCOLOGY; FOLINIC ACID; HUMAN LIVER; CARDIOTOXICITY	Antimetabolites are a class of effective anticancer drugs interfering in essential biochemical processes. 5-Fluorouracil (5-FU) and its prodrug Capecitabine are widely used in the treatment of several solid tumors (gastro-intestinal, gynecological, head and neck, breast carcinomas). Therapy with fluoropyrimidines is associated with a wide range of adverse effects, including diarrhea, dehydration, abdominal pain, nausea, stomatitis, and hand-foot syndrome. Among the 5-FU side effects, increasing attention is given to cardiovascular toxicities induced at different levels and intensities. Since the mechanisms related to 5-FU-induced cardiotoxicity are still unclear, we examined the effects of 5-FU on primary cell cultures of human cardiomyocytes and endothelial cells, which represent two key components of the cardiovascular system. We analyzed at the cellular and molecular level 5-FU effects on cell proliferation, cell cycle, survival and induction of apoptosis, in an experimental cardioncology approach. We observed autophagic features at the ultrastructural and molecular levels, in particular in 5-FU exposed cardiomyocytes. Reactive oxygen species (ROS) elevation characterized the endothelial response. These responses were prevented by a ROS scavenger. We found induction of a senescent phenotype on both cell types treated with 5-FU. In vivo, in a xenograft model of colon cancer, we showed that 5-FU treatment induced ultrastructural changes in the endothelium of various organs. Taken together, our data suggest that 5-FU can affect, both at the cellular and molecular levels, two key cell types of the cardiovascular system, potentially explaining some manifestations of 5-FU-induced cardiovascular toxicity.	[Focaccetti, Chiara; Bruno, Antonino; Bartolini, Desiree; Principi, Elisa; Noonan, Douglas M.] IRCCS MultiMed, Ctr Sci & Technol, Milan, Italy; [Magnani, Elena; Dallaglio, Katiuscia; Albini, Adriana] IRCCS Arcispedale Santa Maria Nuova, Dept Res & Stat, Reggio Emilia, Italy; [Bucci, Eraldo O.] IRCCS MultiMed, Oncol Unit, Castellanza, VA, Italy; [Finzi, Giovanna; Sessa, Fausto] Osped Circolo Varese, Dept Pathol, Varese, Italy; [Sessa, Fausto] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Noonan, Douglas M.] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	IRCCS Multimedica; IRCCS Arcispedale S. Maria Nuova; IRCCS Multimedica; University of Insubria; University of Insubria	Albini, A (corresponding author), IRCCS Arcispedale Santa Maria Nuova, Dept Res & Stat, Reggio Emilia, Italy.	albini.adriana@gmail.com	Noonan, Douglas M/A-8620-2010; Bruno, Antonino/J-7066-2016; Principi, Elisa/O-2424-2015; Bartolini, Desirée/K-5319-2016; Focaccetti, Chiara/AAD-9378-2019	Noonan, Douglas M/0000-0001-8058-0719; Bruno, Antonino/0000-0002-4790-0861; Bartolini, Desirée/0000-0003-3849-757X; Focaccetti, Chiara/0000-0002-7334-3966; Principi, Elisa/0000-0003-3747-1167; Albini, Adriana/0000-0002-9624-5103	Ministero Italiano della Salute, Grande Progetto Strategico (GPS); Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [2010NECHBX 003]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG10228]	Ministero Italiano della Salute, Grande Progetto Strategico (GPS); Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	These studies were supported by the Ministero Italiano della Salute, Grande Progetto Strategico (GPS), by the Ministero dell'Istruzione dell'Universita e della Ricerca, PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) 2010NECHBX 003, AIRC (Associazione Italiana per la Ricerca sul Cancro) (IG10228). AB is a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellow. KD is a Fondazione Veronesi fellow. The authors thank Paola Corradino for assistance and bibliography and Alessandra Panvini Rosati for secretarial help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2012, INTERN EMERG MED, V7, P399, DOI 10.1007/s11739-012-0845-2; Albini A, 2011, FUTUR CARDIOL, V7, P693, DOI [10.2217/fca.11.54, 10.2217/FCA.11.54]; Albini A, 2011, JNCI-J NATL CANCER I, V103, P608, DOI 10.1093/jnci/djr034; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Alili L, 2014, DRUG INDUCED ACCELER; Amstutz U, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-54; Becker K, 1999, DRUGS, V57, P475, DOI 10.2165/00003495-199957040-00003; Bijnsdorp IV, 2010, INT J CANCER, V126, P2457, DOI 10.1002/ijc.24943; Boisen L, 2010, EXP GERONTOL, V45, P779, DOI 10.1016/j.exger.2010.06.003; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Brower V, 2013, JNCI-J NATL CANCER I, V105, P835, DOI 10.1093/jnci/djt161; Bu XX, 2008, CANCER BIOL THER, V7, P392, DOI 10.4161/cbt.7.3.5366; Buchel B, 2013, BIOMED CHROMATOGR, V27, P7, DOI 10.1002/bmc.2741; Cardinale D, 2013, SEMIN ONCOL, V40, P186, DOI 10.1053/j.seminoncol.2013.01.008; Casale F, 2004, PHARMACOL RES, V50, P173, DOI 10.1016/j.phrs.2004.01.006; Coleman PR, 2013, AGING-US, V5, P913, DOI 10.18632/aging.100622; CORONEL B, 1988, INTENS CARE MED, V14, P429, DOI 10.1007/BF00262901; Cwikiel M, 1996, ANN ONCOL, V7, P731; CWIKIEL M, 1995, ACTA ONCOL, V34, P83, DOI 10.3109/02841869509093643; CWIKIEL M, 1995, SCANNING MICROSCOPY, V9, P561; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Durak I, 2000, J TOXICOL ENV HEAL A, V59, P585; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Eskandari MR, 2014, XENOBIOTICA, P1; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Filgueiras MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063177; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; FOX SB, 1995, J PATHOL, V176, P183, DOI 10.1002/path.1711760212; FRAILE RJ, 1980, CANCER RES, V40, P2223; Gajalakshmi P, 2013, TOXICOL APPL PHARM, V269, P121, DOI 10.1016/j.taap.2013.03.011; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Gemma C., 2007, OXIDATIVE STRESS AGI; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grem JL, 1997, SEMIN RADIAT ONCOL, V7, P249, DOI 10.1016/S1053-4296(97)80023-9; Gressett Sarah M, 2006, J Oncol Pharm Pract, V12, P131, DOI 10.1177/1078155206069242; Grover S, 2013, INT J CARDIOL, V168, P5465, DOI 10.1016/j.ijcard.2013.07.246; Hemalatha T, 2010, BIOCHEM CELL BIOL, V88, P491, DOI [10.1139/O09-165, 10.1139/o09-165]; Ignatescu MC, 1999, ARTERIOSCL THROM VAS, V19, P2340, DOI 10.1161/01.ATV.19.10.2340; Ijichi K, 2014, ANTICANCER RES, V34, P2907; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Jensen SA, 2006, CANCER CHEMOTH PHARM, V58, P487, DOI 10.1007/s00280-005-0178-1; Kleiman N S, 1987, Am J Med, V82, P566, DOI 10.1016/0002-9343(87)90465-7; Kosmas C, 2008, J CANCER RES CLIN, V134, P75, DOI 10.1007/s00432-007-0250-9; L'Ecuyer T, 2001, MOL GENET METAB, V74, P370, DOI 10.1006/mgme.2001.3243; Lamberti M, 2014, TOXICOL LETT, V227, P151, DOI 10.1016/j.toxlet.2014.03.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Maseri A, 2001, AM J MED, V111, P326, DOI 10.1016/S0002-9343(01)00930-5; Menna P, 2008, CHEM RES TOXICOL, V21, P978, DOI 10.1021/tx800002r; METZKURSCHEL U, 1990, RENAL FAILURE, V12, P93, DOI 10.3109/08860229009087124; Meyer CC, 1997, PHARMACOTHERAPY, V17, P729; MISSET B, 1990, INTENS CARE MED, V16, P210, DOI 10.1007/BF01724805; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Molteni LP, 2010, BREAST J, V16, pS45, DOI 10.1111/j.1524-4741.2010.01004.x; MOSSERI M, 1993, CANCER RES, V53, P3028; Muneoka Katsuki, 2005, Int J Clin Oncol, V10, P441, DOI 10.1007/s10147-005-0516-7; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Polk A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-47; Polk A, 2013, CANCER TREAT REV, V39, P974, DOI 10.1016/j.ctrv.2013.03.005; Russo G, 2012, INTERN EMERG MED, V7, P439, DOI 10.1007/s11739-012-0794-9; Saif MW, 2009, EXPERT OPIN DRUG SAF, V8, P191, DOI [10.1517/14740330902733961 , 10.1517/14740330902733961]; SCHOBER C, 1993, CANCER, V72, P2242, DOI 10.1002/1097-0142(19931001)72:7<2242::AID-CNCR2820720730>3.0.CO;2-E; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Sereno M, 2008, CLIN TRANSL ONCOL, V10, P35, DOI 10.1007/s12094-008-0150-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sikora E, 2013, CURR VASC PHARM; Sorrentino MF, 2012, CARDIOL J, V19, P453, DOI 10.5603/CJ.2012.0084; Spasojevic I, 2009, MOLECULES, V14, P53, DOI 10.3390/molecules14010053; Swystun LL, 2009, J THROMB HAEMOST, V7, P619, DOI 10.1111/j.1538-7836.2009.03300.x; Tabata T, 2004, DRUG METAB DISPOS, V32, P762, DOI 10.1124/dmd.32.7.762; te Poele RH, 2002, CANCER RES, V62, P1876; Tokalov SV, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-57; Tsibiribi P, 2006, HUM EXP TOXICOL, V25, P305, DOI 10.1191/0960327106ht628oa; Tsibiribi Panayota, 2006, Bull Cancer, V93, pE27; VANGROENINGEN CJ, 1988, CANCER RES, V48, P6956; Vene R, 2007, MOL CANCER THER, V6, P286, DOI 10.1158/1535-7163.MCT-06-0346; Wada H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-361; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; WEIDMANN B, 1994, CANCER, V73, P2001, DOI 10.1002/1097-0142(19940401)73:7<2001::AID-CNCR2820730736>3.0.CO;2-S; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	85	174	176	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115686	10.1371/journal.pone.0115686	http://dx.doi.org/10.1371/journal.pone.0115686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671635	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300012
J	Uchiya, KI; Takahashi, H; Nakagawa, T; Yagi, T; Moriyama, M; Inagaki, T; Ichikawa, K; Nikai, T; Ogawa, K				Uchiya, Kei-ichi; Takahashi, Hiroyasu; Nakagawa, Taku; Yagi, Tetsuya; Moriyama, Makoto; Inagaki, Takayuki; Ichikawa, Kazuya; Nikai, Toshiaki; Ogawa, Kenji			Characterization of a Novel Plasmid, pMAH135, from Mycobacterium avium Subsp hominissuis	PLOS ONE			English	Article							NUMBER TANDEM-REPEAT; SECRETION SYSTEM; VII SECRETION; NONTUBERCULOUS MYCOBACTERIA; EFFLUX TRANSPORTERS; INSERTION SEQUENCES; REPLICATION REGION; PULMONARY-DISEASE; GENOME SEQUENCE; MATE FAMILY	Mycobacterium avium complex (MAC) causes mainly two types of disease. The first is disseminated disease in immunocompromised hosts, such as individuals infected by human immunodeficiency virus (HIV). The second is pulmonary disease in individuals without systemic immunosuppression, and the incidence of this type is increasing worldwide. M. avium subsp. hominissuis, a component of MAC, causes infection in pigs as well as in humans. Many aspects of the different modes of M. avium infection and its host specificity remain unclear. Here, we report the characteristics and complete sequence of a novel plasmid, designated pMAH135, derived from M. avium strain TH135 in an HIV-negative patient with pulmonary MAC disease. The pMAH135 plasmid consists of 194,711 nucleotides with an average G + C content of 66.5% and encodes 164 coding sequences (CDSs). This plasmid was unique in terms of its homology to other mycobacterial plasmids. Interestingly, it contains CDSs with sequence homology to mycobactin biosynthesis proteins and type VII secretion system-related proteins, which are involved in the pathogenicity of mycobacteria. It also contains putative conserved domains of the multidrug efflux transporter. Screening of isolates from humans and pigs for genes located on pMAH135 revealed that the detection rate of these genes was higher in clinical isolates from pulmonary MAC disease patients than in those from HIV-positive patients, whereas the genes were almost entirely absent in isolates from pigs. Moreover, variable number tandem repeats typing analysis showed that isolates carrying pMAH135 genes are grouped in a specific cluster. Collectively, the pMAH135 plasmid contains genes associated with M. avium's pathogenicity and resistance to antimicrobial agents. The results of this study suggest that pMAH135 influence not only the pathological manifestations of MAC disease, but also the host specificity of MAC infection.	[Uchiya, Kei-ichi; Moriyama, Makoto; Inagaki, Takayuki; Nikai, Toshiaki] Meijo Univ, Fac Pharm, Dept Microbiol, Nagoya, Aichi 468, Japan; [Takahashi, Hiroyasu] Kainan Hosp Aichi Prefectural Welf Federat Agr Co, Dept Pharm, Yatomi, Japan; [Nakagawa, Taku; Ogawa, Kenji] Natl Hosp Org, Higashi Nagoya Natl Hosp, Dept Clin Res, Nagoya, Aichi, Japan; [Nakagawa, Taku; Ogawa, Kenji] Natl Hosp Org, Higashi Nagoya Natl Hosp, Dept Pulm Med, Nagoya, Aichi, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Ctr Natl Univ Hosp Infect Control, Dept Infect Dis, Nagoya, Aichi, Japan; [Moriyama, Makoto] Natl Hosp Org, Toyohashi Med Ctr, Dept Pharm, Toyohashi, Aichi, Japan; [Inagaki, Takayuki; Ichikawa, Kazuya] Nagoya Univ Hosp, Dept Pharm, Nagoya, Aichi, Japan	Meijo University; Nagoya University; Nagoya University	Uchiya, KI (corresponding author), Meijo Univ, Fac Pharm, Dept Microbiol, Nagoya, Aichi 468, Japan.	kuchiya@meijo-u.ac.jp	Yagi, Tetsuya/J-3303-2012		JSPS KAKENHI Grant [24590164]; Grants-in-Aid for Scientific Research [24590164] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24590164 (to KU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BEGGS ML, 1995, J BACTERIOL, V177, P4836, DOI 10.1128/jb.177.17.4836-4840.1995; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Gavigan JA, 1997, J BACTERIOL, V179, P4115, DOI 10.1128/jb.179.13.4115-4122.1997; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hughes VM, 2001, J MICROBIOL METH, V44, P209, DOI 10.1016/S0167-7012(00)00246-3; Ichikawa K, 2009, J MED MICROBIOL, V58, P945, DOI 10.1099/jmm.0.008623-0; ICHIYAMA S, 1988, MICROBIOL IMMUNOL, V32, P733, DOI 10.1111/j.1348-0421.1988.tb01434.x; Inagaki T, 2009, J CLIN MICROBIOL, V47, P2156, DOI 10.1128/JCM.02373-08; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Iwamoto T, 2012, INFECT GENET EVOL, V12, P846, DOI 10.1016/j.meegid.2011.06.018; JUCKER MT, 1990, AM REV RESPIR DIS, V142, P858, DOI 10.1164/ajrccm/142.4.858; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; LABIDI A, 1985, ANN INST PASTEUR MIC, V136B, P209, DOI 10.1016/S0769-2609(85)80045-4; Maekawa K, 2011, CHEST, V140, P723, DOI 10.1378/chest.10-2315; Mahillon J, 1999, RES MICROBIOL, V150, P675, DOI 10.1016/S0923-2508(99)00124-2; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Mishra MN, 2013, J BACTERIOL, V195, P1610, DOI 10.1128/JB.01724-12; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; QIN MH, 1994, J BACTERIOL, V176, P419, DOI 10.1128/JB.176.2.419-425.1994; Radomski N, 2010, J CLIN MICROBIOL, V48, P1026, DOI 10.1128/JCM.01869-09; Ramasoota P, 2001, VET MICROBIOL, V78, P251, DOI 10.1016/S0378-1135(00)00302-3; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Sakatani Mitsunori, 2005, Kekkaku, V80, P25; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Sugawara H, 2009, 20 INT C GEN INF KAN; Tanaka E, 1997, AM J RESP CRIT CARE, V155, P2041, DOI 10.1164/ajrccm.155.6.9196113; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Tsuyuguchi K, 2001, CLIN EXP IMMUNOL, V123, P428, DOI 10.1046/j.1365-2249.2001.01474.x; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; VONREYN CF, 1994, LANCET, V343, P1137, DOI 10.1016/S0140-6736(94)90239-9; Weiss CH, 2012, EXPERT REV RESP MED, V6, P597, DOI [10.1586/ERS.12.58, 10.1586/ers.12.58]; Yu XW, 2012, CELL SIGNAL, V24, P1841, DOI 10.1016/j.cellsig.2012.05.014	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117797	10.1371/journal.pone.0117797	http://dx.doi.org/10.1371/journal.pone.0117797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671431	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300071
J	Lion, M; Raimondi, I; Donati, S; Jousson, O; Ciribilli, Y; Inga, A				Lion, Mattia; Raimondi, Ivan; Donati, Stefano; Jousson, Olivier; Ciribilli, Yari; Inga, Alberto			Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay	PLOS ONE			English	Article							DNA-BINDING DOMAIN; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; STRUCTURAL EVOLUTION; CRYSTAL-STRUCTURES; TARGET; RECOGNITION; MECHANISMS; DIVERSITY; HOMOLOG	Co-evolution of transcription factors (TFs) with their respective cis-regulatory network enhances functional diversity in the course of evolution. We present a new approach to investigate transactivation capacity of sequence-specific TFs in evolutionary studies. Saccharomyces cerevisiae was used as an in vivo test tube and p53 proteins derived from human and five commonly used animal models were chosen as proof of concept. p53 is a highly conserved master regulator of environmental stress responses. Previous reports indicated conserved p53 DNA binding specificity in vitro, even for evolutionary distant species. We used isogenic yeast strains where p53-dependent transactivation was measured towards chromosomally integrated p53 response elements (REs). Ten REs were chosen to sample a wide range of DNA binding affinity and transactivation capacity for human p53 and proteins were expressed at two levels using an inducible expression system. We showed that the assay is amenable to study thermo-sensitivity of frog p53, and that chimeric constructs containing an ectopic transactivation domain could be rapidly developed to enhance the activity of proteins, such as fruit fly p53, that are poorly effective in engaging the yeast transcriptional machinery. Changes in the profile of relative transactivation towards the ten REs were measured for each p53 protein and compared to the profile obtained with human p53. These results, which are largely independent from relative p53 protein levels, revealed widespread evolutionary divergence of p53 transactivation specificity, even between human and mouse p53. Fruit fly and human p53 exhibited the largest discrimination among REs while zebrafish p53 was the least selective.	[Lion, Mattia; Raimondi, Ivan; Donati, Stefano; Ciribilli, Yari; Inga, Alberto] Univ Trento, Ctr Integrat Biol CIBIO, Lab Transcript Networks, Mattarello, Trento, Italy; [Jousson, Olivier] Univ Trento, Ctr Integrat Biol CIBIO, Lab Microbial Genom, Mattarello, Trento, Italy	University of Trento; University of Trento	Inga, A (corresponding author), Univ Trento, Ctr Integrat Biol CIBIO, Lab Transcript Networks, Mattarello, Trento, Italy.	inga@science.unitn.it	Ciribilli, Yari/K-2751-2018; Inga, Alberto/AAC-3815-2022; Jousson, Olivier/S-4397-2019	Ciribilli, Yari/0000-0001-9231-379X; Inga, Alberto/0000-0002-8767-1637; Jousson, Olivier/0000-0003-3344-7194; Raimondi, Ivan/0000-0002-9522-2794; Donati, Stefano/0000-0001-9946-0346	Italian Association for Cancer Research, AIRC [12869]; Pezcoller Foundation Fellowship	Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); Pezcoller Foundation Fellowship	This work was partially supported by the Italian Association for Cancer Research, AIRC (IG #12869 to AI) (www.airc.it/). IR is supported by a Pezcoller Foundation Fellowship (http://www.pezcoller.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Andreotti V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020643; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beno I, 2011, NUCLEIC ACIDS RES, V39, P1919, DOI 10.1093/nar/gkq1044; Bensaad K, 2003, J BIOL CHEM, V278, P10546, DOI 10.1074/jbc.M208233200; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brandt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047889; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Ciribilli Y, 2013, NUCLEIC ACIDS RES, V41, P8637, DOI 10.1093/nar/gkt657; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; D'Erchia AM, 2006, CELL CYCLE, V5, P750, DOI 10.4161/cc.5.7.2622; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Dowell RD, 2010, TRENDS GENET, V26, P468, DOI 10.1016/j.tig.2010.08.005; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Ethayathulla AS, 2013, J BIOL CHEM, V288, P4744, DOI 10.1074/jbc.M112.408039; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gordon KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002432; Herzog G, 2012, J BIOL CHEM, V287, P44330, DOI 10.1074/jbc.M112.417980; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; James RS, 2012, J EXP BIOL, V215, P552, DOI 10.1242/jeb.063396; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kennedy BK, 2002, NAT REV MOL CELL BIO, V3, P41, DOI 10.1038/nrm704; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Lang L, 2000, CELL STRESS CHAPERON, V5, P36, DOI 10.1379/1466-1268(2000)005<0036:SITSEO>2.0.CO;2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lion M, 2013, CELL CYCLE, V12, P1211, DOI 10.4161/cc.24309; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Maeso I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0020; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Micale L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046642; Monti P, 2014, ONCOTARGET, V5, P2116, DOI 10.18632/oncotarget.1845; Nagasawa K, 2013, BIOL OPEN, V2, P1057, DOI 10.1242/bio.20136106; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Pagano B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076014; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; Rubinstein M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0017; Rutkowski R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001131; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKORSKI RS, 1989, GENETICS, V122, P19; Simeonova I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002731; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095	74	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116177	10.1371/journal.pone.0116177	http://dx.doi.org/10.1371/journal.pone.0116177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668429	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000006
J	An, YH; Guo, WJ; Li, LN; Xu, CW; Yang, DX; Wang, SS; Lu, YX; Zhang, Q; Zhai, JD; Fan, HX; Qiu, CJ; Qi, J; Chen, Y; Yuan, SJ				An, Yinghong; Guo, Wanjun; Li, Linna; Xu, Chengwang; Yang, Dexuan; Wang, Shanshan; Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia; Qiu, Chuanjiang; Qi, Jie; Chen, Yue; Yuan, Shoujun			Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA CELLS; EFFICACY; TUMOR; PROLIFERATION; RADIOTHERAPY; TEMSIROLIMUS; CONCOMITANT; MODULATION; EXPRESSION	Background There is no highly effective chemotherapy for malignant gliomas to date. We found that dimethylaminomicheliolide (DMAMCL), a selective inhibitor of acute myeloid leukemia (AML) stem/progenitor cells, inhibited the growth of glioma cells. Methods The distribution of DMAMCL in brain was analyzed by an ultraperformance liquid chromatography-mass spectrometry (UPLC-MS/MS) system. The anti-tumor evaluations of DMAMCL in vitro were performed by MTT, FACS and RT-PCR. In vivo, the mixture of C6 cells and matrigel was injected into caudatum, and the anti-tumor activity of DMAMCL was evaluated by tumor growth and rat survival. The toxicity of DMAMCL was evaluated by body weight, daily food intake, hematological or serum biochemical analyses, and histological appearance of tissues. Results The IC50 values of DMAMCL against the C6 and U-87MG cell lines in vitro were 27.18 +/- 1.89 mu M and 20.58 +/- 1.61 mu M, respectively. DAMMCL down-regulated the anti-apoptosis gene Bcl-2 and increased apoptosis in C6 and U-87MG cells in a dose-dependent manner. In a C6 rat tumor model, daily administration of DMAMCL for 21 days reduced the burden of C6 tumors by 60% to 88% compared to controls, and more than doubled the mean lifespan of tumor-bearing rats. Distribution analysis showed that the DMAMCL concentration was higher in the brain than in plasma. Evaluations for toxicity revealed that oral administration of DMAMCL at 200 or 300 mg/kg once a day for 21 days did not result in toxicity. Conclusions These results suggest that DMAMCL is highly promising for the treatment of glioma.	[An, Yinghong] Chinese PLA Air Force Gen Hosp, Clin Lab Ctr, Beijing 100142, Peoples R China; [Guo, Wanjun; Li, Linna; Xu, Chengwang; Yang, Dexuan; Wang, Shanshan; Yuan, Shoujun] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia] Nankai Univ, Coll Pharm, State Key Lab Elementoorgan Chem, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300071, Peoples R China; [Lu, Yaxin; Zhang, Quan; Zhai, Jiadai; Fan, Hongxia] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Qiu, Chuanjiang; Qi, Jie; Chen, Yue] Accendatech Co Ltd, Tianjin 300384, Peoples R China	Air Force General Hospital PLA; Academy of Military Medical Sciences - China; Nankai University; Nankai University	Chen, Y (corresponding author), Accendatech Co Ltd, Tianjin 300384, Peoples R China.	yuechenayh@163.com; yuansj@nic.bmi.ac.cn	li, li/HII-4157-2022; zhai, jiadai/GZB-1710-2022		National Natural Science Foundation of China (NSFC) [21072106, 21372129, 81001377, 81370086]; Fok Ying Tong Education Foundation [122037]; National Program on Key Basic Research Project [2013CB967200]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); National Program on Key Basic Research Project(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC) (NO. 21072106 and NO. 21372129 to Y.C., NO. 81001377 and NO. 81370086 to Q.Z.), Fok Ying Tong Education Foundation (No. 122037), and National Program on Key Basic Research Project (No. 2013CB967200).	Abbott N Joan, 2004, Drug Discov Today Technol, V1, P407, DOI 10.1016/j.ddtec.2004.11.014; Anderson KN, 2008, J PHARMACOL SCI, V106, P318, DOI 10.1254/jphs.SC0060164; [Anonymous], 2010, BRAIN SPIN CORD TUM; Carlisi D, 2011, J CELL PHYSIOL, V226, P1632, DOI 10.1002/jcp.22494; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chen Y., 2010, [No title captured], Patent No. [201,010,153,701.0, 2010101537010]; Colpo A, 2012, ONCOLOGY-BASEL, V82, P165, DOI 10.1159/000336602; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Dell'Agli M, 2009, BIOORG MED CHEM LETT, V19, P1858, DOI 10.1016/j.bmcl.2009.02.080; Feng MR, 2002, CURR DRUG METAB, V3, P647, DOI 10.2174/1389200023337063; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jin P, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0804105; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li D, 2012, INT J NANOMED, V7, P6105, DOI 10.2147/IJN.S38927; Mrugala MM, 2013, DISCOV MED, V15, P221; Murphy S, 2007, J NEURO-ONCOL, V85, P181, DOI 10.1007/s11060-007-9406-3; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; National Cancer Institute, 2010, FDA APPR TEM; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Nieto-Sampedro M, 2011, CLIN MED INSIGHTS-ON, V5, P265, DOI 10.4137/CMO.S7685; Sampson JH, 2011, NEURO-ONCOLOGY, V13, P324, DOI 10.1093/neuonc/noq157; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Strik H, 1999, J NEUROL NEUROSUR PS, V67, P763, DOI 10.1136/jnnp.67.6.763; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun J, 2014, ASIAN PAC J CANCER P, V15, P4897, DOI 10.7314/APJCP.2014.15.12.4897; Tyler B, 2011, NEURO-ONCOLOGY, V13, P700, DOI 10.1093/neuonc/nor050; von Eckardstein K, 2005, J NEURO-ONCOL, V72, P209, DOI 10.1007/s11060-004-3010-6; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Zhai JD, 2012, J ORG CHEM, V77, P7103, DOI 10.1021/jo300888s; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b	35	41	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116202	10.1371/journal.pone.0116202	http://dx.doi.org/10.1371/journal.pone.0116202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658946	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900031
J	Cetz-Navarro, NP; Carpizo-Ituarte, EJ; Espinoza-Avalos, J; Chee-Barragan, G				Cetz-Navarro, Neidy P.; Carpizo-Ituarte, Eugenio J.; Espinoza-Avalos, Julio; Chee-Barragan, Guillermina			The Effect of Filamentous Turf Algal Removal on the Development of Gametes of the Coral Orbicella annularis	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REGION-WIDE DECLINES; LONG-TERM DECLINE; MONTASTRAEA-ANNULARIS; SCLERACTINIAN CORALS; SEXUAL REPRODUCTION; CARIBBEAN CORALS; PHASE-SHIFTS; COMPETITION; MACROALGAE	Macroalgae and filamentous turf algae (FTA) are abundant on degraded coral reefs, and the reproductive responses of corals may indicate sub-lethal stress under these conditions. The percentage of gametogenic stages (PGS) and the maximum diameter of eggs (MDE; or egg size) of Orbicella annularis were used to evaluate the effect of long-(7-10 months) and short-term (2.5 months) FTA removal (treatments T1 and T2, respectively) at both the beginning (May) and the end (August) of gametogenesis. Ramets (individual lobes of a colony) surrounded by FTA (T3) or crustose coralline algae (CCA; T4) were used as controls. The removal of FTA enhanced the development of gametes (i.e., a larger and higher percentage of mature gametes (PMG)) of O. annularis for T1 vs. T3 ramets in May and T1 and T2 vs. T3 ramets in August. Similar values of PGS and MDE between gametes from T3 and T4 in both May and August were unexpected because a previous study had shown that the same ramets of T4 (with higher tissue thickness, chlorophyll a cm(-2) and zooxanthellae density and lower mitotic index values) were less stressed than ramets of T3. Evaluating coral stress through reproduction can reveal more sensitive responses than other biological parameters; within reproductive metrics, PGS can be a better stress indicator than egg size. The presence of turf algae strongly impacted the development of gametes and egg size (e.g., PMG in ramets with FTA removal increased almost twofold in comparison with ramets surrounded by FTA in August), most likely exerting negative chronic effects in the long run due to the ubiquity and permanence of turf algae in the Caribbean. These algae can be considered a stressor that affects coral sexual reproduction. Although the effects of turf algae on O. annularis are apparently less severe than those of other stressors, the future of this species is uncertain because of the combined impacts of these effects, the decline of O. annularis populations and the almost complete lack of recruitment.	[Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio] El Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico; [Cetz-Navarro, Neidy P.] Univ Autonoma Baja California, Fac Ciencias Marinas, Inst Invest Oceanol, Ensenada, Baja California, Mexico; [Carpizo-Ituarte, Eugenio J.; Chee-Barragan, Guillermina] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Autonoma de Baja California; Universidad Autonoma de Baja California	Espinoza-Avalos, J (corresponding author), El Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico.	jespino@ecosur.mx	Espinoza-Avalos, Julio/H-9189-2013	Espinoza-Avalos, Julio/0000-0001-5697-446X; Carpizo-Ituarte, Eugenio/0000-0002-3253-2357	PADI Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [32985]; ECOES; EI Colegio de la Frontera Sur; Universidad Autonoma de Baja California	PADI Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ECOES; EI Colegio de la Frontera Sur; Universidad Autonoma de Baja California	NPCN was supported by PADI Foundation (register number 64, 2009), the Consejo Nacional de Ciencia y Tecnologia (CONACYT, PhD Fellowship 32985), and ECOES (a study mobility grant). JEA was supported by federal funds from EI Colegio de la Frontera Sur. ECI was supported by federal funds from the Universidad Autonoma de Baja California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Antonius A, 2001, CORAL REEFS, V19, P418, DOI 10.1007/s003380000126; Armoza-Zvuloni R, 2012, MAR POLLUT BULL, V64, P1556, DOI 10.1016/j.marpolbul.2012.05.020; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; BAK RPM, 1995, B MAR SCI, V56, P609; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Benzoni F, 2011, MAR BIOL, V158, P2419, DOI 10.1007/s00227-011-1743-2; Blackwood JC, 2012, THEOR ECOL-NETH, V5, P105, DOI 10.1007/s12080-010-0102-0; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buenau KE, 2012, ECOL MODEL, V237, P23, DOI 10.1016/j.ecolmodel.2012.04.013; Buenau KE, 2011, OIKOS, V120, P941, DOI 10.1111/j.1600-0706.2010.18972.x; Cetz-Navarro NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054810; Cox EF, 2002, MAR POLLUT BULL, V44, P1230, DOI 10.1016/S0025-326X(02)00213-8; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Edmunds PJ, 2011, CORAL REEFS, V30, P123, DOI 10.1007/s00338-010-0676-4; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hongo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060952; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jokiel P. L, 1985, P 5 INT CORAL REEF C, V4, P307; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pante E, 2008, HYDROBIOLOGIA, V596, P121, DOI 10.1007/s10750-007-9062-9; PORTER JW, 1992, AM ZOOL, V32, P625; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rodriguez-Troncoso AP, 2011, MAR BIOL, V158, P2673, DOI 10.1007/s00227-011-1765-9; Rogers CS, 2008, P 11 INT COR REEF S, V7, P226; Sudek M, 2012, CORAL REEFS, V31, P351, DOI 10.1007/s00338-011-0844-1; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Szmant-Froelich A, 1985, P 5 INT COR REEF S, V4, P295; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; TOMASCIK T, 1987, MAR BIOL, V94, P77, DOI 10.1007/BF00392901; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P209, DOI 10.3354/meps109209; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Ward S, 2000, J EXP MAR BIOL ECOL, V246, P179, DOI 10.1016/S0022-0981(99)00182-3; Ward S, 2002, P 9 INT COR REEF S, V2, P1123; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Wilkinson C, 2013, MAR POLLUT BULL, V70, P7, DOI 10.1016/j.marpolbul.2013.02.040	71	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117936	10.1371/journal.pone.0117936	http://dx.doi.org/10.1371/journal.pone.0117936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658586	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900244
J	Chen, H; Zheng, DH; Ambadapadi, S; Davids, J; Ryden, S; Samy, H; Bartee, M; Sobel, E; Dai, EB; Liu, LY; Macaulay, C; Yachnis, A; Weyand, C; Thoburn, R; Lucas, A				Chen, Hao; Zheng, Donghang; Ambadapadi, Sriram; Davids, Jennifer; Ryden, Sally; Samy, Hazem; Bartee, Mee; Sobel, Eric; Dai, Erbin; Liu, Liying; Macaulay, Colin; Yachnis, Anthony; Weyand, Cornelia; Thoburn, Robert; Lucas, Alexandra			Serpin Treatment Suppresses Inflammatory Vascular Lesions in Temporal Artery Implants (TAI) from Patients with Giant Cell Arteritis	PLOS ONE			English	Article							FACTOR-XA; RESPONSES; INJURY; COAGULATION; EXPRESSION; INHIBITOR; ADHESION; DISEASE; VESSEL; PAR-2	Giant cell arteritis (GCA) and Takayasu's disease are inflammatory vasculitic syndromes (IVS) causing sudden blindness and widespread arterial obstruction and aneurysm formation. Glucocorticoids and aspirin are mainstays of treatment, predominantly targeting T cells. Serp-1, a Myxomavirus-derived serpin, blocks macrophage and T cells in a wide range of animal models. Serp-1 also reduced markers of myocardial injury in a Phase IIa clinical trial for unstable coronary disease. In recent work, we detected improved survival and decreased arterial inflammation in a mouse Herpesvirus model of IVS. Here we examine Serp-1 treatment of human temporal artery (TA) biopsies from patients with suspected TA GCA arteritis after implant (TAI) into the aorta of immunodeficient SCID (severe combined immunodeficiency) mice. TAI positive for arteritis (GCA(pos)) had significantly increased inflammation and plaque when compared to negative TAI (GCA(neg)). Serp-1 significantly reduced intimal inflammation and CD11b(+) cell infiltrates in TAI, with reduced splenocyte Th1, Th17, and Treg. Splenocytes from mice with GCApos grafts had increased gene expression for interleukin-1beta (IL-1 beta), IL-17, and CD25 and decreased Factor II. Serp-1 decreased IL-1 beta expression. In conclusion, GCA(pos) TAI xenografts in mice provide a viable disease model and have increased intimal inflammation as expected and Serp-1 significantly reduces vascular inflammatory lesions with reduced IL-1 beta.	[Chen, Hao; Zheng, Donghang; Ambadapadi, Sriram; Davids, Jennifer; Ryden, Sally; Bartee, Mee; Sobel, Eric; Dai, Erbin; Liu, Liying; Thoburn, Robert; Lucas, Alexandra] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Chen, Hao; Zheng, Donghang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Samy, Hazem; Lucas, Alexandra] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Yachnis, Anthony] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Macaulay, Colin; Lucas, Alexandra] Viron Therapeut, London, ON, Canada; [Weyand, Cornelia] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Stanford University	Lucas, A (corresponding author), Univ Florida, Dept Med, Gainesville, FL 32611 USA.	alexandra.lucas@medicine.ufl.edu	Weyand, Cornelia/AAH-3343-2021	Yachnis, Anthony/0000-0002-6971-0698; Chen, Hao/0000-0003-0018-480X; Ambadapadi, Sriram/0000-0001-6542-4259	Ethel Smith Endowed Vasculitis Research Chair [F008570]; National Institutes of Health [1RC1HL100202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202, P01HL058000, R01HL117913] Funding Source: NIH RePORTER	Ethel Smith Endowed Vasculitis Research Chair; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the F008570 Ethel Smith Endowed Vasculitis Research Chair and a National Institutes of Health 1RC1HL100202 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard ELR, 2006, TRANSPLANTATION, V81, P908, DOI 10.1097/01.tp.0000203141.02725.8a; Brack A, 1997, MOL MED, V3, P530, DOI 10.1007/BF03401699; Brack A, 1997, J CLIN INVEST, V99, P2842, DOI 10.1172/JCI119477; Cantini F, 2008, DRUG AGING, V25, P281, DOI 10.2165/00002512-200825040-00002; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Deng JS, 2010, CIRCULATION, V121, P906, DOI 10.1161/CIRCULATIONAHA.109.872903; Feinberg HL, 1996, J RHEUMATOL, V23, P1550; Gonzalez-Gay MA, 2001, RHEUM DIS CLIN N AM, V27, P729, DOI 10.1016/S0889-857X(05)70232-5; Guo M, 2011, BLOOD, V117, P936, DOI 10.1182/blood-2010-06-288506; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Kaiser B, 2003, CARDIOVASC DRUG REV, V21, P91; Kawasaki A, 2009, ACTA OPHTHALMOL, V87, P13, DOI 10.1111/j.1755-3768.2008.01314.x; Krupa WM, 2002, AM J PATHOL, V161, P1815, DOI 10.1016/S0002-9440(10)64458-6; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Munuswamy-Ramanujam G, 2010, THROMB HAEMOSTASIS, V103, P545, DOI 10.1160/TH09-07-0441; Napoli C, 2004, J CLIN PATHOL, V57, P513, DOI 10.1136/jcp.2003.015156; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Senden NHM, 1998, J IMMUNOL, V161, P4318; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Tennant GM, 2008, ATHEROSCLEROSIS, V198, P57, DOI 10.1016/j.atherosclerosis.2007.09.043; vanderVeen, 1996, ANN RHEUM DIS, V55, P490; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Weyand CM, 2002, ARTHRITIS RHEUM, V46, P457, DOI 10.1002/art.10071; Weyand CM, 1999, ARTHRITIS RHEUM-US, V42, P844, DOI 10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M; Weyand CM, 2008, CURR OPIN LIPIDOL, V19, P469, DOI 10.1097/MOL.0b013e32830bfdc2	30	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115482	10.1371/journal.pone.0115482	http://dx.doi.org/10.1371/journal.pone.0115482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658487	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900018
J	Diouf, F; Diouf, D; Klonowska, A; Le Quere, A; Bakhoum, N; Fall, D; Neyra, M; Parrinello, H; Diouf, M; Ndoye, I; Moulin, L				Diouf, Fatou; Diouf, Diegane; Klonowska, Agnieszka; Le Quere, Antoine; Bakhoum, Niokhor; Fall, Dioumacor; Neyra, Marc; Parrinello, Hugues; Diouf, Mayecor; Ndoye, Ibrahima; Moulin, Lionel			Genetic and Genomic Diversity Studies of Acacia Symbionts in Senegal Reveal New Species of Mesorhizobium with a Putative Geographical Pattern	PLOS ONE			English	Article							RHIZOBIAL POPULATIONS; PHYLOGENETIC ANALYSES; NITROGEN-FIXATION; HOST-RANGE; SALT; SALINITY; STRAINS; SOILS; L.; STRESS	Acacia senegal (L) Willd. and Acacia seyal Del. are highly nitrogen-fixing and moderately salt tolerant species. In this study we focused on the genetic and genomic diversity of Acacia mesorhizobia symbionts from diverse origins in Senegal and investigated possible correlations between the genetic diversity of the strains, their soil of origin, and their tolerance to salinity. We first performed a multi-locus sequence analysis on five markers gene fragments on a collection of 47 mesorhizobia strains of A. senegal and A. seyal from 8 localities. Most of the strains (60%) clustered with the M. plurifarium type strain ORS 1032(T), while the others form four new clades (MSP1 to MSP4). We sequenced and assembled seven draft genomes: four in the M. plurifarium clade (ORS3356, ORS3365, STM8773 and ORS1032T), one in MSP1 (STM8789), MSP2 (ORS3359) and MSP3 (ORS3324). The average nucleotide identities between these genomes together with the MLSA analysis reveal three new species of Mesorhizobium. A great variability of salt tolerance was found among the strains with a lack of correlation between the genetic diversity of mesorhizobia, their salt tolerance and the soils samples characteristics. A putative geographical pattern of A. senegal symbionts between the dryland north part and the center of Senegal was found, reflecting adaptations to specific local conditions such as the water regime. However, the presence of salt does not seem to be an important structuring factor of Mesorhizobiumspecies.	[Diouf, Fatou; Diouf, Diegane; Bakhoum, Niokhor; Fall, Dioumacor; Ndoye, Ibrahima] Univ Cheikh Anta DIOP Dakar, Ctr Rech Bel Air, Fac Sci & Tech, Dept Biol Vegetal,Lab Commun Microbiol IRD ISRA U, Dakar, Senegal; [Diouf, Fatou; Diouf, Diegane; Bakhoum, Niokhor; Ndoye, Ibrahima; Moulin, Lionel] Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal; [Diouf, Fatou; Klonowska, Agnieszka; Moulin, Lionel] IRD, Lab Symbioses Trop & Mediterraneennes, Montpellier, France; [Le Quere, Antoine] Lab Mixte Int Biotechnol Microbienne & Vegetale L, Rabat, Morocco; [Fall, Dioumacor; Diouf, Mayecor] Inst Senegalais Rech Agr, Dakar, Senegal; [Neyra, Marc] Irstea, UR MALY, Ctr Lyon Villeurbanne, Villeurbanne, France; [Parrinello, Hugues] MGX Montpellier GenomiX, Inst Genom Fonct, Montpellier, France	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Universite de Montpellier	Moulin, L (corresponding author), Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal.	lionel.moulin@ird.fr	Le Quere, antoine/GOH-0137-2022; Moulin, Lionel/C-2921-2008	Le Quere, antoine/0000-0001-7470-5730; Moulin, Lionel/0000-0001-9068-6912; Klonowska, Agnieszka/0000-0003-3325-7980	Institute of Research for Development (IRD); IRD (PEERS grant "RhizAdap"); Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE); Institute of Agronomic Research in Senegal (ISRA)	Institute of Research for Development (IRD); IRD (PEERS grant "RhizAdap"); Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE); Institute of Agronomic Research in Senegal (ISRA)	FD was funded by PhD grant from Institute of Research for Development (IRD, www.ird.fr). The study was funded by IRD (PEERS grant "RhizAdap") and the Joint International Laboratory on adaptation of plants and associated microorganisms to environmental stresses (LMI LAPSE, http://en.lapse.ird.fr/) and the Institute of Agronomic Research in Senegal (ISRA, www.isra.sn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assaf S, 2007, FOOD HYDROCOLLOID, V21, P319, DOI 10.1016/j.foodhyd.2006.04.011; Alexandre A, 2008, INT J SYST EVOL MICR, V58, P2839, DOI 10.1099/ijs.0.2008/001636-0; Arora NK, 2006, WORLD J MICROB BIOT, V22, P603, DOI 10.1007/s11274-005-9077-1; Ba S, 2002, SYST APPL MICROBIOL, V25, P130, DOI 10.1078/0723-2020-00091; Bakhoum N, 2012, WORLD J MICROB BIOT, V28, P2567, DOI 10.1007/s11274-012-1066-6; Barbiero L, 2004, CATENA, V58, P101, DOI 10.1016/j.catena.2004.03.003; Chen WM, 2011, INT J SYST EVOL MICR, V61, P574, DOI 10.1099/ijs.0.022947-0; de la Pena TC, 2012, AGRON SUSTAIN DEV, V32, P65, DOI 10.1007/s13593-011-0024-2; de Lacerda CF, 2005, ENVIRON EXP BOT, V54, P69, DOI 10.1016/j.envexpbot.2004.06.004; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Diouf D, 2005, FUNCT PLANT BIOL, V32, P1143, DOI 10.1071/FP04069; Diouf D, 2010, J APPL MICROBIOL, V108, P818, DOI 10.1111/j.1365-2672.2009.04500.x; Diouf D, 2007, MICROB ECOL, V54, P553, DOI 10.1007/s00248-007-9243-0; Dommergues YR, 1995, FERT RES, V42, P215, DOI 10.1007/BF00750516; Elboutahiri N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-15; Fall D, 2008, LETT APPL MICROBIOL, V47, P85, DOI 10.1111/j.1472-765X.2008.02389.x; Fernandez-Aunion C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-192; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; Lorite MJ, 2010, SYST APPL MICROBIOL, V33, P282, DOI 10.1016/j.syapm.2010.03.006; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; LAL B, 1994, WORLD J MICROB BIOT, V10, P637, DOI 10.1007/BF00327949; Laranjo M, 2008, FEMS MICROBIOL ECOL, V66, P391, DOI 10.1111/j.1574-6941.2008.00584.x; Laranjo M, 2014, MICROBIOL RES, V169, P2, DOI 10.1016/j.micres.2013.09.012; Laranjo M, 2011, ANTON LEEUW INT J G, V99, P651, DOI 10.1007/s10482-010-9539-9; Lorite MJ, 2010, APPL ENVIRON MICROB, V76, P4019, DOI 10.1128/AEM.02555-09; Lortet G, 1996, MOL PLANT MICROBE IN, V9, P736, DOI 10.1094/MPMI-9-0736; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3012, DOI 10.1099/ijs.0.007393-0; Martens M, 2007, INT J SYST EVOL MICR, V57, P489, DOI 10.1099/ijs.0.64344-0; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Midgley JJ, 2001, J TROP ECOL, V17, P871, DOI 10.1017/S026646740100164X; Mishra RPN, 2012, FEMS MICROBIOL ECOL, V79, P487, DOI 10.1111/j.1574-6941.2011.01235.x; Motlagh S, 2006, FOOD HYDROCOLLOID, V20, P848, DOI 10.1016/j.foodhyd.2005.08.007; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nandasena KG, 2009, INT J SYST EVOL MICR, V59, P2140, DOI 10.1099/ijs.0.005728-0; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; NORMAND P, 1992, GENE, V111, P119, DOI 10.1016/0378-1119(92)90612-S; Odee DW, 2002, SOIL BIOL BIOCHEM, V34, P801, DOI 10.1016/S0038-0717(02)00009-3; Op den Camp RHM, 2012, MOL PLANT MICROBE IN, V25, P954, DOI 10.1094/MPMI-11-11-0304; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Qadir M, 2002, LAND DEGRAD DEV, V13, P275, DOI 10.1002/ldr.504; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sarr A, 2005, MICROB ECOL, V50, P152, DOI 10.1007/s00248-004-0077-8; Shamseldin A, 2005, CURR MICROBIOL, V50, P11, DOI 10.1007/s00284-004-4391-7; Singh G, 2009, LAND DEGRAD DEV, V20, P367, DOI 10.1002/ldr.933; Stepkowski T, 2003, SYST APPL MICROBIOL, V26, P483, DOI 10.1078/072320203770865765; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047677; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Thrall PH, 2005, J APPL ECOL, V42, P740, DOI 10.1111/j.1365-2664.2005.01058.x; Turner SL, 2002, FEMS MICROBIOL ECOL, V42, P227, DOI 10.1111/j.1574-6941.2002.tb01012.x; Turner SL, 2000, MOL BIOL EVOL, V17, P309, DOI 10.1093/oxfordjournals.molbev.a026311; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; van Asten PJA, 2003, AGR WATER MANAGE, V60, P13, DOI 10.1016/S0378-3774(02)00155-5; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vincent JM., 1970, MANUAL PRATICAL STUD; Vinuesa P, 2005, SYST APPL MICROBIOL, V28, P702, DOI 10.1016/j.syapm.2005.05.007; Vriezen JAC, 2007, APPL ENVIRON MICROB, V73, P3451, DOI 10.1128/AEM.02991-06; Wade TK, 2014, SYST APPL MICROBIOL, V37, P129, DOI 10.1016/j.syapm.2013.10.002; Wang ET, 2003, ARCH MICROBIOL, V180, P444, DOI 10.1007/s00203-003-0610-z; Wang SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-440; Wei GH, 2008, PEDOSPHERE, V18, P102, DOI 10.1016/S1002-0160(07)60108-8; Wei GH, 2007, CHEM BIODIVERS, V4, P893, DOI 10.1002/cbdv.200790077; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; ZOU N, 1995, SOIL BIOL BIOCHEM, V27, P409, DOI 10.1016/0038-0717(95)98611-Q	75	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117667	10.1371/journal.pone.0117667	http://dx.doi.org/10.1371/journal.pone.0117667			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658650	Green Published, gold			2022-12-26	WOS:000349444900199
J	Karblane, K; Gerassimenko, J; Nigul, L; Piirsoo, A; Smialowska, A; Vinkel, K; Kylsten, P; Ekwall, K; Swoboda, P; Truve, E; Sarmiento, C				Kaerblane, Kairi; Gerassimenko, Jelena; Nigul, Lenne; Piirsoo, Alla; Smialowska, Agata; Vinkel, Kadri; Kylsten, Per; Ekwall, Karl; Swoboda, Peter; Truve, Erkki; Sarmiento, Cecilia			ABCE1 Is a Highly Conserved RNA Silencing Suppressor	PLOS ONE			English	Article							L INHIBITOR; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN INTERACTS; INTERFERING RNA; RISC ACTIVATION; GENE; TRANSLATION; PATHWAY; BIOGENESIS	ATP-binding cassette sub-family E member 1 (ABCE1) is a highly conserved protein among eukaryotes and archaea. Recent studies have identified ABCE1 as a ribosome-recycling factor important for translation termination in mammalian cells, yeast and also archaea. Here we report another conserved function of ABCE1. We have previously described AtRLI2, the homolog of ABCE1 in the plant Arabidopsis thaliana, as an endogenous suppressor of RNA silencing. In this study we show that this function is conserved: human ABCE1 is able to suppress RNA silencing in Nicotiana benthamiana plants, in mammalian HEK293 cells and in the worm Caenorhabditis elegans. Using co-immunoprecipitation and mass spectrometry, we found a number of potential ABCE1-interacting proteins that might support its function as an endogenous suppressor of RNA interference. The interactor candidates are associated with epigenetic regulation, transcription, RNA processing and mRNA surveillance. In addition, one of the identified proteins is translin, which together with its binding partner TRAX supports RNA interference.	[Kaerblane, Kairi; Gerassimenko, Jelena; Nigul, Lenne; Piirsoo, Alla; Vinkel, Kadri; Truve, Erkki; Sarmiento, Cecilia] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Kaerblane, Kairi; Gerassimenko, Jelena; Truve, Erkki; Sarmiento, Cecilia] Competence Ctr Canc Res, Tallinn, Estonia; [Smialowska, Agata; Kylsten, Per; Ekwall, Karl] Sodertorn Univ Coll, Sch Life Sci, S-14189 Huddinge, Sweden; [Smialowska, Agata; Ekwall, Karl; Swoboda, Peter] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Tallinn University of Technology; Competence Centre for Cancer Research; Sodertorn University; Karolinska Institutet	Sarmiento, C (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	cecilia.sarmiento@ttu.ee	Mõttus, Jelena/AAC-9357-2020; SARMIENTO, Cecilia/G-6291-2016; Piirsoo, Alla/G-5890-2017	Mõttus, Jelena/0000-0001-5573-0623; SARMIENTO, Cecilia/0000-0002-8011-1370; Swoboda, Peter/0000-0001-6416-8572; Ekwall, Karl/0000-0002-3029-4041; Karblane, Kairi/0000-0002-1418-2760	EU through the European Regional Development Fund [EU30013]; Estonian Ministry of Education and Research [IUT 193]; Swedish Foundation for Baltic and East European Studies [300501]	EU through the European Regional Development Fund; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Foundation for Baltic and East European Studies	This work was supported by the EU through the European Regional Development Fund (to Centre of Excellence ENVIRON and to Competence Center for Cancer Research via Enterprise Estonia grant EU30013) and by institutional research funding IUT 193 of the Estonian Ministry of Education and Research and by the Swedish Foundation for Baltic and East European Studies (grant 300501 to PK, PS and KE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Christie M, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00099; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dumesic PA, 2013, RNA BIOL, V10, P1653, DOI 10.4161/rna.26800; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hopfner KP, 2012, BIOL CHEM, V393, P1079, DOI 10.1515/hsz-2012-0196; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Maloverjan A, 2010, J BIOL CHEM, V285, P30079, DOI 10.1074/jbc.M110.133991; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Maloveryan A, 2007, J CELL COMMUN SIGNAL, V1, P165, DOI 10.1007/s12079-007-0014-y; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Melnyk CW, 2011, CURR BIOL, V21, P1678, DOI 10.1016/j.cub.2011.08.065; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Olspert A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-19; Olspert A, 2011, J GEN VIROL, V92, P445, DOI 10.1099/vir.0.026476-0; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Popova B, 2006, NUCLEIC ACIDS RES, V34, P773, DOI 10.1093/nar/gkj465; R Core Team, 2018, R LANG ENV STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu S KW, 1997, FIRELAB 1997 VECTOR; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Zhuang JJ, 2012, PARASITOLOGY, V139, P560, DOI 10.1017/S0031182011001788	59	11	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116702	10.1371/journal.pone.0116702	http://dx.doi.org/10.1371/journal.pone.0116702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659154	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900060
J	Moilanen, LJ; Hamalainen, M; Lehtimaki, L; Nieminen, RM; Moilanen, E				Moilanen, Lauri J.; Hamalainen, Mari; Lehtimaki, Lauri; Nieminen, Riina M.; Moilanen, Eeva			Urate Crystal Induced Inflammation and Joint Pain Are Reduced in Transient Receptor Potential Ankyrin 1 Deficient Mice - Potential Role for Transient Receptor Potential Ankyrin 1 in Gout	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ANKLE JOINT; A1 TRPA1; MODEL; HYPERALGESIA; EXPRESSION; CALCIUM; STIMULATION; MECHANISMS; ARTHRITIS	Introduction In gout, monosodium urate (MSU) crystals deposit intra-articularly and cause painful arthritis. In the present study we tested the hypothesis that Transient Receptor Poten-tial Ankyrin 1 (TRPA1), an ion channel mediating nociceptive signals and neurogenic in-flammation, is involved in MSU crystal-induced responses in gout by utilizing three experi-mental murine models. Methods The effects of selective pharmacological inhibition (by HC-030031) and genetic depletion of TRPA1 were studied in MSU crystal-induced inflammation and pain by using 1) spontaneous weight-bearing test to assess MSU crystal-induced joint pain, 2) subcutaneous air-pouch model resembling joint inflammation to measure MSU crystal-induced cytokine production and inflammatory cell accumulation, and 3) MSU crystal-induced paw edema to assess acute vascular inflammatory responses and swelling. Results Intra-articularly injected MSU crystals provoked spontaneous weight shift off from the affected limb in wild type but not in TRPA1 knock-out mice referring alleviated joint pain in TRPA1 deficient animals. MSU crystal-induced inflammatory cell infiltration and accumulation of cytokines MCP-1, IL-6, IL-1beta, MPO, MIP-1alpha and MIP-2 into subcu-taneous air-pouch (resembling joint cavity) was attenuated in TRPA1 deficient mice and in mice treated with the selective TRPA1 inhibitor HC-030031 as compared to control animals. Further, HC-030031 treated and TRPA1 deficient mice developed tempered inflammatory edema when MSU crystals were injected into the paw. Conclusions TRPA1 mediates MSU crystal-induced inflammation and pain in experimental models supporting the role of TRPA1 as a potential mediator and a drug target in gout flare.	[Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	eeva.moilanen@uta.fi		Lehtimaki, Lauri/0000-0003-1586-4998; Hamalainen, Mari/0000-0002-6409-3758	Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; Finnish Medical Society Duodecim, Finland; Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland	Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; Finnish Medical Society Duodecim, Finland; Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland	The study was supported by grants from Medical Research Fund of Tampere University Hospital, Tampere, Finland; Tampere Tuberculosis Foundation, Tampere, Finland; The Finnish Medical Society Duodecim, Finland and Tampereen Reumayhdistys Patient Organization for Rheumatoid Arthritis, Tampere, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; [Anonymous], 2003, ASSAY INTRACELLULAR; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Capasso R, 2012, BRIT J PHARMACOL, V165, P1966, DOI 10.1111/j.1476-5381.2011.01703.x; CODERRE TJ, 1987, PAIN, V28, P379, DOI 10.1016/0304-3959(87)90072-8; de Oliveira C, 2014, J NEUROSCI, V34, P4445, DOI 10.1523/JNEUROSCI.5387-13.2014; DeBerry JJ, 2014, PAIN, V155, P1280, DOI 10.1016/j.pain.2014.03.023; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; DENKO CW, 1976, J RHEUMATOL, V3, P54; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Forrest MJ, 1988, HDB ANIMAL MODELS RH, P125; Graepel R, 2011, J PHARMACOL EXP THER, V337, P117, DOI 10.1124/jpet.110.172403; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hatano N, 2012, J BIOL CHEM, V287, P31962, DOI 10.1074/jbc.M112.361139; Jain A, 2011, PAIN, V152, P2765, DOI 10.1016/j.pain.2011.08.025; Jakobsson PJ, 2010, NAT REV RHEUMATOL, V6, P679, DOI 10.1038/nrrheum.2010.175; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089062; Koivisto A, 2014, BASIC CLIN PHARMACOL, V114, P50, DOI 10.1111/bcpt.12138; Korhonen R, 2001, BIOCHEM J, V354, P351, DOI 10.1042/0264-6021:3540351; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lunam CA, 2004, NEUROSCI LETT, V354, P87, DOI 10.1016/S0304-3940(03)00575-5; Moilanen LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00380; Nassini R, 2014, REV PHYSL BIOCH PHAR; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; OTSUKI T, 1986, BRAIN RES, V365, P235, DOI 10.1016/0006-8993(86)91634-3; Perin-Martins A, 2013, J PERIPHER NERV SYST, V18, P62, DOI 10.1111/jns5.12010; Punzi L, 2012, AUTOIMMUN REV, V12, P66, DOI 10.1016/j.autrev.2012.07.024; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Torres R, 2009, ANN RHEUM DIS, V68, P1602, DOI 10.1136/ard.2009.109355; Trevisan G, 2014, FREE RADICAL BIO MED, V72, P200, DOI 10.1016/j.freeradbiomed.2014.04.021; Trevisan G, 2013, ARTHRITIS RHEUM-US, V65, P2984, DOI 10.1002/art.38112; Trevisan G, 2013, CANCER RES, V73, P3120, DOI 10.1158/0008-5472.CAN-12-4370; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	41	36	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117770	10.1371/journal.pone.0117770	http://dx.doi.org/10.1371/journal.pone.0117770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658427	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900216
J	Oh, IH; Park, JH; Lee, CH; Park, JS				Oh, Il Hwan; Park, Jung Hwan; Lee, Chang Hwa; Park, Joon-Sung			The Association of Normal Range Glycated Hemoglobin with Restrictive Lung Pattern in the General Population	PLOS ONE			English	Article							VASCULAR COMPLICATIONS; SYSTEMIC INFLAMMATION; PULMONARY-FUNCTION; GAS-EXCHANGE; PREVALENCE; MECHANISMS; MARKER	Glycated hemoglobin (HbA1c) is an important diagnostic indicator of diabetes mellitus, and some authors have argued that it is related to impaired lung function in the diabetic population. However, there was rare study for association between lung function and HbA1c in the non-diabetic population. We investigated whether HbA1c below the diagnostic threshold is related to deficits in lung function. We analyzed biochemical and spirometry data from a nation-wide, population-based, case-control study (the KNHANES IV and V). Eligible as cases were all native Koreans aged 40 years or more with no medical illness. A total of 3670 participants were divided into 4 groups according to HbA1c (%) as follows: Group I (n = 842), >= 4.0 and <= 5.3; Group II (n = 833), >5.3 and <= 5.5; Group III (n = 898), >5.5 and <= 5.7; and Group IV (n = 1097), >5.7 and <= 6.4. Group I had the greatest forced vital capacity (FVC, 96.3 +/- 0.5% pred, P < 0.0001), forced expiratory volume per second (FEV1, 93.8 +/- 0.5% pred, P < 0.0001) and FEV1/FVC (0.792 +/- 0.003, P < 0.0001) compared with the other groups. Linear regression showed that HbA1c was closely related to FVC (beta = -6.972154, P < 0.0001) and FEV1 (beta = -5.591589, P < 0.0001), but not to FEV1/FVC. Logistic regression analysis revealed a significant association between HbA1c and a restrictive spirometric pattern (FVC < 80% pred., FEV1/FVC >= 0.70; OR = 3.772, 95% CI = 1.234-11.53), indicating that elevated HbA1c is closely associated with lung impairment in the non-diabetic population. In the healthy population, relatively high HbA1c level is associated with decrements of FVC and FEV1 and may be a reliable predictor of poor lung function, especially the restrictive pattern.	[Oh, Il Hwan; Park, Jung Hwan; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea	Hanyang University	Lee, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr	Park, Jung Hwan/AAA-1951-2022	Park, Jung Hwan/0000-0003-3941-4836	fund of Hanyang University [HY-2014-N]	fund of Hanyang University	This work was supported by the research fund of Hanyang University (HY-2014-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anandhalakshmi S, 2013, J CLIN DIAGN RES, V7, P1874, DOI 10.7860/JCDR/2013/6550.3339; ASANUMA Y, 1985, Diabetes Research and Clinical Practice, V1, P95, DOI 10.1016/S0168-8227(85)80034-6; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Chung JH, 2014, COPD IN PRESS; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Furuya A, 2014, CLIN CHIM ACTA, V436, P93, DOI 10.1016/j.cca.2014.05.005; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Kalhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011431; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Klein OL, 2010, DIABETIC MED, V27, P977, DOI 10.1111/j.1464-5491.2010.03073.x; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076244; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McKeever TM, 2005, AM J EPIDEMIOL, V161, P546, DOI 10.1093/aje/kwi076; Milman S, 2011, MED CLIN N AM, V95, P309, DOI 10.1016/j.mcna.2010.11.004; OFULUE AF, 1988, AM REV RESPIR DIS, V138, P284, DOI 10.1164/ajrccm/138.2.284; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira LMP, 2013, J THORAC DIS, V5, P289, DOI 10.3978/j.issn.2072-1439.2012.07.06; Sokolov EI, 2008, TERAPEVT ARKH, V80, P63; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; van den Borst B, 2010, CHEST, V138, P393, DOI 10.1378/chest.09-2622; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324; Watanabe K, 1997, RESP MED, V91, P406, DOI 10.1016/S0954-6111(97)90254-7; Weynand B, 1999, RESPIRATION, V66, P14, DOI 10.1159/000029331; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117725	10.1371/journal.pone.0117725	http://dx.doi.org/10.1371/journal.pone.0117725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658743	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900209
J	Orikiriza, P; Tibenderana, B; Siedner, MJ; Mueller, Y; Byarugaba, F; Moore, CC; Evans, EE; Bonnet, M; Page, AL; Bazira, J; Boum, Y				Orikiriza, Patrick; Tibenderana, Becky; Siedner, Mark J.; Mueller, Yolanda; Byarugaba, Frederick; Moore, Christopher C.; Evans, Emily E.; Bonnet, Maryline; Page, Anne-Laure; Bazira, Joel; Boum, Yap, II			Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS	Background There are limited data on region-specific drug susceptibility of tuberculosis (TB) in Uganda. We performed resistance testing on specimens collected from treatment-naive patients with pulmonary TB in Southwestern Uganda for first and second line anti-TB drugs. We sought to provide data to guide regional recommendations for empiric TB therapy. Methods Archived isolates, obtained from patients at Mbarara Regional Referral Hospital from February 2009 to February 2013, were tested for resistance to isoniazid and rifampicin using the MTBDRplus and Xpert MTB/RIF assays. A subset of randomly selected isolates was tested for second line agents, including fluoroquinolones (FQs), aminoglycosides, cyclic peptides, and ethambutol using the MTBDRs/assay. We performed confirmatory testing for FQ resistance using repeated MTBDRs/, the Mycobacteria growth indicator tube (MGIT) assay, and sequencing of the gyrA and gyrB genes. Results We tested isolates from 190 patients. The cohort had a median age of 33 years (IQR 2643), 69% (131/190) were male, and the HIV prevalence was 42% (80/190). No isolates (0/190) were rifampicin-resistant and only 1/190 (0.5%) was isoniazid-resistant. Among 92 isolates tested for second-line drug resistance, 71 (77%) had interpretable results, of which none were resistant to aminoglycosides, cyclic peptides or ethambutol. Although 7 (10%) initially tested as resistant to FQs by the MTBDRs/assay, they were confirmed as susceptible by repeat MTBDRs/testing as well as by MGIT and gyrase gene sequencing. Conclusion We found no MDR-TB and no resistance to ethambutol, FQs, or injectable anti-TB drugs in treatment naive patients with pulmonary TB in Southwestern Uganda. Standard treatment guidelines for susceptible TB should be adequate for most patients with TB in this population. Where possible, molecular susceptibility testing methods should be routinely validated by culture methods.	[Orikiriza, Patrick; Mueller, Yolanda; Boum, Yap, II] Epictr Mbarara Res Ctr, Mbarara, Uganda; [Orikiriza, Patrick; Byarugaba, Frederick; Bazira, Joel; Boum, Yap, II] Mbarara Univ Sci & Technol, Dept Microbiol, Mbarara, Uganda; [Tibenderana, Becky; Moore, Christopher C.] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda; [Siedner, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Siedner, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Moore, Christopher C.; Evans, Emily E.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Bonnet, Maryline; Page, Anne-Laure] Epictr Paris, Paris, France	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Virginia	Boum, Y (corresponding author), Epictr Mbarara Res Ctr, Mbarara, Uganda.	yap.boum@epicentre.msf.org	Mueller, Yolanda/AAH-3571-2019	Mueller, Yolanda/0000-0002-8861-4538	Office of Global AIDS Coordinator [5R24TW008886]; U.S. Department of Health and Human Services; Health Resources and Services Administration; National Institutes of Health; Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.; National Institutes of Health [K23 MH099916]; MSF; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER	Office of Global AIDS Coordinator; U.S. Department of Health and Human Services; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSF; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U.S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. Funding for the study was also provided in part by the Pfizer Initiative in International Health and the Center for Global Health at the University of Virginia. This initiative was conceived to fund global infectious disease research and exchange programs between post-doctoral fellows and students from the University of Virginia and several international partners to conduct research on global health issues. The major purpose of this program is to foster and enhance bidirectional research training. An independent board at the University of Virginia determines which research proposals are funded. Pfizer, Inc. provided funds to promote the Initiative but has no role in the planning or execution of research protocols, including the study described in the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJS receives support from National Institutes of Health K23 MH099916. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the government. The authors appreciate MSF for funding the studies from which isolates were collected for this sub-study and Uganda Research Student Support Fund (URSSF) for linking the study team.	Bazira J, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-5; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Kaswa MK, 2014, J CLIN MICROBIOL, V52, P2876, DOI 10.1128/JCM.00398-14; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Ongaya VA, 2012, AFR J HLTH SCI, V20, P77; Organization WH, 2012, WHOHTMTB2012, V6; Uganda MOH, 2010, NAT GUID MAN COMM CO; Umubyeyi A, 2008, INT J INFECT DIS, V12, P152, DOI 10.1016/j.ijid.2007.05.003; van den Boogaard J, 2011, J ANTIMICROB CHEMOTH, V66, P1810, DOI 10.1093/jac/dkr205; Van Deun A, 2013, J CLIN MICROBIOL, DOI [10.1128/JCM.02925-13, DOI 10.1128/JCM.02925-13]; World Health Organization, 2008, MOL LIN PROB ASS RAP	12	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118191	10.1371/journal.pone.0118191	http://dx.doi.org/10.1371/journal.pone.0118191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658921	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900274
J	Salemi, LM; Loureiro, SO; Schild-Poulter, C				Salemi, Louisa M.; Loureiro, Sandra O.; Schild-Poulter, Caroline			Characterization of RanBPM Molecular Determinants that Control Its Subcellular Localization	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; NUCLEAR-LOCALIZATION; BINDING-PROTEIN; GID COMPLEX; MICROTUBULE DYNAMICS; CELL-MIGRATION; INTERACTS; TRANSPORT; SIGNALS; HDAC6	RanBPM/RanBP9 is a ubiquitous, nucleocytoplasmic protein that is part of an evolutionary conserved E3 ubiquitin ligase complex whose function and targets in mammals are still unknown. RanBPM itself has been implicated in various cellular processes that involve both nuclear and cytoplasmic functions. However, to date, little is known about how RanBPM subcellular localization is regulated. We have conducted a systematic analysis of RanBPM regions that control its subcellular localization using RanBPM shRNA cells to examine ectopic RanBPM mutant subcellular localization without interference from the endogenously expressed protein. We show that several domains and motifs regulate RanBPM nuclear and cytoplasmic localization. In particular, RanBPM comprises two motifs that can confer nuclear localization, one proline/glutamine-rich motif in the extreme N-terminus which has a dominant effect on RanBPM localization, and a second motif in the C-terminus which minimally contributes to RanBPM nuclear targeting. We also identified a nuclear export signal (NES) which mutation prevented RanBPM accumulation in the cytoplasm. Likewise, deletion of the central RanBPM conserved domains (SPRY and LisH/CTLH) resulted in the relocalization of RanBPM to the nucleus, suggesting that RanBPM cytoplasmic localization is also conferred by protein-protein interactions that promote its cytoplasmic retention. Indeed we found that in the cytoplasm, RanBPM partially colocalizes with microtubules and associates with a-tubulin. Finally, in the nucleus, a significant fraction of RanBPM is associated with chromatin. Altogether, these analyses reveal that RanBPM subcellular localization results from the combined effects of several elements that either confer direct transport through the nucleocytoplasmic transport machinery or regulate it indirectly, likely through interactions with other proteins and by intramolecular folding.	[Schild-Poulter, Caroline] Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, London, ON, Canada; Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Schild-Poulter, C (corresponding author), Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, London, ON, Canada.	cschild-poulter@robarts.ca	Schild-Poulter, Caroline/K-4476-2013		Canadian Institutes for Health Research (CIHR) [MOP-114958]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grant [MOP-114958] from the Canadian Institutes for Health Research (CIHR) to CSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabakhsh E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047803; Atabakhsh E, 2012, AM J CANCER RES, V2, P549; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Bala S, 2006, BIOCHEM BIOPH RES CO, V342, P1040, DOI 10.1016/j.bbrc.2006.02.060; Barry DM, 2000, ESSAYS BIOCHEM, V36, P89, DOI 10.1042/bse0360089; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; d'Ydewalle C, 2012, TRAFFIC, V13, P771, DOI 10.1111/j.1600-0854.2012.01347.x; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Korlimarla A, 2013, CELL MOL BIOL LETT, V18, P284, DOI 10.2478/s11658-013-0088-x; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mikolajczyk M, 2003, BIOCHEM BIOPH RES CO, V310, P14, DOI 10.1016/j.bbrc.2003.08.116; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Poirier MB, 2006, J MOL ENDOCRINOL, V36, P313, DOI 10.1677/jme.1.01891; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Salemi LM, 2014, BIOL OPEN, V3, P418, DOI 10.1242/bio.20147021; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang L, 2012, MOL CELL BIOCHEM, V359, P83, DOI 10.1007/s11010-011-1002-3; Wei JD, 2013, J BIOL CHEM, V288, P26753, DOI 10.1074/jbc.M113.470260; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200; Zuccotti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052867	67	18	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117655	10.1371/journal.pone.0117655	http://dx.doi.org/10.1371/journal.pone.0117655			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659156	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900195
J	Weng, HC; Endo, K; Li, JW; Kito, N; Iwai, N				Weng, Huachun; Endo, Kosuke; Li, Jiawei; Kito, Naoko; Iwai, Naoharu			Induction of Peroxisomes by Butyrate-Producing Probiotics	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; PPAR-ALPHA; HEPATIC STEATOSIS; INULIN; DIET; PROLIFERATION; PEX11-ALPHA; DEFICIENCY; ELONGATION; DIVISION	We previously found that peroxisomal biogenesis factor 11a (Pex11a) deficiency is associated with a reduction in peroxisome abundance and impaired fatty acid metabolism in hepatocytes, and results in steatosis. In the present study, we investigated whether butyrate induces Pex11a expression and peroxisome proliferation, and studied its effect on lipid metabolism. C57BL/ 6 mice fed standard chow or a high-fat diet (HFD) were treated with tributyrin, 4-phelybutyrate acid (4-PBA), or the butyrate-producing probiotics (Clostridium butyricum MIYAIRI 588 [CBM]) plus inulin (dietary fiber), and the body weight, white adipose tissue, serum triglycerides, mRNA expression, and peroxisome abundance were evaluated. Tributyrin or 4-PBA treatment significantly decreased body weight and increased hepatic mRNA expression of peroxisome proliferator-activated receptor-alpha (PPAR alpha) and Pex11a. In addition, 4-PBA treatment increased peroxisome abundance and the expression of genes involved in peroxisomal fatty acid beta-oxidation (acyl-coenzyme A oxidase 1 and hydroxysteroid [17-beta] dehydrogenase 4). CBM and inulin administration reduced adipose tissue mass and serum triglycerides, induced Pex11a, acyl-coenzyme A oxidase 1, and hydroxysteroid (17-beta) dehydrogenase 4 genes, and increased peroxisome abundance in mice fed standard chow or an HFD. In conclusion, elevation of butyrate availability (directly through administration of butyrate or indirectly via administration of butyrate-producing probiotics plus fiber) induces PPAR alpha and Pex11a and the genes involved in peroxisomal fatty acid beta-oxidation, increases peroxisome abundance, and improves lipid metabolism. These results may provide a new therapeutic strategy against hyperlipidemia and obesity.	[Weng, Huachun; Endo, Kosuke; Li, Jiawei; Kito, Naoko; Iwai, Naoharu] Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Res Inst, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan	Weng, HC (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Res Inst, Suita, Osaka, Japan.	weng@ncvc.go.jp; iwai@ncvc.go.jp	Endo, Kosuke/C-6038-2015; Kito, Naoko/D-3077-2018; Li, Jiawei/GXM-4151-2022	Kito, Naoko/0000-0002-6926-5053; 	Adaptable and Seamless Technology Transfer Program through Target-driven RD, Japan [AS251Z00329Q]	Adaptable and Seamless Technology Transfer Program through Target-driven RD, Japan	This research was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan (AS251Z00329Q). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kaur N, 2002, J BIOSCIENCES, V27, P703, DOI 10.1007/BF02708379; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, pE272, DOI 10.1152/ajpendo.00053.2012; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Seo M, 2013, DIGEST DIS SCI, V58, P3534, DOI 10.1007/s10620-013-2879-3; Sugatani J, 2006, DRUG METAB DISPOS, V34, P1677, DOI 10.1124/dmd.106.010645; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weng HC, 2014, HYPERTENSION, V64, P1054, DOI 10.1161/HYPERTENSIONAHA.114.04094; Weng HC, 2013, AM J PHYSIOL-ENDOC M, V304, pE187, DOI 10.1152/ajpendo.00425.2012; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	26	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117851	10.1371/journal.pone.0117851	http://dx.doi.org/10.1371/journal.pone.0117851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659146	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900231
J	Zou, JM; Dai, W; Gong, SX; Ma, ZY				Zou, Jianmei; Dai, Wei; Gong, Shengxuan; Ma, Zeyu			Analysis of Spatial Variations and Sources of Heavy Metals in Farmland Soils of Beijing Suburbs	PLOS ONE			English	Article							MERCURY	To understand the effect of intense human activities in suburbs on environmental quality, we obtained 758 measurements of the heavy metals in certain farmland soils of the Beijing suburbs. Multivariate statistical analysis and geostatistical analysis were used to conduct a basic analysis of the heavy metal concentrations, the distribution characteristics and the sources of pollution of the farmland soils in these suburbs. The results showed the presence of eight heavy metals in the agricultural soils at levels exceeding the background values for As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn. In particular, all the measured Cr concentrations exceeded the background value, while As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn were present at 1.13, 1.68, 1.95, 1.43, 1.63, 0.79, 0.92 and 1.36 times their background values, respectively. The results of correlation, factor and spatial structure analyses showed that Cd, Cu, Pb and Zn were strongly homologous, whereas Cr and Hg showed a degree of heterogeneity. The analysis further indicated that in addition to natural factors, Cd, Cu, Pb and Zn in the soil were mainly associated with distribution from road traffic and land use status. Different agricultural production measures in the various areas were also important factors that affected the spatial distribution of the soil Cr concentration. The major sources of Hg pollution were landfills for industrial waste and urban domestic garbage, while the spatial distribution of As was more likely to be a result of composite pollution. The regional distribution of the heavy metals indicated that except for Cr and Hg, the high heavy metal levels occurred in districts and counties with higher organic matter concentrations, such as the northwestern and southeastern suburbs of Beijing. There was no significant Ni pollution in the agricultural soils of the Beijing suburbs.	[Zou, Jianmei; Dai, Wei; Gong, Shengxuan; Ma, Zeyu] Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China	Beijing Forestry University	Dai, W (corresponding author), Beijing Forestry Univ, Coll Forestry, 35 Qing Hua East Rd, Beijing 100083, Peoples R China.	daiwei1@bjfu.edu.cn			Fundamental Research Funds for Central University [BLYJ201308]; Major Project of Science and Technology of Beijing [D09040903780801]	Fundamental Research Funds for Central University; Major Project of Science and Technology of Beijing	The research was sponsored by the Fundamental Research Funds for Central University (Grant No. BLYJ201308) and the Major Project of Science and Technology of Beijing (Grant NO. D09040903780801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caceres DD, 2005, ENVIRON RES, V98, P151, DOI 10.1016/j.envres.2005.02.007; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Chen Tong-bin, 2004, Huanjing Kexue, V25, P117; Cheng JZ, 2005, J ENVIRON SCI, V42, P149; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Goovaerts P, 1997, GEOSTATISTICS NATURA, P19; Huo XiaoNi, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P223; Kelly J, 1996, APPL GEOCHEM, V11, P363, DOI 10.1016/0883-2927(95)00084-4; Kitagishi K, 1981, HEAVY METAL POLLUTIO, P3; Kocher B, 2005, PEDOSPHERE, V15, P746; Li J, 1989, DATA MANUAL ENV BACK; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Lin YP, 2002, LANDSCAPE URBAN PLAN, V62, P19, DOI 10.1016/S0169-2046(02)00094-4; Lindstrom M, 2001, WATER AIR SOIL POLL, V126, P363, DOI 10.1023/A:1005291611702; Lu JY, 1998, ANAL CHEM, V70, P2403, DOI 10.1021/ac971278l; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; PETERSEN G, 1995, ATMOS ENVIRON, V29, P47, DOI 10.1016/1352-2310(94)00223-8; Sutherland RA, 2000, ARCH ENVIRON CON TOX, V38, P428, DOI 10.1007/s002449910057; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Wu WenYong, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P165; [姚荣江 Yao Rongjiang], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1912; Zhang JL, 2012, ELECTROCATALYSIS-US, V3, P161, DOI 10.1007/s12678-012-0116-z; [郑袁明 Zheng Yuanming], 2003, [地理学报, Acta Geographica Sinica], V58, P470; Zhong XiaoLan, 2007, Acta Pedologica Sinica, V44, P33; Zhu XF, 2010, J ENVIRON SCI, V30, P2553; Zou JianMei, 2013, Journal of Beijing Forestry University, V35, P132	27	28	30	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118082	10.1371/journal.pone.0118082	http://dx.doi.org/10.1371/journal.pone.0118082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658749	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900263
J	Bailey, JK; Fields, AT; Cheng, KJ; Lee, A; Wagenaar, E; Lagrois, R; Schmidt, B; Xia, B; Ma, D				Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai			WD Repeat-containing Protein 5 (WDR5) Localizes to the Midbody and Regulates Abscission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE LEUKEMIA; HISTONE H3 LYSINE-4; STRUCTURAL BASIS; ESCRT-III; MOLECULAR RECOGNITION; SHOTGUN PROTEOMICS; SET1 FAMILY; CYTOKINESIS; METHYLATION; COMPLEX	Cytokinesis partitions the cytoplasm of a parent cell into two daughter cells and is essential for the completion of cell division. The final step of cytokinesis in animal cells is abscission, which is a process leading to the physical separation of two daughter cells. Abscission requires membrane traffic and microtubule disassembly at a specific midbody region called the secondary ingression. Here, we report that WD repeat-containing protein 5 (WDR5), a core subunit of COMPASS/MLL family histone H3 lysine 4 methyltransferase (H3K4MT) complexes, resides at the midbody and associates with a subset of midbody regulatory proteins, including PRC1 and CYK4/MKLP1. Knockdown of WDR5 impairs abscission and increases the incidence of multinucleated cells. Further investigation revealed that the abscission delay is primarily due to slower formation of secondary ingressions in WDR5 knockdown cells. Consistent with these defects, midbody microtubules in WDR5 knockdown cells also display enhanced resistance to depolymerization by nocodazole. Recruitment of WDR5 to the midbody dark zone appears to require integrity of the WDR5 central arginine-binding cavity, as mutations that disrupt histone H3 and MLL1 binding to this pocket also abolish the midbody localization of WDR5. Taken together, these data suggest that WDR5 is specifically targeted to the midbody in the absence of chromatin and that it promotes abscission, perhaps by facilitating midbody microtubule disassembly.	[Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Ma, D (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu		/0000-0002-6129-2938	Office of The Director, National Institutes of Health Award [S10OD010610]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086853] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010610] Funding Source: NIH RePORTER	Office of The Director, National Institutes of Health Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Cosgrove for the WDR5 S91K and F133A constructs, W. I. Sundquist for the CHMP1B anti-body, L. Johnson for the hTERT-RPE-1 cell line, and to the many undergraduates whose technical assistance contributed to this work. We also thank M. Glotzer for helpful suggestions, C. A. Vandenberg and K. R. Foltz for critically reading this manuscript, T. E. Kippin and K. K. Szumlinski for statistical advice, and Jennifer Knappe for editing assistance. We acknowledge the use of the NRI-MCDB Microscopy Facility and the Spectral Laser Scanning Confocal supported by the Office of The Director, National Institutes of Health Award S10OD010610.	Ali A, 2014, NUCLEIC ACIDS RES, V42, P7611, DOI 10.1093/nar/gku458; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dias J, 2014, GENE DEV, V28, P929, DOI 10.1101/gad.240200.114; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Ernst P, 2012, BRIEF FUNCT GENOMICS, V11, P217, DOI 10.1093/bfgp/els017; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; EUTENEUER U, 1980, J CELL BIOL, V87, P509, DOI 10.1083/jcb.87.2.509; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Goldsworthy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061870; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lafaurie-Janvore J, 2013, SCIENCE, V339, P1625, DOI 10.1126/science.1233866; Lee KY, 2012, J CELL SCI, V125, P3495, DOI 10.1242/jcs.094672; Li DW, 2005, CELL RES, V15, P120, DOI 10.1038/sj.cr.7290276; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4952; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Thoresen SB, 2014, NAT CELL BIOL, V16, P547, DOI 10.1038/ncb2959; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Townsend E., 2012, THESIS U MICHIGAN; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Xu ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009725; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhou H, 2008, MOL CELL BIOCHEM, V311, P45, DOI 10.1007/s11010-007-9692-2	82	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8987	9001		10.1074/jbc.M114.623611	http://dx.doi.org/10.1074/jbc.M114.623611			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666610	hybrid, Green Published			2022-12-26	WOS:000352207100025
J	Brown, NE; Goswami, D; Branch, MR; Ramineni, S; Ortlund, EA; Griffin, PR; Hepler, JR				Brown, Nicole E.; Goswami, Devrishi; Branch, Mary Rose; Ramineni, Suneela; Ortlund, Eric A.; Griffin, Patrick R.; Hepler, John R.			Integration of G Protein alpha (G alpha) Signaling by the Regulator of G Protein Signaling 14 (RGS14)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; DISSOCIATION INHIBITOR; DOMAIN; COMPLEX; BINDING	RGS14 contains distinct binding sites for both active (GTP-bound) and inactive (GDP-bound) forms of G alpha subunits. The N-terminal regulator of G protein signaling (RGS) domain binds active G alpha(i/o)-GTP, whereas the C-terminal G protein regulatory (GPR) motif binds inactive G alpha(i1/3)-GDP. The molecular basis for how RGS14 binds different activation states of G alpha proteins to integrate G protein signaling is unknown. Here we explored the intramolecular communication between the GPR motif and the RGS domain upon G protein binding and examined whether RGS14 can functionally interact with two distinct forms of G alpha subunits simultaneously. Using complementary cellular and biochemical approaches, we demonstrate that RGS14 forms a stable complex with inactive G alpha(i1)-GDP at the plasma membrane and that free cytosolic RGS14 is recruited to the plasma membrane by activated G alpha(o)-AlF4-. Bioluminescence resonance energy transfer studies showed that RGS14 adopts different conformations in live cells when bound to G alpha in different activation states. Hydrogen/deuterium exchange mass spectrometry revealed that RGS14 is a very dynamic protein that undergoes allosteric conformational changes when inactive G alpha(i1)-GDP binds the GPR motif. Pure RGS14 forms a ternary complex with G alpha(o)-AlF4- and an AlF4--insensitive mutant (G42R) of G alpha(i1)-GDP, as observed by size exclusion chromatography and differential hydrogen/deuterium exchange. Finally, a preformed RGS14 center dot G alpha(i1)-GDP complex exhibits full capacity to stimulate the GTPase activity of G alpha(o)-GTP, demonstrating that RGS14 can functionally engage two distinct forms of G alpha subunits simultaneously. Based on these findings, we propose a working model for how RGS14 integrates multiple G protein signals in host CA2 hippocampal neurons to modulate synaptic plasticity.	[Brown, Nicole E.; Branch, Mary Rose; Ramineni, Suneela; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Emory University; Emory University; Scripps Research Institute	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd,Rollins Res Ctr Suite G205, Atlanta, GA 30322 USA.	jhepler@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Brown, Nicole/0000-0002-3184-0550	National Institutes of Health [5R01NS037112, 5R21NS074975]; National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant [T32M008602]; Emory URC grant; American Heart Association [14PRE18850017, 14GRNT20460124]; Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health [P30NS055077]; National Institute of Mental Health [U54MH074404]; National Institutes of Health, NIDDK [R01DK095750]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602, R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R21NS074975, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory URC grant; American Heart Association(American Heart Association); Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS037112 and 5R21NS074975 (to J. R. H.) and National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant T32M008602 (to Emory University in support of N. E. B.). Additional support was provided by an Emory URC grant (to J. R. H.) and American Heart Association Predoctoral Grant 14PRE18850017 (to N. E. B.). This project was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant P30NS055077.; Supported by National Institute of Mental Health Grant U54MH074404.; Supported by National Institutes of Health, NIDDK, Grant R01DK095750 and American Heart Association Grant-in-aid 14GRNT20460124.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Bosch DE, 2011, J BIOL CHEM, V286, P3351, DOI 10.1074/jbc.M110.190496; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Evans P. R., 2012, 42 ANN M SOC NEUR NE; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goswami D, 2014, STRUCTURE, V22, P961, DOI 10.1016/j.str.2014.04.013; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hollinger Susanne, 2003, V237, P205; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Landgraf RR, 2013, STRUCTURE, V21, P1942, DOI 10.1016/j.str.2013.08.023; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Marciano DP, 2014, CURR OPIN STRUC BIOL, V28, P105, DOI 10.1016/j.sbi.2014.08.007; Mittal V, 2006, BIOCHEM J, V394, P309, DOI 10.1042/BJ20051086; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884	55	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9037	9049		10.1074/jbc.M114.634329	http://dx.doi.org/10.1074/jbc.M114.634329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666614	Green Published, hybrid			2022-12-26	WOS:000352207100028
J	Hansen, DB; Garrido-Comas, N; Salter, M; Fern, R				Hansen, Daniel Bloch; Garrido-Comas, Nestor; Salter, Mike; Fern, Robert			HCO3--independent pH Regulation in Astrocytes in Situ Is Dominated by V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT OPTIC-NERVE; CULTURED ASTROCYTES; WHITE-MATTER; H+-ATPASE; CELLS; GLIOGENESIS; HIPPOCAMPUS; COTRANSPORT; EXPRESSION; CAPACITY	The mechanisms of HCO3--independent intracellular pH (pH(i)) regulation were examined in fibrous astrocytes within isolated neonatal rat optic nerve (RON) and in cultured cortical astrocytes. In agreement with previous studies, resting pHi in cultured astrocytes was 6.82 +/- 0.06 and inhibition of the V-ATPase H+ pump by Cl- removal or via the selective inhibitor bafilomycin had only a small effect upon resting pHi and recovery following an acid load. In contrast, resting pH(i) in RON astrocytes was 7.10 +/- 0.04, significantly less acidic than that in cultured cells (p < 0.001), and responded to inhibition of V-ATPase with profound acidification to the 6.3-6.5 range. Fluorescent immuno-staining and immuno-gold labeling confirmed the presence V-ATPase in the cell membrane of RON astrocyte processes and somata. Using ammonia pulse recovery, pHi recovery in RON astrocyte was achieved largely via V-ATPase with sodium-proton exchange (NHE) playing a minor role. The findings indicate that astrocytes in a whole-mount preparation such as the optic nerve rely to a greater degree upon V-ATPase for HCO3--independent pHi regulation than do cultured astrocytes, with important functional consequences for the regulation of pH in the CNS.	[Hansen, Daniel Bloch; Fern, Robert] Univ Plymouth, Peninsula Sch Med, Plymouth PL6 8BU, Devon, England; [Hansen, Daniel Bloch; Fern, Robert] Univ Plymouth, Peninsula Sch Dent, Plymouth PL6 8BU, Devon, England; [Garrido-Comas, Nestor] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 7RH, Leics, England; [Salter, Mike] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Plymouth; University of Plymouth; University of Leicester; University of Leeds	Fern, R (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, John Bull Bldg,Res Way, Plymouth PL6 8BU, Devon, England.	robert.fern@plymouth.ac.uk		fern, robert/0000-0002-0625-3434; Hansen, Daniel Bloch/0000-0002-1250-4754	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J016969/1]; BBSRC [BB/J016969/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J016969/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J016969/1 (to R.F.).	Alix JJP, 2008, J PHYSIOL-LONDON, V586, P4069, DOI 10.1113/jphysiol.2008.155077; Amos BJ, 1998, J NEUROPHYSIOL, V79, P695, DOI 10.1152/jn.1998.79.2.695; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BOYARSKY G, 1993, GLIA, V8, P241, DOI 10.1002/glia.440080404; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Cengiz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084294; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Erlichman JS, 2004, AM J PHYSIOL-REG I, V286, pR289, DOI 10.1152/ajpregu.00245.2003; Fern R, 1998, J NEUROSCI, V18, P7232; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512; JEAN T, 1985, J BIOL CHEM, V260, P9678; KATSURA K, 1993, BRAIN RES, V618, P283, DOI 10.1016/0006-8993(93)91277-Y; KAUNITZ JD, 1985, J BIOL CHEM, V260, P1567; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Malnic G, 2000, J MEMBRANE BIOL, V178, P115, DOI 10.1007/s002320010019; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Mi HY, 1999, J NEUROSCI, V19, P1049; MINTURN JE, 1992, GLIA, V6, P19, DOI 10.1002/glia.440060104; NACHSHEN DA, 1988, J GEN PHYSIOL, V91, P289, DOI 10.1085/jgp.91.2.289; Newman EA, 1999, GLIA, V26, P302, DOI 10.1002/(SICI)1098-1136(199906)26:4<302::AID-GLIA4>3.0.CO;2-A; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; RANSOM BR, 1985, J NEUROSCI, V5, P532; Ransom BR, 1997, GLIA, V21, P134; Roberts EL, 1998, BRAIN RES, V779, P271, DOI 10.1016/S0006-8993(97)01120-7; ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P308, DOI 10.1007/BF00686089; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SHRODE LD, 1994, GLIA, V12, P196, DOI 10.1002/glia.440120305; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; STURROCK RR, 1975, J ANAT, V119, P223; TAKASHIMA S, 1983, ARCH NEUROL-CHICAGO, V40, P14, DOI 10.1001/archneur.1983.04050010034008; Thomas R, 2004, J NEUROPATH EXP NEUR, V63, P856, DOI 10.1093/jnen/63.8.856; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; VAUGHN JE, 1969, Z ZELLFORSCH MIK ANA, V94, P293, DOI 10.1007/BF00319179; Voipio J., 1994, MICROELECTRODE TECHN, V2, P275; WierzbaBobrowicz T, 1997, FOLIA NEUROPATHOL, V35, P29	48	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8039	8047		10.1074/jbc.M115.636597	http://dx.doi.org/10.1074/jbc.M115.636597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666621	Green Published, hybrid			2022-12-26	WOS:000351662600003
J	Wu, HW; Zhu, L; Zhang, H; Shi, XH; Zhang, L; Wang, WZ; Xue, HD; Liang, ZY				Wu, Huanwen; Zhu, Liang; Zhang, Hui; Shi, Xiaohua; Zhang, Li; Wang, Wenze; Xue, Huadan; Liang, Zhiyong			Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; FACTOR RECEPTOR; SIGNALING PATHWAY; TUMOR-CELLS; EXPRESSION; METASTASIS; SURVIVAL; ACTIVATION; AXIS	Background Epidermal growth factor receptor (EGFR) is highly expressed in pancreatic ductal adenocarcinoma (PDAC) and is involved in tumorigenesis and development. However, EGFR expression alone has limited clinical and prognostic significance. Recently, the cross-talk between EGFR and G-protein-coupled chemokine receptor CXCR4 has become increasingly recognized. Methods In the present study, immunohistochemical staining of EGFR and CXCR4 was performed on paraffin-embedded specimens from 131 patients with surgically resected PDAC. Subsequently, the associations between EGFR expression, CXCR4 expression, EGFR/CXCR4 coexpression and clinicopathologic factors were assessed, and survival analyses were performed. Results In total, 64 (48.9%) patients expressed EGFR, 68 (51.9%) expressed CXCR4, and 33 (25.2%) coexpressed EGFR and CXCR4. No significant association between EGFR and CXCR4 expression was observed (P = 0.938). EGFR expression significantly correlated with tumor differentiation (P = 0.031), whereas CXCR4 expression significantly correlated with lymph node metastasis (P = 0.001). EGFR/CXCR4 coexpression was significantly associated with lymph node metastasis (P = 0.026), TNM stage (P = 0.048), and poor tumor differentiation (P = 0.004). By univariate survival analysis, both CXCR4 expression and EGFR/CXCR4 coexpression were significant prognostic factors for poor disease-free survival (DFS) and overall survival (OS). Moreover, EGFR/CXCR4 coexpression significantly increased the hazard ratio for both recurrence and death compared with EGFR or CXCR4 protein expression alone. Multivariate survival analysis demonstrated that EGFR/CXCR4 coexpression was an independent prognostic factor for DFS (HR = 2.33, P<0.001) and OS (HR = 2.48, P = 0.001). Conclusions In conclusion, our data indicate that although EGFR expression alone has limited clinical and prognostic significance, EGFR/CXCR4 coexpression identified a subset of PDAC patients with more aggressive tumor characteristics and a significantly worse prognosis. Our results suggest a potentially important "cross-talk" between CXCR4 and EGFR intracellular pathways and indicate that the simultaneous inhibition of these pathways might be an attractive therapeutic strategy for PDAC.	[Wu, Huanwen; Zhang, Hui; Shi, Xiaohua; Zhang, Li; Wang, Wenze; Liang, Zhiyong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhu, Liang; Xue, Huadan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xue, HD (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China.	bjdanna95@hotmail.com; liangzhiyong1220@yahoo.com		Wu, Huanwen/0000-0002-3996-3176	National Natural Science Foundation of China [81150027]; Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China [201402001]; Peking Union Medical College Hospital Youth Science Foundation [Pumch10700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China; Peking Union Medical College Hospital Youth Science Foundation	This research is supported by the National Natural Science Foundation of China (Project No. 81150027), the Special Foundation for Scientific Research in the Public Interest by the National Health and Family Planning Commission of China (Project No. 201402001) and the Peking Union Medical College Hospital Youth Science Foundation (Project No. Pumch10700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zobair AA, 2013, ONCOL REP, V29, P1524, DOI 10.3892/or.2013.2254; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bachet JB, 2012, ANN ONCOL, V23, P2327, DOI 10.1093/annonc/mdr617; Billadeau DD, 2006, J GASTROINTEST CANC, V37, P110, DOI 10.1007/s12029-007-0011-7; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Funel N, 2011, ANN ONCOL, V22, P482, DOI 10.1093/annonc/mdq686; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Guo JH, 2013, ONCOL LETT, V5, P1572, DOI 10.3892/ol.2013.1261; Guo ZG, 2007, COLLOID SURFACE B, V60, P1, DOI 10.1016/j.colsurfb.2007.05.013; Handra-Luca A, 2013, J CLIN PATHOL; Jacobson O, 2013, THERANOSTICS, V3, P1, DOI 10.7150/thno.5760; Katsumoto K, 2013, THERANOSTICS, V3, P11, DOI 10.7150/thno.4806; Luo GP, 2011, PANCREATOLOGY, V11, P595, DOI 10.1159/000334465; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mori T, 2004, MOL CANCER THER, V3, P29; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Pryczynicz A, 2008, ANTICANCER RES, V28, P1399; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Valsecchi ME, 2012, CANCER-AM CANCER SOC, V118, P3484, DOI 10.1002/cncr.26661; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Zhong WX, 2012, EXP THER MED, V4, P363, DOI 10.3892/etm.2012.631	35	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116803	10.1371/journal.pone.0116803	http://dx.doi.org/10.1371/journal.pone.0116803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679210	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600035
J	Wilkinson, AD; Collier, CJ; Flores, F; Mercurio, P; O'Brien, J; Ralph, PJ; Negri, AP				Wilkinson, Adam D.; Collier, Catherine J.; Flores, Florita; Mercurio, Phil; O'Brien, Jake; Ralph, Peter J.; Negri, Andrew P.			A Miniature Bioassay for Testing the Acute Phytotoxicity of Photosystem II Herbicides on Seagrass	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TROPICAL BENTHIC MICROALGAE; CHLOROPHYLL-A FLUORESCENCE; HALOPHILA-OVALIS; PHOTOSYNTHETIC TOLERANCES; TOXICITY; TEMPERATURE; ECOSYSTEMS; PESTICIDE; AUSTRALIA	Photosystem II (PSII) herbicides have been detected in nearshore tropical waters such as those of the Great Barrier Reef and may add to the pressure posed by runoff containing sediments and nutrients to threatened seagrass habitats. There is a growing number of studies into the potential effects of herbicides on seagrass, generally using large experimental setups with potted plants. Here we describe the successful development of an acute 12-well plate phytotoxicity assay for the PSII herbicide Diuron using isolated Halophila ovalis leaves. Fluorescence images demonstrated Diuron affected the entire leaf surface evenly and responses were not influenced by isolating leaves from the plant. The optimum exposure duration was 24 h, by which time the inhibition of effective quantum yield of PSII (Delta F/F-m') was highest and no deterioration of photosystems was evident in control leaves. The inhibition of Delta F/F-m' by Diuron in isolated H. ovalis leaves was identical to both potted and hydroponically grown plants (with leaves remaining attached to rhizomes), indicating similar reductions in photosynthetic activity in these acute well-plate assays. The sensitivity of the assay was not influenced by irradiance (range tested 40 to 400 mu mol photons m(-2) s(-1)). High irradiance, however, caused photo-oxidative stress in H. ovalis and this generally impacted in an additive or sub-additive way with Diuron to damage PSII. The bioassay using isolated leaves is more rapid, uses far less biological material and does not rely on specialised aquarium facilities in comparison with assays using potted plants. The development and validation of this sensitive bioassay will be useful to reliably screen and monitor the phytotoxicity of existing and emerging PSII herbicides and contribute to risk assessments and water quality guideline development in the future.	[Wilkinson, Adam D.; Collier, Catherine J.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Wilkinson, Adam D.; Flores, Florita; Mercurio, Phil; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Collier, Catherine J.] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res TropWATER, Cairns, Qld, Australia; [Mercurio, Phil; O'Brien, Jake] Univ Queensland, Sch Med, Coopers Plains, Qld, Australia; [Mercurio, Phil; O'Brien, Jake] Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia; [Ralph, Peter J.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW 2007, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; University of Queensland; University of Technology Sydney	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Ralph, Peter/L-1527-2019; Negri, Andrew P/G-9909-2017; Flores, Florita/I-3033-2017; O'Brien, Jake William/C-4749-2015; O'Brien, Jake William/AAD-9103-2019; Ralph, Peter J/C-5029-2009; Collier, Catherine/M-6308-2014	Ralph, Peter/0000-0002-3103-7346; Negri, Andrew P/0000-0003-1388-7395; Flores, Florita/0000-0003-4637-1379; O'Brien, Jake William/0000-0001-9336-9656; Ralph, Peter J/0000-0002-3103-7346; Collier, Catherine/0000-0001-9494-6582	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project [4.2]	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project(Australian Government)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer S, 2006, AQUAT BOT, V84, P367, DOI 10.1016/j.aquabot.2005.11.007; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094014; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Davis AM, 2013, AGR ECOSYST ENVIRON, V180, P123, DOI 10.1016/j.agee.2011.06.019; Durako MJ, 2003, MAR BIOL, V142, P1219, DOI 10.1007/s00227-003-1038-3; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Flores F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075798; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; GBRMPA, 2010, WAT QUAL GUID GREAT; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; Inglis Graeme J., 2000, Pacific Conservation Biology, V5, P251; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; Kahn AE, 2009, AQUAT BOT, V90, P195, DOI 10.1016/j.aquabot.2008.07.003; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kirkman H., 1997, SEAGRASSES AUSTR; Kuster A, 2007, CHEMOSPHERE, V67, P194, DOI 10.1016/j.chemosphere.2006.08.023; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Magnusson M, 2013, WATER RES, V47, P5211, DOI 10.1016/j.watres.2013.06.003; Magnusson M, 2012, MAR POLLUT BULL, V65, P363, DOI 10.1016/j.marpolbul.2011.09.029; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; Marba N, 2006, SEAGRASSES BIOL ECOL; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Negri AP, 2011, LIMNOL OCEANOGR, V56, P471, DOI 10.4319/lo.2011.56.2.0471; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osmond CB, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P1; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 2005, AQUAT BOT, V81, P69, DOI 10.1016/j.aquabot.2004.11.003; Ralph PJ, 2000, AQUAT BOT, V66, P141, DOI 10.1016/S0304-3770(99)00024-8; Ralph PJ, 1998, MAR ECOL PROG SER, V171, P123, DOI 10.3354/meps171123; RALPH PJ, 1995, AQUAT BOT, V51, P55, DOI 10.1016/0304-3770(95)00456-A; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; SCHWARZSCHILD AC, 1994, J EXP MAR BIOL ECOL, V183, P77, DOI 10.1016/0022-0981(94)90158-9; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; van Dam JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033900; Wahedally S.F., 2012, TANZ J NAT APPL SCI, V3, P458; WAYCOTT M, 2004, GUIDE TROPICAL SEAGR; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	49	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117541	10.1371/journal.pone.0117541	http://dx.doi.org/10.1371/journal.pone.0117541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674791	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000026
J	Coelho, A; Fraichard, S; Le Goff, G; Faure, P; Artur, Y; Ferveur, JF; Heydel, JM				Coelho, Alexandra; Fraichard, Stephane; Le Goff, Gaelle; Faure, Philippe; Artur, Yves; Ferveur, Jean-Francois; Heydel, Jean-Marie			Cytochrome P450-Dependent Metabolism of Caffeine in Drosophila melanogaster	PLOS ONE			English	Article							REAL-TIME PCR; GLUTATHIONE-S-TRANSFERASE; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; RELATIVE CONTRIBUTION; PHEROMONE; DETOXIFICATION; RESPONSES; METHYLXANTHINES; THEOPHYLLINE	Caffeine (1, 3, 7-trimethylxanthine), an alkaloid produced by plants, has antioxidant and insecticide properties that can affect metabolism and cognition. In vertebrates, the metabolites derived from caffeine have been identified, and their functions have been characterized. However, the metabolites of caffeine in insects remain unknown. Thus, using radiolabelled caffeine, we have identified some of the primary caffeine metabolites produced in the body of Drosophila melanogaster males, including theobromine, paraxanthine and theophylline. In contrast to mammals, theobromine was the predominant metabolite (paraxanthine in humans; theophylline in monkeys; 1, 3, 7-trimethyluric acid in rodents). A transcriptomic screen of Drosophila flies exposed to caffeine revealed the coordinated variation of a large set of genes that encode xenobiotic-metabolizing proteins, including several cytochromes P450s (CYPs) that were highly overexpressed. Flies treated with metyrapone-an inhibitor of CYP enzymes-showed dramatically decreased caffeine metabolism, indicating that CYPs are involved in this process. Using interference RNA genetic silencing, we measured the metabolic and transcriptomic effect of three candidate CYPs. Silencing of CYP6d5 completely abolished theobromine synthesis, whereas CYP6a8 and CYP12d1 silencing induced different consequences on metabolism and gene expression. Therefore, we characterized several metabolic products and some enzymes potentially involved in the degradation of caffeine. In conclusion, this pioneer approach to caffeine metabolism in insects opens novel perspectives for the investigation of the physiological effects of caffeine metabolites. It also indicates that caffeine could be used as a bio-marker to evaluate CYP phenotypes in Drosophila and other insects.	[Coelho, Alexandra; Fraichard, Stephane; Faure, Philippe; Artur, Yves; Ferveur, Jean-Francois; Heydel, Jean-Marie] Univ Bourgogne, CNRS 6265, INRA 1324, Ctr Sci Gout & Alimentat, F-21000 Dijon, France; [Le Goff, Gaelle] UNSA, INRA, CNRS, UMR 1355,Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Ferveur, JF (corresponding author), Univ Bourgogne, CNRS 6265, INRA 1324, Ctr Sci Gout & Alimentat, F-21000 Dijon, France.	jean-francois.ferveur@u-bourgogne.fr; jean-marie.heydel@u-bourgogne.fr	Legoff, Gaelle/B-7501-2015; Heydel, jean-Marie/E-5379-2017; Fraichard, Stephane/R-1930-2019; ARTUR, Yves E/A-8504-2019	Legoff, Gaelle/0000-0003-1973-7136; Heydel, jean-Marie/0000-0002-6089-9922; 	Regional Council of Burgundy France (PARI); European Funding for Regional Economical Development (FEDER); Centre National de la Recherche Scientifique (CNRS); Institut National de la Recherche Agronomique (INRA); French Ministry of Research and Higher Education	Regional Council of Burgundy France (PARI)(Region Bourgogne-Franche-Comte); European Funding for Regional Economical Development (FEDER); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA); French Ministry of Research and Higher Education	This work was funded in part by the Regional Council of Burgundy France (PARI), the European Funding for Regional Economical Development (FEDER) the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Recherche Agronomique (INRA) and the French Ministry of Research and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshuaib WB, 2006, INT J DEV NEUROSCI, V24, P249, DOI 10.1016/j.ijdevneu.2006.03.002; Ashihara H, 2004, FRONT BIOSCI-LANDMRK, V9, P1864, DOI 10.2741/1367; Bannenberg G, 2003, CHEM-BIOL INTERACT, V143, P449, DOI 10.1016/S0009-2797(02)00183-7; Benchekroun Y, 1997, J CHROMATOGR B, V688, P245, DOI 10.1016/S0378-4347(96)00323-4; BERTHOU F, 1992, XENOBIOTICA, V22, P671, DOI 10.3109/00498259209053129; BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carrillo JA, 2000, THER DRUG MONIT, V22, P409, DOI 10.1097/00007691-200008000-00008; CHOU TM, 1994, COMP BIOCHEM PHYS C, V109, P173, DOI 10.1016/0742-8413(94)00048-F; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Franco R, 2013, NUTRIENTS, V5, P4159, DOI 10.3390/nu5104159; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44; Hollingsworth RG, 2002, NATURE, V417, P915, DOI 10.1038/417915a; ITOYAMA MM, 1992, REV BRAS GENET, V15, P303; Itoyama MM, 1997, BRAZILIAN JOURNAL OF, V20; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jensen HR, 2006, J AGR FOOD CHEM, V54, P1289, DOI 10.1021/jf052046n; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kot M, 2008, BIOCHEM PHARMACOL, V76, P543, DOI 10.1016/j.bcp.2008.05.025; Kot M, 2008, BIOCHEM PHARMACOL, V75, P1538, DOI 10.1016/j.bcp.2007.12.017; Kucharski R, 2005, J MOL NEUROSCI, V27, P269, DOI 10.1385/JMN:27:3:269; KUHLMANN W, 1968, CANCER RES, V28, P2375; KULKARNI AP, 1978, B ENVIRON CONTAM TOX, V20, P227, DOI 10.1007/BF01683513; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Laranja AT, 2006, REV SAUDE PUBL, V40, P1112, DOI 10.1590/S0034-89102006000700022; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Mahapatra CT, 2010, TOXICOL SCI, V116, P225, DOI 10.1093/toxsci/kfq097; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; MATHAVAN S, 1985, EXP BIOL, V44, P133; Matsagas K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006578; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Mitchell ES, 2011, PHYSIOL BEHAV, V104, P816, DOI 10.1016/j.physbeh.2011.07.027; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Morozova TV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r95; Morra R, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00954.x; Nakayama S, 2012, J INSECT PHYSIOL, V58, P750, DOI 10.1016/j.jinsphys.2012.02.011; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Raj MA, 2013, ANAL CHIM ACTA, V771, P14, DOI 10.1016/j.aca.2013.02.017; Sellier MJ, 2011, CHEM SENSES, V36, P323, DOI 10.1093/chemse/bjq133; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Sharma A, 2011, CHEMOSPHERE, V82, P370, DOI 10.1016/j.chemosphere.2010.10.002; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Si A, 2005, PHARMACOL BIOCHEM BE, V82, P664, DOI 10.1016/j.pbb.2005.11.009; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; TANG BK, 1994, PHARMACOGENETICS, V4, P117, DOI 10.1097/00008571-199406000-00002; Thimgan MS, 2011, J CLIN SLEEP MED, V7, pS26, DOI 10.5664/JCSM.1352; Trinh K, 2010, J NEUROSCI, V30, P5525, DOI 10.1523/JNEUROSCI.4777-09.2010; Visetson S., 1991, THESIS; Welsh EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001112.pub2; Willoughby L, 2007, PEST MANAG SCI, V63, P803, DOI 10.1002/ps.1391; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Zornik E, 1999, PEPTIDES, V20, P45, DOI 10.1016/S0196-9781(98)00151-X	60	30	31	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117328	10.1371/journal.pone.0117328	http://dx.doi.org/10.1371/journal.pone.0117328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671424	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300047
J	Takeda, K; Uchihashi, T; Watanabe, H; Ishida, T; Igarashi, K; Nakamura, N; Ohno, H				Takeda, Kouta; Uchihashi, Takayuki; Watanabe, Hiroki; Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi; Ohno, Hiroyuki			Real-Time Dynamic Adsorption Processes of Cytochrome c on an Electrode Observed through Electrochemical High-Speed Atomic Force Microscopy	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; QUARTZ-CRYSTAL MICROBALANCE; INFRARED-ABSORPTION SPECTROSCOPY; SURFACE-PLASMON RESONANCE; REDOX POTENTIALS; ENZYME-ACTIVITY; GOLD ELECTRODE; TAPPING-MODE; PROTEINS; AFM	An understanding of dynamic processes of proteins on the electrode surface could enhance the efficiency of bioelectronics development and therefore it is crucial to gain information regarding both physical adsorption of proteins onto the electrode and its electrochemical property in real-time. We combined high-speed atomic force microscopy (HS-AFM) with electrochemical device for simultaneous observation of the surface topography and electron transfer of redox proteins on an electrode. Direct electron transfer of cytochrome c (cyt c) adsorbed on a self-assembled monolayers (SAMs) formed electrode is very attractive subject in bioelectrochemistry. This paper reports a real-time visualization of cyt c adsorption processes on an 11-mercaptoundecanoic acid-modified Au electrode together with simultaneous electrochemical measurements. Adsorbing cyt c molecules were observed on a subsecond time resolution simultaneously with increasing redox currents from cyt c using EC-HS-AFM. The root mean square roughness (R-RMS) from the AFM images and the number of the electrochemically active cyt c molecules adsorbed onto the electrode (Gamma) simultaneously increased in positive cooperativity. Cyt c molecules were fully adsorbed on the electrode in the AFM images when the peak currents were steady. This use of electrochemical HS-AFM significantly facilitates understanding of dynamic behavior of biomolecules on the electrode interface and contributes to the further development of bioelectronics.	[Takeda, Kouta; Nakamura, Nobuhumi; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Uchihashi, Takayuki; Watanabe, Hiroki] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 920, Japan; [Ishida, Takuya; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan; [Uchihashi, Takayuki; Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi] Japan Sci & Technol Agcy JST, Adv Low Carbon Technol Res & Dev Program ALCA, Tokyo, Japan	Tokyo University of Agriculture & Technology; Kanazawa University; University of Tokyo; Japan Science & Technology Agency (JST)	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp; nobu1@cc.tuat.ac.jp	Uchihashi, Takayuki/D-5209-2011; Ohno, Hiroyuki/F-6459-2012; Nakamura, Nobuhumi/C-1972-2013; Igarashi, Kiyohiko/E-6799-2016; Takeda, Kouta/G-6554-2016	Uchihashi, Takayuki/0000-0002-0263-5312; Ohno, Hiroyuki/0000-0001-9716-3495; Nakamura, Nobuhumi/0000-0002-5373-2972; Igarashi, Kiyohiko/0000-0001-5152-7177; Watanabe, Hiroki/0000-0001-8547-1247; Takeda, Kouta/0000-0001-5227-4132	Japan Society for the Promotion of Science [2125007, 268641]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [14J08641, 24114008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Japan Society for the Promotion of Science (No. 2125007) to H.O., by a Grant-in-Aid for JSPS Fellows (No. 268641) to K.T., and by a grant from the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) to T.U., K.I., and N.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Ataka K, 2004, J AM CHEM SOC, V126, P9445, DOI 10.1021/ja048346n; Ataka K, 2007, ANAL BIOANAL CHEM, V388, P47, DOI 10.1007/s00216-006-1071-4; Avila A, 2000, J PHYS CHEM B, V104, P2759, DOI 10.1021/jp992591p; Boussaad S, 1999, J AM CHEM SOC, V121, P4510, DOI 10.1021/ja990117r; COTTON TM, 1980, J AM CHEM SOC, V102, P7960, DOI 10.1021/ja00547a036; Deng J, 2013, NANOSCALE, V5, P8130, DOI 10.1039/c3nr02327c; Fedurco M, 2000, COORDIN CHEM REV, V209, P263, DOI 10.1016/S0010-8545(00)00292-7; Feng ZQ, 1997, J CHEM SOC FARADAY T, V93, P1367; Fleming BD, 2008, LANGMUIR, V24, P323, DOI 10.1021/la702511w; Fujita K, 2003, ELECTROCHEM COMMUN, V5, P47, DOI 10.1016/S1388-2481(02)00531-3; Furusawa H, 2009, ANAL CHEM, V81, P2268, DOI 10.1021/ac802412t; Goda T, 2012, LANGMUIR, V28, P14730, DOI 10.1021/la302977s; Hiasa T, 2012, PHYS CHEM CHEM PHYS, V14, P8419, DOI 10.1039/c2cp40252a; Hobara D, 2002, NANO LETT, V2, P1021, DOI 10.1021/nl0256863; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jin B, 2012, J PHYS CHEM C, V116, P13038, DOI 10.1021/jp303740e; KASSNER RJ, 1973, J AM CHEM SOC, V95, P2674, DOI 10.1021/ja00789a044; Kranz C, 2004, ULTRAMICROSCOPY, V100, P127, DOI 10.1016/j.ultramic.2003.10.004; Kueng A, 2003, ANGEW CHEM INT EDIT, V42, P3238, DOI 10.1002/anie.200351111; Luo QL, 1998, J COLLOID INTERF SCI, V200, P104, DOI 10.1006/jcis.1997.5364; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MOORE GR, 1983, FEBS LETT, V161, P171, DOI 10.1016/0014-5793(83)81001-1; Murata K, 2009, ELECTROCHEM COMMUN, V11, P1623, DOI 10.1016/j.elecom.2009.06.012; Murgida DH, 2008, CHEM SOC REV, V37, P937, DOI 10.1039/b705976k; Murgida DH, 2004, ACCOUNTS CHEM RES, V37, P854, DOI 10.1021/ar0400443; Murgida DH, 2001, ANGEW CHEM INT EDIT, V40, P728; Nakano K, 2007, LANGMUIR, V23, P6270, DOI 10.1021/la063697w; Niki K, 2003, J PHYS CHEM B, V107, P9947, DOI 10.1021/jp035392l; Paulo TD, 2013, J PHYS CHEM B, V117, P8673, DOI 10.1021/jp400694k; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; SONG S, 1993, J PHYS CHEM-US, V97, P6564, DOI 10.1021/j100126a037; STELLWAGEN E, 1978, NATURE, V275, P73, DOI 10.1038/275073a0; TARLOV MJ, 1991, J AM CHEM SOC, V113, P1847, DOI 10.1021/ja00005a068; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Wei JJ, 2002, ANGEW CHEM INT EDIT, V41, P4700, DOI 10.1002/anie.200290021; Wisitruangsakul N, 2008, PHYS CHEM CHEM PHYS, V10, P5276, DOI 10.1039/b806528d; Zhang L, 2005, BIOSENS BIOELECTRON, V21, P337, DOI 10.1016/j.bios.2004.10.021	42	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116685	10.1371/journal.pone.0116685	http://dx.doi.org/10.1371/journal.pone.0116685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671430	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300023
J	Arauz, MJ; Ridde, V; Hernandez, LM; Charris, Y; Carabali, M; Villar, LA				Arauz, Mara Jose; Ridde, Valery; Hernandez, Libia Milena; Charris, Yaneth; Carabali, Mabel; Villar, Luis Angel			Developing a Social Autopsy Tool for Dengue Mortality: A Pilot Study	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AEDES-AEGYPTI; HEALTH-CARE; DETERMINANTS; SURVEILLANCE; QUALITY; AMERICA; ACCESS; BRAZIL; DELAYS	Background Dengue fever is a public health problem in the tropical and sub-tropical world. Dengue cases have grown dramatically in recent years as well as dengue mortality. Colombia has experienced periodic dengue outbreaks with numerous dengue related-deaths, where the Santander department has been particularly affected. Although social determinants of health (SDH) shape health outcomes, including mortality, it is not yet understood how these affect dengue mortality. The aim of this pilot study was to develop and pre-test a social autopsy (SA) tool for dengue mortality. Methods and Findings The tool was developed and pre-tested in three steps. First, dengue fatal cases and 'near misses' (those who recovered from dengue complications) definitions were elaborated. Second, a conceptual framework on determinants of dengue mortality was developed to guide the construction of the tool. Lastly, the tool was designed and pre-tested among three relatives of fatal cases and six near misses in 2013 in the metropolitan zone of Bucaramanga. The tool turned out to be practical in the context of dengue mortality in Colombia after some modifications. The tool aims to study the social, individual, and health systems determinants of dengue mortality. The tool is focused on studying the socioeconomic position and the intermediary SDH rather than the socioeconomic and political context. Conclusions The SA tool is based on the scientific literature, a validated conceptual framework, researchers' and health professionals' expertise, and a pilot study. It is the first time that a SA tool has been created for the dengue mortality context. Our work furthers the study on SDH and how these are applied to neglected tropical diseases, like dengue. This tool could be integrated in surveillance systems to provide complementary information on the modifiable and avoidable death- related factors and therefore, be able to formulate interventions for dengue mortality reduction.	[Arauz, Mara Jose; Ridde, Valery] Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Sch Publ Hlth ESPUM, Montreal, PQ, Canada; [Hernandez, Libia Milena; Charris, Yaneth] Ctr Atenc Diagnost Enfermedades Infecciosas CDI A, Bucaramanga, Colombia; [Carabali, Mabel] Int Vaccines Inst, Dengue Vaccines Initiat, Seoul, South Korea; [Villar, Luis Angel] Univ Ind Santander, Bucaramanga, Colombia	Universite de Montreal; Universidad Industrial de Santander	Arauz, MJ (corresponding author), Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Sch Publ Hlth ESPUM, Montreal, PQ, Canada.	mariajarauz@gmail.com	ridde, valery/AAV-1016-2020; Ridde, Valery/AAD-2736-2019	Ridde, Valery/0000-0001-9299-8266; Carabali, Mabel/0000-0002-9171-0483	Canadian Institutes of Health Research; Ministere de l'Education, du Loisir et du Sport of Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Education, du Loisir et du Sport of Quebec	MJA received a James Rossiter (MSc) scholarship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) and a Visiting Fellowship from the Ministere de l'Education, du Loisir et du Sport of Quebec (http://www.mels.gouv.qc.ca/). The Centro de atencion y diagnostico de enfermedades infecciosas (http://www.cdi.net.co/) and the Info Vida Foundation from Bucaramanga, Colombia (no URL) contributed to the logistics of the pilot study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Hansen J, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P135; Albert M, 2008, SOC SCI MED, V66, P2520, DOI 10.1016/j.socscimed.2008.01.052; Alvarez Perez A, 2010, REV CUBANA HIGIENE E, V48; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; Carabali JM, 2012, GLOB HEALTH PROMOT, V19, P45, DOI 10.1177/1757975912464250; Cascio W.F., 2011, APPL PSYCHOL HUMAN R, V7 ed.; Castañeda Oneida, 2011, Rev. salud pública, V13, P514; Child Health Epidemiology Reference Group CHERG Verbal and Social Autopsy Survey Tools and Information, FAIL PATHW SURV; CSDH, 2008, CLOS GAP GEN HLTH EQ; Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074; Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gruenais ME, 2012, ANTHROPOL ACTION, V19, P27, DOI 10.3167/aia.2012.190204; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI [10.1371/journal.pntd.0000352, DOI 10.1371/J0URNAL.PNTD.0000352]; Instituto Nacional de Salud, 2013, B EP DENG COL SEM; Instituto Nacional de Salud, 2013, INF EV DENG PER EP D; Kallander K, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-44; Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45; Kouri G, 2007, REV CUBA MED TROP, V59; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Pacagnella RC, 2012, REPROD HEALTH MATTER, V20, P155, DOI 10.1016/S0968-8080(12)39601-8; Padilla J.C., 2012, DENGUE COLOMBIA EPID; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Reidpath DD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-1; Ronsmans C, 2004, NUMBERS REV MATERNAL; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Solar O, 2010, 2 WHO; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Alvarez LS, 2011, INT J HEALTH SERV, V41, P355, DOI 10.2190/HS.41.2.i; Suarez R, 2009, CAD SAUDE PUBLICA, V25, pS104, DOI 10.1590/S0102-311X2009001300010; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Theiss-Nyland K, 2013, PARTNERSHIP MATERNAL; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; Vargas J Julián, 2009, Rev. Fac. Nac. Salud Pública, V27, P121; Waiswa P, 2012, B WORLD HEALTH ORGAN, V90, P403, DOI 10.2471/BLT.12.105718; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, 2013, DENG SEV DENG; Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2013, VERB AUT STAND ASC A; World Health Organization, 2012, GLOB STRAT DENG PREV, DOI [10.1093/trstmh/tru209, DOI 10.1093/TRSTMH/TRU209]	52	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117455	10.1371/journal.pone.0117455	http://dx.doi.org/10.1371/journal.pone.0117455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658485	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900153
J	Fernandez-Marino, AI; Cidad, P; Zafra, D; Nocito, L; Dominguez, J; Olivan-Viguera, A; Kohler, R; Lopez-Lopez, JR; Perez-Garcia, MT; Valverde, MA; Guinovart, JJ; Fernandez-Fernandez, JM				Isabel Fernandez-Marino, Ana; Cidad, Pilar; Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Olivan-Viguera, Aida; Koehler, Ralf; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa; Valverde, Miguel Angel; Guinovart, Joan J.; Fernandez-Fernandez, Jose M.			Tungstate-Targeting of BK alpha beta(1) Channels Tunes ERK Phosphorylation and Cell Proliferation in Human Vascular Smooth Muscle	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; INDUCED DIABETIC-RATS; SODIUM TUNGSTATE; HIGH-CONDUCTANCE; BETA-1 SUBUNIT; ANTIDIABETIC AGENT; GLYCOGEN-SYNTHESIS; VOLTAGE SENSOR; BLOOD-PRESSURE; MAXIK-CHANNEL	Despite the substantial knowledge on the antidiabetic, antiobesity and antihypertensive actions of tungstate, information on its primary target/s is scarce. Tungstate activates both the ERK1/2 pathway and the vascular voltage-and Ca2+-dependent large-conductance BK alpha beta(1) potassium channel, which modulates vascular smooth muscle cell (VSMC) proliferation and function, respectively. Here, we have assessed the possible involvement of BK alpha beta(1) channels in the tungstate-induced ERK phosphorylation and its relevance for VSMC proliferation. Western blot analysis in HEK cell lines showed that expression of vascular BK alpha beta(1) channels potentiates the tungstate-induced ERK1/2 phosphorylation in a G(i/o) protein-dependent manner. Tungstate activated BK alpha beta(1) channels upstream of G proteins as channel activation was not altered by the inhibition of G proteins with GDP beta S or pertussis toxin. Moreover, analysis of Gi/o protein activation measuring the FRET among heterologously expressed G(i) protein subunits suggested that tungstate-targeting of BK alpha beta(1) channels promotes G protein activation. Single channel recordings on VSMCs from wild-type and beta(1)-knockout mice indicated that the presence of the regulatory beta(1) subunit was essential for the tungstate-mediated activation of BK channels in VSMCs. Moreover, the specific BK channel blocker iberiotoxin lowered tungstate-induced ERK phosphorylation by 55% and partially reverted (by 51%) the tungstate-produced reduction of platelet-derived growth factor (PDGF)induced proliferation in human VSMCs. Our observations indicate that tungstate-targeting of BK alpha beta(1) channels promotes activation of PTX-sensitive G(i) proteins to enhance the tungstate-induced phosphorylation of ERK, and inhibits PDGF-stimulated cell proliferation in human vascular smooth muscle.	[Isabel Fernandez-Marino, Ana; Valverde, Miguel Angel; Fernandez-Fernandez, Jose M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] Univ Valladolid, IBGM, Valladolid, Spain; [Cidad, Pilar; Lopez-Lopez, Jose R.; Perez-Garcia, Maria Teresa] CSIC, Valladolid, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Zafra, Delia; Nocito, Laura; Dominguez, Jorge; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Aragon Inst Hlth Sci I CS IIS, Zaragoza, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Fernandez-Fernandez, JM (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain.	jmanuel.fernandez@upf.edu	López, José Ramón López/A-5541-2009; Fernández-Fernández, José Manuel M/M-8157-2015; Oliván-Viguera, Aida/ABG-4048-2020; Cidad, Pilar/G-1904-2016; Perez-Garcia, M. Teresa/F-5173-2015; Oliván-Viguera, Aida/I-4260-2015	López, José Ramón López/0000-0002-3870-421X; Fernández-Fernández, José Manuel M/0000-0003-2330-8449; Oliván-Viguera, Aida/0000-0001-5348-924X; Cidad, Pilar/0000-0002-6338-7738; Perez-Garcia, M. Teresa/0000-0001-8540-8117; Oliván-Viguera, Aida/0000-0001-5348-924X; Valverde, Miguel A./0000-0002-6961-3361; Zafra, Delia/0000-0003-4143-0659; Fernandez-Marino, Ana/0000-0002-6995-4529	Spanish Ministry of Economy and Competitiveness [SAF2012-31089, SAF2012-38140, BFU2013-45867-R]; FEDER Funds, Ministry of Science and Innovation [BFU 2008-00769, BFU2010-15898]; Instituto de Salud Carlos III [RIC RD12/0042/0006, RD12/0042/0014, Red HERACLES]; Junta de Castilla y Leon [VA094A11-2]; European Community [FP7-People-CIG-321721]	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER Funds, Ministry of Science and Innovation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); European Community(European Commission)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2012-31089 to JMFF, SAF2012-38140 to MAV, BFU2013-45867-R to JRLL), FEDER Funds, Ministry of Science and Innovation (BFU 2008-00769 to JG, BFU2010-15898 to MTPG), Instituto de Salud Carlos III (RIC RD12/0042/0006, RD12/0042/0014, Red HERACLES) and Junta de Castilla y Leon (VA094A11-2 to JRLL) and European Community (FP7-People-CIG-321721 to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Ballester J, 2005, J ANDROL, V26, P706, DOI 10.2164/jandrol.04156; Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera A, 1997, DIABETOLOGIA, V40, P143, DOI 10.1007/s001250050655; Barbera A, 2001, DIABETOLOGIA, V44, P507, DOI 10.1007/s001250100479; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen XX, 2011, J GEN PHYSIOL, V138, P137, DOI 10.1085/jgp.201110632; Cidad P, 2015, PFLUG ARCH EUR J PHY, V467, P1711, DOI 10.1007/s00424-014-1607-y; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Dominguez JE, 2003, J BIOL CHEM, V278, P42785, DOI 10.1074/jbc.M308334200; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Fernandez-Marino AI, 2014, PFLUG ARCH EUR J PHY, V466, P1365, DOI 10.1007/s00424-013-1379-9; Fernandez-Marino AI, 2012, CARDIOVASC RES, V95, P29, DOI 10.1093/cvr/cvs139; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Gomez-Ramos A, 2006, J NEUROSCI RES, V83, P264, DOI 10.1002/jnr.20726; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Guo TB, 2005, AM J PHYSIOL-CELL PH, V289, pC257, DOI 10.1152/ajpcell.00010.2005; Hanner M, 1998, J BIOL CHEM, V273, P16289, DOI 10.1074/jbc.273.26.16289; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Hanzu F, 2010, DIABETES OBES METAB, V12, P1013, DOI 10.1111/j.1463-1326.2010.01293.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kohler R, 2012, CARDIOVASC RES, V95, P3, DOI 10.1093/cvr/cvs169; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Miguel-Velado E, 2005, CIRC RES, V97, P1280, DOI 10.1161/01.RES.0000194322.91255.13; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Olivan-Viguera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058614; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Peredo HA, 2010, CLIN EXP HYPERTENS, V32, P453, DOI 10.3109/10641961003686443; Piskorowski RA, 2006, J GEN PHYSIOL, V127, P557, DOI 10.1085/jgp.200509482; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; SCHWARTZ SM, 1984, PROG CARDIOVASC DIS, V26, P355, DOI 10.1016/0033-0620(84)90010-0; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Swei A, 1999, MICROCIRCULATION, V6, P179, DOI 10.1038/sj.mn.7300070; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Xu DZ, 1999, BLOOD, V94, P139, DOI 10.1182/blood.V94.1.139.413k11_139_145; Zafra D, 2013, FEBS LETT, V587, P291, DOI 10.1016/j.febslet.2012.11.034; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	57	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118148	10.1371/journal.pone.0118148	http://dx.doi.org/10.1371/journal.pone.0118148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659150	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900267
J	Isobe, A; Sawada, K; Kinose, Y; Ohyagi-Hara, C; Nakatsuka, E; Makino, H; Ogura, T; Mizuno, T; Suzuki, N; Morii, E; Nakamura, K; Sawada, I; Toda, A; Hashimoto, K; Mabuchi, S; Ohta, T; Morishige, K; Kurachi, H; Kimura, T				Isobe, Aki; Sawada, Kenjiro K; Kinose, Yasuto; Ohyagi-Hara, Chifumi; Nakatsuka, Erika; Makino, Hiroshi; Ogura, Tomonori; Mizuno, Tomoko; Suzuki, Noriko; Morii, Eiichi; Nakamura, Koji; Sawada, Ikuko; Toda, Aska; Hashimoto, Kae; Mabuchi, Seiji; Ohta, Tsuyoshi; Morishige, Ken-ichirou; Kurachi, Hirohisa; Kimura, Tadashi			Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; M2 MACROPHAGES; CELL CARCINOMA; IN-VIVO; EXPRESSION; ANTIBODY; TOCILIZUMAB; METASTASIS; ASCITES; PATHWAY	Ovarian cancer remains the most lethal gynecologic cancer and new targeted molecular therapies against this miserable disease continue to be challenging. In this study, we analyzed the expressional patterns of Interleukin-6 (IL-6) and its receptor (IL-6R) expression in ovarian cancer tissues, evaluated the impact of these expressions on clinical outcomes of patients, and found that a high-level of IL-6R expression but not IL-6 expression in cancer cells is an independent prognostic factor. In in vitro analyses using ovarian cell lines, while six (RMUG-S, RMG-1, OVISE, A2780, SKOV3ip1 and OVCAR-3) of seven overexpressed IL-6R compared with a primary normal ovarian surface epithelium, only two (RMG-1, OVISE) of seven cell lines overexpressed IL-6, suggesting that IL-6/IL-6R signaling exerts in a paracrine manner in certain types of ovarian cancer cells. Ovarian cancer ascites were collected from patients, and we found that primary CD11b(+)CD14(+) cells, which were predominantly M2-polarized macrophages, are the major source of IL-6 production in an ovarian cancer microenvironment. When CD11b(+)CD14(+) cells were co-cultured with cancer cells, both the invasion and the proliferation of cancer cells were robustly promoted and these promotions were almost completely inhibited by pretreatment with anti-IL-6R antibody (tocilizumab). The data presented herein suggest a rationale for anti-IL-6/IL-6R therapy to suppress the peritoneal spread of ovarian cancer, and represent evidence of the therapeutic potential of anti-IL-6R therapy for ovarian cancer treatment.	[Isobe, Aki; Sawada, Kenjiro K; Kinose, Yasuto; Ohyagi-Hara, Chifumi; Nakatsuka, Erika; Nakamura, Koji; Sawada, Ikuko; Toda, Aska; Hashimoto, Kae; Mabuchi, Seiji; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Ohyagi-Hara, Chifumi] JCHO Osaka Hosp, Dept Obstet & Gynecol, Osaka, Japan; [Makino, Hiroshi; Ogura, Tomonori; Mizuno, Tomoko; Suzuki, Noriko; Morishige, Ken-ichirou] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Ohta, Tsuyoshi; Kurachi, Hirohisa] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan	Osaka University; Gifu University; Osaka University; Yamagata University	Sawada, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan.	daasawada@gyne.med.osaka-u.ac.jp	Mabuchi, Seiji/AAX-1986-2020		Ministry of Education, Science, Sports and Culture of Japan [21791555, 23592447, 22390308, 23659779]; Osaka Medical Research Foundation for Intractable Diseases	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Intractable Diseases	This work was supported by a Grant-in-Aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (21791555 and 23592447 to KS, 22390308 to HK, and 23659779 to TK). This work was also partly supported by the Osaka Medical Research Foundation for Intractable Diseases (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Ataie-Kachoie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060817; Bak SP, 2007, CANCER RES, V67, P4783, DOI 10.1158/0008-5472.CAN-06-4410; Cai QC, 2012, FASEB J, V26, P3306, DOI 10.1096/fj.12-207597; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Dijkgraaf EM, 2012, CURR PHARM DESIGN, V18, P3816; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; ERROI A, 1989, INT J CANCER, V44, P795, DOI 10.1002/ijc.2910440508; Fulciniti M, 2009, CLIN CANCER RES, V15, P7144, DOI 10.1158/1078-0432.CCR-09-1483; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Oguro T, 2013, EUR J CANCER, V49, P1715, DOI 10.1016/j.ejca.2012.11.038; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rath KS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.034; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; SCAMBIA G, 1995, BRIT J CANCER, V71, P354, DOI 10.1038/bjc.1995.71; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Wang Y, 2012, CYTOKINE, V59, P228, DOI 10.1016/j.cyto.2012.04.020; WATSON JM, 1990, CANCER RES, V50, P6959	33	51	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118080	10.1371/journal.pone.0118080	http://dx.doi.org/10.1371/journal.pone.0118080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658637	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900262
J	Lombardi, A; Senese, R; De Matteis, R; Busiello, RA; Cioffi, F; Goglia, F; Lanni, A				Lombardi, Assunta; Senese, Rosalba; De Matteis, Rita; Busiello, Rosa Anna; Cioffi, Federica; Goglia, Fernando; Lanni, Antonia			3,5-Diiodo-L-Thyronine Activates Brown Adipose Tissue Thermogenesis in Hypothyroid Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; DIET-INDUCED THERMOGENESIS; HORMONE RECEPTOR BETA-1; RESTING METABOLIC-RATE; CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; THYROID-HORMONE; SKELETAL-MUSCLE; LIVER-MITOCHONDRIA; RAPID STIMULATION	3,5-diiodo-l-thyronine (T2), a thyroid hormone derivative, is capable of increasing energy expenditure, as well as preventing high fat diet-induced overweight and related metabolic dysfunction. Most studies to date on T2 have been carried out on liver and skeletal muscle. Considering the role of brown adipose tissue (BAT) in energy and metabolic homeostasis, we explored whether T2 could activate BAT thermogenesis. Using euthyroid, hypothyroid, and T2-treated hypothyroid rats (all maintained at thermoneutrality) in morphological and functional studies, we found that hypothyroidism suppresses the maximal oxidative capacity of BAT and thermogenesis, as revealed by reduced mitochondrial content and respiration, enlarged cells and lipid droplets, and increased number of unilocular cells within the tissue. In vivo administration of T2 to hypothyroid rats activated BAT thermogenesis and increased the sympathetic innervation and vascularization of tissue. Likewise, T2 increased BAT oxidative capacity in vitro when added to BAT homogenates from hypothyroid rats. In vivo administration of T2 to hypothyroid rats enhanced mitochondrial respiration. Moreover, UCP1 seems to be a molecular determinant underlying the effect of T2 on mitochondrial thermogenesis. In fact, inhibition of mitochondrial respiration by GDP and its reactivation by fatty acids were greater in mitochondria from T2-treated hypothyroid rats than untreated hypothyroid rats. In vivo administration of T2 led to an increase in PGC-1 alpha protein levels in nuclei (transient) and mitochondria (longer lasting), suggesting a coordinate effect of T2 in these organelles that ultimately promotes net activation of mitochondrial biogenesis and BAT thermogenesis. The effect of T2 on PGC-1 alpha is similar to that elicited by triiodothyronine. As a whole, the data reported here indicate T2 is a thyroid hormone derivative able to activate BAT thermogenesis.	[Lombardi, Assunta] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Senese, Rosalba; Lanni, Antonia] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Caserta, Italy; [De Matteis, Rita] Univ Urbino Carlo Bo, Dipartimento Sci Biomol, Sez Sci Motorie & Salute, Urbino, Italy; [Busiello, Rosa Anna; Cioffi, Federica; Goglia, Fernando] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Urbino; University of Sannio	Goglia, F (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy.	goglia@unisannio.it; antonia.lanni@unina2.it	cioffi, federica/AAB-8161-2019; De+Matteis, Rita/AAG-6904-2019	cioffi, federica/0000-0002-1530-8556; GOGLIA, Fernando/0000-0003-0468-9645; DE MATTEIS, Rita/0000-0003-4665-4547; SENESE, Rosalba/0000-0003-1571-0980	COFIN-MIUR [20089SRS2X]; POR Campania [FSE 2007/2013]	COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); POR Campania(Regione Campania)	This work was partially supported by COFIN-MIUR 2008 Protocol No. 20089SRS2X. Rosa Anna Busiello received a grant from POR Campania FSE 2007/2013 project MODO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, J BIOL REG HOMEOS AG, V25, P655; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Ball SG, 1997, J MOL ENDOCRINOL, V19, P137, DOI 10.1677/jme.0.0190137; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Boss O, 2012, FRONT ENDOCRINOL LAU, V6, P14, DOI [10.1056/NEJMoa0808718, DOI 10.1056/NEJM0A0808718]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Carvalho SD, 1996, ENDOCRINOLOGY, V137, P5519, DOI 10.1210/en.137.12.5519; Cavallo A, 2011, J BIOENERG BIOMEMBR, V43, P349, DOI 10.1007/s10863-011-9366-3; Cimmino M, 1996, J ENDOCRINOL, V149, P319, DOI 10.1677/joe.0.1490319; Cinti S, 1999, THE ADIPOSE ORGAN KU; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; De Matteis R, 1998, J NEUROCYTOL, V27, P877, DOI 10.1023/A:1006996922657; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Figueiredo AS, 2014, J ENDOCRINOL, V221, P415, DOI [10.1530/JOE-13-0502, DOI 10.1530/JOE-13-0502]; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; GOGLIA F, 1994, FEBS LETT, V346, P295, DOI 10.1016/0014-5793(94)00476-5; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Grasselli E, 2012, J ENDOCRINOL, V212, P149, DOI 10.1530/JOE-11-0288; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Jonas W, 2014, ENDOCRINOLOGY, V16; Klaus S, 2004, CURR DRUG TARGETS, V5, P241, DOI 10.2174/1389450043490523; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; LANNI A, 1993, J ENDOCRINOL, V136, P59, DOI 10.1677/joe.0.1360059; Lanni A, 1998, PFLUG ARCH EUR J PHY, V436, P407, DOI 10.1007/s004240050650; LANNI A, 1994, MOL CELL ENDOCRINOL, V99, P89, DOI 10.1016/0303-7207(94)90150-3; Lanni A, 1996, J PHYSIOL-LONDON, V494, P831, DOI 10.1113/jphysiol.1996.sp021536; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lombardi A, 2009, AM J PHYSIOL-ENDOC M, V296, pE497, DOI 10.1152/ajpendo.90642.2008; Lombardi A, 2007, FEBS LETT, V581, P5911, DOI 10.1016/j.febslet.2007.11.073; Lombardi A, 2012, AM J PHYSIOL-ENDOC M, V303, pE1222, DOI 10.1152/ajpendo.00037.2012; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mendoza A, 2013, ENDOCRINOLOGY, V154, P2948, DOI 10.1210/en.2013-1030; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; Moreno M, 2002, ENDOCRINOLOGY, V143, P504, DOI 10.1210/en.143.2.504; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Moreno M, 2011, FASEB J, V25, P3312, DOI 10.1096/fj.11-181982; Navarrete-Ramirez P, 2014, J MOL ENDOCRINOL, V52, P1, DOI 10.1530/JME-13-0145; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; OREILLY I, 1992, ACTA ENDOCRINOL-COP, V127, P542, DOI 10.1530/acta.0.1270542; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Shang GG, 2013, BBA-MOL BASIS DIS, V1832, P674, DOI 10.1016/j.bbadis.2013.01.023; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SUNDIN U, 1984, METABOLISM, V33, P1028, DOI 10.1016/0026-0495(84)90232-4	62	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116498	10.1371/journal.pone.0116498	http://dx.doi.org/10.1371/journal.pone.0116498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658324	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900044
J	Michaelides, S; Cornish, N; Griffiths, R; Groombridge, J; Zajac, N; Walters, GJ; Aubret, F; While, GM; Uller, T				Michaelides, Sozos; Cornish, Nina; Griffiths, Richard; Groombridge, Jim; Zajac, Natalia; Walters, Graham J.; Aubret, Fabien; While, Geoffrey M.; Uller, Tobias			Phylogeography and Conservation Genetics of the Common Wall Lizard, Podarcis muralis, on Islands at Its Northern Range	PLOS ONE			English	Article							POPULATION-STRUCTURE; SPECIES RANGE; DIVERSITY; INFERENCE; SOFTWARE; REVEALS; REFUGIA; ORIGIN; ALIEN	Populations at range limits are often characterized by lower genetic diversity, increased genetic isolation and differentiation relative to populations at the core of geographical ranges. Furthermore, it is increasingly recognized that populations situated at range limits might be the result of human introductions rather than natural dispersal. It is therefore important to document the origin and genetic diversity of marginal populations to establish conservation priorities. In this study, we investigate the phylogeography and genetic structure of peripheral populations of the common European wall lizard, Podarcis muralis, on Jersey (Channel Islands, UK) and in the Chausey archipelago. We sequenced a fragment of the mitochondrial cytochrome b gene in 200 individuals of P. muralis to infer the phylogeography of the island populations using Bayesian approaches. We also genotyped 484 individuals from 21 populations at 10 polymorphic microsatellite loci to evaluate the genetic structure and diversity of island and mainland (Western France) populations. We detected four unique haplotypes in the island populations that formed a sub-clade within the Western France clade. There was a significant reduction in genetic diversity (H-O, H-E and A(R)) of the island populations in relation to the mainland. The small fragmented island populations at the northern range margin of the common wall lizard distribution are most likely native, with genetic differentiation reflecting isolation following sea level increase approximately 7000 BP. Genetic diversity is lower on islands than in marginal populations on the mainland, potentially as a result of early founder effects or long-term isolation. The combination of restriction to specific localities and an inability to expand their range into adjacent suitable locations might make the island populations more vulnerable to extinction.	[Michaelides, Sozos; Zajac, Natalia; While, Geoffrey M.; Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Cornish, Nina] States Jersey, Dept Environm, Trinity JE3 5JP, Jersey, England; [Griffiths, Richard; Groombridge, Jim] Univ Kent, DICE, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Walters, Graham J.] London Metropolitan Univ, Int Inst Culture Tourism & Dev, London N7 8HN, England; [Aubret, Fabien] CNRS, Stn Ecol Expt Moulis, F-09200 St Girons, France; [While, Geoffrey M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Uller, Tobias] Lund Univ, Dept Biol, SE-22362 Lund, Sweden	University of Oxford; University of Kent; London Metropolitan University; Centre National de la Recherche Scientifique (CNRS); University of Tasmania; Lund University	Michaelides, S (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England.	sozos.michaelides@zoo.ox.ac.uk; tobias.uller@zoo.ox.ac.uk	While, Geoffrey M/O-6306-2017; Michaelides, Sozos/G-3239-2011	While, Geoffrey M/0000-0001-8122-9322; Michaelides, Sozos/0000-0001-7636-5768	Royal Society of London; Knut Foundation; FP7 Marie Curie Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); AG Leventis Foundation Trust; Alice Wallenberg Foundation; Biotechnology and Biological Sciences Research Council [1091476] Funding Source: researchfish	Royal Society of London(Royal Society of London); Knut Foundation; FP7 Marie Curie Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AG Leventis Foundation Trust; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TU is supported by the Royal Society of London and the Knut and Alice Wallenberg Foundations. GMW was supported by an FP7 Marie Curie Fellowship. SM is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and the AG Leventis Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansted DT, 1865, THE CHANNEL ISLANDS; AVERY RA, 1989, J ZOOL, V217, P73, DOI 10.1111/j.1469-7998.1989.tb02475.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebee TJC, 2005, BIODIVERS CONSERV, V14, P1607, DOI 10.1007/s10531-004-0532-3; Bellati A, 2011, J ZOOL SYST EVOL RES, V49, P240, DOI 10.1111/j.1439-0469.2011.00619.x; Berry RJ, 2009, ISLANDS; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Buckley J, 2005, REINTRODUCTION STRAT; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Cd Gibon, 1919, ANCRE MARINE, V541; Cornish N., 2011, GENETIC DIVERSITY CO; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deichsel Guntram, 2004, Herpetological Review, V35, P289; Drummond A., 2011, GENEIOUS V6 1 7; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gadeau de Kerville H, 1894, RECHERCHES FAUNES MA, P1; Gadeau de Kerville H, 1897, FAUNE NORMANDIE, P1; Gassert F, 2013, J BIOGEOGR, V40, P1475, DOI 10.1111/jbi.12109; Giovannotti M, 2010, ITAL J ZOOL, V77, P277, DOI 10.1080/11250000903143885; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gruschwitz M, 1986, HDB AMPHIBIEN REPTIL, P155; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heathcote RJP, 2014, CONSERVATION GENETIC; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; Jones RL, 1993, QUANERNARY JERSEY FI, P35; Joseph-Lafosse P, 1891, B SOC LINN NORMANDIE, V5, P169; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Le Sueur F, 1976, NATURAL HIST JERSEY; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Livory A, 1997, FLORE CHAUSEY ARCHIP, P87; Michaelides S, 2013, BIOL INVASIONS, V15, P1101, DOI 10.1007/s10530-012-0353-3; MILLAR CI, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P149; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Podnar M, 2004, ORG DIVERS EVOL, V4, P307, DOI 10.1016/j.ode.2004.04.004; Podnar M, 2007, J MOL EVOL, V64, P308, DOI 10.1007/s00239-005-0259-0; Pritchard JK, 2000, GENETICS, V155, P945; Quatrefages AD, 1842, REV DEUX MONDES, P1; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Richard M, 2012, MOL ECOLOGY RESOURCE, P1; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Salvi D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-147; Schulte U, 2008, DIE MAUEREIDECHSE; Schulte U, 2012, AMPHIBIA-REPTILIA, V33, P129, DOI 10.1163/156853812X626160; Schulte U, 2012, GLOBAL ECOL BIOGEOGR, V21, P198, DOI 10.1111/j.1466-8238.2011.00665.x; Schulte Ulrich, 2008, Zeitschrift fuer Feldherpetologie, V15, P139; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sinel J, 1908, T SOC GUERNESIAISE, V4, P466; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uller T, 2011, GLOBAL CHANGE BIOL, V17, P3478, DOI 10.1111/j.1365-2486.2011.02509.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Walters GJ, 2006, B SOC ZOOLOGIQUE FRA, P131	60	10	11	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117113	10.1371/journal.pone.0117113	http://dx.doi.org/10.1371/journal.pone.0117113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659074	Green Published, gold, Green Accepted			2022-12-26	WOS:000349444900104
J	Qin, T; Yin, YY; Yu, QH; Yang, Q				Qin, Tao; Yin, Yinyan; Yu, Qinghua; Yang, Qian			Bursopentin (BP5) Protects Dendritic Cells from Lipopolysaccharide-Induced Oxidative Stress for Immunosuppression	PLOS ONE			English	Article							NF-KAPPA-B; HEME OXYGENASE-1; NITRIC-OXIDE; CHICKEN BURSA; ANTIGEN PRESENTATION; FREE-RADICALS; ANTIBODY-PRODUCTION; ADAPTIVE IMMUNITY; GENE-EXPRESSION; CYTOCHROME-C	Dendritic cells (DCs) play a vital role in the regulation of immune-mediated inflammatory diseases. Thus, DCs have been regarded as a major target for the development of immuno-modulators. However, oxidative stress could disturb inflammatory regulation in DCs. Here, we examined the effect of bursopentine (BP5), a novel pentapeptide isolated from chicken bursa of fabricius, on the protection of DCs against oxidative stress for immunosuppression. BP5 showed potent protective effects against the lipopolysaccharide (LPS)-induced oxidative stress in DCs, including nitric oxide, reactive oxygen species and lipid peroxidation. Furthermore, BP5 elevated the level of cellular reductive status through increasing the reduced glutathione (GSH) and the GSH/GSSG ratio. Concomitant with these, the activities of several antioxidative redox enzymes, including glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD), were obviously enhanced. BP5 also suppressed submucosal DC maturation in the LPS-stimulated intestinal epithelial cells (ECs)/DCs coculture system. Finally, we found that heme oxygenase 1 (HO-1) was remarkably upregulated by BP5 in the LPS-induced DCs, and played an important role in the suppression of oxidative stress and DC maturation. These results suggested that BP5 could protect the LPS-activated DCs against oxidative stress and have potential applications in DC-related inflammatory responses.	[Qin, Tao; Yin, Yinyan; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Chinas Dept Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Chinas Dept Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	Qin, Tao/AAB-3778-2021; Yu, Qinghua/T-3261-2019; yu, qing/HGC-4611-2022; YIN, Yinyan/GPK-5820-2022	Qin, Tao/0000-0003-1596-2168; 	National Natural Science Foundation of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (31172302) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Huseini LMA, 2014, J BIOL CHEM, V289, P16442, DOI 10.1074/jbc.M113.532069; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biswas S, 2013, CURR MED CHEM, V20, P1496, DOI 10.2174/0929867311320120004; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Carey IM, 1998, AM J RESP CRIT CARE, V158, P728, DOI 10.1164/ajrccm.158.3.9712065; Chan RCF, 2006, J ALLERGY CLIN IMMUN, V118, P455, DOI 10.1016/j.jaci.2006.06.006; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen DY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/125643; Chernatynskaya AV, 2011, DIABETES-METAB RES, V27, P809, DOI 10.1002/dmrr.1232; Corinti S, 2003, J INTERF CYTOK RES, V23, P423, DOI 10.1089/107999003322277838; DEAKIN AM, 1995, CYTOKINE, V7, P408, DOI 10.1006/cyto.1995.0056; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Feng XL, 2012, AMINO ACIDS, V43, P2443, DOI 10.1007/s00726-012-1323-x; Feng XL, 2012, PEPTIDES, V36, P292, DOI 10.1016/j.peptides.2012.04.015; Feng XL, 2013, VACCINE, V31, P1535, DOI 10.1016/j.vaccine.2012.09.022; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Im E, 2012, AM J PHYSIOL-GASTR L, V303, pG490, DOI 10.1152/ajpgi.00120.2012; Jeong GS, 2011, EUR J PHARMACOL, V654, P226, DOI 10.1016/j.ejphar.2010.12.027; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1111/j.1365-2567.2004.01945.x; Kuppner MC, 2003, BLOOD, V102, P3668, DOI 10.1182/blood-2003-05-1408; LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4; Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7; Li DY, 2012, CELL PHYSIOL BIOCHEM, V29, P9, DOI 10.1159/000337581; Liu HY, 2012, J ETHNOPHARMACOL, V141, P982, DOI 10.1016/j.jep.2012.03.029; Liu SH, 2010, J AGR FOOD CHEM; Liu XD, 2013, REGUL PEPTIDES, V186, P57, DOI 10.1016/j.regpep.2013.07.007; Liu XD, 2012, PEPTIDES, V35, P107, DOI 10.1016/j.peptides.2012.03.003; Lushchak VI, 2012, AMINO ACIDS, V2012, DOI [10.1155/2012/736837, DOI 10.1155/2012/736837]; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; MASTELLER EL, 1995, J IMMUNOL, V155, P5550; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miwa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052926; MUELLER AP, 1962, J IMMUNOL, V88, P354; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Park Y, 2014, INT IMMUNOPHARMACOL, V22, P400, DOI 10.1016/j.intimp.2014.07.023; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2004, ANN NY ACAD SCI, V1029, P66, DOI 10.1196/annals.1309.009; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P482, DOI 10.1016/j.coph.2009.05.008; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Tobwala S, 2013, FREE RADICAL RES, V47, P740, DOI 10.3109/10715762.2013.819974; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Victor VM, 2003, FREE RADICAL RES, V37, P19, DOI 10.1080/1071576021000038522; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wu Q, 2013, ZHONGGUO ZHONGYAO ZA, V38, P2854; Yamada H, 2006, LIFE SCI, V78, P926, DOI 10.1016/j.lfs.2005.05.106; Yin YY, 2014, AMINO ACIDS, V46, P1763, DOI 10.1007/s00726-014-1735-x; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034830	76	21	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117477	10.1371/journal.pone.0117477	http://dx.doi.org/10.1371/journal.pone.0117477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659113	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900158
J	Schokker, D; Zhang, J; Vastenhouw, SA; Heilig, HGHJ; Smidt, H; Rebel, JMJ; Smits, MA				Schokker, Dirkjan; Zhang, Jing; Vastenhouw, Stephanie A.; Heilig, Hans G. H. J.; Smidt, Hauke; Rebel, Johanna M. J.; Smits, Mari A.			Long-Lasting Effects of Early-Life Antibiotic Treatment and Routine Animal Handling on Gut Microbiota Composition and Immune System in Pigs	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; BACTERIAL; EXTRACTION; EXPRESSION; HEALTH; YOUNG; DIET; DNA	Background In intensive pig husbandry systems, antibiotics are frequently administrated during early life stages to prevent respiratory and gastro-intestinal tract infections, often in combination with stressful handlings. The immediate effects of these treatments on microbial colonization and immune development have been described recently. Here we studied whether the early life administration of antibiotics has long-lasting effects on the pig's intestinal microbial community and on gut functionality. Methodology/Principal Findings To investigate the long-lasting effect of early-life treatment, piglets were divided into three different groups receiving the following treatments: 1) no antibiotics and no stress, 2) antibiotics and no stress, and 3) antibiotics and stress. All treatments were applied at day four after birth. Sampling of jejunal content for community scale microbiota analysis, and jejunal and ileal tissue for genome-wide transcription profiling, was performed at day 55 (similar to 8 weeks) and day 176 (similar to 25 weeks) after birth. Antibiotic treatment in combination with or without exposure to stress was found to have long-lasting effects on host intestinal gene expression involved in a multitude of processes, including immune related processes. Conclusions/Significance The results obtained in this study indicate that early life (day 4 after birth) perturbations have long-lasting effects on the gut system, both in gene expression (day 55) as well as on microbiota composition (day 176). At day 55 high variance was observed in the microbiota data, but no significant differences between treatment groups, which is most probably due to the newly acquired microbiota during and right after weaning (day 28). Based on the observed difference in gene expression at day 55, it is hypothesized that due to the difference in immune programming during early life, the systems respond differently to the post-weaning newly acquired microbiota. As a consequence, the gut systems of the treatment groups develop into different homeostasis.	[Schokker, Dirkjan; Smits, Mari A.] Wageningen UR Livestock Res, NL-8200 AB Lelystad, Netherlands; [Zhang, Jing; Heilig, Hans G. H. J.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Vastenhouw, Stephanie A.; Rebel, Johanna M. J.; Smits, Mari A.] Cent Vet Inst, NL-8200 AB Lelystad, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schokker, D (corresponding author), Wageningen UR Livestock Res, POB 65, NL-8200 AB Lelystad, Netherlands.	dirkjan.schokker@wur.nl	Smidt, Hauke/D-7054-2014; Schokker, Dirkjan/M-6385-2014; smits, mari/J-4892-2013; Schokker, Dirkjan/AAB-2668-2020	Smidt, Hauke/0000-0002-6138-5026; Schokker, Dirkjan/0000-0001-6082-7227; smits, mari/0000-0002-3493-291X; Schokker, Dirkjan/0000-0001-6082-7227; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs; Central Veterinary Institute; China Scholarship Programme; European Union through the Interplay project [227549]; Wageningen Livestock Research	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Central Veterinary Institute; China Scholarship Programme; European Union through the Interplay project; Wageningen Livestock Research	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DS, SAV, JMJR, and MAS were supported by the funding of Dutch Ministry of Economic Affairs, Central Veterinary Institute and Wageningen Livestock Research. JZ was supported by a fellowship of the China Scholarship Programme, and JZ, HGHJH and HS were supported by the European Union through the Interplay project, Grant agreement no. 227549).	Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Brook I, 1997, J ANTIMICROB CHEMOTH, V39, P763, DOI 10.1093/jac/39.6.763; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Geuking MB, 2011, GUT MICROBES, P2; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jalanka-Tuovinen J, 2013, GUT; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Kozyrskyj AL, 2011, CURR OPIN ALLERGY CL, V11, P400, DOI 10.1097/ACI.0b013e328349b166; Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344; Leps J, 2003, MULTIVARIATE ANAL EC; Lewis MC, 2012, PEDIAT ALLERGY IMMUN; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Perez-Gutierrez O, 2010, UNRAVELING PIGLET GU; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell SL, 2013, GUT MICROBES, V4, P158, DOI 10.4161/gmic.23567; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Starke IC, 2013, FEMS MICROBIOL ECOL; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Braak C., 1990, UPDATE NOTES CANOCO; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Weng M, 2013, J DEV ORIG HLTH DIS, V4, DOI [10.1017/S2040174413000068, DOI 10.1017/S2040174413000068]; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867	46	74	80	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116523	10.1371/journal.pone.0116523	http://dx.doi.org/10.1371/journal.pone.0116523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658611	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900046
J	Tivers, MS; Handel, I; Gow, AG; Lipscomb, VJ; Jalan, R; Mellanby, RJ				Tivers, Michael S.; Handel, Ian; Gow, Adam G.; Lipscomb, Victoria J.; Jalan, Rajiv; Mellanby, Richard J.			Attenuation of Congenital Portosystemic Shunt Reduces Inflammation in Dogs	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; NECROSIS-FACTOR-ALPHA; SURGICAL ATTENUATION; LIVER-CIRRHOSIS; AMMONIA; ENDOTOXIN; BLOOD; INTERLEUKIN-6; ASSOCIATION; DIAGNOSIS	Liver disease is a major cause of morbidity and mortality. One of the most significant complications in patients with liver disease is the development of neurological disturbances, termed hepatic encephalopathy. The pathogenesis of hepatic encephalopathy is incompletely understood, which has resulted in the development of a wide range of experimental models. Congenital portosystemic shunt is one of the most common congenital disorders diagnosed in client owned dogs. Our recent studies have demonstrated that the pathophysiology of canine hepatic encephalopathy is very similar to human hepatic encephalopathy, which provides strong support for the use of dogs with a congenital portosystemic shunt as a naturally occurring model of human hepatic encephalopathy. Specifically, we have demonstrated an important role for ammonia and inflammation in the development of hepatic encephalopathy in dogs with a congenital portosystemic shunt. Despite the apparent importance of inflammation in driving hepatic encephalopathy in dogs, it is unclear whether inflammation resolves following the successful treatment of liver disease. We hypothesized that haematological and biochemical evidence of inflammation, as gauged by neutrophil, lymphocyte and monocyte concentrations together with C-reactive protein concentrations, would decrease following successful treatment of congenital portosystemic shunts in dogs. One hundred and forty dogs with a congenital portosystemic shunt were enrolled into the study. We found that the proportion of dogs with a monocyte concentration above the reference range was significantly greater in dogs with hepatic encephalopathy at time of initial diagnosis. Importantly, neutrophil and monocyte concentrations significantly decreased following surgical congenital portosystemic shunt attenuation. We also found a significant decrease in C-reactive protein concentrations following surgical attenuation of congenital portosystemic shunts. Our study demonstrates that haematological and biochemical indices of inflammation reduce following successful treatment of the underlying liver disorder.	[Tivers, Michael S.; Lipscomb, Victoria J.] Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, London, England; [Mellanby, Richard J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of London; University of London Royal Veterinary College; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University College London; University of Edinburgh	Tivers, MS (corresponding author), Georges Farm, Nr Wellington, Somerset, England.	mtivers@cave-vet-specialists.co.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Tivers, Michael/0000-0001-7047-9334; Mellanby, Richard John/0000-0002-3467-7007	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Richard Mellanby is supported by a Wellcome Trust Intermediate Clinical Fellowship.	Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; BRADFIELD JW, 1974, LANCET, V2, P883; Cariou MP, 2009, VET REC, V165, P226, DOI 10.1136/vr.165.8.226; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Falls EL, 2013, VET SURG, V42, P951, DOI 10.1111/j.1532-950X.2013.12072.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Goral V, 2011, HEPATO-GASTROENTEROL, V58, P943; Gow AG, 2012, METAB BRAIN DIS, V27, P227, DOI 10.1007/s11011-012-9278-x; Gow AG, 2010, J VET INTERN MED, V24, P90, DOI 10.1111/j.1939-1676.2009.0408.x; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Howe LM, 1997, AM J VET RES, V58, P83; Hu RH, 1999, J FORMOS MED ASSOC, V98, P85; Hunt GB, 1999, AUST VET J, V77, P303, DOI 10.1111/j.1751-0813.1999.tb10268.x; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Kaser A, 2002, LIVER, V22, P380, DOI 10.1034/j.1600-0676.2002.01666.x; Kilpatrick S, 2014, VET J, V200, P197, DOI 10.1016/j.tvjl.2014.01.007; Kummeling A, 2010, J VET INTERN MED, V24, P114, DOI 10.1111/j.1939-1676.2009.0439.x; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lee KCL, 2006, JAVMA-J AM VET MED A, V229, P1122, DOI 10.2460/javma.229.7.1122; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Luo M, 2013, CLIN RES HEPATOL GAS, V37, P384, DOI 10.1016/j.clinre.2012.08.007; Luo M, 2012, HEPATOL RES, V42, P1202, DOI 10.1111/j.1872-034X.2012.01047.x; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Stieger SM, 2007, VET RADIOL ULTRASOUN, V48, P409, DOI 10.1111/j.1740-8261.2007.00268.x; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; TACHIYAMA G, 1988, JPN J SURG, V18, P403, DOI 10.1007/BF02471464; Tivers MS, 2012, J SMALL ANIM PRACT, V53, P3, DOI 10.1111/j.1748-5827.2011.01144.x; Tivers MS, 2014, VET J, V200, P305, DOI 10.1016/j.tvjl.2014.02.027; Tivers MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082303; Tivers MS, 2013, VET SURG, V42, pE46; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; ZLYDASZYK JC, 1976, INFECT IMMUN, V14, P100, DOI 10.1128/IAI.14.1.100-105.1976	36	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117557	10.1371/journal.pone.0117557	http://dx.doi.org/10.1371/journal.pone.0117557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658922	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000349444900175
J	Lauria, V; Power, AM; Lordan, C; Weetman, A; Johnson, MP				Lauria, Valentina; Power, Anne Marie; Lordan, Colm; Weetman, Adrian; Johnson, Mark P.			Spatial Transferability of Habitat Suitability Models of Nephrops norvegicus among Fished Areas in the Northeast Atlantic: Sufficiently Stable for Marine Resource Conservation?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EASTERN ENGLISH-CHANNEL; NORWAY LOBSTER; DISTRIBUTIONS; VALIDATION; GENERALITY; ABUNDANCE; CRITERIA; BAY	Knowledge of the spatial distribution and habitat associations of species in relation to the environment is essential for their management and conservation. Habitat suitability models are useful in quantifying species- environment relationships and predicting species distribution patterns. Little is known, however, about the stability and performance of habitat suitability models when projected into new areas (spatial transferability) and how this can inform resource management. The aims of this study were to model habitat suitability of Norway lobster (Nephrops norvegicus) in five fished areas of the Northeast Atlantic (Aran ground, Irish Sea, Celtic Sea, Scotland Inshore and Fladen ground), and to test for spatial transferability of habitat models among multiple regions. Nephrops burrow density was modelled using generalised additive models (GAMs) with predictors selected from four environmental variables (depth, slope, sediment and rugosity). Models were evaluated and tested for spatial transferability among areas. The optimum models (lowest AICc) for different areas always included depth and sediment as predictors. Burrow densities were generally greater at depth and in finer sediments, but relationships for individual areas were sometimes more complex. Aside from an inclusion of depth and sediment, the optimum models differed between fished areas. When it came to tests of spatial transferability, however, most of the models were able to predict Nephrops density in other areas. Furthermore, transferability was not dependent on use of the optimum models since competing models were also able to achieve a similar level of transferability to new areas. A degree of decoupling between model 'fitting' performance and spatial transferability supports the use of simpler models when extrapolating habitat suitability maps to different areas. Differences in the form and performance of models from different areas may supply further information on the processes shaping species' distributions. Spatial transferability of habitat models can be used to support fishery management when the information is scarce but caution needs to be applied when making inference and a multi-area transferability analysis is preferable to bilateral comparisons between areas.	[Lauria, Valentina; Johnson, Mark P.] Natl Univ Ireland, Sch Nat Sci, Ryan Inst, Galway, Ireland; [Power, Anne Marie] Natl Univ Ireland, Sch Nat Sci, Ryan Inst, Dept Zool, Galway, Ireland; [Lordan, Colm] Inst Marine, Oranmore, Co Galway, Ireland; [Weetman, Adrian] Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Marine Institute Ireland; Marine Scotland Science (MSS)	Lauria, V (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	valentina.lauria@plymouth.ac.uk	Lauria, Valentina/AAG-4906-2021; Lordan, Colm/AAU-4539-2020; Johnson, Mark/W-4226-2019; Lauria, Valentina/R-9053-2018; Johnson, Mark P/B-5017-2009	Lordan, Colm/0000-0001-8929-3513; Johnson, Mark/0000-0002-5078-1410; Lauria, Valentina/0000-0002-4179-9133; Johnson, Mark P/0000-0002-5078-1410; Power, Anne Marie/0000-0001-7351-2451	European Union through the FP7 Framework Programme FP7-SME-286903	European Union through the FP7 Framework Programme FP7-SME-286903	This work was funded by the European Union through the FP7 Framework Programme FP7-SME-2011-286903 (NEPHROPS project). VL AMP MPJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Dias M, 1998, THESIS U ABERDEEN; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Bailey M. C., 2012, SUSTAINABLE FISHING; Bell MC, 2005, NEW ZEAL J MAR FRESH, V39, P1023, DOI 10.1080/00288330.2005.9517373; Bivand R, 2013, R PACKAGE RGDAL DATA; Bulluck L, 2006, GLOBAL ECOL BIOGEOGR, V15, P27, DOI 10.1111/j.1466-822x.2006.00170.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell N, 2009, ICES J MAR SCI, V66, P646, DOI 10.1093/icesjms/fsp046; Campbell N, 2009, ICES J MAR SCI, V66, P2052, DOI 10.1093/icesjms/fsp176; dos Santos A, 2005, J MAR BIOL ASSOC UK, V85, P937, DOI 10.1017/S0025315405011914; Dueri S, 2014, GLOBAL CHANGE BIOL, V20, P742, DOI 10.1111/gcb.12460; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Fleishman E, 2003, CONSERV BIOL, V17, P806, DOI 10.1046/j.1523-1739.2003.02113.x; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Guay JC, 2003, CAN J FISH AQUAT SCI, V60, P1398, DOI 10.1139/F03-120; Guinan J, 2011, MODELLING HABITAT SU, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Heinanen S, 2008, ECOGRAPHY, V31, P601, DOI 10.1111/j.0906-7590.2008.05410.x; Hijmans R. J., 2013, INTRO RASTER PACKAGE, P1; ICES Advisory Commitee on Fishery Management, 2004, 2004ACFM19 ICES CM; ICES Advisory Commitee on Fishery Management, 2012, STUD GROUP NEPHR SUR; Jensen OP, 2005, MAR ECOL PROG SER, V299, P239, DOI 10.3354/meps299239; Johnson MP, 2013, ADV MAR BIOL, V64, P27, DOI 10.1016/B978-0-12-410466-2.00002-9; Lauria V, 2011, ICES J MAR SCI, V68, P1500, DOI 10.1093/icesjms/fsr081; Leftwich KN, 1997, T AM FISH SOC, P37, DOI [10.1577/1548-8659(1997)126&LT;0725, DOI 10.1577/1548-8659(1997)126<0725]; Maki-Petays A, 2002, CAN J FISH AQUAT SCI, V59, P218, DOI 10.1139/F01-209; Martin CS, 2012, J EXP MAR BIOL ECOL, V418, P91, DOI 10.1016/j.jembe.2012.03.010; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Planque B, 2011, FISH OCEANOGR, V20, P1, DOI 10.1111/j.1365-2419.2010.00546.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Schaub M, 2011, ECOGRAPHY, V34, P693, DOI 10.1111/j.1600-0587.2010.06584.x; Sikder S, 2013, INT J ADV ENG SCI AP, V5, P104, DOI 10.1007/s12572-013-0090-6; Strakosh TR, 2003, ECOL FRESHW FISH, V12, P265, DOI 10.1046/j.1600-0633.2003.00022.x; Strauss B, 2007, ECOL MODEL, V204, P104, DOI 10.1016/j.ecolmodel.2006.12.027; Sundblad G, 2009, ESTUAR COAST SHELF S, V83, P90, DOI 10.1016/j.ecss.2009.03.025; THOMAS JA, 1993, REGUL RIVER, V8, P285, DOI 10.1002/rrr.3450080307; Thompson IS, 1998, 1998CC12 ICES CM; Tuck ID, 1997, ICES J MAR SCI, V54, P125, DOI 10.1006/jmsc.1996.0179; Ungfors A, 2013, ADV MAR BIOL, V64, P247, DOI 10.1016/B978-0-12-410466-2.00007-8; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x; Zhu GP, 2014, BIOL INVASIONS, V16, P1069, DOI 10.1007/s10530-013-0559-z; Zuur AF, 2007, ANAL ECOLOGICAL DATA, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]	58	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117006	10.1371/journal.pone.0117006	http://dx.doi.org/10.1371/journal.pone.0117006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679507	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600044
J	Sasatani, M; Xu, YB; Kawai, H; Cao, LL; Tateishi, S; Shimura, T; Li, JX; Iizuka, D; Noda, A; Hamasaki, K; Kusunoki, Y; Kamiya, K				Sasatani, Megumi; Xu, Yanbin; Kawai, Hidehiko; Cao, Lili; Tateishi, Satoshi; Shimura, Tsutomu; Li, Jianxiang; Iizuka, Daisuke; Noda, Asao; Hamasaki, Kanya; Kusunoki, Yoichiro; Kamiya, Kenji			RAD18 Activates the G2/M Checkpoint through DNA Damage Signaling to Maintain Genome Integrity after Ionizing Radiation Exposure	PLOS ONE			English	Article							STRAND BREAK REPAIR; PCNA MONOUBIQUITINATION; MAMMALIAN-CELLS; UBIQUITIN; 53BP1; SITES; MDC1; RECOMBINATION; RETENTION; MECHANISM	The ubiquitin ligase RAD18 is involved in post replication repair pathways via its recruitment to stalled replication forks, and its role in the ubiquitylation of proliferating cell nuclear antigen (PCNA). Recently, it has been reported that RAD18 is also recruited to DNA double strand break (DSB) sites, where it plays novel functions in the DNA damage response induced by ionizing radiation (IR). This new role is independent of PCNA ubiquitylation, but little is known about how RAD18 functions after IR exposure. Here, we describe a role for RAD18 in the IR-induced DNA damage signaling pathway at G2/M phase in the cell cycle. Depleting cells of RAD18 reduced the recruitment of the DNA damage signaling factors ATM, gamma H2AX, and 53BP1 to foci in cells at the G2/M phase after IR exposure, and attenuated activation of the G2/M checkpoint. Furthermore, depletion of RAD18 increased micronuclei formation and cell death following IR exposure, both in vitro and in vivo. Our data suggest that RAD18 can function as a mediator for DNA damage response signals to activate the G2/M checkpoint in order to maintain genome integrity and cell survival after IR exposure.	[Sasatani, Megumi; Xu, Yanbin; Cao, Lili; Li, Jianxiang; Iizuka, Daisuke; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, Hiroshima 7348553, Japan; [Kawai, Hidehiko] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Minami Ku, Hiroshima 7348553, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Shimura, Tsutomu] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Noda, Asao; Hamasaki, Kanya] Radiat Effects Res Fdn, Dept Genet, Minami Ku, Hiroshima 7320815, Japan; [Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Minami Ku, Hiroshima 7320815, Japan	Hiroshima University; Hiroshima University; Kumamoto University; National Institute of Public Health - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	Kamiya, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	kkamiya@hiroshima-u.ac.jp		IIZUKA, Daisuke/0000-0003-3990-4800; Noda, Asao/0000-0002-9029-9813; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare; NIFS Collaborative Research Program [NIFS10KOBS015, NIFS13KOBA028]; Grants-in-Aid for Scientific Research [26340024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare; NIFS Collaborative Research Program(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Fusion Science (NIFS) - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funding was provided by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), from the Ministry of Health, Labour and Welfare (to KK and MS). The funding was also provided in part by NIFS Collaborative Research Program (NIFS10KOBS015) (NIFS13KOBA028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Liu T, 2012, DNA REPAIR, V11, P131, DOI 10.1016/j.dnarep.2011.10.012; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang B, 2014, METHODS MOL BIOL, V1170, P313, DOI 10.1007/978-1-4939-0888-2_15; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xie C, 2014, BIOCHEM BIOPH RES CO, V445, P263, DOI 10.1016/j.bbrc.2014.02.003; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yoshimura A, 2006, DNA REPAIR, V5, P1307, DOI 10.1016/j.dnarep.2006.05.045; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	34	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117845	10.1371/journal.pone.0117845	http://dx.doi.org/10.1371/journal.pone.0117845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675240	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000034
J	Cermeno, P; Quilez-Badia, G; Ospina-Alvarez, A; Sainz-Trapaga, S; Boustany, AM; Seitz, AC; Tudela, S; Block, BA				Cermeno, Pablo; Quilez-Badia, Gemma; Ospina-Alvarez, Andres; Sainz-Trapaga, Susana; Boustany, Andre M.; Seitz, Andy C.; Tudela, Sergi; Block, Barbara A.			Electronic Tagging of Atlantic Bluefin Tuna (Thunnus thynnus, L.) Reveals Habitat Use and Behaviors in the Mediterranean Sea	PLOS ONE			English	Article							STATE-SPACE MODEL; POPULATION-STRUCTURE; DIVING BEHAVIOR; REPRODUCTIVE-BIOLOGY; MITOCHONDRIAL-DNA; THERMAL BIOLOGY; SEXUAL-MATURITY; YELLOWFIN TUNA; HOME-RANGE; WESTERN	We analyzed the movements of Atlantic tuna (Thunnus thynnus L.) in the Mediterranean Sea using data from 2 archival tags and 37 pop-up satellite archival tags (PAT). Bluefin tuna ranging in size from 12 to 248 kg were tagged on board recreational boats in the western Mediterranean and the Adriatic Sea between May and September during two different periods (2000 to 2001 and 2008 to 2012). Although tuna migrations between the Mediterranean Sea and the Atlantic Ocean have been well reported, our results indicate that part of the bluefin tuna population remains in the Mediterranean basin for much of the year, revealing a more complex population structure. In this study we demonstrate links between the western Mediterranean, the Adriatic and the Gulf of Sidra (Libya) using over 4336 recorded days of location and behavior data from tagged bluefin tuna with a maximum track length of 394 days. We described the oceanographic preferences and horizontal behaviors during the spawning season for 4 adult bluefin tuna. We also analyzed the time series data that reveals the vertical behavior of one pop-up satellite tag recovered, which was attached to a 43.9 kg tuna. This fish displayed a unique diving pattern within 16 days of the spawning season, suggesting a use of the thermocline as a thermoregulatory mechanism compatible with spawning. The results obtained hereby confirm that the Mediterranean is clearly an important habitat for this species, not only as spawning ground, but also as an overwintering foraging ground.	[Cermeno, Pablo; Boustany, Andre M.; Block, Barbara A.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Cermeno, Pablo; Quilez-Badia, Gemma; Ospina-Alvarez, Andres; Sainz-Trapaga, Susana; Tudela, Sergi] WWF Mediterranean Programme, Barcelona 08002, Spain; [Ospina-Alvarez, Andres] Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Marine Conservat, Santiago 6513677, Chile; [Ospina-Alvarez, Andres] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Ecol, Santiago 6513677, Chile; [Boustany, Andre M.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Seitz, Andy C.] Monterey Bay Aquarium, Tuna Res & Conservat Ctr, Monterey, CA 93940 USA; [Seitz, Andy C.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA	Stanford University; World Wildlife Fund; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Duke University; Monterey Bay Aquarium Research Institute; University of Alaska System; University of Alaska Fairbanks	Cermeno, P (corresponding author), Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	pcerme@gmail.com	Ospina-Alvarez, Andres/M-2556-2014	Ospina-Alvarez, Andres/0000-0003-2454-7169	Prince Albert II of Monaco Foundation; Project Oceans United Postcode Lotteries; Tag A Giant Foundation (TAG); Stanford University	Prince Albert II of Monaco Foundation; Project Oceans United Postcode Lotteries; Tag A Giant Foundation (TAG); Stanford University(Stanford University)	The project was supported by the Prince Albert II of Monaco Foundation, the Project Oceans United Postcode Lotteries, Tag A Giant Foundation (TAG) and Stanford University. PC was funded by a Young Researcher Award from the Prince Albert II of Monaco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2004, FISH B-NOAA, V102, P407; Abdelhadi B, 2011, MEDITERRANEA SERIE E; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Alvarado Bremer J.R., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P127; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Arena P, 1988, MMM CNR ATT SEM UU O, P273; Arena P., 2006, LENGTH WEIGHT RELATI; Arena P, 1981, QUAD LAB TECN PESC S, V3, P77; Arena P, 1982, ATT CONV UU OO SOTT, P361; Arena P, 1963, FAO P GEN FISH COUN, V7, P395; Arregui I., 2006, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V59, P769; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Bahurel P, 2009, OCEANOBS 09 OC SOC S; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Broughton RE, 1997, MOL MAR BIOL BIOTECH, V6, P308; Buljan M, 1964, ACTA ADRIAT, V11, P35; Bunag DM, 1956, PHILIPP J FISH, V26, P877; Cannas R, 2012, COL VOL SCI PAP ICCA, V67, P351; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cermeno P, 2012, COL VOL SCI PAP ICCA, V68, P151; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Cort JL, 2013, REV FISH SCI, V21, P181, DOI 10.1080/10641262.2013.793284; de la Serna J.D., 2004, COL VOL SCI PAP ICCA, V56, P1196; De la Serna JM, 1992, COL VOL SCI PAP ICCA, V39, P692; De la Serna JM, 2011, COL VOL SCI PAP ICCA, V66, P984; De la Serna JM, 1993, COL VOL SCI PAP ICCA, V40, P116; De Metrio G., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1163; de Metrio G., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1337; De Metrio G, 2005, P 5 C FISH TEL HELD; Di Natale A, 2005, COL VOL SCI PAP ICCA, V58, P1296; Di Natale A, 2005, COL VOL SCI PAP ICCA, V58, P1285; Di Natale A, 2006, COL VOL SCI PAP ICCA, V59, P829; DiNatale A., 2010, COLLECTIVE VOLUMES S, V65, P1004; Druon JN, 2011, MAR ECOL PROG SER, V439, P223, DOI 10.3354/meps09321; EDMUNDS PH, 1973, J FISH RES BOARD CAN, V30, P1031, DOI 10.1139/f73-172; Ely B, 2002, MAR BIOTECHNOL, V4, P583, DOI 10.1007/s10126-002-0040-y; FAO, 2013, 15 SESS SCI ADV COMM; FAO, 2013, CWP HDB FISH STAT H, V1; FAO, 2006, 8 SESS SCI ADV COMM; Farley JH, 1998, FISH B-NOAA, V96, P223; Fromentin JM, 2014, ICES J MAR SCI, V71, P510, DOI 10.1093/icesjms/fst157; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2009, COL VOL SCI PAP ICCA, V65, P812; Fromentin JM, 2004, COL VOL SCI PAP ICCA, V56, P1182; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P535; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Hattour A, 2003, COLLECTIVE VOLUME SC, V55, P204; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hunter J.R., 1985, NOAA TECH REP NMFS, V36, P67; ICCAT, 2007, COL VOL SCI PAP ICCA, V60, P652; ICCAT, 2009, COLLECT VOL SCI PAP, V64, P1; Idrissi M., 2010, ICCAT COLLECT VOL SC, V65, P968; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; June F. C., 1954, Fishery Bulletin United States, V54, P47; Karakulak F.S., 2009, COLLECTIVE VOLUME SC, V63, P153; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Lloret J, 2000, ICES J MAR SCI, V57, P171, DOI 10.1006/jmsc.2000.0570; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Mather FJ, 1995, NMFSSEFSC370 NOAA; McGowan M. F., 1986, INT COMM CONSERV ATL, V24, P182; MCPHERSON GR, 1991, AUST J MAR FRESH RES, V42, P465, DOI 10.1071/MF9910465; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Morovic Mira, 2004, Gayana (Concepc.), V68, P405; Muhling BA, 2010, FISH OCEANOGR, V19, P526, DOI 10.1111/j.1365-2419.2010.00562.x; Natale AD, 2011, COL VOL SCI PAP ICCA, V66, P995; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Oray I, 1997, COL VOL SCI PAP ICCA, V46; Oray I.K., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1341; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Parrack M., 1979, COL VOL SCI PAP ICCA, V8, P356; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Piccinetti C, 2012, COL VOL SCI PAP ICCA, V69, P891; Platonenko S., 1997, COL VOL SCI PAP ICCA, V46, P496; Pujolar JM, 2003, MAR BIOL, V143, P613, DOI 10.1007/s00227-003-1080-1; Quilez-Badia G, 2013, COL VOL SCI PAP ICCA, V69, P435; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Relini M, 1995, COLL VOL SCI PAP, V44, P378; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RODRIGUEZRODA J, 1969, INVEST PESQ, V33, P87; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; Salat J, 2011, 13 PLIN C MED STORMS, V13, P13; Sara R., 1964, Proceedings of the General Fisheries Council for the Mediterranean FAO, VNo. 7, P371; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Sarasquete C, 2002, HISTOL HISTOPATHOL, V17, P775, DOI 10.14670/HH-17.775; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer Kurt M., 1998, Inter-American Tropical Tuna Commission Bulletin, V21, P205; Serna J. M. de la, 2012, COL VOL SCI PAP ICCA, V68, P115; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sournia A., 1973, B ETUDE COMMUN MEDIT, V5, P1; SPENCER SR, 1990, ECOLOGY, V71, P1817, DOI 10.2307/1937590; STEQUERT B, 1995, AQUAT LIVING RESOUR, V8, P79, DOI 10.1051/alr:1995006; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Takagi M, 1999, FISHERIES SCI, V65, P571, DOI 10.2331/fishsci.65.571; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Thompson Jr HC, 1980, COL VOL SCI PAP ICCA, V9, P499; Tudela S, 2011, COL VOL SCI PAP ICCA, V66, P1157; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vlaming V. de, 1983, Control processes in fish physiology., P176; WALLACE RA, 1981, AM ZOOL, V21, P325; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wurtz M., 2010, MEDITERRANEAN PELAGI; Yamashita H, 2001, COL VOL SCI PAP ICCA, V52, P809; Yuen H. S. H., 1955, 150 US FISH WILDL SE	128	41	42	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116638	10.1371/journal.pone.0116638	http://dx.doi.org/10.1371/journal.pone.0116638			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671316	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300022
J	Goldmacher, VS; Audette, CA; Guan, YH; Sidhom, EH; Shah, JV; Whiteman, KR; Kovtun, YV				Goldmacher, Victor S.; Audette, Charlene A.; Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.; Whiteman, Kathleen R.; Kovtun, Yelena V.			High-Affinity Accumulation of a Maytansinoid in Cells via Weak Tubulin Interaction	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; CALF BRAIN TUBULIN; SOLUTION VARIABLES; VINCA ALKALOIDS; BINDING; CANCER; VINBLASTINE; DRUGS; NUCLEOTIDES; VINCRISTINE	The microtubule-targeting maytansinoids accumulate in cells and induce mitotic arrest at 250-to 1000-fold lower concentrations than those required for their association with tubulin or microtubules. To identify the mechanisms of this intracellular accumulation and exceptional cytotoxicity of maytansinoids we studied interaction of a highly cytotoxic maytansinoid, S-methyl DM1 and several other maytansinoids with cells. S-methyl DM1 accumulated inside the cells with a markedly higher apparent affinity than to tubulin or microtubules. The apparent affinities of maytansinoids correlated with their cytotoxicities. The number of intracellular binding sites for S-methyl DM1 in MCF7 cells was comparable to the number of tubulin molecules per cell (similar to 4-6 x 10(7) copies). Efflux of (3) [H]-S-methyl DM1 from cells was enhanced in the presence of an excess of non-labeled S-methyl DM1, indicating that re-binding of (3) [H]-S-methyl DM1 to intracellular binding sites contributed to its intracellular retention. Liposomes loaded with non-polymerized tubulin recapitulated the apparent high-affinity association of S-methyl DM1 to cells. We propose a model for the intracellular accumulation of maytansinoids in which molecules of the compounds diffuse into a cell and associate with tubulin. Affinities of maytansinoids for individual tubulin molecules are weak, but the high intracellular concentration of tubulin favors, after dissociation of a compound-tubulin complex, their re-binding to a tubulin molecule, or to a tip of a microtubule in the same cell, over their efflux. As a result, a significant fraction of microtubule tips is occupied with a maytansinoid when added to cells at sub-nanomolar concentrations, inducing mitotic arrest and cell death.	[Goldmacher, Victor S.; Audette, Charlene A.; Whiteman, Kathleen R.; Kovtun, Yelena V.] ImmunoGen Inc, Dept Cell Biol, Waltham, MA 02451 USA; [Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Guan, Yinghua; Sidhom, Eriene-Heidi; Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	ImmunoGen, Inc.; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Goldmacher, VS (corresponding author), ImmunoGen Inc, Dept Cell Biol, Waltham, MA 02451 USA.	victor.goldmacher@immunogen.com		Goldmakher, Viktor/0000-0001-6130-4436; Sidhom, Eriene-Heidi/0000-0002-2658-9672	Beckman Laser Institute SPARK program	Beckman Laser Institute SPARK program	Support for FCS work in the Shah Lab was provided by the Beckman Laser Institute SPARK program (YG and JVS): www.beckmanlaserinstitutefoundation.com/programs/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANC DISCOVERY, V3, P366; Barlow SB, 2002, J CELL SCI, V115, P3469; BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; Correia John J., 2008, P21, DOI 10.1007/978-1-59745-336-3_2; CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Flygare JA, 2013, CHEM BIOL DRUG DES, V81, P113, DOI 10.1111/cbdd.12085; Goldmacher VS, 2012, ANNU REP MED CHEM, V47, P349, DOI 10.1016/B978-0-12-396492-2.00023-0; HERZOG W, 1977, P NATL ACAD SCI USA, V74, P1860, DOI 10.1073/pnas.74.5.1860; JORDAN MA, 1991, CANCER RES, V51, P2212; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lobert S, 1996, BIOCHEMISTRY-US, V35, P6806, DOI 10.1021/bi953037i; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; MANDELBAUMSHAVIT F, 1976, BIOCHEM BIOPH RES CO, V72, P47, DOI 10.1016/0006-291X(76)90958-X; NA GC, 1986, BIOCHEMISTRY-US, V25, P6222, DOI 10.1021/bi00368a058; OHTA S, 1993, BRIT J CANCER, V68, P74, DOI 10.1038/bjc.1993.289; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; OSTLUND RE, 1980, J CELL BIOL, V85, P386, DOI 10.1083/jcb.85.2.386; PRAKASH V, 1985, BIOCHEMISTRY-US, V24, P5004, DOI 10.1021/bi00340a007; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; Putnam AJ, 1998, J CELL SCI, V111, P3379; SANDOVAL IV, 1978, P NATL ACAD SCI USA, V75, P3178, DOI 10.1073/pnas.75.7.3178; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SINGER WD, 1988, BIOCHEM PHARMACOL, V37, P2691, DOI 10.1016/0006-2952(88)90264-X; Sontag CA, 2004, BIOPHYS CHEM, V108, P215, DOI 10.1016/j.bpc.2003.10.029; THROWER D, 1991, J IMMUNOL METHODS, V136, P45, DOI 10.1016/0022-1759(91)90248-E; Thrower DA, 1996, CELL MOTIL CYTOSKEL, V35, P121, DOI 10.1002/(SICI)1097-0169(1996)35:2<121::AID-CM5>3.0.CO;2-D; Verdier-Pinard P, 2000, MOL PHARMACOL, V57, P180; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; YORK J, 1981, BIOCHEM PHARMACOL, V30, P3239, DOI 10.1016/0006-2952(81)90524-4	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117523	10.1371/journal.pone.0117523	http://dx.doi.org/10.1371/journal.pone.0117523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671541	gold, Green Published, Green Submitted			2022-12-26	WOS:000349545300056
J	Chakraborty, S; Fernandes, VO; Dias, FMV; Prates, JAM; Ferreira, LMA; Fontes, CMGA; Goyal, A; Centeno, MSJ				Chakraborty, Soumyadeep; Fernandes, Vania O.; Dias, Fernando M. V.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Goyal, Arun; Centeno, Maria S. J.			Role of Pectinolytic Enzymes Identified in Clostridium thermocellum Cellulosome	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; PECTATE-LYASE-C; ERWINIA-CHRYSANTHEMI 3937; PLANT VIRULENCE FACTOR; RHAMNOGALACTURONAN LYASE; PECTIC POLYSACCHARIDE; BACILLUS-SUBTILIS; LIGAND-BINDING; CELL WALLS; FUNCTIONAL IMPLICATIONS	The cloning, expression and characterization of three cellulosomal pectinolytic enzymes viz., two variants of PL1 (PL1A and PL1B) and PL9 from Clostridium thermocellum was carried out. The comparison of the primary sequences of PL1A, PL1B and PL9 revealed that these proteins displayed considerable sequence similarities with family 1 and 9 polysaccharide lyases, respectively. PL1A, PL1B and PL9 are the putative catalytic domains of protein sequence ABN54148.1 and ABN53381.1 respectively. These two protein sequences also contain putative carbohydrate binding module (CBM) and type-I dockerin. The associated putative CBM of PL1A showed strong homology with family 6 CBMs while those of PL1B and PL9 showed homology with family 35 CBMs. Recombinant derivatives of these three enzymes showed molecular masses of approximately 34 kDa, 40 kDa and 32 kDa for PL1A, PL1B and PL9, respectively. PL1A, PL1B and PL9 displayed high activity toward polygalacturonic acid and pectin (up to 55% methyl-esterified) from citrus fruits. However, PL1B showed relatively higher activity towards 55% and 85% methyl-esterified pectin (citrus). PL1A and PL9 showed higher activity on rhamnogalacturonan than PL1B. Both PL1A and PL9 displayed maximum activity at pH 8.5 with optimum temperature of 50 degrees C and 60 degrees C respectively. PL1B achieved highest activity at pH 9.8, under an optimum temperature of 50 degrees C. PL1A, PL1B and PL9 all produced two or more unsaturated galacturonates from pectic substrates as displayed by TLC analysis confirming that they are endo-pectate lyase belonging to family 1 and 9, respectively. This report reveals that pectinolytic activity displayed by Clostridium thermocellum cellulosome is coordinated by a sub-set of at least three multi-modular enzymes.	[Chakraborty, Soumyadeep; Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Fernandes, Vania O.; Dias, Fernando M. V.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Centeno, Maria S. J.] Univ Lisbon, CIISA Fac Med Vet, P-1699 Lisbon, Portugal	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Universidade de Lisboa	Goyal, A (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	arungoyl@iitg.ernet.in; zecenteno@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Dias, Fernando/I-4861-2012	Prates, José A M/0000-0003-1032-5987; Dias, Fernando/0000-0001-8109-2063; Fontes, Carlos/0000-0002-1219-9753; Fernandes, Vania/0000-0002-9671-3923; Chakraborty, Soumyadeep/0000-0002-3882-7172	Department of Science and Technology, India; Fundacao para a Ciencia e a Tecnologia, Portugal; Ministry of Human Resource Development, Government of India through IIT Guwahati;  [SFRH/BDE/51101/2010]	Department of Science and Technology, India(Department of Science & Technology (India)); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ministry of Human Resource Development, Government of India through IIT Guwahati; 	This research work was funded under a Indo-Portugal project grant from Department of Science and Technology, India and Fundacao para a Ciencia e a Tecnologia, Portugal. PhD scholarships to Soumyadeep Chakraborty was provided by Ministry of Human Resource Development, Government of India through IIT Guwahati. PhD Grant (SFRH/BDE/51101/2010) was provided to Vania O. Fernandes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 1998, COMPREHENSIVE BIOL C, V2, P115; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Blum DL, 2000, J BACTERIOL, V182, P1346, DOI 10.1128/JB.182.5.1346-1351.2000; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown IE, 2001, BIOCHEM J, V355, P155, DOI 10.1042/0264-6021:3550155; Bruhlmann F, 1997, GENE, V202, P45, DOI 10.1016/S0378-1119(97)00449-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; COLLMER A, 1988, METHOD ENZYMOL, V161, P329; Cote GL, 2005, J IND MICROBIOL BIOT, V32, P53, DOI 10.1007/s10295-004-0194-x; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Fernandes AC, 1999, BIOCHEM J, V342, P105, DOI 10.1042/0264-6021:3420105; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FONTES CMGA, 1995, APPL MICROBIOL BIOT, V43, P52, DOI 10.1007/BF00170622; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; HASEGAWA S, 1966, J FOOD SCI, V31, P838, DOI 10.1111/j.1365-2621.1966.tb03259.x; HENRISSAT B, 1995, PLANT PHYSIOL, V107, P963, DOI 10.1104/pp.107.3.963; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Herron SR, 2003, J BIOL CHEM, V278, P12271, DOI 10.1074/jbc.M209306200; HINTON JCD, 1989, MOL MICROBIOL, V3, P1785, DOI 10.1111/j.1365-2958.1989.tb00164.x; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jurnak F, 1996, PROGR BIOTECHNOL, V14, P295, DOI 10.1016/S0921-0423(96)80263-2; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LOJKOWSKA E, 1995, MOL MICROBIOL, V16, P1183, DOI 10.1111/j.1365-2958.1995.tb02341.x; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pissavin C, 1996, J BACTERIOL, V178, P7187, DOI 10.1128/jb.178.24.7187-7196.1996; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Shevchik VE, 1997, J BACTERIOL, V179, P7321, DOI 10.1128/jb.179.23.7321-7330.1997; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Soriano M, 2000, MICROBIOL-SGM, V146, P89, DOI 10.1099/00221287-146-1-89; SPINNLER HE, 1986, APPL MICROBIOL BIOT, V23, P434, DOI 10.1007/BF02346055; Sukhumsiirchart W, 2009, BIOSCI BIOTECH BIOCH, V73, P268; Tamaru Y, 2001, P NATL ACAD SCI USA, V98, P4125, DOI 10.1073/pnas.071045598; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; White GW, 1999, J PHARMACEUT BIOMED, V20, P905, DOI 10.1016/S0731-7085(99)00083-7; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; Zverlov VV, 2002, APPL ENVIRON MICROB, V68, P3176, DOI 10.1128/AEM.68.6.3176-3179.2002; ZVERLOV VV, 1994, BIOTECHNOL LETT, V16, P29, DOI 10.1007/BF01022619	61	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116787	10.1371/journal.pone.0116787	http://dx.doi.org/10.1371/journal.pone.0116787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658912	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900067
J	Cho, Y; Kim, JO; Lee, JH; Park, HM; Jeon, YJ; Oh, SH; Bae, J; Park, YS; Kim, OJ; Kim, NK				Cho, Yunkyung; Kim, Jung O.; Lee, Jeong Han; Park, Hye Mi; Jeon, Young Joo; Oh, Seung Hun; Bae, Jinkun; Park, Young Seok; Kim, Ok Joon; Kim, Nam Keun			Association of Reduced Folate Carrier-1 (RFC-1) Polymorphisms with Ischemic Stroke and Silent Brain Infarction	PLOS ONE			English	Article							TOTAL HOMOCYSTEINE CONCENTRATIONS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; HEART-DISEASE; WHITE-MATTER; SERUM FOLATE; GENE; METAANALYSIS; HYPERHOMOCYSTEINEMIA; METHOTREXATE	Stroke is the second leading cause of death in the world and in South Korea. Ischemic stroke and silent brain infarction (SBI) are complex, multifactorial diseases influenced by multiple genetic and environmental factors. Moderately elevated plasma homocysteine levels are a major risk factor for vascular diseases, including stroke and SBI. Folate and vitamin B12 are important regulators of homocysteine metabolism. Reduced folate carrier (RFC), a bidirectional anion exchanger, mediates folate delivery to a variety of cells. We selected three known RFC-1 polymorphisms (-43C>T, 80A>G, 696T>C) and investigated their relationship to cerebral infarction in the Korean population. We used the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to analyze associations between the three RFC-1 polymorphisms, disease status, and folate and homocysteine levels in 584 ischemic stroke patients, 353 SBI patients, and 505 control subjects. The frequencies of the RFC-1-43TT, 80GG, and 696CC genotypes differed significantly between the stroke and control groups. The RFC-1 80A>G substitution was also associated with small artery occlusion and SBI. In a gene-environment analysis, the RFC-1-43C>T, 80A>G, and 696T>C polymorphisms in the ischemic stroke group had combined effects with all environmental factors. In summary, we found that the RFC-1-43C>T, 80A>G, and 696T>C polymorphisms may be risk factors for ischemic stroke.	[Cho, Yunkyung] CHA Univ, CHA Gangnam Med Ctr, Sch Med, Dept Internal Med, Seoul 135081, South Korea; [Kim, Jung O.; Park, Hye Mi; Jeon, Young Joo; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 463712, South Korea; [Lee, Jeong Han; Bae, Jinkun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Emergency Med, Songnam 463712, South Korea; [Oh, Seung Hun; Kim, Ok Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 463712, South Korea; [Park, Young Seok] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Neurosurg, Chongju 361711, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Chungbuk National University; Chungbuk National University Hospital	Kim, OJ (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 463712, South Korea.	okjun77@cha.ac.kr; nkkim@cha.ac.kr			National Research foundation, South Korea [NRF-2012R1A1A2007033, NRF-2013R1A1A2008177, NRF-2013R1A2A2A01067990]	National Research foundation, South Korea(National Research Foundation of Korea)	1. NRF-2012R1A1A2007033: National Research foundation, South Korea; NKK. 2. NRF-2013R1A1A2008177: National Research Foundation, South Korea; OJK. 3. NRF-2013R1A2A2A01067990: National Research Foundation, South Korea; YSP.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ashfield-Watt PAL, 2001, BIOMED PHARMACOTHER, V55, P425, DOI 10.1016/S0753-3322(01)00125-1; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chatzikyriakidou A, 2007, RHEUMATOL INT, V27, P1057, DOI 10.1007/s00296-007-0339-0; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; De Marco P, 2001, EUR J PEDIATR SURG, V11, pS14, DOI 10.1055/s-2001-19739; Frederiksen J, 2004, BLOOD, V104, P3046, DOI 10.1182/blood-2004-03-0897; FREISHEIM JH, 1989, ADV ENZYME REGUL, V29, P13, DOI 10.1016/0065-2571(89)90091-5; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; GILES WH, 1995, STROKE, V26, P1166, DOI 10.1161/01.STR.26.7.1166; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Ifergan I, 2008, J BIOL CHEM, V283, P20687, DOI 10.1074/jbc.M802812200; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; JACOB RA, 1994, J NUTR, V124, P1072, DOI 10.1093/jn/124.7.1072; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jeon YJ, 2011, GENES GENOM, V33, P223, DOI 10.1007/s13258-011-0016-2; Khan U, 2008, STROKE, V39, P2943, DOI 10.1161/STROKEAHA.107.513416; Kim NK, 2003, NEUROLOGY, V61, P1595, DOI 10.1212/01.WNL.0000096010.98989.49; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Kobayashi S, 1997, STROKE, V28, P1932, DOI 10.1161/01.STR.28.10.1932; Lievers KJA, 2001, J MOL MED-JMM, V79, P522, DOI 10.1007/s001090100253; Matsui T, 2001, STROKE, V32, P1116, DOI 10.1161/01.STR.32.5.1116; Maxwell CJ, 2002, DEMENT GERIATR COGN, V13, P225, DOI 10.1159/000057701; MOSCOW JA, 1995, CANCER RES, V55, P3790; Murray RC, 1996, J BIOL CHEM, V271, P19174, DOI 10.1074/jbc.271.32.19174; Pei LJ, 2006, ANN EPIDEMIOL, V16, P352, DOI 10.1016/j.annepidem.2005.02.014; Rah H, 2012, REPROD SCI, V19, P513, DOI 10.1177/1933719111426604; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Szolnoki Z, 2007, NEUROMOL MED, V9, P21, DOI 10.1385/NMM:9:1:21; Szolnoki Z, 2007, CURR MED CHEM, V14, P1027, DOI 10.2174/092986707780362907; Uehara T, 1999, STROKE, V30, P378, DOI 10.1161/01.STR.30.2.378; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Warlow CP, 1998, LANCET, V352, pSIII1; World Health Organization, 2007, STEPWISE APPR STROK; Yates Z, 2005, LIFE SCI, V77, P2735, DOI 10.1016/j.lfs.2005.02.029	48	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115295	10.1371/journal.pone.0115295	http://dx.doi.org/10.1371/journal.pone.0115295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659099	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900014
J	Lavikainen, P; Korhonen, MJ; Huupponen, R; Helin-Salmivaara, A				Lavikainen, Piia; Korhonen, Maarit Jaana; Huupponen, Risto; Helin-Salmivaara, Arja			Accumulation of Cardiovascular and Diabetes Medication among Apparently Healthy Statin Initiators	PLOS ONE			English	Article							PRIMARY PREVENTION; EUROPEAN GUIDELINES; DISEASE PREVENTION; CLINICAL-PRACTICE; ROSUVASTATIN; POPULATION; COHORT	Purpose To characterize accumulation of drug-modifiable cardiovascular (CV) risk factors in statin initiators who had no prior medication or hospitalizations for CV disease or diabetes. Methods A cohort of 45-75-year-old statin initiators in Finland with no prior CV diseases, diabetes or medication for these conditions was followed up for 24 months after statin initiation for accumulation of CV and diabetes drugs. The number of drugs was measured semi-annually since the first statin purchase and analyzed by growth mixture modeling. Results Of the 11 948 apparently healthy statin initiators, 34% purchased at least one additional CV or diabetes drug during the subsequent 24 months. Of those, 20% redeemed no other CV or diabetes drugs at statin initiation but started to accumulate them after 18 months of follow-up, receiving on average 1.3 other drugs at 24 months. The majority, 59%, redeemed on average 0.5 drugs at statin initiation and accumulated 1.5 drugs by the end of 24-month follow-up. Seventeen percent received 1 additional drug at statin initiation, accumulating on average 3 drugs. The remaining 4% with an average of 2 CV or diabetes drugs at statin initiation redeemed 3.5 additional drugs during the follow-up. Conclusions Two years after statin initiation, 2 in 3 apparently healthy initiators could still be defined as such as reflected by CV and diabetes medication use.	[Lavikainen, Piia; Korhonen, Maarit Jaana; Huupponen, Risto; Helin-Salmivaara, Arja] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Lavikainen, Piia] Univ Turku, Drug Res Doctoral Programme, Turku, Finland; [Korhonen, Maarit Jaana] Univ Turku, Dept Publ Hlth, Turku, Finland; [Huupponen, Risto] Turku Univ Hosp, Dept Clin Pharmacol, FIN-20520 Turku, Finland; [Helin-Salmivaara, Arja] Hosp Dist Helsinki & Uusimaa, Unit Primary Hlth Care, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Lavikainen, P (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	piia.lavikainen@utu.fi		Korhonen, Maarit/0000-0002-2953-4757; Lavikainen, Piia/0000-0003-3560-8860	Academy of Finland [138255]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (www.aka.fi,decision number 138255). The Academy of Finland had no role in the design, analyses, interpretation of data, writing the report, or in the decision to submit the manuscript.	Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; [Anonymous], 2007, FINN STAT MED 2006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Germano G, 2012, EUR HEART J, V33, P137; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Greving JP, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1672; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kildemoes HW, 2012, HEALTH POLICY, V108, P216, DOI 10.1016/j.healthpol.2012.08.008; Kildemoes HW, 2012, PHARMACOEPIDEM DR S, V21, P1027, DOI 10.1002/pds.2195; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Mitchell Aaron P, 2012, BMC Res Notes, V5, P373, DOI 10.1186/1756-0500-5-373; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Raymond CB, 2007, CLIN THER, V29, P2107, DOI 10.1016/j.clinthera.2007.09.022; Reinecke J, 2011, ASTA-ADV STAT ANAL, V95, P415, DOI 10.1007/s10182-011-0171-4; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Vartiainen E, 2013, FINRISKI TUTKIMUS 20; WHO, ATC DDD SYST	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117182	10.1371/journal.pone.0117182	http://dx.doi.org/10.1371/journal.pone.0117182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658919	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900112
J	Neves, CDC; Lacerda, ACR; Lage, VKS; Lima, LP; Fonseca, SF; de Avelar, NCP; Teixeira, MM; Mendonca, VA				Neves, Camila D. C.; Rodrigues Lacerda, Ana Cristina; Lage, Vanessa K. S.; Lima, Liliana P.; Fonseca, Sueli F.; de Avelar, Nubia C. P.; Teixeira, Mauro M.; Mendonca, Vanessa A.			Cardiorespiratory Responses and Prediction of Peak Oxygen Uptake during the Shuttle Walking Test in Healthy Sedentary Adult Men	PLOS ONE			English	Article							REFERENCE VALUES; HEART-RATE; EQUATIONS	Background The application of the Shuttle Walking Test (SWT) to assess cardiorespiratory fitness and the intensity of this test in healthy participants has rarely been studied. This study aimed to assess and correlate the cardiorespiratory responses of the SWT with the cardiopulmonary exercise testing (CEPT) and to develop a regression equation for the prediction of peak oxygen uptake (VO2 peak) in healthy sedentary adult men. Methods In the first stage of this study, 12 participants underwent the SWT and the CEPT on a treadmill. In the second stage, 53 participants underwent the SWT twice. In both phases, the VO2 peak, respiratory exchange ratio (R), and heart rate (HR) were evaluated. Results Similar results in VO2 peak (P>0.05), R peak (P>0.05) and predicted maximum HR (P>0.05) were obtained between the SWT and CEPT. Both tests showed strong and significant correlations of VO2 peak (r = 0.704, P = 0.01) and R peak (r = 0.737, P<0.01), as well as the agreement of these measurements by Bland-Altman analysis. Body mass index and gait speed were the variables that explained 40.6%(R2 = 0.406, P = 0.001) of the variance in VO2 peak. The results obtained by the equation were compared with the values obtained by the gas analyzer and no significant difference between them (P>0.05) was found. Conclusions The SWT produced maximal cardiorespiratory responses comparable to the CEPT, and the developed equation showed viability for the prediction of VO2 peak in healthy sedentary men.	[Neves, Camila D. C.; Rodrigues Lacerda, Ana Cristina; Fonseca, Sueli F.; Mendonca, Vanessa A.] Univ Fed Vales Jequitinhonha & Mucuri, Sociedade Brasileira Fisiol, Programa Multicentrico Posgrad Ciencias Fisiol, Diamantina, MG, Brazil; [Neves, Camila D. C.; Lage, Vanessa K. S.; Lima, Liliana P.; Mendonca, Vanessa A.] Univ Fed Vales Jequitinhonha & Mucuri, Labo Inflamacao & Metab, Diamantina, MG, Brazil; [de Avelar, Nubia C. P.] Univ Fed Santa Catarina, Dept Fisioterapia, Ararangua, SC, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Lab Imunofarmacol, Belo Horizonte, MG, Brazil	Sociedade Brasileira de Fisiologia; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais	Neves, CDC (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Sociedade Brasileira Fisiol, Programa Multicentrico Posgrad Ciencias Fisiol, Diamantina, MG, Brazil.	camilinhadcn@yahoo.com.br	Teixeira, Mauro M/A-4587-2008; Lage, Vanessa/AAE-6639-2019; Lacerda, Ana Cristina/J-2181-2012; Mendonça, Vanessa Amaral/T-7958-2019; FONSECA, SUELI/AAP-3800-2021	Teixeira, Mauro M/0000-0002-6944-3008; Lage, Vanessa/0000-0002-0381-5622; Lacerda, Ana Cristina/0000-0001-5366-3754; Mendonça, Vanessa Amaral/0000-0002-1696-6091; 	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) were financial supporters of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2003, DIR ACSM TEST ESF SU; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Dourado VZ, 2013, BRAZ J MED BIOL RES, V46, P194, DOI 10.1590/1414-431X20122376; Dourado VZ, 2010, INT J SPORTS MED, V31, P698, DOI 10.1055/s-0030-1255110; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Dourado VZ, 2011, J BRAS PNEUMOL, V37, P607, DOI 10.1590/S1806-37132011000500007; Green DJ, 2001, J SCI MED SPORT, V4, P292, DOI 10.1016/S1440-2440(01)80038-4; Harrison SL, 2013, J CARDIOPULM REHABIL, V33, P309, DOI 10.1097/HCR.0b013e3182a0297e; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jurgensen SP, 2011, RESPIRATION, V81, P223, DOI 10.1159/000319037; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Moloney ED, 2003, RESP MED, V97, P682, DOI 10.1053/rmed.2003.1501; Morales FJ, 2000, INT J CARDIOL, V76, P101, DOI 10.1016/S0167-5273(00)00393-4; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Onorati P, 2003, EUR J APPL PHYSIOL, V89, P331, DOI 10.1007/s00421-003-0803-9; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Probst VS, 2012, RESP MED, V106, P243, DOI 10.1016/j.rmed.2011.07.023; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; Seixas DM, 2013, J BRAS PNEUMOL, V39, P440, DOI 10.1590/S1806-37132013000400007; SINGH SJ, 1994, EUR RESPIR J, V7, P2016; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Siri WE, 1961, SCIENCE, P223	25	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117563	10.1371/journal.pone.0117563	http://dx.doi.org/10.1371/journal.pone.0117563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659094	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900176
J	Smiga, M; Bielecki, M; Olczak, M; Smalley, JW; Olczak, T				Smiga, Michal; Bielecki, Marcin; Olczak, Mariusz; Smalley, John W.; Olczak, Teresa			Anti-HmuY Antibodies Specifically Recognize Porphyromonas gingivalis HmuY Protein but Not Homologous Proteins in Other Periodontopathogens	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; SERUM ANTIBODY; CHECKERBOARD ASSESSMENTS; PERIODONTAL PATHOGENS; RHEUMATOID-ARTHRITIS; IMMUNOGLOBULIN-G; P. GINGIVALIS; ATHEROSCLEROSIS; HAEMOPHORE; MICROBIOTA	Given the emerging evidence of an association between periodontal infections and systemic conditions, the search for specific methods to detect the presence of P. gingivalis, a principal etiologic agent in chronic periodontitis, is of high importance. The aim of this study was to characterize antibodies raised against purified P. gingivalis HmuY protein and selected epitopes of the HmuY molecule. Since other periodontopathogens produce homologs of HmuY, we also aimed to characterize responses of antibodies raised against the HmuY protein or its epitopes to the closest homologous proteins from Prevotella intermedia and Tannerella forsythia. Rabbits were immunized with purified HmuY protein or three synthetic, KLH-conjugated peptides, derived from the P. gingivalis HmuY protein. The reactivity of anti-HmuY antibodies with purified proteins or bacteria was determined using Western blotting and ELISA assay. First, we found homologs of P. gingivalis HmuY in P. intermedia (PinO and PinA proteins) and T. forsythia (Tfo protein) and identified corrected nucleotide and amino acid sequences of Tfo. All proteins were overexpressed in E. coli and purified using ion-exchange chromatography, hydrophobic chromatography and gel filtration. We demonstrated that antibodies raised against P. gingivalis HmuY are highly specific to purified HmuY protein and HmuY attached to P. gingivalis cells. No reactivity between P. intermedia and T. forsythia or between purified HmuY homologs from these bacteria and antiHmuY antibodies was detected. The results obtained in this study demonstrate that P. gingivalis HmuY protein may serve as an antigen for specific determination of serum antibodies raised against this bacterium.	[Smiga, Michal; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50383 Wroclaw, Poland; [Smalley, John W.] Univ Liverpool, Sch Dent, Liverpool L69 3GN, Merseyside, England	University of Wroclaw; University of Liverpool	Olczak, T (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland.	Teresa.Olczak@biotech.uni.wroc.pl	Śmiga, Michał/AAM-6190-2020	Śmiga, Michał/0000-0002-9236-4236	Wroclaw Research Center EIT+ - European Regional Development Fund (Operational Program Innovative Economy) [POIG 01.01.02-02-003/08/00, 1.1.2]; Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Wroclaw Research Center EIT+ - European Regional Development Fund (Operational Program Innovative Economy); Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	This study was supported by Wroclaw Research Center EIT+ (www.eitplus.pl) under the project "Biotechnologies and advanced medical technologies - BioMed" (POIG 01.01.02-02-003/08/00) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2). Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Albandar JM, 2001, J PERIODONTOL, V72, P1463, DOI 10.1902/jop.2001.72.11.1463; Arvikar SL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4289; Bohnstedt S, 2010, J DENT RES, V89, P938, DOI 10.1177/0022034510370817; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Byrne DP, 2013, MOL ORAL MICROBIOL, V28, P219, DOI 10.1111/omi.12018; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Carvalho PC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-206; Choi J, 2011, J PERIODONTAL IMPLAN, V41, P54, DOI 10.5051/jpis.2011.41.2.54; Craig RG, 2003, J PERIODONTOL, V74, P1007, DOI 10.1902/jop.2003.74.7.1007; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Ebersole JL, 2009, J PERIODONTOL, V80, P953, DOI 10.1902/jop.2009.080464; Franca M, 2007, J APPL ORAL SCI, V15, P213, DOI 10.1590/S1678-77572007000300011; Gmiterek A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067719; Graves DT, 2000, CURR OPIN INFECT DIS, V13, P227, DOI 10.1097/00001432-200006000-00005; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Guo SJ, 2000, J CLIN PERIODONTOL, V27, P769, DOI 10.1034/j.1600-051x.2000.027010769.x; Guyodo H, 2012, FEMS IMMUNOL MED MIC, V64, P175, DOI 10.1111/j.1574-695X.2011.00877.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hanaoka Y, 2013, HYPERTENS RES, V36, P829, DOI 10.1038/hr.2013.46; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Holmlund A, 2011, INT J CARDIOL, V148, P148, DOI 10.1016/j.ijcard.2009.10.034; Honma Y, 2008, J PERIODONTAL RES, V43, P706, DOI 10.1111/j.1600-0765.2007.01078.x; Iida Y, 2004, BRIT J ORAL MAX SURG, V42, P180, DOI 10.1016/S0266-4356(03)00190-6; Kamaguchi A, 2003, MICROBIOL-SGM, V149, P1257, DOI 10.1099/mic.0.25997-0; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Mikuls TR, 2009, INT IMMUNOPHARMACOL, V9, P38, DOI 10.1016/j.intimp.2008.09.008; Ogrendik Mesut, 2005, MedGenMed, V7, P2; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; Papapanou PN, 2000, J PERIODONTOL, V71, P885, DOI 10.1902/jop.2000.71.6.885; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P103, DOI 10.1034/j.1600-051x.2001.280116.x; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Skottrup PD, 2011, ANAL BIOCHEM, V415, P158, DOI 10.1016/j.ab.2011.04.015; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Trindade SC, 2012, J PERIODONTAL RES, V47, P27, DOI 10.1111/j.1600-0765.2011.01401.x; Trindade SC, 2012, ARCH ORAL BIOL, V57, P314, DOI 10.1016/j.archoralbio.2011.09.003; Trindade SC, 2013, J PERIODONTOL, V84, P650, DOI 10.1902/jop.2012.120230; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Vitkov L, 2005, ORAL MICROBIOL IMMUN, V20, P317, DOI 10.1111/j.1399-302X.2005.00233.x; Wojaczynski J, 2011, BIOCHEM BIOPH RES CO, V411, P299, DOI 10.1016/j.bbrc.2011.06.129; Wojtowicz H, 2013, METALLOMICS, V5, P343, DOI 10.1039/c3mt20215a; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006	54	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117508	10.1371/journal.pone.0117508	http://dx.doi.org/10.1371/journal.pone.0117508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658942	Green Published, gold			2022-12-26	WOS:000349444900166
J	Wu, L; Rabe, KG; Petersen, GM				Wu, Lang; Rabe, Kari G.; Petersen, Gloria M.			Do Variants Associated with Susceptibility to Pancreatic Cancer and Type 2 Diabetes Reciprocally Affect Risk?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC SUSCEPTIBILITY; LOCI; METAANALYSIS; GLUCOSE; MELLITUS; MTNR1B; KCNQ1	Objectives Although type 2 diabetes mellitus is a known risk factor for pancreatic cancer, the existence of shared genetic susceptibility is largely unknown. We evaluated whether any reported genetic risk variants of either disease found by genome-wide association studies reciprocally confer susceptibility. Methods Data that were generated in previous genome-wide association studies (GENEVA Type 2 Diabetes; PanScan) were obtained through the National Institutes of Health database of Genotypes and Phenotypes (dbGaP). Using the PanScan datasets, we tested for association of 38 variants within 37 genomic regions known to be susceptibility factors for type 2 diabetes. We further examined whether type 2 diabetes variants predispose to pancreatic cancer risk stratified by diabetes status. Correspondingly, we examined the association of fourteen pancreatic cancer susceptibility variants within eight genomic regions in the GENEVA Type 2 Diabetes dataset. Results Four plausible associations of diabetes variants and pancreatic cancer risk were detected at a significance threshold of p = 0.05, and one pancreatic cancer susceptibility variant was associated with diabetes risk at threshold of p = 0.05, but none remained significant after correction for multiple comparisons. Conclusion Currently identified GWAS susceptibility variants are unlikely to explain the potential shared genetic etiology between Type 2 diabetes and pancreatic cancer.	[Wu, Lang; Rabe, Kari G.; Petersen, Gloria M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Petersen, GM (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA.	Petersen.Gloria@mayo.edu	Wu, Lang/M-4053-2017		National Cancer Institute [P50CA102701, R01CA97075]; National Center for Advancing Translational Sciences [TL1TR000137]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA097075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000137, UL1TR000135] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute (P50CA102701) [www.cancer.gov/] to GMP, the National Cancer Institute (R01CA97075) [www.cancer.gov/] to GMP, and National Center for Advancing Translational Sciences (TL1TR000137) [www.ncats.nih.gov/] to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Austin MA, 2013, CANCER EPIDEM BIOMAR, V22, P1913, DOI 10.1158/1055-9965.EPI-13-0518; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Benjamini Y, 2001, ANN STAT, V29, P1165; Bosetti C, 2014, ANN ONCOLOGY OFFICIA; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Lin YS, 2011, J EPIDEMIOL, V21, P2, DOI 10.2188/jea.JE20100090; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pierce BL, 2011, CANCER CAUSE CONTROL, V22, P877, DOI 10.1007/s10552-011-9760-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wu L, 2014, CANC EPIDEMIOLOGY BI; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117230	10.1371/journal.pone.0117230	http://dx.doi.org/10.1371/journal.pone.0117230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658847	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900120
J	Braiterman, LT; Gupta, A; Chaerkady, R; Cole, RN; Hubbard, AL				Braiterman, Lelita T.; Gupta, Arnab; Chaerkady, Raghothama; Cole, Robert N.; Hubbard, Ann L.			Communication between the N and C Termini Is Required for Copper-stimulated Ser/Thr Phosphorylation of Cu(I)-ATPase (ATP7B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; TANDEM MASS-SPECTROMETRY; POLARIZED HEPATIC CELLS; TRANS-GOLGI NETWORK; ATPASE ATP7B; TRANSPORTING ATPASE; CATALYTIC-ACTIVITY; STATISTICAL-MODEL; BINDING SITES; TRAFFICKING	The Wilson disease protein ATP7B exhibits copper-dependent trafficking. In high copper, ATP7B exits the trans-Golgi network and moves to the apical domain of hepatocytes where it facilitates elimination of excess copper through the bile. Copper levels also affect ATP7B phosphorylation. ATP7B is basally phosphorylated in low copper and becomes more phosphorylated ("hyperphosphorylated") in elevated copper. The functional significance of hyperphosphorylation remains unclear. We showed that hyperphosphorylation occurs even when ATP7B is restricted to the trans-Golgi network. We performed comprehensive phosphoproteomics of ATP7B in low versus high copper, which revealed that 24 Ser/Thr residues in ATP7B could be phosphorylated, and only four of these were copper-responsive. Most of the phosphorylated sites were found in the N- and C-terminal cytoplasmic domains. Using truncation and mutagenesis, we showed that inactivation or elimination of all six N-terminal metal binding domains did not block copper-dependent, reversible, apical trafficking but did block hyperphosphorylation in hepatic cells. We showed that nine of 15 Ser/Thr residues in the C-terminal domain were phosphorylated. Inactivation of 13 C-terminal phosphorylation sites reduced basal phosphorylation and eliminated hyperphosphorylation, suggesting that copper binding at the N terminus propagates to the ATP7B C-terminal region. C-terminal mutants with either inactivating or phosphomimetic substitutions showed little effect upon copper-stimulated trafficking, indicating that trafficking does not depend on phosphorylation at these sites. Thus, our studies revealed that copper-dependent conformational changes in the N-terminal region lead to hyperphosphorylation at C-terminal sites, which seem not to affect trafficking and may instead fine-tune copper sequestration.	[Braiterman, Lelita T.; Gupta, Arnab; Hubbard, Ann L.] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Chaerkady, Raghothama; Cole, Robert N.] Johns Hopkins Univ, Mass Spectrometry & Prote Facil, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Braiterman, LT (corresponding author), Johns Hopkins Univ, Dept Cell Biol, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	lbraite1@jhmi.edu			National Institutes of Health [P01 DK-072084, P01 GM-067166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK-072084 and P01 GM-067166.	Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Borjigin J, 1999, J NEUROSCI, V19, P1018; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Braiterman L, 2011, AM J PHYSIOL-GASTR L, V301, pG69, DOI 10.1152/ajpgi.00038.2011; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Cardoso LHD, 2014, INT J BIOCHEM CELL B, V54, P60, DOI 10.1016/j.biocel.2014.06.019; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nyasae LK, 2014, TRAFFIC, V15, P1344, DOI 10.1111/tra.12229; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Polishchuk R, 2013, HISTOCHEM CELL BIOL, V140, P285, DOI 10.1007/s00418-013-1123-8; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Valverde RHF, 2011, J BIOL CHEM, V286, P6879, DOI 10.1074/jbc.M110.207704; van den Berghe PVE, 2010, J BIOL INORG CHEM, V15, P37, DOI 10.1007/s00775-009-0592-7; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Weiss Karl Heinz, 2012, Curr Gastroenterol Rep, V14, P1, DOI 10.1007/s11894-011-0227-3; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	45	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8803	8819		10.1074/jbc.M114.627414	http://dx.doi.org/10.1074/jbc.M114.627414			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666620	Green Published, hybrid			2022-12-26	WOS:000352207100011
J	Borghese, B; Sibiude, J; Santulli, P; Pillet, MCL; Marcellin, L; Brosens, I; Chapron, C				Borghese, Bruno; Sibiude, Jeanne; Santulli, Pietro; Pillet, Marie-Christine Lafay; Marcellin, Louis; Brosens, Ivo; Chapron, Charles			Low Birth Weight Is Strongly Associated with the Risk of Deep Infiltrating Endometriosis: Results of a 743 Case-Control Study	PLOS ONE			English	Article							IN-UTERO EXPOSURES; ANATOMICAL DISTRIBUTION; BLADDER ENDOMETRIOSIS; DISEASE; WOMEN; EXPRESSION; STENOSIS; OVARY	The influence of intrauterine environment on the risk of endometriosis is still controversial. Whether birth weight modifies the risk of endometriosis in adulthood remains an open question. For this purpose, we designed a case-control study involving 743 women operated on for benign gynecological indications from January 2004 to December 2011. Study group included 368 patients with histologically proven endometriosis: 54 superficial endometriosis (SUP), 79 endometriomas (OMA) and 235 deep infiltrating endometriosis (DIE). Control group included 375 patients without endometriosis as surgically checked. Mean birth weights were compared between patients and controls, according to endometriosis groups and rAFS stages. Mean birth weight was significantly lower for patients with endometriosis as compared to controls (3,119g +/- 614 and 3,251g +/- 557 respectively; p = 0.002). When compared to controls, patients with DIE had the lowest birth weight with a highly significant difference (3,103g +/- 620, p = 0.002). In univariate analysis, patients with low birth weight (LBW), defined as a BW<2,500g, had a higher risk of endometriosis, especially DIE, as compared to the reference group (OR = 1.5, 95% CI: 1.0-2.3 and OR = 1.7, 95% CI: 1.0-2.7, respectively). Multivariate analysis, adjusted on ethnicity and smoking status, showed the persistence of a significant association between endometriosis and LBW with a slight increase in the magnitude of the association (aOR = 1.7, 95% CI: 1.0-2.6 for endometriosis, aOR = 1.8; 95% CI: 1.1-2.9 for DIE). In conclusion, LBW is independently associated with the risk of endometriosis in our population. Among patients with LBW, the risk is almost two-times higher to develop DIE. This association could reflect common signaling pathways between endometriosis and fetal growth regulation. There is also the possibility of a role played by placental insufficiency on the development of the neonate's pelvis and the occurrence of neonatal uterine bleeding that could have consequences on the risk of severe endometriosis.	[Borghese, Bruno; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS UMR 8104, Paris, France; [Borghese, Bruno; Marcellin, Louis; Chapron, Charles] INSERM, U1016, Paris, France; [Borghese, Bruno; Sibiude, Jeanne; Santulli, Pietro; Pillet, Marie-Christine Lafay; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Sorbonne Paris Cite, Grp Hosp Cochin, AP HP,Serv Gynecol Obstet & Med Reprod 2, Paris, France; [Santulli, Pietro] Univ Paris 05, Grp Hosp Cochin, AP HP, Sorbonne Paris Cite,Fac Med,EA 1833,ERTi, Paris, France; [Brosens, Ivo] Katholieke Univ Leuven, Leuven, Belgium; [Brosens, Ivo] Leuven Inst Fertil & Embryol, Leuven, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; KU Leuven	Borghese, B (corresponding author), Univ Paris 05, Inst Cochin, Sorbonne Paris Cite, CNRS UMR 8104, Paris, France.	bruno.borghese@cch.aphp.fr	Santulli, Pi/O-8756-2017; Chapron, Charles/O-8567-2017; Sibiude, Jeanne/GRS-5411-2022; Marcellin, Louis/O-8787-2017; louis, marcellin/V-4728-2019; Santulli, Pietro/T-5201-2019	louis, marcellin/0000-0003-4482-9710; Borghese, Bruno/0000-0002-6385-5829				*AFS, 1985, FERTIL STERIL, V43, P351; Barbieri RL, 1998, FERTIL STERIL, V70, P571, DOI 10.1016/S0015-0282(98)00189-7; Benagiano G, 2014, J MATERN-FETAL NEO M, V27, P303, DOI 10.3109/14767058.2013.814630; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Brosens I, 2013, HUM REPROD, V28, P2026, DOI 10.1093/humrep/det243; Brosens I, 2013, HUM REPROD, V28, P2893, DOI 10.1093/humrep/det359; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2003, HUM REPROD, V18, P157, DOI 10.1093/humrep/deg009; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Chapron C, 2011, J PEDIATR ADOL GYNEC, V24, pS7, DOI 10.1016/j.jpag.2011.07.006; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Chapron C, 2010, FERTIL STERIL, V94, P2353, DOI 10.1016/j.fertnstert.2010.04.020; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; FRASER IS, 1986, OBSTET GYNECOL, V68, P630; Gargett CE, 2014, MOL HUM REPROD, DOI [10.1093/molehr/gau085, DOI 10.1093/MOLEHR/GAU085]; Gondret F, 2013, GEN COMP ENDOCR, V194, P208, DOI 10.1016/j.ygcen.2013.09.018; Holt VL, 2000, EPIDEMIOLOGY, V11, P654, DOI 10.1097/00001648-200011000-00007; Liede A, 2000, J MED GENET, V37, P794, DOI 10.1136/jmg.37.10.794; Mazzuca MQ, 2010, J PHYSIOL-LONDON, V588, P1997, DOI 10.1113/jphysiol.2010.187849; Meola J, 2010, FERTIL STERIL, V93, P1750, DOI 10.1016/j.fertnstert.2008.12.058; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; OBER WB, 1955, PEDIATRICS, V16, P445; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; Pillet MCL, 2012, HUM REPROD, V27, P265, DOI 10.1093/humrep/der346; Somigliana E, 2007, FERTIL STERIL, V87, P1287, DOI 10.1016/j.fertnstert.2006.11.090; Somigliana E, 2011, GYNECOL OBSTET INVES, V72, P135, DOI 10.1159/000323531; Turan N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-10; Wolff EF, 2013, FERTIL STERIL, V99, P790, DOI 10.1016/j.fertnstert.2012.11.013	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117387	10.1371/journal.pone.0117387	http://dx.doi.org/10.1371/journal.pone.0117387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679207	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600063
J	Jia, LN; Ma, XT; Gui, BS; Ge, H; Wang, L; Ou, Y; Tian, LF; Chen, Z; Duan, ZY; Han, J; Fu, RG				Jia, Lining; Ma, Xiaotao; Gui, Baosong; Ge, Heng; Wang, Li; Ou, Yan; Tian, Lifang; Chen, Zhao; Duan, Zhaoyang; Han, Jin; Fu, Rongguo			Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-beta-Induced Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Objective This study was to investigate whether sorafenib can inhibit the progression of renal fibrosis and to study the possible mechanisms of this effect. Methods Eight-week-old rats were subjected to unilateral ureteral obstruction (UUO) and were intragastrically administered sorafenib, while control and sham groups were administered vehicle for 14 or 21 days. NRK-52E cells were treated with TGF-beta 1 and sorafenib for 24 or 48 hours. HE and Masson staining were used to visualize fibrosis of the renal tissue in each group. The expression of alpha-SMA and E-cadherin in kidney tissue and NRK-52E cells were performed using immunohistochemistry and immunofluorescence. The apoptosis rate of NRK-52E cells was determined by flow cytometry analysis. The protein levels of Smad3 and p-Smad3 in kidney tissue and NRK-52E cells were detected by western blot analysis. Results HE staining demonstrated that kidney interstitial fibrosis, tubular atrophy, and inflammatory cell infiltration in the sorafenib-treated-UUO groups were significantly decreased compared with the vehicle-treated-UUO group (p<0.05). Masson staining showed that the area of fibrosis was significantly decreased in the sorafenib-treated-UUO groups compared with vehicle-treated-UUO group (p<0.01). The size of the kidney did not significantly increase; the cortex of the kidney was thicker and had a richer blood supply in the middle-dose sorafenib group compared with the vehicle-treated-UUO group (p<0.05). Compared with the vehicle-treated-UUO and TGF-beta-stimulated NRK-52E groups, the expression of a-SMA and E-cadherin decreased and increased, respectively, in the UUO kidneys and NRK-52E cells of the sorafenib-treated groups (p<0.05). The apoptotic rate of NRK-52E cells treated with sorafenib decreased for 24 hours in a dose-dependent manner (p<0.05). Compared with the vehicle-treated UUO and TGF-beta-stimulated NRK-52E groups, the ratio of p-Smad3 to Smad3 decreased in the sorafenib-treated groups (p<0.05). Conclusion Our results suggest that sorafenib may useful for the treatment of renal fibrosis through the suppression of TGF-beta/Smad3-induced EMT signaling.	[Jia, Lining; Ma, Xiaotao; Gui, Baosong; Ge, Heng; Wang, Li; Ou, Yan; Tian, Lifang; Chen, Zhao; Duan, Zhaoyang; Han, Jin; Fu, Rongguo] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nephropathy, Xian, Peoples R China	Xi'an Jiaotong University	Fu, RG (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nephropathy, Xian, Peoples R China.	jldoctor@126.com						Bae E, 2012, BIOCHEM BIOPH RES CO, V427, P593, DOI 10.1016/j.bbrc.2012.09.103; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Boffa Jean-Jacques, 2012, Rev Prat, V62, P72; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; D'Amico M, 2012, AM J PHYSIOL-GASTR L, V302, pG1191, DOI 10.1152/ajpgi.00252.2011; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Martinelli E, 2010, CLIN CANCER RES, V16, P4990, DOI 10.1158/1078-0432.CCR-10-0923; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Morinaga J, 2013, AM J PHYSIOL-RENAL, V305, pF173, DOI 10.1152/ajprenal.00586.2012; Peer CJ, 2012, CLIN CANCER RES, V18, P2099, DOI 10.1158/1078-0432.CCR-11-2484; Piera-Velazquez S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S7; Reiberger T, 2009, J HEPATOL, V51, P865, DOI 10.1016/j.jhep.2009.06.024; Rosenbloom J, 2013, BBA-MOL BASIS DIS, V1832, P1088, DOI 10.1016/j.bbadis.2012.12.007; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Thabut D, 2011, HEPATOLOGY, V54, P573, DOI 10.1002/hep.24427; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yuanmeng J, 2012, NAT MED, V18, P580, DOI [10.1038/nm.2685, DOI 10.1038/NM.2685]; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang J, 2013, IEEE T INF FOREN SEC, V8, P5, DOI 10.1109/TIFS.2012.2223675	22	20	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117757	10.1371/journal.pone.0117757	http://dx.doi.org/10.1371/journal.pone.0117757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679376	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600085
J	McMahon, MM; Deepak, A; Fernandez-Baca, D; Boss, D; Sanderson, MJ				McMahon, Michelle M.; Deepak, Akshay; Fernandez-Baca, David; Boss, Darren; Sanderson, Michael J.			STBase: One Million Species Trees for Comparative Biology	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DATA SETS; GENE; TIME; CHALLENGES; COALESCENT; BOOTSTRAP; HISTORY; EXAMPLE; RESOLVE	Comprehensively sampled phylogenetic trees provide the most compelling foundations for strong inferences in comparative evolutionary biology. Mismatches are common, however, between the taxa for which comparative data are available and the taxa sampled by published phylogenetic analyses. Moreover, many published phylogenies are gene trees, which cannot always be adapted immediately for species level comparisons because of discordance, gene duplication, and other confounding biological processes. A new database, STBase, lets comparative biologists quickly retrieve species level phylogenetic hypotheses in response to a query list of species names. The database consists of 1 million single-and multi-locus data sets, each with a confidence set of 1000 putative species trees, computed from GenBank sequence data for 413,000 eukaryotic taxa. Two bodies of theoretical work are leveraged to aid in the assembly of multi-locus concatenated data sets for species tree construction. First, multiply labeled gene trees are pruned to conflict-free singly-labeled species-level trees that can be combined between loci. Second, impacts of missing data inmulti-locus data sets are ameliorated by assembling only decisive data sets. Data sets overlapping with the user's query are ranked using a scheme that depends on user-provided weights for tree quality and for taxonomic overlap of the tree with the query. Retrieval times are independent of the size of the database, typically a few seconds. Tree quality is assessed by a real-time evaluation of boot-strap support on just the overlapping subtree. Associated sequence alignments, tree files and metadata can be downloaded for subsequent analysis. STBase provides a tool for comparative biologists interested in exploiting the most relevant sequence data available for the taxa of interest. It may also serve as a prototype for future species tree oriented databases and as a resource for assembly of larger species phylogenies from precomputed trees.	[McMahon, Michelle M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Deepak, Akshay; Fernandez-Baca, David] Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; [Boss, Darren; Sanderson, Michael J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; Iowa State University; University of Arizona	McMahon, MM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	mcmahonm@email.arizona.edu	Deepak, Akshay/AAA-7369-2019	Deepak, Akshay/0000-0001-6854-8599; Boss, Darren/0000-0001-7588-9500	US National Science Foundation, Division of Environmental Biology [DEB-0829674]; Division of Computing and Communication Foundations [1422134] Funding Source: National Science Foundation	US National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the US National Science Foundation, Division of Environmental Biology, grant DEB-0829674, to MJS, MMM, and DFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenta N, 2003, LECT N BIOINFORMAT, V2812, P216; Anderson CNK, 2012, METHODS MOL BIOL, V856, P3, DOI 10.1007/978-1-61779-585-5_1; Ane C, 2005, SYST BIOL, V54, P146, DOI 10.1080/10635150590905984; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bader DA, 2006, ADV COMPUT, V68, P127, DOI 10.1016/S0065-2458(06)68004-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baum D, 2012, TREE THINKING INTRO; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cormen Thomas H., 2009, INTRO ALGORITHMS; Deepak A, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-18; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flynn S, 2006, SEED INFORM DATABASE; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Goldman N, 2008, PHILOS T R SOC B, V363, P3889, DOI 10.1098/rstb.2008.0182; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hinchliff CE, 2013, SYST BIOL, V62, P205, DOI 10.1093/sysbio/sys088; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Huber KT, 2006, J MATH BIOL, V52, P613, DOI 10.1007/s00285-005-0365-z; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Izquierdo-Carrasco F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-470; Jenkins B, 1997, DR DOBBS J, V22, P107; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Lanfear R, 2011, MOL PHYLOGENET EVOL, V61, P958, DOI 10.1016/j.ympev.2011.07.018; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Manning CD, 2008, INTRO INFORM RETRIEV; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Motwani R., 1995, RANDOMIZED ALGORITHM; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Olavsrud T, 2012, IMPLEMENT NEXT GENER; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Piel William H., 2002, Research Report from the National Institute for Environmental Studies Japan, V171, P41; Pringle EG, 2007, PLANT ECOL, V193, P211, DOI 10.1007/s11258-006-9259-4; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Sanderson MJ, 2003, MOL BIOL EVOL, V20, P1036, DOI 10.1093/molbev/msg115; Saslis-Lagoudakis CH, 2012, P NATL ACAD SCI USA, V109, P15835, DOI 10.1073/pnas.1202242109; Scornavacca C, 2011, INFORM COMPUT, V209, P590, DOI 10.1016/j.ic.2010.11.022; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2010, APPL MATH LETT, V23, P82, DOI 10.1016/j.aml.2009.08.009; Stockham Cara, 2002, Bioinformatics, V18 Suppl 1, pS285; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Zobel J, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1132956.1132959	67	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117987	10.1371/journal.pone.0117987	http://dx.doi.org/10.1371/journal.pone.0117987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679219	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600098
J	Diaz-Martinez, I; Pereda-Suberbiola, X; Perez-Lorente, F; Canudo, JI				Diaz-Martinez, Ignacio; Pereda-Suberbiola, Xabier; Perez-Lorente, Felix; Canudo, Jose Ignacio			Ichnotaxonomic Review of Large Ornithopod Dinosaur Tracks: Temporal and Geographic Implications	PLOS ONE			English	Article							CRETACEOUS JIAGUAN FORMATION; SOUTH-KOREA; ORNITHISCHIAN DINOSAURS; VERTEBRATE FOOTPRINTS; JINDONG FORMATION; THEROPOD TRACKS; NATIONAL-PARK; DAKOTA GROUP; SAUROPOD; COUNTY	Background Large ornithopod tracks are known from the Upper Jurassic to the uppermost Cretaceous rocks of all continents but Antarctica. They include the tracks historically called Iguanodon footprints, iguanodontid footprints, hadrosaur/hadrosaurid footprints, and other large ornithopod tracks that have been used to define ichnotaxa. More than 40 ichnospecies based on large ornithopod tracks have been defined, but the validity of many of them is questionable. Methodology/Principal Findings 34 ichnogenera and 44 ichnospecies have been analysed in this work. Many of them are considered to be invalid because they have been defined on the basis of poorly preserved tracks without diagnostic features, have an inadequate diagnosis, or are based on temporal and/or geographical criteria. Only eight ichnospecies belonging to the ichnogenera Caririchnium, lguanodontipus and Hadrosauropodus are here regarded as valid. Conclusions/Significance The monospecific ichnogenus lguanodontipus (I. burrep) is characterized by a small, rounded heel and elongate, narrow digit impressions. Its distribution is limited to the Berriasian-Valanginian of Europe. Caririchnium consists of four ichnospecies (C. magnificum [type ichnospecies], C. kortmeyeri, C. billsarjeanti and C. lotus) with a large, rounded heel and short, wide digit impressions. This ichnogenus ranges from the Berriasian-Hauterivian to the Aptian-Albian of South America, North America, Asia and Europe. Finally, Hadrosauropodus (three ichnospecies: H. langstoni [type ichnospecies], H. leonardii and H. kyoungsookimi) shows a large, bibbed heel and short, wide digit impressions. It is known from the Aptian-Albian to the Maastrichtian of North America, Asia and Europe. The ichnofamily lguanodontipodidae includes large iguanodontian tracks characterized mainly by mesaxonic, tridactyl and subsymmetrical pes tracks that are as wide as (or wider than) long and have one pad impression in each digit and one in the heel. Its distribution is confidently limited to the Cretaceous of Europe, Asia, North America and South America.					PEREDA SUBERBIOLA, Xabier/J-4306-2012; Suberbiola, Xabier Pereda/M-2804-2019; Martínez, Ignacio Díaz/I-2766-2015	PEREDA SUBERBIOLA, Xabier/0000-0002-7336-7167; Martínez, Ignacio Díaz/0000-0001-5301-8384; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Gobierno Vasco/Eusko Jaurlaritza [IT834-13]; Spanish Ministerio de Economia y Competitividad (MINECO) [CGL2010-16447]; European Regional Development Fund; Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"); MINECO [CGL2010-18851/BTE, CGL2013-47521-P]; Gobierno de Argentina (CONICET)	Gobierno Vasco/Eusko Jaurlaritza(Basque Government); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural")(Gobierno de Aragon); MINECO(Spanish Government); Gobierno de Argentina (CONICET)	This paper is a contribution to the projects: IT834-13 of the Gobierno Vasco/Eusko Jaurlaritza; CGL2010-16447 subsidized by the Spanish Ministerio de Economia y Competitividad (MINECO), the European Regional Development Fund, and the Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"); the project CGL2010-18851/BTE (MINECO); and the project CGL2013-47521-P (MINECO). IDM is the beneficiary of a Postdoctoral grant from the Gobierno de Argentina (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRREZABALA L M, 1983, Munibe, V35, P1; Aguirrezabala L.M., 1980, Munibe, V32, P257; Alonso R.N., 1980, Acta Geologica Lilloana, V15, P55; Alonso RN, 1986, ACT 4 C ARG PAL BIOE, V2, P33, DOI [10.1016/j.acuro.2014.11.005, DOI 10.1016/J.ACURO.2014.11.005]; Alvarez Bermejo JM, 2013, ZUBIA, V31, P199; Apesteguia S, 2011, AN ACAD BRAS CIENC, V83, P267, DOI 10.1590/S0001-37652011000100015; Azuma Y, 1991, B FUKUI PREFECTURAL, V4, P33; Ballerstedt M., 1914, Zentralblatt fuer Mineralogie Stuttgart, V1914; Ballerstedt M, 1921, Z DTSCH GEOLOGISCHEN, V72, P231; Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Beckles S.H., 1862, Q J GEOLOGICAL SOC, V18, P443, DOI DOI 10.1144/GSL.JGS.1862.018.01-02.60; Beckles SH, 1854, Q J GEOL SOC LOND, V10, P456, DOI [DOI 10.1144/GSLIGS.1854.010.01-02.52, 10.1144/gsl.jgs.1854.010.01-02.52]; Beckles SH, 1852, Q J GEOL SOC LOND, V8, P396, DOI [10.1144/gsl.jgs.1852.008.01-02.42, DOI 10.1144/GSL.JGS.1852.008.01-02.42]; Bellerstedt M., 1905, NATURWISSENSCHAFTLIC, V4, P481; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; Bertling M, 2006, LETHAIA, V39, P265, DOI 10.1080/00241160600787890; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2012, COMPLETE DINOSAUR, P551; CALVO J O, 1991, Ameghiniana, V28, P241; Calvo JO, 1999, NAT SCI MUS MONOGRAP, V15, P13; Calvo Jorge O., 2007, P314; Carpenter K, 1992, U WYOMING CONTRIBUTI, V29, P81; Casanovas Cladellas M.L., 1993, Zubia Monografico, V5, P9; Casanovas Cladellas Maria Lourdes, 1994, Revue de Paleobiologie Volume Special, V7, P29; Casanovas Cladelles M.L., 1989, Ciencias de la Tierra Instituto de Estudios Riojanos, V12, P1; Casanovas M.L., 1997, Zubia, V15, P229; Casanovas M.L., 1995, ZUBIA, V13, P55, DOI [10.1093/jisesa, DOI 10.1093/JISESA]; Casanovas M.L., 1995, CIENCIAS TIERRA, V18, P27; CASANOVAS ML, 1971, ACTA GEOL HISP, V6, P139, DOI DOI 10.1073/PNAS.1324002111; Casanovas-Cladellas M.L., 1987, Paleontologia i Evolucio, V19, P3; Casier E, 1960, IGUANODONS BERNISSAR; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054177; Chen PJ, 2006, CRETACEOUS RES, V27, P22, DOI 10.1016/j.cretres.2005.10.008; Cobos Alberto, 2012, Geogaceta, V52, P185; Coria Rodolfo A., 2007, P167; Currie P.J., 1989, P293; CURRIE P J, 1983, Acta Palaeontologica Polonica, V28, P63; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; Currie Philip J., 1995, P431; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; CURRIE PJ, 1979, PALAEOGEOGR PALAEOCL, V28, P103, DOI 10.1016/0031-0182(79)90114-7; Dalla Vecchia F.M., 2009, ACT 4 JORN INT PAL D, P45; Delair J.B., 1973, Proceedings Dorset nat Hist Archaeol Soc, V94, P17; Delair JB, 1985, HIST BIBLIOGRAPHY S; Demathieu G, 2009, ICHNOS, V16, P268, DOI 10.1080/10420940802686053; Diaz-Martinez I, 2009, TRIBUTE C DARWIN BER, P34; Diaz-Martinez I, 2012, FUNDAMENTAL, V20, P63; Diaz-Martinez I, 2013, THESIS U LA RIOJA LO; Diaz-Martinez I, 2011, ZUBIA, V29, P61; Diedrich Cajus, 2011, Palaeobiodiversity Palaeoenvironments, V91, P129, DOI 10.1007/s12549-010-0044-y; Diedrich Cajus, 2004, Ichnos, V11, P215, DOI 10.1080/10420940490444924; Dietrich, 1927, Z DTSCH GEOLOGISCHEN, V78, P614; Dollo L, 1905, B SCI FRANCE BELGIQU, V40, P1; Dong Zhi-Ming, 2003, Vertebrata Palasiatica, V41, P324; dos Santos AD, 2013, CRETACEOUS RES, V46, P151, DOI 10.1016/j.cretres.2013.09.005; Doublet S, 2004, THESIS U BOURGOGNE B; Dzhalilov MR, 1993, TRACE FOSSILS DYNAMI, P47; Farlow James O., 2001, P408; Fiorillo AR, 2014, GEOLOGY, V42, P719, DOI 10.1130/G35740.1; FUENTES VIDARTE C., 2005, CELTIBERIA, V99, P367; Fuentes Vidarte C, 2002, HUELLAS DINOSAURIOS, P360; Gabunia LK, 1988, T 30 SESS UN PAL SOC; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; Gangloff Roland A., 2004, Ichnos, V11, P299, DOI 10.1080/10420940490442269; Gierlinski Gerard D., 2008, Oryctos, V8, P107; Gierlinski Gerard D., 2008, Oryctos, V8, P29; Godefroit P., 2012, BERNISSART DINOSAURS, P175; Godefroit Pascal, 2012, P334; Goldring R, 2005, CRETACEOUS RES, V26, P665, DOI 10.1016/j.cretres.2005.03.001; Grabbe H, 1881, VERHANDLUNGEN NATURH, V38, P161; Harris Jerald D., 1998, Modern Geology, V23, P291; Haubold H., 1990, Historical Biology, V4, P75; Haubold H., 1971, ICHNIA AMPHIBIORUM R; HernuYndez Medrano N., 2008, ZUBIA, V23-24, P79, DOI DOI 10.1093/JISESA/IEU138; Hitchcock E, 1844, AM J SCI, V47, P492; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hornung JJ, 2012, PALAEONTOL Z, V86, P231, DOI 10.1007/s12542-012-0131-7; Huh M, 2006, CRETACEOUS RES, V27, P123, DOI 10.1016/j.cretres.2005.10.003; Huh M, 2003, ISL ARC, V12, P132, DOI 10.1046/j.1440-1738.2003.00386.x; Hunt AP, 1998, NEW MEXICO MUSEUM NA, V14, P163; Hunt AP, 2006, NEW MEXICO MUSEUM NA, V35, P62; Ibrahim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090751; Jacobs L.L., 1989, P349; JAILLARD E, 1993, CRETACEOUS RES, V14, P623, DOI 10.1006/cres.1993.1044; Jimenez-Vela A, 2006, ZUBIA, V18-19, P115; Kappus EJ, 2011, NEW MEXICO MUSEUM NA, V53, P272; Kappus Eric, 2003, Palaeontologia Electronica, V6, P1; Kim HM, 1986, 1 INT S DIN TRACKS T, P17; Kim HM, 1993, J NATURAL HIST ENV, V1, P39; Kim JY, 2009, CRETACEOUS RES, V30, P1387, DOI 10.1016/j.cretres.2009.08.003; Kuhn O., 1958, FAHRTEN VORZEITLICHE; Langston W, 1997, DINOSAUR TRACKS CRET, P5; Langston W.J., 1960, NATURAL HIST PA S NA, V4, P1; Lee YN, 1997, CRETACEOUS RES, V18, P849, DOI 10.1006/cres.1997.0091; LEONARDI G, 1979, AN ACAD BRAS CIENC, V51, P501; Leonardi G, 2007, 20 C BRAS PAL, P355; Leonardi G., 1994, ANNOTATED ATLAS S AM; Lim JD, 2012, ICHNOS, V19, P101, DOI 10.1080/10420940.2012.664059; Llompart C., 1984, Acta Geologica Hispanica, V19, P143; Lockley M, 2000, DINOSAUR TRACKS OTHE, DOI [10.2108/jsz.17.323, DOI 10.2108/JSZ.17.323]; Lockley M.G., 1987, Mountain Geologist, V24, P107; Lockley Martin, 2007, Ichnos, V14, P39, DOI 10.1080/10420940601006818; Lockley Martin, 2008, Oryctos, V8, P53; Lockley Martin, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P83; Lockley Martin G., 2001, P428; Lockley Martin G., 2000, Ichnos, V7, P217; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley Martin G., 1994, Gaia, V10, P135; Lockley MG, 2014, BIOL J LINN SOC, V113, P721, DOI 10.1111/bij.12294; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley MG, 2012, ICHNOS, V19, P93, DOI 10.1080/10420940.2011.625726; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 2000, Gaia (Lisboa), V15, P339; Lockley MG, 2006, CRETACEOUS RES, V27, P70, DOI 10.1016/j.cretres.2005.10.010; Lockley MG, 2000, GAIA, V15, P312; Lockley MG, 1995, DINOSAUR TRACKS OTHE, DOI [10.1007/BF02479948, DOI 10.1007/BF02479948]; Lockley MG, 1992, ASPECTS NONMARINE CR, P269; Lockley MG, 1991, TRACKING DINOSAURS N, DOI [10.1007/BF00226257, DOI 10.1007/BF00226257]; Lockley MG, 1988, PROFESSIONAL CONTRIB, V12, P288; Lockley MG, 2004, ICHNOS, V11, P262, DOI [DOI 10.1080/10420940490428805, 10.1080/10420940490428805]; Lockley MG, 1989, DINOSAUR TRACKS TRAC, P441; LOCKLEY MG, 1998, NEW MEXICO MUSEUM NA, V14, P135; Lockley MG, 1987, PALEONTOLOGY GEOLOGY, P85; Lockwood JAF, 2014, BIOL J LINN SOC, V113, P707, DOI 10.1111/bij.12349; Lucas SG, 2001, LETHAIA, V34, P30, DOI 10.1080/002411601300068198; Lucas SG., 2011, NEW MEXICO MUSEUM NA, V53, P357; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MARTY D., 2008, GEOFOCUS, V21, P1; Mateus Octavio, 2008, Oryctos, V8, P47; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; Matsukawa M, 1999, PALAEOGEOGR PALAEOCL, V147, P39, DOI 10.1016/S0031-0182(98)00154-0; MATSUKAWA M, 1995, PALAIOS, V10, P3, DOI 10.2307/3515004; MATSUKAWA M, 1994, CRETACEOUS RES, V15, P101, DOI 10.1006/cres.1994.1005; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; McCrea RT, 2000, THESIS U SASKATCHEWA; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; MEYER C, 2000, 5 EUR WORKSH VERT PA, V39, P52; Meyer Christian A., 2003, Ichnos, V10, P221, DOI 10.1080/10420940390256186; MORATALLA GARCIA J.J., 1993, THESIS U COMPLUTENSE; Moratalla JJ, 2008, ESTUD GEOL-MADRID, V64, P161, DOI 10.3989/egeol.08642.043; Moreno K, 2005, J S AM EARTH SCI, V20, P253, DOI 10.1016/j.jsames.2005.05.012; Moreno K, 2002, REV GEOL CHILE, V29, P191; Moreno K, 1997, 8 C IB BIOD ZOOL VER, P64; Moreno K, 2012, ACTA PALAEONTOL POL, V57, P73, DOI 10.4202/app.2010.0119; Nadon G.C., 2001, P395; Nicosia Umberto, 1999, Geologica Romana, V35, P237; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; Norman David B., 2011, Palaeontological Association Field Guides to Fossils, V14, P407; Norman DB, 2010, ZOOTAXA, P47; Norman David B., 2013, Revue de Paleobiologie, V32, P385; Norman DB, 2002, SPEC PAP PALAEONTOL, P161; Novas FE, 2009, AGE OF DINOSAURS S A, DOI [10.1007/s11940-009-0049-x, DOI 10.1007/S11940-009-0049-X]; Pascual-Arribas C, 2000, ESTUD GEOL, V56, P41, DOI [10.3989/egeol.00561-2155, DOI 10.3989/EGE01.00561-2155]; Pascual-Arribas Carlos, 2009, Studia Geologica Salmanticensia, V45, P105; Pereda-Suberbiola X, 2009, ACT 4 JORN INT PAL D, P207; Perez-Lorente F., 1993, Zubia Monografico, V5, P189; Perez-Lorente F, 2006, ZUBIA, V18-19, P9; Perez-Lorente F, 2003, DINOSAURIOS OTROS RE, P161; Petti FM, 2010, CRETACEOUS RES, V31, P546, DOI 10.1016/j.cretres.2010.07.004; Pinuela L, 2000, THESIS U OVIEDO SPAI; Pittman J.G., 1989, P135; Psihoyos L, 1994, HUNTING DINOSAURS, DOI [10.1007/BF01412372, DOI 10.1007/BF01412372]; Romero Molina M.M., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P13; Romilio A, 2011, CRETACEOUS RES, V32, P135, DOI 10.1016/j.cretres.2010.11.003; Rozhdestvensky AK, 1964, P TASHK GOV U, P227; Ruiz-Omenaca Jose Ignacio, 2007, P3; Sampson SD, 2011, LIFE STONE NATURAL H, P143; Sarjeant W.A.S., 1989, P369; SARJEANT WA, 1974, PALAEOGEOGR PALAEOCL, V16, P265, DOI 10.1016/0031-0182(74)90024-8; Sarjeant William A.S., 1998, Ichnos, V6, P183; Schulp AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002243; Schumacher B.A., 2003, Ichnos, V10, P255, DOI 10.1080/10420940390256302; STERNBERG C.H., 1932, NATL MUSEUM CANADA B, P59; Strevell, 1932, DINOSAUROPODES; Struckmann C, 1880, NEUES JB MINERALOGIE, V1, P125; Suner Maite, 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P397; Tagart E, 1846, Q J GEOL SOC LOND, V2, P267, DOI [DOI 10.1144/GSL.JGS.1846.002.01-02.45, 10.1144/gsl.jgs.1846.002.01-02.45]; Taquet, 1984, ORME DINOSAURI, P165; Teilhard de Chardin P., 1929, GEOL SOC CHINA B, V8, P131, DOI [10.1111/j.1755-6724.1929.mp8002005.x, DOI 10.1111/J.1755-6724.1929.MP8002005.X]; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn T, 1990, DINOSAUR TRACKS, DOI [10.1007/BF00232411, DOI 10.1007/BF00232411]; Torcida F., 2003, DINOSAURIOS OTROS RE, V26, P109; Tylor A, 1862, Q J GEOL SOC LOND, V18, P247, DOI [10.1144/gsl.jgs.1862.018.01-02.37, DOI 10.1144/GSL.JGS.1862.018.01-02.37]; Viera LI, 1984, MUNIBE, V36, P3; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072579; Vyalov O.S., 1988, Ezhegodnik Vsesoyuznogo Paleontologicheskogo Obshchestva, V31, P322; Weems RE, 2004, GEOLOGICAL SOC AM AB, P116; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wings O, 2005, 53 S VERT PAL COMP A, P24; Wu W.H., 2012, BERNISSART DINOSAURS, P293; Xing Li-da, 2009, Dizhi Tongbao, V28, P829; Xing LD, 2013, PALAEOGEOGR PALAEOCL, V392, P177, DOI 10.1016/j.palaeo.2013.09.003; Xing LD, 2012, ACTA GEOL SIN-ENGL, V86, P304, DOI 10.1111/j.1755-6724.2012.00660.x; Xing Lida, 2007, Dizhi Xuebao, V81, P1591; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; Young C.C., 1943, B GEOLOGICAL SOC CHI, V23, P151, DOI DOI 10.1111/J.1755-6724.1943.MP233-4006.X; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhen S., 1989, P187; Zhen S, 1996, STUDY DINOSAUR FOOTP; Zhen Shuonan, 1995, Memoirs of Beijing Natural History Museum, V54, P105	203	56	56	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115477	10.1371/journal.pone.0115477	http://dx.doi.org/10.1371/journal.pone.0115477			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674787	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000349914000002
J	Strauss, WM; Hetem, RS; Mitchell, D; Maloney, SK; Meyer, LCR; Fuller, A				Strauss, W. Maartin; Hetem, Robyn S.; Mitchell, Duncan; Maloney, Shane K.; Meyer, Leith C. R.; Fuller, Andrea			Selective Brain Cooling Reduces Water Turnover in Dehydrated Sheep	PLOS ONE			English	Article							CAROTID RETE; ARTERIAL BLOOD; HEAT-STRESS; TEMPERATURE; REHYDRATION; ENVIRONMENT; THERMOREGULATION; MAGNITUDE; RUMINANTS; SIGNALS	In artiodactyls, arterial blood destined for the brain can be cooled through counter-current heat exchange within the cavernous sinus via a process called selective brain cooling. We test the hypothesis that selective brain cooling, which results in lowered hypothalamic temperature, contributes to water conservation in sheep. Nine Dorper sheep, instrumented to provide measurements of carotid blood and brain temperature, were dosed with deuterium oxide (D2O), exposed to heat for 8 days (40 degrees C for 6-h per day) and deprived of water for the last five days (days 3 to 8). Plasma osmolality increased and the body water fraction decreased over the five days of water deprivation, with the sheep losing 16.7% of their body mass. Following water deprivation, both the mean 24h carotid blood temperature and the mean 24h brain temperature increased, but carotid blood temperature increased more than did brain temperature resulting in increased selective brain cooling. There was considerable inter-individual variation in the degree to which individual sheep used selective brain cooling. In general, sheep spent more time using selective brain cooling, and it was of greater magnitude, when dehydrated compared to when they were euhydrated. We found a significant positive correlation between selective brain cooling magnitude and osmolality (an index of hydration state). Both the magnitude of selective brain cooling and the proportion of time that sheep spent selective brain cooling were negatively correlated with water turnover. Sheep that used selective brain cooling more frequently, and with greater magnitude, lost less water than did conspecifics using selective brain cooling less efficiently. Our results show that a 50kg sheep can save 2.6L of water per day (similar to 60% of daily water intake) when it employs selective brain cooling for 50% of the day during heat exposure. We conclude that selective brain cooling has a water conservation function in artiodactyls.	[Strauss, W. Maartin; Hetem, Robyn S.; Mitchell, Duncan; Maloney, Shane K.; Meyer, Leith C. R.; Fuller, Andrea] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa; [Strauss, W. Maartin] Univ S Africa, Coll Agr & Environm Sci, Dept Environm Sci, Johannesburg, South Africa; [Meyer, Leith C. R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA 6009, Australia	University of Witwatersrand; University of South Africa; University of Western Australia	Strauss, WM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa.	strauwm@unisa.ac.za	Meyer, Leith/AAN-4930-2020; Fuller, Andrea/P-3133-2016; maloney, shane k/AAU-5811-2021; Strauss, W. Maartin/F-8579-2014; Hetem, Robyn Sheila/A-1438-2015	Fuller, Andrea/0000-0001-6370-8151; maloney, shane k/0000-0002-5878-2266; Strauss, W. Maartin/0000-0002-3087-1937; Hetem, Robyn Sheila/0000-0003-1953-3520; Meyer, Leith/0000-0002-5122-2469	National Research Foundation (NRF) Thuthuka grant [76248]; University of the Witwatersrand Medical Faculty Research Endowment Fund [0014108521201BFRU000]	National Research Foundation (NRF) Thuthuka grant; University of the Witwatersrand Medical Faculty Research Endowment Fund	This study was funded through a National Research Foundation (NRF) Thuthuka grant, awarded to WMS (grant code: 76248), and the University of the Witwatersrand Medical Faculty Research Endowment Fund, awarded to WMS (grant number: 0014108521201BFRU000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MA, 1972, J PHYSIOL-LONDON, V220, P711, DOI 10.1113/jphysiol.1972.sp009731; BAKER MA, 1989, J PHYSIOL-LONDON, V417, P421, DOI 10.1113/jphysiol.1989.sp017810; DAWES JDK, 1953, J ANAT, V87, P311; DEGEN AA, 1992, J AGR SCI, V119, P419, DOI 10.1017/S0021859600012260; DORIS PA, 1983, PFLUG ARCH EUR J PHY, V398, P337, DOI 10.1007/BF00657244; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Ehleringer JR., 1989, STABLE ISOTOPES ECOL, V68, P525, DOI [10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-23]; FINCH VA, 1979, AM J PHYSIOL, V237, pR192, DOI 10.1152/ajpregu.1979.237.3.R192; Fuller A, 1999, J COMP PHYSIOL B, V169, P605, DOI 10.1007/s003600050261; Fuller A, 2007, AM J PHYSIOL-REG I, V293, pR438, DOI 10.1152/ajpregu.00074.2007; Fuller A, 2011, AM J PHYSIOL-REG I, V300, pR1409, DOI 10.1152/ajpregu.00731.2010; HALES JRS, 1973, PFLUG ARCH EUR J PHY, V345, P123, DOI 10.1007/BF00585835; HAYWARD JN, 1966, P SOC EXP BIOL MED, V121, P547; HECKER JF, 1964, AUST J AGR RES, V15, P961, DOI 10.1071/AR9640961; Hetem RS, 2008, AM J PHYSIOL-REG I, V294, pR246, DOI 10.1152/ajpregu.00570.2007; Hetem RS, 2012, J EXP BIOL, V215, P3917, DOI 10.1242/jeb.074666; JESSEN C, 1994, AM J PHYSIOL-REG I, V267, pR1528, DOI 10.1152/ajpregu.1994.267.6.R1528; Jessen C, 1998, PFLUG ARCH EUR J PHY, V436, P659, DOI 10.1007/s004240050686; JOHNSEN HK, 1987, AM J PHYSIOL, V253, pR848, DOI 10.1152/ajpregu.1987.253.6.R848; JOHNSON JA, 1970, AM J PHYSIOL, V218, P1273, DOI 10.1152/ajplegacy.1970.218.5.1273; Kuhnen G, 1997, COMP BIOCHEM PHYS A, V118, P891, DOI 10.1016/S0300-9629(97)00235-1; KUHNEN G, 1994, AM J PHYSIOL, V267, pR355, DOI 10.1152/ajpregu.1994.267.2.R355; Magilton JH, 1968, IEEE CONFERENCE RECO; Maloney SK, 2007, AM J PHYSIOL-REG I, V292, pR1298, DOI 10.1152/ajpregu.00275.2006; Maloney SK, 2002, PFLUG ARCH EUR J PHY, V443, P437, DOI 10.1007/s004240100704; Maloney SK, 2001, AM J PHYSIOL-REG I, V281, pR108, DOI 10.1152/ajpregu.2001.281.1.R108; McKinley M, 2008, CLIN EXP PHARMACOL P, V35, P701, DOI 10.1111/j.1440-1681.2007.04833.x; MCKINLEY MJ, 1983, AM J PHYSIOL, V245, pR287, DOI 10.1152/ajpregu.1983.245.2.R287; Mitchell D, 2002, COMP BIOCHEM PHYS B, V131, P571, DOI 10.1016/S1096-4959(02)00012-X; Mitchell D, 1997, J COMP PHYSIOL B, V167, P335, DOI 10.1007/s003600050082; Mitchell G, 2008, BIOL LETTERS, V4, P415, DOI 10.1098/rsbl.2008.0138; PLESCHKA K, 1979, PFLUG ARCH EUR J PHY, V382, P255, DOI 10.1007/BF00583710; PUROHIT GR, 1972, AUST J AGR RES, V23, P685, DOI 10.1071/AR9720685; Schoeman SJ, 1995, S AFR J ANIM SCI, V25, P75; Shkoinik A., 1972, Symposia Zool Soc Lond, VNo. 31, P229; SIEBERT BD, 1975, PHYSIOL ZOOL, V48, P36, DOI 10.1086/physzool.48.1.30155636; SILANIKOVE N, 1992, LIVEST PROD SCI, V30, P175, DOI 10.1016/S0301-6226(06)80009-6; SILANIKOVE N, 1994, EXP PHYSIOL, V79, P281, DOI 10.1113/expphysiol.1994.sp003764; Speakman J.R., 1997, DOUBLY LABELLED WATE; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1136, DOI 10.1152/ajplegacy.1970.219.4.1136; Vesterdorf K, 2011, J COMP PHYSIOL B, V181, P277, DOI 10.1007/s00360-010-0513-7	41	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115514	10.1371/journal.pone.0115514	http://dx.doi.org/10.1371/journal.pone.0115514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675092	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000003
J	Zhan, LB; Zheng, LP; Hosoi, T; Okuma, Y; Nomura, Y				Zhan, Libin; Zheng, Luping; Hosoi, Toru; Okuma, Yasunobu; Nomura, Yasuyuki			Stress-Induced Neuroprotective Effects of Epiregulin and Amphiregulin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-ALPHA; IN-VITRO; ISCHEMIA; EXPRESSION; GENE; STEM; PROTECTS; PROMOTES; SURVIVAL	Members of the epidermal growth factor family play important roles in the regulation of cell growth, proliferation, and survival. However, the specific roles of each epidermal growth factor family member with respect to brain injury are not well understood. Gene chip assay screens have revealed drastic increases in the expression of the epidermal growth factor family members amphiregulin and epiregulin following lipopolysaccharide stimulation, which activates an immune response. Both immune activity and endoplasmic reticulum stress are activated during cerebral ischemia. We found that the expression levels of amphiregulin and epiregulin were significantly increased under conditions of cerebral ischemia. Because endoplasmic reticulum stress increased the expression of amphiregulin and epiregulin in glial cells, endoplasmic reticulum stress may be a key mediatory factor of pathophysiological activity. Recombinant epiregulin and amphiregulin proteins effectively inhibited endoplasmic reticulum stress and the subsequent induction of neuronal cell death. Therefore, the upregulation of the epidermal growth factor family members epiregulin and amphiregulin may play a critical role in preventing endoplasmic reticulum stress- induced cell death, thus providing a potential therapy for brain injury.	[Zhan, Libin] Dalian Med Univ, Affiliated Hosp 2, Dept Tradit Chinese Med, Dalian, Peoples R China; [Zhan, Libin; Hosoi, Toru; Okuma, Yasunobu; Nomura, Yasuyuki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Zhan, Libin; Zheng, Luping] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Peoples R China; [Hosoi, Toru] Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan	Dalian Medical University; Hokkaido University; Dalian Medical University; Hiroshima University; Kurume University	Nomura, Y (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan.	nomura_yasuyuki@kurume-u.ac.jp	Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X	Ministry of Education, Science and Culture of Japan; Japan-China Sasakawa Medical Fellowship	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-China Sasakawa Medical Fellowship	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture of Japan and was also supported in part by the Japan-China Sasakawa Medical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2005, J BIOL CHEM, V280, P19012, DOI 10.1074/jbc.M413344200; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kawahara N, 1999, J CEREBR BLOOD F MET, V19, P307, DOI 10.1097/00004647-199903000-00009; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Moskowitz MA, 2003, STROKE, V34, P324, DOI 10.1161/01.STR.0000054047.14853.AD; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Nilsson A, 2005, NEUROREPORT, V16, P213, DOI 10.1097/00001756-200502280-00002; Nishimura T, 2008, ONCOL REP, V19, P105; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; PUTTABYATAPPA M, 2013, BIOL REPROD, V88, DOI DOI 10.1095/BOLREPROD.112.103002; Qi X, 2004, J PHARMACOL EXP THER, V311, P388, DOI 10.1124/jpet.104.069088; Rizzi M, 2013, GROWTH FACTORS, V31, P90, DOI 10.3109/08977194.2013.795958; Shirasawa S, 2004, P NATL ACAD SCI USA, V101, P13921, DOI 10.1073/pnas.0404217101; Sisto M, 2010, HISTOCHEM CELL BIOL, V134, P345, DOI 10.1007/s00418-010-0735-5; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Tsuda N, 2008, BRAIN DEV-JPN, V30, P533, DOI 10.1016/j.braindev.2008.01.006; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076157; Xian CJ, 2001, EXP NEUROL, V172, P182, DOI 10.1006/exnr.2001.7771; Zhang JG, 2014, BIOMED REP, V2, P233, DOI 10.3892/br.2014.225	35	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118280	10.1371/journal.pone.0118280	http://dx.doi.org/10.1371/journal.pone.0118280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675253	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000046
J	Bishop, BM; Juba, ML; Devine, MC; Barksdale, SM; Rodriguez, CA; Chung, MC; Russo, PS; Vliet, KA; Schnur, JM; van Hoek, ML				Bishop, Barney M.; Juba, Melanie L.; Devine, Megan C.; Barksdale, Stephanie M.; Rodriguez, Carlos Alberto; Chung, Myung C.; Russo, Paul S.; Vliet, Kent A.; Schnur, Joel M.; van Hoek, Monique L.			Bioprospecting the American Alligator (Alligator mississippiensis) Host Defense Peptidome	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MASS-SPECTROMETRY; HYDROGEL PARTICLES; ANTIBACTERIAL; CATHELICIDIN; ASSAY; SURVIVAL	Cationic antimicrobial peptides and their therapeutic potential have garnered growing interest because of the proliferation of bacterial resistance. However, the discovery of new antimicrobial peptides from animals has proven challenging due to the limitations associated with conventional biochemical purification and difficulties in predicting active peptides from genomic sequences, if known. As an example, no antimicrobial peptides have been identified from the American alligator, Alligator mississippiensis, although their serum is antimicrobial. We have developed a novel approach for the discovery of new antimicrobial peptides from these animals, one that capitalizes on their fundamental and conserved physico-chemical properties. This sample-agnostic process employs custom-made functionalized hydrogel microparticles to harvest cationic peptides from biological samples, followed by de novo sequencing of captured peptides, eliminating the need to isolate individual peptides. After evaluation of the peptide sequences using a combination of rational and web-based bioinformatic analyses, forty-five potential antimicrobial peptides were identified, and eight of these peptides were selected to be chemically synthesized and evaluated. The successful identification of multiple novel peptides, exhibiting antibacterial properties, from Alligator mississippiensis plasma demonstrates the potential of this innovative discovery process in identifying potential new host defense peptides.	[Bishop, Barney M.; Juba, Melanie L.; Devine, Megan C.; Rodriguez, Carlos Alberto] George Mason Univ, Dept Chem & Biochem, Fairfax, VA 22030 USA; [Barksdale, Stephanie M.; Chung, Myung C.; van Hoek, Monique L.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Russo, Paul S.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Vliet, Kent A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Schnur, Joel M.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [van Hoek, Monique L.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA	George Mason University; George Mason University; George Mason University; State University System of Florida; University of Florida; George Mason University; George Mason University	Bishop, BM (corresponding author), George Mason Univ, Dept Chem & Biochem, Fairfax, VA 22030 USA.	bbishop1@gmu.edu	van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899	Defense Threat Reduction Agency [HDTRA1-12-C-0039]; George Mason University College of Science	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); George Mason University College of Science	The authors gratefully acknowledge the Defense Threat Reduction Agency (http://www.dtra.mil/) HDTRA1-12-C-0039 and the George Mason University College of Science (http://www.gmu.edu) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; Darville LNF, 2010, COMP BIOCHEM PHYS D, V5, P308, DOI 10.1016/j.cbd.2010.09.001; Dean SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00128; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Lata S, 2007, BMC BIOINFORMATICS, V10, P1; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Mak PA, 2011, CLIN VACCINE IMMUNOL, V18, P1252, DOI 10.1128/CVI.05028-11; Mariscal A, 2009, APPL MICROBIOL BIOT, V82, P773, DOI 10.1007/s00253-009-1879-x; Merchant ME, 2006, VET IMMUNOL IMMUNOP, V110, P221, DOI 10.1016/j.vetimm.2005.10.001; Merchant ME, 2003, COMP BIOCHEM PHYS B, V136, P505, DOI 10.1016/S1096-4959(03)00256-2; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Nagaoka I, 2005, INFLAMM RES, V54, P66, DOI 10.1007/s00011-004-1323-8; Nakajima Y, 1997, FEBS LETT, V415, P64, DOI 10.1016/S0014-5793(97)01101-0; Okuda D, 2006, ANTIMICROB AGENTS CH, V50, P2602, DOI 10.1128/AAC.00331-06; Olsson B, 2010, METABOLISM, V59, P1736, DOI 10.1016/j.metabol.2010.04.017; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Pata S, 2011, DEV COMP IMMUNOL, V35, P545, DOI 10.1016/j.dci.2010.12.011; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Sorensen O, 1997, BLOOD, V90, P2796; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tratnyek PG, 2001, CHEM ED, V6, P172, DOI [10.1007/s00897010471a, DOI 10.1007/S00897010471A]; van Hoek ML, 2014, PHARMACEUTICALS, V7, P723, DOI 10.3390/ph7060723; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	31	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117394	10.1371/journal.pone.0117394	http://dx.doi.org/10.1371/journal.pone.0117394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671663	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300052
J	Janssen, A; Kaiser, S; Meissner, K; Brenke, N; Menot, L; Arbizu, PM				Janssen, Annika; Kaiser, Stefanie; Meissner, Karin; Brenke, Nils; Menot, Lenaick; Arbizu, Pedro Martinez			A Reverse Taxonomic Approach to Assess Macrofaunal Distribution Patterns in Abyssal Pacific Polymetallic Nodule Fields	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BENTHIC DISTURBANCE; POPULATION-SIZE; RANGE SIZE; DEEP; SEA; DIVERSITY; DISPERSAL; COMMUNITIES; CRUSTACEA	Heightened interest in the exploitation of deep seafloor minerals is raising questions on the consequences for the resident fauna. Assessing species ranges and determination of processes underlying current species distributions are prerequisites to conservation planning and predicting faunal responses to changing environmental conditions. The abyssal central Pacific nodule belt, located between the Clarion and Clipperton Fracture Zones (CCZ), is an area prospected for mining of polymetallic nodules. We examined variations in genetic diversity and broad-scale connectivity of isopods and polychaetes across the CCZ. Faunal assemblages were studied from two mining claims (the eastern German and French license areas) located 1300 km apart and influenced by different productivity regimes. Using a reverse taxonomy approach based on DNA barcoding, we tested to what extent distance and large-scale changes in environmental parameters lead to differentiation in two macrofaunal taxa exhibiting different functions and life-history patterns. A fragment of the mitochondrial gene Cytochrome Oxidase Subunit 1 (COI) was analyzed. At a 97% threshold the molecular operational taxonomic units (MOTUs) corresponded well to morphological species. Molecular analyses indicated high local and regional diversity mostly because of large numbers of singletons in the samples. Consequently, variation in composition of genotypic clusters between sites was exceedingly large partly due to paucity of deep-sea sampling and faunal patchiness. A higher proportion of wide-ranging species in polychaetes was contrasted with mostly restricted distributions in isopods. Remarkably, several cryptic lineages appeared to be sympatric and occurred in taxa with putatively good dispersal abilities, whereas some brooding lineages revealed broad distributions across the CCZ. Geographic distance could explain variation in faunal connectivity between regions and sites to some extent, while assumed dispersal capabilities were not as important.	[Janssen, Annika; Kaiser, Stefanie; Brenke, Nils; Arbizu, Pedro Martinez] Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, D-26382 Wilhelmshaven, Germany; [Meissner, Karin] Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, Biozentrum Grindel, D-20146 Hamburg, Germany; [Menot, Lenaick] IFREMER, Ctr Brest, F-29280 Plouzane, France	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Hamburg; Ifremer	Janssen, A (corresponding author), Deutsch Zentrum Marine Biodiversitatsforsch, Senckenberg Meer, Sudstrand 44, D-26382 Wilhelmshaven, Germany.	ajanssen@senckenberg.de	MENOT, LENAICK/N-6899-2016	MENOT, LENAICK/0000-0002-8117-1607; Kaiser, Stefanie/0000-0003-2026-4663; Martinez-Arbizu, Pedro/0000-0002-0891-1154	Federal Ministry of Education and Research (BMBF, Germany) [03G0205D]; Federal Institute of Geoscience and Natural Resources (BGR, Germany); French Research Institute for Exploitation of the Sea (IFREMER, France); European Union [603418]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Federal Institute of Geoscience and Natural Resources (BGR, Germany); French Research Institute for Exploitation of the Sea (IFREMER, France); European Union(European Commission)	AJ and PMA received financial support from the Federal Ministry of Education and Research (BMBF, Germany, grant 03G0205D), the Federal Institute of Geoscience and Natural Resources (BGR, Germany) and the French Research Institute for Exploitation of the Sea (IFREMER, France) for the financial support of the investigation. SK, LM and PMA acknowledge funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS project, grant agreement no 603418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Basualdo Carola V., 2011, Rev. Soc. Entomol. Argent., V70, P27; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhaud M, 1998, HYDROBIOLOGIA, V375-76, P35, DOI 10.1023/A:1017073409259; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Blake JA, 2004, DEEP-SEA RES PT II, V51, P1797, DOI 10.1016/j.dsr2.2004.07.014; Blake James A., 2006, P565; Blank M, 2009, ZOOL SCR, V38, P313, DOI 10.1111/j.1463-6409.2008.00370.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Boggemann M, 2005, NEUE FOLGEN, V39, P1; Borowski C, 1998, DEEP-SEA RES PT II, V45, P55, DOI 10.1016/S0967-0645(97)00073-8; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A, 2005, ORG DIVERS EVOL, V5, P105, DOI 10.1016/j.ode.2004.10.007; Brenke N, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787444015; Brix S, 2011, ZOOTAXA, P79; Brix S, 2015, MAR BIODIVERS, V45, P7, DOI 10.1007/s12526-014-0218-3; Brokeland W, 2010, MAR BIOL, V157, P177, DOI 10.1007/s00227-009-1308-9; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clark AL, 2013, DEV REGULATORY FRAMC, V11; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cohen D, 1990, FAO SPECIEES CTALOGU, V10; Cronan DS, 1980, UNDERWATER MINERALS; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Ebbe Brigitte, 2010, P139, DOI 10.1002/9781444325508.ch8; Elsner NO, 2013, DEEP-SEA RES PT II, V86-87, P103, DOI 10.1016/j.dsr2.2012.07.043; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukushima T, 1995, OVERVIEW JAPAN DEEP; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Glover A, 2001, DEEP-SEA RES PT I, V48, P217, DOI 10.1016/S0967-0637(00)00053-4; Glover AG, 2002, MAR ECOL PROG SER, V240, P157, DOI 10.3354/meps240157; Gudmundsson G, 2000, DEEP-SEA RES PT I, V47, P2093, DOI 10.1016/S0967-0637(00)00013-3; Guerrero-Kommritz J, 2004, NEW SPECIES TANAELLA; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; HALBACH P, 1975, MINER DEPOSITA, V10, P397; Halbach P., 1980, GEOJOURNAL, V4, P407, DOI 10.1007/BF01795925; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannides A, 2003, BIOGEOCHEMISTERY MAR, P29; Hartman O, 1971, DEEP WATER BENTHIC P; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Havermans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HESSLER RR, 1974, DEEP-SEA RES, V21, P185, DOI 10.1016/0011-7471(74)90058-8; HESSLER RR, 1979, SARSIA, V64, P67, DOI 10.1080/00364827.1979.10411365; Horst R., 1923, Zoologische Mededeelingen Leiden, V7, P221; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; International Seabed Authority, 2013, CONT; International Seabed Authority, 2010, ISA TECHN STUD; Jennings RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077594; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Kaiser S, 2007, DEEP-SEA RES PT II, V54, P1776, DOI 10.1016/j.dsr2.2007.07.006; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Khodami S, 2014, POLISH POLAR RES, V35; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Letunic I, 2006, BIOINFORMATICS, V23, P172; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Mahon AR, 2009, MAR BIOL RES, V5, P172, DOI 10.1080/17451000802317683; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; MANTEL N, 1967, CANCER RES, V27, P209; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Meissner K, 2009, ZOOTAXA, V2278, P25; Menzel L, 2011, DEEP-SEA RES PT I, V58, P839, DOI 10.1016/j.dsr.2011.05.008; Mewes K, 2014, DEEP-SEA RES PT I, V91, P125, DOI 10.1016/j.dsr.2014.06.001; Miljutin DM, 2011, DEEP-SEA RES PT I, V58, P885, DOI 10.1016/j.dsr.2011.06.003; Miljutina Maria A., 2010, Marine Biodiversity, V40, P1, DOI 10.1007/s12526-009-0029-0; Osborn KJ, 2009, ZOOL SCR, V38, P617, DOI 10.1111/j.1463-6409.2009.00394.x; Paterson GLJ, 1998, DEEP-SEA RES PT II, V45, P225, DOI 10.1016/S0967-0645(97)00084-2; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Puillandre N, 2012, MOL ECOL, V21, P13; Radziejewska T, 2002, INT REV HYDROBIOL, V87, P457, DOI 10.1002/1522-2632(200207)87:4<457::AID-IROH457>3.0.CO;2-3; Raghukumar C, 2001, DEEP-SEA RES PT II, V48, P3381, DOI 10.1016/S0967-0645(01)00047-9; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Randrianiaina RD, 2011, CONTRIB ZOOL, V80, P17, DOI 10.1163/18759866-08001002; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Riehl T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049354; Rizzo Alexandra Elaine, 2004, Rev. Bras. Zool., V21, P937, DOI 10.1590/S0101-81752004000400031; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Roskop F, 1977, DEEP-SEA RES, V24, P10; ROUSE G.W., 2001, POLYCHAETES; Salton G, 1983, INTRO MODERN INFORM; Schuller M, 2012, ZOOTAXA, P1; Sharma R, 2001, DEEP-SEA RES PT II, V48, P3363, DOI 10.1016/S0967-0645(01)00046-7; Sharma R, 2000, MAR GEORESSOUR GEOTE, V23, P174; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Smith CR, 2008, ISA TECHNICAL STUDY; Smith CR, 2006, INT SEABED AUTHORITY; Smith CR, 2003, ECOLOGY DEEP PACIFIC; SSNER K, 2014, ZOOTAXA, V3786, P201; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thiel H, 2001, DEEP-SEA RES PT II, V48, P3869, DOI 10.1016/S0967-0645(01)00071-6; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Veillette J, 2007, DEEP-SEA RES PT I, V54, P1912, DOI 10.1016/j.dsr.2007.06.011; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wedding L, 2013, P R SOC B, V280; Wiedicke M, 2012, MARINE MINERALISCHE; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WILSON WH, 1991, B MAR SCI, V48, P500; Wolff T., 1962, Galathea Report, V6, P1; Zhou H, 2010, CHIN J OCEANOL LIMN, V28, P899, DOI 10.1007/s00343-010-9131-1	124	59	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117790	10.1371/journal.pone.0117790	http://dx.doi.org/10.1371/journal.pone.0117790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671322	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300070
J	Sreekar, R; Zhang, K; Xu, JC; Harrison, RD				Sreekar, Rachakonda; Zhang, Kai; Xu, Jianchu; Harrison, Rhett D.			Yet Another Empty Forest: Considering the Conservation Value of a Recently Established Tropical Nature Reserve	PLOS ONE			English	Article							PROTECTED AREAS; CLIMATE-CHANGE; WESTERN-GHATS; BIODIVERSITY; BIRDS; DEFORESTATION; EXTINCTIONS; LANDSCAPE; DIVERSITY; CHINA	The primary approach used to conserve tropical biodiversity is in the establishment of protected areas. However, many tropical nature reserves are performing poorly and interventions in the broader landscape may be essential for conserving biodiversity both within reserves and at large. Between October 2010 and 2012, we conducted bird surveys in and around a recently established nature reserve in Xishuangbanna, China. We constructed a checklist of observed species, previously recorded species, and species inferred to have occurred in the area from their distributions and habitat requirements. In addition, we assessed variation in community composition and habitat specificity at a landscape-scale. Despite the fact that the landscape supports a large area of natural forest habitat (similar to 50,000 ha), we estimate that >40% of the bird fauna has been extirpated and abundant evidence suggests hunting is the primary cause. A large proportion (52%) of the bigger birds (>20 cm) were extirpated and for large birds there was a U-shaped relationship between habitat breadth and extirpation probability. Habitat specificity was low and bird communities were dominated by widespread species of limited conservation concern. We question whether extending tropical protected area networks will deliver desired conservation gains, unless much greater effort is channeled into addressing the hunting problem both within existing protected areas and in the broader landscape.	[Sreekar, Rachakonda] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Peoples R China; [Zhang, Kai] Chinese Acad Sci, Ecol Conservat & Environm Ctr, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Sreekar, Rachakonda; Zhang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Jianchu; Harrison, Rhett D.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Xu, Jianchu; Harrison, Rhett D.] World Agroforestry Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Harrison, RD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	r.harrison@cgiar.org	Xu, Jianchu/Y-2890-2019; Sreekar, Rachakonda/C-4377-2008	Sreekar, Rachakonda/0000-0001-5445-6589; Harrison, Rhett/0000-0001-9055-3546	German GIZ/BMZ Making the Mekong Connected through the World Agroforestry Centre, East Asia Node [08.7860.3- 001.00]	German GIZ/BMZ Making the Mekong Connected through the World Agroforestry Centre, East Asia Node	Funding for this work was generously provided by the German GIZ/BMZ Making the Mekong Connected, Project No. 08.7860.3- 001.00, through the World Agroforestry Centre, East Asia Node. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Balaji D, 2014, J NAT CONSERV, V22, P337, DOI 10.1016/j.jnc.2014.03.004; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; BECKSCHFER P, 2013, OPEN J FORESTRY, V0003; Benchimol M, 2013, DIVERS DISTRIB, V19, P1339, DOI 10.1111/ddi.12111; Bhupathy S, 2013, TROP CONSERV SCI, V6, P241, DOI 10.1177/194008291300600206; Brashares JS, 2010, SCIENCE, V329, P402, DOI 10.1126/science.1190095; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Cheng T. h., 1961, Acta Zoologica Sinica, V13, P53; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Corlett RT, 2013, BIOTROPICA, V45, P273, DOI 10.1111/btp.12028; Dalvi S, 2013, SCIENCE, V339, P270, DOI 10.1126/science.339.6117.270-a; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Fan PF, 2014, ORYX, V48, P52, DOI 10.1017/S0030605312001305; FAO (Food and Agricultural Organization of the United Nations), 2010, GLOB FOR RES ASS 201, DOI [10.1073/pnas.0913658107, DOI 10.1073/PNAS.0913658107]; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Hallingback T, 2006, APPL IUCN 2001 RED L; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; Harris JBC, 2012, RAFFLES B ZOOL, P197; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; Harrison RD, 2011, BIOSCIENCE, V61, P919, DOI 10.1525/bio.2011.61.11.11; Ivanov Al, 1961, ACTA ZOOL SINCA, V13, P70; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Liang W, 2013, BIRD CONSERV INT, V23, P45, DOI 10.1017/S0959270911000499; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; McConkey KR, 2004, ORYX, V38, P439, DOI 10.1017/S0030605304000821; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Mikusinski G, 2006, ANN ZOOL FENN, V43, P86; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palomo I, 2014, BIOSCIENCE, V64, P181, DOI 10.1093/biosci/bit033; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Raman TRS, 2006, BIODIVERS CONSERV, V15, P1577, DOI 10.1007/s10531-005-2352-5; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Rao M, 2002, CONSERV BIOL, V16, P360, DOI 10.1046/j.1523-1739.2002.00219.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson JG, 2000, HUNTING SUSTAINABILI, DOI [10.1111/j.15231739.2009.01224.x, DOI 10.1111/J.1523-1739.2009.01224.X]; Robson C, 2000, NEW HOLLAND FIELD GU; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez JP, 2001, TRENDS ECOL EVOL, V16, P17, DOI 10.1016/S0169-5347(00)02050-4; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; SCHONEWALDCOX C, 1992, ENVIRON MANAGE, V16, P273, DOI 10.1007/BF02393833; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sodhi NS, 2010, CONSERV BIOL, V24, P1290, DOI 10.1111/j.1523-1739.2010.01495.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Sodhi NS, 2009, CAUSES CONSEQUENCES, DOI [10.1098/rstb.2008.0278, DOI 10.1098/RSTB.2008.0278]; Sreekar R, 2015, DIVERS DISTRIB, V21, P441, DOI 10.1111/ddi.12292; Sreekar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070379; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wang ZJ, 2003, BIOL CONSERV, V110, P231, DOI 10.1016/S0006-3207(02)00222-7; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Xi J, 2009, VALUATION ECOSYSTEM; Xu JC, 2007, CONSERV BIOL, V21, P318, DOI 10.1111/j.1523-1739.2006.00636.x; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; Xu JC, 2009, ECOL SOC, V14; Yang D. H., 1993, FAUNA XISHUANGBANNA; Yang L., 1995, AVIFAUNA YUNNAN CHIN, VI; Yang L., 2004, AVIFAUNA YUNNAN CHIN, VII; Zhang KX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085720, 10.1371/journal.pone.0086598]; Zheng Z., 1962, ACTA ZOOL SINICA, V14, P74; Zhu H, 2005, BIODIVERS CONSERV, V14, P2855, DOI 10.1007/s10531-004-8220-x	85	24	24	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117920	10.1371/journal.pone.0117920	http://dx.doi.org/10.1371/journal.pone.0117920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668338	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000032
J	Guo, Y; Yang, TL; Dong, SS; Yan, H; Hao, RH; Chen, XF; Chen, JB; Tian, Q; Li, J; Shen, H; Deng, HW				Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin; Tian, Qing; Li, Jian; Shen, Hui; Deng, Hong-Wen			Genetic Analysis Identifies DDR2 as a Novel Gene Affecting Bone Mineral Density and Osteoporotic Fractures in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR TYROSINE KINASES; RUNX2 ACTIVATION; HIP FRACTURE; EXPRESSION; COLLAGEN; DOMAIN; DIFFERENTIATION; DWARFISM; ALLELE	DDR2 gene, playing an essential role in regulating osteoblast differentiation and chondrocyte maturation, may influence bone mineral density (BMD) and osteoporosis, but the genetic variations actually leading to the association remain to be elucidated. Therefore, the aim of this study was to investigate whether the genetic variants in DDR2 are associated with BMD and fracture risk. This study was performed in three samples from two ethnicities, including 1,300 Chinese Han subjects, 700 Chinese Han subjects (350 with osteoporotic hip fractures and 350 healthy controls) and 2,286 US white subjects. Twenty-eight SNPs in DDR2 were genotyped and tested for associations with hip BMD and fractures. We identified 3 SNPs in DDR2 significantly associated with hip BMD in the Chinese population after multiple testing adjustments, which were rs7521233 (P = 1.06x10(-4), beta: -0.018 for allele C), rs7553831 (P = 1.30x10(-4), beta: -0.018 for allele T), and rs6697469 (P = 1.59x10(-3), beta: -0.015 for allele C), separately. These three SNPs were in high linkage disequilibrium. Haplotype analyses detected two significantly associated haplotypes, including one haplotype in block 2 (P = 9.54x10(-4), beta: -0.016) where these three SNPs located. SNP rs6697469 was also associated with hip fractures (P = 0.043, OR: 1.42) in the Chinese population. The effect on fracture risk was consistent with its association with lower BMD. However, in the white population, we didn't observe significant associations with hip BMD. eQTL analyses revealed that SNPs associated with BMD also affected DDR2 mRNA expression levels in Chinese. Our findings, together with the prior biological evidence, suggest that DDR2 could be a new candidate for osteoporosis in Chinese population. Our results also reveal an ethnic difference, which highlights the need for further genetic studies in each ethnic group.	[Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Guo, Yan; Yang, Tie-Lin; Dong, Shan-Shan; Yan, Han; Hao, Ruo-Han; Chen, Xiao-Feng; Chen, Jia-Bin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Tian, Qing; Li, Jian; Shen, Hui; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Tulane University	Yang, TL (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China.	yangtielin@mail.xjtu.edu.cn; hdeng2@tulane.edu	Chen, Xiao-Feng/AAN-8808-2020; Li, Jian/G-4445-2015; Yang, Tie-Lin/G-8365-2014; Guo, Yan/G-8742-2014	Chen, Xiao-Feng/0000-0002-5886-6427; Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Natural Science Foundation of China [31371278, 31471188]; NIH [P50AR055081, R01AG026564, R01AR050496, R01AR057049]; Fundamental Research Funds for the Central Universities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR050496, R01AR059781, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Natural Science Foundation of China (31371278, 31471188), the grants from NIH (P50AR055081, R01AG026564, R01AR050496, and R01AR057049), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Dvornyk V, 2003, ANN HUM GENET, V67, P216, DOI 10.1046/j.1469-1809.2003.00037.x; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; KARN T, 1993, ONCOGENE, V8, P3433; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lau EMC, 2001, OSTEOPOROSIS INT, V12, P239, DOI 10.1007/s001980170135; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lin KL, 2010, J BONE MINER RES, V25, P2489, DOI 10.1002/jbmr.159; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Yang TL, 2012, OSTEOPOROSIS INT, V23, P781, DOI 10.1007/s00198-011-1626-x; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225	30	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117102	10.1371/journal.pone.0117102	http://dx.doi.org/10.1371/journal.pone.0117102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658585	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900100
J	Kanda, E; Muneyuki, T; Kanno, Y; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Kanno, Yoshihiko; Suwa, Kaname; Nakajima, Kei			Uric Acid Level Has a U-Shaped Association with Loss of Kidney Function in Healthy People: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; URATE EXCRETION; MOUSE KIDNEY; RISK-FACTOR; HYPOURICEMIA; EXERCISE; DISEASE; JAPAN; HYPERURICEMIA; HYPOURICAEMIA	Background The relationship between hyperuricemia and chronic kidney disease (CKD) has been found in various observational studies. Although hypouricemia is associated with cardiovascular events, it has not been established as a risk factor for CKD. We investigated the relationship between serum uric acid level and the loss of kidney function and incident CKD in healthy people. Materials and Methods Healthy people were enrolled in this community-based prospective cohort study, the Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. The analysis was conducted on 4188 subjects followed up for at least 3 years, 3102 for 6 years and 1052 for 9 years. Their data including glomerular filtration rate (eGFR) decline were examined every three years. The outcome event was incident CKD or the decrease in eGFR by more than 25% in three years. Multivariate statistical models were adjusted for the baseline characteristics. Results The following data was obtained: mean +/- SD age, male, 39.6 +/- 10.4 years, female 38.4 +/- 10.8 years; eGFR, male, 81.9 +/- 16.4 ml/min/1.73m2, female, 82.1 +/- 17.5 ml/min/1.73m2; serum uric acid level, male, 5.8 +/- 1.2 mg/dl, female, 4.1 +/- 0.9 mg/dl. Both low and high serum uric acid levels were associated with the outcome and eGFR decline in males (multivariate logistic additional additive models, linear p = 0.0001, spline p = 0.043; generalized additive models, linear p = 0.0001, spline p = 0.012). In subjects with low serum uric acid levels (male, < 5 mg/dl; female, < 3.6 mg/dl), multivariate linear mixed models showed that low serum uric acid levels were associated with eGFR decline in a time-dependent manner (male, p = 0.0001; female, p = 0.045). Conclusion This study showed that low as well as high levels of uric acid are associated with the loss of kidney function. Hypouricemia is a candidate predictor of kidney function decline in healthy people.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Saitama Citizens Med Ctr, Saitama, Japan; [Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, Tokyo 1608402, Japan; Saitama Hlth Promotion Corp, Hikigun, Saitama, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Saitama, Japan; [Nakajima, Kei] Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, Sakado, Saitama 35002, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical University; Josai University	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Nakajima, Kei/AAF-2801-2019	Nakajima, Kei/0000-0002-1788-3896				AKIZUKI S, 1982, ANN RHEUM DIS, V41, P272, DOI 10.1136/ard.41.3.272; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Hakoda M, 2005, J RHEUMATOL, V32, P906; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; HISATOME I, 1989, NEPHRON, V51, P13, DOI 10.1159/000185233; Hosoyamada M, 2010, NUCLEOS NUCLEOT NUCL, V29, P574, DOI 10.1080/15257770.2010.494651; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Ishikawa I, 2002, NEPHRON, V91, P559, DOI 10.1159/000065013; Iwai N, 2004, KIDNEY INT, V66, P935, DOI 10.1111/j.1523-1755.2004.00839.x; Kawashima M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-31; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Muneyuki T, 2013, OPEN J ENDOCRINE MET, V3; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; MURAKAMI T, 1993, PEDIATR NEPHROL, V7, P772, DOI 10.1007/BF01213352; Neri L, 2011, AM J KIDNEY DIS, V58, P398, DOI 10.1053/j.ajkd.2011.04.025; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Odden MC, 2014, AM J KIDNEY DIS; OGINO K, 1991, J MED, V22, P76; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; SHICHIRI M, 1987, NEPHRON, V45, P31, DOI 10.1159/000184067; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Takiue Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P113, DOI 10.1080/15257770.2010.551645; Wang SF, 2011, NEPHROLOGY, V16, P767, DOI 10.1111/j.1440-1797.2011.01513.x	26	49	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118031	10.1371/journal.pone.0118031	http://dx.doi.org/10.1371/journal.pone.0118031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658588	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900253
J	Loying, P; Manhas, J; Sen, S; Bose, B				Loying, Pojul; Manhas, Janvie; Sen, Sudip; Bose, Biplab			Autoregulation and Heterogeneity in Expression of Human Cripto-1	PLOS ONE			English	Article							COLON-CANCER CELLS; GENE-EXPRESSION; POSITIVE FEEDBACK; STEM-CELLS; GROWTH; NOISE; TIME; STOCHASTICITY; ACTIVATION; CONVERSION	Cripto-1 (CR-1) is involved in various processes in embryonic development and cancer. Multiple pathways regulate CR-1 expression. Our present work demonstrates a possible positive feedback circuit where CR-1 induces its own expression. Using U-87 MG cells treated with exogenous CR-1, we show that such induction involves ALK4/SMAD2/3 pathway. Stochasticity in gene expression gives rise to heterogeneity in expression in genetically identical cells. Positive feedback increases such heterogeneity and often gives rise to two subpopulations of cells, having higher and lower expression of a gene. Using flow cytometry, we show that U-87 MG cells have a minuscule subpopulation with detectable expression of CR-1. Induction of CR-1 expression, by exogenous CR-1, increases the size of this CR-1 positive subpopulation. However, even at very high dose, most of the cells remain CR-1 negative. We show that population behavior of CR-1 induction has a signature similar to bimodal expression expected in a transcriptional circuit with positive feedback. We further show that treatment of U-87 MG cells with CR-1 leads to higher expression of drug efflux protein MDR-1 in the CR-1 positive subpopulation, indicating correlated induction of these two proteins. Positive feedback driven heterogeneity in expression of CR-1 may play crucial role in phenotypic diversification of cancer cells.	[Loying, Pojul; Bose, Biplab] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India; [Manhas, Janvie; Sen, Sudip] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; All India Institute of Medical Sciences (AIIMS) New Delhi	Bose, B (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, India.	biplabbose@iitg.ernet.in	Bose, Biplab/C-8151-2009	Bose, Biplab/0000-0002-7616-6838; Manhas, Janvie/0000-0001-6004-8004; Sen, Sudip/0000-0003-0303-2836	Department of Biotechnology, India [BT/239/NE/TBP/2011]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work has been funded by a research grant from Department of Biotechnology, India, project no. BT/239/NE/TBP/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alon U., 2006, INTRO SYSTEMS BIOL D; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Birtwistle MR, 2012, MOL BIOSYST, V8, P3068, DOI 10.1039/c2mb25168j; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Castro NP, 2011, EMBRYONIC STEM CELLS, P347, DOI [10.1109/EMBC.2014.6945038, DOI 10.1109/EMBC.2014.6945038]; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Comerford KM, 2002, CANCER RES, V62, P3387; Das AB, 2012, CANCER LETT, V318, P189, DOI 10.1016/j.canlet.2011.12.013; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Davidson E.H., 2006, REGULATORY GENOME; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Ebert AD, 1999, CANCER RES, V59, P4502; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hentschke M, 2006, J BIOL CHEM, V281, P33497, DOI 10.1074/jbc.M606975200; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Hu XF, 2007, BRIT J CANCER, V96, P918, DOI 10.1038/sj.bjc.6603641; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Mancino M, 2008, J CELL PHYSIOL, V215, P192, DOI 10.1002/jcp.21301; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nakahata Adriana M, 2010, J Stem Cells, V5, P103, DOI jsc.2010.5.3.103; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Palani S, 2012, CELL REP, V1, P215, DOI 10.1016/j.celrep.2012.01.007; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Strizzi L, 2013, CELL CYCLE, V12, P1450, DOI 10.4161/cc.24601; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Utsunomiya Y, 1997, LEUKEMIA, V11, P894, DOI 10.1038/sj.leu.2400663; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Yamada T, 2000, CANCER RES, V60, P4761; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526	51	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116748	10.1371/journal.pone.0116748	http://dx.doi.org/10.1371/journal.pone.0116748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658584	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900064
J	Ohtani, M; Villumsen, KR; Koppang, EO; Raida, MK				Ohtani, Maki; Villumsen, Kasper Romer; Koppang, Erling Olaf; Raida, Martin Kristian			Global 3D Imaging of Yersinia ruckeri Bacterin Uptake in Rainbow Trout Fry	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; SALMO-GAIRDNERI RICHARDSON; BOVINE SERUM-ALBUMIN; CARP CYPRINUS-CARPIO; VIBRIO-ANGUILLARUM; DIRECT IMMERSION; ANTIGEN UPTAKE; VACCINE DILUTION; BROWN TROUT; GILL CELLS	Yersinia ruckeri is the causative agent of enteric redmouth disease (ERM) in rainbow trout, and the first commercially available fish vaccine was an immersion vaccine against ERM consisting of Y. ruckeri bacterin. The ERM immersion vaccine has been successfully used in aquaculture farming of salmonids for more than 35 years. The gills and the gastrointestinal (GI) tract are believed to be the portals of antigen uptake during waterborne vaccination against ERM; however, the actual sites of bacterin uptake are only partly understood. In order to obtain insight into bacterin uptake during waterborne vaccination, optical projection tomography (OPT) together with immunohistochemistry (IHC) was applied to visualize bacterin uptake and processing in whole rainbow trout fry. Visualization by OPT revealed that the bacterin was initially taken up via gill lamellae from within 30 seconds post vaccination. Later, bacterin uptake was detected on other mucosal surfaces such as skin and olfactory bulb from 5 to 30 minutes post vaccination. The GI tract was found to be filled with a complex of bacterin and mucus at 3 hours post vaccination and the bacterin remained in the GI tract for at least 24 hours. Large amounts of bacterin were present in the blood, and an accumulation of bacterin was found in filtering lymphoid organs such as spleen and trunk kidney where the bacterin accumulates 24 hours post vaccination as demonstrated by OPT and IHC. These results suggest that bacterin is taken up via the gill epithelium in the earliest phases of the bath exposure and from the GI tract in the later phase. The bacterin then enters the blood circulatory system, after which it is filtered by spleen and trunk kidney, before finally accumulating in lymphoid organs where adaptive immunity against ERM is likely to develop.	[Ohtani, Maki; Villumsen, Kasper Romer; Raida, Martin Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol, Frederiksberg, Denmark; [Koppang, Erling Olaf] Norwegian Univ Life Sci, Norwegian Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway	University of Copenhagen; Norwegian University of Life Sciences	Ohtani, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol, Frederiksberg, Denmark.	maki@sund.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095	Danish research council [11-105095]	Danish research council(Det Frie Forskningsrad (DFF))	This research was supported by the Danish research council (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-teknologi-og-produktion) Grant no. 11-105095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; AMEND DF, 1976, SCIENCE, V192, P793, DOI 10.1126/science.1265480; AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1979, J FISH RES BOARD CAN, V36, P636, DOI 10.1139/f79-092; ANDERSON DP, 1979, AM ZOOL, V19, P931; ANDERSON DP, 1979, J FISH BIOL, V15, P317, DOI 10.1111/j.1095-8649.1979.tb03611.x; ANDERSON DP, 1974, J FISH RES BOARD CAN, V31, P214, DOI 10.1139/f74-035; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; BOWERS A, 1981, J FISH BIOL, V18, P9, DOI 10.1111/j.1095-8649.1981.tb03754.x; Buchmann K, 2003, J FISH DIS, V26, P183, DOI 10.1046/j.1365-2761.2003.00442.x; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; CIPRIANO RC, 1987, J WILDLIFE DIS, V23, P545, DOI 10.7589/0090-3558-23.4.545; COSSARINIDUNIER M, 1986, J FISH DIS, V9, P27, DOI 10.1111/j.1365-2761.1986.tb00976.x; Deshmukh S, 2012, VET IMMUNOL IMMUNOP, V145, P379, DOI 10.1016/j.vetimm.2011.12.014; Evenhuis JP, 2014, DEV COMP IMMUNOL, V44, P145, DOI 10.1016/j.dci.2013.12.004; FERGUSON HW, 1976, J COMP PATHOL, V86, P377, DOI 10.1016/0021-9975(76)90005-0; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Fuglem B, 2010, DEV COMP IMMUNOL, V34, P768, DOI 10.1016/j.dci.2010.02.007; JOHNSON KA, 1982, J FISH DIS, V5, P197, DOI 10.1111/j.1365-2761.1982.tb00474.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; Joosten PHM, 1997, FISH SHELLFISH IMMUN, V7, P471, DOI 10.1006/fsim.1997.0100; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Kryvi H, 1997, FISKEANATOMI; LAURENT P, 1980, AM J PHYSIOL, V238, pR147, DOI 10.1152/ajpregu.1980.238.3.R147; Maas M. G., 1982, Developmental and Comparative Immunology, P47; MACARTHUR JI, 1983, J RETICULOENDOTH SOC, V34, P13; McIntosh D, 2000, J FISH BIOL, V56, P1053, DOI 10.1111/j.1095-8649.2000.tb02122.x; MCLEAN E, 1986, COMP BIOCHEM PHYS A, V84, P687, DOI 10.1016/0300-9629(86)90388-9; Mendez J, 2013, ENV MICROBIOL REP, V5, P179, DOI 10.1111/1758-2229.12030; Moore JD, 1998, FISH SHELLFISH IMMUN, V8, P393, DOI 10.1006/fsim.1998.0143; NELSON J S, 1985, Fish Pathology, V19, P263; Ohtani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089672; OLESEN NJ, 1991, J APPL ICHTHYOL, V7, P36, DOI 10.1111/j.1439-0426.1991.tb00592.x; Ototake M, 1996, FISH SHELLFISH IMMUN, V6, P321, DOI 10.1006/fsim.1996.0033; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2007, DIS AQUAT ORGAN, V77, P41, DOI 10.3354/dao01808; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; ROMBOUT JWHM, 1986, DEV COMP IMMUNOL, V10, P341, DOI 10.1016/0145-305X(86)90024-8; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Smith P. D., 1982, Developmental and Comparative Immunology, P181; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; TATNER MF, 1985, AQUACULTURE, V46, P11, DOI 10.1016/0044-8486(85)90170-X; Tebbit G. L., 1981, Developments in Biological Standardization, V49, P395; Tobback E, 2010, J FISH DIS, V33, P197, DOI 10.1111/j.1365-2761.2009.01106.x; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363; Vandenberg Grant W., 2004, Animal Health Research Reviews, V5, P301, DOI 10.1079/AHR200488; Welch TJ, 2011, APPL ENVIRON MICROB, V77, P3493, DOI 10.1128/AEM.02997-10; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	52	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117263	10.1371/journal.pone.0117263	http://dx.doi.org/10.1371/journal.pone.0117263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658600	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900127
J	Overmyer, KA; Thonusin, C; Qi, NR; Burant, CF; Evans, CR				Overmyer, Katherine A.; Thonusin, Chanisa; Qi, Nathan R.; Burant, Charles F.; Evans, Charles R.			Impact of Anesthesia and Euthanasia on Metabolomics of Mammalian Tissues: Studies in a C57BL/6J Mouse Model	PLOS ONE			English	Article							RAT-LIVER; BLOOD; CANCER; PERFORMANCE; METABOLITES; SUCCINATE; SELECTION; FUMARATE; HYPOXIA; STRESS	A critical application of metabolomics is the evaluation of tissues, which are often the primary sites of metabolic dysregulation in disease. Laboratory rodents have been widely used for metabolomics studies involving tissues due to their facile handing, genetic manipulability and similarity to most aspects of human metabolism. However, the necessary step of administration of anesthesia in preparation for tissue sampling is not often given careful consideration, in spite of its potential for causing alterations in the metabolome. We examined, for the first time using untargeted and targeted metabolomics, the effect of several commonly used methods of anesthesia and euthanasia for collection of skeletal muscle, liver, heart, adipose and serum of C57BL/6J mice. The data revealed dramatic, tissue-specific impacts of tissue collection strategy. Among many differences observed, post-euthanasia samples showed elevated levels of glucose 6-phosphate and other glycolytic intermediates in skeletal muscle. In heart and liver, multiple nucleotide and purine degradation metabolites accumulated in tissues of euthanized compared to anesthetized animals. Adipose tissue was comparatively less affected by collection strategy, although accumulation of lactate and succinate in euthanized animals was observed in all tissues. Among methods of tissue collection performed pre-euthanasia, ketamine showed more variability compared to isoflurane and pentobarbital. Isoflurane induced elevated liver aspartate but allowed more rapid initiation of tissue collection. Based on these findings, we present a more optimal collection strategy mammalian tissues and recommend that rodent tissues intended for metabolomics studies be collected under anesthesia rather than post-euthanasia.	[Overmyer, Katherine A.; Thonusin, Chanisa] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Qi, Nathan R.; Burant, Charles F.; Evans, Charles R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Evans, CR (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	chevans@umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Evans, Charles/0000-0001-6698-5330	National Institute of Diabetes and Digestive and Kidney Diseases [K25 DK092558, R01 DK077200]; Michigan Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [DK020572]; Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund) [U24 DK097153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, P30DK020572, U24DK097153, P30DK089503, K25DK092558, R01DK077200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (K25 DK092558 to C.R.E and R01 DK077200 to C.F.B.) and utilized core services provided by the Michigan Nutrition Obesity Research Center (P30 DK089503), the Michigan Diabetes Research and Training Center (DK020572) and the Michigan Regional Comprehensive Metabolomics Research Core (NIH Common Fund U24 DK097153) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez B, 2010, TRAC-TREND ANAL CHEM, V29, P111, DOI 10.1016/j.trac.2009.12.003; Arnold M, 2010, PHYSIOL BEHAV, V99, P592, DOI 10.1016/j.physbeh.2010.01.021; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEBUYCK JF, 1973, BRIT J ANAESTH, V45, P263, DOI 10.1093/bja/45.3.263; Brooks SPJ, 1999, CONTEMP TOP LAB ANIM, V38, P19; Brown MV, 2012, GENOME MED, V4, DOI 10.1186/gm332; Bruce SJ, 2009, ANAL CHEM, V81, P3285, DOI 10.1021/ac8024569; BRUNNER EA, 1975, ANNU REV MED, V26, P391, DOI 10.1146/annurev.me.26.020175.002135; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CASCARANO J, 1976, J EXP ZOOL, V198, P149, DOI 10.1002/jez.1401980204; Cheema AK, 2014, J PROTEOME RES, V13, P3065, DOI 10.1021/pr500278t; Christians U, 2011, CURR PHARM BIOTECHNO, V12, P1053, DOI 10.2174/138920111795909078; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; El Rammouz R, 2010, ANAL BIOCHEM, V398, P169, DOI 10.1016/j.ab.2009.12.006; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; HOBERMAN HD, 1967, BIOCHIM BIOPHYS ACTA, V148, P392, DOI 10.1016/0304-4165(67)90135-3; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; KRAL JG, 1974, HORM METAB RES, V6, P483, DOI 10.1055/s-0028-1093808; La Monaca E, 2012, CURR DRUG SAF, V7, P126, DOI 10.2174/157488612802715681; Lutz NW, 2013, METHODOLOGIES METABO, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Ly-Verdu S, 2013, BIOMEDICAL CHROMATOG; Ly-Verdu S, 2014, BIOMED CHROMATOGR, V28, P231, DOI 10.1002/bmc.3010; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MUSCH TI, 1989, J APPL PHYSIOL, V66, P2895, DOI 10.1152/jappl.1989.66.6.2895; Pekkinen J, 2013, MOL NUTR FOOD RES, V57, P1959, DOI 10.1002/mnfr.201300142; PENICAUD L, 1987, AM J PHYSIOL, V252, pE365, DOI 10.1152/ajpendo.1987.252.3.E365; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pomplun D, 2004, HORM METAB RES, V36, P67, DOI 10.1055/s-2004-814104; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sheedy JR, 2013, METHODS MOL BIOL, V1055, P81, DOI 10.1007/978-1-62703-577-4_7; Song H, 2011, ONCOL REP, V26, P431, DOI 10.3892/or.2011.1302; Stewart S, 2014, CHEM SOC REV, V43, P70, DOI 10.1039/c3cs60183h; Takahashi K, 1998, BRIT J ANAESTH, V80, P782, DOI 10.1093/bja/80.6.782; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	51	70	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117232	10.1371/journal.pone.0117232	http://dx.doi.org/10.1371/journal.pone.0117232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658945	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900121
J	Reichel, CA; Hessenauer, MET; Pflieger, K; Rehberg, M; Kanse, SM; Zahler, S; Krombach, F; Berghaus, A; Strieth, S				Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Pflieger, Kerstin; Rehberg, Markus; Kanse, Sandip M.; Zahler, Stefan; Krombach, Fritz; Berghaus, Alexander; Strieth, Sebastian			Components of the Plasminogen Activation System Promote Engraftment of Porous Polyethylene Biomaterial via Common and Distinct Effects	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSES; INHIBITOR-1 PROMOTES; UROKINASE RECEPTOR; TURKISH DELIGHT; HOST TISSUE; IMPLANTS; ANGIOGENESIS; RECONSTRUCTION	Rapid fibrovascularization is a prerequisite for successful biomaterial engraftment. In addition to their well-known roles in fibrinolysis, urokinase-type plasminogen activator (uPA) and tissue plasminogen activator (tPA) or their inhibitor plasminogen activator inhibitor-1 (PAI-1) have recently been implicated as individual mediators in non-fibrinolytic processes, including cell adhesion, migration, and proliferation. Since these events are critical for fibrovascularization of biomaterial, we hypothesized that the components of the plasminogen activation system contribute to biomaterial engraftment. Employing in vivo and ex vivo microscopy techniques, vessel and collagen network formation within porous polyethylene (PPE) implants engrafted into dorsal skinfold chambers were found to be significantly impaired in uPA-, tPA-, or PAI-1-deficient mice. Consequently, the force required for mechanical disintegration of the implants out of the host tissue was significantly lower in the mutant mice than in wild-type controls. Conversely, surface coating with recombinant uPA, tPA, non-catalytic uPA, or PAI-1, but not with non-catalytic tPA, accelerated implant vascularization in wild-type mice. Thus, uPA, tPA, and PAI-1 contribute to the fibrovascularization of PPE implants through common and distinct effects. As clinical perspective, surface coating with recombinant uPA, tPA, or PAI-1 might provide a novel strategy for accelerating the vascularization of this biomaterial.	[Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Berghaus, Alexander] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Strieth, Sebastian] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-55122 Mainz, Germany	University of Munich; University of Munich; University of Munich; University of Oslo; Johannes Gutenberg University of Mainz	Reichel, CA (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	christoph.reichel@med.uni-muenchen.de		Zahler, Stefan/0000-0002-5140-7287; Rehberg, Markus/0000-0001-7314-6332; Kanse, Sandip/0000-0003-0782-9957	Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen	Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen	This study was supported by Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen (to CAR and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644; BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154; Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243; Brodsky S, 2001, AM J PHYSIOL-HEART C, V281, pH1784, DOI 10.1152/ajpheart.2001.281.4.H1784; Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002; Deindl E, 2003, FASEB J, V17, P1174, DOI 10.1096/fj.02-0800fje; Del Rosso M, 2011, CURR PHARM DESIGN, V17, P1924; DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379; Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.tea.2011.0340, 10.1089/ten.TEA.2011.0340]; Erol OO, 2000, PLAST RECONSTR SURG, V105, P2229, DOI 10.1097/00006534-200005000-00051; Gosau M, 2006, ORAL MAXILLOFAC SURG, V10, P178, DOI 10.1007/s10006-006-0688-y; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; Isogai C, 2001, CANCER RES, V61, P5587; Kim Nam Ju, 2006, Korean J Ophthalmol, V20, P143; Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104; Laschke MW, 2012, EUR CELLS MATER, V24, P266, DOI 10.22203/eCM.v024a19; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lau CL, 2009, J THORAC CARDIOV SUR, V137, P1241, DOI 10.1016/j.jtcvs.2008.12.029; LEHR HA, 1993, AM J PATHOL, V143, P1055; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004; Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025; Nicaeus TE, 1996, OPHTHALMIC PLAST REC, V12, P235, DOI 10.1097/00002341-199612000-00004; Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4; Park Won Chan, 2005, Korean J Ophthalmol, V19, P1; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Potter JK, 2012, ORAL MAXIL SURG CLIN, V24, P609, DOI 10.1016/j.coms.2012.07.002; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Reichel CA, 2012, TRENDS CARDIOVAS MED, V22, P192, DOI 10.1016/j.tcm.2012.07.019; Reichel CA, 2011, CIRCULATION, V124, P1849, DOI 10.1161/CIRCULATIONAHA.110.017012; Richardson S, 2011, INT J ORAL MAX SURG, V40, P979, DOI 10.1016/j.ijom.2011.03.013; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Schumann P, 2013, J BIOMED MAT RES A; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Soparkar CNS, 2000, OPHTHALMIC PLAST REC, V16, P337, DOI 10.1097/00002341-200009000-00006; Stefansson Steingrimur, 2003, Sci STKE, V2003, ppe24, DOI 10.1126/stke.2003.189.pe24; Stelter K, 2007, RHINOLOGY, V45, P325; Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Thakker MM, 2004, OPHTHAL PLAST RECONS, V20, P368, DOI 10.1097/01.IOP.0000134247.29702.90; Uhl B, 2014, ARTERIOSCL THROM VAS, V34, P1495, DOI 10.1161/ATVBAHA.114.303721; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A; Yip HK, 2013, INT J CARDIOL, V168, P226, DOI 10.1016/j.ijcard.2012.09.090; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116883	10.1371/journal.pone.0116883	http://dx.doi.org/10.1371/journal.pone.0116883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658820	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900075
J	Seven, E; Husemoen, LLN; Ibsen, H; Friedrich, N; Nauck, M; Wachtell, K; Linneberg, A; Jeppesen, JL				Seven, Ekim; Husemoen, Lise L. N.; Ibsen, Hans; Friedrich, Nele; Nauck, Matthias; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.			Higher Serum Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide Associate with Prevalent Hypertension whereas Lower Associate with Incident Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE TRACKING; ANGIOTENSIN-II; RISK-FACTORS; BRAIN; ENDOCRINE; IMPACT; BIOMARKERS; OBESITY; SYSTEM; AGE	Background The role of the natriuretic peptides (NPs) in hypertension is complex. Thus, a higher blood NP concentration is a robust marker of pressure-induced cardiac damage in patients with hypertension, whereas genetically elevated NP concentrations are associated with a reduced risk of hypertension and overweight individuals presumably at high risk of hypertension have lower NP concentrations. Objective To investigate the associations between serum N-terminal pro-B-type natriuretic peptide (NT-proBNP), used as a surrogate marker for active BNP, and prevalent as well as 5-year incident hypertension in a Danish general population sample. Methods Cross-sectional and prospective population-based study. Results At baseline, among 5,307 participants (51.3% women, mean age 46.0 +/- 7.9 years) with a complete set of data, we recorded 1,979 cases with prevalent hypertension (PHT). Among 2,389 normotensive participants at baseline with a complete set of data, we recorded 324 cases with incident hypertension (IHT) on follow-up 5 years later. In models adjusted for age, sex, lifestyle, social, dietary, anthropometric, pulmonic, lipid, metabolic and renal risk factors, as well as heart rate and baseline blood pressure (only incident model), one standard deviation increase in baseline log-transformed NT-proBNP concentrations was on one side associated with a 21% higher risk of PHT (odds ratio [OR]: 1.21 [95% confidence interval (CI): 1.13-1.30], P<0.001), and on the other side with a 14% lower risk of IHT (OR: 0.86 [95% CI: 0.76-0.98], P = 0.020). Conclusions Higher serum concentrations of NT-proBNP associate with PHT whereas lower concentrations associate with IHT. This suggests that a lower amount of circulating BNP, resulting in diminished vasodilation and natriuresis, could be involved in the pathogenesis of hypertension in its early stages.	[Seven, Ekim; Wachtell, Kristian; Jeppesen, Jorgen L.] Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark; [Seven, Ekim; Husemoen, Lise L. N.; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ibsen, Hans] Univ Copenhagen, Holbaek Hosp, Dept Internal Med, Holbaek, Denmark; [Ibsen, Hans; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Friedrich, Nele; Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Linneberg, Allan] Glostrup Cty Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen; Holbaek Hospital; University of Copenhagen; University of Copenhagen; Greifswald Medical School; University of Copenhagen	Seven, E (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark.	ekim.seven@regionh.dk		Linneberg, Allan/0000-0002-0994-0184	Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen foundation; Interreg IVa program; European Union Region Development fund	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen foundation; Interreg IVa program; European Union Region Development fund	The Inter99 study was supported by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, The Novo Nordisk Foundation, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation and The Ib Henriksen foundation. ES and KW have been supported by Interreg IVa program, The European Union Region Development fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Asferg C, 2010, AM J HYPERTENS, V23, P327, DOI 10.1038/ajh.2009.244; Asferg CL, 2013, HYPERTENSION, V62, P147, DOI 10.1161/HYPERTENSIONAHA.111.00791; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; BUCKLEY MG, 1994, J HYPERTENS, V12, P809; CARGILL RI, 1994, BRIT J CLIN PHARMACO, V38, P139, DOI 10.1111/j.1365-2125.1994.tb04337.x; Clerico A, 2006, AM J PHYSIOL-HEART C, V290, pH17, DOI 10.1152/ajpheart.00684.2005; Cui JS, 2002, HYPERTENSION, V40, P7, DOI 10.1161/01.HYP.0000022693.11752.E9; Fox ER, 2013, HYPERTENSION, V61, P48, DOI 10.1161/HYPERTENSIONAHA.112.197657; Fox ER, 2011, CIRCULATION, V124, P1021, DOI 10.1161/CIRCULATIONAHA.110.991943; Freitag MH, 2003, HYPERTENSION, V41, P978, DOI 10.1161/01.HYP.0000061116.20490.8D; GANAU A, 1989, J AM COLL CARDIOL, V14, P715, DOI 10.1016/0735-1097(89)90116-2; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Hildebrandt P, 2010, EUR HEART J, V31, P1881, DOI 10.1093/eurheartj/ehq163; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; Jeppesen JL, 2012, AM J HYPERTENS, V25, P1095, DOI 10.1038/ajh.2012.96; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181; LANG CC, 1993, J HYPERTENS, V11, P737, DOI 10.1097/00004872-199307000-00009; LAVILLA G, 1994, J CLIN ENDOCR METAB, V78, P1166, DOI 10.1210/jc.78.5.1166; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luchner A, 2010, CLIN CHEM LAB MED, V48, P121, DOI 10.1515/CCLM.2010.011; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nadir MA, 2012, J AM COLL CARDIOL, V60, P960, DOI 10.1016/j.jacc.2012.04.049; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RICHARDS AM, 1993, J HYPERTENS, V11, P163, DOI 10.1097/00004872-199302000-00008; Sanchez OA, 2014, METABOLISM, V63, P475, DOI 10.1016/j.metabol.2013.11.017; Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207; Skaaby T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090654; Takase H, 2008, HYPERTENS RES, V31, P1737, DOI 10.1291/hypres.31.1737; Toft U, 2008, EUR J CLIN NUTR, V62, P1038, DOI 10.1038/sj.ejcn.1602815; Toft UN, 2007, EUR J PUBLIC HEALTH, V17, P455, DOI 10.1093/eurpub/ckl262; van Gestel YRBM, 2009, J AM COLL CARDIOL, V53, P458, DOI 10.1016/j.jacc.2008.09.047; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117864	10.1371/journal.pone.0117864	http://dx.doi.org/10.1371/journal.pone.0117864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658326	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900233
J	Xia, W; Shi, PJ; Xu, XX; Qian, LC; Cui, Y; Xia, MJ; Yao, B				Xia, Wei; Shi, Pengjun; Xu, Xinxin; Qian, Lichun; Cui, Ying; Xia, Mengjuan; Yao, Bin			High Level Expression of a Novel Family 3 Neutral beta-Xylosidase from Humicola insolens Y1 with High Tolerance to D-Xylose	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PAECILOMYCES-THERMOPHILA; XYLANOLYTIC ENZYMES; SEQUENCE-ANALYSIS; PURIFICATION; XYLAN; GENE; DEGRADATION	A novel beta-xylosidase gene of glycosyl hydrolase (GH) family 3, xyl3A, was identified from the thermophilic fungus Humicola insolens Y1, which is an innocuous and non-toxic fungus that produces a wide variety of GHs. The cDNA of xyl3A, 2334 bp in length, encodes a 777-residue polypeptide containing a putative signal peptide of 19 residues. The gene fragment without the signal peptide-coding sequence was cloned and overexpressed in Pichia pastoris GS115 at a high level of 100 mg/L in 1-L Erlenmeyer flasks without fermentation optimization. Recombinant Xyl3A showed both beta-xylosidase and alpha-arabinfuranosidase activities, but had no hydrolysis capacity towards polysaccharides. It was optimally active at pH 6.0 and 60 degrees C with a specific activity of 11.6 U/mg. It exhibited good stability over pH 4.0-9.0 (incubated at 37 degrees C for 1 h) and at temperatures of 60 degrees C and below, retaining over 80% maximum activity. The enzyme had stronger tolerance to xylose than most fungal GH3 beta-xylosidases with a high K-I value of 29 mM, which makes Xyl3A more efficient to produce xylose in fermentation process. Sequential combination of Xyl3A following endoxylanase Xyn11A of the samemicrobial source showed significant synergistic effects on the degradation of various xylans and deconstructed xylo-oligosaccharides to xylose with high efficiency. Moreover, using pNPX as both the donor and acceptor, Xyl3A exhibited a transxylosylation activity to synthesize pNPX(2). All these favorable properties suggest that Xyl3A has good potential applications in the bioconversion of hemicelluloses to biofuels.	[Xia, Wei; Qian, Lichun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xia, Wei; Shi, Pengjun; Cui, Ying; Xia, Mengjuan; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Xu, Xinxin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Qian, LC (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	lcqian@zju.edu.cn; binyao@caas.cn			National High-Tech Research and Development Program of China (863 Program) [2012AA022105]; National Science Foundation for Distinguished Young Scholars of China [31225026]; 948 program of the Ministry of Agriculture [2014-S1]; China Modern Agriculture Research System [CARS-42]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 948 program of the Ministry of Agriculture; China Modern Agriculture Research System	This work was supported by the National High-Tech Research and Development Program of China (863 Program, 2012AA022105) and the National Science Foundation for Distinguished Young Scholars of China (31225026) and the 948 program of the Ministry of Agriculture (2014-S1) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XY, 2012, J IND MICROBIOL BIOT, V39, P869, DOI 10.1007/s10295-012-1087-z; DEALMEIDA EM, 1995, FEMS MICROBIOL LETT, V130, P171, DOI 10.1111/j.1574-6968.1995.tb07715.x; Dilokpimol A, 2011, CARBOHYD RES, V346, P421, DOI 10.1016/j.carres.2010.12.010; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Eneyskaya EV, 2003, CARBOHYD RES, V338, P313, DOI 10.1016/S0008-6215(02)00467-6; Guerfali M, 2008, APPL BIOCHEM BIOTECH, V150, P267, DOI 10.1007/s12010-008-8260-x; HEBRAUD M, 1990, FEMS MICROBIOL LETT, V72, P11, DOI 10.1111/j.1574-6968.1990.tb03853.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Ito T, 2003, J BIOSCI BIOENG, V96, P354, DOI 10.1016/S1389-1723(03)90136-8; Jordan DB, 2010, APPL MICROBIOL BIOT, V86, P1647, DOI 10.1007/s00253-010-2538-y; Kitamoto N, 1999, APPL ENVIRON MICROB, V65, P20; Knob A, 2010, WORLD J MICROB BIOT, V26, P389, DOI 10.1007/s11274-009-0190-4; Kumar S, 1996, FEMS MICROBIOL LETT, V135, P287, DOI 10.1016/0378-1097(95)00468-8; Kurakake M, 1997, BIOSCI BIOTECH BIOCH, V61, P2010, DOI 10.1271/bbb.61.2010; Li YK, 2000, BIOTECHNOL APPL BIOC, V31, P119, DOI 10.1042/BA19990072; Li Z, 2013, BIORESOURCE TECHNOL, V149, P413, DOI 10.1016/j.biortech.2013.09.101; Mozolowski GA, 2009, ENZYME MICROB TECH, V45, P436, DOI 10.1016/j.enzmictec.2009.08.011; Ohta K, 2010, J BIOSCI BIOENG, V110, P152, DOI 10.1016/j.jbiosc.2010.02.008; Puchart V, 2007, J BIOTECHNOL, V128, P576, DOI 10.1016/j.jbiotec.2006.12.011; Puls J, 1993, CHEM HEMICELLULOSES, P1; Rahman AKMS, 2003, CAN J MICROBIOL, V49, P58, DOI 10.1139/W02-114; Raweesri P, 2008, BIORESOURCE TECHNOL, V99, P8981, DOI 10.1016/j.biortech.2008.05.016; Reen FJ, 2003, BIOCHEM BIOPH RES CO, V305, P579, DOI 10.1016/S0006-291X(03)00829-5; Rizzatti ACS, 2001, J IND MICROBIOL BIOT, V26, P156, DOI 10.1038/sj.jim.7000107; Saha BC, 2003, BIORESOURCE TECHNOL, V90, P33, DOI 10.1016/S0960-8524(03)00098-1; Saha BC, 2001, J IND MICROBIOL BIOT, V27, P241, DOI 10.1038/sj.jim.7000184; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-27; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Teng C, 2011, BIORESOURCE TECHNOL, V102, P1822, DOI 10.1016/j.biortech.2010.09.055; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Wakiyama M, 2008, J BIOSCI BIOENG, V106, P398, DOI 10.1263/jbb.106.398; Wang LX, 2009, CURR OPIN CHEM BIOL, V13, P592, DOI 10.1016/j.cbpa.2009.08.014; Yan QJ, 2008, BIORESOURCE TECHNOL, V99, P5402, DOI 10.1016/j.biortech.2007.11.033; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062	35	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117578	10.1371/journal.pone.0117578	http://dx.doi.org/10.1371/journal.pone.0117578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658646	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900181
J	Xu, JH; Prosperi, JR; Choudhury, N; Olopade, OI; Goss, KH				Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Olopade, Olufunmilayo I.; Goss, Kathleen H.			beta-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							STEM-CELLS; COLON-CANCER; PATHWAY; MARKER; IDENTIFICATION; ACTIVATION; DISEASE; TARGET; ROLES	Our previous data illustrated that activation of the canonical Wnt signaling pathway was enriched in triple-negative breast cancer and associated with reduced overall survival in all patients. To determine whether Wnt signaling may be a promising therapeutic target for triple-negative breast cancer, we investigated whether beta-catenin was necessary for tumorigenic behaviors in vivo and in vitro. beta-catenin expression level was significantly reduced in two human triple-negative breast cancer cell lines, MDA-MB-231 and HCC38, using lentiviral delivery of beta-catenin-specific small hairpin RNAs (shRNAs). Upon implantation of the cells in the mammary fat pad of immunocompromised mice, we found that beta-catenin shRNA HCC38 cells formed markedly smaller tumors than control cells and grew much more slowly. In in vitro assays, beta-catenin silencing significantly reduced the percentage of Aldefluor-positive cells, a read-out of the stem-like cell population, as well as the expression of stem cell-related target genes including Bmi-1 and c-Myc. beta-catenin-knockdown cells were also significantly impaired in their ability to migrate in wound-filling assays and formanchorage-independent colonies in soft agar. beta-catenin-knockdown cells were more sensitive to chemotherapeutic agents doxorubicin and cisplatin. Collectively, these data suggest that beta-catenin is required for triple-negative breast cancer development by controlling numerous tumor-associated properties, such as migration, stemness, anchorage-independent growth and chemosensitivity.	[Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Goss, Kathleen H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Xu, Jinhua; Prosperi, Jenifer R.; Choudhury, Noura; Goss, Kathleen H.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Xu, Jinhua; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Xu, Jinhua] Jianghan Univ, Sch Med, Wuhan 430056, Hubei, Peoples R China; [Prosperi, Jenifer R.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46530 USA	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; Jianghan University; Indiana University System; Indiana University South Bend	Xu, JH (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	xu5520@gmail.com		Goss, Kathleen/0000-0002-7379-5639; Prosperi, Jenifer/0000-0001-8439-4411	National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago [P50 CA125183-05]; American Cancer Society Illinois Division; Breast Cancer Research Foundation [634366]; Jianghan Univesity [101006850001]; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago; American Cancer Society Illinois Division(American Cancer Society); Breast Cancer Research Foundation; Jianghan Univesity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute Cancer Center Breast Cancer SPORE at University of Chicago (OO, P50 CA125183-05), a grant from the American Cancer Society Illinois Division (KG), and The Breast Cancer Research Foundation (OO, 634366). Start up funding was received from Jianghan Univesity (JX, 101006850001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bakker ERM, 2013, ONCOGENE, V32, P4579, DOI 10.1038/onc.2012.449; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Elsawaf Z, 2011, BREAST CARE, V6, P273, DOI 10.1159/000331643; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guarneri V, 2013, DRUGS, V73, P1257, DOI 10.1007/s40265-013-0091-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Joensuu H, 2012, ANN ONCOL, V23, P40, DOI 10.1093/annonc/mds194; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Liedtke C, 2013, BREAST CARE, V8, P408, DOI 10.1159/000357534; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Odenwald MA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-12; Prosperi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029339; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; von Minckwitz G, 2012, ANN ONCOL, V23, P35, DOI 10.1093/annonc/mds193; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Xu JH, 2010, BREAST CANCER RES TR, V120, P593, DOI 10.1007/s10549-009-0422-1; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	36	116	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117097	10.1371/journal.pone.0117097	http://dx.doi.org/10.1371/journal.pone.0117097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658419	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900099
J	Xu, L; Qu, YH; Chu, XD; Wang, RW; Nelson, HH; Gao, YT; Yuan, JM				Xu, Ling; Qu, Yong-Hua; Chu, Xin-Di; Wang, Renwei; Nelson, Heather H.; Gao, Yu-Tang; Yuan, Jian-Min			Urinary Levels of N-Nitroso Compounds in Relation to Risk of Gastric Cancer: Findings from the Shanghai Cohort Study	PLOS ONE			English	Article							ENDOGENOUS FORMATION; FOLLOW-UP; NITRITE; NITRATE; ACID; ESOPHAGEAL; EXPOSURE; NITROSAMINES; MODULATION; MECHANISMS	Background N-Nitroso compounds are thought to play a significant role in the development of gastric cancer. Epidemiological data, however, are sparse in examining the associations between biomarkers of exposure to N-nitroso compounds and the risk of gastric cancer. Methods A nested case-control study within a prospective cohort of 18,244 middle-aged and older men in Shanghai, China, was conducted to examine the association between urinary level of N-nitroso compounds and risk of gastric cancer. Information on demographics, usual dietary intake, and use of alcohol and tobacco was collected through in-person interviews at enrollment. Urinary levels of nitrate, nitrite, N-nitroso-2-methylthiazolidine-4-carboxylic acid (NMTCA), N-nitrosoproline (NPRO), N-nitrososarcosine (NSAR), N-nitrosothiazolidine-4-carboxylic acid (NTCA), as well as serum H. pylori antibodies were quantified in 191 gastric cancer cases and 569 individually matched controls. Logistic regression method was used to assess the association between urinary levels of N-nitroso compounds and risk of gastric cancer. Results Compared with controls, gastric cancer patients had overall comparable levels of urinary nitrate, nitrite, and N-nitroso compounds. Among individuals seronegative for antibodies to H. pylori, elevated levels of urinary nitrate were associated with increased risk of gastric cancer. The multivariate-adjusted odds ratios for the second and third tertiles of nitrate were 3.27 (95% confidence interval = 0.76-14.04) and 4.82 (95% confidence interval = 1.05-22.17), respectively, compared with the lowest tertile (P for trend = 0.042). There was no statistically significant association between urinary levels of nitrite or N-nitroso compounds and risk of gastric cancer. Urinary NMTCA level was significantly associated with consumption of alcohol and preserved meat and fish food items. Conclusion The present study demonstrates that exposure to nitrate, a precursor of N-nitroso compounds, may increase the risk of gastric cancer among individuals without a history of H. pylori infection.	[Xu, Ling; Nelson, Heather H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Xu, Ling; Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Xu, Ling] Florida Int Univ, Dept Nutr & Dietet, Robert R Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Qu, Yong-Hua; Chu, Xin-Di; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Qu, Yong-Hua; Chu, Xin-Di; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Inst Canc, Shanghai 200030, Peoples R China; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; Florida International University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yuan, JM (corresponding author), Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.	yuanj@upmc.edu	Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022	Yuan, Jian-Min/0000-0002-4620-3108; Nelson, Heather/0000-0003-1901-9513	National Cancer Institute of the National Institutes of Health [R01CA043092, R01CA129534, R01CA144034]; NATIONAL CANCER INSTITUTE [R01CA129534, UM1CA182876, R01CA144034, R01CA043092] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA043092, R01CA129534 and R01CA144034. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslow N E, 1980, IARC Sci Publ, P5; CALMELS S, 1987, CARCINOGENESIS, V8, P1085, DOI 10.1093/carcin/8.8.1085; CARBONI M, 1988, LANGENBECK ARCH CHIR, V373, P82, DOI 10.1007/BF01262769; Cross AJ, 2003, CANCER RES, V63, P2358; De Stefani E, 1998, NUTR CANCER, V30, P158, DOI 10.1080/01635589809514656; DEBERNARDINIS G, 1983, TUMORI, V69, P231, DOI 10.1177/030089168306900311; GONZALEZ CA, 1994, AM J EPIDEMIOL, V139, P466, DOI 10.1093/oxfordjournals.aje.a117029; Griesenbeck JS, 2009, NUTR METAB, V6, DOI 10.1186/1475-2891-8-16; Grosse Y, 2006, LANCET ONCOL, V7, P628, DOI 10.1016/S1470-2045(06)70789-6; He SL, 2005, CHINESE FOOD TECHNOL, V1, P94; Herod-Leszczynska T, 1992, Rocz Panstw Zakl Hig, V43, P253; HOTCHKISS JH, 1989, CANCER SURV, V8, P295; International Agenecy for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, V94, P43; Jakszyn P, 2006, CARCINOGENESIS, V27, P1497, DOI 10.1093/carcin/bgl019; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji FD, 2009, J FOOD PROCESS PRES, V33, P175, DOI 10.1111/j.1745-4549.2008.00291.x; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LaVecchia C, 1997, NUTR CANCER, V27, P65, DOI 10.1080/01635589709514503; Lijinsky W, 1990, CHEM CARCINOGENESIS, P179; Lunn JC, 2007, CARCINOGENESIS, V28, P685, DOI 10.1093/carcin/bgl192; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; OHSHIMA H, 1982, CARCINOGENESIS, V3, P115, DOI 10.1093/carcin/3.1.115; OHSHIMA H, 1981, CANCER RES, V41, P3658; OHSHIMA H, 1984, J CANCER RES CLIN, V108, P121, DOI 10.1007/BF00390983; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POBEL D, 1995, EUR J EPIDEMIOL, V11, P67, DOI 10.1007/BF01719947; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; SCHOENTAL R, 1962, BRIT J CANCER, V16, P92, DOI 10.1038/bjc.1962.9; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; SEN NP, 1978, J ASSOC OFF ANA CHEM, V61, P1389; Stewart BW, 2014, WORLD CANC REPORT 20, P16, DOI DOI 10.1136/oemed-2019-106012; Stuff JE, 2009, J FOOD COMPOS ANAL, V22, pS42, DOI 10.1016/j.jfca.2009.01.008; Sun CL, 2002, CARCINOGENESIS, V23, P1497, DOI 10.1093/carcin/23.9.1497; Suzuki H, 2003, GUT, V52, P1095, DOI 10.1136/gut.52.8.1095; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; TRICKER AR, 1991, MUTAT RES, V259, P277, DOI 10.1016/0165-1218(91)90123-4; vanMaanen JM, 1996, CANCER DETECT PREV, V20, P590; WAGNER DA, 1984, IARC SCI PUBL, P223; Yuan JM, 1999, CANCER EPIDEM BIOMAR, V8, P621; Yuan JM, 2004, CANCER EPIDEM BIOMAR, V13, P1772; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646	46	23	26	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117326	10.1371/journal.pone.0117326	http://dx.doi.org/10.1371/journal.pone.0117326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658333	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000349444900134
J	Elmes, MW; Kaczocha, M; Berger, WT; Leung, K; Ralph, BP; Wang, LQ; Sweeney, JM; Miyauchi, JT; Tsirka, SE; Ojima, I; Deutsch, DG				Elmes, Matthew W.; Kaczocha, Martin; Berger, William T.; Leung, KwanNok; Ralph, Brian P.; Wang, Liqun; Sweeney, Joseph M.; Miyauchi, Jeremy T.; Tsirka, Stella E.; Ojima, Iwao; Deutsch, Dale G.			Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Delta(9)-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; PLANT CANNABINOIDS; AMIDE HYDROLASE; CRYSTAL-STRUCTURE; NEUROPATHIC PAIN; CELLULAR UPTAKE; FREE-ENERGIES; DOUBLE-BLIND; ANANDAMIDE; RECEPTORS	Delta(9)-Tetrahydrocannabinol (THC) and cannabidiol (CBD) occur naturally in marijuana (Cannabis) and may be formulated, individually or in combination in pharmaceuticals such as Marinol or Sativex. Although it is known that these hydrophobic compounds can be transported in blood by albumin or lipoproteins, the intracellular carrier has not been identified. Recent reports suggest that CBD and THC elevate the levels of the endocannabinoid anandamide (AEA) when administered to humans, suggesting that phytocannabinoids target cellular proteins involved in endocannabinoid clearance. Fatty acid-binding proteins (FABPs) are intracellular proteins that mediate AEA transport to its catabolic enzyme fatty acid amide hydrolase (FAAH). By computational analysis and ligand displacement assays, we show that at least three human FABPs bind THC and CBD and demonstrate that THC and CBD inhibit the cellular uptake and catabolism of AEA by targeting FABPs. Furthermore, we show that in contrast to rodent FAAH, CBD does not inhibit the enzymatic actions of human FAAH, and thus FAAH inhibition cannot account for the observed increase in circulating AEA in humans following CBD consumption. Using computational molecular docking and site-directed mutagenesis we identify key residues within the active site of FAAH that confer the species-specific sensitivity to inhibition by CBD. Competition for FABPs may in part or wholly explain the increased circulating levels of endocannabinoids reported after consumption of cannabinoids. These data shed light on the mechanism of action of CBD in modulating the endocannabinoid tone in vivo and may explain, in part, its reported efficacy toward epilepsy and other neurological disorders.	[Elmes, Matthew W.; Kaczocha, Martin; Leung, KwanNok; Ralph, Brian P.; Wang, Liqun; Sweeney, Joseph M.; Deutsch, Dale G.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Biochem & Cell Biol, Stony Brook, NY 11795 USA; [Kaczocha, Martin] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Anesthesiol, Stony Brook, NY 11795 USA; [Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11795 USA; [Miyauchi, Jeremy T.; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11795 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Deutsch, DG (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Biochem & Cell Biol, Stony Brook, NY 11795 USA.	Dale.Deutsch@Stonybrook.edu	Tsirka, Stella/AAD-4018-2019	Ojima, Iwao/0000-0002-3628-1161; Kaczocha, Martin/0000-0002-2527-1398	National Institutes of Health [DA032232, DA035923, DA035949, DA016419, DA026593, GM007518, GM008444, NS042168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008468, T32GM007518, T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026593, R01DA035923, R01DA035949, R01DA016419, R21DA032232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA032232, DA035923, DA035949, DA016419, DA026593, GM007518, GM008444, and NS042168.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; ALOZIE SO, 1980, PHARMACOL BIOCHEM BE, V12, P217, DOI 10.1016/0091-3057(80)90359-7; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Balius TE, 2011, J COMPUT CHEM, V32, P2273, DOI 10.1002/jcc.21814; Balius TE, 2009, BIOCHEMISTRY-US, V48, P8435, DOI 10.1021/bi900729a; Basavarajappa BS, 2007, CURR NEUROPHARMACOL, V5, P81, DOI 10.2174/157015907780866910; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bergamaschi MM, 2013, ANAL BIOANAL CHEM, V405, P4679, DOI 10.1007/s00216-013-6837-x; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103479; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Case D. A., 2012, AMBER 12; CASE DA, 2004, AMBER8; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Garcia MD, 2009, EUR J PHARMACOL, V610, P75, DOI 10.1016/j.ejphar.2009.03.021; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Fanali G, 2011, IUBMB LIFE, V63, P446, DOI 10.1002/iub.466; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gomes FV, 2011, PSYCHOPHARMACOLOGY, V213, P465, DOI 10.1007/s00213-010-2036-z; Happyana N, 2013, PHYTOCHEMISTRY, V87, P51, DOI 10.1016/j.phytochem.2012.11.001; Hayakawa K, 2007, NEUROPHARMACOLOGY, V52, P1079, DOI 10.1016/j.neuropharm.2006.11.005; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Huang YL, 2012, BIOCHEMISTRY-US, V51, P2390, DOI 10.1021/bi2016553; Huestis MA, 2005, HANDB EXP PHARMACOL, V168, P657; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; HUNT CA, 1981, J PHARMACOKINET BIOP, V9, P245, DOI 10.1007/BF01059266; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McArdle K, 2001, TOXICOLOGY, V168, P133; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Meiri E, 2007, CURR MED RES OPIN, V23, P533, DOI 10.1185/030079907X167525; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Mileni M, 2009, J AM CHEM SOC, V131, P10497, DOI 10.1021/ja902694n; Min XS, 2011, P NATL ACAD SCI USA, V108, P7379, DOI 10.1073/pnas.1016167108; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Nadulski T, 2005, THER DRUG MONIT, V27, P799, DOI 10.1097/01.ftd.0000177223.19294.5c; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanson B, 2014, ACTA CRYSTALLOGR D, V70, P290, DOI 10.1107/S1399004713026795; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Walter C, 2013, J CLIN PSYCHOPHARM, V33, P699, DOI 10.1097/JCP.0b013e3182984015; Yu SL, 2014, J BIOL CHEM, V289, P12748, DOI 10.1074/jbc.M114.559062; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x	73	159	163	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8711	8721		10.1074/jbc.M114.618447	http://dx.doi.org/10.1074/jbc.M114.618447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666611	Green Published, hybrid			2022-12-26	WOS:000352207100003
J	Patra, A; Zhang, QQ; Lei, L; Su, Y; Egli, M; Guengerich, FP				Patra, Amritaj; Zhang, Qianqian; Lei, Li; Su, Yan; Egli, Martin; Guengerich, F. Peter			Structural and Kinetic Analysis of Nucleoside Triphosphate Incorporation Opposite an Abasic Site by Human Translesion DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-RULE; DEOXYRIBONUCLEIC-ACID; APYRIMIDINIC SITES; CRYSTAL-STRUCTURES; LESION BYPASS; REPLICATION; MECHANISM; SPECIFICITY; MUTAGENESIS; SNAPSHOTS	The most common lesion in DNA is an abasic site resulting from glycolytic cleavage of a base. In a number of cellular studies, abasic sites preferentially code for dATP insertion (the "A rule"). In some cases frameshifts are also common. X-ray structures with abasic sites in oligonucleotides have been reported for several microbial and human DNA polymerases (pols), e.g. Dpo4, RB69, KlenTaq, yeast pol iota, human (h) pol iota, and human pol beta. Wereported previously that hpol eta is a major pol involved in abasic site bypass (Choi, J.-Y., Lim, S., Kim, E. J., Jo, A., and Guengerich, F.P. (2010 J. Mol. Biol. 404, 34-44). hpol eta inserted all four dNTPs in steady-state and pre-steady-state assays, preferentially inserting A and G. In LC-MS analysis of primer-template pairs, A and G were inserted but little C or T was inserted. Frameshifts were observed when an appropriate pyrimidine was positioned 5' to the abasic site in the template. In x-ray structures of hpol eta with a non-hydrolyzable analog of dATP or dGTP opposite an abasic site, H-bonding was observed between the phosphate 5' to the abasic site and water H-bonded to N1 and N6 of A and N1 and O6 of G nucleoside triphosphate analogs, offering an explanation for what appears to be a "purine rule." A structure was also obtained for an A inserted and bonded in the primer opposite the abasic site, but it did not pair with a 5' T in the template. We conclude that hpol eta, a major copying enzyme with abasic sites, follows a purine rule, which can also lead to frameshifts. The phenomenon can be explained with H-bonds.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu; f.guengerich@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to K. Trisler for assistance in the preparation of this manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BOITEUX S, 1982, BIOCHEMISTRY-US, V21, P6746, DOI 10.1021/bi00269a020; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JUCKER FM, 1995, RNA, V1, P219; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Nair DT, 2011, J MOL BIOL, V406, P18, DOI 10.1016/j.jmb.2010.12.016; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; O'Flaherty D. K., 2014, NUCL ACID CHEM, V59; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; SCHAAPER RM, 1982, MUTAT RES, V106, P1, DOI 10.1016/0027-5107(82)90186-5; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao B, 2004, NUCLEIC ACIDS RES, V32, P3984, DOI 10.1093/nar/gkh710	37	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8028	8038		10.1074/jbc.M115.637561	http://dx.doi.org/10.1074/jbc.M115.637561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666608	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000351662600002
J	Ao, HS; Xu, F; Wang, XQ; Tang, XR; Zheng, Z; Hu, SS				Ao, Hushan; Xu, Fei; Wang, Xianqiang; Tang, Xinran; Zheng, Zhe; Hu, Shengshou			Effects of Metabolic Syndrome with or without Obesity on Outcomes after Coronary Artery Bypass Graft. A Cohort and 5-Year Study	PLOS ONE			English	Article							LONG-TERM OUTCOMES; BODY-MASS INDEX; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEART-DISEASE; FOLLOW-UP; RISK; MORTALITY; SURGERY	Background Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular disease, however, it remains unclear about effects of MetS with or without obesity on perioperative and long-term morbidity and mortality after coronary artery bypass graft (CABG). Methods An observational cohort study was performed on 4,916 consecutive patients receiving isolated primary CABG in Fuwai hospital. Of all patients, 1238 patients met the inclusion criteria and were divided into three groups: control, MetS with obesity and MetS without obesity (n = 868, 76 and 294 respectively). The patient's 5-year survival and major adverse cerebral and cardiovascular events (MACCE) were studied. Results Among all three groups, there were no significant differences in in-hospital postoperative complications, epinephrine use, stroke, ICU stay, ventilation time, atrial fibrillation, renal failure, coma, myocardial infarction, repeated revascularization, and long-term stroke. The patients in MetS without obesity group were not associated with increased perioperative or long-term morbidities and mortality. In contrast, the patients in MetS with obesity group were associated with significant increased perioperative complications including MACCE (30.26% vs. 20.75%, 16.7%, p = 0.0074) and mortality (11.84% vs. 3.74%, 3.11%, p = 0.0007) respectively. Patients in MetS with obesity group was associated with significantly increased long-term of MACCE (adjusted OR: 2.040; 95%CI:1.196-3.481; P < 0.05) and 5-years of mortality (adjusted HR:4.659; 95%CI:1.966-11.042; P < 0.05). Conclusions Patients with metabolic syndrome and obesity are associated with significant increased perioperative and long-term complications and mortality, while metabolic syndrome without obesity do not worsen outcomes after CABG.	[Ao, Hushan] Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Translat Cardiovasc Med, Dept Anesthesiol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Ao, HS (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Translat Cardiovasc Med, Dept Anesthesiol, Beijing 100730, Peoples R China.	aohushan@sina.com		Xu, Fei/0000-0003-0569-661X				Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Ao HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095223; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304; Echahidi N, 2007, J AM COLL CARDIOL, V50, P843, DOI 10.1016/j.jacc.2007.04.075; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Habib RH, 2005, ANN THORAC SURG, V79, P1976, DOI 10.1016/j.athoracsur.2004.11.029; HERLITZ J, 1988, ACTA MED SCAND, V224, P31; Ivanovic B, 2014, THORAC CARDIOV SURG, V62, P561, DOI 10.1055/s-0034-1372349; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kajimoto K, 2009, J THORAC CARDIOV SUR, V137, P658, DOI 10.1016/j.jtcvs.2008.11.043; Kasai T, 2009, J HYPERTENS, V27, P1017, DOI 10.1097/HJH.0b013e32832961cf; Kasai T, 2008, HYPERTENS RES, V31, P235, DOI 10.1291/hypres.31.235; Krauss Ronald M., 1998, Circulation, V98, P1472; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; Nigam A, 2006, AM HEART J, V151, P514, DOI 10.1016/j.ahj.2005.03.050; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REED GL, 1988, NEW ENGL J MED, V319, P1246, DOI 10.1056/NEJM198811103191903; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1; Yatskar L, 2008, ATHEROSCLEROSIS, V198, P389, DOI 10.1016/j.atherosclerosis.2007.09.046; Zacharias A, 2005, CIRCULATION, V112, P3247, DOI 10.1161/CIRCULATIONAHA.105.553743; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	30	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117671	10.1371/journal.pone.0117671	http://dx.doi.org/10.1371/journal.pone.0117671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679397	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600078
J	Li, TC; Iwasaki, K; Katano, H; Kataoka, M; Nagata, N; Kobayashi, K; Mizutani, T; Takeda, N; Wakita, T; Suzuki, T				Li, Tian-Cheng; Iwasaki, Kenji; Katano, Harutaka; Kataoka, Michiyo; Nagata, Noriyo; Kobayashi, Kazumi; Mizutani, Tetsuya; Takeda, Naokazu; Wakita, Takaji; Suzuki, Tetsuro			Characterization of Self-Assembled Virus-Like Particles of Merkel Cell Polyomavirus	PLOS ONE			English	Article							CAPSID PROTEIN VP1; HEPATITIS-E-VIRUS; DNA; SIMIAN-VIRUS-40; RESOLUTION; CARCINOMA; ANTIBODIES; SYSTEM	In our recombinant baculovirus system, VP1 protein of merkel cell polyomavirus (MCPyV), which is implicated as a causative agent in Merkel cell carcinoma, was self-assembled into MCPyV-like particles (MCPyV-LP) with two different sizes in insect cells, followed by being released into the culture medium. DNA molecules of 1.5- to 5-kb, which were derived from host insect cells, were packaged in large, similar to 50-nm spherical particles but not in small, similar to 25-nm particles. Structure reconstruction using cryo-electron microscopy showed that large MCPyV-LPs are composed of 72 pentameric capsomeres arranged in a T = 7 icosahedral surface lattice and are 48 nm in diameter. The MCPyV-LPs did not share antigenic determinants with BK- and JC viruses (BKPyV and JCPyV). The VLP-based enzyme immunoassay was applied to investigate age-specific prevalence of MCPyV infection in the general Japanese population aged 1-70 years. While seroprevalence of MCPyV increased with age in children and young individuals, its seropositivity in each age group was lower compared with BKPyV and JCPyV.	[Li, Tian-Cheng; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Iwasaki, Kenji] Osaka Univ, Inst Prot Res, Osaka, Japan; [Katano, Harutaka; Kataoka, Michiyo; Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kobayashi, Kazumi] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi 4648601, Japan; [Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Tokyo, Japan; [Takeda, Naokazu] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Suzuki, Tetsuro] Hamamatsu Univ, Sch Med, Dept Infect Dis, Shizuoka, Japan	National Institute of Infectious Diseases (NIID); Osaka University; National Institute of Infectious Diseases (NIID); Nagoya University; Tokyo University of Agriculture & Technology; Osaka University; Hamamatsu University School of Medicine	Li, TC (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	litc@nih.go.jp; tesuzuki@hama-med.ac.jp	MIZUTANI, Tetsuya/G-1086-2013	MIZUTANI, Tetsuya/0000-0003-2570-0452; Katano, Harutaka/0000-0002-5332-4434	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labour, and Welfare of Japan (to TL and TS), and by the Platform for drug discovery, informatics and structural life science (to KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; Faust H, 2011, J INFECT DIS, V203, P1096, DOI 10.1093/infdis/jiq173; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Gillock ET, 1997, J VIROL, V71, P2857, DOI 10.1128/JVI.71.4.2857-2865.1997; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; Kanesashi SN, 2003, J GEN VIROL, V84, P1899, DOI 10.1099/vir.0.19067-0; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Li PP, 2001, J VIROL, V75, P7321, DOI 10.1128/JVI.75.16.7321-7329.2001; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2003, VIROLOGY, V311, P115, DOI 10.1016/S0042-6822(03)00141-7; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Matsuura Y, 2007, ARCH VIROL, V152, P1375, DOI 10.1007/s00705-007-0965-6; Mizutani T, 2007, EMERG INFECT DIS, V13, P322, DOI 10.3201/eid1302.061032; Neu U, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002738; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Nilsson J, 2005, J VIROL, V79, P5337, DOI 10.1128/JVI.79.9.5337-5345.2005; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Pawlita M, 1996, J VIROL, V70, P7517, DOI 10.1128/JVI.70.11.7517-7526.1996; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAYMENT I, 1982, NATURE, V295, P110, DOI 10.1038/295110a0; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schmidt U, 2000, J VIROL, V74, P1658, DOI 10.1128/JVI.74.4.1658-1662.2000; Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SOUSSI T, 1986, J VIROL, V59, P740, DOI 10.1128/JVI.59.3.740-742.1986; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Zhang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106430	38	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115646	10.1371/journal.pone.0115646	http://dx.doi.org/10.1371/journal.pone.0115646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671590	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300010
J	Liang, JY; Kang, DD; Wang, YG; Yu, Y; Fan, JL; Takashi, E				Liang, Jingyan; Kang, Dedong; Wang, Yingge; Yu, Ying; Fan, Jianglin; Takashi, En			Carbonate Ion-Enriched Hot Spring Water Promotes Skin Wound Healing in Nude Rats	PLOS ONE			English	Article							ARTERIAL-DISEASE; SPA THERAPY; CO2; METALLOPROTEINASES; ANGIOGENESIS; EXPRESSION; TIBERIAS; REPAIR; FOOT	Hot spring or hot spa bathing (Onsen) is a traditional therapy for the treatment of certain ailments. There is a common belief that hot spring bathing has therapeutic effects for wound healing, yet the underlying molecular mechanisms remain unclear. To examine this hypothesis, we investigated the effects of Nagano hot spring water (rich in carbonate ion, 42 degrees C) on the healing process of the skin using a nude rat skin wound model. We found that hot spring bathing led to an enhanced healing speed compared to both the unbathed and hot-water (42 degrees C) control groups. Histologically, the hot spring water group showed increased vessel density and reduced inflammatory cells in the granulation tissue of the wound area. Real-time RT-PCR analysis along with zymography revealed that the wound area of the hot spring water group exhibited a higher expression of matrix metalloproteinases-2 and -9 compared to the two other control groups. Furthermore, we found that the enhanced wound healing process induced by the carbonate ion-enriched hot spring water was mediated by thermal insulation and moisture maintenance. Our results provide the evidence that carbonate ion-enriched hot spring water is beneficial for the treatment of skin wounds.	[Liang, Jingyan; Wang, Yingge] Yangzhou Univ, Sch Med, Yangzhou 225009, Jiangsu, Peoples R China; [Liang, Jingyan; Wang, Yingge; Takashi, En] Nagano Coll Nursing, Komagane, Japan; [Kang, Dedong; Yu, Ying; Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan	Yangzhou University; University of Yamanashi	Fan, JL (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan.	jianglin@yamanashi.ac.jp; takashi@nagano-nurs.ac.jp		Fan, Jianglin/0000-0002-1737-6130; Liang, Jingyan/0000-0002-9674-0235	Ministry of Education, Culture, Sports and Technology, Japan	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports and Technology, Japan (JL, JF), http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, J DERMATOL SCI, V24, P112, DOI 10.1016/S0923-1811(00)00091-8; Andreassi L, 1996, CLIN DERMATOL, V14, P627, DOI 10.1016/S0738-081X(96)00095-8; Farina S, 2011, J DERMATOL TREAT, V22, P366, DOI 10.3109/09546634.2010.512950; Fioravanti A, 2011, RHEUMATOL INT, V31, P1, DOI 10.1007/s00296-010-1628-6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Hashimoto M, 2004, J APPL PHYSIOL, V96, P226, DOI 10.1152/japplphysiol.00812.2003; Hashkes PJ, 2002, SCAND J RHEUMATOL, V31, P172; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; ITO T, 1989, J INVEST DERMATOL, V93, P259, DOI 10.1111/1523-1747.ep12277584; Jiang HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4838; Kim DH, 2013, INT J PEDIATR OTORHI, V77, P117, DOI 10.1016/j.ijporl.2012.10.008; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Millikan LE, 2000, CLIN DERMATOL, V18, P125, DOI 10.1016/S0738-081X(99)00102-9; Oyama J, 2013, HEART VESSELS, V28, P173, DOI 10.1007/s00380-011-0220-7; SALO T, 1994, LAB INVEST, V70, P176; SAVIN E, 1995, ANGIOLOGY, V46, P785, DOI 10.1177/000331979504600904; Shirakura T, 1994, NYUYOKUKENKOUJUTSU, P14; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; TANIZAKI Y, 1986, ACTA MED OKAYAMA, V40, P55; TISHLER M, 1995, CLIN RHEUMATOL, V14, P21, DOI 10.1007/BF02208080; Toriyama I, 2002, INT ANGIOL, V21, P367; Yu Y, 2008, HISTOL HISTOPATHOL, V23, P1503, DOI 10.14670/HH-23.1503	26	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117106	10.1371/journal.pone.0117106	http://dx.doi.org/10.1371/journal.pone.0117106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671581	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300034
J	Murtagh, EM; Murphy, MH; Murphy, NM; Woods, C; Nevill, AM; Lane, A				Murtagh, Elaine M.; Murphy, Marie H.; Murphy, Niamh M.; Woods, Catherine; Nevill, Alan M.; Lane, Aoife			Prevalence and Correlates of Physical Inactivity in Community-Dwelling Older Adults in Ireland	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; PEOPLE; HEALTH; PARTICIPATION; INTERVENTIONS; PREDICTORS; WOMEN; MODEL; LIFE; IPAQ	The public health challenges associated with rapid population ageing are likely to be exacerbated by poor physical activity levels. The purpose of this study was to identify correlates of physical inactivity in a population-representative sample of older adults in Ireland. This paper reports a secondary analysis of data from 4892 adults aged 60+ from the Irish Longitudinal Study on Ageing (TILDA). TILDA includes an assessment of the mental and physical health, and social and financial circumstances of participants assessed in a home interview and self-completion questionnaire. Chi squared statistics and forced entry logistic regression were used to identify factors associated with physical inactivity. Females were over twice as likely to be inactive as their male counterparts (Odds Ratio 2.2). Increasing old age was associated with inactivity among males and females. Those who reported above secondary level education, no reported falls in the last year and no fear of falling were less likely to be physically inactive. While older adults who noted poor/fair self-reported health, that they did not look after grandchildren, did not own a car or did not attend a course were also more likely to be inactive than those who reported positively for these items. Gender displayed a strong but often contrasting influence on factors that affect physical activity among older adults. Among females, living alone or in a rural area, retirement, fair/poor emotional health and activity being limited by illness were all significantly associated with inactivity. While cohabiting, being employed and residing in an urban area were related to low levels of activity in males. Our findings identify specific groups of the older Irish population who may be at particular risk of physical inactivity and thereby the associated physiological and psychological hazards. These results can support the development of tailored interventions to promote healthy ageing.	[Murtagh, Elaine M.] Univ Limerick, Dept Arts Educ & Phys Educ, Mary Immaculate Coll, Limerick, Ireland; [Murphy, Marie H.] Univ Ulster, Sport & Exercise Sci Res Inst, Newtownabbey, Antrim, North Ireland; [Murphy, Niamh M.; Lane, Aoife] Waterford Inst Technol, Ctr Hlth Behav Res, Waterford, Ireland; [Woods, Catherine] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Nevill, Alan M.] Wolverhampton Univ, Fac Educ Hlth & Wellbeing, Walsall, W Midlands, England	University of Limerick; Mary Immaculate College - University Limerick; Ulster University; South East Technological University (SETU); Dublin City University; University of Wolverhampton	Murtagh, EM (corresponding author), Univ Limerick, Dept Arts Educ & Phys Educ, Mary Immaculate Coll, Limerick, Ireland.	elaine.murtagh@mic.ul.ie	Nevill, Alan/Q-1010-2019; Murtagh, Elaine M/AAF-4146-2022; Murtagh, Elaine M/AEO-8704-2022; Murtagh, Elaine M/AEU-2463-2022	Nevill, Alan/0000-0003-0506-3652; Murtagh, Elaine M/0000-0003-4232-1403; Murtagh, Elaine M/0000-0003-4232-1403; Murphy, Niamh/0000-0002-0176-2897; Woods, Catherine/0000-0002-0892-6591; Lane, Aoife/0000-0001-9991-554X	Centre for Ageing Research and Development in Ireland through a Data Mining grant	Centre for Ageing Research and Development in Ireland through a Data Mining grant	This project was funded by the Centre for Ageing Research and Development in Ireland through a Data Mining 2013 grant (www.cardi.ie) to EM, MHM, NMM, CW, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banister D., 2004, TRANSPORT POLICY, V11, P105, DOI [10.1016/S0967-070X(03)00052-0, DOI 10.1016/S0967-070X(03)00052-0]; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Benyamini Y, 2000, PSYCHOSOM MED, V62, P354, DOI 10.1097/00006842-200005000-00009; Bergman P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-367; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Burke KE, 2012, AGING MENT HEALTH, V16, P288, DOI 10.1080/13607863.2011.628976; Central Statistics Office, 2013, POP LAB FORC PROJ 20; Cerin E, 2010, J PHYS ACT HEALTH, V7, P451, DOI 10.1123/jpah.7.4.451; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crombie IK, 2004, AGE AGEING, V33, P287, DOI 10.1093/ageing/afh089; Department of Health, 2011, START ACT STAY ACT R; Department of Health and Children Health Service Executive, 2009, NAT GUID PHYS ACT IR; DiPietro L, 2007, PHYS ACTIVITY HLTH, P271; Donorfio LKM, 2009, J SAFETY RES, V40, P221, DOI 10.1016/j.jsr.2009.04.002; Eyler AA, 1998, HEALTH EDUC BEHAV, V25, P640, DOI 10.1177/109019819802500510; Finch H., 1997, PHYS ACTIVITY OUR AG; Fleury J, 2006, AM J COMMUN PSYCHOL, V37, P129, DOI 10.1007/s10464-005-9002-7; Gebel K, 2014, PREV MED, V60, P131, DOI 10.1016/j.ypmed.2013.12.030; Giuli C, 2012, ARCH GERONTOL GERIAT, V54, P50, DOI 10.1016/j.archger.2011.02.017; Hahs-Vaughn DL, 2005, J EXP EDUC, V73, P221, DOI 10.3200/JEXE.73.3.221-248; Haley C, 2010, J AGING PHYS ACTIV, V18, P375, DOI 10.1123/japa.18.4.375; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hansen BH, 2013, INTERNATIONAL JOURNA, P1, DOI [10.1007/s00038-012-0436-z, DOI 10.1007/S00038-012-0436-Z]; Heesch Kristiann C, 2010, Int J Behav Nutr Phys Act, V7, P35, DOI 10.1186/1479-5868-7-35; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; International Physical Activity Questionnaire, 2005, IPAQ SCOR PROT; Katzmarzyk P., 2007, PHYS ACTIVITY FITNES, P37; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Kohl HW, 2012, LANCET, DOI [10.1016/S2213-2600(12)70053-X, DOI 10.1016/S2213-2600(12)70053-X]; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Moschny A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-559; Murphy R, 2009, PHYS ACT HLTH PROM E, P3; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Noone J, 2010, RES AGING, V32, P715, DOI 10.1177/0164027510383531; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Plonczynski Donna J, 2003, Medsurg Nurs, V12, P213; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Sattelmair JR, 2009, CLIN GERIATR MED, V25, P677, DOI 10.1016/j.cger.2009.07.004; Savva GM, 2013, J AM GERIATR SOC, V61, pS291, DOI 10.1111/jgs.12196; Shaw BA, 2008, J AGING HEALTH, V20, P767, DOI 10.1177/0898264308321081; Stubbs B, 2014, ARCH GERONTOL GERIAT, V59, P195, DOI 10.1016/j.archger.2014.06.006; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; The Irish Longitudinal Study on Ageing, 2009, MAIN QUEST; Thurston M, 2004, HEALTH PROMOT INT, V19, P379, DOI 10.1093/heapro/dah311; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vagetti GC, 2013, ARCH GERONTOL GERIAT, V56, P492, DOI 10.1016/j.archger.2012.12.003; Walsh JME, 2001, J GEN INTERN MED, V16, P721, DOI 10.1111/j.1525-1497.2001.00506.x; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x	54	54	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118293	10.1371/journal.pone.0118293	http://dx.doi.org/10.1371/journal.pone.0118293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671621	Green Published, gold			2022-12-26	WOS:000349545300092
J	van Logtestijn, MDA; Dominguez-Huttinger, E; Stamatas, GN; Tanaka, RJ				van Logtestijn, Mark D. A.; Dominguez-Huettinger, Elisa; Stamatas, Georgios N.; Tanaka, Reiko J.			Resistance to Water Diffusion in the Stratum Corneum Is Depth-Dependent	PLOS ONE			English	Article							SKIN BARRIER FUNCTION; IN-VIVO; ANATOMIC SITE; TRANSPORT; ADULT; PROTEASES; OILS; AGE	The stratum corneum (SC) provides a permeability barrier that limits the inflow and outflow of water. The permeability barrier is continuously and dynamically formed, maintained, and degraded along the depth, from the bottom to the top, of the SC. Naturally, its functioning and structure also change dynamically in a depth-dependent manner. While transepidermal water loss is typically used to assess the function of the SC barrier, it fails to provide any information about the dynamic mechanisms that are responsible for the depth-dependent characteristics of the permeability barrier. This paper aims to quantitatively characterize the depth-dependency of the permeability barrier using in vivo non-invasive measurement data for understanding the underlying mechanisms for barrier formation, maintenance, and degradation. As a framework to combine existing experimental data, we propose a mathematical model of the SC, consisting of multiple compartments, to explicitly address and investigate the depth-dependency of the SC permeability barrier. Using this mathematical model, we derive a measure of the water permeability barrier, i.e. resistance to water diffusion in the SC, from the measurement data on transepidermal water loss and water concentration profiles measured non-invasively by Raman spectroscopy. The derived resistance profiles effectively characterize the depth-dependency of the permeability barrier, with three distinct regions corresponding to formation, maintenance, and degradation of the barrier. Quantitative characterization of the obtained resistance profiles allows us to compare and evaluate the permeability barrier of skin with different morphology and physiology ( infants vs adults, different skin sites, before and after application of oils) and elucidates differences in underlying mechanisms of processing barriers. The resistance profiles were further used to predict the spatial-temporal effects of skin treatments by in silico experiments, in terms of spatial-temporal dynamics of percutaneous water penetration.	[van Logtestijn, Mark D. A.; Dominguez-Huettinger, Elisa; Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Stamatas, Georgios N.] Johnson & Johnson Sante Beaute France, Issy Les Moulineaux, France	Imperial College London; Johnson & Johnson	Tanaka, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	r.tanaka@imperial.ac.uk		Tanaka, Reiko/0000-0002-0769-9382; Dominguez Huttinger, Elisa/0000-0002-9086-099X	Johnson & Johnson Consumer Companies; Mexican Council for Science and Technology (CONACyT); Engineering and Physical Sciences Research Council through Career Acceleration Fellowship [EP/G007446/1]; EPSRC [EP/G007446/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	Johnson & Johnson Consumer Companies; Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Engineering and Physical Sciences Research Council through Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported by a research grant from Johnson & Johnson Consumer Companies. EDH is supported by a PhD scholarship from the Mexican Council for Science and Technology (CONACyT; www.conacyt.mx). RJT received funding from Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) through Career Acceleration Fellowship (EP/G007446/1). The funder provided support in the form of salaries for one of the authors, GNS, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Please note that the authors did not collect any new data in this work, but carried out the meta-analysis of the data already presented in other papers (References 17, 18, and 19).	Anissimov YG, 2008, MATH MODELS DIFFEREN, P271; Anissimov YG, 2013, ADV DRUG DELIVER REV, V65, P169, DOI 10.1016/j.addr.2012.04.009; Bielfeldt S, 2009, IFSCC MAGAZINE, V12, P9; Bohling A, 2014, SKIN RES TECHNOL, V20, P50, DOI 10.1111/srt.12082; Boireau- Adamezyk E, 2014, SKIN RES TECHNOL, DOI [10.1111/srt.12198, DOI 10.1111/SRT.12198]; Bouwstra JA, 2003, J INVEST DERMATOL, V120, P750, DOI 10.1046/j.1523-1747.2003.12128.x; Caspers PJ, 2000, J RAMAN SPECTROSC, V31, P813, DOI 10.1002/1097-4555(200008/09)31:8/9<813::AID-JRS573>3.0.CO;2-7; Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Damien F, 2010, J INVEST DERMATOL, V130, P611, DOI 10.1038/jid.2009.272; Elias P, 2004, SKIN PHARMACOL PHYS, V14, P28; ELIAS PM, 1991, J CONTROL RELEASE, V15, P199, DOI 10.1016/0168-3659(91)90111-P; Elias PM, 2013, BIOCHIM BIOPHYS ACTA, P9, DOI [10.1016/ j. bbagrm. 2012.09.002, DOI 10.1016/J.BBAGRM.2012.09.002]; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Ishida-Yamamoto A, 2011, J DERMATOL, V38, P645, DOI 10.1111/j.1346-8138.2011.01227.x; Kalia YN, 1998, J INVEST DERMATOL, V111, P320, DOI 10.1046/j.1523-1747.1998.00289.x; Kalia YN, 1996, BIOPHYS J, V71, P2692, DOI 10.1016/S0006-3495(96)79460-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kikuchi K, 2006, PEDIATR DERMATOL, V23, P109, DOI 10.1111/j.1525-1470.2006.00191.x; Kubo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01731; Loden M, 2003, AM J CLIN DERMATOL, V4, P771; Lu N, 2014, INT J COSMETIC SCI, V36, P167, DOI 10.1111/ics.12112; Machado M., 2010, International Journal of Cosmetic Science, V32, P397, DOI 10.1111/j.1468-2494.2010.00587.x; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; McCarley KD, 2001, J PHARM SCI-US, V90, P1699, DOI 10.1002/jps.1120; Mohammed D, 2011, BRIT J DERMATOL, V164, P957, DOI 10.1111/j.1365-2133.2011.10211.x; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V126, P574, DOI 10.1016/j.jaci.2010.04.038; Patzelt A, 2012, SKIN RES TECHNOL, V18, P364, DOI 10.1111/j.1600-0846.2011.00578.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rawlings AV, 2013, CELL TISSUE RES, V351, P217, DOI 10.1007/s00441-012-1501-x; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Rogiers V, 2001, SKIN PHARMACOL APPL, V14, P117, DOI 10.1159/000056341; ROUGIER A, 1988, J SOC COSMET CHEM, V39, P15; SCHEUPLEIN RJ, 1971, PHYSIOL REV, V51, P702, DOI 10.1152/physrev.1971.51.4.702; Schwindt DA, 1998, J INVEST DERMATOL, V111, P385, DOI 10.1046/j.1523-1747.1998.00321.x; Stamatas GN, 2011, INT J COSMETIC SCI, V33, P17, DOI 10.1111/j.1468-2494.2010.00611.x; Stamatas GN, 2008, J DERMATOL SCI, V50, P135, DOI 10.1016/j.jdermsci.2007.11.006; Stamatas GN, 2010, PEDIATR DERMATOL, V27, P125, DOI 10.1111/j.1525-1470.2009.00973.x; Stamatas GN, 2006, BRIT J DERMATOL, V154, P125, DOI 10.1111/j.1365-2133.2005.06949.x; Tanaka RJ, 2013, J INVEST DERMATOL, V133, P1472, DOI 10.1038/jid.2013.69; Wurm EMT, 2012, BRIT J DERMATOL, V167, P270, DOI 10.1111/j.1365-2133.2012.10943.x; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; ZATZ JL, 1992, J SOC COSMET CHEM, V43, P37	44	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117292	10.1371/journal.pone.0117292	http://dx.doi.org/10.1371/journal.pone.0117292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671323	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300046
J	Wu, CH; Huang, TY; Chen, BS; Chiou, LL; Lee, HS				Wu, Cheng-Han; Huang, Ting-Yu; Chen, Bo-Sung; Chiou, Ling-Ling; Lee, Hsuan-Shu			Long-Duration Muscle Dedifferentiation during Limb Regeneration in Axolotls	PLOS ONE			English	Article							DIFFERENTIATED CELLS; PAX7; PLASTICITY; ORIGIN; TAIL; EXPRESSION; MYOGENESIS; MODEL	Although still debated, limb regeneration in salamanders is thought to depend on the dedifferentiation of remnant tissue occurring early after amputation and generating the progenitor cells that initiate regeneration. This dedifferentiation has been demonstrated previously by showing the fragmentation of muscle fibers into mononucleated cells and by revealing the contribution of mature muscle fibers to the regenerates by using lineage-tracing studies. Here, we provide additional evidence of dedifferentiation by showing that Pax7 (paired-box protein-7) transcripts are expressed at the ends of remnant muscle fibers in axolotls by using in situ hybridization and by demonstrating the presence of Pax7(+) muscle-fiber nuclei in the early bud and mid-bud stages by means of immunohistochemical staining. During the course of regeneration, the remnant muscles did not progress; instead, muscle progenitors migrated out from the remnants and proliferated and differentiated in the new tissues at an early stage of differentiation. The regenerating muscles and remnant muscles were largely disconnected, and this left a gap between them until extremely late in the late stage of differentiation, at which point the new and old muscles connected together. Notably, Pax7 transcripts were detected in the regions of muscles that faced these gaps; thus, Pax7 expression might indicate dedifferentiation in the remnant-muscle ends and partial differentiation in the regenerating muscles. The roles of this long-duration dedifferentiation in the remnants remain unknown. However, the results presented here could support the hypothesis that long-duration muscle dedifferentiation facilitates the connection and fusion between the new and old muscles that are both in an immature state; this is because immature Pax7(+) myoblasts readily fuse during developmental myogenesis.	[Wu, Cheng-Han; Huang, Ting-Yu; Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan; [Chen, Bo-Sung; Lee, Hsuan-Shu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Bo-Sung; Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Lee, HS (corresponding author), Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan.	benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434	Ministry of Science and Technology, Taiwan [MOST 102-2314-B-002 -127 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant to HSL from Ministry of Science and Technology (MOST 102-2314-B-002 -127 -MY3), Taiwan (http://www.most.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; CAMERON JA, 1986, NATURE, V321, P607, DOI 10.1038/321607a0; CARLSON BM, 1970, ANAT REC, V166, P423, DOI 10.1002/ar.1091660302; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Enwere EK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00034; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Horst D, 2006, INT J DEV BIOL, V50, P47, DOI 10.1387/ijdb.052111dh; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; LENTZ TL, 1969, AM J ANAT, V124, P447, DOI 10.1002/aja.1001240404; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Sambasivan R, 2007, SEMIN CELL DEV BIOL, V18, P870, DOI 10.1016/j.semcdb.2007.09.013; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Schnapp E, 2005, DEV DYNAM, V232, P162, DOI 10.1002/dvdy.20203; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Straube WL, 2004, CLONING STEM CELLS, V6, P333, DOI 10.1089/clo.2004.6.333; TASSAVA RA, 1975, DIFFERENTIATION, V4, P23, DOI 10.1111/j.1432-0436.1975.tb01439.x; Thornton CS, 1983, J MORPHOL, V62, P17; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	37	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116068	10.1371/journal.pone.0116068	http://dx.doi.org/10.1371/journal.pone.0116068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671422	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300015
J	Zhao, YQ; Wang, YJ; Gao, YD; Li, GH; Huang, JF				Zhao, Yuqi; Wang, Yanjie; Gao, Yuedong; Li, Gonghua; Huang, Jingfei			Integrated Analysis of Residue Coevolution and Protein Structures Capture Key Protein Sectors in HIV-1 Proteins	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; T-CELL RESPONSES; REVERSE-TRANSCRIPTASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; COUPLING ANALYSIS; PHAGE DISPLAY; DOMAIN; INHIBITORS; COMPLEX	HIV type 1 (HIV-1) is characterized by its rapid genetic evolution, leading to challenges in anti-HIV therapy. However, the sequence variations in HIV-1 proteins are not randomly distributed due to a combination of functional constraints and genetic drift. In this study, we examined patterns of sequence variability for evidence of linked sequence changes (termed as coevolution or covariation) in 15 HIV-1 proteins. It shows that the percentage of charged residues in the coevolving residues is significantly higher than that in all the HIV-1 proteins. Most of the coevolving residues are spatially proximal in the protein structures and tend to form relatively compact and independent units in the tertiary structures, termed as "protein sectors". These protein sectors are closely associated with anti-HIV drug resistance, T cell epitopes, and antibody binding sites. Finally, we explored candidate peptide inhibitors based on the protein sectors. Our results can establish an association between the coevolving residues and molecular functions of HIV-1 proteins, and then provide us with valuable knowledge of pathology of HIV-1 and therapeutics development.	[Zhao, Yuqi; Li, Gonghua; Huang, Jingfei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 650223, Yunnan, Peoples R China; [Zhao, Yuqi] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Wang, Yanjie] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Wang, Yanjie] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Gao, Yuedong] Chinese Acad Sci, Kunming Inst Zool, Kunming Biol Divers Reg Ctr Instruments, Kunming 650223, Peoples R China; [Huang, Jingfei] Collaborat Innovat Ctr Nat Prod & Biol Drugs Yunn, Kunming 650223, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhao, YQ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang Donglu Kunming, Beijing 650223, Yunnan, Peoples R China.	zhaoyq@mail.kiz.ac.cn; huangjf@mail.kiz.ac.cn	Zhao, Yuqi/L-5639-2016	Zhao, Yuqi/0000-0003-0730-5854; Zhao, Yuqi/0000-0002-4256-4512; Li, Gong-Hua/0000-0002-9311-6613	National Natural Science Foundation of China [31123005]; West Light Foundation of The Chinese Academy of Sciences [Y302401081, Y302401082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grant No. 31123005), and West Light Foundation of The Chinese Academy of Sciences (awarded to Yuqi Zhao; Grant Nos. Y302401081 and Y302401082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar AA, 2012, N AM J MED SCI, V4, P120, DOI 10.4103/1947-2714.93882; Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Brackenridge S, 2011, J VIROL, V85, P5415, DOI 10.1128/JVI.00238-11; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Castel G, 2011, MOLECULES, V16, P3499, DOI 10.3390/molecules16053499; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Desjobert C, 2004, BIOCHEMISTRY-US, V43, P13097, DOI 10.1021/bi049385e; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Echegoyen L, 2011, J PHYS ORG CHEM, V24, P743, DOI 10.1002/poc.1909; Esposito F, 2011, FEBS J, V278, P1444, DOI 10.1111/j.1742-4658.2011.08057.x; Forssmann WG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001697; Fossen T, 2005, J BIOL CHEM, V280, P42515, DOI 10.1074/jbc.M507375200; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Nyamweya S, 2013, REV MED VIROL, V23, P221, DOI 10.1002/rmv.1739; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Okazaki T, 2006, J IMMUNOL, V176, P3753, DOI 10.4049/jimmunol.176.6.3753; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Poveda E, 2006, ANTIRETROVIRAL RESIS; Qureshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054908; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; SWAIN AL, 1990, P NATL ACAD SCI USA, V87, P8805, DOI 10.1073/pnas.87.22.8805; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wang JW, 2013, FEBS LETT, V587, P136, DOI 10.1016/j.febslet.2012.11.001; Wecker K, 2002, EUR J BIOCHEM, V269, P3779, DOI 10.1046/j.1432-1033.2002.03067.x; Willbold D, 1997, EUR J BIOCHEM, V245, P581, DOI 10.1111/j.1432-1033.1997.t01-1-00581.x; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11	75	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117506	10.1371/journal.pone.0117506	http://dx.doi.org/10.1371/journal.pone.0117506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671429	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300055
J	Illien-Junger, S; Lu, Y; Qureshi, SA; Hecht, AC; Cai, WJ; Vlassara, H; Striker, GE; Iatridis, JC				Illien-Juenger, Svenja; Lu, Young; Qureshi, Sheeraz A.; Hecht, Andrew C.; Cai, Weijing; Vlassara, Helen; Striker, Gary E.; Iatridis, James C.			Chronic Ingestion of Advanced Glycation End Products Induces Degenerative Spinal Changes and Hypertrophy in Aging Pre-Diabetic Mice	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; BODY-MASS INDEX; DIABETES-MELLITUS; NONENZYMATIC GLYCATION; DIETARY GLYCOTOXINS; INSULIN-RESISTANCE; OXIDANT STRESS; RISK-FACTOR; BONE; CALCIFICATION	Intervertebral disc (IVD) degeneration and pathological spinal changes are major causes of back pain, which is the top cause of global disability. Obese and diabetic individuals are at increased risk for back pain and musculoskeletal complications. Modern diets contain high levels of advanced glycation end products (AGEs), cyto-toxic components which are known contributors to obesity, diabetes and accelerated aging pathologies. There is little information about potential effects of AGE rich diet on spinal pathology, which may be a contributing cause for back pain which is common in obese and diabetic individuals. This study investigated the role of specific AGE precursors (e.g. methylglyoxal-derivatives (MG)) on IVD and vertebral pathologies in aging C57BL6 mice that were fed isocaloric diets with standard (dMG+) or reduced amounts of MG derivatives (dMG-; containing 60-70% less dMG). dMG + mice exhibited a pre-diabetic phenotype, as they were insulin resistant but not hyperglycemic. Vertebrae of dMG+ mice displayed increased cortical-thickness and cortical-area, greater MG-AGE accumulation and ectopic calcification in vertebral endplates. IVD morphology of dMG+ mice exhibited ectopic calcification, hypertrophic differentiation and glycosaminoglycan loss relative to dMG-mice. Overall, chronic exposure to dietary AGEs promoted age-accelerated IVD degeneration and vertebral alterations involving ectopic calcification which occurred in parallel with insulin resistance, and which were prevented with dMG-diet. This study described a new mouse model for diet-induced spinal degeneration, and results were in support of the hypothesis that chronic AGE ingestion could be a factor contributing to a pre-diabetic state, ectopic calcifications in spinal tissues, and musculoskeletal complications that are more generally known to occur with chronic diabetic conditions.	[Illien-Juenger, Svenja; Lu, Young; Qureshi, Sheeraz A.; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA; [Cai, Weijing; Vlassara, Helen; Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, Div Expt Diabet & Aging, New York, NY 10029 USA; [Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.	james.iatridis@mssm.edu	Illien-Junger, Svenja/B-9105-2018; Illien-Junger, Svenja/AAV-1853-2020	Illien-Junger, Svenja/0000-0001-9895-0693; Illien-Junger, Svenja/0000-0001-9895-0693	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [R01AR051146]; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [RO1 AG023188]; Juvenile Diabetes Research Foundation (JDRF) [17-2008-1041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051146, R01AR064157, R01AR057397] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS); National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by JCI: National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS; R01AR051146) http://www.niams.nih.gov/.HV: National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK; RO1 AG023188) http://www.niddk.nih.gov/.GES: Juvenile Diabetes Research Foundation (JDRF; 17-2008-1041) https://jdrf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Boos N, 1997, J ORTHOP RES, V15, P141, DOI 10.1002/jor.1100150121; Brodeur MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085922; Burner TW, 2009, CURR OPIN RHEUMATOL, V21, P50, DOI 10.1097/BOR.0b013e32831bc0c4; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Gruber HE, 2007, SPINE J, V7, P444, DOI 10.1016/j.spinee.2006.08.015; Hamann C, 2014, ENDOCRINOLOGY; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Hristova GI, 2011, J ORTHOP RES, V29, P1888, DOI 10.1002/jor.21456; Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986; Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302; Jazini E, 2012, SPINE, V37, pE209, DOI 10.1097/BRS.0b013e31822ce81f; Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8; Tolosa MJ, 2013, DIABETES RES CLIN PR, V101, P177, DOI 10.1016/j.diabres.2013.05.016; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; Kilpadi KL, 2014, J IMMIGR MINOR HEALT, V16, P440, DOI 10.1007/s10903-013-9833-5; Kim J, 2010, BIOCHEM BIOPH RES CO, V391, P346, DOI 10.1016/j.bbrc.2009.11.061; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Moore RJ, 2006, EUR SPINE J, V15, pS333, DOI 10.1007/s00586-006-0170-4; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; Noble Brendon, 2003, European Cells & Materials, V6, P46; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Pattijn V, 2001, ANN BIOMED ENG, V29, P1064, DOI 10.1114/1.1424922; Peppa M, 2003, DIABETES, V52, P2805, DOI 10.2337/diabetes.52.11.2805; Prasad C, 2014, AGING DIS, V5, P212, DOI 10.14336/AD.2014.0500212; Robinson D, 1998, SPINE, V23, P849, DOI 10.1097/00007632-199804150-00001; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Sellam J, 2013, JOINT BONE SPINE, V80, P568, DOI 10.1016/j.jbspin.2013.09.007; SILBERBERG R, 1986, EXP CELL BIOL, V54, P121; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Srikanthan P, 2014, J BONE MINER RES, V29, P796, DOI 10.1002/jbmr.2083; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2008, CLIN BIOMECH, V23, P122, DOI 10.1016/j.clinbiomech.2007.08.010; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vos PAJM, 2012, OSTEOARTHR CARTILAGE, V20, P233, DOI 10.1016/j.joca.2011.12.007; Vulesevic B, 2014, BIOCHEM SOC T, V42, P523, DOI 10.1042/BST20130254; Wagner DR, 2006, J BIOMECH, V39, P1021, DOI 10.1016/j.jbiomech.2005.02.013; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Williams FMK, 2011, ANN RHEUM DIS, V70, P1203, DOI 10.1136/ard.2010.146001; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yamaguchi T, 2011, ENDOCR J, V58, P613, DOI 10.1507/endocrj.EJ11-0063; Yan WB, 2013, FRONT MED-PRC, V7, P81, DOI 10.1007/s11684-013-0243-9; Yoshida T, 2009, SPINE, V34, P1544, DOI 10.1097/BRS.0b013e3181a98390; Zhang LP, 2009, ACTA DIABETOL, V46, P119, DOI 10.1007/s00592-008-0068-1; ZIV I, 1992, J ORTHOPAED RES, V10, P205, DOI 10.1002/jor.1100100207	73	43	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116625	10.1371/journal.pone.0116625	http://dx.doi.org/10.1371/journal.pone.0116625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668621	gold, Green Submitted, Green Published			2022-12-26	WOS:000349493000008
J	Chowdhury, BP; Bandyopadhyay, S; Das, S; Majumder, S; Jha, MK; Majumdar, SB; Saha, B; Majumdar, S				Chowdhury, Bidisha Paul; Bandyopadhyay, Syamdas; Das, Shibali; Majumder, Saikat; Jha, Mukesh Kumar; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			The Host-Protective Effect of Arabinosylated Lipoarabinomannan against Leishmania donovani Infection Is Associated with Restoration of IFN-gamma Responsiveness	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; REGULATORY FACTOR FAMILY; NF-KAPPA-B; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; DENDRITIC CELLS; MESSENGER-RNA; T-CELLS; ACTIVATION	Visceral leishmaniasis (VL), which is endemic as a major infectious disease in the tropical and subtropical countries, is caused by a protozoan parasite Leishmania donovani. At present, restricted treatment options and lack of vaccines intensify the problem of controlling VL. Therefore, finding a novel immunoprophylactic or therapeutic principle is a pressing need. Here, we report that arabinosylated lipoarabinomannan (Ara-LAM), a TLR2-ligand isolated from Mycobacterium smegmatis, exhibits a strong immunomodulatory property that conferred protection against L. donovani infection. Although, Ara-LAM modulates TLR2 and MAPK signaling, it is not known whether Ara-LAM involves IFN-gamma signaling for effective parasite clearance. Because, it is reported that IFN-gamma signaling, a principle mediator of NO generation and macrophage and Tcell activation, is hampered during leishmanial pathogenesis. Ara-LAM increases IFN-gamma receptor expression and potentiates IFN-gamma receptor signaling through JAK-STAT pathway. Moreover, Ara-LAM reciprocally modulates IRF4 and IRF8 expression and reinstates anti-leishmanial Th1 response that eventuates in significantly reduced parasite load in spleen and liver of L. donovani-infected BALB/c mice. IFN-gamma Ra silencing resulted in the suppression of these host-protective mechanisms affected by Ara-LAM. Thus, Ara-LAM-mediated restoration of IFN-gamma responsiveness is a novel immunomodulatory principle for protection against L. donovani susceptible host.	[Chowdhury, Bidisha Paul; Bandyopadhyay, Syamdas; Das, Shibali; Majumder, Saikat; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Jha, Mukesh Kumar; Saha, Bhaskar] NCCS, Lab 5, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@jcbose.ac.in	Das, Shibali/AAA-2683-2021; Majumder, Saikat/ABC-2194-2020	Das, Shibali/0000-0003-1263-8178; Majumder, Saikat/0000-0002-6591-9515	Department of Biotechnology, Govt. of India [BT/PR14435/MED/29/201/2010]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Govt. of India [Grant number BT/PR14435/MED/29/201/2010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Akbari M, 2014, J IMMUNOL, V192, P2271, DOI 10.4049/jimmunol.1301914; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Bhardwaj N, 2005, INT J PARASITOL, V35, P75, DOI 10.1016/j.ijpara.2004.10.018; Bhattacharjee S, 2007, INDIAN J BIOCHEM BIO, V44, P366; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bhattacharya P, 2010, J INFECT DIS, V202, P145, DOI 10.1086/653210; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Constantinescu CS, 1998, EUR J IMMUNOL, V28, P2227, DOI 10.1002/(SICI)1521-4141(199807)28:07<2227::AID-IMMU2227>3.0.CO;2-N; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; Croft SL, 2006, INDIAN J MED RES, V123, P399; Delvig AA, 2002, J LEUKOCYTE BIOL, V72, P163; den Boer ML, 2009, EXPERT OPIN EMERG DR, V14, P395, DOI 10.1517/14728210903153862; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jayakumar A, 2008, INFECT IMMUN, V76, P2138, DOI 10.1128/IAI.01252-07; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Majumder N, 2008, MICROBES INFECT, V10, P349, DOI 10.1016/j.micinf.2007.12.013; Majumder N, 2006, GLYCOCONJUGATE J, V23, P675, DOI 10.1007/s10719-006-9017-9; Marinho FAV, 2013, EUR J IMMUNOL, V43, P2373, DOI 10.1002/eji.201243208; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Matte C, 2010, INFECT IMMUN, V78, P3736, DOI 10.1128/IAI.00046-10; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Okwor I, 2013, IMMUNOL RES, V56, P163, DOI 10.1007/s12026-013-8389-8; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; REINER NE, 1988, P NATL ACAD SCI USA, V85, P4330, DOI 10.1073/pnas.85.12.4330; Reyes JL, 2011, INT J BIOL SCI, V7, P1323, DOI 10.7150/ijbs.7.1323; Rosas LE, 2006, J IMMUNOL, V177, P22, DOI 10.4049/jimmunol.177.1.22; Sen S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002229; Srivastava S, 2013, CLIN EXP IMMUNOL, V172, P403, DOI 10.1111/cei.12074; Sundar S, 2013, EXPERT OPIN PHARMACO, V14, P53, DOI 10.1517/14656566.2013.755515; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Wadhone P, 2009, J IMMUNOL, V182, P7146, DOI 10.4049/jimmunol.0803859; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117247	10.1371/journal.pone.0117247	http://dx.doi.org/10.1371/journal.pone.0117247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658110	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900124
J	Dametto, P; Lakkaraju, AKK; Bridel, C; Villiger, L; O'Connor, T; Herrmann, US; Pelczar, P; Rulicke, T; McHugh, D; Adili, A; Aguzzi, A				Dametto, Paolo; Lakkaraju, Asvin K. K.; Bridel, Claire; Villiger, Lukas; O'Connor, Tracy; Herrmann, Uli S.; Pelczar, Pawel; Ruelicke, Thomas; McHugh, Donal; Adili, Arlind; Aguzzi, Adriano			Neurodegeneration and Unfolded-Protein Response in Mice Expressing a Membrane-Tethered Flexible Tail of PrP	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRION PROTEIN; ER STRESS; IN-VIVO; TOXICITY; DISEASE; IMPAIRMENT; AGGREGATION; ANTIBODIES; APOPTOSIS	The cellular prion protein (PrPC) consists of a flexible N-terminal tail (FT, aa 23-128) hinged to a membrane-anchored globular domain (GD, aa 129-231). Ligation of the GD with antibodies induces rapid neurodegeneration, which is prevented by deletion or functional inactivation of the FT. Therefore, the FT is an allosteric effector of neurotoxicity. To explore its mechanism of action, we generated transgenic mice expressing the FT fused to a GPI anchor, but lacking the GD (PrP Delta 141-225, or "FTgpi"). Here we report that FTgpi mice develop a progressive, inexorably lethal neurodegeneration morphologically and biochemically similar to that triggered by anti-GD antibodies. FTgpi was mostly retained in the endoplasmic reticulum, where it triggered a conspicuous unfolded protein response specifically activating the PERK pathway leading to phosphorylation of eIF2a and upregulation of CHOP ultimately leading to neurodegeration similar to what was observed in prion infection.	[Dametto, Paolo; Lakkaraju, Asvin K. K.; Bridel, Claire; Villiger, Lukas; O'Connor, Tracy; Herrmann, Uli S.; McHugh, Donal; Adili, Arlind; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Zurich; University Zurich Hospital; University of Zurich; University of Veterinary Medicine Vienna	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	bridel, claire/GOH-1227-2022	Lakkaraju, Asvin/0000-0001-8752-148X; Herrmann, Uli Simon/0000-0002-1327-5199; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union (PRIORITY, NEURINOX); Swiss National Foundation; University of Zurich; Novartis Research Foundation	European Research Council(European Research Council (ERC)European Commission); European Union (PRIORITY, NEURINOX); Swiss National Foundation(Swiss National Science Foundation (SNSF)); University of Zurich; Novartis Research Foundation	AA is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, NEURINOX), the Swiss National Foundation, the Clinical Research Priority Programs (KFSP) "Small RNAs" and "Human Hemato-Lymphatic Diseases" of the University of Zurich, SystemsX.ch as part of medical research and development project, and the Novartis Research Foundation. PD is supported by the Swiss National Foundation and a Career Development Award of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; BAINTON DF, 1981, J CELL BIOL, V91, pS66, DOI 10.1083/jcb.91.3.66s; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoozemans JJM, 2012, INT J BIOCHEM CELL B, V44, P1295, DOI 10.1016/j.biocel.2012.04.023; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; McHugh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037881; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rulicke T, 2004, METH MOL B, V254, P165; Sakudo A, 2007, MICROBIOL IMMUNOL, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Sun LW, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-52; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221	47	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117412	10.1371/journal.pone.0117412	http://dx.doi.org/10.1371/journal.pone.0117412			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658480	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900144
J	Fei, L; Tian, SS; Moysey, R; Misca, M; Barker, JJ; Smith, MA; McEwan, PA; Pilka, ES; Crawley, L; Evans, T; Sun, DP				Fei, Li; Tian, SiSi; Moysey, Ruth; Misca, Mihaela; Barker, John J.; Smith, Myron A.; McEwan, Paul A.; Pilka, Ewa S.; Crawley, Lauren; Evans, Tom; Sun, Dapeng			Structural and Biochemical Studies of a Moderately Thermophilic Exonuclease I from Methylocaldum szegediense	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; ESCHERICHIA-COLI; SP-NOV.; GENOME SEQUENCE; MECHANISM; BACTERIUM; PROCESSIVITY; SPECIFICITY; STABILITY; KINETICS	A novel exonuclease, designated as MszExo I, was cloned from Methylocaldum szegediense, a moderately thermophilic methanotroph. It specifically digests single-stranded DNA in the 3' to 5' direction. The protein is composed of 479 amino acids, and it shares 47% sequence identity with E. coli Exo I. The crystal structure of MszExo I was determined to a resolution of 2.2 angstrom and it aligns well with that of E. coli Exo I. Comparative studies revealed that MszExo I and E. coli Exo I have similar metal ion binding affinity and similar activity at mesophilic temperatures (25-47 degrees C). However, the optimum working temperature of MszExo I is 10 degrees C higher, and the melting temperature is more than 4 degrees C higher as evaluated by both thermal inactivation assays and DSC measurements. More importantly, two thermal transitions during unfolding of MszExo I were monitored by DSC while only one transition was found in E. coli Exo I. Further analyses showed that magnesium ions not only confer structural stability, but also affect the unfolding of MszExo I. MszExo I is the first reported enzyme in the DNA repair systems of moderately thermophilic bacteria, which are predicted to have more efficient DNA repair systems than mesophilic ones.	[Fei, Li; Tian, SiSi; Sun, Dapeng] Shanghai R&D Ctr, New England Biolabs, Shanghai, Peoples R China; [Moysey, Ruth; Misca, Mihaela] Oxford Nanopore Technol Ltd, Oxford OX4, England; [Barker, John J.; Smith, Myron A.; McEwan, Paul A.; Pilka, Ewa S.; Crawley, Lauren] Evotec UK Ltd, Abingdon OX14 4RZ, Oxon, England; [Evans, Tom] New England Biolabs Inc, Ipswich, MA 01938 USA	Oxford Nanopore Technologies; Evotec; New England Biolabs	Sun, DP (corresponding author), Shanghai R&D Ctr, New England Biolabs, Bldg 5,917 Halei Rd, Shanghai, Peoples R China.	Sund@neb.com		mcewan, paul/0000-0001-6097-1528	New England Biolabs Shanghai RD Center; Oxford Nanopore Technologies Ltd.; New England Biolabs; Evotec (UK) Ltd	New England Biolabs Shanghai RD Center; Oxford Nanopore Technologies Ltd.; New England Biolabs; Evotec (UK) Ltd	The authors received no specific funding for this work. Li Fei, SiSi Tian, and Dapeng Sun are employees of New England Biolabs, Shanghai R&D Center. Tom Evans is an employee of New England Biolabs Inc. Ruth Moysey and Mihaela Misca are employees of Oxford Nanopore Technologies Ltd. John J. Barker, Myron A Smith, Paul A McEwan, Ewa S Pilka, and Lauren Crawley are employees of Evotec (UK) Ltd. New England Biolabs Shanghai R&D Center, Oxford Nanopore Technologies Ltd., Evotec (UK) Ltd and New England Biolabs provided support in the form of salaries, supplies, equipment, and infrastructure support for authors LF, ST, DS, TE, RM, MM, JJB, MAS, PAM, ESP and LC, provided editorial suggestions on content and data presentation for the manuscript and approved submission of the manuscript for publication, but did not have any additional role in control of the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson I, 2012, STAND GENOMIC SCI, V6, P293, DOI 10.4056/sigs.2736042; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Bodrossy L, 1997, ARCH MICROBIOL, V168, P493, DOI 10.1007/s002030050527; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; BRODY RS, 1986, J BIOL CHEM, V261, P7136; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Busam RD, 2008, ACTA CRYSTALLOGR D, V64, P206, DOI 10.1107/S090744490706012X; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106, DOI 10.2144/01315rv02; Feschenko VV, 2003, P NATL ACAD SCI USA, V100, P1134, DOI 10.1073/pnas.0233122100; Frols S, 2009, BIOCHEM SOC T, V37, P36, DOI 10.1042/BST0370036; GHOSH SS, 1994, NUCLEIC ACIDS RES, V22, P3155, DOI 10.1093/nar/22.15.3155; Goker M, 2012, STAND GENOMIC SCI, V6, P230, DOI 10.4056/sigs.2726028; Kataoka M, 2013, APPL MICROBIOL BIOTE; Korada SKC, 2013, NUCLEIC ACIDS RES, V41, P5887, DOI 10.1093/nar/gkt278; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; Li Z, 2013, BIOCHEM SOC T, V41, P332, DOI 10.1042/BST20120303; Lino T, 2008, INT J SYST EVOL MICR, V58, P1675, DOI 10.1099/ijs.0.65714-0; Liu WF, 2007, FEBS LETT, V581, P1047, DOI 10.1016/j.febslet.2007.02.008; Slobodkina GB, 2008, INT J SYST EVOL MICR, V58, P852, DOI 10.1099/ijs.0.65485-0; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039; Tori K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058497; Ueda J, 2013, INT J SYST EVOL MICR, V63, P3330, DOI 10.1099/ijs.0.048090-0; van Wolferen M, 2013, EXTREMOPHILES, V17, P545, DOI 10.1007/s00792-013-0552-6; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; You ZQ, 2013, INT J SYST EVOL MICR, V63, P4243, DOI 10.1099/ijs.0.051714-0	30	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117470	10.1371/journal.pone.0117470	http://dx.doi.org/10.1371/journal.pone.0117470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658953	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900157
J	Giron, MD; Vilchez, JD; Shreeram, S; Salto, R; Manzano, M; Cabrera, E; Campos, N; Edens, NK; Rueda, R; Lopez-Pedrosa, JM				Giron, Maria D.; Vilchez, Jose D.; Shreeram, Sathyavageeswaran; Salto, Rafael; Manzano, Manuel; Cabrera, Elena; Campos, Nefertiti; Edens, Neile K.; Rueda, Ricardo; Lopez-Pedrosa, Jose M.			beta-Hydroxy-beta-Methylbutyrate (HMB) Normalizes Dexamethasone-Induced Autophagy-Lysosomal Pathway in Skeletal Muscle	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; GENE-EXPRESSION; AGED RATS; ATROPHY; UBIQUITIN; CELLS; PROLIFERATION; MECHANISM; RECOVERY	Dexamethasone-induced muscle atrophy is due to an increase in protein breakdown and a decrease in protein synthesis, associated with an over-stimulation of the autophagy-lysosomal pathway. These effects are mediated by alterations in IGF-1 and PI3K/Akt signaling. In this study, we have investigated the effects of beta-Hydroxy-beta-methylbutyrate (HMB) on the regulation of autophagy and proteosomal systems. Rats were treated during 21 days with dexamethasone as a model of muscle atrophy. Co-administration of HMB attenuated the effects promoted by dexamethasone. HMB ameliorated the loss in body weight, lean mass and the reduction of the muscle fiber cross-sectional area (shrinkage) in gastrocnemius muscle. Consequently, HMB produced an improvement in muscle strength in the dexamethasone-treated rats. To elucidate the molecular mechanisms responsible for these effects, rat L6 myotubes were used. In these cells, HMB significantly attenuated lysosomal proteolysis induced by dexamethasone by normalizing the changes observed in autophagosome formation, LC3 II, p62 and Bnip3 expression after dexamethasone treatment. HMB effects were mediated by an increase in FoxO3a phosphorylation and concomitant decrease in FoxO transcriptional activity. The HMB effect was due to the restoration of Akt signaling diminished by dexamethasone treatment. Moreover, HMB was also involved in the regulation of the activity of ubiquitin and expression of MurF1 and Atrogin-1, components of the proteasome system that are activated or up-regulated by dexamethasone. In conclusion, in vivo and in vitro studies suggest that HMB exerts protective effects against dexamethasone- induced muscle atrophy by normalizing the Akt/FoxO axis that controls autophagy and ubiquitin proteolysis.	[Giron, Maria D.; Vilchez, Jose D.; Salto, Rafael; Cabrera, Elena] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Shreeram, Sathyavageeswaran] Abbott Nutr R&D, Singapore, Singapore; [Manzano, Manuel; Campos, Nefertiti; Rueda, Ricardo; Lopez-Pedrosa, Jose M.] Abbott Nutr R&D, Granada, Spain; [Edens, Neile K.] Abbott Nutr R&D, Columbus, OH USA	University of Granada	Giron, MD (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain.	mgiron@ugr.es	Vílchez, Dámaso/E-9823-2016; Giron, Maria D/K-2487-2014; Salto, Rafael/A-6486-2011	Vílchez, Dámaso/0000-0003-3256-8525; Giron, Maria D/0000-0001-9638-988X; Salto, Rafael/0000-0002-7044-3611; Sathyavageeswaran, Shreeram/0000-0002-6111-1818	Abbott Nutrition RD	Abbott Nutrition RD	This project has been funded by Abbott Nutrition R&D. The funder provided support in the form of salaries for authors SS, MM, NC, NKE, RR and JMLP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baptista IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076752; Giron MD, 2009, CLIN NUTR, V28, P565, DOI 10.1016/j.clnu.2009.04.018; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GULVE EA, 1989, BIOCHEM J, V260, P377, DOI 10.1042/bj2600377; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; HONG DH, 1995, MOL CELL ENDOCRINOL, V108, P199, DOI 10.1016/0303-7207(95)03476-N; Kaasik P, 2007, J STEROID BIOCHEM, V105, P85, DOI 10.1016/j.jsbmb.2006.11.024; Kimura K, 2014, NUTR RES, V34, P368, DOI 10.1016/j.nutres.2014.02.003; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kovarik M, 2010, J PHYSIOL BIOCHEM, V66, P311, DOI 10.1007/s13105-010-0037-3; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marinovic AC, 2000, BIOCHEM BIOPH RES CO, V274, P537, DOI 10.1006/bbrc.2000.3171; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Russell ST, 2009, MOL CELL BIOCHEM, V330, P171, DOI 10.1007/s11010-009-0130-5; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wilson JM, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-18; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	37	40	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117520	10.1371/journal.pone.0117520	http://dx.doi.org/10.1371/journal.pone.0117520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658432	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900171
J	Hu, YY; Wu, JF; Lu, TL; Wu, H; Sun, W; Wang, XR; Bi, HS; Jonas, JB				Hu, Yuan Yuan; Wu, Jian Feng; Lu, Tai Liang; Wu, Hui; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng; Jonas, Jost B.			Effect of Cycloplegia on the Refractive Status of Children: The Shandong Children Eye Study	PLOS ONE			English	Article							VISUAL IMPAIRMENT; SCHOOL-CHILDREN; SOUTHERN CHINA; ERROR; AUTOREFRACTION	Purpose To determine the effect of 1% cyclopentolate on the refractive status of children aged 4 to 18 years. Methods Using a random cluster sampling in a cross-sectional school-based study design, children with an age of 4-18 years were selected from kindergardens, primary schools, junior and senior high schools in a rural county and a city. Auto-refractometry was performed before and after inducing cycloplegia which was achieved by 1% cyclopentolate eye drops. Results Out of 6364 eligible children, data of 5999 (94.3%) children were included in the statistical analysis. Mean age was 10.0 +/- 3.3 years (range: 4-18 years). Mean difference between cycloplegic and non-cycloplegic refractive error (DIFF) was 0.78 +/- 0.79D (median: 0.50D; range: -1.00D to +10.75D). In univariate analysis, DIFF decreased significantly with older age (P<0.001; correlation coefficient r:-0.24), more hyperopic non-cycloplegic refractive error (P<0.001; r = 0.13) and more hyperopic cycloplegic refractive error (P<0.001; r = 0.49). In multivariate analysis, higher DIFF was associated with higher cycloplegic refractive error (P<0.001; standardized regression coefficient beta: 0.50; regression coefficient B: 0.19; 95% confidence interval (CI): 0.18, 0.20), followed by lower intraocular pressure (P<0.001; beta: -0.06; B: -0.02; 95% CI: -0.03, -0.01), rural region of habitation (P = 0.001; beta: -0.04; B: -0.07; 95% CI: -0.11, -0.03), and, to a minor degree, with age (P = 0.006; beta: 0.04; B: 0.009; 95% CI: 0.003, 0.016). 66.4% of all eyes with non-cycloplegic myopia (<=-0.50D) remained myopic after cycloplegia while the remaining 33.6% of eyes became emmetropic (18.0%) or hyperopic (15.7%) under cycloplegia. Prevalence of emmetropia decreased from 37.5% before cycloplegia to 19.8% after cycloplegia while the remaining eyes became hyperopic under cycloplegia. Conclusions The error committed by using non-cycloplegic versus cycloplegic refractometry in children with mid to dark-brown iris color decreased with older age, and in parallel manner, with more myopic cycloplegic refractive error. Non-cycloplegic refractometric measures lead to a misclassification of refractive error in a significant proportion of children.	[Hu, Yuan Yuan; Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan, Shandong, Peoples R China; [Hu, Yuan Yuan; Lu, Tai Liang; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Wu, Hui; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China.	hongshengbi@126.com			Shandong Science & Technology Department [2011GGB14097, 2011GGH21835, 2012YD18081]; Shandong Health Department [2011HD014]; Jinan Science & Technology Bureau [201102061]	Shandong Science & Technology Department; Shandong Health Department; Jinan Science & Technology Bureau	This study was supported by the Shandong Science & Technology Department (2011GGB14097, 2011GGH21835, 2012YD18081), Shandong Health Department (2011HD014), Jinan Science & Technology Bureau (201102061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choong YF, 2006, AM J OPHTHALMOL, V142, P68, DOI 10.1016/j.ajo.2006.01.084; EGASHIRA SM, 1993, OPTOMETRY VISION SCI, V70, P1019, DOI 10.1097/00006324-199312000-00005; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Hopkins S, 2012, OPTOMETRY VISION SCI, V89, P1734, DOI 10.1097/OPX.0b013e318277182c; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Lan WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078003; Prabakaran S, 2009, OPHTHAL PHYSL OPT, V29, P422, DOI 10.1111/j.1475-1313.2008.00616.x; Rotsos T, 2009, CLIN OPHTHALMOL, V3, P429; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	16	43	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117482	10.1371/journal.pone.0117482	http://dx.doi.org/10.1371/journal.pone.0117482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658329	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900161
J	Kong, LW; Wu, JF; Lin, YH; Wang, GF; Wang, J; Liu, JQ; Chen, MX; Du, X; Sun, J; Lin, JP; Dong, JC				Kong, Lingwen; Wu, Jingfeng; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng			BuShenYiQi Granule Inhibits Atopic Dermatitis via Improving Central and Skin Hypothalamic -Pituitary -Adrenal Axis Function	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; MAST-CELLS; HPA AXIS; ASTHMATIC-CHILDREN; IMMUNE-SYSTEM; MOUSE MODEL; STRESS; INFLAMMATION; RESPONSES; CRH	Background Dysfunction of central and skin Hypothalamic-Pituitary-Adrenal (HPA) axis play important roles in pathogenesis of atopic dermatitis (AD). Our previous studies showed that several Chinese herbs could improve HPA axis function. In this study, we evaluated the antiinflammatory effects of BuShenYiQi granule (BSYQ), a Chinese herbs formula, in AD mice and explored the effective mechanism from regulation of HPA axis. Methods The ovalbumin (OVA) induced AD mice model were established and treated with BSYQ. We evaluated dermatitis score and histology analysis of dorsal skin lesions, meanwhile, serum corticosterone (CORT), adrenocorticotropic hormone (ACTH), corticotropin-releasing hormone (CRH) and inflammatory cytokines were determined by ELISA. The changes of CRH/proopiomelanocortin(POMC) axis elements, corresponding functional receptors and crucial genes of glucocorticosteroidogenesis in the skin were measured by quantitative real-time PCR and western blot, respectively. Results The symptoms and pathological changes in skin of AD mice were significantly improved and several markers of inflammation and allergy descended obviously after BSYQ treatment. We found that AD mice had insufficient central HPA tone, but these conditions were markedly improved after BSYQ treatment. The AD mice also showed a disturbed expression of skin HPA. In lesion skin of AD mice, the mRNA and protein expressions of CRH decreased significantly, on the contrary, POMC and cytochrome P450 side-chain cleavage enzyme (CYP11A1) increased markedly, meanwhile, NR3C1 (mouse GR), CRHR2 and 11-hydroxylase type 1(CYP11B1) were reduced locally. Most of these tested indexes were improved after BSYQ treatment. Conclusions AD mice displayed the differential expression pattern of central and skin HPA axis and BSYQ treatment significantly alleviated the symptoms of AD mice and presented antiinflammatory and anti-allergic effects via regulating the expression of central and skin HPA axis.	[Kong, Lingwen; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng] Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Kong, Lingwen; Lin, Yanhua; Wang, Genfa; Wang, Jia; Liu, Jiaqi; Chen, Meixia; Du, Xin; Sun, Jing; Lin, Jinpei; Dong, Jingcheng] Fudan Univ, Inst Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Wu, Jingfeng] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China.	jcdong2004@126.com		Dong, Jingcheng/0000-0002-5194-367X; Du, Xin/0000-0002-9682-1211	National Basic Science Program of China [2009CB523000]; National Natural Science Foundation of China [81173390/H2902]	National Basic Science Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Science Program of China (no. 2009CB523000) and the National Natural Science Foundation of China (no. 81173390/H2902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buske-Kirschbaum A, 2006, PSYCHONEUROENDOCRINO, V31, P439, DOI 10.1016/j.psyneuen.2005.10.006; Buske-Kirschbaum A, 2003, ANN NY ACAD SCI, V992, P231, DOI 10.1111/j.1749-6632.2003.tb03153.x; Buske-Kirschbaum A, 2010, BRAIN BEHAV IMMUN, V24, P1347, DOI 10.1016/j.bbi.2010.06.013; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gibb J, 2011, BRAIN BEHAV IMMUN, V25, P468, DOI 10.1016/j.bbi.2010.11.008; Gong Zhao-Hua, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P348; Hannen RF, 2011, BIOCHEM BIOPH RES CO, V404, P62, DOI 10.1016/j.bbrc.2010.11.059; Harbuz MS, 2006, ANN NY ACAD SCI, V1069, P51, DOI 10.1196/annals.1351.005; Hendrix S, 2008, J INVEST DERMATOL, V128, P260, DOI 10.1038/sj.jid.5701171; Huang JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/938425; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jin HL, 2013, INT IMMUNOPHARMACOL, V15, P42, DOI 10.1016/j.intimp.2012.11.009; Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x; MIGLIORATI G, 1994, PHARMACOL RES, V30, P43, DOI 10.1016/1043-6618(94)80086-3; Priftis KN, 2008, TRENDS ENDOCRIN MET, V19, P32, DOI 10.1016/j.tem.2007.10.005; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Slominski A, 2009, BRIT J DERMATOL, V160, P229, DOI 10.1111/j.1365-2133.2008.08958.x; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Sprecher E, 2013, J ALLERGY CLIN IMMUN, V132, P1130, DOI 10.1016/j.jaci.2013.09.026; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Vasiadi M, 2012, J ALLERGY CLIN IMMUN, V129, P1410, DOI 10.1016/j.jaci.2012.01.041; Wang GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103168; Wang J, 2014, J ETHNOPHARMACOL, V154, P131, DOI 10.1016/j.jep.2014.03.041; Wen MC, 2005, J ALLERGY CLIN IMMUN, V116, P517, DOI 10.1016/j.jaci.2005.05.029; Wu JF, 2011, IMMUNOPHARM IMMUNOT, V33, P49, DOI 10.3109/08923971003725144; Wu JF, 2011, PHARMACOL BIOCHEM BE, V98, P273, DOI 10.1016/j.pbb.2011.01.008; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Zbytek B, 2007, J INVEST DERMATOL, V127, P730, DOI 10.1038/sj.jid.5700607; Zollner EW, 2007, PEDIATR ALLERGY IMMU, V18, P469, DOI 10.1111/j.1399-3038.2007.00539.x	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116427	10.1371/journal.pone.0116427	http://dx.doi.org/10.1371/journal.pone.0116427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658752	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900038
J	Maesawa, S; Bagarinao, E; Fujii, M; Futamura, M; Motomura, K; Watanabe, H; Mori, D; Sobue, G; Wakabayashi, T				Maesawa, Satoshi; Bagarinao, Epifanio; Fujii, Masazumi; Futamura, Miyako; Motomura, Kazuya; Watanabe, Hirohisa; Mori, Daisuke; Sobue, Gen; Wakabayashi, Toshihiko			Evaluation of Resting State Networks in Patients with Gliomas: Connectivity Changes in the Unaffected Side and Its Relation to Cognitive Function	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; BRAIN; PATTERNS; OPTIMIZATION; EFFICIENCY; ROBUST; FMRI	In this study, we investigated changes in resting state networks (RSNs) in patients with gliomas located in the left hemisphere and its relation to cognitive function. We hypothesized that long distance connection, especially between hemispheres, would be affected by the presence of the tumor. We further hypothesized that these changes would correlate with, or reflect cognitive changes observed in patients with gliomas. Resting state functional MRI datasets from 12 patients and 12 healthy controls were used in the analysis. The tumor's effect on three well-known RSNs including the default mode network (DMN), executive control network (ECN), and salience network (SN) identified using independent component analysis were investigated using dual regression analysis. Scores of neuropsychometric testing (WAIS-III and WMS-R) were also compared. Compared to the healthy control group, the patient group showed significant decrease in functional connectivity in the right angular gyrus/inferior parietal lobe of the ventral DMN and in the dorsolateral prefrontal cortex of the left ECN, whereas a significant increase in connectivity in the right ECN was observed in the right parietal lobe. Changes in connectivity in the right ECN correlated with spatial memory, while that on the left ECN correlated with attention. Connectivity changes in the ventral DMN correlated with attention, working memory, full IQ, and verbal IQ measures. Although the tumors were localized in the left side of the brain, changes in connectivity were observed in the contralateral side. Moreover, these changes correlated with some aspects of cognitive function indicating that patients with gliomas may undergo cognitive changes even in the absence of or before the onset of major symptoms. Evaluation of resting state networks could be helpful in advancing our hodological understanding of brain function in glioma cases.	[Maesawa, Satoshi; Bagarinao, Epifanio; Watanabe, Hirohisa; Mori, Daisuke; Sobue, Gen; Wakabayashi, Toshihiko] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi 4648601, Japan; [Maesawa, Satoshi; Fujii, Masazumi; Motomura, Kazuya; Wakabayashi, Toshihiko] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Futamura, Miyako] Nagoya Hosp Org, Nagoya Med Ctr, Dept Rehabil, Nagoya, Aichi, Japan; [Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Sch Med, Dept Neurol, Nagoya, Aichi 466, Japan	Nagoya University; Nagoya University; Nagoya Medical Center; Nagoya University	Maesawa, S (corresponding author), Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi 4648601, Japan.	smaesawa@med.nagoya-u.ac.jp	Wakabayashi, Toshihiko/I-3526-2012; Bagarinao, Epifanio/A-5002-2012; MAESAWA, Satoshi/I-7416-2014; Mori, Daisuke/M-4952-2014; Motomura, Kazuya/AAF-8776-2021	Wakabayashi, Toshihiko/0000-0001-5254-2088; Bagarinao, Epifanio/0000-0001-5000-6943; Mori, Daisuke/0000-0002-9072-2546; Motomura, Kazuya/0000-0002-4376-1104; Watanabe, Hirohisa/0000-0001-8553-8536	KAKENHI [26462202]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grant number 26462202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; ELWOOD R W, 1991, Neuropsychology Review, V2, P179, DOI 10.1007/BF01109053; Esposito R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040231; Filippi M, 2013, CORTEX, V49, P2389, DOI 10.1016/j.cortex.2012.09.017; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harris RJ, 2014, J NEURO-ONCOL, V116, P373, DOI 10.1007/s11060-013-1304-2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kokkonen SM, 2009, MAGN RESON IMAGING, V27, P733, DOI 10.1016/j.mri.2008.11.002; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ryan JJ, 2003, ASSESSMENT, V10, P151, DOI 10.1177/1073191103010002006; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Waltz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057257; Xu HZ, 2013, NEUROSCI LETT, V543, P27, DOI 10.1016/j.neulet.2013.02.062; Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879	33	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118072	10.1371/journal.pone.0118072	http://dx.doi.org/10.1371/journal.pone.0118072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659130	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900258
J	Salek, ME; Zarybnicka, M				Salek, Miroslav E.; Zarybnicka, Marketa			Different Temperature and Cooling Patterns at the Blunt and Sharp Egg Poles Reflect the Arrangement of Eggs in an Avian Clutch	PLOS ONE			English	Article							INCUBATION BEHAVIOR; THERMAL-PROPERTIES; SIZE; NESTS	Incubation is an energetically demanding process during which birds apply heat to their eggs to ensure embryonic development. Parent behaviours such as egg turning and exchanging the outer and central eggs in the nest cup affect the amount of heat lost to the environment from individual eggs. Little is known, however, about whether and how egg surface temperature and cooling rates vary among the different areas of an egg and how the arrangement of eggs within the clutch influences heat loss. We performed laboratory (using Japanese quail eggs) and field (with northern lapwing eggs) experiments using infrared imaging to assess the temperature and cooling patterns of heated eggs and clutches. We found that (i) the sharp poles of individual quail eggs warmed to a higher egg surface temperature than did the blunt poles, resulting in faster cooling at the sharp poles compared to the blunt poles; (ii) both quail and lapwing clutches with the sharp poles oriented towards the clutch centre (arranged clutches) maintained higher temperatures over the central part of the clutch than occurred in those clutches where most of the sharp egg poles were oriented towards the exterior (scattered clutches); and (iii) the arranged clutches of both quail and lapwing showed slower cooling rates at both the inner and outer clutch positions than did the respective parts of scattered clutches. Our results demonstrate that egg surface temperature and cooling rates differ between the sharp and blunt poles of the egg and that the orientation of individual eggs within the nest cup can significantly affect cooling of the clutch as a whole. We suggest that birds can arrange their eggs within the nest cup to optimise thermoregulation of the clutch.	[Salek, Miroslav E.; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Czech University of Life Sciences Prague	Zarybnicka, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	zarybnicka.marketa@seznam.cz	Šálek, Miroslav/K-1934-2016; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Salek, Miroslav/0000-0002-8238-3644; Zarybnicka, Marketa/0000-0001-5883-0988	Faculty of Environmental Sciences, Czech University of Life Sciences Prague [IGA 20144273]; Czech University of Life Sciences Prague [CIGA 20144203]	Faculty of Environmental Sciences, Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	This study was supported by grants from Faculty of Environmental Sciences, Czech University of Life Sciences Prague (IGA 20144273) and Czech University of Life Sciences Prague (CIGA 20144203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, ENVIRON INT, V33, P773, DOI 10.1016/j.envint.2007.02.012; Ar A, 2002, OX ORN SER, V13, P143; Barta Z, 1997, FUNCT ECOL, V11, P656, DOI 10.1046/j.1365-2435.1997.00136.x; Boulton RL, 2012, J AVIAN BIOL, V43, P289, DOI 10.1111/j.1600-048X.2012.05657.x; Bustnes JO, 2008, ENVIRON INT, V34, P193, DOI 10.1016/j.envint.2007.07.016; Deeming DC, 2002, OX ORN SER, V13, P161; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Drent R., 1975, AVIAN BIOL, P333; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; GALBRAITH H, 1988, J ZOOL, V214, P383, DOI 10.1111/j.1469-7998.1988.tb03747.x; Jimenez-Munoz JC, 2012, J THEOR BIOL, V304, P304, DOI 10.1016/j.jtbi.2012.03.029; Lamprecht I, 2004, THERMOCHIM ACTA, V415, P141, DOI 10.1016/j.tca.2003.08.029; McCafferty DJ, 2013, IBIS, V155, P4, DOI 10.1111/ibi.12010; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Rockweit JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041498; Shinder D, 2009, POULTRY SCI, V88, P636, DOI 10.3382/ps.2008-00213; SILVER R, 1989, CONDOR, V91, P966, DOI 10.2307/1368081; Smart I.H.M., 1991, P101, DOI 10.1017/CBO9780511585739.009; Sockman KW, 2000, HORM BEHAV, V38, P168, DOI 10.1006/hbeh.2000.1616; Thomas L., 1980, FUNDAMENTALS HEAT TR; Tulp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038041; Turner JS, 2002, OX ORN SER, V13, P119; Verboven N, 2009, ANIM BEHAV, V77, P411, DOI 10.1016/j.anbehav.2008.10.022; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Windsor RL, 2013, J AVIAN BIOL, V44, P305, DOI 10.1111/j.1600-048X.2013.05768.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	28	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117728	10.1371/journal.pone.0117728	http://dx.doi.org/10.1371/journal.pone.0117728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658846	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900210
J	Wang, RJ; Li, JW; Bao, BH; Wu, HC; Du, ZH; Su, JL; Zhang, MH; Liang, HQ				Wang, Ren-jie; Li, Jian-wei; Bao, Bu-he; Wu, Huan-cheng; Du, Zhen-hua; Su, Jing-liang; Zhang, Ming-hua; Liang, Hai-qian			MicroRNA-873 (MiRNA-873) Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; GLIOMA; GROWTH; RNA; BRAIN; PROLIFERATION; PROTEINS; CANCER; TUMORS; CELLS	Glioblastoma multiforme (GBM) is known as a highly malignant brain tumor with a poor prognosis, despite intensive research and clinical efforts. In this study, we observed that microRNA-873 (miR-873) was expressed at low levels in GBM and that the overexpression of miR-873 dramatically reduced the cell proliferation, migration, and invasion of GBM cells. Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1, which stabilizes the mRNA transcripts of its target genes. These results demonstrate that miR-873 may constitute a potential target for GBM therapy.	[Wang, Ren-jie; Bao, Bu-he; Du, Zhen-hua; Zhang, Ming-hua] Logist Coll Armed Police Forces, Pingjin Hosp, Dept Clin Lab, Tianjin 300162, Peoples R China; [Li, Jian-wei; Wu, Huan-cheng; Su, Jing-liang; Liang, Hai-qian] Logist Coll Armed Police Forces, Pingjin Hosp, Dept Neurosurg, Tianjin 300162, Peoples R China		Liang, HQ (corresponding author), Logist Coll Armed Police Forces, Pingjin Hosp, Dept Neurosurg, 220 Chenglin Rd, Tianjin 300162, Peoples R China.	lianghaiqian711@163.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Kanu OO, 2009, CLIN MED INSIGHTS-ON, V3, P39; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun G, 2013, CANCER BIOTHER RADIO, V28, P327, DOI 10.1089/cbr.2012.1380; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	38	81	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8938	8948		10.1074/jbc.M114.624700	http://dx.doi.org/10.1074/jbc.M114.624700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670861	hybrid, Green Published			2022-12-26	WOS:000352207100021
J	Zhang, Y; Ying, JQ; Jiang, DS; Chang, ZG; Li, H; Zhang, GQ; Gong, S; Jiang, XH; Tao, J				Zhang, Yuan; Ying, Jiaoqian; Jiang, Dongsheng; Chang, Zhigang; Li, Hua; Zhang, Guoqiang; Gong, Shan; Jiang, Xinghong; Tao, Jin			Urotensin-II Receptor Stimulation of Cardiac L-type Ca2+ Channels Requires the beta gamma Subunits of G(i/o)-protein and Phosphatidylinositol 3-Kinase-dependent Protein Kinase C beta 1 Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CAV1.2 CALCIUM-CHANNELS; HEART-FAILURE; ACTIVATION; INHIBITION; MODULATION; CURRENTS; REGION; ALPHA; CELLS	Recent studies have demonstrated that urotensin-II (U-II) plays important roles in cardiovascular actions including cardiac positive inotropic effects and increasing cardiac output. However, the mechanisms underlying these effects of U-II in cardiomyocytes still remain unknown. We show by electrophysiological studies that U-II dose-dependently potentiates L-type Ca2+ currents (I-Ca,I- L) in adult rat ventricular myocytes. This effect was U-II receptor (U-IIR)-dependent and was associated with a depolarizing shift in the voltage dependence of inactivation. Intracellular application of guanosine-5'-O-(2-thiodiphosphate) and pertussis toxin pretreatment both abolished the stimulatory effects of U-II. Dialysis of cells with the QEHA peptide, but not scrambled peptide SKEE, blocked the U-II-induced response. The phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin as well as the class I PI3K antagonist CH132799 blocked the U-II-induced I-Ca,I- L response. Protein kinase C antagonists calphostin C and chelerythrine chloride as well as dialysis of cells with 1,2bis(2aminophenoxy)-ethaneN, N,N',N'-tetraacetic acid abolished the U-II-induced responses, whereas PKC beta inhibition or PKA blockade had no effect. Exposure of ventricular myocytes to U-II markedly increased membrane PKC beta(1) expression, whereas inhibition of PKC beta(1) pharmacologically or by shRNA targeting abolished the U-II-induced I-Ca,I- L response. Functionally, we observed a significant increase in the amplitude of sarcomere shortening induced by U-II; blockade of U-IIR as well as PKC beta inhibition abolished this effect, whereas Bay K8644 mimicked the U-II response. Taken together, our results indicate that U-II potentiates I-Ca,I- L through the beta gamma subunits of G(i/o)-protein and downstream activation of the class I PI3K-dependent PKC beta(1) isoform. This occurred via the activation of U-IIR and contributes to the positive inotropic effect on cardiomyocytes.	[Zhang, Yuan; Ying, Jiaoqian; Jiang, Dongsheng; Chang, Zhigang; Li, Hua; Gong, Shan; Jiang, Xinghong; Tao, Jin] Soochow Univ, Dept Physiol & Neurobiol, Coll Med, Suzhou 215123, Peoples R China; [Zhang, Yuan] Soochow Univ, Dept Geriatr, Suzhou 215004, Peoples R China; [Zhang, Yuan] Soochow Univ, Inst Neurosci, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Ying, Jiaoqian; Zhang, Guoqiang] China Japan Friendship Hosp, Dept Emergency Med, Beijing 100029, Peoples R China; [Jiang, Dongsheng] Univ Ulm, Dept Dermatol & Allerg Dis, D-89081 Ulm, Germany; [Li, Hua] Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; China-Japan Friendship Hospital; Ulm University	Tao, J (corresponding author), Soochow Univ, Dept Physiol & Neurobiol, Coll Med, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	taoj@suda.edu.cn	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671; Tao, Jin/0000-0002-8481-3732	National Natural Science Foundation of China [81171056, 31271258, 81200852, 81371229]; National Natural Science Foundation of China-CNRS Joint Program [81311130114]; Natural Science Funding of Jiangsu Province [BK2011293]; Natural Science Funding for Colleges and Universities in Jiangsu Province [12KJB320010]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; Soochow University; National University Student Innovation Programs; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-CNRS Joint Program; Natural Science Funding of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Funding for Colleges and Universities in Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Soochow University; National University Student Innovation Programs; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81171056, 31271258, 81200852, and 81371229; National Natural Science Foundation of China-CNRS Joint Program Grant 81311130114; Natural Science Funding of Jiangsu Province Grant BK2011293; Natural Science Funding for Colleges and Universities in Jiangsu Province Grant 12KJB320010; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to J. T.); Dong-Wu Scholar Funding of Soochow University (to J. T.); National University Student Innovation Programs (to Hong Jin); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blumenstein Y, 2002, J BIOL CHEM, V277, P3419, DOI 10.1074/jbc.C100642200; Bonneau B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004480; Bousette N, 2006, CURR HYPERTENS REP, V8, P479, DOI 10.1007/s11906-006-0026-7; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003936; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Douglas SA, 2002, LANCET, V359, P1990, DOI 10.1016/S0140-6736(02)08831-1; El Khoury N, 2014, J BIOL CHEM, V289, P21896, DOI 10.1074/jbc.M114.549642; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Farren MR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004656; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Gartlon J, 2001, PSYCHOPHARMACOLOGY, V155, P426, DOI 10.1007/s002130100715; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Herold CL, 2003, BRIT J PHARMACOL, V139, P203, DOI 10.1038/sj.bjp.0705251; Hoddah H, 2009, CELL CALCIUM, V46, P303, DOI 10.1016/j.ceca.2009.08.007; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lin YZ, 2003, HYPERTENS RES, V26, P839, DOI 10.1291/hypres.26.839; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mohan ML, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003308; Ng LL, 2002, CIRCULATION, V106, P2877, DOI 10.1161/01.CIR.0000044388.19119.02; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Niepel M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004379; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Richards AM, 2004, PEPTIDES, V25, P1795, DOI 10.1016/j.peptides.2004.04.017; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Russell FD, 2008, VASC HEALTH RISK MAN, V4, P775, DOI 10.2147/VHRM.S1983; Sainsily X, 2014, BIOCHEM PHARMACOL, V92, P280, DOI 10.1016/j.bcp.2014.08.023; Sardesai N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004518; Shaw RM, 2013, CARDIOVASC RES, V98, P177, DOI 10.1093/cvr/cvt021; Sirenko S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003391; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Tao J, 2004, PHARMACOL RES, V50, P471, DOI 10.1016/j.phrs.2004.05.006; Tao JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005125; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; TSENG GN, 1991, AM J PHYSIOL, V261, pH364, DOI 10.1152/ajpheart.1991.261.2.H364; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Viard P, 2001, BRIT J PHARMACOL, V132, P669, DOI 10.1038/sj.bjp.0703864; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Wu BN, 2009, VASC PHARMACOL, V51, P65, DOI 10.1016/j.vph.2009.03.001; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Zhang HY, 2010, BRIT J PHARMACOL, V160, P1631, DOI 10.1111/j.1476-5381.2010.00798.x; Zhang YM, 2012, J BIOL CHEM, V287, P18562, DOI 10.1074/jbc.M111.322271; Zhang YA, 2010, CELL SIGNAL, V22, P1660, DOI 10.1016/j.cellsig.2010.06.006; Zhang ZH, 1997, CIRC RES, V80, P720, DOI 10.1161/01.RES.80.5.720	68	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8644	8655		10.1074/jbc.M114.615021	http://dx.doi.org/10.1074/jbc.M114.615021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678708	hybrid, Green Published			2022-12-26	WOS:000351662600054
J	Huang, TC; Wu, YY; Chen, YG; Lai, SW; Wu, SC; Ye, RH; Lu, CS; Chen, JH				Huang, Tzu-Chuan; Wu, Yi-Ying; Chen, Yu-Guang; Lai, Shiue-Wei; Wu, Sheng-Cheng; Ye, Ren-Hua; Lu, Chieh-Sheng; Chen, Jia-Hong			Discrimination Index of Microcytic Anemia in Young Soldiers: A Single Institutional Analysis	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BETA-THALASSEMIA TRAIT; BLOOD-CELL INDEXES; DIFFERENTIAL-DIAGNOSIS; POPULATION; FORMULAS; ALPHA; RELIABILITY; PREVALENCE; CHILDREN	Background The common differential diagnosis of microcytic anemia in young Asian men includes iron deficiency anemia (IDA), alpha-thalassemia (alpha T) and beta-thalassemia (beta T). In this study, we aimed to distinguish between these diseases in a distinct population of young men using a specific index. Patients and Methods We retrospectively reviewed the laboratory data of young men with microcytic anemia. The clinical, characteristic and laboratory data, including complete blood cell counts, serum ferritin and hemoglobin electrophoresis results, were collected; genomic DNA mutations were also evaluated. Based on these data, ten discrimination indices were used to differentiate thalassemia from IDA. The sensitivity, specificity, positive and negative predictive values, Youden's index and receiver operating characteristic (ROC) curves were also calculated. Results A total of 877 patients (92 patients with IDA, 332 with aT and 453 with beta T) were enrolled; the Shine and Lal (S&L) formula was the best method with which to discriminate IDA from thalassemia (100% sensitivity, 91% specificity). The new cut-off values were evaluated, and the approaches used in our study cohort, particularly the Green & King (G&K) formula, significantly increased the accuracies of red cell distribution width-containing indices (cut-off value: 58.66; 89.62% sensitivity and 96.2% specificity; AUC: 0.9716). In addition, when applied properly, these indices could differentiate IDA patients from aT patients, especially Huber-Herklotz index (HH). Conclusions The sensitivity and specificity differed among ethnic and age groups. We concluded that when using the original cut-off value, the S&L formula was the best discriminating index for differentiating between IDA and thalassemia in young Asian men. However, when using the formula, the newly obtained cut-off value must be applied to increase accuracy based on the results from our cohort.	[Huang, Tzu-Chuan; Wu, Yi-Ying; Chen, Yu-Guang; Lai, Shiue-Wei; Wu, Sheng-Cheng; Ye, Ren-Hua; Lu, Chieh-Sheng; Chen, Jia-Hong] Triserv Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Wu, Yi-Ying] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University	Chen, JH (corresponding author), Triserv Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan.	ndmc_tw.tw@yahoo.com.tw		Lu, Chieh-Sheng/0000-0002-9056-3135; Wu, Yi-Ying/0000-0003-0411-6265				AlFadhli SM, 2007, J TROP PEDIATRICS, V53, P93, DOI 10.1093/tropej/fml070; Batebi A, 2012, TURK J MED SCI, V42, P275, DOI 10.3906/sag-0909-294; Beyan C, 2007, EUR J HAEMATOL, V78, P524, DOI 10.1111/j.1600-0609.2007.00853.x; Chern JPS, 2006, PEDIATR BLOOD CANCER, V46, P72, DOI 10.1002/pbc.20343; Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.x; Ehsani M A, 2009, Pak J Biol Sci, V12, P473, DOI 10.3923/pjbs.2009.473.475; Ferrara M, 2010, HEMATOLOGY, V15, P112, DOI 10.1179/102453310X12583347010098; Gorakshakar Ajit C, 2011, Indian J Hum Genet, V17, P115, DOI 10.4103/0971-6866.92079; GREEN R, 1989, BLOOD CELLS, V15, P481; HAMBLIN TJ, 1973, LANCET, V1, P676; Huber AR, 2004, SCHWEIZ MED FORUM, V4, P947; Janel A, 2011, HEMATOLOGY, V16, P123, DOI 10.1179/102453311X12940641877849; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Lima C S, 1996, Sao Paulo Med J, V114, P1265; LIN CK, 1991, J LAB CLIN MED, V118, P599; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Martin A, 2013, PEDIATR CLIN N AM, V60, P1383, DOI 10.1016/j.pcl.2013.08.008; Matos JF, 2013, HEMATOLOGY, V18, P169, DOI 10.1179/1607845412Y.0000000054; Mehdi Syed Riaz, 2011, Indian J Hum Genet, V17, P207, DOI 10.4103/0971-6866.92106; MENTZER WC, 1973, LANCET, V1, P882; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Nalbantoglu B, 2012, PEDIATR HEMAT ONCOL, V29, P472, DOI 10.3109/08880018.2012.705230; Nesa A, 2011, Mymensingh Med J, V20, P110; Niazi M, 2010, GOMAL J MED SCI, V8, P125; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-x; Okan V, 2009, J INT MED RES, V37, P25, DOI 10.1177/147323000903700103; Pranpanus Savitree, 2009, Journal of the Medical Association of Thailand, V92, P739; Rahim Fakher, 2009, Indian J Med Sci, V63, P101; Rathod DA, 2007, AM J CLIN PATHOL, V128, P585, DOI 10.1309/R1YL4B4BT2WCQDGV; RICERCA BM, 1987, HAEMATOLOGICA, V72, P409; Shen CA, 2010, J PEDIAT HEMATOL ONC, V32, pE218, DOI 10.1097/MPH.0b013e3181e5e26e; SHINE I, 1977, LANCET, V1, P692; Sirdah M, 2008, INT J LAB HEMATOL, V30, P324, DOI 10.1111/j.1751-553X.2007.00966.x; SRIVASTAVA PC, 1973, LANCET, V1, P832; Urrechaga E, 2009, INT J LAB HEMATOL, V31, P528, DOI 10.1111/j.1751-553X.2008.01073.x	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0114061	10.1371/journal.pone.0114061	http://dx.doi.org/10.1371/journal.pone.0114061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679510	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600002
J	Abdelmagid, SA; Clarke, SE; Nielsen, DE; Badawi, A; El-Sohemy, A; Mutch, DM; Ma, DWL				Abdelmagid, Salma A.; Clarke, Shannon E.; Nielsen, Daiva E.; Badawi, Alaa; El-Sohemy, Ahmed; Mutch, David M.; Ma, David W. L.			Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults	PLOS ONE			English	Article							SERUM PHOSPHOLIPIDS; FISH-OIL; OMEGA-3-FATTY-ACID LEVELS; DESATURASE ACTIVITIES; INSULIN-RESISTANCE; METABOLIC SYNDROME; REFERENCE RANGES; LINOLENIC ACID; GENE VARIANTS; ASSOCIATION	Circulating fatty acids (FA) are associated with a multitude of chronic diseases. However, a major gap in establishing such relationships is the lack of accepted fatty acid reference ranges representing healthy individuals. Data on validated FA reference ranges would provide a better understanding of study baseline measures and aid in the evaluation and interpretation of pharmaceutical or dietary interventions. Reference ranges for plasma FA levels have been reported in a few small studies and on a limited number of FA. Therefore, we determined the average and percentiles of a broad set of 61 FA (C14 - C24:1) from plasma total lipids from an ethnically diverse population of healthy young Canadian males and females (Total n = 826). Plasma concentrations of some of the major FA ranged from 0.3 to 4.1 mmol/L for palmitic acid, 0.1 to 1.0 mmol/L for stearic acid, 0.03 to 3.2 mmol/L for oleic acid, 0.2 to 5.0 mmol/L for linoleic acid (LA), 12.0 to 186.9 mu mol/L for alpha-linolenic acid, and 7.2 to 237.5 mu mol/L for docosahexaenoic acid (DHA). Males had significantly higher plasma concentrations of.-linolenic acid (GLA) and n-3 docosapentaenoic acid and lower concentrations of palmitoleic acid, LA and DHA than females. Comparison of FA concentrations between Caucasians, East Asians and South Asians revealed that South Asians had significantly lower levels of palmitoleic acid (p < 0.01) and oleic acid (p = 0.01) while East Asians had lower levels of GLA (p = 0.02) and dihomo-gamma-linolenic acid (p = 0.03). Overall, these data provide a comprehensive set of quantitative values that profiles a small cohort of Canadians which highlights the utility of establishing validated FA reference ranges thatmay be used to understand how deficient, suboptimal, or excess amounts of a given FA may be associated with chronic disease.	[Abdelmagid, Salma A.; Clarke, Shannon E.; Mutch, David M.; Ma, David W. L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Nielsen, Daiva E.; El-Sohemy, Ahmed] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Badawi, Alaa] Publ Hlth Agcy Canada, Off Biotechnol Genom & Populat Hlth, Toronto, ON, Canada	University of Guelph; University of Toronto; Public Health Agency of Canada	Ma, DWL (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	davidma@uoguelph.ca	Nielsen, Daiva/AAT-5028-2020; Badawi, Alaa/ABC-1300-2021; Nielsen, Daiva/ACI-1414-2022	Nielsen, Daiva/0000-0002-4265-5748; Mutch, David/0000-0002-0908-7259; Ma, David/0000-0002-1165-5972; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Food and Materials Network; Public Health Agency of Canada; Canada Foundation for Innovation; Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada	Advanced Food and Materials Network; Public Health Agency of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by grants from the Advanced Food and Materials Network (AES), the Public Health Agency of Canada (DMM and AB), and the Canada Foundation for Innovation with matching funds from the Ontario Research Fund (DWLM and DMM) and Natural Sciences and Engineering Research Council of Canada (DWLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum SJ, 2013, PROSTAG LEUKOTR ESS, V88, P3, DOI 10.1016/j.plefa.2012.05.001; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Bradbury KE, 2011, NUTRIENTS, V3, P152, DOI 10.3390/nu3010152; Buydens-Branchey L, 2011, PSYCHIAT RES, V188, P422, DOI 10.1016/j.psychres.2011.05.027; Cantwell MM, 2000, P NUTR SOC, V59, P187, DOI 10.1017/S0029665100000203; Chien KL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-33; Chorell E, 2012, MOL BIOSYST, V8, P1187, DOI 10.1039/c2mb05428k; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; DAYTON S, 1966, J LIPID RES, V7, P103; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-62; Evans SJ, 2012, J PSYCHIATR RES, V46, P1435, DOI 10.1016/j.jpsychires.2012.07.016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontaine-Bisson B, 2009, ATHEROSCLEROSIS, V204, P465, DOI 10.1016/j.atherosclerosis.2008.10.037; Gallo S, 2010, J CLIN ENDOCR METAB, V95, P2410, DOI 10.1210/jc.2009-1975; Garneau V, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-46; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Glaser C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012045; Glew RH, 2010, J HEALTH POPUL NUTR, V28, P159; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Holub BJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-58; Kawashima A, 2009, J NUTR SCI VITAMINOL, V55, P400, DOI 10.3177/jnsv.55.400; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Klein CJ, 2013, NUTR CLIN PRACT, V28, P87, DOI 10.1177/0884533612469989; Kris-Etherton PM, 1999, CIRCULATION, V100, P1253, DOI 10.1161/01.CIR.100.11.1253; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee S, 2012, BRIT J NUTR, V107, P567, DOI 10.1017/S0007114511003199; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; MATTHEWS D R, 1985, Netherlands Journal of Medicine, V28, P20; Meldrum SJ, 2012, PROSTAG LEUKOTR ESS, V86, P233, DOI 10.1016/j.plefa.2012.03.006; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Miller MR, 2010, MATERN CHILD NUTR, V6, P338, DOI 10.1111/j.1740-8709.2009.00230.x; Monteiro J, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-60; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Neggers YH, 2009, ASIA PAC J CLIN NUTR, V18, P22; Ottestad I, 2012, BRIT J NUTR, V108, P315, DOI 10.1017/S0007114511005484; Park Y, 2009, NUTR RES, V29, P825, DOI 10.1016/j.nutres.2009.10.018; Park Y, 2009, J MED FOOD, V12, P803, DOI 10.1089/jmf.2008.1250; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pawlosky R, 2003, BRIT J NUTR, V90, P993, DOI 10.1079/BJN2003985; Pawlosky RJ, 2003, AM J CLIN NUTR, V77, P565, DOI 10.1093/ajcn/77.3.565; Perez-Martinez P, 2012, MOL NUTR FOOD RES, V56, P309, DOI 10.1002/mnfr.201100504; Rasic-Milutinovic Z, 2012, ARCH MED RES, V43, P75, DOI 10.1016/j.arcmed.2011.12.008; REEVES V B, 1984, American Journal of Clinical Nutrition, V40, P1345, DOI 10.1093/ajcn/40.6.1345; Roke K, 2013, PROSTAGLANDINS LEUKO, DOI [10.1016/j.plefa.2013.12.006, DOI 10.1016/J.PLEFA.2013.12.006]; Sabel KG, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-20; Sauerwald UC, 2012, J PEDIATR GASTR NUTR, V54, P353, DOI 10.1097/MPG.0b013e31823c3bfd; Schuchardt JP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-145; SCHWERTNER HA, 1993, CLIN CHEM, V39, P659; SERA RK, 1994, J CLIN LAB ANAL, V8, P81, DOI 10.1002/jcla.1860080205; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Steffen BT, 2012, EUR J CLIN NUTR, V66, P600, DOI 10.1038/ejcn.2011.215; Sun Q, 2007, AM J CLIN NUTR, V86, P74, DOI 10.1093/ajcn/86.1.74; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Telle-Hansen VH, 2012, LIPIDS, V47, P151, DOI 10.1007/s11745-011-3637-y; Wheeler SJ, 2011, BRIT J NUTR, V105, P601, DOI 10.1017/S0007114510004083; Wilk JB, 2012, AM J CLIN NUTR, V96, P882, DOI 10.3945/ajcn.112.042671; Woods MN, 2009, AM J CLIN NUTR, V89, P1180, DOI 10.3945/ajcn.2009.27444; Yaemsiri S, 2013, STROKE, V44, P2710, DOI 10.1161/STROKEAHA.111.000834; Yamagishi K, 2013, CEREBROVASC DIS, V36, P38, DOI [10.1159/000351205, 10.1159/000351151]; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008; Zulyniak MA, 2012, APPL PHYSIOL NUTR ME, V37, P1003, DOI [10.1139/h2012-081, 10.1139/H2012-081]	73	179	180	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116195	10.1371/journal.pone.0116195	http://dx.doi.org/10.1371/journal.pone.0116195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675440	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000007
J	Marcil, V; Amre, D; Seidman, EG; Boudreau, F; Gendron, FP; Menard, D; Beaulieu, JF; Sinnett, D; Lambert, M; Levy, E				Marcil, Valerie; Amre, Devendra; Seidman, Ernest G.; Boudreau, Francois; Gendron, Fernand P.; Menard, Daniel; Beaulieu, Jean Francois; Sinnett, Daniel; Lambert, Marie; Levy, Emile			Hepatocyte Nuclear Factor 4 Alpha Polymorphisms and the Metabolic Syndrome in French-Canadian Youth	PLOS ONE			English	Article							P2 PROMOTER VARIANTS; TYPE-2 DIABETES SUSCEPTIBILITY; FACTOR 4-ALPHA; GENETIC-VARIANTS; FACTOR-4-ALPHA GENE; COMMON VARIANTS; FATTY-ACID; TRANSCRIPTIONAL REGULATION; REPRESENTATIVE SAMPLE; INSULIN-RESISTANCE	Objectives Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a transcription factor involved in the regulation of serum glucose and lipid levels. Several HNF4A gene variants have been associated with the risk of developing type 2 diabetes mellitus. However, no study has yet explored its association with insulin resistance and the cardiometabolic risk in children. We aimed to investigate the relationship between HNF4A genetic variants and the presence of metabolic syndrome (MetS) and metabolic parameters in a pediatric population. Design and Methods Our study included 1,749 French-Canadians aged 9, 13 and 16 years and evaluated 24 HNF4A polymorphisms that were previously identified by sequencing. Results Analyses revealed that, after correction for multiple testing, one SNP (rs736824; P< 0.022) and two haplotypes (P1 promoter haplotype rs6130608-rs2425637; P< 0.032 and intronic haplotype rs736824-rs745975-rs3212183; P< 0.025) were associated with the risk of MetS. Additionally, a significant association was found between rs3212172 and apolipoprotein B levels (coefficient: -0.14 +/- 0.05; P<0.022). These polymorphisms are located in HNF4A P1 promoter or in intronic regions. Conclusions Our study demonstrates that HNF4 alpha genetic variants are associated with the MetS and metabolic parameters in French Canadian children and adolescents. This study, the first exploring the relation between HNF4A genetic variants and MetS and metabolic variables in a pediatric cohort, suggests that HNF4 alpha could represent an early marker for the risk of developing type 2 diabetes mellitus.	[Marcil, Valerie; Seidman, Ernest G.] McGill Univ, Res Inst, Montreal, PQ H3G 1A4, Canada; [Amre, Devendra; Sinnett, Daniel; Lambert, Marie] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Seidman, Ernest G.; Boudreau, Francois; Gendron, Fernand P.; Menard, Daniel; Beaulieu, Jean Francois; Levy, Emile] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Levy, Emile] Univ Montreal, CHU St Justine, Dept Nutr, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Levy, E (corresponding author), Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.	emile.levy@recherche-ste-Justine.qc.ca	AMRE, DEVENDRA K/D-4988-2015; Menard, Daniel/AAL-7821-2021; sinnett, daniel/S-4589-2017; Gendron, Fernand-Pierre/AAN-2965-2021	sinnett, daniel/0000-0003-3625-6676; 	Canadian Institutes of Health Research Team Grant [CTP-82942]; J.A. DeSeve Research Chair in Nutrition; Canada Research Chair in Immune Mediated Gastrointestinal Disorders; Canadian Institutes of Health Research Fellowship Award; Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR)); J.A. DeSeve Research Chair in Nutrition; Canada Research Chair in Immune Mediated Gastrointestinal Disorders; Canadian Institutes of Health Research Fellowship Award(Canadian Institutes of Health Research (CIHR)); Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University	This study was supported by the Canadian Institutes of Health Research Team Grant (CTP-82942), the J.A. DeSeve Research Chair in Nutrition (EL), the Canada Research Chair in Immune Mediated Gastrointestinal Disorders (ES), the Canadian Institutes of Health Research Fellowship Award and The Richard and Edith Strauss Postdoctoral Fellowships Award in Medicine, McGill University (VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Allard P, 2003, CLIN CHEM, V49, P644, DOI 10.1373/49.4.644; Andrulionye L, 2006, J MOL MED-JMM, V84, P701, DOI 10.1007/s00109-006-0063-3; Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Bourgey M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019368; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Chavali S, 2011, J HUM GENET, V56, P695, DOI 10.1038/jhg.2011.83; Cook S, 2008, J PEDIATR, V152, P165, DOI 10.1016/j.jpeds.2007.06.004; D'Adamo E, 2013, CURR PROB PEDIATR AD, V43, P114, DOI 10.1016/j.cppeds.2013.02.004; Damcott CM, 2004, DIABETES, V53, P3337, DOI 10.2337/diabetes.53.12.3337; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ek J, 2006, DIABETES, V55, P1869, DOI 10.2337/db05-1684; Eppens MC, 2006, CURR MED RES OPIN, V22, P1013, DOI 10.1185/030079906X104795; Ettinger LM, 2005, J PEDIATR-US, V147, P67, DOI 10.1016/j.jpeds.2005.02.003; Flegal KM, 2011, ADV NUTR, V2, p159S, DOI 10.3945/an.111.000307; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hansen SK, 2005, DIABETOLOGIA, V48, P452, DOI 10.1007/s00125-005-1671-0; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Hara K, 2006, DIABETES, V55, P1260, DOI 10.2337/db05-0620; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Huang WH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S68; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koo SH, 2007, BIOL PROCED ONLINE, V9, P27, DOI 10.1251/bpo131; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Lehman DM, 2007, DIABETES, V56, P513, DOI 10.2337/db06-0881; Leng SY, 2007, AM J PHYSIOL-GASTR L, V293, pG475, DOI 10.1152/ajpgi.00072.2007; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; Malecki MT, 1998, DIABETES, V47, P970, DOI 10.2337/diabetes.47.6.970; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; METZGER S, 1993, J BIOL CHEM, V268, P16831; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Muller YHL, 2005, DIABETES, V54, P3035, DOI 10.2337/diabetes.54.10.3035; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Paradis G, 2003, CAN J CARDIOL, V19, P523; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Pramfalk C, 2009, ARTERIOSCL THROM VAS, V29, P1235, DOI 10.1161/ATVBAHA.109.188581; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Saif-Ali R, 2011, ACTA BIOCHIM POL, V58, P179; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sookoian S, 2010, MOL GENET METAB, V99, P80, DOI 10.1016/j.ymgme.2009.08.004; Stan S, 2005, CLIN CHEM, V51, P1192, DOI 10.1373/clinchem.2004.046771; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Tanahashi T, 2006, HUM GENET, V120, P527, DOI 10.1007/s00439-006-0231-0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Vaxillaire M, 2005, DIABETOLOGIA, V48, P440, DOI 10.1007/s00125-004-1665-3; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wanic K, 2006, DIABETES METAB, V32, P86, DOI 10.1016/S1262-3636(07)70252-5; Weedon MN, 2004, DIABETES, V53, P3002, DOI 10.2337/diabetes.53.11.3002; Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902; Weissglas-Volkov D, 2006, DIABETES, V55, P1970, DOI 10.2337/db06-0035; Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	78	21	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117238	10.1371/journal.pone.0117238	http://dx.doi.org/10.1371/journal.pone.0117238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671620	gold, Green Published, Green Submitted			2022-12-26	WOS:000349545300043
J	Mukesh; Kumar, VP; Sharma, LK; Shukla, M; Sathyakumar, S				Mukesh; Kumar, Ved P.; Sharma, Lalit K.; Shukla, Malay; Sathyakumar, Sambandam			Pragmatic Perspective on Conservation Genetics and Demographic History of the Last Surviving Population of Kashmir Red Deer (Cervus elaphus hanglu) in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; VIABILITY ANALYSIS; STATISTICAL TESTS; PHYLOGEOGRAPHY; GROWTH; NEUTRALITY; PHYLOGENY; DIVERSITY; SOFTWARE; NUMBER	The hangul (Cervus elaphus hanglu) is of great conservation concern because it represents the easternmost and only hope for an Asiatic survivor of the red deer species in the Indian subcontinent. Despite the rigorous conservation efforts of the Department of Wildlife Protection in Jammu & Kashmir, the hangul population has experienced a severe decline in numbers and range contraction in the past few decades. The hangul population once abundant in the past has largely become confined to the Dachigam landscape, with a recent population estimate of 218 individuals. We investigated the genetic variability and demographic history of the hangul population and found that it has shown a relatively low diversity estimates when compared to other red deer populations of the world. Neutrality tests, which are used to evaluate demographic effects, did not support population expansion, and the multi-modal pattern of mismatch distribution indicated that the hangul population is under demographic equilibrium. Furthermore, the hangul population did not exhibit any signature of bottleneck footprints in the past, and Coalescent Bayesian Skyline plot analysis revealed that the population had not experienced any dramatic changes in the effective population size over the last several thousand years. We observed a strong evidence of sub-structuring in the population, wherein the majority of individuals were assigned to different clusters in Bayesian cluster analysis. Population viability analysis demonstrated insignificant changes in the mean population size, with a positive growth rate projected for the next hundred years. We discuss the phylogenetic status of hangul for the first time among the other red deer subspecies of the world and strongly recommend to upgrade hangul conservation status under IUCN that should be discrete from the other red deer subspecies of the world to draw more conservation attention from national and international bodies.	[Mukesh; Kumar, Ved P.; Sharma, Lalit K.; Sathyakumar, Sambandam] Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India; [Shukla, Malay] Gujarat Forens Sci Univ, Gandhinagar 382007, Gujarat, India	Wildlife Institute of India; National Forensic Sciences University	Mukesh (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India.	thamukesh@gmail.com		SHUKLA, MALAY/0000-0002-7239-5537; Sharma, Lalit Kumar/0000-0003-1214-7416				Ahmad Khursheed, 2009, Journal of the Bombay Natural History Society, V106, P245; [Anonymous], 2014, TRACER V1 6; Balakrishnan CN, 2003, MOL ECOL, V12, P1, DOI 10.1046/j.1365-294X.2003.01751.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Bennett A. F, 2003, LINKAGES LANDSCAPE R, DOI DOI 10.2305/IUCN.CH.2004.FR.1.EN; BENTON TG, 1995, EVOL ECOL, V9, P559, DOI 10.1007/BF01237655; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brown LM, 2004, CONSERV GENET, V5, P743, DOI 10.1007/s10592-004-1865-x; Charoo SA, 2010, SPAN J WILDL GALEMYS, V22, P171; Charoo SA, 2011, MONITORING HANGUL DA; Cornuet JM, 1996, GENETICS, V144, P2001; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feulner PGD, 2004, HEREDITY, V93, P299, DOI 10.1038/sj.hdy.6800504; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gaur A, 2003, MOL ECOL NOTES, V3, P607, DOI 10.1046/j.1471-8286.2003.00528.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Huang HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091570; IUCN, 1987, IUCN POL STAT CAPT B; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Lacy RC, 2014, VORTEX 10 USERS MANU, DOI [10.1097/OPX.0000000000000387, DOI 10.1097/0PX.0000000000000387]; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mahmut H, 2002, ZOOL SCI, V19, P485, DOI 10.2108/zsj.19.485; McDevitt AD, 2009, MAMM BIOL, V74, P263, DOI 10.1016/j.mambio.2009.03.015; Meffe G. K., 1994, PRINCIPLES CONSERVAT; Mukesh, 2013, BMC Res Notes, V6, P326, DOI 10.1186/1756-0500-6-326; Mukesh, 2013, ZOO BIOL, V32, P476, DOI 10.1002/zoo.21081; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Perez-Espona S, 2009, HEREDITY, V102, P199, DOI 10.1038/hdy.2008.111; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Pritchard JK, 2000, GENETICS, V155, P945; Pudovkin AI, 1996, GENETICS, V144, P383; Qureshi Qamar, 2009, Journal of the Bombay Natural History Society, V106, P63; Randi E, 1998, P ROY SOC B-BIOL SCI, V265, P793, DOI 10.1098/rspb.1998.0362; Randi E, 2001, ANIM CONSERV, V4, P1, DOI 10.1017/S1367943001001019; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; SCHALLER G B, 1969, Journal of the Bombay Natural History Society, V66, P1; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stoneking M, 1992, PHIL T ROY B, V337, P34; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1995, GENETICS, V140, P767; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Zachos FE, 2011, MAMMAL REV, V41, P138, DOI 10.1111/j.1365-2907.2010.00177.x; Zachos FE, 2009, WILDLIFE BIOL, V15, P175, DOI 10.2981/07-075	61	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117069	10.1371/journal.pone.0117069	http://dx.doi.org/10.1371/journal.pone.0117069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671567	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300033
J	Wang, FF; Zou, YF; Shen, YF; Zhong, YQ; Lv, YN; Huang, DM; Chen, KC; Li, Q; Qing, L; Xia, B; Su, C; Ma, SY; Yang, XB				Wang, Fenfen; Zou, Yunfeng; Shen, Yuefei; Zhong, Yaoqiu; Lv, Yingnan; Huang, Damin; Chen, Kangcheng; Li, Qin; Qing, Li; Xia, Bing; Su, Cheng; Ma, Shuyan; Yang, Xiaobo			Synergistic Impaired Effect between Smoking and Manganese Dust Exposure on Pulmonary Ventilation Function in Guangxi Manganese-Exposed Workers Healthy Cohort (GXMEWHC)	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; LUNG-FUNCTION; INHALATION; EMPLOYEES	Purpose The aims of this study were to investigate the effects of manganese (Mn) dust exposure on lung functions and evaluate the potential synergistic effect between smoking and Mn dust exposure among refinery workers. Methods A retrospective study including 1658 workers in a ferromanganese refinery was conducted, with subjects who were from the Guangxi manganese-exposed workers healthy cohort (GXMEWHC). Based on the Mn manganese cumulative exposure index (Mn-CEI), all subjects were divided into the low exposure group (n = 682) and the high exposure group (n = 976). A pulmonary function test was performed using an electronic spirometer, including the values and percentages of FVC, FEV1, FEV1/FVC, MMEF, PEFR, MVV, respectively. Results No significant effect of Mn dust exposure on the pulmonary function was found in the female workers (all p> 0.05). However, there was an obvious decrease in the male workers in the high exposure group compared with those in the low exposure group (FVC -60 ml, FEV1 -120 ml, MMEF -260 ml/s, MVV -5.06 L, all p< 0.05). In the high exposure group, the reduction in FVC% predicted, MMEF and MMEF% predicted was 1.0%, 210 mL/s, and 4.9%, respectively. In particular, among the exposed subjects smokers had a statistically significant decrease in lung function compared with non-smokers and the reduction in FVC% predicted, MMEF and MMEF % predicted was 1.0%, 210 mL/s, and 4.9%, respectively (p<0.05). Partial correlation analysis showed that there was also negative correlation between Mn-CEI and decreased changes in MMEF (r = -0.159, p = 0.018) and also MMEF% predicted (r = -0.163, p = 0.015). Conclusions Mn dust can impair the pulmonary ventilation function of male workers but not females, and individual smoking habits and manganese exposure had a synergistic effect on the lung function decrease.	[Wang, Fenfen; Zhong, Yaoqiu; Lv, Yingnan; Huang, Damin; Chen, Kangcheng; Xia, Bing; Su, Cheng; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Zou, Yunfeng; Li, Qin; Qing, Li; Ma, Shuyan] Guangxi Med Univ, Sch Publ Hlth, Dept Toxicol, Nanning, Guangxi, Peoples R China; [Shen, Yuefei] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Yang, XB (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China.	yxbo21021@163.com	Yang, Xiaobo/G-3854-2016		National Natural Science Foundation of China [81472962, 21167004, 81160339]; Guangxi Science Fund for Distinguished Young Scholars [2012jjFA40011]; Guangxi Natural Science Foundation [2011jjA40294]; Guangxi science and technology development project [1355007-1]; Program for New Century Excellent Talents in University [NCET-12-0653]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi science and technology development project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was funded by National Natural Science Foundation of China (81472962, 21167004, and 81160339); Guangxi Science Fund for Distinguished Young Scholars (2012jjFA40011); Guangxi Natural Science Foundation (2011jjA40294); Guangxi science and technology development project (1355007-1); and Program for New Century Excellent Talents in University (NCET-12-0653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Beaupre LA, 2004, INHAL TOXICOL, V16, P231, DOI 10.1080/08958370490277245; Beckett WS, 1996, J OCCUP ENVIRON MED, V38, P1229, DOI 10.1097/00043764-199612000-00008; Boojar MMA, 2002, J OCCUP ENVIRON MED, V44, P282; Bowler RM, 2007, OCCUP ENVIRON MED, V64, P167, DOI 10.1136/oem.2006.028761; Burton NC, 2009, ENVIRON HEALTH PERSP, V117, P325, DOI [10.1289/ehp.0800035, 10.1289/ehp.1173c25]; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Deng Q, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-30; Dimich-Ward H, 2012, LUNG, V190, P147, DOI 10.1007/s00408-011-9344-x; Dorman DC, 2008, TOXICOL SCI, V106, P46, DOI 10.1093/toxsci/kfn159; Dorman DC, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-121; Etemadinejad Siavash, 2009, Indian J Med Sci, V63, P543, DOI 10.4103/0019-5359.59987; Jaakkola MS, 2011, INT ARCH OCC ENV HEA, V84, P151, DOI 10.1007/s00420-010-0603-6; Jaen Angeles, 2006, Environ Health, V5, P2, DOI 10.1186/1476-069X-5-2; Johnsen HL, 2008, AM J IND MED, V51, P296, DOI 10.1002/ajim.20557; Johnsen HL, 2010, AM J RESP CRIT CARE, V181, P1234, DOI 10.1164/rccm.200809-1381OC; KESSEL R, 1989, BRIT J IND MED, V46, P128; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Levy BS, 2003, INT J OCCUP ENV HEAL, V9, P153, DOI 10.1179/oeh.2003.9.2.153; Loukzadeh Z, 2009, OCCUP MED-OXFORD, V59, P267, DOI 10.1093/occmed/kqp033; Lv YN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005070; Melville AM, 2010, EUR RESPIR J, V36, P488, DOI 10.1183/09031936.00038309; Meo SA, 2013, INT J ENV RES PUB HE, V10, P390, DOI 10.3390/ijerph10010390; Myers JE, 2003, NEUROTOXICOLOGY, V24, P885, DOI 10.1016/S0161-813X(03)00081-0; Neghab M, 2012, IRAN RED CRESCENT ME, V14, P549; Nemoto T, 2011, INTERNAL MED, V50, P2547, DOI 10.2169/internalmedicine.50.5948; Nicola ML, 2014, CHEST, V145, P998, DOI 10.1378/chest.13-1355; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sharifian Seyed Akbar, 2011, Acta Med Iran, V49, P98; Soyseth V, 2011, AM J IND MED, V54, P707, DOI 10.1002/ajim.20946; Steliga MA, 2011, SURG ONCOL CLIN N AM, V20, P605, DOI 10.1016/j.soc.2011.07.003; Wittczak T, 2008, INT J OCCUP MED ENV, V21, P81, DOI 10.2478/v10001-007-0041-1; Zou L, 2014, EUR J CANCER, V50, P193, DOI 10.1016/j.ejca.2013.08.014; Zou YF, 2014, OCCUP ENVIRON MED, V71, P189, DOI 10.1136/oemed-2013-101896	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116558	10.1371/journal.pone.0116558	http://dx.doi.org/10.1371/journal.pone.0116558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664879	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100010
J	Banas, M; Zegar, A; Kwitniewski, M; Zabieglo, K; Marczynska, J; Kapinska-Mrowiecka, M; LaJevic, M; Zabel, BA; Cichy, J				Banas, Magdalena; Zegar, Aneta; Kwitniewski, Mateusz; Zabieglo, Katarzyna; Marczynska, Joanna; Kapinska-Mrowiecka, Monika; LaJevic, Melissa; Zabel, Brian A.; Cichy, Joanna			The Expression and Regulation of Chemerin in the Epidermis	PLOS ONE			English	Article							SKIN INFLAMMATION; ONCOSTATIN-M; EPITHELIAL-CELLS; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; RECEPTOR CCRL2; DISEASED SKIN; MESSENGER-RNA	Chemerin is a protein ligand for the G protein-coupled receptor CMKLR1 and also binds to two atypical heptahelical receptors, CCRL2 and GPR1. Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein. Although chemerin was initially identified as a highly expressed gene in healthy skin keratinocytes that was downregulated during psoriasis, the regulation of chemerin and its receptors in the skin by specific cytokines and microbial factors remains unexplored. Here we show that chemerin, CMKLR1, CCRL2 and GPR1 are expressed in human and mouse epidermis, suggesting that this tissue may be both a source and target for chemerin mediated effects. In human skin cultures, chemerin is significantly downregulated by IL-17 and IL-22, key cytokines implicated in psoriasis, whereas it is upregulated by acute phase cytokines oncostatin M and IL-1 beta. Moreover, we show that human keratinocytes in vitro and mouse skin in vivo respond to specific microbial signals to regulate expression levels of chemerin and its receptors. Furthermore, in a cutaneous infection model, chemerin is required for maximal bactericidal effects in vivo. Together, our findings reveal previously uncharacterized regulators of chemerin expression in skin and identify a physiologic role for chemerin in skin barrier defense against microbial pathogens.	[Banas, Magdalena; Zegar, Aneta; Kwitniewski, Mateusz; Zabieglo, Katarzyna; Marczynska, Joanna; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kapinska-Mrowiecka, Monika] Zeromski Hosp, Dept Dermatol, Krakow, Poland; [LaJevic, Melissa] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [LaJevic, Melissa; Zabel, Brian A.] VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA USA	Jagiellonian University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Cichy, J (corresponding author), Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Kwitniewski, Mateusz/V-4523-2019	Kwitniewski, Mateusz/0000-0002-2743-6934; Cichy, Joanna/0000-0002-0552-8344	Polish National Science Center [0724/B/P01/2011/40, UMO-2014/12/W/NZ6/00454]; Foundation for Polish Science [TEAM/2010-5/1]; European Union within European Regional Development Fund; European Union [POIG.02.01.00-12-064/08]; DoD [W81XWH-11-1-0512]; NIH [AI-079320]; National Institutes of Health Training Grants [5 T32AI07290, T32CA09151, F32CA180415]; NATIONAL CANCER INSTITUTE [T32CA009151, F32CA180415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320, T32AI007290] Funding Source: NIH RePORTER	Polish National Science Center; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union within European Regional Development Fund; European Union(European Commission); DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from Polish National Science Center 0724/B/P01/2011/40, UMO-2014/12/W/NZ6/00454 and the Foundation for Polish Science TEAM/2010-5/1, co-financed by the European Union within European Regional Development Fund (to JC); The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08). This work was also supported by DoD grant W81XWH-11-1-0512 and NIH grant AI-079320 (to BAZ). ML was a recipient of fellowship support under National Institutes of Health Training Grants 5 T32AI07290, T32CA09151 and F32CA180415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Baumann H, 2000, J BIOL CHEM, V275, P22014, DOI 10.1074/jbc.M002830200; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cichy J, 1997, J BIOL CHEM, V272, P8250, DOI 10.1074/jbc.272.13.8250; CICHY J, 1995, J CLIN INVEST, V95, P2729, DOI 10.1172/JCI117975; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gonzalvo-Feo S, 2014, J IMMUNOL, V192, P2366, DOI 10.4049/jimmunol.1302028; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham KL, 2009, J IMMUNOL, V183, P6717, DOI 10.4049/jimmunol.0803435; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kulig P, 2005, CYTOKINE, V30, P269, DOI 10.1016/j.cyto.2005.01.019; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; KUPPER TS, 1988, J CLIN INVEST, V82, P1787, DOI 10.1172/JCI113792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rourke JL, 2014, J ENDOCRINOL; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Skrzeczynska-Moncznik J, 2009, BIOCHEM BIOPH RES CO, V380, P323, DOI 10.1016/j.bbrc.2009.01.071; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zabel BA, 2014, AM J CLIN EXP IMMUNO, V3, P1	53	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117830	10.1371/journal.pone.0117830	http://dx.doi.org/10.1371/journal.pone.0117830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659101	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900230
J	Chou, ML; Burnouf, T; Chang, SP; Hung, TC; Lin, CC; Richardson, CD; Lin, LT				Chou, Ming-Li; Burnouf, Thierry; Chang, Shun-Pang; Hung, Ting-Chun; Lin, Chun-Ching; Richardson, Christopher D.; Lin, Liang-Tzung			TnBP/Triton X-45 Treatment of Plasma for Transfusion Efficiently Inactivates Hepatitis C Virus	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; SOLVENT/DETERGENT TREATMENT; CELL-CULTURE; PATHOGEN INACTIVATION; TREATED PLASMA; BAG SYSTEM; BLOOD; CRYOPRECIPITATE; REPLICATION; REDUCTION	Risk of transmission of hepatitis C virus (HCV) by clinical plasma remains high in countries with a high prevalence of hepatitis C, justifying the implementation of viral inactivation treatments. In this study, we assessed the extent of inactivation of HCV during minipool solvent/detergent (SD; 1% TnBP / 1% Triton X-45) treatment of human plasma. Luciferase-tagged infectious cell culture-derived HCV (HCVcc) particles were used to spike human plasma prior to treatment by SD at 31 +/- 0.5 degrees C for 30 min. Samples were taken before and after SD treatment and filtered on a Sep-Pak Plus C18 cartridge to remove the SD agents. Risk of cytotoxicity was assessed by XTT cell viability assay. Viral infectivity was analyzed based on the luciferase signals, 50% tissue culture infectious dose viral titer, and immunofluorescence staining for HCV NS5A protein. Total protein, cholesterol, and triglyceride contents were determined before and after SD treatment and C18 cartridge filtration. Binding analysis, using patient-derived HCV clinical isolates, was also examined to validate the efficacy of the inactivation by SD. SD treatment effectively inactivated HCVcc within 30 min, as demonstrated by the baseline level of reporter signals, total loss of viral infectivity, and absence of viral protein NS5A. SD specifically targeted HCV particles to render them inactive, with essentially no effect on plasma protein content and hemostatic function. More importantly, the efficacy of the SD inactivation method was confirmed against various genotypes of patient-derived HCV clinical isolates and against HCVcc infection of primary human hepatocytes. Therefore, treatment by 1% TnBP / 1% Triton X-45 at 31 degrees C is highly efficient to inactivate HCV in plasma for transfusion, showing its capacity to enhance the safety of therapeutic plasma products. We propose that the methodology used here to study HCV infectivity can be valuable in the validation of viral inactivation and removal processes of human plasma-derived products.	[Chou, Ming-Li; Lin, Liang-Tzung] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Chang, Shun-Pang; Lin, Chun-Ching] Kaohsiung Med Univ, Sch Pharm, Coll Pharm, Kaohsiung, Taiwan; [Hung, Ting-Chun] Chi Mei Med Ctr, Dept Clin Pathol, Tainan, Taiwan; [Richardson, Christopher D.] Izaak Walton Killam Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Richardson, Christopher D.] Izaak Walton Killam Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Kaohsiung Medical University; Chi Mei Hospital; Dalhousie University; Dalhousie University; Taipei Medical University	Lin, LT (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.	ltlin@tmu.edu.tw	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Lin, Liang-Tzung/0000-0001-7374-7234	Taipei Medical University [TMU101-AE3-Y19]; Ministry of Science and Technology of Taiwan [MOST101-2320-B-038-038-MY2]	Taipei Medical University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	LTL is supported in part by research grants from Taipei Medical University (TMU101-AE3-Y19) and the Ministry of Science and Technology of Taiwan (MOST101-2320-B-038-038-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Attia MA, 1998, ANTIVIR THER, V3, P1; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Blaising J, 2013, BIOCHIMIE, V95, P96, DOI 10.1016/j.biochi.2012.07.016; Burnouf T, 2008, TRANSFUS CLIN BIOL, V15, P129, DOI 10.1016/j.tracli.2008.04.007; Burnouf T, 2013, VOX SANG, V104, P1, DOI 10.1111/j.1423-0410.2012.01621.x; Burnouf T, 2007, BIOLOGICALS, V35, P349, DOI 10.1016/j.biologicals.2007.03.002; Burnouf T, 2006, TRANSFUSION, V46, P2100, DOI 10.1111/j.1537-2995.2006.01035.x; Burnouf T, 2014, LANCET, V384, P1347, DOI 10.1016/S0140-6736(14)61693-7; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Alarcon P, 2005, TRANSFUSION, V45, P1362, DOI 10.1111/j.1537-2995.2005.00216.x; El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Findlay JY, 2000, J CLIN ANESTH, V12, P319, DOI 10.1016/S0952-8180(00)00162-8; Gondeau C, 2014, GUT, V63, P1490, DOI 10.1136/gutjnl-2013-304623; Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552; Hornsey VS, 2009, TRANSFUSION, V49, P2167, DOI 10.1111/j.1537-2995.2009.02272.x; Horowitz B, 2004, WHO TECH REP SER, V924, P1; HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x; HOROWITZ B, 1992, BLOOD, V79, P826; Horowitz B, 1998, VOX SANG, V74, P203, DOI 10.1111/j.1423-0410.1998.tb05473.x; Jellinger PS, 2012, ENDOCR PRACT, V18, P270, DOI 10.4158/EP.18.2.269; Kakkar N, 2004, TRANSFUSION MED, V14, P231, DOI 10.1111/j.0958-7578.2004.00505.x; Klein HG, 2013, NEW ENGL J MED, V368, P199, DOI 10.1056/NEJMp1213134; Klein HG, 2005, J INTERN MED, V257, P224, DOI 10.1111/j.1365-2796.2005.01451.x; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LUNDSGAARDHANSEN P, 1983, B WORLD HEALTH ORGAN, V61, P7; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; MOHR H, 1993, INFUSIONSTHERAPIE, V20, P19; PIQUET Y, 1992, VOX SANG, V63, P251, DOI 10.1111/j.1423-0410.1992.tb01230.x; Reker C, 2014, INT J INFECT DIS; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Shimakami T, 2009, CURR OPIN PHARMACOL, V9, P537, DOI 10.1016/j.coph.2009.08.008; Steinmann E, 2013, TRANSFUSION, V53, P1010, DOI 10.1111/j.1537-2995.2012.03858.x; The Merck Manuals Online, 2013, NORMAL LABORATORY VA; Thursz M, 2014, NAT REV GASTRO HEPAT, V11, P28, DOI 10.1038/nrgastro.2013.179; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	41	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117800	10.1371/journal.pone.0117800	http://dx.doi.org/10.1371/journal.pone.0117800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658612	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900226
J	Cowell, JM; Samek, A; List, J; Decety, J				Cowell, Jason M.; Samek, Anya; List, John; Decety, Jean			The Curious Relation between Theory of Mind and Sharing in Preschool Age Children	PLOS ONE			English	Article							YOUNG-CHILDREN; ALTRUISTIC BEHAVIOR; PROSOCIAL BEHAVIOR; EXECUTIVE FUNCTION; HUMAN COOPERATION; CONCEPTIONS; FAIRNESS	Young children have long been known to act selfishly and gradually appear to become more generous across middle childhood. While this apparent change has been well documented, the underlying mechanisms supporting this remain unclear. The current study examined the role of early theory of mind and executive functioning in facilitating sharing in a large sample (N = 98) of preschoolers. Results reveal a curious relation between early false-belief understanding and sharing behavior. Contrary to many commonsense notions and predominant theories, competence in this ability is actually related to less sharing. Thus, the relation between developing theory of mind and sharing may not be as straightforward as it seems in preschool age children. It is precisely the children who can engage in theory of mind that decide to share less with others.	[Cowell, Jason M.; Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Samek, Anya] Univ Wisconsin, Dept Consumer Sci, Madison, WI USA; [List, John] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Decety, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	decety@uchicago.edu		List, John/0000-0002-1740-3848	Kenneth and Anne Griffin Foundation; John Templeton Foundation ("Science of Philanthropy Initiative"); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Kenneth and Anne Griffin Foundation; John Templeton Foundation ("Science of Philanthropy Initiative"); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by a grant from the Kenneth and Anne Griffin Foundation and the John Templeton Foundation ("Science of Philanthropy Initiative"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Pardo D, 2013, COGN PROCESS, V14, P301, DOI 10.1007/s10339-013-0552-6; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; DAMON W, 1975, CHILD DEV, V46, P301, DOI 10.2307/1128122; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2008, NATURE; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Li YY, 2013, PSYCHOL SCI, V24, P1686, DOI 10.1177/0956797613479975; Monin B, 2007, REV GEN PSYCHOL, V11, P99, DOI 10.1037/1089-2680.11.2.99; Moore C, 1998, SOC DEV, V7, P198, DOI 10.1111/1467-9507.00062; Moore C, 2009, PSYCHOL SCI; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Robbins E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00353; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Thompson RA, 2013, INFANCY, V18, P120, DOI 10.1111/j.1532-7078.2012.00139.x; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P226, DOI 10.1037/a0025361; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	27	36	41	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117947	10.1371/journal.pone.0117947	http://dx.doi.org/10.1371/journal.pone.0117947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658696	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900245
J	Mehta, S; Williamson, CM; Ball, S; Tibbit, C; Beechey, C; Fray, M; Peters, J				Mehta, Stuti; Williamson, Christine M.; Ball, Simon; Tibbit, Charlotte; Beechey, Colin; Fray, Martin; Peters, Jo			Transcription Driven Somatic DNA Methylation within the Imprinted Gnas Cluster	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; GERM-CELL DEVELOPMENT; DE-NOVO METHYLATION; CONTROL REGION; CHROMOSOME 2; GS-ALPHA; MOUSE; GENE; LOCUS; IDENTIFICATION	Differential marking of genes in female and male gametes by DNA methylation is essential to genomic imprinting. In female gametes transcription traversing differentially methylated regions (DMRs) is a common requirement for de novo methylation at DMRs. At the imprinted Gnas cluster oocyte specific transcription of a protein-coding transcript, Nesp, is needed for methylation of two DMRs intragenic to Nesp, namely the Nespas-Gnasxl DMR and the Exon1A DMR, thereby enabling expression of the Gnas transcript and repression of the Gnasxl transcript. On the paternal allele, Nesp is repressed, the germline DMRs are unmethylated, Gnas is repressed and Gnasxl is expressed. Using mutant mouse models, we show that on the paternal allele, ectopic transcription of Nesp traversing the intragenic Exon1A DMR (which regulates Gnas expression) results in de novo methylation of the Exon1A DMR and de-repression of Gnas just as on the maternal allele. However, unlike the maternal allele, methylation on the mutant paternal allele occurs post-fertilisation, i.e. in somatic cells. This, to our knowledge is the first example of transcript/transcription driven DNA methylation of an intragenic CpG island, in somatic tissues, suggesting that transcription driven de novo methylation is not restricted to the germline in the mouse. Additionally, Gnasxl is repressed on a paternal chromosome on which Nesp is ectopically expressed. Thus, a paternally inherited Gnas cluster showing ectopic expression of Nesp is "maternalised" in terms of Gnasxl and Gnas expression. We show that these mice have a phenotype similar to mutants with two expressed doses of Gnas and none of Gnasxl.	[Mehta, Stuti; Williamson, Christine M.; Ball, Simon; Tibbit, Charlotte; Beechey, Colin; Peters, Jo] MRC Harwell, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Fray, Martin] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	MRC Harwell; MRC Harwell	Mehta, S (corresponding author), Massachusetts Gen Hosp, Thier 340,60 Blossom St, Boston, MA 02114 USA.	smehta6@mgh.harvard.edu	Williamson, Christine/GSE-3696-2022; Mehta, Stuti/E-9477-2017	Mehta, Stuti/0000-0002-6810-6771	UK Medical Research Council; UK India Education and Research Initiative; MRC [MC_U142636336] Funding Source: UKRI; Medical Research Council [MC_U142636336] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK India Education and Research Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council. SM's doctoral studies were supported by the UK India Education and Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Ball ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065639; Bastepe M, 2012, HORM METAB RES, V44, P732, DOI 10.1055/s-0032-1316331; Bhogal B, 2004, GENOMICS, V84, P961, DOI 10.1016/j.ygeno.2004.08.004; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Eaton SA, 2012, MOL CELL BIOL, V32, P1017, DOI 10.1128/MCB.06174-11; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Ischia R, 1997, J BIOL CHEM, V272, P11657; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; McEwen Kirsten R., 2009, P235, DOI 10.1007/978-1-4020-9187-2_14; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nowak K, 2011, EPIGENETICS-US, V6, P1012, DOI 10.4161/epi.6.8.16075; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sato S, 2011, GENOMICS, V98, P120, DOI 10.1016/j.ygeno.2011.05.003; Singh P, 2013, CELL REP, V4, P205, DOI 10.1016/j.celrep.2013.06.004; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Tomizawa SI, 2012, INT J DEV BIOL, V56, P867, DOI 10.1387/ijdb.120152gk; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Williamson CM, 2002, MAMM GENOME, V13, P74, DOI 10.1007/s00335-001-2102-2; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117378	10.1371/journal.pone.0117378	http://dx.doi.org/10.1371/journal.pone.0117378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659103	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900140
J	Dong, AW; Wodziak, D; Lowe, AW				Dong, Aiwen; Wodziak, Dariusz; Lowe, Anson W.			Epidermal Growth Factor Receptor (EGFR) Signaling Requires a Specific Endoplasmic Reticulum Thioredoxin for the Post-translational Control of Receptor Presentation to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-ISOMERASE FAMILY; ANTERIOR GRADIENT 2; AGR2 EXPRESSION; PROTEIN-KINASE; ESTROGEN-RECEPTOR; PLASMA-MEMBRANE; CARCINOMA-CELLS; LIVING CELLS; LUNG-CANCER; GENE	The epidermal growth factor receptor (EGFR) is a well characterized receptor-tyrosine kinase that functions in development and serves a vital role in many human cancers. Understanding EGFR regulatory mechanisms, and hence approaches for clinical intervention, has focused on ligand-receptor interactions and tyrosine kinase activity. Here, we show using the NCI-H460 lung and A431 epidermoid human cancer cell lines that EGFR binding to anterior gradient homolog 2 (AGR2) in the endoplasmic reticulum is required for receptor delivery to the plasma membrane and thus EGFR signaling. Reduced AGR2 protein levels or mutation of an essential cysteine in the active site result in decreased cell surface EGFR and a concomitant decrease in signaling as reflected by AREG, EGR1, and FOS expression. Similar to previously described EGFR nulls, an AGR2 null also resulted in embryonic lethality. Consistent with its role in regulating EGFR-mediated signaling, AGR2 expression is also enhanced in many human cancers and promotes the transformed phenotype. Furthermore, EGFR-mediated signaling in NCI-H460 cells, which are resistant to the tyrosine kinase inhibitor AG1478, is also disrupted with reduced AGR2 expression. The results provide insights into why cancer prognosis or response to therapy often does not correlate with EGFR protein or RNA levels because they do not reflect delivery to the cell surface where signaling is initiated. AGR2, therefore, represents a novel post-translational regulator of EGFR-mediated signaling and a promising target for treating human cancers.	[Dong, Aiwen; Wodziak, Dariusz; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu			NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA124435, P30 CA124435] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Armes JE, 2013, PATHOLOGY, V45, P49, DOI 10.1097/PAT.0b013e32835bd561; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bergstrom JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104186; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chen YT, 2013, CANCER LETT, V339, P270, DOI 10.1016/j.canlet.2013.06.025; COHEN S, 1982, J BIOL CHEM, V257, P1523; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; COHEN S, 1980, J BIOL CHEM, V255, P4834; Di Maro G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-160; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hong XY, 2013, CELL BIOCHEM BIOPHYS, V67, P1487, DOI 10.1007/s12013-013-9650-4; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Koziel K, 2009, INT J BIOCHEM CELL B, V41, P2440, DOI 10.1016/j.biocel.2009.07.003; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092081; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; LYALL RM, 1989, J BIOL CHEM, V264, P14503; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SLIEKER LJ, 1985, J BIOL CHEM, V260, P687; SOULE HD, 1990, CANCER RES, V50, P6075; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119; YARDEN Y, 1985, J BIOL CHEM, V260, P315; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	54	25	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8016	8027		10.1074/jbc.M114.623207	http://dx.doi.org/10.1074/jbc.M114.623207			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666625	Green Published, hybrid			2022-12-26	WOS:000351662600001
J	Rayner, LE; Hui, GK; Gor, J; Heenan, RK; Dalby, PA; Perkins, SJ				Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Heenan, Richard K.; Dalby, Paul A.; Perkins, Stephen J.			The Solution Structures of Two Human IgG1 Antibodies Show Conformational Stability and Accommodate Their C1q and Fc gamma R Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; COMPLEMENT ACTIVATION; HUMAN-IMMUNOGLOBULIN; NEUTRON-SCATTERING; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC REFINEMENT; HYDRODYNAMIC PROPERTIES; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODY	The human IgG1 antibody subclass shows distinct properties compared with the IgG2, IgG3, and IgG4 subclasses and is the most exploited subclass in therapeutic antibodies. It is the most abundant subclass, has a half-life as long as that of IgG2 and IgG4, binds the Fc gamma R receptor, and activates complement. There is limited structural information on full-length human IgG1 because of the challenges of crystallization. To rectify this, we have studied the solution structures of two human IgG1 6a and 19a monoclonal antibodies in different buffers at different temperatures. Analytical ultracentrifugation showed that both antibodies were predominantly monomeric, with sedimentation coefficients s(20,w)(0) of 6.3-6.4 S. Only a minor dimer peak was observed, and the amount was not dependent on buffer conditions. Solution scattering showed that the x-ray radius of gyration R-g increased with salt concentration, whereas the neutron R-g values remained unchanged with temperature. The x-ray and neutron distance distribution curves P(r) revealed two peaks, M1 and M2, whose positions were unchanged in different buffers to indicate conformational stability. Constrained atomistic scattering modeling revealed predominantly asymmetric solution structures for both antibodies with extended hinge structures. Both structures were similar to the only known crystal structure of full-length human IgG1. The Fab conformations in both structures were suitably positioned to permit the Fc region to bind readily to its Fc gamma R and C1q ligands without steric clashes, unlike human IgG4. Our molecular models for human IgG1 explain its immune activities, and we discuss its stability and function for therapeutic applications.	[Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Heenan, Richard K.] Rutherford Appleton Lab, ISIS Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England; [Dalby, Paul A.] UCL, Div Engn, Dept Biochem Engn, London WC1E 7JE, England	University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Dalby, Paul A/C-1639-2008	Dalby, Paul A/0000-0002-0980-8167	Biotechnology and Biological Sciences Research Council; CCP-SAS project; Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; BBSRC [BB/K021354/1, BB/I017119/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017119/1, BB/K021354/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CCP-SAS project; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. Support for this work was also provided in part by the CCP-SAS project, a joint Engineering and Physical Sciences Research Council (EP/K039121/1) and National Science Foundation (CHE-1265821) grant.	Abe Y, 2010, BIOCHEM J, V432, P101, DOI 10.1042/BJ20100641; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ashish, 2010, BIOCHEM BIOPH RES CO, V391, P947, DOI 10.1016/j.bbrc.2009.11.170; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CALMETTES P, 1991, ARCH BIOCHEM BIOPHYS, V291, P277, DOI 10.1016/0003-9861(91)90135-6; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; DORAI H, 1992, MOL IMMUNOL, V29, P1487, DOI 10.1016/0161-5890(92)90222-J; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton R.G., 2001, HUMAN IGG SUBCLASSES; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; HUGHESJONES NC, 1979, MOL IMMUNOL, V16, P697, DOI 10.1016/0161-5890(79)90010-5; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; ISENMAN DE, 1975, J IMMUNOL, V114, P1726; Iwura T, 2014, J BIOCHEM, V155, P63, DOI 10.1093/jb/mvt095; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; KILAR F, 1985, EUR J BIOCHEM, V147, P17, DOI 10.1111/j.1432-1033.1985.tb08712.x; KLEIN M, 1981, P NATL ACAD SCI-BIOL, V78, P524, DOI 10.1073/pnas.78.1.524; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lilyestrom WG, 2012, J PHYS CHEM B, V116, P9611, DOI 10.1021/jp303839t; LUND J, 1991, J IMMUNOL, V147, P2657; Luo Y, 2009, MABS-AUSTIN, V1, P491, DOI 10.4161/mabs.1.5.9631; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; Michaelsen TE, 2006, EUR J IMMUNOL, V36, P129, DOI 10.1002/eji.200535178; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1991, J MOL BIOL, V221, P1345; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; PILZ I, 1973, BIOCHEMISTRY-US, V12, P4998, DOI 10.1021/bi00748a028; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; Remmele RL, 2006, J PHARM SCI-US, V95, P126, DOI 10.1002/jps.20515; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Roux KH, 1997, J IMMUNOL, V159, P3372; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SARMA R, 1982, J APPL CRYSTALLOGR, V15, P476, DOI 10.1107/S002188988201245X; Schneider S, 2012, MOL IMMUNOL, V51, P66, DOI 10.1016/j.molimm.2012.02.111; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Strohl WR, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818096; Sun Z, 2005, J MOL BIOL, V353, P155, DOI 10.1016/j.jmb.2005.07.072; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Thommesen JE, 2000, MOL IMMUNOL, V37, P995, DOI 10.1016/S0161-5890(01)00010-4; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Yang J, 2014, MOL IMMUNOL, V58, P108, DOI 10.1016/j.molimm.2013.11.011	74	27	29	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8420	8438		10.1074/jbc.M114.631002	http://dx.doi.org/10.1074/jbc.M114.631002			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659433	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000351662600035
J	Lin, L; Jin, Y; Hu, KB				Lin, Ling; Jin, Yang; Hu, Kebin			Tissue-type Plasminogen Activator (tPA) Promotes M1 Macrophage Survival through p90 Ribosomal S6 Kinase (RSK) and p38 Mitogen-activated Protein Kinase (MAPK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Signaling; Macrophage; Serine Protease; Tissue Plasminogen Activator (tPA)	RECEPTOR-RELATED PROTEIN; NF-KAPPA-B; IN-VIVO; MICE; POLARIZATION; KIDNEY; INJURY; FAMILY; INFLAMMATION; EXPRESSION	Background: Macrophages become resistant to apoptosis in response to pathogenic cues. Results: Tissue-type plasminogen activator (tPA) protects the classically activated macrophages from apoptosis. Conclusion: tPA is an endogenous factor that promotes macrophage survival. Significance: tPA modulates inflammation by promoting the survival of polarized macrophages through a new signaling cascade. Macrophage accumulation is one of the hallmarks of progressive kidney disease. Resting macrophages have a finite lifespan, but become resistant to apoptosis in response to pathogenic cues, whereas the underlying mechanism remains unknown. Tissue-type plasminogen activator (tPA), a protease up-regulated in the kidneys with chronic injury, has been shown to promote macrophage accumulation and renal inflammation. We hypothesized that tPA may be the endogenous factor that promotes macrophage survival and extends their lifespan that leads to their accumulation in the injured kidneys. We examined the role of tPA in macrophage survival, and found that tPA protected macrophages from both staurosporine and H2O2-induced apoptosis. tPA promoted the survival of both resting and lipopolysaccharide- or interferon--induced M1 macrophages, but failed to do so in the interleukin 4 (IL4)-induced M2 macrophages. In the kidneys with unilateral ureteral obstruction, there were significantly more apoptotic M1 macrophages in tPA-deficient mice than their wild-type counterparts, and obstruction-induced M1 macrophages accumulation and M1 chemokine expression were markedly reduced in these knock-out mice. The cytoprotective effect of tPA required its receptor, LDL receptor-related protein-1 (LRP-1). tPA induced the phosphorylation of Erk1/2, p90 ribosomal S6 kinase (RSK), and p38 in a temporal order. The tPA-mediated macrophage survival was eliminated by PD98059, BI-D1870, or sc68376, the specific inhibitors for Erk1/2, p90RSK, or p38, respectively. Thus, it is clear that tPA promoted M1 macrophage survival through its receptor LRP-1-mediated novel signaling cascade involving Erk1/2, p90RSK, and p38, which leads to the accumulation of these cells in the injured kidneys.	[Lin, Ling; Hu, Kebin] Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA; [Jin, Yang] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med,Med Sch, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hu, KB (corresponding author), Penn State Univ, Coll Med, Dept Med, Mail Code H040,500 Univ Dr, Hershey, PA 17033 USA.	kebinhu@hmc.psu.edu	Hu, Kebin/AAT-7840-2021	Lin, Ling/0000-0001-5527-0575; Hu, Kebin/0000-0002-0829-4256	National Institutes of Health [DK102624]; American Heart Association [14GRNT20380289, 10SDG3900029]; Barsumian Trust [157904]; Kidney Foundation of Central Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Barsumian Trust; Kidney Foundation of Central Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK102624, American Heart Association Grants 14GRNT20380289 and 10SDG3900029, Barsumian Trust Grant 157904, and the Kidney Foundation of Central Pennsylvania (to K. H.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Higazi AA, 2008, CLIN EXP IMMUNOL, V152, P163, DOI 10.1111/j.1365-2249.2008.03606.x; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lin L, 2014, INT J MOL SCI, V15, P22887, DOI 10.3390/ijms151222887; Lin L, 2014, AM J PATHOL, V184, P2757, DOI 10.1016/j.ajpath.2014.06.013; Lin L, 2014, AM J CLIN EXP IMMUNO, V3, P30; Lin L, 2012, J AM SOC NEPHROL, V23, P1329, DOI 10.1681/ASN.2011111123; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	42	20	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7910	7917		10.1074/jbc.M114.599688	http://dx.doi.org/10.1074/jbc.M114.599688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670857	Green Published, hybrid			2022-12-26	WOS:000351613600048
J	Lee, IT; Liu, SW; Chi, PL; Lin, CC; Hsiao, LD; Yang, CM				Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Lin, Chih-Chung; Hsiao, Li-Der; Yang, Chuen-Mao			TNF-alpha Mediates PKC delta/JNK1/2/c-Jun-Dependent Monocyte Adhesion via ICAM-1 Induction in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; SIGNALING PATHWAYS; EXPRESSION; INFLAMMATION; MOLECULE-1; ACTIVATION; MOTILITY; DISEASES; STRESS	Retinal inflammatory diseases induced by cytokines, such as tumor necrosis factor-alpha (TNF-alpha) are associated with an up-regulation of intercellular adhesion molecule-1 (ICAM-1) in the retinal pigment epithelial cells (RPECs). Retinal pigment epithelium (RPE) is a monolayer of epithelial cells that forms the outer blood-retinal barrier in the posterior segment of the eye, and is also implicated in the pathology of, such as neovascularization in age-related macular degeneration (AMD). However, the detailed mechanisms of TNF-alpha-induced ICAM-1 expression are largely unclear in human RPECs. We demonstrated that in RPECs, TNF-alpha could induce ICAM-1 protein and mRNA expression and promoter activity, and monocyte adhesion. TNF-alpha-mediated responses were attenuated by pretreatment with the inhibitor of PKCs (Ro318220), PKC delta (Rottlerin), MEK1/2 (U0126), JNK1/2 (SP600125), or AP-1 (Tanshinone IIA) and transfection with siRNA of TNFR1, TRAF2, JNK2, p42, or c-Jun. We showed that TNF-alpha could stimulate the TNFR1 and TRAF2 complex formation. TNF-alpha stimulated JNK1/2 was also reduced by Rottlerin or SP600125. However, Rottlerin had no effect on TNF-alpha-induced p42/p44 MAPK phosphorylation. We observed that TNF-alpha induced c-Jun phosphorylation which was inhibited by Rottlerin or SP600125. On the other hand, TNF-alpha-stimulated ICAM-1 promoter activity was prominently lost in RPECs transfected with the point-mutated AP-1 ICAM-1 promoter plasmid. These results suggest that TNF-alpha-induced ICAM-1 expression and monocyte adhesion is mediated through a TNFR1/TRAF2/PKC delta/JNK1/2/c-Jun pathway in RPECs. These findings concerning TNF-alpha induced ICAM-1 expression in RPECs imply that TNF-alpha might play an important role in ocular inflammation and diseases.	[Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Lee, I-Ta; Liu, Shiau-Wen; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Ageing Res Ctr, Taoyuan, Taiwan; [Lin, Chih-Chung] Chang Gung Univ, Chang Gung Mem Hosp Lin Kou, Dept Anesthet, Taoyuan, Taiwan; [Lin, Chih-Chung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.	chuenmao@mail.cgu.edu.tw		Chi, Belinda/0000-0003-0332-6682; Yang, Chuen-Mao/0000-0002-3208-5438; Lee, I-Te/0000-0003-2665-3635	National Science Council, Taiwan [NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, NSC101-2314-B-182-182A-112]; Ministry of Education, Taiwan [EMRPD1C0261, EMRPD1C0271]; Chang Gung Medical Research Foundation, Taiwan [CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPG3B1092, CMRPG3C1301]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, and NSC101-2314-B-182-182A-112 from National Science Council, Taiwan; EMRPD1C0261 and EMRPD1C0271 from Ministry of Education, Taiwan; and CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPG3B1092 and CMRPG3C1301 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2011, CLIN EXP ALLERGY, V41, P149, DOI 10.1111/j.1365-2222.2010.03658.x; bdala-Valencia H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041054, DOI 10.1371/JOURNAL.PONE.0041054]; Ding RQ, 2011, J CARDIOVASC PHARM T, V16, P160, DOI 10.1177/1074248410382106; Giansanti V, 2013, J CELL MOL MED, V17, P103, DOI 10.1111/j.1582-4934.2012.01652.x; Huang XB, 2012, PHARM BIOL, V50, P1111, DOI 10.3109/13880209.2012.658476; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee CW, 2011, J CELL PHYSIOL, V226, P2103, DOI 10.1002/jcp.22537; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee IT, 2010, J CELL PHYSIOL, V224, P454, DOI 10.1002/jcp.22142; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Mullins RF, 2006, MOL VIS, V12, P224; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	20	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117911	10.1371/journal.pone.0117911	http://dx.doi.org/10.1371/journal.pone.0117911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675437	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000037
J	Oathes, DJ; Hilt, LM; Nitschke, JB				Oathes, Desmond J.; Hilt, Lori M.; Nitschke, Jack B.			Affective Neural Responses Modulated by Serotonin Transporter Genotype in Clinical Anxiety and Depression	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ANTERIOR CINGULATE; AMYGDALA ACTIVITY; GENETIC-VARIATION; PROMOTER REGION; ACTIVATION; DISORDER; BRAIN; POLYMORPHISM; UNCERTAINTY	Serotonin transporter gene variants are known to interact with stressful life experiences to increase chances of developing affective symptoms, and these same variants have been shown to influence amygdala reactivity to affective stimuli in non-psychiatric populations. The impact of these gene variants on affective neurocircuitry in anxiety and mood disorders has been studied less extensively. Utilizing a triallelic assay (5-HTTLPR and rs25531) to assess genetic variation linked with altered serotonin signaling, this fMRI study investigated genetic influences on amygdala and anterior insula activity in 50 generalized anxiety disorder patients, 26 of whom also met DSM-IV criteria for social anxiety disorder and/or major depressive disorder, and 39 healthy comparison subjects. A Group x Genotype interaction was observed for both the amygdala and anterior insula in a paradigm designed to elicit responses in these brain areas during the anticipation of and response to aversive pictures. Patients who are S/L-G carriers showed less activity than their L-A/L-A counterparts in both regions and less activity than S/L-G healthy comparison subjects in the amygdala. Moreover, patients with greater insula responses reported higher levels of intolerance of uncertainty, an association that was particularly pronounced for patients with two L-A alleles. A genotype effect was not established in healthy controls. These findings link the serotonin transporter gene to affective circuitry findings in anxiety and depression psychopathology and further suggest that its impact on patients may be different from effects typically observed in healthy populations.	[Oathes, Desmond J.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Hilt, Lori M.] Lawrence Univ, Dept Psychol, Appleton, WI 54912 USA; [Nitschke, Jack B.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Nitschke, Jack B.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Stanford University; Lawrence University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Oathes, DJ (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	desmond.oathes@gmail.com	Oathes, Desmond/X-4088-2019; Oathes, Desmond/AAW-3048-2021	Oathes, Desmond/0000-0001-7346-2669; 	National Institute of Mental Health [F32-MH081667, R01-MH74847, K02-MH082130, K08-MH63984]; National Institute of Child Health and Human Development [P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074847, K08MH063984, K02MH082130, T32MH018931] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health [F32-MH081667 to DJO and R01-MH74847, K02-MH082130, and K08-MH63984 to JBN]; and by a core grant to the Waisman Center from the National Institute of Child Health and Human Development [P30-HD03352]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Barlow D., 2001, ANXIETY ITS DISORDER, V2; Bauernfeind AL, 2013, J HUM EVOL, V64, P263, DOI 10.1016/j.jhevol.2012.12.003; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Caspi Avshalom, 2010, Am J Psychiatry, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Debiec J, 2014, P NATL ACAD SCI USA, V111, P12222, DOI 10.1073/pnas.1316740111; Domschke K, 2006, INT J NEUROPSYCHOPH, V9, P349, DOI 10.1017/S1461145705005869; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Friedel E, 2009, PSYCHOPHARMACOLOGY, V205, P261, DOI 10.1007/s00213-009-1536-1; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Goldstein AN, 2013, J NEUROSCI, V33, P10607, DOI 10.1523/JNEUROSCI.5578-12.2013; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Grupe DW, 2013, CEREB CORTEX, V23, P1874, DOI 10.1093/cercor/bhs175; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kalin NH, 2008, MOL PSYCHIATR, V13, P1021, DOI 10.1038/mp.2008.37; Keedwell PA, 2010, J AFFECT DISORDERS, V120, P120, DOI 10.1016/j.jad.2009.04.031; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Lau JYF, 2009, BIOL PSYCHIAT, V65, P349, DOI 10.1016/j.biopsych.2008.08.037; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lim JE, 2006, MOL PSYCHIATR, V11, P649, DOI 10.1038/sj.mp.4001797; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917; Mueller A, 2011, NEUROPSYCHOPHARMACOL, V36, P1332, DOI 10.1038/npp.2011.11; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Nemeroff CB, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-202, 10.1186/1741-7015-11-132]; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Nitschke JB, 2001, COGNITIVE THER RES, V25, P1, DOI 10.1023/A:1026485530405; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Somerville LH, 2013, CEREB CORTEX, V23, P49, DOI 10.1093/cercor/bhr373; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Whalen PJ, 2008, BIOL PSYCHIAT, V63, P858, DOI 10.1016/j.biopsych.2007.08.019; Williams LM, 2009, NEUROIMAGE, V47, P804, DOI 10.1016/j.neuroimage.2009.05.009	67	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0115820	10.1371/journal.pone.0115820	http://dx.doi.org/10.1371/journal.pone.0115820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675343	Green Published, Green Submitted, gold			2022-12-26	WOS:000349914000005
J	Hsu, CT; Jacobs, AM; Altmann, U; Conrad, M				Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike; Conrad, Markus			The Magical Activation of Left Amygdala when Reading Harry Potter: An fMRI Study on How Descriptions of Supra-Natural Events Entertain and Enchant	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN MECHANISMS; METAANALYSIS; EMOTION; NETWORK; FICTION; SYSTEM; COMPREHENSION; SIMULATION; HEMISPHERE	Literature containing supra-natural, or magical events has enchanted generations of readers. When reading narratives describing such events, readers mentally simulate a text world different from the real one. The corresponding violation of world-knowledge during this simulation likely increases cognitive processing demands for ongoing discourse integration, catches readers' attention, and might thus contribute to the pleasure and deep emotional experience associated with ludic immersive reading. In the present study, we presented participants in an MR scanner with passages selected from the Harry Potter book series, half of which described magical events, while the other half served as control condition. Passages in both conditions were closely matched for relevant psycholinguistic variables including, e.g., emotional valence and arousal, passage-wise mean word imageability and frequency, and syntactic complexity. Post-hoc ratings showed that readers considered supra-natural contents more surprising and more strongly associated with reading pleasure than control passages. In the fMRI data, we found stronger neural activation for the supra-natural than the control condition in bilateral inferior frontal gyri, bilateral inferior parietal lobules, left fusiform gyrus, and left amygdala. The increased activation in the amygdala (part of the salience and emotion processing network) appears to be associated with feelings of surprise and the reading pleasure, which supra-natural events, full of novelty and unexpectedness, brought about. The involvement of bilateral inferior frontal gyri likely reflects higher cognitive processing demand due to world knowledge violations, whereas increased attention to supra-natural events is reflected in inferior frontal gyri and inferior parietal lobules that are part of the fronto-parietal attention network.	[Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike] Free Univ Berlin, Dept Educ & Psychol, D-14195 Berlin, Germany; [Hsu, Chun-Ting; Jacobs, Arthur M.; Altmann, Ulrike; Conrad, Markus] Free Univ Berlin, Languages Emot, D-14195 Berlin, Germany; [Jacobs, Arthur M.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, D-14195 Berlin, Germany; [Conrad, Markus] Univ La Laguna, Dept Cognit Social & Org Psychol, San Cristobal De La Lagu 38205, Spain	Free University of Berlin; Free University of Berlin; Free University of Berlin; Universidad de la Laguna	Hsu, CT (corresponding author), Free Univ Berlin, Dept Educ & Psychol, D-14195 Berlin, Germany.	hsuchunting@gmail.com	Hsu, Chun-Ting/J-8874-2019; Conrad, Markus/N-3184-2014	Hsu, Chun-Ting/0000-0002-1829-6642; Conrad, Markus/0000-0003-1335-437X; Jacobs, Arthur/0000-0002-7910-3955	Deutsche Forschungsgemeinschaft (DFG); Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin [Project 201, Project 410]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin	This research was supported by two grants from Deutsche Forschungsgemeinschaft (DFG) to MC: "Bilingualism and Affectivity in Reading", Project 201 and "Sound-physiognomy in Language Organization, Processing and Production", Project 410 from the Research Excellence Cluster "Languages of Emotion" at the Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Altmann U, 2014, SOC COGN AFFECT NEUR, V9, P22, DOI 10.1093/scan/nss098; Altmann U, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00192; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bohrn IC, 2013, BRAIN LANG, V124, P1, DOI 10.1016/j.bandl.2012.10.003; Bohrn IC, 2012, NEUROPSYCHOLOGIA, V50, P2669, DOI 10.1016/j.neuropsychologia.2012.07.021; Bohrn IC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00204; Briesemeister BB, 2014, COGN AFFECT BEHAV NE; Briesemeister BB, 2014, BRAIN RES, V1564, P62, DOI 10.1016/j.brainres.2014.03.045; Briesemeister BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023743; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Citron FMM, 2014, J COGNITIVE NEUROSCI, V26, P2585, DOI 10.1162/jocn_a_00654; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Ewbank MP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00056; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Forgacs B, 2012, NEUROIMAGE, V63, P1432, DOI 10.1016/j.neuroimage.2012.07.029; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Graesser AC, 1997, ANNU REV PSYCHOL, V48, P163, DOI 10.1146/annurev.psych.48.1.163; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Harel A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00885; Herbert C, 2009, SOC COGN AFFECT NEUR, V4, P35, DOI 10.1093/scan/nsn027; Hsu CT, 2015, CORTEX, V63, P282, DOI 10.1016/j.cortex.2014.09.002; Hsu CT, 2014, NEUROREPORT, V25, P1356, DOI 10.1097/WNR.0000000000000272; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jacobs A. M., 2011, GEHIRN GEDICHT WIE W, P492; Jacobs AM, 2013, STIMMUNG METHODE; Jacobs AM, 2015, COGNITIVE NEUROSCIENCE OF NATURAL LANGUAGE USE, P135; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Kringelbach ML, 2008, INTERDISCIPL SCI REV, V33, P321, DOI 10.1179/174327908X392889; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leiner DJ, 2014, SOSCI SURVEY 2 4 00; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Menenti L, 2009, J COGNITIVE NEUROSCI, V21, P2358, DOI 10.1162/jocn.2008.21163; MIALL DS, 1994, POETICS, V22, P389, DOI 10.1016/0304-422X(94)00011-5; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nell V., 1988, LOST BOOK PSYCHOL RE; OATLEY K, 1995, POETICS, V23, P53, DOI 10.1016/0304-422X(94)P4296-S; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Raposo A, 2011, SOC COGN AFFECT NEUR, V6, P260, DOI 10.1093/scan/nsq033; Rowling, 2010, HARRY POTTER HALF BL; Rowling J. K., 2003, HARRY POTTER ORDER P; Rowling J. K., 1998, HARRY POTTER CHAMBER; Rowling J.K., 1997, HARRY POTTER PHILOSO, Vfirst; Rowling JK, 2007, HARRY POTTER DEATHLY, DOI [10.1093/jxb/erm028 PMID: 25506957, DOI 10.1093/JXB/ERM028]; Rowling JK, 2000, HARRY POTTER GOBLET; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; SCHMALHOFER F, 1986, J MEM LANG, V25, P279, DOI 10.1016/0749-596X(86)90002-1; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Schrott R, 2011, GEHIRN GEDICHT WIE W, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sharon T, 2004, BRIT J DEV PSYCHOL, V22, P293, DOI 10.1348/026151004323044627; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Subbotsky E, 2012, OPEN BEHAV SCI J, V6, P23; Subbotsky E, 2010, PERCEPT MOTOR SKILL, V111, P261, DOI 10.2466/04.09.11.PMS.111.4.261-277; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van Dijk T., 1983, STRATEGIES DISCOURSE; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viviani R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00746; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	89	23	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118179	10.1371/journal.pone.0118179	http://dx.doi.org/10.1371/journal.pone.0118179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671315	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300086
J	Jung, M; Shin, MK; Jung, YK; Yoo, HS				Jung, Myunghwan; Shin, Min-Kyoung; Jung, Yeon-Kwon; Yoo, Han Sang			Modulation of Macrophage Activities in Proliferation, Lysosome, and Phagosome by the Nonspecific Immunostimulator, Mica	PLOS ONE			English	Article							BIOTITE-V SUPPLEMENTATION; SILICATE IN-VITRO; DNA-REPLICATION; P53 PATHWAY; ACTIVATION; NANOPARTICLES; MECHANISM; PIGS; PHAGOCYTOSIS; RECEPTORS	It was reported that the aluminosilicate material mica activated macrophages and showed its immunostimulating effects. However, the mechanisms by which it exerts these effects are unclear. To address this, we evaluated the effects of mica fine particles (MFP, 804.1 +/- 0.02 nm) on the murine macrophage cell line, RAW 264.7. Specifically, RAW 264.7 cells were treated with 100 and 500 mu g/mL MFP and their proliferative response was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Changes in global gene expression upon MFP treatment for 12 and 48 h were also determined using microarrays. Following the MFP treatment, RAW 264.7 cells showed a low level of proliferation compared to nontreated cells (p < 0.01). There was a change in an expression level of 1,128 genes after 48 h treatment. Specifically, genes associated with the cell cycle, DNA replication, and pyrimidine and purine metabolisms, were down-regulated in cells treated with MFP, which resulted in reduction of cell proliferation. MFP treatment also up-regulated genes associated with lysosome and phagosome function, which are both required for macrophage activities. We speculate that activation of macrophages by mica is in part derived from up-regulation of these pathways.	[Jung, Myunghwan; Shin, Min-Kyoung; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Jung, Yeon-Kwon] Seobong BioBesstech Co Ltd, Seoul, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.	yoohs@snu.ac.kr	Jung, Myunghwan/AAO-3582-2021; Jung, Myunghwan/AAL-6549-2021	Jung, Myunghwan/0000-0001-8124-8945; Jung, Myunghwan/0000-0001-8124-8945	NRF grant - MSIP [2014R1A2A2A01007291]; Research Institute for Veterinary Science, Seoul National University, Seoul, Korea; Seobong Biostech Co. Ltd.	NRF grant - MSIP; Research Institute for Veterinary Science, Seoul National University, Seoul, Korea; Seobong Biostech Co. Ltd.	This work was supported by Seobong Biostech Co. Ltd., NRF grant funded by MSIP (No. 2014R1A2A2A01007291) and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikoh T, 1998, INT J ONCOL, V12, P1355; Araki H, 2010, BBA-PROTEINS PROTEOM, V1804, P520, DOI 10.1016/j.bbapap.2009.10.020; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen YJ, 2005, ASIAN AUSTRAL J ANIM, V18, P1642, DOI 10.5713/ajas.2005.1642; Chen YJ, 2005, ASIAN AUSTRAL J ANIM, V18, P1147, DOI 10.5713/ajas.2005.1147; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Harrison RE, 2002, BIOCHEM CELL BIOL, V80, P509, DOI 10.1139/O02-142; Holian A, 1997, ENVIRON HEALTH PERSP, V105, P1139, DOI 10.2307/3433522; Huang YCT, 2009, AM J RESP CELL MOL, V41, P544, DOI 10.1165/rcmb.2008-0064OC; Jung BG, 2013, J VET SCI, V14, P135, DOI 10.4142/jvs.2013.14.2.135; Jung BG, 2010, VET MICROBIOL, V143, P117, DOI 10.1016/j.vetmic.2009.11.009; Jung M, 2012, PAK VET J, V32, P319; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Lim DH, 2012, BIOMATERIALS, V33, P4690, DOI 10.1016/j.biomaterials.2012.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 2012, ADV IMMUNOL, V120, P163; Matsusaki T, 2007, J ARTHROPLASTY, V22, P960, DOI 10.1016/j.arth.2007.03.013; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Thomson EM, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-6; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; UEKI A, 1994, IMMUNOLOGY, V82, P332; VENEZIE RD, 1995, J NEUROSCI RES, V40, P99, DOI 10.1002/jnr.490400111; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117838	10.1371/journal.pone.0117838	http://dx.doi.org/10.1371/journal.pone.0117838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668030	gold, Green Submitted, Green Published			2022-12-26	WOS:000349493000028
J	Shahaduzzaman, M; Nash, K; Hudson, C; Sharif, M; Grimmig, B; Lin, XY; Bai, G; Liu, H; Ugen, KE; Cao, CH; Bickford, PC				Shahaduzzaman, Md; Nash, Kevin; Hudson, Charles; Sharif, Masroor; Grimmig, Bethany; Lin, Xiaoyang; Bai, Ge; Liu, Hui; Ugen, Kenneth E.; Cao, Chuanhai; Bickford, Paula C.			Anti-Human alpha-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-alpha-Synuclein Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MEMBRANE-BINDING; IMMUNOTHERAPY; IMMUNIZATION; NEURODEGENERATION; PHOSPHORYLATION; MICROGLIA; STRATEGY	The protein alpha-synuclein (alpha-Syn) has a central role in the pathogenesis of Parkinson's disease (PD) and immunotherapeutic approaches targeting this molecule have shown promising results. In this study, novel antibodies were generated against specific peptides from full length human alpha-Syn and evaluated for effectiveness in ameliorating alpha-Syn-induced cell death and behavioral deficits in an AAV-alpha-Syn expressing rat model of PD. Fisher 344 rats were injected with rAAV vector into the right substantia nigra (SN), while control rats received an AAV vector expressing green fluorescent protein (GFP). Beginning one week after injection of the AAV-alpha-Syn vectors, rats were treated intraperitoneally with either control IgG or antibodies against the N-terminal (AB1), or central region (AB2) of alpha-Syn. An unbiased stereological estimation of TH+, NeuN+, and OX6 (MHC-II) immunostaining revealed that the alpha-Syn peptide antibodies (AB1 and AB2) significantly inhibited alpha-Syn-induced dopaminergic cell (DA) and NeuN+ cell loss (one-way ANOVA (F (3, 30) = 5.8, p = 0.002 and (F (3, 29) = 7.92, p = 0.002 respectively), as well as decreasing the number of activated microglia in the ipsilateral SN (one-way ANOVA F = 14.09; p = 0.0003). Antibody treated animals also had lower levels of alpha-Syn in the ipsilateral SN (one-way ANOVA F (7, 37) = 9.786; p = 0.0001) and demonstrated a partial intermediate improvement of the behavioral deficits. Our data suggest that, in particular, an alpha-Syn peptide antibody against the N-terminal region of the protein can protect against DA neuron loss and, to some extent behavioral deficits. As such, these results may be a potential therapeutic strategy for halting the progression of PD.	[Shahaduzzaman, Md; Sharif, Masroor; Grimmig, Bethany; Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Nash, Kevin; Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Tampa, FL 33612 USA; [Hudson, Charles; Bickford, Paula C.] James A Haley Vet Affairs Hosp, Res Serv, Tampa, FL 33612 USA; [Nash, Kevin; Lin, Xiaoyang; Bai, Ge; Liu, Hui; Cao, Chuanhai] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33612 USA; [Ugen, Kenneth E.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ugen, Kenneth E.] Univ S Florida, Ctr Mol Delivery, Tampa, FL 33612 USA; [Cao, Chuanhai] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cao, CH (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33612 USA.	ccao@health.usf.edu; pbickfor@health.usf.edu	Bickford, Paula C/J-5970-2012; Ugen, Kenneth E/H-6544-2011	Bickford, Paula C/0000-0001-9657-7725; Cao, Chuanhai/0000-0002-5765-6401	VA Medical Research Service grant [1I01BX000231]; Veterans Affairs [I01BX000231] Funding Source: NIH RePORTER	VA Medical Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	Funding provided by VA Medical Research Service grant 1I01BX000231 to PCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P995, DOI 10.1074/mcp.M800446-MCP200; Angela M., 2005, UTILITY OF 6 HYDROXY; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Fagerqvist T, 2013, J NEUROCHEM, V126, P131, DOI 10.1111/jnc.12175; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; Ghochikyan A, 2014, NEUROSCI LETT, V560, P86, DOI 10.1016/j.neulet.2013.12.028; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hutter-Saunders JAL, 2011, EXPERT REV NEUROTHER, V11, P1703, DOI [10.1586/ERN.11.163, 10.1586/ern.11.163]; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kirik D, 2002, P NATL ACAD SCI USA, V99, P4708, DOI 10.1073/pnas.062047599; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kosloski LM, 2010, J NEUROCHEM, V114, P1261, DOI 10.1111/j.1471-4159.2010.06834.x; Kothawala A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043505; Kristen Marciniuk RT, 2013, CLINICAL AND DEVELOP; Lambracht-Washington D, 2013, DISCOV MED, V15, P319; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lemere CA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-36; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Liu L, 2014, DRUG TODAY, V50, P33, DOI 10.1358/dot.2014.50.1.2076506; Madeo J, 2013, AGING DIS, V4, P210; Mandler M, 2014, ACTA NEUROPATHOL; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Rafii MS, 2013, REV RECENT CLIN TRIA; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schneeberger A, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS11, DOI 10.1016/S1353-8020(11)70006-2; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vekrellis K, 2012, EXPERT OPIN THER TAR, V16, P421, DOI 10.1517/14728222.2012.674111; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Zhang Y, 2011, NEUROSCIENTIST, V17, P163, DOI 10.1177/1073858410381532	56	62	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116841	10.1371/journal.pone.0116841	http://dx.doi.org/10.1371/journal.pone.0116841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658425	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900072
J	Thompson, BC; Halliday, GM; Damian, DL				Thompson, Benjamin C.; Halliday, Gary M.; Damian, Diona L.			Nicotinamide Enhances Repair of Arsenic and Ultraviolet Radiation-Induced DNA Damage in HaCaT Keratinocytes and Ex Vivo Human Skin	PLOS ONE			English	Article							INDUCED IMMUNOSUPPRESSION; DRINKING-WATER; NITRIC-OXIDE; WEST-BENGAL; GENERATION; APOPTOSIS; CELLS; METABOLISM; SURVIVAL; PROTEIN	Arsenic-induced skin cancer is a significant global health burden. In areas with arsenic contamination of water sources, such as China, Pakistan, Myanmar, Cambodia and especially Bangladesh and West Bengal, large populations are at risk of arsenic-induced skin cancer. Arsenic acts as a co-carcinogen with ultraviolet (UV) radiation and affects DNA damage and repair. Nicotinamide (vitamin B3) reduces premalignant keratoses in sun-damaged skin, likely by prevention of UV-induced cellular energy depletion and enhancement of DNA repair. We investigated whether nicotinamide modifies DNA repair following exposure to UV radiation and sodium arsenite. HaCaT keratinocytes and ex vivo human skin were exposed to 2 mu M sodium arsenite and low dose (2J/cm(2)) solar-simulated UV, with and without nicotinamide supplementation. DNA photolesions in the form of 8-oxo-7,8-dihydro-2'-deoxyguanosine and cyclobutane pyrimidine dimers were detected by immunofluorescence. Arsenic exposure significantly increased levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine in irradiated cells. Nicotinamide reduced both types of photolesions in HaCaT keratinocytes and in ex vivo human skin, likely by enhancing DNA repair. These results demonstrate a reduction of two different photolesions over time in two different models in UV and arsenic exposed cells. Nicotinamide is a nontoxic, inexpensive agent with potential for chemoprevention of arsenic induced skin cancer.	[Thompson, Benjamin C.; Halliday, Gary M.; Damian, Diona L.] Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney Canc Ctr,Dept Dermatol, Sydney, NSW 2006, Australia; [Damian, Diona L.] Melanoma Inst Australia, Sydney, NSW, Australia	University of Sydney; Melanoma Institute Australia	Damian, DL (corresponding author), Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney Canc Ctr,Dept Dermatol, Sydney, NSW 2006, Australia.	diona.damian@sswahs.nsw.gov.au			Australasian College of Dermatologists Scientific Research Fund; Sydney Medical School Foundation; Cancer Council New South Wales; National Health and Medical Research Council of Australia	Australasian College of Dermatologists Scientific Research Fund; Sydney Medical School Foundation; Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by the Australasian College of Dermatologists Scientific Research Fund (DD) the Sydney Medical School Foundation (BT), Cancer Council New South Wales and the National Health and Medical Research Council of Australia (DD, GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Centeno JA, 2002, ENVIRON HEALTH PERSP, V110, P883, DOI 10.1289/ehp.02110s5883; Damian DL, 2008, J INVEST DERMATOL, V128, P447, DOI 10.1038/sj.jid.5701058; Damian DL, 2002, METHODS, V28, P34, DOI 10.1016/S1046-2023(02)00208-6; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Fernandez MI, 2012, J UROLOGY, V187, P856, DOI 10.1016/j.juro.2011.10.157; Gupta R, 2007, J INVEST DERMATOL, V127, P707, DOI 10.1038/sj.jid.5700597; Halliday GM, 2011, SEMIN CUTAN MED SURG, V30, P214, DOI 10.1016/j.sder.2011.08.002; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Haque R, 2003, EPIDEMIOLOGY, V14, P174, DOI 10.1097/00001648-200303000-00011; Ivanov VN, 2006, EXP CELL RES, V312, P4120, DOI 10.1016/j.yexcr.2006.09.019; Jacobson EL, 2001, J PHOTOCH PHOTOBIO B, V63, P141, DOI 10.1016/S1011-1344(01)00211-1; Javeri A, 2008, DNA REPAIR, V7, P1542, DOI 10.1016/j.dnarep.2008.05.011; Klein CB, 2007, TOXICOL APPL PHARM, V222, P289, DOI 10.1016/j.taap.2006.12.033; Komissarova EV, 2010, TOXICOL APPL PHARM, V243, P399, DOI 10.1016/j.taap.2009.12.014; Lee CH, 2013, J INVEST DERMATOL, V133, P1890, DOI 10.1038/jid.2013.55; Lee CH, 2011, KAOHSIUNG J MED SCI, V27, P396, DOI 10.1016/j.kjms.2011.05.007; Liao WT, 2009, CARCINOGENESIS, V30, P1064, DOI 10.1093/carcin/bgp095; Moloney F, 2010, BRIT J DERMATOL, V162, P1138, DOI 10.1111/j.1365-2133.2010.09659.x; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Park J, 2010, PHOTOCHEM PHOTOBIOL, V86, P942, DOI 10.1111/j.1751-1097.2010.00746.x; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Rahman MM, 2001, J TOXICOL-CLIN TOXIC, V39, P683, DOI 10.1081/CLT-100108509; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Rossman TG, 2001, TOXICOL APPL PHARM, V176, P64, DOI 10.1006/taap.2001.9277; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Sivapirabu G, 2009, BRIT J DERMATOL, V161, P1357, DOI 10.1111/j.1365-2133.2009.09244.x; Snopov SA, 2004, PHOTOCH PHOTOBIO SCI, V3, P85, DOI 10.1039/b305135h; Sun Y, 2011, TOXICOL APPL PHARM, V255, P242, DOI 10.1016/j.taap.2011.07.006; Surjana D, 2013, CARCINOGENESIS, V34, P1144, DOI 10.1093/carcin/bgt017; Thompson BC, 2014, EXP DERMATOL, V23, P509, DOI 10.1111/exd.12430; Wang F, 2013, FREE RADICAL BIO MED, V61, P249, DOI 10.1016/j.freeradbiomed.2013.04.019; Wu F, 2005, ENVIRON HEALTH PERSP, V113, P983, DOI 10.1289/ehp.7846; Wu MM, 2001, ENVIRON HEALTH PERSP, V109, P1011, DOI 10.2307/3454955; Yiasemides E, 2009, CARCINOGENESIS, V30, P101, DOI 10.1093/carcin/bgn248; YIH LH, 1991, CELL BIOL INT REP, V15, P253, DOI 10.1016/0309-1651(91)90157-E	40	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117491	10.1371/journal.pone.0117491	http://dx.doi.org/10.1371/journal.pone.0117491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658450	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900162
J	Du, YP; Cramer, M; Lee, CA; Tang, J; Muthusamy, A; Antonetti, DA; Jin, H; Palczewski, K; Kern, TS				Du, Yunpeng; Cramer, Megan; Lee, Chieh Allen; Tang, Jie; Muthusamy, Arivalagan; Antonetti, David A.; Jin, Hui; Palczewski, Krzysztof; Kern, Timothy S.			Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability	FASEB JOURNAL			English	Article						GPCRs; NADPH oxidase; diabetic retinopathy; inflammation	SMOOTH-MUSCLE-CELLS; PROTEIN-COUPLED RECEPTORS; NADPH OXIDASE; OXIDATIVE STRESS; G(I)ALPHA PROTEINS; STARGARDT DISEASE; ENDOTHELIAL-CELLS; TACTILE ALLODYNIA; MOUSE MODEL; RAT RETINA	Reactive oxygen species play an important role in the pathogenesis of diabetic retinopathy. We studied the role of adrenergic and serotonin receptors in the generation of superoxide by retina and 661W retinal cells in high glucose and of the alpha(1)-adrenergic receptor (AR) on vascular lesions of the retinopathy in experimentally diabetic C57Bl/6J mice (and controls) after 2 and 8 months. Compared with 5 mM glucose, incubating cells or retinal explants in 30 mM glucose induced superoxide generation. This response was reduced or ablated by pharmacologic inhibition of the alpha(1)-AR (a G(q)-coupled receptor) or G(s)-coupled serotonin (5-HT2, 5-HT4, 5-HT6, and 5-HT7) receptors or by activation of the G(i)-coupled (2)-AR. In elevated glucose, the alpha(1)-AR produced superoxide via phospholipase C, inositol triphosphate-induced Ca2+ release, and NADPH oxidase, and pharmacologic inhibition of these reactions prevented the superoxide increase. Generation of retinal superoxide, expression of proinflammatory proteins, and degeneration of retinal capillaries in diabetes all were significantly inhibited with daily doxazosin or apocynin (inhibitors of (1)-AR and NADPH oxidase, respectively), but increased vascular permeability was not significantly affected. Adrenergic receptors, and perhaps other GPCRs, represent novel targets for inhibiting the development of important features of diabetic retinopathy.	[Du, Yunpeng; Cramer, Megan; Lee, Chieh Allen; Tang, Jie; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Muthusamy, Arivalagan; Antonetti, David A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Jin, Hui; Palczewski, Krzysztof; Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kern, Timothy S.] Vet Adm Med Ctr, Res Serv 151, Cleveland, OH 44106 USA	Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kern, TS (corresponding author), Case Western Reserve Univ, 441 Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	tsk@case.edu		antonetti, david/0000-0003-1130-6577	U.S. National Institutes of Health, National Eye Institute [R01EY00300, R01EY022938, R24EY021126]; Medical Research Service of the Department of Veteran Affairs; Office of Research and Technology Management at Case Western Reserve University; Services of the Case Western Reserve University Visual Science Research Center Core Facilities [P30EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY000300, R01EY022938, R24EY021126, P30EY021721, R01EY012021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002117] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Service of the Department of Veteran Affairs; Office of Research and Technology Management at Case Western Reserve University; Services of the Case Western Reserve University Visual Science Research Center Core Facilities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the U.S. National Institutes of Health, National Eye Institute (R01EY00300, R01EY022938, and R24EY021126), the Medical Research Service of the Department of Veteran Affairs, and the Office of Research and Technology Management at Case Western Reserve University. Services of the Case Western Reserve University Visual Science Research Center Core Facilities are acknowledged (P30EY11373). K.P. is John H. Hord Professor of Pharmacology. The authors declare no conflicts of interest.	ABBRACCHIO MP, 1991, J NEUROSCI RES, V29, P196, DOI 10.1002/jnr.490290209; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Best TM, 1999, J APPL PHYSIOL, V87, P74, DOI 10.1152/jappl.1999.87.1.74; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Buonfiglio DD, 2011, INVEST OPHTH VIS SCI, V52, P7416, DOI 10.1167/iovs.10-6756; Chan EC, 2013, INVEST OPHTH VIS SCI, V54, P7061, DOI 10.1167/iovs.13-12883; Chang JCF, 2014, J TOXICOL PATHOL, V27, P31, DOI 10.1293/tox.2013-0033; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Descorbeth M, 2010, FREE RADICAL BIO MED, V49, P1395, DOI 10.1016/j.freeradbiomed.2010.07.023; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Elms SC, 2013, DIABETOLOGIA, V56, P654, DOI 10.1007/s00125-012-2789-5; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gavras I, 2001, CURR CONTR TRIALS C, V2, P257, DOI 10.1186/CVM-2-6-257; GORAYA TY, 1995, J NEUROSCI RES, V41, P518, DOI 10.1002/jnr.490410411; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; HADJICONSTANTINOU M, 1988, EUR J PHARMACOL, V149, P193, DOI 10.1016/0014-2999(88)90064-7; Inoue T, 2008, BBA-MOL CELL RES, V1783, P789, DOI 10.1016/j.bbamcr.2007.12.004; Jiang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070555; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jiang YD, 2010, INVEST OPHTH VIS SCI, V51, P2730, DOI 10.1167/iovs.09-4779; Kanwar M, 2008, MICROVASC RES, V76, P189, DOI 10.1016/j.mvr.2008.04.002; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Kern TS, 2010, AM J PATHOL, V176, P2550, DOI 10.2353/ajpath.2010.091062; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lee CA, 2013, INVEST OPHTHALMOL VI, V93, P135; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li GY, 2011, MOL VIS, V17, P3156; Li Y, 2008, AM J PHYSIOL-HEART C, V294, pH2845, DOI 10.1152/ajpheart.91422.2007; Li Y, 2007, AM J PHYSIOL-HEART C, V292, pH1922, DOI 10.1152/ajpheart.01166.2006; LIVINGSTONE C, 1991, BIOCHIM BIOPHYS ACTA, V1096, P127, DOI 10.1016/0925-4439(91)90050-J; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Renganathan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076325; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shen JY, 2012, P NATL ACAD SCI USA, V109, P3540, DOI 10.1073/pnas.1119201109; Steinle JJ, 2008, EXP EYE RES, V87, P30, DOI 10.1016/j.exer.2008.04.008; Suzuki F, 2002, BRIT J PHARMACOL, V135, P600, DOI 10.1038/sj.bjp.0704503; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062081; Thampi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034468; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357; Woldemussie E, 2007, VISUAL NEUROSCI, V24, P745, DOI 10.1017/S0952523807070605; Yamamori T, 2000, FEBS LETT, V467, P253, DOI 10.1016/S0014-5793(00)01167-4; ZARBIN MA, 1986, BRAIN RES, V374, P75, DOI 10.1016/0006-8993(86)90396-3; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	61	37	38	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2194	2204		10.1096/fj.14-269431	http://dx.doi.org/10.1096/fj.14-269431			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25667222	Green Submitted, Green Published			2022-12-26	WOS:000354114600049
J	Burkinshaw, BJ; Deng, WY; Lameignere, E; Wasney, GA; Zhu, HZ; Worrall, LJ; Finlay, BB; Strynadka, NCJ				Burkinshaw, Brianne J.; Deng, Wanyin; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.			Structural Analysis of a Specialized Type III Secretion System Peptidoglycan-cleaving Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cell Wall; Peptidoglycan; Type III Secretion System (T3SS); X-ray Crystallography	ENTEROPATHOGENIC ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES; MACROMOLECULAR STRUCTURES; PROTEIN CRYSTALLIZATION; NEEDLE COMPLEX; FLGJ; TRANSLOCATION; LOCUS; CELLS; RESOLUTION	Background: Bacterial virulence-associated type III secretion system (T3SS) assembly requires a dedicated enzyme to penetrate peptidoglycan (PG). Results: We structurally characterized a T3SS PG-lytic enzyme, identified catalytically important residues, and characterized its activity. Conclusion: The active site is similar to lysozymes and lytic transglycosylases and interaction with the T3SS enhances activity. Significance: Structural information is critical for development of drugs targeting T3SS PG-lytic enzymes. The Gram-negative bacterium enteropathogenic Escherichia coli uses a syringe-like type III secretion system (T3SS) to inject virulence or effector proteins into the cytoplasm of host intestinal epithelial cells. To assemble, the T3SS must traverse both bacterial membranes, as well as the peptidoglycan layer. Peptidoglycan is made of repeating N-acetylmuramic acid and N-acetylglucosamine disaccharides cross-linked by pentapeptides to form a tight mesh barrier. Assembly of many macromolecular machines requires a dedicated peptidoglycan lytic enzyme (PG-lytic enzyme) to locally clear peptidoglycan. Here we have solved the first structure of a T3SS-associated PG-lytic enzyme, EtgA from enteropathogenic E. coli. Unexpectedly, the active site of EtgA has features in common with both lytic transglycosylases and hen egg white lysozyme. Most notably, the -hairpin region resembles that of lysozyme and contains an aspartate that aligns with lysozyme Asp-52 (a residue critical for catalysis), a conservation not observed in other previously characterized lytic transglycosylase families to which the conserved T3SS enzymes had been presumed to belong. Mutation of the EtgA catalytic glutamate, Glu-42, conserved across lytic transglycosylases and hen egg white lysozyme, and this differentiating aspartate diminishes type III secretion in vivo, supporting its essential role in clearing the peptidoglycan for T3SS assembly. Finally, we show that EtgA forms a 1:1 complex with the building block of the polymerized T3SS inner rod component, EscI, and that this interaction enhances PG-lytic activity of EtgA in vitro, collectively providing the necessary strict localization and regulation of the lytic activity to prevent overall cell lysis.	[Burkinshaw, Brianne J.; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Burkinshaw, Brianne J.; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca			CIHR; HHMI International Scholar program; University of British Columbia Centre for Blood Research graduate student fellowship; Cystic Fibrosis Canada Fellowship	CIHR(Canadian Institutes of Health Research (CIHR)); HHMI International Scholar program; University of British Columbia Centre for Blood Research graduate student fellowship; Cystic Fibrosis Canada Fellowship	This work was funded by CIHR operating grants to NCJS and BBF and operating funding from the HHMI International Scholar program to NCJS.; Supported by a University of British Columbia Centre for Blood Research graduate student fellowship.; Supported by a Cystic Fibrosis Canada Fellowship.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; ALLAOUI A, 1993, INFECT IMMUN, V61, P1707, DOI 10.1128/IAI.61.5.1707-1714.1993; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Gomez E, 2011, MICROBIOL-SGM, V157, P1145, DOI 10.1099/mic.0.045617-0; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; Hoppner C, 2005, MICROBIOL-SGM, V151, P3469, DOI 10.1099/mic.0.28326-0; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Oh HS, 2007, J BACTERIOL, V189, P8277, DOI 10.1128/JB.00998-07; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pucciarelli MG, 2003, MOL MICROBIOL, V48, P573, DOI 10.1046/j.1365-2958.2003.03469.x; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; TAYLOR CJ, 1986, J PEDIATR GASTR NUTR, V5, P70, DOI 10.1097/00005176-198601000-00013; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YA, 2006, STRUCTURE, V14, P1189, DOI 10.1016/j.str.2006.05.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Yu YC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-52; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhong DL, 2012, J BIOL CHEM, V287, P25303, DOI 10.1074/jbc.M112.381574	59	31	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10406	10417		10.1074/jbc.M115.639013	http://dx.doi.org/10.1074/jbc.M115.639013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25678709	Green Published, hybrid			2022-12-26	WOS:000353241100041
J	Truttmann, MC; Wu, Q; Stiegeler, S; Duarte, JN; Ingram, J; Ploegh, HL				Truttmann, Matthias C.; Wu, Qin; Stiegeler, Sarah; Duarte, Joao N.; Ingram, Jessica; Ploegh, Hidde L.			HypE-specific Nanobodies as Tools to Modulate HypE-mediated Target AMPylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIC DOMAIN; POSTTRANSLATIONAL MODIFICATION; ADP-RIBOSYLATION; PROTEIN; ADENYLYLATION; OPTIMIZATION; TRANSFERASE; SUBSTRATE; MECHANISM; REVEALS	The covalent addition of mono-AMP to target proteins (AMPylation) by Fic domain-containing proteins is a poorly understood, yet highly conserved post-translational modification. Here, we describe the generation, evaluation, and application of four HypE-specific nanobodies: three that inhibit HypE-mediated target AMPylation in vitro and one that acts as an activator. All heavy chain-only antibody variable domains bind HypE when expressed as GFP fusions in intact cells. We observed localization of HypE at the nuclear envelope and further identified histones H2-H4, but not H1, as novel in vitro targets of the human Fic protein. Its role in histone modification provides a possible link between AMPylation and regulation of gene expression.	[Truttmann, Matthias C.; Wu, Qin; Stiegeler, Sarah; Duarte, Joao N.; Ingram, Jessica; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ploegh, Hidde L.] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Duarte, Joao N/T-3839-2017; truttmann, matthias/ABC-2727-2021	Duarte, Joao N/0000-0002-4173-484X; truttmann, matthias/0000-0002-0536-7923; Stiegeler, Sarah/0000-0001-9622-7629	Swiss National Science Foundation; Champalimaud Foundation; Portuguese Science and Technology Foundation; Portuguese Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106409] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Champalimaud Foundation; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Portuguese Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Recipient of an Early Postdoc. Mobility fellowship from the Swiss National Science Foundation.; Calouste Gulbenkian Foundation Scholar. Supported by the Champalimaud Foundation, the Portuguese Science and Technology Foundation, and the Portuguese Ministry of Health.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BOULIKAS T, 1989, P NATL ACAD SCI USA, V86, P3499, DOI 10.1073/pnas.86.10.3499; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Bunney T. D., 2014, STRUCTURE, V1016; BURZIO LO, 1979, J BIOL CHEM, V254, P3029; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gonzalez JM, 2011, BIOCHEM SOC T, V39, P1758, DOI 10.1042/BST20110653; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Itzen A, 2011, TRENDS BIOCHEM SCI, V36, P219, DOI 10.1016/j.tibs.2010.12.004; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Leavy O, 2010, NAT REV IMMUNOL, V10, P297, DOI 10.1038/nri2763; Lewallen DM, 2014, ACS CHEM BIOL, V9, P433, DOI 10.1021/cb4006886; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mishra N, 2012, J THROMB HAEMOST, V10, P1091, DOI 10.1111/j.1538-7836.2012.04738.x; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Sosa BA, 2014, ELIFE, V3, DOI 10.7554/eLife.03239; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	46	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9087	9100		10.1074/jbc.M114.634287	http://dx.doi.org/10.1074/jbc.M114.634287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678711	Green Published, hybrid			2022-12-26	WOS:000352207100032
J	Park, CH; Park, JE; Kim, TS; Kang, YH; Soung, NK; Zhou, M; Kim, NH; Bang, JK; Lee, KS				Park, Chi Hoon; Park, Jung-Eun; Kim, Tae-Sung; Kang, Young Hwi; Soung, Nak-Kyun; Zhou, Ming; Kim, Nam-Hyung; Bang, Jeong Kyu; Lee, Kyung S.			Mammalian Polo-like Kinase 1 (Plk1) Promotes Proper Chromosome Segregation by Phosphorylating and Delocalizing the PBIP1.CENP-Q Complex from Kinetochores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-CYCLE; CENP-A; LOCALIZATION; POLO-LIKE-KINASE-1; CYTOKINESIS; MECHANISM; DIVISION; MITOSIS; DOMAIN	Mammalian Plk1 is critically required for proper M phase progression. Plk1 is self-recruited to prekinetochores/kinetochores by phosphorylating and binding to the Thr-78 motif of a kinetochore scaffold protein, PBIP1 (also called CENP-U/50), which forms a stable complex with another kinetochore component, CENP-Q. However, the mechanism regulating Plk1 localization to this site remains largely unknown. Here, we demonstrate that the PBIP1 . CENP-Q complex became hyperphosphorylated and rapidly delocalized from kinetochores as cells entered mitosis. Plk1 phosphorylated the CENP-Q subunit of the PBIP1.CENP-Q complex at multiple sites, and mutation of nine Plk1-dependent phosphorylation sites to Ala (9A) enhanced CENP-Q association with chromatin and prolonged CENP-Q localization to kinetochores. Conversely, mutation of the nine sites to phospho-mimicking Asp/Glu (9D/E) residues dissociated CENP-Q from chromatin and kept the CENP-Q(9D/E) mutant from localizing to interphase prekinetochores. Strikingly, both the 9A and 9D/E mutants induced a defect in proper chromosome segregation, suggesting that both timely localization of the PBIP1.CENP-Q complex to prekinetochores and delocalization from kinetochores are critical for normal M phase progression. Notably, although Plk1 did not alter the level of PBIP1 and CENP-Q ubiquitination, Plk1-dependent phosphorylation and delocalization of these proteins from kinetochores appeared to indirectly lead to their degradation in the cytosol. Thus, we propose that Plk1 regulates the timing of the delocalization and ultimate destruction of the PBIP1.CENP-Q complex and that these processes are important not only for promoting Plk1-dependent mitotic progression, but also for resetting the timing of Plk1 recruitment to prekinetochores in the next cell cycle.	[Park, Chi Hoon; Park, Jung-Eun; Kim, Tae-Sung; Lee, Kyung S.] NCI, NIH, Lab Metab, Bethesda, MD 20892 USA; [Kang, Young Hwi] Ewha Womans Univ, Immune & Vasc Cell Network Res Ctr, Dept Life Sci, Seoul 120750, South Korea; [Kang, Young Hwi] Ewha Womans Univ, Immune & Vasc Cell Network Res Ctr, GT5 Program, Seoul 120750, South Korea; [Soung, Nak-Kyun] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Ochang 363883, Chungbuk, South Korea; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Leidos Biomed Res, Frederick, MD 21702 USA; [Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea; [Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang 363883, Chungbuk, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ewha Womans University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chungbuk National University; Korea Basic Science Institute (KBSI)	Lee, KS (corresponding author), NCI, NIH, Lab Metab, Ctr Canc Res, Bldg. 37,Rm 3118,9000 Rockville Pike, Bethesda, MD 20892 USA.	kyunglee@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC011324] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Eskat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044717; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Kagawa N, 2014, CHROMOSOME RES, V22, P293, DOI 10.1007/s10577-014-9404-1; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Park JE, 2011, P NATL ACAD SCI USA, V108, P8200, DOI 10.1073/pnas.1102020108; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219	25	20	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8569	8581		10.1074/jbc.M114.623546	http://dx.doi.org/10.1074/jbc.M114.623546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670858	Green Published, hybrid			2022-12-26	WOS:000351662600047
J	Zhao, XC; Yang, H; Liu, W; Duan, XY; Shang, WN; Xia, DJ; Tong, C				Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Xia, Dajing; Tong, Chao			Sec22 Regulates Endoplasmic Reticulum Morphology but Not Autophagy and Is Required for Eye Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Drosophila; Endoplasmic Reticulum (ER); Golgi; SNARE Proteins	MEMBRANE-FUSION; PLASMA-MEMBRANE; MOLECULAR-BASIS; GOLGI; ER; TRANSPORT; COMPLEX; MORPHOGENESIS; BIOGENESIS; EXPANSION	Background: ER morphological changes are often observed in disease conditions, but the molecular mechanisms remain unclear. Results: Malfunction of Sec22 and its binding partners resulted in ER expansion and defects in fly eye development. Conclusion: Sec22 regulates ER morphology through regulating ER-Golgi trafficking but not autophagy. Significance: ER morphology changes under the disease conditions might be due to the defects of ER-Golgi trafficking. The endoplasmic reticulum (ER) is a highly dynamic organelle that plays a critical role in many cellular processes. Abnormal ER morphology is associated with some human diseases, although little is known regarding how ER morphology is regulated. Using a forward genetic screen to identify genes that regulated ER morphology in Drosophila, we identified a mutant of Sec22, the orthologs of which in yeast, plants, and humans are required for ER to Golgi trafficking. However, the physiological function of Sec22 has not been previously investigated in animal development. A loss of Sec22 resulted in ER proliferation and expansion, enlargement of late endosomes, and abnormal Golgi morphology in mutant larvae fat body cells. However, starvation-induced autophagy was not affected by a loss of Sec22. Mosaic analysis of the eye revealed that Sec22 was required for photoreceptor morphogenesis. In Sec22 mutant photoreceptor cells, the ER was highly expanded and gradually lost normal morphology with aging. The rhabdomeres in mutants were small and sometimes fused with each other. The morphology of Sec22 mutant eyes resembled the eye morphology of flies with overexpressed eyc (eyes closed). eyc encodes for a Drosophila p47 protein that is required for membrane fusion. A loss of Syntaxin5 (Syx5), encoding for a t-SNARE on Golgi, also phenocopied the Sec22 mutant. Sec22 formed complexes with Syx5 and Eyc. Thus, we propose that appropriate trafficking between the ER and Golgi is required for maintaining ER morphology and for Drosophila eye morphogenesis.	[Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Tong, Chao] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Tong, Chao] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huan; Xia, Dajing] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xia, DJ (corresponding author), Zhejiang Univ, Sch Publ Hlth, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	dxia@zju.edu.cn		Tong, Chao/0000-0001-6521-5465	National Basic Research Program of China [2012CB966600, 2014CB943100]; National Natural Science Foundation of China [31271432]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20130101110116]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant	Supported by National Basic Research Program of China Grants 2012CB966600 and 2014CB943100, National Natural Science Foundation of China Grant 31271432, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130101110116. To whom correspondence may be addressed: Life Sciences Institute, Zhejiang University, 866 Yuhangtang Rd., Hangzhou 310058, China. Tel.: 86-571-88981370; E-mail: ctong@zju.edu.cn.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bernard A, 2013, DEV CELL, V25, P116, DOI 10.1016/j.devcel.2013.04.004; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Draxl S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3092; Edwardson JM, 1998, CURR BIOL, V8, pR390, DOI 10.1016/S0960-9822(98)70245-3; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lin SY, 2012, INT J BIOCHEM CELL B, V44, P1436, DOI 10.1016/j.biocel.2012.05.013; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; MELLMAN I, 1995, CELL, V82, P869, DOI 10.1016/0092-8674(95)90018-7; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2012, AUTOPHAGY, V8, P861, DOI 10.4161/auto.20060; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Paek I, 1997, J CELL BIOL, V137, P1017, DOI 10.1083/jcb.137.5.1017; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; Sang TK, 2002, DEVELOPMENT, V129, P143; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zhang K, 2013, J CELL BIOL, V200, P807, DOI 10.1083/jcb.201208033	47	21	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7943	7951		10.1074/jbc.M115.640920	http://dx.doi.org/10.1074/jbc.M115.640920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670863	Green Published, hybrid			2022-12-26	WOS:000351613600051
J	Ito, T; Taniguchi, H; Fukagai, K; Okamuro, S; Kobayashi, A				Ito, Takao; Taniguchi, Hiroaki; Fukagai, Kousuke; Okamuro, Shota; Kobayashi, Akira			Inhibitory Mechanism of FAT4 Gene Expression in Response to Actin Dynamics during Src-Induced Carcinogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO SIGNALING PATHWAY; DNA METHYLATION; CELL-ADHESION; SIZE CONTROL; KINASE; CANCER; GROWTH; PHOSPHORYLATION; CYTOSKELETON	Oncogenic transformation is characterized by morphological changes resulting from alterations in actin dynamics and adhesive activities. Emerging evidence suggests that the protocadherin FAT4 acts as a tumor suppressor in humans, and reduced FAT4 gene expression has been reported in breast and lung cancers and melanoma. However, the mechanism controlling FAT4 gene expression is poorly understood. In this study, we show that transient activation of the Src oncoprotein represses FAT4 mRNA expression through actin depolymerization in the immortalized normal human mammary epithelial cell line MCF-10A. Src activation causes actin depolymerization via the MEK/Erk/Cofilin cascade. The MEK inhibitor U0126 blocks the inhibitory effect of Src on FAT4 mRNA expression and Src-induced actin depolymerization. To determine whether actin dynamics act on the regulation of FAT4 mRNA expression, we treated MCF-10A cells with the ROCK inhibitor Y-27632. Y-27632 treatment decreased FAT4 mRNA expression. This suppressive effect was blocked by siRNA-mediated knockdown of Cofilin1. Furthermore, simultaneous administration of Latrunculin A (an actin depolymerizing agent), Y-27632, and Cofilin1 siRNA to the cells resulted in a marked reduction of FAT4 mRNA expression. Intriguingly, we also found that FAT4 mRNA expression was reduced under both low cell density and low stiffness conditions, which suggests that mechanotransduction affects FAT4 mRNA expression. Additionally, we show that siRNA-mediated FAT4 knockdown induced the activity of the Hippo effector YAP/TAZ in MCF-10A cells. Taken together, our results reveal a novel inhibitory mechanism of FAT4 gene expression through actin depolymerization during Src-induced carcinogenesis in human breast cells.	[Ito, Takao; Taniguchi, Hiroaki; Fukagai, Kousuke; Okamuro, Shota; Kobayashi, Akira] Doshisha Univ, Grad Sch Life & Med Sci, Lab Genet Code, Kyoto 602, Japan	Doshisha University	Kobayashi, A (corresponding author), Doshisha Univ, Grad Sch Life & Med Sci, Lab Genet Code, Kyoto 602, Japan.	akobayas@mail.doshisha.ac.jp	Taniguchi, Hiroaki/H-6329-2016; Kobayashi, Akira/AAN-8003-2020	Ito, Takao/0000-0003-2224-034X; Taniguchi, Hiroaki/0000-0001-7270-390X; Kobayashi, Akira/0000-0001-9727-1218	Ministry of Education, Sports, Science and Technology; Strategic Research Foundation at Private Universities from the Ministry of Education, Sports, Science and Technology; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [26116725] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation at Private Universities from the Ministry of Education, Sports, Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding from Grants-in-aid from the Ministry of Education, Sports, Science and Technology (http://www.mext.go.jp/english/), AK, HT; The Strategic Research Foundation at Private Universities (2012-2016) from the Ministry of Education, Sports, Science and Technology (http://www.mext.go.jp/english/), AK; The Takeda Science Foundation (http://www.takeda-sci.or.jp/), HT; and The Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai/), HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cappello S, 2013, NAT GENET, V45, P1300, DOI 10.1038/ng.2765; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Edme N, 2002, J CELL SCI, V115, P2591; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Lund P, 2006, ONCOGENE, V25, P4890, DOI 10.1038/sj.onc.1209502; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Murphy AJ, 2014, PEDIATR BLOOD CANCER, V61, P198, DOI 10.1002/pbc.24788; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; SOULE HD, 1990, CANCER RES, V50, P6075; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sung J, 2005, CARCINOGENESIS, V26, P487, DOI 10.1093/carcin/bgh318; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	56	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118336	10.1371/journal.pone.0118336	http://dx.doi.org/10.1371/journal.pone.0118336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679223	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600119
J	Mehta, SD; Donovan, B; Weber, KM; Cohen, M; Ravel, J; Gajer, P; Gilbert, D; Burgad, D; Spear, GT				Mehta, Supriya D.; Donovan, Brock; Weber, Kathleen M.; Cohen, Mardge; Ravel, Jacques; Gajer, Pawel; Gilbert, Douglas; Burgad, Derick; Spear, Greg T.			The Vaginal Microbiota over an 8-to 10-Year Period in a Cohort of HIV-Infected and HIV-Uninfected Women	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIAL VAGINOSIS; GENITAL-TRACT; GARDNERELLA-VAGINALIS; PRETERM DELIVERY; RISK-FACTORS; ACQUISITION; PREVALENCE; ASSOCIATION; MICROFLORA; MODEL	Background We identified predominant vaginal microbiota communities, changes over time, and how this varied by HIV status and other factors in a cohort of 64 women. Methods Bacterial DNA was extracted from reposited cervicovaginal lavage samples collected annually over an 8-10 year period from Chicago Women's Interagency HIV Study participants: 22 HIV-negative, 22 HIV-positive with stable infection, 20 HIV-positive with progressive infection. The vaginal microbiota was defined by pyrosequencing of the V1/V2 region of the 16S rRNA gene. Scheduled visits included Bacterial vaginsosis (BV) screening; clinically detected cases were referred for treatment. Hierarchical clustering identified bacterial community state types (CST). Multinomial mixed effects modeling determined trends over time in CST, by HIV status and other factors. Results The median follow-up time was 8.1 years (range 5.5-15.3). Six CSTs were identified. The mean relative abundance (RA) of Lactobacillus spp. by CST (with median number of bacterial taxa) was: CST-1-25.7% (10), CST-2-27.1% (11), CST-3-34.6%(9), CST-4-46.8% (9), CST-5-57.9% (4), CST-6-69.4%(2). The two CSTs representing the highest RA of Lactobacillus and lowest diversity increased with each additional year of follow-up (CST-5, adjusted odds ratio (aOR) = 1.62 [95% CI: 1.34-1.94]; CST-6, aOR = 1.57 [95 CI: 1.31-1.89]), while the two CSTs representing lowest RA of Lactobacillus and higher diversity decreased with each additional year (CST-1, aOR = 0.89 [95% CI: 0.80-1.00]; CST-2, aOR = 0.86 [95% CI: 0.75-0.99]). There was no association between HIV status and CST at baseline or over time. CSTs representing lower RA of Lactobacillus were associated with current cigarette smoking. Conclusions The vaginal microbial community significantly improved over time in this cohort of women with HIV and at high risk for HIV who had regular detection and treatment referral for BV.	[Mehta, Supriya D.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Donovan, Brock] Univ Illinois, Coll Med, Dept Bioengn, Chicago, IL USA; [Weber, Kathleen M.; Cohen, Mardge] Cook Cty Hlth & Hosp Syst, Core Ctr, Chicago, IL USA; [Ravel, Jacques; Gajer, Pawel] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Ravel, Jacques; Gajer, Pawel] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Gilbert, Douglas; Burgad, Derick; Spear, Greg T.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; John H Stroger Junior Hospital Cook County; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Rush University	Mehta, SD (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	Supriyad@uic.edu	Ravel, Jacques/D-2530-2009	Mehta, Supriya/0000-0002-7926-2489; Ravel, Jacques/0000-0002-0851-2233	National Institute of Allergy and Infectious Diseases [UO1-AI-34994]; National Cancer Institute; National Institute on Drug Abuse; American Recovery and Reinvestment Act (ARRA) NIAID supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Recovery and Reinvestment Act (ARRA) NIAID supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Chicago WIHS-I-IV was funded by the National Institute of Allergy and Infectious Diseases, UO1-AI-34994 (PI: Mardge H. Cohen MD) and co-funded by the National Cancer Institute and the National Institute on Drug Abuse. This WIHS substudy was funded by an American Recovery and Reinvestment Act (ARRA) NIAID supplement to the Chicago WIHS (ARRA PI: G. Spear). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bradshaw CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034540; Brotman RM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-471; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2011, ANAEROBE, V17, P191, DOI 10.1016/j.anaerobe.2011.01.001; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hemalatha R, 2012, AM J MED SCI, V344, P35, DOI 10.1097/MAJ.0b013e318235597b; Hessol NA, 2009, J WOMENS HEALTH, V18, P1627, DOI 10.1089/jwh.2008.1337; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Langstrom N, 2006, ARCH SEX BEHAV, V35, P37, DOI 10.1007/s10508-006-8993-y; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mirmonsef P, 2012, AM J REPROD IMMUNOL, V67, P391, DOI 10.1111/j.1600-0897.2011.01089.x; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Pavlova SI, 2000, MUTAT RES-GEN TOX EN, V466, P57, DOI 10.1016/S1383-5718(00)00003-6; R Core Team, 2012, R LANG ENV STAT COMP; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg JJ, 2012, AIDS, V26, P387, DOI 10.1097/QAD.0b013e32834ed7f0; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schwebke JR, 2007, SEX TRANSM DIS, V34, P876, DOI 10.1097/OLQ.0b013e318073bd82; Schwebke JR, 2007, AM J OBSTET GYNECOL, V196, P517, DOI 10.1016/j.ajog.2007.02.048; Schwebke JR, 2014, SEX TRANSM INFECT, V90, P61, DOI 10.1136/sextrans-2013-051232; Simhan HN, 2005, AM J OBSTET GYNECOL, V193, P1999, DOI 10.1016/j.ajog.2005.04.054; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; TOTTEN PA, 1982, J CLIN MICROBIOL, V15, P141, DOI 10.1128/JCM.15.1.141-147.1982; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watts DH, 2006, JAIDS-J ACQ IMM DEF, V43, P161, DOI 10.1097/01.qai.0000242448.90026.13; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X	55	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0116894	10.1371/journal.pone.0116894	http://dx.doi.org/10.1371/journal.pone.0116894			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675346	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000011
J	Casas-Agustench, P; Fernandes, FS; do Carmo, MGT; Visioli, F; Herrera, E; Davalos, A				Casas-Agustench, Patricia; Fernandes, Flavia S.; Tavares do Carmo, Maria G.; Visioli, Francesco; Herrera, Emilio; Davalos, Alberto			Consumption of Distinct Dietary Lipids during Early Pregnancy Differentially Modulates the Expression of microRNAs in Mothers and Offspring	PLOS ONE			English	Article							FATTY-ACIDS; GENE-EXPRESSION; HIGH GLUCOSE; THERAPEUTICS; NUTRITION; DISEASE; FEMALE; MIR-21; GROWTH; CELLS	Diet during pregnancy and lactation influences the offspring's health in the long-term. Indeed, human epidemiological studies and animal experiments suggest that different type of fatty acids consumption during pregnancy affect offspring development and susceptibility to metabolic disorders. Epigenetic changes are thought to be elicited by dietary factors during critical timing of development. microRNAs (miRNAs) are versatile regulators of gene expression. Thus, we aimed to determine the influence of different fatty acids on miRNA expression in offspring when given during early pregnancy. We fed pregnant either soybean (SO), olive (OO), fish (FO), linseed (LO), or palm-oil (PO) diets from conception to day 12 of gestation; and standard diet thereafter. miRNA expression was assessed in liver an adipose tissue of pregnant rats and their virgin counterparts. While liver concentrations of fatty acids in pregnant or virgin rats replicated those of the diets consumed during early pregnancy, their pups' liver tissue marginally reflected those of the respective experimental feeds. By contrast, the liver fatty acid profile of adult offsprings was similar, regardless of the diet fed during gestation. Different parental miRNAs were modulated by the different type of fatty acid: in adult offspring, miR-215, miR-10b, miR-26, miR-377-3p, miR-21, and miR-192 among others, were differentially modulated by the different fatty acids fed during early pregnancy. Overall, our results show that maternal consumption of different types of fatty acids during early pregnancy influences miRNA expression in both maternal and offspring tissues, which may epigenetically explain the long-term phenotypic changes of the offspring.	[Casas-Agustench, Patricia; Visioli, Francesco; Davalos, Alberto] CEI UAM CSIC, Madrid Inst Adv Studies IMDEA Food, Lab Disorders Lipid Metab & Mol Nutr, Madrid, Spain; [Fernandes, Flavia S.; Tavares do Carmo, Maria G.] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Herrera, Emilio] Univ San Pablo CEU, Fac Pharm, Dept Biochem & Chem, Madrid, Spain; [Herrera, Emilio] Univ San Pablo CEU, Fac Med, Dept Biochem & Chem, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidade Federal do Rio de Janeiro; San Pablo CEU University; San Pablo CEU University	Herrera, E (corresponding author), Univ San Pablo CEU, Fac Pharm, Dept Biochem & Chem, Madrid, Spain.	eherrera@ceu.es; alberto.davalos@imdea.org	Visioli, Francesco/AAE-8510-2020; Herrera-Castillon, Emilio/D-9143-2012; Visioli, Francesco/J-9356-2013; Davalos, Alberto/AAA-9949-2021; , Patricia Casas-Agustench/M-7762-2014	Herrera-Castillon, Emilio/0000-0002-8152-787X; Visioli, Francesco/0000-0002-1756-1723; , Patricia Casas-Agustench/0000-0003-4424-1087; Davalos, Alberto/0000-0001-5709-6443	Instituto de Salud Carlos III (FIS) [PI11/00315]; European FEDER Funds; Sociedad Espanola de Arteriosclerosis; Ministerio de Economia y Competitividad [AGL2011-28995]; European Union [PIOF-GA-2010-272581]; Fundacion Ramon Areces [CIVP16A1835]	Instituto de Salud Carlos III (FIS)(Instituto de Salud Carlos IIIEuropean Commission); European FEDER Funds(European Commission); Sociedad Espanola de Arteriosclerosis; Ministerio de Economia y Competitividad(Spanish Government); European Union(European Commission); Fundacion Ramon Areces	This work was supported in part by the Instituto de Salud Carlos III (FIS, PI11/00315), European FEDER Funds and the Sociedad Espanola de Arteriosclerosis to A. D.; by the Ministerio de Economia y Competitividad to F. V. (AGL2011-28995); by the European Union Seventh Framework Programme (grant agreement no. PIOF-GA-2010-272581) to P. C-A. and by the Fundacion Ramon Areces to E. H (CIVP16A1835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Ayed R, 2014, BR J NUTR, P1; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Burdge GC, 2014, CURR OPIN CLIN NUTR, V17, P156, DOI 10.1097/MCO.0000000000000023; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Fernandes FS, 2012, PROSTAG LEUKOTR ESS, V86, P167, DOI 10.1016/j.plefa.2012.03.001; Fernandes FS, 2012, LIPIDS, V47, P505, DOI 10.1007/s11745-012-3660-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Karbiener M, 2013, STEM CELLS, DOI [10.1002/stem.1574, DOI 10.1002/STEM.1574]; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lamaziere A, 2013, PROSTAG LEUKOTR ESS, V88, P149, DOI 10.1016/j.plefa.2012.12.001; Lauritzen L, 2011, MATERN CHILD NUTR, V7, P41, DOI 10.1111/j.1740-8709.2011.00303.x; Leon DA, 1998, EUR J CLIN NUTR, V52, pS72; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCAS A, 1991, CIBA F SYMP, V156, P38; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058622; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rodriguez-Bernal CL, 2010, AM J CLIN NUTR, V91, P1659, DOI 10.3945/ajcn.2009.28866; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Sardinha FLC, 2013, AM J PHYSIOL-REG I, V304, pR313, DOI 10.1152/ajpregu.00392.2012; Shi Y, 2014, INT J INF TECH DECIS, V13, P1, DOI 10.1142/S0219622014010019; Simmons R, 2011, P NUTR SOC, V70, P73, DOI 10.1017/S0029665110003988; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song GX, 2014, GENE, V533, P481, DOI 10.1016/j.gene.2013.10.011; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Visioli F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00042; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Xu GF, 2014, MOL MED REP, V10, P223, DOI 10.3892/mmr.2014.2204; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62; Zhu LL, 2013, MOL BIOL REP, V40, P5669, DOI 10.1007/s11033-013-2668-2	53	31	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117858	10.1371/journal.pone.0117858	http://dx.doi.org/10.1371/journal.pone.0117858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671565	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300073
J	Ferreira, LC; Thums, M; Meeuwig, JJ; Vianna, GMS; Stevens, J; McAuley, R; Meekan, MG				Ferreira, Luciana C.; Thums, Michele; Meeuwig, Jessica J.; Vianna, Gabriel M. S.; Stevens, John; McAuley, Rory; Meekan, Mark G.			Crossing Latitudes-Long-Distance Tracking of an Apex Predator	PLOS ONE			English	Article							SHARKS CARCHARODON-CARCHARIAS; NEW-SOUTH-WALES; MARINE PROTECTED AREA; GULF-OF-MEXICO; GALEOCERDO-CUVIER; TIGER SHARK; MOVEMENT PATTERNS; GUADALUPE ISLAND; MESHING PROGRAM; HABITAT USE	Tiger sharks (Galeocerdo cuvier) are apex predators occurring in most tropical and warm temperate marine ecosystems, but we know relatively little of their patterns of residency and movement over large spatial and temporal scales. We deployed satellite tags on eleven tiger sharks off the north-western coast of Western Australia and used the Brownian Bridge kernel method to calculate home ranges and analyse movement behaviour. One individual recorded one of the largest geographical ranges of movement ever reported for the species, travelling over 4000 km during 517 days of monitoring. Tags on the remainder of the sharks reported for shorter periods (7-191 days). Most of these sharks had restricted movements and long-term (30-188 days) residency in coastal waters in the vicinity of the area where they were tagged. Core home range areas of sharks varied greatly from 1166.9 to 634,944 km(2). Tiger sharks spent most of their time in water temperatures between 23 degrees-26 degrees C but experienced temperatures ranging from 6 degrees C to 33 degrees C. One shark displayed seasonal movements among three distinct home range cores spread along most of the coast of Western Australia and generalized linear models showed that this individual had different patterns of temperature and depth occupancy in each region of the coast, with the highest probability of residency occurring in the shallowest areas of the coast with water temperatures above 23 degrees C. These results suggest that tiger sharks can migrate over very large distances and across latitudes ranging from tropical to the cool temperate waters. Such extensive long-term movements may be a key element influencing the connectivity of populations within and among ocean basins.	[Ferreira, Luciana C.; Vianna, Gabriel M. S.] Univ Western Australia, Sch Anim Biol, UWA Oceans Inst, Crawley, WA, Australia; [Ferreira, Luciana C.; Thums, Michele; Vianna, Gabriel M. S.; Meekan, Mark G.] Australian Inst Marine Sci, Perth, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Crawley, WA, Australia; [Stevens, John] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [McAuley, Rory] Govt Western Australia, WA Fisheries & Marine Res Labs, Dept Fisheries, Perth, WA, Australia	University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ferreira, LC (corresponding author), Univ Western Australia, Sch Anim Biol, UWA Oceans Inst, Crawley, WA, Australia.	luciana.ferreira@research.uwa.edu.au	Thums, Michele/A-3850-2013	Thums, Michele/0000-0002-8669-8440; Meekan, Mark/0000-0002-3067-9427; Meeuwig, Jessica/0000-0003-1169-8785	Australian Institute of Marine Science; CSIRO Marine and Atmospheric Research; Department of Fisheries, Government of Western Australia	Australian Institute of Marine Science; CSIRO Marine and Atmospheric Research(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of Fisheries, Government of Western Australia	Funding was provided by the Australian Institute of Marine Science, CSIRO Marine and Atmospheric Research and the Department of Fisheries, Government of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 1997, FISH RES, V29, P101, DOI 10.1016/S0165-7836(96)00536-X; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Bullard F., 1991, THESIS U N CAROLINA; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calange C, 2011, HOME RANGE ESTIMATIO; Carlstein E, 1998, BERNOULLI, V4, P305, DOI 10.2307/3318719; Castillo-Geniz JL, 1998, MAR FRESHWATER RES, V49, P611, DOI 10.1071/MF97120; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Compagno L. J. V., 1984, SHARKS WORLD ANNOTAT, V4; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; CRESSWELL G, 2000, PAP P R SOC TASMANIA, V133, P21, DOI DOI 10.26749/RSTPP.133.3.21; Dicken ML, 2009, AFR J MAR SCI, V31, P227, DOI 10.2989/AJMS.2009.31.2.10.882; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Drymon JM, 2013, FISH B-NOAA, V111, P370, DOI 10.7755/FB.111.4.6; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Estes J., 2001, ENCY BIODIVERSITY, P857, DOI [DOI 10.1006/RWBD.1999.0280, 10.1016/B0-12-226865-2/00358-8]; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Farmer BM, 2011, ENVIRON BIOL FISH, V91, P71, DOI 10.1007/s10641-010-9761-3; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Green M, 2009, REPORT NSW SHARK MES; GUDGER EW, 1949, COPEIA, P39; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Handley AJ, 2010, FISHERY REPORTS 2009; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Hazin FHV, 2008, B MAR SCI, V82, P199; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heithaus MR, 2010, CRC MAR BIOL SER, P611; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hooker SK, 1999, CONSERV BIOL, V13, P592, DOI 10.1046/j.1523-1739.1999.98099.x; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Kerstetter DW, 2004, FISH B-NOAA, V102, P750; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; KROGH M, 1994, AUST J MAR FRESH RES, V45, P1087; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Matsumoto T, 2005, COLLECT VOL SCI PAP, V58, P1694; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; PATERSON RA, 1990, BIOL CONSERV, V52, P147, DOI 10.1016/0006-3207(90)90123-7; Patton A, 2009, ECONOMET REV, V28, P372, DOI 10.1080/07474930802459016; PEPPERELL JG, 1992, AUST J MAR FRESH RES, V43, P213, DOI 10.1071/MF9920213; Politis D. N., 2004, ECON REV, V23, P53, DOI [DOI 10.1081/ETC-120028836, 10.1081/ETC-120028836]; Polovina JJ, 1993, MAR FISH REV, V55, P1; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; REID JL, 1994, PROG OCEANOGR, V33, P1, DOI 10.1016/0079-6611(94)90014-0; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rousseaux CSG, 2012, CONT SHELF RES, V32, P22, DOI 10.1016/j.csr.2011.10.010; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer C. A., 2009, IUCN RED LIST THREAT; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Sims DW, 2010, CRC MAR BIOL SER, P351; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; SMITH RL, 1991, J PHYS OCEANOGR, V21, P323, DOI 10.1175/1520-0485(1991)021<0323:TLCOWA>2.0.CO;2; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Team RDC, 2013, R LANG ENV STAT COMP; Vaudo JJ, 2014, ECOL EVOL, P1; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x	101	42	42	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116916	10.1371/journal.pone.0116916	http://dx.doi.org/10.1371/journal.pone.0116916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671609	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300027
J	Marquez, N; Martinez-Harms, J; Vasquez, RA; Mpodozis, J				Marquez, Natalia; Martinez-Harms, Jaime; Vasquez, Rodrigo A.; Mpodozis, Jorge			Early Olfactory Environment Influences Social Behaviour in Adult Octodon degus	PLOS ONE			English	Article							KIN RECOGNITION; GROUND-SQUIRRELS; ODOR; RAT; EXPERIENCE	We evaluated the extent to which manipulation of early olfactory environment can influence social behaviours in the South American Hystricognath rodent Octodon degus. The early olfactory environment of newborn degus was manipulated by scenting all litter members with eucalyptol during the first month of life. The social behaviour of sexually mature animals (5-7 months old) towards conspecifics was then assessed using a y-maze to compare the response of control (naive) and treated animals to two different olfactory configurations (experiment 1): (i) a non-familiarized conspecific impregnated with eucalyptol (eucalyptol arm) presented against (ii) a non-familiarized unscented conspecific (control arm). In addition, in dyadic encounters, we assessed the behaviour of control and eucalyptol treated animals towards a non-familiarized conspecific scented with eucalyptol (experiment 2). We found that control subjects explored and spent significantly less time in the eucalyptol arm, indicating neophobic behaviours towards the artificially scented conspecific. Treated subjects explored and spent similar time in both arms of the maze, showing the same interest for both olfactory stimuli presented. During dyadic encounters in experiment 2, an interaction effect between early experience and sex was observed. Control males escaped and avoided their scented partnermore frequently than eucalyptol treatedmale subjects and than females. Both groups did not differ in the exploration of their scented partners, suggesting that avoidance within agonistic context does not relate to neophobic behaviours. Our results suggest that the exposure to eucalyptol during early ontogeny decreases evasive behaviours within an agonistic context as a result of olfactory learning. Altogether, these results indicate that olfactory cues learned in early ontogeny can influence olfactory-guided behaviours in adult degus.	[Marquez, Natalia; Martinez-Harms, Jaime; Vasquez, Rodrigo A.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Inst Ecol & Biodiversidad, Santiago, Chile; [Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Universidad de Chile; Universidad de Chile	Marquez, N (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	nmarquez@zedat.fu-berlin.de	Márquez, Natalia/GPW-8415-2022	Marquez, Natalia/0000-0002-4200-6211	Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP [UCO-0214]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT [AT-24050185]; Iniciativa Cientifica Milenio [ICM-P05-002]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile [PFB-23-CONICYT]; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1140548, 1120124]	Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Iniciativa Cientifica Milenio; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	NM was founded by Programa de Mejoramiento de la Calidad de la Educacion Superior MECESUP UCO-0214, and by Comision Nacional de Investigacion Cientifica y Tecnologica de Chile CONICYT AT-24050185; RAV was founded by Iniciativa Cientifica Milenio ICM-P05-002, Comision Nacional de Investigacion Cientifica y Tecnologica de Chile PFB-23-CONICYT, and Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1140548; JM was founded by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1120124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APFELBACH R, 1986, BEHAV PROCESS, V12, P363, DOI 10.1016/0376-6357(86)90005-7; BAUDOIN C, 1991, BEHAV PROCESS, V24, P49, DOI 10.1016/0376-6357(91)90086-F; CARTER CS, 1970, ANIM BEHAV, V18, P238, DOI 10.1016/S0003-3472(70)80033-1; DAVIS TM, 1975, BEHAV BIOL, V14, P511, DOI 10.1016/S0091-6773(75)90696-3; Dawkins Richard, 1976, SELFISH GENE; DUVEAU A, 1988, PHYSIOL BEHAV, V42, P265, DOI 10.1016/0031-9384(88)90080-7; Ebensperger LA, 2004, NATURWISSENSCHAFTEN, V91, P391, DOI 10.1007/s00114-004-0545-5; Ebensperger LA, 2012, BEHAV ECOL SOCIOBIOL, V66, P261, DOI 10.1007/s00265-011-1274-3; FILLION TJ, 1986, SCIENCE, V231, P729, DOI 10.1126/science.3945807; FULK GW, 1976, J MAMMAL, V57, P495, DOI 10.2307/1379298; GOTTLIEB G, 1991, DEV PSYCHOL, V27, P35, DOI 10.1037/0012-1649.27.1.35; GOTTLIEB GILBERT, 1961, BEHAVIOUR, V18, P205, DOI 10.1163/156853961X00132; Haplin Z.T., 1991, P220; Hepper P.G., 1991, P259, DOI 10.1017/CBO9780511525414.011; HOLMES WG, 1986, ANIM BEHAV, V34, P38, DOI 10.1016/0003-3472(86)90004-7; HOLMES WG, 1984, BEHAV ECOL SOCIOBIOL, V14, P225, DOI 10.1007/BF00299622; HOLMES WG, 1982, AM ZOOL, V22, P491; Jesseau SA, 2004, KIN DISCRIMINATION S; Jesseau SA, 2008, ANIM BEHAV, V75, P573, DOI 10.1016/j.anbehav.2007.06.015; KLEIMAN DG, 1975, BEHAV BIOL, V14, P519, DOI 10.1016/S0091-6773(75)90708-7; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lorenz K. Z., 1937, Auk, V1937, P245; MARR JN, 1969, BEHAVIOUR, V33, P277, DOI 10.1163/156853969X00116; MARR JN, 1965, J GENET PSYCHOL, V107, P167, DOI 10.1080/00221325.1965.10532774; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; Maturana-Romesin H, 2000, REV CHIL HIST NAT, V73, P261; MESERVE PL, 1993, OECOLOGIA, V94, P153, DOI 10.1007/BF00341311; Mino GPY, 1999, CAN J ZOOL, V77, P118; Mino GPY, 1999, CAN J ZOOL, V77, P1631, DOI 10.1139/cjz-77-10-1631; Oyama S, 1985, ONTOGENY INFORM DEV; RUSINIAK KW, 1979, BEHAV NEURAL BIOL, V25, P1, DOI 10.1016/S0163-1047(79)90688-5; Sevelinges Y, 2009, BEHAV BRAIN RES, V198, P313, DOI 10.1016/j.bbr.2008.11.003; Sokal RR, 2012, BIOMETRY PRINCIPLES, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Soto-Gamboa M, 2005, HORM BEHAV, V47, P311, DOI 10.1016/j.yhbeh.2004.11.010; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; Tang-Martinez Z, 2001, BEHAV PROCESS, V53, P21, DOI 10.1016/S0376-6357(00)00148-0; Vasquez RA, 2002, BEHAV ECOL, V13, P182, DOI 10.1093/beheco/13.2.182; Vasquez RA, 1997, REV CHIL HIST NAT, V70, P557; Villavicencio CP, 2009, ANIM BEHAV, V78, P377, DOI 10.1016/j.anbehav.2009.04.026; WILSON SC, 1974, AM ZOOL, V14, P341; WOO CC, 1987, DEV BRAIN RES, V36, P309, DOI 10.1016/0165-3806(87)90038-1	42	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118018	10.1371/journal.pone.0118018	http://dx.doi.org/10.1371/journal.pone.0118018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671542	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300080
J	Sanders, KL; Schroeder, T; Guinea, ML; Rasmussen, AR				Sanders, Kate L.; Schroeder, Tina; Guinea, Michael L.; Rasmussen, Arne R.			Molecules and Morphology Reveal Overlooked Populations of Two Presumed Extinct Australian Sea Snakes (Aipysurus: Hydrophiinae)	PLOS ONE			English	Article							CONSERVATION STATUS; PHYLOGENY	The critically endangered leaf-scaled (Aipysurus foliosquamaI) and short-nosed (A. aprae-frontalis) sea snakes are currently recognised only from Ashmore and Hibernia reefs similar to 600km off the northwest Australian coast. Steep population declines in both species were documented over 15 years and neither has been sighted on dedicated surveys of Ashmore and Hibernia since 2001. We examine specimens of these species that were collected from coastal northwest Australian habitats up until 2010 (A. foliosquama) and 2012 (A. apraefrontalis) and were either overlooked or treated as vagrants in conservation assessments. Morphological variation and mitochondrial sequence data confirm the assignment of these coastal specimens to A. foliosquama (Barrow Island, and offshore from Port Hedland) and A. apraefrontalis (Exmouth Gulf, and offshore from Roebourne and Broome). Collection dates, and molecular and morphological variation between coastal and offshore specimens, suggest that the coastal specimens are not vagrants as previously suspected, but instead represent separate breeding populations. The newly recognised populations present another chance for leaf-scaled and short-nosed sea snakes, but coastal habitats in northwest Australia are widely threatened by infrastructure developments and sea snakes are presently omitted from environmental impact assessments for industry. Further studies are urgently needed to assess these species' remaining distributions, population structure, and extent of occurrence in protected areas.	[Sanders, Kate L.; Schroeder, Tina] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5000, Australia; [Guinea, Michael L.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Rasmussen, Arne R.] Royal Danish Acad Fine Arts, Sch Architecture Design & Conservat, DK-1263 Copenhagen, Denmark	University of Adelaide; Charles Darwin University	Sanders, KL (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5000, Australia.	kate.sanders@adelaide.edu.au	Sanders, Kate L/D-1507-2019	Sanders, Kate L/0000-0002-9581-268X; Parkhurst, Tina/0000-0002-8481-9069; Rasmussen, Arne Redsted/0000-0001-5454-4423	Australian Research Council [FT130101965]; Australian Biological Resources Study grant [RF214-34]; PTTEP (Exploration and Production Public Company Limited) Australasia; School of Conservation, Copenhagen	Australian Research Council(Australian Research Council); Australian Biological Resources Study grant; PTTEP (Exploration and Production Public Company Limited) Australasia; School of Conservation, Copenhagen	This work was funded by an Australian Research Council Future Fellowship (FT130101965 Sanders) to KLS, an Australian Biological Resources Study grant (ID: RF214-34) to KLS, Timor Sea survey grants from PTTEP (Exploration and Production Public Company Limited) Australasia to MLG, and a School of Conservation, Copenhagen, Research Fund 2012-13 grant to ARR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094844; Armstrong Graham, 1992, Herpetofauna (Sydney), V22, P3; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Cogger H.G., 1975, P1; Cogger H.G., 1975, BIOL SEA SNAKES, P59; Cogger H.G., 1983, ZOOLOGICAL CATALOGUE, P241; Cogger HG, 2014, REPTILES AMPHIBIANS, DOI [10.1682/JRRD.2014.01.0007, DOI 10.1682/JRRD.2014.01.0007]; David P., 1999, DUMERILIA, V3, P3; Director of National Parks, 2013, DRAFT N W COMM MAR R; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GENEIOUS V5 0 4; Elfes CT, 2013, HERPETOL CONSERV BIO, V8, P37; Golay P., 1993, ENDOGLYPHS OTHER MAJ; Greer A.E., 1997, BIOL EVOLUTION AUSTR; Guinea Michael L., 2005, Beagle, P199; Guinea ML, 2012, SURVEYS SEA SNAKES S; Guinea ML, 2007, CONSULTANTS REPORT D; Guinea ML, 1995, REPORT AUSTR NATURE; Heatwole Harold, 1994, P167; Hibbard E., 1975, BIOL SEA SNAKES, P355; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kharin V.E., 2005, IZV TINRO, V140, P71; KHARIN VE, 1981, ZOOL ZH, V60, P257; Kharin VE, 2006, RUSS J MAR BIOL, V32, P194; LEVITON AE, 1985, COPEIA, P802; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Masini R, 2011, NODE 1 DREDGING SCI, P23; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McCosker J., 1975, BIOL SEA SNAKES, V75, P217; Minton S. A., 1975, BIOL SEA SNAKES, P141; Minton S.A., 1975, BIOL SEA SNAKES, P21; Miras JAM, 2009, IUCN RED LIST THREAT; Moore GI, 2015, MAR BIODIVERS, V45, P595, DOI 10.1007/s12526-014-0267-7; Nijman V, 2012, HERPETOL J, V22, P83; Rambaut A., 2007, TRACER V1 4; Rasmussen A.R., 1989, AMPHIBIA-REPTILIA, V10, P397, DOI DOI 10.1163/156853889X00043; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Rasmussen Arne Redsted, 2002, Steenstrupia, V27, P47; Rasmussen Arne Redsted, 1993, Bulletin of the British Museum (Natural History) Zoology, V59, P97; Sadlier RA, 2010, IUCN RED LIST THREAT; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2013, MOL PHYLOGENET EVOL, V66, P575, DOI 10.1016/j.ympev.2012.09.021; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Shuntov V.P., 1971, EKOLOGIYA, V4, P65; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith L.A., 1974, REC W AUSTR MUS, V3, P93; Smith M. A., 1926, MONOGRAPH SEA SNAKES; Storr G. M., 2002, SNAKES W AUSTR; Sutherland S, 2001, AUSTR ANIMAL TOXINS; THOMAS RA, 1976, COPEIA, P839; TSSC (Threatened Species Scientific Committee), 2010, LIST ADV AIP APR SHO; TSSC (Threatened Species Scientific Committee), 2010, LIST ADV AIP FOL LEA; Voris H., 1972, J MAR BIOL ASSOC IND, V14, P429; VORIS H K, 1977, Fieldiana Zoology, V70, P79; Wallach V, 2014, SNAKES WORLD CATALOG, DOI [10.1682/JRRD.2014.01.0007, DOI 10.1682/JRRD.2014.01.0007]; Wells R.W, 2007, AUSTRAL BIODIV REC, V8, P1	59	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115679	10.1371/journal.pone.0115679	http://dx.doi.org/10.1371/journal.pone.0115679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671608	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300011
J	Argueso, D; Evans, JP; Pitman, AJ; Di Luca, A				Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.; Di Luca, Alejandro			Effects of City Expansion on Heat Stress under Climate Change Conditions	PLOS ONE			English	Article							URBAN CANOPY MODEL; ISLAND; TEMPERATURE; ENERGY; PARAMETERIZATION; PROJECTION; WRF	We examine the joint contribution of urban expansion and climate change on heat stress over the Sydney region. A Regional Climate Model was used to downscale present (1990-2009) and future (2040-2059) simulations from a Global Climate Model. The effects of urban surfaces on local temperature and vapor pressure were included. The role of urban expansion in modulating the climate change signal at local scales was investigated using a human heat-stress index combining temperature and vapor pressure. Urban expansion and climate change leads to increased risk of heat-stress conditions in the Sydney region, with substantially more frequent adverse conditions in urban areas. Impacts are particularly obvious in extreme values; daytime heat-stress impacts are more noticeable in the higher percentiles than in the mean values and the impact at night is more obvious in the lower percentiles than in the mean. Urban expansion enhances heat-stress increases due to climate change at night, but partly compensates its effects during the day. These differences are due to a stronger contribution from vapor pressure deficit during the day and from temperature increases during the night induced by urban surfaces. Our results highlight the inappropriateness of assessing human comfort determined using temperature changes alone and point to the likelihood that impacts of climate change assessed using models that lack urban surfaces probably underestimate future changes in terms of human comfort.	[Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.; Di Luca, Alejandro] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Argueeso, Daniel; Evans, Jason P.; Pitman, Andrew J.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia	University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney	Argueso, D (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia.	d.argueso@unsw.edu.au	Di Luca, Alejandro/Y-4908-2019; Evans, Jason P./F-3716-2011; Argüeso, Daniel/G-1970-2012; Pitman, Andrew J/A-7353-2011	Di Luca, Alejandro/0000-0002-1481-2961; Evans, Jason P./0000-0003-1776-3429; Argüeso, Daniel/0000-0002-4792-162X; Pitman, Andrew J/0000-0003-0604-3274	Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science [CE110001028]; NSW Environment Trust [RM08603]; NSW Office of Environment and Heritage; Australian Research Council Future Fellowship [FT110100576]	Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science(Australian Research Council); NSW Environment Trust; NSW Office of Environment and Heritage; Australian Research Council Future Fellowship(Australian Research Council)	This work was made possible by funding from the Australian Research Council (ARC) as part of the Centre of Excellence for Climate System Science (CE110001028), as well as the NSW Environment Trust (RM08603) and the NSW Office of Environment and Heritage. Jason Evans was supported by the Australian Research Council Future Fellowship FT110100576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso D, 2013, HYDROL EARTH SYST SC, V17, P4379, DOI 10.5194/hess-17-4379-2013; Argueso D, 2014, CLIM DYNAM, V42, P2183, DOI 10.1007/s00382-013-1789-6; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Chen F, 2012, B AM METEOROL SOC, V93, P1725, DOI 10.1175/BAMS-D-11-00217.1; Childs PP, 2005, PURE APPL GEOPHYS, V162, P1955, DOI 10.1007/s00024-005-2700-0; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Edenhofer O., 2014, CONTRIBUTION WORKING; Evans JP, 2014, GEOSCI MODEL DEV, V7, P621, DOI 10.5194/gmd-7-621-2014; Evans JP, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013816; Evans JP, 2012, J CLIMATE, V25, P7232, DOI 10.1175/JCLI-D-11-00616.1; Fischer EM, 2013, NAT CLIM CHANGE, V3, P126, DOI [10.1038/nclimate1682, 10.1038/NCLIMATE1682]; Fischer EM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050576; Ganeshan M, 2013, URBAN CLIMATE; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Georgescu M, 2014, P NATL ACAD SCI USA, V111, P2909, DOI 10.1073/pnas.1322280111; Gordon H.B., 2010, 21 CTR AUSTR WEATH C; Grimmond CSB, 2011, INT J CLIMATOL, V31, P244, DOI 10.1002/joc.2227; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; Kusaka H, 2004, J METEOROL SOC JPN, V82, P67, DOI 10.2151/jmsj.82.67; Kusaka H, 2001, BOUND-LAY METEOROL, V101, P329, DOI 10.1023/A:1019207923078; Kusaka H, 2012, J METEOROL SOC JPN, V90B, P47, DOI 10.2151/jmsj.2012-B04; Liu WD, 2009, THEOR APPL CLIMATOL, V96, P201, DOI 10.1007/s00704-008-0024-6; Martilli A, 2007, INT J CLIMATOL, V27, P1909, DOI 10.1002/joc.1620; McCarthy MP, 2012, INT J CLIMATOL, V32, P1875, DOI 10.1002/joc.2402; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; OKE TR, 1988, PROG PHYS GEOG, V12, P471, DOI 10.1177/030913338801200401; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1038, DOI 10.1175/2007JAMC1597.1; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1061, DOI 10.1175/2007JAMC1598.1; Oleson KW, 2015, CLIMATIC CHANGE, V129, P525, DOI 10.1007/s10584-013-0936-8; Oleson KW, 2011, INT J CLIMATOL, V31, P1848, DOI 10.1002/joc.2201; Oleson K, 2012, J CLIMATE, V25, P1390, DOI 10.1175/JCLI-D-11-00098.1; Parker DE, 2006, J CLIMATE, V19, P2882, DOI 10.1175/JCLI3730.1; Roth M, 2007, INT J CLIMATOL, V27, P1859, DOI 10.1002/joc.1591; Salamanca F, 2012, INT J CLIMATOL, V32, P2372, DOI 10.1002/joc.3398; Sertel E, 2010, INT J CLIMATOL, V30, P1942, DOI 10.1002/joc.2036; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Skamarock WC, 2009, NCARTN475STR, P125; Steadman R. G., 1994, Australian Meteorological Magazine, V43, P1; Theeuwes NE, 2013, J GEOPHYS RES-ATMOS, V118, P8881, DOI 10.1002/jgrd.50704; United Nations, 2012, WORLD URB PROSP 2011; USDAAF, 2003, HEAT STRESS CONTR HE, P1; Willett KM, 2012, INT J CLIMATOL, V32, P161, DOI 10.1002/joc.2257	44	73	73	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117066	10.1371/journal.pone.0117066	http://dx.doi.org/10.1371/journal.pone.0117066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668390	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000014
J	Fang, Y; Sun, M; Ramani, K				Fang, Yi; Sun, Mengtian; Ramani, Karthik			Heat-Passing Framework for Robust Interpretation of Data in Networks	PLOS ONE			English	Article							OF-THE-ART; ELECTRON-MICROSCOPY; COMPLEX NETWORKS; PROTEIN; MAPS	Researchers are regularly interested in interpreting the multipartite structure of data entities according to their functional relationships. Data is often heterogeneous with intricately hidden inner structure. With limited prior knowledge, researchers are likely to confront the problem of transforming this data into knowledge. We develop a new framework, called heatpassing, which exploits intrinsic similarity relationships within noisy and incomplete raw data, and constructs a meaningful map of the data. The proposed framework is able to rank, cluster, and visualize the data all at once. The novelty of this framework is derived from an analogy between the process of data interpretation and that of heat transfer, in which all data points contribute simultaneously and globally to reveal intrinsic similarities between regions of data, meaningful coordinates for embedding the data, and exemplar data points that lie at optimal positions for heat transfer. We demonstrate the effectiveness of the heatpassing framework for robustly partitioning the complex networks, analyzing the globin family of proteins and determining conformational states of macromolecules in the presence of high levels of noise. The results indicate that the methodology is able to reveal functionally consistent relationships in a robust fashion with no reference to prior knowledge. The heatpassing framework is very general and has the potential for applications to a broad range of research fields, for example, biological networks, social networks and semantic analysis of documents.	[Fang, Yi] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Sun, Mengtian; Ramani, Karthik] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fang, Y (corresponding author), New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.	yfang@nyu.edu			Institute for Pure & Applied Mathematics	Institute for Pure & Applied Mathematics	The authors would like to thank the Institute for Pure & Applied Mathematics for providing fellowship to support KR's visit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bai X, 2004, LECT NOTES COMPUT SC, V3138, P198; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Cashon RE, 1997, COMP BIOCHEM PHYS B, V117, P613, DOI 10.1016/S0305-0491(97)00011-4; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Frank J, 2006, 3 DIMENSIONAL ELECT; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Givoni IE, 2012, THESIS U TORONTO; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Herman GT, 2008, ULTRAMICROSCOPY, V108, P327, DOI 10.1016/j.ultramic.2007.05.005; Iyer N, 2005, COMPUT AIDED DESIGN, V37, P509, DOI 10.1016/j.cad.2004.07.002; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lerman G, 2007, P NATL ACAD SCI USA, V104, P11334, DOI 10.1073/pnas.0702965104; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Lipman Y, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1805964.1805971; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Page L, 1998, TECHNICAL REPORT; Qiu HJ, 2007, IEEE T PATTERN ANAL, V29, P1873, DOI 10.1109/TPAMI.2007.1103; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Singer A, 2008, P NATL ACAD SCI USA, V105, P9507, DOI 10.1073/pnas.0709842104; Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d; Sun JA, 2009, COMPUT GRAPH FORUM, V28, P1383, DOI 10.1111/j.1467-8659.2009.01515.x; Wang K, 2007, ACTA AUTOMATICA SINI, V33, P242; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang XL, 2008, LECT NOTES ARTIF INT, V5212, P628, DOI 10.1007/978-3-540-87481-2_41	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116121	10.1371/journal.pone.0116121	http://dx.doi.org/10.1371/journal.pone.0116121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668316	Green Submitted, Green Published, gold			2022-12-26	WOS:000349493000005
J	Namatovu, A; Tjornehoj, K; Belsham, GJ; Dhikusooka, MT; Wekesa, SN; Muwanika, VB; Siegismund, HR; Ayebazibwe, C				Namatovu, Alice; Tjornehoj, Kirsten; Belsham, Graham J.; Dhikusooka, Moses T.; Wekesa, Sabenzia N.; Muwanika, Vincent B.; Siegismund, Hans R.; Ayebazibwe, Chrisostom			Characterization of Foot-And-Mouth Disease Viruses (FMDVs) from Ugandan Cattle Outbreaks during 2012-2013: Evidence for Circulation of Multiple Serotypes	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; ANTIBODIES; DIVERSITY; ALIGNMENT; LINEAGES; EASTERN; SURFACE; KENYA	To investigate the foot-and-mouth disease virus (FMDV) serotypes circulating in Uganda's cattle population, both serological and virological analyses of samples from outbreaks that occurred during 2012-2013 were performed. Altogether, 79 sera and 60 oropharyngeal fluid (OP)/ tissue/oral swab samples were collected from herds with reported FMD outbreaks in seven different Ugandan districts. Overall, 61/79 (77%) of the cattle sera were positive for antibodies against FMDV by PrioCHECK FMDV NS ELISA and solid phase blocking ELISA detected titres >= 80 for serotypes O, SAT 1, SAT 2 and SAT 3 in 41, 45, 30 and 45 of these 61 seropositive samples, respectively. Virus neutralisation tests detected the highest levels of neutralising antibodies (titres >= 45) against serotype O in the herds from Kween and Rakai districts, against SAT 1 in the herd from Nwoya district and against SAT 2 in the herds from Kiruhura, Isingiro and Ntungamo districts. The isolation of a SAT 2 FMDV from Isingiro was consistent with the detection of high levels of neutralising antibodies against SAT 2; sequencing (for the VP1 coding region) indicated that this virus belonged to lineage I within this serotype, like the currently used vaccine strain. From the Wakiso district 11 tissue/swab samples were collected; serotype A FMDV, genotype Africa (G-I), was isolated from the epithelial samples. This study shows that within a period of less than one year, FMD outbreaks in Uganda were caused by four different serotypes namely O, A, SAT 1 and SAT 2. Therefore, to enhance the control of FMD in Uganda, there is need for efficient and timely determination of outbreak virus strains/serotypes and vaccine matching. The value of incorporating serotype A antigen into the imported vaccines along with the current serotype O, SAT 1 and SAT 2 strains should be considered.	[Namatovu, Alice; Dhikusooka, Moses T.; Ayebazibwe, Chrisostom] Minist Agr Anim Ind & Fisheries, Natl Anim Dis Diagnost & Epidemiol Ctr, Entebbe, Uganda; [Namatovu, Alice] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Biotech & Diagnost Sci, Kampala, Uganda; [Tjornehoj, Kirsten; Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, DK-4771 Kalvehave, Denmark; [Wekesa, Sabenzia N.; Muwanika, Vincent B.] Makerere Univ, Coll Agr & Environm Sci, Dept Environm Management, Kampala, Uganda; [Wekesa, Sabenzia N.] Minist Livestock Dev, Foot & Mouth Dis Lab, Nairobi, Kenya; [Siegismund, Hans R.] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Makerere University; Technical University of Denmark; Makerere University; University of Copenhagen	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, DK-4771 Kalvehave, Denmark.	grbe@vet.dtu.dk	Ibrahim, Essam Hassan/G-1960-2018; Belsham, Graham J./H-8589-2019; Muwanika, Vincent/AGP-2612-2022; Muwanika, Vincent/GQH-5983-2022; Siegismund, Hans R./K-4332-2014; Belsham, Graham/J-3132-2019	Ibrahim, Essam Hassan/0000-0003-0130-2257; Belsham, Graham J./0000-0003-1187-4873; Siegismund, Hans R./0000-0001-5757-3131; Belsham, Graham/0000-0003-1187-4873	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC [10-006KU]	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC	This work was funded by the Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa project, DFC no. 10-006KU (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayebazibwe C, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-54; Ayebazibwe C, 2010, TROP ANIM HEALTH PRO, V42, P1547, DOI 10.1007/s11250-010-9605-3; Ayelet G, 2009, EMERG INFECT DIS, V15, P1409, DOI 10.3201/eid1509.090091; Balinda SN, 2010, EPIDEMIOL INFECT, V138, P1204, DOI 10.1017/S0950268809991427; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Balinda SN, 2010, INFECT GENET EVOL, V10, P1058, DOI 10.1016/j.meegid.2010.06.017; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; CROWTHER JR, 1993, EPIDEMIOL INFECT, V111, P391, DOI 10.1017/S0950268800057083; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; *FAO OIE, 2011, PROGR CONTR PATHW FM; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Habiela M, 2010, TRANSBOUND EMERG DIS, V57, P305, DOI 10.1111/j.1865-1682.2010.01151.x; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P123, DOI 10.1016/0022-1759(86)90442-4; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P115, DOI 10.1016/0022-1759(86)90441-2; HEDGER R S, 1982, Revue Scientifique et Technique Office International des Epizooties, V1, P387, DOI 10.20506/rst.1.2.75; Kalema-Zikusoka G, 2005, ONDERSTEPOORT J VET, V72, P145; Kasambula L, 2012, TRANSBOUND EMERG DIS, V59, P323, DOI 10.1111/j.1865-1682.2011.01276.x; KASANGA CJ, 2014, TRANSBOUND EMERG DIS; Kitching RP, 2002, REV SCI TECH OIE, V21, P499, DOI 10.20506/rst.21.3.1343; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Knowles NJ, 2009, TRANSBOUND EMERG DIS, V56, P157, DOI 10.1111/j.1865-1682.2009.01074.x; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Mohapatra JK, 2011, J GEN VIROL, V92, P873, DOI 10.1099/vir.0.028555-0; Muleme M, 2012, TROP ANIM HEALTH PRO, V45, P35, DOI 10.1007/s11250-012-0254-6; Mwiine F. N., 2010, Journal of Veterinary Medicine and Animal Health, V2, P46; Mwiine FN, 2010, TRANSBOUND EMERG DIS, V57, P365, DOI 10.1111/j.1865-1682.2010.01157.x; NAMATOVU A, 2013, TRANSBOUND EMERG DIS; Namatovu A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-19; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roeder P., 2009, GLOBAL CONTROL FMD T; RUTAGWENDA T, 2 FAO AN PROD HLTH D; Rweyemamu MM, 1999, ADV VIRUS RES, V53, P111, DOI 10.1016/S0065-3527(08)60345-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Samuel AR, 1999, EPIDEMIOL INFECT, V122, P529, DOI 10.1017/S0950268899002265; Sangare O, 2004, EPIDEMIOL INFECT, V132, P525, DOI 10.1017/S0950268803001833; Sangula AK, 2010, ARCH VIROL, V155, P1625, DOI 10.1007/s00705-010-0742-9; SANGULA AK, 2010, EPIDEMIOL INFECT; Stanway G, 2005, VIRUS TAXONOMY, P757; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VOSLOO W, 1992, EPIDEMIOL INFECT, V109, P547, DOI 10.1017/S0950268800050536; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; Wekesa SN, 2014, INFECT GENET EVOL, V21, P408, DOI 10.1016/j.meegid.2013.12.006; WEKESA SN, 2013, TRANSBOUND EMERG DIS	53	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0114811	10.1371/journal.pone.0114811	http://dx.doi.org/10.1371/journal.pone.0114811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664876	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100002
J	Ding, YH; Zou, XJ; Jiang, X; Wu, JY; Zhang, YR; Chen, D; Liang, B				Ding, YiHong; Zou, XiaoJu; Jiang, Xue; Wu, JieYu; Zhang, YuRu; Chen, Dan; Liang, Bin			Pu-Erh Tea Down-Regulates Sterol Regulatory Element-Binding Protein and Stearyol-CoA Desaturase to Reduce Fat Storage in Caenorhaditis elegans	PLOS ONE			English	Article							GALLIC ACID; CAENORHABDITIS-ELEGANS; OXIDATIVE DAMAGE; LIPID-METABOLISM; BODY-FAT; EXTRACT; BLACK; MICE; DIET; CHOLESTEROL	Consumption of Pu-erh has been reported to result in numerous health benefits, but the mechanisms underlying purported weight-loss and lowering of lipid are poorly understood. Here, we used the nematode Caenorhaditis elegans to explore the water extract of Pu-erh tea (PTE) functions to reduce fat storage. We found that PTE down-regulates the expression of the master fat regulator SBP-1, a homologue of sterol regulatory element binding protein (SREBP) and its target stearoyl-CoA desaturase (SCD), a key enzyme in fat biosynthesis, leading to an increased ratio of stearic acid (C18:0) to oleic acid (C18:1n-9), and subsequently decreased fat storage. We also found that both the pharyngeal pumping rate and food uptake of Caenorhaditis elegans decreased with exposure to PTE. Collectively, these results provide an experimental basis for explaining the ability of Pu-erh tea in promoting inhibition of food uptake and the biosynthesis of fat via SBP-1 and SCD, thereby reducing fat storage.	[Ding, YiHong; Jiang, Xue; Wu, JieYu; Zhang, YuRu; Liang, Bin] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Zou, XiaoJu; Chen, Dan] Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming 650214, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming University	Zou, XJ (corresponding author), Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming 650214, Peoples R China.	xiaojuzou@163.com; liangb@mail.kiz.ac.cn			National Natural Science Foundation of China (NSFC) [31160216, 31171134]; Yunnan Natural Science Foundation [2011FZ179]; Kunming University Science Project [YJL11018]; Yunnan Provincial Science and Technology Department [2014HB022]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Kunming University Science Project; Yunnan Provincial Science and Technology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Natural Science Foundation of China (NSFC) 31160216 to XJ Zou and 31171134 to B Liang; Yunnan Natural Science Foundation 2011FZ179 and Kunming University Science Project YJL11018 to XJ Zou; and Yunnan Provincial Science and Technology Department 2014HB022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; Bak EJ, 2013, SCAND J CLIN LAB INV, V73, P607, DOI 10.3109/00365513.2013.831470; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247; Chen HX, 2013, J FOOD SCI, V78, pC1665, DOI 10.1111/1750-3841.12288; Chiang CT, 2006, ONCOL RES, V16, P119, DOI 10.3727/000000006783981143; Duh PD, 2004, J AGR FOOD CHEM, V52, P8169, DOI 10.1021/jf0490551; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fujita H, 2008, PHYTOTHER RES, V22, P1275, DOI 10.1002/ptr.2477; Fujita H, 2008, NUTR RES, V28, P450, DOI 10.1016/j.nutres.2008.04.005; Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x; Gong JiaShun, 2009, Asian Journal of Agricultural Sciences, V1, P48; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Hou Y, 2009, EXP GERONTOL, V44, P434, DOI 10.1016/j.exger.2009.03.007; Huang HC, 2011, FOOD FUNCT; Huang QF, 2013, FOOD CHEM TOXICOL, V53, P75, DOI 10.1016/j.fct.2012.11.039; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jie GL, 2006, J AGR FOOD CHEM, V54, P8058, DOI 10.1021/jf061663o; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kade IJ, 2013, J BASIC CLIN PHYSL P, P1; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Ku KM, 2010, J AGR FOOD CHEM, V58, P345, DOI 10.1021/jf902818c; Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ma X, 2013, J MED FOOD, V16, P259, DOI 10.1089/jmf.2012.2520; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Prince PSM, 2011, J BIOCHEM MOL TOXIC, V25, P101, DOI 10.1002/jbt.20365; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Punithavathi VR, 2011, EUR J PHARMACOL, V650, P465, DOI 10.1016/j.ejphar.2010.08.059; SANO M, 1986, CHEM PHARM BULL, V34, P221; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; Shimamura Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1455, DOI 10.1271/bbb.130097; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Way TD, 2009, J AGR FOOD CHEM, V57, P5257, DOI 10.1021/jf900730e; Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang TTC, 1997, PHARMACOL RES, V35, P505, DOI 10.1006/phrs.1997.0176; Yuan H, 2009, ACTA NUTR SIN, V31, P176; Yuan HuaBing, 2009, Acta Nutrimenta Sinica, V31, P167; Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345; Zhang SBO, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-96; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhao LJ, 2011, INT J MOL SCI, V12, P7581, DOI 10.3390/ijms12117581; Zheng J, 2011, INT J OBES LOND	62	19	22	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0113815	10.1371/journal.pone.0113815	http://dx.doi.org/10.1371/journal.pone.0113815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659129	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900006
J	Doshi, H; Wiseman, N; Liu, J; Wang, WT; Welch, RD; O'Neil, BJ; Zuk, C; Wang, X; Mika, V; Szaflarski, JP; Haacke, EM; Kou, ZF				Doshi, Hardik; Wiseman, Natalie; Liu, Jun; Wang, Wentao; Welch, Robert D.; O'Neil, Brian J.; Zuk, Conor; Wang, Xiao; Mika, Valerie; Szaflarski, Jerzy P.; Haacke, E. Mark; Kou, Zhifeng			Cerebral Hemodynamic Changes of Mild Traumatic Brain Injury at the Acute Stage	PLOS ONE			English	Article							OXYGEN EXTRACTION FRACTION; DEOXYGENATED BLOOD-VOLUME; IN-VIVO MEASUREMENT; HEAD-INJURY; AXONAL INJURY; INTRACRANIAL HYPERTENSION; QUANTITATIVE MEASUREMENTS; GLUCOSE-METABOLISM; ENERGY-METABOLISM; MR SUSCEPTOMETRY	Mild traumatic brain injury (mTBI) is a significant public health care burden in the United States. However, we lack a detailed understanding of the pathophysiology following mTBI and its relation to symptoms and recovery. With advanced magnetic resonance imaging (MRI), we can investigate brain perfusion and oxygenation in regions known to be implicated in symptoms, including cortical gray matter and subcortical structures. In this study, we assessed 14 mTBI patients and 18 controls with susceptibility weighted imaging and mapping (SWIM) for blood oxygenation quantification. In addition to SWIM, 7 patients and 12 controls had cerebral perfusion measured with arterial spin labeling (ASL). We found increases in regional cerebral blood flow (CBF) in the left striatum, and in frontal and occipital lobes in patients as compared to controls (p = 0.01, 0.03, 0.03 respectively). We also found decreases in venous susceptibility, indicating increases in venous oxygenation, in the left thalamostriate vein and right basal vein of Rosenthal (p = 0.04 in both). mTBI patients had significantly lower delayed recall scores on the standardized assessment of concussion, but neither susceptibility nor CBF measures were found to correlate with symptoms as assessed by neuropsychological testing. The increased CBF combined with increased venous oxygenation suggests an increase in cerebral blood flow that exceeds the oxygen demand of the tissue, in contrast to the regional hypoxia seen in more severe TBI. This may represent a neuroprotective response following mTBI, which warrants further investigation.	[Doshi, Hardik; Liu, Jun; Wang, Xiao; Mika, Valerie; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Wiseman, Natalie; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Translat Neurosci Program, Detroit, MI USA; [Liu, Jun] Cent S Univ, Sch Publ Hlth, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Wang, Wentao] South Cent Univ Nationalities, Coll Comp Sci, Wuhan, Peoples R China; [Welch, Robert D.; O'Neil, Brian J.; Mika, Valerie] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Zuk, Conor; Wang, Xiao; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Wang, Xiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan Province, Peoples R China; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	Wayne State University; Wayne State University; Central South University; South Central Minzu University; Wayne State University; Wayne State University; Zhengzhou University; University of Alabama System; University of Alabama Birmingham	Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	zhifeng_kou@wayne.edu	Mika, Valerie H./AAO-2816-2020	Wiseman, Natalie/0000-0003-0884-6425; Liu, Jun/0000-0002-7851-6782	International Society for Magnetic Resonance in Medicine; Department of Defense [W81XWH-11-1-0493]	International Society for Magnetic Resonance in Medicine; Department of Defense(United States Department of Defense)	Supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: ZFK) and a research grant from the Department of Defense (award number W81XWH-11-1-0493; PI: EMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; An HY, 2001, NMR BIOMED, V14, P441, DOI 10.1002/nbm.717; An HY, 2002, MAGNET RESON MED, V47, P958, DOI 10.1002/mrm.10148; An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Ashburner John, 1997, HUMAN BRAIN FUNCTION, P43; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; BRANDT RB, 1984, P SOC EXP BIOL MED, V175, P328; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; CHIEN D, 1994, MAGNET RESON MED, V32, P540, DOI 10.1002/mrm.1910320419; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Golay X, 2001, MAGN RESON MED, V46, P282, DOI 10.1002/mrm.1189; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; He X, 2008, MAGN RESON MED, V60, P882, DOI 10.1002/mrm.21719; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; HOLMES A, 1997, HUMAN BRAIN FUNCTION, P59; HOPPEL BE, 1993, MAGN RESON MED, V30, P715, DOI 10.1002/mrm.1910300609; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jost SC, 2005, J NEUROSURG, V103, P25, DOI 10.3171/jns.2005.103.1.0025; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; Langham MC, 2010, J AM COLL CARDIOL, V55, P598, DOI 10.1016/j.jacc.2009.08.068; Langham MC, 2009, MAGN RESON MED, V62, P333, DOI 10.1002/mrm.21981; Langham MC, 2009, MAGN RESON MED, V61, P626, DOI 10.1002/mrm.21499; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Li DB, 1998, MAGNET RESON MED, V39, P685, DOI 10.1002/mrm.1910390503; Li DB, 1998, JMRI-J MAGN RESON IM, V8, P1236, DOI 10.1002/jmri.1880080609; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Liu YJ, 1999, MAGNET RESON MED, V41, P407, DOI 10.1002/(SICI)1522-2594(199902)41:2<407::AID-MRM27>3.0.CO;2-4; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCKENNA MC, 1994, DEV NEUROSCI-BASEL, V16, P291, DOI 10.1159/000112122; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oja JME, 1999, J CEREBR BLOOD F MET, V19, P1289, DOI 10.1097/00004647-199912000-00001; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pandian DSJ, 2008, J MAGN RESON IMAGING, V28, P727, DOI 10.1002/jmri.21487; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Qin Q, 2011, MAGN RESON MED, V65, P471, DOI 10.1002/mrm.22556; Sedlacik J, 2010, MAGN RESON MED, V63, P910, DOI 10.1002/mrm.22274; Sedlacilk J, 2009, Z MED PHYS, V19, P48, DOI 10.1016/j.zemedi.2008.07.005; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tang J, 2012, MAGN RESON MED; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Weiskoff R, 1991, QUANTITATIVE VIVO BL, P307; WRIGHT GA, 1991, JMRI-J MAGN RESON IM, V1, P275, DOI 10.1002/jmri.1880010303; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yablonskiy DA, 1997, MAGN RESON MED, V37, P214, DOI 10.1002/mrm.1910370213; Yablonskiy DA, 1997, MAGNET RESON MED, V37, P872, DOI 10.1002/mrm.1910370611; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505; [No title captured]	86	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118061	10.1371/journal.pone.0118061	http://dx.doi.org/10.1371/journal.pone.0118061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659079	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900257
J	Ishikawa, K; Tsunekawa, S; Ikeniwa, M; Izumoto, T; Iida, A; Ogata, H; Uenishi, E; Seino, Y; Ozaki, N; Sugimura, Y; Hamada, Y; Kuroda, A; Shinjo, K; Kondo, Y; Oiso, Y				Ishikawa, Kota; Tsunekawa, Shin; Ikeniwa, Makoto; Izumoto, Takako; Iida, Atsushi; Ogata, Hidetada; Uenishi, Eita; Seino, Yusuke; Ozaki, Nobuaki; Sugimura, Yoshihisa; Hamada, Yoji; Kuroda, Akio; Shinjo, Keiko; Kondo, Yutaka; Oiso, Yutaka			Long-Term Pancreatic Beta Cell Exposure to High Levels of Glucose but Not Palmitate Induces DNA Methylation within the Insulin Gene Promoter and Represses Transcriptional Activity	PLOS ONE			English	Article							EPIGENETIC CHANGES; TYPE-2; EXPRESSION; DEMETHYLATION; METABOLISM; PDX-1	Recent studies have implicated epigenetics in the pathophysiology of diabetes. Furthermore, DNA methylation, which irreversibly deactivates gene transcription, of the insulin promoter, particularly the cAMP response element, is increased in diabetes patients. However, the underlying mechanism remains unclear. We aimed to investigate insulin promoter DNA methylation in an over-nutrition state. INS-1 cells, the rat pancreatic beta cell line, were cultured under normal-culture-glucose (11.2mmol/l) or experimental-high-glucose (22.4mmol/l) conditions for 14 days, with or without 0.4 mmol/l palmitate. DNA methylation of the rat insulin 1 gene (Ins1) promoter was investigated using bisulfite sequencing and pyrosequencing analysis. Experimental-high-glucose conditions significantly suppressed insulin mRNA and increased DNA methylation at all five CpG sites within the Ins1 promoter, including the cAMP response element, in a time-dependent and glucose concentration-dependent manner. DNA methylation under experimental-high-glucose conditions was unique to the Ins1 promoter; however, palmitate did not affect DNA methylation. Artificial methylation of Ins1 promoter significantly suppressed promoter-driven luciferase activity, and a DNA methylation inhibitor significantly improved insulin mRNA suppression by experimental-high-glucose conditions. Experimental-high-glucose conditions significantly increased DNA methyltransferase activity and decreased ten-eleven-translocation methylcytosine dioxygenase activity. Oxidative stress and endoplasmic reticulum stress did not affect DNA methylation of the Ins1 promoter. High glucose but not palmitate increased ectopic triacylglycerol accumulation parallel to DNA methylation. Metformin upregulated insulin gene expression and suppressed DNA methylation and ectopic triacylglycerol accumulation. Finally, DNA methylation of the Ins1 promoter increased in isolated islets from Zucker diabetic fatty rats. This study helps to clarify the effect of an over-nutrition state on DNA methylation of the Ins1 promoter in pancreatic beta cells. It provides new insights into the irreversible pathophysiology of diabetes.	[Ishikawa, Kota; Tsunekawa, Shin; Ikeniwa, Makoto; Iida, Atsushi; Ogata, Hidetada; Uenishi, Eita; Seino, Yusuke; Ozaki, Nobuaki; Sugimura, Yoshihisa; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Izumoto, Takako] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Hamada, Yoji] Nagoya Univ, Grad Sch Med, Dept Metab Med, Nagoya, Aichi 4668550, Japan; [Kuroda, Akio] Univ Tokushima, Diabet Therapeut & Res Ctr, Tokushima 770, Japan; [Shinjo, Keiko; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Tokushima University; Nagoya City University	Tsunekawa, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tsune87@med.nagoya-u.ac.jp	Hamada, Yoji/I-7344-2014; Sugimura, Yoshihisa/Q-8716-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology [24790920]; Grants-in-Aid for Scientific Research [24790920] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grant-in-Aid for Young Scientists B (No. 24790920) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/ english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON C, 1993, J BIOL CHEM, V268, P4276; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Chen JG, 2014, AM J PHYSIOL-RENAL, V306, pF916, DOI 10.1152/ajprenal.00697.2012; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Chiang EPI, 2009, J CLIN ENDOCR METAB, V94, P1017, DOI 10.1210/jc.2008-2038; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donkena KV, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/302051; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Harmon JS, 2001, DIABETES, V50, P2481, DOI 10.2337/diabetes.50.11.2481; Haseeb A, 2014, J BIOL CHEM; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wijekoon EP, 2005, DIABETES, V54, P3245, DOI 10.2337/diabetes.54.11.3245; Williams KT, 2012, DIABETES-METAB RES, V28, P123, DOI 10.1002/dmrr.1281; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004	40	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115350	10.1371/journal.pone.0115350	http://dx.doi.org/10.1371/journal.pone.0115350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658116	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900016
J	James, MI; Howells, LM; Karmokar, A; Higgins, JA; Greaves, P; Cai, H; Dennison, A; Metcalfe, M; Garcea, G; Lloyd, DM; Berry, DP; Steward, WP; Brown, K				James, Mark I.; Howells, Lynne M.; Karmokar, Ankur; Higgins, Jennifer A.; Greaves, Peter; Cai, Hong; Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M.; Berry, David P.; Steward, William P.; Brown, Karen			Characterization and Propagation of Tumor Initiating Cells Derived from Colorectal Liver Metastases: Trials, Tribulations and a Cautionary Note	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE 1; COLON-CANCER; CD133 EXPRESSION; SOLID TUMORS; MARKER; TUMORIGENESIS; MORPHOGENESIS; ASSOCIATION; POPULATIONS	Tumor initiating cells (TIC) are increasingly being put forward as a potential target for intervention within colorectal cancer. Whilst characterisation and outgrowth of these cells has been extensively undertaken in primary colorectal cancers, few data are available describing characteristics within the metastatic setting. Tissue was obtained from patients undergoing surgical resection for colorectal liver metastases, and processed into single cell suspension for assessment. Tumor initiating cells from liver metastases were characterised using combinations of EPCAM, Aldehyde dehydrogenase activity, CD133 and CD26. CD133 expression was significantly lower in patients who had received chemotherapy, but this was accounted for by a decrease observed in the male patient cohort only. ALDH(high) populations were rare (0.4 and 0.3% for EPCAM(+)/ALDH(high)/CD133-and EPCAM(+)/ALDH(high)/CD133(+) populations respectively) and below the limits of detection in 28% of samples. Spheroid outgrowth of metastatic tumor cells across all samples could not be readily achieved using standard spheroid-formation techniques, thus requiring further method validation to reliably propagate cells from the majority of tissues. Spheroid formation was not enhanced using additional growth factors or fibroblast co-culture, but once cells were passaged through NOD-SCID mice, spheroid formation was observed in 82% samples, accompanied by a significant increase in CD26. Order of spheroid forming ability was ALDH(high) >CD133> CD26. Samples sorted by these markers each had the ability to reform ALDH(high), CD133 and CD26 positive populations to a similar extent, suggestive of a high degree of plasticity for each population. Ex vivo TIC models are increasingly being utilised to assess efficacy of therapeutic interventions. It is therefore essential that such investigations use well-characterised models that are able to sustain TIC populations across a large patient cohort in order that the inherent heterogeneity observed in cancer populations is maintained.	[James, Mark I.; Howells, Lynne M.; Karmokar, Ankur; Higgins, Jennifer A.; Greaves, Peter; Cai, Hong; Steward, William P.; Brown, Karen] Univ Leicester, Leicester, Leics, England; [Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M.] Univ Hosp Leicester, Leicester, Leics, England; [Berry, David P.] Univ Wales Hosp, Cardiff, Wales	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Cardiff University	Howells, LM (corresponding author), Univ Leicester, Leicester, Leics, England.	lh28@le.ac.uk		Brown, Karen/0000-0002-5217-1501	Hope Against Cancer, Leicester, UK; Cancer Research UK [C325/A13101]; UK Department of Health on an Experimental Cancer Medicine Centre [C325/A15575]; MRC [MC_G0802524] Funding Source: UKRI; Cancer Research UK [13101] Funding Source: researchfish; Medical Research Council [MC_G0802524] Funding Source: researchfish	Hope Against Cancer, Leicester, UK; Cancer Research UK(Cancer Research UK); UK Department of Health on an Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a studentship from Hope Against Cancer (http://www.hfcr.org/), Leicester, UK (KB/LMH), by Cancer Research UK (http://www.cancerresearchuk.org/) on a programme grant [C325/A13101] (KB/WPS) and by Cancer Research UK in conjunction with the UK Department of Health on an Experimental Cancer Medicine Centre grant [C325/A15575] (WPS/KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetti LR, 2012, SCAND J GASTROENTERO, V47, P1211, DOI 10.3109/00365521.2012.694904; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Cammareri P, 2008, METHOD CELL BIOL, V86, P311, DOI 10.1016/S0091-679X(08)00014-9; Chen L, 2013, REPROD SCI, DOI [10.1177/1933719113512533, DOI 10.1177/1933719113512533]; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Chirgwin JM, 2012, ANTI-CANCER AGENT ME, V12, P187; Du L, 2013, CANCER RES, DOI [10.1158/0008-5472, DOI 10.1158/0008-5472.CAN-13-2440]; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herrmann JL, 2010, J CARDIOVASC TRANSL, V3, P103, DOI 10.1007/s12265-009-9149-y; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hong SH, 2004, MOL CELLS, V18, P320; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Irmisch A, 2013, EXP CELL RES, DOI [10.1016/j.yexcr.2013.10.012, DOI 10.1016/J.YEXCR.2013.10.012]; Irollo E, 2013, AM J TRANSL RES, V5, P563; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kunz-Schughart L, 2004, J BIOMOL SCREEN, V9, P12; Li CY, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-56; Li GQ, 2010, CLIN EXP METASTAS, V27, P517, DOI 10.1007/s10585-010-9341-0; Malanchi I, 2012, NATURE, V481, P5, DOI [10.1038/481005a, DOI 10.1038/481005A]; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; Matsuyama M, 2010, ONCOL LETT, V1, P431, DOI 10.3892/ol_00000076; Mostafa G, 2004, AM SURGEON, V70, P259; NAKAMURA S, 1984, J NATL CANCER I, V73, P41; Paduch R, 2011, EXP TOXICOL PATHOL, V63, P79, DOI 10.1016/j.etp.2009.09.011; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Preston SL, 2003, CANCER RES, V63, P3819; Ray S, 2012, J CANC, V3, P11, DOI [10.1093/jscr/2012.3.11, DOI 10.1093/JSCR/2012.3.11]; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rousseau A, 2010, FERTIL STERIL, V93, P843, DOI 10.1016/j.fertnstert.2008.10.062; Saigusa S, 2010, ONCOL REP, V24, P345, DOI 10.3892/or_00000865; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Tamura K, 2013, J NEUROSURG, V119, P1145, DOI 10.3171/2013.7.JNS122417; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Waldron J, 2010, STEM CELLS CLONING, V3, P119, DOI 10.2147/SCCAA.S13035; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Weiswald LB, 2009, BRIT J CANCER, V101, P473, DOI 10.1038/sj.bjc.6605173; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Ye J, 2014, TUMOUR BIOL; Zhang J, 2012, ONCOGENE, DOI [10.1038/onc.2012.584, DOI 10.1038/ONC.2012.584]	54	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117776	10.1371/journal.pone.0117776	http://dx.doi.org/10.1371/journal.pone.0117776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658706	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900218
J	Miyatake, H; Sanjoh, A; Unzai, S; Matsuda, G; Tatsumi, Y; Miyamoto, Y; Dohmae, N; Aida, Y				Miyatake, Hideyuki; Sanjoh, Akira; Unzai, Satoru; Matsuda, Go; Tatsumi, Yuko; Miyamoto, Yoichi; Dohmae, Naoshi; Aida, Yoko			Crystal Structure of Human Importin-alpha 1 (Rch1), Revealing a Potential Autoinhibition Mode Involving Homodimerization	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; PORE COMPLEX; PROTEIN CRYSTALLOGRAPHY; ALPHA; RECOGNITION; MACROMOLECULES; SOFTWARE; SPRING-8; IMPORT; SYSTEM	In this study, we determined the crystal structure of N-terminal importin-beta-binding domain (IBB)-truncated human importin-alpha 1 (Delta IBB-h-importin-alpha 1) at 2.63 angstrom resolution. The crystal structure of Delta IBB-h-importin-alpha 1 reveals a novel closed homodimer. The homodimer exists in an autoinhibited state in which both the major and minor nuclear localization signal (NLS) binding sites are completely buried in the homodimerization interface, an arrangement that restricts NLS binding. Analytical ultracentrifugation studies revealed that Delta IBB-h-importin-alpha 1 is in equilibrium between monomers and dimers and that NLS peptides shifted the equilibrium toward the monomer side. This finding suggests that the NLS binding sites are also involved in the dimer interface in solution. These results show that when the IBB domain dissociates from the internal NLS binding sites, e.g., by binding to importin-beta, homodimerization possibly occurs as an autoinhibition state.	[Miyatake, Hideyuki; Dohmae, Naoshi] RIKEN, Global Res Cluster Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Sanjoh, Akira; Tatsumi, Yuko] Prot Wave Corp, Nara 6310006, Japan; [Unzai, Satoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Matsuda, Go; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Miyamoto, Yoichi] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Miyamoto, Yoichi] Natl Inst Biomed Innovat, Lab Nucl Transport Dynam, Osaka 5670085, Japan	RIKEN; Yokohama City University; RIKEN; Monash University; National Institute of Health Sciences - Japan	Miyatake, H (corresponding author), RIKEN, Global Res Cluster Collaborat Promot Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	miyatake@riken.jp; aida@riken.jp	Dohmae, Naoshi/C-2040-2011; hideyuki, miyatake/S-4993-2019	Dohmae, Naoshi/0000-0002-5242-9410; hideyuki, miyatake/0000-0001-8872-9784	RIKEN; Ministry of Health, Labor and Welfare of Japan; program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	RIKEN; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was partly supported by the RIKEN incentive research grant (to HM), and also by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) and by the program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (to YA).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Okazaki N, 2008, J SYNCHROTRON RADIAT, V15, P288, DOI 10.1107/S0909049507064679; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115995	10.1371/journal.pone.0115995	http://dx.doi.org/10.1371/journal.pone.0115995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658636	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900028
J	Sargent, KM; Lu, N; Clopton, DT; Pohlmeier, WE; Brauer, VM; Ferrara, N; Silversides, DW; Cupp, AS				Sargent, Kevin M.; Lu, Ningxia; Clopton, Debra T.; Pohlmeier, William E.; Brauer, Vanessa M.; Ferrara, Napoleone; Silversides, David W.; Cupp, Andrea S.			Loss of Vascular Endothelial Growth Factor A (VEGFA) Isoforms in Granulosa Cells Using pDmrt-1-Cre or Amhr2-Cre Reduces Fertility by Arresting Follicular Development and by Reducing Litter Size in Female Mice	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; OOCYTE-SPECIFIC EXPRESSION; DIFFERENTIATION FACTOR-9; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; RHESUS-MONKEY; OVARIAN; MOUSE; ESTROGEN; GENES	Because VEGFA has been implicated in follicle development, the objective of this study was to determine the effects of granulosa-and germ cell-specific VEGFA loss on ovarian morphogenesis, function, and female fertility. pDmrt1-Cre mice were mated to floxed VEGFA mice to develop granulosa-/germ cell-specific knockouts (pDmrt1-Cre; Vegfa(-/-)). The time from mating to first parturition was increased when pDmrt1-Cre;Vegfa(-/-) females were mated to control males (P = 0.0008) and tended to be longer for heterozygous females (P < 0.07). Litter size was reduced for pDmrt1-Cre; Vegfa(-/-) females (P < 0.007). The time between the first and second parturitions was also increased for heterozygous females (P < 0.04) and tended to be increased for pDmrt1-Cre;Vegfa(-/-) females (P < 0.07). pDmrt1-Cre;Vegfa(-/-) females had smaller ovaries (P < 0.04), reduced plasma estradiol (P < 0.007), fewer developing follicles (P < 0.008) and tended to have fewer corpora lutea (P < 0.08). Expression of Igf1r was reduced (P < 0.05); expression of Foxo3a tended to be increased (P < 0.06); and both Fshr (P < 0.1) and Sirt6 tended to be reduced (P < 0.06) in pDmrt1-Cre;Vegfa(-/-) ovaries. To compare VEGFA knockouts, we generated Amhr2-Cre; Vegfa(-/-) mice that required more time from mating to first parturition (P < 0.003) with variable ovarian size. Both lines had more apoptotic granulosa cells, and vascular staining did not appear different. Taken together these data indicate that the loss of all VEGFA isoforms in granulosa/germ cells (proangiogenic and antiangiogenic) causes subfertility by arresting follicular development, resulting in reduced ovulation rate and fewer pups per litter.	[Sargent, Kevin M.; Lu, Ningxia; Clopton, Debra T.; Pohlmeier, William E.; Brauer, Vanessa M.; Cupp, Andrea S.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA; [Ferrara, Napoleone] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Silversides, David W.] Univ Montreal, Fac Vet Med, Dept Vet Biomed, St Hyacinthe, PQ J2S 7C6, Canada	University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California San Diego; Universite de Montreal	Cupp, AS (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA.	acupp2@unl.edu		Sargent, Kevin/0000-0001-6059-0776	NIH/NICHD [HD051979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051979] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by NIH/NICHD HD051979 and a contribution from the University of Nebraska Agricultural Research Division, Lincoln, Nebraska.	Abramovich D, 2010, FERTIL STERIL, V93, P1369, DOI 10.1016/j.fertnstert.2009.01.127; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Artac RA, 2009, BIOL REPROD, V81, P978, DOI 10.1095/biolreprod.109.078097; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Berisha B, 2010, BIOL REPROD, V82, P940, DOI 10.1095/biolreprod.109.076752; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Boyer A, 2002, GENESIS, V34, P236, DOI 10.1002/gene.10158; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Caires KC, 2012, ENDOCRINOLOGY, V153, P887, DOI 10.1210/en.2011-1323; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Ha CS, 2010, J OBSTET GYNAECOL RE, V36, P789, DOI 10.1111/j.1447-0756.2010.01212.x; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Iijima K, 2005, J REPROD DEVELOP, V51, P161, DOI 10.1262/jrd.51.161; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Krentz AD, 2011, DEV BIOL, V356, P63, DOI 10.1016/j.ydbio.2011.05.658; Lei N, 2007, BIOL REPROD, V77, P466, DOI 10.1095/biolreprod.106.058784; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Lu NX, 2013, ENDOCRINOLOGY, V154, P4790, DOI 10.1210/en.2013-1363; Mattioli M, 2001, BIOL REPROD, V65, P1014, DOI 10.1095/biolreprod65.4.1014; McFee RM, 2013, REPROD FERT DEVELOP, V25, P333, DOI 10.1071/RD12134; Mcfee RM, 2009, BIOL REPROD, V81, P966, DOI 10.1095/biolreprod.109.078071; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Pellatt L, 2011, FERTIL STERIL, V96, P1246, DOI 10.1016/j.fertnstert.2011.08.015; Qiu Y, 2012, REPROD EPUB; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Roberts AE, 2007, BIOL REPROD, V76, P218, DOI 10.1095/biolreprod.106.050880; Sadeu JC, 2008, REPRODUCTION, V136, P195, DOI 10.1530/REP-08-0065; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307; Zimmermann RC, 2002, ENDOCRINOLOGY, V143, P2496, DOI 10.1210/en.143.7.2496; Zimmermann RC, 2001, J CLIN ENDOCR METAB, V86, P768, DOI 10.1210/jc.86.2.768	49	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116332	10.1371/journal.pone.0116332	http://dx.doi.org/10.1371/journal.pone.0116332			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658474	Green Published, gold			2022-12-26	WOS:000349444900036
J	Xia, WR; Fu, WL; Cai, X; Wang, M; Chen, HH; Xing, WW; Wang, YY; Zou, MJ; Xu, T; Xu, DG				Xia, Wenrong; Fu, Wenliang; Cai, Xin; Wang, Min; Chen, Huihua; Xing, Weiwei; Wang, Yuanyuan; Zou, Minji; Xu, Tao; Xu, Donggang			Angiogenin Promotes U87MG Cell Proliferation by Activating NF-kappa B Signaling Pathway and Downregulating Its Binding Partner FHL3	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; CARCINOMA-CELLS; GROWTH-FACTOR; PROTEIN; EXPRESSION; IDENTIFICATION; GLIOBLASTOMA; SURVIVAL; RECEPTOR; KINASE	Angiogenin (Ang) is known to induce cell proliferation and inhibit apoptosis by cellular signaling pathways and its direct nuclear functions, but the mechanism of action for Ang in astrocytoma is not yet clear. Astrocytoma is the most frequent one among various neurogliomas, of which a subtype known as glioblastoma multiforme (GBM) is the most malignant brain glioma and seriously influences the life quality of the patients. The expression of Ang and Bcl-xL were detected in 28 cases of various grades of astrocytoma and 6 cases of normal human tissues by quantitative real-time PCR. The results showed that the expression of Ang and Bcl-xL positively correlated with the malignant grades. Cytological experiments indicated that Ang facilitated human glioblastoma U87MG cell proliferation and knock-down of endogenous Ang promoted cell apoptosis. Furthermore, Ang activated NF-kappa B pathway and entered the U87MG cell nuclei, and blocking NF-kappa B pathway or inhibiting Ang nuclear translocation partially suppressed Ang-induced cell proliferation. The results suggested that Ang participated in the regulation of evolution process of astrocytoma by interfering NF-kappa B pathway and its nucleus function. In addition, four and a half LIM domains 3 (FHL3), a novel Ang binding partner, was required for Ang-mediated HeLa cell proliferation in our previous study. We also found that knockdown of FHL3 enhanced I kappa B alpha phosphorylation and overexpression of Ang inhibited FHL3 expression in U87MG cells. Together our findings suggested that Ang could activate NF-kappa B pathway by regulating the expression of FHL3. In conclusion, the present study established a link between Ang and FHL3 proteins and identifies a new pathway for regulating astrocytoma progression.	[Xia, Wenrong; Fu, Wenliang; Cai, Xin; Wang, Min; Chen, Huihua; Xing, Weiwei; Wang, Yuanyuan; Zou, Minji; Xu, Tao; Xu, Donggang] Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Xu, DG (corresponding author), Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China.	xudg@bmi.ac.cn	Chen, Huihua/D-9162-2019; Lv, Yuanjie/AER-0767-2022	Chen, Huihua/0000-0002-5045-6845; 	National Natural Science Foundation of China [81170255]; Major State Basic Research Development Program of China (973 Program) [2011CB503803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This research was supported by grants from National Natural Science Foundation of China (No. 81170255) and the Major State Basic Research Development Program of China (973 Program) (No. 2011CB503803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Eberle K, 2000, ANTICANCER RES, V20, P1679; Fernandez-Santiago R, 2009, J NEUROL, V256, P1337, DOI 10.1007/s00415-009-5124-4; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Hu GF, 2000, J CELL BIOCHEM, V76, P452, DOI 10.1002/(SICI)1097-4644(20000301)76:3<452::AID-JCB12>3.0.CO;2-Z; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kwak JH, 2011, EXPERT OPIN THER PAT, V21, P1897, DOI 10.1517/13543776.2011.638285; Li S, 2011, J CELL PHYSL, V227, P1639, DOI DOI 10.1002/JCP.22881; Li SP, 2013, MOL CANCER RES, V11, P1203, DOI 10.1158/1541-7786.MCR-13-0072; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Li SP, 2010, FEBS J, V277, P3575, DOI 10.1111/j.1742-4658.2010.07766.x; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nakamura M, 2006, NEPHROL DIAL TRANSPL, V21, P1489, DOI 10.1093/ndt/gfl041; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Xia WR, 2012, GENE, V504, P233, DOI 10.1016/j.gene.2012.05.019; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255	30	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116983	10.1371/journal.pone.0116983	http://dx.doi.org/10.1371/journal.pone.0116983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659096	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900086
J	Zhao, X; Wang, Y; Shang, QH; Li, YY; Hao, HT; Zhang, YB; Guo, ZH; Yang, G; Xie, ZK; Wang, RY				Zhao, Xia; Wang, Yun; Shang, Qianhan; Li, Yuyao; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu			Collagen-Like Proteins (ClpA, ClpB, ClpC, and ClpD) Are Required for Biofilm Formation and Adhesion to Plant Roots by Bacillus amyloliquefaciens FZB42	PLOS ONE			English	Article							STREPTOCOCCUS-PYOGENES; FUNCTIONAL-CHARACTERIZATION; LEGIONELLA-PNEUMOPHILA; SURFACE HYDROPHOBICITY; SPORE SURFACE; GENE CLUSTERS; ANTHRACIS; SUBTILIS; EXOSPORIUM; BACTERIAL	The genes of collagen-like proteins (CLPs) have been identified in a broad range of bacteria, including some human pathogens. They are important for biofilm formation and bacterial adhesion to host cells in some human pathogenic bacteria, including several Bacillus spp. strains. Interestingly, some bacterial CLP-encoding genes (clps) have also been found in non-human pathogenic strains such as B. cereus and B. amyloliquefaciens, which are types of plant-growth promoting rhizobacteria (PGPR). In this study, we investigated a putative cluster of clps in B. amyloliquefaciens strain FZB42 and a collagen-related structuralmotif containing glycine-X-threonine repeats was found in the genes RBAM_007740, RBAM_007750, RBAM_007760, and RBAM_007770. Interestingly, biofilm formation was disrupted when these genes were inactivated separately. Scanning electronmicroscopy and hydrophobicity value detection were used to assess the bacterial cell shape morphology and cell surface architecture of clps mutant cells. The results showed that the CLPs appeared to have roles in bacterial autoaggregation, as well as adherence to the surface of abiotic materials and the roots of Arabidopsis thaliana. Thus, we suggest that the CLPs located in the outer layer of the bacterial cell (including the cell wall, outer membrane, flagella, or other associated structures) play important roles in biofilm formation and bacteria-plant interactions. This is the first study to analyze the function of a collagen-like motif-containing protein in a PGPR bacterium. Knocking out each clp gene produced distinctive morphological phenotypes, which demonstrated that each product may play specific roles in biofilm formation. Our in silico analysis suggested that these four tandemly ranked genes might not belong to an operon, but further studies are required at the molecular level to test this hypothesis. These results provide insights into the functions of clps during interactions between bacteria and plants.	[Zhao, Xia; Shang, Qianhan; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Gaolan Stn Agr & Ecol Expt, Lanzhou, Peoples R China; [Zhao, Xia; Shang, Qianhan; Hao, Haiting; Zhang, Yubao; Guo, Zhihong; Yang, Guo; Xie, Zhongkui; Wang, Ruoyu] Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Lanzhou, Peoples R China; [Wang, Yun] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China; [Li, Yuyao] Lanzhou Univ, Sch Life Sci, Key Lab Arid & Grassland Agroecol, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Lanzhou University	Wang, RY (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Gaolan Stn Agr & Ecol Expt, Lanzhou, Peoples R China.	wangruoyu@lzb.ac.cn	Hao, haiting/GRX-2777-2022	Wang, Ruoyu/0000-0002-0422-6408	Natural Science Foundation of China [31370447]; Chinese Academy of Sciences [27Y127L41002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Natural Science Foundation of China No. 31370447 and the Chinese Academy of Sciences under the "One Hundred Talents" program No.27Y127L41002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Nour M, 2013, APPLIED AND ENVIRONM; Abdel-Nour M, 2014, APPL ENVIRON MICROB, V80, P1441, DOI 10.1128/AEM.03254-13; Ahimou F, 2001, J MICROBIOL METH, V45, P119, DOI 10.1016/S0167-7012(01)00240-8; Becherelli M, 2012, MOL MICROBIOL, V83, P1035, DOI 10.1111/j.1365-2958.2012.07987.x; Boydston JA, 2006, J BACTERIOL, V188, P7440, DOI 10.1128/JB.00639-06; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Chagnot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059386; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Dietel K, 2013, PLANT PATHOLOGY J, V29, P59, DOI 10.5423/PPJ.OA.10.2012.0155; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; ERICKSON PR, 1987, J IMMUNOL, V138, P3360; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Fan B, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-307, DOI 10.1186/1471-2180-12-307]; Fan B, 2012, J MICROBIOL, V50, P38, DOI 10.1007/s12275-012-1439-4; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Ghosh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037872; Gusils C, 2002, CAN J MICROBIOL, V48, P34, DOI [10.1139/w01-122, 10.1139/W01-122]; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07; Makarewicz I, 2006, J BACTERIOL, V188, P6953, DOI 10.1128/JB.00681-06; Mallegol J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046462; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; O'Toole GA, 1999, GENETIC APPROACHES T; Oliver-Kozup HA, 2011, BMC MICROBIOL, V11, DOI [10.1186/1471-2180-11-269, DOI 10.1186/1471-2180-11-269]; Pan WH, 2006, ANAEROBE, V12, P148, DOI 10.1016/j.anaerobe.2006.03.001; Parsek MR, 2004, J BACTERIOL, V186, P4427, DOI 10.1128/JB.186.14.4427-4440.2004; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Recorbet G, 1997, LETT APPL MICROBIOL, V25, P375, DOI 10.1046/j.1472-765X.1997.00246.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Steichen CT, 2005, J BACTERIOL, V187, P5868, DOI 10.1128/JB.187.17.5868-5876.2005; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tayapad JB, 2013, CURR OPIN OPHTHALMOL, V24, P288, DOI 10.1097/ICU.0b013e32836229c5; Thompson BM, 2008, MOL MICROBIOL, V70, P421, DOI 10.1111/j.1365-2958.2008.06420.x; Thompson BM, 2007, J BACTERIOL, V189, P6704, DOI 10.1128/JB.00762-07; Tomich M, 2003, FEMS MICROBIOL LETT, V228, P287, DOI 10.1016/S0378-1097(03)00785-7; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xue QO, 2011, CELL MICROBIOL, V13, P620, DOI 10.1111/j.1462-5822.2010.01558.x; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu Z, 2014, JOURNAL OF STRUCTURA, DOI [10.1016/j.jsb.2015.01.001, DOI 10.1016/J.JSB.2015.01.001]	58	22	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117414	10.1371/journal.pone.0117414	http://dx.doi.org/10.1371/journal.pone.0117414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658640	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900145
J	Enesa, K; Moll, HP; Luong, L; Ferran, C; Evans, PC				Enesa, Karine; Moll, Herwig P.; Luong, Le; Ferran, Christiane; Evans, Paul C.			A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes	FASEB JOURNAL			English	Article						NF-kappa B; molecular mechanism; receptor interacting protein	NF-KAPPA-B; ZINC-FINGER PROTEIN; LINEAR POLYUBIQUITIN; ENDOTHELIAL-CELLS; ACTIVATION; UBIQUITINATION; BINDING; COMPLEX; AGGREGATION; INHIBITION	A20 protects against pathologic vascular remodeling by inhibiting the inflammatory transcription factor NF-kappa B. A20's function has been attributed to ubiquitin editing of receptor-interacting protein 1 (RIP1) to influence activity/stability. The validity of this mechanism was tested using a murine model of transplant vasculopathy and human cells. Mouse C57BL/6 aortae transduced with adenoviruses containing A20 (or beta-galactosidase as a control) were allografted into major histocompatibility complex-mismatched BALB/c mice. Primary endothelial cells, smooth muscle cells, or transformed epithelial cells (all human) were transfected with wild-type A20 or with catalytically inactive mutants as a control. NF-kappa B activity and intracellular localization of RIP1 was monitored by reporter gene assay, immunofluorescent staining, and Western blotting. Native and catalytically inactive versions of A20 had similar inhibitory effects on NF-kappa B activity (-70% vs. -76%; P > 0.05). A20 promoted localization of RIP1 to insoluble aggresomes in murine vascular allografts and in human cells (53% vs. 0%) without altering RIP1 expression, and this process was increased by the assembly of polyubiquitin chains (87% vs. 28%; P < 0.05). A20 captures polyubiquitinated signaling intermediaries in insoluble aggresomes, thus reducing their bioavailability for downstream NF-kappa B signaling. This novel mechanism contributes to protection from vasculopathy in transplanted organs treated with exogenous A20.	[Enesa, Karine; Luong, Le] Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Cardiovasc Sci, London, England; [Moll, Herwig P.; Ferran, Christiane] Harvard Univ, Sch Med, Vasc Biol Res Ctr, Div Vasc & Endovasc Surg, Cambridge, MA 02138 USA; [Moll, Herwig P.; Ferran, Christiane] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Inst,Dept Surg, Cambridge, MA 02138 USA; [Evans, Paul C.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England; [Evans, Paul C.] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield S10 2RX, S Yorkshire, England	Imperial College London; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; University of Sheffield; University of Sheffield	Evans, PC (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Fac Med Dent & Hlth, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	paul.evans@sheffield.ac.uk	Moll, Herwig P./H-2836-2019	Moll, Herwig P./0000-0001-6438-9068; Evans, Paul/0000-0001-7975-681X	British Heart Foundation; National Heart and Lung Institute, Imperial College London, United Kingdom; U.S. National Institutes of Health R01 Grant [HL080130, DK063275]; Austrian Science Fund Grant [J3398-BW23]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086741, R01HL080130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK063275, R01DK063275] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); National Heart and Lung Institute, Imperial College London, United Kingdom; U.S. National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Shuang Feng and Cleide G. da Silva for technical assistance. This work was funded by the British Heart Foundation and the National Heart and Lung Institute, Imperial College London, United Kingdom (to P.C.E.), and U.S. National Institutes of Health R01 Grants HL080130 and DK063275 (to C.F.). H.P.M. was supported by Austrian Science Fund Grant J3398-BW23. The authors declare no conflicts of interest.	Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Damrauer SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017715; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GARCIAVALDECASAS JC, 1995, TRANSPLANTATION, V60, P662, DOI 10.1097/00007890-199510150-00008; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kunter U, 2003, TRANSPLANTATION, V75, P3, DOI 10.1097/00007890-200301150-00002; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Lutz J, 2008, J MOL MED, V86, P1329, DOI 10.1007/s00109-008-0405-4; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Siracuse JJ, 2012, TRANSPLANTATION, V93, P373, DOI 10.1097/TP.0b013e3182419829; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tanaka M, 2004, CIRCULATION, V110, pII200, DOI 10.1161/01.CIR.0000138390.81640.54; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu MQ, 2009, J SURG RES, V152, P35, DOI 10.1016/j.jss.2008.04.029	49	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1869	1878		10.1096/fj.14-258533	http://dx.doi.org/10.1096/fj.14-258533			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25667218	Green Published			2022-12-26	WOS:000354114600022
J	Sarkar, P; Randall, SM; Collier, TS; Nero, A; Russell, TA; Muddiman, DC; Rao, BM				Sarkar, Prasenjit; Randall, Shan M.; Collier, Timothy S.; Nero, Anthony; Russell, Teal A.; Muddiman, David C.; Rao, Balaji M.			Activin/Nodal Signaling Switches the Terminal Fate of Human Embryonic Stem Cell-derived Trophoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EFFICIENT NEURAL CONVERSION; HUMAN OVIDUCTAL CELLS; IN-VITRO; GENE-EXPRESSION; EXTRAEMBRYONIC LINEAGES; CHORIONIC-GONADOTROPIN; CULTURE-CONDITIONS; CARCINOMA-CELLS; HUMAN-PLACENTA	Human embryonic stem cells (hESCs) have been routinely treated with bone morphogenetic protein and/or inhibitors of activin/nodal signaling to obtain cells that express trophoblast markers. Trophoblasts can terminally differentiate to either extravillous trophoblasts or syncytiotrophoblasts. The signaling pathways that govern the terminal fate of these trophoblasts are not understood. We show that activin/nodal signaling switches the terminal fate of these hESC-derived trophoblasts. Inhibition of activin/nodal signaling leads to formation of extravillous trophoblast, whereas loss of activin/nodal inhibition leads to the formation of syncytiotrophoblasts. Also, the ability of hESCs to form bona fide trophoblasts has been intensely debated. We have examined hESC-derived trophoblasts in the light of stringent criteria that were proposed recently, such as hypomethylation of the ELF5-2b promoter region and down-regulation of HLA class I antigens. We report that trophoblasts that possess these properties can indeed be obtained from hESCs.	[Sarkar, Prasenjit; Nero, Anthony; Rao, Balaji M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Randall, Shan M.; Collier, Timothy S.; Muddiman, David C.] N Carolina State Univ, WM Keck FT ICR Mass Spectrometry Lab, Dept Chem, Raleigh, NC 27695 USA; [Russell, Teal A.] N Carolina State Univ, Dept Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rao, BM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905,EB1, Raleigh, NC 27695 USA.	bmrao@ncsu.edu	Sarkar, Prasenjit/ABB-8088-2021	Sarkar, Prasenjit/0000-0001-6459-3181; Collier, Timothy/0000-0002-1102-8741; Muddiman, David/0000-0003-2216-499X; Rao, Balaji/0000-0001-5695-8953	National Science Foundation [CBET-0966859]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant CBET-0966859.	Aghajanova L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092775; Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Andrews GL, 2009, J CHROMATOGR B, V877, P948, DOI 10.1016/j.jchromb.2009.02.040; Arganaraz ME, 2007, GENES GENET SYST, V82, P171, DOI 10.1266/ggs.82.171; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Birkedal-Hansen Henning, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1008s40; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Chen Y, 2013, BIOCHEM BIOPH RES CO, V436, P677, DOI 10.1016/j.bbrc.2013.06.016; Collier TS, 2011, RAPID COMMUN MASS SP, V25, P2524, DOI 10.1002/rcm.5151; Collier TS, 2010, J AM SOC MASS SPECTR, V21, P879, DOI 10.1016/j.jasms.2010.01.031; Das P, 2007, STEM CELL RES, V1, P61, DOI 10.1016/j.scr.2007.09.004; Arganaraz ME, 2012, ZYGOTE, V20, P53, DOI 10.1017/S0967199410000602; Erb TM, 2011, STEM CELLS DEV, V20, P1601, DOI 10.1089/scd.2010.0281; Ezashi T, 2012, CELL TISSUE RES, V349, P809, DOI 10.1007/s00441-012-1371-2; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011595; Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Giakoumopoulos M, 2010, REPROD SCI, V17, P798, DOI 10.1177/1933719110371853; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Hoya-Arias R, 2011, STEM CELLS DEV, V20, P1889, DOI 10.1089/scd.2010.0437; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Lai YM, 1996, HUM REPROD, V11, P1281; LaMarca HL, 2008, HUM REPROD, V23, P1733, DOI 10.1093/humrep/den178; Laurila R, 2013, INT J CLIN EXP PATHO, V6, P1400; Law J, 2014, CELL SIGNAL, V26, P1935, DOI 10.1016/j.cellsig.2014.05.009; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155; Lichtner B, 2013, BIOMATERIALS, V34, P9789, DOI 10.1016/j.biomaterials.2013.08.084; Lin G, 2010, METHODS MOL BIOL, V636, P1, DOI 10.1007/978-1-60761-691-7_1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; MINAMI N, 1994, THERIOGENOLOGY, V41, P1435, DOI 10.1016/0093-691X(94)90194-N; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; O'Driscoll CM, 2013, BBA-MOL CELL RES, V1833, P460, DOI 10.1016/j.bbamcr.2012.11.012; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Peiffer I, 2007, STEM CELLS DEV, V16, P393, DOI 10.1089/scd.2006.0013; Peng S, 2011, CELL BIOL INT, V35, P587, DOI 10.1042/CBI20100452; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Refaat B, 2011, HUM REPROD, V26, P3346, DOI 10.1093/humrep/der331; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Salilew-Wondim D, 2012, ANIM REPROD SCI, V134, P9, DOI 10.1016/j.anireprosci.2012.08.006; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sudheer S, 2012, STEM CELLS DEV, V21, P2987, DOI 10.1089/scd.2012.0099; Telugu BP, 2013, PLACENTA, V34, P536, DOI 10.1016/j.placenta.2013.03.016; Tiruthani K, 2013, BIOTECHNOL J, V8, P421, DOI 10.1002/biot.201200203; Trigal B, 2011, THERIOGENOLOGY, V75, P584, DOI 10.1016/j.theriogenology.2010.09.010; Udayashankar R, 2011, HUM REPROD, V26, P398, DOI 10.1093/humrep/deq350; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu JS, 2000, FERTIL STERIL, V74, P1215, DOI 10.1016/S0015-0282(00)01618-6; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2006, METH MOLEC MED, V121, P189; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yadav PS, 1998, ANIM REPROD SCI, V51, P301, DOI 10.1016/S0378-4320(98)00076-1; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	102	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8834	8848		10.1074/jbc.M114.620641	http://dx.doi.org/10.1074/jbc.M114.620641			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670856	Green Published, hybrid			2022-12-26	WOS:000352207100013
J	Al-Amery, SM; Nambiar, P; Jamaludin, M; John, J; Ngeow, WC				Al-Amery, Samah M.; Nambiar, Phrabhakaran; Jamaludin, Marhazlinda; John, Jacob; Ngeow, Wei Cheong			Cone Beam Computed Tomography Assessment of the Maxillary Incisive Canal and Foramen: Considerations of Anatomical Variations When Placing Immediate Implants	PLOS ONE			English	Article							NASOPALATINE DUCT; JAW; MORPHOLOGY; PLACEMENT; LOCATION; BONES; NERVE	Introduction The maxillary incisive canal connects the roof of the oral cavity with the floor of nasal cavity and has the incisive and nasal foramina respectively at its two opposite ends. Its close proximity with the anterior incisors affects one's ability to place immediate implants in ideal position. Objective To avoid causing complication, variations in their dimensions were studied. Material and Methods Images of ninety Mongoloids patients examined with i-CAT Cone Beam Computed Tomography were included. The sizes of the nasopalatine foramen, the incisive canal and foramen, and anterior maxillary bone thickness were measured. The direction and course of the canals were assessed. Results The mean labiopalatal and mesiodistal measurements of the incisive foramen were 2.80mm and 3.49 mm respectively, while the labiopalatal width of the nasal foramen was 6.06mm. The incisive canal was 16.33mm long and 3.85 mm wide. The anterior maxillary bone has an average thickness of 7.63 mm. The dimensions of the incisive foramen and incisive canal, and anterior maxillary bone thickness demonstrated gender differences with males showing greater values. The anterior maxillary bone thickness was affected by age but this difference was not observed in canal dimensions. The majority of subjects have a funnel shape-like incisive canal with the broader opening located at its superior. They seem to have a longer slanted-curve canal with one channel at its middle portion and a narrower incisive foramen opening than those reported elsewhere. Conclusions This study found that gender is an important factor that affected the characteristics of the IC and the amount of bone anterior to it. Male generally had bigger IC and thicker anterior bone. In addition, the anterior maxillary bone thickness was affected by aging, where it becomes thinner with increased age even though the subjects were fully dentate.	[Al-Amery, Samah M.; Nambiar, Phrabhakaran; John, Jacob] Univ Malaya, Fac Dent, Dept Diagnost & Integrated Dent Practice, Kuala Lumpur, Malaysia; [Jamaludin, Marhazlinda] Univ Malaya, Fac Dent, Dept Community Oral Hlth & Clin Prevent, Kuala Lumpur, Malaysia; [Ngeow, Wei Cheong] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ngeow, WC (corresponding author), Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia.	ngeowy@um.edu.my	NAMBIAR, PHRABHAKARAN K N/B-9495-2010; JOHN, JACOB/AAU-1464-2021; Jamaludin, Marhazlinda/B-8936-2010; Cheong, Ngeow Wei/A-2530-2009; JOHN, JACOB/B-8683-2010; John, Jacob/ABD-7448-2020	JOHN, JACOB/0000-0001-8452-0676; Jamaludin, Marhazlinda/0000-0003-1177-1508; Cheong, Ngeow Wei/0000-0003-4354-3518; JOHN, JACOB/0000-0001-8452-0676; 	Ministry of Education, Malaysia [UM.C/HIR/MOHE/DENT/19]	Ministry of Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by the Ministry of Education, Malaysia Grant (UM.C/HIR/MOHE/DENT/19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artzi Z, 2000, CLIN ORAL IMPLAN RES, V11, P505, DOI 10.1034/j.1600-0501.2000.011005505.x; Asaumi R, 2010, ORAL RADIOL, V26, P20, DOI 10.1007/s11282-010-0039-4; Bornstein MM, 2011, CLIN ORAL IMPLAN RES, V22, P295, DOI 10.1111/j.1600-0501.2010.02010.x; Casado PL, 2008, IMPLANT DENT, V17, P169, DOI 10.1097/ID.0b013e3181776c52; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; Chandler Nicholas P., 1996, New Zealand Dental Journal, V92, P80; Chatriyanuyoke P, 2012, J ORAL IMPLANTOL, V38, P713, DOI 10.1563/AAID-JOI-D-10-00106; Cheng S, 1997, Zhonghua Kou Qiang Yi Xue Za Zhi, V32, P149; DALEY TD, 1994, ORAL SURG ORAL MED O, V77, P276, DOI 10.1016/0030-4220(94)90299-2; Drake R., 2009, GRAYS ANATOMY STUDEN; Ennis LM, 1967, DENT ROENTGENOLOGY, P334; Filippi A, 1999, BRIT J ORAL MAX SURG, V37, P134, DOI 10.1054/bjom.1997.0092; Ghom AG, 2008, TXB ORAL RADIOLOGY, P191; Glickman GN, 2002, PATHWAY PF THE PULP, P77; Guler AU, 2005, J ORAL REHABIL, V32, P741, DOI 10.1111/j.1365-2842.2005.01499.x; Guncu GN, 2013, CLIN ORAL IMPLAN RES, V24, P1023, DOI 10.1111/j.1600-0501.2012.02493.x; Iordanishvili A, 1990, STOMATOLOGIIA MOSK, P25; Jacob S, 2000, ARCH OTOLARYNGOL, V126, P741, DOI 10.1001/archotol.126.6.741; Jacobs R, 2007, ORAL SURG ORAL MED O, V103, P683, DOI 10.1016/j.tripleo.2006.11.014; KREIDLER JF, 1993, J CRANIO MAXILL SURG, V21, P339, DOI 10.1016/S1010-5182(05)80494-9; Liang X, 2009, J CLIN PERIODONTOL, V36, P598, DOI 10.1111/j.1600-051X.2009.01429.x; Mardinger O, 2008, J PERIODONTOL, V79, P1659, DOI 10.1902/jop.2008.080043 ; Mecall R A, 1991, Int J Periodontics Restorative Dent, V11, P8; Moss HD, 2000, J ENDODONT, V26, P107, DOI 10.1097/00004770-200002000-00012; Mraiwa N, 2004, DENTOMAXILLOFAC RAD, V33, P396, DOI 10.1259/dmfr/53801969; Penarrocha M, 2009, INT J ORAL MAX IMPL, V24, P936; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1130; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1125; Rosenfeld A, 1996, COMPEND CONTIN ED DE, V17, P1146; ROSENQUIST JB, 1992, INT J ORAL MAX SURG, V21, P210, DOI 10.1016/S0901-5027(05)80220-6; Sarandha DL, 2008, TXB COMPLETE DENTURE; Scheid RC, 2007, WOELFELS DENT ANATOM, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Scher E L, 1994, Implant Dent, V3, P38, DOI 10.1097/00008505-199404000-00007; Scortecci GM, 2001, IMPLANTS RESTORATIVE, P265; Song WC, 2009, ORAL SURG ORAL MED O, V108, P583, DOI 10.1016/j.tripleo.2009.06.036; Standring S, 2005, GRAYS ANATOMY ANATOM, P538; SWANSON KS, 1991, J ORAL MAXIL SURG, V49, P268, DOI 10.1016/0278-2391(91)90217-A; Tozum TF, 2012, J PERIODONTOL, V83, P337, DOI 10.1902/jop.2011.110326; 김규태, 2004, Imaging Science in Dentistry, V34, P7	39	40	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117251	10.1371/journal.pone.0117251	http://dx.doi.org/10.1371/journal.pone.0117251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679505	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000350682600058
J	Vortman, Y; Safran, RJ; Brodetzki, TR; Dor, R; Lotem, A				Vortman, Yoni; Safran, Rebecca J.; Brodetzki, Tali Reiner; Dor, Roi; Lotem, Arnon			Expression of Multiple Sexual Signals by Fathers and Sons in the East-Mediterranean Barn Swallow: Are Advertising Strategies Heritable?	PLOS ONE			English	Article							BODY-MASS INDEX; HIRUNDO-RUSTICA; TAIL ORNAMENTS; TRADE-OFF; SELECTION; COLOR; PATERNITY; TRAITS; FERTILIZATION; REPEATABILITY	The level of expression of sexually selected traits is generally determined by genes, environment and their interaction. In species that use multiple sexual signals which may be costly to produce, investing in the expression of one sexual signal may limit the expression of the other, favoring the evolution of a strategy for resource allocation among signals. As a result, even when the expression of sexual signals is condition dependent, the relative level of expression of each signal may be heritable. We tested this hypothesis in the East-Mediterranean barn swallow (Hirundo rustica transitiva), in which males have been shown to express two uncorrelated sexual signals: red-brown ventral coloration, and long tail streamers. We show that variation in both signals may partially be explained by age, as well as by paternal origin (genetic father-son regressions), but that the strongest similarity between fathers and sons is the relative allocation towards one trait or the other (relative expression index), rather than the expression of the traits themselves. These results suggest that the expression of one signal is not independent of the other, and that genetic strategies for resource allocation among sexual signals may be selected for during the evolution of multiple sexual signals.	[Vortman, Yoni] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Vortman, Yoni; Brodetzki, Tali Reiner; Dor, Roi; Lotem, Arnon] Tel Aviv Univ, Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Safran, Rebecca J.; Dor, Roi] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Dor, Roi] Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY USA	University of Haifa; Tel Aviv University; University of Colorado System; University of Colorado Boulder; Cornell University	Vortman, Y (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	vortmanyo@gmail.com	Brodetzki, Tali Reiner/W-8137-2019	Brodetzki, Tali Reiner/0000-0002-1705-2056; Dor, Roi/0000-0002-8743-9387	Israel Science Foundation (ISF) [1181/07]; National Science Foundation [NSF IOS 07071421]; Dan David Prize scholarship; University of Haifa Post-doctoral fellowship	Israel Science Foundation (ISF)(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); Dan David Prize scholarship; University of Haifa Post-doctoral fellowship	This work was funded by the Israel Science Foundation (ISF grant number 1181/07 to AL) and the National Science Foundation, (NSF IOS 07071421 to RJS). YV was supported by the Dan David Prize scholarship and by the University of Haifa Post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Badyaev AV, 2002, EVOLUTION, V56, P412; Balbontin J, 2011, J EVOLUTION BIOL, V24, P440, DOI 10.1111/j.1420-9101.2010.02183.x; Becker WA, 1992, MANUAL QUANTITATIVE, V5th; Bro-Jorgensen J, 2007, CURR BIOL, V17, P850, DOI 10.1016/j.cub.2007.03.042; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cotton S, 2004, J EVOLUTION BIOL, V17, P1310, DOI 10.1111/j.1420-9101.2004.00754.x; Dohm MR, 2002, FUNCT ECOL, V16, P273; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dor R, 2010, MOL PHYLOGENET EVOL, V56, P409, DOI 10.1016/j.ympev.2010.02.008; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Evans MR, 1998, NATURE, V394, P233, DOI 10.1038/28297; Falconer D. S., 1996, INTRO QUANTITATIVE G; Galvan I, 2011, J EVOLUTION BIOL, V24, P999, DOI 10.1111/j.1420-9101.2011.02232.x; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hering E., 1878, LEHRE LICHTSINNE; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Lifjeld JT, 2011, BEHAV ECOL SOCIOBIOL, V65, P1687, DOI 10.1007/s00265-011-1176-4; Maguire SE, 2010, J AVIAN BIOL, V41, P74, DOI 10.1111/j.1600-048X.2009.04806.x; MOLLER AP, 1991, EVOLUTION, V45, P1823, DOI 10.1111/j.1558-5646.1991.tb02690.x; MOLLER AP, 1988, NATURE, V332, P640, DOI 10.1038/332640a0; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moller AP., 1994, SEXUAL SELECTION BAR; Murai M, 2009, EVOLUTION, V63, P2363, DOI 10.1111/j.1558-5646.2009.00726.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; RATHBUN GB, 1981, J MAMMAL, V62, P635, DOI 10.2307/1380414; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Saino N, 2003, BEHAV ECOL SOCIOBIOL, V54, P465, DOI 10.1007/s00265-003-0642-z; Saino N, 2003, ITAL J ZOOL, V70, P167, DOI 10.1080/11250000309356511; Saino N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Saino N, 2014, ANIM BEHAV, V87, P137, DOI 10.1016/j.anbehav.2013.10.022; Scandolara C, 2014, ANIM BEHAV, V87, P187, DOI 10.1016/j.anbehav.2013.10.030; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Shutler D, 2011, BIOL LETTERS, V7, P101, DOI 10.1098/rsbl.2010.0531; Smith HG, 1991, BEHAV ECOL, V2, P90, DOI 10.1093/beheco/2.1.90; Sokal RR, 1995, BIOMETRY; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Vortman Y, 2013, AM NAT, V182, P514, DOI 10.1086/671908; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Wagner WE, 2012, P ROY SOC B-BIOL SCI, V279, P2899, DOI 10.1098/rspb.2012.0275; White P.S., 1992, MOL GENETIC ANAL POP, P50; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; [No title captured]	61	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118054	10.1371/journal.pone.0118054	http://dx.doi.org/10.1371/journal.pone.0118054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679206	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600105
J	Yin, L; Xie, YY; Yin, SY; Lv, XL; Zhang, J; Gu, ZZ; Sun, HD; Liu, SQ				Yin, Liang; Xie, Yingying; Yin, Songyue; Lv, Xiaolei; Zhang, Jia; Gu, Zezong; Sun, Haidan; Liu, Siqi			The S-Nitrosylation Status of PCNA Localized in Cytosol Impacts the Apoptotic Pathway in a Parkinson's Disease Paradigm	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; NITRIC-OXIDE; CYSTEINE RESIDUES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SH-SY5Y CELLS; CYTOCHROME-C; CASPASE-9; DEATH; ACTIVATION	It is generally accepted that nitric oxide (NO) or its derivatives, reactive nitrogen species (RNS), are involved in the development of Parkinson's disease (PD). Recently, emerging evidence in the study of PD has indicated that protein S-nitrosylation triggers the signaling changes in neurons. In this study, SH-SY5Y cells treated with rotenone were used as a model of neuronal death in PD. The treated cells underwent significant apoptosis, which was accompanied by an increase in intracellular NO in a rotenone dose-dependent manner. The CyDye switch approach was employed to screen for changes in S-nitrosylated (SNO) proteins in response to the rotenone treatment. Seven proteins with increased S-nitrosylation were identified in the treated SH-SY5Y cells, which included proliferating cell nuclear antigen (PCNA). Although PCNA is generally located in the nucleus and participates in DNA replication and repair, significant PCNA was identified in the SH-SY5Y cytosol. Using immunoprecipitation and pull-down approaches, PCNA was found to interact with caspase-9; using mass spectrometry, the two cysteine residues PCNA-Cys81 and -Cys162 were identified as candidate S-nitrosylated residues. In addition, the evidence obtained from in vitro and the cell model studies indicated that the S-nitrosylation of PCNA-Cys81 affected the interaction between PCNA and caspase-9. Furthermore, the interaction of PCNA and caspase-9 partially blocked caspase-9 activation, indicating that the S-nitrosylation of cytosolic PCNA may be a mediator of the apoptotic pathway.	[Yin, Liang; Xie, Yingying; Yin, Songyue; Sun, Haidan; Liu, Siqi] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Yin, Liang; Liu, Siqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lv, Xiaolei; Zhang, Jia; Liu, Siqi] Beijing Prot Innovat, Beijing, Peoples R China; [Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Sun, HD (corresponding author), Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	sunhd@genomics.org.cn; siqiliu@genomics.org.cn			National Key Basic Research Program of China [2010CB912703]; National High Technology Research and Development Program of China [2012AA020205]; Nature Science Foundation of China [91131009]	National Key Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Key Basic Research Program of China: 2010CB912703; National High Technology Research and Development Program of China: 2012AA020205; Nature Science Foundation of China: 91131009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthwal MK, 2001, REDOX REP, V6, P297, DOI 10.1179/135100001101536436; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Casey DP, 2013, J APPL PHYSIOL, V115, P446, DOI 10.1152/japplphysiol.00446.2013; Chen JS, 2010, FEBS J, V277, P3028, DOI 10.1111/j.1742-4658.2010.07712.x; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gatto EM, 1996, MOVEMENT DISORD, V11, P261, DOI 10.1002/mds.870110308; Gatto EM, 2000, NITRIC OXIDE-BIOL CH, V4, P534, DOI 10.1006/niox.2000.0288; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jiang ZL, 2009, WOUND REPAIR REGEN, V17, P224, DOI 10.1111/j.1524-475X.2009.00459.x; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Lam YW, 2010, PLOS ONE, DOI [10.1371/journal.pone.0014462, DOI 10.1371/JOURNAL.PONE.0014462]; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Martin MC, 2008, J BIOL CHEM, V283, P3854, DOI 10.1074/jbc.M705647200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; MICHEL PP, 2006, SCIENCE STKE, V332, pPE19, DOI DOI 10.1126/STKE.3322006PE19; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Ortiz-Ortiz MA, 2009, NEUROTOX RES, V16, P160, DOI 10.1007/s12640-009-9065-6; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Petit C, 1999, BRAZ J MED BIOL RES, V32, P1407, DOI 10.1590/S0100-879X1999001100011; Phattanarudee S, 2013, CAN J PHYSIOL PHARM, V91, P510, DOI 10.1139/cjpp-2013-0066; Qu Z, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-17; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Shaikh SB, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-55; Shi Q, 2008, BIOL PHARM BULL, V31, P1536, DOI 10.1248/bpb.31.1536; Singh S, 2005, REDOX REP, V10, P103, DOI 10.1179/135100005X38842; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sumbayev VV, 2003, ARCH BIOCHEM BIOPHYS, V415, P133, DOI 10.1016/S0003-9861(03)00199-1; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Torta F, 2008, PROTEOMICS, V8, P4484, DOI 10.1002/pmic.200800089; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang LC, 1998, J NEUROSCI, V18, P8145; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yu Y, 2009, J BIOL CHEM, V284, P19310, DOI 10.1074/jbc.M109.015289; Zhang HH, 2011, BIOL REPROD, V84, P966, DOI 10.1095/biolreprod.110.090688; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang JL, 2005, AM J PHYSIOL-CELL PH, V288, pC840, DOI 10.1152/ajpcell.00325.2004; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang XL, 2014, ONCOL LETT, V7, P411, DOI 10.3892/ol.2013.1703; Zhang ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106669; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	65	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117546	10.1371/journal.pone.0117546	http://dx.doi.org/10.1371/journal.pone.0117546			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675097	Green Submitted, gold, Green Published			2022-12-26	WOS:000349914000027
J	Barbosa-Resende, W; Rangel, VD; Frontarolli, AC; Araujo, RRH; da Silva, CHM; Pinto, RDC; Morales, NDO				Barbosa-Resende, Wener; Rangel, Viviane de Oliveira; Frontarolli, Ana Claudia; Hoffman Araujo, Renata R.; Martins da Silva, Carlos Henrique; Costa Pinto, Rogerio de Melo; Oliveira Morales, Nivea de Macedo			Psychometric Properties of the Autoquestionnaire Qualite De Vie Enfant Image (AUQEI) Applied to Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; OF-LIFE; HEALTH QUESTIONNAIRE; BRAZILIAN VERSION; RELIABILITY; ADOLESCENTS; VALIDITY; INSTRUMENTS; AGREEMENT	Background Quality of life (QL) assessments of children with incapacitating diseases, such as cerebral palsy (CP), have often been conducted with the help of the representatives of a child, making QL assessment more subjective. TheAutoquestionnaireQualite de Vie Enfant Image (AUQEI) is a QL assessment designed for children to self-report-it uses images to facilitate the reporting process. Objective evaluate the psychometric properties of AUQEI when responses are given by children with CP. Findings Children aged 4 to 12 years (45 with CP and 45 healthy children) gave responses to the questionnaire. The data quality, reliability and validity were assessed. The data loss rate ranged from 8.8% to 46.7%, and was highest for the "autonomy" factor. No floor or ceiling effect was detected. The success rate for reliability of the internal consistency of the items was less than 80% for the "autonomy" factor. Cronbach's alpha coefficient was 0.71 for the instrument and less than 0.5 for the factors. All the factors had a success rate of greater than 80% for the discriminating validity of the items. The factors did not have correlations between each other, thus indicating adequate discriminating validity. Convergent validity was tested and a significant correlation was demonstrated only between the AUQEI "functioning" factor and the Child Health Questionnaire-50-Item (CHQ-PF50) physical summary score (r = 0.31, p = 0.042). The AUQEI scores did not have correlations with the gross motor function scores (p>0.05) as expected for divergent validity. Regarding construct validity, the total AUQEI score obtained by the CP group was lower (median: 47.3) than that of the healthy group (median: 51.0) (p<0.01). Conclusion The AUQEI was shown to be a reliable and valid instrument for assessing children with CP when the total score was used. Convergent validity should continue to be tested in future studies.	[Barbosa-Resende, Wener; Costa Pinto, Rogerio de Melo] Univ Fed Uberlandia, Grad Program Hlth Sci, Fac Med, BR-38400 Uberlandia, MG, Brazil; [Rangel, Viviane de Oliveira] Univ Fed Uberlandia, Fac Med, BR-38400 Uberlandia, MG, Brazil; [Frontarolli, Ana Claudia] Phys Therapy & Specialty Ctr Unimed, Uberlandia, MG, Brazil; [Hoffman Araujo, Renata R.] Assoc Assistance Disabled Children, Uberlandia, MG, Brazil; [Martins da Silva, Carlos Henrique; Oliveira Morales, Nivea de Macedo] Univ Fed Uberlandia, Fac Med, Grad Program Hlth Sci, Dept Pediat, BR-38400 Uberlandia, MG, Brazil; [Costa Pinto, Rogerio de Melo] Fac Math, Ctr Exact Sci & Technol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Barbosa-Resende, W (corresponding author), Univ Fed Uberlandia, Grad Program Hlth Sci, Fac Med, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	wener_educa@hotmail.com						Akodu A K, 2012, Nig Q J Hosp Med, V22, P99; Assumpcao FB, 2000, ARQ NEURO-PSIQUIAT, V58, P119, DOI 10.1590/S0004-282X2000000100018; Barbosa APM, 2012, REV NEUROCIENC, V20, P367; Barreire Simone G., 2003, J. Pediatr. (Rio J.), V79, P55, DOI 10.1590/S0021-75572003000100010; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Brasil: Ministerio da Saude, 2013, DIR AT PESS COM PAR; Carlon S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-81; Centro de Estudos Pesquisas e Projetos Economico-Sociais (CEPES), 2003, UB PAIN INF MUN PAIN; Dalvand H, 2012, ARCH PHYS MED REHAB, V93, P480, DOI 10.1016/j.apmr.2011.10.019; Davis E, 2010, DEV MED CHILD NEUROL, V52, P174, DOI 10.1111/j.1469-8749.2009.03382.x; Dey M, 2012, QUAL LIFE RES, V21, P1797, DOI 10.1007/s11136-012-0109-7; Dickinson H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-273; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Elias AV, 2006, ARQ NEURO-PSIQUIAT, V64, P295, DOI 10.1590/S0004-282X2006000200022; Ferreira PRA, 2008, HOR CI, V2, P47; Gates P, 2010, DEV MED CHILD NEUROL, V52, P843, DOI 10.1111/j.1469-8749.2010.03666.x; Green Liza B, 2007, Phys Med Rehabil Clin N Am, V18, P859, DOI 10.1016/j.pmr.2007.07.005; Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232; Health outcomes methodology symposium, 2000, MED CARE S2, V38, P7; Himmelmann K, 2014, ACTA PAEDIATR, V103, P618, DOI 10.1111/apa.12614; Hodgkinson I., 2002, Annales de Readaptation et de Medecine Physique, V45, P154, DOI 10.1016/S0168-6054(02)00195-2; Kucynski E, 2003, AN PEDIATR, V58, P550; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Machado CSM, 2001, CLIN EXP RHEUMATOL, V19, pS25; Manificat S, 1997, ARCH PEDIATRIE, V4, P1238, DOI 10.1016/S0929-693X(97)82616-4; Manificat S, 1997, NEUROPSYCHIAT ENFAN, V45, P106; McCarthy ML, 2002, DEV MED CHILD NEUROL, V44, P468; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Morales NDO, 2007, QUAL LIFE RES, V16, P437, DOI 10.1007/s11136-006-9136-6; Morales NMO, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-109; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Sankar Chitra, 2005, Indian Journal of Pediatrics, V72, P865, DOI 10.1007/BF02731117; Scholtes VAB, 2006, DEV MED CHILD NEUROL, V48, P64; Shikako-Thomas K, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/387280; Borges MBS, 2011, ARQ NEURO-PSIQUIAT, V69, P799, DOI 10.1590/S0004-282X2011000600014; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2005, DEV MED CHILD NEUROL, V47, P592, DOI 10.1017/S0012162205001179; Vilibor RHH, 2010, REV NEUROCIENC, V18, P380; Waters E, 2007, DEV MED CHILD NEUROL, V49, P49, DOI 10.1017/S0012162207000126; Wechsler D, 2002, WISC 3 ESCALA INTELI, DOI [10.1016/j.ophtha.2014.10.028, DOI 10.1016/J.OPHTHA.2014.10.028]; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; WHOQOL, 1997, MEAS QUAL LIF	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115643	10.1371/journal.pone.0115643	http://dx.doi.org/10.1371/journal.pone.0115643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671523	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300008
J	Crenshaw, DG; Asin, K; Gottschalk, WK; Liang, ZF; Zhang, NY; Roses, AD				Crenshaw, Donna G.; Asin, Karen; Gottschalk, William K.; Liang, Zhifeng; Zhang, Nanyin; Roses, Allen D.			Effects of Low Doses of Pioglitazone on Resting-State Functional Connectivity in Conscious Rat Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ACTIVATED-RECEPTOR-GAMMA; ALZHEIMERS ASSOCIATION WORKGROUPS; MITOCHONDRIAL BIOGENESIS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ROSIGLITAZONE; DISEASE; EXPRESSION; NETWORKS	Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-gamma (PPAR.) agonist in clinical use for treatment of type 2 diabetes (T2DM). Accumulating evidence suggests PPAR gamma agonists may be useful for treating or delaying the onset of Alzheimer's disease (AD), possibly via actions on mitochondria, and that dose strengths lower than those clinically used for T2DM may be efficacious. Our major objective was to determine if low doses of pioglitazone, administered orally, impacted brain activity. We measured blood-oxygenation-level dependent (BOLD) low-frequency fluctuations in conscious rats to map changes in brain resting-state functional connectivity due to daily, oral dosing with low-dose PIO. The connectivity in two neural circuits exhibited significant changes compared with vehicle after two days of treatment with PIO at 0.08 mg/kg/day. After 7 days of treatment with a range of PIO dose-strengths, connections between 17 pairs of brain regions were significantly affected. Functional connectivity with the CA1 region of the hippocampus, a region that is involved in memory and is affected early in the progression of AD, was specifically investigated in a seed-based analysis. This approach revealed that the spatial pattern of CA1 connectivity was consistent among all dose groups at baseline, prior to treatment with PIO, and in the control group imaged on day 7. Compared to baseline and controls, increased connectivity to CA1 was observed regionally in the hypothalamus and ventral thalamus in all PIO-treated groups, but was least pronounced in the group treated with the highest dose of PIO. These data support our hypothesis that PIO modulates neuronal and/or cerebrovascular function at dose strengths significantly lower than those used to treat T2DM and therefore may be a useful therapy for neurodegenerative diseases including AD.	[Crenshaw, Donna G.; Gottschalk, William K.; Roses, Allen D.] Zinfandel Pharmaceut Inc, Chapel Hill, NC 27517 USA; [Asin, Karen] Takeda Dev Ctr Amer Inc, Deerfield, IL USA; [Liang, Zhifeng; Zhang, Nanyin] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Crenshaw, DG (corresponding author), Zinfandel Pharmaceut Inc, Chapel Hill, NC 27517 USA.	dcrenshaw@zinfandelpharma.com; roses@zinfandelpharma.com	Liang, Zhfieng/A-4914-2016; Zhang, Nanyin/N-3457-2014	Liang, Zhfieng/0000-0001-7940-3467; Gottschalk, William/0000-0001-6760-2338; Zhang, Nanyin/0000-0002-5824-9058	Takeda Development Center Americas, Inc.; National Institute of Mental Health [R01MH098003]; National Institute of Neurological Disorders and Stroke [R01NS085200]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085200] Funding Source: NIH RePORTER	Takeda Development Center Americas, Inc.(Takeda Pharmaceutical Company Ltd); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by Takeda Development Center Americas, Inc. An employee of the funder and employees of, or consultants to, Zinfandel Pharmaceuticals, Inc, which is in a business alliance with the funder, participated in study design and data analysis, the decision to publish, and preparation of the manuscript. Data was collected and analyzed by individuals according to a sponsored research contract with the funder. These individuals also participated in manuscript preparation and the decision to publish. The work was also supported by grants to NZ from the National Institute of Mental Health (R01MH098003) and the National Institute of Neurological Disorders and Stroke (R01NS085200).	Abbatecola AM, 2010, DIABETES CARE, V33, P1706, DOI 10.2337/dc09-2030; Akram Afia, 2010, Mol Neurodegener, V5, P36, DOI 10.1186/1750-1326-5-36; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, 2010, CHANGING THE TRAJECT; Beason-Held LL, 2013, J NEUROSCI, V33, P18008, DOI 10.1523/JNEUROSCI.1402-13.2013; Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Elbrecht A, 1996, BIOCHEM BIOPH RES CO, V224, P431, DOI 10.1006/bbrc.1996.1044; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Geldmacher DS, 2011, ARCH NEUROL-CHICAGO, V68, P45, DOI 10.1001/archneurol.2010.229; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; Grossman S L, 1997, Expert Opin Investig Drugs, V6, P1025, DOI 10.1517/13543784.6.8.1025; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Kummer MP, 2008, PPAR RESEARCH, P8; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Liang ZF, 2015, NEUROIMAGE, V104, P89, DOI 10.1016/j.neuroimage.2014.10.013; Liang ZF, 2014, NEUROIMAGE, V103, P485, DOI 10.1016/j.neuroimage.2014.08.050; Liang ZF, 2013, NEUROIMAGE, V83, P237, DOI 10.1016/j.neuroimage.2013.06.029; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Lorenzi M, 2011, DRUG AGING, V28, P205, DOI 10.2165/11586440-000000000-00000; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Moon JH, 2012, INT J NEUROPSYCHOPH, V15, P135, DOI 10.1017/S1461145711001611; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Nicolakakis N, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00021; Papadopoulos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068612; Pflanzner T, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.025; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Sanabria-Diaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068860; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Vasudevan Abu R, 2004, Diabetes Technol Ther, V6, P850, DOI 10.1089/dia.2004.6.850; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	58	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117973	10.1371/journal.pone.0117973	http://dx.doi.org/10.1371/journal.pone.0117973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671601	gold, Green Published, Green Submitted			2022-12-26	WOS:000349545300075
J	Neupane, D; Panthi, B; McLachlan, CS; Mishra, SR; Kohrt, BA; Kallestrup, P				Neupane, Dinesh; Panthi, Bindu; McLachlan, Craig S.; Mishra, Shiva Raj; Kohrt, Brandon A.; Kallestrup, Per			Prevalence of Undiagnosed Depression among Persons with Hypertension and Associated Risk Factors: A Cross-Sectional Study in Urban Nepal	PLOS ONE			English	Article							MENTAL-HEALTH; SYMPTOMS; COMORBIDITY; DISEASE; ANXIETY; IMPACT; TWIN	Background Despite an increasing number of studies exploring prevalence of depression among hypertensive patients in high income countries, limited data is available from low and middle income countries, particularly Nepal. Our aim was to investigate the prevalence of undiagnosed (sub clinical) depression and associated risk factors among hypertensive patients attending a tertiary health care clinic in Nepal. Methods The study was based on a cross-sectional study design, with 321 hypertensive patients attending the Out-Patient Department of a central hospital in Nepal. Blood measure was recorded via a mercury column sphygmomanometer. Depression levels were assessed using the Beck Depression Inventory-Ia (BDI) scale. Demographics and risk factors were assessed. Result The proportion of participants with undiagnosed depression was 15%. Multivariable analyses demonstrated an increase in BDI scores with increased aging. Approximately a 1 point increase in the BDI score was observed for each additional decade of aging in hypertensive patients. Additional factors associated with increased risk of depression included being female (4.28 point BDI score increase), smoking (5.61 point BDI score increase), being hypertensive with no hypertensive medication (4.46 point BDI score increase) and being illiterate (4.46 point BDI score increase). Conclusions Among persons with hypertension in outpatient settings in Nepal, demographic (age, sex, education), behavioural (smoking,) and adherence factors (anti-hypertensive medication) were associated with undiagnosed depression. Screening programs in Nepal may assist early intervention in hypertensive patients with sub clinical depression.	[Neupane, Dinesh; Kallestrup, Per] Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark; [Panthi, Bindu] Fac Sci & Technol, Nobel Coll, Kathmandu, Nepal; [McLachlan, Craig S.] Univ New S Wales, Rural Clin Sch, Sydney, NSW, Australia; [Mishra, Shiva Raj] Nepal Dev Soc, Kathmandu, Nepal; [Kohrt, Brandon A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Aarhus University; University of New South Wales Sydney; Duke University	Neupane, D (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark.	neupane.dinesh@gmail.com	Neupane, Dinesh/C-3631-2014; Mishra, Shiva Raj/C-4172-2014; Kallestrup, Per/AAA-8313-2022	Neupane, Dinesh/0000-0002-1501-2990; Mishra, Shiva Raj/0000-0002-2993-3504; Kallestrup, Per/0000-0001-6041-4510; McLachlan, Craig/0000-0001-9843-8980				Agrawal SK, 2012, 17 WORLD C HEART DIS; Aryal KK, 2014, NONCOMMUNICABLE DIS; Beck AT., 1996, MANUAL BECK DEPRESSI; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bogner HR, 2005, AM J GERIAT PSYCHIAT, V13, P861, DOI 10.1176/appi.ajgp.13.10.861; BRIGHT RA, 1992, JAMA-J AM MED ASSOC, V267, P1783; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Das R, 2010, CELL CYCLE, V9, P638, DOI 10.4161/cc.9.4.11016; Gea A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-192; Health Management Information System (HMIS), 2010, ETHN GROUP; Joshi M, 2006, KATHMANDU U J SCI EN, V2, P1; Kataoka C, 2004, AM J PHYSIOL-HEART C, V286, pH768, DOI 10.1152/ajpheart.00937.2002; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kim MT, 2003, ANN BEHAV MED, V26, P24, DOI 10.1207/S15324796ABM2601_04; Kohrt B.A., 2002, NEPAL J PSYCHIAT, V2, P123; Kohrt BA, 2008, CULT MED PSYCHIAT, V32, P462, DOI 10.1007/s11013-008-9110-6; Kohrt BA, 2012, BRIT J PSYCHIAT, V201, P268, DOI 10.1192/bjp.bp.111.096222; Kohrt BA, 2009, ANN HUM BIOL, V36, P261, DOI 10.1080/03014460902839194; Lokshin M, 2009, WORLD BANK ECON REV, V23, P481, DOI 10.1093/wber/lhp011; Luitel NP, 2013, SOC PSYCH PSYCH EPID, V48, P183, DOI 10.1007/s00127-012-0539-0; Luitel NP, 2013, SOC PSCYCHIATRY PSYC, V48, P182; Marazziti D, 2014, CNS SPECTRUMS, V19, P293, DOI 10.1017/S1092852913000667; Mehta KD, 2011, SE ASIAN J TROP MED, V42, P197; Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Niraula K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-309; Patten SB, 2004, PSYCHOTHER PSYCHOSOM, V73, P207, DOI 10.1159/000077739; Patten SB, 2001, COMPR PSYCHIAT, V42, P124, DOI 10.1053/comp.2001.21218; PATTEN SB, 1995, CAN J PSYCHIAT, V40, P264; Ried L. Douglas, 2000, Journal of Pharmacoepidemiology, V8, P1, DOI 10.1300/J055v08n01_01; Saboya PMHP, 2010, INT J PSYCHIAT MED, V40, P307, DOI 10.2190/PM.40.3.f; Scherrer JF, 2003, PSYCHOSOM MED, V65, P548, DOI 10.1097/01.PSY.0000077507.29863.CB; Sharma SK, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/821971; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Shrestha UK, 2006, DIABETIC MED, V23, P1130, DOI 10.1111/j.1464-5491.2006.01953.x; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Weaver LJ, 2011, ETHOS, V39, P211, DOI 10.1111/j.1548-1352.2011.01185.x; WHO, 2012, REP FORM M MEMB STAT; WHO, 2012, DEPRESSION, DOI [10.1002/da.22048, DOI 10.1002/DA.22048]; WHO, 2013, GLOB BRIEF HYP, DOI [10.1016/S0140-6736(13)60772-2, DOI 10.1016/S0140-6736(13)60772-2]; World Health Organization, 1995, PHYS STAT US INT ANT; Zhao J, 2009, PSYCHOSOM MED, V71, P691, DOI 10.1097/PSY.0b013e3181b05c57	43	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117329	10.1371/journal.pone.0117329	http://dx.doi.org/10.1371/journal.pone.0117329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671522	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300048
J	Cowart, DA; Pinheiro, M; Mouchel, O; Maguer, M; Grall, J; Mine, J; Arnaud-Haond, S				Cowart, Dominique A.; Pinheiro, Miguel; Mouchel, Olivier; Maguer, Marion; Grall, Jacques; Mine, Jacques; Arnaud-Haond, Sophie			Metabarcoding Is Powerful yet Still Blind: A Comparative Analysis of Morphological and Molecular Surveys of Seagrass Communities	PLOS ONE			English	Article							DNA; BIODIVERSITY; POPULATION; DIVERSITY; TAXONOMY; SEARCH; TOOL	In the context of the sixth wave of extinction, reliable surveys of biodiversity are increasingly needed to infer the cause and consequences of species and community declines, identify early warning indicators of tipping points, and provide reliable impact assessments before engaging in activities with potential environmental hazards. DNA metabarcoding has emerged as having potential to provide speedy assessment of community structure from environmental samples. Here we tested the reliability of metabarcoding by comparing morphological and molecular inventories of invertebrate communities associated with sea-grasses through estimates of alpha and beta diversity, as well as the identification of the most abundant taxa. Sediment samples were collected from six Zostera marina seagrass meadows across Brittany, France. Metabarcoding surveys were performed using both mitochondrial (Cytochrome Oxidase I) and nuclear (small subunit 18S ribosomal RNA) markers, and compared to morphological inventories compiled by a long-term benthic monitoring network. A sampling strategy was defined to enhance performance and accuracy of results by preventing the dominance of larger animals, boosting statistical support through replicates, and using two genes to compensate for taxonomic biases. Molecular barcodes proved powerful by revealing a remarkable level of diversity that vastly exceeded the morphological survey, while both surveys identified congruent differentiation of the meadows. However, despite the addition of individual barcodes of common species into taxonomic reference databases, the retrieval of only 36% of these species suggest that the remaining were either not present in the molecular samples or not detected by the molecular screening. This finding exemplifies the necessity of comprehensive and well-curated taxonomic reference libraries and multi-gene surveys. Overall, results offer methodological guidelines and support for metabarcoding as a powerful and repeatable method of characterizing communities, while also presenting suggestions for improvement, including implementation of pilotstudies prior to performing full "blind" metabarcoding assessments to optimize sampling and amplification protocols.	[Cowart, Dominique A.; Mouchel, Olivier; Arnaud-Haond, Sophie] IFREMER, Unite Environm Profond, Dept Ressources Phys & Ecosyst Fond Mer REM, F-29280 Plouzane, France; [Pinheiro, Miguel] Univ St Andrews, St Andrews KY16 9TF, Fife, Scotland; [Maguer, Marion; Grall, Jacques] Inst Univ Europeen Mer, F-29280 Plouzane, France; [Mine, Jacques] Direct HSE, F-92078 Paris, France	Ifremer; University of St Andrews; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Arnaud-Haond, S (corresponding author), IFREMER, Unite Environm Profond, Dept Ressources Phys & Ecosyst Fond Mer REM, BP 70, F-29280 Plouzane, France.	dominique.cowart@gmail.com; sophie.arnaud@ifremer.fr	Arnaud-Haond, Sophie/B-2479-2008; Pinheiro, Miguel/K-6572-2017	Arnaud-Haond, Sophie/0000-0001-5814-8452; Pinheiro, Miguel/0000-0002-6601-7513; Mouchel, Olivier/0000-0002-5991-3360; Cowart, Dominique/0000-0002-2581-0355; Grall, Jacques/0000-0002-3107-6740	Total Exploration Production [FR00003996]	Total Exploration Production(Total SA)	This research was funded by a grant from Total Exploration & Production (FR00003996) to SAH. The funding institution had no role in the data collections, analyses and interpretations of this study. However, the funding organization did have a role in conceiving and designing the study, as well as in the contributions to the final manuscript. Additionally, the funding organization in no way restricted the data and results presented in this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ficetola GF, 2014, MOL ECOLOGY RESOURCE, DOI [10.1111/1755-0998.12366, DOI 10.1111/1755-0998.12366]; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; MCINTYRE AD, 1969, BIOL REV, V44, P245, DOI 10.1111/j.1469-185X.1969.tb00828.x; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Puillandre N, 2012, MOL ECOLOGY RESOURCE, V12, DOI [10.1111/1755-0998.12018, DOI 10.1111/1755-0998.12018]; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; UHLIG G, 1973, HELGOLAND WISS MEER, V25, P173, DOI 10.1007/BF01609968; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	60	138	140	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117562	10.1371/journal.pone.0117562	http://dx.doi.org/10.1371/journal.pone.0117562			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668035	Green Published, gold			2022-12-26	WOS:000349493000019
J	Ssematimba, A; Jores, J; Mariner, JC				Ssematimba, Amos; Jores, Joerg; Mariner, Jeffrey C.			Mathematical Modelling of the Transmission Dynamics of Contagious Bovine Pleuropneumonia Reveals Minimal Target Profiles for Improved Vaccines and Diagnostic Assays	PLOS ONE			English	Article							SPREAD; VACCINATION; PERSISTENCE; POPULATION; CHALLENGES; SIMULATION; EFFICACY; CATTLE; IMPACT; TESTS	Contagious bovine pleuropneumonia (CBPP) is a cattle disease that has hampered the development of the livestock sector in sub-Saharan Africa. Currently, vaccination with a live vaccine strain is its recommended control measure although unofficial antimicrobial use is widely practiced. Here, modelling techniques are used to assess the potential impact of early elimination of infected cattle via accurate diagnosis on CBPP dynamics. A herd-level stochastic epidemiological model explicitly incorporating test sensitivity and specificity is developed. Interventions by annual vaccination, annual testing and elimination and a combination of both are implemented in a stepwise manner and their effectiveness compared by running 1000 simulations per intervention over ten years. The model predicts that among the simulated interventions, the ones likely to eliminate the disease from an isolated herd all involved annual vaccination of more than 75% of the animals with a vaccine that protects for at least 18 months combined with annual testing (and elimination of positive reactors) of 75% of the animals every six months after vaccination. The highest probability of disease elimination was 97.5% and this could occur within a median of 2.3 years. Generally, our model predicts that regular testing and elimination of positive reactors using improved tests will play a significant role in minimizing CBPP burden especially in the current situation where improved vaccines are yet to be developed.	[Ssematimba, Amos; Jores, Joerg; Mariner, Jeffrey C.] Int Livestock Res Inst, Nairobi 00100, Kenya; [Jores, Joerg] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland; [Mariner, Jeffrey C.] Tufts Cummings Sch Vet Med, North Grafton, MA USA	CGIAR; International Livestock Research Institute (ILRI); University of Bern	Ssematimba, A (corresponding author), Int Livestock Res Inst, Old Naivasha Rd,POB 30709, Nairobi 00100, Kenya.	a.ssematimba@cgiar.org	Ssematimba, Amos/S-3217-2019	Ssematimba, Amos/0000-0002-5407-2478; Jores, Joerg/0000-0003-3790-5746	CGIAR research program on "Livestock and Fish"; BBSRC-CIDLID project; German Federal Ministry for Economic Cooperation and Development [09.7860.1-001.00, 81121408]	CGIAR research program on "Livestock and Fish"; BBSRC-CIDLID project; German Federal Ministry for Economic Cooperation and Development	This work was financed by the CGIAR research program on "Livestock and Fish" and supported via a BBSRC-CIDLID project. It was also supported from the German Federal Ministry for Economic Cooperation and Development (project No 09.7860.1-001.00, contract No: 81121408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanfu W, 2009, ONDERSTEPOORT J VET, V76, P13; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Bellini S, 1998, REV SCI TECH OIE, V17, P654, DOI 10.20506/rst.17.3.1124; FAO, 2004, SUST CBPP CONTR PROG; Jores J, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-122; Kairu-Wanyoike SW, 2013, PREV VET MED, V110, P356, DOI 10.1016/j.prevetmed.2013.02.013; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lu Z, 2013, PREV VET MED, V108, P148, DOI 10.1016/j.prevetmed.2012.08.001; Mariam SH, 2010, WIPING TEARS AFRICAN; Mariner JC, 2006, PREV VET MED, V73, P55, DOI 10.1016/j.prevetmed.2005.09.001; Mariner JC, 2006, PREV VET MED, V73, P75, DOI 10.1016/j.prevetmed.2005.09.002; Masiga WN, 1996, REV SCI TECH OIE, V15, P1283, DOI 10.20506/rst.15.4.980; Matthews L, 2005, NAT REV MICROBIOL, V3, P529, DOI 10.1038/nrmicro1178; Muuka G, 2012, TROP ANIM HEALTH PRO, V45, P9, DOI 10.1007/s11250-012-0235-9; Muuka G, 2011, TROP ANIM HEALTH PRO, V43, P1057, DOI 10.1007/s11250-011-9805-5; Ngotho A, 2014, STANGE DIS KILLS LIV; Nkando I, 2012, RES VET SCI, V93, P568, DOI 10.1016/j.rvsc.2011.08.020; Ochola F, 2013, VACCINATION CONTAGIO; Rich KM, 2012, NAT RES MANAG POLICY, P305, DOI 10.1007/978-1-4419-7077-0_16; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Sidibe CAK, 2012, TROP ANIM HEALTH PRO, V44, P1233, DOI 10.1007/s11250-011-0063-3; Swai Emmanuel, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P303, DOI 10.1016/S2221-1691(13)60067-2; Tambi NE, 2006, REV SCI TECH OIE, V25, P999, DOI 10.20506/rst.25.3.1710; Teshale Sori, 2005, International Journal of Applied Research in Veterinary Medicine, V3, P344; Thiaucourt F., 2004, Infectious diseases of livestock. Volume Three, P2045; Thiaucourt F., 2003, VVolume 114, P147; Thiaucourt F, 2000, ANN NY ACAD SCI, V916, P71, DOI 10.1111/j.1749-6632.2000.tb05276.x; Wanyoike SW, 2009, THESIS U READING UK; Webb CR, 2011, VET REC, V168, P14; WINDSOR RS, 1977, RES VET SCI, V23, P224, DOI 10.1016/S0034-5288(18)33158-8; Woolhouse MEJ, 2003, J APPL MICROBIOL, V94, p126S	34	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116730	10.1371/journal.pone.0116730	http://dx.doi.org/10.1371/journal.pone.0116730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668725	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000009
J	Maggi, M; Chiarelli, LR; Valentini, G; Scotti, C				Maggi, Maristella; Chiarelli, Laurent R.; Valentini, Giovanna; Scotti, Claudia			Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants	PLOS ONE			English	Article							CONJUGATED L-ASPARAGINASE; COLI L-ASPARAGINASE; CRYSTAL-STRUCTURE; GLUTAMINE DEPLETION; PHASE-I; SYNTHETASE; LEUKEMIA	Bacterial L-asparaginases have been used as anti-cancer drugs for over 4 decades though presenting, along with their therapeutic efficacy, several side effects due to their bacterial origin and, seemingly, to their secondary glutaminase activity. Helicobacter pylori type II L-asparaginase possesses interesting features, among which a reduced catalytic efficiency for L-GLN, compared to the drugs presently used in therapy. In the present study, we describe some enzyme variants with catalytic and in vitro cytotoxic activities different from the wild type enzyme. Particularly, replacements on catalytic threonines (T16D and T95E) deplete the enzyme of both its catalytic activities, once more underlining the essential role of such residues. One serendipitous mutant, M121C/T169M, had a preserved efficiency vs L-asparagine but was completely unable to carry out L-glutamine hydrolysis. Interestingly, this variant did not exert any cytotoxic effect on HL-60 cells. The M121C and T169M single mutants had reduced catalytic activities (nearly 2.5- to 4-fold vs wild type enzyme, respectively). Mutant Q63E, endowed with a similar catalytic efficiency versus asparagine and halved glutaminase efficiency with respect to the wild type enzyme, was able to exert a cytotoxic effect comparable to, or higher than, the one of the wild type enzyme when similar asparaginase units were used. These findings may be relevant to determine the role of glutaminase activity of L-asparaginase in the anti-proliferative effect of the drug and to shed light on how to engineer the best asparaginase/glutaminase combination for an ever improved, patients-tailored therapy.	[Maggi, Maristella; Scotti, Claudia] Univ Pavia, Dept Mol Med, Unit Immunol & Gen Pathol, I-27100 Pavia, Italy; [Chiarelli, Laurent R.] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Mol Microbiol Lab, I-27100 Pavia, Italy; [Maggi, Maristella; Valentini, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Lab Prot Biochem, I-27100 Pavia, Italy	University of Pavia; University of Pavia; University of Pavia	Scotti, C (corresponding author), Univ Pavia, Dept Mol Med, Unit Immunol & Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Scotti, Claudia/A-7126-2012; Chiarelli, Laurent Roberto/J-8368-2016; Scotti, Claudia/AAM-3372-2021; Maggi, Maristella/O-6759-2014; Maggi, Maristella/P-2896-2019	Scotti, Claudia/0000-0002-5790-1833; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Maggi, Maristella/0000-0002-9075-8143; Maggi, Maristella/0000-0002-9075-8143	Regione Lombardia Ricerca	Regione Lombardia Ricerca	MM's salary comes from an Istituto Universitario di Studi Superiori fellowship. The salaries for LRC, GV and CS come from Ministero dell' Istruzione, Universitae e Ricerca. The funds of Regione Lombardia Ricerca. tissimi prize was used to buy the reagents needed for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NR, 2003, CANCER, V98, P94, DOI 10.1002/cncr.11480; Aung HP, 2000, BBA-PROTEIN STRUCT M, V1481, P349, DOI 10.1016/S0167-4838(00)00179-5; Avramis VI, 2014, BLOOD, V123, P3532, DOI 10.1182/blood-2014-04-565523; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; Berlier W, 2013, BLOOD, V122; Bunpo P, 2008, J NUTR, V138, P338, DOI 10.1093/jn/138.2.338; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chan WK, 2014, BLOOD; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; Dhavala P, 2009, ACTA CRYSTALLOGR D, V65, P1253, DOI 10.1107/S0907444909038244; Ehsanipour EA, 2013, CANCER RES, V73, P2998, DOI 10.1158/0008-5472.CAN-12-4402; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; KILLANDER D, 1976, CANCER, V37, P220, DOI 10.1002/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto Y, 2003, LEUKEMIA LYMPHOMA, V44, P879, DOI 10.1080/1042819031000067873; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Miller AJ, 1996, LYMPHOLOGY, V29, P158; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Palm GJ, 1996, FEBS LETT, V390, P211, DOI 10.1016/0014-5793(96)00660-6; Parmentier J, 2014, GLUTAMINASE ACTIVITY; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Rempe DA, 2010, NEUROTHERAPEUTICS, V7, P335, DOI 10.1016/j.nurt.2010.08.003; Sanches M, 2007, CURR CHEM BIOL, V1, P75, DOI DOI 10.2174/2212796810701010075; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Taylor CW, 2001, CANCER CHEMOTH PHARM, V47, P83, DOI 10.1007/s002800000207; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061	33	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117025	10.1371/journal.pone.0117025	http://dx.doi.org/10.1371/journal.pone.0117025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664771	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100016
J	Oumeraci, T; Jensen, V; Talbot, SR; Hofmann, W; Kostrzewa, M; Schlegelberger, B; von Neuhoff, N; Haussler, S				Oumeraci, Tonio; Jensen, Vanessa; Talbot, Steven R.; Hofmann, Winfried; Kostrzewa, Markus; Schlegelberger, Brigitte; von Neuhoff, Nils; Haeussler, Susanne			Comprehensive MALDI-TOF Biotyping of the Non-Redundant Harvard Pseudomonas aeruginosa PA14 Transposon Insertion Mutant Library	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; ROUTINE IDENTIFICATION; RAPID IDENTIFICATION; PEAK DETECTION; BACTERIA; CLASSIFICATION; OPTIMIZATION; STRAINS	Background Pseudomonas aeruginosa is a gram-negative bacterium that is ubiquitously present in the aerobic biosphere. As an antibiotic-resistant facultative pathogen, it is a major cause of hospital- acquired infections. Its rapid and accurate identification is crucial in clinical and therapeutic environments. Methods In a large-scale MALDI-TOF mass spectrometry-based screen of the Harvard transposon insertion mutant library of P. aeruginosa strain PA14, intact-cell proteome profile spectra of 5547 PA14 transposon mutants exhibiting a plethora of different phenotypes were acquired and analyzed. Results Of all P. aeruginosa PA14 mutant profiles 99.7% were correctly identified as P. aeruginosa with the Biotyper software on the species level. On the strain level, 99.99% of the profiles were mapped to five different individual P. aeruginosa Biotyper database entries. A principal component analysis-based approach was used to determine the most important discriminatory mass features between these Biotyper groups. Although technical replicas were consistently categorized to specific Biotyper groups in 94.2% of the mutant profiles, biological replicas were not, indicating that the distinct proteotypes are affected by growth conditions. Conclusions The PA14 mutant profile collection presented here constitutes the largest coherent P. aeruginosa MALDI-TOF spectral dataset publicly available today. Transposon insertions in thousands of different P. aeruginosa genes did not affect species identification from MALDI-TOF mass spectra, clearly demonstrating the robustness of the approach. However, the assignment of the individual spectra to sub-groups proved to be non-consistent in biological replicas, indicating that the differentiation between biotyper groups in this nosocomial pathogen is unassured.	[Oumeraci, Tonio; Hofmann, Winfried; Schlegelberger, Brigitte; von Neuhoff, Nils] Hannover Med Sch MHH, Inst Cell & Mol Pathol, Hannover, Germany; [Jensen, Vanessa; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Jensen, Vanessa; Haeussler, Susanne] Twincore, Ctr Expt & Clin Infect Res, Inst Mol Bacteriol, Hannover, Germany; [Talbot, Steven R.] MHH, Inst Mol & Cell Physiol, Hannover, Germany; [Kostrzewa, Markus] Bruker Daltonik GmbH, Bremen, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Bruker Corporation; Bruker Daltonik GmbH	Haussler, S (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany.	Susanne.haeussler@helmholtz-hzi.de	Häussler, Susanne/I-2605-2014; Pohl, Sarah/B-3102-2016	Häussler, Susanne/0000-0001-6141-9102; Pohl, Sarah/0000-0003-2655-7037				Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Anderson NW, 2012, J CLIN MICROBIOL, V50, P1008, DOI 10.1128/JCM.05209-11; Berrazeg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061428; Bessede E, 2011, CLIN MICROBIOL INFEC, V17, P533, DOI 10.1111/j.1469-0691.2010.03274.x; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cunningham SA, 2013, J CLIN MICROBIOL, V51, P1639, DOI 10.1128/JCM.00267-13; Davies AP, 2012, J CLIN MICROBIOL, V50, P4087, DOI 10.1128/JCM.02387-12; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Dossat N, 2007, CANCER INFORM, V3, P295; Ford BA, 2013, J CLIN MICROBIOL, V51, P1412, DOI 10.1128/JCM.01803-12; He Y, 2010, J CLIN MICROBIOL, V48, P3888, DOI 10.1128/JCM.01290-10; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Khot PD, 2012, J CLIN MICROBIOL, V50, P3845, DOI 10.1128/JCM.00626-12; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu QZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S3; Novais A, 2014, EUR J CLIN MICROBIOL, V33, P1391, DOI 10.1007/s10096-014-2071-5; Pommerenke C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001074; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sogawa K, 2012, ANAL BIOANAL CHEM, V403, P1811, DOI 10.1007/s00216-011-5656-1; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Szabados F, 2010, J MED MICROBIOL, V59, P787, DOI 10.1099/jmm.0.016733-0; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; TeKippe EM, 2013, J CLIN MICROBIOL, V51, P1421, DOI 10.1128/JCM.02680-12; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Tong Dong L, 2011, Clin Proteomics, V8, P14, DOI 10.1186/1559-0275-8-14; Wang ZP, 2002, ANAL CHEM, V74, P3174, DOI 10.1021/ac015725f; WIETEN G, 1981, J GEN MICROBIOL, V122, P109; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4	30	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117144	10.1371/journal.pone.0117144	http://dx.doi.org/10.1371/journal.pone.0117144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665154	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100020
J	Czysz, K; Minger, S; Thomas, N				Czysz, Katherine; Minger, Stephen; Thomas, Nick			DMSO Efficiently Down Regulates Pluripotency Genes in Human Embryonic Stem Cells during Definitive Endoderm Derivation and Increases the Proficiency of Hepatic Differentiation	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; DIMETHYL-SULFOXIDE; LIVER DEVELOPMENT; IN-VITRO; RAT HEPATOCYTES; DRUG; GENERATION; THERAPIES; PROTOCOL	Background Definitive endoderm (DE) is one of the three germ layers which during in vivo vertebrate development gives rise to a variety of organs including liver, lungs, thyroid and pancreas; consequently efficient in vitro initiation of stem cell differentiation to DE cells is a prerequisite for successful cellular specification to subsequent DE-derived cell types [1, 2]. In this study we present a novel approach to rapidly and efficiently down regulate pluripotency genes during initiation of differentiation to DE cells by addition of dimethyl sulfoxide (DMSO) to Activin Abased culture medium and report its effects on the downstream differentiation to hepatocyte-like cells. Materials and Methods Human embryonic stem cells (hESC) were differentiated to DE using standard methods in medium supplemented with 100ng/ml of Activin A and compared to cultures where DE specification was additionally enhanced with different concentrations of DMSO. DE cells were subsequently primed to generate hepatic-like cells to investigate whether the addition of DMSO during formation of DE improved subsequent expression of hepatic markers. A combination of flow cytometry, real-time quantitative reverse PCR and immunofluorescence was applied throughout the differentiation process to monitor expression of pluripotency (POUF5/OCT4 & NANOG), definitive endoderm (SOX17, CXCR4 & GATA4) and hepatic (AFP & ALB) genes to generate differentiation stage-specific signatures. Results Addition of DMSO to the Activin A-based medium during DE specification resulted in rapid down regulation of the pluripotency genes OCT4 and NANOG, accompanied by an increase expression of the DE genes SOX17, CXCR4 and GATA4. Importantly, the expression level of ALB in DMSO-treated cells was also higher than in cells which were differentiated to the DE stage via standard Activin A treatment.	[Czysz, Katherine; Minger, Stephen; Thomas, Nick] GE Healthcare Life Sci, Maynard Ctr, Cardiff, S Glam, Wales	General Electric	Czysz, K (corresponding author), GE Healthcare Life Sci, Maynard Ctr, Cardiff, S Glam, Wales.	katherine.czysz@yahoo.co.uk			GE Healthcare; MRC ITTP PhD studentship	GE Healthcare(General ElectricGE Healthcare); MRC ITTP PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by GE Healthcare and a MRC ITTP PhD studentship to KC. All of the authors have an affiliation to the commercial funders of this research study (GE Healthcare). GE Healthcare provided support in the form of salaries for authors Nick Thomas and Stephen Minger, as well as covered laboratory bench fees for Katherine Czysz. MRC ITTP provided support in the form of salary for Katherine Czysz, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SP, 2013, BRIT J PHARMACOL, V169, P269, DOI 10.1111/j.1476-5381.2012.01978.x; Bukong TN, 2012, LIVER INT, V32, P732, DOI 10.1111/j.1478-3231.2011.02743.x; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DELAVEGA FM, 1991, BIOCHIMIE, V73, P621, DOI 10.1016/0300-9084(91)90033-W; Fletcher J, 2008, CLONING STEM CELLS, V10, P331, DOI 10.1089/clo.2007.0094; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hollebeeck S, 2011, TOXICOL LETT, V206, P268, DOI 10.1016/j.toxlet.2011.08.010; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002; Pal R, 2012, ARCH TOXICOL, V86, P651, DOI 10.1007/s00204-011-0782-2; Rowntree RK, 2010, REGEN MED, V5, P557, DOI [10.2217/rme.10.36, 10.2217/RME.10.36]; Singh MK, 2013, REPROD DOMEST ANIM, V48, P284, DOI 10.1111/j.1439-0531.2012.02146.x; Su T, 2004, ARCH BIOCHEM BIOPHYS, V424, P226, DOI 10.1016/j.abb.2004.02.008; Synnergren J, 2010, STEM CELLS DEV, V19, P961, DOI 10.1089/scd.2009.0220; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Yoshizawa T, 1997, J GASTROEN HEPATOL, V12, P325, DOI 10.1111/j.1440-1746.1997.tb00429.x; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zorn A.M., 2008, LIVER DEV	30	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117689	10.1371/journal.pone.0117689	http://dx.doi.org/10.1371/journal.pone.0117689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659159	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900204
J	David, AS; Zarnetske, PL; Hacker, SD; Ruggiero, P; Biel, RG; Seabloom, EW				David, Aaron S.; Zarnetske, Phoebe L.; Hacker, Sally D.; Ruggiero, Peter; Biel, Reuben G.; Seabloom, Eric W.			Invasive Congeners Differ in Successional Impacts across Space and Time	PLOS ONE			English	Article							AMMOPHILA-ARENARIA; VEGETATION DYNAMICS; RANGE SIZE; COASTAL; PLANTS; GRASSES; NICHE; COMMUNITIES; MECHANISMS; ALIEN	Invasive species can alter the succession of ecological communities because they are often adapted to the disturbed conditions that initiate succession. The extent to which this occurs may depend on how widely they are distributed across environmental gradients and how long they persist over the course of succession. We focus on plant communities of the USA Pacific Northwest coastal dunes, where disturbance is characterized by changes in sediment supply, and the plant community is dominated by two introduced grasses - the long-established Ammophila arenaria and the currently invading A. breviligulata. Previous studies showed that A. breviligulata has replaced A. arenaria and reduced community diversity. We hypothesize that this is largely due to A. breviligulata occupying a wider distribution across spatial environmental gradients and persisting in later-successional habitat than A. arenaria. We used multi-decadal chronosequences and a resurvey study spanning 2 decades to characterize distributions of both species across space and time, and investigated how these distributions were associated with changes in the plant community. The invading A. breviligulata persisted longer and occupied a wider spatial distribution across the dune, and this corresponded with a reduction in plant species richness and native cover. Furthermore, backdunes previously dominated by A. arenaria switched to being dominated by A. breviligulata, forest, or developed land over a 23-yr period. Ammophila breviligulata likely invades by displacing A. arenaria, and reduces plant diversity by maintaining its dominance into later successional backdunes. Our results suggest distinct roles in succession, with A. arenaria playing a more classically facilitative role and A. breviligulata a more inhibitory role. Differential abilities of closely-related invasive species to persist through time and occupy heterogeneous environments allows for distinct impacts on communities during succession.	[David, Aaron S.; Seabloom, Eric W.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Zarnetske, Phoebe L.; Hacker, Sally D.; Biel, Reuben G.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Zarnetske, Phoebe L.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Ruggiero, Peter] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; Michigan State University; Oregon State University	David, AS (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	david250@umn.edu	Zarnetske, Phoebe/V-3974-2019; Zarnetske, Phoebe/C-5484-2012	Zarnetske, Phoebe/0000-0001-6257-6951; Zarnetske, Phoebe/0000-0001-6257-6951; Ruggiero, Peter/0000-0001-7425-9953; Seabloom, Eric/0000-0001-6780-9259	Oregon Sea Grant Program [NA060AR4170010]; United States Environmental Protection Agency (EPA/NCER) [R833836]; National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT); Introduced Species and Genotypes program [DGE-0653827]; NSF Graduate Research Fellowship program (NSF) [00039202]; NSF-IGERT Ecosystem Informatics program (NSF) [0333257]	Oregon Sea Grant Program; United States Environmental Protection Agency (EPA/NCER)(United States Environmental Protection Agency); National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT)(National Science Foundation (NSF)); Introduced Species and Genotypes program; NSF Graduate Research Fellowship program (NSF); NSF-IGERT Ecosystem Informatics program (NSF)(National Science Foundation (NSF))	Funding provided by Oregon Sea Grant Program (NA060AR4170010, http://seagrant.oregonstate.edu/) and United States Environmental Protection Agency (EPA/NCER R833836, http://www.epa.gov/) to SDH, EWS, and PR, by the National Science Foundation Integrative Graduate Education and Research Traineeship (NSF-IGERT, http://www. nsf.gov/crssprgm/igert/gradopps.jsp) Introduced Species and Genotypes program (DGE-0653827) and NSF Graduate Research Fellowship program (NSF 00039202, http://www.nsfgrfp.org/) to ASD, and by the NSF-IGERT Ecosystem Informatics program to PLZ (NSF 0333257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLET GH, 1994, J ECOL, V82, P137, DOI 10.2307/2261393; Bates D., 2013, LME4 LINEAR MIXED EF; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beckstead J, 2003, ECOLOGY, V84, P2824, DOI 10.1890/02-0517; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cooper W. S., 1958, MEMOIR, V72; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [10.1086/327796, DOI 10.1086/327796]; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; Donnegan JA, 1999, ECOLOGY, V80, P1370, DOI 10.1890/0012-9658(1999)080[1370:RAMOSF]2.0.CO;2; Duran O, 2013, P NATL ACAD SCI USA, V110, P17217, DOI 10.1073/pnas.1307580110; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Gram WK, 2004, PLANT ECOL, V172, P159, DOI 10.1023/B:VEGE.0000026332.57007.7b; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hacker SD, 2012, OIKOS, V121, P138, DOI 10.1111/j.1600-0706.2011.18887.x; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; HESP PA, 1989, P ROY SOC EDINB B, V96, P181, DOI 10.1017/S0269727000010927; Hilton M, 2005, J COASTAL RES, V21, P175, DOI 10.2112/01041.1; Keeley JE, 2005, ECOL APPL, V15, P2109, DOI 10.1890/04-1222; Kery M., 2010, INTRO WINBUGS ECOLOG, VFirst, DOI [10.1016/B978-0-12-378605-0.00054-5, DOI 10.1016/B978-0-12-378605-0.00054-5]; Lambdon PW, 2008, J BIOGEOGR, V35, P1095, DOI 10.1111/j.1365-2699.2008.01894.x; Lichter J, 1998, ECOL MONOGR, V68, P487, DOI 10.1890/0012-9615(1998)068[0487:PSAFDO]2.0.CO;2; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Lubke RA, 2004, ECOL STU AN, V171, P67; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; OLFF H, 1993, J ECOL, V81, P693, DOI 10.2307/2261667; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; Pickett STA, 2009, APPL VEG SCI, V12, P9, DOI 10.1111/j.1654-109X.2009.01019.x; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Psuty N.P., 1988, J COASTAL RES, V3, P1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Ruesink JL, 2010, BIOL INVASIONS, V12, P1773, DOI 10.1007/s10530-009-9588-z; Ruggiero P., 2013, 20121007 US GEOL SUR, P62, DOI [10.3133/ofr20121007, DOI 10.3133/0FR20121007]; SCHWENDIMAN JL, 1977, INT J BIOMETEOROL, V21, P281, DOI 10.1007/BF01552882; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P824, DOI 10.1111/gcb.12078; SEABLOOM EW, 1994, J COASTAL RES, V10, P178; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Su Y.-S, 2011, R2JAGS PACKAGE RUNNI; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; van der Putten WH, 2005, BIOL INVASIONS, V7, P733, DOI 10.1007/s10530-004-1196-3; Veeneklaas RM, 2013, APPL VEG SCI, V16, P205, DOI 10.1111/j.1654-109X.2012.01228.x; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wiedemann AM, 2004, ECOL STU AN, V171, P53; Zarnetske PL, 2013, J ECOL, V101, P905, DOI 10.1111/1365-2745.12093; Zarnetske PL, 2012, ECOLOGY, V93, P1439, DOI 10.1890/11-1112.1; Zarnetske PL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00101.1	52	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117283	10.1371/journal.pone.0117283	http://dx.doi.org/10.1371/journal.pone.0117283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658824	Green Published, gold			2022-12-26	WOS:000349444900129
J	Wang, CZ; Wang, XY; Zhou, HM; Dong, GF; Guan, X; Wang, LF; Xu, XP; Wang, SM; Chen, P; Peng, RY; Hu, XJ				Wang, Changzhen; Wang, Xiaoyan; Zhou, Hongmei; Dong, Guofu; Guan, Xue; Wang, Lifeng; Xu, Xinping; Wang, Shuiming; Chen, Peng; Peng, Ruiyun; Hu, Xiangjun			Effects of Pulsed 2.856 GHz Microwave Exposure on BM-MSCs Isolated from C57BL/6 Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ELECTROMAGNETIC-FIELD; BRAIN-TUMORS; RADIATION; MOBILE; MHZ; DIFFERENTIATION; WAVES; ULTRASOUND; INDUCTION	The increasing use of microwave devices over recent years has meant the bioeffects of microwave exposure have been widely investigated and reported. However the exact biological fate of bone marrow MSCs (BM-MSCs) after microwave radiation remains unknown. In this study, the potential cytotoxicity on MSC proliferation, apoptosis, cell cycle, and in vitro differentiation were assayed following 2.856 GHz microwave exposure at a specific absorption rate (SAR) of 4 W/kg. Importantly, our findings indicated no significant changes in cell viability, cell division and apoptosis after microwave treatment. Furthermore, we detected no significant effects on the differentiation ability of these cells in vitro, with the exception of reduction in mRNA expression levels of osteopontin (OPN) and osteocalcin (OCN). These findings suggest that microwave treatment at a SAR of 4 W/kg has undefined adverse effects on BM-MSCs. However, the reduced-expression of proteins related to osteogenic differentiation suggests that microwave can the influence at the mRNA expression genetic level.	[Wang, Changzhen; Zhou, Hongmei; Dong, Guofu; Wang, Lifeng; Xu, Xinping; Wang, Shuiming; Chen, Peng; Peng, Ruiyun; Hu, Xiangjun] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Xiaoyan] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Guan, Xue] Peoples Liberat Army, Hosp 281, Qinhuangdao, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Wang, CZ (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	wangcz2002@aliyun.com; fei21@sohu.com						Aksoy U, 2005, SAUDI MED J, V26, P1388; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; BELYAEV IY, 1993, ELECTRO MAGNETOBIOL, V12, P39, DOI 10.3109/15368379309012861; Belyaev IY, 2006, BIOELECTROMAGNETICS, V27, P295, DOI 10.1002/bem.20216; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; Cao Y, 2009, J TOXICOL ENV HEAL A, V72, P727, DOI 10.1080/15287390902841466; Carlberg M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-60; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Celuch M, 2007, J MICROWAVE POWER EE, V41, P62; Cleary SF, 1996, FASEB J, V10, P913; Coureau G, 2014, OCCUP ENVIRON MED, V71, P514, DOI 10.1136/oemed-2013-101754; Cucurachi S, 2013, ENVIRON INT, V51, P116, DOI 10.1016/j.envint.2012.10.009; Das Madhurima, 2013, J Stem Cells, V8, P1; de Vocht F, 2013, OCCUP ENVIRON MED, V70, P349, DOI 10.1136/oemed-2012-100954; Diem E, 2005, MUTAT RES-GEN TOX EN, V583, P178, DOI 10.1016/j.mrgentox.2005.03.006; Esmekaya MA, 2010, INT J RADIAT BIOL, V86, P1106, DOI 10.3109/09553002.2010.502960; Esposito M, 2013, IN VIVO, V27, P495; Ghanbari M, 2013, INT J FERTIL STERIL, V7, P21; Hardell L, 2013, INT J ONCOL, V43, P1833, DOI 10.3892/ijo.2013.2111; Hardell L, 2013, INT J ONCOL, V43, P1036, DOI 10.3892/ijo.2013.2025; Hardell Lennart, 2013, Pathophysiology, V20, P85, DOI 10.1016/j.pathophys.2012.11.001; Hardell L, 2013, NEUROEPIDEMIOLOGY, V40, P101, DOI 10.1159/000341905; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Kesari KK, 2013, INDIAN J EXP BIOL, V51, P187; Kesari KK, 2013, CELL BIOCHEM BIOPHYS, V65, P85, DOI 10.1007/s12013-012-9414-6; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kubinyi G, 1996, BIOELECTROMAGNETICS, V17, P497, DOI 10.1002/(SICI)1521-186X(1996)17:6<497::AID-BEM10>3.0.CO;2-I; Lin JC, 2003, IEEE MICROW MAG, V4, P22, DOI 10.1109/MMW.2003.1266063; Markova E, 2010, ENVIRON HEALTH PERSP, V118, P394, DOI 10.1289/ehp.0900781; Massari L, 2009, CLIN CASES MINER BON, V6, P149; McNamee JP, 2003, RADIAT RES, V159, P693, DOI 10.1667/0033-7587(2003)159[0693:NEFGEF]2.0.CO;2; Midura RJ, 2005, J ORTHOP RES, V23, P1035, DOI 10.1016/j.orthres.2005.03.015; Pakhomov AG, 1998, BIOELECTROMAGNETICS, V19, P393, DOI 10.1002/(SICI)1521-186X(1998)19:7<393::AID-BEM1>3.0.CO;2-X; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Szmigielski S, 2013, SCI TOTAL ENVIRON, V454, P393, DOI 10.1016/j.scitotenv.2013.03.034; Teven CM, 2012, J CRANIOFAC SURG, V23, P586, DOI 10.1097/SCS.0b013e31824cd6de; Tice RR, 2002, BIOELECTROMAGNETICS, V23, P113, DOI 10.1002/bem.104; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Vijayalaxmi, 2000, RADIAT RES, V153, P479, DOI 10.1667/0033-7587(2000)153[0479:PDDIHB]2.0.CO;2; Walker NA, 2007, J ATHL TRAINING, V42, P530; Wang C, 2013, FREE RADICAL RES, V47, P276, DOI 10.3109/10715762.2013.768342; Wang H, 2013, INT J RADIAT BIOL, V89, P1100, DOI 10.3109/09553002.2013.817701; Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333; Wu GW, 2009, INT J MOL MED, V23, P461, DOI 10.3892/ijmm_00000152; Yang Yan-Mei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1563, DOI 10.7534/j.issn.1009-2137.2013.06.037	46	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117550	10.1371/journal.pone.0117550	http://dx.doi.org/10.1371/journal.pone.0117550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658708	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900173
J	Takai, S; Yasumatsu, K; Inoue, M; Iwata, S; Yoshida, R; Shigemura, N; Yanagawa, Y; Drucker, DJ; Margolskee, RF; Ninomiya, Y				Takai, Shingo; Yasumatsu, Keiko; Inoue, Mayuko; Iwata, Shusuke; Yoshida, Ryusuke; Shigemura, Noriatsu; Yanagawa, Yuchio; Drucker, Daniel J.; Margolskee, Robert F.; Ninomiya, Yuzo			Glucagon-like peptide-1 is specifically involved in sweet taste transmission	FASEB JOURNAL			English	Article						gustation; transmitter; incretin	VASOACTIVE-INTESTINAL-PEPTIDE; COEXPRESSION PATTERNS; CHORDA TYMPANI; ATP RELEASE; RECEPTOR; CELLS; EXPRESSION; GUSTDUCIN; CHOLECYSTOKININ; GLP-1	Five fundamental taste qualities (sweet, bitter, salty, sour, umami) are sensed by dedicated taste cells (TCs) that relay quality information to gustatory nerve fibers. In peripheral taste signaling pathways, ATP has been identified as a functional neurotransmitter, but it remains to be determined how specificity of different taste qualities is maintained across synapses. Recent studies demonstrated that some gut peptides are released from taste buds by prolonged application of particular taste stimuli, suggesting their potential involvement in taste information coding. In this study, we focused on the function of glucagon-like peptide-1 (GLP-1) in initial responses to taste stimulation. GLP-1 receptor (GLP-1R) null mice had reduced neural and behavioral responses specifically to sweet compounds compared to wild-type (WT) mice. Some sweet responsive TCs expressed GLP-1 and its receptors were expressed in gustatory neurons. GLP-1 was released immediately from taste bud cells in response to sweet compounds but not to other taste stimuli. Intravenous administration of GLP-1 elicited transient responses in a subset of sweet-sensitive gustatory nerve fibers but did not affect other types of fibers, and this response was suppressed by pre-administration of the GLP-1R antagonist Exendin-4(3-39). Thus GLP-1 may be involved in normal sweet taste signal transmission in mice.	[Takai, Shingo; Inoue, Mayuko; Iwata, Shusuke; Yoshida, Ryusuke; Shigemura, Noriatsu; Ninomiya, Yuzo] Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Fukuoka 8128582, Japan; [Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Div Sensory Physiol, Fukuoka 8128582, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] JST, CREST, Maebashi, Gunma, Japan; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Margolskee, Robert F.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Kyushu University; Kyushu University; Gunma University; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Monell Chemical Senses Center	Ninomiya, Y (corresponding author), Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ninomoiya.yuzo.285@m.kyushu-u.ac.jp	Drucker, Daniel J/A-4092-2010	Iwata, Shusuke/0000-0001-8655-3471; Shigemura, Noriatsu/0000-0002-3061-6362; Margolskee, Robert/0000-0002-9572-2887	KAKENHI from Japan Society for the promotion of science [18077004, 18109013, 23249081, 20689034, 23689076]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155, P30DC011735, R01DC014105, R01DC003055] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K11044, 15K11043] Funding Source: KAKEN	KAKENHI from Japan Society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Charles Pyke (Novo Nordisk A/S) for providing the GLP-1R antibody. This work was supported by KAKENHI 18077004, 18109013, 23249081 (Y.N.), 20689034 (N.S.), 23689076 (R.Y.) for Scientific Research from Japan Society for the promotion of science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no competing financial interests.	Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; Dotson CD, 2013, SEMIN CELL DEV BIOL, V24, P232, DOI 10.1016/j.semcdb.2013.01.004; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Feng XH, 2008, ACTA HISTOCHEM, V110, P151, DOI 10.1016/j.acthis.2007.10.005; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Geraedts MCP, 2013, J NEUROSCI, V33, P7559, DOI 10.1523/JNEUROSCI.0372-13.2013; Hansen L, 1999, ENDOCRINOLOGY, V140, P5356, DOI 10.1210/en.140.11.5356; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; Herness S, 2002, J NEUROSCI, V22, P10018; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; KELLING ST, 1983, SCIENCE, V219, P412, DOI 10.1126/science.6849142; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Murata Y, 2010, J NEUROPHYSIOL, V104, P896, DOI 10.1152/jn.00414.2010; NAGAHAMA S, 1985, J GEN PHYSIOL, V85, P431, DOI 10.1085/jgp.85.3.431; Nakabayashi H, 1996, AM J PHYSIOL-ENDOC M, V271, pE808, DOI 10.1152/ajpendo.1996.271.5.E808; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087, DOI 10.1152/jn.1999.81.6.3087; NINOMIYA Y, 1995, AM J PHYSIOL-REG I, V268, pR1019, DOI 10.1152/ajpregu.1995.268.4.R1019; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Roper SD, 2013, SEMIN CELL DEV BIOL, V24, P71, DOI 10.1016/j.semcdb.2012.12.002; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2013, P NATL ACAD SCI USA, V110, P14789, DOI 10.1073/pnas.1309468110; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Yoshida R, 2006, J NEUROPHYSIOL, V96, P3088, DOI 10.1152/jn.00409.2006; Yoshida R, 2010, INT REV CEL MOL BIO, V279, P101, DOI 10.1016/S1937-6448(10)79004-3; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	52	49	51	0	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2268	2280		10.1096/fj.14-265355	http://dx.doi.org/10.1096/fj.14-265355			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25678625	Green Published			2022-12-26	WOS:000355209500006
J	Nakanishi, K; Kakiguchi, K; Yonemura, S; Nakano, A; Morishima, N				Nakanishi, Keiko; Kakiguchi, Kisa; Yonemura, Shigenobu; Nakano, Akihiko; Morishima, Nobuhiro			Transient Ca2+ depletion from the endoplasmic reticulum is critical for skeletal myoblast differentiation	FASEB JOURNAL			English	Article						ER deformation; ER stress; myoblast fusion; STIM1	UNFOLDED PROTEIN RESPONSE; PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM; CYCLOPIAZONIC ACID; MUSCLE; STRESS; FUSION; CELL; ER; CHANNELS	Endoplasmic reticulum (ER) stress is a cellular condition in which unfolded proteins accumulate in the ER because of various but specific causes. Physiologic ER stress occurs transiently during myoblast differentiation, and although its cause remains unknown, it plays a critical role in myofiber formation. To examine the mechanism underlying ER stress, we monitored ER morphology during differentiation of murine myoblasts. Novel ER-derived structures transiently appeared prior to myoblast fusion both in vitro and in vivo. Electron microscopy studies revealed that these structures consisted of pseudoconcentric ER cisternae with narrow lumens. Similar structures specifically formed by pharmacologically induced ER Ca2+ depletion, and inhibition of ER Ca2+ efflux channels in differentiating myoblasts considerably suppressed ER-specific deformation and ER stress signaling. Thus, we named the novel structures stress-activated response to Ca2+ depletion (SARC) bodies. Prior to SARC body formation, stromal interaction molecule 1 (STIM1), an ER Ca2+ sensor protein, formed ER Ca2+ depletion-specific clusters. Furthermore, myoblast differentiation manifested by myoblast fusion did not proceed under the same conditions as inhibition of ER Ca2+ depletion. Altogether, these observations suggest that ER Ca2+ depletion is a prerequisite for myoblast fusion, causing both physiologic ER stress signaling and SARC body formation.Nakanishi, K., Kakiguchi, K., Yonemura, S., Nakano, A., Morishima, N. Transient Ca2+ depletion from the endoplasmic reticulum is critical for skeletal myoblast differentiation.	[Nakanishi, Keiko; Nakano, Akihiko; Morishima, Nobuhiro] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; [Kakiguchi, Kisa; Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan; [Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 113, Japan	RIKEN; RIKEN; University of Tokyo	Morishima, N (corresponding author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	morishim@riken.jp	Nakano, Akihiko/G-4942-2014; Morishima, Nobuhiro/D-3946-2017; Nakano, Akihiko/A-6420-2016	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X	RIKEN Bioarchitect Research Project; RIKEN Cellular System Program; RIKEN Incentive Research Grant; Japan Society for the Promotion of Science	RIKEN Bioarchitect Research Project; RIKEN Cellular System Program; RIKEN Incentive Research Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Tetsuya Tajima and Kaori Higuchi (RIKEN BSI-Olympus Collaboration Center) for technical support with fluorescent microscopy, Takashi Yoshiura (Yokogawa Electric Group) for support with 3-dimensional image reconstruction, and Yasue Ichikawa and Rie Nakazawa for DNA sequencing. K.N. was a Research Fellow of the Japan Society for the Promotion of Science. This work was supported in part by grants from the RIKEN Bioarchitect Research Project (to N.M.), RIKEN Cellular System Program (to N.M.), RIKEN Incentive Research Grant (to N.M.), and Japan Society for the Promotion of Science (to N.M. and K.N.). The authors declare no conflicts of interest.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Bennett DL, 1996, J BIOL CHEM, V271, P6356, DOI 10.1074/jbc.271.11.6356; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Caridha D, 2008, ANTIMICROB AGENTS CH, V52, P684, DOI 10.1128/AAC.00874-07; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Constantin B, 1996, CELL CALCIUM, V19, P365, DOI 10.1016/S0143-4160(96)90109-8; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; EZERMAN EB, 1967, J CELL BIOL, V35, P405, DOI 10.1083/jcb.35.2.405; Finger F, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005671; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; LI WWF, 1993, J BIOL CHEM, V268, P12003; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Martonosi A, 2000, DEV SARCOPLASMIC RET; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; ORCI L, 1993, P NATL ACAD SCI USA, V90, P11089, DOI 10.1073/pnas.90.23.11089; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Parys JB, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005093; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; PRZYBYLSKI RJ, 1989, IN VITRO CELL DEV B, V25, P830; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shin KS, 1996, DEV BIOL, V175, P14, DOI 10.1006/dbio.1996.0091; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Vandecaetsbeek I, 2011, COLD SPRING HARB PER, V3; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	53	19	19	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2137	2149		10.1096/fj.14-261529	http://dx.doi.org/10.1096/fj.14-261529			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25678623				2022-12-26	WOS:000354114600044
J	Daidoji, T; Watanabe, Y; Ibrahim, MS; Yasugi, M; Maruyama, H; Masuda, T; Arai, F; Ohba, T; Honda, A; Ikuta, K; Nakaya, T				Daidoji, Tomo; Watanabe, Yohei; Ibrahim, Madiha S.; Yasugi, Mayo; Maruyama, Hisataka; Masuda, Taisuke; Arai, Fumihito; Ohba, Tomoyuki; Honda, Ayae; Ikuta, Kazuyoshi; Nakaya, Takaaki			Avian Influenza Virus Infection of Immortalized Human Respiratory Epithelial Cells Depends upon a Delicate Balance between Hemagglutinin Acid Stability and Endosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AIRWAY EPITHELIUM; RECEPTOR-MEDIATED ENDOCYTOSIS; HAMSTER OVARY CELLS; MEMBRANE-FUSION; A VIRUSES; MOLECULAR-BASIS; ACIDIFICATION; TRANSFERRIN; PATHOGENICITY; GLYCOPROTEIN	The highly pathogenic avian influenza (AI) virus, H5N1, is a serious threat to public health worldwide. Both the currently circulating H5N1 and previously circulating AI viruses recognize avian-type receptors; however, only the H5N1 is highly infectious and virulent in humans. The mechanism(s) underlying this difference in infectivity remains unclear. The aim of this study was to clarify the mechanisms responsible for the difference in infectivity between the current and previously circulating strains. Primary human small airway epithelial cells (SAECs) were transformed with the SV40 large T-antigen to establish a series of clones (SAEC-Ts). These clones were then used to test the infectivity of AI strains. Human SAEC-Ts could be broadly categorized into two different types based on their susceptibility (high or low) to the viruses. SAEC-T clones were poorly susceptible to previously circulating AI but were completely susceptible to the currently circulating H5N1. The hemagglutinin (HA) of the current H5N1 virus showed greater membrane fusion activity at higher pH levels than that of previous AI viruses, resulting in broader cell tropism. Moreover, the endosomal pH was lower in high susceptibility SAEC-T clones than that in low susceptibility SAEC-T clones. Taken together, the results of this study suggest that the infectivity of AI viruses, including H5N1, depends upon a delicate balance between the acid sensitivity of the viral HA and the pH within the endosomes of the target cell. Thus, one of the mechanisms underlying H5N1 pathogenesis in humans relies on its ability to fuse efficiently with the endosomes in human airway epithelial cells.	[Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Infect Dis, Kyoto 6028566, Japan; [Watanabe, Yohei; Ibrahim, Madiha S.; Yasugi, Mayo; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 5650871, Japan; [Ibrahim, Madiha S.] Damanhour Univ, Fac Vet Med, Dept Microbiol, Damanhour 22771, Egypt; [Yasugi, Mayo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988537, Japan; [Maruyama, Hisataka; Masuda, Taisuke; Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ohba, Tomoyuki; Honda, Ayae] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 7848584, Japan	Kyoto Prefectural University of Medicine; Osaka University; Egyptian Knowledge Bank (EKB); Damanhour University; Osaka Metropolitan University; Nagoya University; Hosei University	Nakaya, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Infect Dis, Kyoto 6028566, Japan.	makaya@koto.kpu-m.ac.jp	Oba, Tomoyuki/ABT-2152-2022; Ibrahim, Madiha Salah/AAS-6256-2021	Oba, Tomoyuki/0000-0002-6715-7892; Ibrahim, Madiha Salah/0000-0002-5756-5198; Watanabe, Yohei/0000-0002-8305-6952	Ministry of Education, Culture, Sports, Science and Technology [22790953, 24591480, 24659482, 23406033]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in aid for Scientific Research 22790953, 24591480, 24659482, and 23406033 from the Ministry of Education, Culture, Sports, Science and Technology.	Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; BOWEN TE, 1969, POULTRY SCI, V48, P608, DOI 10.3382/ps.0480608; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chapdelaine P, 2006, MOL HUM REPROD, V12, P309, DOI 10.1093/molehr/gal034; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Di Lonardo A, 2002, J VIROL METHODS, V101, P189, DOI 10.1016/S0166-0934(01)00437-2; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; EVANS MJ, 1978, LAB INVEST, V38, P648; Farner Donald S., 1942, POULTRY SCI, V21, P445, DOI 10.3382/ps.0210445; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Ilyushina NA, 2012, J VIROL, V86, P11725, DOI 10.1128/JVI.01477-12; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KILLISCH I, 1992, J CELL SCI, V103, P211; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; LI Y, 1993, J VIROL, V67, P4070, DOI 10.1128/JVI.67.7.4070-4077.1993; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nagahama M, 2011, FEBS J, V278, P3395, DOI 10.1111/j.1742-4658.2011.08263.x; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; ROBBINS AR, 1983, J CELL BIOL, V96, P1064, DOI 10.1083/jcb.96.4.1064; Rybak SL, 1998, J CELL PHYSIOL, V176, P216, DOI 10.1002/(SICI)1097-4652(199807)176:1<216::AID-JCP23>3.3.CO;2-M; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; SIPE DM, 1991, J BIOL CHEM, V266, P3469; SIPE DM, 1987, P NATL ACAD SCI USA, V84, P7119, DOI 10.1073/pnas.84.20.7119; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SLEMONS RD, 1995, AVIAN DIS, V39, P521, DOI 10.2307/1591804; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; Washington N, 2000, INT J PHARM, V198, P139, DOI 10.1016/S0378-5173(99)00442-1; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; World Health Organization, 2013, CUM NUMB CONF HUM CA; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99; Zhang XY, 2002, CLIN EXP IMMUNOL, V129, P288, DOI 10.1046/j.1365-2249.2002.01889.x; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	69	23	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10627	10642		10.1074/jbc.M114.611327	http://dx.doi.org/10.1074/jbc.M114.611327			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25673693	Green Published, hybrid			2022-12-26	WOS:000353404500005
J	Huang, W; Kim, HRC				Huang, Wei; Kim, Hyeong-Reh Choi			Dynamic Regulation of Platelet-derived Growth Factor D (PDGF-D) Activity and Extracellular Spatial Distribution by Matriptase-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED LIGAND; PROSTATE-CANCER; BETA-RECEPTOR; PERICYTE LOSS; B RETENTION; MEMBERS; FAMILY; CELLS; CHAIN; IDENTIFICATION	The oncogenic roles of PDGF-D and its proteolytic activator, matriptase, have been strongly implicated in human prostate cancer. Latent full-length PDGF-D (FL-D) consists of a CUB domain, a growth factor domain (GFD), and the hinge region in between. Matriptase processes the FL-D dimer into a GFD dimer (GFD-D) in a stepwise manner, involving generation of a hemidimer (HD), an intermediate product containing one FL-D subunit and one GFD subunit. Although the HD is a pro-growth factor that can be processed into the GFD-D by matriptase, the HD can also act as a dominant-negative ligand that prevents PDGF-B-mediated beta-PDGF receptor activation in fibroblasts. The active GFD-D can be further cleaved into a smaller and yet inactive form if matriptase-mediated proteolysis persists. Through mutagenesis and functional analyses, we found that the R(340)R(341)GR(343)A (P4-P1/P1') motif within the GFD is the matriptase cleavage site through which matriptase can deactivate PDGF-D. Comparative sequence analysis based on the published crystal structure of PDGF-B predicted that the matriptase cleavage site R(340)R(341)GR(343)A is within loop III of the GFD, a critical structural element for its binding with the beta-PDGF receptor. Interestingly, we also found that matriptase processing regulates the deposition of PDGF-D dimer species into the extracellular matrix (ECM) with increased binding from the FL-D dimer, to the HD, and to the GFD-D. Furthermore, we provide evidence that R(340)R(341)GR(343)A within the GFD is critical for PDGF-D deposition and binding to the ECM. In this study, we report a structural element crucial for the biological function and ECM deposition of PDGF-D and provide molecular insight into the dynamic functional interplay between the serine protease matriptase and PDGF-D.	[Huang, Wei; Kim, Hyeong-Reh Choi] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kim, HRC (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.	hrckim@med.wayne.edu			National Institutes of Health from NCI [R01 CA123362]; NATIONAL CANCER INSTITUTE [R01CA123362] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA123362 from NCI (to H.- R. C. K.).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; DIGLIO CA, 1983, J CELL BIOL, V97, P15, DOI 10.1083/jcb.97.1.15; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Floege J, 2003, J AM SOC NEPHROL, V14, P2690, DOI 10.1097/01.ASN.0000090831.40856.69; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hsu YC, 2011, J CELL PHYSIOL, V226, P2721, DOI 10.1002/jcp.22623; Huang W, 2012, ONCOGENE, V31, P4527, DOI 10.1038/onc.2011.573; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Najy AJ, 2012, MOL CANCER RES, V10, P1087, DOI 10.1158/1541-7786.MCR-12-0071; Nystrom HC, 2006, CARDIOVASC RES, V71, P557, DOI 10.1016/j.cardiores.2006.05.019; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Schilling D, 1998, BIOCHEM J, V333, P637, DOI 10.1042/bj3330637; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, CANCER RES, V63, P1458; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhou Z, 2009, THROMB RES, V124, P323, DOI 10.1016/j.thromres.2008.09.007; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	35	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9162	9170		10.1074/jbc.M114.610865	http://dx.doi.org/10.1074/jbc.M114.610865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678707	Green Published, hybrid			2022-12-26	WOS:000352207100039
J	Peng, LR; Yuan, ZG; Li, YX; Ling, HB; Izumi, V; Fang, B; Fukasawa, K; Koomen, J; Chen, JD; Seto, E				Peng, Lirong; Yuan, Zhigang; Li, Yixuan; Ling, Hongbo; Izumi, Victoria; Fang, Bin; Fukasawa, Kenji; Koomen, John; Chen, Jiandong; Seto, Edward			Ubiquitinated Sirtuin 1 (SIRT1) Function Is Modulated during DNA Damage-induced Cell Death and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; MAMMALIAN SIRTUINS; P53; PROTEIN; DEACETYLATION; DEGRADATION; APOPTOSIS; ACETYLATION; ACTIVATION; MDM2	Downstream signaling of physiological and pathological cell responses depends on post-translational modification such as ubiquitination. The mechanisms regulating downstream DNA damage response (DDR) signaling are not completely elucidated. Sirtuin 1 (SIRT1), the founding member of Class III histone deacetylases, regulates multiple steps in DDR and is closely associated with many physiological and pathological processes. However, the role of post-translational modification or ubiquitination of SIRT1 during DDR is unclear. We show that SIRT1 is dynamically and distinctly ubiquitinated in response to DNA damage. SIRT1 was ubiquitinated by the MDM2 E3 ligase in vitro and in vivo. SIRT1 ubiquitination under normal conditions had no effect on its enzymatic activity or rate of degradation; hypo-ubiquitination, however, reduced SIRT1 nuclear localization. Ubiquitination of SIRT1 affected its function in cell death and survival in response to DNA damage. Our results suggest that ubiquitination is required for SIRT1 function during DDR.	[Peng, Lirong; Yuan, Zhigang; Li, Yixuan; Ling, Hongbo; Izumi, Victoria; Fang, Bin; Fukasawa, Kenji; Koomen, John; Chen, Jiandong; Seto, Edward] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org	li, yixuan/P-5376-2016	Li, Yixuan/0000-0002-3550-8192	National Institutes of Health; Kaul Foundation; James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE [R01CA169210, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaul Foundation; James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants (to E. S.). This work was also supported by grants from Kaul Foundation (to E. S.) and a fellowship from the James and Esther King Biomedical Research Program (to L. P.).	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Byles V, 2010, INT J BIOL SCI, V6, P599; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Guan D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.185; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mao YF, 2011, J BIOL CHEM, V286, P41852, DOI 10.1074/jbc.M111.288514; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	43	37	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8904	8912		10.1074/jbc.M114.612796	http://dx.doi.org/10.1074/jbc.M114.612796			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670865	Green Published, hybrid			2022-12-26	WOS:000352207100018
J	Nolan, KD; Franco, OE; Hance, MW; Hayward, SW; Isaacs, JS				Nolan, Krystal D.; Franco, Omar E.; Hance, Michael W.; Hayward, Simon W.; Isaacs, Jennifer S.			Tumor-secreted Hsp90 Subverts Polycomb Function to Drive Prostate Tumor Growth and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EPITHELIAL-MESENCHYMAL TRANSITION; GROUP PROTEIN EZH2; E-CADHERIN; CELL-MIGRATION; TRANSCRIPTIONAL REPRESSION; NASOPHARYNGEAL CARCINOMA; CANCER METASTASIS; SERUM BIOMARKER; UP-REGULATION	Prostate cancer remains the second highest contributor to male cancer-related lethality. The transition of a subset of tumors from indolent to invasive disease is associated with a poor clinical outcome. Activation of the epithelial to mesenchymal transition (EMT) genetic program is a major risk factor for cancer progression. We recently reported that secreted extracellular Hsp90 (eHsp90) initiates EMT in prostate cancer cells, coincident with its enhanced expression in mesenchymal models. Our current work substantially extended these findings in defining a pathway linking eHsp90 signaling to EZH2 function, a methyltransferase of the Polycombrepressor complex. EZH2 is also implicated in EMT activation, and its up-regulation represents one of the most frequent epigenetic alterations during prostate cancer progression. We have now highlighted a novel epigenetic function for eHsp90 via its modulation of EZH2 expression and activity. Mechanistically, eHsp90 initiated sustained activation of MEK/ERK, a signal critical for facilitating EZH2 transcriptional up-regulation and recruitment to the E-cadherin promoter. We further demonstrated that an eHsp90-EZH2 pathway orchestrates an expanded repertoire of EMT-related events including Snail and Twist expression, tumor cell motility, and anoikis resistance. To evaluate the role of eHsp90 in vivo, eHsp90 secretion was stably enforced in a prostate cancer cell line resembling indolent disease. Remarkably, eHsp90 was sufficient to induce tumor growth, suppress E-cadherin, and initiate localized invasion, events that are exquisitely dependent upon EZH2 function. In summary, our findings illuminate a hitherto unknown epigenetic function for eHsp90 and support a model wherein tumor eHsp90 functions as a rheostat for EZH2 expression and activity to orchestrate mesenchymal properties and coincident aggressive behavior.	[Nolan, Krystal D.; Hance, Michael W.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol & Canc Biol, Nashville, TN 37232 USA	Medical University of South Carolina; Vanderbilt University	Isaacs, JS (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	ofrancocoronel@northshore.org; shayward@northshore.org; isaacsj@musc.edu		Hayward, Simon/0000-0002-6059-6550	Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313, F31CA177015, R01CA187342, U01CA151924] Funding Source: NIH RePORTER	Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Joy Ware for the P69 and M12 cells, Chris Lindsey and Craig Beeson for synthesis of NPGA, and Maarten van Lohuizen for the EZH2-H694L expression plasmid. The imaging facilities for this research were supported in part by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Bohonowych JE, 2014, PROSTATE, V74, P395, DOI 10.1002/pros.22761; Burgess EF, 2008, PROTEOM CLIN APPL, V2, P1223, DOI 10.1002/prca.200780073; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen JZ, 2014, CANCER RES, V74, P4353, DOI 10.1158/0008-5472.CAN-14-0181; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Efstathiou E, 2010, CLIN CANCER RES, V16, P1100, DOI 10.1158/1078-0432.CCR-09-1215; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fujii S, 2011, ONCOGENE, V30, P4118, DOI 10.1038/onc.2011.118; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hance MW, 2014, CANCERS, V6, P1065, DOI 10.3390/cancers6021065; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hwang-Verslues WW, 2013, P NATL ACAD SCI USA, V110, P12331, DOI 10.1073/pnas.1222684110; Ishii K, 2005, LAB INVEST, V85, P1086, DOI 10.1038/labinvest.3700310; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Sun YY, 2010, INT J MOL SCI, V11, P1423, DOI 10.3390/ijms11041423; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	52	52	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8271	8282		10.1074/jbc.M115.637496	http://dx.doi.org/10.1074/jbc.M115.637496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670862	Green Published, hybrid			2022-12-26	WOS:000351662600023
J	Hoehlig, K; Bethge, L; Klussmann, S				Hoehlig, Kai; Bethge, Lucas; Klussmann, Sven			Stereospecificity of Oligonucleotide Interactions Revisited: No Evidence for Heterochiral Hybridization and Ribozyme/DNAzyme Activity	PLOS ONE			English	Article							NUCLEIC-ACIDS; RNA ENZYME; LIGANDS; DNA; SELECTION; IDENTIFICATION; AMPLIFICATION; POLYMERASE; BINDING	A major challenge for the application of RNA-or DNA-oligonucleotides in biotechnology and molecular medicine is their susceptibility to abundant nucleases. One intriguing possibility to tackle this problem is the use of mirror-image (L-) oligonucleotides. For aptamers, this concept has successfully been applied to even develop therapeutic agents, so-called Spiegelmers. However, for technologies depending on RNA/RNA or RNA/DNA hybridization, like antisense or RNA interference, it has not been possible to use mirror-image oligonucleotides because Watson-Crick base pairing of complementary strands is (thought to be) stereospecific. Many scientists consider this a general principle if not a dogma. A recent publication proposing heterochiral Watson-Crick base pairing and sequence-specific hydrolysis of natural RNA by mirror-image ribozymes or DNAzymes (and vice versa) prompted us to systematically revisit the stereospecificity of oligonucleotides hybridization and catalytic activity. Using hyperchro-micity measurements we demonstrate that hybridization only occurs among homochiral antiparallel complementary oligonucleotide strands. As expected, achiral PNA hybridizes to RNA and DNA irrespective of their chirality. In functional assays we could not confirm an alleged heterochiral hydrolytic activity of ribozymes or DNAzymes. Our results confirm a strict stereospecificity of oligonucleotide hybridization and clearly argue against the possibility to use mirror-image oligonucleotides for gene silencing or antisense applications.	[Hoehlig, Kai; Bethge, Lucas; Klussmann, Sven] NOXXON Pharma AG, Berlin, Germany	NOXXON Pharma	Klussmann, S (corresponding author), NOXXON Pharma AG, Berlin, Germany.	sklussmann@noxxon.com						ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; ASSELINE U, 1991, NUCLEIC ACIDS RES, V19, P4067, DOI 10.1093/nar/19.15.4067; Bada, 1995, NATURE, V374, P594; Bethge L, 2008, BIOORGAN MED CHEM, V16, P114, DOI 10.1016/j.bmc.2006.12.044; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Froeyen M, 2007, CHEM BIODIVERS, V4, P803, DOI 10.1002/cbdv.200790065; FUJIMORI S, 1990, J AM CHEM SOC, V112, P7436, DOI 10.1021/ja00176a077; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; HASHIMOTO Y, 1993, J AM CHEM SOC, V115, P9883, DOI 10.1021/ja00075a002; Hoffmann S, 2011, CURR PROTOC NUCL ACI, P1; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Olea C, 2012, J AM CHEM SOC, V134, P8050, DOI 10.1021/ja302197x; Purschke WG, 2014, BIOCHEM J, V462, P153, DOI 10.1042/BJ20131422; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sczepanski JT, 2014, NATURE, V515, P440, DOI 10.1038/nature13900; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; THOMSON SA, 1995, TETRAHEDRON, V51, P6179, DOI 10.1016/0040-4020(95)00286-H; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VANBOECKEL CAA, 1987, J MOL EVOL, V25, P100, DOI 10.1007/BF02101751; Vater A, 2003, CURR OPIN DRUG DI DE, V6, P253; Williams KP, 1997, P NATL ACAD SCI USA, V94, P11285, DOI 10.1073/pnas.94.21.11285; Wyszko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086673; Wyszko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054741; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5	28	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115328	10.1371/journal.pone.0115328	http://dx.doi.org/10.1371/journal.pone.0115328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679211	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600007
J	Budell, L; Kunz, M; Jackson, PL; Rainville, P				Budell, Lesley; Kunz, Miriam; Jackson, Philip L.; Rainville, Pierre			Mirroring Pain in the Brain: Emotional Expression versus Motor Imitation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; FACIAL EXPRESSIONS; NEURAL MECHANISMS; EMPATHY; AREAS; SYSTEM; PREMOTOR; RESPONSES; OTHERS	Perception of pain in others via facial expressions has been shown to involve brain areas responsive to self-pain, biological motion, as well as both performed and observedmotor actions. Here, we investigated the involvement of these different regions during emotional and motor mirroring of pain expressions using a two-task paradigm, and including both observation and execution of the expressions. BOLD responses were measured as subjects watched video clips showing different intensities of pain expression and, after a variable delay, either expressed the amount of pain they perceived in the clips (pain task), or imitated the facial movements (movement task). In the pain task condition, pain coding involved overlapping activation across observation and execution in the anterior cingulate cortex, supplementary motor area, inferior frontal gyrus/anterior insula, and the inferior parietal lobule, and a painrelated increase (pain vs. neutral) in the anterior cingulate cortex/supplementary motor area, the right inferior frontal gyrus, and the postcentral gyrus. The 'mirroring' response was stronger in the inferior frontal gyrus and middle temporal gyrus/superior temporal sulcus during the pain task, and stronger in the inferior parietal lobule in the movement task. These results strongly suggest that while motor mirroring may contribute to the perception of pain expressions in others, interpreting these expressions in terms of pain content draws more heavily on networks involved in the perception of affective meaning.	[Budell, Lesley] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Budell, Lesley; Rainville, Pierre] Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Budell, Lesley; Rainville, Pierre] Ctr Rech Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Jackson, Philip L.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Jackson, Philip L.] Univ Laval, CIRRIS, Quebec City, PQ, Canada; [Jackson, Philip L.] Univ Laval, CRIUSMQ, Quebec City, PQ, Canada; [Rainville, Pierre] Univ Montreal, Dept Stomatol, Montreal, PQ, Canada; [Kunz, Miriam] Otto Friedrich Univ Bamberg, Dept Psychol, D-96047 Bamberg, Germany	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal; Otto Friedrich University Bamberg	Rainville, P (corresponding author), Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada.	Pierre.Rainville@umontreal.ca	Rainville, Pierre/M-5480-2015; Kunz, Miriam/P-8160-2016	Rainville, Pierre/0000-0001-9801-757X; Kunz, Miriam/0000-0002-0740-6738; Jackson, Philip/0000-0001-8991-3217	National Sciences and Engineering Research Council of Canada (NSERC) [341472-2013]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC; #341472-2013; http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Ekman P, 1997, WHAT FACE REVEALS BA, pxvi; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hadjistavropoulos T, 2011, PSYCHOL BULL, V137, P910, DOI 10.1037/a0023876; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Kunz M, 2006, J PAIN, V7, P915, DOI 10.1016/j.jpain.2006.04.012; Kunz M, 2011, J NEUROSCI, V31, P8730, DOI 10.1523/JNEUROSCI.0217-11.2011; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee T, 2006, RACE ETHN POLIT, P1; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mailhot JP, 2012, EUR J NEUROSCI, V35, P271, DOI 10.1111/j.1460-9568.2011.07953.x; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montgomery KJ, 2008, J COGNITIVE NEUROSCI, V20, P1866, DOI 10.1162/jocn.2008.20127; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Morrison I, 2007, COGNITION, V104, P407, DOI 10.1016/j.cognition.2006.07.006; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Noppeney U, 2008, J PHYSIOL-PARIS, V102, P40, DOI 10.1016/j.jphysparis.2008.03.009; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Perini I, 2013, J NEUROSCI, V33, P15930, DOI 10.1523/JNEUROSCI.3135-12.2013; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Straube B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051207; Talairach J., 1988, COPLANAR STEREOTAXIC; Vachon-Presseau E, 2012, NEUROIMAGE, V63, P54, DOI 10.1016/j.neuroimage.2012.06.030; Vachon-Presseau E, 2011, PAIN, V152, P1525, DOI 10.1016/j.pain.2011.02.039; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	65	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0107526	10.1371/journal.pone.0107526	http://dx.doi.org/10.1371/journal.pone.0107526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671563	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300001
J	Saha, C; Hegde, P; Friboulet, A; Bayry, J; Kaveri, SV				Saha, Chaitrali; Hegde, Pushpa; Friboulet, Alain; Bayry, Jagadeesh; Kaveri, Srinivas V.			Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYCLOOXYGENASE-2 EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; MISTLETOE EXTRACTS; CANCER-PATIENTS; IMMUNE-SYSTEM; L. EXTRACTS; MOUSE SKIN; IN-VIVO; CELLS	Extensive use of Viscum album (VA) preparations in the complementary therapy of cancer and in several other human pathologies has led to an increasing number of cellular and molecular approaches to explore the mechanisms of action of VA. We have recently demonstrated that, VA preparations exert a potent anti-inflammatory effect by selectively downregulating the COX-2-mediated cytokine-induced secretion of prostaglandin E2 (PGE2), one of the important molecular signatures of inflammatory reactions. In this study, we observed a significant down-regulation of COX-2 protein expression in VA-treated A549 cells however COX-2 mRNA levels were unaltered. Therefore, we hypothesized that VA induces destabilisation of COX-2 mRNA, thereby depleting the available functional COX-2 mRNA for the protein synthesis and for the subsequent secretion of PGE2. To address this question, we analyzed the molecular degradation of COX-2 protein and its corresponding mRNA in A549 cell line. Using cyclohexamide pulse chase experiment, we demonstrate that, COX-2 protein degradation is not affected by the treatment with VA whereas experiments on transcriptional blockade with actinomycin D, revealed a marked reduction in the half life of COX-2 mRNA due to its rapid degradation in the cells treated with VA compared to that in IL-1 beta-stimulated cells. These results thus demonstrate that VA-mediated inhibition of PGE2 implicates destabilization of COX-2 mRNA.	[Saha, Chaitrali; Hegde, Pushpa; Bayry, Jagadeesh; Kaveri, Srinivas V.] INSERM, Unite 1138, Paris, France; [Saha, Chaitrali; Hegde, Pushpa; Friboulet, Alain] Univ Technol Compiegne, UMR CNRS 6022, Compiegne, France; [Saha, Chaitrali; Hegde, Pushpa; Bayry, Jagadeesh; Kaveri, Srinivas V.] Ctr Rech Cordeliers Equipe Immunopathol & therape, Paris, France; [Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 06, Sorbonne Univ, UMR S 1138, Paris, France; [Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Technologie de Compiegne; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kaveri, SV (corresponding author), INSERM, Unite 1138, Paris, France.	srini.kaveri@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053; Hegde, Pushpa/0000-0002-2376-8659	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie; French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland	This work is supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie and Universite Paris Descartes, Regional Program Bio-Asie 2010 by the French Ministry of Foreign and European Affairs and Institut Hiscia, Arlesheim, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock PR, 2004, ARZNEIMITTELFORSCH, V54, P456; Bussing A, 1999, ANTICANCER RES, V19, P23; Bussing A, 2005, ANTICANCER RES, V25, P4753; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Christen-Clottu O, 2010, J VET INTERN MED, V24, P1483, DOI 10.1111/j.1939-1676.2010.0597.x; Chrubasik S, 2001, RHEUMATOLOGY, V40, P1388, DOI 10.1093/rheumatology/40.12.1388; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cravotto G, 2010, J CLIN PHARM THER, V35, P11, DOI 10.1111/j.1365-2710.2009.01096.x; Crofford LJ, 1997, J RHEUMATOL, V24, P15; DAVENPORT HW, 1967, NEW ENGL J MED, V276, P1307, DOI 10.1056/NEJM196706082762308; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Elluru SR, 2009, ANTICANCER RES, V29, P2945; Elluru S, 2006, ARZNEIMITTEL-FORSCH, V56, P461; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Hegde P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026312; Hostanska K, 1995, NAT IMMUN, V14, P295; Kam PCA, 2000, ANAESTHESIA, V55, P442, DOI 10.1046/j.1365-2044.2000.01271.x; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Kis B, 2003, J CEREBR BLOOD F MET, V23, P1287, DOI 10.1097/01.WCB.0000090681.07515.81; Klopp R, 2005, ANTICANCER RES, V25, P601; Kundu JK, 2003, J NUTR, V133, p3805S, DOI 10.1093/jn/133.11.3805S; Lavastre V, 2004, CLIN EXP IMMUNOL, V137, P272, DOI 10.1111/j.1365-2249.2004.02545.x; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Shrotriya S, 2010, CANCER RES, V70, P1932, DOI 10.1158/0008-5472.CAN-09-3501; Surh YJ, 2005, ARCH PHARM RES, V28, P1, DOI 10.1007/BF02975128; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; Tong X, 2007, MOL CELL BIOL, V27, P283, DOI 10.1128/MCB.01282-06; Tusenius KJ, 2005, ARZNEIMITTELFORSCH, V55, P749; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; Zhang L, 2007, ARTHRITIS RHEUM-US, V56, P4132, DOI 10.1002/art.23054; Zhao XS, 2008, CANCER RES, V68, P467, DOI 10.1158/0008-5472.CAN-07-0782	40	15	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0114965	10.1371/journal.pone.0114965	http://dx.doi.org/10.1371/journal.pone.0114965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664986	Green Published, gold, Green Submitted			2022-12-26	WOS:000349123100003
J	Cattane, N; Minelli, A; Milanesi, E; Maj, C; Bignotti, S; Bortolomasi, M; Chiavetto, LB; Gennarelli, M				Cattane, Nadia; Minelli, Alessandra; Milanesi, Elena; Maj, Carlo; Bignotti, Stefano; Bortolomasi, Marco; Chiavetto, Luisella Bocchio; Gennarelli, Massimo			Altered Gene Expression in Schizophrenia: Findings from Transcriptional Signatures in Fibroblasts and Blood	PLOS ONE			English	Article							FUNCTIONAL DOPAMINERGIC-NEURONS; BIPOLAR DISORDER; DIFFERENTIAL EXPRESSION; COMMON VARIANTS; CONFERRING RISK; STEM-CELLS; TCF4; COMPARABILITY; CALCINEURIN; EPIGENETICS	Background Whole-genome expression studies in the peripheral tissues of patients affected by schizophrenia (SCZ) can provide new insight into the molecular basis of the disorder and innovative biomarkers that may be of great utility in clinical practice. Recent evidence suggests that skin fibroblasts could represent a non-neural peripheral model useful for investigating molecular alterations in psychiatric disorders. Methods A microarray expression study was conducted comparing skin fibroblast transcriptomic profiles from 20 SCZ patients and 20 controls. All genes strongly differentially expressed were validated by real-time quantitative PCR (RT-qPCR) in fibroblasts and analyzed in a sample of peripheral blood cell (PBC) RNA from patients (n = 25) and controls (n = 22). To evaluate the specificity for SCZ, alterations in gene expression were tested in additional samples of fibroblasts and PBCs RNA from Major Depressive Disorder (MDD) (n = 16; n = 21, respectively) and Bipolar Disorder (BD) patients (n = 15; n = 20, respectively). Results Six genes (JUN, HIST2H2BE, FOSB, FOS, EGR1, TCF4) were significantly upregulated in SCZ compared to control fibroblasts. In blood, an increase in expression levels was confirmed only for EGR1, whereas JUN was downregulated; no significant differences were observed for the other genes. EGR1 upregulation was specific for SCZ compared to MDD and BD. Conclusions Our study reports the upregulation of JUN, HIST2H2BE, FOSB, FOS, EGR1 and TCF4 in the fibroblasts of SCZ patients. A significant alteration in EGR1 expression is also present in SCZ PBCs compared to controls and to MDD and BD patients, suggesting that this gene could be a specific biomarker helpful in the differential diagnosis of major psychoses.	[Cattane, Nadia; Minelli, Alessandra; Gennarelli, Massimo] Univ Brescia, Dept Mol & Translat Med, Biol & Genet Div, Brescia, Italy; [Milanesi, Elena; Maj, Carlo; Chiavetto, Luisella Bocchio; Gennarelli, Massimo] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Genet Unit, Brescia, Italy; [Bignotti, Stefano] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Psychiat Unit, Brescia, Italy; [Bortolomasi, Marco] Psychiat Hosp Villa Santa Chiara, Verona, Italy; [Chiavetto, Luisella Bocchio] eCampus Univ, Fac Psychol, Novedrate, Como, Italy	University of Brescia; Universita Ecampus	Gennarelli, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Biol & Genet Div, Brescia, Italy.	massimo.gennarelli@unibs.it	BIGNOTTI, STEFANO/AAB-6036-2022; Cattane, Nadia/K-5906-2016; Maj, Carlo/I-4245-2015; Chiavetto, Luisella Bocchio/D-3884-2012; Milanesi, Elena/J-9489-2014; Minelli, Alessandra/ABI-2890-2020; Gennarelli, Massimo/AAL-3542-2020; Cattane, Nadia/AAE-4316-2022	BIGNOTTI, STEFANO/0000-0002-7840-9637; Cattane, Nadia/0000-0002-6532-583X; Maj, Carlo/0000-0002-9559-1725; Chiavetto, Luisella Bocchio/0000-0002-9801-603X; Minelli, Alessandra/0000-0002-9463-7808; Cattane, Nadia/0000-0002-6532-583X; Milanesi, Elena/0000-0003-2753-3395; GENNARELLI, Massimo/0000-0003-4192-945X	Italian Ministry of Health (RC); Italian Ministry of Health (RF2007 Conv.42); Regione Lombardia [17387 SAL-13]	Italian Ministry of Health (RC)(Ministry of Health, Italy); Italian Ministry of Health (RF2007 Conv.42); Regione Lombardia(Regione Lombardia)	This research was supported by grants from the Italian Ministry of Health (RC and RF2007 Conv.42) and Regione Lombardia (ID: 17387 SAL-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2010, CURR TOP BEHAV NEURO, V4, P611, DOI 10.1007/7854_2010_38; Akin D, 2004, NEUROPSYCHOPHARMACOL, V29, P2081, DOI 10.1038/sj.npp.1300505; Asp L, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-25; Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Bongiovanni R, 2013, SCHIZOPHR RES, V150, P386, DOI 10.1016/j.schres.2013.08.041; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; Gasso P, 2013, J PSYCHIATR RES; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard SL, 2012, CURR NEUROL NEUROSCI, V12, P261, DOI 10.1007/s11910-012-0266-7; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Hall J, 2015, BIOL PSYCHIAT, V77, P52, DOI 10.1016/j.biopsych.2014.07.011; Hansson AC, 2008, BRAIN RES, V1215, P1, DOI 10.1016/j.brainres.2008.03.080; Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; Johansson AS, 2013, J PSYCHIATR RES, V47, P1815, DOI 10.1016/j.jpsychires.2013.08.008; Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Kumarasinghe N, 2012, AUST NZ J PSYCHIAT, V46, P598, DOI 10.1177/0004867412442405; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lennertz L, 2011, EUR ARCH PSY CLIN N, V261, P161, DOI 10.1007/s00406-011-0256-9; Mahgoub M, 2013, NEUROTHERAPEUTICS, V10, P734, DOI 10.1007/s13311-013-0213-6; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; Mattheisen M, 2012, SCHIZOPHR RES, V141, P262, DOI 10.1016/j.schres.2012.08.027; Matthews PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038211; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Mistry M, 2013, MOL PSYCHIATR, V18, P215, DOI 10.1038/mp.2011.172; Monin A, 2014, MOL PSYCHIAT; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Navarrete K, 2013, AM J MED GENET B, V162B, P1, DOI 10.1002/ajmg.b.32109; Pae CU, 2009, NEUROPSYCHOBIOLOGY, V59, P135, DOI 10.1159/000218075; Perez-Santiago J, 2012, J PSYCHIATR RES, V46, P1464, DOI 10.1016/j.jpsychires.2012.08.005; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pitman KA, 2014, EUR J NEUROSCI; Quednow BB, 2014, CELL MOL LIFE SCI, V71, P2815, DOI 10.1007/s00018-013-1553-4; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slot LAB, 2009, EUR J PHARMACOL, V620, P27, DOI 10.1016/j.ejphar.2009.08.019; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Steullet P, 2014, SCHIZOPHR RES; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Theka I, 2013, STEM CELL TRANSL MED, V2, P473, DOI 10.5966/sctm.2012-0133; Todorova VK, 2003, NEUROPSYCHOPHARMACOL, V28, P1506, DOI 10.1038/sj.npp.1300211; Tomasik J, 2014, SCHIZOPHR RES; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Wang L, 2010, J PROTEOME RES, V9, P521, DOI 10.1021/pr900867x; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Wolf J, 2012, EXP GERONTOL, V47, P749, DOI 10.1016/j.exger.2012.07.001; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Zhang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056108	67	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116686	10.1371/journal.pone.0116686	http://dx.doi.org/10.1371/journal.pone.0116686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658856	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900057
J	Ge, H; Yuan, W; Liu, JD; He, Q; Ding, S; Pu, J; He, B				Ge, Heng; Yuan, Wei; Liu, Jidong; He, Qing; Ding, Song; Pu, Jun; He, Ben			Functional Relevance of Protein Glycosylation to the Pro-Inflammatory Effects of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) on Monocytes/Macrophages	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; ATHEROSCLEROTIC PLAQUE; IMMUNOGLOBULIN SUPERFAMILY; THERAPEUTIC PROTEINS; EXPRESSION; CD147; IMMUNE; MACROPHAGES; INHIBITOR; MONOCYTES	Background and Objective Extracellular matrix metalloproteinase inducer (EMMPRIN) is an important pro-inflammatory protein involved in the cellular functions of monocytes/macrophages. We have hypothesized that high-level heterogeneousness of protein glycosylation of EMMPRIN may have functional relevance to its biological effects and affect the inflammatory activity of monocytes/macrophages. Methods The glycosylation patterns of EMMPRIN expressed by monocytes/macrophages (THP-1 cells) in response to different extracellular stimuli were observed, and the structures of different glycosylation forms were identified. After the purification of highly-and less-glycosylated proteins respectively, the impacts of different glycosylation forms on the pro-inflammatory effects of EMMPRIN were examined in various aspects, such as cell adhesion to endothelial cells, cell migrations, cytokine expression, and activation of inflammatory signalling pathway. Results 1) It was mainly the highly-glycosylated form of EMMPRIN (HG-EMMPRIN) that increased after being exposed to inflammatory signals (PMA and H2O2).2) Glycosylation of EMMPRIN in monocytes/macrophages led to N-linked-glycans being added to the protein, with the HG form containing complex-type glycans and the less-glycosylated form (LG) the simple type. 3) Only the HG-EMMPRIN but not the LG-EMMPRIN exhibited pro-inflammatory effects and stimulated inflammatory activities of the monocytes/macrophages (i.e., activation of ERK1/2 and NF-kappa B pathway, enhancedmonocyte-endothelium adhesion, cell migration and matrix metalloproteinase - 9 expression). Conclusions Post-transcriptional glycosylation represents an important mechanism that determines the biological effects of EMMPRIN in monocytes/macrophages. Glycosylation of EMMPRIN may serve as a potential target for regulating the inflammatory activities of monocytes/macrophages.	[Ge, Heng; Yuan, Wei; He, Qing; Ding, Song; Pu, Jun; He, Ben] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Liu, Jidong] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Pu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	pujun310@hotmail.com; heben@medmail.com.cn			Natural Science Foundation of China [81000114, 81200163, 81330006, 81270282]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (grant numbers 81000114 (GH), 81200163 (PJ), 81330006 (HB) and 81270282(PJ) [www.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISWAS C, 1995, CANCER RES, V55, P434; Chen HC, 2005, BOYDEN CHAMBER ASSAY, P15; Chi Z, 2007, CELL ADHES MIGR, V1, P171, DOI 10.4161/cam.1.4.5321; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ge H, 2007, VASC PHARMACOL, V46, P114, DOI 10.1016/j.vph.2006.08.412; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Kim Ju-Young, 2009, Immune Netw, V9, P90, DOI 10.4110/in.2009.9.3.90; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Major TC, 2002, ARTERIOSCL THROM VAS, V22, P1200, DOI 10.1161/01.ATV.0000021411.53577.1C; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schulz C, 2011, J THROMB HAEMOST, V9, P1007, DOI 10.1111/j.1538-7836.2011.04235.x; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wei YA, 2010, ATHEROSCLEROSIS, V213, P415, DOI 10.1016/j.atherosclerosis.2010.09.033; Yoon YW, 2005, ATHEROSCLEROSIS, V180, P37, DOI 10.1016/j.atherosclerosis.2004.11.021; Yu XL, 2006, INT J BIOCHEM CELL B, V38, P1939, DOI 10.1016/j.biocel.2006.05.008; Zhang JF, 2007, INT J CARDIOL, V117, P373, DOI 10.1016/j.ijcard.2006.05.023	34	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117463	10.1371/journal.pone.0117463	http://dx.doi.org/10.1371/journal.pone.0117463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658763	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900155
J	Rahman, MA; Mitra, S; Sarkar, A; Wewers, MD				Rahman, Mohd Akhlakur; Mitra, Srabani; Sarkar, Anasuya; Wewers, Mark D.			Alpha 1-Antitrypsin Does Not Inhibit Human Monocyte Caspase-1	PLOS ONE			English	Article							ALPHA1-ANTITRYPSIN DEFICIENCY; INTERLEUKIN-1-BETA-CONVERTING ENZYME; WHOLE-BLOOD; TNF-ALPHA; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; ELASTASE; RELEASE; ALPHA(1)-ANTITRYPSIN	Background Alpha 1-antitrypsin (A1AT) is a 52 kDa serine protease inhibitor produced largely by hepatocytes but also by mononuclear phagocytes. A1AT chiefly inhibits neutrophil elastase and proteinase-3 but has also been reported to have immune modulatory functions including the ability to inhibit caspases. Its clinical availability for infusion suggests that A1AT therapy might modulate caspase related inflammation. Here we tested the ability of A1AT to modulate caspase-1 function in human mononuclear phagocytes. Methods Purified plasma derived A1AT was added to active caspase-1 in a cell-free system (THP-1 lysates) as well as added exogenously to cell-culture models and human whole blood models of caspase-1 activation. Functional caspase-1 activity was quantified by the cleavage of the caspase-1 specific fluorogenic tetrapeptide substrate (WEHD-afc) and the release of processed IL-18 and IL-1 beta. Results THP-1 cell lysates generated spontaneous activation of caspase-1 both by WEHD-afc cleavage and the generation of p20 caspase-1. A1AT added to this cell free system was unable to inhibit caspase-1 activity. Release of processed IL-18 by THP-1 cells was also unaffected by the addition of exogenous A1AT prior to stimulation with LPS/ATP, a standard caspase-1 activating signal. Importantly, the A1AT exhibited potent neutrophil elastase inhibitory capacity. Furthermore, A1AT complexed to NE (and hence conformationally modified) also did not affect THP-1 cell caspase-1 activation. Finally, exogenous A1AT did not inhibit the ability of human whole blood samples to process and release IL-1 beta. Conclusions A1AT does not inhibit human monocyte caspase-1.	[Rahman, Mohd Akhlakur; Mitra, Srabani; Sarkar, Anasuya; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med,Wexner Med, Columbus, OH 43210 USA	Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med,Wexner Med, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021		National Institute of Health (NIH) [HL07627]; Alpha-1 Foundation	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha-1 Foundation	This study was supported by the National Institute of Health (NIH HL07627) and Alpha-1 Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN JN, 1992, J LAB CLIN MED, V119, P538; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Carroll TP, 2010, J IMMUNOL, V184, P4538, DOI 10.4049/jimmunol.0802864; Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Ghonime MG, 2012, BIOCHEM BIOPH RES CO, V425, P384, DOI 10.1016/j.bbrc.2012.07.102; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hu CB, 2002, AM J PHYSIOL-LUNG C, V282, pL757, DOI 10.1152/ajplung.00271.2001; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; JANOFF A, 1972, AM REV RESPIR DIS, V105, P121; Knoell DL, 1998, AM J RESP CRIT CARE, V157, P246, DOI 10.1164/ajrccm.157.1.9702033; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MEYER JF, 1975, CLIN CHIM ACTA, V62, P43, DOI 10.1016/0009-8981(75)90278-8; MILLER DK, 1993, J BIOL CHEM, V268, P18062; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; MORSE JO, 1978, NEW ENGL J MED, V299, P1045, DOI 10.1056/NEJM197811092991905; MORSE JO, 1978, NEW ENGL J MED, V299, P1099, DOI 10.1056/NEJM197811162992003; OHLSSON K, 1971, SCAND J CLIN LAB INV, V28, P251, DOI 10.3109/00365517109095696; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P795, DOI 10.1073/pnas.82.3.795; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; PUTNAM CW, 1977, SURGERY, V81, P258; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; Rooney CP, 2001, AM J RESP CELL MOL, V24, P747, DOI 10.1165/ajrcmb.24.6.4147; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; SIFERS RN, 1989, AM J RESP CELL MOL, V1, P341, DOI 10.1165/ajrcmb/1.5.341; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Swaan PW, 2001, PHARMACEUT RES, V18, P1083, DOI 10.1023/A:1010958406364; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051078; WEWERS MD, 1988, J CLIN INVEST, V82, P1260, DOI 10.1172/JCI113724; Wewers MD, 1997, J IMMUNOL, V159, P5964; WEWERS MD, 1993, J IMMUNOL METHODS, V165, P269, DOI 10.1016/0022-1759(93)90353-9; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	43	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117330	10.1371/journal.pone.0117330	http://dx.doi.org/10.1371/journal.pone.0117330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658455	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900135
J	Tian, C; Jiang, Q; Wang, F; Wang, GL; Xu, ZS; Xiong, AS				Tian, Chang; Jiang, Qian; Wang, Feng; Wang, Guang-Long; Xu, Zhi-Sheng; Xiong, Ai-Sheng			Selection of Suitable Reference Genes for qPCR Normalization under Abiotic Stresses and Hormone Stimuli in Carrot Leaves	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TRANSCRIPTION FACTOR DREB2A; TIME RT-PCR; HOUSEKEEPING GENES; SALICYLIC-ACID; QUANTITATIVE-PCR; INTERNAL CONTROL; RNA EXPRESSION; IDENTIFICATION; VALIDATION	Carrot, a biennial herb of the Apiaceae family, is among the most important vegetable crops in the world. In this study, nine candidate reference genes (GAPDH, ACTIN, eIF-4 alpha, PP2A, SAND, TIP41, UBQ, EF-1 alpha, and TUB) were cloned from carrot. Carrot plants were subjected to abiotic stresses (heat, cold, salt, and drought) and hormone stimuli (gibberellin, salicylic acid, methyl jasmonate, and abscisic acid). The expression profiles of the candidate reference genes were evaluated in three technical and biological replicates. Real-time qPCR data analyses were performed using three commonly used Excel-based applets namely, BestKeeper, geNorm, and NormFinder. ACTIN and TUB were the most stable genes identified among all sample groups, but individual analysis revealed changes in their expression profiles. GAPDH displayed the maximum stability for most of single stresses. To further validate the suitability of the reference genes identified in this study, the expression profile of DcDREB-A1 gene (homolog of AtDREB-A1 gene of Arabidophsis) was studied in carrot. The appropriate reference genes were selected that showed stable expression under the different experimental conditions.	[Tian, Chang; Jiang, Qian; Wang, Feng; Wang, Guang-Long; Xu, Zhi-Sheng; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	xiongaisheng@njau.edu.cn	Wang, Guang-Long/ABC-2687-2020	Xiong, Ai-Sheng/0000-0002-7900-5001	New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; China Postdoctoral Science Foundation [2014M551609]; Priority Academic Program Development of Jiangsu Higher Education Institutions	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions	The research was supported by the New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); China Postdoctoral Science Foundation (2014M551609); Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charron CS, 2009, J AGR FOOD CHEM, V57, P1226, DOI 10.1021/jf802988s; Chung HJ, 2005, PLANTA, V220, P424, DOI 10.1007/s00425-004-1366-7; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Eraslan F, 2007, SCI HORTIC-AMSTERDAM, V113, P120, DOI 10.1016/j.scienta.2007.03.012; Fan XT, 2000, PHYSIOL PLANTARUM, V110, P450, DOI 10.1111/j.1399-3054.2000.1100404.x; Feng YJ, 2012, J CHEM ECOL, V38, P984, DOI 10.1007/s10886-012-0155-1; Galli V, 2013, PLANT CELL REP, V32, P1869, DOI 10.1007/s00299-013-1499-x; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; 何亚丽, 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P89; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIBBERD KA, 1980, PLANTA, V148, P183, DOI 10.1007/BF00386420; HILLER LK, 1979, PLANT PHYSIOL, V63, P1055, DOI 10.1104/pp.63.6.1055; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; IKUMA H, 1960, PLANT PHYSIOL, V35, P557, DOI 10.1104/pp.35.5.557; Ishitani R, 1996, J NEUROCHEM, V66, P928; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Li MY, 2013, PLANT MOL BIOL REP, V31, P1002, DOI 10.1007/s11105-013-0570-7; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luby CH, 2014, HORTICULTURE RES, V1, P1, DOI DOI 10.1038/H0RTRES.2014.15; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ransbotyn V, 2006, LIMNOL OCEANOGR-METH, V4, P367, DOI 10.4319/lom.2006.4.367; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sabater-Jara AB, 2014, PLANT PHYSIOL BIOCH, V77, P133, DOI 10.1016/j.plaphy.2014.02.006; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Simon P. W., 1997, Journal of Applied Genetics, V38A, P57; Simon PW, 2008, CARROT VEGETABLES, P327; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Small IM, 2012, CROP PROT, V41, P10, DOI 10.1016/j.cropro.2012.05.016; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; WIXOM RL, 1961, PLANT PHYSIOL, V36, P598, DOI 10.1104/pp.36.5.598; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Yperman J, 2006, CELL REPOPULATION BI, V13, P25; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhuang J, 2014, CRIT REV PLANT SCI, V33, P225, DOI 10.1080/07352689.2014.870420	79	112	121	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117569	10.1371/journal.pone.0117569	http://dx.doi.org/10.1371/journal.pone.0117569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658122	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900178
J	Nieves-Cintron, M; Nystoriak, MA; Prada, MP; Johnson, K; Fayer, W; Dell'Acqua, ML; Scott, JD; Navedo, MF				Nieves-Cintron, Madeline; Nystoriak, Matthew A.; Prada, Maria Paz; Johnson, Kenneth; Fayer, William; Dell'Acqua, Mark L.; Scott, John D.; Navedo, Manuel F.			Selective Down-regulation of K(V)2.1 Function Contributes to Enhanced Arterial Tone during Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Ion Channel; Scaffold Protein; Type 2 Diabetes; Vascular Smooth Muscle Cells; AKAP150; Cerebral Arteries; High Fat Diet Mouse; Hyperglycemia	SMOOTH-MUSCLE-CELLS; GATED K+ CHANNELS; PROTEIN-KINASE-C; CEREBRAL-ARTERIES; POTASSIUM CHANNELS; LARGE-CONDUCTANCE; LOCAL-REGULATION; CA2+ CHANNELS; RAT; DIAMETER	Background: K-V channels in vascular smooth muscle cells (VSMCs) regulate arterial tone. Results: K(V)2.1 in VSMCs is down-regulated via AKAP150-CaN-dependent NFATc3 signaling during diabetes. Conclusion: Transcriptional suppression of K(V)2.1 contributes to enhanced arterial tone in diabetes. Significance: AKAP150-CaN-dependent activation of NFATc3 may be a general mechanism for transcriptional regulation of K+ channels, and a valuable target to prevent and treat diabetic vascular complications. Enhanced arterial tone is a leading cause of vascular complications during diabetes. Voltage-gated K+ (K-V) channels are key regulators of vascular smooth muscle cells (VSMCs) contractility and arterial tone. Whether impaired K-V channel function contributes to enhance arterial tone during diabetes is unclear. Here, we demonstrate a reduction in K-V-mediated currents (I-Kv) in VSMCs from a high fat diet (HFD) mouse model of type 2 diabetes. In particular, I-Kv sensitive to stromatoxin (ScTx), a potent K(V)2 blocker, were selectively reduced in diabetic VSMCs. This was associated with decreased K(V)2-mediated regulation of arterial tone and suppression of the K(V)2.1 subunit mRNA and protein in VSMCs/arteries isolated from HFD mice. We identified protein kinase A anchoring protein 150 (AKAP150), via targeting of the phosphatase calcineurin (CaN), and the transcription factor nuclear factor of activated T-cells c3 (NFATc3) as required determinants of K(V)2.1 suppression during diabetes. Interestingly, substantial reduction in transcript levels for K(V)2.1 preceded down-regulation of large conductance Ca2+-activated K+ (BKCa) channel 1 subunits, which are ultimately suppressed in chronic hyperglycemia to a similar extent. Together, our study supports the concept that transcriptional suppression of K(V)2.1 by activation of the AKAP150-CaN/NFATc3 signaling axis contributes to enhanced arterial tone during diabetes.	[Nieves-Cintron, Madeline; Nystoriak, Matthew A.; Prada, Maria Paz; Johnson, Kenneth; Fayer, William; Navedo, Manuel F.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Dell'Acqua, Mark L.] Univ Colorado, Dept Pharmacol, Denver, CO 80045 USA; [Scott, John D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Scott, John D.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Denver; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Navedo, MF (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	mfnavedo@ucdavis.edu			National Institutes of Health [R01HL098200]; American Heart Association Grant (AHA) [AHA-14GRNT18730054]; NHLBI [HL-086350, HL-07828]; Lawrence J. and Florence A. DeGeorge Charitable Trust; National Institutes of Health through the NIGMS [T32GM099608];  [AHA-13POST12730001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098200, T32HL007828, T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, P30DK017047, R01DK105542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant (AHA)(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lawrence J. and Florence A. DeGeorge Charitable Trust; National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01HL098200 and American Heart Association Grant (AHA) AHA-14GRNT18730054 (to M. F. N.), and NHLBI training grants HL-086350 and HL-07828 and Grant AHA-13POST12730001 and the Lawrence J. and Florence A. DeGeorge Charitable Trust (to M. A. N.). This work was also supported by National Institutes of Health Grant T32GM099608 (to M. P. P.) through the NIGMS.	Albarwani S, 2003, J PHYSIOL-LONDON, V551, P751, DOI 10.1113/jphysiol.2003.040014; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Amberg GC, 2006, AM J PHYSIOL-CELL PH, V291, pC348, DOI 10.1152/ajpcell.00086.2006; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gomez MF, 2003, J BIOL CHEM, V278, P46847, DOI 10.1074/jbc.M304765200; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Kidd MW, 2013, FASEB J, V27; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Liu YP, 2001, CIRC RES, V89, P146, DOI 10.1161/hh1401.093294; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Marzian S, 2013, NAT CHEM BIOL, V9, P507, DOI 10.1038/nchembio.1271; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; Moore CL, 2014, CIRC RES, V114, P1258, DOI 10.1161/CIRCRESAHA.114.303167; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Navedo MF, 2013, MICROCIRCULATION, V20, P290, DOI 10.1111/micc.12021; Navedo MF, 2013, J MOL CELL CARDIOL, V58, P67, DOI 10.1016/j.yjmcc.2012.11.018; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nieves-Cintron M, 2008, P NATL ACAD SCI USA, V105, P15623, DOI 10.1073/pnas.0808759105; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Nystoriak MA, 2013, BBA-MOL CELL RES, V1833, P1657, DOI 10.1016/j.bbamcr.2012.10.027; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Rainbow RD, 2006, J PHYSIOL-LONDON, V575, P833, DOI 10.1113/jphysiol.2006.114009; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Straub SV, 2009, AM J PHYSIOL-CELL PH, V297, pC788, DOI 10.1152/ajpcell.00148.2009; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu CL, 1999, AM J PHYSIOL-GASTR L, V277, pG1055, DOI 10.1152/ajpgi.1999.277.5.G1055; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P4519, DOI 10.1113/jphysiol.2010.196618; Zimmermann PA, 1997, CIRC RES, V81, P996	47	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7918	7929		10.1074/jbc.M114.622811	http://dx.doi.org/10.1074/jbc.M114.622811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670860	Green Published, hybrid			2022-12-26	WOS:000351613600049
J	Okabayashi, S; Shimozawa, N; Yasutomi, Y; Yanagisawa, K; Kimura, N				Okabayashi, Sachi; Shimozawa, Nobuhiro; Yasutomi, Yasuhiro; Yanagisawa, Katsuhiko; Kimura, Nobuyuki			Diabetes Mellitus Accelerates A beta Pathology in Brain Accompanied by Enhanced GA beta Generation in Nonhuman Primates	PLOS ONE			English	Article							ENDOCYTIC PATHWAY ABNORMALITIES; SPORADIC ALZHEIMERS-DISEASE; AMYLOID FIBRIL FORMATION; AGE-RELATED-CHANGES; INSULIN-RESISTANCE; MOUSE MODEL; AUTOPHAGIC PATHWAY; LIPID-METABOLISM; SENILE PLAQUES; TAU PATHOLOGY	Growing evidence suggests that diabetes mellitus (DM) is one of the strongest risk factors for developing Alzheimer's disease (AD). However, it remains unclear why DM accelerates AD pathology. In cynomolgus monkeys older than 25 years, senile plaques (SPs) are spontaneously and consistently observed in their brains, and neurofibrillary tangles are present at 32 years of age and older. In laboratory-housed monkeys, obesity is occasionally observed and frequently leads to development of type 2 DM. In the present study, we performed histopathological and biochemical analyses of brain tissue in cynomolgus monkeys with type 2 DM to clarify the relationship between DM and AD pathology. Here, we provide the evidence that DM accelerates A beta pathology in vivo in nonhuman primates who had not undergone any genetic manipulation. In DM-affected monkey brains, SPs were observed in frontal and temporal lobe cortices, even in monkeys younger than 20 years. Biochemical analyses of brain revealed that the amount of GM1-ganglioside-bound A beta (GA beta)-the endogenous seed for A beta fibril formation in the brain-was clearly elevated in DM-affected monkeys. Furthermore, the level of Rab GTPases was also significantly increased in the brains of adult monkeys with DM, almost to the same levels as in aged monkeys. Intraneuronal accumulation of enlarged endosomes was also observed in DM-affected monkeys, suggesting that exacerbated endocytic disturbance may underlie the acceleration of A beta pathology due to DM.	[Okabayashi, Sachi; Shimozawa, Nobuhiro; Yasutomi, Yasuhiro; Kimura, Nobuyuki] Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, Tsukuba, Ibaraki 3050843, Japan; [Okabayashi, Sachi] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; [Yanagisawa, Katsuhiko; Kimura, Nobuyuki] Natl Ctr Geriatr & Gerontol, Sect Cell Biol & Pathol, Dept Alzheimers Dis Res, Ctr Dev Adv Med Dementia, Obu, Aichi 4748511, Japan	National Institute of Health Sciences - Japan; National Center for Geriatrics & Gerontology	Kimura, N (corresponding author), Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, 1-1 Hachimandai, Tsukuba, Ibaraki 3050843, Japan.	kimura@ncgg.go.jp			National Center for Geriatrics and Gerontology (NCGG), Japan [25-20]	National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology)	This study was supported by The Research Funding for Longevity Sciences (25-20) from National Center for Geriatrics and Gerontology (NCGG), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2009, FOLIA NEUROPATHOL, V47, P289; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Baptista FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065515; Bauer SA, 2011, COMPARATIVE MED, V61, P541; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen YX, 2013, MOL NEUROBIOL, V47, P711, DOI 10.1007/s12035-012-8375-5; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Currais A, 2012, AGING CELL, V11, P1017, DOI 10.1111/acel.12002; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; KAMADA T, 1992, DIABETES RES CLIN PR, V16, P85, DOI 10.1016/0168-8227(92)90077-5; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Kimura N, 2007, NEUROREPORT, V18, P1669, DOI 10.1097/WNR.0b013e3282f0d2ab; Kimura N, 2012, AM J PATHOL, V180, P550, DOI 10.1016/j.ajpath.2011.10.037; Kimura N, 2009, J BIOL CHEM, V284, P31291, DOI 10.1074/jbc.M109.012625; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu Y, 2011, J ENDOCRINOL INVEST, V34, P169, DOI 10.1007/BF03347055; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Nakamura S, 1998, J MED PRIMATOL, V27, P244, DOI 10.1111/j.1600-0684.1998.tb00244.x; NATARAJAN V, 1981, J NEUROCHEM, V36, P413, DOI 10.1111/j.1471-4159.1981.tb01609.x; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oikawa N, 2010, BRAIN RES, V1315, P137, DOI 10.1016/j.brainres.2009.12.005; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Runyan CE, 2012, J BIOL CHEM, V287, P35815, DOI 10.1074/jbc.M112.380493; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; Son SM, 2012, AUTOPHAGY, V8, P1842, DOI 10.4161/auto.21861; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; THAKKER JK, 1989, J BIOL CHEM, V264, P7169; TOOZE J, 1990, J CELL BIOL, V111, P329, DOI 10.1083/jcb.111.2.329; Tsuchida J, 2008, J AM ASSOC LAB ANIM, V47, P29; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Yuyama K, 2009, J NEUROCHEM, V109, P1250, DOI 10.1111/j.1471-4159.2009.06046.x; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	71	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117362	10.1371/journal.pone.0117362	http://dx.doi.org/10.1371/journal.pone.0117362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675436	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000019
J	Bernardino, F; Rentmeister, K; Schmidt, MJ; Bruehschwein, A; Matiasek, K; Matiasek, LA; Lauda, A; Schoon, HA; Fischer, A				Bernardino, Filipa; Rentmeister, Kai; Schmidt, Martin J.; Bruehschwein, Andreas; Matiasek, Kaspar; Matiasek, Lara A.; Lauda, Alexander; Schoon, Heinz A.; Fischer, Andrea			Inferior Cerebellar Hypoplasia Resembling a Dandy-Walker-Like Malformation in Purebred Eurasier Dogs with Familial Non-Progressive Ataxia: A Retrospective and Prospective Clinical Cohort Study	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; IMAGING DIAGNOSIS; DYSEQUILIBRIUM SYNDROME; VERMIAN HYPOPLASIA; PRENATAL-DIAGNOSIS; MENTAL-RETARDATION; VARIANT; CLASSIFICATION; HYDROCEPHALUS; MUTATIONS	Cerebellar malformations can be inherited or caused by insults during cerebellar development. To date, only sporadic cases of cerebellar malformations have been reported in dogs, and the genetic background has remained obscure. Therefore, this study's objective was to describe the clinical characteristics, imaging features and pedigree data of a familial cerebellar hypoplasia in purebred Eurasier dogs. A uniform cerebellar malformation characterized by consistent absence of the caudal portions of the cerebellar vermis and, to a lesser degree, the caudal portions of the cerebellar hemispheres in association with large retrocerebellar fluid accumulations was recognized in 14 closely related Eurasier dogs. Hydrocephalus was an additional feature in some dogs. All dogs displayed non-progressive ataxia, which had already been noted when the dogs were 5 - 6 weeks old. The severity of the ataxia varied between dogs, from mild truncal sway, subtle dysmetric gait, dysequilibrium and pelvic limb ataxia to severe cerebellar ataxia in puppies and episodic falling or rolling. Follow-up examinations in adult dogs showed improvement of the cerebellar ataxia and a still absent menace response. Epileptic seizures occurred in some dogs. The association of partial vermis agenesis with an enlarged fourth ventricle and an enlarged caudal (posterior) fossa resembled a Dandy-Walker-like malformation in some dogs. Pedigree analyses were consistent with autosomal recessive inheritance.	[Bernardino, Filipa; Matiasek, Lara A.; Lauda, Alexander; Fischer, Andrea] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany; [Rentmeister, Kai] Tierarztliche Praxis Neurol, Dettelbach, Germany; [Schmidt, Martin J.] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, D-35390 Giessen, Germany; [Bruehschwein, Andreas] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Surg & Reprod, Munich, Germany; [Matiasek, Kaspar] Univ Munich, Ctr Clin Vet Med, Sect Clin & Comparat Neuropathol, Munich, Germany; [Schoon, Heinz A.] Univ Leipzig, Fac Vet Med, Inst Pathol, D-04109 Leipzig, Germany	University of Munich; Justus Liebig University Giessen; University of Munich; University of Munich; Leipzig University	Fischer, A (corresponding author), Univ Munich, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany.	andreafischer@lmu.de	Fischer, Andrea/AFV-0155-2022	Matiasek, Kaspar/0000-0001-5021-3280; Fischer, Andrea/0000-0001-7094-1947				Abdel-Salam GMH, 2006, BRAIN DEV-JPN, V28, P529, DOI 10.1016/j.braindev.2006.01.009; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Alexiou GA, 2010, J CHILD NEUROL, V25, P188, DOI 10.1177/0883073809338410; Ali BR, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-80; Barkovich AJ, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00007; Barkovich AJ, 2009, BRAIN, V132, P3199, DOI 10.1093/brain/awp247; BARKOVICH AJ, 1989, AM J NEURORADIOL, V10, P977; BENDA CE, 1954, J NEUROPATH EXP NEUR, V13, P14, DOI 10.1093/jnen/13.1.14; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Bolduc ME, 2009, DEV MED CHILD NEUROL, V51, P256, DOI 10.1111/j.1469-8749.2008.03224.x; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Choi H, 2007, VET RADIOL ULTRASOUN, V48, P129, DOI 10.1111/j.1740-8261.2007.00217.x; Dandy WE, 1914, AM J DIS CHILD, V8, P406; DeLahunta A, 2009, CEREBELLUM VET NEURO, P348, DOI [10.1002/wsbm.50, DOI 10.1002/WSBM.50]; Dow RS, 1940, J COMP NEUROL, V72, P569, DOI 10.1002/cne.900720307; Economou A, 2012, J CHILD NEUROL, V27, P930, DOI 10.1177/0883073811429500; Ferraris A, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-75; Garel C, 2011, J CHILD NEUROL, V26, P1483, DOI 10.1177/0883073811420148; Gerber M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0108917; Glass HC, 2005, DEV MED CHILD NEUROL, V47, P691, DOI 10.1017/S0012162205001404; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Guibaud L, 2012, PRENATAL DIAG, V32, P185, DOI 10.1002/pd.3828; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Imataka George, 2007, Congenital Anomalies, V47, P113, DOI 10.1111/j.1741-4520.2007.00158.x; Klein O, 2003, CHILD NERV SYST, V19, P484, DOI 10.1007/s00381-003-0782-5; KNECHT CD, 1979, J AM ANIM HOSP ASSOC, V15, P51; Kobatake Y, 2013, J VET MED SCI, V75, P1379, DOI 10.1292/jvms.12-0550; Kolb LE, 2010, NEUROGENETICS, V11, P319, DOI 10.1007/s10048-009-0232-y; KORNEGAY JN, 1986, VET PATHOL, V23, P374, DOI 10.1177/030098588602300405; Lim BC, 2011, J CHILD NEUROL, V26, P615, DOI 10.1177/0883073810384996; Lim JH, 2008, J VET SCI, V9, P215, DOI 10.4142/jvs.2008.9.2.215; Mademont-Soler I, 2010, AM J MED GENET A, V152A, P2308, DOI 10.1002/ajmg.a.33550; Malinger G, 2009, PRENATAL DIAG, V29, P372, DOI 10.1002/pd.2196; McCormack WM, 2002, AM J MED GENET, V112, P384, DOI 10.1002/ajmg.10659; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; MURRAY JC, 1985, CLIN GENET, V28, P272; Niesen Charles E, 2002, Semin Pediatr Neurol, V9, P320, DOI 10.1053/spen.2002.32508; Notaridis G, 2006, NEUROPATH APPL NEURO, V32, P344, DOI 10.1111/j.1365-2990.2006.00719.x; Noureddine C, 2004, VET RADIOL ULTRASOUN, V45, P336, DOI 10.1111/j.1740-8261.2004.04064.x; Oczelik T, 2008, P NATL ACAD SCI USA, V105, P4032, DOI [10.1073/pnas.0800376105, DOI 10.1073/PNAS.0800376105]; PALMER AC, 1973, J SMALL ANIM PRACT, V14, P343, DOI 10.1111/j.1748-5827.1973.tb06468.x; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; PASS DA, 1981, VET PATHOL, V18, P405, DOI 10.1177/030098588101800315; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Resibois A, 2007, VET PATHOL, V44, P831, DOI 10.1354/vp.44-6-831; Sarac O, 2012, OPHTHALMIC GENET, V33, P249, DOI 10.3109/13816810.2012.689412; Sasaki-Adams D, 2008, J NEUROSURG-PEDIATR, V2, P194, DOI 10.3171/PED/2008/2/9/194; Schatzberg SJ, 2003, J VET INTERN MED, V17, P538, DOI 10.1892/0891-6640(2003)017&lt;0538:PCRPAO&gt;2.3.CO;2; SCHMID V, 1992, J AM ANIM HOSP ASSOC, V28, P355; Schmidt MJ, 2008, VET RADIOL ULTRASOUN, V49, P264, DOI 10.1111/j.1740-8261.2008.00362.x; Shekdar K, 2011, SEMIN ULTRASOUND CT, V32, P228, DOI 10.1053/j.sult.2011.02.003; Spennato P, 2011, CHILD NERV SYST, V27, P1665, DOI 10.1007/s00381-011-1544-4; STOLL C, 1990, AM J MED GENET, V37, P124, DOI 10.1002/ajmg.1320370129; Taggart JK, 1942, ARCH NEURO PSYCHIATR, V48, P583, DOI 10.1001/archneurpsyc.1942.02290100083008; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73; Vasudevan C, 2012, SEMIN FETAL NEONAT M, V17, P295, DOI 10.1016/j.siny.2012.07.001; Wakeling EL, 2002, CLIN DYSMORPHOL, V11, P15, DOI 10.1097/00019605-200201000-00003; Weimer J, 2006, CYTOGENET GENOME RES, V114, P235, DOI 10.1159/000094206; Zanni G, 2011, NEUROGENETICS, V12, P241, DOI 10.1007/s10048-011-0283-8	61	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117670	10.1371/journal.pone.0117670	http://dx.doi.org/10.1371/journal.pone.0117670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668516	gold, Green Published, Green Submitted			2022-12-26	WOS:000349493000025
J	D'Aoust, LN; Cummings, AC; Laux, R; Fuzzell, D; Caywood, L; Reinhart-Mercer, L; Scott, WK; Pericak-Vance, MA; Haines, JL				D'Aoust, Laura N.; Cummings, Anna C.; Laux, Renee; Fuzzell, Denise; Caywood, Laura; Reinhart-Mercer, Lori; Scott, William K.; Pericak-Vance, Margaret A.; Haines, Jonathan L.			Examination of Candidate Exonic Variants for Association to Alzheimer Disease in the Amish	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; IDENTIFIES VARIANTS; COGNITIVE DECLINE; COMMON VARIANTS; DEMENTIA; ONSET; ALLELE; GENOTYPE; AGE	Alzheimer disease (AD) is the most common cause of dementia. As with many complex diseases, the identified variants do not explain the total expected genetic risk that is based on heritability estimates for AD. Isolated founder populations, such as the Amish, are advantageous for genetic studies as they overcome heterogeneity limitations associated with complex population studies. We determined that Amish AD cases harbored a significantly higher burden of the known risk alleles compared to Amish cognitively normal controls, but a significantly lower burden when compared to cases from a dataset of unrelated individuals. Whole-exome sequencing of a selected subset of the overall study population was used as a screening tool to identify variants located in the regions of the genome that are most likely to contribute risk. By then genotyping the top candidate variants from the known AD genes and from linkage regions implicated previous studies in the full dataset, new associations could be confirmed. The most significant result (p = 0.0012) was for rs73938538, a synonymous variant in LAMA1 within the previously identified linkage peak on chromosome 18. However, this association is specific to the Amish and did not generalize when tested in a dataset of unrelated individuals. These results suggest that additional risk variation in the Amish remains to be identified and likely resides outside of the classical protein coding gene regions.	[D'Aoust, Laura N.; Cummings, Anna C.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA; [Laux, Renee; Fuzzell, Denise; Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Laux, Renee; Fuzzell, Denise; Haines, Jonathan L.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Caywood, Laura; Reinhart-Mercer, Lori; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33101 USA	Vanderbilt University; Case Western Reserve University; Case Western Reserve University; University of Miami	Cummings, AC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA.	laura.n.daoust@vanderbilt.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	National Institutes of Health [AG019085, AG019726]; National Institute of General Medical Sciences [T32 GM007347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019085, R01AG019726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health [AG019085 to JLH and MAP-V, AG019726 to WKS]; and the National Institute of General Medical Sciences [T32 GM007347]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2003, AM J MED GENET C, V121C, P32, DOI 10.1002/ajmg.c.20004; Beachy L, 2011, UNSER LEIT THE STORY; Bomboi G, 2010, NEUROL SCI, V31, P1, DOI 10.1007/s10072-009-0151-6; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cummings AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062615; Cummings AC, 2012, ANN HUM GENET, V76, P342, DOI 10.1111/j.1469-1809.2012.00721.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Goldstein FC, 2001, NEUROLOGY, V57, P1923, DOI 10.1212/WNL.57.10.1923; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Holder J, 1998, J NEUROPSYCH CLIN N, V10, P100, DOI 10.1176/jnp.10.1.100; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hsiung GYR, 2004, CAN MED ASSOC J, V171, P863, DOI 10.1503/cmaj.1031789; Johnson CC, 1997, INT J EPIDEMIOL, V26, P387, DOI 10.1093/ije/26.2.387; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Lambert JC, 2013, NAT GENET, DOI [10.1038/ng.2856, DOI 10.1038/NG.2856]; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Skoog I, 1998, J NEUROL NEUROSUR PS, V64, P37, DOI 10.1136/jnnp.64.1.37; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0118043	10.1371/journal.pone.0118043	http://dx.doi.org/10.1371/journal.pone.0118043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668194	gold, Green Published, Green Submitted			2022-12-26	WOS:000349493000039
J	Denes, J; Kasuki, L; Trivellin, G; Colli, LM; Takiya, CM; Stiles, CE; Barry, S; de Castro, M; Gadelha, MR; Korbonits, M				Denes, Judit; Kasuki, Leandro; Trivellin, Giampaolo; Colli, Leandro M.; Takiya, Christina M.; Stiles, Craig E.; Barry, Sayka; de Castro, Margaret; Gadelha, Monica R.; Korbonits, Marta			Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas	PLOS ONE			English	Article							PITUITARY-ADENOMA PREDISPOSITION; SOMATOSTATIN ANALOGS; CELL-LINE; MUTATIONS; GROWTH; GENE; PREDICTOR; MICRORNAS; MIRNAS; FAMILY	Introduction Patients with germline AIP mutations or low AIP protein expression have large, invasive somatotroph adenomas and poor response to somatostatin analogues (SSA). Methods To study the mechanism of low AIP protein expression 31 sporadic somatotropinomas with low (n = 13) or high (n = 18) AIP protein expression were analyzed for expression of AIP messenger RNA (mRNA) and 11 microRNAs (miRNAs) predicted to bind the 3'UTR of AIP. Luciferase reporter assays of wild-type and deletion constructs of AIP-3'UTR were used to study the effect of the selected miRNAs in GH3 cells. Endogenous AIP protein and mRNA levels were measured after miRNA over-and underexpression in HEK293 and GH3 cells. Results No significant difference was observed in AIP mRNA expression between tumors with low or high AIP protein expression suggesting post-transcriptional regulation. miR-34a was highly expressed in low AIP protein samples compared high AIP protein adenomas and miR-34a levels were inversely correlated with response to SSA therapy. miR-34a inhibited the luciferase-AIP-3'UTR construct, suggesting that miR-34a binds to AIP-3'UTR. Deletion mutants of the 3 different predicted binding sites in AIP-3'UTR identified the c.*6-30 site to be involved in miR-34a's activity. miR-34a overexpression in HEK293 and GH3 cells resulted in inhibition of endogenous AIP protein expression. Conclusion Low AIP protein expression is associated with high miR-34a expression. miR-34a can down-regulate AIP-protein but not RNA expression in vitro. miR-34a is a negative regulator of AIP-protein expression and could be responsible for the low AIP expression observed in somatotropinomas with an invasive phenotype and resistance to SSA.	[Denes, Judit; Trivellin, Giampaolo; Stiles, Craig E.; Barry, Sayka; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, William Harvey Res Inst, London, England; [Denes, Judit] Semmelweis Univ, Doctoral Sch Clin Med, Sch PhD Studies, H-1085 Budapest, Hungary; [Kasuki, Leandro; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Endocrinol Unit, Rio De Janeiro, Brazil; [Colli, Leandro M.; de Castro, Margaret] Univ Sao Paulo, Ribeirao Preto Med Sch, Endocrinol Lab, Dept Internal Med, Sao Paulo, Brazil; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Biofis Carlos Chagas Filho Inst, Rio De Janeiro, Brazil	University of London; Queen Mary University London; Semmelweis University; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Korbonits, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, William Harvey Res Inst, London, England.	m.korbonits@qmul.ac.uk	de Castro, Margaret/A-4918-2009; Colli, Leandro/A-3445-2009; Trivellin, Giampaolo/J-6583-2016; Takiya, Christina/AAU-5959-2021; Kasuki, Leandro/R-8117-2019	de Castro, Margaret/0000-0003-4932-4623; Colli, Leandro/0000-0001-6928-1195; Trivellin, Giampaolo/0000-0003-2384-4153; Takiya, Christina/0000-0002-8019-628X; Korbonits, Marta/0000-0002-4101-9432	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142479/2011-0, 308105 2011-7]; Wellcome Trust Clinical Training Fellowship [097970/Z/11/Z]; Pfizer [WS 733753]; National Institute for Health Research [ACF-2010-19-002] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust Clinical Training Fellowship(Wellcome Trust); Pfizer(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR))	LK received a grant (142479/2011-0) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br). CES was supported by a Wellcome Trust Clinical Training Fellowship (097970/Z/11/Z, www.wellcome.ac.uk) and part of the work was supported by a research grant from Pfizer to MK (WS 733753, www.pfizer.com). MRG received a grant (308105 2011-7) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; BANCROFT FC, 1969, J CELL BIOL, V43, P432, DOI 10.1083/jcb.43.3.432; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; D'Angelo D, 2012, J CLIN ENDOCR METAB, V97, pE1128, DOI 10.1210/jc.2011-3482; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fougner SL, 2012, CLIN ENDOCRINOL, V76, P96, DOI 10.1111/j.1365-2265.2011.04163.x; Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; de Pinho LKJ, 2011, NEUROENDOCRINOLOGY, V94, P39, DOI 10.1159/000322787; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Kasuki L, 2013, EUR J ENDOCRINOL, V169, P217, DOI 10.1530/EJE-13-0349; Kasuki L, 2012, ENDOCR-RELAT CANCER, V19, pL25, DOI 10.1530/ERC-12-0020; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mao ZG, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-79; Nanzer AM, 2004, EUR J ENDOCRINOL, V151, P233, DOI 10.1530/eje.0.1510233; Obari A, 2008, ENDOCR PATHOL, V19, P82, DOI 10.1007/s12022-008-9029-z; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Patel MI, 2005, BIOTECHNOL LETT, V27, P805, DOI 10.1007/s10529-005-5803-x; Raitila A, 2007, ENDOCR-RELAT CANCER, V14, P901, DOI 10.1677/ERC-07-0025; Rizzo M, 2012, NUCLEIC ACID THER, V22, P283, DOI 10.1089/nat.2012.0343; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011; Neto LV, 2011, ARQ BRAS ENDOCRINOL, V55, P91, DOI 10.1590/S0004-27302011000200001; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Zatelli MC, 2013, PITUITARY, V16, P238, DOI 10.1007/s11102-012-0409-5	44	43	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117107	10.1371/journal.pone.0117107	http://dx.doi.org/10.1371/journal.pone.0117107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658813	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900102
J	Gabruk, M; Stecka, A; Strzalka, W; Kruk, J; Strzalka, K; Mysliwa-Kurdziel, B				Gabruk, Michal; Stecka, Anna; Strzalka, Wojciech; Kruk, Jerzy; Strzalka, Kazimierz; Mysliwa-Kurdziel, Beata			Photoactive Protochlorophyllide-Enzyme Complexes Reconstituted with PORA, PORB and PORC Proteins of A. thaliana: Fluorescence and Catalytic Properties	PLOS ONE			English	Article							ETIOPLAST INNER MEMBRANES; ARABIDOPSIS-THALIANA; CHLOROPHYLL BIOSYNTHESIS; PROLAMELLAR BODIES; BARLEY ETIOPLASTS; WHEAT ETIOPLASTS; OXIDOREDUCTASE; LIGHT; NADPH; FORMS	Photoactive Pchlide-POR-NADPH complexes were reconstituted using protochlorophyllide (Pchlide) and recombinant light-dependent protochlorophyllide oxidoreductase (POR) proteins, His(6)-PORA, His(6)-PORB and His(6)-PORC, from Arabidopsis thaliana. We did not observe any differences in the kinetics of the protochlorophyllide photoreduction at room temperature among the PORA, PORB and PORC proteins. In contrast, the PORC protein showed lower yield of Chlide formation than PORA and PORB when preincubated in the dark for 30 min and then illuminated for a short time. The most significant observation was that reconstituted Pchlide-POR-NADPH complexes showed fluorescence maxima at 77 K similar to those observed for highly aggregated Pchlide-POR-NADPH complexes in prolamellar bodies (PLBs) in vivo. Homology models of PORA, PORB and PORC of Arabidopsis thaliana were developed to compare predicted structures of POR isoforms. There were only slight structural differences, mainly in the organisation of helices and loops, but not in the shape of whole molecules. This is the first comparative analysis of all POR isoforms functioning at different stages of A. thaliana development.	[Gabruk, Michal; Stecka, Anna; Kruk, Jerzy; Strzalka, Kazimierz; Mysliwa-Kurdziel, Beata] Jagiellonian Univ, Dept Plant Physiol & Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Strzalka, Wojciech] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University; Jagiellonian University	Mysliwa-Kurdziel, B (corresponding author), Jagiellonian Univ, Dept Plant Physiol & Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	b.mysliwa-kurdziel@uj.edu.pl	Mysliwa-Kurdziel, Beata/AAF-1478-2020	Mysliwa-Kurdziel, Beata/0000-0002-3361-7934; Strzalka, Wojciech/0000-0002-4541-8545; Gabruk, Michal/0000-0002-5639-2475	Polish National Centre of Science (NCN) [2011/01/B/NZ1/00119]	Polish National Centre of Science (NCN)	This work was supported by grant 2011/01/B/NZ1/00119 from the Polish National Centre of Science (NCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Armstrong GA, 2000, TRENDS PLANT SCI, V5, P40, DOI 10.1016/S1360-1385(99)01513-7; Belyaeva OB, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1458, DOI 10.1134/S0006297907130044; Blomqvist LA, 2008, PHOTOSYNTH RES, V96, P37, DOI 10.1007/s11120-007-9281-y; BODDI B, 1993, J PHOTOCH PHOTOBIO B, V21, P125, DOI 10.1016/1011-1344(93)80174-8; BODDI B, 1992, J PHOTOCH PHOTOBIO B, V12, P389, DOI 10.1016/1011-1344(92)85043-T; BODDI B, 1989, PHYSIOL PLANTARUM, V76, P135, DOI 10.1111/j.1399-3054.1989.tb05622.x; BODDI B, 1991, PHOTOCHEM PHOTOBIOL, V53, P667; BODDI B, 1990, PHOTOCHEM PHOTOBIOL, V52, P83, DOI 10.1111/j.1751-1097.1990.tb01759.x; Boddi B, 1994, HUM ENV SCI, V3, P39; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Chahdi MAO, 1998, PLANTA, V206, P673, DOI 10.1007/s004250050446; Gabruk M, 2012, PHOTOSYNTHETICA, V50, P529, DOI 10.1007/s11099-012-0057-z; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kis-Petik K, 1999, PHOTOSYNTH RES, V60, P87, DOI 10.1023/A:1006238921189; Klement H, 2000, FEBS LETT, V480, P306, DOI 10.1016/S0014-5793(00)01887-1; Kosa A, 2006, BBA-BIOENERGETICS, V1757, P811, DOI 10.1016/j.bbabio.2006.05.039; KOTZABASIS K, 1990, PHOTOCHEM PHOTOBIOL, V52, P95, DOI 10.1111/j.1751-1097.1990.tb01761.x; Kruk J, 2004, CHROMATOGRAPHIA, V60, P117, DOI 10.1365/s10337-004-0320-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Mylsiwa-Kurdziel B, 2004, PHOTOCHEM PHOTOBIOL, V79, P62; Mysliwa-Kurdziel B, 2013, BIOPHYS CHEM, V175, P28, DOI 10.1016/j.bpc.2013.02.002; Oosawa N, 2000, FEBS LETT, V474, P133, DOI 10.1016/S0014-5793(00)01568-4; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Ploscher M, 2009, FEBS J, V276, P1074, DOI 10.1111/j.1742-4658.2008.06850.x; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; RYBERG M, 1982, PHYSIOL PLANTARUM, V56, P133, DOI 10.1111/j.1399-3054.1982.tb00314.x; RYBERG M, 1986, PHYSIOL PLANTARUM, V66, P616, DOI 10.1111/j.1399-3054.1986.tb05589.x; Scheumann V, 1999, FEBS LETT, V445, P445, DOI 10.1016/S0014-5793(99)00169-6; Schoefs B, 2005, PHOTOSYNTHETICA, V43, P329, DOI 10.1007/s11099-005-0056-4; Schoefs B, 2003, PHOTOCHEM PHOTOBIOL, V78, P543, DOI 10.1562/0031-8655(2003)078&lt;0543:PRMAE&gt;2.0.CO;2; Schoefs B, 2000, FEBS LETT, V486, P243, DOI 10.1016/S0014-5793(00)02309-7; SELISKAR CJ, 1968, BIOCHIM BIOPHYS ACTA, V153, P685, DOI 10.1016/0005-2728(68)90195-3; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Yang J, 2004, PLANT BIOLOGY, V6, P537, DOI 10.1055/s-2004-821270; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010	48	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116990	10.1371/journal.pone.0116990	http://dx.doi.org/10.1371/journal.pone.0116990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659137	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900087
J	Geltz, JJ; Gershburg, E; Halford, WP				Geltz, Joshua J.; Gershburg, Edward; Halford, William P.			Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; GLYCOPROTEIN-D; GENITAL HERPES; RECOMBINANT GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; PROTECTS MICE; TYPE-2 GLYCOPROTEINS; IMMUNE-RESPONSE; UNITED-STATES; SUBUNIT	Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0(-) mutant virus, HSV-2 0 Delta NLS, are 10 to 100 times better protected against genital herpes than mice immunized with a HSV-2 gD subunit vaccine (PLoS ONE 6:e17748). In light of these results, we sought to determine which viral proteins were the dominant antibody- generators (antigens) of the live HSV-2 0 Delta NLS vaccine. Western blot analyses indicated the live HSV-2 0 Delta NLS vaccine elicited an IgG antibody response against 9 or more viral proteins. Many antibodies were directed against infected-cell proteins of > 100 kDa in size, and only 10 +/- 5% of antibodies were directed against gD. Immunoprecipitation (IP) of total HSV-2 antigen with 0 Delta NLS antiserum pulled down 19 viral proteins. Mass spectrometry suggested 44% of immunoprecipitated viral peptides were derived from two HSV-2 infected cells proteins, RR-1 and ICP8, whereas only 14% of immunoprecipitated peptides were derived from HSV-2's thirteen glycoproteins. Collectively, the results suggest the immune response to the live HSV-2 0 Delta NLS vaccine includes antibodies specific for infected cell proteins, capsid proteins, tegument proteins, and glycoproteins. This increased breadth of antibody-generating proteins may contribute to the live HSV-2 vaccine's capacity to elicit superior protection against genital herpes relative to a gD subunit vaccine.	[Geltz, Joshua J.; Gershburg, Edward; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENAKIS M, 1981, INFECT IMMUN, V33, P22, DOI 10.1128/IAI.33.1.22-28.1981; ARSENAKIS M, 1982, BRIT J VENER DIS, V58, P48; ASHER LVS, 1978, AM J OBSTET GYNECOL, V131, P788; ASHLEY R, 1985, J VIROL, V56, P475, DOI 10.1128/JVI.56.2.475-481.1985; ASHLEY RL, 1987, J VIROL METHODS, V18, P159, DOI 10.1016/0166-0934(87)90121-2; AURELIAN L, 1973, SCIENCE, V181, P161, DOI 10.1126/science.181.4095.161; BACCHETTI S, 1984, J VIROL, V49, P591, DOI 10.1128/JVI.49.2.591-593.1984; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Belur Lalitha R., 2008, V434, P267, DOI 10.1007/978-1-60327-248-3_16; BERMAN PW, 1985, SCIENCE, V227, P1490, DOI 10.1126/science.2983428; BERNSTEIN DI, 1985, J MED VIROL, V15, P251, DOI 10.1002/jmv.1890150306; Brockman MA, 2006, J VIROL, V80, P7111, DOI 10.1128/JVI.01421-05; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; COHEN GH, 1984, J VIROL, V49, P102, DOI 10.1128/JVI.49.1.102-108.1984; Cohen ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020597; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Dinh TH, 2008, SEX TRANSM DIS, V35, P19, DOI 10.1097/OLQ.0b013e318162c4c6; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; EVANS L, 1983, J VIROL METHODS, V6, P245, DOI 10.1016/0166-0934(83)90039-3; EVANS LA, 1985, ARCH VIROL, V85, P13, DOI 10.1007/BF01317002; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GAO M, 1988, VIROLOGY, V163, P319, DOI 10.1016/0042-6822(88)90272-3; GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2014, EXPERT REV VACCINES, V13, P691, DOI 10.1586/14760584.2014.910121; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Higgins TJ, 2000, J INFECT DIS, V182, P1311, DOI 10.1086/315879; HIGHLANDER SL, 1987, J VIROL, V61, P3356, DOI 10.1128/JVI.61.11.3356-3364.1987; Hildinger M, 1999, GENE THER, V6, P1222, DOI 10.1038/sj.gt.3300942; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; HUNTER JCR, 1995, VIROLOGY, V210, P345, DOI 10.1006/viro.1995.1351; Ivics Z, 2004, CURR ISSUES MOL BIOL, V6, P43; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; LONG D, 1984, INFECT IMMUN, V43, P761, DOI 10.1128/IAI.43.2.761-764.1984; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; MAINGAY JP, 1988, MICROBIOL SCI, V5, P211; MERTZ GJ, 1990, J INFECT DIS, V161, P653, DOI 10.1093/infdis/161.4.653; MOREIN B, 1985, VACCINE, V3, P83, DOI 10.1016/0264-410X(85)90055-6; Morello CS, 2011, J VIROL, V85, P3461, DOI 10.1128/JVI.02521-10; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Peng T, 1998, J VIROL, V72, P65, DOI 10.1128/JVI.72.1.65-72.1998; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Richardus JH, 2013, VACCINE, V31, P6136, DOI 10.1016/j.vaccine.2013.06.081; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Schmeisser F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-22; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STANBERRY LR, 1987, J INFECT DIS, V155, P914, DOI 10.1093/infdis/155.5.914; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WEIS JH, 1983, NATURE, V302, P72, DOI 10.1038/302072a0; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; ZARLING JM, 1988, J VIROL, V62, P4481, DOI 10.1128/JVI.62.12.4481-4485.1988; Zhang PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101373; ZWEERINK HJ, 1982, INFECT IMMUN, V37, P413, DOI 10.1128/IAI.37.2.413-421.1982	73	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116091	10.1371/journal.pone.0116091	http://dx.doi.org/10.1371/journal.pone.0116091			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658852	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900030
J	Jiang, D; Fang, JJ; Lou, LM; Zhao, JF; Yuan, SJ; Yin, L; Sun, W; Peng, LX; Guo, BT; Li, XY				Jiang, Dan; Fang, Jingjing; Lou, Lamei; Zhao, Jinfeng; Yuan, Shoujiang; Yin, Liang; Sun, Wei; Peng, Lixiang; Guo, Baotai; Li, Xueyong			Characterization of a Null Allelic Mutant of the Rice NAL1 Gene Reveals Its Role in Regulating Cell Division	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; ADVENTITIOUS ROOT-FORMATION; VASCULAR PATTERN-FORMATION; S-PHASE PROGRESSION; FUNCTIONAL-ANALYSIS; LEAF DEVELOPMENT; INCREASES YIELD; LATERAL ORGANS; ARABIDOPSIS; PROTEIN	Leaf morphology is closely associated with cell division. In rice, mutations in Narrow leaf 1 (NAL1) show narrow leaf phenotypes. Previous studies have shown that NAL1 plays a role in regulating vein patterning and increasing grain yield in indica cultivars, but its role in leaf growth and development remains unknown. In this report, we characterized two allelic mutants of NARROW LEAF1 (NAL1), nal1-2 and nal1-3, both of which showed a 50% reduction in leaf width and length, as well as a dwarf culm. Longitudinal and transverse histological analyses of leaves and internodes revealed that cell division was suppressed in the anticlinal orientation but enhanced in the periclinal orientation in the mutants, while cell size remained unaltered. In addition to defects in cell proliferation, the mutants showed abnormal midrib in leaves. Map-based cloning revealed that nal1-2 is a null allelic mutant of NAL1 since both the whole promoter and a 404-bp fragment in the first exon of NAL1 were deleted, and that a 6-bp fragment was deleted in the mutant nal1-3. We demonstrated that NAL1 functions in the regulation of cell division as early as during leaf primordia initiation. The altered transcript level of G1-and S-phase-specific genes suggested that NAL1 affects cell cycle regulation. Heterogenous expression of NAL1 in fission yeast (Schizosaccharomyces pombe) further supported that NAL1 affects cell division. These results suggest that NAL1 controls leaf width and plant height through its effects on cell division.	[Jiang, Dan; Guo, Baotai] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Jiang, Dan; Fang, Jingjing; Lou, Lamei; Zhao, Jinfeng; Peng, Lixiang; Li, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Yuan, Shoujiang; Yin, Liang; Sun, Wei] Shandong Rice Res Inst, Jinan, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Guo, BT (corresponding author), Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China.	btguo12@163.com; lixueyong@caas.cn			Ministry of Agriculture of China [2013ZX08009-003]; Agricultural Science and Technology Innovation Program of China	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Agricultural Science and Technology Innovation Program of China	This work was supported by grants from the Ministry of Agriculture of China (2013ZX08009-003) and the Agricultural Science and Technology Innovation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Bowman JL, 2000, CURR OPIN PLANT BIOL, V3, P17, DOI 10.1016/S1369-5266(99)00035-7; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Chandler PM, 1999, PLANT PHYSIOL, V120, P623, DOI 10.1104/pp.120.2.623; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; Cho SH, 2014, PLANT MOL BIOL REP, V32, P270, DOI 10.1007/s11105-013-0675-z; Cho SH, 2013, NEW PHYTOL, V198, P1071, DOI 10.1111/nph.12231; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; Eloy NB, 2011, PLANT J, V68, P351, DOI 10.1111/j.1365-313X.2011.04691.x; Errera L., 1888, BOTTANISCHES CENTRAL, V34, P395, DOI DOI 10.1002/CPLX.20074; Fabian-Marwedel T, 2002, PLANT CELL, V14, P197, DOI 10.1105/tpc.010386; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Genschik P, 1998, PLANT CELL, V10, P2063; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; HOWELL SH, 1998, MOL GENETICS PLANT D; Kessler S, 2002, DEVELOPMENT, V129, P1859; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lewis D, 2009, PLANT CELL PHYSIOL, V50, P554, DOI 10.1093/pcp/pcp015; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu SP, 2009, CELL RES, V19, P1110, DOI 10.1038/cr.2009.70; Lyndon R F, 1986, Symp Soc Exp Biol, V40, P233; Lyndon R.F., 1998, Q REV BIOL, V144, P51; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Nelson T, 1997, PLANT CELL, V9, P1121, DOI 10.1105/tpc.9.7.1121; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Renaudin JP, 1996, PLANT MOL BIOL, V32, P1003, DOI 10.1007/BF00041384; Sauter M, 1997, PLANT J, V11, P181, DOI 10.1046/j.1365-313X.1997.11020181.x; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yoshikawa T, 2013, J EXP BOT, V64, P2049, DOI 10.1093/jxb/ert060; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhao SQ, 2010, CELL RES, V20, P935, DOI 10.1038/cr.2010.109; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	53	58	71	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118169	10.1371/journal.pone.0118169	http://dx.doi.org/10.1371/journal.pone.0118169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658704	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900272
J	Makita, N; Kawamura, A				Makita, Naoki; Kawamura, Ayumi			Temperature Sensitivity of Microbial Respiration of Fine Root Litter in a Temperate Broad-Leaved Forest	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; RHIZOSPHERE RESPIRATION; WATER-CONTENT; DECOMPOSITION; CLIMATE; QUALITY; ADAPTATION; EFFLUX; RATES; LEAF	The microbial decomposition respiration of plant litter generates a major CO2 efflux from terrestrial ecosystems that plays a critical role in the regulation of carbon cycling on regional and global scales. However, the respiration from root litter decomposition and its sensitivity to temperature changes are unclear in current models of carbon turnover in forest soils. Thus, we examined seasonal changes in the temperature sensitivity and decomposition rates of fine root litter of two diameter classes (0-0.5 and 0.5-2.0 mm) of Quercus serrata and Ilex pedunculosa in a deciduous broad-leaved forest. During the study period, fine root litter of both diameter classes and species decreased approximately exponentially over time. The Q(10) values of microbial respiration rates of root litter for the two classes were 1.59-3.31 and 1.28-6.27 for Q. serrata and 1.36-6.31 and 1.65-5.86 for I. pedunculosa. A significant difference in Q(10) was observed between the diameter classes, indicating that root diameter represents the initial substrate quality, which may determine the magnitude of Q(10) value of microbial respiration. Changes in these Q(10) values were related to seasonal soil temperature patterns; the values were higher in winter than in summer. Moreover, seasonal variations in Q(10) were larger during the 2-year decomposition period than the 1-year period. These results showed that the Q(10) values of fine root litter of 0-0.5 and 0.5-2.0 mm have been shown to increase with lower temperatures and with the higher recalcitrance pool of the decomposed substrate during 2 years of decomposition. Thus, the temperature sensitivity of microbial respiration in root litter showed distinct patterns according to the decay period and season because of the temperature acclimation and adaptation of the microbial decomposer communities in root litter.	[Makita, Naoki] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto 6120855, Japan; [Kawamura, Ayumi] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Forestry & Forest Products Research Institute - Japan; Kyoto University	Makita, N (corresponding author), Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto 6120855, Japan.	makita701@gmail.com			Japan Society for the Promotion of Science [JSPS] [13J09602]	Japan Society for the Promotion of Science [JSPS](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Japan Society for the Promotion of Science [JSPS; grant number 13J09602 (http://www.jsps.go.jp/english/index.html)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Barcenas-Moreno G, 2009, GLOBAL CHANGE BIOL, V15, P2950, DOI 10.1111/j.1365-2486.2009.01882.x; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Chen H, 2000, FOREST ECOL MANAG, V138, P51, DOI 10.1016/S0378-1127(00)00411-4; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Epron D, 2001, TREE PHYSIOL, V21, P145, DOI 10.1093/treephys/21.2-3.145; Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2003, TELLUS B, V55, P692, DOI 10.1034/j.1600-0889.2003.01461.x; Fujii S, 2010, SOIL BIOL BIOCHEM, V42, P2224, DOI 10.1016/j.soilbio.2010.08.022; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Karhu K, 2010, ECOLOGY, V91, P370, DOI 10.1890/09-0478.1; Kawamura A, 2013, PLANT ROOT, V7, P77, DOI 10.3117/plantroot.7.77; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lin CF, 2011, PLANT SOIL, V338, P311, DOI 10.1007/s11104-010-0547-3; Liski J, 1999, AMBIO, V28, P171; Makita N, 2011, ECOL RES, V26, P95, DOI 10.1007/s11284-010-0764-5; Malcolm GM, 2009, SOIL BIOL BIOCHEM, V41, P1075, DOI 10.1016/j.soilbio.2009.02.011; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2009, SOIL CARBON DYNAMICS, P207; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Suzina NE, 2004, MICROBIOLOGY+, V73, P435, DOI 10.1023/B:MICI.0000036990.94039.af; Talbot JM, 2012, BIOGEOCHEMISTRY, V108, P279, DOI 10.1007/s10533-011-9599-6; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Wang W, 2014, PLANT SOIL, V374, P677, DOI 10.1007/s11104-013-1902-y; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850	42	7	7	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117694	10.1371/journal.pone.0117694	http://dx.doi.org/10.1371/journal.pone.0117694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658106	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900205
J	Zhang, J; Wong, MG; Wong, M; Gross, S; Chen, J; Pollock, C; Saad, S				Zhang, Jie; Wong, Muh Geot; Wong, May; Gross, Simon; Chen, Jason; Pollock, Carol; Saad, Sonia			A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-beta(1)	PLOS ONE			English	Article							BETA SIGNAL-TRANSDUCTION; TGF-BETA; RENAL FIBROSIS; IN-VITRO; DISEASE; LATENT; CELLS; MANNOSE-6-PHOSPHATE; INFLAMMATION; NEPHROPATHY	The activity of transforming growth factor-beta(1) (TGF-beta(1)) is regulated by its conversion from the latent to the active form. We have previously shown that the conversion is at least in part mediated by the cationic-independent mannose 6-phosphate receptor (CI-M6PR), as the CI-M6PR inhibitor, PXS-25 has anti-fibrotic properties in human kidney tubular (HK-2) cells under high glucose conditions. However, its clinical use is limited by low bioavailability. Our aim was to determine the effects of PXS64, a pro-drug of PXS25, in in vitro and in vivo models of renal fibrosis. HK-2 cells were exposed to latent TGF beta(1)+/- PXS64 for 48 hours. The mRNA and protein levels of pro-fibrotic and pro-inflammatory markers were determined. A 7 day unilateral ureteric obstruction (UUO) model was used and the following experimental groups were studied: (i) Sham operated, (ii) UUO, (iii) UUO + telmisartan (iv) UUO + PSX64. HK-2 cells exposed to PXS64 reduced TGF beta mediated effects on collagen IV, fibronectin, macrophage chemotactic protein-1 (MCP-1) and phospho-smad2 protein expression, consistent with inhibition of the conversion of latent to active TGF-beta(1). PXS 64 treated UUO mice had a lower tubulointerstitial fibrosis index, collagen IV and fibronectin protein and mRNA expression when compared to untreated UUO mice. In addition, these animals had lower MCP-1 mRNA expression, reduced inflammarory cell infiltrate, as indicated by fewer CD45, F4/80 positive cells, and reduced phospho-Smad2 protein expression when compared to untreated UUO animals. Our data demonstrates that PSX64 is an effective anti-fibrotic agent by inhibiting the activation of latent TGF-beta(1).	[Zhang, Jie; Wong, Muh Geot; Wong, May; Gross, Simon; Pollock, Carol; Saad, Sonia] Kolling Inst Med Res, Sydney, NSW, Australia; [Chen, Jason] Royal N Shore Hosp, St Leonards, NSW 2065, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital	Saad, S (corresponding author), Kolling Inst Med Res, Sydney, NSW, Australia.	sonia.saad@sydney.edu.au	Saad, Sonia/D-2914-2015	Saad, Sonia/0000-0001-8067-8046	Australian Research Council (ARC) industry partnership linkage grant	Australian Research Council (ARC) industry partnership linkage grant(Australian Research Council)	The study is funded by the Australian Research Council (ARC) industry partnership linkage grant. None the co-authors has a financial disclosure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Berl Tomas, 2009, J Renin Angiotensin Aldosterone Syst, V10, P1, DOI 10.1177/1470320309102747; Black David A, 2012, Biomed Sci Instrum, V48, P43; Bohle A, 1979, Contrib Nephrol, V16, P109; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Djamali A, 2010, TRANSPLANTATION, V90, P387, DOI 10.1097/TP.0b013e3181e6ae0a; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Harris WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070196; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hsieh PF, 2012, MOL IMMUNOL, V50, P74, DOI 10.1016/j.molimm.2011.12.004; Jones-Carson J, 2005, J INFECT DIS, V192, P1039, DOI 10.1086/432727; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066356; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Ngeow WC, 2011, BRAIN RES, V1394, P40, DOI 10.1016/j.brainres.2011.04.021; Pan MM, 2013, FOOD CHEM TOXICOL, V58, P487, DOI 10.1016/j.fct.2013.04.037; Rogers ML, 1996, J ENDOCRINOL, V151, P77, DOI 10.1677/joe.0.1510077; Ruiz-Torres MP, 2005, J NEPHROL, V18, P334; Sakairi T, 2011, NEPHROLOGY, V16, P76, DOI 10.1111/j.1440-1797.2010.01367.x; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Strutz F, 1999, KIDNEY BLOOD PRESS R, V22, P71, DOI 10.1159/000025911; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; White KE, 2000, J AM SOC NEPHROL, V11, P1667, DOI 10.1681/ASN.V1191667; WILLENBORG DO, 1989, FASEB J, V3, P1968, DOI 10.1096/fasebj.3.8.2721857; Wong MG, 2011, AM J PHYSIOL-RENAL, V301, pF84, DOI 10.1152/ajprenal.00287.2010; Yu Q, 2000, GENE DEV, V14, P163	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116888	10.1371/journal.pone.0116888	http://dx.doi.org/10.1371/journal.pone.0116888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658916	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900076
J	Zhu, ZJ; Qian, FJ; Yang, R; Chen, JJ; Luo, QJ; Chen, HM; Yan, XJ				Zhu, Zhujun; Qian, Feijian; Yang, Rui; Chen, Juanjuan; Luo, Qijun; Chen, Haimin; Yan, Xiaojun			A Lipoxygenase from Red Alga Pyropia haitanensis, a Unique Enzyme Catalyzing the Free Radical Reactions of Polyunsaturated Fatty Acids with Triple Ethylenic Bonds	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; FUNGUS GAEUMANNOMYCES-GRAMINIS; FUSION PROTEIN; CHONDRUS-CRISPUS; INNATE IMMUNITY; HYDROPEROXIDE; OXYLIPINS; CATALYSIS; PURIFICATION; HEMOPROTEIN	Lipoxygenases (LOXs) are key enzymes to regulate the production of hormones and defensive metabolites in plants, animals and algae. In this research, a full length LOX gene has been cloned and expressed from the red alga Pyropia haitanensis (Bangiales, Rhodophyta) gametophyte (PhLOX2). Subsequent phylogenetic analysis showed that such LOX enzymes are separated at the early stage of evolution, establishing an independent branch. The LOX activity was investigated at the optimal pH of 8.0. It appears that PhLOX2 is a multifunctional enzyme featuring both lipoxygenase and hydroperoxidase activities. Additionally, PhLOX2 exhibits remarkable substrate and position flexibility, and it can catalyze an array of chemical reactions involving various polyunsaturated fatty acids, ranging from C18 to C22. As a matter of fact, mono-hydroperoxy, di-hydroperoxy and hydroxyl products have been obtained from such transformations, and eicosapentaenoic acid seem to be the most preferred substrate. It was found that at least triple ethylenic bonds are required for PhLOX2 to function as a LOX, and the resulting hydroxy products should be originated from the PhLOX2 mediated reduction of mono-hydroperoxides, in which the hydrogen abstraction occurs on the carbon atom between the second and third double bond. Most of the di-hydroperoxides observed seem to be missing their mono-position precursors. The substrate and position flexibility, as well as the function versatility of PhLOXs represent the ancient enzymatic pathway for organisms to control intracellular oxylipins.	[Zhu, Zhujun; Qian, Feijian; Yang, Rui; Chen, Juanjuan; Luo, Qijun; Chen, Haimin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China; [Yan, Xiaojun] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Chen, HM (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China.	haiminch75@hotmail.com; yanxiaojun@nbu.edu.cn	LUO, QI/GQH-7209-2022	Yan, Xiaojun/0000-0003-0257-0157	National Natural Science Foundation of China [81370532]; Ningbo Marine Algae Biotechnology Innovative Team [2011B81007]; National Spark Major Project [2013GA701001]; Ningbo Programs for Science and Technology Development [201201C1011016]; Zhejiang major technology project for breeding of new variety [2012C12907-6]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo Marine Algae Biotechnology Innovative Team; National Spark Major Project; Ningbo Programs for Science and Technology Development; Zhejiang major technology project for breeding of new variety; K.C. Wong Magna Fund in Ningbo University	This project was funded by National Natural Science Foundation of China (81370532), Ningbo Marine Algae Biotechnology Innovative Team (No. 2011B81007), National Spark Major Project (2013GA701001), Ningbo Programs for Science and Technology Development (201201C1011016), Zhejiang major technology project for breeding of new variety (2012C12907-6), K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; BILD GS, 1977, BIOCHEM BIOPH RES CO, V74, P949, DOI 10.1016/0006-291X(77)91610-2; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FURSTENBERGER G, 1991, J BIOL CHEM, V266, P15738; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; Gaquerel E, 2007, BBA-MOL CELL BIOL L, V1771, P565, DOI 10.1016/j.bbalip.2007.02.007; Graber MA, 1996, TETRAHEDRON LETT, V37, P4635, DOI 10.1016/0040-4039(96)00921-5; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; GREGSON RP, 1979, TETRAHEDRON LETT, P4505; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Jiang ZD, 1997, LIPIDS, V32, P231, DOI 10.1007/s11745-997-0029-9; Jiang ZD, 2000, PHYTOCHEMISTRY, V53, P129, DOI 10.1016/S0031-9422(99)00445-8; Joo YC, 2012, BIOTECHNOL ADV, V30, P1524, DOI 10.1016/j.biotechadv.2012.04.004; Kantarci A, 2003, CRIT REV ORAL BIOL M, V14, P4, DOI 10.1177/154411130301400102; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; OHKI S, 1979, J BIOL CHEM, V254, P829; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Qian FJ, 2014, J APPL PHYCOL; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	35	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117351	10.1371/journal.pone.0117351	http://dx.doi.org/10.1371/journal.pone.0117351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658744	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900137
J	Zuo, QS; Li, D; Zhang, L; Elsayed, AK; Lian, C; Shi, QQ; Zhang, ZT; Zhu, R; Wang, YJ; Jin, K; Zhang, YN; Li, BC				Zuo, Qisheng; Li, Dong; Zhang, Lei; Elsayed, Ahmed Kamel; Lian, Chao; Shi, Qingqing; Zhang, Zhentao; Zhu, Rui; Wang, Yinjie; Jin, Kai; Zhang, Yani; Li, Bichun			Study on the Regulatory Mechanism of the Lipid Metabolism Pathways during Chicken Male Germ Cell Differentiation Based on RNA-Seq	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS	Here, we explore the regulatory mechanism of lipid metabolic signaling pathways and related genes during differentiation of male germ cells in chickens, with the hope that better understanding of these pathways may improve in vitro induction. Fluorescence-activated cell sorting was used to obtain highly purified cultures of embryonic stem cells (ESCs), primitive germ cells (PGCs), and spermatogonial stem cells (SSCs). The total RNA was then extracted from each type of cell. High-throughput analysis methods (RNA-seq) were used to sequence the transcriptome of these cells. Gene Ontology (GO) analysis and the KEGG database were used to identify lipid metabolism pathways and related genes. Retinoic acid (RA), the end-product of the retinol metabolism pathway, induced in vitro differentiation of ESC into male germ cells. Quantitative real-time PCR (qRT-PCR) was used to detect changes in the expression of the genes involved in the retinol metabolic pathways. From the results of RNA-seq and the database analyses, we concluded that there are 328 genes in 27 lipid metabolic pathways continuously involved in lipid metabolism during the differentiation of ESC into SSC in vivo, including retinol metabolism. Alcohol dehydrogenase 5 (ADH5) and aldehyde dehydrogenase 1 family member A1 (ALDH1A1) are involved in RA synthesis in the cell. ADH5 was specifically expressed in PGC in our experiments and aldehyde dehydrogenase 1 family member A1 (ALDH1A1) persistently increased throughout development. CYP26b1, a member of the cytochrome P450 superfamily, is involved in the degradation of RA. Expression of CYP26b1, in contrast, decreased throughout development. Exogenous RA in the culture medium induced differentiation of ESC to SSC-like cells. The expression patterns of ADH5, ALDH1A1, and CYP26b1 were consistent with RNA-seq results. We conclude that the retinol metabolism pathway plays an important role in the process of chicken male germ cell differentiation.	[Zuo, Qisheng; Li, Dong; Zhang, Lei; Elsayed, Ahmed Kamel; Lian, Chao; Shi, Qingqing; Zhang, Zhentao; Zhu, Rui; Wang, Yinjie; Jin, Kai; Zhang, Yani; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China; [Elsayed, Ahmed Kamel] Suez Canal Univ, Coll Vet Med, Ismailia 41522, Egypt	Yangzhou University; Egyptian Knowledge Bank (EKB); Suez Canal University	Zhang, YN (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China.	ynzhang@yzu.edu.cn; yubcli@yzu.edu.cn	Elsayed, Ahmed/AAC-9689-2020; JIN, KAI/AAY-8565-2020	JIN, KAI/0000-0003-2489-2173; Zhu, Rui/0000-0002-8791-677X; Kamel, Ahmed/0000-0002-2519-1531	National Natural Science Foundation of China [31272429, 31301959]; Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education [20123250120009, 20103250110006]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the National Natural Science Foundation of China (31272429, 31301959); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance in 2010; Major Basic Research Program for Natural Science of Jiangsu Proviance Jiangsu Proviance; Research Fund for the Doctoral Program of Higher Education(20123250120009, 20103250110006); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2005, CURR OPIN BIOTECH, V16, P530, DOI 10.1016/j.copbio.2005.08.008; Andreola F, 1997, CANCER RES, V57, P2835; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Dong YL, 2011, CHINESE J FAMILY PLA, V19, P247; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Fujisawa Y, 2013, EARLY HUM DEV, V89, P713, DOI 10.1016/j.earlhumdev.2013.05.002; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Li BiChun, 2002, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V23, P18; Lu JianXiong, 2006, Veterinary Science in China, V36, P306; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oresti GM, 2013, REPRODUCTION, V146, P471, DOI 10.1530/REP-13-0199; Pan SH, 2010, STUDY MOUSE EMBRYONI; Sun M, 2012, STUDYON MALE GERM CE; Sun SY, 2008, CHINESE J VET SCI, V28, P102; [唐新燕 Tang Xinyan], 2006, [农业生物技术学报, Journol of Agricultural Biotechnology], V14, P174; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Trofimova-Griffin ME, 2000, DEV BRAIN RES, V120, P7, DOI 10.1016/S0165-3806(99)00185-6; [王萍 WANG Ping], 2011, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V16, P474; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu XS, 2008, CHINA POULTRY, V30, P30, DOI DOI 10.16372/J.ISSN.1004-6364.2008.22.007	27	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0109469	10.1371/journal.pone.0109469	http://dx.doi.org/10.1371/journal.pone.0109469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658587	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900001
J	Bhattacharjee, A; Reuter, S; Trojnar, E; Kolodziejczyk, R; Seeberger, H; Hyvarinen, S; Uzonyi, B; Szilagyi, A; Prohaszka, Z; Goldman, A; Jozsi, M; Jokiranta, TS				Bhattacharjee, Arnab; Reuter, Stefanie; Trojnar, Eszter; Kolodziejczyk, Robert; Seeberger, Harald; Hyvarinen, Satu; Uzonyi, Barbara; Szilagyi, Agnes; Prohaszka, Zoltan; Goldman, Adrian; Jozsi, Mihaly; Jokiranta, T. Sakari			The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; RECOGNITION FUNCTIONS; ALTERNATIVE PATHWAY; C-TERMINUS; C3B; MUTATIONS; GENE; BINDING; SURFACE; CELLS	Atypical hemolytic uremic syndrome (aHUS) is characterized by complement attack against host cells due to mutations in complement proteins or autoantibodies against complement factor H (CFH). It is unknown why nearly all patients with autoimmune aHUS lack CFHR1 (CFH-related protein-1). These patients have autoantibodies against CFH domains 19 and 20 (CFH19-20), which are nearly identical to CFHR1,1 domains 4 and 5 (CFHR1(4-5)), Here, binding site mapping of autoantibodies from 17 patients using mutant CFH19-20 constructs revealed an autoantibody epitope cluster within a loop on domain 20, next to the two buried residues that are different in CFH19-20 and CFHR1(4-5). The crystal structure of CFHR1(4-5) revealed a difference in conformation of the autoantigenic loop in the C-terminal domains of CFH and CFHR1, explaining the variation in binding of autoantibodies from some aHUS patients to CFH19-20 and CFHR1(4-5). The autoantigenic loop on CFH seems to be generally flexible, as its conformation in previously published structures of CFH19-20 bound to the microbial protein OspE and a sialic acid glycan is somewhat altered. Cumulalively, our data suggest that association of CFHR1 deficiency with autoimmune aHUS could be due to the structural difference between CFHR1 and the autoantigenic CFH epitope, suggesting a novel explanation for CFHR1 deficiency in the pathogenesis of autoimmune aHUS.	[Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Medicum, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Immunobiol Res Program Unit, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Helsinki Univ Hosp, Helsinki 00014, Finland; [Bhattacharjee, Arnab; Kolodziejczyk, Robert; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kolodziejczyk, Robert; Goldman, Adrian] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Reuter, Stefanie; Seeberger, Harald; Jozsi, Mihaly] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immupobiol, D-07745 Jena, Germany; [Trojnar, Eszter; Szilagyi, Agnes; Prohaszka, Zoltan] Semmelweis Univ, Dept Internal Med 3, Res Lab, H-1125 Budapest, Hungary; [Uzonyi, Barbara] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, H-1117 Budapest, Hungary; [Jozsi, Mihaly] Eotvos Lorand Univ, MTA ELTE Lendulet Complement Res Grp, Dept Immunol, H-1117 Budapest, Hungary	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Hans Knoll Institute (HKI); Semmelweis University; Eotvos Lorand University; Eotvos Lorand University	Bhattacharjee, A (corresponding author), Univ Helsinki, Haartman Inst, POB 21 Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	arnab.bhattacharjee@helsinki.fi; mihaly.jozsi@gmx.net	Trojnar, Eszter/R-2833-2016; Prohászka, Zoltán/F-2191-2010; Jozsi, Mihaly/I-7872-2018; Uzonyi, Barbara/J-3973-2018; Szilagyi, Agnes/F-2337-2010; Kolodziejczyk, Robert/G-9274-2015	Trojnar, Eszter/0000-0002-3266-2477; Prohászka, Zoltán/0000-0003-1761-7982; Jozsi, Mihaly/0000-0002-5520-5535; Uzonyi, Barbara/0000-0002-9680-1974; Szilagyi, Agnes/0000-0002-9769-3215; Reuter nee Strobel, Stefanie/0000-0002-3805-4632; Bhattacharjee, Arnab/0000-0002-9613-7911; Goldman, Adrian/0000-0001-8032-9700	Sigrid Juselius Foundation; Academy of Finland [1252206, 128646, 255922, 259793]; Hungarian Scientific Research Fund [OTKA 100687, OTKA 109055]; German Research Fund [JO 844/1-1]; Hungarian Academy of Sciences [LP2012-43]; Biotechnology and Biological Sciences Research Council [BB/L015056/1, BB/M021610/1] Funding Source: researchfish; BBSRC [BB/M021610/1, BB/L015056/1] Funding Source: UKRI	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Research Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Sigrid Juselius Foundation and Academy of Finland Grant 1252206 (to A. G.) and Grants 128646, 255922, and 259793 (to T. S. J.); Hungarian Scientific Research Fund Grants OTKA 100687 (to Z. P.) and OTKA 109055 (to M. J.); and German Research Fund Grant JO 844/1-1 and Hungarian Academy of Sciences Grant LP2012-43 (to M. J.).	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyler SJ, 2013, PEDIATR NEPHROL, V28, P2221, DOI 10.1007/s00467-013-2560-2; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; FREDDO L, 1986, J IMMUNOL, V137, P3821; FRITZLER MJ, 1991, CLIN MICROBIOL REV, V4, P256, DOI 10.1128/CMR.4.3.256-269.1991; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Herbert AP, 2012, BIOCHEMISTRY-US, V51, P1874, DOI 10.1021/bi201689j; Hofer J, 2013, CLIN J AM SOC NEPHRO, V8, P407, DOI 10.2215/CJN.01260212; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Roumenina L, 2013, MOL IMMUNOL, V56, P248, DOI 10.1016/j.molimm.2013.05.030; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Sanchez-Corral P, 2010, BRIT J HAEMATOL, V150, P529, DOI 10.1111/j.1365-2141.2010.08295.x; Sinha A, 2014, KIDNEY INT, V85, P1151, DOI 10.1038/ki.2013.373; Strobel S, 2011, KIDNEY INT, V80, P397, DOI 10.1038/ki.2011.152; Strobel S, 2010, NEPHROL DIAL TRANSPL, V25, P136, DOI 10.1093/ndt/gfp388; Venables JP, 2006, PLOS MED, V3, P1957, DOI 10.1371/journal.pmed.0030431; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	48	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9500	9510		10.1074/jbc.M114.630871	http://dx.doi.org/10.1074/jbc.M114.630871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25659429	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000352729400017
J	Grabarczyk, DB; Chappell, PE; Eisel, B; Johnson, S; Lea, SM; Berks, BC				Grabarczyk, Daniel B.; Chappell, Paul E.; Eisel, Bianca; Johnson, Steven; Lea, Susan M.; Berks, Ben C.			Mechanism of Thiosulfate Oxidation in the SoxA Family of Cysteine-ligated Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME PROTEIN; COMPLEX; SYSTEM; REPLACEMENT; REFINEMENT; GENERATION	Thiosulfate dehydrogenase (TsdA) catalyzes the oxidation of two thiosulfate molecules to form tetrathionate and is predicted to use an unusual cysteine-ligated heme as the catalytic cofactor. We have determined the structure of Allochromatium vinosum TsdA to a resolution of 1.3 angstrom. This structure confirms the active site heme ligation, identifies a thiosulfate binding site within the active site cavity, and reveals an electron transfer route from the catalytic heme, through a second heme group to the external electron acceptor. We provide multiple lines of evidence that the catalytic reaction proceeds through the intermediate formation of a S-thiosulfonate derivative of the heme cysteine ligand: the cysteine is reactive and is accessible to electrophilic attack; cysteine S-thiosulfonate is formed by the addition of thiosulfate or following the reverse reaction with tetrathionate; the S-thiosulfonate modification is removed through catalysis; and alkylating the cysteine blocks activity. Active site amino acid residues required for catalysis were identified by mutagenesis and are inferred to also play a role in stabilizing the S-thiosulfonate intermediate. The enzyme SoxAX, which catalyzes the first step in the bacterial Sox thiosulfate oxidation pathway, is homologous to TsdA and can be inferred to use a related catalytic mechanism.	[Grabarczyk, Daniel B.; Eisel, Bianca; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Chappell, Paul E.; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Lea, Susan M/B-7678-2009; Johnson, Steven J/F-9182-2016	Lea, Susan M/0000-0001-9287-8053; Johnson, Steven J/0000-0002-7877-3543; Berks, Ben/0000-0001-9685-4067; Grabarczyk, Daniel/0000-0003-0216-7085	Biotechnology and Biological Sciences Research Council; Medical Research Council [G0900888]; Biotechnology and Biological Sciences Research Council [1091176, 991163] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by studentships from the Biotechnology and Biological Sciences Research Council.; Supported by Medical Research Council Grant G0900888.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bach RD, 2008, J ORG CHEM, V73, P12, DOI 10.1021/jo702051f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedurco M, 2004, BBA-PROTEINS PROTEOM, V1703, P31, DOI 10.1016/j.bbapap.2004.09.013; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NICOLA NA, 1977, EUR J BIOCHEM, V78, P133, DOI 10.1111/j.1432-1033.1977.tb11722.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Sun YH, 2014, P NATL ACAD SCI USA, V111, P6570, DOI 10.1073/pnas.1322274111; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; TERVOORT MJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P245, DOI 10.1016/0005-2728(81)90163-8; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	41	14	14	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9209	9221		10.1074/jbc.M114.618025	http://dx.doi.org/10.1074/jbc.M114.618025			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673696	Green Published, hybrid			2022-12-26	WOS:000352207100043
J	Lee, TH; Sottile, J; Chiang, HY				Lee, Ting-Hein; Sottile, Jane; Chiang, Hou-Yu			Collagen Inhibitory Peptide R1R2 Mediates Vascular Remodeling by Decreasing Inflammation and Smooth Muscle Cell Activation	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; GROWTH-FACTOR-BINDING; DOMAIN RECEPTOR 2; KAPPA-B LIGAND; EXTRACELLULAR-MATRIX; I COLLAGEN; NEOINTIMA FORMATION; ARTERIAL STIFFNESS; ENDOTHELIAL-CELLS; OSTEOCLAST MATURATION	The extracellular matrix (ECM) is a major constituent of the vessel wall. In addition to providing a structural scaffold, the ECM controls numerous cellular functions in both physiologic and pathologic settings. Vascular remodeling occurs after injury and is characterized by endothelial cell activation, inflammatory cell infiltration, phenotypic modulation of smooth muscle cells (SMCs), and augmented deposition of collagen-rich ECM. R1R2, a peptide derived from the bacterial adhesin SFS, with sequence homology to collagen, is known to inhibit collagen type I deposition in vitro by inhibiting the binding of fibronectin to collagen. However, the inhibitory effects of R1R2 during vascular remodeling have not been explored. We periadventitially delivered R1R2 to carotid arteries using pluronic gel in a vascular remodeling mouse model induced by blood flow cessation, and evaluated its effects on intima-media thickening, ECM deposition, SMC activation, and inflammatory cell infiltration. Morphometric analysis demonstrated that R1R2 reduced intima-media thickening compared to the control groups. R1R2 treatment also decreased collagen type I deposition in the vessel wall, and maintained SMC in the contractile phenotype. Interestingly, R1R2 dramatically reduced inflammatory cell infiltration into the vessel by similar to 78%. This decrease was accompanied by decreased VCAM-1 and ICAM-1 expression. Our in vitro studies revealed that R1R2 attenuated SMC proliferation and migration, and also decreased monocyte adhesion and transendothelial migration through endothelial cells. Together, these data suggest that R1R2 attenuates vascular remodeling responses by decreasing inflammation and by modulating SMC proliferation and migration, and suggest that the R1R2 peptide may have therapeutic potential in treating occlusive vascular diseases.	[Lee, Ting-Hein; Chiang, Hou-Yu] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan; [Sottile, Jane] Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Rochester, NY USA	Chang Gung University; University of Rochester	Chiang, HY (corresponding author), Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan.	hchiang@mail.cgu.edu.tw		Lee, Ting-Hein/0000-0001-7077-3138	CMRPD [190971];  [NSC99-2320-B-182-019-MY2];  [NSC101-2320-B-182-004];  [NSC102-2320-B-182-007-MY3];  [RO1GM097347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097347] Funding Source: NIH RePORTER	CMRPD; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants: NSC99-2320-B-182-019-MY2, NSC101-2320-B-182-004, NSC102-2320-B-182-007-MY3, and CMRPD 190971 to HYC in Taiwan, and RO1GM097347 to JS in USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2013, BLOOD, V121, P1644, DOI 10.1182/blood-2012-08-451575; Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Braun M, 1999, CARDIOVASC RES, V41, P395, DOI 10.1016/S0008-6363(98)00302-2; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Chung CY, 1997, J CELL SCI, V110, P1413; Coats WD, 1996, J MOL CELL CARDIOL, V28, P441; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Grafe I., 2014, NAT MED, V20, P670, DOI DOI 10.1038/NM.3544; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Hastings NE, 2009, ARTERIOSCL THROM VAS, V29, P725, DOI 10.1161/ATVBAHA.109.184382; Hirai F, 2007, BIOCHEM BIOPH RES CO, V356, P279, DOI 10.1016/j.bbrc.2007.02.121; Hofmann CS, 2004, ARTERIOSCL THROM VAS, V24, P1608, DOI 10.1161/01.ATV.0000139010.71779.f3; HOPKINS KD, 1994, LANCET, V343, P1447, DOI 10.1016/S0140-6736(94)92577-1; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Hou GP, 2012, CARDIOVASC PATHOL, V21, P214, DOI 10.1016/j.carpath.2011.07.006; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Ishikawa J, 2005, HYPERTENS RES, V28, P995, DOI 10.1291/hypres.28.995; Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9; Janic M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/621437; Johnson CP, 2001, J CLIN PATHOL, V54, P139, DOI 10.1136/jcp.54.2.139; KELLEY J, 1980, J LAB CLIN MED, V96, P954; Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349; Korshunov VA, 2004, CIRCULATION, V110, P220, DOI 10.1161/01.CIR.0000134958.88379.2E; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kulkarni NB, 2014, J CLIN DIAGN RES, V8, pBC8, DOI 10.7860/JCDR/2014/7859.4438; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Landry DB, 1997, AM J PATHOL, V151, P1085; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lawson C, 1999, J IMMUNOL, V162, P2990; Lee TH, 2014, MOL BIOL CELL, V25, P583, DOI 10.1091/mbc.E13-07-0382; Lee TH, 2009, CIRC RES, V105, P271, DOI 10.1161/CIRCRESAHA.109.199869; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Libby P, 2000, CIRCULATION, V102, P1874, DOI 10.1161/01.CIR.102.16.1874; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Lin FB, 2011, J INVEST DERMATOL, V131, P84, DOI 10.1038/jid.2010.253; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; LITTLE CD, 1982, J CELL SCI, V55, P35; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Lu KK, 2011, CARDIOVASC PATHOL, V20, P71, DOI 10.1016/j.carpath.2009.12.006; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; MIYAKE S, 1993, J EXP MED, V177, P863, DOI 10.1084/jem.177.3.863; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Nakayamada S, 2003, ARTHRITIS RHEUM, V48, P1239, DOI 10.1002/art.10941; Ng K, 2011, AM J PHYSIOL-RENAL, V300, pF1431, DOI 10.1152/ajprenal.00079.2011; Nguyen TTB, 2005, AM J RESP CRIT CARE, V171, P217, DOI 10.1164/rccm.200408-1046OC; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; OWENS RJ, 1986, EMBO J, V5, P2825, DOI 10.1002/j.1460-2075.1986.tb04575.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258; Poitevin S, 2008, J THROMB HAEMOST, V6, P1586, DOI 10.1111/j.1538-7836.2008.03051.x; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; RAINES EW, 1993, BRIT HEART J, V69, pS30; RILEY DJ, 1980, J CLIN INVEST, V65, P643, DOI 10.1172/JCI109709; Rocnik EF, 1998, J CLIN INVEST, V101, P1889, DOI 10.1172/JCI1025; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Sheikh H, 2000, J CELL SCI, V113, P1021; Shyu KG, 2008, ARTERIOSCL THROM VAS, V28, P1447, DOI 10.1161/ATVBAHA.108.165993; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SKINNER MP, 1994, AM J PATHOL, V145, P1070; Sluijter JPG, 2004, CARDIOVASC RES, V61, P186, DOI 10.1016/j.cardiores.2003.09.028; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; STRAUSS BH, 1994, CIRC RES, V75, P650, DOI 10.1161/01.RES.75.4.650; Vaiyapuri S, 2012, J BIOL CHEM, V287, P26235, DOI 10.1074/jbc.M112.381483; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Wang WL, 2014, BIOMATERIALS, V35, P3829, DOI 10.1016/j.biomaterials.2014.01.049; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Wang Yi-Xin, 2004, Current Vascular Pharmacology, V2, P379, DOI 10.2174/1570161043385448; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016; Zhang WD, 1999, J VASC SURG, V30, P169, DOI 10.1016/S0741-5214(99)70189-8; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	98	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117356	10.1371/journal.pone.0117356	http://dx.doi.org/10.1371/journal.pone.0117356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675397	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000018
J	Lucas, A; Lucas, M; Strhyn, A; Keane, NM; McKinnon, E; Pavlos, R; Moran, EM; Meyer-Pannwitt, V; Gaudieri, S; D'Orsogna, L; Kalams, S; Ostrov, DA; Buus, S; Peters, B; Mallal, S; Phillips, E				Lucas, Andrew; Lucas, Michaela; Strhyn, Anette; Keane, Niamh M.; McKinnon, Elizabeth; Pavlos, Rebecca; Moran, Ellen M.; Meyer-Pannwitt, Viola; Gaudieri, Silvana; D'Orsogna, Lloyd; Kalams, Spyros; Ostrov, David A.; Buus, Soren; Peters, Bjoern; Mallal, Simon; Phillips, Elizabeth			Abacavir-Reactive Memory T Cells Are Present in Drug Naive Individuals	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; HLA-B-ASTERISK-5701; ACTIVATION; ALLORECOGNITION; REPERTOIRE; RESPONSES	Background Fifty-five percent of individuals with HLA-B*57:01 exposed to the antiretroviral drug abacavir develop a hypersensitivity reaction (HSR) that has been attributed to naive T-cell responses to neo-antigen generated by the drug. Immunologically confirmed abacavir HSR can manifest clinically in less than 48 hours following first exposure suggesting that, at least in some cases, abacavir HSR is due to re-stimulation of a pre-existing memory T-cell population rather than priming of a high frequency naive T-cell population. Methods To determine whether a pre-existing abacavir reactive memory T-cell population contributes to early abacavir HSR symptoms, we studied the abacavir specific naive or memory T-cell response using HLA-B*57:01 positive HSR patients or healthy controls using ELISpot assay, intra-cellular cytokine staining and tetramer labelling. Results Abacavir reactive CD8+ T-cell responses were detected in vitro in one hundred percent of abacavir unexposed HLA-B*57:01 positive healthy donors. Abacavir-specific CD8+ T cells from such donors can be expanded from sorted memory, and sorted naive, CD8+ T cells without need for autologous CD4+ T cells. Conclusions We propose that these pre-existing abacavir-reactive memory CD8+ T-cell responses must have been primed by earlier exposure to another foreign antigen and that these T cells cross-react with an abacavir-HLA-B*57:01-endogenous peptide ligand complex, in keeping with the model of heterologous immunity proposed in transplant rejection.	[Lucas, Andrew; Lucas, Michaela; Keane, Niamh M.; McKinnon, Elizabeth; Pavlos, Rebecca; Moran, Ellen M.; Meyer-Pannwitt, Viola; Gaudieri, Silvana; D'Orsogna, Lloyd; Mallal, Simon; Phillips, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Strhyn, Anette; Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, Copenhagen, Denmark; [Gaudieri, Silvana] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [D'Orsogna, Lloyd; Mallal, Simon] Royal Perth Hosp & Pathwest, Dept Clin Immunol & Immunogenet, Perth, WA, Australia; [D'Orsogna, Lloyd] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Kalams, Spyros; Mallal, Simon; Phillips, Elizabeth] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA	Murdoch University; University of Copenhagen; University of Western Australia; Royal Perth Hospital; University of Western Australia; Vanderbilt University; State University System of Florida; University of Florida; La Jolla Institute for Immunology	Phillips, E (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	elizabeth.j.phillips@vanderbilt.edu	D'Orsogna, Lloyd/ABE-9573-2021; Mallal, Simon Alexander/HDM-9561-2022; Buus, Soren/F-5446-2010; Pavlos, Rebecca/AAY-9072-2020; Moran, Ellen/H-7722-2019	D'Orsogna, Lloyd/0000-0002-6824-4189; Mallal, Simon Alexander/0000-0002-7036-1309; Pavlos, Rebecca/0000-0002-8884-9855; Moran, Ellen/0000-0002-0743-0770; , Silvana/0000-0001-6873-0198; Lucas, Andrew Douglas/0000-0003-2899-1806; Lucas, Michaela/0000-0001-8881-9990	National Institutes of Health (NIH) [RO1A1103348]; Australian National Health & Medical Research Council [APP1012608]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103348] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (RO1A1103348) and Australian National Health & Medical Research Council (APP1012608). GlaxoSmithKline sponsored the PREDICT-1 study. The funders and sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2012, EUR J IMMUNOL, DOI [10.1002/eji.201270094, DOI 10.1002/EJI.201270094]; Adam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095339; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Britten CM, 2011, CANCER IMMUNOL IMMUN, V60, P15, DOI 10.1007/s00262-010-0940-z; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Flynn K, 1996, IMMUNOL CELL BIOL, V74, P413, DOI 10.1038/icb.1996.71; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; Martin AM, 2007, AIDS, V21, P1233, DOI 10.1097/QAD.0b013e3280119579; Ostrov DA, 2012, P NATL ACAD SCI USA, DOI [10.1073/pnas.1219540110, DOI 10.1073/PNAS.1219540110]; Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb; Phillips EJ, 2002, AIDS, V16, P2223, DOI 10.1097/00002030-200211080-00017; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Schnyder B, 2013, J ALLERGY CLIN IMMUN, V132, P756, DOI 10.1016/j.jaci.2013.04.013; Shear NH, 2008, AIDS, V22, P999, DOI 10.1097/QAD.0b013e3282f7cb60; Zhai Y, 2002, J IMMUNOL, V169, P4667, DOI 10.4049/jimmunol.169.8.4667; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	33	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117160	10.1371/journal.pone.0117160	http://dx.doi.org/10.1371/journal.pone.0117160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674793	Green Published, gold			2022-12-26	WOS:000349914000014
J	Schmidt, B; Beyer, J; Dietrich, D; Bork, I; Liebenberg, V; Fleischhacker, M				Schmidt, Bernd; Beyer, Julia; Dietrich, Dimo; Bork, Ines; Liebenberg, Volker; Fleischhacker, Michael			Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients	PLOS ONE			English	Article							CYFRA 21-1; CHEMOTHERAPY; DIAGNOSIS; METHYLATION; NUCLEOSOMES; PREDICTION; BIOMARKERS; MANAGEMENT; PROGNOSIS; SURVIVAL	Purpose Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. Material and Methods In a pilot study we prospectively enrolled 36 patients with advanced NSCLC and SCLC (34 stage IV, 2 stage IIIB) of whom 34 received standard platinum-based chemo/ radiotherapy and two were treated with a tyrosine kinase inhibitor. We measured the levels of extracellular methylated SHOX2 DNA (mSHOX2) in plasma before and during therapy until restaging. The mSHOX2 analysis was blinded with respect to the clinical data making it an observational study. Results According to the re-staging of 31 first-line patients, 19 patients were classified as nonresponders while 12 patients were in the responder group. We observed a tight correlation between radiological data and the change of plasma mSHOX2 level as the equivalent for a therapy response. A ROC analysis showed a high discriminatory power for both patient groups already one week after therapy start (AUC 0.844). Additionally, a Kaplan-Meier and Cox Proportional Hazards analyses revealed a strong relationship between survival and plasma mSHOX2 value p <= 0.001 (hazard ratio 11.08) providing some evidence for mSHOX2 also being a predictive marker. Conclusion The longitudinal measurement of extracellular plasma mSHOX2 DNA yields information about the response to cytotoxic treatment and allows an early assessment of treatment response for lung cancer patients. If confirmed in a larger study this would be a valuable tool for selecting and guiding a cytotoxic treatment.	[Schmidt, Bernd; Beyer, Julia; Bork, Ines; Fleischhacker, Michael] UKH, Dept Pneumol, Clin Internal Med 1, Halle, Germany; [Dietrich, Dimo] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Liebenberg, Volker] Metan Hlth GmbH, Berlin, Germany	University of Bonn	Fleischhacker, M (corresponding author), UKH, Dept Pneumol, Clin Internal Med 1, Halle, Germany.	michael.fleischhacker@uk-halle.de	Liebenberg, Volker/AAY-7687-2021	Liebenberg, Volker/0000-0003-1936-1247	Kirstin Diehl Stiftung; Metanomics Health GmbH	Kirstin Diehl Stiftung; Metanomics Health GmbH	This work was supported by the Kirstin Diehl Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metanomics Health GmbH provided support in the form of salaries for authors [Volker Liebenberg], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Brunetti G, 1999, LUNG CANCER-J IASLC, V23, P1, DOI 10.1016/S0169-5002(98)00094-4; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cho WCS, 2007, BIOMED PHARMACOTHER, V61, P515, DOI 10.1016/j.biopha.2007.08.005; Darwiche K, 2013, ANN ONCOL, DOI [10.1093/annonc/mdt547, DOI 10.1093/ANNONC/MDT547]; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084225; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Fathi AT, 2008, SEMIN THORAC CARDIOV, V20, P210, DOI 10.1053/j.semtcvs.2008.09.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fleischhacker M, 2013, EXPERT REV RESP MED, V7, P363, DOI 10.1586/17476348.2013.814397; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Hammerschmidt S, 2009, DTSCH ARZTEBL INT, V106, P809, DOI 10.3238/arztebl.2009.0809; Holdenrieder S, 2004, CLIN CANCER RES, V10, P5981, DOI 10.1158/1078-0432.CCR-04-0625; Holdenrieder S, 2006, ANN NY ACAD SCI, V1075, P244, DOI 10.1196/annals.1368.033; Holdenrieder S, 2010, ANTICANCER RES, V30, P1855; Holdenrieder S, 2008, CLIN CANCER RES, V14, P7813, DOI 10.1158/1078-0432.CCR-08-0678; Holdenrieder S, 2009, LUNG CANCER, V63, P128, DOI 10.1016/j.lungcan.2008.05.001; JOHNSON PWM, 1993, BRIT J CANCER, V67, P760, DOI 10.1038/bjc.1993.138; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kratochwil C, 2010, RADIOLOGE, V50, P684, DOI 10.1007/s00117-009-1960-6; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Scheff RJ, 2013, SEMIN INTERVENT RAD, V30, P191, DOI 10.1055/s-0033-1342961; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; SPLINTER TAW, 1989, J CANCER RES CLIN, V115, P400, DOI 10.1007/BF00400971; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Thatcher N, 2010, ONCOLOGIST, V15, P1034, DOI 10.1634/theoncologist.2009-0292; Toffart AC, 2013, LUNG CANCER, DOI [10.1016/j.lungcan.2013.08.029, DOI 10.1016/J.LUNGCAN.2013.08.029]; Varughese S, 2012, AM J MED SCI, V344, P147, DOI 10.1097/MAJ.0b013e318246e1b8; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108	38	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118195	10.1371/journal.pone.0118195	http://dx.doi.org/10.1371/journal.pone.0118195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675432	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000042
J	Castro-Anon, O; de Llano, LAP; Sanchez, SD; Golpe, R; Marote, LM; Castro-Castro, J; Quintela, AG				Castro-Anon, Olalla; Perez de Llano, Luis A.; De la Fuente Sanchez, Sandra; Golpe, Rafael; Mendez Marote, Lidia; Castro-Castro, Julian; Gonzalez Quintela, Arturo			Obesity-Hypoventilation Syndrome: Increased Risk of Death over Sleep Apnea Syndrome	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; CARDIAC-FUNCTION; OXYGEN-THERAPY; PREVALENCE; MORTALITY; TERM	Aim To study whether mortality and cardiovascular morbidity differ in non-invasive ventilation (NIV)-treated patients with severe obesity-hypoventilation syndrome (OHS) as compared with CPAP-treated patients with obstructive sleep apnea syndrome (OSAS), and to identify independent predictors of mortality in OHS. Material and methods Two retrospective cohorts of OHS and OSAS were matched 1: 2 according to sex, age (+/- 10 year) and length of time since initiation of CPAP/NIV therapy (+/- 6 months). Results Three hundred and thirty subjects (110 patients with OHS and 220 patients with OSAS) were studied. Mean follow-up time was 7 +/- 4 years. The five yearmortality rates were 15.5% in OHS cohort and 4.5% in OSAS cohort (p < 0.05). Patients with OHS had a 2-fold increase (OR 2; 95% CI: 1.11-3.60) in the risk of mortality and 1.86 fold (OR 1.86; 95% CI: 1.14-3.04) increased risk of having a cardiovascular event. Diabetes, baseline diurnal SaO(2) < 83%, EPAP < 7 cmH2O after titration and adherence to NIV < 4 hours independently predicted mortality in OHS. Conclusion Mortality of severe OHS is high and substantially worse than that of OSAS. Severe OHS should be considered a systemic disease that encompasses respiratory, metabolic and cardiovascular components that require a multimodal therapeutic approach.	[Castro-Anon, Olalla; Perez de Llano, Luis A.; Golpe, Rafael; Mendez Marote, Lidia] Lucus Augusti Univ Hosp, Galician Hlth Serv, Div Resp, Lugo, Spain; [Castro-Anon, Olalla; Perez de Llano, Luis A.; Golpe, Rafael; Mendez Marote, Lidia] Lucus Augusti Univ Hosp, Galician Hlth Serv, Sleep Disorders Unit, Lugo, Spain; [De la Fuente Sanchez, Sandra] Lucus Augusti Univ Hosp, Galician Hlth Serv, Lugo, Spain; [Castro-Castro, Julian] Galician Hlth Serv, Lugo, Spain; [Gonzalez Quintela, Arturo] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Universidade de Santiago de Compostela	Castro-Anon, O (corresponding author), Lucus Augusti Univ Hosp, Galician Hlth Serv, Div Resp, Lugo, Spain.	Olalla.Castro.Anon@sergas.es	Golpe, Rafael/AAA-4736-2019; Castro-Añón, Olalla/AAG-2018-2021; Sánchez, Susana/HII-3113-2022	Golpe, Rafael/0000-0002-3759-5322; Castro-Añón, Olalla/0000-0003-0121-5639; 				Bandyopadhyay T, 2004, CHEST, V125, P352, DOI 10.1378/chest.125.1.352; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Borel JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006733; Budweiser S, 2007, J INTERN MED, V261, P375, DOI 10.1111/j.1365-2796.2007.01765.x; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; de Llano LAP, 2008, RESPIRATION, V75, P34, DOI 10.1159/000105460; Galimberti S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-16; GRACE MP, 1982, CRIT CARE MED, V10, P358, DOI 10.1097/00003246-198206000-00002; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lacalzada CC, 2008, EUR RESPIR J, V32, P817, DOI 10.1183/09031936.00059508; Littleton SW, 2009, CLIN CHEST MED, V30, P467, DOI 10.1016/j.ccm.2009.05.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Pepin JL, 2005, REV MAL RESPIR, V22, P113, DOI 10.1016/S0761-8425(05)85442-7; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabec CA, 2002, CHEST, V122, P1498, DOI 10.1378/chest.122.4.1498; RANKIN JS, 1982, CIRCULATION, V66, P108, DOI 10.1161/01.CIR.66.1.108; Rechtschaffen A, 1968, NIH PUBLICATION; SCHOENFELD DA, 1987, BIOMETRIKA, V74, P167, DOI 10.2307/2336031; Toyama T, 2009, CIRC J, V73, P299, DOI 10.1253/circj.CJ-07-0297; Trakada GP, 2010, SLEEP BREATH, V14, P381, DOI 10.1007/s11325-010-0360-5; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	28	97	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117808	10.1371/journal.pone.0117808	http://dx.doi.org/10.1371/journal.pone.0117808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671545	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300072
J	Faron, J; Bernas, T; Sas-Nowosielska, H; Klag, J				Faron, Justyna; Bernas, Tytus; Sas-Nowosielska, Hanna; Klag, Jerzy			Analysis of the Behavior of Mitochondria in the Ovaries of the Earthworm Dendrobaena veneta Rosa 1839	PLOS ONE			English	Article							CYTOCHROME-OXIDASE ACTIVITY; CONFOCAL MICROSCOPY; STEREOLOGICAL ANALYSIS; RAPID SEGREGATION; OOCYTE MATURATION; GERM-LINE; EMBRYO; MOUSE; DNA; OOGENESIS	We examined six types of cells that form the ovary of the earthworm Dendrobena veneta ogonia, prooocytes, vitellogenic oocytes, trophocytes, fully grown postvitellogenic oocytes and somatic cells of the gonad. The quantitative stereological method revealed a much higher "volume density" of mitochondria in all of the types of germ-line cells except for the somatic cells. Fluorescent vital stain JC-1, however, showed a much higher oxidative activity of mitochondria in the somatic cells than in the germ-line cells. The distribution of active and inactive mitochondria within the studied cells was assessed using the computer program ImageJ. The analysis showed a higher luminosity of inactive mitochondria in all of the types of germ-line cells and a higher luminosity of active mitochondria in somatic cells. The OXPHOS activity was found in somatic cells mitochondria and in the peripheral mitochondria of the vitellogenic oocytes. The detection of reactive oxygen species (ROS) revealed a differentiated distribution of ROS in the different cell types. The amount of ROS substances was lower in somatic cells than in younger germ-line cells. The ROS level was also low in the cytoplasm of fully grown postwitellogenic oocytes. The distribution of the MnSOD enzyme that protects mitochondria against destructive role of ROS substances was high in the oogonia and in prooocytes and it was very high in vitellogenic and postvitellogenic oocytes. However, a much lower level of this protective enzyme was observed in the trophocytes and the lowest level was found in the cytoplasm of somatic cells. The lower mitochondrial activity and higher level of MnSOD activity in germ-line cells when compared to somatic cells testifies to the necessity of the organisms to protect the mitochondria of oocytes against the destructive role of the ROS that are produced during oxidative phosphorylation. The protection of the mitochondria in oocytes is essential for the transfer of healthy organelles to the next generation.	[Faron, Justyna; Klag, Jerzy] Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland; [Bernas, Tytus; Sas-Nowosielska, Hanna] Nencki Inst Expt Biol, Lab Imaging Tissue Struct & Funct, Warsaw, Poland	University of Silesia in Katowice; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Klag, J (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland.	jerzy.klag@us.edu.pl	Bernas, Tytus/P-2385-2016; Sas-Nowosielska, Hanna/V-6338-2018	Bernas, Tytus/0000-0003-0841-5940; Faron, Justyna/0000-0001-9551-5602; Sas-Nowosielska, Hanna/0000-0001-6736-9740	Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland	Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland	This research was financed by the Department of Animal Histology and Embryology, University of Silesia, Katowice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; AKIYAMA T, 1992, DEVELOPMENT, V115, P1175; Allen CA, 2007, ORIGIN OF MITOCHONDR; Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089; [Anonymous], 1979, STEREOLOGICAL METHOD; Bergstrom CT, 1998, GENETICS, V149, P2135; BRINSTER RL, 1977, EXP CELL RES, V109, P111, DOI 10.1016/0014-4827(77)90050-7; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Callebaut M, 2008, BELG J ZOOL, V138, P20; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Cossarizza A, 1998, PURDUE CYTOMETRY CD, V4; Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/ror.0.0030172; De la Iglesia F. A, 1981, TOXICOL PATHOL, V9, P21; Delesse A., 1847, CR HEBD ACAD SCI, V25, P544; DEPAZ P, 1986, HISTOL HISTOPATHOL, V1, P197; DHERDE K, 1995, REPROD NUTR DEV, V35, P305, DOI 10.1051/rnd:19950306; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5; Fernandez-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Gomes IC, 2002, TISSUE CELL, V34, P177, DOI 10.1016/S0040-8166(02)00029-0; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kasashima Katsumi, 2014, Reproductive Medicine and Biology, V13, P11, DOI 10.1007/s12522-013-0162-0; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; KOWALD A, 1994, J THEOR BIOL, V168, P75, DOI 10.1006/jtbi.1994.1089; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745; Luo J, 2001, MANGANESE SUPEROXIDE, P1; MARINOS E, 1981, J EMBRYOL EXP MORPH, V62, P395; MARINOS E, 1978, J HISTOCHEM CYTOCHEM, V26, P658, DOI 10.1177/26.8.211159; MAYORDOMO F, 1992, INT J DEV BIOL, V36, P311; MIGNOTTE F, 1987, BIOL CELL, V60, P97, DOI 10.1111/j.1768-322X.1987.tb00549.x; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Morici G, 2007, J MICROSC-OXFORD, V228, P165, DOI 10.1111/j.1365-2818.2007.01860.x; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Moyes CD, 1998, J EXP BIOL, V201, P299; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET; Pathi B, 2012, J EXP BIOL, V215, P1871, DOI 10.1242/jeb.067207; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Persson U, 2003, EVOLUTIONARY ECOLOGY, P1; Piccoli C, 2004, CURRENT ISSUES MULTI, P130; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Romek M, 2005, FOLIA HISTOCHEM CYTO, V43, P57; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229; Siekierska E, 2003, TISSUE CELL, V35, P252, DOI 10.1016/S0040-8166(03)00038-7; Skulachev VP, BIOSCIENCE REPORTS, V17, P347; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sundberg MD, 1992, TESTED STUDIES FOR L, V6, P51; Suzuki H., 2005, J MAMM OVA RES, V22, P163; Swiatek P, 2004, CAN J ZOOL, V82, P714, DOI 10.1139/Z04-040; Swiatek P, 2001, FOLIA BIOL-KRAKOW, V49, P85; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; TOURMENTE S, 1990, BIOL CELL, V68, P119, DOI 10.1016/0248-4900(90)90296-F; TOURTE M, 1984, EUR J CELL BIOL, V34, P171; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2003, HUM REPROD, V18, P2429, DOI 10.1093/humrep/deg466; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Van Blerkom J, 2006, REPRODUCTION, V131, P961, DOI 10.1530/rep.1.00458; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Weibel E., 1980, STEREOLOGICAL METHOD; Wilding M, 2001, ZYGOTE, V9, P347, DOI 10.1017/S096719940100140X; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wilding M, 2009, REPRODUCTION, V137, P619, DOI 10.1530/REP-08-0444; Wolff JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020522; Zhang HJ, 2004, MNSOD A SPECIAL ENZY; Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI [10.1111/j.1440-169x.2008.00988.x, 10.1111/j.1440-169X.2008.00988.x]	81	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117187	10.1371/journal.pone.0117187	http://dx.doi.org/10.1371/journal.pone.0117187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671521	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300040
J	Jin, J; Wu, RJ; Zhu, J; Yang, SY; Lei, Z; Wang, N; Singh, VK; Zheng, JM; Jia, ZC				Jin, Jin; Wu, Ruijuan; Zhu, Jia; Yang, Shaoyuan; Lei, Zhen; Wang, Nan; Singh, Vinay K.; Zheng, Jimin; Jia, Zongchao			Insights into the Cellular Function of YhdE, a Nucleotide Pyrophosphatase from Escherichia coli	PLOS ONE			English	Article							BACILLUS-SUBTILIS; RNASE-E; IDENTIFICATION; PROTEINS; FTSZ; MAF; INHIBITION; FILAMENTS; GROWTH; DOMAIN	YhdE, a Maf-like protein in Escherichia coli, exhibits nucleotide pyrophosphatase (PPase) activity, yet its cellular function remains unknown. Here, we characterized the PPase activity of YhdE on dTTP, UTP and TTP and determined two crystal structures of YhdE, revealing 'closed' and 'open' conformations of an adaptive active site. Our functional studies demonstrated that YhdE retards cell growth by prolonging the lag and log phases, particularly under stress conditions. Morphology studies showed that yhdE-knockout cells transformed the normal rod shape of wild-type cells to a more spherical form, and the cell wall appeared to become more flexible. In contrast, YhdE overexpression resulted in filamentous cells. This study reveals the previously unknown involvement of YhdE in cell growth inhibition under stress conditions, cell-division arrest and cell-shape maintenance, highlighting YhdE's important role in Escherichia coli cell-cycle checkpoints.	[Jin, Jin; Wu, Ruijuan; Zhu, Jia; Yang, Shaoyuan; Lei, Zhen; Wang, Nan; Zheng, Jimin; Jia, Zongchao] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China; [Singh, Vinay K.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Beijing Normal University; Queens University - Canada	Zheng, JM (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	jimin_z@bnu.edu.cn; jia@queensu.ca		Wang, Nan/0000-0001-7129-6089	National Natural Science Foundation of China [21133003, 21273023]; Canadian Institutes of Health Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the National Natural Science Foundation of China (No. 21133003 and No. 21273023) and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran AT, 2013, ORG BIOMOL CHEM, V11, P8113, DOI 10.1039/c3ob41896k; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BI E, 1991, RES MICROBIOL, V142, P249, DOI 10.1016/0923-2508(91)90037-B; Briley K, 2011, MOL MICROBIOL, V81, P23, DOI 10.1111/j.1365-2958.2011.07695.x; BUTLER YX, 1993, J BACTERIOL, V175, P3139, DOI 10.1128/JB.175.10.3139-3145.1993; Hwang KY, 1999, NAT STRUCT BIOL, V6, P691; JANCARIK J, 1991, J MOL BIOL, V221, P31, DOI 10.1016/0022-2836(91)80198-4; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Minasov G, 2000, P NATL ACAD SCI USA, V97, P6328, DOI 10.1073/pnas.97.12.6328; OKADA Y, 1994, J BACTERIOL, V176, P917, DOI 10.1128/jb.176.3.917-922.1994; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Tchigvintsev A, 2013, CHEM BIOL, V20, P1386, DOI 10.1016/j.chembiol.2013.09.011; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200; Zheng JM, 2005, STRUCTURE, V13, P1511, DOI 10.1016/j.str.2005.07.007; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005	28	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117823	10.1371/journal.pone.0117823	http://dx.doi.org/10.1371/journal.pone.0117823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658941	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900229
J	Koide, N; Kubo, T; Nishida, S; Shibata, T; Ikeda, K				Koide, Naoko; Kubo, Takatomi; Nishida, Satoshi; Shibata, Tomohiro; Ikeda, Kazushi			Art Expertise Reduces Influence of Visual Salience on Fixation in Viewing Abstract-Paintings	PLOS ONE			English	Article							EYE; ATTENTION; ARTISTS; SHIFTS; PERCEPTION; APPRAISAL; OVERT	When viewing a painting, artists perceive more information from the painting on the basis of their experience and knowledge than art novices do. This difference can be reflected in eye scan paths during viewing of paintings. Distributions of scan paths of artists are different from those of novices even when the paintings contain no figurative object (i.e. abstract paintings). There are two possible explanations for this difference of scan paths. One is that artists have high sensitivity to high-level features such as textures and composition of colors and therefore their fixations are more driven by such features compared with novices. The other is that fixations of artists are more attracted by salient features than those of novices and the fixations are driven by low-level features. To test these, we measured eye fixations of artists and novices during the free viewing of various abstract paintings and compared the distribution of their fixations for each painting with a topological attentional map that quantifies the conspicuity of low-level features in the painting (i.e. saliency map). We found that the fixation distribution of artists was more distinguishable from the saliency map than that of novices. This difference indicates that fixations of artists are less driven by low-level features than those of novices. Our result suggests that artists may extract visual information from paintings based on high-level features. This ability of artists may be associated with artists' deep aesthetic appreciation of paintings.	[Koide, Naoko; Kubo, Takatomi; Shibata, Tomohiro; Ikeda, Kazushi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Nishida, Satoshi] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan; [Shibata, Tomohiro] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Fukuoka, Japan	Nara Institute of Science & Technology; National Institute of Information & Communications Technology (NICT) - Japan; Kyushu Institute of Technology	Ikeda, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan.	kazushi@is.naist.jp		Nishida, Satoshi/0000-0003-0555-518X; Shibata, Tomohiro/0000-0002-8766-4250; Koide-Majima, Naoko/0000-0002-3805-5758	JSPS KAKENHI [23240028]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant number: JSPS KAKENHI Grant Number 23240028. URL: https://kaken.nii.ac.jp/d/p/23240028.en.html. Author: TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES JR, 1991, PERCEPT MOTOR SKILL, V73, P893, DOI 10.2466/PMS.73.7.893-894; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunye TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103447; Cela-Conde CJ, 2011, PROG NEUROBIOL, V94, P39, DOI 10.1016/j.pneurobio.2011.03.003; Cohen DJ., 2008, PSYCHOL ASTHETICS CR, V2, P8, DOI [10.1037/1931-3896.2.1.8, DOI 10.1037/1931-3896.2.1.8]; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cupchik G, 1992, VIS ARTS RES, V14, P37; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; GREENSPAN H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P222, DOI 10.1109/CVPR.1994.323833; Hekkert P, 1996, AM J PSYCHOL, V109, P389, DOI 10.2307/1423013; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Humphrey K, 2009, BRIT J PSYCHOL, V100, P377, DOI 10.1348/000712608X344780; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 1999, P SOC PHOTO-OPT INS, V3644, P473, DOI 10.1117/12.348467; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kozbelt A, 2001, VIS COGN, V8, P705, DOI 10.1080/13506280042000090; Lansdale M, 2010, APPL COGNITIVE PSYCH, V24, P213, DOI 10.1002/acp.1552; Long ZY, 2011, NEUROSCI LETT, V487, P191, DOI 10.1016/j.neulet.2010.10.020; NODINE CF, 1993, LEONARDO, V26, P219, DOI 10.2307/1575815; Nothdurft HC, 2002, VISION RES, V42, P1287, DOI 10.1016/S0042-6989(02)00016-0; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Putko A, 1989, POLISH PSYCHOL B, V20, P33; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Vogt S, 2007, PERCEPTION, V36, P91, DOI 10.1068/p5262; Yamamura H, 2009, NEUROREPORT, V20, P1630, DOI 10.1097/WNR.0b013e3283331322; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T; Zhao Q, 2011, J VISION, V11, DOI 10.1167/11.3.9	34	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117696	10.1371/journal.pone.0117696	http://dx.doi.org/10.1371/journal.pone.0117696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658327	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900206
J	LeCain, D; Smith, D; Morgan, J; Kimball, BA; Pendall, E; Miglietta, F				LeCain, Daniel; Smith, David; Morgan, Jack; Kimball, Bruce A.; Pendall, Elise; Miglietta, Franco			Microclimatic Performance of a Free-Air Warming and CO2 Enrichment Experiment in Windy Wyoming, USA	PLOS ONE			English	Article							INFRARED HEATER ARRAYS; WATER RELATIONS; PHOTOSYNTHETIC RESPONSES; C-4 GRASSES; ECOSYSTEM; SOIL; PRACTICALITY; GRASSLAND; ARONSON; WHEAT	In order to plan for global changing climate experiments are being conducted in many countries, but few have monitored the effects of the climate change treatments (warming, elevated CO2) on the experimental plot microclimate. During three years of an eight year study with year-round feedback-controlled infra-red heater warming (1.5/3.0 degrees C day/night) and growing season free-air CO2 enrichment (600 ppm) in the mixed-grass prairie of Wyoming, USA, we monitored soil, leaf, canopy-air, above-canopy-air temperatures and relative humidity of control and treated experimental plots and evaluated ecologically important temperature differentials. Leaves were warmed somewhat less than the target settings (1.1 & 1.5 degrees C day/night) but soil was warmed more creating an average that matched the target settings extremely well both during the day and night plus the summer and winter. The site typically has about 50% bare or litter covered soil, therefore soil heat transfer is more critical than in dense canopy ecosystems. The Wyoming site commonly has strong winds (5 ms(-1) average) and significant daily and seasonal temperature fluctuations (as much as 30 degrees C daily) but the warming system was nearly always able to maintain the set temperatures regardless of abiotic variation. The within canopy-air was only slightly warmed and above canopy-air was not warmed by the system, therefore convective warming was minor. Elevated CO2 had no direct effect nor interaction with the warming treatment on microclimate. Relative humidity within the plant canopy was only slightly reduced by warming. Soil water content was reduced by warming but increased by elevated CO2. This study demonstrates the importance of monitoring the microclimate in manipulative field global change experiments so that critical physiological and ecological conclusions can be determined. Highly variable energy demand fluctuations showed that passive IR heater warming systems will not maintain desired warming for much of the time.	[LeCain, Daniel; Smith, David; Morgan, Jack] ARS, USDA, Rangelands Resources Res Unit, Northern Plains Area, Ft Collins, CO 80521 USA; [Kimball, Bruce A.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Pendall, Elise] Univ Western Sydney, Hawkesbury Inst Environm, Sydney, NSW, Australia; [Miglietta, Franco] Ist Biometeorol, Florence, Italy	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Western Sydney University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR)	LeCain, D (corresponding author), ARS, USDA, Rangelands Resources Res Unit, Northern Plains Area, Ft Collins, CO 80521 USA.	dan.lecain@ars.usda.gov	Pendall, Elise/AAF-5667-2020; Miglietta, Franco/B-6137-2008	Miglietta, Franco/0000-0003-1474-8143; Pendall, Elise/0000-0002-1651-8969	US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program; USDA-CSREES Soil Processes Program [2008-35107-18655]; US Department of Energy Office of Science (BER), through Terrestrial Ecosystem Science program [DE-SC0006973]; Western Regional Center of the National Institute for Climatic Change Research; National Science Foundation (DEB) [1021559]	US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program; USDA-CSREES Soil Processes Program; US Department of Energy Office of Science (BER), through Terrestrial Ecosystem Science program(United States Department of Energy (DOE)); Western Regional Center of the National Institute for Climatic Change Research; National Science Foundation (DEB)(National Science Foundation (NSF))	This material is based upon work supported by the US Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program, USDA-CSREES Soil Processes Program (#2008-35107-18655), US Department of Energy Office of Science (BER), through the Terrestrial Ecosystem Science program (#DE-SC0006973) and the Western Regional Center of the National Institute for Climatic Change Research, and by the National Science Foundation (DEB#1021559). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor JS, 2010, AGR FOREST METEOROL, V150, P497, DOI 10.1016/j.agrformet.2009.11.020; Aronson EL, 2010, AGR FOREST METEOROL, V150, P499, DOI 10.1016/j.agrformet.2009.11.021; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Brigham SD, 1999, ECOL APPL, V9, P134; Campbell G.S., 1977, INTRO ENV PHYS; de Boeck HJ, 2011, J ECOL, V99, P724, DOI 10.1111/j.1365-2745.2011.01799.x; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Frelich LE, 2010, FRONT ECOL ENVIRON, V8, P371, DOI 10.1890/080191; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Hovenden MJ, 2006, AUST J BOT, V54, P1, DOI 10.1071/BT04194; IPCC, 2007, CONTRIBUTION WORKING; Gaihre YK, 2014, AGR ECOSYST ENVIRON, V184, P88, DOI 10.1016/j.agee.2013.11.024; Kimball BA, 1999, WATER RESOUR RES, V35, P1179, DOI 10.1029/1998WR900115; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kimball BA, 2011, HDB CLIMATE CHANGE A, P87; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kimball BA, 2012, THEOR APPL CLIMATOL, V108, P247, DOI 10.1007/s00704-011-0518-5; Kimball BA, 2011, AGR FOREST METEOROL, V151, P420, DOI 10.1016/j.agrformet.2010.11.013; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Loik ME, 2000, FUNCT ECOL, V14, P166, DOI 10.1046/j.1365-2435.2000.00411.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Pinter PJ, 2000, AGR FOREST METEOROL, V103, P319, DOI 10.1016/S0168-1923(00)00150-7; Rehmani MIA, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-41; Ruiz-Vera UM, 2013, PLANT PHYSIOL, V162, P410, DOI 10.1104/pp.112.211938; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Wall GW, 2011, GLOBAL CHANGE BIOL, V17, P2113, DOI 10.1111/j.1365-2486.2011.02399.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009	34	24	24	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116834	10.1371/journal.pone.0116834	http://dx.doi.org/10.1371/journal.pone.0116834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658313	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900071
J	Singh, DN; Gupta, A; Singh, VS; Mishra, R; Kateriya, S; Tripathi, AK				Singh, Durgesh Narain; Gupta, Ankush; Singh, Vijay Shankar; Mishra, Rajeev; Kateriya, Suneel; Tripathi, Anil Kumar			Identification and Characterization of a Novel Phosphodiesterase from the Metagenome of an Indian Coalbed	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; METAL-ION BINDING; ALKALINE-PHOSPHATASE; GENE; SUPERFAMILY; GMP; BED	Phosphoesterases are involved in the degradation of organophosphorus compounds. Although phosphomonoesterases and phosphotriesterases have been studied in detail, studies on phosphodiesterases are rather limited. In our search to find novel phosphodiesterases using metagenomic approach, we cloned a gene encoding a putative phosphodiesterase (PdeM) from the metagenome of the formation water collected from an Indian coal bed. Bioinformatic analysis showed that PdeM sequence possessed the characteristic signature motifs of the class III phosphodiesterases and phylogenetic study of PdeM enabled us to identify three distinct subclasses (A, B, and C) within class III phosphodiesterases, PdeM clustering in new subclass IIIB. Bioinformatic, biochemical and biophysical characterization of PdeM further revealed some of the characteristic features of the phosphodiesterases belonging to newly described subclass IIIB. PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25 degrees C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP. The recombinant PdeM possessed phosphodiesterase, phosphonate-ester hydrolase and nuclease activity. It lacked phosphomonoesterase, phosphotriesterase, and RNAse activities. Overexpression of PdeM in E. coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP. Although Mn2+ was required for the activity of PdeM, but addition of metals (Mn2+ or Fe3+) did not induce oligomerization. Further increase in concentration of Mn2+ upto 3 mM, increased alpha-helical content as well as the phosphodiesterase activity. Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP). PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases.	[Singh, Durgesh Narain; Gupta, Ankush; Singh, Vijay Shankar; Tripathi, Anil Kumar] Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India; [Mishra, Rajeev] Banaras Hindu Univ, Mahila Maha Vidyalaya, Bioinformat Programme, Varanasi 221005, Uttar Pradesh, India; [Kateriya, Suneel] Univ Delhi South Campus, Dept Biochem, New Delhi 110021, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); University of Delhi	Tripathi, AK (corresponding author), Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India.	tripathianil@rediffmail.com	Tripathi, Anil Kumar/AAP-8558-2020	Kateriya, Suneel/0000-0001-5428-4297; Mishra, Rajeev/0000-0001-8559-5258; Gupta, Ankush/0000-0001-7575-3187; Tripathi, Anil Kumar/0000-0001-5662-3344	Department of Biotechnology, Government of India; University Grants Commission, New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by a grant from the Department of Biotechnology, Government of India to AKT. DNS and AG were supported by fellowships from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmada E, 2012, J BIOMOL STRUC DYNAM, V1, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUDHRY GR, 1988, APPL ENVIRON MICROB, V54, P288, DOI 10.1128/AEM.54.2.288-293.1988; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; FAISON BD, 1991, CRIT REV BIOTECHNOL, V11, P347, DOI 10.3109/07388559109040624; Igunnu A, 2001, BIOCHEM J, V5, P67; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; KOONIN EV, 1994, PROTEIN SCI, V3, P356; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorenzetti R, 2007, J CHROMATOGR B, V859, P37, DOI 10.1016/j.jchromb.2007.09.008; Manavathi B, 2005, PESTIC BIOCHEM PHYS, V83, P37, DOI 10.1016/j.pestbp.2005.03.007; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLaughlin K, 2004, LIMNOL OCEANOGR-METH, V2, P202, DOI 10.4319/lom.2004.2.202; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Miller JH, 1992, SHORT COURSE BACTERI; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; Penner TJ, 2010, INT J COAL GEOL, V82, P81, DOI 10.1016/j.coal.2010.02.002; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shim H, 1998, J BIOL CHEM, V273, P17445, DOI 10.1074/jbc.273.28.17445; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Singh DN, 2012, APPL MICROBIOL BIOT, V93, P1337, DOI 10.1007/s00253-011-3778-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strapoc D, 2008, APPL ENVIRON MICROB, V74, P2424, DOI 10.1128/AEM.02341-07; Tehara SK, 2003, APPL ENVIRON MICROB, V69, P504, DOI 10.1128/AEM.69.1.504-508.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059; Zambonelli C, 2003, J BIOL CHEM, V278, P13706, DOI 10.1074/jbc.M210363200	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118075	10.1371/journal.pone.0118075	http://dx.doi.org/10.1371/journal.pone.0118075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658120	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900259
J	Song, DL; Altice, FL; Copenhaver, MM; Long, EF				Song, Dahye L.; Altice, Frederick L.; Copenhaver, Michael M.; Long, Elisa F.			Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CLINICAL-TRIAL; HETEROSEXUAL TRANSMISSION; HEROIN USERS; PREVENTION; CARE; BEHAVIORS; ADHERENCE; COMMUNITY; METHADONE	Aims Two behavioral HIV prevention interventions for people who inject drugs (PWID) infected with HIV include the Holistic Health Recovery Program for HIV+ (HHRP+), a comprehensive evidence-based CDC-supported program, and an abbreviated Holistic Health for HIV (3H+) Program, an adapted HHRP+ version in treatment settings. We compared the projected health benefits and cost-effectiveness of both programs, in addition to opioid substitution therapy (OST), to the status quo in the U.S. Methods A dynamic HIV transmission model calibrated to epidemic data of current US populations was created. Projected outcomes include future HIV incidence, HIV prevalence, and quality-adjusted life years (QALYs) gained under alternative strategies. Total medical costs were estimated to compare the cost-effectiveness of each strategy. Results Over 10 years, expanding HHRP+ access to 80% of PWID could avert up to 29,000 HIV infections, or 6% of the projected total, at a cost of $7,777/QALY gained. Alternatively, 3H+ could avert 19,000 infections, but is slightly more cost-effective ($7,707/QALY), and remains so under widely varying effectiveness and cost assumptions. Nearly two-thirds of infections averted with either program are among non-PWIDs, due to reduced sexual transmission from PWID to their partners. Expanding these programs with broader OST coverage could avert up to 74,000 HIV infections over 10 years and reduce HIV prevalence from 16.5% to 14.1%, but is substantially more expensive than HHRP+ or 3H+ alone. Conclusions Both behavioral interventions were effective and cost-effective at reducing HIV incidence among both PWID and the general adult population; however, 3H+, the economical HHRP+ version, was slightly more cost-effective than HHRP+.	[Song, Dahye L.] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT USA; [Copenhaver, Michael M.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Copenhaver, Michael M.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA; [Long, Elisa F.] UCLA Anderson Sch Management, Los Angeles, CA USA	Harvard University; Yale University; Yale University; University of Connecticut; University of California System; University of California Los Angeles	Song, DL (corresponding author), Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA.	dsong@fas.harvard.edu	Long, Elisa/AFQ-5915-2022	Altice, Frederick/0000-0002-7860-693X	National Institute on Drug Abuse [R01 DA032290]; career development awards [K24 DA017072, K02 DA033139]; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA032290, K02DA033139] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); career development awards; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by the National Institute on Drug Abuse (http://www.drugabuse.gov/) for research (R01 DA032290 for FLA and MMC) and career development awards (K24 DA017072 for FLA and K02 DA033139 for MMC.) The funding sources played no role in study design, data collection, analysis, or interpretation, writing of the manuscript, or the decision to submit the paper for publication.	Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Arias E, 2012, NATL VITAL STAT REP, V61, P1; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Avants SK, 2004, J SUBST ABUSE TREAT, V26, P67, DOI 10.1016/S0740-5472(03)00159-4; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2012, HIV US STAG CAR; Centers for Disease Control and Prevention (CDC), 2013, HIV SURV REP 2011; Centers for Disease Control and Prevention (CDC), 2012, ESTIMATED HIV INCIDE; Centers for Disease Control and Prevention (CDC), 2009, EFF ANT THER RISK SE; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Copenhaver MM, 2011, SUBST ABUS, V32, P16, DOI 10.1080/08897077.2011.540466; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Dolan KA, 2003, DRUG ALCOHOL DEPEN, V72, P59, DOI 10.1016/S0376-8716(03)00187-X; Effective Interventions, 2012, HIGH IMP HIV AIDS PR; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harris ZK, 2006, HEALTH ECON, V15, P147, DOI 10.1002/hec.1021; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Howden LM, 2011, AGE SEX COMPOSITION, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Latkin CA, 2003, HEALTH PSYCHOL, V22, P332, DOI 10.1037/0278-6133.22.4.332; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Margolin A, 2003, HEALTH PSYCHOL, V22, P223, DOI 10.1037/0278-6133.22.2.223; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Meader N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007192.pub2; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Neaigus A, 2001, ADDICTION, V96, P847, DOI 10.1046/j.1360-0443.2001.9668476.x; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; SAMHSA, 2012, RES 2011 NAT SURV DR; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Substance Abuse and Mental Health Services Administration (SAMHSA), 2011, RES 2010 NAT SURV DR, VH-41; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; U.S. Bureau of Labor Statistics, 2014, CONS PRIC IND ALL UR; Valdez A, 2011, DRUG ALCOHOL DEPEN, V114, P233, DOI 10.1016/j.drugalcdep.2010.09.014; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; Vlahov D, 2010, CLIN INFECT DIS, V50, pS114, DOI 10.1086/651482; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; WHO, 2003, MAKING CHOICES HLTH; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; Wood E, 2012, CURR OPIN HIV AIDS, V7, P151, DOI 10.1097/COH.0b013e32834f9927; World Bank, 2013, GDP PER CAP CURR US; World Health Organization, 2014, TABL THRESH VAL INT, DOI [10.3928/01913913-20140923-03, DOI 10.3928/01913913-20140923-03]; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	79	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116694	10.1371/journal.pone.0116694	http://dx.doi.org/10.1371/journal.pone.0116694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658949	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900058
J	Vaillancourt, K; LeBel, G; Frenette, M; Gottschalk, M; Grenier, D				Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel			Suicin 3908, a New Lantibiotic Produced by a Strain of Streptococcus suis Serotype 2 Isolated from a Healthy Carrier Pig	PLOS ONE			English	Article							NISIN; BACTERIOCINS; VIRULENT	While Streptococcus suis serotype 2 is known to cause severe infections in pigs, it can also be isolated from the tonsils of healthy animals that do not develop infections. We hypothesized that S. suis strains in healthy carrier pigs may have the ability to produce bacteriocins, which may contribute to preventing infections by pathogenic S. suis strains. Two of ten S. suis serotype 2 strains isolated from healthy carrier pigs exhibited antibacterial activity against pathogenic S. suis isolates. The bacteriocin produced by S. suis 3908 was purified to homogeneity using a three-step procedure: ammonium sulfate precipitation, cationic exchange HPLC, and reversed-phase HPLC. The bacteriocin, called suicin 3908, had a low molecular mass; was resistant to heat, pH, and protease treatments; and possessed membrane permeabilization activity. Additive effects were obtained when suicin 3908 was used in combination with penicillin G or amoxicillin. The amino acid sequence of suicin 3908 suggested that it is lantibiotic-related and made it possible to identify a bacteriocin locus in the genome of S. suis D12. The putative gene cluster involved in suicin production by S. suis 3908 was amplified by PCR, and the sequence analysis revealed the presence of nine open reading frames (ORFs), including the structural gene and those required for the modification of amino acids, export, regulation, and immunity. Suicin 3908, which is encoded by the suiA gene, exhibited approximately 50% identity with bovicin HJ50 (Streptococcus bovis), thermophilin 1277 (Streptococcus thermophilus), and macedovicin (Streptococcus macedonicus). Given that S. suis 3908 cannot cause infections in animal models, that it is susceptible to conventional antibiotics, and that it produces a bacteriocin with antibacterial activity against all pathogenic S. suis strains tested, it could potentially be used to prevent infections and to reduce antibiotic use by the swine industry.	[Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel] FRQNT, CRIPA, Quebec City, PQ, Canada; [Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc GREMIP, St Hyacinthe, PQ J2S 7C6, Canada	Laval University; Universite de Montreal	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015; Gottschalk, Marcelo/I-8116-2012	Grenier, Daniel/0000-0003-0878-4674; 	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ)	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ)	This study was supported by a grant from the Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BRETON J, 1986, CAN J VET RES, V50, P338; Callens BF, 2013, MICROB DRUG RESIST, V19, P146, DOI 10.1089/mdr.2012.0131; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; ELIOPOULOS GM, 1996, ANTIBIOTICS LAB MED, P330; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gottschalk M., 2012, DIS SWINE, P841; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Hagiwara A, 2010, FOOD CHEM TOXICOL, V48, P2421, DOI 10.1016/j.fct.2010.06.002; Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; JOOSTEN HMLJ, 1995, LETT APPL MICROBIOL, V21, P389, DOI 10.1111/j.1472-765X.1995.tb01089.x; LeBel G, 2014, APPL ENVIRON MICROB, V80, P5484, DOI 10.1128/AEM.01055-14; Lebel G, 2013, PEPTIDES, V50, P19, DOI 10.1016/j.peptides.2013.09.014; Luque I, 2010, VET J, V186, P396, DOI 10.1016/j.tvjl.2009.09.005; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Snyder AB, 2014, J SCI FOOD AGR, V94, P28, DOI 10.1002/jsfa.6293; Svetoch EA, 2008, J AGR FOOD CHEM, V56, P1942, DOI 10.1021/jf073284g; Varela NP, 2013, ANIM HEALTH RES REV, V20, P1; Wang J, 2014, APPL ENVIRON MICROB, V80, P1062, DOI 10.1128/AEM.03213-13; Zhang CP, 2009, AGR SCI CHINA, V8, P638, DOI 10.1016/S1671-2927(08)60257-6	27	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117245	10.1371/journal.pone.0117245	http://dx.doi.org/10.1371/journal.pone.0117245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659110	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900122
J	Wang, M; Wu, CP; Pan, JY; Zheng, WW; Cao, XJ; Fan, GK				Wang, Mei; Wu, Chun-Ping; Pan, Jun-Yan; Zheng, Wen-Wei; Cao, Xiao-Juan; Fan, Guo-Kang			Cancer-Associated Fibroblasts in a Human HEp-2 Established Laryngeal Xenografted Tumor Are Not Derived from Cancer Cells through Epithelial-Mesenchymal Transition, Phenotypically Activated but Karyotypically Normal	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; HUMAN BREAST; STROMAL FIBROBLASTS; MICROENVIRONMENT; GROWTH; LINE; PROGRESSION; METASTASIS; TISSUES; PROTEIN	Cancer-associated fibroblasts (CAFs) play a crucial role in cancer progression and even initiation. However, the origins of CAFs in various cancer types remain controversial, and one of the important hypothesized origins is through epithelial-mesenchymal transition (EMT) from cancer cells. In this study, we investigated whether the HEp-2 laryngeal cancer cells are able to generate CAFs via EMT during tumor formation, which is now still unknown. The laryngeal xenografted tumor model was established by inoculating the HEp-2 laryngeal cancer cell line in nude mice. Primary cultured CAFs from the tumor nodules and matched normal fibroblasts (NFs) from the adjacent connective tissues were subcultured, purified, and verified by immunofluorescence. Migration, invasion, and proliferation potentials were compared between the CAFs and NFs. A co-culture of CAFs with HEp-2 cells and a co-injection of CAFs with HEp-2 cells in nude mice were performed to examine the cancer-promoting potential of CAFs to further verify their identity. Karyotypic analyses of the CAFs, NFs, and HEp-2 cells were conducted. A co-culture of NFs with HEp-2 cells was also performed to examine the expression of activated markers of CAFs. A pathological examination confirmed that the laryngeal xenografted tumor model was successfully established, containing abundant CAFs. Immunocytochemical staining verified the purities and identities of the CAFs and NFs. Although the CAFs manifested higher migration, invasion, proliferation, and cancer-promoting capacities compared with the NFs, an analysis of chromosomes revealed that both the CAFs and NFs showed typical normal mouse karyotypes. In addition, the NFs co-cultured with HEp-2 cells did not show induced expressions of activated markers of CAFs. Our findings reveal that the CAFs in the HEp-2 established laryngeal xenografted tumor are not of laryngeal cancer origin but of mouse origin, indicating that the HEp-2 laryngeal cancer cells cannot generate their own CAFs via EMT in this model.	[Wang, Mei; Pan, Jun-Yan; Zheng, Wen-Wei; Cao, Xiao-Juan] Shanghai Municipal Hosp Tradit Chinese Med, Dept Otolaryngol, Shanghai, Peoples R China; [Wang, Mei] Jiaxing Univ, Affiliated Hosp 2, Dept Otolaryngol, Jiaxing, Zhejiang, Peoples R China; [Wu, Chun-Ping] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China; [Fan, Guo-Kang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China	Jiaxing University; Fudan University; Zhejiang University	Fan, GK (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otolaryngol, Hangzhou 310003, Zhejiang, Peoples R China.	fgkxfz@hzcnc.com		Wu, Chunping/0000-0002-0712-8715				CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Du HD, 2013, ACTA OTO-LARYNGOL, V133, P755, DOI 10.3109/00016489.2013.766925; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; FJELDE A, 1962, LIFE SCI, P683, DOI 10.1016/0024-3205(62)90135-2; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Haviv I, 2009, CELL CYCLE, V8, P589, DOI 10.4161/cc.8.4.7669; Jacob M, 2012, CURR MOL MED, V12, P1220, DOI 10.2174/156652412803833607; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kucerova L, 2013, NEOPLASMA, V60, P1, DOI 10.4149/neo_2013_001; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li G, 2003, ONCOGENE, V22, P3162, DOI 10.1038/sj.onc.1206455; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Liu R, 2012, CANCER BIOL THER, V13, P123, DOI 10.4161/cbt.13.3.18696; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McDonald LT, 2012, INT J CLIN EXP PATHO, V5, P863; NORRYD C, 1963, CANCER RES, V23, P197; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Zeisberg M, 2000, J NEPHROL, V13, pS111	29	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117405	10.1371/journal.pone.0117405	http://dx.doi.org/10.1371/journal.pone.0117405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658113	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900142
J	Webb, RC; Pielak, RM; Bastien, P; Ayers, J; Niittynen, J; Kurniawan, J; Manco, M; Lin, A; Cho, NH; Malyrchuk, V; Balooch, G; Rogers, JA				Webb, R. Chad; Pielak, Rafal M.; Bastien, Philippe; Ayers, Joshua; Niittynen, Juha; Kurniawan, Jonas; Manco, Megan; Lin, Athena; Cho, Nam Heon; Malyrchuk, Viktor; Balooch, Guive; Rogers, John A.			Thermal Transport Characteristics of Human Skin Measured In Vivo Using Ultrathin Conformal Arrays of Thermal Sensors and Actuators	PLOS ONE			English	Article							STRATUM-CORNEUM THICKNESS; CONDUCTIVITY; DIFFUSIVITY; PRESSURE; DESIGN	Measurements of the thermal transport properties of the skin can reveal changes in physical and chemical states of relevance to dermatological health, skin structure and activity, thermoregulation and other aspects of human physiology. Existing methods for in vivo evaluations demand complex systems for laser heating and infrared thermography, or they require rigid, invasive probes; neither can apply to arbitrary regions of the body, offers modes for rapid spatial mapping, or enables continuous monitoring outside of laboratory settings. Here we describe human clinical studies using mechanically soft arrays of thermal actuators and sensors that laminate onto the skin to provide rapid, quantitative in vivo determination of both the thermal conductivity and thermal diffusivity, in a completely non-invasive manner. Comprehensive analysis of measurements on six different body locations of each of twenty-five human subjects reveal systematic variations and directional anisotropies in the characteristics, with correlations to the thicknesses of the epidermis (EP) and stratum corneum (SC) determined by optical coherence tomography, and to the water content assessed by electrical impedance based measurements. Multivariate statistical analysis establishes four distinct locations across the body that exhibit different physical properties: heel, cheek, palm, and wrist/volar forearm/dorsal forearm. The data also demonstrate that thermal transport correlates negatively with SC and EP thickness and positively with water content, with a strength of correlation that varies from region to region, e. g., stronger in the palmar than in the follicular regions.	[Webb, R. Chad; Ayers, Joshua; Kurniawan, Jonas; Lin, Athena; Cho, Nam Heon; Malyrchuk, Viktor; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Pielak, Rafal M.; Balooch, Guive] LOreal Calif Res Ctr, San Francisco, CA 94109 USA; [Bastien, Philippe] LOreal Res & Innovat, Aulnay Sous Bois, France; [Niittynen, Juha] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Manco, Megan] LOreal Early Clin, Clark, NJ USA; [Balooch, Guive] LOreal Digital Incubator, Clark, NJ USA	University of Illinois System; University of Illinois Urbana-Champaign; L'Oreal Group; L'Oreal Group; Tampere University	Balooch, G (corresponding author), LOreal Calif Res Ctr, San Francisco, CA 94109 USA.	gbalooch@rd.us.loreal.com; jrogers@illinois.edu	huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016; Cho, Nam Heon/ABF-9534-2020	Bastien, Philippe/0000-0002-5602-5827; Kurniawan, Jonas/0000-0002-1840-632X	National Science Foundation [DGE-1144245]; Tekes [40150/12]; L'Oreal Research Innovation	National Science Foundation(National Science Foundation (NSF)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); L'Oreal Research Innovation(L'Oreal Group)	RCW acknowledges support from the National Science Foundation under grant no. DGE-1144245 (http://www.nsf.gov/). JN acknowledges support from Tekes grant no: 40150/12 (http://www.tekes.fi/). The above funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Materials, instrumentation and human study costs were supported by L'Oreal Research & Innovation. RMP PB MM and GB are employed by L'Oreal and contributed to study design, data analysis and writing of the paper.	ARNAUD F, 1994, SENSOR ACTUAT A-PHYS, V41, P240, DOI 10.1016/0924-4247(94)80117-7; Bohling A, 2014, SKIN RES TECHNOL, V20, P50, DOI 10.1111/srt.12082; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; DUCHARME MB, 1991, J APPL PHYSIOL, V70, P2682, DOI 10.1152/jappl.1991.70.6.2682; Egawa M, 2007, ACTA DERM-VENEREOL, V87, P4, DOI 10.2340/00015555-0183; El-Brawany M. A., 2009, Journal of Medical Engineering & Technology, V33, P249, DOI 10.1080/03091900802451265; Graffe KVD, 2001, HUMAN ANATOMY; GUSTAFSSON SE, 1991, REV SCI INSTRUM, V62, P797, DOI 10.1063/1.1142087; Huang X, 2013, IEEE T BIO-MED ENG, V60, P2848, DOI 10.1109/TBME.2013.2264879; Jin C, 2012, INFRARED PHYS TECHN, V55, P462, DOI 10.1016/j.infrared.2012.07.007; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P179, DOI 10.1109/LED.2004.825190; Li T, 2004, APPL PHYS LETT, V85, P3435, DOI 10.1063/1.1806275; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Raamat R, 2002, MICROVASC RES, V64, P214, DOI 10.1006/mvre.2002.2433; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Sun JY, 2009, J MATER RES, V24, P3338, DOI 10.1557/JMR.2009.0417; TOGAWA T, 1994, PHYSIOL MEAS, V15, P291, DOI 10.1088/0967-3334/15/3/007; Wang SD, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005963; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; WERNER U, 1992, PHYS MED BIOL, V37, P21, DOI 10.1088/0031-9155/37/1/002	23	52	58	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0118131	10.1371/journal.pone.0118131	http://dx.doi.org/10.1371/journal.pone.0118131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658947	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900265
J	Zhang, J; Wang, B; Dong, SL; Cao, DP; Dong, JF; Walker, WB; Liu, Y; Wang, GR				Zhang, Jin; Wang, Bing; Dong, Shuanglin; Cao, Depan; Dong, Junfeng; Walker, William B.; Liu, Yang; Wang, Guirong			Antennal Transcriptome Analysis and Comparison of Chemosensory Gene Families in Two Closely Related Noctuidae Moths, Helicoverpa armigera and H-assulta	PLOS ONE			English	Article							PHEROMONE-BINDING PROTEIN; NEURON MEMBRANE-PROTEINS; HELIOTHIS-VIRESCENS; BOMBYX-MORI; EXPRESSION PATTERN; DIFFERENTIAL EXPRESSION; CHEMICAL COMMUNICATION; SPODOPTERA-LITTORALIS; ANTHERAEA-POLYPHEMUS; SIGNAL-TRANSDUCTION	To better understand the olfactory mechanisms in the two lepidopteran pest model species, the Helicoverpa armigera and H. assulta, we conducted transcriptome analysis of the adult antennae using Illumina sequencing technology and compared the chemosensory genes between these two related species. Combined with the chemosensory genes we had identified previously in H. armigera by 454 sequencing, we identified 133 putative chemosensory unigenes in H. armigera including 60 odorant receptors (ORs), 19 ionotropic receptors (IRs), 34 odorant binding proteins (OBPs), 18 chemosensory proteins (CSPs), and 2 sensory neuron membrane proteins (SNMPs). Consistent with these results, 131 putative chemosensory genes including 64 ORs, 19 IRs, 29 OBPs, 17 CSPs, and 2 SNMPs were identified through male and female antennal transcriptome analysis in H. assulta. Reverse Transcription-PCR (RT-PCR) was conducted in H. assulta to examine the accuracy of the assembly and annotation of the transcriptome and the expression profile of these unigenes in different tissues. Most of the ORs, IRs and OBPs were enriched in adult antennae, while almost all the CSPs were expressed in antennae as well as legs. We compared the differences of the chemosensory genes between these two species in detail. Our work will surely provide valuable information for further functional studies of pheromones and host volatile recognition genes in these two related species.	[Zhang, Jin; Wang, Bing; Cao, Depan; Liu, Yang; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhang, Jin; Dong, Shuanglin] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing 210095, Jiangsu, Peoples R China; [Dong, Junfeng] Henan Univ Sci & Technol, Coll Forestry, Luoyang 471003, Peoples R China; [Walker, William B.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol Res Grp, Alnarp, Sweden	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Nanjing Agricultural University; Henan University of Science & Technology; Swedish University of Agricultural Sciences	Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yangliu@ippcaas.cn; grwang@ippcaas.cn	dong, junfeng/GZL-6072-2022	dong, junfeng/0000-0002-5908-9981; Liu, Yang/0000-0002-3424-7111; Zhang, Jin/0000-0002-0077-0748	National Natural Science Foundation of China [31230062, 31201578]; China National "973" Basic Research Program [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "973" Basic Research Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31230062 to G. W. and 31201578 to Y.L.) and the China National "973" Basic Research Program (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Hua JF, 2013, J INSECT PHYSIOL, V59, P690, DOI 10.1016/j.jinsphys.2013.04.013; Ishida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051779; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2007, COMP BIOCHEM PHYS A, V148, pS81, DOI 10.1016/j.cbpa.2007.06.210; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li PY, 2011, APPL ENTOMOL ZOOL, V46, P497, DOI 10.1007/s13355-011-0067-5; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083180; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu S, 2013, ARCH INSECT BIOCHEM, V82, P29, DOI 10.1002/arch.21069; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062094; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Liu ZD, 2004, ENVIRON ENTOMOL, V33, P1570, DOI 10.1603/0046-225X-33.6.1570; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Prestwich GD, 1996, BIOORGAN MED CHEM, V4, P505, DOI 10.1016/0968-0896(96)00033-8; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Sun MJ, 2013, J INSECT PHYSIOL, V59, P46, DOI 10.1016/j.jinsphys.2012.10.020; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang J, 2014, INSECT SCI; Zhang YN, 2014, J CHEM ECOL, V40, P439, DOI 10.1007/s10886-014-0433-1; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	83	80	98	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117054	10.1371/journal.pone.0117054	http://dx.doi.org/10.1371/journal.pone.0117054			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659090	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900095
J	Zhang, L; Song, HY; Ge, YL; Ji, G; Yao, ZM				Zhang, Li; Song, Haiyan; Ge, Yingli; Ji, Guang; Yao, Zemin			Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SOLUBLE LEPTIN RECEPTOR; HEPATIC STEATOSIS; INDUCED OBESITY; CARBOHYDRATE-METABOLISM; GLUCONEOGENIC GENES; SIGNAL TRANSDUCER; TRANSCRIPTION 3; SERUM LEPTIN; MICE	Rats fed with high-fat-high-sucrose (HFHS) diet are known to manifest metabolic syndrome including hyperinsulinemia, hyperleptinemia, hyperglycemia, diabetic dyslipidemia, and hepatic steatosis. The aim of the current study is to determine the temporal relationships between the development of hepatic steatosis and the onset of insulin and leptin resistance in hypothalamus and liver in male Wistar rats (six weeks of age) fed chow or HFHS diet for up to 8 weeks. Fasting plasma glucose, lipids/lipoproteins, insulin and leptin levels were quantified, histopathologic score of hepatic steatosis and inflammation were assessed, and the responses of common checkpoints of insulin and leptin signalling responsible for lipogenesis and gluconeogenesis were analyzed. In addition, acute insulin or leptin administration was performed at different stages of HFHS dieting to determine the responsiveness of the respective signalling pathways. Hyperinsulinemia, hyperglycemia, dyslipidemia, and increased homeostasis model assessment of basal insulin resistance occurred 1-week after HFHS dieting, coinciding with upregulation of suppressor of cytokine signalling 3 in both hypothalamus and liver. However, hepatosteatosis, accompanied with increased expression of sterol regulatory element binding protein 1c and phosphoenolpyruvate carboxykinase, did not manifest until 4- to 8-week after HFHS dieting. Lowered insulin sensitivity (shown by decreased insulin receptor substrate 1 and protein kinase B phosphorylation) occurred approximately 2 weeks prior to leptin resistance (shown by impaired signal transducer and activator of transcription 3 activation) in both the liver and hypothalamus. Acute insulin/leptin administration also demonstrated the impaired insulin or leptin signalling transduction. These data suggest that lowered insulin sensitivity and leptin resistance occurred at least 2-3 weeks earlier than the manifestation of hepatosteatosis in rats fed HFHS diet.	[Zhang, Li; Song, Haiyan; Ge, Yingli; Ji, Guang] Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai 200032, Peoples R China; [Ji, Guang] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Educ Commiss, E Inst, Shanghai 200032, Peoples R China; [Yao, Zemin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON, Canada	Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine; University of Ottawa	Ji, G (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai 200032, Peoples R China.	jiliver@vip.sina.com; zyao@uottawa.ca			National Nature Science Foundation of China [81273727, 81302927]; Innovation Program of Shanghai Municipal Education Commission [14YZ053]; Shanghai Discipline Project [ZYSNXD-CC-ZDYJ042]; Longhua Medicial Project [D-09]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Discipline Project; Longhua Medicial Project	This work was supported by the National Nature Science Foundation of China (No. 81273727, 81302927), Innovation Program of Shanghai Municipal Education Commission, No. 14YZ053, Shanghai Discipline Project (No. ZYSNXD-CC-ZDYJ042), and Longhua Medicial Project (No. D-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bhandari U, 2011, HUM EXP TOXICOL, V30, P1313, DOI 10.1177/0960327110389499; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com; Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hajiaghamohammadi AA, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6099; Higuchi T, 2008, J NUTR BIOCHEM, V19, P577, DOI 10.1016/j.jnutbio.2007.08.001; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Kanu A, 2003, METABOLISM, V52, P60, DOI 10.1053/meta.2003.50005; Kim IK, 2008, ANN NUTR METAB, V53, P109, DOI 10.1159/000165360; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lacombe Veronique A, 2014, ISRN Vet Sci, V2014, P409547, DOI 10.1155/2014/409547; Li JM, 2010, HEPATOLOGY, V51, P1555, DOI 10.1002/hep.23524; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Medici V, 2010, OBESITY, V18, P2268, DOI 10.1038/oby.2010.95; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Nobili V, 2006, EUR J ENDOCRINOL, V155, P735, DOI 10.1530/eje.1.02288; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tom RZ, 2011, ENDOCRINOLOGY, V152, P2237, DOI 10.1210/en.2010-0040; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Yang ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047493; Yue JTY, 2012, CELL METAB, V15, P646, DOI 10.1016/j.cmet.2012.01.013	49	23	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117008	10.1371/journal.pone.0117008	http://dx.doi.org/10.1371/journal.pone.0117008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658428	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900090
J	Nakajima, T; Kitagawa, K; Ohhata, T; Sakai, S; Uchida, C; Shibata, K; Minegishi, N; Yumimoto, K; Nakayama, KI; Masumoto, K; Katou, F; Niida, H; Kitagawa, M				Nakajima, Tomomi; Kitagawa, Kyoko; Ohhata, Tatsuya; Sakai, Satoshi; Uchida, Chiharu; Shibata, Kiyoshi; Minegishi, Naoko; Yumimoto, Kanae; Nakayama, Keiichi I.; Masumoto, Kazuma; Katou, Fuminori; Niida, Hiroyuki; Kitagawa, Masatoshi			Regulation of GATA-binding Protein 2 Levels via Ubiquitin-dependent Degradation by Fbw7 INVOLVEMENT OF CYCLIN B-CYCLIN- DEPENDENT KINASE 1-MEDIATED PHOSPHORYLATION OF THR176 IN GATA-BINDING PROTEIN 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (CDK); GATA Transcription Factor; Phosphorylation; Protein Degradation; Ubiquitin Ligase; Ubiquitylation (Ubiquitination); Fbw7	T-CELL DEVELOPMENT; F-BOX PROTEIN; MOUSE C-MYB; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; ENFORCED EXPRESSION; HEMATOPOIETIC STEM; BUTYROLACTONE-I; FBXW7 ACTS; SCFFBW7	A GATA family transcription factor, GATA-binding protein 2 (GATA2), participates in cell growth and differentiation of various cells, such as hematopoietic stem cells. Although its expression level is controlled by transcriptional induction and proteolytic degradation, the responsible E3 ligase has not been identified. Here, we demonstrate that F-box/WD repeat-containing protein 7 (Fbw7/Fbxw7), a component of Skp1, Cullin 1, F-box-containing complex (SCF)-type E3 ligase, is an E3 ligase for GATA2. GATA2 contains a cell division control protein 4 (Cdc4) phosphodegron (CPD), a consensus motif for ubiquitylation by Fbw7, which includes Thr(176). Ectopic expression of Fbw7 destabilized GATA2 and promoted its proteasomal degradation. Substitution of threonine 176 to alanine in GATA2 inhibited binding with Fbw7, and the ubiquitylation and degradation of GATA2 by Fbw7 was suppressed. The CPD kinase, which mediates the phosphorylation of Thr(176), was cyclin B-cyclin-dependent kinase 1 (CDK1). Moreover, depletion of endogenous Fbw7 stabilized endogenous GATA2 in K562 cells. Conditional Fbw7 depletion in mice increased GATA2 levels in hematopoietic stem cells and myeloid progenitors at the early stage. Increased GATA2 levels in Fbw7-conditional knock-out mice were correlated with a decrease in a c-Kit high expressing population of myeloid progenitor cells. Our results suggest that Fbw7 is a bona fide E3 ubiquitin ligase for GATA2 in vivo.	[Nakajima, Tomomi; Kitagawa, Kyoko; Ohhata, Tatsuya; Sakai, Satoshi; Niida, Hiroyuki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nakajima, Tomomi; Masumoto, Kazuma; Katou, Fuminori] Hamamatsu Univ Sch Med, Oral & Maxillofacial Surg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Uchida, Chiharu; Shibata, Kiyoshi] Hamamatsu Univ Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Minegishi, Naoko] Tohoku Univ, Dept Biobank Life Sci, Sch Med, Aoba Ku, Sendai, Miyagi 9808573, Japan; [Yumimoto, Kanae; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Tohoku University; Kyushu University	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Biol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp		Ohhata, Tatsuya/0000-0003-1124-6164	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24570151, 25112508]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-aid 24570151 (to K. K.) and 25112508 (to M. K.).	Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Fukushima H, 2012, CELL REP, V1, P434, DOI 10.1016/j.celrep.2012.04.002; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Ishida H, 2012, EUR J PEDIATR, V171, P1273, DOI 10.1007/s00431-012-1715-7; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kitagawa K, 2014, MOL CELL BIOL, V34, P2732, DOI 10.1128/MCB.01549-13; Kitagawa K, 2012, CURR DRUG TARGETS, V13, P1641, DOI 10.2174/138945012803529974; Kitagawa K, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-27; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; KITAGAWA M, 1994, ONCOGENE, V9, P2549; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KITAGAWA M, 1993, ONCOGENE, V8, P2425; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koga S, 2007, BLOOD, V109, P4200, DOI 10.1182/blood-2006-08-044149; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Shimizu R, 2012, CANCER SCI, V103, P2039, DOI 10.1111/cas.12007; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Wang ZW, 2012, EMBO REP, V13, P36, DOI 10.1038/embor.2011.231; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10368	10381		10.1074/jbc.M114.613018	http://dx.doi.org/10.1074/jbc.M114.613018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670854	Green Published, hybrid			2022-12-26	WOS:000353241100038
J	Scrima, N; Lepault, J; Boulard, Y; Pasdeloup, D; Bressanelli, S; Roche, S				Scrima, Nathalie; Lepault, Jean; Boulard, Yves; Pasdeloup, David; Bressanelli, Stephane; Roche, Stephane			Insights into Herpesvirus Tegument Organization from Structural Analyses of the 970 Central Residues of HSV-1 UL36 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS 1; NUCLEAR-LOCALIZATION SIGNAL; PSEUDORABIES VIRUS; CAPSID TRANSPORT; MOLECULAR-DYNAMICS; TYPE-1; VP1-2; DNA; VISUALIZATION; ASSOCIATION	The tegument of all herpesviruses contains a capsid-bound large protein that is essential for multiple viral processes, including capsid transport, decapsidation at the nuclear pore complex, particle assembly, and secondary envelopment, through mechanisms that are still incompletely understood. We report here a structural characterization of the central 970 residues of this protein for herpes simplex virus type 1 (HSV-1 UL36, 3164 residues). This large fragment is essentially a 34-nm-long monomeric fiber. The crystal structure of its C terminus shows an elongated domain-swapped dimer. Modeling and molecular dynamics simulations give a likely molecular organization for the monomeric form and extend our findings to alphaherpesvirinae. Hence, we propose that an essential feature of UL36 is the existence in its central region of a stalk capable of connecting capsid and membrane across the tegument and that the ability to switch between monomeric and dimeric forms may help UL36 fulfill its multiple functions.	[Scrima, Nathalie; Lepault, Jean; Boulard, Yves; Bressanelli, Stephane; Roche, Stephane] Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Boulard, Yves] Commissariat Energie Atom, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Pasdeloup, David] INSERM, Fac Pharm, UMR 984, F-92290 Chatenay Malabry, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bressanelli, S (corresponding author), Inst Integrat Biol Cell I2BC, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	stephane.bressanelli@vms.cnrs-gif.fr; stephane.roche@vms.cnrs-gif.fr	Lepault, Jean/AAN-8859-2020	Bressanelli, Stephane/0000-0002-0921-6727; Pasdeloup, David/0000-0003-3922-4493				Abaitua F, 2008, J VIROL, V82, P5234, DOI 10.1128/JVI.02497-07; Abaitua F, 2012, J VIROL, V86, P8998, DOI 10.1128/JVI.01209-12; Abaitua F, 2011, J VIROL, V85, P2024, DOI 10.1128/JVI.01895-10; Abaitua F, 2009, J GEN VIROL, V90, P2353, DOI 10.1099/vir.0.012492-0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal A, 2012, J VIROL, V86, P6123, DOI 10.1128/JVI.07016-11; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolstad M, 2011, J VIROL, V85, P8738, DOI 10.1128/JVI.00798-11; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Coller KE, 2007, J VIROL, V81, P11790, DOI 10.1128/JVI.01113-07; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Jambunathan N, 2014, J VIROL, V88, P5927, DOI 10.1128/JVI.00278-14; Jovasevic V, 2008, J VIROL, V82, P3311, DOI 10.1128/JVI.01919-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; Ko DH, 2010, J VIROL, V84, P1397, DOI 10.1128/JVI.01721-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JIH, 2006, J VIROL, V80, P12086, DOI 10.1128/JVI.01184-06; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; McElwee M, 2013, J VIROL, V87, P11008, DOI 10.1128/JVI.01633-13; Mijatov B, 2007, VIROLOGY, V368, P26, DOI 10.1016/j.virol.2007.07.005; Newcomb WW, 2010, J VIROL, V84, P9408, DOI 10.1128/JVI.00361-10; Pasdeloup D, 2013, J VIROL, V87, P7102, DOI 10.1128/JVI.00764-13; Pasdeloup D, 2013, J VIROL, V87, P2857, DOI 10.1128/JVI.02676-12; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandbaumhuter M, 2013, CELL MICROBIOL, V15, P248, DOI 10.1111/cmi.12075; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Svobodova S, 2012, J VIROL, V86, P473, DOI 10.1128/JVI.05981-11; Tullman JA, 2014, J VIROL, V88, P8256, DOI 10.1128/JVI.00971-14; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Wang SM, 2013, J SPECTROSC, V2013, P1, DOI 10.1155/2013/646050; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	53	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8820	8833		10.1074/jbc.M114.612838	http://dx.doi.org/10.1074/jbc.M114.612838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678705	hybrid, Green Published			2022-12-26	WOS:000352207100012
J	Hamberg, L; Vartiamaki, H; Hantula, J				Hamberg, Leena; Vartiamaki, Henna; Hantula, Jarkko			Breeding Increases the Efficacy of Chondrostereum purpureum in the Sprout Control of Birch	PLOS ONE			English	Article							FOREST VEGETATION MANAGEMENT; BIOLOGICAL-CONTROL AGENT; SORBUS-AUCUPARIA; GROWTH; DEGRADATION; INFECTION; STRAINS; LIGNIN; PRUNUS; STANDS	We tested whether the pairing of selected isolates could be used to increase the efficiency of a decay fungus Chondrostereum purpureum (Pers. Ex Fr.) Pouzar to control hardwood sprouting in Finland. We paired C. purpureum strains efficient in sprout control or highly active in laccase production, and tested the efficacy of their progeny in spout control experiments. This procedure resulted in a strain with an efficacy superior to that of the parental strains. The mortality of birch (Betula pendula Roth. and B. pubescens Ehrh.) 1 cm in stump diameter was 78%, 56% and 9% for the best progeny, the best parental strain and the control, respectively. Mortality was only slightly higher for B. pendula than for B. pubescens but no significant differences were found between the number or maximum height of stump sprouts. Our results showed that cross breeding of this decay fungus is a good alternative in attempts to produce efficient biocontrol agents against hardwood sprouting.	[Hamberg, Leena; Vartiamaki, Henna; Hantula, Jarkko] Finnish Forest Res Inst, Vantaa Res Unit, FIN-01301 Vantaa, Finland	Natural Resources Institute Finland (Luke)	Hamberg, L (corresponding author), Finnish Forest Res Inst, Vantaa Res Unit, FIN-01301 Vantaa, Finland.	leena.hamberg@metla.fi		Hamberg, Leena/0000-0002-0009-7768; Hantula, Jarkko/0000-0002-1016-0636	Finnish Funding Agency for Technology and Innovation [265/31/2012]; Verdera Ltd.; Metsateho Ltd.; Finnish Transport Agency; UPM-Kymmene Ltd.; Marjatta and Eino Kolli Foundation [1041]; Finnish Cultural Foundation [00081430]; Finnish Forest Research Institute; Fingrid Ltd.	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Verdera Ltd.; Metsateho Ltd.; Finnish Transport Agency; UPM-Kymmene Ltd.; Marjatta and Eino Kolli Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Forest Research Institute; Fingrid Ltd.	The study was funded by the Finnish Funding Agency for Technology and Innovation (http://www.tekes.fi/en/, project number 265/31/2012), Verdera Ltd. (http://verdera.fi/en/front-page/), Metsateho Ltd. (http://www.metsateho.fi/aboutus/presentation), Fingrid Ltd. (http://www.fingrid.fi/en/Pages/default.aspx), The Finnish Transport Agency (http://portal.liikennevirasto.fi/sivu/www/e/), UPM-Kymmene Ltd. (http://www.upm.com/en/Pages/default.aspx), Marjatta and Eino Kolli Foundation (http://www.kollinsaatio.com/,project number 1041), the Finnish Cultural Foundation (http://www.skr.fi/en, project number 00081430) and the Finnish Forest Research Institute (http://www.metla.fi/index-en.html). LH received salary from the Finnish Forest Research Institute which obtained funding from the abovementioned sources. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijala O., 2014, METSANHOIDON SUOSITU; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; Bates D, 2012, LME4 LINEAR MIXED EF; Finnish Forest Research Institute, 1995, NATIONAL FOREST INVE; Finnish FSC association, 2010, FSC STANDARD FOR FIN; Gosselin L, 1996, MYCOL RES, V100, P151, DOI 10.1016/S0953-7562(96)80113-4; Hamberg L, 2014, BIOCONTROL, V59, P125, DOI 10.1007/s10526-013-9550-y; Hamberg L, 2011, SCAND J FOREST RES, V26, P505, DOI 10.1080/02827581.2011.592144; Harper GJ, 1999, CAN J FOREST RES, V29, P852, DOI 10.1139/cjfr-29-7-852; Hyvamaki T., 2002, TAPION TASKUKIRJA; Jobidon R, 2000, FOREST ECOL MANAG, V130, P77, DOI 10.1016/S0378-1127(99)00176-0; JONES M, 1987, PROC R SOC SER B-BIO, V232, P1, DOI 10.1098/rspb.1987.0058; Jones S.G, 1949, PLANT PATHOL, P763; Kaila S, 2006, SCAND J FOREST RES, V21, P496, DOI 10.1080/02827580601073263; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LEATHAM GF, 1986, APPL MICROBIOL BIOT, V24, P51, DOI 10.1007/BF00266285; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Pinheiro J, 2012, NLME LINEAR AND NONL; Pitt DG, 1999, CAN J FOREST RES, V29, P841, DOI 10.1139/cjfr-29-7-841; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Roy V, 2010, FOREST ECOL MANAG, V259, P1571, DOI 10.1016/j.foreco.2010.01.033; Scheepens P.C., 1989, P 7 INT S BIOL CONTR, P545; SPIERS AG, 1987, NEW ZEAL J BOT, V25, P411, DOI 10.1080/0028825X.1987.10413358; Spiers AG, 1998, MYCOL RES, V102, P881, DOI 10.1017/S0953756297005923; Spiers AG, 2000, MYCOL RES, V104, P395, DOI 10.1017/S0953756299001732; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Strunz GM, 1997, CAN J CHEM, V75, P742, DOI 10.1139/v97-090; Sun H, 2009, FEMS MICROBIOL ECOL, V69, P266, DOI 10.1111/j.1574-6941.2009.00711.x; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Uotila K, 2014, SCAND J FOREST RES, V29, P111, DOI 10.1080/02827581.2013.869349; Valkonen S, 2003, SCAND J FOREST RES, V18, P416, DOI 10.1080/02827581.2003.9610645; Vandenbroucke Jack Eric, 2005, Journal of Arboriculture, V31, P251; Vartiamaki H, 2008, FOREST PATHOL, V38, P381, DOI 10.1111/j.1439-0329.2008.00551.x; Vartiamaki H, 2008, BIOL CONTROL, V47, P46, DOI 10.1016/j.biocontrol.2008.06.005; Vartiamaki H, 2009, CAN J FOREST RES, V39, P731, DOI 10.1139/X09-009; Wall R. E., 1990, Northern Journal of Applied Forestry, V7, P17; Wall RE, 1997, CAN J PLANT PATHOL, V19, P181, DOI 10.1080/07060669709500550; Wall RE, 1996, BIOL CONTROL, V7, P205, DOI 10.1006/bcon.1996.0085	39	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117381	10.1371/journal.pone.0117381	http://dx.doi.org/10.1371/journal.pone.0117381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674794	Green Submitted, Green Published, gold			2022-12-26	WOS:000349914000020
J	Wang, WS; Du, ZQ; Cheng, BH; Wang, YX; Yao, J; Li, YM; Cao, ZP; Luan, P; Wang, N; Li, H				Wang, Weishi; Du, Zhi-Qiang; Cheng, Bohan; Wang, Yuxiang; Yao, Jing; Li, Yumao; Cao, Zhiping; Luan, Peng; Wang, Ning; Li, Hui			Expression Profiling of Preadipocyte MicroRNAs by Deep Sequencing on Chicken Lines Divergently Selected for Abdominal Fatness	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ADIPOSE-TISSUE; ADIPOGENIC DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ASSOCIATION ANALYSIS; INSULIN-RESISTANCE; LIPID-METABOLISM; PRE-ADIPOCYTE; SEED REGION	Through posttranscriptional gene regulation, microRNA (miRNA) is linked to a wide variety of biological processes, including adipogenesis and lipid metabolism. Although miRNAs in mammalian adipogenesis have been worked on extensively, their study in chicken adipogenesis is still very limited. To find miRNAs potentially important for chicken preadipocyte development, we compared the preadipocyte miRNA expression profiles in two broiler lines divergently selected for abdominal fat content, by sequencing two small RNA libraries constructed for primary preadipocytes isolated from abdominal adipose tissues. After bioinformatics analyses, from chicken miRNAs deposited in miRBase 20.0, we identified 225 miRNAs to be expressed in preadipocytes, 185 in the lean line and 200 in the fat line (derived from 208 and 203 miRNA precursors, respectively), which corresponds to 114 miRNA families. The let-7 family miRNAs were the most abundant. Furthermore, we validated the sequencing results of 15 known miRNAs by qRT-PCR, and confirmed that the expression levels of most miRNAs correlated well with those of Solexa sequencing. A total of 33 miRNAs was significantly differentially expressed between the two chicken lines (P<0.05). Gene ontology analysis revealed that they could target genes enriched in the regulation of gene transcription and chromatin function, response to insulin stimulation, and IGF-1 signaling pathways, which could have important roles in preadipocyte development. Therefore, a valuable information and resource of miRNAs on chicken adipogenesis were provided in this study. Future functional investigations on these miRNAs could help explore related genes and molecular networks fundamental to preadipocyte development.	[Wang, Weishi; Du, Zhi-Qiang; Cheng, Bohan; Wang, Yuxiang; Yao, Jing; Li, Yumao; Cao, Zhiping; Luan, Peng; Wang, Ning; Li, Hui] Northeast Agr Univ, Coll Anim Sci & Technol, Educ Dept Heilongjiang Prov, Key Lab Chicken Genet & Breeding,Minist Agr,Key L, Harbin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Wang, N (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Educ Dept Heilongjiang Prov, Key Lab Chicken Genet & Breeding,Minist Agr,Key L, Harbin, Peoples R China.	wayane123@aliyun.com; lihui@neau.edu.cn			National 863 project of China [2013AA102501]; National Basic Research Program of China [2009CB941604]; China Agriculture Research System [CARS-42]	National 863 project of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	This study was supported by the National 863 project of China (No. 2013AA102501), National Basic Research Program of China (No. 2009CB941604), and China Agriculture Research System (No. CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; [Anonymous], 2010, PMID; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baselga-Escudero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069817; Baselga-Escudero L, 2012, MOL NUTR FOOD RES, V56, P1636, DOI 10.1002/mnfr.201200237; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Chakraborty C, 2014, WILEY INTERDISCIP RE, DOI [10.1002/wrna.1274, DOI 10.1002/WRNA.1274]; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen F, 2014, MOL BIOL REP, V41, P5505, DOI 10.1007/s11033-014-3426-9; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chen YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090842; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Crepin D, 2014, MOL CELL ENDOCRINOL, V384, P1, DOI 10.1016/j.mce.2013.12.016; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CRYER J, 1987, COMP BIOCHEM PHYS A, V86, P515, DOI 10.1016/0300-9629(87)90535-4; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dinh H, 2014, VET IMMUNOL IMMUNOP, V159, P74, DOI 10.1016/j.vetimm.2014.02.003; Dong PY, 2014, ACTA BIOCH BIOPH SIN, V46, P565, DOI 10.1093/abbs/gmu043; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Garten A, 2012, ENDOCRIN METAB CLIN, V41, P283, DOI 10.1016/j.ecl.2012.04.011; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2011, POULTRY SCI, V90, P2024, DOI 10.3382/ps.2010-00863; Hansen TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010961; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Inukai S, 2012, CELL CYCLE, V11, P1060, DOI 10.4161/cc.11.6.19786; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kaur K, 2011, MOL BIOSYST, V7, P3234, DOI 10.1039/c1mb05041a; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2012, J CELL PHYSIOL, V227, P183, DOI 10.1002/jcp.22716; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2012, BRIT POULTRY SCI, V53, P770, DOI 10.1080/00071668.2012.750716; Li H, 2013, J APPL GENET, V54, P209, DOI 10.1007/s13353-013-0142-4; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Luo C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-112; Martini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089755; Meale SJ, 2014, J ANIM SCI, DOI [10.2527/jas.2014-7873, DOI 10.2527/JAS.2014-7873]; Moreno-Navarrete J. M., 2012, ADIPOSE TISSUE BIOL, P17, DOI [10.1007/978-1-4614-0965-6_2, DOI 10.1007/978-1-4614-0965-6]; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rengaraj D, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.105692; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schiller ZA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt230; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shang ZC, 2014, BIOSCIENCE REP, V34, P51, DOI 10.1042/BSR20130120; Shao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091236; Shende VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065300; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Shi R, 2010, PLANTA, V232, P1281, DOI 10.1007/s00425-010-1253-3; Shin D, 2012, NEUROSCIENCE, V213, P29, DOI 10.1016/j.neuroscience.2012.03.054; Simionescu N, 2014, MOL BIOL REP; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soares AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039417; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Sun XH, 2014, CIRC RES, V115, P2, DOI 10.1161/CIRCRESAHA.114.304228; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang YF, 2009, OMICS, V13, P331, DOI 10.1089/omi.2009.0017; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Vuppalanchi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074471; Wang Q, 2013, VET MICROBIOL, V162, P232, DOI 10.1016/j.vetmic.2012.10.023; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444; Yang WL, 2013, BIOCHEM J, V449, P605, DOI 10.1042/BJ20121121; Yao J, 2011, BIOSCI BIOTECH BIOCH, V75, P54, DOI 10.1271/bbb.100530; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-517; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040736; Zhang QH, 2014, BBA-MOL CELL BIOL L, V1841, P934, DOI 10.1016/j.bbalip.2014.03.009; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119; Zhang SP, 2013, BRIT POULTRY SCI, V54, P312, DOI 10.1080/00071668.2013.791383; Zhang XF, 2014, INSECT BIOCHEM MOLEC, V47, P12, DOI 10.1016/j.ibmb.2014.01.008; Zhong D, 2013, CELL SIGNAL, V25, P1429, DOI 10.1016/j.cellsig.2013.03.003; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	110	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117843	10.1371/journal.pone.0117843	http://dx.doi.org/10.1371/journal.pone.0117843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675096	gold, Green Submitted, Green Published			2022-12-26	WOS:000349914000033
J	Kolowerzo-Lubnau, A; Niedojadlo, J; Swidzinski, M; Bednarska-Kozakiewicz, E; Smolinski, DJ				Kolowerzo-Lubnau, Agnieszka; Niedojadlo, Janusz; Swidzinski, Michal; Bednarska-Kozakiewicz, Elzbieta; Smolinski, Dariusz J.			Transcriptional Activity in Diplotene Larch Microsporocytes, with Emphasis on the Diffuse Stage	PLOS ONE			English	Article							MEIOTIC PROPHASE-I; SMALL NUCLEAR RNAS; COILED BODIES; CAJAL BODIES; POLY(A) RNA; CHROMATIN CONFIGURATION; SPLICING MACHINERY; MALE GAMETOPHYTE; U-SNRNA; POLLEN	Manuscript provides insights into the biology of long-lived plants, different from Arabidopsis, tomato or grass species that are widely studied. In the European larch the diplotene stage lasts approximately 5 months and it is possible to divide it into several substages and to observe each of them in details. The diplotene stage is a period of intensive microsporocyte growth associated with the synthesis and accumulation of different RNA and proteins. Larch microsporocytes display changes in chromatin morphology during this stage, alternating between 4 short stages of chromatin condensation (contraction) and 5 longer diffusion (relaxation) stages. The occurrence of a diplotene diffusion stage has been observed in many plant species. Interestingly, they have also been observed during spermiogenesis and oogenesis in animals. The aim of this study was to examine whether chromatin relaxation during the diplotene is accompanied by the synthesis and maturation of mRNA. The results reveal a correlation between the diffusion and chromatin decondensation, transcriptional activity. We also found decreasing amount of poly(A) mRNA synthesis in the consecutive diffusion stages. During the early diffusion stages, mRNA is intensively synthesized. In the nuclei large amounts of RNA polymerase II, and high levels of snRNPs were observed. In the late diffusion stages, the synthesized mRNA is not directly subjected to translation but it is stored in the nucleus, and later transported to the cytoplasm and translated. In the last diffusion stage, the level of poly(A) RNA is low, but that of splicing factors is still high. It appears that the mRNA synthesized in early stages is used during the diplotene stage and is not transmitted to dyad and tetrads. In contrast, splicing factors accumulate and are most likely transmitted to the dyad and tetrads, where they are used after the resumption of intense transcription. Similar meiotic process were observed during oogenesis in animals. This indicates the existence of an evolutionarily conserved mechanism of chromatin-based regulation of gene expression during meiotic prophase I.	[Kolowerzo-Lubnau, Agnieszka; Niedojadlo, Janusz; Swidzinski, Michal; Bednarska-Kozakiewicz, Elzbieta; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland; [Kolowerzo-Lubnau, Agnieszka; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Kolowerzo-Lubnau, A (corresponding author), Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland.	agakol@umk.pl; darsmol@umk.pl	Smolinski, Dariusz Jan/AAV-8969-2021; Bednarska-Kozakiewicz, Elżbieta/O-4072-2015; Smolinski, Dariusz/M-3794-2014; Niedojadło, Janusz/O-3211-2015; Kołowerzo-Lubnau, Agnieszka/B-9362-2012	Smolinski, Dariusz Jan/0000-0002-8272-0196; Smolinski, Dariusz/0000-0002-8272-0196; Kołowerzo-Lubnau, Agnieszka/0000-0002-1337-6715; Swidzinski, Michal/0000-0002-4247-1455	Polish National Science Center (NCN) [303 799640, 7796/B/P01/2011/40]	Polish National Science Center (NCN)	This work was supported by Polish National Science Center (NCN): no.N 303 799640 and no.of agreement 7796/B/P01/2011/40.Start 2011-06-13, end 2014-06-12.URL: https://osf.opi.org.pl/app/aawi/wynikiKonkursow.do? sortowanie=nr_rejestracyjny&kryteriaWyszukiwania=&do=pokaz&zakresDziedziny6Do30=%25&zakresDziedziny31=%25&zakresDziedzinyPodstawowe=N302&FiltrBut=Ustaw+filtr&zakresKonkursu=40&zakresDziedziny= N303&zakresPodTypu=%25&zakresDecyzji=3. Grant has already finished and there is no money from this resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SJ, 2003, J EXP BOT, V54, P1, DOI 10.1093/jxb/54.380.1; BAKKEN AH, 1978, CHROMOSOMA, V67, P21, DOI 10.1007/BF00285645; Bednarska E, 1984, ADV CELL BIOL, V11, P585; Bogolyubov D, 2007, FOLIA HISTOCHEM CYTO, V45, P129; Bonnet F, 1999, NUCLEIC ACIDS RES, V27, P4399, DOI 10.1093/nar/27.22.4399; Bressa MJ, 2002, HEREDITAS, V137, P125, DOI 10.1034/j.1601-5223.2002.01650.x; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Castanhole MMU, 2008, GENET MOL RES, V7, P1398, DOI 10.4238/vol7-4gmr527; CENCI G, 1994, J CELL SCI, V107, P3521; CHWIROT WB, 1981, ACTA SOC BOT POL, V50, P33; Comizzoli P, 2011, HUM REPROD, V26, P2165, DOI 10.1093/humrep/der176; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Dickmanns A, 2005, TOP CURR GENET, V12, P179, DOI 10.1007/106799; EKBERG I, 1968, HEREDITAS-GENETISK A, V59, P427; EKBERG I, 1967, HEREDITAS-GENETISK A, V57, P303; Franklin AE, 1999, PLANT CELL, V11, P523, DOI 10.1105/tpc.11.4.523; GALL JG, 1962, P NATL ACAD SCI USA, V48, P562, DOI 10.1073/pnas.48.4.562; Gall JG, 2012, CHROMOSOME RES, V20, P905, DOI 10.1007/s10577-012-9329-5; Hinrichs K, 2000, BIOL REPROD, V62, P1402, DOI 10.1095/biolreprod62.5.1402; Hruba P, 2005, PLANTA, V220, P931, DOI 10.1007/s00425-004-1409-0; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; KLASTERSKA I, 1976, HEREDITAS, V82, P193; KLASTERSKA I, 1977, HEREDITAS, V86, P205; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Kolowerzo A, 2009, PROTOPLASMA, V236, P13, DOI 10.1007/s00709-009-0042-y; Lodde V, 2008, MOL REPROD DEV, V75, P915, DOI 10.1002/mrd.20824; Lorkovic ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003989; MASCARENHAS JP, 1975, BOT REV, V41, P259, DOI 10.1007/BF02860839; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Niedojadlo J, 2003, BIOL CELL, V95, P303, DOI 10.1016/S0248-4900(03)00061-3; OWENS JN, 1979, CAN J BOT, V57, P2673, DOI 10.1139/b79-317; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; She WJ, 2013, DEVELOPMENT, V140, P4008, DOI 10.1242/dev.095034; Sheehan MJ, 2009, P NATL ACAD SCI USA, V106, P20989, DOI 10.1073/pnas.0906498106; Sheidai M, 2005, J GENET, V84, P189, DOI 10.1007/BF02715845; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Sleeman JE, 2001, J CELL SCI, V114, P4407; Smith KP, 2000, MOL BIOL CELL, V11, P2987, DOI 10.1091/mbc.11.9.2987; Smolinski DJ, 2007, PROTOPLASMA, V232, P109, DOI 10.1007/s00709-007-0270-y; Smolinski DJ, 2011, HISTOCHEM CELL BIOL, V136, P527, DOI 10.1007/s00418-011-0861-8; Smolinski DJ, 2012, CHROMOSOMA, V121, P37, DOI 10.1007/s00412-011-0339-4; Stack SM, 2001, CHROMOSOME RES, V9, P175, DOI 10.1023/A:1016690802570; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Straatman KR, 2001, PROTOPLASMA, V216, P191, DOI 10.1007/BF02673871; Stronghill PE, 2007, AM J BOT, V94, P2063, DOI 10.3732/ajb.94.12.2063; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Tiang CL, 2012, PLANT PHYSIOL, V158, P26, DOI 10.1104/pp.111.187161; TUPY J, 1983, BIOL PLANTARUM, V25, P231, DOI 10.1007/BF02902110; Zhang SG, 2008, PLANT CELL REP, V27, P1687, DOI 10.1007/s00299-008-0579-9; Zienkiewicz K, 2006, PROTOPLASMA, V227, P95, DOI 10.1007/s00709-005-0153-z; Zienkiewicz K, 2009, Int J Cell Biol, V2009, P209303, DOI 10.1155/2009/209303; Zienkiewicz K, 2008, SEX PLANT REPROD, V21, P233, DOI 10.1007/s00497-008-0085-9; Zienkiewicz K, 2008, SEX PLANT REPROD, V21, P217, DOI 10.1007/s00497-008-0086-8	62	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117337	10.1371/journal.pone.0117337	http://dx.doi.org/10.1371/journal.pone.0117337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671569	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300049
J	Stapley, J; Garcia, M; Andrews, RM				Stapley, Jessica; Garcia, Milton; Andrews, Robin M.			Long-Term Data Reveal a Population Decline of the Tropical Lizard Anolis apletophallus, and a Negative Affect of El Nino Years on Population Growth Rate	PLOS ONE			English	Article							CLIMATE-CHANGE; FOREST CHRONOSEQUENCE; LIMIFRONS; DYNAMICS; ECTOTHERMS; RESPONSES; SURVIVAL; IMPACTS; EGGS	Climate change threatens biodiversity worldwide, however predicting how particular species will respond is difficult because climate varies spatially, complex factors regulate population abundance, and species vary in their susceptibility to climate change. Studies need to incorporate these factors with long-term data in order to link climate change to population abundance. We used 40 years of lizard abundance data and local climate data from Barro Colorado Island to ask how climate, total lizard abundance and cohort-specific abundance have changed over time, and how total and cohort-specific abundance relate to climate variables including those predicted to make the species vulnerable to climate change (i.e. temperatures exceeding preferred body temperature). We documented a decrease in lizard abundance over the last 40 years, and changes in the local climate. Population growth rate was related to the previous years' southern oscillation index; increasing following cooler-wetter, la nina years, decreasing following warmer-drier, el nino years. Within-year recruitment was negatively related to rainfall and minimum temperature. This study simultaneously identified climatic factors driving long-termpopulation fluctuations and climate variables influencing short-term annual recruitment, both of which may be contributing to the population decline and influence the population's future persistence.	[Stapley, Jessica; Garcia, Milton] Smithsonian Trop Res Inst, Panama City, Panama; [Andrews, Robin M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Virginia Polytechnic Institute & State University	Stapley, J (corresponding author), Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Panama City, Panama.	j.stapley@sheffield.ac.uk	Stapley, Jessica/B-3858-2010	Stapley, Jessica/0000-0002-9138-5684; Andrews@vt.edu, Robin/0000-0001-6974-3732	Smithsonian Tropical Research Institute; Smithsonian Tropical Research Institute Postdoctoral Fellowship	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute Postdoctoral Fellowship	Smithsonian Tropical Research Institute (http://www.stri.si.edu/) has funded the long-term data collection. JS was supported by a Smithsonian Tropical Research Institute Postdoctoral Fellowship.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Andrews R.M., 1982, Biology of Reptilia, V13, P273; ANDREWS RM, 1991, ECOLOGY, V72, P1204, DOI 10.2307/1941094; ANDREWS RM, 1990, OIKOS, V57, P215, DOI 10.2307/3565942; ANDREWS RM, 1988, OECOLOGIA, V76, P376, DOI 10.1007/BF00377032; ANDREWS RM, 1981, ECOLOGY, V62, P556, DOI 10.2307/1937721; Andrews RM, 1982, ADV HERPETOLOGY EVOL; Andrews RM, 1982, ECOLOGY TROPICAL FOR; Andrews RM, 1994, LIZARD ECOLOGY HIST; [Anonymous], 2007, CONTRIBUTION WORKING; BALLINGER RE, 1970, ECOLOGY, V51, P246, DOI 10.2307/1933660; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Chalcraft DR, 1999, OECOLOGIA, V119, P285, DOI 10.1007/s004420050788; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Denslow JS, 2000, J VEG SCI, V11, P201, DOI 10.2307/3236800; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DeWalt SJ, 2003, FOREST ECOL MANAG, V182, P139, DOI 10.1016/S0378-1127(03)00029-X; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Logan ML, 2013, GLOBAL CHANGE BIOL, V19, P3093, DOI 10.1111/gcb.12253; McGregor S, 2013, CLIM PAST, V9, P2269, DOI 10.5194/cp-9-2269-2013; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; R Development Core Team, 2006, R LANG ENV STAT COMP; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; SEXTON O J, 1980, Caribbean Journal of Science, V16, P13; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552	33	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115450	10.1371/journal.pone.0115450	http://dx.doi.org/10.1371/journal.pone.0115450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671423	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000349545300007
J	Wang, LJ; Feng, LS; Yao, Y; Wang, YZ; Chen, Y; Feng, JC; Xing, YQ				Wang, Lijuan; Feng, Liangshu; Yao, Yan; Wang, Yuzhi; Chen, Ying; Feng, Jiachun; Xing, Yingqi			Optimal Optic Nerve Sheath Diameter Threshold for the Identification of Elevated Opening Pressure on Lumbar Puncture in a Chinese Population	PLOS ONE			English	Article							RAISED INTRACRANIAL-PRESSURE; CEREBRAL PERFUSION-PRESSURE; ULTRASOUND; ULTRASONOGRAPHY; SONOGRAPHY	Ultrasonography of the optic nerve sheath diameter (ONSD) is a non-invasive and rapid method that might be helpful in the identification of increased intracranial pressure (ICP). The use of an ONSD greater than 5 mm on ultrasound as an indicator of increased ICP in a Caucasian population has been studied. However, the cut-off point of this predictor in Chinese patients has not been established. Thus, we conducted this study to identify the ONSD criterion for the detection of elevated opening pressure on lumbar puncture (LP) in a Chinese population and to investigate the influencing factors. This study was a blind cross-sectional study. Patients who presented with suspected increased ICP were included. The opening pressure on LP of each participant was confirmed. We analyzed the clinical differences between the groups of patients with abnormal and normal opening pressures on LP. A receiver operating characteristic curve was constructed to determine the ONSD cut-off point for the identification of abnormal opening pressure on LP. In total, 279 patients were recruited, and 101 patients presented with elevated opening pressure on LP. ONSD was a significant independent predictor of elevated opening pressure on LP (p<0.001). However, no statistical significance was observed regarding the factors that might have affected this relationship including gender, age, body mass index, waistline, head circumference, hypertension and pathological subtype. The ONSD cut-off point for the identification of elevated opening pressure on LP was 4.1 mm; this cut-off yielded a sensitivity of 95% and a specificity of 92%. ONSD is a strong and accurate predictor of elevated opening pressure on LP. The cut-off point of this predictor in a Chinese population was remarkably lower than that found in a Caucasian population. Thus, ethnic differences should be noted when using the ONSD as an indicator of increased ICP.	[Wang, Lijuan; Feng, Liangshu; Chen, Ying; Feng, Jiachun; Xing, Yingqi] Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China; [Yao, Yan] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun 130023, Peoples R China	Jilin University; Jilin University	Feng, JC (corresponding author), Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China.	fengjcfrank@163.com; xingyq@sina.com		Wang, Li-juan/0000-0002-5439-8988; Xing, Yingqi/0000-0002-7403-5789				Adams RD, 2001, PRINCIPLES NEUROLOGY; Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1111/j.1553-2712.2003.tb01352.x; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; HAYREH SS, 1968, DOC OPHTHALMOL, V24, P289, DOI 10.1007/BF02550944; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lagreze WA, 2007, INVEST OPHTH VIS SCI, V48, P1913, DOI 10.1167/iovs.06-1075; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; LIU D, 1993, AM J OPHTHALMOL, V116, P548, DOI 10.1016/S0002-9394(14)73195-2; Lundberg N, 1959, ACTA PSYCHIAT SCAND, V36, P1; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Raboel P, 2012, CRITICAL CARE RES PR, V2012, DOI [10.1155/2012/964547, DOI 10.1155/2012/964547]; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Romagnuolo L, 2005, AM J EMERG MED, V23, P686, DOI 10.1016/j.ajem.2004.11.004; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32	34	55	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117939	10.1371/journal.pone.0117939	http://dx.doi.org/10.1371/journal.pone.0117939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664663	Green Submitted, Green Published, gold			2022-12-26	WOS:000349123100023
J	Hauer, A; De Cruz, K; Cochard, T; Godreuil, S; Karoui, C; Henault, S; Bulach, T; Banuls, AL; Biet, F; Boschiroli, ML				Hauer, Amandine; De Cruz, Krystel; Cochard, Thierry; Godreuil, Sylvain; Karoui, Claudine; Henault, Sylvie; Bulach, Tabatha; Banuls, Anne-Laure; Biet, Franck; Boschiroli, Maria Laura			Genetic Evolution of Mycobacterium bovis Causing Tuberculosis in Livestock and Wildlife in France since 1978	PLOS ONE			English	Article							TANDEM REPEATS; VARIABLE NUMBERS; CLONAL COMPLEX; SURVEILLANCE; DIVERSITY; STRAINS; EPIDEMIOLOGY; SPOLIGOTYPE; ANIMALS; HUMANS	To study the dynamics of bovine tuberculosis (bTB) in France, 4,654 M. bovis strains isolated mainly from livestock and wildlife since 1978 were characterized by spoligotyping and MLVA based on MIRU-VNTR. In our study spoligotyping allowed the discrimination of 176 types although 3 spoligotypes are predominant and account for more than half of the total strain population: SB0120 (26%), SB0134 (11%) and SB0121 (6%). In addition, 11% of the isolates, principally from Southern France, showing close spoligotypes and MIRU-VNTR types have been gathered in a family designated as the "F4-family". MLVA typing allowed extensive discrimination, particularly for strains with predominant spoligotypes, with a total of 498 genotypes, several of which were highly regionalized. The similarity of the strains' genetic relationships based on spoligotyping and MIRU-VNTR markers supports the coexistence of different clonal populations within the French M. bovis population. A genetic evolution of the strains was observed both geographically and in time. Indeed, as a result of the reduction of bTB due to the national control campaigns, a large reduction of the strains' genetic variability took place in the last ten years. However, in the regions were bTB is highly prevalent at present, cases in both livestock and in wildlife are due to the spread of unique local genotype profiles. Our results show that the highly discriminating genotyping tools used in this study for molecular studies of bTB are useful for addressing pending questions, which would lead to a better insight into the epidemiology of the disease, and for finding proper solutions for its sustainable control in France.	[Hauer, Amandine; De Cruz, Krystel; Karoui, Claudine; Henault, Sylvie; Bulach, Tabatha; Boschiroli, Maria Laura] Univ Paris Est, Lab Natl Reference Tuberculose, Unite Zoonoses Bacteriennes, Lab Sante Anim,ANSES, Maisons Alfort, France; [Hauer, Amandine; Cochard, Thierry; Biet, Franck] INRA, UMR1282, F-37380 Nouzilly, France; [Godreuil, Sylvain] INSERM, Infect VIH & Agents Tropisme Cutaneomuqueux Patho, Montpellier, France; [Godreuil, Sylvain] Hop Arnaud de Villeneuve, Ctr Hosp Reg Univ Montpellier, Dept Bacteriol Virol, Montpellier, France; [Banuls, Anne-Laure] Univ Montpellier I, MIVEGEC, UMR IRD CNRS 5290 224, Ctr IRD, Montpellier, France; [Banuls, Anne-Laure] Univ Montpellier 2, MIVEGEC, UMR IRD CNRS 5290 224, Ctr IRD, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boschiroli, ML (corresponding author), Univ Paris Est, Lab Natl Reference Tuberculose, Unite Zoonoses Bacteriennes, Lab Sante Anim,ANSES, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021; Biet, Franck/ABA-4151-2021	Biet, Franck/0000-0001-8425-6158; Banuls, Anne-Laure/0000-0002-2106-8667; godreuil, sylvain/0000-0003-3436-0082	CNRSMIE project	CNRSMIE project	This work was partly funded by a CNRSMIE project (MLB, ALB and SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The rest of the funding was internal to the authors' organization.	Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; [Anonymous], 2000, EUR COMMUN J L, V176, P51; Aranaz A, 1996, J CLIN MICROBIOL, V34, P2734, DOI 10.1128/JCM.34.11.2734-2740.1996; Bekara ME, 2014, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12310, DOI 10.1111/TBED.12310]; Berg S, 2014, TRENDS MICROBIOL, V22, P552, DOI 10.1016/j.tim.2014.08.007; Berg S, 2011, J BACTERIOL, V193, P670, DOI 10.1128/JB.00750-10; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Gordejo FJR, 2006, VET MICROBIOL, V112, P101, DOI 10.1016/j.vetmic.2005.11.034; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Henault S, 2006, DEV BIOLOGICALS, V126, P123; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Joshi D, 2012, J CLIN MICROBIOL, V50, P3853, DOI 10.1128/JCM.01499-12; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; le Roex N, 2013, PHYSIOL GENOMICS, V45, P631, DOI 10.1152/physiolgenomics.00061.2013; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Muller B, 2009, J BACTERIOL, V191, P1951, DOI 10.1128/JB.01590-08; [OIE OIE], 2012, MAN DIAGN TESTS VACC, P674; Palmer Mitchell V., 2012, Veterinary Medicine International, P236205, DOI 10.1155/2012/236205; Payne A, 2013, EUR J WILDLIFE RES, V59, P331, DOI 10.1007/s10344-012-0678-3; Richomme C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077842; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2014, RES VET SCI, DOI [10.1016/j.rvsc.2014.12.013, DOI 10.1016/J.RVSC.2014.12.013]; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P866, DOI 10.1016/j.meegid.2011.09.004; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Torgerson PR, 2010, TRENDS MICROBIOL, V18, P67, DOI 10.1016/j.tim.2009.11.002; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	47	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117103	10.1371/journal.pone.0117103	http://dx.doi.org/10.1371/journal.pone.0117103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658691	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900101
J	Kaiser, ML; Romisch, K				Kaiser, Marie-Luise; Roemisch, Karin			Proteasome 19S RP Binding to the Sec61 Channel Plays a Key Role in ERAD	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MISFOLDED SECRETORY PROTEIN; TRANSLOCATION; DEGRADATION; YEAST; SUBSTRATE; UBIQUITIN; RETROTRANSLOCATION; IDENTIFICATION; PREDICTION	Import of secretory proteins into the Endoplasmic Reticulum (ER) is an established function of the Sec61 channel. The contribution of the Sec61 channel to export of misfolded proteins from the ER for degradation by proteasomes is still controversial, but the proteasome 19S regulatory particle (RP) is necessary and sufficient for extraction of specific misfolded proteins from the ER, and binds directly to the Sec61 channel. In this work we have identified an import-competent sec61 mutant, S353C, carrying a point mutation in ER-lumenal loop 7 which reduces affinity of the cytoplasmic face of the Sec61 channel for the 19S RP. This indicates that the interaction between the 19S RP and the Sec61 channel is dependent on conformational changes in Sec61p hinging on loop 7. The sec61-S353C mutant had no measurable ER import defects and did not cause ER stress in intact cells, but reduced ER-export of a 19S RP-dependent misfolded protein when proteasomes were limiting in a cell-free assay. Our data suggest that the interaction between the 19S RP and the Sec61 channel is essential for the export of specific substrates from the ER to the cytosol for proteasomal degradation.	[Kaiser, Marie-Luise; Roemisch, Karin] Univ Saarland, Dept Microbiol, Fac Nat Sci & Technol 8, D-66123 Saarbrucken, Germany	Saarland University	Romisch, K (corresponding author), Univ Saarland, Dept Microbiol, Fac Nat Sci & Technol 8, D-66123 Saarbrucken, Germany.	k.roemisch@mx.uni-saarland.de	Römisch, Karin/AAO-1210-2021	Römisch, Karin/0000-0003-0415-6558	Saarland University	Saarland University	This work was supported by core research funding of the Saarland University to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dudek J, 2014, J MOL BIOL, DOI [10.1016/j.jmb.2014.12.016, DOI 10.1016/J.JMB.2014.12.016]; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Levy R, 2001, J BIOL CHEM, V276, P2340, DOI 10.1074/jbc.M004867200; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; MAYINGER P, 1993, EMBO J, V12, P659, DOI 10.1002/j.1460-2075.1993.tb05699.x; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Romisch K, 2003, J CELL SCI, V116, P2875, DOI 10.1242/jcs.00597; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Servas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082058; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tretter T, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-56; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wheeler MC, 2012, BIOCHEM BIOPH RES CO, V427, P768, DOI 10.1016/j.bbrc.2012.09.136; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	59	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117260	10.1371/journal.pone.0117260	http://dx.doi.org/10.1371/journal.pone.0117260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658429	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900126
J	Liu, YF; Li, DW; Yan, L; Huang, HW				Liu, Yifei; Li, Dawei; Yan, Ling; Huang, Hongwen			The Microgeographical Patterns of Morphological and Molecular Variation of a Mixed Ploidy Population in the Species Complex Actinidia chinensis	PLOS ONE			English	Article							KIWIFRUIT ACTINIDIA; INTROGRESSION; HYBRIDIZATION; COEXISTENCE; ADAPTATION; DIVERGENCE; DIVERSITY; CYTOTYPES; SELECTION; INVASION	Polyploidy and hybridization are thought to have significant impacts on both the evolution and diversification of the genus Actinidia, but the structure and patterns of morphology and molecular diversity relating to ploidy variation of wild Actinidia plants remain much less understood. Here, we examine the distribution of morphological variation and ploidy levels along geographic and environmental variables of a large mixed-ploidy population of the A. chinensis species complex. We then characterize the extent of both genetic and epigenetic diversity and differentiation exhibited between individuals of different ploidy levels. Our results showed that while there are three ploidy levels in this population, hexaploids were constituted the majority (70.3%). Individuals with different ploidy levels were microgeographically structured in relation to elevation and extent of niche disturbance. The morphological characters examined revealed clear difference between diploids and hexaploids, however tetraploids exhibited intermediate forms. Both genetic and epigenetic diversity were high but the differentiation among cytotypes was weak, suggesting extensive gene flow and/or shared ancestral variation occurred in this population even across ploidy levels. Epigenetic variation was clearly correlated with changes in altitudes, a trend of continuous genetic variation and gradual increase of epigenomic heterogeneities of individuals was also observed. Our results show that complex interactions between the locally microgeographical environment, ploidy and gene flow impact A. chinensis genetic and epigenetic variation. We posit that an increase in ploidy does not broaden the species habitat range, but rather permits A. chinensis adaptation to specific niches.	[Liu, Yifei; Huang, Hongwen] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Li, Dawei; Yan, Ling] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specially A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Huang, HW (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	huanghw@mail.scbg.ac.cn		LI, Dawei/0000-0002-5138-4492	National Natural Science Foundation of China [30900119]; Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Actinidia Germplasm Repository in Wuhan Botanical Garden	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Actinidia Germplasm Repository in Wuhan Botanical Garden	This work was supported by the National Natural Science Foundation of China grant no. 30900119 and also supported by the Youth Innovation Promotion Association of the Chinese Academy of Sciences, and the National Actinidia Germplasm Repository in Wuhan Botanical Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Chapman MA, 2010, NEW PHYTOL, V186, P63, DOI 10.1111/j.1469-8137.2009.03091.x; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui Z.X., 2002, ACTINIDIA CHINA; Doyle J. J., 1987, PHYTOCHEM B, P11; Duchoslav M, 2010, ANN BOT-LONDON, V105, P719, DOI 10.1093/aob/mcq035; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Garnier S, 2004, MOL ECOL, V13, P1883, DOI 10.1111/j.1365-294X.2004.02212.x; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; He ZC, 2005, BOT J LINN SOC, V147, P369, DOI 10.1111/j.1095-8339.2005.00372.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Kliber A, 2005, EVOLUTION, V59, P1900; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; Li DW, 2010, BOT J LINN SOC, V164, P72, DOI 10.1111/j.1095-8339.2010.01073.x; Li DW, 2010, NEW ZEAL J CROP HORT, V38, P137, DOI 10.1080/01140671.2010.482966; Li JQ, 2002, SYST BOT, V27, P408; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Liu YF, 2010, TREE GENET GENOMES, V6, P801, DOI 10.1007/s11295-010-0293-y; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; MANTEL N, 1967, CANCER RES, V27, P209; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Petit C, 1999, EVOL ECOL, V13, P45, DOI 10.1023/A:1006534130327; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; R DCT, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Ramsey J, 2008, EVOLUTION, V62, P639, DOI 10.1111/j.1558-5646.2007.00264.x; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rieseberg LH, 2004, NEW PHYTOL, V161, P3; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonnleitner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078959; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Weiss H, 2002, NEW PHYTOL, V156, P85, DOI 10.1046/j.1469-8137.2002.00500.x; Zhang Tian, 2007, Shengwu Duoyangxing, V15, P1, DOI 10.1360/biodiv.060277	47	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117596	10.1371/journal.pone.0117596	http://dx.doi.org/10.1371/journal.pone.0117596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658107	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900187
J	Loo, LWM; Fong, AYW; Cheng, I; Le Marchand, L				Loo, Lenora W. M.; Fong, Aaron Y. W.; Cheng, Iona; Le Marchand, Loic			In Silico Functional Pathway Annotation of 86 Established Prostate Cancer Risk Variants	PLOS ONE			English	Article							LONG-RANGE INTERACTION; NONCODING RNA; ANDROGEN; TRANSCRIPTION; EXPRESSION; RESOURCE; BINDING; GENE; MYC	Heritability is one of the strongest risk factors of prostate cancer, emphasizing the importance of the genetic contribution towards prostate cancer risk. To date, 86 established prostate cancer risk variants have been identified by genome-wide association studies (GWAS). To determine if these risk variants are located near genes that interact together in biological networks or pathways contributing to prostate cancer initiation or progression, we generated gene sets based on proximity to the 86 prostate cancer risk variants. We took two approaches to generate gene lists. The first strategy included all immediate flanking genes, up-and downstream of the risk variant, regardless of distance from the index variant, and the second strategy included genes closest to the index GWAS marker and to variants in high LD (r(2) >= 0.8 in Europeans) with the index variant, within a 100 kb window up-and downstream. Pathway mapping of the two gene sets supported the importance of the androgen receptor-mediated signaling in prostate cancer biology. In addition, the hedgehog andWnt/beta-catenin signaling pathways were identified in pathway mapping for the flanking gene set. We also used the HaploReg resource to examine the 86 risk loci and variants high LD (r(2) >= 0.8) for functional elements. We found that there was a 12.8 fold (p = 2.9 x 10(-4)) enrichment for enhancer motifs in a stem cell line and a 4.4 fold (p = 1.1 x 10(-3)) enrichment of DNase hypersensitivity in a prostate adenocarcinoma cell line, indicating that the risk and correlated variants are enriched for transcriptional regulatory motifs. Our pathway-based functional annotation of the prostate cancer risk variants highlights the potential regulatory function that GWAS risk markers, and their highly correlated variants, exert on genes. Our study also shows that these genes may function cooperatively in key signaling pathways in prostate cancer biology.	[Loo, Lenora W. M.; Fong, Aaron Y. W.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Cheng, Iona] Canc Prevent Inst Calif, Epidemiol Res Dept, Fremont, CA USA	Cancer Research Center of Hawaii; University of Hawaii System; Cancer Prevention Institute of California	Loo, LWM (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	lloo@cc.hawaii.edu						Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gowda PS, 2013, MOL CANCER RES, V11, P1448, DOI 10.1158/1541-7786.MCR-13-0278; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hindorff L., 2013, CATALOG PUBLISHED GE; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Manser C, 2012, ONCOGENE, V31, P2773, DOI 10.1038/onc.2011.437; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Martin JJ, 2001, PROSTATE, V46, P11; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Rattray M, 2012, J NEUROCHEM, V121, P327, DOI 10.1111/j.1471-4159.2012.07654.x; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schmidt LJ, 2013, CURR DRUG TARGETS, V14, P401; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117873	10.1371/journal.pone.0117873	http://dx.doi.org/10.1371/journal.pone.0117873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658610	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900235
J	Nissen, KB; Haugaard-Kedstrom, LM; Wilbek, TS; Nielsen, LS; Aberg, E; Kristensen, AS; Bach, A; Jemth, P; Stromgaard, K				Nissen, Klaus B.; Haugaard-Kedstrom, Linda M.; Wilbek, Theis S.; Nielsen, Line S.; Aberg, Emma; Kristensen, Anders S.; Bach, Anders; Jemth, Per; Stromgaard, Kristian			Targeting Protein-Protein Interactions with Trimeric Ligands: High Affinity Inhibitors of the MAGUK Protein Family	PLOS ONE			English	Article							GUANYLATE KINASE PROTEINS; ISCHEMIC BRAIN-DAMAGE; POSTSYNAPTIC DENSITY; PDZ DOMAIN; FLUORESCENCE POLARIZATION; SUPERTERTIARY STRUCTURE; RECEPTOR INTERACTION; GLUTAMATE RECEPTORS; BINDING SELECTIVITY; DIMERIC INHIBITOR	PDZ domains in general, and those of PSD-95 in particular, are emerging as promising drug targets for diseases such as ischemic stroke. We have previously shown that dimeric ligands that simultaneously target PDZ1 and PDZ2 of PSD-95 are highly potent inhibitors of PSD-95. However, PSD-95 and the related MAGUK proteins contain three consecutive PDZ domains, hence we envisioned that targeting all three PDZ domains simultaneously would lead to more potent and potentially more specific interactions with the MAGUK proteins. Here we describe the design, synthesis and characterization of a series of trimeric ligands targeting all three PDZ domains of PSD-95 and the related MAGUK proteins, PSD93, SAP-97 and SAP-102. Using our dimeric ligands targeting the PDZ1-2 tandem as starting point, we designed novel trimeric ligands by introducing a PDZ3-binding peptide moiety via a cysteine-derivatized NPEG linker. The trimeric ligands generally displayed increased affinities compared to the dimeric ligands in fluorescence polarization binding experiments and optimized trimeric ligands showed low nanomolar inhibition towards the four MAGUK proteins, thus being the most potent inhibitors described. Kinetic experiments using stopped-flow spectrometry showed that the increase in affinity is caused by a decrease in the dissociation rate of the trimeric ligand as compared to the dimeric ligands, likely reflecting the lower probability of simultaneous dissociation of all three PDZ ligands. Thus, we have provided novel inhibitors of the MAGUK proteins with exceptionally high affinity, which can be used to further elucidate the therapeutic potential of these proteins.	[Nissen, Klaus B.; Haugaard-Kedstrom, Linda M.; Wilbek, Theis S.; Nielsen, Line S.; Kristensen, Anders S.; Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Aberg, Emma; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Uppsala, Sweden	University of Copenhagen; Uppsala University	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, Copenhagen, Denmark.	kristian.stromgaard@sund.ku.dk	Haugaard-Kedstrom, Linda/O-7121-2014; Kristensen, Anders Skov/B-4414-2009	Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Kristensen, Anders Skov/0000-0001-8955-6790; Stromgaard, Kristian/0000-0003-2206-4737; Bach, Anders/0000-0003-4305-9910	University of Copenhagen	University of Copenhagen	Support was provided by the University of Copenhagen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2003, BIOCHEM PHARMACOL, V66, P877, DOI 10.1016/S0006-2952(03)00297-1; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; BOLLHAGEN R, 1994, J CHEM SOC CHEM COMM, P2559, DOI 10.1039/c39940002559; Chi CN, 2011, J BIOL CHEM, V286, P3597, DOI 10.1074/jbc.M110.190264; Chi CN, 2010, J BIOL CHEM, V285, P28252, DOI 10.1074/jbc.M110.124040; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; D'Mello R, 2011, MOL THER, V19, P1780, DOI 10.1038/mt.2011.42; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Eildal JNN, 2015, CHEMBIOCHEM, V16, P64, DOI 10.1002/cbic.201402547; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Gardoni F, 2008, EUR J PHARMACOL, V585, P147, DOI 10.1016/j.ejphar.2008.01.048; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim E, 2009, CURR BIOL, V19, pR723, DOI 10.1016/j.cub.2009.07.047; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117668	10.1371/journal.pone.0117668	http://dx.doi.org/10.1371/journal.pone.0117668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658767	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900200
J	Seo, H; Yoon, SJ; Yoon, J; Kim, D; Gong, Y; Kim, AR; Oh, IH; Kim, EJ; Lee, YH				Seo, Hyeyoung; Yoon, Seok-Jun; Yoon, Jihyun; Kim, Dongwoo; Gong, Younghoon; Kim, A. Rim; Oh, In-Hwan; Kim, Eun-Jung; Lee, Yo-Han			Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASES; GLOBAL BURDEN; RISK-FACTORS; COST; MORTALITY; REGISTRY; STROKE; RATES; UK	In 2010, ischemic heart disease was the leading cause of disability-adjusted life-years (DALYs) worldwide. More specially, the prevalence of acute myocardial infarctions (AMI) is increasing in the aged population as mortality decreases; South Korea is no exception. This study aims to examine the economic burden of AMI in the Korean population between 2007 and 2012. AMI-related costs were assessed from a societal perspective. A prevalence-based cost-of-illness framework was used for this analysis. The subjects included all South Koreans with AMI-related ICD-10 codes (I21, I22, I23, I25.0, and I25.1). Data on direct (medical and non-medical) costs and indirect (productivity loss due to AMI-associated morbidity and mortality) costs were collected from the Korean National Health Insurance Service's claims data. The human capital approach was used to calculate indirect costs. The total estimated cost of AMI in 2012 was $1,177,649,323 USD. The majority (52%) of this amount was made up of medical costs, followed by productivity losses due to mortality and morbidity (42% of annual cost). Although the total cost declined by approximately 18% compared to 2007 ($1,427,643,854 USD), the cost of AMI in the over 60 age group amounted to 47% of the total cost of AMI in 2012. AMI led to a high economic burden in 2012. This study, which identified not only the size, but also the trends of AMI-related costs, will provide information to evaluate effects of governmental health projects and the effective allocation of public research funds.	[Seo, Hyeyoung; Yoon, Jihyun; Kim, A. Rim; Lee, Yo-Han] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Yoon, Seok-Jun; Kim, Dongwoo; Gong, Younghoon] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Eun-Jung] Korea Univ, Econ Res Inst, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Korea University	Yoon, SJ (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.	yoonsj02@korea.ac.kr	Lee, Yo Han/J-1911-2019; Oh, In Hwan/AAI-9070-2020	Lee, Yo Han/0000-0002-9631-9969; Oh, In Hwan/0000-0002-5450-9887; Yoon, Seok-Jun/0000-0003-3297-0071	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health Industry Development Institute [H113C0729]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea and by grant H113C0729 from the Korea Health Industry Development Institute. URL: https://www.khidi.or.kr/eps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartwright WS, 1999, J MENT HEALTH POLICY, V2, P43, DOI DOI 10.1002/(SICI)1099-176X(199903)2:1<43::AID-MHP36>3.0.CO;2-7; Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Cheng YW, 2005, INT J CARDIOL, V100, P47, DOI 10.1016/j.ijcard.2004.05.021; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467; Kauf TL, 2006, AM HEART J, V151, P206, DOI 10.1016/j.ahj.2005.02.028; Kim HJ, 2012, J KOREAN MED ASSOC, V55, P1226, DOI 10.5124/jkma.2012.55.12.1226; Kim J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-55; Kim Y, 2013, COSTING METHODS HEAL, P2; Kolansky Daniel M, 2009, Am J Manag Care, V15, pS36; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Leeder S, 2004, RACE TIME CHALLENGE; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oh IH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-157; Pearson-Stuttard J, 2012, HEART, V98, P1573, DOI 10.1136/heartjnl-2012-302435; Seo HY, 2013, RHEUMATOL INT, V33, P1505, DOI 10.1007/s00296-012-2554-6; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Turpie AGG, 2006, AM J MANAG CARE, V12, pS430	25	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117446	10.1371/journal.pone.0117446	http://dx.doi.org/10.1371/journal.pone.0117446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658119	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900151
J	Jing, YP; Liu, W; Wang, JX; Zhao, XF				Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone via Nongenomic Pathway Activates Ca2+/Calmodulin-dependent Protein Kinase II to Regulate Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DROSOPHILA METAMORPHOSIS; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; PHOSPHORYLATION; RECEPTOR; CAMKII; MECHANISMS; CALMODULIN; COMPLEX	The steroid hormone 20-hydroxyecdysone (20E) triggers calcium signaling pathway to regulate 20E response gene expression, but the mechanism underlying this process remains unclear. We propose that the 20E-induced phosphorylation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) serves an important function in 20E response gene transcription in the lepidopteran insect Helicoverpa armigera. CaMKII showed increased expression and phosphorylation during metamorphosis. 20E elevated CaMKII phosphorylation. However, the G protein-coupled receptor (GPCR) and ryanodine receptor inhibitor suramin, the phospholipase C inhibitor U73122, and the inositol 1,4,5-triphosphate receptor inhibitor xestospongin Csuppressed 20E-induced CaMKII phosphorylation. Twoecdysone- responsible GPCRs and G alpha(q) protein were involved in 20E-induced CaMKII phosphorylation by RNA interference analysis. 20E regulated CaMKII threonine phosphorylation at amino acid 290, thereby inducing CaMKII nuclear translocation. CaMKII knockdown by dsCaMKII injection into the larvae prevented the occurrence of larval-pupal transition and suppressed 20E response gene expression. CaMKII phosphorylation and nuclear translocation maintained USP1 lysine acetylation at amino acid 303 by inducing histone deacetylase 3 phosphorylation and nuclear export. The lysine acetylation of USP1 was necessary for the interaction of USP1 with EcRB1 and their binding to the ecdysone response element. Results suggest that 20E (via GPCR activation and calcium signaling) activates CaMKII phosphorylation and nuclear translocation, which regulate USP1 lysine acetylation to form an EcRB1-USP1 complex for 20E response gene transcription.	[Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Jing, Yu-Pu/AAE-3531-2022; Liu, Wen/S-8027-2019; Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021	Liu, Wen/0000-0002-4985-0618; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067]; National Basic Research Program of China Program 973 [2012CB114101]; Ph.D. Program Foundation of Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Program 973(National Basic Research Program of China); Ph.D. Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China Program 973 Grant 2012CB114101, and Ph.D. Program Foundation of Ministry of Education of China Grant 20120131110025.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Davis PJ, 2002, J ENDOCRINOL INVEST, V25, P377, DOI 10.1007/BF03344022; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fluck M, 2000, BIOCHEM BIOPH RES CO, V270, P488, DOI 10.1006/bbrc.2000.2457; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KENNEDY MB, 1981, P NATL ACAD SCI-BIOL, V78, P1293, DOI 10.1073/pnas.78.2.1293; Kreusser MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00036; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Loweth JA, 2008, NEUROSCI LETT, V444, P157, DOI 10.1016/j.neulet.2008.08.004; Lu HQ, 2009, J BIOL CHEM, V284, P11100, DOI 10.1074/jbc.M806956200; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Meldrum DR, 2007, AM J PATHOL, V170, P1148, DOI 10.2353/ajpath.2007.070025; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nishita Y, 2014, INSECT MOL BIOL, V23, P341, DOI 10.1111/imb.12085; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Ren J, 2014, J STEROID BIOCHEM, V144, P313, DOI 10.1016/j.jsbmb.2014.08.006; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Takeuchi M, 2001, J BIOCHEM, V130, P833, DOI 10.1093/oxfordjournals.jbchem.a003055; THOMPSON EB, 1995, CURR BIOL, V5, P730, DOI 10.1016/S0960-9822(95)00146-1; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wolner I, 2005, BRIT J PHARMACOL, V146, P525, DOI 10.1038/sj.bjp.0706359; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	52	18	23	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8469	8481		10.1074/jbc.M114.622696	http://dx.doi.org/10.1074/jbc.M114.622696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670853	Green Published, hybrid			2022-12-26	WOS:000351662600039
J	Bordi, L; Caglioti, C; Garbuglia, AR; Lapa, D; Castilletti, C; Taibi, C; Capobianchi, MR; Lalle, E				Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Lapa, Daniele; Castilletti, Concetta; Taibi, Chiara; Capobianchi, Maria Rosaria; Lalle, Eleonora			IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BLOOD MONONUCLEAR-CELLS; PEGYLATED INTERFERON-ALPHA; VIROLOGICAL RESPONSE; GENETIC-VARIATION; LAMBDA RECEPTOR; VIRAL CLEARANCE; IN-VITRO; IL28B; GENOTYPE	Single-nucleotide polymorphism in IFNL3 gene (rs12979860) predicts spontaneous and therapy-induced HCV clearance. In a previous study from our group PBMC from patients with favourable rs12979860 genotype showed higher levels of IFNAR-1 mRNA. Recently, a dinucleotide polymorphism, ss469415590 (TT or Delta G), has been discovered in the region upstream IFNL3 gene, which is in high linkage disequilibrium with rs12979860. ss469415590[Delta G] is a frameshift variant that creates a novel gene, designed IFNL4, encoding the interferon-lambda 4 protein (IFNL4). The aim of the present study was to extend the analysis of IFNAR-1 mRNA levels to the ss469415590 variants. Our results highlight that the difference of IFNAR-1 mRNA levels between favourable and unfavourable genotype combinations, at both rs12979860 and ss469415590 loci, is stronger than that observed for single polymorphisms at each locus. These findings suggest may represent the biological basis for the observed association between IFNL3 CC and IFNL4 TT/TT genotypes and favourable outcome of either natural HCV infection (clearance vs chronic evolution) or IFN-based therapy.	[Bordi, Licia; Caglioti, Claudia; Garbuglia, Anna Rosa; Lapa, Daniele; Castilletti, Concetta; Capobianchi, Maria Rosaria; Lalle, Eleonora] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Taibi, Chiara] Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016; Bordi, Licia/B-6827-2017; GARBUGLIA, ANNA ROSA/AAC-6556-2022	Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Bordi, Licia/0000-0003-3962-3646; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642; Capobianchi, Maria Rosaria/0000-0003-3465-0071; lalle, eleonora/0000-0002-7063-9905	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata(Ministry of Health, Italy)	This work was partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080078; Chinnaswamy S, 2014, J INTERF CYTOK RES, V34, P479, DOI 10.1089/jir.2013.0113; Cimini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037014; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Holder KA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/903764; Inglot M, 2013, POSTEP HIG MED DOSW, V67, P186, DOI 10.5604/17322693.1038785; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lalle E, 2008, J BIOL REG HOMEOS AG, V22, P153; Lalle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093434; Lange CM, 2011, J HEPATOL, V55, P692, DOI 10.1016/j.jhep.2011.03.006; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Pawelczyk A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-346; Pawlotsky JM, 1996, ANTIMICROB AGENTS CH, V40, P320, DOI 10.1128/AAC.40.2.320; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Petry H, 2006, J INTERF CYTOK RES, V26, P699, DOI 10.1089/jir.2006.26.699; Piazzolla G, 2000, J CLIN IMMUNOL, V20, P54, DOI 10.1023/A:1006694627907; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117397	10.1371/journal.pone.0117397	http://dx.doi.org/10.1371/journal.pone.0117397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25675103	Green Submitted, gold, Green Published			2022-12-26	WOS:000349914000021
J	Ferrera, I; Aristegui, J; Gonzalez, JM; Montero, MF; Fraile-Nuez, E; Gasol, JM				Ferrera, Isabel; Aristegui, Javier; Gonzalez, Jose M.; Montero, Maria F.; Fraile-Nuez, Eugenio; Gasol, Josep M.			Transient Changes in Bacterioplankton Communities Induced by the Submarine Volcanic Eruption of El Hierro (Canary Islands)	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SPATIAL-PATTERNS; COASTAL WATERS; RIBOSOMAL-RNA; VARIABILITY; ABUNDANCE; INSIGHTS	The submarine volcanic eruption occurring near El Hierro (Canary Islands) in October 2011 provided a unique opportunity to determine the effects of such events on the microbial populations of the surrounding waters. The birth of a new underwater volcano produced a large plume of vent material detectable from space that led to abrupt changes in the physicalchemical properties of the water column. We combined flow cytometry and 454-pyrosequencing of 16S rRNA gene amplicons (V1-V3 regions for Bacteria and V3-V5 for Archaea) to monitor the area around the volcano through the eruptive and post-eruptive phases (November 2011 to April 2012). Flow cytometric analyses revealed higher abundance and relative activity (expressed as a percentage of high-nucleic acid content cells) of heterotrophic prokaryotes during the eruptive process as compared to post-eruptive stages. Changes observed in populations detectable by flow cytometry were more evident at depths closer to the volcano (similar to 70-200 m), coinciding also with oxygen depletion. Alpha-diversity analyses revealed that species richness (Chao1 index) decreased during the eruptive phase; however, no dramatic changes in community composition were observed. The most abundant taxa during the eruptive phase were similar to those in the post-eruptive stages and to those typically prevalent in oceanic bacterioplankton communities (i.e. the alphaproteobacterial SAR11 group, the Flavobacteriia class of the Bacteroidetes and certain groups of Gammaproteobacteria). Yet, although at low abundance, we also detected the presence of taxa not typically found in bacterioplankton communities such as the Epsilonproteobacteria and members of the candidate division ZB3, particularly during the eruptive stage. These groups are often associated with deep-sea hydrothermal vents or sulfur-rich springs. Both cytometric and sequence analyses showed that once the eruption ceased, evidences of the volcano-induced changes were no longer observed.	[Ferrera, Isabel; Gasol, Josep M.] CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanog, Barcelona, Spain; [Aristegui, Javier; Montero, Maria F.] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Spain; [Gonzalez, Jose M.] Univ La Laguna, Dept Microbiol, E-38207 San Cristobal la Laguna, Spain; [Fraile-Nuez, Eugenio] Ctr Oceanog Canarias, Inst Espanol Oceanog, Santa Cruz De Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidad de Las Palmas de Gran Canaria; Universidad de la Laguna; Spanish Institute of Oceanography	Ferrera, I (corresponding author), CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanog, Barcelona, Spain.	iferrera@icm.csic.es	Nuez, Eugenio Fraile/R-2258-2019; Ferrera, Isabel/L-7200-2014; Gonzalez, Jose M./C-3333-2013; Gasol, Josep M M/B-1709-2008; Fraile-Nuez, Eugenio/D-1521-2010; Arístegui, Javier/D-5833-2013	Nuez, Eugenio Fraile/0000-0003-4250-4445; Ferrera, Isabel/0000-0003-3484-516X; Gonzalez, Jose M./0000-0002-9926-3323; Gasol, Josep M M/0000-0001-5238-2387; Fraile-Nuez, Eugenio/0000-0003-4250-4445; Arístegui, Javier/0000-0002-7526-7741; Montero, Maria F./0000-0001-8124-8136	project VULCANO - suppressed Spanish Ministry of Science and Innovation [CTM2012-36317]; project MarineGems - suppressed Spanish Ministry of Science and Innovation [CTM2010-20361]; project STORM - suppressed Spanish Ministry of Science and Innovation [CTM2009-09352/MAR]; Ministry of Economy and Competitiveness (project EcoBGM) [CTM2013-48292-C3-3-R]	project VULCANO - suppressed Spanish Ministry of Science and Innovation; project MarineGems - suppressed Spanish Ministry of Science and Innovation; project STORM - suppressed Spanish Ministry of Science and Innovation; Ministry of Economy and Competitiveness (project EcoBGM)	This work was partly supported by projects VULCANO (CTM2012-36317) to E. Fraile-Nuez and J. Aristegui, MarineGems (CTM2010-20361) to J. M. Gonzalez and STORM (CTM2009-09352/MAR) to J. M. Gasol and I. Ferrera, all funded by the suppressed Spanish Ministry of Science and Innovation. J. M. Gonzalez received additional funding from the Ministry of Economy and Competitiveness (project EcoBGM, CTM2013-48292-C3-3-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves N, 2015, ARCH MICROBIOL, V197, P165, DOI 10.1007/s00203-014-1035-6; Aristegui J, 2001, SCI MAR, V65, P51, DOI 10.3989/scimar.2001.65s151; Ariza A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102354; Baker ET, 1995, SEAFLOOR HYDROTHERMA, P47, DOI [10.1029/GM091p0047, DOI 10.1029/GM091P0047]; Baltar F, 2012, APPL ENVIRON MICROB, V78, P3309, DOI 10.1128/AEM.07962-11; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carracedo JC, 2012, EOS T AM GEOPHYS UN, V93, P89, DOI DOI 10.1029/2012E0090002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Eugenio F, 2014, INT J APPL EARTH OBS, V29, P53, DOI 10.1016/j.jag.2013.12.009; Ferrera I, 2007, ELS, DOI [10.1002/9780470015902.a0000406, DOI 10.1002/9780470015902.A0000406]; Ferrera I, 2014, SYST APPL MICROBIOL, V37, P442, DOI 10.1016/j.syapm.2014.04.002; Flores GE, 2012, GEOBIOLOGY, V10, P333, DOI 10.1111/j.1472-4669.2012.00325.x; Flores GE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00047; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Fraile-Nuez E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00486; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Page A, 2008, ENVIRON MICROBIOL, V10, P874, DOI 10.1111/j.1462-2920.2007.01505.x; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Sanchez O, 2013, MICROB BIOTECHNOL, V6, P435, DOI 10.1111/1751-7915.12052; Santana-Casiano JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01140; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Singer E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00052; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Tivey MK, 2004, GEOPH MONOG SERIES, V144, P137, DOI 10.1029/144GM09; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778	44	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118136	10.1371/journal.pone.0118136	http://dx.doi.org/10.1371/journal.pone.0118136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671714	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300085
J	Mahajan, S; Manetsch, R; Merkler, DJ; Stevens, SM				Mahajan, Shikha; Manetsch, Roman; Merkler, David J.; Stevens, Stanley M., Jr.			Synthesis and Evaluation of a Novel Adenosine-Ribose Probe for Global-Scale Profiling of Nucleoside and Nucleotide-Binding Proteins	PLOS ONE			English	Article							SITES; KINASE; CANCER; EXPRESSION; RECEPTORS; ANALOG	Proteomics is a powerful approach used for investigating the complex molecular mechanisms of disease pathogenesis and progression. An important challenge in modern protein profiling approaches involves targeting of specific protein activities in order to identify altered molecular processes associated with disease pathophysiology. Adenosine-binding proteins represent an important subset of the proteome where aberrant expression or activity changes of these proteins have been implicated in numerous human diseases. Herein, we describe an affinity-based approach for the enrichment of adenosine-binding proteins from a complex cell proteome. A novel N-6-biotinylated-8-azido-adenosine probe (AdoR probe) was synthesized, which contains a reactive group that forms a covalent bond with the target proteins, as well as a biotin tag for affinity enrichment using avidin chromatography. Probe specificity was confirmed with protein standards prior to further evaluation in a complex protein mixture consisting of a lysate derived from mouse neuroblastoma N(18)TG(2) cells. Protein identification and relative quantitation using mass spectrometry allowed for the identification of small variations in abundance of nucleoside- and nucleotide-binding proteins in these samples where a significant enrichment of AdoR-binding proteins in the labeled proteome from the neuroblastoma cells was observed. The results from this study demonstrate the utility of this method to enrich for nucleoside- and nucleotide-binding proteins in a complex protein mixture, pointing towards a unique set of proteins that can be examined in the context of further understanding mechanisms of disease, or fundamental biological processes in general.	[Mahajan, Shikha; Manetsch, Roman; Merkler, David J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Manetsch, Roman] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Manetsch, Roman] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; Northeastern University; Northeastern University; State University System of Florida; University of South Florida	Stevens, SM (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave, Tampa, FL 33620 USA.	smstevens@usf.edu		Stevens, Stanley/0000-0002-1399-0256	National Cancer Institute at the National Institutes of Health [CA110084]; National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [AA021245]; Bankhead-Coley Biomedical Research Program of the Florida Department of Health [08BN-04]; University of South Florida's Byrd, Sr. Alzheimer's Institute; NATIONAL CANCER INSTITUTE [R03CA110084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021245] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bankhead-Coley Biomedical Research Program of the Florida Department of Health; University of South Florida's Byrd, Sr. Alzheimer's Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank the National Cancer Institute at the National Institutes of Health (grant CA110084) to D.J.M., the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health (grant AA021245) to S.M.S., the Bankhead-Coley Biomedical Research Program of the Florida Department of Health (08BN-04) to D.J.M. and R.M., and the University of South Florida's Byrd, Sr. Alzheimer's Institute to D.J.M. and R.M. for financial support.	Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLMAN RF, 1983, ANNU REV BIOCHEM, V52, P67, DOI 10.1146/annurev.bi.52.070183.000435; Colman RF, 2006, LETT DRUG DES DISCOV, V3, P462, DOI 10.2174/157018006778194853; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Czarnecki J, 1979, Methods Enzymol, V56, P642; Dong SW, 2011, MOL DIAGN THER, V15, P211, DOI 10.2165/11590360-000000000-00000; Farrell EK, 2012, J LIPID RES, V53, P247, DOI 10.1194/jlr.M018606; GERSTER JF, 1968, J ORG CHEM, V33, P1070, DOI 10.1021/jo01267a027; Gessi S, 2004, CLIN CANCER RES, V10, P5895, DOI 10.1158/1078-0432.CCR-1134-03; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; HALEY BE, 1975, BIOCHEMISTRY-US, V14, P3852, DOI 10.1021/bi00688a018; Hanoulle X, 2006, J PROTEOME RES, V5, P3438, DOI 10.1021/pr060313e; Komatsu K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-63; Lishmanov AY, 2007, B EXP BIOL MED+, V143, P187, DOI 10.1007/s10517-007-0046-6; Masuda S, 2011, BIOORG MED CHEM LETT, V21, P2252, DOI 10.1016/j.bmcl.2011.02.113; MINNA J, 1972, NATURE-NEW BIOL, V235, P225, DOI 10.1038/newbio235225a0; NAGATA K, 1978, J BIOCHEM-TOKYO, V83, P599, DOI 10.1093/oxfordjournals.jbchem.a131947; Nair KS, 2004, AM J PHYSIOL-ENDOC M, V286, pE863, DOI 10.1152/ajpendo.00370.2003; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; POMERANTZ AH, 1975, BIOCHEMISTRY-US, V14, P3858, DOI 10.1021/bi00688a019; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; POULOS TL, 1974, J BIOL CHEM, V249, P1453; Ratcliffe SJ, 2007, J BIOMOL SCREEN, V12, P126, DOI 10.1177/1087057106296685; Roelen H, 1996, J MED CHEM, V39, P1463, DOI 10.1021/jm950267m; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; SZEKERES GL, 1975, J HETEROCYCLIC CHEM, V12, P15, DOI 10.1002/jhet.5570120103; TOMICH JM, 1981, BIOCHEMISTRY-US, V20, P6711, DOI 10.1021/bi00526a029; ZHOU GC, 1993, J BIOL CHEM, V268, P10471	29	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115644	10.1371/journal.pone.0115644	http://dx.doi.org/10.1371/journal.pone.0115644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671571	Green Published, gold, Green Submitted			2022-12-26	WOS:000349545300009
J	Uzana, R; Eisenberg, G; Merims, S; Frankenburg, S; Pato, A; Yefenof, E; Engelstein, R; Peretz, T; Machlenkin, A; Lotem, M				Uzana, Ronny; Eisenberg, Galit; Merims, Sharon; Frankenburg, Shoshana; Pato, Aviad; Yefenof, Eitan; Engelstein, Roni; Peretz, Tamar; Machlenkin, Arthur; Lotem, Michal			Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer	PLOS ONE			English	Article							CLASS-I COMPLEXES; ANTIGEN PRESENTATION; SURFACE MOLECULES; TROGOCYTOSIS; RESPONSES; CAPTURE; IDENTIFICATION; MACROPHAGES; LYMPHOCYTES; RECEPTORS	Trogocytosis is a contact-dependent unidirectional transfer of membrane fragments between immune effector cells and their targets, initially detected in T cells following interaction with professional antigen presenting cells (APC). Previously, we have demonstrated that trogocytosis also takes place between melanoma-specific cytotoxic T lymphocytes (CTLs) and their cognate tumors. In the present study, we took this finding a step further, focusing on the ability of melanoma membrane-imprinted CD8(+) T cells to act as APCs (CD8(+) T-APCs). We demonstrate that, following trogocytosis, CD8(+) T-APCs directly present a variety of melanoma derived peptides to fraternal T cells with the same TCR specificity or to T cells with different TCRs. The resulting T cell-T cell immune synapse leads to (1) Activation of effector CTLs, as determined by proliferation, cytokine secretion and degranulation; (2) Fratricide (killing) of CD8(+) T-APCs by the activated CTLs. Thus, trogocytosis enables cross-reactivity among CD8(+) T cells with interchanging roles of effectors and APCs. This dual function of tumor-reactive CTLs may hint at their ability to amplify or restrict reactivity against the tumor and participate in modulation of the anti-cancer immune response.	[Uzana, Ronny; Eisenberg, Galit; Merims, Sharon; Frankenburg, Shoshana; Pato, Aviad; Engelstein, Roni; Peretz, Tamar; Machlenkin, Arthur; Lotem, Michal] Hadassah Med Org, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; [Yefenof, Eitan] Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Lotem, M (corresponding author), Hadassah Med Org, Sharett Inst Oncol, POB 12000, IL-91120 Jerusalem, Israel.	mlotem@hadassah.org.il			AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; DFG, Deutsche Forschungsgemeinschaft [SCHU 1186/9-1]; ICA, Israel Cancer Association [20130060-B]	AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; DFG, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ICA, Israel Cancer Association	The work was supported by the following: 1. AMRF, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, URL: http://www.adelsonfoundation.org/amrfphil.html, Author: ML; 2. DFG, Deutsche Forschungsgemeinschaft; URL: http://www.dfg.de/en/research_funding/index.html, Grant number: trilateral project SCHU 1186/9-1, Author: ML; and 3. ICA, Israel Cancer Association, URL:http://en.cancer.org.il/,Grant number: 20130060-B, Author: ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; BONA C, 1973, IMMUNOLOGY, V24, P831; Brown R, 2012, BLOOD, V120, P2055, DOI 10.1182/blood-2012-03-416792; Byrne KT, 2011, J CLIN INVEST, V121, P1797, DOI 10.1172/JCI44849; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chung B, 2014, CELL REP, V8, P871, DOI 10.1016/j.celrep.2014.06.052; Cox JH, 2007, J IMMUNOL, V179, P830, DOI 10.4049/jimmunol.179.2.830; Dhainaut M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00112; Eisenberg G, 2013, J IMMUNOL, V190, P5856, DOI 10.4049/jimmunol.1202879; Espinosa E, 2002, J IMMUNOL, V168, P6336, DOI 10.4049/jimmunol.168.12.6336; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gary R, 2012, J IMMUNOL, V188, P744, DOI 10.4049/jimmunol.1101412; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; HoWangYin KY, 2010, CELL MOL LIFE SCI, V67, P1133, DOI 10.1007/s00018-009-0239-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; LeMaoult J, 2007, HUM IMMUNOL, V68, P240, DOI 10.1016/j.humimm.2006.11.001; Lotem M, 2002, BRIT J CANCER, V86, P1534, DOI 10.1038/sj.bjc.6600251; Machlenkin A, 2008, CANCER RES, V68, P2006, DOI 10.1158/0008-5472.CAN-07-3119; Nakamura K, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas.1321248111, DOI 10.1073/PNAS.1321248111]; Nakayama M, 2011, P NATL ACAD SCI USA, V108, P18360, DOI 10.1073/pnas.1110584108; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Quah BJC, 2008, P NATL ACAD SCI USA, V105, P4259, DOI 10.1073/pnas.0800259105; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Schneiders FL, 2014, CANCER IMMUNOL RES, V2, P732, DOI 10.1158/2326-6066.CIR-13-0167; Tsang JYS, 2003, BLOOD, V101, P2704, DOI 10.1182/blood-2002-04-1230; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Uzana R, 2012, J IMMUNOL, V188, P632, DOI 10.4049/jimmunol.1101429; Vernitsky H, 2012, J IMMUNOL, V189, P4361, DOI 10.4049/jimmunol.1200019; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Xia DJ, 2006, J IMMUNOL, V177, P2976, DOI 10.4049/jimmunol.177.5.2976; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Zhang H, 2007, J IMMUNOL, V178; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	39	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118244	10.1371/journal.pone.0118244	http://dx.doi.org/10.1371/journal.pone.0118244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671577	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300090
J	Chakraborty, N; Sharma, P; Kanyuka, K; Pathak, RR; Choudhury, D; Hooley, RA; Raghuram, N				Chakraborty, Navjyoti; Sharma, Priyanka; Kanyuka, Kostya; Pathak, Ravi R.; Choudhury, Devapriya; Hooley, Richard A.; Raghuram, Nandula			Transcriptome Analysis of Arabidopsis GCR1 Mutant Reveals Its Roles in Stress, Hormones, Secondary Metabolism and Phosphate Starvation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR; ALPHA-SUBUNIT; BETA-SUBUNIT; GENE; DEFENSE; RESISTANCE; GPA1; RICE; ACTIVATION	The controversy over the existence or the need for G-protein coupled receptors (GPCRs) in plant G-protein signalling has overshadowed a more fundamental quest for the role of AtGCR1, the most studied and often considered the best candidate for GPCR in plants. Our whole transcriptome microarray analysis of the GCR1-knock-out mutant (gcr1-5) in Arabidopsis thaliana revealed 350 differentially expressed genes spanning all chromosomes. Many of them were hitherto unknown in the context of GCR1 or G-protein signalling, such as in phosphate starvation, storage compound and fatty acid biosynthesis, cell fate, etc. We also found some GCR1-responsive genes/processes that are reported to be regulated by heterotrimeric G-proteins, such as biotic and abiotic stress, hormone response and secondary metabolism. Thus, GCR1 could have G-protein-mediated as well as independent roles and regardless of whether it works as a GPCR, further analysis of the organism-wide role of GCR1 has a significance of its own.	[Chakraborty, Navjyoti; Sharma, Priyanka; Pathak, Ravi R.; Raghuram, Nandula] GGS Indraprastha Univ, Univ Sch Biotechnol, New Delhi 110078, India; [Kanyuka, Kostya] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden AL5 2JQ, Herts, England; [Choudhury, Devapriya] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Hooley, Richard A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	GGS Indraprastha University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Jawaharlal Nehru University, New Delhi; University of Bath	Raghuram, N (corresponding author), GGS Indraprastha Univ, Univ Sch Biotechnol, Sect 16 C, New Delhi 110078, India.	raghuram98@hotmail.com	Chakraborty, Navjyoti/E-5854-2011; Raghuram, Nandula/F-5775-2011; Kanyuka, Kostya/F-9156-2016	Chakraborty, Navjyoti/0000-0003-4782-1650; Raghuram, Nandula/0000-0002-9486-754X; Kanyuka, Kostya/0000-0001-6324-4123; Pathak, Ravi/0000-0002-9689-6475	Council of Scientific and Industrial Research (CSIR), Government of India [60(0056)/02/EMRII, 38(1246)/10/EMRII, 09/806(015)/2008-EMRI, PS 60(0056)/02/EMRII]; BBSRC [BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203] Funding Source: researchfish	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants to NR [60(0056)/02/EMRII and 38(1246)/10/EMRII] and research fellowships to NC [09/806(015)/2008-EMRI] and PS 60(0056)/02/EMRII] from the Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apone F, 2003, PLANT PHYSIOL, V133, P571, DOI 10.1104/pp.103.026005; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Bradford W, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003768; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Delgado-Cerezo M, 2012, MOL PLANT, V5, P98, DOI 10.1093/mp/ssr082; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Etheridge N, 1999, PLANT MOL BIOL, V39, P1113, DOI 10.1023/A:1006137221259; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Hackenberg D, 2013, PLANT PHYSIOL, V163, P1510, DOI 10.1104/pp.113.230425; Hooley R, 2001, SIGNAL TRANSDUCTION, P193; Humphrey TV, 2001, J PLANT PHYSIOL, V158, P645, DOI 10.1078/0176-1617-00316; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kanyuka K, 2001, CURR BIOL, V11, P535, DOI 10.1016/S0960-9822(01)00157-9; Kim HG, 2014, FEBS LETT, V588, P1652, DOI 10.1016/j.febslet.2014.02.062; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Liu F, 2012, MOL PLANT MICROBE IN, V25, P677, DOI 10.1094/MPMI-10-11-0274; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lu YT, 2014, PLANT PHYSIOL, V164, P1456, DOI 10.1104/pp.113.229740; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pathak RR, 2010, CAN J MICROBIOL, V56, P578, DOI [10.1139/W10-045, 10.1139/w10-045]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2010, SIGNAL COMMUN PLANTS, P221, DOI 10.1007/978-3-642-03524-1_12; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2013, PLANT PHYSIOL, V161, P1097, DOI 10.1104/pp.112.212324; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Yadav DK, 2013, PLANT PHYSIOL BIOCH, V63, P262, DOI 10.1016/j.plaphy.2012.11.031; Yadav DK, 2012, PLANT SIGNAL BEHAV, V7, P733, DOI 10.4161/psb.20356; Zhao ZX, 2010, J PROTEOME RES, V9, P1637, DOI 10.1021/pr901011h; Zhou SJ, 2013, GENET MOL RES, V12, P6565, DOI 10.4238/2013.December.11.8	59	18	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117819	10.1371/journal.pone.0117819	http://dx.doi.org/10.1371/journal.pone.0117819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668726	gold, Green Published, Green Submitted			2022-12-26	WOS:000349493000027
J	Lee, MY; Huang, CH; Kuo, CJ; Lin, CLS; Lai, WT; Chiou, SH				Lee, Min-Yi; Huang, Chun-Hao; Kuo, Chao-Jen; Lin, Chen-Lung Steve; Lai, Wen-Ter; Chiou, Shyh-Horng			Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SOLUBLE CD14; HELICOBACTER-PYLORI; RECEPTOR 4; ACTIVATION; INFLAMMATION; COMPLEXES; MONOCYTES; ENDOTOXIN; MARKER	Inflammation plays a key role in coronary artery disease (CAD) and other manifestations of atherosclerosis. Recently, urinary proteins were found to be useful markers for reflecting inflammation status of different organs. To identify potential biomarker for diagnosis of CAD, we performed one-dimensional SDS-gel electrophoresis followed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Among the proteins differentially expressed in urine samples, monocyte antigen CD14 was found to be consistently expressed in higher amounts in the CAD patients as compared to normal controls. Using enzyme-linked immunosorbent assays to analyze the concentrations of CD14 in urine and serum, we confirmed that urinary CD14 levels were significantly higher in patients (n = 73) with multi-vessel and single vessel CAD than in normal control (n = 35) (P < 0.001). Logistic regression analysis further showed that urinary CD14 concentration level is associated with severity or number of diseased vessels and SYNTAX score after adjustment for potential confounders. Concomitantly, the proportion of CD14+ monocytes was significantly increased in CAD patients (59.7 +/- 3.6%) as compared with healthy controls (14.9 +/- 2.1%) (P < 0.001), implicating that a high level of urinary CD14 may be potentially involved in mechanism(s) leading to CAD pathogenesis. By performing shotgun proteomics, we further revealed that CD14-associated inflammatory response networks may play an essential role in CAD. In conclusion, the current study has demonstrated that release of CD14 in urine coupled with more CD14+ monocytes in CAD patients is significantly correlated with severity of CAD, pointing to the potential application of urinary CD14 as a novel noninvasive biomarker for large-scale diagnostic screening of susceptible CAD patients.	[Lee, Min-Yi; Huang, Chun-Hao; Kuo, Chao-Jen; Lin, Chen-Lung Steve; Chiou, Shyh-Horng] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lee, Min-Yi] Kaohsiung Municipal Ming Sheng Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Kuo, Chao-Jen; Chiou, Shyh-Horng] Kaohsiung Med Univ, Ctr Res Resources & Dev, Quantitat Proteom Ctr, Kaohsiung, Taiwan; [Lin, Chen-Lung Steve] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Lai, Wen-Ter] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chiou, Shyh-Horng] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan	Lai, WT (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	wtlai@kmu.edu.tw; shchiou@kmu.edu.tw			National Science Council (NSC), Taipei, Taiwan [96-2311-B-037-005-MY3, 100-2320-B-037-019, 101-2113-M-037-004, 02-2320-B-037-025]; Quantitative Proteomics Center (NSC) at the Center for Research Resources and Development (CRRD) [99-2745-B-037-005]; Kaohsiung Medical University under National Science Council, Taipei, Taiwan; Kaohsiung Medical University (KMU); Academia Sinica	National Science Council (NSC), Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Quantitative Proteomics Center (NSC) at the Center for Research Resources and Development (CRRD); Kaohsiung Medical University under National Science Council, Taipei, Taiwan; Kaohsiung Medical University (KMU); Academia Sinica(Academia Sinica - Taiwan)	work was supported in part by Kaohsiung Medical University (KMU), Academia Sinica and the National Science Council (NSC Grants 96-2311-B-037-005-MY3, 100-2320-B-037-019, 101-2113- M-037-004 and 102-2320-B-037-025 to S.-H. Chiou), Taipei, Taiwan. The authors also thank the core facility grant from the Quantitative Proteomics Center (NSC Grant 99-2745-B-037-005 to S.-H. Chiou) at the Center for Research Resources and Development (CRRD), Kaohsiung Medical University under the auspices of National Science Council, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2010, MOL CELL PROTEOMICS, V9, P2195, DOI 10.1074/mcp.M110.000992; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bhagat K, 1996, CARDIOVASC RES, V32, P822; Chiou SH, 2011, KAOHSIUNG J MED SCI, V27, P1, DOI 10.1016/j.kjms.2010.12.001; Mello APD, 2010, LIPIDS, V45, P619, DOI 10.1007/s11745-010-3439-7; Estruch M, 2013, ATHEROSCLEROSIS, V229, P356, DOI 10.1016/j.atherosclerosis.2013.05.011; Fitzsimmons PJ, 2007, ATHEROSCLEROSIS, V194, P196, DOI 10.1016/j.atherosclerosis.2006.07.027; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Greco TP, 2010, AM J CLIN PATHOL, V133, P737, DOI 10.1309/AJCP88WVRDRDFBAS; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; HORNEFF G, 1993, CLIN EXP IMMUNOL, V91, P207; Huang CH, 2014, WORLD J GASTROENTERO, V20, P1529, DOI 10.3748/wjg.v20.i6.1529; Huang CH, 2011, KAOHSIUNG J MED SCI, V27, P544, DOI 10.1016/j.kjms.2011.06.019; Huang CH, 2011, BIOCHIMIE, V93, P1115, DOI 10.1016/j.biochi.2011.03.008; Huang CH, 2011, MOL VIS, V17, P186; Huang CH, 2010, J BIOCHEM, V147, P535, DOI 10.1093/jb/mvp200; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; Koenig W, 2002, J AM COLL CARDIOL, V40, P34, DOI 10.1016/S0735-1097(02)01937-X; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nair A, 2012, ARTHRITIS RHEUM-US, V64, P2268, DOI 10.1002/art.34495; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V96, P15; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schroecksnadel K, 2010, THROMB HAEMOSTASIS, V103, P926, DOI 10.1160/TH09-07-0422; SCHUMANN RR, 1994, MED MICROBIOL IMMUN, V183, P279; Sianos Georgios, 2005, EuroIntervention, V1, P219; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Sonmez K, 2006, ANGIOLOGY, V57, P15, DOI 10.1177/000331970605700103; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; Takeshita S, 2000, CLIN EXP IMMUNOL, V119, P376; van der Laan AM, 2012, AM HEART J, V163, P57, DOI 10.1016/j.ahj.2011.09.002; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WUTHRICH B, 1992, ARCH DERMATOL RES, V284, P339, DOI 10.1007/BF00372036; Yu S, 1998, RHEUMATOL INT, V17, P237, DOI 10.1007/s002960050041; Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117169	10.1371/journal.pone.0117169	http://dx.doi.org/10.1371/journal.pone.0117169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668619	Green Submitted, Green Published, gold			2022-12-26	WOS:000349493000016
J	Pratesi, C; Zanussi, S; Tedeschi, R; Bortolin, MT; Talamini, R; Rupolo, M; Scaini, C; Basaglia, G; Di Maso, M; Mazzucato, M; Zanet, E; Tirelli, U; Michieli, M; Carbone, A; De Paoli, P				Pratesi, Chiara; Zanussi, Stefania; Tedeschi, Rosamaria; Bortolin, Maria Teresa; Talamini, Renato; Rupolo, Maurizio; Scaini, Chiara; Basaglia, Giancarlo; Di Maso, Matteo; Mazzucato, Mario; Zanet, Ernesto; Tirelli, Umberto; Michieli, Mariagrazia; Carbone, Antonino; De Paoli, Paolo			Upsilon-Herpesvirus Load as Surrogate Marker of Early Death in HIV-1 Lymphoma Patients Submitted to High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation	PLOS ONE			English	Article							BARR-VIRUS-DNA; T-CELL; VIRAL LOAD; LYMPHOPROLIFERATIVE DISORDER; NON-HODGKIN; COOPERATIVE GROUP; INFECTED PATIENTS; AIDS; HUMAN-HERPESVIRUS-8; THERAPY	Autologous stem cell transplantation (ASCT) is a feasible procedure for human immunodeficiency virus-1 (HIV-1) lymphoma patients, whose underlying disease and intrinsic HIV-1- and ASCT-associated immunodeficiency might increase the risk for gamma-herpesvirus load persistence and/or reactivation. We evaluated this hypothesis by investigating the levels of Epstein-Barr virus (EBV)- and Kaposi sarcoma-associated herpesvirus (KSHV)-DNA levels in the peripheral blood of 22 HIV-1-associated lymphoma patients during ASCT, highlighting their relationship with.-herpesvirus lymphoma status, immunological parameters, and clinical events. EBV-DNA was detected in the pre-treatment plasma and peripheral blood mononuclear cells (PBMCs) of 12 (median 12135 copies/mL) and 18 patients (median 417 copies/10(6) PBMCs), respectively; the values in the two compartments were correlated (r = 0.77, p = 0.0001). Only EBV-positive lymphomas showed detectable levels of plasma EBV-DNA. After debulking chemotherapy, plasma EBV-DNA was associated with lymphoma chemosensitivity (p = 0.03) and a significant higher mortality risk by multivariate Cox analysis adjusted for EBV-lymphoma status (HR, 10.46, 95% CI, 1.11-98.32, p = 0.04). After infusion, EBV-DNA was detectable in five EBV-positive lymphoma patients who died within six months. KSHV-DNA load was positive in only one patient, who died from primary effusion lymphoma. Fluctuations in levels of KSHV-DNA reflected the patient's therapy and evolution of his underlying lymphoma. Other gamma-herpesvirus-associated malignancies, such as multicentric Castleman disease and Kaposi sarcoma, or end-organ complications after salvage treatment were not found. Overall, these findings suggest a prognostic and predictive value of EBV-DNA and KSHV-DNA, the monitoring of which could be a simple, complementary tool for the management of gamma-herpesvirus-positive lymphomas in HIV-1 patients submitted to ASCT.	[Pratesi, Chiara; Zanussi, Stefania; Tedeschi, Rosamaria; Bortolin, Maria Teresa; Scaini, Chiara; Basaglia, Giancarlo] CRO Natl Canc Inst, IRCCS, Microbiol Immunol & Virol Unit, Aviano, Pordenone, Italy; [Talamini, Renato; Di Maso, Matteo] CRO Natl Canc Inst, IRCCS, Epidemiol & Biostat Unit, Aviano, Pordenone, Italy; [Rupolo, Maurizio; Zanet, Ernesto; Michieli, Mariagrazia] CRO Natl Canc Inst, IRCCS, Cellular Therapy & High Dose Chemotherapy Unit, Aviano, Pordenone, Italy; [Mazzucato, Mario] CRO Natl Canc Inst, IRCCS, Stem Cell Collect & Proc Unit, Aviano, Pordenone, Italy; [Tirelli, Umberto] CRO Natl Canc Inst, IRCCS, Div Med Oncol A, Aviano, Pordenone, Italy; [Carbone, Antonino] CRO Natl Canc Inst, IRCCS, Dept Pathol, Aviano, Pordenone, Italy; [De Paoli, Paolo] CRO Natl Canc Inst, IRCCS, Sci Directorate, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO)	Zanussi, S (corresponding author), CRO Natl Canc Inst, IRCCS, Microbiol Immunol & Virol Unit, Aviano, Pordenone, Italy.	szanussi@cro.it	Mazzucato, Mario/ABF-5472-2020; Rupolo, Maurizio/ABE-7008-2020; Zanet, Ernesto/ABD-8879-2020; Di Maso, Matteo/AAC-4816-2022; Zanussi, Stefania/I-2558-2018; Michieli, Mariagrazia/AAC-3302-2020; Carbone, Antonino/AAA-2217-2019; De Paoli, Paolo/AAG-2586-2021	Mazzucato, Mario/0000-0001-8319-053X; Rupolo, Maurizio/0000-0001-7932-2827; Zanet, Ernesto/0000-0002-3451-075X; Di Maso, Matteo/0000-0002-6481-990X; Zanussi, Stefania/0000-0003-0608-9766; Michieli, Mariagrazia/0000-0001-6302-0488; Carbone, Antonino/0000-0003-2211-639X; Bortolin, Maria Teresa/0000-0003-0589-1669; De Paoli, Paolo/0000-0002-9502-1781	Ministero del lavoro, della salute e delle politiche sociali [40H73]	Ministero del lavoro, della salute e delle politiche sociali	This work was supported by Grant N. 40H73 from "Ministero del lavoro, della salute e delle politiche sociali." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaya N, 2006, LEUKEMIA RES, V30, P1059, DOI 10.1016/j.leukres.2005.10.022; Balsalobre P, 2009, J CLIN ONCOL, V27, P2192, DOI 10.1200/JCO.2008.18.2683; Benicchi T, 2005, TRANSPLANTATION, V80, P673, DOI 10.1097/01.tp.0000168490.29862.b8; Bonnet F, 2006, J CLIN VIROL, V36, P258, DOI 10.1016/j.jcv.2006.04.005; Bortolin MT, 2010, AIDS RES HUM RETROV, V26, P245, DOI 10.1089/aid.2009.0081; Bortolin MT, 2006, CANCER LETT, V233, P247, DOI 10.1016/j.canlet.2005.03.015; Capobianchi A, 2011, J CLIN VIROL, V52, P247, DOI 10.1016/j.jcv.2011.07.003; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Cesarman E, 2011, CANCER LETT, V305, P163, DOI 10.1016/j.canlet.2011.03.003; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Chijioke O, 2013, J LEUKOCYTE BIOL, V94, P1185, DOI 10.1189/jlb.0313173; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzzola M, 2003, CLIN INFECT DIS, V37, pE102, DOI 10.1086/377268; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Diez-Martin JL, 2009, BLOOD, V113, P6011, DOI 10.1182/blood-2008-12-195388; Fan HX, 2005, J MED VIROL, V75, P59, DOI 10.1002/jmv.20238; Gabarre J, 2004, HAEMATOLOGICA, V89, P1100; Gabriel I, 2008, AIDS, V22, P539, DOI 10.1097/QAD.0b013e3282f0e3e5; Gallagher A, 1999, INT J CANCER, V84, P442, DOI 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.3.CO;2-A; Gloghini A, 2013, SEMIN CANCER BIOL, V23, P457, DOI 10.1016/j.semcancer.2013.08.004; Gulley ML, 2010, CLIN MICROBIOL REV, V23, P350, DOI 10.1128/CMR.00006-09; Heslop Helen E, 2005, Hematology Am Soc Hematol Educ Program, P260; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Jansen CA, 2006, ANTIVIR THER, V11, P105; Juvonen E, 2007, HAEMATOLOGICA, V92, P819, DOI 10.3324/haematol.10751; Kanakry JA, 2013, BLOOD, V121, P3547, DOI 10.1182/blood-2012-09-454694; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koh YW, 2012, ANN HEMATOL, V91, P1403, DOI 10.1007/s00277-012-1464-8; Krishnan A, 2010, CURR OPIN ONCOL, V22, P456, DOI 10.1097/CCO.0b013e32833d2cf0; Leruez-Ville M, 2012, HIV MED, V13, P479, DOI 10.1111/j.1468-1293.2012.00998.x; Lin L, 2009, J CLIN ONCOL, V27, P2496, DOI 10.1200/JCO.2008.20.1707; Luppi M, 2000, BLOOD, V96, P2355; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Ma SD, 2011, J VIROL, V85, P165, DOI 10.1128/JVI.01512-10; Marcelin AG, 2007, J INFECT DIS, V196, P1163, DOI 10.1086/521625; Navarro JT, 2010, MED CLIN-BARCELONA, V135, P485, DOI 10.1016/j.medcli.2010.02.041; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Paydas S, 2008, LEUKEMIA RES, V32, P1424, DOI 10.1016/j.leukres.2008.01.008; Piriou E, 2005, J IMMUNOL, V175, P2010, DOI 10.4049/jimmunol.175.3.2010; Pratesi C, 2008, CLIN EXP IMMUNOL, V151, P101, DOI 10.1111/j.1365-2249.2007.03516.x; Raphael M, 2008, WHO CLASSIFICATION T, P340; Re A, 2009, BLOOD, V114, P1306, DOI 10.1182/blood-2009-02-202762; Shamay M, 2012, J INFECT DIS, V205, P1095, DOI 10.1093/infdis/jis032; Simonelli C, 2010, CLIN INFECT DIS, V50, P1672, DOI 10.1086/652866; Smets F, 2002, TRANSPLANTATION, V73, P1603, DOI 10.1097/00007890-200205270-00014; Spacek M, 2011, APMIS, V119, P10, DOI 10.1111/j.1600-0463.2010.02685.x; Stevens SJC, 2007, AIDS, V21, P2141, DOI 10.1097/QAD.0b013e3282eeeba0; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Suwiwat S, 2007, J CLIN VIROL, V40, P277, DOI 10.1016/j.jcv.2007.08.013; Suzuki R, 2011, BLOOD, V118, P6018, DOI 10.1182/blood-2011-05-354142; Takahashi S, 2007, EUR J DERMATOL, V17, P242; Tedeschi R, 2001, J CLIN MICROBIOL, V39, P4269, DOI 10.1128/JCM.39.12.4269-4273.2001; Tedeschi R, 2012, J CLIN VIROL, V53, P297, DOI 10.1016/j.jcv.2011.12.021; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Yin CC, 2006, EXPERT REV MOL DIAGN, V6, P831, DOI 10.1586/14737159.6.6.831; Yufu Y, 2000, BONE MARROW TRANSPL, V26, P1339, DOI 10.1038/sj.bmt.1702721	56	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116887	10.1371/journal.pone.0116887	http://dx.doi.org/10.1371/journal.pone.0116887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668032	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000010
J	Capraro, J; Sessa, F; Magni, C; Scarafoni, A; Maffioli, E; Tedeschi, G; Croy, RRD; Duranti, M				Capraro, Jessica; Sessa, Fabio; Magni, Chiara; Scarafoni, Alessio; Maffioli, Elisa; Tedeschi, Gabriella; Croy, Ron R. D.; Duranti, Marcello			Proteolytic Cleavage at Twin Arginine Residues Affects Structural and Functional Transitions of Lupin Seed 11S Storage Globulin	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; PRECURSOR; SUBUNITS; PLANTS; ALBUS; SITE	The 11S storage globulin of white lupin seeds binds to a metal affinity chromatography matrix. Two unusual stretches of contiguous histidine residues, reminiscent of the multiple histidines forming metal binding motifs, at the C-terminal end of 11S globulin acidic chains were hypothesized as candidate elements responsible for the binding capacity. To prove this, the protein was incubated with a lupin seed endopeptidase previously shown to cleave at twin arginine motifs, recurrent in the sequence region of interest. Upon incubation with this enzyme, the loss of metal binding capacity paralleled that of the anti-his-tag reactive polypeptides. The recovered small proteolytic fragment was analyzed by mass spectrometry and N-terminal sequencing and found to correspond to the 24-mer region cleaved off at twin arginine residues and containing the natural his-tag-like region. Similarly, when lupin seeds were germinated for a few days, the his-tag containing 11S globulin chain was converted to a form devoid of such region, suggesting that this mechanism is a part of the natural degradatory process of the protein. The hypothesis that the ordered and controlled dismantling of storage proteins may generate peptide fragments with potential functional roles in plant ontogenesis is presented and discussed.	[Capraro, Jessica; Sessa, Fabio; Magni, Chiara; Scarafoni, Alessio; Duranti, Marcello] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Maffioli, Elisa; Tedeschi, Gabriella] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Croy, Ron R. D.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of Milan; University of Milan; Durham University	Scarafoni, A (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.	alessio.scarafoni@unimi.it	Maffioli, Elisa/U-5511-2017; Tedeschi, Gabriella/I-6247-2017; Scarafoni, Alessio/Q-1093-2015	Maffioli, Elisa/0000-0002-5539-1825; Tedeschi, Gabriella/0000-0003-2082-6443; Scarafoni, Alessio/0000-0003-1970-0122; CAPRARO, JESSICA/0000-0002-9114-3212; MAGNI, CHIARA/0000-0002-9641-2223	"Dote Ricerca" of Regione Lombardia; European Social Fund	"Dote Ricerca" of Regione Lombardia; European Social Fund(European Social Fund (ESF))	JC was supported by a grant "Dote Ricerca" of Regione Lombardia and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Avitabile C, 2013, J PEPT SCI, V19, P240, DOI 10.1002/psc.2479; Becker K. L., 2001, PRINCIPLES PRACTICE, V3rd; Boulter D, 1997, ADV BOT RES, V27, P1; Candido ED, 2011, FASEB J, V25, P3290, DOI 10.1096/fj.11-184291; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; CROY RRD, 1982, NATURE, V295, P76, DOI 10.1038/295076a0; DIEFENBACHJAGGER H, 1995, EUR J BIOCHEM, V229, P91, DOI 10.1111/j.1432-1033.1995.tb20442.x; dosRamos PCR, 1997, PLANTA, V203, P26, DOI 10.1007/s004250050161; Duranti M, 2004, J NUTR, V134, P1334, DOI 10.1093/jn/134.6.1334; DURANTI M, 1984, J AGR FOOD CHEM, V32, P490, DOI 10.1021/jf00123a018; DURANTI M, 1992, EUR J BIOCHEM, V206, P941, DOI 10.1111/j.1432-1033.1992.tb17004.x; Eggert K, 2013, METALLOMICS, V5, P1316, DOI 10.1039/c3mt00109a; Elliott AG, 2014, PLANT CELL, V26, P981, DOI 10.1105/tpc.114.123620; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Magni C, 2005, J AGR FOOD CHEM, V53, P4567, DOI 10.1021/jf0500785; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; Magni C, 2012, MOL PLANT, V5, P1011, DOI 10.1093/mp/ssr116; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; Monteiro S, 2010, PLOS ONE, V5, P1; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Rehman S, 2011, PAK J BOT, V43, P2971; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Silva FD, 2009, J BIOL CHEM, V284, P34735, DOI 10.1074/jbc.M109.016410; Tandang-Silvas MRG, 2011, ANNU REV FOOD SCI T, V2, P59, DOI 10.1146/annurev-food-022510-133718; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wright DJ, 1988, DEV FOOD PROTEINS, V6, P119; Xiaoping Fu, 2010, Biochemical Journal, V427, P313; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	32	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117406	10.1371/journal.pone.0117406	http://dx.doi.org/10.1371/journal.pone.0117406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658355	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000349444900143
J	Finch, ML; Passman, AM; Strauss, RP; Yeoh, GC; Callus, BA				Finch, Megan L.; Passman, Adam M.; Strauss, Robyn P.; Yeoh, George C.; Callus, Bernard A.			Sub-Cellular Localisation Studies May Spuriously Detect the Yes-Associated Protein, YAP, in Nucleoli Leading to Potentially Invalid Conclusions of Its Function	PLOS ONE			English	Article							HIPPO PATHWAY; PROGENITOR CELLS; SIZE-CONTROL; ORGAN SIZE; OVAL CELLS; DOMAIN; GROWTH; MST2; INACTIVATION; ONCOPROTEIN	The Yes-associated protein (YAP) is a potent transcriptional co-activator that functions as a nuclear effector of the Hippo signaling pathway. YAP is oncogenic and its activity is linked to its cellular abundance and nuclear localisation. Activation of the Hippo pathway restricts YAP nuclear entry via its phosphorylation by Lats kinases and consequent cytoplasmic retention bound to 14-3-3 proteins. We examined YAP expression in liver progenitor cells (LPCs) and surprisingly found that transformed LPCs did not show an increase in YAP abundance compared to the non-transformed LPCs from which they were derived. We then sought to ascertain whether nuclear YAP was more abundant in transformed LPCs. We used an antibody that we confirmed was specific for YAP by immunoblotting to determine YAP's sub-cellular localisation by immunofluorescence. This antibody showed diffuse staining for YAP within the cytosol and nuclei, but, noticeably, it showed intense staining of the nucleoli of LPCs. This staining was non-specific, as shRNA treatment of cells abolished YAP expression to undetectable levels by Western blot yet the nucleolar staining remained. Similar spurious YAP nucleolar staining was also seen in mouse embryonic fibroblasts and mouse liver tissue, indicating that this antibody is unsuitable for immunological applications to determine YAP sub-cellular localisation in mouse cells or tissues. Interestingly nucleolar staining was not evident in D645 cells suggesting the antibody may be suitable for use in human cells. Given the large body of published work on YAP in recent years, many of which utilise this antibody, this study raises concerns regarding its use for determining sub-cellular localisation. From a broader perspective, it serves as a timely reminder of the need to perform appropriate controls to ensure the validity of published data.	[Finch, Megan L.; Passman, Adam M.; Strauss, Robyn P.; Yeoh, George C.; Callus, Bernard A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Yeoh, George C.] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Yeoh, George C.] Univ Western Australia, Med Res Ctr, Crawley, WA 6009, Australia	University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Callus, BA (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia.	Bernard.Callus@uwa.edu.au	Yeoh, George/B-5339-2011; Finch-Edmondson, Megan/S-7340-2017	Yeoh, George/0000-0002-4740-4702; Strauss, Robyn/0000-0002-5571-5797; Finch-Edmondson, Megan/0000-0002-9628-5842; Passman, Adam/0000-0003-3212-6938	Association of International Cancer Research [09-0084]; Cancer Council of Western Australia (CCWA) [APP1010749, APP1067515]; CCWA [1030183]; NHMRC of Australia [APP1023187, APP1022498, APP1042368]; Australian Postgraduate Award from University of Western Australia (UWA); National Stem Cell Foundation of Australia; University Postgraduate Award and top-up scholarship from UWA; top-up scholarship from the CCWA; Prescott Postgraduate Scholarship from UWA; top-up scholarships from the University of Western Australia (UWA); STFC [ST/H000429/1] Funding Source: UKRI	Association of International Cancer Research; Cancer Council of Western Australia (CCWA)(Cancer Council Western Australia); CCWA(Cancer Council Western Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award from University of Western Australia (UWA); National Stem Cell Foundation of Australia; University Postgraduate Award and top-up scholarship from UWA; top-up scholarship from the CCWA; Prescott Postgraduate Scholarship from UWA; top-up scholarships from the University of Western Australia (UWA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by funding from the Association of International Cancer Research (#09-0084; http://www.aicr.org.uk) and the Cancer Council of Western Australia (CCWA; http://www.cancerwa.asn.au) (APP1010749 and APP1067515) to BAC and from the CCWA (1030183) and the NHMRC (http://www.nhmrc.gov.au) of Australia (APP1023187, APP1022498 and APP1042368) to GCY. MLF is a recipient of an Australian Postgraduate Award and top-up scholarships from the University of Western Australia (UWA) and the National Stem Cell Foundation of Australia. AMP is a recipient of a University Postgraduate Award and top-up scholarship from UWA and a top-up scholarship from the CCWA. RPS is a recipient of a Prescott Postgraduate Scholarship from UWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The financial support from the funders does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALEXANDER WS, 1989, ONCOGENE, V4, P575; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BENAVENTE R, 1988, CHROMOSOMA, V97, P115, DOI 10.1007/BF00327368; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Dong G, 1997, J CELL BIOCHEM, P90; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; Jellicoe MM, 2008, CARCINOGENESIS, V29, P1124, DOI 10.1093/carcin/bgn093; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER CELL, V16, P363, DOI 10.1016/j.ccr.2009.10.008; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114813	10.1371/journal.pone.0114813	http://dx.doi.org/10.1371/journal.pone.0114813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658431	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900009
J	Jin, QJ; Xue, ZY; Dong, CL; Wang, YJ; Chu, LL; Xu, YC				Jin, Qijiang; Xue, Zeyun; Dong, Chunlan; Wang, Yanjie; Chu, Lingling; Xu, Yingchun			Identification and Characterization of MicroRNAs from Tree Peony (Paeonia ostii) and Their Response to Copper Stress	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; SMALL RNAS; DOWN-REGULATION; ARABIDOPSIS; GENES; ROLES; MECHANISMS; PHYTOCHELATINS; EXPRESSION; TOLERANCE	MicroRNAs (miRNAs) are a class of non-coding, small RNAs recognized as important regulators of gene expression. Although plant miRNAs have been extensively studied in model systems, less is known in other plants with limited genome sequence data, including Paeonia ostii. In this work, we used high-throughput sequencing to identify conserved and nonconserved miRNAs and other short RNAs in Paeonia ostii under control and copper stressed condition. 102 previously known plant miRNAs were identified and classified into 89 families according to their gene sequence identity. Some miRNAs were highly conserved in the plant kingdom suggesting that these miRNA play important and conserved roles. Combined our transcriptome sequencing data of Paeonia ostii under same conditions, 34 novel potential miRNAs were identified. The potential targets of the identified known and novel miRNAs were also predicted based on sequence homology search. Comparing the two libraries, it was observed that 12 conserved miRNAs and 18 novel miRNAs showed significantly changes in response to copper stress. Some of the new identified potential miRNAs might be involved in Paeonia ostii-specific regulating mechanisms under copper stress. These results provide a framework for further analysis of miRNAs and their role in regulating Paeonia ostii response to copper stress.	[Jin, Qijiang; Xue, Zeyun; Dong, Chunlan; Wang, Yanjie; Chu, Lingling; Xu, Yingchun] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YC (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	wbshenh@njau.edu.cn; xyc@njau.edu.cn			National Natural Science Foundation of China [31101560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant no. 31101560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gielen H, 2012, INT J MOL SCI, V13, P15826, DOI 10.3390/ijms131215826; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hong DY, 2007, ACTA PHYTOTAXON SIN, V45, P285, DOI 10.1360/aps07043; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jin QJ, 2013, PLANT SOIL, V366, P605, DOI 10.1007/s11104-012-1451-9; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Leitao AL, 2014, METHODS MOL BIOL, V1182, P265, DOI 10.1007/978-1-4939-1062-5_23; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072840; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	27	32	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117584	10.1371/journal.pone.0117584	http://dx.doi.org/10.1371/journal.pone.0117584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658957	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900184
J	Marinova, IN; Engelbrecht, J; Ewald, A; Langholm, LL; Holmberg, C; Kragelund, BB; Gordon, C; Nielsen, O; Hartmann-Petersen, R				Marinova, Irina N.; Engelbrecht, Jacob; Ewald, Adrian; Langholm, Lasse L.; Holmberg, Christian; Kragelund, Birthe B.; Gordon, Colin; Nielsen, Olaf; Hartmann-Petersen, Rasmus			Single Site Suppressors of a Fission Yeast Temperature-Sensitive Mutant in cdc48 Identified by Whole Genome Sequencing	PLOS ONE			English	Article							AAA-ATPASE; TRANSCRIPTION FACTOR; UBIQUITIN; P97; SEGREGASE; ER; CDC48(UFD1/NPL4); STABILITY; PROTEINS; ADAPTER	The protein called p97 in mammals and Cdc48 in budding and fission yeast is a homo-hexameric, ring-shaped, ubiquitin-dependent ATPase complex involved in a range of cellular functions, including protein degradation, vesicle fusion, DNA repair, and cell division. The cdc48(+) gene is essential for viability in fission yeast, and point mutations in the human orthologue have been linked to disease. To analyze the function of p97/Cdc48 further, we performed a screen for cold-sensitive suppressors of the temperature-sensitive cdc48-353 fission yeast strain. In total, 29 independent pseudo revertants that had lost the temperature- sensitive growth defect of the cdc48-353 strain were isolated. Of these, 28 had instead acquired a cold-sensitive phenotype. Since the suppressors were all spontaneous mutants, and not the result of mutagenesis induced by chemicals or UV irradiation, we reasoned that the genome sequences of the 29 independent cdc48-353 suppressors were most likely identical with the exception of the acquired suppressor mutations. This prompted us to test if a whole genome sequencing approach would allow us to map the mutations. Indeed genome sequencing unambiguously revealed that the cold-sensitive suppressors were all second site intragenic cdc48 mutants. Projecting these onto the Cdc48 structure revealed that while the original temperature-sensitive G338D mutation is positioned near the central pore in the hexameric ring, the suppressor mutations locate to subunit-subunit and inter-domain boundaries. This suggests that Cdc48-353 is structurally compromized at the restrictive temperature, but re-established in the suppressor mutants. The last suppressor was an extragenic frame shift mutation in the ufd1 gene, which encodes a known Cdc48 co-factor. In conclusion, we show, using a novel whole genome sequencing approach, that Cdc48-353 is structurally compromized at the restrictive temperature, but stabilized in the suppressors.	[Marinova, Irina N.; Engelbrecht, Jacob; Ewald, Adrian; Langholm, Lasse L.; Holmberg, Christian; Kragelund, Birthe B.; Nielsen, Olaf; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gordon, Colin] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Copenhagen; University of Edinburgh	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Nielsen, Olaf/G-4980-2012; Hartmann-Petersen, Rasmus/K-4434-2014; Holmberg, Christian/L-8011-2014; Kragelund, Birthe/M-3927-2014	Nielsen, Olaf/0000-0001-7440-5201; Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Holmberg, Christian/0000-0001-9224-0543; Kragelund, Birthe/0000-0002-7454-1761; Langholm, Lasse Locke/0000-0003-0549-5797; Marinova, Irina/0000-0002-3626-7095; Ewald, David Adrian/0000-0001-6620-2738	Medical Research Council; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Foundation; Lundbeck Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Medical Research Council funding to C. G. as well as by grants from the Danish Council for Independent Research (Natural Sciences), The Novo Nordisk Foundation and the Lundbeck Foundation to R. H. P. and J.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kohler JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080442; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOIR D, 1982, GENETICS, V100, P547; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Naula N, 2003, CURR GENET, V43, P400, DOI 10.1007/s00294-003-0413-4; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Sommer T, 2001, REV PHYSIOL BIOCH P, V142, P97, DOI 10.1007/BFb0117492; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117779	10.1371/journal.pone.0117779	http://dx.doi.org/10.1371/journal.pone.0117779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658828	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900219
J	Mlynarek, JJ; Iserbyt, A; Nagel, L; Forbes, MR				Mlynarek, Julia J.; Iserbyt, Arne; Nagel, Laura; Forbes, Mark R.			Differential Water Mite Parasitism, Phenoloxidase Activity, and Resistance to Mites Are Unrelated across Pairs of Related Damselfly Species	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENETIC DIVERSITY; HOST DAMSELFLIES; EXPRESSION; MELANIZATION; DRAGONFLIES; MAINTENANCE; INFECTION; ECOLOGY; ODONATA	Related host species often demonstrate differences in prevalence and/or intensity of infection by particular parasite species, as well as different levels of resistance to those parasites. The mechanisms underlying this interspecific variation in parasitism and resistance expression are not well understood. Surprisingly, few researchers have assessed relations between actual levels of parasitism and resistance to parasites seen in nature across multiple host species. The main goal of this study was to determine whether interspecific variation in resistance against ectoparasitic larval water mites either was predictive of interspecific variation in parasitism for ten closely related species of damselflies (grouped into five "species pairs"), or was predicted by interspecific variation in a commonly used measure of innate immunity (total Phenoloxidase or potential PO activity). Two of five species pairs had interspecific differences in proportions of individuals resisting larval Arrenurus water mites, only one of five species pairs had species differences in prevalence of larval Arrenurus water mites, and another two of five species pairs showed species differences in mean PO activity. Within the two species pairs where species differed in proportion of individuals resisting mites the species with the higher proportion did not have correspondingly higher PO activity levels. Furthermore, the proportion of individuals resisting mites mirrored prevalence of parasitism in only one species pair. There was no interspecific variation in median intensity of mite infestation within any species pair. We conclude that a species' relative ability to resist particular parasites does not explain interspecific variation in parasitism within species pairs and that neither resistance nor parasitism is reflected by interspecific variation in total PO or potential PO activity.	[Mlynarek, Julia J.; Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Iserbyt, Arne] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Iserbyt, Arne] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Nagel, Laura] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Carleton University; University of Antwerp; University of Antwerp; Queens University - Canada	Mlynarek, JJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Julia.mlynarek@carleton.ca		Mlynarek, Julia J./0000-0002-1569-9403; Forbes, Mark/0000-0002-2288-3209; Iserbyt, Arne/0000-0002-6414-6688	Natural Sciences and Engineering Research Council (NSERC) Canada; agency for Innovation by Science and Technology (IWT Flanders); Fund for Scientific Research (FWO Flanders); Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); agency for Innovation by Science and Technology (IWT Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research (FWO Flanders)(FWO); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council (NSERC) Canada Graduate Scholarship awarded to JJM and a Natural Sciences and Engineering Research Council (NSERC) discovery grant awarded to MRF. AI was funded by the agency for Innovation by Science and Technology (IWT Flanders) and the Fund for Scientific Research (FWO Flanders).	Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Fedorka KM, 2013, EVOL ECOL, V27, P521, DOI 10.1007/s10682-012-9620-0; Forbes MR, 2014, IDEAS ECOL EVOL, V7, P17, DOI 10.4033/iee.2014.7.5.n; Forbes MR, 1999, INT J PARASITOL, V29, P991, DOI 10.1016/S0020-7519(99)00061-2; Gonzalez-Santoyo I, 2010, BEHAVIOUR, V147, P1285, DOI 10.1163/000579510X516777; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; HAM PJ, 1995, PARASITOL TODAY, V11, P63, DOI 10.1016/0169-4758(95)80118-9; Iserbyt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032648; Jearaphunt M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004059; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kaunisto KM, 2013, J EVOLUTION BIOL, V26, P1784, DOI 10.1111/jeb.12177; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; Marmaras VJ, 1996, ARCH INSECT BIOCHEM, V31, P119, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;119::AID-ARCH1&gt;3.0.CO;2-V; May ML, 2002, SYST ENTOMOL, V27, P387, DOI 10.1046/j.1365-3113.2002.00188.x; Mlynarek JJ, 2014, EVOL BIOL, V41, P115, DOI 10.1007/s11692-013-9251-6; Mlynarek JJ, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-50; Mlynarek JJ, 2012, ECOL ENTOMOL, V37, P419, DOI 10.1111/j.1365-2311.2012.01381.x; Morand S, 2010, BIOGEOGRAPHY HOST PA, P159; Morand S, 2010, BIOGEOGRAPHY HOST PA, DOI [10.1111/j.1758-8111.2010.00001.x, DOI 10.1111/J.1758-8111.2010.00001.X]; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Nagel Laura, 2010, BMC Ecology, V10, P5, DOI 10.1186/1472-6785-10-5; Nagel L, 2011, ECOL ENTOMOL, V36, P736, DOI 10.1111/j.1365-2311.2011.01323.x; Pauwels K, 2011, BIOL LETTERS, V7, P156, DOI 10.1098/rsbl.2010.0634; Poulin R., 2007, EVOL ECOL, V2; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sanchez-Guillen RA, 2013, OECOLOGIA, V171, P105, DOI 10.1007/s00442-012-2388-7; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Smilanich AM, 2009, ECOLOGY, V90, P1434, DOI 10.1890/08-1906.1; Stoks R, 2006, ECOLOGY, V87, P809, DOI 10.1890/0012-9658(2006)87[809:TCMPPI]2.0.CO;2; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Vogelweith F, 2014, J INSECT PHYSIOL, V64, P54, DOI 10.1016/j.jinsphys.2014.03.009; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Wilson K, 2013, ADV STUD BEHAV, V45, P81, DOI 10.1016/B978-0-12-407186-5.00003-3; Yourth CP, 2002, ECOL ENTOMOL, V27, P123, DOI 10.1046/j.1365-2311.2002.0376a.x; Yourth CP, 2001, CAN J ZOOL, V79, P815, DOI 10.1139/cjz-79-5-815; Zar JH, 1999, BIOSTATISTICAL ANAL	43	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115539	10.1371/journal.pone.0115539	http://dx.doi.org/10.1371/journal.pone.0115539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658982	gold, Green Published			2022-12-26	WOS:000349444900022
J	Picazo, C; Orozco, H; Matallana, E; Aranda, A				Picazo, Cecilia; Orozco, Helena; Matallana, Emilia; Aranda, Agustn			Interplay among Gcn5, Sch9 and Mitochondria during Chronological Aging of Wine Yeast Is Dependent on Growth Conditions	PLOS ONE			English	Article							LIFE-SPAN; RETROGRADE RESPONSE; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; LONGEVITY; AUTOPHAGY; STRESS; METABOLISM; CHROMATIN; STRAINS	Saccharomyces cerevisiae chronological life span (CLS) is determined by a wide variety of environmental and genetic factors. Nutrient limitation without malnutrition, i.e. dietary restriction, expands CLS through the control of nutrient signaling pathways, of which TOR/Sch9 has proven to be the most relevant, particularly under nitrogen deprivation. The use of prototrophic wine yeast allows a better understanding of the role of nitrogen in longevity in natural and more demanding environments, such as grape juice fermentation. We previously showed that acetyltransferase Gcn5, a member of the SAGA complex, has opposite effects on CLS under laboratory and winemaking conditions, and is detrimental under the latter. Here we demonstrate that integrity of the SAGA complex is necessary for prolonged longevity, as its dismantling by SPT20 deletion causes a drop in CLS under both laboratory and winemaking conditions. The sch9 Delta mutant is long-lived in synthetic SC medium, as expected, and the combined deletion of GCN5 partially suppresses this phenotype. However it is short-lived in grape juice, likely due to its low nitrogen/carbon ratio. Therefore, unbalance of nutrients can be more relevant for life span than total amounts of them. Deletion of RTG2, which codes for a protein associated with Gcn5 and is a component of the mitochondrial retrograde signal, and which communicates mitochondrial dysfunction to the nucleus, is detrimental under laboratory, but not under winemaking conditions, where respiration seems not so relevant for longevity. Transcription factor Rgm1 was found to be a novel CLS regulator Sch9-dependently.	[Picazo, Cecilia; Orozco, Helena; Matallana, Emilia; Aranda, Agustn] IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Spain; [Picazo, Cecilia; Orozco, Helena; Matallana, Emilia] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Aranda, A (corresponding author), IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Spain.	arandaa@iata.csic.es	Picazo, Cecilia/AAT-7426-2021; Aranda, Agustin/K-6483-2017; Matallana, Emilia/L-4619-2014	Picazo, Cecilia/0000-0002-2882-9537; Aranda, Agustin/0000-0003-3320-7326; Matallana, Emilia/0000-0002-3889-0454	Spanish Ministry of Science [AGL2011-24353]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by a grant from the Spanish Ministry of Science (AGL2011-24353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1998, METHODS YEAST GENETI, Vxiv; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bisson LF, 2007, ADV FOOD NUTR RES, V53, P65, DOI 10.1016/S1043-4526(07)53003-2; Cai L, 2013, CELL REP, V4, P1063, DOI 10.1016/j.celrep.2013.08.016; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CURRAN BPG, 1986, CURR GENET, V10, P943, DOI 10.1007/BF00398292; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fleet GH, 1993, WINE MICROBIOLOGY BI; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kim SY, 2004, BIOGERONTOLOGY, V5, P305, DOI 10.1007/s10522-004-2568-x; Kirchman PA, 1999, GENETICS, V152, P179; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mak HC, 2009, GENOME RES, V19, P1014, DOI 10.1101/gr.084178.108; McCormick MA, 2014, CELL REP, V8, P476, DOI 10.1016/j.celrep.2014.06.037; Mirzaei H, 2014, TRENDS ENDOCRIN MET, DOI [10.1016/j.tem.2014.11.005, DOI 10.1016/J.TEM.2014.11.005]; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Orozco H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-1; Orozco H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-104; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Orozco H, 2012, APPL ENVIRON MICROB, V78, P2748, DOI 10.1128/AEM.07261-11; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Rachidi N, 2000, CURR GENET, V37, P1, DOI 10.1007/s002940050001; Ribereau-Gayon P., 2006, HDB ENOLOGY MICROBIO, VVolume 1, P327, DOI [10.1002/0470010398, DOI 10.1002/0470010398]; ROBYT JF, 1972, ANAL BIOCHEM, V45, P510, DOI 10.1016/0003-2697(72)90213-8; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Sampaio-Marques B, 2011, BIOCHEM SOC T, V39, P1466, DOI 10.1042/BST0391466; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Walker ME, 2003, FEMS YEAST RES, V4, P339, DOI 10.1016/S1567-1356(03)00161-2; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079319; Zuzuarregui A, 2004, FEMS YEAST RES, V4, P699, DOI 10.1016/j.femsyr.2004.01.008	47	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117267	10.1371/journal.pone.0117267	http://dx.doi.org/10.1371/journal.pone.0117267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658705	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900128
J	Rabilotta, A; Desrosiers, M; Labbe, JC				Rabilotta, Alexia; Desrosiers, Marianne; Labbe, Jean-Claude			CDK-1 and Two B-Type Cyclins Promote PAR-6 Stabilization during Polarization of the Early C. elegans Embryo	PLOS ONE			English	Article							POLO-LIKE KINASE; CAENORHABDITIS-ELEGANS; CELL-CYCLE; OOCYTE MATURATION; POLARITY; PROTEINS; ASYMMETRY; DIVISION; CUL-2; ESTABLISHMENT	In the C. elegans embryo, formation of an antero-posterior axis of polarity relies on signaling by the conserved PAR proteins, which localize asymmetrically in two mutually exclusive groups at the embryonic cortex. Depletion of any PAR protein causes a loss of polarity and embryonic lethality. A genome-wide RNAi screen previously identified two B-type cyclins, cyb-2.1 and cyb-2.2, as suppressors of par-2(it5ts) lethality. We found that the loss of cyb-2.1 or cyb-2.2 suppressed the lethality and polarity defects of par-2(it5ts) mutants and that these cyclins act in cell polarity with their cyclin-dependent kinase partner, CDK-1. Interestingly, cyb-2.1; cyb-2.2 double mutants did not show defects in cell cycle progression or timing of polarity establishment, suggesting that they regulate polarity independently of their typical role in cell cycle progression. Loss of both cyclin genes or of cdk-1 resulted in a decrease in PAR-6 levels in the embryo. Furthermore, the activity of the cullin CUL-2 was required to achieve suppression of par-2 lethality when both cyclins were absent. Our results support a model in which CYB-2.1/2/CDK-1 antagonize CUL-2 activity to promote stabilization of PAR-6 levels during polarization of the early C. elegans embryo. They also suggest that CYB-2.1 and CYB-2.2 contribute to the coupling of cell cycle progression and asymmetric segregation of cell fate determinants.	[Rabilotta, Alexia; Desrosiers, Marianne; Labbe, Jean-Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Labbe, Jean-Claude] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Labbe, JC (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	jc.labbe@umontreal.ca		Labbe, Jean-Claude/0000-0003-0520-4566	Canadian Institutes of Health Research (CIHR); Cole Foundation; Cancer Research Society of Canada; Canada Foundation for Innovation; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cole Foundation; Cancer Research Society of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	AR held studentships from the Canadian Institutes of Health Research (CIHR; http://www.cihr.ca) and the Cole Foundation (http://colefoundation.ca). This work was funded by a grant from the Cancer Research Society of Canada (http://www.crssrc.ca) to JCL, who holds the Canada Research Chair in Cell Division and Differentiation. The Institute of Research in Immunology and Cancer is supported in part by the Canada Foundation for Innovation (http://www.innovation.ca) and the Fonds de Recherche du Quebec-Sante (http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty A, 2013, DEVELOPMENT, V140, P2005, DOI 10.1242/dev.088310; Benkemoun L, 2014, J CELL BIOL, V205, P447, DOI 10.1083/jcb.201312029; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Burger J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003375; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; Chartier NT, 2011, CURR BIOL, V21, P259, DOI 10.1016/j.cub.2011.01.010; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hyenne V, 2008, DEV BIOL, V321, P368, DOI 10.1016/j.ydbio.2008.06.037; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kemphues KJ, 1997, C ELEGANS; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu J, 2004, DEVELOPMENT, V131, P3513, DOI 10.1242/dev.01245; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Narayan N, 2009, J CELL SCI, V122, P65, DOI 10.1242/jcs.024554; Noatynska A, 2010, DEVELOPMENT, V137, P3315, DOI 10.1242/dev.055293; Pacquelet A, 2008, DEV BIOL, V319, P267, DOI 10.1016/j.ydbio.2008.04.016; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Shakes DC, 2003, DEVELOPMENT, V130, P1605, DOI 10.1242/dev.00385; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Starostina NG, 2007, DEV CELL, V13, P127, DOI 10.1016/j.devcel.2007.05.008; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; van der Voet M, 2009, CELL CYCLE, V8, P4091, DOI 10.4161/cc.8.24.10171; Watts JL, 1996, DEVELOPMENT, V122, P3133	41	10	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117656	10.1371/journal.pone.0117656	http://dx.doi.org/10.1371/journal.pone.0117656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658117	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900196
J	Zhang, XD; Tong, F; Li, CX; Yan, YM; Kempf, D; Nair, G; Wang, SL; Muly, EC; Zola, S; Howell, L				Zhang, Xiaodong; Tong, Frank; Li, Chun-Xia; Yan, Yumei; Kempf, Doty; Nair, Govind; Wang, Silun; Muly, E. Chris; Zola, Stuart; Howell, Leonard			Temporal Evolution of Ischemic Lesions in Nonhuman Primates: A Diffusion and Perfusion MRI Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; STROKE MODEL; SERIAL DIFFUSION; INFARCT VOLUME; TISSUE SODIUM; INJURY; BRAIN; TIME; MISMATCH; RECOVERY	Background and Purpose Diffusion-weighted imaging (DWI) and perfusion MRI were used to examine the spatiotemporal evolution of stroke lesions in adult macaques with ischemic occlusion. Methods Permanent MCA occlusion was induced with silk sutures through an interventional approach via the femoral artery in adult rhesus monkeys (n = 8, 10-21 years old). The stroke lesions were examined with high-resolution DWI and perfusion MRI, and T2-weighted imaging (T2W) on a clinical 3T scanner at 1-6, 48, and 96 hours post occlusion and validated with H&E staining. Results The stroke infarct evolved via a natural logarithmic pattern with the mean infarct growth rate = 1.38 +/- 1.32 ml per logarithmic time scale (hours) (n = 7) in the hyperacute phase (1-6 hours). The mean infarct volume after 6 hours post occlusion was 3.6 +/- 2.8 ml (n = 7, by DWI) and increased to 3.9 +/- 2.9 ml (n = 5, by T2W) after 48 hours, and to 4.7 +/- 2.2ml (n = 3, by T2W) after 96 hours post occlusion. The infarct volumes predicted by the natural logarithmic function were correlated significantly with the T2W-derived lesion volumes (n = 5, r = 0.92, p = 0.01) at 48 hours post occlusion. The final infarct volumes derived from T2W were correlated significantly with those from H&E staining (r = 0.999, p < 0.0001, n = 4). In addition, the diffusion-perfusion mismatch was visible generally at 6 hours but nearly diminished at 48 hours post occlusion. Conclusion The infarct evolution follows a natural logarithmic pattern in the hyperacute phase of stroke. The logarithmic pattern of evolution could last up to 48 hours after stroke onset and may be used to predict the infarct volume growth during the acute phase of ischemic stroke. The nonhuman primate model, MRI protocols, and post data processing strategy may provide an excellent platform for characterizing the evolution of acute stroke lesion in mechanistic studies and therapeutic interventions of stroke disease.	[Zhang, Xiaodong; Li, Chun-Xia; Yan, Yumei; Kempf, Doty; Nair, Govind; Wang, Silun; Muly, E. Chris; Zola, Stuart; Howell, Leonard] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Tong, Frank] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; [Nair, Govind] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Nair, Govind] Georgia Inst Technol, Atlanta, GA 30322 USA; [Muly, E. Chris; Zola, Stuart; Howell, Leonard] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Zola, Stuart] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Zhang, XD (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	xzhang8@emory.edu		Nair, Govind/0000-0003-3725-615X	NCRR; Office of Research Infrastructure Programs [P51RR000165, OD P51OD011132, DA 031246]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by NCRR and currently by the Office of Research Infrastructure Programs (P51RR000165 and OD P51OD011132), DA 031246 (LH), and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 (XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardutzky J, 2005, BRAIN RES, V1043, P155, DOI 10.1016/j.brainres.2005.02.073; Bardutzky J, 2005, STROKE, V36, P2000, DOI 10.1161/01.STR.0000177486.85508.4d; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; BOLAS NM, 1988, STROKE, V19, P608, DOI 10.1161/01.STR.19.5.608; Cheng BT, 2013, J CEREBR BLOOD F MET, V33, P76, DOI 10.1038/jcbfm.2012.129; Chin Y, 2010, NEUROSCI RES, V66, P406, DOI 10.1016/j.neures.2010.01.001; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Crowell RM, 1970, STROKE, V1, P439, DOI 10.1161/01.STR.1.6.439; D'Arceuil HE, 2006, J MED PRIMATOL, V35, P78, DOI 10.1111/j.1600-0684.2006.00147.x; de Crespigny Alex J, 2005, J Stroke Cerebrovasc Dis, V14, P80, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.005; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Hudgins WR, 1970, STROKE, V1, P107, DOI 10.1161/01.STR.1.2.107; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; MACDONALD RL, 1995, STROKE, V26, P1247, DOI 10.1161/01.STR.26.7.1247; Marshall JWB, 2003, BRAIN RES BULL, V61, P577, DOI 10.1016/S0361-9230(03)00214-4; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Murphy SJ, 2008, COMPARATIVE MED, V58, P588; Olivot JM, 2009, STROKE, V40, P3245, DOI 10.1161/STROKEAHA.109.558635; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Rodriguez-Mercado R, 2012, COMPARATIVE MED, V62, P427; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rordorf G, 1998, STROKE, V29, P939, DOI 10.1161/01.STR.29.5.939; Sato Y, 2009, NEUROSCI RES, V65, P71, DOI 10.1016/j.neures.2009.05.010; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Schellinger PD, 2000, STROKE, V31, P1318, DOI 10.1161/01.STR.31.6.1318; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tatlisumak Turgut, 2004, Current Vascular Pharmacology, V2, P343, DOI 10.2174/1570161043385493; Thulborn KR, 1999, RADIOLOGY, V213, P156, DOI 10.1148/radiology.213.1.r99se15156; Wang Y, 2000, STROKE, V31, P1386, DOI 10.1161/01.STR.31.6.1386; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Wheeler HM, 2013, STROKE, V44, P681, DOI 10.1161/STROKEAHA.111.000135; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Zhang XD, 2014, QUANT IMAGING MED SU, V4, P112, DOI [10.3978/j.issn.2223-4292.2014.03.01, 10.3978/j.issn.2223-4292.2014.04.06]; [Zhang Xiaodong 张晓东], 2010, [波谱学杂志, Chinese Journal of Magnetic Resonance], V27, P548; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	43	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117290	10.1371/journal.pone.0117290	http://dx.doi.org/10.1371/journal.pone.0117290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659092	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900131
J	Dewi, V; Kwok, A; Lee, S; Lee, MM; Tan, YM; Nicholas, HR; Isono, K; Wienert, B; Mak, KS; Knights, AJ; Quinlan, KGR; Cordwell, SJ; Funnell, APW; Pearson, RCM; Crossley, M				Dewi, Vitri; Kwok, Alister; Lee, Stella; Lee, Ming Min; Tan, Yee Mun; Nicholas, Hannah R.; Isono, Kyo-ichi; Wienert, Beeke; Mak, Ka Sin; Knights, Alexander J.; Quinlan, Kate G. R.; Cordwell, Stuart J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin			Phosphorylation of Kruppel-like Factor 3 (KLF3/BKLF) and C-terminal Binding Protein 2 (CtBP2) by Homeodomain-interacting Protein Kinase 2 (HIPK2) Modulates KLF3 DNA Binding and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-VIVO; P53 ACTIVITY; REPRESSION; APOPTOSIS; DOMAIN; CELLS; PROTEIN-KINASE-2; DIFFERENTIATION; DEGRADATION	Kruppel-like factor 3 (KLF3/BKLF), a member of the Kruppel-like factor (KLF) family of transcription factors, is a widely expressed transcriptional repressor with diverse biological roles. Although there is considerable understanding of the molecular mechanisms that allow KLF3 to silence the activity of its target genes, less is known about the signal transduction pathways and post-translational modifications that modulate KLF3 activity in response to physiological stimuli. We observed that KLF3 is modified in a range of different tissues and found that the serine/threonine kinase homeodomain-interacting protein kinase 2 (HIPK2) can both bind and phosphorylate KLF3. Mass spectrometry identified serine 249 as the primary phosphorylation site. Mutation of this site reduces the ability of KLF3 to bind DNA and repress transcription. Furthermore, we also determined that HIPK2 can phosphorylate the KLF3 co-repressor C-terminal binding protein 2 (CtBP2) at serine 428. Finally, we found that phosphorylation of KLF3 and CtBP2 by HIPK2 strengthens the interaction between these two factors and increases transcriptional repression by KLF3. Taken together, our results indicate that HIPK2 potentiates the activity of KLF3.	[Dewi, Vitri; Wienert, Beeke; Mak, Ka Sin; Knights, Alexander J.; Quinlan, Kate G. R.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Kwok, Alister; Lee, Stella; Lee, Ming Min; Tan, Yee Mun; Nicholas, Hannah R.; Cordwell, Stuart J.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Isono, Kyo-ichi] RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	University of New South Wales Sydney; University of Sydney; RIKEN	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011; Knights, Alexander/AAL-1769-2021	Crossley, Merlin/0000-0003-2057-3642; Nicholas, Hannah/0000-0002-2239-9249; Cordwell, Stuart/0000-0002-0995-0171; Isono, Kyoichi/0000-0002-4609-8985; Knights, Alexander/0000-0001-8402-2212; Quinlan, Kate/0000-0002-5722-8183	Australian National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Australian Postgraduate Award	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Postgraduate Award(Australian Government)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC).; Supported by an Australian Postgraduate Award.	Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; Crossley M, 1996, MOL CELL BIOL, V16, P1695; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Guerra FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035533; Hancock D, 2010, BIOCHEM MOL BIOL EDU, V38, P309, DOI 10.1002/bmb.20414; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hattangadi SM, 2010, BLOOD, V115, P4853, DOI 10.1182/blood-2009-07-235093; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Mak KS, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r58; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Ouyang L, 1998, J BIOL CHEM, V273, P23019, DOI 10.1074/jbc.273.36.23019; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pearson RCM, 2011, IUBMB LIFE, V63, P86, DOI 10.1002/iub.422; Pei JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081109; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sjolund J, 2014, P NATL ACAD SCI USA, V111, P7373, DOI 10.1073/pnas.1322275111; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turchinovich G, 2011, BLOOD, V117, P3780, DOI 10.1182/blood-2010-09-308742; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2003, J BIOL CHEM, V278, P12786, DOI 10.1074/jbc.M300587200; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102	54	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8591	8605		10.1074/jbc.M115.638338	http://dx.doi.org/10.1074/jbc.M115.638338			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659434	Green Published, hybrid			2022-12-26	WOS:000351662600049
J	Newman, JA; Cooper, CDO; Aitkenhead, H; Gileadi, O				Newman, Joseph A.; Cooper, Christopher D. O.; Aitkenhead, Hazel; Gileadi, Opher			Structural Insights into the Autoregulation and Cooperativity of the Human Transcription Factor Ets-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; STROMELYSIN-1 PROMOTER; FAMILY; SEQUENCES; SITES; PHOSPHORYLATION; EXPRESSION; DOMAIN	Ets-2, like its closely related homologue Ets-1, is a member of the Ets family of DNA binding transcription factors. Both proteins are subject to multiple levels of regulation of their DNA binding and transactivation properties. One such regulatory mechanism is the presence of an autoinhibitory module, which in Ets-1 allosterically inhibits the DNA binding activity. This inhibition can be relieved by interaction with protein partners or cooperative binding to closely separated Ets binding sites in a palindromic arrangement. In this study we describe the 2.5 angstrom resolution crystal structure of a DNA complex of the Ets-2 Ets domain. The Ets domain crystallized with two distinct species in the asymmetric unit, which closely resemble the autoinhibited and DNA bound forms of Ets-1. This discovery prompted us to re-evaluate the current model for the autoinhibitory mechanism and the structural basis for cooperative DNA binding. In contrast to Ets-1, in which the autoinhibition is caused by a combination of allosteric and steric mechanisms, we were unable to find clear evidence for the allosteric mechanism in Ets-2. We also demonstrated two possibly distinct types of cooperative binding to substrates with Ets binding motifs separated by four and six base pairs and suggest possible molecular mechanisms for this behavior.	[Newman, Joseph A.; Cooper, Christopher D. O.; Aitkenhead, Hazel; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, SGC, ORCRB, Roosevelt Dr, Oxford OX3 7DQ, England.	christopher.cooper@path.ox.ac.uk; opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; Gileadi, Opher/0000-0001-6886-898X; newman, Joseph/0000-0003-4488-0516	Structural Genomics Consortium, a registered charity [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	Structural Genomics Consortium, a registered charity(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babayeva ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033698; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Cowley DO, 2000, GENE DEV, V14, P366; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Guen VJ, 2013, P NATL ACAD SCI USA, V110, P19525, DOI 10.1073/pnas.1306814110; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; LIM F, 1992, EMBO J, V11, P643, DOI 10.1002/j.1460-2075.1992.tb05096.x; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shaikhibrahim Z, 2012, INT J MOL MED, V30, P1029, DOI 10.3892/ijmm.2012.1097; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang ZP, 2009, EVOL BIOINFORM, V5, P119; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	30	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8539	8549		10.1074/jbc.M114.619270	http://dx.doi.org/10.1074/jbc.M114.619270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670864	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000351662600044
J	Huang, BX; Zhu, MF; Wu, T; Zhou, JY; Liu, Y; Chen, XL; Zhou, RF; Wang, LJ; Chen, YM; Zhu, HL				Huang, Bi-xia; Zhu, Ming-fan; Wu, Ting; Zhou, Jing-ya; Liu, Yan; Chen, Xiao-lin; Zhou, Rui-fen; Wang, Li-jun; Chen, Yu-ming; Zhu, Hui-lian			Neck Circumference, along with Other Anthropometric Indices, Has an Independent and Additional Contribution in Predicting Fatty Liver Disease	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; HEPATIC STEATOSIS; OBESITY; ASSOCIATION; POPULATION; PREVALENCE; OVERWEIGHT	Background and Aim Previous studies have indicated that neck circumference is a valuable predictor for obesity and metabolic syndrome, but little evidence is available for fatty liver disease. We examined the association of neck circumference with fatty liver disease and evaluated its predictive value in Chinese adults. Methods This cross-sectional study comprised 4053 participants (1617 women and 2436 men, aged 20-88) recruited from the Health Examination Center in Guangzhou, China between May 2009 and April 2010. Anthropometric measurements were taken, abdominal ultrasonography was conducted and blood biochemical parameters were measured. Covariance, logistic regression and receiver operating characteristic curve analyses were employed. Results The mean neck circumference was greater in subjects with fatty liver disease than those without the disease in both women and men after adjusting for age (P<0.001). Logistic regression analysis showed that the age-adjusted ORs (95% CI) of fatty liver disease for quartile 4 (vs. quartile 1) of neck circumference were 7.70 (4.95-11.99) for women and 12.42 (9.22-16.74) for men. After further adjusting for other anthropometric indices, both individually and combined, the corresponding ORs remained significant (all P-trends<0.05) but were attenuated to 1.94-2.53 for women and 1.45-2.08 for men. An additive interaction existed between neck circumference and the other anthropometric measures (all P<0.05). A high neck circumference value was associated with a much greater prevalence of fatty liver disease in participants with both high and normal BMI, waist circumference and waist-to-hip ratio values. Conclusions Neck circumference was an independent predictor for fatty liver disease and provided an additional contribution when applied with other anthropometric measures.	[Huang, Bi-xia; Wu, Ting; Zhou, Jing-ya; Liu, Yan; Chen, Xiao-lin; Zhou, Rui-fen; Wang, Li-jun; Chen, Yu-ming; Zhu, Hui-lian] Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Ming-fan] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Examinat Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhu, HL (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou 510275, Guangdong, Peoples R China.	zhuhl@mail.sysu.edu.cn	Zhu, Huilian/V-1040-2019; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019; HUANG, Bixia/AAV-1397-2020	Huang, Bi-xia/0000-0001-6458-0655	National Science Foundation of China [81273050]; Science and Technology Program of Guangzhou, China [201300000148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China	This study was supported by the National Science Foundation of China (no. 81273050) and Science and Technology Program of Guangzhou, China (no. 201300000148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Aswathappa J, 2013, N AM J MED SCI, V5, P28, DOI 10.4103/1947-2714.106188; Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Ballestri S, 2008, HEPATOLOGY, V47, P361, DOI 10.1002/hep.21977; Ben-Noun L, 2001, OBES RES, V9, P470, DOI 10.1038/oby.2001.61; Chakraborty S, 2014, ANN GASTROENTEROL, V27, P250; Cheung O, 2007, HEPATOLOGY, V46, P1091, DOI 10.1002/hep.21803; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Gray B, 2013, NUTR RES, V33, P781, DOI 10.1016/j.nutres.2013.07.019; Iwao S, 2001, OBES RES, V9, P685, DOI 10.1038/oby.2001.93; Lonardo A, 2010, EXPERT REV ENDOCRINO, V5, P403, DOI 10.1586/EEM.10.5; Machado MV, 2014, EXPERT REV GASTROENT, P1, DOI [10.1586/17474124.1.1.1, DOI 10.1586/17474124.1.1.1]; Meng LH, 2011, BIOMED ENVIRON SCI, V24, P22, DOI 10.3967/0895-3988.2011.01.003; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Preis SR, 2013, DIABETES CARE, V36, pE3, DOI 10.2337/dc12-0738; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Rodriguez-Torres M, 2008, J HEPATOL, V48, P756, DOI 10.1016/j.jhep.2008.01.015; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Satapathy SK, 2007, J GASTROEN HEPATOL, V22, P634, DOI 10.1111/j.1440-1746.2006.04756.x; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Targher G, 2008, J AM SOC NEPHROL, V19, P1564, DOI 10.1681/ASN.2007101155; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Tuan NT, 2010, PUBLIC HEALTH NUTR, V13, P639, DOI 10.1017/S1368980009991479; Gomez EV, 2009, ALIMENT PHARM THER, V30, P999, DOI 10.1111/j.1365-2036.2009.04122.x; Volzke H, 2012, WORLD J GASTROENTERO, V18, P3492, DOI 10.3748/wjg.v18.i27.3492; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086; Yan Q, 2014, DIABETES-METAB RES, V30, P69, DOI 10.1002/dmrr.2464; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x; Zheng RD, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/362147; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76; Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419	46	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118071	10.1371/journal.pone.0118071	http://dx.doi.org/10.1371/journal.pone.0118071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679378	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600106
J	Signa, G; Mazzola, A; Costa, V; Vizzini, S				Signa, Geraldina; Mazzola, Antonio; Costa, Valentina; Vizzini, Salvatrice			Bottom-Up Control of Macrobenthic Communities in a Guanotrophic Coastal System	PLOS ONE			English	Article							HYDROBIA-ULVAE; SOFT-BOTTOM; TRANSITIONAL WATERS; SPECIES RICHNESS; BIRD COLONIES; ASSEMBLAGES; ESTUARINE; NUTRIENT; EUTROPHICATION; LAGOONS	Soft bottom macrobenthic communities were studied seasonally in three coastal ponds (Marinello ponds, Italy) at increasing distances from a gull (Larus michahellis) colony to investigate the effect of seabird-induced eutrophication (i.e. guanotrophication) on macrobenthic fauna. We hypothesized that enhanced nutrient concentration and organic load caused by guano input significantly alter the trophic and sedimentological condition of ponds, affecting benthic fauna through a bottom-up control. The influence of a set of environmental features on macrobenthic assemblages was also tested. Overall, the lowest macrobenthic abundances and functional group diversity were found in deeper sites, especially in the pond characterised by severe guanotrophication, where the higher disturbance resulted in a decline in suspension feeders and carnivores in favour of deposit feeders. An increase in opportunistic/tolerant taxa (e.g. chironomid larvae and paraonids) and totally azoic sediments were also found as an effect of the harshest environmental conditions, resulting in a very poor ecological status. We conclude that macrobenthic assemblages of the Marinello coastal system display high spatial variability due to a synergistic effect of trophic status and the geomorphological features of the ponds. The macrobenthic response to guanotrophication, which was a clear decrease in abundance, diversity and trophic functional groups, was associated with the typical response to severe eutrophication, magnified by the geomorphological features.	[Signa, Geraldina; Mazzola, Antonio; Costa, Valentina; Vizzini, Salvatrice] Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Palermo, Italy	CoNISMa; University of Palermo	Signa, G (corresponding author), Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Via Archirafi 18, Palermo, Italy.	geraldina.signa@unipa.it	Costa, Valentina/A-8319-2015; Signa, Geraldina/G-3357-2017; Signa, Geraldina/AAQ-9090-2020	Costa, Valentina/0000-0002-1513-0284; Signa, Geraldina/0000-0003-2171-3299; Signa, Geraldina/0000-0003-2171-3299	PRIN; University of Palermo	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Palermo	This study was funded by PRIN 2008 and University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Armitage P.D., 1995, THE CHIRONOMIDAE BIO; Bachelet G, 2000, ICES J MAR SCI, V57, P1495, DOI 10.1006/jmsc.2000.0902; Basset A, 2006, AQUAT CONSERV, V16, P441, DOI 10.1002/aqc.767; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Blanchard GF, 2000, J EXP MAR BIOL ECOL, V255, P247, DOI 10.1016/S0022-0981(00)00292-6; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BOSMAN AL, 1986, MAR ECOL PROG SER, V32, P247, DOI 10.3354/meps032247; Cardoso PG, 2005, MAR ECOL PROG SER, V289, P191, DOI 10.3354/meps289191; Casu D, 2009, AQUAT ECOL, V43, P1023, DOI 10.1007/s10452-008-9223-6; Chaichana R, 2010, HYDROBIOLOGIA, V646, P111, DOI 10.1007/s10750-010-0166-2; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Como S, 2008, MAR BIOL, V153, P1087, DOI 10.1007/s00227-007-0881-z; Como S, 2007, MAR POLLUT BULL, V54, P733, DOI 10.1016/j.marpolbul.2007.01.007; De Haas EM, 2006, J ANIM ECOL, V75, P148, DOI 10.1111/j.1365-2656.2005.01030.x; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Garcia LV, 2002, OIKOS, V98, P75, DOI 10.1034/j.1600-0706.2002.980108.x; Grall J, 2002, GLOBAL CHANGE BIOL, V8, P813, DOI 10.1046/j.1365-2486.2002.00519.x; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Hagerthey SE, 2002, MAR ECOL PROG SER, V245, P47, DOI 10.3354/meps245047; Hyland J, 2005, MAR ECOL PROG SER, V295, P91, DOI 10.3354/meps295091; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Koutsoubas D, 2000, BELG J ZOOL, V130, P135; LEENTVAAR P, 1967, Hydrobiologia, V29, P441, DOI 10.1007/BF00189906; Leonardi M, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P305; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Magni P, 2006, MAR BIOL, V149, P1185, DOI 10.1007/s00227-006-0298-0; Magni P, 2003, CHEM ECOL, V19, P363, DOI 10.1080/02757540310001603718; Mazzola A, 2010, CHEM ECOL, V26, P267, DOI 10.1080/02757541003627704; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Michelutti N, 2011, POLAR BIOL, V34, P799, DOI 10.1007/s00300-010-0934-5; Mistri M, 2008, MAR POLLUT BULL, V56, P587, DOI 10.1016/j.marpolbul.2007.12.002; Mouillot D, 2006, AQUAT CONSERV, V16, P469, DOI 10.1002/aqc.769; Mucha AP, 2005, MAR ENVIRON RES, V60, P531, DOI 10.1016/j.marenvres.2004.12.004; Palomo G, 1999, B MAR SCI, V65, P119; Pardal MA, 2000, MAR ECOL PROG SER, V196, P207, DOI 10.3354/meps196207; Pasquaud S, 2010, ESTUAR COAST SHELF S, V86, P237, DOI 10.1016/j.ecss.2009.11.019; Payne LX, 2006, OIKOS, V115, P69; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Ponti M, 2011, HELGOLAND MAR RES, V65, P25, DOI 10.1007/s10152-010-0197-0; Post DM, 1998, CONSERV BIOL, V12, P910, DOI 10.1046/j.1523-1739.1998.97112.x; POWELL GVN, 1991, ESTUAR COAST SHELF S, V32, P567, DOI 10.1016/0272-7714(91)90075-M; Reizopoulou S, 2004, AQUAT CONSERV, V14, pS93, DOI 10.1002/aqc.653; Reizopoulou S, 2007, HYDROBIOLOGIA, V577, P141, DOI 10.1007/s10750-006-0423-6; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Signa G, 2013, MAR POLLUT BULL, V74, P237, DOI 10.1016/j.marpolbul.2013.06.051; Signa G, 2012, ESTUAR COAST SHELF S, V111, P27, DOI 10.1016/j.ecss.2012.06.008; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; Tagliapietra D, 1998, ESTUAR COAST SHELF S, V47, P217, DOI 10.1006/ecss.1998.0340; Tagliapietra D, 2012, HYDROBIOLOGIA, V686, P15, DOI 10.1007/s10750-012-1001-8; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302	54	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117544	10.1371/journal.pone.0117544	http://dx.doi.org/10.1371/journal.pone.0117544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679400	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600071
J	Pal, A; Banerjee, R; Mondal, UK; Mukhopadhyay, S; Bothra, AK				Pal, Ayon; Banerjee, Rachana; Mondal, Uttam K.; Mukhopadhyay, Subhasis; Bothra, Asim K.			Deconstruction of Archaeal Genome Depict Strategic Consensus in Core Pathways Coding Sequence Assembly	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; METHANOMASSILIICOCCUS-LUMINYENSIS; TRANSLATIONAL SELECTION; NANOARCHAEUM-EQUITANS; ADAPTATION INDEX; CONTEXT ANALYSIS; EFFECTIVE NUMBER; BIAS; EVOLUTION; BACTERIA	A comprehensive in silico analysis of 71 species representing the different taxonomic classes and physiological genre of the domain Archaea was performed. These organisms differed in their physiological attributes, particularly oxygen tolerance and energy metabolism. We explored the diversity and similarity in the codon usage pattern in the genes and genomes of these organisms, emphasizing on their core cellular pathways. Our thrust was to figure out whether there is any underlying similarity in the design of core pathways within these organisms. Analyses of codon utilization pattern, construction of hierarchical linear models of codon usage, expression pattern and codon pair preference pointed to the fact that, in the archaea there is a trend towards biased use of synonymous codons in the core cellular pathways and the Nc-plots appeared to display the physiological variations present within the different species. Our analyses revealed that aerobic species of archaea possessed a larger degree of freedom in regulating expression levels than could be accounted for by codon usage bias alone. This feature might be a consequence of their enhanced metabolic activities as a result of their adaptation to the relatively O-2-rich environment. Species of archaea, which are related from the taxonomical viewpoint, were found to have striking similarities in their ORF structuring pattern. In the anaerobic species of archaea, codon bias was found to be a major determinant of gene expression. We have also detected a significant difference in the codon pair usage pattern between the whole genome and the genes related to vital cellular pathways, and it was not only species-specific but pathway specific too. This hints towards the structuring of ORFs with better decoding accuracy during translation. Finally, a codon-pathway interaction in shaping the codon design of pathways was observed where the transcription pathway exhibited a significantly different coding frequency signature.	[Pal, Ayon] Raiganj Coll Univ Coll, Dept Bot, Uttar Dinajpur, W Bengal, India; [Banerjee, Rachana; Mukhopadhyay, Subhasis] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Mondal, Uttam K.; Bothra, Asim K.] Raiganj Coll Univ Coll, Dept Chem, Cheminformat Bioinformat Lab, Uttar Dinajpur, W Bengal, India	University of Calcutta	Pal, A (corresponding author), Raiganj Coll Univ Coll, Dept Bot, Uttar Dinajpur, W Bengal, India.	ayonpal.ruc@gmail.com	Mondal, Uttam K/F-7219-2011; Pal, Ayon/AAD-1643-2019; Banerjee, Rachana/GLR-4701-2022	Mondal, Uttam K/0000-0003-2408-1258; Pal, Ayon/0000-0002-8446-0295; Banerjee, Rachana/0000-0002-5672-5196	Department of Biotechnology, Govt. of India [BT/BI/04/026/93, BT/BI/010/019/99]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	SM and RB received grants from the Department of Biotechnology, Govt. of India (http://dbtindia.nic.in) vide grant no. BT/BI/04/026/93 and BT/BI/010/019/99. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Aller JY, 2008, FEMS MICROBIOL ECOL, V65, P74, DOI 10.1111/j.1574-6941.2008.00498.x; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; [Anonymous], 1999, AN COD US; AOTA S, 1986, NUCLEIC ACIDS RES, V14, P6345, DOI 10.1093/nar/14.16.6345; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Brochier C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r42; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BULMER M, 1991, GENETICS, V129, P897; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chowdhury AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-236; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Emery LR, 2011, BIOL LETTERS, V7, P131, DOI 10.1098/rsbl.2010.0620; Epstein RJ, 2000, GENE, V245, P291, DOI 10.1016/S0378-1119(00)00042-1; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fuglsang A, 2006, GENETICS, V172, P1301, DOI 10.1534/genetics.105.049643; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gorlas A, 2012, J BACTERIOL, V194, P4745, DOI 10.1128/JB.00956-12; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7309, DOI 10.1073/pnas.0502314102; Khrustalev Vladislav V., 2010, Genomics Proteomics & Bioinformatics, V8, P22, DOI 10.1016/S1672-0229(10)60003-4; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lahr DJG, 2011, MOL BIOL EVOL, V28, P223, DOI 10.1093/molbev/msq200; Lithwick G, 2005, NUCLEIC ACIDS RES, V33, P1051, DOI 10.1093/nar/gki261; Liu WQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-325; Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OHAMA T, 1990, NUCLEIC ACIDS RES, V18, P1565, DOI 10.1093/nar/18.6.1565; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sakai A, 2006, GENES CELLS, V11, P767, DOI 10.1111/j.1365-2443.2006.00982.x; Schmidt A, 2012, J BASIC MICROB, V52, P195, DOI 10.1002/jobm.201100067; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith NGC, 2001, J MOL EVOL, V53, P225, DOI 10.1007/s002390010212; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Tats A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-463; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Witzany G, 2011, J MOL CELL BIOL, V3, P181, DOI 10.1093/jmcb/mjr005; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia Xuhua, 2007, Evol Bioinform Online, V3, P53; Zeeberg B, 2002, GENOME RES, V12, P944, DOI 10.1101/gr.213402	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0118245	10.1371/journal.pone.0118245	http://dx.doi.org/10.1371/journal.pone.0118245			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674789	gold, Green Submitted, Green Published			2022-12-26	WOS:000349914000044
J	Hartter, J; Stevens, FR; Hamilton, LC; Congalton, RG; Ducey, MJ; Oester, PT				Hartter, Joel; Stevens, Forrest R.; Hamilton, Lawrence C.; Congalton, Russell G.; Ducey, Mark J.; Oester, Paul T.			Modelling Associations between Public Understanding, Engagement and Forest Conditions in the Inland Northwest, USA	PLOS ONE			English	Article							LAND-USE CHANGE; WILDFIRE; MANAGEMENT; PRONE; RISK; DISTURBANCE; PERCEPTION; MITIGATION; DRIVERS; LESSONS	Opinions about public lands and the actions of private non-industrial forest owners in the western United States play important roles in forested landscape management as both public and private forests face increasing risks from large wildfires, pests and disease. This work presents the responses from two surveys, a random-sample telephone survey of more than 1500 residents and a mail survey targeting owners of parcels with 10 or more acres of forest. These surveys were conducted in three counties (Wallowa, Union, and Baker) in northeast Oregon, USA. We analyze these survey data using structural equation models in order to assess how individual characteristics and understanding of forest management issues affect perceptions about forest conditions and risks associated with declining forest health on public lands. We test whether forest understanding is informed by background, beliefs, and experiences, and whether as an intervening variable it is associated with views about forest conditions on publicly managed forests. Individual background characteristics such as age, gender and county of residence have significant direct or indirect effects on our measurement of understanding. Controlling for background factors, we found that forest owners with higher self-assessed understanding, and more education about forest management, tend to hold more pessimistic views about forest conditions. Based on our results we argue that self-assessed understanding, interest in learning, and willingness to engage in extension activities together have leverage to affect perceptions about the risks posed by declining forest conditions on public lands, influence land owner actions, and affect support for public policies. These results also have broader implications for management of forested landscapes on public and private lands amidst changing demographics in rural communities across the Inland Northwest where migration may significantly alter the composition of forest owner goals, understanding, and support for various management actions.	[Hartter, Joel] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Hartter, Joel; Hamilton, Lawrence C.; Ducey, Mark J.] Univ New Hampshire, Carsey Sch Publ Policy, Durham, NH 03824 USA; [Stevens, Forrest R.] Univ Louisville, Dept Geog & Geosci, Louisville, KY 40292 USA; [Hamilton, Lawrence C.] Univ New Hampshire, Dept Sociol, Durham, NH 03824 USA; [Congalton, Russell G.; Ducey, Mark J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Oester, Paul T.] Oregon State Univ, Extens Serv, La Grande, OR USA	University of Colorado System; University of Colorado Boulder; University System Of New Hampshire; University of New Hampshire; University of Louisville; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Oregon State University	Hartter, J (corresponding author), Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA.	joel.hartter@colorado.edu	Ducey, Mark/K-1101-2016	Ducey, Mark/0000-0002-2027-1188; Stevens, Forrest/0000-0002-9328-3753	Disaster Resilience for Rural Communities Program, National Institute of Food and Agriculture program of the United States Department of Agriculture [2010-67023-21705]; Office Of The Director [1101245] Funding Source: National Science Foundation	Disaster Resilience for Rural Communities Program, National Institute of Food and Agriculture program of the United States Department of Agriculture; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The Communities and Forests in Oregon (CAFOR) project is supported by a grant from the Disaster Resilience for Rural Communities Program, which is part of the National Institute of Food and Agriculture program (www.csrees.usda.gov) of the United States Department of Agriculture (Award #2010-67023-21705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2005, ENVIRON MANAGE, V36, P495, DOI 10.1007/s00267-004-7256-8; Abrams J., 2011, THESIS OREGON STATE; Abrams J, 2013, J RURAL COMMUNITY D, V8, P144; Abrams J, 2013, SOC NATUR RESOUR, V26, P845, DOI 10.1080/08941920.2012.719587; Abrams JB, 2012, J RURAL STUD, V28, P30, DOI 10.1016/j.jrurstud.2011.09.004; Adams DM, 2006, PNWGTR659 US DEP AGR; Agee JK, 2003, NAT AREA J, V23, P114; Agrawal S., 2006, General Technical Report - USDA Forest Service, P163; American Association for Public Opinion Research (AAPOR), 2006, STAND DEF FIN DISP C; Barbour RJ, 2005, FOREST ECOL MANAG, V211, P210, DOI 10.1016/j.foreco.2005.02.034; Barnum P, 2013, OSAF ANN M PENDL OR; Beck U., 1994, RISK SOC NEW MODERNI; BEEBE GS, 1993, J FOREST, V91, P19; Bliss JC, 2008, SMALL SCALE RURAL FO; Brummel RF, 2010, J ENVIRON PLANN MAN, V53, P681, DOI 10.1080/09640568.2010.488090; Burns S, 2002, US FOR SERV RMRS-P, P213; Dale L, 2006, SOC NATUR RESOUR, V19, P275, DOI 10.1080/08941920500460898; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DiStefano C, 2002, STRUCT EQU MODELING, V9, P327, DOI 10.1207/S15328007SEM0903_2; Dominguez G, 2011, EUR J FOREST RES, V130, P435, DOI 10.1007/s10342-009-0332-0; Eriksen C, 2011, INT J WILDLAND FIRE, V20, P612, DOI 10.1071/WF10018; Fernandez-Gimenez ME, 2008, ECOL SOC, V13; Fischer AP, 2012, ENVIRON MANAGE, V49, P1192, DOI 10.1007/s00267-012-9848-z; Fischer AP, 2011, J FOREST, V109, P260; Flint CG, 2009, ENVIRON MANAGE, V43, P1174, DOI 10.1007/s00267-008-9193-4; Franklin JF, 2007, NRS19 GTR USDA; Garber-Yonts BE, 2004, PNWGTR617 USFS USDA; Gorte R.W., 2013, RISING COST WILDFIRE; Gude P, 2008, J FOREST, V106, P198; Hamilton LC, 2014, RURAL SOCIOL, V79, P257, DOI 10.1111/ruso.12023; Hamilton LC, 2010, RURAL SOCIOL, V75, P326, DOI 10.1111/j.1549-0831.2010.00013.x; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hansen AJ, 2005, ECOL APPL, V15, P1849, DOI 10.1890/03-5219; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Hartter J, CONSERVATION CONFLIC; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hessburg PF, 2004, EMULATING NATURAL FOREST LANDSCAPED DISTURBANCES: CONCEPTS AND APPLICATIONS, P158; Heyerdahl EK, 2001, ECOLOGY, V82, P660, DOI 10.1890/0012-9658(2001)082[0660:SCOHFR]2.0.CO;2; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson JD, 1995, J RURAL STUD, V11, P405, DOI 10.1016/0743-0167(95)00029-1; Johnson KM, 1998, RES RUR SOC, V7, P23; Kline RB, 2011, PRINCIPLES PRACTICE, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Koontz TM, 2008, CONSERV BIOL, V22, P60, DOI 10.1111/j.1523-1739.2007.00860.x; Langston Nancy, 1995, FOREST DREAMS FOREST; Lee ES., 2006, ANAL COMPLEX SURVEY, P50, DOI 10.4135/9781412983341.n6; Lettman GJ, 2004, FORESTS FARMS PEOPLE; Martin WE, 2009, J ENVIRON MANAGE, V91, P489, DOI 10.1016/j.jenvman.2009.09.007; McCaffrey S, 2013, INT J WILDLAND FIRE, V22, P15, DOI 10.1071/WF11115; McGee TK, 2011, J ENVIRON MANAGE, V92, P2524, DOI 10.1016/j.jenvman.2011.05.017; Mcgee TK, 2009, SOC NATUR RESOUR, V22, P308, DOI 10.1080/08941920801910765; Mindrila D, 2010, INT J DIGITAL SOC, V1, P60, DOI [10.20533/ijds.2040.2570.2010.0010, DOI 10.20533/IJDS.2040.2570.2010.0010]; National Interagency Fire Center, 2013, FED FIR COSTS SUPPR; Neugarten RA, 2011, BIOSCIENCE, V61, P631, DOI 10.1525/bio.2011.61.8.10; Noss RF, 2006, FRONT ECOL ENVIRON, V4, P481, DOI 10.1890/1540-9295(2006)4[481:MFFITW]2.0.CO;2; Oregon Solutions, 2013, OR FOR COLL STAT INV; Paton D., 2013, PLANET RISK, V1, P44; Paul F Ehinger & Associates, 2010, MILL CLOS DAT 1990 2, P1; Petts J, 2007, GEOGR J, V173, P300, DOI 10.1111/j.1475-4959.2007.00254.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sheppard SRJ, 2005, FOREST ECOL MANAG, V207, P171, DOI 10.1016/j.foreco.2004.10.032; Shindler B, 2003, J FOREST, V101, P8; Swan L, 2012, E OREGON PRIMARY WOO, DOI [10.1007/s12070-012-0514-9 PMID: 25621271, DOI 10.1007/S12070-012-0514-9]; Theobald DM, 2005, ECOL APPL, V15, P1906, DOI 10.1890/03-5331; Thomas JW, 2004, FOREST FUTURES SCI P, P3; Toman E, 2002, US FOR SERV RMRS-P, P241; Torn M S, 1998, LBNL42592; US Census Bureau, 2013, COUNT TOT DAT POP PO; US Forest Service, 2010, FIR HIST POL FIREHIS; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	74	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117975	10.1371/journal.pone.0117975	http://dx.doi.org/10.1371/journal.pone.0117975			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671619	gold, Green Submitted, Green Published			2022-12-26	WOS:000349545300076
J	Katoh, D; Nishizuka, M; Osada, S; Imagawa, M				Katoh, Daiki; Nishizuka, Makoto; Osada, Shigehiro; Imagawa, Masayoshi			Fad104, a Positive Regulator of Adipocyte Differentiation, Suppresses Invasion and Metastasis of Melanoma Cells by Inhibition of STAT3 Activity	PLOS ONE			English	Article							FACTOR-KAPPA-B; MATRIX METALLOPROTEINASE-2; EARLY-STAGE; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; CRUCIAL ROLE; GENE FAD104; ACTIVATION; EXPRESSION; FIBRONECTIN	Metastasis is the main cause of death in patients with cancer, and understanding the mechanisms of metastatic processes is essential for the development of cancer therapy. Although the role of several cell adhesion, migration or proliferation molecules in metastasis is established, a novel target for cancer therapy remains to be discovered. Previously, we reported that fad104 (factor for adipocyte differentiation 104), a regulatory factor of adipogenesis, regulates cell adhesion and migration. In this report, we clarify the role of fad104 in the invasion and metastasis of cancer cells. The expression level of fad104 in highly metastatic melanoma A375SM cells was lower than that in poorly metastatic melanoma A375C6 cells. Reduction of fad104 expression enhanced the migration and invasion of melanoma cells, while over-expression of FAD104 inhibited migration and invasion. In addition, melanoma cells stably expressing FAD104 showed a reduction in formation of lung colonization compared with control cells. FAD104 interacted with STAT3 and down-regulated the phosphorylation level of STAT3 in melanoma cells. These findings together demonstrate that fad104 suppressed the invasion and metastasis of melanoma cells by inhibiting activation of the STAT3 signaling pathway. These findings will aid a comprehensive description of the mechanism that controls the invasion and metastasis of cancer cells.	[Katoh, Daiki; Nishizuka, Makoto; Osada, Shigehiro; Imagawa, Masayoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [21390024]; Aichi Cancer Research Foundation; Research Foundation for Pharmaceutical Sciences, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Research Foundation for Pharmaceutical Sciences, Japan	This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS): (http://www.jsps.go.jp/), 21390024 (MI), Aichi Cancer Research Foundation: (http://www.acrf.or.jp/) (MN), and The Research Foundation for Pharmaceutical Sciences, Japan: (http://www15.ocn.ne.jp/similar to yakusho/) (MN).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bohm M, 2001, J INVEST DERMATOL, V117, P132, DOI 10.1046/j.0022-202x.2001.01372.x; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; ChiRosso G, 1997, J BIOL CHEM, V272, P31447, DOI 10.1074/jbc.272.50.31447; Chung YH, 2004, J VIROL, V78, P6489, DOI 10.1128/JVI.78.12.6489-6497.2004; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Fan XL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-61; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Hayashi H, 1997, INT J CANCER, V71, P416, DOI 10.1002/(SICI)1097-0215(19970502)71:3<416::AID-IJC19>3.0.CO;2-D; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hofmann UB, 2000, J PATHOL, V191, P245; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Huang FJ, 2008, CANCER RES, V68, P9634, DOI 10.1158/0008-5472.CAN-08-1429; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kishimoto K, 2013, J BIOL CHEM, V288, P31772, DOI 10.1074/jbc.M113.452961; Kishimoto K, 2011, EXP CELL RES, V317, P2110, DOI 10.1016/j.yexcr.2011.06.003; Kishimoto K, 2010, BIOCHEM BIOPH RES CO, V397, P187, DOI 10.1016/j.bbrc.2010.05.077; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2009, EXP CELL RES, V315, P809, DOI 10.1016/j.yexcr.2008.12.013; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Rotte A, 2012, CELL ONCOL, V35, P207, DOI 10.1007/s13402-012-0080-x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; STRETCH JR, 1991, CANCER RES, V51, P5976; Su FQ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3134; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yang Chuan He, 2010, Int J Interferon Cytokine Mediat Res, V2010, P1; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117197	10.1371/journal.pone.0117197	http://dx.doi.org/10.1371/journal.pone.0117197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671570	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300041
J	Narasimha, S; Kolly, S; Sokolowski, MB; Kawecki, TJ; Vijendravarma, RK				Narasimha, Sunitha; Kolly, Sylvain; Sokolowski, Marla B.; Kawecki, Tadeusz J.; Vijendravarma, Roshan K.			Prepupal Building Behavior in Drosophila melanogaster and Its Evolution under Resource and Time Constraints	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CHRONIC MALNUTRITION; PUPATION HEIGHT; LARVAL; METAMORPHOSIS; CONSEQUENCES; POLYMORPHISM; HYMENOPTERA; SELECTION; DIPTERA	Structures built by animals are a widespread and ecologically important 'extended phenotype'. While its taxonomic diversity has been well described, factors affecting short-term evolution of building behavior within a species have received little experimental attention. Here we describe how, given the opportunity, wandering Drosophila melanogaster larvae often build long tunnels in agar substrates and embed their pupae within them. These embedded larvae are characterized by a longer egg-to-pupariation developmental time than larvae that pupate on the surface. Assuming that such building behaviors are likely to be energetically costly and/or time consuming, we hypothesized that they should evolve to be less pronounced under resource or time limitation. In accord with this prediction, larvae from populations evolved for 160 generations under a regime that combines larval malnutrition with limited developmental time dug shorter tunnels than larvae from control unselected populations. However, the proportion of larvae that embedded before pupation did not differ between the malnutrition-adapted and control populations, suggesting that tunnel length and likelihood of embedding before pupation are controlled by different genetic loci. The behaviors exhibited by wandering larvae of Drosophila melanogaster prior to pupation offer a model system to study evolution of animal building behaviors because the tunneling and embedding phenotypes are simple, facultative and highly variable.	[Narasimha, Sunitha; Kolly, Sylvain; Kawecki, Tadeusz J.; Vijendravarma, Roshan K.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Lausanne; University of Toronto	Vijendravarma, RK (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	roshan.vijendravarma@unil.ch	Kawecki, Tadeusz/K-5466-2015; Vijendravarma, Roshan K/E-7746-2018	Kawecki, Tadeusz/0000-0002-9244-1991; Vijendravarma, Roshan K/0000-0002-3274-0682; Vijendravarma, Roshan Kumar/0000-0002-4930-3040; Sokolowski, Marla/0000-0002-7462-8007	Swiss National Science Foundation [31003A_143939]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work has been supported by the Swiss National Science Foundation (grant# 31003A_143939) to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 1998, AUST J ENTOMOL, V37, P158, DOI 10.1111/j.1440-6055.1998.tb01564.x; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; BERRIGAN D, 1993, J EXP BIOL, V179, P245; CARTON Y, 1994, J INSECT BEHAV, V7, P129, DOI 10.1007/BF01989833; DENLINGER DL, 1994, ANNU REV ENTOMOL, V39, P243, DOI 10.1146/annurev.en.39.010194.001331; Eisner T, 2000, P NATL ACAD SCI USA, V97, P2632, DOI 10.1073/pnas.050002197; GODOYHERRERA R, 1989, ANIM BEHAV, V37, P820, DOI 10.1016/0003-3472(89)90066-3; Hansell M., 2005, OXF ANIMAL BIOL SER; Hansell MH., 1984, ANIMAL ARCHITECTURE; Hodge S, 1998, J INSECT BEHAV, V11, P47, DOI 10.1023/A:1020814516158; JOSHI A, 1993, EVOLUTION, V47, P176, DOI [10.2307/2410127, 10.1111/j.1558-5646.1993.tb01208.x]; Josso C, 2011, NATURWISSENSCHAFTEN, V98, P705, DOI 10.1007/s00114-011-0813-0; Kawecki TJ, 2012, EXPT EVOLUTION; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; MANNING M, 1981, BEHAV GENET, V11, P557, DOI 10.1007/BF01065790; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Riedl CAL, 2007, FLY, V1, P23, DOI 10.4161/fly.3830; RODRIGUEZ L, 1992, J EVOLUTION BIOL, V5, P61, DOI 10.1046/j.1420-9101.1992.5010061.x; Roff Derek, 2002, pi; SEWELL DF, 1975, BEHAV BIOL, V15, P213, DOI 10.1016/S0091-6773(75)91587-4; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; SOKOLOWSKI MB, 1989, HEREDITY, V62, P177, DOI 10.1038/hdy.1989.26; SOKOLOWSKI MB, 1985, J INSECT PHYSIOL, V31, P857, DOI 10.1016/0022-1910(85)90103-9; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; Stearns S.C., 1992, pi; Vijendravarma RK, 2012, J EVOLUTION BIOL, V25, P288, DOI 10.1111/j.1420-9101.2011.02419.x; Vijendravarma RK, 2013, NATURE COMMUNICATION, V4, DOI [10.1038/ncomms3763, DOI 10.1038/NCOMMS3763]; Vijendravarma RK, 2012, P ROY SOC B-BIOL SCI, V279, P3540, DOI 10.1098/rspb.2012.0966; Vijendravarma RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030650; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; WONG JL, 1985, BEHAV GENET, V15, P155, DOI 10.1007/BF01065896; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	41	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117280	10.1371/journal.pone.0117280	http://dx.doi.org/10.1371/journal.pone.0117280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671711	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300045
J	Nuvolone, M; Sorce, S; Schwarz, P; Aguzzi, A				Nuvolone, Mario; Sorce, Silvia; Schwarz, Petra; Aguzzi, Adriano			Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CYTOKINE GENE-EXPRESSION; NF-KAPPA-B; MICROGLIAL ACTIVATION; NALP3 INFLAMMASOME; IMMUNE-RESPONSE; FAMILY-MEMBERS; IL-1-BETA; SCRAPIE; PROTEIN	The accumulation of the scrapie prion protein PrPSc, a misfolded conformer of the cellular prion protein PrPC, is a crucial feature of prion diseases. In the central nervous system, this process is accompanied by conspicuous microglia activation. The NLRP3 inflammasome is a multi-molecular complex which can sense heterogeneous pathogen-associated molecular patterns and culminates in the activation of caspase 1 and release of IL 1 beta. The NLRP3 inflammasome was reported to be essential for IL 1 beta release after in vitro exposure to the amyloidogenic peptide PrP106-126 and to recombinant PrP fibrils. We therefore studied the role of the NLRP3 inflammasome in a mouse model of prion infection. Upon intracerebral inoculation with scrapie prions (strain RML), mice lacking NLRP3 (Nlrp3(-/-)) or the inflammasome adaptor protein ASC (Pycard(-/-)) succumbed to scrapie with attack rates and incubation times similar to wild-type mice, and developed the classic histologic and biochemical features of prion diseases. Genetic ablation of NLRP3 or ASC did not significantly impact on brain levels of IL 1 beta at the terminal stage of disease. Our results exclude a significant role for NLRP3 and ASC in prion pathogenesis and invalidate their claimed potential as therapeutic target against prion diseases.	[Nuvolone, Mario; Sorce, Silvia; Schwarz, Petra; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Nuvolone, M (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	mario.nuvolone@usz.ch; adriano.aguzzi@usz.ch	Nuvolone, Mario/K-4763-2018	Nuvolone, Mario/0000-0001-8334-1684; Sorce, Silvia/0000-0002-3843-8644; Aguzzi, Adriano/0000-0002-0344-6708	Collegio Ghislieri, Pavia; Roche post-doc fellowship; Betty and David Koetser Award for Brain Research; Advanced Grant of the European Research Council [250356]; European Union [222887, 278611]; Swiss National Foundation (Sinergia grant) [31003A_141193]; Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; Clinical Research Priority Program "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich; Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases")	Collegio Ghislieri, Pavia; Roche post-doc fellowship; Betty and David Koetser Award for Brain Research; Advanced Grant of the European Research Council; European Union(European Commission); Swiss National Foundation (Sinergia grant)(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; Clinical Research Priority Program "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich; Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases")	MN was supported by an investigator fellowship from Collegio Ghislieri, Pavia. SS was supported by a Roche post-doc fellowship, and by the Betty and David Koetser Award for Brain Research. AA is the recipient of an Advanced Grant of the European Research Council (#250356) and is supported by grants from the European Union (PRIORITY: # 222887, NEURINOX: 278611), the Swiss National Foundation (31003A_141193 and Sinergia grant), the Novartis Research Foundation, the Clinical Research Priority Programs "Small RNAs" and "Mechanisms and Models of Primary Human Hemato-Lymphatic Diseases" of the University of Zurich, and the Swiss Initiative in System Biology SystemsX. ch ("Systems biology of prion diseases"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not alter the Authors' adherence to PLOS ONE policies on sharing data and materials.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; BARCIKOWSKA M, 1993, ACTA NEUROPATHOL, V85, P623, DOI 10.1007/BF00334672; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bradford BM, 2012, VIRUSES-BASEL, V4, P3389, DOI 10.3390/v4123389; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAMPBELL IL, 1994, J VIROL, V68, P2383, DOI 10.1128/JVI.68.4.2383-2387.1994; Case CL, 2011, MBIO, V2, DOI 10.1128/mBio.00117-11; Chang JX, 2012, J MOL NEUROSCI, V48, P248, DOI 10.1007/s12031-012-9821-6; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; GUIROY DC, 1994, ACTA NEUROPATHOL, V87, P526; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ishibashi D, 2012, J VIROL, V86, P4947, DOI 10.1128/JVI.06326-11; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Marcos-Carcavilla A, 2007, MAMM GENOME, V18, P53, DOI 10.1007/s00335-006-0095-6; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2005, J NEUROPATH EXP NEUR, V64, P902, DOI 10.1097/01.jnen.0000183346.19447.55; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Sharief MK, 1999, NEUROLOGY, V52, P1289, DOI 10.1212/WNL.52.6.1289; Shi FS, 2013, J NEUROIMMUNOL, V260, P121, DOI 10.1016/j.jneuroim.2013.04.016; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shi Q, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-216; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Stoeck K, 2006, J NEUROIMMUNOL, V172, P175, DOI 10.1016/j.jneuroim.2005.10.008; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tribouillard-Tanvier D, 2012, J VIROL, V86, P10377, DOI 10.1128/JVI.01340-12; Van Everbroeck B, 2002, NEUROBIOL AGING, V23, P59, DOI 10.1016/S0197-4580(01)00236-6; Walsh DT, 2001, J NEUROPATH EXP NEUR, V60, P173, DOI 10.1093/jnen/60.2.173; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Williams A, 1997, BRAIN RES, V754, P171, DOI 10.1016/S0006-8993(97)00067-X; Xie WL, 2013, J MOL NEUROSCI, V51, P919, DOI 10.1007/s12031-013-0002-z; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	71	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117208	10.1371/journal.pone.0117208	http://dx.doi.org/10.1371/journal.pone.0117208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671600	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300042
J	Chen, Y; Feng, J; Gilbert, C; Yin, H; Liang, JH; Li, XX				Chen, Yi; Feng, Jing; Gilbert, Clare; Yin, Hong; Liang, Jianhong; Li, Xiaoxin			Time at Treatment of Severe Retinopathy of Prematurity in China: Recommendations for Guidelines in More Mature Infants	PLOS ONE			English	Article							THRESHOLD RETINOPATHY; OUTCOMES	Purpose To investigate the postmenstrual (PMA) age at treatment of severe retinopathy of prematurity (i.e. Type 1 prethreshold or threshold) in infants in a tertiary referral center in China. Principal Findings 76.6% (359/469) of infants were treated for threshold disease. 67.5% (317/469) of infants had a birth weight (BW) of 1250g or above and almost 30% (126) had a gestational age (GA) of 32 weeks or above. There was little difference in the characteristics of infants treated for Type 1 prethreshold or threshold ROP. After controlling for GA, PMA age at treatment was highest in infants with BW >= 2000g (mean PMA 40.3 +/- 4.4 weeks, p<0.001); after controlling for BW, higher GA was associated with higher PMA at treatment (mean PMA 41.5 weeks for gestational age >34 weeks, p<0.001). For every three weeks increase in GA there was a two-week increase in PMA at treatment (R2 = 0.20, p<0.001). The time at treatment of Type 1 prethreshold disease was similar to that for threshold disease i.e. chronological age 5.6-7.4 weeks, or PMA 34.1-40.2 weeks but the lower end of the 95% confidence interval for chronological age for Type 1 prethreshold disease among infants with BW >= 2000g was 3.7 weeks (i.e. before the recommended interval of 4-6 weeks after birth). Significance The Chinese guidelines regarding timing of the first examination are appropriate for infants with BW <2000g, but more mature infants should be examined a little earlier, at 3 weeks after birth, in order to detect Type 1 prethreshold disease which has a better prognosis than threshold.	[Chen, Yi; Feng, Jing; Yin, Hong; Liang, Jianhong; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Chen, Yi; Feng, Jing; Yin, Hong; Liang, Jianhong; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Gilbert, Clare] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England	Peking University; University of London; London School of Hygiene & Tropical Medicine	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drli_xiao_xin@163.com		Feng, Jing/0000-0002-7658-9865				Asano Matthew K, 2014, Int Ophthalmol Clin, V54, P225, DOI 10.1097/IIO.0000000000000012; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Carden SM, 2008, CLIN EXP OPHTHALMOL, V36, P159, DOI 10.1111/j.1442-9071.2008.01682.x; Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063; Chinese Medical Association, 2005, ZHONGHUA YAN KE ZA Z, V41, P375; Coats DK, 2000, J AAPOS, V4, P183, DOI 10.1016/S1091-8531(00)70011-5; Coordination Group for the Survey of Present Status of Oxygen Use in Premature Infants in NICUs and Prevention and Treatment of ROP, 2012, Zhonghua Er Ke Za Zhi, V50, P167; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2010, ARCH OPHTHALMOL-CHIC, V128, P663, DOI 10.1001/archophthalmol.2010.72; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Houston SK, 2013, LASER MED SCI, V28, P683, DOI 10.1007/s10103-011-1021-z; Hutchinson AK, 1998, ARCH OPHTHALMOL-CHIC, V116, P608, DOI 10.1001/archopht.116.5.608; Limburg H, 2012, OPHTHALMOLOGY, V119, P355, DOI 10.1016/j.ophtha.2011.07.037; Nguyen TH, 2000, OBSTET GYNECOL, V95, P867, DOI 10.1016/S0029-7844(99)00639-0; Nicoara SD, 2014, J PEDIAT OPHTH STRAB, V51, P39, DOI 10.3928/01913913-20131112-02; Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311; Palmer EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P595; Palmer EA, 2006, J AAPOS, V10, P500, DOI 10.1016/j.jaapos.2006.09.005; Repka MX, 2011, ARCH OPHTHALMOL-CHIC, V129, P1175, DOI 10.1001/archophthalmol.2011.229; Sinha Renu, 2014, J Anaesthesiol Clin Pharmacol, V30, P258, DOI 10.4103/0970-9185.130050; Wei KL., 2005, CHIN J NAT MED, V7, P25; Weller A, 1998, J PSYCHOSOM OBST GYN, V19, P111, DOI 10.3109/01674829809048504; Wilkinson AR, 2009, EYE, V23, P2137, DOI 10.1038/eye.2008.128; Yang CY, 2011, PEDIATR NEONATOL, V52, P321, DOI 10.1016/j.pedneo.2011.08.004; 黎晓新, 2004, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V20, P384	29	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0116669	10.1371/journal.pone.0116669	http://dx.doi.org/10.1371/journal.pone.0116669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664992	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000349123100011
J	Deng, Y; Gao, L; Wang, BB; Guo, XL				Deng, Yue; Gao, Lin; Wang, Bingbo; Guo, Xingli			HPOSim: An R Package for Phenotypic Similarity Measure and Enrichment Analysis Based on the Human Phenotype Ontology	PLOS ONE			English	Article							SEMANTIC SIMILARITY; GENE ONTOLOGY; TOOL; GO; INTERACTOME; NETWORK	Background Phenotypic features associated with genes and diseases play an important role in diseaserelated studies and most of the available methods focus solely on the Online Mendelian Inheritance in Man (OMIM) database without considering the controlled vocabulary. The Human Phenotype Ontology (HPO) provides a standardized and controlled vocabulary covering phenotypic abnormalities in human diseases, and becomes a comprehensive resource for computational analysis of human disease phenotypes. Most of the existing HPObased software tools cannot be used offline and provide only few similarity measures. Therefore, there is a critical need for developing a comprehensive and offline software for phenotypic features similarity based on HPO. Results HPOSim is an R package for analyzing phenotypic similarity for genes and diseases based on HPO data. Seven commonly used semantic similarity measures are implemented in HPOSim. Enrichment analysis of gene sets and disease sets are also implemented, including hypergeometric enrichment analysis and network ontology analysis (NOA). Conclusions HPOSim can be used to predict disease genes and explore disease-related function of gene modules. HPOSim is open source and freely available at SourceForge (https://sourceforge.net/p/hposim/).	[Deng, Yue; Gao, Lin; Wang, Bingbo; Guo, Xingli] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Deng, Yue] Xidian Univ, Inst Software Engn, Xian, Peoples R China	Xidian University; Xidian University	Gao, L (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	lgao@mail.xidian.edu.cn			National Natural Science Foundation of China [61402349, 91130006, 61303122, 61303118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (Grant Numbers: 61402349 to YD, 91130006 to LG, 61303122 to BW and 61303118 to XG), and the website is http://www.nsfc.gov.cn/publish/portal1/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2010, TOPGO TOPGO ENRICHME; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoehndorf R, 2012, BIOINFORMATICS, V28, P2169, DOI 10.1093/bioinformatics/bts350; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang J, 1997, INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS, 1997 DIGEST OF TECHNICAL PAPERS, P94; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; KOHLER S, 2013, NUCL ACIDS RES, P87044; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li B., 2010, ARXIV10010958; Li J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-266; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pesquita C, 2007, P 10 ANN BIOONT M; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; SANO T, 1993, MAYO CLIN PROC, V68, P971, DOI 10.1016/S0025-6196(12)62269-1; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SILVERBERG SJ, 1989, NEW ENGL J MED, V320, P277, DOI 10.1056/NEJM198902023200503; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vulto-van Silfhout AT, 2013, EUR J MED GENET, V56, P471, DOI 10.1016/j.ejmg.2013.06.010; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wittkop T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-53; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	41	32	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0115692	10.1371/journal.pone.0115692	http://dx.doi.org/10.1371/journal.pone.0115692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664462	Green Published, gold, Green Submitted			2022-12-26	WOS:000349123100005
J	Zhang, JP; Yang, ZJ; Xiao, JZ; Xing, XY; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Lin, LX; Wang, N; Yang, WY				Zhang, Jinping; Yang, Zhaojun; Xiao, Jianzhong; Xing, Xiaoyan; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Lin, Lixiang; Wang, Na; Yang, Wenying		China Natl Diabet Metab Disorders	Association between Family History Risk Categories and Prevalence of Diabetes in Chinese Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; FASTING GLUCOSE; SECRETION; OBESITY; HYPERINSULINEMIA; TRANSMISSION; INDIVIDUALS; RELATIVES; INDEXES	Aim To investigate the association between different family history risk categories and prevalence of diabetes in the Chinese population. Methods The family history of diabetes was obtained from each subject, and an oral glucose tolerance test was performed for measuring the fasting and postload glucose and insulin levels based on a national representative cross-sectional survey of 46,239 individuals (age >= 20 years) in the 2007-2008 China National Diabetes and Metabolism Disorders Study. The family history risk categories of diabetes were high, moderate, and average (FH2 and FH1: at least two generations and one generation of first-degree relatives with diabetes, respectively; FH0: no first-degree relatives with diabetes). Results The age-and gender-adjusted prevalence rates of diabetes were 32.7% (95% confidence interval (CI): 26.4-39.7%) in FH2, 20.1% (95% CI: 18.2-22.1%) in FH1, and 8.4% (95% CI: 7.9-8.9%) in FH0 (P < 0.0001). The calculated homeostatic model assessment-estimated insulin resistance (HOMA-IR), Matsuda insulin sensitivity index (ISI), and insulinogenic index (Delta I30/Delta G30) values showed significant trending changes among the three risk categories, with the most negative effects in FH2. Multivariate logistic regression analysis showed that the odds ratios of having diabetes were 6.16 (95% CI: 4.46-8.50) and 2.86 (95% CI: 2.41-3.39) times higher in FH2 and FH1, respectively, than in FH0 after adjustment for classical risk factors for diabetes. Conclusions Family history risk categories of diabetes have a significant, independent, and graded association with the prevalence of this disease in the Chinese population.	[Zhang, Jinping; Yang, Zhaojun; Xiao, Jianzhong; Xing, Xiaoyan; Wang, Na; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujiang, Peoples R China	China-Japan Friendship Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; Fujian Provincial Hospital	Yang, ZJ (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	yzj69@aliyun.com; ywying_1010@163.com	Jia, Weiping/B-7483-2012; zhang, jin/GXV-9154-2022; Linong, Ji/AAB-6543-2020	Yang, Wenying/0000-0002-7997-9404; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This study was supported by grants from the Chinese Medical Association Foundation and the Chinese Diabetes Society (grant numbers: 07020470055). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Davies MJ, 2000, DIABETIC MED, V17, P433, DOI 10.1046/j.1464-5491.2000.00246.x; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Franks PW, 2010, DIABETES, V59, P2732, DOI 10.2337/db10-0768; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P192, DOI 10.1210/jc.2002-020917; Grill V, 1999, DIABETOLOGIA, V42, P15, DOI 10.1007/s001250051106; GULLI G, 1992, DIABETES, V41, P1575, DOI 10.2337/diabetes.41.12.1575; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hariri S, 2006, GENET MED, V8, P102, DOI 10.1097/01.gim.0000200949.52795.df; International Diabetes Federation, 2013, IDF DIABETES ATLAS, DOI [10.3390/jpm3040288, DOI 10.3390/JPM3040288]; Ishikawa M, 1998, DIABETES, V47, P788, DOI 10.2337/diabetes.47.5.788; Isomaa B, 2010, DIABETOLOGIA, V53, P1709, DOI 10.1007/s00125-010-1776-y; Kim DJ, 2004, DIABETES RES CLIN PR, V65, P117, DOI 10.1016/j.diabres.2003.11.020; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Moonesinghe R, 2012, EUR J HUM GENET, V20, P831, DOI 10.1038/ejhg.2012.15; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Temelkova-Kurktschiev T, 2012, EXP CLIN ENDOCR DIAB, V120, P1, DOI 10.1055/s-0031-1285832; Utzschneider KM, 2006, DIABETES CARE, V29, P356, DOI 10.2337/diacare.29.02.06.dc05-1963; Valdez R, 2007, DIABETES CARE, V30, P2517, DOI 10.2337/dc07-0720; van Haeften TW, 1998, DIABETES CARE, V21, P278, DOI 10.2337/diacare.21.2.278; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	30	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117044	10.1371/journal.pone.0117044	http://dx.doi.org/10.1371/journal.pone.0117044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25664814	Green Published, Green Submitted, gold			2022-12-26	WOS:000349123100017
J	Caldwell, JZK; Armstrong, JM; Hanson, JL; Sutterer, MJ; Stodola, DE; Koenigs, M; Kalin, NH; Essex, MJ; Davidson, RJ				Caldwell, Jessica Z. K.; Armstrong, Jeffrey M.; Hanson, Jamie L.; Sutterer, Matthew J.; Stodola, Diane E.; Koenigs, Michael; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.			Preschool Externalizing Behavior Predicts Gender-Specific Variation in Adolescent Neural Structure	PLOS ONE			English	Article							CONDUCT DISORDER; AMYGDALA VOLUME; BRAIN STRUCTURE; DEVELOPMENTAL PATHWAYS; ACADEMIC DIFFICULTIES; PSYCHOPATHIC TRAITS; PREFRONTAL CORTEX; MIDDLE CHILDHOOD; MENTAL-HEALTH; NEUROBIOLOGY	Dysfunction in the prefrontal cortex, amygdala, and hippocampus is believed to underlie the development of much psychopathology. However, to date only limited longitudinal data relate early behavior with neural structure later in life. Our objective was to examine the relationship of early life externalizing behavior with adolescent brain structure. We report here the first longitudinal study linking externalizing behavior during preschool to brain structure during adolescence. We examined the relationship of preschool externalizing behavior with amygdala, hippocampus, and prefrontal cortex volumes at age 15 years in a community sample of 76 adolescents followed longitudinally since their mothers' pregnancy. A significant gender by externalizing behavior interaction revealed that males-but not females-with greater early childhood externalizing behavior had smaller amygdala volumes at adolescence (t = 2.33, p =.023). No significant results were found for the hippocampus or the prefrontal cortex. Greater early externalizing behavior also related to smaller volume of a cluster including the angular gyrus and tempoparietal junction across genders. Results were not attributable to the impact of preschool anxiety, preschool maternal stress, school-age internalizing or externalizing behaviors, or adolescent substance use. These findings demonstrate a novel, gender-specific relationship between early-childhood externalizing behavior and adolescent amygdala volume, as well as a cross-gender result for the angular gyrus and tempoparietal junction.	[Caldwell, Jessica Z. K.; Hanson, Jamie L.; Sutterer, Matthew J.; Stodola, Diane E.; Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Armstrong, Jeffrey M.; Koenigs, Michael; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Ctr Investigating Hlth Minds, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Caldwell, JZK (corresponding author), Michigan State Univ, Marquette Gen Hosp, Marquette, MI 49855 USA.	Jessica.kirklandcaldwell@mghs.org	Hanson, Jamie/B-9420-2014	Hanson, Jamie/0000-0002-0469-8886; Davidson, Richard/0000-0002-8506-4964; Kalin, Ned/0000-0003-1184-0868; Sutterer, Matthew/0000-0001-5223-857X; Koenigs, Michael/0000-0002-5799-4881	National Institutes of Health [P30-HD003352, R01-MH044340, P50-MH052354, P50-MH069315, P50-MH084051, P50-MH100031]; Ruth L. Kirschstein National Research Service Award [F31-DA028087]; John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084051, P50MH052354, R01MH044340, T32MH018931, P50MH069315, R01MH043454, P50MH100031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (www.nih.gov) grants: P30-HD003352 (Marsha Seltzer, Waisman Center Core), R01-MH044340 (MJE), P50-MH052354 (RJD), P50-MH069315 (RJD), P50-MH084051 (RJD), and P50-MH100031 (RJD); Ruth L. Kirschstein National Research Service Award F31-DA028087 (JLH); and the John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development (MJE) (www.macfound.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablow JC, 1999, J AM ACAD CHILD PSY, V38, P1580, DOI 10.1097/00004583-199912000-00020; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Anderson NE, 2012, TRENDS COGN SCI, V16, P52, DOI 10.1016/j.tics.2011.11.008; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Blair RJR, 2010, CURR PSYCHIAT REP, V12, P76, DOI 10.1007/s11920-009-0086-x; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Boccardi M, 2011, PSYCHIAT RES-NEUROIM, V193, P85, DOI 10.1016/j.pscychresns.2010.12.013; Bornstein MH, 2013, DEV PSYCHOPATHOL, V25, P857, DOI 10.1017/S0954579413000217; Boyce WT, 2002, J AM ACAD CHILD PSY, V41, P580, DOI 10.1097/00004583-200205000-00016; Bubier JL, 2009, CLIN PSYCHOL REV, V29, P658, DOI 10.1016/j.cpr.2009.08.005; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Burk LR, 2011, PSYCHOL ADDICT BEHAV, V25, P1, DOI 10.1037/a0022349; Burk LR, 2011, J ABNORM CHILD PSYCH, V39, P225, DOI 10.1007/s10802-010-9454-6; Cheetham A, 2014, PSYCHOPHARMACOLOGY, V231, P1731, DOI 10.1007/s00213-014-3483-8; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Costello EJ, 2011, J CHILD PSYCHOL PSYC, V52, P1015, DOI 10.1111/j.1469-7610.2011.02446.x; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Dennison M, 2013, DEVELOPMENTAL SCI, V16, P772, DOI 10.1111/desc.12057; Duvernoy HM, 1999, THE HUMAN BRAIN SURF; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P85, DOI 10.1017/S0954579410000660; Ermer E, 2011, J ABNORM PSYCHOL; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fox J., 1991, SAGE U PAPER SERIES; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hanson JL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00166; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; Hill SY, 2010, PSYCHIAT RES-NEUROIM, V182, P14, DOI 10.1016/j.pscychresns.2009.11.006; Hill SY, 2001, BIOL PSYCHIAT, V49, P894, DOI 10.1016/S0006-3223(01)01088-5; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; HYDE JS, 1995, PSYCHOL WOMEN QUART, V19, P257, DOI 10.1111/j.1471-6402.1995.tb00291.x; Kendler KS, 2014, PSYCHOL MED, V44, P647, DOI 10.1017/S0033291713000585; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kochanska G, 2012, DEV PSYCHOPATHOL, V24, P783, DOI 10.1017/S0954579412000375; Koenigs M, 2012, REV NEUROSCIENCE, V23, P253, DOI 10.1515/revneuro-2012-0036; Kraemer HC, 2003, AM J PSYCHIAT, V160, P1566, DOI 10.1176/appi.ajp.160.9.1566; Kruesi MJP, 2004, PSYCHIAT RES-NEUROIM, V132, P1, DOI 10.1016/j.pscychresns.2004.07.002; Laakso MP, 2001, BEHAV BRAIN RES, V118, P187, DOI 10.1016/S0166-4328(00)00324-7; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lemery-Chalfant K, 2007, J AM ACAD CHILD PSY, V46, P1315, DOI 10.1097/chi.0b013e3180f616c6; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mackey S, 2013, NEUROSCI BIOBEHAV R, V37, P300, DOI 10.1016/j.neubiorev.2012.12.003; Mai JK, 1997, ATLAS OF THE HUMAN B; Malykhin NV, 2007, PSYCHIAT RES-NEUROIM, V155, P155, DOI 10.1016/j.pscychresns.2006.11.011; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Meintjes EM, NEUROIMAGE CLIN; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Paus T, 2010, PROG BRAIN RES, V186, P13, DOI 10.1016/B978-0-444-53630-3.00002-6; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 2004, BIOL PSYCHIAT, V55, P185, DOI 10.1016/S0006-3223(03)00727-3; Rusch BD, 2001, BIOL PSYCHIAT, V50, P960, DOI 10.1016/S0006-3223(01)01248-3; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schiffer B, 2011, ARCH GEN PSYCHIAT, V68, P1039, DOI 10.1001/archgenpsychiatry.2011.61; Schwartz CE, 2012, MOL PSYCHIATR, V17, P1042, DOI 10.1038/mp.2011.96; Schwartz CE, 2010, ARCH GEN PSYCHIAT, V67, P78, DOI 10.1001/archgenpsychiatry.2009.171; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Tanner JM, 1962, GROWTH AT ADOLESCENC, V2nd; Visser TAW, 2014, SOC COGN AFFECT NEUR, V9, P553, DOI 10.1093/scan/nst013; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Whittle S, 2013, J AM ACAD CHILD PSY, V52, P940, DOI 10.1016/j.jaac.2013.06.007; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Yang YL, 2011, J NEUROPSYCH CLIN N, V23, P107, DOI 10.1176/appi.neuropsych.23.1.107; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110; Yoon U, 2011, NEUROSCI LETT, V493, P8, DOI 10.1016/j.neulet.2011.01.070; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	95	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117453	10.1371/journal.pone.0117453	http://dx.doi.org/10.1371/journal.pone.0117453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658357	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900152
J	da Silva, LG; Ribeiro, MC; Hasui, E; da Costa, CA; da Cunha, RGT				da Silva, Lucas Goulart; Ribeiro, Milton Cezar; Hasui, Erica; da Costa, Carla Aparecida; Teixeira da Cunha, Rogerio Grassetto			Patch Size, Functional Isolation, Visibility and Matrix Permeability Influences Neotropical Primate Occurrence within Highly Fragmented Landscapes	PLOS ONE			English	Article							ATLANTIC FOREST; TRICHROMATIC VISION; FEEDING ADAPTATIONS; SPECIES RICHNESS; SEED DISPERSAL; HOME-RANGE; SAO-PAULO; BODY SIZE; CONSERVATION; HABITAT	Forest fragmentation and habitat loss are among the major current extinction causes. Remaining fragments are mostly small, isolated and showing poor quality. Being primarily arboreal, Neotropical primates are generally sensitive to fragmentation effects. Furthermore, primates are involved in complex ecological process. Thus, landscape changes that negatively interfere with primate population dynamic affect the structure, composition, and ultimately the viability of the whole community. We evaluated if fragment size, isolation and visibility and matrix permeability are important for explaining the occurrence of three Neotropical primate species. Employing playback, we verified the presence of Callicebus nigrifrons, Callithrix aurita and Sapajus nigritus at 45 forest fragments around the municipality of Alfenas, Brazil. We classified the landscape and evaluated the metrics through predictive models of occurrence. We selected the best models through Akaike Selection Criterion. Aiming at validating our results, we applied the plausible models to another region (20 fragments at the neighboring municipality of Poco Fundo, Brazil). Twelve models were plausible, and three were validated, two for Sapajus nigritus (Area and Area+Visibility) and one for Callicebus nigrifrons (Area+Matrix). Our results reinforce the contribution of fragment size to maintain biodiversity within highly degraded habitats. At the same time, they stress the importance of including novel, biologically relevant metrics in landscape studies, such as visibility and matrix permeability, which can provide invaluable help for similar studies in the future and on conservation practices in the long run.	[da Silva, Lucas Goulart; Hasui, Erica; da Costa, Carla Aparecida; Teixeira da Cunha, Rogerio Grassetto] Fed Univ Alfenas UNIFAL MG, Inst Nat Sci, Alfenas, Brazil; [Ribeiro, Milton Cezar] Sao Paulo State Univ, UNESP, Dept Ecol, Spatial Ecol & Conservat Lab LEEC, Rio Claro, Brazil	Universidade Federal de Alfenas; Universidade Estadual Paulista	da Cunha, RGT (corresponding author), Fed Univ Alfenas UNIFAL MG, Inst Nat Sci, Alfenas, Brazil.	rogcunha@hotmail.com	Hasui, Erica/AAF-5580-2019; Rotta, Polyana P/L-4722-2016; Rotta, Polyana/AAT-8719-2020; da Cunha, Rogério Grassetto Teixeira/AAS-6530-2020; Costa e Silva, Luiz Fernando/T-6073-2019; Silva, Flávia/AAQ-6163-2021; da Cunha, Rogério Grassetto Teixeira/J-1738-2012; Marcondes, Marcos/AAH-7553-2020	Hasui, Erica/0000-0002-9938-9284; Rotta, Polyana/0000-0002-1185-8120; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Silva, Flávia/0000-0001-5819-5638; da Cunha, Rogério Grassetto Teixeira/0000-0002-2368-3540; Marcondes, Marcos/0000-0003-4843-2809	Foundation for Research Support of the State of Minas Gerais (FAPEMIG); Vale S.A. [CRA-RDP-00104-10]; National Council for Scientific and Technological Development (CNPq) [472250/2010-8, process 312045/2013-1]; Sao Paulo Research Foundation (FAPESP) [process 2013/50421-2]	Foundation for Research Support of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Vale S.A.; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	LGS, EH, CAC and RGTC thank the Foundation for Research Support of the State of Minas Gerais (FAPEMIG, http://www.fapemig.br/) and Vale S.A. (joint process CRA-RDP-00104-10) and the National Council for Scientific and Technological Development (CNPq, Process N 472250/2010-8, http://www.cnpq.br) for financial support. MCR thanks the National Council for Scientific and Technological Development (CNPq, process 312045/2013-1, http://www.cnpq.br) and Sao Paulo Research Foundation (FAPESP, process 2013/50421-2, http://www.fapesp.br) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert A, 2013, INT J PRIMATOL, V34, P170, DOI 10.1007/s10764-012-9649-5; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Anzures-Dadda A, 2007, ANIM CONSERV, V10, P69, DOI 10.1111/j.1469-1795.2006.00074.x; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2009, INT J PRIMATOL, V30, P497, DOI 10.1007/s10764-009-9355-0; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Bicca-Marques JC, 2006, MAMIFEROS BRASIL; Bonilla-Sanchez YM, 2010, ORYX, V44, P293, DOI 10.1017/S0030605310000025; Boscolo D, 2006, AN ACAD BRAS CIENC, V78, P629, DOI 10.1590/S0001-37652006000400003; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 1998, AM J PRIMATOL, V45, P127; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Chiarello AG, 2001, INT J PRIMATOL, V22, P379, DOI 10.1023/A:1010751527749; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cowlishaw G., 2000, PRIMATE CONSERVATION; Dew JL, 1998, BIOTROPICA, V30, P425, DOI 10.1111/j.1744-7429.1998.tb00076.x; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Emmons LH, 1997, SOUNDS NEOTROPICAL R; Estrada A, 1996, INT J PRIMATOL, V17, P759, DOI 10.1007/BF02735263; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falls J.B., 1981, Studies in Avian Biology, P86; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; FORD SM, 1992, AM J PHYS ANTHROPOL, V88, P415, DOI 10.1002/ajpa.1330880403; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Garber PA, 2012, AM J PRIMATOL, V74, P344, DOI 10.1002/ajp.20957; GARBER PA, 1992, AM J PHYS ANTHROPOL, V88, P469, DOI 10.1002/ajpa.1330880404; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gonzalez-Solis J, 2001, BIODIVERS CONSERV, V10, P1267, DOI 10.1023/A:1016678126099; Greenberg DB, 2008, COPEIA, P801, DOI 10.1643/CE-07-119; Heiduck S, 2002, ORYX, V36, P133, DOI 10.1017/S0030605302000200; Hershkovitz P., 1990, FIELDIANA ZOOL, V55, P1, DOI DOI 10.5962/BHL.TITLE.2843; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Hobbs RJ, 2003, AUST J BOT, V51, P471, DOI 10.1071/BT03037; IUCN, 2013, IUCN RED LIST THREAT; Izar P, 1999, THESIS U SAO PAULO S; Jerusalinsky L, 2013, THESIS; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Lima EF, 2012, ESTRUTURA COMUNIDADE; Lovejoy T.E., 1986, P257; MAC ARTHUR ROBERT H., 1967; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Martins MM, 2005, BIODIVERS CONSERV, V14, P2321, DOI 10.1007/s10531-004-1666-z; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mittermeier R.A., 1982, International Zoo Yearbook, V22, P2, DOI 10.1111/j.1748-1090.1982.tb02004.x; MUSKIN A, 1984, AM J PRIMATOL, V7, P377, DOI 10.1002/ajp.1350070406; Norconk MA, 2007, PRIMATES PERSPECTIVE, P123, DOI DOI 10.1017/CBO9781139034210.023.; Nowak RM, 1999, WALKERS PRIMATES WOR; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Pearson RG, 2010, AM MUSEUM NATURAL HI, V3, P56; Pereira ACR, 2010, REV CIENTIFICA DEP C, V1, P49; Pontes ARM, 2005, J ZOOL, V266, P55, DOI 10.1017/S095283690500662X; Pozo-Montuy G, 2011, PRIMATES, V52, P139, DOI 10.1007/s10329-010-0231-5; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Core Team, 2021, R LANGUAGE ENV STAT; Riketts TH, 2001, AM NAT, V158, P87, DOI [10.1086/320863, DOI 10.1086/320863]; ROBINSON J G, 1981, Primates, V22, P161, DOI 10.1007/BF02382607; Rocha VJ, 1995, THESIS U FEDERAL PAR; Rocha VJ, 2007, INT J PRIMATOL, V28, P231, DOI 10.1007/s10764-006-9108-2; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Rowe N, 1996, PICTORIAL GUIDE LIVI; Rylands Anthony B., 1993, P262; SOS Mata Atlantica, 2008, ATL REM MAT ATL; Stone KD, 1997, AM MIDL NAT, V137, P106, DOI 10.2307/2426759; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Trevelin LC, 2007, REV BRAS ZOOL, V24, P1071, DOI 10.1590/S0101-81752007000400026; Umetsu F, 2008, ECOGRAPHY, V31, P359, DOI 10.1111/j.0906-7590.2008.05302.x; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wheeler BC, 2008, ANIM BEHAV, V76, P1465, DOI 10.1016/j.anbehav.2008.06.023; Wieczkowski J, 2004, AM J PRIMATOL, V63, P125, DOI 10.1002/ajp.20046; Youngentob KN, 2013, J BIOGEOGR, V40, P2082, DOI 10.1111/jbi.12158; Zuur Alain F., 2009, P1	84	47	49	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0114025	10.1371/journal.pone.0114025	http://dx.doi.org/10.1371/journal.pone.0114025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658108	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900007
J	Kodigepalli, KM; Nanjundan, M				Kodigepalli, Karthik M.; Nanjundan, Meera			Induction of PLSCR1 in a STING/IRF3-Dependent Manner upon Vector Transfection in Ovarian Epithelial Cells	PLOS ONE			English	Article							PHOSPHOLIPID SCRAMBLASE 1; PROTEIN FAMILY-MEMBERS; GROWTH-FACTOR RECEPTOR; TOLL-LIKE RECEPTORS; PLASMA-MEMBRANE; GENE-EXPRESSION; SNON/SKIL EXPRESSION; COLORECTAL-CANCER; VIRUS-REPLICATION; INTERFERON-ALPHA	Toll-like receptors (TLRs) are the primary sensors of the innate immune system that recognize pathogenic nucleic acids including double-stranded plasmid DNA (dsDNA). TLR signaling activates multiple pathways including IRF3 which is involved in transcriptional induction of inflammatory cytokines (i.e. interferons (IFNs)). Phospholipid scramblase 1, PLSCR1, is a highly inducible IFN-regulated gene mediating anti-viral properties of IFNs. Herein, we report a novel finding that dsDNA transfection in T80 immortalized normal ovarian surface epithelial cell line leads to a marked increase in PLSCR1 mRNA and protein. We also noted a comparable response in primary mammary epithelial cells (HMECs). Similar to IFN-2 alpha treated cells, de novo synthesized PLSCR1 was localized predominantly to the plasma membrane. dsDNA transfection, in T80 and HMEC cells, led to activation of MAPK and IRF3. Although inhibition of MAPK (using U0126) did not modulate PLSCR1 mRNA and protein, IRF3 knockdown (using siRNA) significantly ablated the PLSCR1 induction. In prior studies, the activation of IRF3 was shown to be mediated by cGAS-STING pathway. To investigate the contribution of STING to PLSCR1 induction, we utilized siRNA to reduce STING expression and observed that PLSCR1 protein was markedly reduced. In contrast to normal T80/HMECs, the phosphorylation of IRF3 as well as induction of STING and PLSCR1 were absent in ovarian cancer cells (serous, clear cell, and endometrioid) suggesting that the STING/IRF3 pathway may be dysregulated in these cancer cells. However, we also noted induction of different TLR and IFN mRNAs between the T80 and HEY (serous epithelial ovarian carcinoma) cell lines upon dsDNA transfection. Collectively, these results indicate that the STING/IRF3 pathway, activated following dsDNA transfection, contributes to upregulation of PLSCR1 in ovarian epithelial cells.	[Kodigepalli, Karthik M.; Nanjundan, Meera] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Nanjundan, M (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	mnanjund@usf.edu			University of South Florida CMMB Departmental Start-up Funds	University of South Florida CMMB Departmental Start-up Funds	Funding from the University of South Florida CMMB Departmental Start-up Funds to MN were used to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bauckman KA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.87; Bhat N, 2014, EUR J IMMUNOL, V44, P634, DOI 10.1002/eji.201344127; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Chen N, 2014, ONCOL REP, V31, P376, DOI 10.3892/or.2013.2847; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Cui W, 2012, HEPATOB PANCREAT DIS, V11, P393, DOI 10.1016/S1499-3872(12)60197-0; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Fan CW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-254; Francis VG, 2014, BIOCHEM BIOPH RES CO, V450, P172, DOI 10.1016/j.bbrc.2014.05.094; He XB, 2013, ACTA BIOCH BIOPH SIN, V45, P241, DOI 10.1093/abbs/gms122; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Huang Y, 2006, ONCOGENE, V25, P6618, DOI 10.1038/sj.onc.1209677; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kodigepalli KM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-32; Kodigepalli KM, 2013, FEBS LETT, V587, P5, DOI 10.1016/j.febslet.2012.11.003; Kundu SD, 2008, PROSTATE, V68, P223, DOI 10.1002/pros.20710; Kuo YB, 2011, MOL MED, V17, P41, DOI 10.2119/molmed.2010.00115; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Midoux P, 2008, CURR GENE THER, V8, P335, DOI 10.2174/156652308786071014; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Silverman RH, 2002, CANCER RES, V62, P397; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; Tamassia N, 2012, J IMMUNOL, V189, P1500, DOI 10.4049/jimmunol.1102985; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wyles JP, 2007, NUCLEIC ACIDS RES, V35, P4076, DOI 10.1093/nar/gkm434; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang J, 2012, ANTIVIR RES, V94, P9, DOI 10.1016/j.antiviral.2012.01.010; Yoshida H, 2009, J GENE MED, V11, P708, DOI 10.1002/jgm.1348; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	57	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117464	10.1371/journal.pone.0117464	http://dx.doi.org/10.1371/journal.pone.0117464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658875	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900156
J	Qu, YLW; Chi, W; Hua, X; Deng, RZ; Li, J; Liu, ZG; Pflugfelder, SC; Li, DQ				Qu, Yangluowa; Chi, Wei; Hua, Xia; Deng, Ruzhi; Li, Jin; Liu, Zuguo; Pflugfelder, Stephen C.; Li, De-Quan			Unique Expression Pattern and Functional Role of Periostin in Human Limbal Stem Cells	PLOS ONE			English	Article							ADULT STEM; EPITHELIAL-CELLS; PROTEIN; POPULATION; MARKERS; BONE; SKIN; IDENTIFICATION; REGENERATION; PHENOTYPE	Periostin is a non-structural matricellular protein. Little is known about periostin in human limbal stem cells (LSCs). This study was to explore the unique expression pattern and functional role of periostin in maintaining the properties of human LSCs. Fresh donor corneal tissues were used to make cryosections for evaluation of periostin expression on ex vivo tissues. Primary human limbal epithelial cells (HLECs) were generated from limbal explant culture. In vitro culture models for proliferation and epithelial regeneration were performed to explore functional role of periostin in LSCs. The mRNA expression was determined by reverse transcription and quantitative real-time PCR (RT-qPCR), and the protein production and localization were detected by immunofluorescent staining and Western blot analysis. Periostin protein was found to be exclusively immunolocalized in the basal layer of human limbal epithelium. Periostin localization was well matched with nuclear factor p63, but not with corneal epithelial differentiation marker Keratin 3. Periostin transcripts was also highly expressed in limbal than corneal epithelium. In primary HLECs, periostin expression at mRNA and protein levels was significantly higher in 50% and 70% confluent cultures at exponential growth stage than in 100% confluent cultures at slow growth or quiescent condition. This expression pattern was similar to other stem/progenitor cell markers (p63, integrin beta 1 and TCF4). Periostin expression at transcripts, protein and immunoreactivity levels increased significantly during epithelial regeneration in wound healing process, especially in 16-24 hours at wound edge, which was accompanied by similar upregulation and activation of p63, integrin beta 1 and TCF4. Our findings demonstrated that periostin is exclusively produced by limbal basal epithelium and co-localized with p63, where limbal stem cells reside. Periostin promotes HLEC proliferation and regeneration with accompanied activation of stem/progenitor cell markers p63, integrin beta 1 and TCF4, suggesting its novel role in maintaining the phenotype and functional properties of LSC.	[Qu, Yangluowa; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Peoples R China; [Qu, Yangluowa; Chi, Wei; Hua, Xia; Deng, Ruzhi; Li, Jin; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Chi, Wei] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Hua, Xia] Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin Eye Hosp, Tianjin, Peoples R China	Xiamen University; Baylor College of Medicine; Sun Yat Sen University; Tianjin Medical University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Peoples R China.	zuguoliu@xmu.edu.cn; dequanl@bcm.tmc.edu			NIH NEI Grant [R01EY023598]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; Lions Foundation for Sight; NATIONAL EYE INSTITUTE [R01EY023598] Funding Source: NIH RePORTER	NIH NEI Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; Lions Foundation for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH NEI Grant R01EY023598 (DQL), Lions Foundation for Sight, Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; Bian F, 2010, INT J BIOCHEM CELL B, V42, P1142, DOI 10.1016/j.biocel.2010.03.022; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Borge OJ, 2004, ACTA VET SCAND, V45, P39; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Diaz-Flores L, 2006, HISTOL HISTOPATHOL, V21, P995, DOI 10.14670/HH-21.995; Donisi PM, 2003, CORNEA, V22, P533, DOI 10.1097/00003226-200308000-00009; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Gillan L, 2002, CANCER RES, V62, P5358; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim SY, 2009, J CUTAN PATHOL, V36, P825, DOI 10.1111/j.1600-0560.2008.01167.x; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Liu AY, 2014, MATRIX BIOL; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsunoda T, 2009, PROSTATE, V69, P1398, DOI 10.1002/pros.20988; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002	49	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117139	10.1371/journal.pone.0117139	http://dx.doi.org/10.1371/journal.pone.0117139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658308	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900107
J	Samad, M; Chung, AJ; Shams, L				Samad, Majed; Chung, Albert Jin; Shams, Ladan			Perception of Body Ownership Is Driven by Bayesian Sensory Inference	PLOS ONE			English	Article							BODILY SELF-CONSCIOUSNESS; MULTISENSORY INTEGRATION; PERIPERSONAL SPACE; SKIN-CONDUCTANCE; RUBBER HAND; ILLUSION; LIMB; PROPRIOCEPTION; RECALIBRATION; ATTRIBUTION	Recent studies have shown that human perception of body ownership is highly malleable. A well-known example is the rubber hand illusion (RHI) wherein ownership over a dummy hand is experienced, and is generally believed to require synchronized stroking of real and dummy hands. Our goal was to elucidate the computational principles governing this phenomenon. We adopted the Bayesian causal inference model of multisensory perception and applied it to visual, proprioceptive, and tactile stimuli. The model reproduced the RHI, predicted that it can occur without tactile stimulation, and that synchronous stroking would enhance it. Various measures of ownership across two experiments confirmed the predictions: a large percentage of individuals experienced the illusion in the absence of any tactile stimulation, and synchronous stroking strengthened the illusion. Altogether, these findings suggest that perception of body ownership is governed by Bayesian causal inference-i.e., the same rule that appears to govern the perception of outside world.	[Samad, Majed; Chung, Albert Jin; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Shams, Ladan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Samad, M (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	majedsamad@ucla.edu			Direct For Social, Behav & Economic Scie [1057969] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Beierholm UR, 2009, J VISION, V9, DOI 10.1167/9.5.23; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Christie M, 1980, TECHNIQUES PSYCHOPHY, P2; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; EPSTEIN S, 1970, J PERS SOC PSYCHOL, V16, P20, DOI 10.1037/h0029786; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; Hein A, 1958, PERCEPT MOTOR SKILL, V8, P87, DOI [DOI 10.2466/PMS.1958.8.3.87, 10.2466/pms.1958.8.3.87]; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Kalckert A, 2012, MOVING RUBBER HAND F; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Magnotti JF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00798; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Rohe T, PLOS BIOL IN PRESS; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; STAUB E, 1971, J PERS SOC PSYCHOL, V18, P157, DOI 10.1037/h0030851; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075; Wozny DR, 2011, J NEUROSCI, V31, P4607, DOI 10.1523/JNEUROSCI.6079-10.2011; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Wozny DR, 2008, J VISION, V8, DOI 10.1167/8.3.24	46	175	176	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117178	10.1371/journal.pone.0117178	http://dx.doi.org/10.1371/journal.pone.0117178			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2GK	25658822	Green Published, gold			2022-12-26	WOS:000349444900111
J	Srinivasan, R; Karaoz, U; Volegova, M; MacKichan, J; Kato-Maeda, M; Miller, S; Nadarajan, R; Brodie, EL; Lynch, SV				Srinivasan, Ramya; Karaoz, Ulas; Volegova, Marina; MacKichan, Joanna; Kato-Maeda, Midori; Miller, Steve; Nadarajan, Rohan; Brodie, Eoin L.; Lynch, Susan V.			Use of 16S rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; SEQUENCE-ANALYSIS; RAPID DETECTION; SYSTEM; IMPACT; DIFFERENTIATION; DATABASE; ASSAY	According to World Health Organization statistics of 2011, infectious diseases remain in the top five causes of mortality worldwide. However, despite sophisticated research tools for microbial detection, rapid and accurate molecular diagnostics for identification of infection in humans have not been extensively adopted. Time-consuming culture-based methods remain to the forefront of clinical microbial detection. The 16S rRNA gene, a molecular marker for identification of bacterial species, is ubiquitous to members of this domain and, thanks to ever-expanding databases of sequence information, a useful tool for bacterial identification. In this study, we assembled an extensive repository of clinical isolates (n = 617), representing 30 medically important pathogenic species and originally identified using traditional culture-based or non-16S molecular methods. This strain repository was used to systematically evaluate the ability of 16S rRNA for species level identification. To enable the most accurate species level classification based on the paucity of sequence data accumulated in public databases, we built a Naive Bayes classifier representing a diverse set of high-quality sequences from medically important bacterial organisms. We show that for species identification, a model-based approach is superior to an alignment based method. Overall, between 16S gene based and clinical identities, our study shows a genus-level concordance rate of 96% and a species-level concordance rate of 87.5%. We point to multiple cases of probable clinical misidentification with traditional culture based identification across a wide range of gram-negative rods and gram-positive cocci as well as common gram-negative cocci.	[Srinivasan, Ramya; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, Dept Med, San Francisco, CA 94143 USA; [Karaoz, Ulas; Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Miller, Steve; Nadarajan, Rohan] Univ Calif San Francisco, Clin Microbiol Lab, San Francisco, CA 94107 USA; [Volegova, Marina] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kato-Maeda, Midori] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [MacKichan, Joanna] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; San Francisco General Hospital Medical Center; Victoria University Wellington	Lynch, SV (corresponding author), Univ Calif San Francisco, Div Gastroenterol, Dept Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Brodie, Eoin L/A-7853-2008; Karaoz, Ulas/J-7093-2014; Nadarajan, R/AAB-8676-2019	Brodie, Eoin L/0000-0002-8453-8435; Karaoz, Ulas/0000-0002-8238-6757; MacKichan, Joanna/0000-0001-9309-3282	NIH [U01 AI075410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by NIH U01 AI075410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Barbut F, 2011, EUR J CLIN MICROBIOL, V30, P1279, DOI 10.1007/s10096-011-1224-z; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Bernards AT, 1996, EUR J CLIN MICROBIOL, V15, P303, DOI 10.1007/BF01695662; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carvalho MGS, 2003, J CLIN MICROBIOL, V41, P4415, DOI 10.1128/JCM.41.9.4415-4417.2003; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Coenye T, 2002, J CLIN MICROBIOL, V40, P3300, DOI 10.1128/JCM.40.9.3300-3307.2002; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Day AM, 2001, LETT APPL MICROBIOL, V33, P392, DOI 10.1046/j.1472-765X.2001.01017.x; de Filippis I, 2007, LETT APPL MICROBIOL, V45, P426, DOI 10.1111/j.1472-765X.2007.02205.x; Deasy BM, 2000, SYST APPL MICROBIOL, V23, P510, DOI 10.1016/S0723-2020(00)80025-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Enright MC, 2000, EUR J CLIN MICROBIOL, V19, P627, DOI 10.1007/s100960000321; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Fontana C, 2005, J CLIN MICROBIOL, V43, P615, DOI 10.1128/JCM.43.2.615-619.2005; Fournier PE, 2011, ANNU REV MICROBIOL, V65, P169, DOI 10.1146/annurev-micro-090110-102922; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Hallin M, 2003, J CLIN MICROBIOL, V41, P3942, DOI 10.1128/JCM.41.8.3942-3944.2003; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harmsen D, 2002, NUCLEIC ACIDS RES, V30, P416, DOI 10.1093/nar/30.1.416; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hulbert RR, 2009, CURR PROTOC MICROBIO; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Joyanes P, 2001, J CLIN MICROBIOL, V39, P3247, DOI 10.1128/JCM.39.9.3247-3253.2001; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; LaClaire LL, 2000, J CLIN MICROBIOL, V38, P2037; Larson E, 2007, ANNU REV PUBL HEALTH, V28, P435, DOI 10.1146/annurev.publhealth.28.021406.144020; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Liu D, 2011, MOL DETECTION HUMAN, Vxxvii; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Park JS, 2011, J MED MICROBIOL, V60, P492, DOI 10.1099/jmm.0.020768-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Simmon KE, 2006, J CLIN MICROBIOL, V44, P4400, DOI 10.1128/JCM.01364-06; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Teng JLL, 2014, DIAGN MICR INFEC DIS, V78, P105, DOI 10.1016/j.diagmicrobio.2013.10.019; Versalovic J., 2011, MANUAL CLIN MICROBIO, V10, DOI DOI 10.1111/J.1758-8111.2010.00005.X; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Woo PCY, 2011, J CLIN MICROBIOL, V49, P1799, DOI 10.1128/JCM.02350-10; Woo PCY, 2003, J CLIN PATHOL, V56, P690, DOI 10.1136/jcp.56.9.690; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	70	166	177	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117617	10.1371/journal.pone.0117617	http://dx.doi.org/10.1371/journal.pone.0117617			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658760	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900191
J	Yu, X; Liu, X; Zhao, Z; Liu, JL; Zhang, SX				Yu, Xuan; Liu, Xu; Zhao, Zhong; Liu, Jinliang; Zhang, Shunxiang			Effect of Monospecific and Mixed SeaBuckthorn (Hippophae rhamnoides) Plantations on the Structure and Activity of Soil Microbial Communities	PLOS ONE			English	Article							ORGANIC-CARBON POOLS; LOESS PLATEAU; NORWAY SPRUCE; LEAF-LITTER; SCOTS PINE; BIOMASS; DIVERSITY; PATTERNS; FORESTS; DECOMPOSITION	This study aims to evaluate the effect of different afforestation models on soil microbial composition in the Loess Plateau in China. In particular, we determined soil physicochemical properties, enzyme activities, and microbial community structures in the top 0 cm to 10 cm soil underneath a pure Hippophae rhamnoides (SS) stand and three mixed stands, namely, H. rhamnoides and Robinia pseucdoacacia (SC), H. rhamnoides and Pinus tabulaeformis (SY), and H. rhamnoides and Platycladus orientalis (SB). Results showed that total organic carbon (TOC), total nitrogen, and ammonium (NH4+) contents were higher in SY and SB than in SS. The total microbial biomass, bacterial biomass, and Gram(+) biomass of the three mixed stands were significantly higher than those of the pure stand. However, no significant difference was found in fungal biomass. Correlation analysis suggested that soil microbial communities are significantly and positively correlated with some chemical parameters of soil, such as TOC, total phosphorus, total potassium, available phosphorus, NH4+ content, nitrate content (NH3-), and the enzyme activities of urease, peroxidase, and phosphatase. Principal component analysis showed that the microbial community structures of SB and SS could clearly be discriminated from each other and from the others, whereas SY and SC were similar. In conclusion, tree species indirectly but significantly affect soil microbial communities and enzyme activities through soil physicochemical properties. In addition, mixing P. tabulaeformis or P. orientalis in H. rhamnoides plantations is a suitable afforestation model in the Loess Plateau, because of significant positive effects on soil nutrient conditions, microbial community, and enzyme activities over pure plantations.	[Yu, Xuan; Zhao, Zhong; Liu, Jinliang; Zhang, Shunxiang] Northwest A&F Univ, Coll Forestry, Dept Forestry, Yangling, Peoples R China; [Yu, Xuan; Zhao, Zhong] Minist Educ, Key Lab Environm & Ecol Western China, Yangling, Peoples R China; [Liu, Xu] Northwest A&F Univ, Coll Enol, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhao, Z (corresponding author), Northwest A&F Univ, Coll Forestry, Dept Forestry, Yangling, Peoples R China.	zhaozh@nwsuaf.edu.cn			National Natural Science Foundation of China [305021210]; Northwest Agriculture & Forestry University [QN2011160]; Ph.D. Programs Foundation of Ministry of Education of China [20120204120043]; Natural Science Foundation of Shannxi Province, China [2013JQ3004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest Agriculture & Forestry University; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Shannxi Province, China(Natural Science Foundation of Shanxi Province)	Project supported by the National Natural Science Foundation of China (305021210, http://www.nsfc.gov.cn) and Northwest Agriculture & Forestry University (QN2011160, http://www.nwsuaf.edu.cn). Ph.D. Programs Foundation of Ministry of Education of China (20120204120043, http://www.moe.gov.cn/), project supported by the Natural Science Foundation of Shannxi Province, China (2013JQ3004, http://www.sninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk B, 2014, PEDOBIOLOGIA, V57, P97, DOI 10.1016/j.pedobi.2013.12.003; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Aon MA, 2001, APPL SOIL ECOL, V18, P239, DOI 10.1016/S0929-1393(01)00153-6; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caldwell BA, 1999, SOIL BIOL BIOCHEM, V31, P1603, DOI 10.1016/S0038-0717(99)00067-X; [陈金泉 CHEN Jinquan], 2011, [土壤通报, Journal of Soil Science], V42, P616; Chen MM, 2007, EUR J SOIL BIOL, V43, P31, DOI 10.1016/j.ejsobi.2006.05.001; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Fang SZ, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0085642; Fanin N, 2014, PLANT SOIL, V379, P79, DOI 10.1007/s11104-014-2051-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Galka B, 2014, GEODERMA, V213, P287, DOI 10.1016/j.geoderma.2013.08.029; Grayston SJ, 2005, SOIL BIOL BIOCHEM, V37, P1157, DOI 10.1016/j.soilbio.2004.11.014; Guan S.Y., 1986, SOIL ENZYME ITS STUD, P270; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hansson K, 2011, FOREST ECOL MANAG, V262, P522, DOI 10.1016/j.foreco.2011.04.021; Hao A, 2005, J FAC AGR KYUSHU U, V50, P223; Hassett JE, 2005, SOIL SCI SOC AM J, V69, P227, DOI 10.2136/sssaj2005.0227; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Huang XM, 2014, SOIL BIOL BIOCHEM, V73, P42, DOI 10.1016/j.soilbio.2014.01.021; Huang ZQ, 2013, SOIL BIOL BIOCHEM, V62, P68, DOI 10.1016/j.soilbio.2013.03.008; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jiang YM, 2012, J SOIL SEDIMENT, V12, P228, DOI 10.1007/s11368-011-0442-4; Kiikkila O, 2014, PLANT SOIL, V377, P169, DOI 10.1007/s11104-013-1988-2; Koller R, 2013, NEW PHYTOL, V199, P203, DOI 10.1111/nph.12249; Koranda M, 2013, SOIL BIOL BIOCHEM, V60, P95, DOI 10.1016/j.soilbio.2013.01.025; [张金屯 Li Bin], 2003, [生态学报, Acta Ecologica Sinica], V23, P82; Li YF, 2013, FOREST ECOL MANAG, V303, P121, DOI 10.1016/j.foreco.2013.04.021; Li YY, 2006, J ARID ENVIRON, V64, P77, DOI 10.1016/j.jaridenv.2005.04.005; Lin L, 2012, MICROBES ENVIRON, V27, P391, DOI 10.1264/jsme2.ME11275; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; Liu L, 2010, PLANT SOIL, V327, P413, DOI 10.1007/s11104-009-0067-1; Lucas-Borja ME, 2012, PLANT SOIL, V354, P359, DOI 10.1007/s11104-011-1072-8; Lucas-Borja ME, 2011, LAND DEGRAD DEV, V22, P383, DOI 10.1002/ldr.1014; Mancinelli R, 2010, APPL SOIL ECOL, V46, P64, DOI 10.1016/j.apsoil.2010.06.013; Mao R, 2010, EUR J SOIL BIOL, V46, P325, DOI 10.1016/j.ejsobi.2010.05.005; MONTAGNINI F, 2005, TROP FOR, P1; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Nichols JD, 2006, FOREST ECOL MANAG, V233, P344, DOI 10.1016/j.foreco.2006.05.031; Phillips LA, 2014, ISME J, V8, P699, DOI 10.1038/ismej.2013.195; Porazinska DL, 2003, ECOL MONOGR, V73, P377, DOI 10.1890/0012-9615(2003)073[0377:RATAIP]2.0.CO;2; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Rinklebe J, 2006, SOIL BIOL BIOCHEM, V38, P2144, DOI 10.1016/j.soilbio.2006.01.018; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Sundh I, 1997, APPL ENVIRON MICROB, V63, P1476, DOI 10.1128/AEM.63.4.1476-1482.1997; Swallow M, 2013, APPL SOIL ECOL, V63, P120, DOI 10.1016/j.apsoil.2012.09.006; Thoms C, 2013, SOIL BIOL BIOCHEM, V66, P239, DOI 10.1016/j.soilbio.2013.05.018; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Trasar-Cepeda C, 1998, BIOL FERT SOILS, V26, P100, DOI 10.1007/s003740050350; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; Ushio M, 2010, PEDOBIOLOGIA, V53, P227, DOI 10.1016/j.pedobi.2009.12.003; Vitousek P, 2006, J ECOL, V94, P510, DOI 10.1111/j.1365-2745.2006.01119.x; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Weand MP, 2010, SOIL BIOL BIOCHEM, V42, P2161, DOI 10.1016/j.soilbio.2010.08.012; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Xue D, 2010, J ENVIRON SCI, V22, P1253, DOI 10.1016/S1001-0742(09)60246-1; Yang YQ, 2005, PHYSIOL PLANTARUM, V124, P431, DOI 10.1111/j.1399-3054.2005.00517.x; ZELLES L, 1994, SOIL BIOL BIOCHEM, V26, P439, DOI 10.1016/0038-0717(94)90175-9; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang JT, 2007, ECOL ENG, V31, P115, DOI 10.1016/j.ecoleng.2007.06.003; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807	67	10	11	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117505	10.1371/journal.pone.0117505	http://dx.doi.org/10.1371/journal.pone.0117505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658843	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900165
J	Kinugasa, H; Whelan, KA; Tanaka, K; Natsuizaka, M; Long, A; Guo, A; Chang, S; Kagawa, S; Srinivasan, S; Guha, M; Yamamoto, K; St Clair, DK; Avadhani, NG; Diehl, JA; Nakagawa, H				Kinugasa, H.; Whelan, K. A.; Tanaka, K.; Natsuizaka, M.; Long, A.; Guo, A.; Chang, S.; Kagawa, S.; Srinivasan, S.; Guha, M.; Yamamoto, K.; St Clair, D. K.; Avadhani, N. G.; Diehl, J. A.; Nakagawa, H.			Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression	ONCOGENE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; NF-KAPPA-B; OXIDATIVE STRESS; CANCER; EMT; PROMOTES; GROWTH; GENE; IDENTIFICATION; ACTIVATION	Epithelial-mesenchymal transition (EMT) promotes cancer cell invasion, metastasis and treatment failure. EMT may be activated in cancer cells by reactive oxygen species (ROS). EMT may promote conversion of a subset of cancer cells from a CD44(low)-CD24(high) (CD44L) epithelial phenotype to a CD44(high)-CD24(-/low) (CD44H) mesenchymal phenotype, the latter associated with increased malignant properties of cancer cells. ROS are required for cells undergoing EMT, although excessive ROS may induce cell death or senescence; however, little is known as to how cellular antioxidant capabilities may be regulated during EMT. Mitochondrial superoxide dismutase 2 (SOD2) is frequently overexpressed in oral and esophageal cancers. Here, we investigate mechanisms of SOD2 transcriptional regulation in EMT, as well as the functional role of this antioxidant in EMT. Using well-characterized genetically engineered oral and esophageal human epithelial cell lines coupled with RNA interference and flow cytometric approaches, we find that transforming growth factor (TGF)-beta stimulates EMT, resulting in conversion of CD44L to CD44H cells, the latter of which display SOD2 upregulation. SOD2 induction in transformed keratinocytes was concurrent with suppression of TGF-beta-mediated induction of both ROS and senescence. SOD2 gene expression appeared to be transcriptionally regulated by NF-kappa B and ZEB2, but not ZEB1. Moreover, SOD2-mediated antioxidant activity may restrict conversion of CD44L cells to CD44H cells at the early stages of EMT. These data provide novel mechanistic insights into the dynamic expression of SOD2 during EMT. In addition, we delineate a functional role for SOD2 in EMT via the influence of this antioxidant upon distinct CD44L and CD44H subsets of cancer cells that have been implicated in oral and esophageal tumor biology.	[Kinugasa, H.; Whelan, K. A.; Tanaka, K.; Natsuizaka, M.; Long, A.; Guo, A.; Chang, S.; Kagawa, S.; Diehl, J. A.; Nakagawa, H.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Kinugasa, H.; Whelan, K. A.; Tanaka, K.; Natsuizaka, M.; Long, A.; Guo, A.; Chang, S.; Kagawa, S.; Diehl, J. A.; Nakagawa, H.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Kinugasa, H.; Yamamoto, K.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan; [Natsuizaka, M.] Hokkaido Univ, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Srinivasan, S.; Guha, M.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Srinivasan, S.; Guha, M.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [St Clair, D. K.] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY USA; [Diehl, J. A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Okayama University; Hokkaido University; University of Pennsylvania; University of Pennsylvania; University of Kentucky; Medical University of South Carolina	Nakagawa, H (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, 421Curie Blvd,956 BRB, Philadelphia, PA 19104 USA.	nakagawh@mail.med.upenn.edu		Natsuizaka, Mitsuteru/0000-0002-1819-1955	NIH [P01CA098101, F32CA174176, F30CA175133, K26RR032714, R01CA073599]; Pennsylvania CURE Program Grant; Edward P. Evans Foundation; University of Pennsylvania University Research Foundation Award; University of Pennsylvania, Abramson Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE [F31CA174176, R01CA073599, P30CA177558, R01CA022762, P01CA098101, F32CA174146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania CURE Program Grant; Edward P. Evans Foundation; University of Pennsylvania University Research Foundation Award; University of Pennsylvania, Abramson Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the Molecular Pathology & Imaging, Molecular Biology/Gene Expression and Cell Culture Core Facilities of the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and of the NIH P01CA098101. This study was supported in part by NIH Grants P01CA098101 (to HK, KAW, KT, MN, AL, AG, SC, SK, JAD and HN), F32CA174176 (KAW), F30CA175133 (AL), K26RR032714 (HN), R01CA073599 (DKS) as well as Pennsylvania CURE Program Grant (HN), the Edward P. Evans Foundation (DKS), University of Pennsylvania University Research Foundation Award (HN) and University of Pennsylvania, Abramson Cancer Center Pilot Project Grant (HN).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367; Chaudhuri L, 2012, ONCOGENE, V31, P1207, DOI 10.1038/onc.2011.325; Chen PM, 2013, CARCINOGENESIS, V34, P2655, DOI 10.1093/carcin/bgt220; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dhar SK, 2011, CANCER RES, V71, P6684, DOI 10.1158/0008-5472.CAN-11-1233; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Gammon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062493; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ji GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069351; Ju XM, 2014, CANCER RES, V74, P508, DOI 10.1158/0008-5472.CAN-13-1313; Kagawa S, 2015, ONCOGENE, V34, P2347, DOI 10.1038/onc.2014.169; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin CH, 2013, INT J MOL SCI, V14, P13266, DOI 10.3390/ijms140713266; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng XQ, 2013, GASTROENTEROLOGY, V145, P426, DOI 10.1053/j.gastro.2013.04.004; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nam EH, 2014, CARCINOGENESIS, V35, P302, DOI 10.1093/carcin/bgt340; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Natsuizaka M, 2014, AM J CANCER RES, V4, P29; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yeh CC, 1998, DNA CELL BIOL, V17, P921, DOI 10.1089/dna.1998.17.921; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	52	52	53	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5229	5239		10.1038/onc.2014.449	http://dx.doi.org/10.1038/onc.2014.449			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25659582	Green Accepted			2022-12-26	WOS:000362575400003
J	Kocab, AJ; Veloso, A; Paulsen, MT; Ljungman, M; Duckett, CS				Kocab, A. J.; Veloso, A.; Paulsen, M. T.; Ljungman, M.; Duckett, C. S.			Effects of physiological and synthetic IAP antagonism on c-IAP-dependent signaling	ONCOGENE			English	Article							NF-KAPPA-B; LARGE-CELL LYMPHOMA; TRANSCRIPTION FACTORS; CD30; TNF; DEGRADATION; ACTIVATION; APOPTOSIS; PATHWAYS; COMPLEX	Cellular inhibitor of apoptosis proteins 1 and 2 (c-IAP1/2) have central roles in signal transduction mediated by numerous receptors that participate in inflammatory and immune responses. In certain pathways, such as activation of NF-kappa B, their degradation is a major regulatory event and is physiologically induced by activation of receptors. In addition, a number of synthetic compounds have been developed that also target the c-IAPs and induce their degradation. However, the extent of a synthetic IAP antagonist's ability to mirror the transcriptional program by a physiological signal remains unclear. Here we take a systems approach to compare the transcriptional programs triggered by activation of CD30, a well-characterized receptor previously shown to induce the degradation of the c-IAPs, to SM-164, a synthetic IAP antagonist that specifically triggers c-IAP degradation. Employing a technique that allows the specific analysis of newly transcribed RNA, we have generated comparative transcriptome profiles for CD30 activation and SM-164 treatment. Analysis of these profiles revealed that the genes regulated by each stimulus were not completely shared, indicating novel functions of IAP antagonists and consequences of c-IAP1/2 degradation. The data identified a role for c-IAP1/2 in the regulation of the ribosome and protein synthesis, which was subsequently confirmed by biological assays. These findings expand our knowledge of the roles of c-IAP1/2 in signaling and provide insight into the mechanism of synthetic IAP antagonists, furthering our understanding of their therapeutic potential.	[Kocab, A. J.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Kocab, A. J.; Duckett, C. S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Veloso, A.; Paulsen, M. T.; Ljungman, M.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Veloso, A.] Univ Michigan, Dept Computat Med & Bioinformat, Bioinformat Program, Ann Arbor, MI 48109 USA; [Ljungman, M.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), Univ Michigan, Dept Pathol & Internal Med, NCRC Bldg 18,Rm 133,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	colind@med.umich.edu		Kocab, Andrew/0000-0001-6069-2166; Duckett, Colin/0000-0001-9413-2263	NIH [R01CA142809, 1R01HG006786, T32AI007413]; NATIONAL CANCER INSTITUTE [R01CA142809] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs Shaomeng Wang (University of Michigan, Ann Arbor, MI, USA) for the kind gift of SM-164, Judith Sebolt-Leopold (University of Michigan) for the gift of Trametinib, Niall Kenneth (Newcastle University, Newcastle upon Tyne, UK) for his insightful suggestions, Elizabeth Lawlor (University of Michigan, Ann Arbor, MI, USA) for her critical reading of the manuscript, Thomas Wilson (University of Michigan, Ann Arbor, MI, USA) for use of his data analysis software, the members of the Duckett laboratory for their helpful advice and the personnel at the University of Michigan Molecular and Behavioral Neuroscience Institute computing cluster and the University of Michigan Sequencing Core for their technical assistance. This work was supported in part by NIH R01CA142809 (to CSD), NIH 1R01HG006786 (to ML) and NIH T32AI007413 (to AJK).	Buchan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045244; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Csomos RA, 2009, BIOCHEM J, V420, P83, DOI 10.1042/BJ20082140; Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Kenneth NS, 2014, CELL CYCLE, V13, P1006, DOI 10.4161/cc.27922; Kenneth NS, 2012, CURR OPIN CELL BIOL, V24, P871, DOI 10.1016/j.ceb.2012.11.004; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mir SS, 2000, BLOOD, V96, P4307; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Paulsen MT, 2014, METHODS, V67, P45, DOI 10.1016/j.ymeth.2013.08.015; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; TIAN ZG, 1995, CANCER RES, V55, P5335; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Wright CW, 2009, SCIENCE, V323, P251, DOI 10.1126/science.1162818; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zhang JB, 2014, AUTOPHAGY, V10, P901, DOI 10.4161/auto.28267	38	7	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5472	5481		10.1038/onc.2015.3	http://dx.doi.org/10.1038/onc.2015.3			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25659587	Green Accepted			2022-12-26	WOS:000363479700007
J	Sakurai, K; Chen, J; Khani, SC; Kefalov, VJ				Sakurai, Keisuke; Chen, Jeannie; Khani, Shahrokh C.; Kefalov, Vladimir J.			Regulation of Mammalian Cone Phototransduction by Recoverin and Rhodopsin Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PHOTON RESPONSES; VISUAL PIGMENT PHOSPHORYLATION; LIGHT ADAPTATION; ROD PHOTORECEPTORS; RETINAL RODS; GUANYLATE-CYCLASE; TRANSGENIC MICE; FROG RETINA; S-MODULIN; CALCIUM	Cone photoreceptors function under daylight conditions and are essential for color perception and vision with high temporal and spatial resolution. A remarkable feature of cones is that, unlike rods, they remain responsive in bright light. In rods, light triggers a decline in intracellular calcium, which exerts a well studied negative feedback on phototransduction that includes calcium-dependent inhibition of rhodopsin kinase (GRK1) by recoverin. Rods and cones share the same isoforms of recoverin and GRK1, and photoactivation also triggers a calcium decline in cones. However, the molecular mechanisms by which calcium exerts negative feedback on cone phototransduction through recoverin and GRK1 are not well understood. Here, we examined this question using mice expressing various levels of GRK1 or lacking recoverin. We show that although GRK1 is required for the timely inactivation of mouse cone photoresponse, gradually increasing its expression progressively delays the cone response recovery. This surprising result is in contrast with the known effect of increasing GRK1 expression in rods. Notably, the kinetics of cone responses converge and become independent of GRK1 levels for flashes activating more than similar to 1% of cone pigment. Thus, mouse cone response recovery in bright light is independent of pigment phosphorylation and likely reflects the spontaneous decay of photoactivated visual pigment. We also find that recoverin potentiates the sensitivity of cones in dim light conditions but does not contribute to their capacity to function in bright light.	[Sakurai, Keisuke; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Jeannie] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Chen, Jeannie] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Khani, Shahrokh C.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Khani, Shahrokh C.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Washington University (WUSTL); University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	kefalov@vision.wustl.edu		Kefalov, Vladimir/0000-0002-1659-008X	National Institutes of Health [EY19543, EY19312, EY12703, EY12155, EY02687]; Research to Prevent Blindness; Uehara Memorial Foundation, Japan; NATIONAL EYE INSTITUTE [P30EY002687, R01EY019312, R01EY012155, R21EY019543, R01EY012703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Uehara Memorial Foundation, Japan(Uehara Memorial Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY19543 and EY19312 (to V. J. K.), EY12703 and EY12155 (to J. C.), and EY02687 (to Washington University Department Ophthalmology). This work was also supported by Research to Prevent Blindness and a grant from the Uehara Memorial Foundation, Japan (to K. S.).	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; BOLNICK DA, 1979, VISION RES, V19, P1117, DOI 10.1016/0042-6989(79)90006-3; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chan S, 2007, INVEST OPHTH VIS SCI, V48, P1968, DOI 10.1167/iovs.06-1287; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; Estevez ME, 2009, J GEN PHYSIOL, V134, P137, DOI 10.1085/jgp.200910232; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GREEN DG, 1971, SCIENCE, V174, P598, DOI 10.1126/science.174.4009.598; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Hurley J B, 2001, Prog Brain Res, V131, P395; IMAI H, 1995, BIOCHEMISTRY-US, V34, P10525, DOI 10.1021/bi00033a026; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawamura S, 1999, Novartis Found Symp, V224, P208; Kawamura S, 1996, J BIOL CHEM, V271, P21359, DOI 10.1074/jbc.271.35.21359; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; Matthews HR, 2010, J GEN PHYSIOL, V135, P355, DOI 10.1085/jgp.200910394; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Sakurai K, 2011, INVEST OPHTH VIS SCI, V52, P6793, DOI 10.1167/iovs.11-7158; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Vogalis F, 2011, J PHYSIOL-LONDON, V589, P2321, DOI 10.1113/jphysiol.2010.204156; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Whitcomb T, 2010, INVEST OPHTH VIS SCI, V51, P1728, DOI 10.1167/iovs.09-4499; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Zang JJ, 2012, J GEN PHYSIOL, V140, P219, DOI 10.1085/jgp.201110762; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	52	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9239	9250		10.1074/jbc.M115.639591	http://dx.doi.org/10.1074/jbc.M115.639591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673692	Green Published, hybrid			2022-12-26	WOS:000352207100045
J	Aguileta, MA; Korac, J; Durcan, TM; Trempe, JF; Haber, M; Gehring, K; Elsasser, S; Waidmann, O; Fon, EA; Husnjak, K				Aguileta, Miguel A.; Korac, Jelena; Durcan, Thomas M.; Trempe, Jean-Francois; Haber, Michael; Gehring, Kalle; Elsasser, Suzanne; Waidmann, Oliver; Fon, Edward A.; Husnjak, Koraljka			The E3 Ubiquitin Ligase Parkin Is Recruited to the 26 S Proteasome via the Proteasomal Ubiquitin Receptor Rpn13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Parkin; Parkinson Disease; Proteasome; Ubiquitin; Ubiquitylation (Ubiquitination); Rpn13	PROTEIN LIGASE; MITOCHONDRIAL DEPOLARIZATION; DEUBIQUITINATING ENZYME; INTERACTING PROTEIN; ACTIVATE PARKIN; DISEASE; DOMAIN; SUBUNIT; BINDING; MITOPHAGY	Background: The role of the N-terminal ubiquitin-like domain of the E3 ligase parkin is not fully understood. Results: Parkin is recruited to the 26 S proteasome through the interaction of its ubiquitin-like domain with the intrinsic proteasomal ubiquitin receptor Rpn13. Conclusion: Parkin turnover and E3 ligase activity can be regulated by its recruitment to the 26 S proteasome via Rpn13. Significance: Parkin-Rpn13 interaction might be exploited as a potential therapeutic strategy. Mutations in the Park2 gene, encoding the RING-HECT hybrid E3 ubiquitin ligase parkin, are responsible for a common familial form of Parkinson disease. By mono- and polyubiquitinating target proteins, parkin regulates various cellular processes, including degradation of proteins within the 26 S proteasome, a large multimeric degradation machine. In our attempt to further elucidate the function of parkin, we have identified the proteasomal ubiquitin receptor Rpn13/ADRM1 as a parkin-interacting protein. We show that the N-terminal ubiquitin-like (Ubl) domain of parkin binds directly to the pleckstrin-like receptor for ubiquitin (Pru) domain within Rpn13. Using mutational analysis and NMR, we find that Pru binding involves the hydrophobic patch surrounding Ile-44 in the parkin Ubl, a region that is highly conserved between ubiquitin and Ubl domains. However, compared with ubiquitin, the parkin Ubl exhibits greater than 10-fold higher affinity for the Pru domain. Moreover, knockdown of Rpn13 in cells increases parkin levels and abrogates parkin recruitment to the 26 S proteasome, establishing Rpn13 as the major proteasomal receptor for parkin. In contrast, silencing Rpn13 did not impair parkin recruitment to mitochondria or parkin-mediated mitophagy upon carbonyl cyanide m-chlorophenyl hydrazone-induced mitochondrial depolarization. However, it did delay the clearance of mitochondrial proteins (TIM23, TIM44, and TOM20) and enhance parkin autoubiquitination. Taken together, these findings implicate Rpn13 in linking parkin to the 26 S proteasome and regulating the clearance of mitochondrial proteins during mitophagy.	[Aguileta, Miguel A.; Durcan, Thomas M.; Haber, Michael; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Aguileta, Miguel A.; Durcan, Thomas M.; Haber, Michael; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Korac, Jelena; Fon, Edward A.] Univ Split, Sch Med, Split 21000, Croatia; [Trempe, Jean-Francois; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Elsasser, Suzanne] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Waidmann, Oliver; Husnjak, Koraljka] Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany	McGill University; McGill University; University of Split; McGill University; Harvard University; Harvard Medical School; Goethe University Frankfurt	Husnjak, K (corresponding author), Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany.	husnjak@biochem2.de	Prlic, Jelena Korac/AAJ-1029-2021; Prlic, Jelena Korac/I-7988-2012; Husnjak, Koraljka/C-3717-2015; Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Prlic, Jelena Korac/0000-0002-7840-9979; Prlic, Jelena Korac/0000-0002-7840-9979; Husnjak, Koraljka/0000-0003-0573-6239; Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-62714, MOP-125924]; LOEWE program of the State of Hesse (Germany); Consejo Nacional de Ciencia y Tecnologia Scholarship [206679/303781]; City of Split, Croatia; National Institutes of Health [GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM043601] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); LOEWE program of the State of Hesse (Germany); Consejo Nacional de Ciencia y Tecnologia Scholarship; City of Split, Croatia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-62714 and MOP-125924, as well as the LOEWE program of the State of Hesse (Germany).; Supported by Consejo Nacional de Ciencia y Tecnologia Scholarship 206679/303781.; Supported by National Institutes of Health Grant GM043601.	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Finney N, 2003, J BIOL CHEM, V278, P16054, DOI 10.1074/jbc.C300051200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Safadi SS, 2011, BIOCHEMISTRY-US, V50, P2603, DOI 10.1021/bi200065g; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Um JW, 2010, J NEUROSCI, V30, P11805, DOI 10.1523/JNEUROSCI.2862-09.2010; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	61	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7492	7505		10.1074/jbc.M114.614925	http://dx.doi.org/10.1074/jbc.M114.614925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25666615	Green Published, hybrid			2022-12-26	WOS:000351613600017
J	Cai, SP; Huang, LY; Zou, J; Jing, LL; Zhai, BZ; Ji, GJ; von Deneen, KM; Ren, JC; Ren, AF				Cai, Suping; Huang, Liyu; Zou, Jia; Jing, Longlong; Zhai, Buzhong; Ji, Gongjun; von Deneen, Karen M.; Ren, Junchan; Ren, Aifeng		Alzheimer's Dis Neuroimaging Initi	Changes in Thalamic Connectivity in the Early and Late Stages of Amnestic Mild Cognitive Impairment: A Resting-State Functional Magnetic Resonance Study from ADNI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; WORKING-MEMORY; EPISODIC MEMORY; BASAL GANGLIA; DEFAULT MODE; HEAD MOTION; CORTEX; MRI; IMPACT; BRAIN	We used resting-state functional magnetic resonance imaging (fMRI) to investigate changes in the thalamus functional connectivity in early and late stages of amnestic mild cognitive impairment. Data of 25 late stages of amnestic mild cognitive impairment (LMCI) patients, 30 early stages of amnestic mild cognitive impairment (EMCI) patients and 30 well-matched healthy controls (HC) were analyzed from the Alzheimer's disease Neuroimaging Initiative (ADNI). We focused on the correlation between low frequency fMRI signal fluctuations in the thalamus and those in all other brain regions. Compared to healthy controls, we found functional connectivity between the left/right thalamus and a set of brain areas was decreased in LMCI and/or EMCI including right fusiform gyrus (FG), left and right superior temporal gyrus, left medial frontal gyrus extending into supplementary motor area, right insula, left middle temporal gyrus (MTG) extending into middle occipital gyrus (MOG). We also observed increased functional connectivity between the left/right thalamus and several regions in LMCI and/or EMCI including left FG, right MOG, left and right precuneus, right MTG and left inferior temporal gyrus. In the direct comparison between the LMCI and EMCI groups, we obtained several brain regions showed thalamus-seeded functional connectivity differences such as the precentral gyrus, hippocampus, FG and MTG. Briefly, these brain regions mentioned above were mainly located in the thalamo-related networks including thalamo-hippocampus, thalamo-temporal, thalamo-visual, and thalamo-default mode network. The decreased functional connectivity of the thalamus might suggest reduced functional integrity of thalamo-related networks and increased functional connectivity indicated that aMCI patients could use additional brain resources to compensate for the loss of cognitive function. Our study provided a new sight to understand the two important states of aMCI and revealed resting-state fMRI is an appropriate method for exploring pathophysiological changes in aMCI.	[Cai, Suping; Huang, Liyu; Zou, Jia; Jing, Longlong; Zhai, Buzhong; von Deneen, Karen M.; Ren, Junchan; Ren, Aifeng] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China; [Ji, Gongjun] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou 311121, Zhejiang, Peoples R China	Xidian University	Huang, LY (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.	huangly@mail.xidian.edu.cn		JI, Gong-Jun/0000-0002-7073-5534; Ren, Aifeng/0000-0003-1129-5601	National Natural Science Foundation of China [81071221, 31271063]; National Institutes of Health (NIH) [U01 AG024904, P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China under grant NO. 81071221 and 31271063. The ADNI work was supported by National Institutes of Health (NIH) Grant U01 AG024904, NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chao-Gan Y, 2010, FRONTIERS SYSTEMS NE, V4, DOI [10.3389/fnsys.2010.00158, DOI 10.3389/FNSYS.2010.00158]; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; DELAPAZ RL, 1994, RADIOGRAPHICS, V14, P1045, DOI 10.1148/radiographics.14.5.7991813; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Di Paola M, 2007, J NEUROL, V254, P774, DOI 10.1007/s00415-006-0435-1; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043; Hunt A, 2007, PSYCHIAT RES-NEUROIM, V155, P147, DOI 10.1016/j.pscychresns.2006.12.003; Huntley J, 2011, BRIT J PSYCHIAT, V198, P398, DOI 10.1192/bjp.bp.110.083857; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kim DJ, 2013, HUM BRAIN MAPP, V34, P1371, DOI 10.1002/hbm.21517; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Murayama N, 2010, PSYCHOGERIATRICS, V10, P62, DOI 10.1111/j.1479-8301.2010.00316.x; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Ota M, 2007, NEUROREPORT, V18, P1071, DOI 10.1097/WNR.0b013e3281c10e27; Panayiotopoulos CP, 1999, J NEUROL NEUROSUR PS, V66, P536, DOI 10.1136/jnnp.66.4.536; Pearlson GD, 1997, PROG NEURO-PSYCHOPH, V21, P1203, DOI 10.1016/S0278-5846(97)00159-0; Pergola G, 2013, NEUROIMAGE, V74, P195, DOI 10.1016/j.neuroimage.2013.02.017; Peterburs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021517; Peters F, 2009, BRAIN, V132, P1833, DOI 10.1093/brain/awp075; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raettig T, 2008, NEUROIMAGE, V39, P1420, DOI 10.1016/j.neuroimage.2007.09.030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540; Zhou B, 2013, CURR ALZHEIMER RES, V10, P754, DOI 10.2174/15672050113109990146; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	57	42	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115573	10.1371/journal.pone.0115573	http://dx.doi.org/10.1371/journal.pone.0115573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679386	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600008
J	Takeda, K; Matsumura, H; Ishida, T; Samejima, M; Ohno, H; Yoshida, M; Igarashi, K; Nakamura, N				Takeda, Kouta; Matsumura, Hirotoshi; Ishida, Takuya; Samejima, Masahiro; Ohno, Hiroyuki; Yoshida, Makoto; Igarashi, Kiyohiko; Nakamura, Nobuhumi			Characterization of a Novel PQQ-Dependent Quinohemoprotein Pyranose Dehydrogenase from Coprinopsis cinerea Classified into Auxiliary Activities Family 12 in Carbohydrate-Active Enzymes	PLOS ONE			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; CELLULOSE-BINDING DOMAINS; CELLOBIOSE DEHYDROGENASE; PHANEROCHAETE-CHRYSOSPORIUM; PYRROLOQUINOLINE QUINONE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; GLUCONOBACTER-SUBOXYDANS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER	The basidiomycete Coprinopsis cinerea contains a quinohemoprotein (CcPDH named as CcSDH in our previous paper), which is a new type of pyrroloquinoline-quinone (PQQ)-dependent pyranose dehydrogenase and is the first found among all eukaryotes. This enzyme has a three-domain structure consisting of an N-terminal heme b containing a cytochrome domain that is homologous to the cytochrome domain of cellobiose dehydrogenase (CDH; EC 1.1.99.18) from the wood-rotting basidiomycete Phanerochaete chrysosporium, a C-terminal family 1-type carbohydrate-binding module, and a novel central catalytic domain containing PQQ as a cofactor. Here, we describe the biochemical and electrochemical characterization of recombinant CcPDH. UV-vis and resonance Raman spectroscopic studies clearly reveal characteristics of a 6-coordinated low-spin heme b in both the ferric and ferrous states, as well as intramolecular electron transfer from the PQQ to heme b. Moreover, the formal potential of the heme was evaluated to be 130 mV vs. NHE by cyclic voltammetry. These results indicate that the cytochrome domain of CcPDH possesses similar biophysical properties to that in CDH. A comparison of the conformations of monosaccharides as substrates and the associated catalytic efficiency (k(cat)/K-m) of CcPDH indicates that the enzyme prefers monosaccharides with equatorial C-2, C-3 hydroxyl groups and an axial C-4 hydroxyl group in the C-1(4) chair conformation. Furthermore, a binding study shows a high binding affinity of CcPDH for cellulose, suggesting that CcPDH function is related to the enzymatic degradation of plant cell wall.	[Takeda, Kouta; Ohno, Hiroyuki; Nakamura, Nobuhumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Matsumura, Hirotoshi; Ishida, Takuya; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Tokyo, Japan; [Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; Tokyo University of Agriculture & Technology	Yoshida, M (corresponding author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan.	ymakoto@cc.tuat.ac.jp; aquarius@mail.ecc.u-tokyo.ac.jp; nobu1@cc.tuat.ac.jp	Nakamura, Nobuhumi/C-1972-2013; Igarashi, Kiyohiko/E-6799-2016; Takeda, Kouta/G-6554-2016; Yoshida, Makoto/E-8017-2013; Ohno, Hiroyuki/F-6459-2012	Nakamura, Nobuhumi/0000-0002-5373-2972; Igarashi, Kiyohiko/0000-0001-5152-7177; Ohno, Hiroyuki/0000-0001-9716-3495; Takeda, Kouta/0000-0001-5227-4132	Japan Society for the Promotion of Science (JSPS) [21605004]; Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114008]; JSPS [268641, 208304]; Grants-in-Aid for Scientific Research [14J08641] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported financially by a Grant-in-Aid for Scientific Research (No. 21605004 to N.N.) from the Japan Society for the Promotion of Science (JSPS), by a Grant-in-Aid for Innovative Areas (No. 24114001 and 24114008 to K.I.) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT), and by a Grant-in-Aid for JSPS Fellows (Grant No. 268641 to K.T.). H.M. was supported by a Grant-in-Aid for JSPS Fellows (Grant No. 208304) during his postdoc period at the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAMA M, 1981, AGR BIOL CHEM TOKYO, V45, P851, DOI 10.1080/00021369.1981.10864633; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Babot ED, 2013, BIOTECHNOL BIOENG, V110, P2323, DOI 10.1002/bit.24904; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Freimund S, 2002, CARBOHYD RES, V337, P1585, DOI 10.1016/S0008-6215(02)00261-6; GEIGER O, 1989, BIOCHEM J, V261, P415, DOI 10.1042/bj2610415; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROEN BW, 1986, BIOCHEM J, V234, P611, DOI 10.1042/bj2340611; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hallberg BM, 2000, STRUCT FOLD DES, V8, P79, DOI 10.1016/S0969-2126(00)00082-4; Hancock RD, 2002, TRENDS BIOTECHNOL, V20, P299, DOI 10.1016/S0167-7799(02)01991-1; Henriksson G, 1997, BIOCHEM J, V324, P833, DOI 10.1042/bj3240833; HENRIKSSON G, 1991, EUR J BIOCHEM, V196, P101, DOI 10.1111/j.1432-1033.1991.tb15791.x; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hoshino T, 2003, BBA-PROTEINS PROTEOM, V1647, P278, DOI 10.1016/S1570-9639(03)00071-2; Igarashi K, 1999, J BIOL CHEM, V274, P3338, DOI 10.1074/jbc.274.6.3338; Igarashi K, 2005, FEBS J, V272, P2869, DOI 10.1111/j.1742-4658.2005.04707.x; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Karapetyan KN, 2006, J BIOTECHNOL, V121, P34, DOI 10.1016/j.jbiotec.2005.06.024; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ludwig R, 2013, ANAL BIOANAL CHEM, V405, P3637, DOI 10.1007/s00216-012-6627-x; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; Matsumura H, 2012, LANGMUIR, V28, P10925, DOI 10.1021/la3018858; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; MUTZEL A, 1991, AGR BIOL CHEM TOKYO, V55, P1721, DOI 10.1080/00021369.1991.10870854; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olsthoorn AJJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P42, DOI 10.1006/abbi.1996.0530; Olsthoorn AJJ, 1998, BIOCHEMISTRY-US, V37, P13854, DOI 10.1021/bi9808868; Ortiz R, 2012, ANAL CHEM, V84, P10315, DOI 10.1021/ac3022899; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Oubrie A, 2003, BBA-PROTEINS PROTEOM, V1647, P143, DOI 10.1016/S1570-9639(03)00087-6; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; RENGANATHAN V, 1990, APPL MICROBIOL BIOT, V32, P609, DOI 10.1007/BF00173735; Rotsaert FAJ, 2003, J BIOL CHEM, V278, P33224, DOI 10.1074/jbc.M302653200; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; Salusjarvi Tuomas, 2004, Appl Environ Microbiol, V70, P5503, DOI 10.1128/AEM.70.9.5503-5510.2004; SAMEJIMA M, 1992, EUR J BIOCHEM, V207, P103, DOI 10.1111/j.1432-1033.1992.tb17026.x; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200; Sugimoto N, 2012, PROTEIN EXPRES PURIF, V82, P290, DOI 10.1016/j.pep.2012.01.007; Takeda K, 2013, BIOELECTROCHEMISTRY, V94, P75, DOI 10.1016/j.bioelechem.2013.08.001; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yamada M, 2003, BBA-PROTEINS PROTEOM, V1647, P185, DOI 10.1016/S1570-9639(03)00100-6; Yoshida M, 2005, APPL ENVIRON MICROB, V71, P4548, DOI 10.1128/AEM.71.8.4548-4555.2005; Yoshida M, 2009, BIOSCI BIOTECH BIOCH, V73, P67, DOI 10.1271/bbb.80477	67	25	26	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115722	10.1371/journal.pone.0115722	http://dx.doi.org/10.1371/journal.pone.0115722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679509	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600009
J	Izuhara, L; Tatsumi, N; Miyagawa, S; Iwai, S; Watanabe, M; Yamanaka, S; Katsuoka, Y; Nagashima, H; Okano, HJ; Yokoo, T				Izuhara, Luna; Tatsumi, Norifumi; Miyagawa, Shuji; Iwai, Satomi; Watanabe, Masahito; Yamanaka, Shuichiro; Katsuoka, Yuichi; Nagashima, Hiroshi; Okano, Hirotaka J.; Yokoo, Takashi			Generation of a Felinized Swine Endothelial Cell Line by Expression of Feline Decay-Accelerating Factor	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COMPLEMENT REGULATORY PROTEINS; CHRONIC-RENAL-FAILURE; TRANSGENIC PIG; HYPERACUTE REJECTION; NONHUMAN PRIMATE; ERYTHROPOIETIN; SITES; CATS; GENE	Embryonic stem cell research has facilitated the generation of many cell types for the production of tissues and organs for both humans and companion animals. Because >= 30% of pet cats suffer from chronic kidney disease (CKD), xenotransplantation between pigs and cats has been studied. For a successful pig to cat xenotransplant, the immune reaction must be overcome, especially hyperacute rejection. In this study, we isolated the gene for feline decay-accelerating factor (fDAF), an inhibitor of complement proteins, and transfected a swine endothelial cell line with fDAF to "felinize" the pig cells. These fDAF-expressing cells were resistant to feline serum containing anti-pig antibodies, suggesting that felinized pig cells were resistant to hyperacute rejection. Our results suggest that a "felinized" pig kidney can be generated for the treatment of CKD in cats in the future.	[Izuhara, Luna; Yamanaka, Shuichiro; Katsuoka, Yuichi; Okano, Hirotaka J.] Jikei Univ, Sch Med, Div Regenerat Med, Tokyo, Japan; [Tatsumi, Norifumi] Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan; [Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Regenerat Med, Div Organ Transplantat, Osaka, Japan; [Iwai, Satomi] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan; [Yamanaka, Shuichiro; Nagashima, Hiroshi] Meiji Univ, Int Inst Bio Resource Res, Kawasaki, Kanagawa, Japan; [Yamanaka, Shuichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan	Jikei University; Jikei University; Osaka University; Kitasato University; Meiji University; Jikei University	Yokoo, T (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	tyokoo@jikei.ac.jp	Okano, Hideyuki/I-7584-2019	Nagashima, Hiroshi/0000-0001-9940-8783; Tatsumi, Norifumi/0000-0001-6640-150X; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Health, Labour and Welfare of Japan; Adaptable and Seamless Technology transfer Program from Japan Science and Technology Agency [AS242Z01218N]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Adaptable and Seamless Technology transfer Program from Japan Science and Technology Agency	This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan and a Adaptable and Seamless Technology transfer Program (AS242Z01218N) from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2011, CELLULAR MOL IMMUNOL, DOI [10.1038/cmi.2011.48, DOI 10.1038/CMI.2011.48]; Cowgill LD, 1998, J AM VET MED ASSOC, V212, P521; DALMASSO AP, 1992, AM J PATHOL, V140, P1157; de la Lastra JMP, 2000, J IMMUNOL, V165, P2563, DOI 10.4049/jimmunol.165.5.2563; Diaz-Roman TM, 2006, TRANSPL IMMUNOL, V16, P125, DOI 10.1016/j.trim.2006.03.008; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Elliott J, 2000, J SMALL ANIM PRACT, V41, P235, DOI 10.1111/j.1748-5827.2000.tb03932.x; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Hensel F, 2001, LAB INVEST, V81, P1553, DOI 10.1038/labinvest.3780369; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Jones M, 2004, KIDNEY INT, V65, P757, DOI 10.1111/j.1523-1755.2004.00450.x; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kunii H, 1998, Fukushima J Med Sci, V44, P69; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; LUBLIN DM, 1991, J EXP MED, V174, P35, DOI 10.1084/jem.174.1.35; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Marchetti S, 2002, J CELL SCI, V115, P2075; Matsumoto K, 2012, STEM CELLS, V30, P1228, DOI 10.1002/stem.1101; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; MIYAGAWA S, 1994, TRANSPLANTATION, V58, P834, DOI 10.1097/00007890-199410150-00015; Murakami H, 2002, MOL REPROD DEV, V61, P302, DOI 10.1002/mrd.10043; PETERSON ME, 1995, J AM VET MED ASSOC, V207, P1422; PLATT JL, 1990, TRANSPLANTATION, V50, P817, DOI 10.1097/00007890-199011000-00015; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; Randolph JF, 2004, AM J VET RES, V65, P1355, DOI 10.2460/ajvr.2004.65.1355; Rees MA, 2002, TRANSPLANTATION, V73, P1194, DOI 10.1097/00007890-200204270-00003; Roy BB, 2006, J EXP ZOOL PART B, V306B, P59, DOI 10.1002/jez.b.21072; Schuurman HJ, 2002, TRANSPLANTATION, V73, P1146, DOI 10.1097/00007890-200204150-00024; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Yokoo T, 2008, MED MOL MORPHOL, V41, P5, DOI 10.1007/s00795-008-0396-9; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Yokoo T, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/591731	38	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117682	10.1371/journal.pone.0117682	http://dx.doi.org/10.1371/journal.pone.0117682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671605	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300067
J	Kawafune, K; Hongoh, Y; Hamaji, T; Sakamoto, T; Kurata, T; Hirooka, S; Miyagishima, SY; Nozaki, H				Kawafune, Kaoru; Hongoh, Yuichi; Hamaji, Takashi; Sakamoto, Tomoaki; Kurata, Tetsuya; Hirooka, Shunsuke; Miyagishima, Shin-ya; Nozaki, Hisayoshi			Two Different Rickettsial Bacteria Invading Volvox carteri	PLOS ONE			English	Article							GENE-TRANSFER; PHYLOGENIES; EVOLUTION; PROTIST; MODELS; LOCUS	Background Bacteria of the family Rickettsiaceae are principally associated with arthropods. Recently, endosymbionts of the Rickettsiaceae have been found in non-phagotrophic cells of the volvocalean green algae Carteria cerasiformis, Pleodorina japonica, and Volvox carteri. Such endosymbionts were present in only C. cerasiformis strain NIES-425 and V. carteri strain UTEX 2180, of various strains of Carteria and V. carteri examined, suggesting that rickettsial endosymbionts may have been transmitted to only a few algal strains very recently. However, in preliminary work, we detected a sequence similar to that of a rickettsial gene in the nuclear genome of V. carteri strain EVE. Methodology/Principal Findings Here we explored the origin of the rickettsial gene-like sequences in the endosymbiont-lacking V. carteri strain EVE, by performing comparative analyses on 13 strains of V. carteri. By reference to our ongoing genomic sequence of rickettsial endosymbionts in C. cerasiformis strain NIES-425 cells, we confirmed that an approximately 9-kbp DNA sequence encompassing a region similar to that of four rickettsial genes was present in the nuclear genome of V. carteri strain EVE. Phylogenetic analyses, and comparisons of the synteny of rickettsial gene-like sequences from various strains of V. carteri, indicated that the rickettsial gene-like sequences in the nuclear genome of V. carteri strain EVE were closely related to rickettsial gene sequences of P. japonica, rather than those of V. carteri strain UTEX 2180. Conclusion/Significance At least two different rickettsial organisms may have invaded the V. carteri lineage, one of which may be the direct ancestor of the endosymbiont of V. carteri strain UTEX 2180, whereas the other may be closely related to the endosymbiont of P. japonica. Endosymbiotic gene transfer from the latter rickettsial organism may have occurred in an ancestor of V. carteri. Thus, the rickettsiae may be widely associated with V. carteri, and likely have often been lost during host evolution.	[Kawafune, Kaoru; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Hongoh, Yuichi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Meguro Ku, Tokyo 152, Japan; [Hamaji, Takashi] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma, Nara, Japan; [Hirooka, Shunsuke; Miyagishima, Shin-ya] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan	University of Tokyo; Tokyo Institute of Technology; Donald Danforth Plant Science Center; Nara Institute of Science & Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kawafune, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	kawafune@bs.s.u-tokyo.ac.jp	Hongoh, Yuichi/A-2303-2014	Hongoh, Yuichi/0000-0002-5901-9625; Miyagishima, Shin-ya/0000-0002-9111-0832; Nozaki, Hisayoshi/0000-0002-9308-4498; Hamaji, Takashi/0000-0002-2801-2148; Sakamoto, Tomoaki/0000-0002-1583-0993	Nara Institute of Science and Technology [24-9265]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [26117708, 24247042]	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	This work was supported by Grants-in-Aid for JSPS Fellows (No. 24-9265 to KK), Scientific Research for Plant Graduate Students from Nara Institute of Science and Technology (to TS and TK), Scientific Research on Innovative Areas (No. 26117708 to HN) and Scientific Research (A) (No. 24247042 to HN) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Coleman AW, 1999, P NATL ACAD SCI USA, V96, P13892, DOI 10.1073/pnas.96.24.13892; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Dumler JS, 2005, BERGEYS MANUAL OF SY, V2, DOI [10.1097/01.NURSE.0000459798.79840.95, DOI 10.1097/01.NURSE.0000459798.79840.95]; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris EH, 1989, THE CHLAMYDOMONAS SO; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hiraide R, 2013, MOL BIOL EVOL, V30, P1038, DOI 10.1093/molbev/mst018; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Kawafune K, 2014, PHYCOLOGIA, V53, P95, DOI 10.2216/13-193.1; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; Kikuchi Y, 2005, MICROBIAL ECOL, V49, P265, DOI 10.1007/s00248-004-0140-5; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato T, 2014, ISME J, V8, P1008, DOI 10.1038/ismej.2013.222; Schrallhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072581; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Vannini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087718; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Yu XJ, 2012, BIOTERRORISM, P179; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116192	10.1371/journal.pone.0116192	http://dx.doi.org/10.1371/journal.pone.0116192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671568	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300017
J	Nijhof, AD; Willems, RM				Nijhof, Annabel D.; Willems, Roel M.			Simulating Fiction: Individual Differences in Literature Comprehension Revealed with fMRI	PLOS ONE			English	Article							COGNITIVE-PROCESSES; SOCIAL COGNITION; NEURAL BASES; SYSTEMS; MOTOR; AREAS; MIND; REPRESENTATIONS; ACTIVATIONS; INFERENCE	When we read literary fiction, we are transported to fictional places, and we feel and think along with the characters. Despite the importance of narrative in adult life and during development, the neurocognitive mechanisms underlying fiction comprehension are unclear. We used functional magnetic resonance imaging (fMRI) to investigate how individuals differently employ neural networks important for understanding others' beliefs and intentions (mentalizing), and for sensori-motor simulation while listening to excerpts from literary novels. Localizer tasks were used to localize both the cortical motor network and the mentalizing network in participants after they listened to excerpts from literary novels. Results show that participants who had high activation in anterior medial prefrontal cortex (aMPFC; part of the mentalizing network) when listening to mentalizing content of literary fiction, had lower motor cortex activity when they listened to action-related content of the story, and vice versa. This qualifies how people differ in their engagement with fiction: some people are mostly drawn into a story by mentalizing about the thoughts and beliefs of others, whereas others engage in literature by simulating more concrete events such as actions. This study provides on-line neural evidence for the existence of qualitatively different styles of moving into literary worlds, and adds to a growing body of literature showing the potential to study narrative comprehension with neuroimaging methods.	[Nijhof, Annabel D.; Willems, Roel M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Willems, Roel M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society	Willems, RM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	roel.willems@donders.ru.nl		Nijhof, Annabel/0000-0002-4153-1284; Willems, Roel/0000-0002-4963-5387	Donders Institute for Brain, Cognition and Behaviour	Donders Institute for Brain, Cognition and Behaviour	The authors received funding from the Donders Institute for Brain, Cognition and Behaviour for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann U, 2014, SOC COGN AFFECT NEUR, V9, P22, DOI 10.1093/scan/nss098; Altmann U, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00192; [Anonymous], 2006, SIMULATING MINDS PHI; Barker R.G.., 1951, ONE BOYS DAY SPECIME; Boersma P, 2021, PRAAT DOING PHONETIC; Boyd B, 2009, ORIGIN STORIES EVOLU, DOI [10.1007/s10916-009-9391-5, DOI 10.1007/S10916-009-9391-5]; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Bruner J, 1986, ACTUAL MINDS POSSIBL; Bruner J.S, 1984, LANGUAGE MIND READIN; Buchweitz Augusto, 2009, Psychol. Neurosci., V2, P111, DOI 10.3922/j.psns.2009.2.003; Burke M, 2010, LIT READING COGNITIO, DOI [10.1111/j.1758-8111.2010.00001.x, DOI 10.1111/J.1758-8111.2010.00001.X]; Busselle R, 2009, MEDIA PSYCHOL, V12, P321, DOI 10.1080/15213260903287259; Chow HM, 2014, J COGNITIVE NEUROSCI, V26, P279, DOI 10.1162/jocn_a_00487; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Deen B, 2010, NEUROPSYCHOLOGIA, V48, P1607, DOI 10.1016/j.neuropsychologia.2010.01.028; Dils AT, 2010, P NATL ACAD SCI USA, V107, P16396, DOI 10.1073/pnas.1009438107; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Ferstl EC, 2010, ITAL J LINGUIST, V22, P61; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fong K, 2013, PSYCHOL AESTHET CREA, V7, P370, DOI 10.1037/a0034084; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gerrig R, 2011, SCI STUDY LIT, V1, P88, DOI DOI 10.1075/SS0L.1.1.09GER; Gerrig R.J., 1999, EXPERIENCING NARRATI; Gibbs J, 2011, SCI STUDY LIT, V1, P95; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hakemulder F, 2011, SCI STUDY LIT, V1, P144; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hejnar MR, 2007, HUM BRAIN MAPP, V28, P860, DOI 10.1002/hbm.20321; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jacobs AM, 2015, COGNITIVE NEUROSCIENCE OF NATURAL LANGUAGE USE, P135; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; LONG SA, 1989, READ RES QUART, V24, P353, DOI 10.2307/747774; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2006, J RES PERS, V40, P694, DOI 10.1016/j.jrp.2005.08.002; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mars RB, 2013, P NATL ACAD SCI USA, V110, P10806, DOI 10.1073/pnas.1302956110; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; Metz-Lutz MN, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00059; Myers R., 1990, CLASSICAL MODERN REG; Nell V, 1988, LOST BOOK PSYCHOL RE, DOI [10.1016/0169-5347(88)90090-0, DOI 10.1016/0169-5347(88)90090-0]; Oostdijk N., 2000, P 2 INT C LANG RES E, P887; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Speer NK, 2009, PSYCHOL SCI, V20, P989, DOI 10.1111/j.1467-9280.2009.02397.x; Spunt RP, 2012, J NEUROSCI, V32, P3575, DOI 10.1523/JNEUROSCI.5715-11.2012; Steen G, 2011, HUM COGN PROCESS, V30, P21; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Van Overwalle F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00560; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wallentin M, 2011, BRAIN LANG, V119, P221, DOI 10.1016/j.bandl.2011.04.006; Wallentin M, 2011, NEUROIMAGE, V58, P963, DOI 10.1016/j.neuroimage.2011.06.077; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Willems RM, 2010, J COGNITIVE NEUROSCI, V22, P2387, DOI 10.1162/jocn.2009.21386; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072; Zacks JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00168; ZWAAN RA, 1995, PSYCHOL SCI, V6, P292, DOI 10.1111/j.1467-9280.1995.tb00513.x	72	42	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0116492	10.1371/journal.pone.0116492	http://dx.doi.org/10.1371/journal.pone.0116492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671708	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300021
J	Gu, WJ; Zhu, Y; Wang, HK; Zhang, HL; Shi, GH; Liu, XH; Ye, DW				Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Liu, Xiaohang; Ye, Dingwei			Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series	PLOS ONE			English	Article							VISCERAL OBESITY; CHEMOTHERAPY; VALIDATION; PREDICTORS; BIOMARKER; SURVIVAL; TISSUE; MODEL; FAT	Background To evaluate the association between various components of body composition and overall survival of patients treated with targeted therapies for advanced renal cell carcinoma. Methods This retrospective study included 124 Chinese patients with advanced renal cell carcinoma who had been treated with targeted therapy from 2008 to 2012 at Fudan University Cancer Center. The L3 plane from a computed tomography scan was analyzed. Area and density were recorded as quantitative and quality measures. Univariate and multivariate Cox proportion hazard regression models were constructed to calculate the crude and adjusted hazard ratio (HR) of various components of body composition for overall survival. X-tile software was used to search for optimal cutoffs for male and female patients and the concordance index evaluated incremental changes in prognostication. Results After adjusting for age, sex and Heng risk stratification, only visceral adipose tissue index (HR 0.981, p = 0.002) and subcutaneous adipose tissue index (HR 0.987, p = 0.048) were independently associated with overall survival. Visceral adipose tissue remained a significant prognostic factor (HR 0.997, p = 0.005) when the influence of body mass index was included. Using defined cutoffs, patients with low VAT had double the death rate (p = 0.007). Visceral adipose tissue also added significant benefit to Heng risk stratification. Further exploratory analysis revealed that visceral adipose tissue may be an indicator of nutritional status in patients with advanced renal cell carcinoma. Conclusion Radiologic measurement of VAT is an independent prognostic factor for Asian patients treated with targeted therapy for advanced renal cell carcinoma.	[Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Ye, Dingwei] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Liu, Xiaohang] Fudan Univ, Dept Radiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Gu, Weijie; Zhu, Yao; Wang, Hongkai; Zhang, Hailiang; Shi, Guohai; Liu, Xiaohang; Ye, Dingwei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Ye, DW (corresponding author), Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	dwye.shca@gmail.com	Zhang, Hailiang/AAF-4937-2020		national natural science foundation of China [81001131]	national natural science foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the national natural science foundation of China (Grant No. 81001131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Antoun S, 2014, EXPERT REV ANTICANC, P1, DOI [10.1586/14737140.2015.992420, DOI 10.1586/14737140.2015.992420]; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Aslani A, 2000, CANCER-AM CANCER SOC, V88, P796, DOI 10.1002/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Choueiri T, 2010, J CLIN ONCOL, P4524, DOI DOI 10.1200/JCO.2010.28.15_SUPPL.4524; Chuang MJ, 2008, CANCER SCI, V99, P905, DOI 10.1111/j.1349-7006.2008.00756.x; Clark W, 2013, J AM COLL SURGEONS, V216, P1070, DOI 10.1016/j.jamcollsurg.2013.01.007; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Guiu B, 2010, GUT, V59, P341, DOI 10.1136/gut.2009.188946; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen GL, 2013, JPEN-PARENTER ENTER, V37, P802, DOI 10.1177/0148607113492338; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Motzer RJ, 2012, J CLIN ONCOL, V30, P1371, DOI 10.1200/JCO.2011.36.4133; Naya Y, 2010, UROL INT, V85, P30, DOI 10.1159/000318988; OGIWARA H, 1994, J SURG ONCOL, V57, P129, DOI 10.1002/jso.2930570211; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Salas S, 2008, RADIOTHER ONCOL, V87, P195, DOI 10.1016/j.radonc.2008.02.011; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Steffens S, 2011, ONCOLOGIST, V16, P1565, DOI 10.1634/theoncologist.2011-0213; Thibault R, 2012, CLIN NUTR, V31, P435, DOI 10.1016/j.clnu.2011.12.011; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2005, PHYSIOLOGY, V20, P340, DOI 10.1152/physiol.00019.2005; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; Zhu Y, 2013, J UROLOGY, V189, P447, DOI 10.1016/j.juro.2012.09.030	34	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0118022	10.1371/journal.pone.0118022	http://dx.doi.org/10.1371/journal.pone.0118022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668688	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000035
J	Jansen, SEM; Tiest, WMB; Kappers, AML				Jansen, Sander E. M.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Haptic Exploratory Behavior During Object Discrimination: A Novel Automatic Annotation Method	PLOS ONE			English	Article							HAND; RECOGNITION; SYSTEM	In order to acquire information concerning the geometry and material of handheld objects, people tend to execute stereotypical hand movement patterns called haptic Exploratory Procedures (EPs). Manual annotation of haptic exploration trials with these EPs is a laborious task that is affected by subjectivity, attentional lapses, and viewing angle limitations. In this paper we propose an automatic EP annotation method based on position and orientation data from motion tracking sensors placed on both hands and inside a stimulus. A set of kinematic variables is computed from these data and compared to sets of predefined criteria for each of four EPs. Whenever all criteria for a specific EP are met, it is assumed that that particular hand movement pattern was performed. This method is applied to data from an experiment where blindfolded participants haptically discriminated between objects differing in hardness, roughness, volume, and weight. In order to validate the method, its output is compared to manual annotation based on video recordings of the same trials. Although mean pairwise agreement is less between human-automatic pairs than between human-human pairs (55.7% vs 74.5%), the proposed method performs much better than random annotation (2.4%). Furthermore, each EP is linked to a specific object property for which it is optimal (e. g., Lateral Motion for roughness). We found that the percentage of trials where the expected EP was found does not differ between manual and automatic annotation. For now, this method cannot yet completely replace a manual annotation procedure. However, it could be used as a starting point that can be supplemented by manual annotation.	[Jansen, Sander E. M.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Jansen, SEM (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands.	s.e.m.jansen@vu.nl		Kappers, Astrid/0000-0003-4101-7717	European Commission within program "Cognitive Systems and Robotics." [FP7-ICT-2009-4-2-1]; Collaborative Project "THE Hand Embodied," [248587]	European Commission within program "Cognitive Systems and Robotics."; Collaborative Project "THE Hand Embodied,"	This work has been supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied," within the FP7-ICT-2009-4-2-1 program " Cognitive Systems and Robotics." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; COREN S, 1993, PERCEPT MOTOR SKILL, V76, P1035, DOI 10.2466/pms.1993.76.3.1035; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Holden EJ, 1996, INT J EXPERT SYST, V9, P465; Jansen SEM, 2013, IEEE T HAPTICS, V6, P464, DOI [10.1109/ToH.2013.22, 10.1109/TOH.2013.22]; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Klatzky RL, 2009, SCHOLARPEDIA, V4, P7941, DOI [10.4249/scholarpedia.7941, DOI 10.4249/SCHOLARPEDIA.7941]; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Oz C, 2011, ENG APPL ARTIF INTEL, V24, P1204, DOI 10.1016/j.engappai.2011.06.015; van Dam EA, 2013, J NEUROSCI METH, V218, P214, DOI 10.1016/j.jneumeth.2013.05.012; van Polanen V, 2012, ATTEN PERCEPT PSYCHO, V74, P204, DOI 10.3758/s13414-011-0216-5; Wang XY, 2012, MYCOPATHOLOGIA, V173, P295, DOI 10.1007/s11046-011-9484-9; Withagen A, 2013, ATTEN PERCEPT PSYCHO, V75, P1451, DOI 10.3758/s13414-013-0479-0	13	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117017	10.1371/journal.pone.0117017	http://dx.doi.org/10.1371/journal.pone.0117017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658703	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900092
J	Kitamura, S; Morisseau, C; Inceoglu, B; Kamita, SG; De Nicola, GR; Nyegue, M; Hammock, BD				Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; De Nicola, Gina R.; Nyegue, Maximilienne; Hammock, Bruce D.			Potent Natural Soluble Epoxide Hydrolase Inhibitors from Pentadiplandra brazzeana Baillon: Synthesis, Quantification, and Measurement of Biological Activities In Vitro and In Vivo	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; DOCOSAHEXAENOIC ACID; INFLAMMATORY PAIN; UREA DERIVATIVES; MORINGA-OLEIFERA; RAT MODEL; ETHNOBOTANY; DISCOVERY; PRODUCTS; PROFILE	We describe here three urea-based soluble epoxide hydrolase (sEH) inhibitors from the root of the plant Pentadiplandra brazzeana. The concentration of these ureas in the root was quantified by LC-MS/MS, showing that 1, 3-bis (4-methoxybenzyl) urea (MMU) is the most abundant (42.3 mu g/g dry root weight). All of the ureas were chemically synthesized, and their inhibitory activity toward recombinant human and recombinant rat sEH was measured. The most potent compound, MMU, showed an IC50 of 92 nM via fluorescent assay and a Ki of 54 nM via radioactivity-based assay on human sEH. MMU effectively reduced inflammatory pain in a rat nociceptive pain assay. These compounds are among the most potent sEH inhibitors derived from natural sources. Moreover, inhibition of sEH by these compounds may mechanistically explain some of the therapeutic effects of P. brazzeana.	[Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [De Nicola, Gina R.] Ctr Ric Colture Ind CRA CIN, Consiglio Ric & Sperimentaz Agr, Bologna, Italy; [Nyegue, Maximilienne] Univ Yaounde I, Dept Biochem, Yaounde, Cameroon; [Nyegue, Maximilienne] Univ Yaounde I, Dept Microbiol, Yaounde, Cameroon	University of California System; University of California Davis; University of California System; University of California Davis; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Yaounde I; University of Yaounde I	Hammock, BD (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	bdhammock@ucdavis.edu	De Nicola, Gina Rosalinda/AAC-9218-2021; Inceoglu, Bora/G-2892-2015	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Inceoglu, Bora/0000-0002-8473-6036	National Institute of Environmental Health Sciences (NIEHS) grant [R01ES002710]; NIEHS Superfund Research Program grant [P42 ES04699]; National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH) [R21AR062866]; NIH Counter Act Program [U54 NS079202-01]; Japan Student Services Organization; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS079202] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) grant; NIEHS Superfund Research Program grant; National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Counter Act Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Student Services Organization(Japan Student Services Organization); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by National Institute of Environmental Health Sciences (NIEHS) grant R01ES002710, NIEHS Superfund Research Program grant P42 ES04699, National Institute Of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health (NIH) under Award Number R21AR062866, and NIH Counter Act Program U54 NS079202-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. SK is financially supported by Japan Student Services Organization. BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahroun A, 1985, J SOC CHIMIQUE TUNIS, V2, P15; BEETHAM JK, 1993, ARCH BIOCHEM BIOPHYS, V305, P197, DOI 10.1006/abbi.1993.1411; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Betti J.L., 2004, AFRICAN STUDY MONOGR, V25, P1, DOI DOI 10.14989/68229; BORHAN B, 1995, ANAL BIOCHEM, V231, P188, DOI 10.1006/abio.1995.1520; De Nicola GR, 2012, PHYTOCHEMISTRY, V73, P51, DOI 10.1016/j.phytochem.2011.09.006; DIXON M, 1972, BIOCHEM J, V129, P197, DOI 10.1042/bj1290197; Dounias E, 2008, PROTA; GIL V, 1980, PHYTOCHEMISTRY, V19, P1369, DOI 10.1016/0031-9422(80)80176-2; Guedes AGP, 2013, VET ANAESTH ANALG, V40, P440, DOI 10.1111/vaa.12030; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2006, LIFE SCI, V79, P2311, DOI 10.1016/j.lfs.2006.07.031; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jiofack T, 2009, AFR J PHARM PHARMACO, V3, P144; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee GH, 2014, FOOD CHEM TOXICOL, V64, P225, DOI 10.1016/j.fct.2013.11.042; Lee KSS, 2013, ANAL BIOCHEM, V434, P259, DOI 10.1016/j.ab.2012.11.015; LIN WK, 1990, BIOCHEM BIOPH RES CO, V167, P977, DOI 10.1016/0006-291X(90)90619-X; Liu JY, 2009, MOL CANCER THER, V8, P2193, DOI 10.1158/1535-7163.MCT-09-0119; Makumbelo E., 2008, Tropicultura, V26, P129; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Nakagawa Y, 2000, BIOORGAN MED CHEM, V8, P2663, DOI 10.1016/S0968-0896(00)00198-X; Nyegue M, 2009, ADV PHYTOTHERAPY RES, P91; RAY AB, 1975, CHEM IND-LONDON, P517; Reema KT, 2013, BIOORG MED CHEM LETT, V23, P3584, DOI 10.1016/j.bmcl.2013.04.019; Rodman JE, 1998, AM J BOT, V85, P997, DOI 10.2307/2446366; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Sashidhara KV, 2009, EUR J MED CHEM, V44, P432, DOI 10.1016/j.ejmech.2007.12.018; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sofrata A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023045; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; Tsopmo A, 1999, J NAT PROD, V62, P1435, DOI 10.1021/np990111f; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; WIXTROM RN, 1988, ANAL BIOCHEM, V169, P71, DOI 10.1016/0003-2697(88)90256-4; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	40	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117438	10.1371/journal.pone.0117438	http://dx.doi.org/10.1371/journal.pone.0117438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659109	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900149
J	Richter, M; Dayaram, T; Gilmartin, AG; Ganji, G; Pemmasani, SK; Van der Key, H; Shohet, JM; Donehower, LA; Kumar, R				Richter, Mark; Dayaram, Tajhal; Gilmartin, Aidan G.; Ganji, Gopinath; Pemmasani, Sandhya Kiran; Van der Key, Harjeet; Shohet, Jason M.; Donehower, Lawrence A.; Kumar, Rakesh			WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; MDM2 ANTAGONIST NUTLIN-3; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; PROTEIN PHOSPHATASE; PPM1D MUTATIONS; DOWN-REGULATION; STEM-CELLS; P53; TUMORIGENESIS	The wild-type p53-induced phosphatase 1 (WIP1) is a serine/threonine phosphatase that negatively regulates multiple proteins involved in DNA damage response including p53, CHK2, Histone H2AX, and ATM, and it has been shown to be overexpressed or amplified in human cancers including breast and ovarian cancers. We examined WIP1 mRNA levels across multiple tumor types and found the highest levels in breast cancer, leukemia, medulloblastoma and neuroblastoma. Neuroblastoma is an exclusively TP53 wild type tumor at diagnosis and inhibition of p53 is required for tumorigenesis. Neuroblastomas in particular have previously been shown to have 17q amplification, harboring the WIP1 (PPM1D) gene and associated with poor clinical outcome. We therefore sought to determine whether inhibiting WIP1 with a selective antagonist, GSK2830371, can attenuate neuroblastoma cell growth through reactivation of p53 mediated tumor suppression. Neuroblastoma cell lines with wild-type TP53 alleles were highly sensitive to GSK2830371 treatment, while cell lines with mutant TP53 were resistant to GSK2830371. The majority of tested neuroblastoma cell lines with copy number gains of the PPM1D locus were also TP53 wild-type and sensitive to GSK2830371A; in contrast cell lines with no copy gain of PPM1D were mixed in their sensitivity to WIP1 inhibition, with the primary determinant being TP53 mutational status. Since WIP1 is involved in the cellular response to DNA damage and drugs used in neuroblastoma treatment induce apoptosis through DNA damage, we sought to determine whether GSK2830371 could act synergistically with standard of care chemotherapeutics. Treatment of wild-type TP53 neuroblastoma cell lines with both GSK2830371 and either doxorubicin or carboplatin resulted in enhanced cell death, mediated through caspase 3/7 induction, as compared to either agent alone. Our data suggests that WIP1 inhibition represents a novel therapeutic approach to neuroblastoma that could be integrated with current chemotherapeutic approaches.	[Richter, Mark; Gilmartin, Aidan G.; Ganji, Gopinath; Kumar, Rakesh] GlaxoSmithKline, Oncol R&D, Collegeville, PA USA; [Dayaram, Tajhal; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Dayaram, Tajhal; Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Pemmasani, Sandhya Kiran] Ocimum Biosolut Ltd, HUDA Techno Enclave, Hyderabad, Andhra Pradesh, India; [Van der Key, Harjeet] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA; [Shohet, Jason M.] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	GlaxoSmithKline; Baylor College of Medicine; Baylor College of Medicine; GlaxoSmithKline; Baylor College of Medicine; Texas Children's Cancer Center	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	larryd@bcm.edu; rakesh.2.kumar@gsk.com	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	GlaxoSmithKline; Cancer Research and Prevention Institute of Texas [RP110040]	GlaxoSmithKline(GlaxoSmithKline); Cancer Research and Prevention Institute of Texas	Support for this research has been provided by GlaxoSmithKline (employer of MR, GG, HVDK, AGG and RK); and Cancer Research and Prevention Institute of Texas (Grant Number RP110040) (LAD).	Barone G, 2014, CURR DRUG TARGETS, V15, P114, DOI 10.2174/13894501113149990194; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; CASTRESANA JS, 1994, GENE CHROMOSOME CANC, V10, P136, DOI 10.1002/gcc.2870100209; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fuku T, 2007, PATHOL INT, V57, P566, DOI 10.1111/j.1440-1827.2007.02140.x; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; IMAMURA J, 1993, CANCER RES, V53, P4053; Kim E, 2009, JNCI-J NATL CANCER I, V101, P1527, DOI 10.1093/jnci/djp376; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Lee JS, 2009, STEM CELLS, V27, P1963, DOI 10.1002/stem.121; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2008, CELL CYCLE, V7, P164, DOI 10.4161/cc.7.2.5299; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moon SH, 2010, CELL CYCLE, V9, P2092, DOI 10.4161/cc.9.11.11810; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Saito-Ohara F, 2003, CANCER RES, V63, P1876; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; VOGAN K, 1993, CANCER RES, V53, P5269; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Zhang LW, 2014, NAT GENET, V46, P726, DOI 10.1038/ng.2995; Zhu YH, 2009, STEM CELLS, V27, P1433, DOI 10.1002/stem.65; Zhu YH, 2014, J CLIN INVEST, V124, P3263, DOI 10.1172/JCI73015	50	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0115635	10.1371/journal.pone.0115635	http://dx.doi.org/10.1371/journal.pone.0115635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658463	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900027
J	Xu, YH; Li, ZR; Yin, Y; Lan, H; Wang, J; Zhao, J; Feng, J; Li, Y; Zhang, WZ				Xu, Yanhui; Li, Ziru; Yin, Yue; Lan, He; Wang, Jun; Zhao, Jing; Feng, Juan; Li, Yin; Zhang, Weizhen			Ghrelin Inhibits the Differentiation of T Helper 17 Cells through mTOR/STAT3 Signaling Pathway	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY CYTOKINE EXPRESSION; ROR-GAMMA; TH17 CELLS; MTOR; ACTIVATION; RECEPTOR; MICE; HOMEOSTASIS; PROMOTES	Enhanced activity of interleukin 17 (IL-17) producing T helper 17 (Th17) cells plays an important role in autoimmune and inflammatory diseases. Significant loss of body weight and appetite is associated with chronic inflammation and immune activation, suggesting the cross talk between immune and neuroendocrine systems. Ghrelin has been shown to regulate the organism immune function. However, the effects of ghrelin on the differentiation of Th17 cells remain elusive. In the present study, we observed the enhanced differentiation of Th17 cells in spleens of growth hormone secretagogue receptor 1a (GHSR1a)(-/-) mice. Treatment of ghrelin repressed Th17 cell differentiation in a time- and concentration-dependent manner. Phosphorylation of mammalian target of rapamycin (mTOR) and signal transducer and activator of transcription 3 (STAT3) was increased in the spleens of GHSR1a(-/-) mice. Activation of mTOR signaling by injection of Cre-expressiong adenovirus into tuberous sclerosis complex 1 (TSC1) (loxp/loxp) mice increased the differentiation of Th17 cells in spleen, which was associated with an increment in the phosphorylation of STAT3. Activation of mTOR signaling by leucine or overexpression of p70 ribosome protein subunit 6 kinase 1 (S6K1) activated mTOR signaling in isolated T cells, while reversed the ghrelin-induced inhibition of iTh17 cell differentiation. In conclusion, mTOR mediates the inhibitory effect of ghrelin on the differentiation of Th17 cells by interacting with STAT3.	[Xu, Yanhui; Li, Ziru; Yin, Yue; Lan, He; Wang, Jun; Zhao, Jing; Feng, Juan; Li, Yin; Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci, Hlth Sci Ctr,Minist Educ, Beijing 100191, Peoples R China; [Zhang, Weizhen] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan	Li, Y (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci, Hlth Sci Ctr,Minist Educ, Beijing 100191, Peoples R China.	yinli@bjmu.edu.cn	zhang, weizhen/K-1484-2018; Li, Yin/P-9296-2016	zhang, weizhen/0000-0001-8791-2798; Li, Yin/0000-0002-4019-3391; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81170795, 81370962, 81390354, 81330010, 81030012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81170795, 81370962, 81390354, 81330010, and 81030012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2009, BLOOD, V113, P5202, DOI 10.1182/blood-2008-09-181255; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hattori N, 2009, GROWTH HORM IGF RES, V19, P187, DOI 10.1016/j.ghir.2008.12.001; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Li ZR, 2013, PROG MOL BIOL TRANSL, V114, P45, DOI 10.1016/B978-0-12-386933-3.00002-9; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004; Souza-Moreira L, 2013, BRAIN BEHAV IMMUN, V30, P54, DOI 10.1016/j.bbi.2013.01.080; Theil MM, 2009, J IMMUNOL, V183, P2859, DOI 10.4049/jimmunol.0803362; Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Zhang WZ, 2013, EXP PHYSIOL, V98, P1696, DOI 10.1113/expphysiol.2013.074930; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou Z, 2012, PPAR RES, V2012, DOI [10.1155/2012/145654, DOI 10.1155/2012/145654]; Zhu JH, 2014, PEPTIDES, V52, P23, DOI 10.1016/j.peptides.2013.11.015	30	31	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117081	10.1371/journal.pone.0117081	http://dx.doi.org/10.1371/journal.pone.0117081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658305	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900098
J	Zheng, XQ; Gao, Y; Zhang, Q; Liu, YQ; Peng, Y; Fu, M; Ji, YH				Zheng, Xiaoqun; Gao, Yan; Zhang, Qi; Liu, Yanqing; Peng, Ying; Fu, Miao; Ji, Yanhong			Identification of Transcription Factor AML-1 Binding Site Upstream of Human Cytomegalovirus UL111A Gene	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT HUMAN CYTOMEGALOVIRUS; IMMEDIATE-EARLY PROMOTER; HISTONE MODIFICATIONS; HUMAN INTERLEUKIN-10; DENDRITIC CELLS; EXPRESSION; INFECTION; HOMOLOG; DIFFERENTIATION	Human cytomegalovirus (HCMV) interleukin-10 (hcmvIL-10), encoded by HCMV UL111A gene, is a homolog of human IL-10. It exerts immunomodulatory effects that allow HCMV to evade host defense mechanisms. However, the exact mechanism underlying the regulation of hcmvIL-10 expression is not well understood. The transcription factor acute myeloid leukemia 1 (AML-1) plays an important role in the regulation of various genes involved in the differentiation of hematopoietic lineages. A putative AML-1 binding site is present within the upstream regulatory region (URR) of UL111A gene. To provide evidence that AML-1 is involved in regulating UL111A gene expression, we examined the interaction of AML-1 with the URR of UL111A in HCMV-infected human monocytic THP-1 cells using a chromatin immunoprecipitation assay. HcmvIL-10 transcription was detected in differentiated THP-1 cells, but not in undifferentiated ones. Furthermore, the URR of UL111A showed a higher intensity of AML-1 binding, a higher level of histone H3 acetyl-K9, but a lower level of histone H3 dimethyl-K9 in differentiated THP-1 cells than undifferentiated cells. Down-regulation of AML1 by RNA interference decreased the expression of the UL111A gene. Our results suggest that AML-1 may contribute to the epigenetic regulation of UL111A gene via histone modification in HCMV-infected differentiated THP-1 cells. This finding could be useful for the development of new anti-viral therapies.	[Zheng, Xiaoqun; Ji, Yanhong] Xi An Jiao Tong Univ, Sch Med, Dept Immunol & Pathogen Biol, Xian 710049, Shaanxi, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing; Peng, Ying] Wenzhou Med Univ, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Xiaoqun; Zhang, Qi; Liu, Yanqing; Peng, Ying] Educ Minist China, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Gao, Yan] First Peoples Hosp Changde, Changde, Hunan, Peoples R China; [Fu, Miao] Jinhua Municipal Cent Hosp, Jinhua, Zhejiang, Peoples R China	Xi'an Jiaotong University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Ji, YH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Immunol & Pathogen Biol, Xian 710049, Shaanxi, Peoples R China.	jiyanhong@mail.xjtu.edu.cn	peng, ye/GXZ-9245-2022	Liu, Yanqing/0000-0003-4033-4016	Chinese National Science Foundation Grant (NSFC) [81071365]; Zhejiang Provincial Natural Science Foundation Grant (ZJSFC) [LY13H190006]	Chinese National Science Foundation Grant (NSFC); Zhejiang Provincial Natural Science Foundation Grant (ZJSFC)	This study was supported by Chinese National Science Foundation Grant (NSFC) 81071365 (URL:http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), and Zhejiang Provincial Natural Science Foundation Grant (ZJSFC) LY13H190006 (URL:http://www.zjnsf.gov.cn/1/xm/lx.aspx). Xiao-Qun Zheng received those two grants, and designed the project. In addition, both NSFC and ZJSFC also contributed to design this project.	Alazard N, 2003, J VIROL, V77, P8166, DOI 10.1128/JVI.77.14.8166-8172.2003; Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13; Bain M, 2003, J GEN VIROL, V84, P41, DOI 10.1099/vir.0.18633-0; Boomker JM, 2006, VIRUS RES, V118, P196, DOI 10.1016/j.virusres.2005.12.011; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Chao SH, 2004, J BIOL CHEM, V279, P16111, DOI 10.1074/jbc.M312304200; Cheung AKL, 2009, BLOOD, V114, P4128, DOI 10.1182/blood-2008-12-197111; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Duan YL, 2014, J VIROL, V88, P3861, DOI 10.1128/JVI.01166-13; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Jenkins C, 2008, J VIROL, V82, P3736, DOI 10.1128/JVI.02173-07; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Jenkins C, 2008, VIROLOGY, V370, P285, DOI 10.1016/j.virol.2007.09.002; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Mao ZQ, 2007, ARCH VIROL, V152, P115, DOI 10.1007/s00705-006-0826-8; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Paradowska E, 2012, EUR J CLIN MICROBIOL, V31, P1335, DOI 10.1007/s10096-011-1447-z; Penkert RR, 2013, MBIO, V4, DOI 10.1128/mBio.00298-13; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Rawlinson William, 2003, Aust Fam Physician, V32, P789; Reeves MB, 2010, J GEN VIROL, V91, P599, DOI 10.1099/vir.0.015602-0; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Sanchez V, 2012, VIROLOGY, V433, P64, DOI 10.1016/j.virol.2012.07.015; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Tabi Z, 2001, J IMMUNOL, V166, P5695, DOI 10.4049/jimmunol.166.9.5695; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Yurochko AD, 1999, J IMMUNOL, V162, P4806	45	102	104	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117773	10.1371/journal.pone.0117773	http://dx.doi.org/10.1371/journal.pone.0117773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658598	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900217
J	Stankiewicz, TR; Ramaswami, SA; Bouchard, RJ; Aktories, K; Linseman, DA				Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Bouchard, Ron J.; Aktories, Klaus; Linseman, Daniel A.			Neuronal Apoptosis Induced by Selective Inhibition of Rac GTPase versus Global Suppression of Rho Family GTPases Is Mediated by Alterations in Distinct Mitogen-activated Protein Kinase Signaling Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ERK5 PATHWAY; SURVIVAL; BAD; PHOSPHORYLATION; TRANSDUCER; EXPRESSION; RAC/CDC42; MACHINERY; INTERACT	Rho family GTPases play integral roles in neuronal differentiation and survival. We have shown previously that Clostridium difficile toxin B (ToxB), an inhibitor of RhoA, Rac1, and Cdc42, induces apoptosis of cerebellar granule neurons (CGNs). In this study, we compared the effects of ToxB to a selective inhibitor of the Rac-specific guanine nucleotide exchange factors Tiam1 and Trio (NSC23766). In a manner similar to ToxB, selective inhibition of Rac induces CGN apoptosis associated with enhanced caspase-3 activation and reduced phosphorylation of the Rac effector p21-activated kinase. In contrast to ToxB, caspase inhibitors do not protect CGNs from targeted inhibition of Rac. Also dissimilar to ToxB, selective inhibition of Rac does not inhibit MEK1/2/ERK1/2 or activate JNK/c-Jun. Instead, targeted inhibition of Rac suppresses distinct MEK5/ERK5, p90Rsk, and Akt-dependent signaling cascades known to regulate the localization and expression of the Bcl-2 homology 3 domain-only protein Bad. Adenoviral expression of a constitutively active mutant of MEK5 is sufficient to attenuate neuronal cell death induced by selective inhibition of Rac with NSC23766 but not apoptosis induced by global inhibition of Rho GTPases with Tox B. Collectively, these data demonstrate that global suppression of Rho family GTPases with ToxB causes a loss of MEK1/2/ERK1/2 signaling and activation of JNK/c-Jun, resulting in diminished degradation and enhanced transcription of the Bcl-2 homology 3 domain-only protein Bim. In contrast, selective inhibition of Rac induces CGN apoptosis by repressing unique MEK5/ERK5, p90Rsk, and Akt-dependent prosurvival pathways, ultimately leading to enhanced expression, dephosphorylation, and mitochondrial localization of proapoptotic Bad.	[Stankiewicz, Trisha R.; Bouchard, Ron J.; Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Linseman, Daniel A.] Univ Colorado Denver, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Denver; University of Denver; University of Freiburg; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Linseman, DA (corresponding author), Vet Affairs Med Ctr, Res 151,1055 Clermont St, Denver, CO 80220 USA.	dan.linseman@ucdenver.edu	Linseman, Daniel/L-3846-2019; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review award from the Department of Veterans Affairs (to D. A. L).	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Barberan S, 2011, EUR J NEUROSCI, V34, P1737, DOI 10.1111/j.1460-9568.2011.07891.x; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Cheng JZ, 2012, CIRC RES, V110, P230, DOI 10.1161/CIRCRESAHA.111.246025; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Desagher S, 2005, J BIOL CHEM, V280, P5693, DOI 10.1074/jbc.M408971200; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ha S, 2008, DEV NEUROBIOL, V68, P1565, DOI 10.1002/dneu.20682; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kitada S, 1998, AM J PATHOL, V152, P51; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Le SS, 2005, J NEUROCHEM, V94, P1025, DOI 10.1111/j.1471-4159.2005.03252.x; Lennartsson J, 2010, CELL SIGNAL, V22, P955, DOI 10.1016/j.cellsig.2010.01.020; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Park EM, 2006, NEUROSCI LETT, V402, P190, DOI 10.1016/j.neulet.2006.04.004; Porter AC, 1999, ONCOGENE, V18, P7794, DOI 10.1038/sj.onc.1203214; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stankiewicz TR, 2012, J BIOL CHEM, V287, P16835, DOI 10.1074/jbc.M111.302166; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Tanaka T, 2000, J NEUROSCI, V20, P2852; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	46	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9363	9376		10.1074/jbc.M114.575217	http://dx.doi.org/10.1074/jbc.M114.575217			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666619	Green Published, hybrid			2022-12-26	WOS:000352729400006
J	Yang, JG; Rees, DC				Yang, Janet G.; Rees, Douglas C.			The Allosteric Regulatory Mechanism of the Escherichia coli MetNI Methionine ATP Binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; R-DOMAIN; BTUCD-F; PHOSPHORYLATION; SYSTEMS; TRANSINHIBITION; INTERMEDIATE; SUPERFAMILY	The MetNI methionine importer of Escherichia coli, an ATP binding cassette (ABC) transporter, uses the energy of ATP binding and hydrolysis to catalyze the high affinity uptake of D- and L-methionine. Early in vivo studies showed that the uptake of external methionine is repressed by the level of the internal methionine pool, a phenomenon termed transinhibition. Our understanding of the MetNI mechanism has thus far been limited to a series of crystal structures in an inward-facing conformation. To understand the molecular mechanism of transinhibition, we studied the kinetics of ATP hydrolysis using detergent-solubilized MetNI. We find that transinhibition is due to noncompetitive inhibition by L-methionine, much like a negative feedback loop. Thermodynamic analyses revealed two allosteric methionine binding sites per transporter. This quantitative analysis of transinhibition, the first to our knowledge for a structurally defined transporter, builds upon the previously proposed structurally based model for regulation. This mechanism of regulation at the transporter activity level could be applicable to not only ABC transporters but other types of membrane transporters as well.	[Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Yang, Janet/P-2003-2015		National Institutes of Health [R01 GM45162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM45162 (to D. C. R.).	Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hines KE, 2014, J GEN PHYSIOL, V143, P401, DOI 10.1085/jgp.201311116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Ingraham J. L., 1983, GROWTH BACTERIAL CEL, P129; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Johnson E, 2012, PROTEIN SCI, V21, P84, DOI 10.1002/pro.765; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; KADNER RJ, 1975, J BACTERIOL, V122, P110, DOI 10.1128/JB.122.1.110-119.1975; KADNER RJ, 1974, J BACTERIOL, V117, P232, DOI 10.1128/JB.117.1.232-241.1974; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RICH DP, 1993, J BIOL CHEM, V268, P20259; Romeo Y, 2003, MOL MICROBIOL, V47, P1135, DOI 10.1046/j.1365-2958.2003.03362.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	36	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9135	9140		10.1074/jbc.M114.603365	http://dx.doi.org/10.1074/jbc.M114.603365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678706	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000352207100036
J	Leavey, K; Bainbridge, SA; Cox, BJ				Leavey, Katherine; Bainbridge, Shannon A.; Cox, Brian J.			Large Scale Aggregate Microarray Analysis Reveals Three Distinct Molecular Subclasses of Human Preeclampsia	PLOS ONE			English	Article							GENE-EXPRESSION; ANGIOGENIC FACTORS; TROPHOBLAST CELLS; INFECTION; FETAL; DYSFUNCTION; PLACENTAS; GROWTH	Background Preeclampsia (PE) is a life-threatening hypertensive pathology of pregnancy affecting 3-5% of all pregnancies. To date, PE has no cure, early detection markers, or effective treatments short of the removal of what is thought to be the causative organ, the placenta, which may necessitate a preterm delivery. Additionally, numerous small placental microarray studies attempting to identify "PE-specific" genes have yielded inconsistent results. We therefore hypothesize that preeclampsia is a multifactorial disease encompassing several pathology subclasses, and that large cohort placental gene expression analysis will reveal these groups. Results To address our hypothesis, we utilized known bioinformatic methods to aggregate 7 microarray data sets across multiple platforms in order to generate a large data set of 173 patient samples, including 77 with preeclampsia. Unsupervised clustering of these patient samples revealed three distinct molecular subclasses of PE. This included a "canonical" PE subclass demonstrating elevated expression of known PE markers and genes associated with poor oxygenation and increased secretion, as well as two other subclasses potentially representing a poor maternal response to pregnancy and an immunological presentation of preeclampsia. Conclusion Our analysis sheds new light on the heterogeneity of PE patients, and offers up additional avenues for future investigation. Hopefully, our subclassification of preeclampsia based on molecular diversity will finally lead to the development of robust diagnostics and patient-based treatments for this disorder.	[Leavey, Katherine; Cox, Brian J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Bainbridge, Shannon A.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Toronto; University of Ottawa	Bainbridge, SA (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	shannon.bainbridge@uottawa.ca; b.cox@utoronto.ca	Bainbridge, Shannon A/F-9715-2015; Bainbridge, Shannon/GRN-7894-2022	Bainbridge, Shannon A/0000-0002-8947-8152; 	Canadian Institutes of Health Research [128369]; University of Toronto Open Fellowship fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Open Fellowship fund	This research was funded by the Canadian Institutes of Health Research Grant # 128369 to SB and BC. KL was supported in part by the University of Toronto Open Fellowship fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonios TFT, 2013, AM J HYPERTENS, V26, P1162, DOI 10.1093/ajh/hpt087; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Bainbridge SA, 2012, HYPERTENSION, V59, P732, DOI 10.1161/HYPERTENSIONAHA.111.183939; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; Carreiras M, 2002, AM J REPROD IMMUNOL, V48, P176, DOI 10.1034/j.1600-0897.2002.01076.x; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Constantin CM, 2007, J IMMUNOL, V179, P4383, DOI 10.4049/jimmunol.179.7.4383; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; Dekker G, 2002, J REPROD IMMUNOL, V57, P203, DOI 10.1016/S0165-0378(02)00039-6; Fraley C, 2007, J STAT SOFTW, V18; Gleicher N, 2007, AM J OBSTET GYNECOL, V196, P5, DOI 10.1016/j.ajog.2006.09.016; Gomez LM, 2008, HUM REPROD, V23, P709, DOI 10.1093/humrep/dem404; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; HUNT JS, 1988, J IMMUNOL, V140, P1293; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jordan JA, 2001, WOMEN INFECTED WITH, V8, DOI [doi: 10.1128/ CDLI. 8.2.288, DOI 10.1128/CDLI.8.2.288]; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Kulandavelu S, 2013, HYPERTENSION, V61, P259, DOI 10.1161/HYPERTENSIONAHA.112.201996; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lecarpentier E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062140; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mayhew TM, 2008, PLACENTA, V29, P1, DOI 10.1016/j.placenta.2007.05.010; McDonnold M, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.040; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Rademacher TW, 2007, J REPROD IMMUNOL, V76, P78, DOI 10.1016/j.jri.2007.03.019; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Ruano Rodrigo, 2005, Clinics, V60, P407, DOI 10.1590/S1807-59322005000500010; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szekeres-Bartho J, INT REV IMMUNOL, V21, P471; Tan EK, 2013, BEST PRACT RES CL OB, V27, P791, DOI 10.1016/j.bpobgyn.2013.08.001; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vigil-De Gracia P, 2009, INT J GYNECOL OBSTET, V104, P90, DOI 10.1016/j.ijgo.2008.09.014; Vinnars MT, 2008, HYPERTENSION, V51, P1295, DOI 10.1161/HYPERTENSIONAHA.107.104844; von Dadelszen P, 2003, BJOG-INT J OBSTET GY, V110, P725, DOI 10.1111/j.1471-0528.2003.02481.x; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Xiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059753; Yuen RKC, 2011, PLACENTA, V32, pS136, DOI 10.1016/j.placenta.2011.01.003	58	65	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116508	10.1371/journal.pone.0116508	http://dx.doi.org/10.1371/journal.pone.0116508			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679511	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600023
J	Lima, DB; Melo, JWS; Guedes, NMP; Gontijo, LM; Guedes, RNC; Gondim, MGC				Lima, Debora B.; Melo, Jose Wagner S.; Guedes, Nelsa Maria P.; Gontijo, Lessando M.; Guedes, Raul Narciso C.; Gondim, Manoel Guedes C., Jr.			Bioinsecticide-Predator Interactions: Azadirachtin Behavioral and Reproductive Impairment of the Coconut Mite Predator Neoseiulus baraki	PLOS ONE			English	Article							BOTANICAL INSECTICIDE; TETRANYCHUS-URTICAE; PHYTOSEIULUS-PERSIMILIS; ACARI TETRANYCHIDAE; ACERIA-GUERRERONIS; SELECTIVITY; PESTICIDES; TOXICITY; COMPATIBILITY; AVOIDANCE	Synthetic pesticide use has been the dominant form of pest control since the 1940s. However, biopesticides are emerging as sustainable pest control alternatives, with prevailing use in organic agricultural production systems. Foremost among botanical biopesticides is the limonoid azadirachtin, whose perceived environmental safety has come under debate and scrutiny in recent years. Coconut production, particularly organic coconut production, is one of the agricultural systems in which azadirachtin is used as a primary method of pest control for the management of the invasive coconut mite, Aceria guerreronis Keifer (Acari: Eriophyidae). The management of this mite species also greatly benefits from predation by Neoseiulus baraki (Athias-Henriot) (Acari: Phytoseiidae). Here, we assessed the potential behavioral impacts of azadirachtin on the coconut mite predator, N. baraki. We explored the effects of this biopesticide on overall predator activity, female searching time, and mating behavior and fecundity. Azadirachtin impairs the overall activity of the predator, reducing it to nearly half; however, female searching was not affected. In contrast, mating behavior was compromised by azadirachtin exposure particularly when male predators were exposed to the biopesticide. Consequently, predator fecundity was also compromised by azadirachtin, furthering doubts about its environmental safety and selectivity towards biological control agents.	[Lima, Debora B.; Melo, Jose Wagner S.; Gondim, Manoel Guedes C., Jr.] Univ Fed Rural Pernambuco, Area Fitossanidade, Dept Agron, BR-52171900 Recife, PE, Brazil; [Guedes, Nelsa Maria P.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Gontijo, Lessando M.] Univ Fed Vicosa, BR-35690000 Florestal, MG, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Vicosa; Universidade Federal de Vicosa	Lima, DB (corresponding author), Univ Fed Rural Pernambuco, Area Fitossanidade, Dept Agron, BR-52171900 Recife, PE, Brazil.	deboralima_85@yahoo.com.br	Lima, Debora Barbosa/D-6777-2015; Gontijo, Lessando M./AAG-8181-2019; melo, Jose wagner S/I-1027-2012; Guedes, Raul Narciso Carvalho/L-3924-2013	Gontijo, Lessando M./0000-0001-6041-7404; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Lima, Debora/0000-0003-1491-7285; Melo, Jose Wagner/0000-0003-1056-8129	Brazilian agency: Pernambuco State Foundation for Research Aid (FACEPE); Brazilian agency: CAPES Foundation (Brazilian Ministry of Education); Brazilian agency: National Council of Scientific and Technological Development (CNPq)	Brazilian agency: Pernambuco State Foundation for Research Aid (FACEPE); Brazilian agency: CAPES Foundation (Brazilian Ministry of Education); Brazilian agency: National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by the following Brazilian agencies: Pernambuco State Foundation for Research Aid (FACEPE), CAPES Foundation (Brazilian Ministry of Education), and the National Council of Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoabeng BW, 2014, CROP PROT, V57, P71, DOI 10.1016/j.cropro.2013.11.019; Aratchige NS, 2007, EXP APPL ACAROL, V43, P97, DOI 10.1007/s10493-007-9107-9; Bernardi D, 2013, PEST MANAG SCI, V69, P75, DOI 10.1002/ps.3364; Campos MR, 2011, CROP PROT, V30, P1535, DOI 10.1016/j.cropro.2011.08.013; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Castagnoli M, 2005, BIOCONTROL, V50, P611, DOI 10.1007/s10526-004-8121-7; COATS JR, 1994, ANNU REV ENTOMOL, V39, P489, DOI 10.1146/annurev.en.39.010194.002421; Cooper J, 2007, CROP PROT, V26, P1337, DOI 10.1016/j.cropro.2007.03.022; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Cote KW, 2002, HORTSCIENCE, V37, P906, DOI 10.21273/HORTSCI.37.6.906; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DORN A, 1986, J APPL ENTOMOL, V102, P313, DOI 10.1111/j.1439-0418.1986.tb00928.x; Duso C, 2008, BIOL CONTROL, V47, P16, DOI 10.1016/j.biocontrol.2008.06.011; Fernando LCP, 2003, EXP APPL ACAROL, V31, P71, DOI 10.1023/B:APPA.0000005126.16574.3b; Gerwick BC, 2014, PEST MANAG SCI; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005; Kidd H., 2000, PESTIC OUTLOOK, V11, P215; Kramer W, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, pXXIII; Lima DB, 2013, BIOCONTROL, V58, P595, DOI 10.1007/s10526-013-9520-4; Lima DB, 2013, EXP APPL ACAROL, V60, P381, DOI 10.1007/s10493-012-9644-8; Lima DB, 2012, EXP APPL ACAROL, V56, P233, DOI 10.1007/s10493-012-9515-3; Linton YM, 1997, J INSECT PHYSIOL, V43, P1077, DOI 10.1016/S0022-1910(97)00060-7; Manuweera G, 2008, ENVIRON HEALTH PERSP, V116, P492, DOI 10.1289/ehp.11029; MAPA (Ministerio da Agricultura Pecuaria e Abastecimento), 2014, COORD GER AGR AFINS; Matsumura F, 2004, J PESTIC SCI, V29, P299, DOI 10.1584/jpestics.29.299; Matthews GA, 2008, CROP PROT, V27, P834, DOI 10.1016/j.cropro.2007.10.013; Medina P, 2004, J ECON ENTOMOL, V97, P43, DOI 10.1603/0022-0493-97.1.43; Melo JWS, 2011, EXP APPL ACAROL, V55, P191, DOI 10.1007/s10493-011-9465-1; METCALF RL, 1980, ANNU REV ENTOMOL, V25, P219, DOI 10.1146/annurev.en.25.010180.001251; Mordue AJ., 2010, INSECT CONTROL BIOL, P185; Mordue (Luntz) A. Jennifer, 2000, Anais da Sociedade Entomologica do Brasil, V29, P615, DOI 10.1590/S0301-80592000000400001; Pappas ML, 2005, EXP APPL ACAROL, V36, P187, DOI 10.1007/s10493-005-5303-7; Qi BY, 2001, BIOL CONTROL, V22, P185, DOI 10.1006/bcon.2001.0965; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Reis AC, 2008, NEOTROP ENTOMOL, V37, P457, DOI 10.1590/S1519-566X2008000400015; SAS Institute SAS/STAT User's Guide, 2008, SAS I SAS STAT US GU; SHIMIZU T, 1988, ENTOMOL EXP APPL, V46, P197, DOI 10.1007/BF00190851; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stark JD, 1999, ECOTOX ENVIRON SAFE, V42, P282, DOI 10.1006/eesa.1998.1760; Villaverde JJ, 2014, PEST MANAG SCI, V70, P2, DOI 10.1002/ps.3663; Zhang ZQ, 1997, EXP APPL ACAROL, V21, P393, DOI 10.1023/A:1018475728005	46	33	34	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118343	10.1371/journal.pone.0118343	http://dx.doi.org/10.1371/journal.pone.0118343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679393	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600120
J	McMaster, SR; Gabbard, JD; Koutsonanos, DG; Compans, RW; Tripp, RA; Tompkins, SM; Kohlmeier, JE				McMaster, Sean R.; Gabbard, Jon D.; Koutsonanos, Dimitris G.; Compans, Richard W.; Tripp, Ralph A.; Tompkins, S. Mark; Kohlmeier, Jacob E.			Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity	PLOS ONE			English	Article							A(H7N9) VIRUS; A VIRUSES; CHINA; TRANSMISSION; VACCINATION; EMERGENCE; INFECTION; FERRETS	Influenza virus is a source of significant health and economic burden from yearly epidemics and sporadic pandemics. Given the potential for the emerging H7N9 influenza virus to cause severe respiratory infections and the lack of exposure to H7 and N9 influenza viruses in the human population, we aimed to quantify the H7N9 cross-reactive memory T cell reservoir in humans and mice previously exposed to common circulating influenza viruses. We identified significant cross-reactive T cell populations in humans and mice; we also found that cross-reactive memory T cells afforded heterosubtypic protection by reducing morbidity and mortality upon lethal H7N9 challenge. In context with our observation that PR8-primed mice have limited humoral cross-reactivity with H7N9, our data suggest protection from H7N9 challenge is indeed mediated by cross-reactive T cell populations established upon previous priming with another influenza virus. Thus, pre-existing cross-reactive memory T cells may limit disease severity in the event of an H7N9 influenza virus pandemic.	[McMaster, Sean R.; Koutsonanos, Dimitris G.; Compans, Richard W.; Kohlmeier, Jacob E.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gabbard, Jon D.; Tripp, Ralph A.; Tompkins, S. Mark] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA USA	Emory University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kohlmeier, JE (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jkohlmeier@emory.edu	Tompkins, Stephen/A-3317-2008; Compans, Richard W/I-4087-2013	Tompkins, Stephen/0000-0002-1523-5588; Compans, Richard W/0000-0003-2360-335X	Centers of Excellence in Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]; Emory University; NIH [T32 AI007610-14]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL118954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Centers of Excellence in Influenza Research and Surveillance (CEIRS); Emory University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Centers of Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C (S.M.T., R.A.T., R.W.C., and J.E.K.) and funds from Emory University. S.R.M. is supported in part by NIH T32 AI007610-14. The funders had no role in study design, data collection and analysis, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Gabbard JD, 2014, J VIROL, V88, P1502, DOI 10.1128/JVI.02959-13; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Koutsonanos DG, 2011, J INFECT DIS, V204, P582, DOI 10.1093/infdis/jir094; Meng Z, 2014, EURO SURVEILL, V19; Mooney AJ, 2013, J VIROL, V87, P363, DOI 10.1128/JVI.02330-12; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; World Health Organization, 2013, NUMB CONF HUM CAS AV; World Health Organization, 2014, WHO RISK ASS HUM INF; Xu LL, 2014, J INFECT DIS, V209, P551, DOI 10.1093/infdis/jit474; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	21	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115725	10.1371/journal.pone.0115725	http://dx.doi.org/10.1371/journal.pone.0115725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671696	Green Published, Green Submitted, gold			2022-12-26	WOS:000349545300013
J	Mitteroecker, P; Windhager, S; Muller, GB; Schaefer, K				Mitteroecker, Philipp; Windhager, Sonja; Mueller, Gerd B.; Schaefer, Katrin			The Morphometrics of "Masculinity" in Human Faces	PLOS ONE			English	Article							4TH DIGIT RATIO; SEXUAL-DIMORPHISM; MENSTRUAL-CYCLE; GEOMETRIC MORPHOMETRICS; FACIAL MASCULINITY; SYMMETRY; TESTOSTERONE; PREFERENCES; ALLOMETRY; SHAPE	In studies of social inference and human mate preference, a wide but inconsistent array of tools for computing facial masculinity has been devised. Several of these approaches implicitly assumed that the individual expression of sexually dimorphic shape features, which we refer to as maleness, resembles facial shape features perceived as masculine. We outline a morphometric strategy for estimating separately the face shape patterns that underlie perceived masculinity and maleness, and for computing individual scores for these shape patterns. We further show how faces with different degrees of masculinity or maleness can be constructed in a geometric morphometric framework. In an application of these methods to a set of human facial photographs, we found that shape features typically perceived as masculine are wide faces with a wide inter-orbital distance, a wide nose, thin lips, and a large and massive lower face. The individual expressions of this combination of shape features-the masculinity shape scores-were the best predictor of rated masculinity among the compared methods (r = 0.5). The shape features perceived as masculine only partly resembled the average face shape difference between males and females (sexual dimorphism). Discriminant functions and Procrustes distances to the female mean shape were poor predictors of perceived masculinity.	[Mitteroecker, Philipp; Mueller, Gerd B.] Univ Vienna, Dept Theoret Biol, A-1090 Vienna, Austria; [Windhager, Sonja; Schaefer, Katrin] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria	University of Vienna; University of Vienna	Mitteroecker, P (corresponding author), Univ Vienna, Dept Theoret Biol, Althanstr 14, A-1090 Vienna, Austria.	philipp.mitteroecker@univie.ac.at	Windhager, Sonja/K-7618-2013; Schaefer, Katrin/G-8632-2011; Mitteroecker, Philipp/A-1591-2012	Windhager, Sonja/0000-0003-1809-8678; Schaefer, Katrin/0000-0002-0173-3092; Mitteroecker, Philipp/0000-0002-5308-3837	Open Access Publishing Fund of the University of Vienna; University of Vienna	Open Access Publishing Fund of the University of Vienna; University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna, which is covering the publication costs. This research was supported by the Focus of Excellence grant "Biometrics of EvoDevo" and the Emerging Field grant "Comparative Human Life History: A Multilevel Approach" from the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein FL, 1991, MORPHOMETRIC TOOLS F; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; Burriss RP, 2007, ARCH SEX BEHAV, V36, P377, DOI 10.1007/s10508-006-9136-1; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DeBruine LM, 2010, J EXP PSYCHOL HUMAN, V36, P751, DOI 10.1037/a0016457; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Little AC, 2008, PERS INDIV DIFFER, V45, P478, DOI 10.1016/j.paid.2008.05.024; Mardia K, 1979, MULTIVARIATE ANALYSI; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1987, SYST ZOOL, V36, P356, DOI 10.2307/2413400; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Sanchez-Pages S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112157; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; Schaefer K, 2004, ANN ANAT, V186, P471, DOI 10.1016/S0940-9602(04)80086-4; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Sforza C, 2013, J ANTHROPOL SCI, V91, P159, DOI [10.4436/jass.91007, 10.4436/JASS.91007]; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; Sylvester AD, 2008, AM J PHYS ANTHROPOL, V137, P371, DOI 10.1002/ajpa.20880; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Wade TJ., 2004, J BLACK PSYCHOL, V30, P477, DOI [10.1177/0095798403260726, DOI 10.1177/0095798403260726]; Windhager S, 2012, EVOL HUM BEHAV, V33, P109, DOI 10.1016/j.evolhumbehav.2011.06.003; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Zollikofer CPE, 2002, P ROY SOC B-BIOL SCI, V269, P801, DOI 10.1098/rspb.2002.1960	54	43	43	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0118374	10.1371/journal.pone.0118374	http://dx.doi.org/10.1371/journal.pone.0118374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB3RF	25671667	gold, Green Published			2022-12-26	WOS:000349545300093
J	Kim, NKD; Higashi, T; Lee, KY; Kim, AR; Kitajiri, S; Kim, MY; Chang, MY; Kim, V; Oh, SH; Kim, D; Furuse, M; Park, WY; Choi, BY				Kim, Nayoung K. D.; Higashi, Tomohito; Lee, Kyoung Yeul; Kim, Ah Reum; Kitajiri, Shin-ichiro; Kim, Min Young; Chang, Mun Young; Kim, Veronica; Oh, Seung-Ha; Kim, Dongsup; Furuse, Mikio; Park, Woong-Yang; Choi, Byung Yoon			Downsloping High-Frequency Hearing Loss Due to Inner Ear Tricellular Tight Junction Disruption by a Novel ILDR1 Mutation in the Ig-Like Domain	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; PROTEIN; IMPAIRMENT; BARRIER; PERMEABILITY; OCCLUDIN; CELLS; SMPX	The immunoglobulin (Ig)-like domain containing receptor 1 (ILDR1) gene encodes angulin-2/ILDR1, a recently discovered tight junction protein, which forms tricellular tight junction (tTJ) structures with tricellulin and lipolysis-stimulated lipoprotein receptor (LSR) at tricellular contacts (TCs) in the inner ear. Previously reported recessive mutations within ILDR1 have been shown to cause severe to profound nonsyndromic sensorineural hearing loss (SNHL), DFNB42. Whole-exome sequencing of a Korean multiplex family segregating partial deafness identified a novel homozygous ILDR1 variant (p.P69H) within the Ig-like domain. To address the pathogenicity of p. P69H, the angulin-2/ILDR1 p.P69H variant protein, along with the previously reported pathogenic ILDR1 mutations, was expressed in angulin-1/LSR knockdown epithelial cells. Interestingly, partial mislocalization of the p.P69H variant protein and tricellulin at TCs was observed, in contrast to a severe mislocalization and complete failure of tricellulin recruitment of the other reported ILDR1 mutations. Additionally, three-dimensional protein modeling revealed that angulin-2/ILDR1 contributed to tTJ by forming a homo-trimer structure through its Ig-like domain, and the p.P69H variant was predicted to disturb homo-trimer formation. In this study, we propose a possible role of angulin-2/ILDR1 in tTJ formation in the inner ear and a wider audiologic phenotypic spectrum of DFNB42 caused by mutations within ILDR1.	[Kim, Nayoung K. D.; Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Lee, Kyoung Yeul; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Ah Reum; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Seoul, South Korea; [Kitajiri, Shin-ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Kim, Min Young; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea; [Kim, Dongsup] Univ Toronto St George, Dept Cell & Syst Biol, Toronto, ON, Canada; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea	Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Kobe University; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Kyoto University; Seoul National University (SNU); University of Toronto; Sungkyunkwan University (SKKU)	Park, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.	woongyang.park@samsung.com; choiby@snubh.org	Higashi, Tomohito/AHE-7942-2022; Kim, Dongsup/C-1612-2011	Higashi, Tomohito/0000-0001-5616-1477; Park, Woong-Yang/0000-0003-4234-0380; Furuse, Mikio/0000-0003-2847-8156	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI11C13310000, A111377]; Seoul National University Bundang Hospital Research Fund [14-2014-033]; Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea [HI12C0014]; Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science [LS084]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Seoul National University Bundang Hospital Research Fund; Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea; Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science	This work was supported by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea, Grant HI11C13310000 (previously A111377 to B. Y. Choi), the Seoul National University Bundang Hospital Research Fund 14-2014-033 (to B. Y. Choi), the Korean Health Technology R&D Project, Ministry of health and Welfare, Republic of Korea (HI12C0014) and the Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy [Grand number LS084] (to M. Furuse). T. Higashi is a research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Brozkova DS, 2012, CLIN GENET, V82, P579, DOI 10.1111/j.1399-0004.2011.01817.x; Chandra R, 2013, J CLIN INVEST, V123, P3343, DOI 10.1172/JCI68587; Chishti MS, 2008, J HUM GENET, V53, P101, DOI 10.1007/s10038-007-0209-3; Chung J, 2014, J MOL MED BERL; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; FRIEND DS, 1972, J CELL BIOL, V53, P758, DOI 10.1083/jcb.53.3.758; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Mariano C, 2011, EUR J CELL BIOL, V90, P787, DOI 10.1016/j.ejcb.2011.06.005; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MARTINEZPALOMO A, 1975, P NATL ACAD SCI USA, V72, P4487, DOI 10.1073/pnas.72.11.4487; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Morozko EL, 2014, HUM MOL GENET; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Ramzan K, 2014, EUR J MED GENET; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tekin M, 2013, J CLIN INVEST, V123, P2094, DOI 10.1172/JCI65853; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0116931	10.1371/journal.pone.0116931	http://dx.doi.org/10.1371/journal.pone.0116931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2XY	25668204	Green Published, Green Submitted, gold			2022-12-26	WOS:000349493000012
J	Roubova, V; Konecna, M; Smilauer, P; Wallner, B				Roubova, Veronika; Konecna, Martina; Smilauer, Petr; Wallner, Bernard			Whom to Groom and for What? Patterns of Grooming in Female Barbary Macaques (Macaca sylvanus)	PLOS ONE			English	Article							JAPANESE MACAQUES; AGONISTIC SUPPORT; RELATIONSHIP QUALITY; RECIPROCAL ALTRUISM; BIOLOGICAL MARKETS; DOMINANCE STYLE; SOCIAL RANK; PRIMATES; METAANALYSIS; INTERCHANGE	Grooming is one of the most conspicuous social interactions among nonhuman primates. The selection of grooming partners can provide important clues about factors relevant for the distribution of grooming within a social group. We analyzed grooming behavior among 17 semi-free ranging female Barbary macaques (Macaca sylvanus). We tested whether grooming is related to kinship, rank and friendship. Furthermore, we tested whether grooming is reciprocated or exchanged for rank related benefits (i.e. lower aggression and increased tolerance whilst feeding). We found that in general grooming was reciprocally exchanged, directed up the hierarchy and at the same time affected by friendship and kinship. Grooming was more frequent among individuals with higher friendship values as well as amongst related individuals. We also divided our data set on the basis of rank difference and tested if different power asymmetries between individuals affected the tendency to exchange grooming for rank related benefits and grooming reciprocation. In support of our initial hypothesis our results show that the reciprocation of grooming was a significant predictor of grooming interactions between individuals of similar rank, but not between those individuals more distantly separated in the social hierarchy. However, we did not find any evidence for grooming being exchanged for rank related benefits in either data set. Our results, together with previously published studies, illustrate the behavioral flexibility of macaques. It is clear that multiple studies of the same species are necessary to gather the data required for the solid comparative studies needed to shed light on patterns of grooming behavior in primates.	[Roubova, Veronika; Konecna, Martina] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Smilauer, Petr] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Wallner, Bernard] Univ Vienna, Dept Anthropol, Vienna, Austria	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; University of Vienna	Roubova, V (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	veronikaroubova@centrum.cz	Konecna, Martina/D-7724-2016; Smilauer, Petr/D-7277-2016; Šmilauer, Petr/N-8313-2019; Wallner, Bernard/B-1089-2009	Konecna, Martina/0000-0002-2650-1597; Smilauer, Petr/0000-0003-3065-5721; Šmilauer, Petr/0000-0003-3065-5721; 	Czech-Austrian Aktion Program for Cooperation in Science and Education [50p13, 53p6]; Grant Agency of the University of South Bohemia GAJU N [159/2013/P]	Czech-Austrian Aktion Program for Cooperation in Science and Education; Grant Agency of the University of South Bohemia GAJU N	This work was supported by Czech-Austrian Aktion Program for Cooperation in Science and Education in 2008 (Project 50p13) and in 2009 (Project 53p6) (MK, BW), Zdenek Veselovsky student prize from CSEtS (VR, MK) and Team Grant of the Grant Agency of the University of South Bohemia GAJU N. No. 159/2013/P (VR, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Balasubramaniam KN, 2011, AM J PRIMATOL, V73, P1269, DOI 10.1002/ajp.20999; Bates D, 2014, LME4 1 0 6 LINEAR MI; Bayly KL, 2006, BEHAV PROCESS, V73, P1, DOI 10.1016/j.beproc.2006.01.011; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Call J, 1999, ANIM BEHAV, V58, P165, DOI 10.1006/anbe.1999.1116; Carne C, 2011, AM J PRIMATOL, V73, P1127, DOI 10.1002/ajp.20979; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Cords M, 2002, BEHAVIOUR, V139, P291, DOI 10.1163/156853902760102681; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; DOLHINOW P, 1978, Primates, V19, P449, DOI 10.1007/BF02373308; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemelrijk CK, 1998, BEHAV ECOL SOCIOBIOL, V42, P207, DOI 10.1007/s002650050432; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hinde RA, 1978, J SOC BIOL STRUCT, V1, P27, DOI [10.1016/0140-1750(78)90016-7, DOI 10.1016/0140-1750(78)90016-7]; JARAM Van Hooff, 1987, MAN WOLF, P219; Konecna M, 2012, J RES PERS, V46, P581, DOI 10.1016/j.jrp.2012.06.004; KUSTER J, 1984, FOLIA PRIMATOL, V43, P69, DOI 10.1159/000156173; Macdonald S, 2013, INT J PRIMATOL, V34, P571, DOI 10.1007/s10764-013-9680-1; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028826; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026893; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Schino G, 2005, PRIMATES, V46, P207, DOI 10.1007/s10329-004-0124-6; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2008, BIOL J LINN SOC, V95, P439, DOI 10.1111/j.1095-8312.2008.01067.x; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Semple S, 2013, ETHOLOGY, V119, P779, DOI 10.1111/eth.12119; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Xia DP, 2012, AM J PRIMATOL, V74, P569, DOI 10.1002/ajp.21985; Zhang P, 2014, PRIMATES, V55, P69, DOI 10.1007/s10329-013-0370-6	49	17	17	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117298	10.1371/journal.pone.0117298	http://dx.doi.org/10.1371/journal.pone.0117298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668722	Green Published, gold, Green Submitted			2022-12-26	WOS:000349493000017
J	Banlaki, Z; Elek, Z; Nanasi, T; Szekely, A; Nemoda, Z; Sasvari-Szekely, M; Ronai, Z				Banlaki, Zsofia; Elek, Zsuzsanna; Nanasi, Tibor; Szekely, Anna; Nemoda, Zsofia; Sasvari-Szekely, Maria; Ronai, Zsolt			Polymorphism in the Serotonin Receptor 2a (HTR2A) Gene as Possible Predisposal Factor for Aggressive Traits	PLOS ONE			English	Article							INTERMITTENT EXPLOSIVE DISORDER; ACUTE TRYPTOPHAN DEPLETION; DEFENSIVE RAGE BEHAVIOR; HUMAN ESTERASE D; PERSONALITY-TRAITS; PROACTIVE AGGRESSION; HAPLOTYPE RECONSTRUCTION; ENVIRONMENTAL-INFLUENCES; ANTIAGGRESSIVE RESPONSE; MEDIAL HYPOTHALAMUS	Aggressive manifestations and their consequences are a major issue of mankind, highlighting the need for understanding the contributory factors. Still, aggression-related genetic analyses have so far mainly been conducted on small population subsets such as individuals suffering from a certain psychiatric disorder or a narrow-range age cohort, but no data on the general population is yet available. In the present study, our aim was to identify polymorphisms in genes affecting neurobiological processes that might explain some of the inter-individual variation between aggression levels in the non-clinical Caucasian adult population. 55 single nucleotide polymorphisms (SNP) were simultaneously determined in 887 subjects who also filled out the self-report Buss-Perry Aggression Questionnaire (BPAQ). Single marker association analyses between genotypes and aggression scores indicated a significant role of rs7322347 located in the HTR2A gene encoding serotonin receptor 2a following Bonferroni correction for multiple testing (p = 0.0007) both for males and females. Taking the four BPAQ subscales individually, scores for Hostility, Anger and Physical Aggression showed significant association with rs7322347 T allele in themselves, while no association was found with Verbal Aggression. Of the subscales, relationship with rs7322347 was strongest in the case of Hostility, where statistical significance virtually equaled that observed with the whole BPAQ. In conclusion, this is the first study to our knowledge analyzing SNPs in a wide variety of genes in terms of aggression in a large sample-size non-clinical adult population, also describing a novel candidate polymorphism as predisposal to aggressive traits.	[Banlaki, Zsofia; Elek, Zsuzsanna; Nanasi, Tibor; Nemoda, Zsofia; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Szekely, Anna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary	Semmelweis University; Eotvos Lorand University	Ronai, Z (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	ronai.zsolt@med.semmelweis-univ.hu	Ronai, Zsolt/A-2473-2008	Ronai, Zsolt/0000-0002-0909-7932	NIH Fogarty International Research grant [R03 TW007656]; Hungarian Scientific Research Funds [OTKA K100845, K83766]; FOGARTY INTERNATIONAL CENTER [R03TW007656] Funding Source: NIH RePORTER	NIH Fogarty International Research grant; Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the NIH R03 TW007656 Fogarty International Research grant to Maria Sasvari-Szekely and the following Hungarian Scientific Research Funds: OTKA K100845 and K83766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh MD, 2010, J AM ACAD CHILD PSY, V49, P841, DOI 10.1016/j.jaac.2010.05.015; Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Angoa-Perez M, 2014, GENES BRAIN BEHAV, V13, P579, DOI 10.1111/gbb.12159; Aslund C, 2013, AGGRESSIVE BEHAV, V39, P52, DOI 10.1002/ab.21451; Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Baker LA, 2008, J ABNORM CHILD PSYCH, V36, P1265, DOI 10.1007/s10802-008-9249-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Efraim Y, 2013, MOL PSYCHIATR, V18, P758, DOI 10.1038/mp.2012.86; Berman ME, 2009, PSYCHOL SCI, V20, P714, DOI 10.1111/j.1467-9280.2009.02355.x; Bezdjian S, 2011, CHILD DEV, V82, P1267, DOI 10.1111/j.1467-8624.2011.01598.x; Blasi G, 2013, JAMA PSYCHIAT, V70, P921, DOI 10.1001/jamapsychiatry.2013.1378; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Bray NJ, 2004, MOL PSYCHIATR, V9, P109, DOI 10.1038/sj.mp.4001366; Brendgen M, 2006, DEV PSYCHOL, V42, P1299, DOI 10.1037/0012-1649.42.6.1299; BROWN GL, 1990, J CLIN PSYCHIAT, V51, P31; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Bryant CD, 2012, NEUROPSYCHOPHARMACOL, V37, P1026, DOI 10.1038/npp.2011.287; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cairns RB, 1996, CIBA F SYMP, V194, P45; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Coccaro EF, 1997, BIOL PSYCHIAT, V42, P546, DOI 10.1016/S0006-3223(97)00309-0; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; Coccaro EF, 2010, J PSYCHIATR RES, V44, P137, DOI 10.1016/j.jpsychires.2009.07.004; Coccaro EF, 2010, J NEURAL TRANSM, V117, P241, DOI 10.1007/s00702-009-0359-x; Coccaro EF, 2010, NEUROPSYCHOPHARMACOL, V35, P435, DOI 10.1038/npp.2009.148; Coccaro EF, 2009, J CLIN PSYCHIAT, V70, P653, DOI 10.4088/JCP.08m04150; Constantino JN, 1997, J CHILD ADOL PSYCHOP, V7, P31, DOI 10.1089/cap.1997.7.31; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dijkstra JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054821; Erdmann J, 1996, HUM GENET, V97, P614, DOI 10.1007/s004390050104; Fairbanks LA, 2001, NEUROPSYCHOPHARMACOL, V24, P370, DOI 10.1016/S0893-133X(00)00211-6; Fanning JR, 2014, J PERS DISORD, V28, P449, DOI 10.1521/pedi_2012_26_065; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Georgiev AV, 2013, EVOL PSYCHOL-US, V11, P678, DOI 10.1177/147470491301100313; Gerevich J, 2007, INT J METH PSYCH RES, V16, P124, DOI 10.1002/mpr.221; Godar SC, 2014, J PSYCHIATR RES, V56, P1, DOI 10.1016/j.jpsychires.2014.04.014; Goveas JS, 2004, PSYCHIAT RES, V126, P23, DOI 10.1016/j.psychres.2004.01.006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grigorenko EL, 2010, AGGRESSIVE BEHAV, V36, P158, DOI 10.1002/ab.20339; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Hassanain M, 2003, BRAIN RES, V981, P201, DOI 10.1016/S0006-8993(03)03036-1; Hazelwood LA, 2004, MOL PHARMACOL, V66, P1293, DOI 10.1124/mol.66.5.1293; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Ho HP, 2001, NEUROPSYCHOPHARMACOL, V24, P502, DOI 10.1016/S0893-133X(00)00219-0; Jakubczyk A, 2012, J PSYCHIATR RES, V46, P44, DOI 10.1016/j.jpsychires.2011.09.001; Kachadourian LK, 2012, PSYCHOL ADDICT BEHAV, V26, P414, DOI 10.1037/a0025842; Kiryanova V, 2014, DEV NEUROSCI-BASEL, V36, P396, DOI 10.1159/000363102; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; Kovacs-Nagy R, 2013, AM J MED GENET B, V162B, P404, DOI 10.1002/ajmg.b.32157; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kuepper Y, 2013, BEHAV BRAIN RES, V247, P73, DOI 10.1016/j.bbr.2013.03.002; Kusumi I, 2002, J AFFECT DISORDERS, V68, P235, DOI 10.1016/S0165-0327(00)00324-4; Latalova K, 2014, INT J CLIN PRACT, V68, P330, DOI 10.1111/ijcp.12327; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; Marseille R, 2012, PROG NEURO-PSYCHOPH, V36, P277, DOI 10.1016/j.pnpbp.2011.10.004; McCloskey M, 2009, PSYCHOPHARMACOLOGY, V203, P53, DOI 10.1007/s00213-008-1374-6; Meng YJ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-8; Miller GA, 2010, PERSPECT PSYCHOL SCI, V5, P716, DOI 10.1177/1745691610388774; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Ni XQ, 2006, NEUROSCI LETT, V408, P214, DOI 10.1016/j.neulet.2006.09.002; Niv S, 2013, J CRIM JUST, V41, P285, DOI 10.1016/j.jcrimjus.2013.06.014; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Ozaki N, 1997, J NEUROCHEM, V68, P2186; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Phan KL, 2011, INT CLIN PSYCHOPHARM, V26, P278, DOI 10.1097/YIC.0b013e32834978ac; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Ribases M, 2009, MOL PSYCHIATR, V14, P71, DOI 10.1038/sj.mp.4002100; Ricci LA, 2012, BEHAV NEUROSCI, V126, P640, DOI 10.1037/a0029761; Robinson OJ, 2012, PSYCHOPHARMACOLOGY, V219, P599, DOI 10.1007/s00213-011-2410-5; Rubin DH, 2013, J CHILD PSYCHOL PSYC, V54, P1337, DOI 10.1111/jcpp.12108; Saiz PA, 2011, PROG NEURO-PSYCHOPH, V35, P1518, DOI 10.1016/j.pnpbp.2011.04.011; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Spurlock G, 1998, MOL PSYCHIATR, V3, P42, DOI 10.1038/sj.mp.4000342; Stanley B, 2000, AM J PSYCHIAT, V157, P609, DOI 10.1176/appi.ajp.157.4.609; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stoltenberg SF, 2012, PROG NEURO-PSYCHOPH, V39, P182, DOI 10.1016/j.pnpbp.2012.06.012; Swann AC, 2003, J CLIN PSYCHIAT, V64, P26; Ten Eyck GR, 2014, PHARMACOL BIOCHEM BE, V124, P86, DOI 10.1016/j.pbb.2014.05.018; Terranova C, 2012, J FORENSIC SCI, V57, P1343, DOI 10.1111/j.1556-4029.2012.02243.x; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tops M, 2009, BRAIN COGNITION, V71, P427, DOI 10.1016/j.bandc.2009.03.009; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Tuvblad C, 2009, AGGRESSIVE BEHAV, V35, P437, DOI 10.1002/ab.20319; VARTIAINEN H, 1995, ACTA PSYCHIAT SCAND, V91, P348, DOI 10.1111/j.1600-0447.1995.tb09793.x; Volavka J, 2013, PSYCHIAT DANUB, V25, P24; Weber ET, 2010, FRONT NEUROSCI, V4, DOI [10.3389/fnins.2010.00300, DOI 10.3389/FNINS.2010.00300]; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wexler E, 2013, NEUROL CLIN, V31, P1121, DOI 10.1016/j.ncl.2013.04.016; Wilkie MJV, 2009, PHARMACOGENOMICS J, V9, P61, DOI 10.1038/sj.tpj.6500491; Winstanley CA, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.136; Wu D, 2009, FASEB J, V23, P1441, DOI 10.1096/fj.08-125286; Xu H, 2013, FASEB J, V27, P4157, DOI 10.1096/fj.12-226555; Yildirim BO, 2013, NEUROSCI BIOBEHAV R, V37, P1254, DOI 10.1016/j.neubiorev.2013.04.009; Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014	114	28	32	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117792	10.1371/journal.pone.0117792	http://dx.doi.org/10.1371/journal.pone.0117792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658328	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900224
J	Deng, T; Nie, ZL; Drew, BT; Volis, S; Kim, C; Xiang, CL; Zhang, JW; Wang, YH; Sun, H				Deng, Tao; Nie, Ze-Long; Drew, Bryan T.; Volis, Sergei; Kim, Changkyun; Xiang, Chun-Lei; Zhang, Jian-Wen; Wang, Yue-Hua; Sun, Hang			Does the Arcto-Tertiary Biogeographic Hypothesis Explain the Disjunct Distribution of Northern Hemisphere Herbaceous Plants? The Case of Meehania (Lamiaceae)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; SCRUB MINTS LAMIACEAE; MOLECULAR PHYLOGENY; NONCODING REGIONS; EVOLUTION; NUCLEAR; GENUS; DNA; HYBRIDIZATION; PATTERNS	Despite considerable progress, many details regarding the evolution of the Arcto-Tertiary flora, including the timing, direction, and relative importance of migration routes in the evolution of woody and herbaceous taxa of the Northern Hemisphere, remain poorly understood. Meehania (Lamiaceae) comprises seven species and five subspecies of annual or perennial herbs, and is one of the few Lamiaceae genera known to have an exclusively disjunct distribution between eastern Asia and eastern North America. We analyzed the phylogeny and biogeographical history of Meehania to explore how the Arcto-Tertiary biogeographic hypothesis and two possible migration routes explain the disjunct distribution of Northern Hemisphere herbaceous plants. Parsimony and Bayesian inference were used for phylogenetic analyses based on five plastid sequences (rbcL, rps16, rpl32-trnH, psbA-trnH, and trnL-F) and two nuclear (ITS and ETS) gene regions. Divergence times and biogeographic inferences were performed using Bayesian methods as implemented in BEAST and S-DIVA, respectively. Analyses including 11 of the 12 known Meehania taxa revealed incongruence between the chloroplast and nuclear trees, particularly in the positions of Glechoma and Meehania cordata, possibly indicating allopolyploidy with chloroplast capture in the late Miocene. Based on nrDNA, Meehania is monophyletic, and the North American species M. cordata is sister to a clade containing the eastern Asian species. The divergence time between the North American M. cordata and the eastern Asian species occurred about 9.81 Mya according to the Bayesian relaxed clock methods applied to the combined nuclear data. Biogeographic analyses suggest a primary role of the Arcto-Tertiary flora in the study taxa distribution, with a northeast Asian origin of Meehania. Our results suggest an Arcto-Tertiary origin of Meehania, with its present distribution most probably being a result of vicariance and southward migrations of populations during climatic oscillations in the middle Miocene with subsequent migration into eastern North America via the Bering land bridge in the late Miocene.	[Deng, Tao; Wang, Yue-Hua] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Deng, Tao; Volis, Sergei; Kim, Changkyun; Xiang, Chun-Lei; Zhang, Jian-Wen; Sun, Hang] Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Deng, Tao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Nie, Ze-Long] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou, Hunan, Peoples R China; [Drew, Bryan T.] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA	Yunnan University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University; University of Nebraska System	Wang, YH (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	wangyh58212@126.com; sunhang@mail.kib.ac.cn	Nie, Ze-Long/N-8471-2015; , wenzi/ABB-4126-2021; Volis, Sergei/GLU-5848-2022; Xiang, Chun-Lei/AAC-8433-2021; Xiang, Chunlei/Z-1799-2019; ZHANG, Jianwen/AAG-7743-2020	Nie, Ze-Long/0000-0001-8065-3981; Xiang, Chunlei/0000-0001-8775-6967; ZHANG, Jianwen/0000-0002-4735-168X	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03030106]; NSFC-Yunnan Natural Science Foundation United Project [U1136601]; CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Yunnan Natural Science Foundation United Project; CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences	This study was supported by grants-in-aid from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB03030106), NSFC-Yunnan Natural Science Foundation United Project (Grant no. U1136601) and The CAS/SAFEA International Partnership Program for Creative Research Teams, Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini G, 2012, MOL PHYLOGENET EVOL, V65, P739, DOI 10.1016/j.ympev.2012.07.030; Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; [安芷生 An Zhisheng], 2006, [第四纪研究, Quaternary Sciences], V26, P678; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1967, BERING LAND BRIDGE; Baird KE, 2010, J SYST EVOL, V48, P161, DOI 10.1111/j.1759-6831.2010.00077.x; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; BUDANTSEV LY, 1992, BOT REV, V58, P1, DOI 10.1007/BF02858542; CHANEY RW, 1947, ECOL MONOGR, V17, P139, DOI 10.2307/1943260; CHEN C, 1979, Acta Botanica Yunnanica, V1, P81; Chen CH, 2009, BOT STUD, V50, P425; Conn BJ, 2009, AUST SYST BOT, V22, P243, DOI 10.1071/SB09011; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Douglas R.G., 1981, OCEANIC LITHOSPHERE, P1233; Drew BT, 2013, BOT J LINN SOC, V171, P171, DOI 10.1111/j.1095-8339.2012.01325.x; Drew BT, 2012, AM J BOT, V99, P933, DOI 10.3732/ajb.1100549; Drew BT, 2011, SYST BOT, V36, P1038, DOI 10.1600/036364411X605047; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards CE, 2006, SYST BOT, V31, P193, DOI 10.1600/036364406775971688; Edwards CE, 2008, INT J PLANT SCI, V169, P579, DOI 10.1086/528758; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Funamoto Tsuneo, 2000, Chromosome Science, V4, P107; Gobert V, 2006, PLANT BIOLOGY, V8, P470, DOI 10.1055/s-2006-924043; Gould Katherine R., 2000, Harvard Papers in Botany, V5, P157; Guggisberg A, 2009, SYSTEMATIC BIOL SYP0; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harley RM, 2004, FA GE VAS P, V7, P167; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Kar RK, 1996, PALAEOBOTANIST, V43; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li XW, 1994, FLORA CHINA, P122; MAI DH, 1991, REV PALAEOBOT PALYNO, V68, P29, DOI 10.1016/0034-6667(91)90055-8; Manchester SR, 2001, INT J PLANT SCI, V162, pS19, DOI 10.1086/323657; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Meng Y, 2008, MOL PHYLOGENET EVOL, V49, P424, DOI 10.1016/j.ympev.2008.07.017; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Moon HK, 2010, TAXON, V59, P1065, DOI 10.1002/tax.594007; Murata G., 1993, FLORA JAPAN, P289; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nie ZL, 2005, AM J BOT, V92, P642, DOI 10.3732/ajb.92.4.642; NYLANDER J.A.A., 2004, MRMODELTEST V2 3; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliveira LO, 2007, AM J BOT, V94, P1017, DOI 10.3732/ajb.94.6.1017; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reid E.M., 1926, CATALOGUE CAINZOIC P, VI; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryding O, 2007, PLANT SYST EVOL, V268, P45, DOI 10.1007/s00606-007-0537-y; SAKAI A, 1971, NEW PHYTOL, V70, P1199, DOI 10.1111/j.1469-8137.1971.tb04598.x; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Scheen AC, 2010, ANN MO BOT GARD, V97, P191, DOI 10.3417/2007174; Schonhofer AL, 2013, MOL PHYLOGENET EVOL, V66, P303, DOI 10.1016/j.ympev.2012.10.001; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SOLTIS DE, 1995, EVOLUTION, V49, P727, DOI 10.1111/j.1558-5646.1995.tb02309.x; Soltis DE, 1996, SYST BOT, V21, P169, DOI 10.2307/2419746; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P671; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Sytsma KJ, 2014, BIOL J LINN IN PRESS; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takhtajan A, 1969, FLOWERING PLANTS ORI; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Tiffney BH, 2008, ANN MO BOT GARD, V95, P135, DOI 10.3417/2006199; Trusty JL, 2004, SYST BOT, V29, P702, DOI 10.1600/0363644041744347; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J, 2009, J SYST EVOL, V47, P327, DOI 10.1111/j.1759-6831.2009.00052.x; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu CY, 1959, ACTA PHYTOTAXONOMICA, V8, P3; Wu CY, 1977, FLORA REIPUBLICAE PO, P334; [夏国华 Xia Guohua], 2011, [广西植物, Guihaia], V31, P581; Xiang CL, 2013, TAXON, V62, P375, DOI 10.12705/622.11; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xie L, 2009, MOL PHYLOGENET EVOL, V53, P995, DOI 10.1016/j.ympev.2009.09.009; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yu Y, 2013, RASP RECONSTRUCT ANC, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yuan YW, 2008, MOL PHYLOGENET EVOL, V48, P23, DOI 10.1016/j.ympev.2008.04.004; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x; ZURAWSKI G, 1981, NUCLEIC ACIDS RES, V9, P3251, DOI 10.1093/nar/9.14.3251	96	37	41	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117171	10.1371/journal.pone.0117171	http://dx.doi.org/10.1371/journal.pone.0117171			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658699	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900110
J	Matsuda, Y; Ishiwata, T; Izumiyama-Shimomura, N; Hamayasu, H; Fujiwara, M; Tomita, KI; Hiraishi, N; Nakamura, K; Ishikawa, N; Aida, J; Takubo, K; Arai, T				Matsuda, Yoko; Ishiwata, Toshiyuki; Izumiyama-Shimomura, Naotaka; Hamayasu, Hideki; Fujiwara, Mutsunori; Tomita, Ken-ichiro; Hiraishi, Naoki; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo; Arai, Tomio			Gradual Telomere Shortening and Increasing Chromosomal Instability among PanIN Grades and Normal Ductal Epithelia with and without Cancer in the Pancreas	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; TISSUE; LENGTH; CELLS; FISH; ASSOCIATION; SECTIONS; FIGURES; BIOLOGY	A large body of evidence supports a key role for telomere dysfunction in carcinogenesis due to the induction of chromosomal instability. To study telomere shortening in precancerous pancreatic lesions, we measured telomere lengths using quantitative fluorescence in situ hybridization in the normal pancreatic duct epithelium, pancreatic intraepithelial neoplasias (PanINs), and cancers. The materials employed included surgically resected pancreatic specimens without cancer (n = 33) and with invasive ductal carcinoma (n = 36), as well as control autopsy cases (n = 150). In comparison with normal ducts, telomere length was decreased in PanIN-1, -2 and -3 and cancer. Furthermore, telomeres were shorter in cancer than in PanIN-1 and -2. Telomere length in cancer was not associated with histological type, lesion location, or cancer stage. PanINs with or without cancer showed similar telomere lengths. The incidences of atypical mitosis and anaphase bridges, which are morphological characteristics of chromosomal instability, were negatively correlated with telomere length. The telomeres in normal duct epithelium became shorter with aging, and those in PanINs or cancers were shorter than in age-matched controls, suggesting that telomere shortening occurs even when histological changes are absent. Our data strongly suggest that telomere shortening occurs in the early stages of pancreatic carcinogenesis and progresses with precancerous development. Telomere shortening and chromosomal instability in the duct epithelium might be associated with carcinogenesis of the pancreas. Determination of telomere length in pancreatic ductal lesions may be valuable for accurate detection and risk assessment of pancreatic cancer.	[Matsuda, Yoko; Hamayasu, Hideki; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Itabashi Ku, Tokyo 1730015, Japan; [Ishiwata, Toshiyuki] Nippon Med Sch, Grad Sch Med, Dept Integrated Diagnost Pathol, Bunkyo Ku, Tokyo, Japan; [Izumiyama-Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo] Tokyo Metropolitan Geriatr Hosp, Res Team Geriatr Pathol, Itabashi Ku, Tokyo 1730015, Japan; [Matsuda, Yoko; Nakamura, Ken-ichi; Ishikawa, Naoshi; Aida, Junko; Takubo, Kaiyo] Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan; [Fujiwara, Mutsunori; Tomita, Ken-ichiro] Japanese Red Cross Med Ctr, Dept Pathol, Shibuya Ku, Tokyo 1508935, Japan; [Hiraishi, Naoki] Hadano Red Cross Hosp, Dept Lab Med, Hadano, Kanagawa 2570017, Japan	Nippon Medical School; Japanese Red Cross Medical Center	Matsuda, Y (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	yoko_matsuda@tmghig.jp; takubo@tmig.or.jp	Aida, Junko/Q-5697-2019	Aida, Junko/0000-0003-4923-5540	Japan Society for the Promotion of Science [25462127]; Cancer Research Institute of Kanazawa University; Alumni Association of Kagawa University Faculty of Medicine Sanjukai	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research Institute of Kanazawa University; Alumni Association of Kagawa University Faculty of Medicine Sanjukai	This work was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science (C, No. 25462127) and grants from the Cancer Research Institute of Kanazawa University and the Alumni Association of Kagawa University Faculty of Medicine Sanjukai to Y. Matsuda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Aida J, 2010, EUR J CANCER, V46, P430, DOI 10.1016/j.ejca.2009.10.018; Amosenko FA, 2009, MOL BIOL+, V43, P381, DOI 10.1134/S0026893309030054; Arai T, 2007, PATHOL INT, V57, P303, DOI 10.1111/j.1440-1827.2007.02101.x; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Baumgart M, 2010, PANCREAS, V39, P1093, DOI 10.1097/MPA.0b013e3181dc62f6; Bidoli E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-443; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Boardman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080015; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Friis-Ottessen M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hong SM, 2011, MODERN PATHOL, V24, P256, DOI 10.1038/modpathol.2010.181; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Hruban RH, 2010, WHO CLASSIFICATION T; Ikeda H, 2014, HUM PATHOL, V45, P473, DOI 10.1016/j.humpath.2013.10.009; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Kawano Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093749; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Korc M, 2010, CANCER BIOL THER, V10, P588, DOI 10.4161/cbt.10.6.13128; Kurabayashi R, 2008, HUM PATHOL, V39, P1647, DOI 10.1016/j.humpath.2008.04.005; Kure S, 2010, MOYAMOYA DISEASE UPDATE, P41, DOI 10.1007/978-4-431-99703-0_6; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Lillemoe KD, 2000, CA-CANCER J CLIN, V50, P241, DOI 10.3322/canjclin.50.4.241; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Luttges J, 2001, AM J PATHOL, V158, P1677, DOI 10.1016/S0002-9440(10)64123-5; Montgomery E, 2003, CANCER BIOL THER, V2, P248, DOI 10.4161/cbt.2.3.362; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Pandol S, 2012, J GASTROEN HEPATOL, V27, P127, DOI 10.1111/j.1440-1746.2011.07013.x; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sipos B, 2009, PANCREATOLOGY, V9, P45, DOI 10.1159/000178874; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704; Tamura Y, 2014, J CLIN ENDOCR METAB; Terai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02401; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; VANLEEUWEN AM, 1995, VIRCHOWS ARCH, V427, P139, DOI 10.1007/BF00196518	50	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117575	10.1371/journal.pone.0117575	http://dx.doi.org/10.1371/journal.pone.0117575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658358	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900179
J	Nascimento, FRF; Gomes, EA; Russo, M; Lepique, AP				Nascimento, Flavia R. F.; Gomes, Eliane A.; Russo, Momtchilo; Lepique, Ana P.			Interferon Regulatory Factor (IRF)-1 Is a Master Regulator of the Cross Talk between Macrophages and L929 Fibrosarcoma Cells for Nitric Oxide Dependent Tumoricidal Activity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MURINE MACROPHAGES; TRANSCRIPTIONAL ACTIVATION; CHRONIC INFLAMMATION; SYNTHASE GENE; UP-REGULATION; IRF FAMILY; TNF-ALPHA; FACTOR-I; EXPRESSION	Macrophage tumoricidal activity relies, mainly, on the release of Tumor Necrosis Factor alpha (TNF alpha) and/or on reactive oxygen or nitrogen intermediates. In the present work, we investigated the cytotoxic activity of resident peritoneal macrophages against L929 fibrosarcoma cell line in vitro and in vivo. Resident macrophages lysed L929 cells in a mechanism independent of TNF alpha and cell-to-cell contact. The cytotoxic activity was largely dependent on nitric oxide (NO) release since treatment with L-NAME (NOS inhibitor) inhibited L929 cells killing. Macrophages from mice with targeted deletion of inducible NO synthase (iNOS) together with L929 cells produced less NO and displayed lower, but still significant, tumoricidal activity. Notably, NO production and tumor lysis were abolished in co-cultures with macrophages deficient in Interferon Regulatory Factor, IRF-1. Importantly, the in vitro findings were reproduced in vivo as IRF-1 deficient animals inoculated i.p with L929 cells were extremely susceptible to tumor growth and their macrophages did not produce NO, while WT mice killed L929 tumor cells and their macrophages produced high levels of NO. Our results indicate that IRF-1 is a master regulator of bi-directional interaction between macrophages and tumor cells. Overall, IRF-1 was essential for NO production by co-cultures and macrophage tumoricidal activity in vitro as well as for the control of tumor growth in vivo.	[Nascimento, Flavia R. F.] Univ Fed Maranhao, Ctr Biol Sci & Hlth, Dept Pathol, Sao Luis, Brazil; [Gomes, Eliane A.; Russo, Momtchilo; Lepique, Ana P.] Univ Sao Paulo, Inst Biomed Sci, Dept Imunol, Sao Paulo, Brazil	Universidade Federal do Maranhao; Universidade de Sao Paulo	Russo, M (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Imunol, Sao Paulo, Brazil.	momrusso@icb.usp.br	Nascimento, F/F-8173-2016; Lepique, Ana Paula/T-2427-2019; Lepique, Ana Paula/D-5878-2013	Nascimento, F/0000-0001-9328-1806; Lepique, Ana Paula/0000-0002-4707-2912	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/20010-2, 2013/24694-1]; FAPESP doctorate scholarship; Universidade Federal do Maranhao (UFMA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP doctorate scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Federal do Maranhao (UFMA)	The main funder was from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2010/20010-2 to APL and 2013/24694-1 to MR. FRFN had a FAPESP doctorate scholarship and support from Universidade Federal do Maranhao (UFMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; CUI SJ, 1994, CANCER RES, V54, P2462; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DARZYNKIEWICZ Z, 1984, CANCER RES, V44, P83; FAST DJ, 1992, J LEUKOCYTE BIOL, V52, P255, DOI 10.1002/jlb.52.3.255; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Harhaji L, 2006, FREE RADICAL BIO MED, V40, P226, DOI 10.1016/j.freeradbiomed.2005.08.027; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HOSSHOMFELD A, 1989, VIROLOGY, V173, P539, DOI 10.1016/0042-6822(89)90566-7; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; ISOBE K, 1993, BIOCHEM BIOPH RES CO, V192, P499, DOI 10.1006/bbrc.1993.1443; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KLOSTERGAARD J, 1991, J IMMUNOL, V147, P2802; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; KOIDE M, 1993, FEBS LETT, V318, P213, DOI 10.1016/0014-5793(93)80514-U; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Lehtonen A, 1997, J IMMUNOL, V159, P794; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Massi D, 2007, HUM PATHOL, V38, P1516, DOI 10.1016/j.humpath.2007.02.018; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nascimento FRF, 1998, BRAZ J MED BIOL RES, V31, P1593; Nascimento FRF, 2003, BRAZ J MED BIOL RES, V36, P1221, DOI 10.1590/S0100-879X2003000900012; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NOZAKI Y, 1993, INT J ONCOL, V2, P1053; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park YH, 2013, BIOCHEM BIOPH RES CO, V435, P244, DOI 10.1016/j.bbrc.2013.04.071; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Schwartsburd PM, 2003, CANCER METAST REV, V22, P95, DOI 10.1023/A:1022220219975; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; Sodhi A, 2007, MOL IMMUNOL, V44, P2265, DOI 10.1016/j.molimm.2006.11.008; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tazawa H, 2013, EXP CELL RES, V319, P2835, DOI 10.1016/j.yexcr.2013.08.006; Tonetti M, 1997, BIOCHEM BIOPH RES CO, V230, P636, DOI 10.1006/bbrc.1996.6022; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; VASILIEV VY, 1990, TSITOLOGIYA+, V32, P275; Vercammen E, 2008, ONCOGENE, V27, P3780, DOI 10.1038/onc.2008.4; WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403; ZEMBALA M, 1994, EUR J IMMUNOL, V24, P435, DOI 10.1002/eji.1830240225	52	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117782	10.1371/journal.pone.0117782	http://dx.doi.org/10.1371/journal.pone.0117782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659093	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900221
J	Ring, M; Eskofier, BM				Ring, Matthias; Eskofier, Bjoern M.			Data Mining in the US National Toxicology Program (NTP) Database Reveals a Potential Bias Regarding Liver Tumors in Rodents Irrespective of the Test Agent	PLOS ONE			English	Article							NONGENOTOXIC CARCINOGENESIS; GENDER-DIFFERENCES; B6C3F(1) MICE; BODY-WEIGHT; PREDICTION; TOXICITY; VALIDATION; MUTAGENS; BIOASSAY; DESIGNS	Long-term studies in rodents are the benchmark method to assess carcinogenicity of single substances, mixtures, and multi-compounds. In such a study, mice and rats are exposed to a test agent at different dose levels for a period of two years and the incidence of neoplastic lesions is observed. However, this two-year study is also expensive, time-consuming, and burdensome to the experimental animals. Consequently, various alternatives have been proposed in the literature to assess carcinogenicity on basis of short-term studies. In this paper, we investigated if effects on the rodents' liver weight in short-term studies can be exploited to predict the incidence of liver tumors in long-term studies. A set of 138 paired short-and long-term studies was compiled from the database of the U.S. National Toxicology Program (NTP), more precisely, from (long-term) two-year carcinogenicity studies and their preceding (short-term) dose finding studies. In this set, data mining methods revealed patterns that can predict the incidence of liver tumors with accuracies of over 80%. However, the results simultaneously indicated a potential bias regarding liver tumors in two-year NTP studies. The incidence of liver tumors does not only depend on the test agent but also on other confounding factors in the study design, e.g., species, sex, type of substance. We recommend considering this bias if the hazard or risk of a test agent is assessed on basis of a NTP carcinogenicity study.	[Ring, Matthias; Eskofier, Bjoern M.] Univ Erlangen Nurnberg, Pattern Recognit Lab, Digital Sports Grp, D-91054 Erlangen, Fau, Germany	University of Erlangen Nuremberg	Ring, M (corresponding author), Univ Erlangen Nurnberg, Pattern Recognit Lab, Digital Sports Grp, D-91054 Erlangen, Fau, Germany.	matthias.ring@cs.fau.de	Ring, Matthias/I-3822-2016; Eskofier, Bjoern/ABF-1284-2021	Ring, Matthias/0000-0003-3601-3228; Eskofier, Bjoern/0000-0002-0417-0336	Deutsche Telekom Stiftung	Deutsche Telekom Stiftung	MR is supported by a research fellowship from the Deutsche Telekom Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden CL, 1996, TOXICOL PATHOL, V24, P722, DOI 10.1177/019262339602400610; Allen DG, 2004, TOXICOL PATHOL, V32, P393, DOI 10.1080/01926230490440934; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anisimov VN, 2005, NAT REV CANCER, V5, P807, DOI 10.1038/nrc1715; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Benfenati E, 2009, J ENVIRON SCI HEAL C, V27, P57, DOI 10.1080/10590500902885593; Benigni R, 1996, ENVIRON HEALTH PERSP, V104, P1041, DOI 10.2307/3433028; Benigni R, 2008, TOXICOL MECH METHOD, V18, P137, DOI 10.1080/15376510701857056; Boobis AR, 2009, TOXICOL PATHOL, V37, P714, DOI 10.1177/0192623309343779; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bristol DW, 1996, ENVIRON HEALTH PERSP, V104, P1001, DOI 10.1289/ehp.96104s51001; Bucher JR, 2002, ANN NY ACAD SCI, V982, P198; CHHABRA RS, 1990, ENVIRON HEALTH PERSP, V86, P313, DOI 10.2307/3430970; Duda RO, 2001, PATTERN CLASSIFICATI, P2; Dunnick JK, 2013, TOXICOL PATHOL, V41, P374, DOI 10.1177/0192623312466451; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; Faustman E.M., 2008, CASARETT DOULLS TOXI; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; GRASSO P, 1991, MUTAT RES, V248, P271, DOI 10.1016/0027-5107(91)90062-S; Greaves P, 2012, HISTOPATHOLOGY OF PRECLINICAL TOXICITY STUDIES: INTERPRETATION AND RELEVANCE IN DRUG SAFETY EVALUATION, 4TH EDITION, P1; Gutlein M, 2013, MOL INFORM, V32, P516, DOI 10.1002/minf.201200134; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haseman JK, 1997, TOXICOL PATHOL, V25, P256, DOI 10.1177/019262339702500302; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hayes AW, 2011, REGUL TOXICOL PHARM, V60, pS1, DOI 10.1016/j.yrtph.2010.10.002; Helma C, 2000, STAT METHODS MED RES, V9, P329, DOI 10.1191/096228000701555190; Helma C, 2003, BIOINFORMATICS, V19, P1179, DOI 10.1093/bioinformatics/btg084; HIRTZ J, 1985, BRIT J CLIN PHARMACO, V19, pS77, DOI 10.1111/j.1365-2125.1985.tb02746.x; Kadekar S, 2012, TOXICOL PATHOL, V40, P1160, DOI 10.1177/0192623312446527; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Moore NP, 2013, EXP TOXICOL PATHOL, V65, P1109, DOI 10.1016/j.etp.2013.05.001; Moriguchi I, 1996, ENVIRON HEALTH PERSP, V104, P1051, DOI 10.2307/3433030; NTP, 2014, CHEM ASS SIT SPEC NE; NTP, 2011, SPEC COND STUD EV TO; NTP, 2013, NTP TECHN REP; NTP, 2013, CARTOX DAT; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy MV, 2010, VET PATHOL, V47, P614, DOI 10.1177/0300985810373242; SEILKOP SK, 1995, FUND APPL TOXICOL, V24, P247, DOI 10.1006/faat.1995.1028; Spielmann H, 2003, TOXICOL PATHOL, V31, P54, DOI 10.1080/01926230390173897; Toivonen H, 2003, BIOINFORMATICS, V19, P1183, DOI 10.1093/bioinformatics/btg130; Travlos GS, 2011, TOXICOL PATHOL, V39, P381, DOI 10.1177/0192623310388432; Ward JM, 2007, J TOXICOL PATHOL, V20, P13, DOI DOI 10.1293/TOX.20.13; Williams GM, 2002, TOXICOL PATHOL, V30, P41, DOI 10.1080/01926230252824699; Witten IH, 2011, MOR KAUF D, P1	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116488	10.1371/journal.pone.0116488	http://dx.doi.org/10.1371/journal.pone.0116488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658102	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900043
J	Xing, F; Sharma, S; Liu, Y; Mo, YY; Wu, K; Zhang, YY; Pochampally, R; Martinez, LA; Lo, HW; Watabe, K				Xing, F.; Sharma, S.; Liu, Y.; Mo, Y-Y; Wu, K.; Zhang, Y-Y; Pochampally, R.; Martinez, L. A.; Lo, H-W; Watabe, K.			nmiR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-alpha	ONCOGENE			English	Article							BARRIER PERMEABILITY; PROSTATE-CANCER; MICRORNAS; EXPRESSION; LET-7; MICE	The median survival time of breast cancer patients with brain metastasis is less than 6 months, and even a small metastatic lesion often causes severe neurological disabilities. Because of the location of metastatic lesions, a surgical approach is limited and most chemotherapeutic drugs are ineffective owing to the blood brain barrier (BBB). Despite this clinical importance, the molecular basis of the brain metastasis is poorly understood. In this study, we have isolated RNA from samples obtained from primary breast tumors and also from brain metastatic lesions followed by microRNA profiling analysis. Our results revealed that the miR-509 is highly expressed in the primary tumors, whereas the expression of this microRNA is significantly decreased in the brain metastatic lesions. MicroRNA target prediction and the analysis of cytokine array for the cells ectopically expressed with miR-509 demonstrated that this microRNA was capable of modulating the two genes essential for brain invasion, RhoC and TNF-alpha that affect the invasion of cancer cells and permeability of BBB, respectively. Importantly, high levels of TNF-alpha and RhoC-induced MMP9 were significantly correlated with brain metastasis-free survival of breast cancer patients. Furthermore, the results of our in vivo experiments indicate that miR-509 significantly suppressed the ability of cancer cells to metastasize to the brain. These findings suggest that miR-509 has a critical role in brain metastasis of breast cancer by modulating the RhoC-TNF-alpha network and that this miR-509 axis may represent a potential therapeutic target or serve as a prognostic tool for brain metastasis.	[Xing, F.; Sharma, S.; Liu, Y.; Wu, K.; Lo, H-W; Watabe, K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Xing, F.; Sharma, S.; Liu, Y.; Wu, K.; Lo, H-W; Watabe, K.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Mo, Y-Y; Zhang, Y-Y; Pochampally, R.; Martinez, L. A.] Univ Mississippi, Med Ctr, Canc Inst, Jackson, MS 39216 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Mississippi Medical Center	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Mo, Yin-Yuan/R-8255-2019	Pochampally, Radhika/0000-0002-4263-0364	National Institutes of Health [R01CA124650, R01CA129000, R01CA173499]; US Department of Defense [BC096982]; NATIONAL CANCER INSTITUTE [R01CA173499, R01CA129000, R01CA151851, R01CA124650, R01CA154989, P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants R01CA124650, R01CA129000 and R01CA173499 to K Watabe) and the US Department of Defense (BC096982 to K Watabe).	Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Arslan C, 2010, EXPERT OPIN PHARMACO, V11, P1089, DOI 10.1517/14656561003702412; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Bindal AK, 1996, J NEUROSURG, V84, P748, DOI 10.3171/jns.1996.84.5.0748; BINDAL RK, 1993, J NEUROSURG, V79, P210, DOI 10.3171/jns.1993.79.2.0210; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Eichler AF, 2008, CANCER, V112, P2359, DOI 10.1002/cncr.23468; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Izraely S, 2012, INT J CANCER, V131, P1071, DOI 10.1002/ijc.27324; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Langley RR, 2003, CANCER RES, V63, P2971; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Nie WW, 2013, CANCER BIOTHER RADIO, V28, P71, DOI 10.1089/cbr.2012.1311; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Ramakrishna Rohan, 2013, Surg Neurol Int, V4, pS256, DOI 10.4103/2152-7806.111303; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Rosenthal DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040979; SAIJA A, 1995, LIFE SCI, V56, P775, DOI 10.1016/0024-3205(95)00008-T; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Tie J, 2011, HISTOL HISTOPATHOL, V26, P1353, DOI 10.14670/HH-26.1353; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; van Golen KL, 2000, CANCER RES, V60, P5832; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wang W, 2011, EUR J GASTROEN HEPAT, V23, P552, DOI 10.1097/MEG.0b013e3283470212; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; Yang GY, 1999, MOL BRAIN RES, V69, P135, DOI 10.1016/S0169-328X(99)00007-8; Yang YL, 2004, WORLD J GASTROENTERO, V10, P3161; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	40	60	64	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4890	4900		10.1038/onc.2014.412	http://dx.doi.org/10.1038/onc.2014.412			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25659578	Green Accepted			2022-12-26	WOS:000361050000009
J	Tilleman, L; Germani, F; De Henau, S; Helbo, S; Desmet, F; Berghmans, H; Van Doorslaer, S; Hoogewijs, D; Schoofs, L; Braeckman, BP; Moens, L; Fago, A; Dewilde, S				Tilleman, Lesley; Germani, Francesca; De Henau, Sasha; Helbo, Signe; Desmet, Filip; Berghmans, Herald; Van Doorslaer, Sabine; Hoogewijs, David; Schoofs, Liliane; Braeckman, Bart P.; Moens, Luc; Fago, Angela; Dewilde, Sylvia			A Globin Domain in a Neuronal Transmembrane Receptor of Caenorhabditis elegans and Ascaris suum MOLECULAR MODELING AND FUNCTIONAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Paramagnetic Resonance (EPR); Hemoglobin; Kinetics; Oxygen Binding; Redox Signaling	ELECTRON-PARAMAGNETIC RESONANCE; FMRFAMIDE-RELATED NEUROPEPTIDE; PROTEIN-COUPLED RECEPTORS; CYTOCHROME-C PEROXIDASE; SPERM-WHALE MYOGLOBIN; LIGAND-BINDING; NITRIC-OXIDE; GENE FAMILY; HEME OXYGENASE; HORSERADISH-PEROXIDASE	We report the structural and biochemical characterization of GLB-33, a putative neuropeptide receptor that is exclusively expressed in the nervous system of the nematode Caenorhabditis elegans. This unique chimeric protein is composed of a 7-transmembrane domain (7TM), GLB-33 7TM, typical of a G-protein-coupled receptor, and of a globin domain (GD), GLB-33 GD. Comprehensive sequence similarity searches in the genome of the parasitic nematode, Ascaris suum, revealed a chimeric protein that is similar to a Phe-Met-Arg-Phe-amide neuropeptide receptor. The three-dimensional structures of the separate domains of both species and of the full-length proteins were modeled. The 7TM domains of both proteins appeared very similar, but the globin domain of the A. suum receptor surprisingly seemed to lack several helices, suggesting a novel truncated globin fold. The globin domain of C. elegans GLB-33, however, was very similar to a genuine myoglobin-type molecule. Spectroscopic analysis of the recombinant GLB-33 GD showed that the heme is pentacoordinate when ferrous and in the hydroxide-ligated form when ferric, even at neutral pH. Flash-photolysis experiments showed overall fast biphasic CO rebinding kinetics. In its ferrous deoxy form, GLB-33 GD is capable of reversibly binding O-2 with a very high affinity and of reducing nitrite to nitric oxide faster than other globins. Collectively, these properties suggest that the globin domain of GLB-33 may serve as a highly sensitive oxygen sensor and/or as a nitrite reductase. Both properties are potentially able to modulate the neuropeptide sensitivity of the neuronal transmembrane receptor.	[Tilleman, Lesley; Germani, Francesca; Berghmans, Herald; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Desmet, Filip; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2610 Antwerp, Belgium; [De Henau, Sasha; Braeckman, Bart P.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Helbo, Signe; Fago, Angela] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark; [Hoogewijs, David] Univ Zurich, Inst Physiol, CH-8006 Zurich, Switzerland; [Hoogewijs, David] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland; [Hoogewijs, David] Univ Duisburg Essen, Inst Physiol, D-45147 Essen, Germany; [Schoofs, Liliane] Katholieke Univ Leuven, Funct Genom & Prote Grp, B-3000 Leuven, Belgium	University of Antwerp; University of Antwerp; Ghent University; Aarhus University; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Duisburg Essen; KU Leuven	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, Univ Pl 1, B-2610 Antwerp, Belgium.	sylvia.dewilde@uantwerpen.be	Van Doorslaer, Sabine/E-5050-2017; Fago, Angela/J-5946-2013; Hoogewijs, David/L-5144-2016; schoofs, liliane/ABD-2943-2020; Schoofs, Liliane/F-2815-2010	Van Doorslaer, Sabine/0000-0002-1685-9202; Fago, Angela/0000-0001-7315-2628; Schoofs, Liliane/0000-0002-1673-432X	Bijzonder Onderzoeksfonds TOP University of Antwerp; Fund for Scientific Research Project [G.0247.09]; Lundbeck Foundation; Danish Council for Independent Research, Natural Sciences Grant [10-084565]; KU Leuven; Fund for Scientific Research	Bijzonder Onderzoeksfonds TOP University of Antwerp; Fund for Scientific Research Project; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Natural Sciences Grant; KU Leuven(KU Leuven); Fund for Scientific Research	This work was supported in part by Bijzonder Onderzoeksfonds TOP University of Antwerp 2006 (to S. D. and L. M.) and by Fund for Scientific Research Project G.0247.09 (to S. D., L. M., S. V. D., and B. B.).; Supported by the Lundbeck Foundation and The Danish Council for Independent Research, Natural Sciences Grant 10-084565.; Supported by KU Leuven and the Fund for Scientific Research.	ALLOCATELLI CT, 1993, BIOCHEMISTRY-US, V32, P6041; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; BAUMGARTL H, 1994, ACTA OECOL, V15, P781; BIRNBAUMER L, 1990, AM REV RESPIR DIS, V141, pS106, DOI 10.1164/ajrccm/141.3_Pt_2.S106; Blumberg W. E., 1972, WENNER GREN CTR INT, V18, P219; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; BOUTILIER RG, 1984, FISH PHYSIOL, V10, P403; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BOWMAN JW, 1995, J NEUROPHYSIOL, V74, P1880, DOI 10.1152/jn.1995.74.5.1880; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Cantacessi C, 2009, MOL CELL PROBE, V23, P205, DOI 10.1016/j.mcp.2009.03.003; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; CHO KC, 1981, BIOCHIM BIOPHYS ACTA, V668, P186, DOI 10.1016/0005-2795(81)90162-8; Couture M, 2001, J BIOL CHEM, V276, P38280; COWDEN C, 1989, NEURON, V2, P1465, DOI 10.1016/0896-6273(89)90192-X; Cutruzzola F, 1996, BIOCHEM J, V314, P83, DOI 10.1042/bj3140083; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Davis RE, 2001, PEPTIDES, V22, P7, DOI 10.1016/S0196-9781(00)00351-X; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEBAERE I, 1994, P NATL ACAD SCI USA, V91, P1594, DOI 10.1073/pnas.91.4.1594; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dunham CM, 2003, BIOCHEMISTRY-US, V42, P7701, DOI 10.1021/bi0343370; Fierro-Gonzalez JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016561; FOOTE N, 1987, BIOCHEM J, V246, P659, DOI 10.1042/bj2460659; Geuens E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-17; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HANANIA GIH, 1966, BIOCHEM J, V98, P189, DOI 10.1042/bj0980189; Helbo S, 2011, AM J PHYSIOL-REG I, V300, pR101, DOI 10.1152/ajpregu.00374.2010; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; HORI H, 1985, J BIOL CHEM, V260, P349; Howes BD, 2011, J BIOL INORG CHEM, V16, P299, DOI 10.1007/s00775-010-0726-y; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Hu ZT, 2011, NEURON, V71, P92, DOI 10.1016/j.neuron.2011.04.021; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Moens L, 1996, MOL BIOL EVOL, V13, P324, DOI 10.1093/oxfordjournals.molbev.a025592; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nicoletti FP, 2013, BBA-PROTEINS PROTEOM, V1834, P1901, DOI 10.1016/j.bbapap.2013.02.033; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Pedersen CL, 2010, J EXP BIOL, V213, P2755, DOI 10.1242/jeb.041624; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pesce A, 2001, J MOL BIOL, V309, P1153, DOI 10.1006/jmbi.2001.4731; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; ROUSSEAU DL, 1989, J BIOL CHEM, V264, P7878; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SICK H, 1969, ANAL BIOCHEM, V32, P362, DOI 10.1016/S0003-2697(69)80002-3; SITTER AJ, 1988, J BIOL CHEM, V263, P13032; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Tilleman L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048768; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; TRAVAGLINI ALLOCATELLI C, 1994, FEBS LETT, V352, P63, DOI 10.1016/0014-5793(94)00918-X; Vergara A, 2007, BIOPHYS J, V93, P2822, DOI 10.1529/biophysj.107.105700; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WITTENBERG BA, 1968, J BIOL CHEM, V243, P1863; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Yoon J, 2010, BIOCHEMISTRY-US, V49, P5662, DOI 10.1021/bi100710a; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	102	5	6	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10336	10352		10.1074/jbc.M114.576520	http://dx.doi.org/10.1074/jbc.M114.576520			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25666609	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000353241100036
J	Abouzeid, M; Versace, VL; Janus, ED; Davey, MA; Philpot, B; Oats, J; Dunbar, JA				Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Davey, Mary-Ann; Philpot, Benjamin; Oats, Jeremy; Dunbar, James A.			Socio-Cultural Disparities in GDM Burden Differ by Maternal Age at First Delivery	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; NEW-SOUTH-WALES; SOCIOECONOMIC-STATUS; PREGNANCY OUTCOMES; RISK-FACTOR; WOMEN; POPULATION; COMPLICATIONS; ASSOCIATION; PREVALENCE	Aims Several socio-cultural and biomedical risk factors for gestational diabetes mellitus ( GDM) are modifiable. However, few studies globally have examined socio-cultural associations. To eliminate confounding of increased risk of diabetes in subsequent pregnancies, elucidating socio-cultural associations requires examination only of first pregnancies. Methods Data for all women who delivered their first child in Victoria, Australia between 1999 and 2008 were extracted from the Victorian Perinatal Data Collection. Crude and adjusted GDM rates were calculated. Multivariate logistic regression was used to examine odds of GDM within and between socio-cultural groups. Results From 1999 to 2008, 269,682 women delivered their first child in Victoria. GDM complicated 11,763 (4.4%) pregnancies and burden increased with maternal age, from 2.1% among women aged below 25 years at delivery to 7.0% among those aged 35 years or more. Among younger women, GDM rates were relatively stable across socioeconomic levels. Amongst older women GDM rates were highest in those living in most deprived areas, with a strong social gradient. Asian-born mothers had highest GDM rates. All migrant groups except women born in North-West Europe had higher odds of GDM than Australian-born non-Indigenous women. In all ethnic groups, these differences were not pronounced among younger mothers, but became increasingly apparent amongst older women. Conclusions Socio-cultural disparities in GDM burden differ by maternal age at first delivery. Socio-cultural gradients were not evident among younger women. Health and social programs should seek to reduce the risk amongst all older women to that of the least deprived older mothers.	[Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Philpot, Benjamin; Dunbar, James A.] Flinders Univ S Australia, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia; [Abouzeid, Marion; Versace, Vincent L.; Janus, Edward D.; Philpot, Benjamin; Dunbar, James A.] Deakin Univ, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia; [Abouzeid, Marion] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Janus, Edward D.] Univ Melbourne, Northwest Acad Ctr, Dept Med, Melbourne, Vic 3010, Australia; [Janus, Edward D.] Western Hlth, Melbourne, Vic, Australia; [Davey, Mary-Ann; Oats, Jeremy] Dept Hlth, Clin Councils Unit, Consultat Council Obstet & Paediat Mortal & Morbi, Melbourne, Vic, Australia; [Davey, Mary-Ann] La Trobe Univ, Mother & Child Hlth Res, Bundoora, Vic 3086, Australia; [Oats, Jeremy] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia	Flinders University South Australia; Deakin University; Monash University; University of Melbourne; La Trobe University; University of Melbourne	Dunbar, JA (corresponding author), Flinders Univ S Australia, Greater Green Triangle Univ Dept Rural Hlth, Warrnambool, Vic, Australia.	director@greaterhealth.org	Versace, Vincent/AAL-6418-2021; Janus, Edward/AAU-8652-2020	Versace, Vincent/0000-0002-8514-1763; 				Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Australia Bureau of Statistics, 2008, INF PAP INTR SOC IND; BEISCHER NA, 1991, DIABETES, V40, P35, DOI 10.2337/diab.40.2.S35; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bertolotto A, 2012, DIABETIC MED, V29, P416, DOI 10.1111/j.1464-5491.2011.03484.x; Bo S, 2002, DIABETES METAB, V28, P139; Bombard JM, 2012, MATERN CHILD HLTH J, V16, P60, DOI 10.1007/s10995-010-0717-1; Carolan M, 2012, MIDWIFERY, V28, P778, DOI 10.1016/j.midw.2011.08.014; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen T, 2006, ACTA OBSTET GYN SCAN, V85, P526, DOI 10.1080/00016340500523644; Consultative Council on Obstetric and Paediatric Mortality and Morbidity, 2011, BIRTHS VICT 2007 200, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Davey MA, 2013, HEALTH INF MANAG J, V42, P12, DOI 10.1177/183335831304200301; Devlin HM, 2008, AM J PUBLIC HEALTH, V98, P59, DOI 10.2105/AJPH.2006.095877; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Janghorbani M, 2006, DIABETIC MED, V23, P313, DOI 10.1111/j.1464-5491.2006.01774.x; JONAS O, 1992, AUST NZ J OBSTET GYN, V32, P1, DOI 10.1111/j.1479-828X.1992.tb01885.x; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Ma J, 1996, AUST NZ J OBSTET GYN, V36, P119, DOI 10.1111/j.1479-828X.1996.tb03265.x; Park JH, 2011, J OBSTET GYNAECOL RE, V37, P138, DOI 10.1111/j.1447-0756.2010.01332.x; Shand AW, 2008, DIABETIC MED, V25, P708, DOI 10.1111/j.1464-5491.2008.02431.x; Stone CA, 2002, MED J AUSTRALIA, V177, P486, DOI 10.5694/j.1326-5377.2002.tb04916.x; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Templeton M, 2008, DIABETES SERIES AUST, V10; van der Ploeg HP, 2011, J SCI MED SPORT, V14, P149, DOI 10.1016/j.jsams.2010.09.002; von Katterfeld B, 2011, AUST NZ J OBSTET GYN, V51, P225, DOI 10.1111/j.1479-828X.2010.01282.x; Yang H, 2009, RISK FACTORS GESTATI	28	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117085	10.1371/journal.pone.0117085	http://dx.doi.org/10.1371/journal.pone.0117085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679221	gold, Green Published			2022-12-26	WOS:000350682600049
J	Wu, CJ; Chen, PL; Hsueh, PR; Chang, MC; Tsai, PJ; Shih, HI; Wang, HC; Chou, PH; Ko, WC				Wu, Chi-Jung; Chen, Po-Lin; Hsueh, Po-Ren; Chang, Ming-Chung; Tsai, Pei-Jane; Shih, Hsin-I; Wang, Hsuan-Chen; Chou, Pei-Hsin; Ko, Wen-Chien			Clinical Implications of Species Identification in Monomicrobial Aeromonas Bacteremia	PLOS ONE			English	Article							GRAM-NEGATIVE BACTEREMIA; GENUS AEROMONAS; BETA-LACTAMASE; SOUTHERN TAIWAN; AQUARIORUM; HYDROPHILA; DHAKENSIS; SEPTICEMIA; GENES; EPISODES	Background Advances in Aeromonas taxonomy have led to the reclassification of aeromonads. Hereon, we aimed to re-evaluate the characteristics of Aeromonas bacteremia, including those of a novel species, Aeromonas dhakensis. Methodology/Principal Findings A retrospective study of monomicrobial Aeromonas bacteremia at a medical center in southern Taiwan from 2004-2011 was conducted. Species identification was based on rpoB sequencing. Of bacteremia of 153 eligible patients, A. veronii (50 isolates, 32.7%), A. dhakensis (48, 31.4%), A. caviae (43, 28.1%), and A. hydrophila (10, 6.5%) were the principal causative species. A. dhakensis and A. veronii bacteremia were mainly community-acquired and presented as primary bacteremia, spontaneous bacterial peritonitis, or skin and soft-tissue infection, whereas A. caviae was associated with hospital-onset bacteremia. The distribution of the AmpC beta-lactamase and metallo-beta-lactamase genes was species-specific: bla(AQU-1), bla(MOX), or bla(CepH) was present in A. dhakensis, A. caviae, or A. hydrophila, respectively, and bla(CphA) was present in A. veronii, A. dhakensis, and A. hydrophila. The cefotaxime resistance rates of the A. caviae, A. dhakensis, and A. hydrophila isolates were higher than that of A. veronii (39.5%%, 25.0%, and 30% vs. 2%, respectively). A. dhakensis bacteremia was linked to the highest 14-day sepsis-related mortality rate, followed by A. hydrophila, A. veronii, and A. caviae bacteremia (25.5%, 22.2%, 14.0%, and 4.7%, respectively; P = 0.048). Multivariate analysis revealed that A. dhakensis bacteremia, active malignancies, and a Pitt bacteremia score >= 4 was an independent mortality risk factor. Conclusions/Significance Characteristics of Aeromonas bacteremia vary between species. A. dhakensis prevalence and its associated poor outcomes suggest it an important human pathogen.	[Wu, Chi-Jung; Wang, Hsuan-Chen; Chou, Pei-Hsin] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wu, Chi-Jung; Chen, Po-Lin] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Wu, Chi-Jung; Chen, Po-Lin; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Shih, Hsin-I] Natl Cheng Kung Univ Hosp, Emergency Med, Tainan 70428, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Hsueh, Po-Ren] Coll Med, Dept Lab Med, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan; [Hsueh, Po-Ren] Coll Med, Taipei, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chang, Ming-Chung] Natl Cheng Kung Univ, Coll Med, Biochem & Mol Biol Med, Tainan 70101, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Ko, WC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan.	winston3415@gmail.com	Hsueh, Po-Ren/ABE-1594-2021; Wu, Chi-Jung/F-8364-2011; Ko, Wen-Chien/ABG-4316-2020; Tsai, Pei-Jane/G-3563-2011	Ko, Wen-Chien/0000-0001-7497-149X; 	National Health Research Institutes [ID-100-PP-17, IV-101-SP-13]; National Science Council [NSC 102-2628-B-006-015-MY3]; Ministry of Health and Welfare [MOHW103-TDU-B-211-113002]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	CJW PLC PRH MCC PJT HIS HCW PHC WCK and CJW received grants from National Health Research Institutes (ID-100-PP-17 and IV-101-SP-13)(http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do). WCK received grants from National Science Council (NSC 102-2628-B-006-015-MY3) (http://www.most.gov.tw/) and Ministry of Health and Welfare (MOHW103-TDU-B-211-113002) (http://www.mohw.gov.tw/EN/Ministry/), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Beaz-Hidalgo R, 2013, SYST APPL MICROBIOL, V36, P171, DOI 10.1016/j.syapm.2012.12.007; Chen PL, 2014, CLIN MICROBIOL INFEC, V20, pO428, DOI 10.1111/1469-0691.12456; Chen PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111213; Chen PL, 2014, J CLIN MICROBIOL, V52, P2625, DOI 10.1128/JCM.01025-14; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Clinical and Laboratory Standards Institute, 2010, M45A2 CLSI; Clinical and Laboratory Standards Institute, 2006, M45A CLSI; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Fosse T, 2003, PATHOL BIOL, V51, P290, DOI 10.1016/S0369-8114(03)00027-0; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; JANDA JM, 1994, CLIN INFECT DIS, V19, P77, DOI 10.1093/clinids/19.1.77; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Morinaga Y, 2013, DIAGN MICR INFEC DIS, V76, P106, DOI 10.1016/j.diagmicrobio.2013.01.019; Puthucheary SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030205; Rice LB, 1996, ANTIBIOTICS LAB MED, P453; ROSSOLINI GM, 1995, ANTIMICROB AGENTS CH, V39, P346, DOI 10.1128/AAC.39.2.346; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Walsh TR, 1997, J ANTIMICROB CHEMOTH, V40, P171, DOI 10.1093/jac/40.2.171; Wu CJ, 2013, INT J ANTIMICROB AG, V42, P456, DOI 10.1016/j.ijantimicag.2013.08.002; Wu CJ, 2012, DIAGN MICR INFEC DIS, V74, P406, DOI 10.1016/j.diagmicrobio.2012.08.005; Wu CJ, 2012, J MED MICROBIOL, V61, P712, DOI 10.1099/jmm.0.038323-0; Wu CJ, 2011, ANTIMICROB AGENTS CH, V55, P5813, DOI 10.1128/AAC.00634-11	30	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117821	10.1371/journal.pone.0117821	http://dx.doi.org/10.1371/journal.pone.0117821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679227	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600091
J	Silva, IT; Carvalho, A; Lang, KL; Dudek, SE; Masemann, D; Duran, FJ; Caro, MSB; Rapp, UR; Wixler, V; Schenkel, EP; Simoes, CMO; Ludwig, S				Silva, Izabella T.; Carvalho, Annelise; Lang, Karen L.; Dudek, Sabine E.; Masemann, Doerthe; Duran, Fernando J.; Caro, Miguel S. B.; Rapp, Ulf R.; Wixler, Viktor; Schenkel, Eloir P.; Simoes, Claudia M. O.; Ludwig, Stephan			In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B	PLOS ONE			English	Article							CELL LUNG-CANCER; SIGNALING PATHWAY; THERAPEUTIC TARGETS; MOLECULAR TARGETS; PROTEIN-KINASE; APOPTOSIS; SURVIVIN; GROWTH; STAT3; ACTIVATION	Lung cancer is the most deadly type of cancer in humans, with non-small-cell lung cancer (NSCLC) being the most frequent and aggressive type of lung cancer showing high resistance to radiation and chemotherapy. Despite the outstanding progress made in anti-tumor therapy, discovering effective anti-tumor drugs is still a challenging task. Here we describe a new semisynthetic derivative of cucurbitacin B (DACE) as a potent inhibitor of NSCLC cell proliferation. DACE arrested the cell cycle of lung epithelial cells at the G2/M phase and induced cell apoptosis by interfering with EGFR activation and its downstream signaling, including AKT, ERK, and STAT3. Consistent with our in vitro studies, intraperitoneal application of DACE significantly suppressed the growth of mouse NSCLC that arises from type II alveolar pneumocytes due to constitutive expression of a human oncogenic c-RAF kinase (c-RAF-1-BxB) transgene in these cells. Taken together, these findings suggest that DACE is a promising lead compound for the development of an anti-lung-cancer drug.	[Silva, Izabella T.; Carvalho, Annelise; Schenkel, Eloir P.; Simoes, Claudia M. O.] Univ Fed Santa Catarina, Dept Pharmaceut Sci, Florianopolis, SC, Brazil; [Lang, Karen L.; Caro, Miguel S. B.] Univ Fed Santa Catarina, Dept Chem, Florianopolis, SC, Brazil; [Silva, Izabella T.; Dudek, Sabine E.; Masemann, Doerthe; Wixler, Viktor; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Duran, Fernando J.] Univ Buenos Aires, Dept Organ Chem, UMYMFOR, Buenos Aires, DF, Argentina; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Wixler, Viktor; Ludwig, Stephan] Univ Munster, Cluster Excellence, D-48149 Munster, Germany; [Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of Munster; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Max Planck Society; University of Munster; University of Munster	Ludwig, S (corresponding author), Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Silva, Izabella/B-9407-2015; Simões, Cláudia/N-1712-2015	Silva, Izabella/0000-0002-1893-4317; Ludwig, Stephan/0000-0003-4490-3052; Duran, Fernando Javier/0000-0002-4359-8239	Brazilian funding agency, as CNPq/MCTI [472979/2011-6]; Brazilian funding agency PRONEX/FAPESC [2671/2012-9]; Deutsche Forschungsgemeinschaft (DFG); Interdisciplinary Center of Clinical Research (IZKF) Muenster; Open Access Publication Fund of University of Muenster, Germany	Brazilian funding agency, as CNPq/MCTI; Brazilian funding agency PRONEX/FAPESC; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) Muenster; Open Access Publication Fund of University of Muenster, Germany	This study was supported in part by Brazilian funding agencies, as CNPq/MCTI (grant number 472979/2011-6) and PRONEX/FAPESC (grant number 2671/2012-9) as well as by different grants from the Deutsche Forschungsgemeinschaft (DFG) and Interdisciplinary Center of Clinical Research (IZKF) Muenster. The authors also acknowledge support by Open Access Publication Fund of University of Muenster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/490136; Alghasham AA, 2013, INT J HEALTH SCI-IJH, V7, P77, DOI 10.12816/0006025; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; BELLOMO G, 1992, ANN NY ACAD SCI, V663, P97, DOI 10.1111/j.1749-6632.1992.tb38653.x; Bernard SA, 2010, J MED PLANTS RES, V4, P2821; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Ciuffreda L, 2009, CURR SIGNAL TRANSD T, V4, P130, DOI 10.2174/157436209788167466; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Duangmano S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-185; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Duffy A, 2009, TARGET ONCOL, V4, P267, DOI 10.1007/s11523-009-0125-x; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; Fletcher S, 2009, BIOCHEM CELL BIOL, V87, P825, DOI [10.1139/O09-044, 10.1139/o09-044]; Guo JJ, 2014, ANTI-CANCER AGENT ME, V14, P1146, DOI 10.2174/1871520614666140601220915; Gupta P, 2014, ONCOTARGET, V5, P1812, DOI 10.18632/oncotarget.1743; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Herrera R, 2002, TRENDS MOL MED, V8, pS27, DOI 10.1016/S1471-4914(02)02307-9; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Johnson AL, 2002, ENDOCRINOLOGY, V143, P3405, DOI 10.1210/en.2002-220107; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Lang KL, 2014, J MOL GRAPH MODEL, V48, P70, DOI 10.1016/j.jmgm.2013.12.004; Lang KL, 2011, PLANTA MED, V77, P1648, DOI 10.1055/s-0030-1270962; Lang KL, 2012, BIOORGAN MED CHEM, V20, P3016, DOI 10.1016/j.bmc.2012.03.001; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee DH, 2011, CANCER LETT, V306, P161, DOI 10.1016/j.canlet.2011.03.001; Lee HY, 2003, J BIOL CHEM, V278, P23630, DOI 10.1074/jbc.M300997200; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Rios JL, 2012, CURR PHARM DESIGN, V18, P1663, DOI 10.2174/138161212799958549; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Silva I. T., 2013, International Journal of Cancer Research (USA), V9, P54; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wiart C, 2013, CANCER LETT, V328, P188, DOI 10.1016/j.canlet.2012.01.033; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Zhao J, 2000, J CELL SCI, V113, P4363; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	66	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2015	10	2							e0117794	10.1371/journal.pone.0117794	http://dx.doi.org/10.1371/journal.pone.0117794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB8WX	25674792	Green Published, gold, Green Submitted			2022-12-26	WOS:000349914000032
J	Artemov, G; Bondarenko, S; Sapunov, G; Stegniy, V				Artemov, Gleb; Bondarenko, Semen; Sapunov, Gleb; Stegniy, Vladimir			Tissue-Specific Differences in the Spatial Interposition of X-Chromosome and 3R Chromosome Regions in the Malaria Mosquito Anopheles messeae Fall.	PLOS ONE			English	Article							ERYTHROCEPHALA MG. DIPTERA; NURSE CELLS; INTERPHASE NUCLEI; POLYTENE CHROMOSOMES; ORGANIZATION; ARCHITECTURE; ATTACHMENT; REORGANIZATION; POLYTENIZATION; CALLIPHORIDAE	Spatial organization of a chromosome in a nucleus is very important in biology but many aspects of it are still generally unresolved. We focused on tissue-specific features of chromosome architecture in closely related malaria mosquitoes, which have essential inter-specific differences in polytene chromosome attachments in nurse cells. We showed that the region responsible for X-chromosome attachment interacts with nuclear lamina stronger in nurse cells, then in salivary glands cells in Anopheles messeae Fall. The inter-tissue differences were demonstrated more convincingly in an experiment of two distinct chromosomes interposition in the nucleus space of cells from four tissues. Microdissected DNA-probes from nurse cells X-chromosome (2BC) and 3R chromosomes (32D) attachment regions were hybridized with intact nuclei of nurse cells, salivary gland cells, follicle epithelium cells and imaginal discs cells in 3D-FISH experiments. We showed that only salivary gland cells and follicle epithelium cells have no statistical differences in the interposition of 2BC and 32D. Generally, the X-chromosome and 3R chromosome are located closer to each other in cells of the somatic system in comparison with nurse cells on average. The imaginal dis.s cell nuclei have an intermediate arrangement of chromosome interposition, similar to other somatic cells and nurse cells. In spite of species-specific chromosome attachments there are no differences in interposition of nurse cells chromosomes in An. messeae and An. atroparvus Thiel. Nurse cells have an unusual chromosome arrangement without a chromocenter, which could be due to the special mission of generative system cells in ontogenesis and evolution.	[Artemov, Gleb; Stegniy, Vladimir] Tomsk State Univ, Tomsk 634050, Russia; [Bondarenko, Semen] RAS, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Sapunov, Gleb] RAS, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia	Tomsk State University; Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences	Artemov, G (corresponding author), Tomsk State Univ, Tomsk 634050, Russia.	g-artemov@mail.ru	Artemov, Gleb N./N-7651-2014; Artemov, Gleb/E-7935-2019; Stegniy, Vladimir/N-7656-2014; Stegniy, Vladimir/ABC-6763-2020; Bondarenko, Semen/ABD-5283-2020	Stegniy, Vladimir/0000-0001-8947-041X; Bondarenko, Semen/0000-0003-0753-581X	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant [MK-4158.2012.4]	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant	Tomsk State University Competitiveness Improvement Program, The President of Russia Federation Grant for young scientists - MK-4158.2012.4 (https://grants.extech.ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan'ina TV, 2005, RUSS J GENET+, V41, P1106, DOI 10.1007/s11177-005-0207-5; Andreeva IuV, 2007, PARAZITOLOGIIA, V41, P348; Artemov GN, 2011, RUSS J GENET+, V47, P1161, DOI 10.1134/S1022795411100024; Artemov GN, 2010, RUSS J GENET+, V46, P1048, DOI 10.1134/S1022795410090085; Artemov GN, 2010, TOMSK STATE U J BIOL, V10, P123; Artemov GN, 2013, TOMSK STATE U J BIOL, V4, P98; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Cremer T, 1993, COLD SPRING HARB S Q, VLVIII; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; Kinney NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091943; Kokhanenko A, 2014, PROTOPLASMA, V251, P93, DOI 10.1007/s00709-013-0529-4; Kokhanenko AA, 2013, PROTOPLASMA, V250, P141, DOI 10.1007/s00709-012-0385-7; Kumar V., 1997, The molecular biology of insect disease vectors: a methods manual., P337; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; Rodriguez-Ubreva J, 2014, METHODS MOL BIOL, V1094, P309, DOI 10.1007/978-1-62703-706-8_24; Sharakhov IV, 2001, GENETICS, V159, P211; Sharakhova M.V., 1999, Tsitologiya, V41, P226; Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459; STEGNII VN, 1979, DOKL AKAD NAUK SSSR+, V249, P1231; Stegnii VN, 1993, ARCHITECTONICS GENOM; Stegniy VN, 2006, RUSS J GENET+, V42, P1011, DOI 10.1134/S1022795406090079; STEGNY VN, 1991, GENETIKA+, V27, P828; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0115281	10.1371/journal.pone.0115281	http://dx.doi.org/10.1371/journal.pone.0115281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671311	gold, Green Published, Green Submitted			2022-12-26	WOS:000349545300006
J	Bearoff, F; Case, LK; Krementsov, DN; Wall, EH; Saligrama, N; Blankenhorn, EP; Teuscher, C				Bearoff, Frank; Case, Laure K.; Krementsov, Dimitry N.; Wall, Emma H.; Saligrama, Naresha; Blankenhorn, Elizabeth P.; Teuscher, Cory			Identification of Genetic Determinants of the Sexual Dimorphism in CNS Autoimmunity	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; MICE; SUSCEPTIBILITY; STRAINS; LOCI; POLYMORPHISMS; SEVERITY; MUSCULUS	Multiple sclerosis (MS) is a debilitating chronic inflammatory disease of the nervous system that affects approximately 2.3 million individuals worldwide, with higher prevalence in females, and a strong genetic component. While over 200 MS susceptibility loci have been identified in GWAS, the underlying mechanisms whereby they contribute to disease susceptibility remains ill-defined. Forward genetics approaches using conventional laboratory mouse strains are useful in identifying and functionally dissecting genes controlling disease- relevant phenotypes, but are hindered by the limited genetic diversity represented in such strains. To address this, we have combined the powerful chromosome substitution (consomic) strain approach with the genetic diversity of a wild-derived inbred mouse strain. Using experimental allergic encephalomyelitis (EAE), a mouse model of MS, we evaluated genetic control of disease course among a panel of 26 consomic strains of mice inheriting chromosomes from the wild-derived PWD strain on the C57BL/6J background, which models the genetic diversity seen in human populations. Nineteen linkages on 18 chromosomes were found to harbor loci controlling EAE. Of these 19 linkages, six were male-specific, four were female-specific, and nine were non-sex-specific, consistent with a differential genetic control of disease course between males and females. An MS-GWAS candidate-driven bioinformatic analysis using orthologous genes linked to EAE course identified sex-specific and non-sex-specific gene networks underlying disease pathogenesis. An analysis of sex hormone regulation of genes within these networks identified several key molecules, prominently including the MAP kinase family, known hormone-dependent regulators of sex differences in EAE course. Importantly, our results provide the framework by which consomic mouse strains with overall genome-wide genetic diversity, approximating that seen in humans, can be used as a rapid and powerful tool for modeling the genetic architecture of MS. Moreover, our data represent the first step towards mechanistic dissection of genetic control of sexual dimorphism in CNS autoimmunity.	[Bearoff, Frank; Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Case, Laure K.; Krementsov, Dimitry N.; Wall, Emma H.; Saligrama, Naresha; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Drexel University; University of Vermont; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Burlington, VT 05405 USA.	C.Teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466; Bearoff, Frank/0000-0002-1344-8168; Saligrama, Naresha/0000-0003-2526-7150	National Multiple Sclerosis Society [RG4471A6/2]; National Institutes of Health [NS061014, NS060901, NS069628, NS036526, NS076200]; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118228, P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036526, R01NS061014, R01NS069628, R01NS060901, R21NS076200] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by National Multiple Sclerosis Society grant #RG4471A6/2 (E.P.B. and C.T.) (http://www.nationalmssociety.org/For-Professionals/Researchers/Society-Funding/Research-Grants); and National Institutes of Health grants NS061014, NS060901, NS069628, NS036526, and NS076200 (C.T.) (http://grants.nih.gov/grants/oer.htm). This work was also supported by a postdoctoral fellowship from National Multiple Sclerosis Society to D.N.K. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Batoulis H, 2012, GLIA, V60, P794, DOI 10.1002/glia.22309; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Blankenhorn EP, 2011, ANN NEUROL, V70, P887, DOI 10.1002/ana.22642; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Cowley AW, 2004, J PHYSIOL-LONDON, V554, P46, DOI 10.1113/jphysiol.2003.052613; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Donahue L, 2012, PERIPHERAL BLOOD LEU; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hestvik ALK, 2010, TOXINS, V2, P856, DOI 10.3390/toxins2040856; Kantarci OH, 2005, GENES IMMUN, V6, P153, DOI 10.1038/sj.gene.6364164; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Krementsov DN, 2013, MOL CELL BIOL, V33, P3728, DOI 10.1128/MCB.00688-13; MONTAGUTELLI X, 1991, MAMM GENOME, V1, P255, DOI 10.1007/BF00352333; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Palaszynski KM, 2004, J NEUROIMMUNOL, V146, P144, DOI 10.1016/j.jneuroim.2003.11.004; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Voskuhl RR, 2012, NAT REV NEUROL, V8, P255, DOI 10.1038/nrneurol.2012.43; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804	30	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117993	10.1371/journal.pone.0117993	http://dx.doi.org/10.1371/journal.pone.0117993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671658	Green Submitted, gold, Green Published			2022-12-26	WOS:000349545300077
J	Edgar, CE; Terrell, DR; Vesely, SK; Wren, JD; Dozmorov, IM; Niewold, TB; Brown, M; Zhou, F; Frank, MB; Merrill, JT; Hovinga, JAK; Lammle, B; James, JA; George, JN; Farris, AD				Edgar, Contessa E.; Terrell, Deirdra R.; Vesely, Sara K.; Wren, Jonathan D.; Dozmorov, Igor M.; Niewold, Timothy B.; Brown, Michael; Zhou, Fang; Frank, Mark Barton; Merrill, Joan T.; Hovinga, Johanna A. Kremer; Lammle, Bernhard; James, Judith A.; George, James N.; Farris, A. Darise			Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; SEVERE ADAMTS13 DEFICIENCY; INDUCIBLE GENE-EXPRESSION; HEMOLYTIC-UREMIC SYNDROME; INTERFERON-ALPHA; DISEASE-ACTIVITY; RISK-FACTOR; PLASMA	Approximately 40% of patients who survive acute episodes of thrombotic thrombocytopenic purpura (TTP) associated with severe acquired ADAMTS13 deficiency experience one or more relapses. Risk factors for relapse other than severe ADAMTS13 deficiency and ADAMTS13 autoantibodies are unknown. ADAMTS13 autoantibodies, TTP episodes following infection or type I interferon treatment and reported ensuing systemic lupus erythematosus in some patients suggest immune dysregulation. This cross-sectional study asked whether autoantibodies against RNA-binding proteins or peripheral blood gene expression profiles measured during remission are associated with history of prior relapse in acquired ADAMTS13-deficient TTP. Peripheral blood from 38 well-characterized patients with autoimmune ADAMTS13-deficient TTP in remission was examined for autoantibodies and global gene expression. A subset of TTP patients (9 patients, 24%) exhibited a peripheral blood gene signature composed of elevated ribosomal transcripts that associated with prior relapse. A non-overlapping subset of TTP patients (9 patients, 24%) displayed a peripheral blood type I interferon gene signature that associated with autoantibodies to RNA-binding proteins but not with history of relapse. Patients who had relapsed bimodally expressed higher HLA transcript levels independently of ribosomal transcripts. Presence of any one potential risk factor (ribosomal gene signature, elevated HLA-DRB1, elevated HLA-DRB5) associated with relapse (OR = 38.4; p = 0.0002) more closely than any factor alone or all factors together. Levels of immune transcripts typical of natural killer (NK) and T lymphocytes positively correlated with ribosomal gene expression and number of prior episodes but not with time since the most recent episode. Flow cytometry confirmed elevated expression of cell surface markers encoded by these transcripts on T and/or NK cell subsets of patients who had relapsed. These data associate elevated ribosomal and immune transcripts with relapse history in acquired, ADAMTS13-deficient TTP.	[Edgar, Contessa E.; Wren, Jonathan D.; Dozmorov, Igor M.; Brown, Michael; Zhou, Fang; Frank, Mark Barton; James, Judith A.; Farris, A. Darise] OMRF, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Terrell, Deirdra R.; Vesely, Sara K.; George, James N.] Univ Oklahoma Hlth Sci Ctr OUHSC, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Niewold, Timothy B.] Mayo Clin, Div Rheumatol, Rochester, MN USA; [Niewold, Timothy B.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Merrill, Joan T.] OMRF, Clin Pharmacol Program, Oklahoma City, OK USA; [James, Judith A.; George, James N.] OUHSC, Dept Med, Oklahoma City, OK USA; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Hosp Bern, Inselspital, Dept Hematol, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Hosp Bern, Inselspital, Cent Hematol Lab, Bern, Switzerland; [Hovinga, Johanna A. Kremer; Lammle, Bernhard] Univ Bern, Bern, Switzerland	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; Mayo Clinic; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Farris, AD (corresponding author), OMRF, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA.	Darise-Farris@omrf.org	Niewold, Timothy B/D-2669-2018; Merrill, Joan/HDL-9141-2022; Wren, Jonathan D/E-5611-2011; Laemmle, Bernhard/AAJ-1216-2020; Hovinga, Johanna A Kremer/M-3482-2013	Wren, Jonathan D/0000-0003-2776-3545; Laemmle, Bernhard/0000-0003-4538-5154; Hovinga, Johanna A Kremer/0000-0002-1300-7135; Terrell, Deirdra/0000-0003-0794-5851; Vesely, Sara/0000-0003-3448-0156	National Institutes of Health [U19AI082714, R01AI048097, P50AR060804, Kirschstein-NRSA T32AI007633, U01HL072283, P30GM103510, U01AI101934, P30AR053483, P20GM103636, U54GM104938, P20GM103456, AR060861, AI071651]; American Heart Association [13POST14220000]; Lupus Research Institute; Swiss National Science Foundation [32003B-124892]; Administration for Children and Families; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048097, U19AI082714, U01AI101934, T32AI007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060861, P50AR060804, P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456, P20GM103636, P30GM103510, U54GM104938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lupus Research Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Administration for Children and Families(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by funding from the National Institutes of Health (http://www.nih.gov/) U19AI082714 (CEE JAJ ADF), R01AI048097 (ADF), P50AR060804 (ADF), Kirschstein-NRSA T32AI007633 (CEE), U01HL072283 (DRT SKV JNG), P30GM103510 (MBF JAJ), U01AI101934 (JAJ), P30AR053483 (MBF JAJ), P20GM103636 (JDW), U54GM104938 (DRT SKV JAJ JNG), P20GM103456 (ID MB), AR060861 (TBN), AI071651 (TBN), the American Heart Association (http://www.heart.org/) 13POST14220000 (FZ), the Lupus Research Institute (http://www.lupusresearchinstitute.org/) (TBN), the Swiss National Science Foundation (http://www.snf.ch/) 32003B-124892 (JAKH BL), and the Administration for Children and Families (https://www.acf.hhs.gov/) for The POWER Through Choices Demonstration, Evaluation, and Dissemination Project (SKV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Albrecht I, 2010, EUR J IMMUNOL, V40, P2993, DOI 10.1002/eji.201040936; Alcina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029819; Alvarez-Larran A, 2003, BRIT J HAEMATOL, V120, P129, DOI 10.1046/j.1365-2141.2003.04030.x; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bettoni G, 2012, J THROMB HAEMOST, V10, P1556, DOI 10.1111/j.1538-7836.2012.04808.x; Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Bielawska-Pohl A, 2005, J IMMUNOL, V174, P5573, DOI 10.4049/jimmunol.174.9.5573; Brunner HI, 1999, ARTHRITIS RHEUM, V42, P2346, DOI 10.1002/1529-0131(199911)42:11<2346::AID-ANR13>3.0.CO;2-X; BURNS ER, 1982, BLOOD, V60, P1030; BUYON JP, 1989, J CLIN INVEST, V84, P627, DOI 10.1172/JCI114208; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2010, J THROMB HAEMOST, V8, P856, DOI 10.1111/j.1538-7836.2010.03772.x; Deford CC, 2013, BLOOD, V122, P2023, DOI 10.1182/blood-2013-04-496752; Douglas KW, 2010, J CLIN APHERESIS, V25, P47, DOI 10.1002/jca.20226; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov IM, 2011, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkr1278, DOI 10.1093/NAR/GKR1278]; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; George JN, 2007, SOUTH MED J, V100, P512, DOI 10.1097/SMJ.0b013e318046583f; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; John ML, 2012, ANN HEMATOL, V91, P507, DOI 10.1007/s00277-011-1384-z; Kahaleh MB, 1997, CLIN IMMUNOL IMMUNOP, V83, P32, DOI 10.1006/clin.1996.4322; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; LANIER LL, 1994, J IMMUNOL, V153, P2417; Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Parzen M, 2002, J COMPUT GRAPH STAT, V11, P420, DOI 10.1198/106186002760180590; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pisoni R, 2001, DRUG SAFETY, V24, P491, DOI 10.2165/00002018-200124070-00002; Pober J S, 2006, Handb Exp Pharmacol, P135; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; ROSE M, 1987, AM J MED, V83, P437, DOI 10.1016/0002-9343(87)90753-4; SHUMAK KH, 1995, ANN INTERN MED, V122, P569, DOI 10.7326/0003-4819-122-8-199504150-00002; Sridhar K, 2009, BLOOD, V114, P4847, DOI 10.1182/blood-2009-08-236422; Swisher KK, 2007, HAEMATOLOGICA, V92, P936, DOI 10.3324/haematol.10963; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tangye SG, 1999, J IMMUNOL, V162, P6981; Toh BH, 2013, CELL MOL IMMUNOL, V10, P379, DOI 10.1038/cmi.2013.35; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WADA H, 1992, AM J HEMATOL, V40, P167, DOI 10.1002/ajh.2830400303; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Zhou F, 2010, INT REV IMMUNOL, V29, P38, DOI 10.3109/08830180903247889	66	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117614	10.1371/journal.pone.0117614	http://dx.doi.org/10.1371/journal.pone.0117614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671313	gold, Green Published			2022-12-26	WOS:000349545300062
J	Zhu, YZ; Song, XM; Han, F; Li, YK; Wei, J; Liu, XM				Zhu, Yongzhao; Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun; Liu, Xiaoming			Alteration of Histone Acetylation Pattern during Long-Term Serum-Free Culture Conditions of Human Fetal Placental Mesenchymal Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; IN-VITRO CULTURE; REPLICATIVE SENESCENCE; TELOMERASE ACTIVITY; DIFFERENTIATION; HDAC; TRANSFORMATION; INHIBITOR; CANCER	Increasing evidence suggests that the mesenchymal stem cells (MSCs) derived from placenta of fetal origin (fPMSCs) are superior to MSCs of other sources for cell therapy. Since the initial number of isolated MSCs is limited, in vitro propagation is often required to reach sufficient numbers of cells for therapeutic applications, during which MSCs may undergo genetic and/or epigenetic alterations that subsequently increase the probability of spontaneous malignant transformation. Thus, factors that influence genomic and epigenetic stability of MSCs following long-term expansions need to be clarified before cultured MSCs are employed for clinical settings. To date, the genetic and epigenetic stability of fPMSCs after long-term in vitro expansion has not been fully investigated. In this report, alterations to histone acetylation and consequence on the expression pattern of fPMSCs following in vitro propagation under serum-free conditions were explored. The results show that fPMSCs maintain their MSC characteristics before they reached a senescent state. Furthermore, acetylation modification patterns were changed in fPMSCs along with gradually increased global histone deacetylase (HDAC) activity and expression of HDAC subtypes HDAC4, HDAC5 and HDAC6, as well as a down-regulated global histone H3/H4 acetylation during in vitro culturing. In line with the acetylation alterations, the expression of oncogenes Oct4, Sox2 and TERT were significantly decreased over the propagation period. Of note, the down-regulation of Oct4 was strongly associated with changes in acetylation. Intriguingly, telomere length in fPMSCs did not significantly change during the propagating process. These findings suggest that human fPMSCs may be a safe and reliable resource of MSCs and can be propagated under serum-free conditions with less risk of spontaneous malignancy, and warrants further validation in clinical settings.	[Zhu, Yongzhao; Liu, Xiaoming] Ningxia Univ, Key Lab, Minist Educ Conservat & Utilizat Special Biol Res, Yinchuan 750021, Peoples R China; [Zhu, Yongzhao; Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun; Liu, Xiaoming] Ningxia Med Univ, Gen Hosp, Human Stem Cell Inst, Yinchuan 750004, Peoples R China; [Song, Xumei; Han, Fei; Li, Yukui; Wei, Jun] Ningxia Med Univ, Sch Lab Med, Yinchuan 750004, Peoples R China	Ningxia University; Ningxia Medical University; Ningxia Medical University	Wei, J (corresponding author), Ningxia Med Univ, Gen Hosp, Human Stem Cell Inst, Yinchuan 750004, Peoples R China.	lydiajunwei@hotmail.com; erc1080@163.com		LIU, XIAOMING/0000-0002-3902-9105	Ningxia Key Science and Technologies R D program	Ningxia Key Science and Technologies R D program	This work was supported by a grant of Ningxia Key Science and Technologies R & D program for Jun Wei (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Atadja PW, 2011, PROG DRUG RES, V67, P175, DOI 10.1007/978-3-7643-8989-5_9; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Camarena FS, 2007, CLIN TRANSL ONCOL, V9, P145, DOI 10.1007/s12094-007-0028-1; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098565; Christodoulou I, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/246134; Cosentino C, 2013, CELL MOL LIFE SCI, V70, P1525, DOI 10.1007/s00018-013-1295-3; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gou SM, 2010, CELLS TISSUES ORGANS, V191, P185, DOI 10.1159/000240246; Guo L, 2014, J CELL MOL MED, DOI [10.1111/jcmm.12509, DOI 10.1111/JCMM.12509]; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; He L, 2014, HISTOCHEM CELL BIOL; Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562; Jo CH, 2008, CELL TISSUE RES, V334, P423, DOI 10.1007/s00441-008-0696-3; Kang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098894; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kong PR, 2013, BIOCHEM BIOPH RES CO, V438, P410, DOI 10.1016/j.bbrc.2013.07.088; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Li XY, 2014, CURR DRUG TARGETS, V15, P622, DOI 10.2174/1389450115666140306152642; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Lv FJ, 2012, CURR STEM CELL RES T, V7, P389, DOI 10.2174/157488812804484611; Mark P, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/698076; Meraviglia V, 2012, DIFFERENTIATION, V83, P260, DOI 10.1016/j.diff.2012.02.006; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pievani A, 2014, CYTOTHERAPY, V16, P893, DOI 10.1016/j.jcyt.2014.02.008; Poloni A, 2011, CELL TRANSPLANT, V20, P643, DOI 10.3727/096368910X536518; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081844; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Wang J, 2013, MOL CANCER THER, V12, P925, DOI 10.1158/1535-7163.MCT-12-1045; Wang LB, 2012, MOL MED REP, V6, P760, DOI 10.3892/mmr.2012.1000; Wegmeyer H, 2013, STEM CELLS DEV, V22, P2606, DOI 10.1089/scd.2013.0016; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu S, 2013, ACTA PHARMACOL SIN, V34, P699, DOI 10.1038/aps.2012.182; Yamaoka E, 2011, INT J ONCOL, V39, P5, DOI 10.3892/ijo.2011.1029; Zhang SJ, 2010, CHEM-BIOL INTERACT, V188, P119, DOI 10.1016/j.cbi.2010.06.008; Zhou XG, 2011, CHINESE MED J-PEKING, V124, P729, DOI 10.3760/cma.j.issn.0366-6999.2011.05.018; Zhu YM, 2014, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2014-137; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436	62	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2015	10	2							e0117068	10.1371/journal.pone.0117068	http://dx.doi.org/10.1371/journal.pone.0117068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RF	25671548	Green Submitted, Green Published, gold			2022-12-26	WOS:000349545300032
J	Jongen, S; Perrier, J; Vuurman, EF; Ramaekers, JG; Vermeeren, A				Jongen, Stefan; Perrier, Joy; Vuurman, Eric F.; Ramaekers, Johannes G.; Vermeeren, Annemiek			Sensitivity and Validity of Psychometric Tests for Assessing Driving Impairment: Effects of Sleep Deprivation	PLOS ONE			English	Article							FIELD-OF-VIEW; PSYCHOMOTOR PERFORMANCE; ALCOHOL; RISK; DURATION; ZOLPIDEM; PLACEBO; MDMA; METAANALYSIS; WAKEFULNESS	Objective To assess drug induced driving impairment, initial screening is needed. However, no consensus has been reached about which initial screening tools have to be used. The present study aims to determine the ability of a battery of psychometric tests to detect performance impairing effects of clinically relevant levels of drowsiness as induced by one night of sleep deprivation. Methods Twenty four healthy volunteers participated in a 2-period crossover study in which the highway driving test was conducted twice: once after normal sleep and once after one night of sleep deprivation. The psychometric tests were conducted on 4 occasions: once after normal sleep (at 11 am) and three times during a single night of sleep deprivation (at 1 am, 5 am, and 11 am). Results On-the-road driving performance was significantly impaired after sleep deprivation, as measured by an increase in Standard Deviation of Lateral Position (SDLP) of 3.1 cm compared to performance after a normal night of sleep. At 5 am, performance in most psychometric tests showed significant impairment. As expected, largest effect sizes were found on performance in the Psychomotor Vigilance Test (PVT). Large effects sizes were also found in the Divided Attention Test (DAT), the Attention Network Test (ANT), and the test for Useful Field of View (UFOV) at 5 and 11 am during sleep deprivation. Effects of sleep deprivation on SDLP correlated significantly with performance changes in the PVT and the DAT, but not with performance changes in the UFOV. Conclusion From the psychometric tests used in this study, the PVT and DAT seem most promising for initial evaluation of drug impairment based on sensitivity and correlations with driving impairment. Further studies are needed to assess the sensitivity and validity of these psychometric tests after benchmark sedative drug use.	[Jongen, Stefan; Perrier, Joy; Vuurman, Eric F.; Ramaekers, Johannes G.; Vermeeren, Annemiek] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands; [Perrier, Joy] INSERM, COMETE U1075, Caen, France	Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Jongen, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands.	stefan.jongen@maastrichtuniversity.nl		Perrier, Joy/0000-0002-8639-9985; Jongen, Stefan/0000-0002-9798-651X	GlaxoSmithKline; Transcept; Merck companies; NWO; ZonMW; EU; Dutch Ministry of Infrastructure and Environment; Lundbeck; Transcept Pharmaceuticals Inc; Purdue Pharma LP; Merck Sharp and Dohme	GlaxoSmithKline(GlaxoSmithKline); Transcept; Merck companies; NWO(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); EU(European Commission); Dutch Ministry of Infrastructure and Environment; Lundbeck(Lundbeck Corporation); Transcept Pharmaceuticals Inc; Purdue Pharma LP; Merck Sharp and Dohme(Merck & Company)	Dr. E.F. Vuurman is a full time employee of Maastricht University and has received grants/research support grants from GlaxoSmithKline, Transcept, and Merck companies. Prof. Dr. J.G. Ramaekers is a full time employee of Maastricht University and has received grants/research support from NWO, ZonMW, EU, Dutch Ministry of Infrastructure and Environment and Lundbeck. Dr. A. Vermeeren is a full time employee of Maastricht University. As employee of Maastricht University, she participated-as investigator-in studies sponsored by for-profit businesses (Transcept Pharmaceuticals Inc, Purdue Pharma LP, Merck Sharp and Dohme) and non-profit organizations (Dutch Ministry of Infrastructure and Environment) She acted as a consultant for IntecPharma. The other authors have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2001, SLEEP, V24, P401, DOI 10.1093/sleep/24.4.401; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Baulk SD, 2008, ACCIDENT ANAL PREV, V40, P396, DOI 10.1016/j.aap.2007.07.008; Borbely A.A, 1982, HUM NEUROBIOL; Borkenstein F, 1964, ROLE DRINKING DRIVER; Bosker WM, 2012, PSYCHOPHARMACOLOGY, V222, P367, DOI 10.1007/s00213-011-2497-8; Bosker WM, 2010, PSYCHOPHARMACOLOGY, V209, P69, DOI 10.1007/s00213-009-1767-1; Boyle J, 2009, BRIT J CLIN PHARMACO, V67, P180, DOI 10.1111/j.1365-2125.2008.03331.x; Brookhuis K, 1985, EFFECTS INCREASING D; Brookhuis KA, 2003, ERGONOMICS, V46, P433, DOI 10.1080/001401302/1000039556; Brunnauer A, 2008, J CLIN PSYCHIAT, V69, P1880, DOI 10.4088/JCP.v69n1205; Clark PG, 2011, CONTEMP CLIN TRIALS, V32, P129, DOI 10.1016/j.cct.2010.10.002; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dorrian J, 2005, THESIS U PENSYLVANIA; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Forsman P, 2014, ACCIDENT ANAL PREV, V62, P186, DOI 10.1016/j.aap.2013.09.015; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Greenblatt DJ, 2006, J CLIN PHARMACOL, V46, P1469, DOI 10.1177/0091270006293303; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Howard ME, 2007, SLEEP, V30, P1334, DOI 10.1093/sleep/30.10.1334; International Council on Alcohol Drugs and Traffic Safety (ICADTS), 1999, GUID EXP STUD UND DE, P1; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Jex HR., 1966; Jongen S, 2014, PSYCHOPHARMACOLOGY, V231, P2435, DOI 10.1007/s00213-013-3408-y; Jugovac D, 2012, EXP PSYCHOL, V59, P115, DOI 10.1027/1618-3169/a000133; Kay G., 2011, DRUGGED DRIVING EXPE; Kleykamp BA, 2010, EXP CLIN PSYCHOPHARM, V18, P1, DOI 10.1037/a0018407; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V192, P111, DOI 10.1007/s00213-006-0679-6; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Leufkens TRM, 2014, CLIN THER, V36, P141, DOI 10.1016/j.clinthera.2013.11.005; Leufkens TRM, 2009, J SLEEP RES, V18, P387, DOI 10.1111/j.1365-2869.2009.00746.x; Leufkens TRM, 2014, PSYCHOPHARMACOLOGY, P1, DOI [10.1007/s00213-014-3807-8, DOI 10.1007/S00213-014-3807-8]; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Louwerens JW., 1987, ALCOHOL DRUGS TRAFFI, P183, DOI DOI 10.1080/15389588.2014.935356; Martella D, 2011, EXP BRAIN RES, V210, P81, DOI 10.1007/s00221-011-2605-3; Martiniuk ALC, 2013, JAMA PEDIATR, V167, P647, DOI 10.1001/jamapediatrics.2013.1429; MCLEOD DR, 1982, BEHAV RES METH INSTR, V14, P463, DOI 10.3758/BF03203313; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Mets MAJ, 2010, SLEEP MED REV, V14, P259, DOI 10.1016/j.smrv.2009.10.008; MOSKOWITZ H, 1973, J SAFETY RES, V5, P185; Mulder-Hajonides van der Meulen WREH, 1984, 14 CINP C FLOR; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; O'Hanlon J, 1986, DRUGS AND DRIVING; OHANLON JF, 1984, BRIT J CLIN PHARMACO, V18, pS121, DOI 10.1111/j.1365-2125.1984.tb02590.x; OHANLON JF, 1995, ALLERGY, V50, P234, DOI 10.1111/j.1398-9995.1995.tb01140.x; OHANLON JF, 1982, SCIENCE, V217, P79, DOI 10.1126/science.7089544; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Ramaekers JG, 2003, J CLIN PSYCHIAT, V64, P20, DOI 10.4088/JCP.v64n0106; Riedel WJ, 2006, CURR PHARM DESIGN, V12, P2525, DOI 10.2174/138161206777698882; ROBBE HWJ, 1995, EUR NEUROPSYCHOPHARM, V5, P35, DOI 10.1016/0924-977X(94)00130-4; Roge J, 2003, VISION RES, V43, P1465, DOI 10.1016/S0042-6989(03)00143-3; Roth T, 2014, TRAFFIC INJ PREV, V15, P439, DOI 10.1080/15389588.2013.830211; Roth T, 2008, HUM PSYCHOPHARM CLIN, V23, P13, DOI 10.1002/hup.884; Schnabel E, 2010, METAANALYSIS EMPIRIC; Schuhfried G., 2005, MANUAL EXPERT SYSTEM; SEPPALA T, 1979, DRUGS, V17, P389, DOI 10.2165/00003495-197917050-00008; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; Tiplady B, 2003, J PSYCHOPHARMACOL, V17, P41, DOI 10.1177/0269881103017001691; Valent F, 2010, SLEEP, V33, P349, DOI 10.1093/sleep/33.3.349; Van der Elst W, 2006, PSYCHOL ASSESSMENT, V18, P424, DOI 10.1037/1040-3590.18.4.424; van Steveninck AL, 1999, J PSYCHOPHARMACOL, V13, P10, DOI 10.1177/026988119901300102; Vermeeren A, 2002, SLEEP, V25, P224; Vermeeren A, 1994, J TRAFFIC MED, V22, P173; Vermeeren A, 2014, SLEEP, V37, P489, DOI 10.5665/sleep.3482; Verster JC, 2012, PSYCHOPHARMACOLOGY, V220, P293, DOI 10.1007/s00213-011-2484-0; Verster JC, 2011, INT J GEN MED, V4, P359, DOI 10.2147/IJGM.S19639; Verstraete A., 2011, SE LIMITS METHODS DE; Vingilis E, 2002, TRAFFIC INJ PREV, V3, P1, DOI DOI 10.1080/15389580210522; Vuurman EFPM, 2004, EUR J CLIN PHARMACOL, V60, P307, DOI 10.1007/s00228-004-0757-9; Walsh JM, 2008, ADDICTION, V103, P1258, DOI 10.1111/j.1360-0443.2008.02277.x; Walsh J Michael, 2004, Traffic Inj Prev, V5, P241; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	82	40	41	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2015	10	2							e0117045	10.1371/journal.pone.0117045	http://dx.doi.org/10.1371/journal.pone.0117045			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB2XY	25668292	Green Published, gold			2022-12-26	WOS:000349493000013
J	Foran, CM; Baker, KM; Grosso, NR; Linkov, I				Foran, Christy M.; Baker, Kelsie M.; Grosso, Nancy R.; Linkov, Igor			An Enhanced Adaptive Management Approach for Remediation of Legacy Mercury in the South River	PLOS ONE			English	Article								Uncertainties about future conditions and the effects of chosen actions, as well as increasing resource scarcity, have been driving forces in the utilization of adaptive management strategies. However, many applications of adaptive management have been criticized for a number of shortcomings, including a limited ability to learn from actions and a lack of consideration of stakeholder objectives. To address these criticisms, we supplement existing adaptive management approaches with a decision-analytical approach that first informs the initial selection of management alternatives and then allows for periodic re-evaluation or phased implementation of management alternatives based on monitoring information and incorporation of stakeholder values. We describe the application of this enhanced adaptive management (EAM) framework to compare remedial alternatives for mercury in the South River, based on an understanding of the loading and behavior of mercury in the South River near Waynesboro, VA. The outcomes show that the ranking of remedial alternatives is influenced by uncertainty in the mercury loading model, by the relative importance placed on different criteria, and by cost estimates. The process itself demonstrates that a decision model can link project performance criteria, decision-maker preferences, environmental models, and short- and long-term monitoring information with management choices to help shape a remediation approach that provides useful information for adaptive, incremental implementation.	[Foran, Christy M.; Linkov, Igor] US Army Corps Engineers New England Dist, US States Army Engineer Res & Dev Ctr, Duty Stn, Concord, MA 01742 USA; [Baker, Kelsie M.] US States Army Engineer Res & Dev Ctr, Concord, MA 01742 USA; [Grosso, Nancy R.] DuPont Corp, Remediat Grp, Wilmington, DE 19805 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; DuPont	Linkov, I (corresponding author), US Army Corps Engineers New England Dist, US States Army Engineer Res & Dev Ctr, Duty Stn, Concord, MA 01742 USA.	Igor.Linkov@usace.army.mil	Linkov, Igor/AAH-5981-2019	Linkov, Igor/0000-0002-0823-8107	USACE through Cooperative Research and Development Agreement (CRADA); DuPont	USACE through Cooperative Research and Development Agreement (CRADA); DuPont	This study was funded by DuPont and USACE through Cooperative Research and Development Agreement (CRADA). One author, Nancy Grosso, has an affiliation to the commercial funders of this research study (DuPont). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolgiano RW, 1981, BASIC DATA B, V48; Brent RN, 2011, ARCH ENVIRON CON TOX, V61, P614, DOI 10.1007/s00244-011-9664-0; Convertino M, 2013, SCI REPORTS; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Johnson BL, 1999, CONSERV ECOL, V3; Keeney L.R., 1976, DECISIONS MULTIPLE O; Lee K.N., 1999, CONSERV ECOL, V3, P3, DOI DOI 10.5751/ES-00131-030203; Light S., 2013, Journal of Sustainable Development, V6, P31; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Linkov I, 2012, MULTICRITERIA DECISI; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; McLain RJ, 1996, ENVIRON MANAGE, V20, P437, DOI 10.1007/BF01474647; National Research Council, 2006, PROGR REST EV 1 BIEN; National Research Council, 2004, AD MAN WAT RES PROJ; Pi J.H, 2014, EVALUATION IMPACT DA; RECOVER (Restoration Coordination and Verification), 2010, CERP AD MAN INT GUID; URS, 2012, FIN REP EC STUD S RI; Walters C., 1986, ADAPTIVE MANAGEMENT; Walters Carl, 1997, Conservation Ecology, V1, pUnpaginated; Yu RQ, 2012, ENVIRON SCI TECHNOL, V46, P2684, DOI 10.1021/es2033718	22	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2015	10	2							e0117140	10.1371/journal.pone.0117140	http://dx.doi.org/10.1371/journal.pone.0117140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UO	25665032	Green Published, gold, Green Submitted			2022-12-26	WOS:000349123100019
J	Bang, MA; Seo, JH; Seo, JW; Jo, GH; Jung, SK; Yu, R; Park, DH; Park, SJ				Bang, Mi-Ae; Seo, Ji-Hye; Seo, Joung-Wook; Jo, Gyung Hyun; Jung, Seoung Ki; Yu, Ri; Park, Dae-Hun; Park, Sang-Joon			Bacillus subtilis KCTC 11782BP-Produced Alginate Oligosaccharide Effectively Suppresses Asthma via T-Helper Cell Type 2-Related Cytokines	PLOS ONE			English	Article							SODIUM ALGINATE; TRANSCRIPTION FACTOR; IMMUNOLOGY; PATHWAYS; PREVENTS; DISEASES; BET	According to the World Health Organization in 2013, 235 million people are afflicted with asthma. Asthma is a severe pulmonary disease that can be caused by the imbalance of T-helper (Th) type 1 (Th1) and type 2 (Th2) cells, and it is potentially fatal. In this study, we evaluated the anti-asthmatic effect of alginate oligosaccharide (AO), which was prepared from seaweed and converted by Bacillus subtilis KCTC 11782BP, in the mouse model of ovalbumin (OVA)-induced asthma. BALB/c mice were divided into the vehicle control (sensitized but not challenged), asthma induction, positive control (1 mg/kg dexamethasone), 50 mg/kg/day AO-treated, 200 mg/kg/day AO-treated, and 400 mg/kg/day AO-treated groups. The numbers or levels of inflammatory cells, eosinophils, and immunoglobulin (Ig) E were measured in bronchoalveolar lavage fluid (BALF), and asthma-related morphological and cytokine changes were analyzed in lung tissues. Our results show that AO dramatically reduced inflammatory cell numbers, eosinophil count, and IgE levels in BALF, and it dose-dependently inhibited asthmatic histopathological changes in the lung. In addition, AO dose-dependently suppressed the expression of CD3+ T-cell co-receptors, CD4+ Th cells, CD8+ cytotoxic T-cell-related factors, macrophages, and MHCII class. AO dose-dependently decreased the expression levels of Th1/2 cells-regulatory transcription factors such as GATA-3 which modulates Th2 cell proliferation and T-bet which does Th1 cell proliferation. The mRNA levels of all Th1/2-related cytokines, except IL-12 alpha, were dose-dependently suppressed by AO treatment. In particular, the mRNA levels of IL-5, IL-6, and IL-13 were significantly inhibited by AO treatment. Our findings suggest that AO has the potential to be an anti-asthmatic drug candidate, due to its modulation of Th1/Th2 cytokines, which contribute to the pathogenesis of asthma.	[Bang, Mi-Ae] Jeonnam Biofood Technol Ctr, Food Ind Dev Team, Naju, South Korea; [Seo, Ji-Hye; Park, Dae-Hun] Dongshin Univ, Dept Oriental Med Mat, Naju, South Korea; [Seo, Joung-Wook] Korea Inst Toxicol, Taejon, South Korea; [Jo, Gyung Hyun; Jung, Seoung Ki] Bioresource Inc, Res Inst Biosci & Biotechnol, Naju, South Korea; [Yu, Ri; Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea	Dongshin University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Kyungpook National University	Park, DH (corresponding author), Dongshin Univ, Dept Oriental Med Mat, Naju, South Korea.	dhj1221@paran.com; psj26@knu.ac.kr			Fishery Commercialization Technology Development Program, Korea [112098-03-2-SB010]; Research Institute of Bioscience and Biotechnology, Bioresource Inc.	Fishery Commercialization Technology Development Program, Korea; Research Institute of Bioscience and Biotechnology, Bioresource Inc.	The Fishery Commercialization Technology Development Program, Korea (112098-03-2-SB010). The Research Institute of Bioscience and Biotechnology, Bioresource Inc., provided support in the form of salaries for authors GHJ & SKJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Akinbami O.J., 2012, TRENDS ASTHMA PREVAL; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Foster KA, 2013, J PHARM SCI-US, V102, P2440, DOI 10.1002/jps.23630; Hamid Q, 2005, CYTOKINES CHEMOKINES, P453; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Jung S- K, 2012, Korea Patent, DOI 10.3346/jkms.2014.29.11.1544, Patent No. [10- 2012- 0097841, 1020120097841]; KAM JC, 1993, J IMMUNOL, V151, P3460; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Khan S, 2012, ANTIMICROB AGENTS CH, V56, P5134, DOI 10.1128/AAC.00525-12; Liu K, 2013, J AGR FOOD CHEM, V61, P6562, DOI 10.1021/jf4010065; Mamessier E, 2006, EUR J DERMATOL, V16, P103; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; McGrath MG, 2014, EUR J PHARM BIOPHARM, V86, P200, DOI 10.1016/j.ejpb.2013.04.023; Moriya C, 2013, CLIN EXP HYPERTENS, V35, P607, DOI 10.3109/10641963.2013.776568; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Razavi A, 2008, IRAN J ALLERGY ASTHM, V7, P13, DOI 07.01/ijaai.1318; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Sarithakumari CH, 2013, INFLAMMOPHARMACOLOGY, V21, P261, DOI 10.1007/s10787-012-0159-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slejko JF, 2014, J ALLERGY CLIN IMMUN, V133, P1579, DOI 10.1016/j.jaci.2013.10.028; Stirling RG, 2000, EUR RESPIR J, V16, P1158, DOI 10.1034/j.1399-3003.2000.16f24.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yoshida T, 2004, INT ARCH ALLERGY IMM, V133, P239, DOI 10.1159/000076830; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	35	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117524	10.1371/journal.pone.0117524	http://dx.doi.org/10.1371/journal.pone.0117524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658604	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900172
J	Blonde, GD; Bales, MB; Spector, AC				Blonde, Ginger D.; Bales, Michelle B.; Spector, Alan C.			Extensive Lesions in Rat Insular Cortex Significantly Disrupt Taste Sensitivity to NaCl and KCl and Slow Salt Discrimination Learning	PLOS ONE			English	Article							CONCENTRATION-DEPENDENT LICKING; GUSTATORY CORTEX; PARABRACHIAL NUCLEI; ALBINO RAT; AVERSION; AMYGDALA; NEOCORTEX; AVOIDANCE; RESPONSES; SUCROSE	While studies of the gustatory cortex (GC) mostly focus on its role in taste aversion learning and memory, the necessity of GC for other fundamental taste-guided behaviors remains largely untested. Here, rats with either excitotoxic lesions targeting GC (n = 26) or sham lesions (n = 14) were assessed for postsurgical retention of a presurgically LiCl-induced conditioned taste aversion (CTA) to 0.1M sucrose using a brief-access taste generalization test in a gustometer. The same animals were then trained in a two-response operant taste detection task and psychophysically tested for their salt (NaCl or KCl) sensitivity. Next, the rats were trained and tested in a NaCl vs. KCl taste discrimination task with concentrations varied. Rats meeting our histological inclusion criterion had large lesions (resulting in a group averaging 80% damage to GC and involving surrounding regions) and showed impaired postsurgical expression of the presurgical CTA (LiCl-injected, n = 9), demonstrated rightward shifts in the NaCl (0.54 log(10) shift) and KCl (0.35 log(10) shift) psychometric functions, and displayed retarded salt discrimination acquisition (n = 18), but eventually learned and performed the discrimination comparable to sham-operated animals. Interestingly, the degree of deficit between tasks correlated only modestly, if at all, suggesting that idiosyncratic differences in insular cortex lesion topography were the root of the individual differences in the behavioral effects demonstrated here. This latter finding hints at some degree of interanimal variation in the functional topography of insular cortex. Overall, GC appears to be necessary to maintain normal taste sensitivity to NaCl and KCl and for salt discrimination learning. However, higher salt concentrations can be detected and discriminated by rats with extensive damage to GC suggesting that the other resources of the gustatory system are sufficient to maintain partial competence in these tasks, supporting the view that such basic sensory-discriminative taste functions involve distributed processes among central gustatory structures.	[Spector, Alan C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Spector, AC (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	spector@psy.fsu.edu	Spector, Alan/W-2925-2019		National Institute on Deafness and Other Communication Disorders [R01-DC-DC009821, T32-DC-000044]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000044, R01DC009821, K08DC000044] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institute on Deafness and Other Communication Disorders: R01-DC-DC009821 (ACS); T32-DC-000044 (MBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Adolphs R, 2005, NAT NEUROSCI, V8, P860, DOI 10.1038/nn1489; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BENJAMIN RM, 1959, J COMP NEUROL, V111, P231, DOI 10.1002/cne.901110203; BENJAMIN RM, 1955, J COMP PHYSIOL PSYCH, V48, P119, DOI 10.1037/h0041257; BENJAMIN RM, 1955, J NEUROPHYSIOL, V18, P56, DOI 10.1152/jn.1955.18.1.56; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; Blonde G, 2010, AM J PHYSIOL-REG I, V299, pR1027, DOI 10.1152/ajpregu.00843.2009; Blonde GD, 2006, BEHAV NEUROSCI, V120, P580, DOI 10.1037/0735-7044.120.3.580; BRAUN JJ, 1981, EXP NEUROL, V72, P711, DOI 10.1016/0014-4886(81)90020-0; BRAUN JJ, 1972, PHYSIOL BEHAV, V9, P637; BRAUN JJ, 1982, PHYSIOL PSYCHOL, V10, P13; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cubero I, 1999, BRAIN RES, V839, P323, DOI 10.1016/S0006-8993(99)01745-X; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Fresquet N, 2004, BEHAV BRAIN RES, V153, P357, DOI 10.1016/j.bbr.2003.12.011; Gal-Ben-Ari S, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00087; Geddes RI, 2008, BEHAV NEUROSCI, V122, P1038, DOI 10.1037/a0012748; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hanamori T, 1998, J NEUROPHYSIOL, V79, P2535, DOI 10.1152/jn.1998.79.5.2535; Hashimoto K, 2014, CHEM SENSES, V39, P57, DOI 10.1093/chemse/bjt054; John SJS, 1997, BEHAV NEUROSCI, V111, P450; Kany Y, 2009, BRAIN RES, V1248, P76, DOI 10.1016/j.brainres.2008.10.075; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; KIEFER SW, 1984, BEHAV NEUROSCI, V98, P590; KIEFER SW, 1992, BEHAV NEUROSCI, V106, P140, DOI 10.1037/0735-7044.106.1.140; KOSAR E, 1986, BRAIN RES, V379, P342, DOI 10.1016/0006-8993(86)90788-2; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; LORDEN JF, 1976, J COMP PHYSIOL PSYCH, V90, P665, DOI 10.1037/h0077237; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; MacDonald CJ, 2012, J PHYSIOL-LONDON, V590, P3169, DOI 10.1113/jphysiol.2012.233486; Maier JX, 2013, J NEUROPHYSIOL, V109, P2108, DOI 10.1152/jn.00917.2012; Moo L, 1999, J Stroke Cerebrovasc Dis, V8, P353, DOI 10.1016/S1052-3057(99)80011-1; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Nerad L, 1996, NEUROBIOL LEARN MEM, V66, P44, DOI 10.1006/nlme.1996.0042; Paxinos G, 2007, RAT BRAIN STEREOTAXI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Pritchard T. C., 2004, HUMAN NERVOUS SYSTEM, P1171, DOI DOI 10.1016/B978-012547626-3/50032-6; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Roman C, 2007, EUR J NEUROSCI, V26, P2627, DOI 10.1111/j.1460-9568.2007.05872.x; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Samuelsen CL, 2012, NEURON, V74, P410, DOI 10.1016/j.neuron.2012.02.031; Schafe GE, 1998, BRAIN RES, V800, P40, DOI 10.1016/S0006-8993(98)00492-2; Schier LA, 2014, P NATL ACAD SCI USA, V111, P1162, DOI 10.1073/pnas.1315624111; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Small DM, 2005, NEUROLOGY, V64, P311, DOI 10.1212/01.WNL.0000149515.77718.35; Spector A. C., 2003, Handbook of olfaction and gustation, P861; SPECTOR AC, 1995, REV NEUROSCIENCE, V6, P143, DOI 10.1515/REVNEURO.1995.6.2.143; SPECTOR AC, 1995, BEHAV NEUROSCI, V109, P939, DOI 10.1037/0735-7044.109.5.939; Spector AC, 1996, J NEUROSCI, V16, P8115; SPECTOR AC, 1993, PHYSIOL BEHAV, V53, P277, DOI 10.1016/0031-9384(93)90205-T; Spector AC, 2010, BRAIN RES, V1310, P46, DOI 10.1016/j.brainres.2009.11.021; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; Stehberg J, 2011, NEUROBIOL LEARN MEM, V95, P14, DOI 10.1016/j.nlm.2010.10.002; Stone ME, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00003; Treesukosol Y, 2012, AM J PHYSIOL-REG I, V303, pR218, DOI 10.1152/ajpregu.00089.2012; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117515	10.1371/journal.pone.0117515	http://dx.doi.org/10.1371/journal.pone.0117515			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658323	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900170
J	Kim, JY; Sohn, JH; Lee, JH; Park, JW				Kim, Joo Young; Sohn, Jung-Ho; Lee, Jae-Hyun; Park, Jung-Won			Obesity Increases Airway Hyperresponsiveness via the TNF-alpha Pathway and Treating Obesity Induces Recovery	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; WEIGHT-LOSS; ASTHMA; INFLAMMATION; DISEASE; DIET	Obesity is a known risk factor for allergic asthma. It has been recognized as a key player in the pathogenesis of several inflammatory disorders via activation of macrophages, which is also vital to the development of allergic asthma. We investigated the mechanism of obesity-related asthma and whether treating obesity through exercise or diet ameliorates the severity of asthma in the obesity-related asthma model. We generated diet-induced obesity (DIO) in C57BL/6 mice by high-fat-feeding and ovalbumin-induced asthma (lean-OVA or DIOOVA). The DIO-OVA mice were then treated with tumor necrosis factor (TNF)-alpha neutralizing antibody as a TNF-alpha blockade or a Cl2MDP-containing liposome to induce an alveolar macrophage deficiency. To treat obesity, the DIO-OVA mice were under dietary restrictions or exercised. The pathophysiological and immunological responses were analyzed. Airway hyperresponsiveness (AHR), serum IgE and TNF-alpha levels in the lung tissue increased in the DIO-OVA mice compared to the lean-OVA mice. Both the TNF-alpha blockade and depletion of alveolar macrophages in the DIO-OVA mice decreased AHR compared to the DIOOVA mice. Treating obesity by exercise or through dietary means also reduced pulmonary TNF-alpha levels and AHR in the DIO-OVA mice. These results suggest that restoring normal body weight is an appropriate strategy for reducing TNF-alpha levels, and controlling inflammation may help improve asthma severity and control in obesity-related asthma.	[Kim, Joo Young] Ewha Womans Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Sohn, Jung-Ho; Lee, Jae-Hyun; Park, Jung-Won] Yonsei Univ, Coll Med, Inst Allergy, Dept Internal Med, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System	Park, JW (corresponding author), Yonsei Univ, Coll Med, Inst Allergy, Dept Internal Med, Seoul, South Korea.	parkjw@yuhs.ac	Kim, Jooyoung/R-5839-2018; Lee, Jae-Hyun/ABE-3803-2020; Lee, Jae-Hyun/H-2260-2016	Kim, Jooyoung/0000-0003-4846-6259; Lee, Jae-Hyun/0000-0002-0760-0071; Lee, Jae-Hyun/0000-0002-0760-0071; Park, Jung-Won/0000-0003-0249-8749	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0010]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0010). JWP received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi FB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009339.pub2; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786; Celedon JC, 2014, NAT MED, V20, P20, DOI 10.1038/nm.3433; Centers for Disease Control and Prevention, 2012, BRFSS 2010 SURVEY DA; Chiu S, 2004, OBES RES, V12, P1243, DOI 10.1038/oby.2004.158; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Eneli IU, 2008, THORAX, V63, P671, DOI 10.1136/thx.2007.086470; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Gibson Peter G, 2013, Ann Am Thorac Soc, V10 Suppl, pS138, DOI 10.1513/AnnalsATS.201302-038AW; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Irani BG, 2005, BIOCHEM BIOPH RES CO, V326, P638, DOI 10.1016/j.bbrc.2004.11.084; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047971; Lee BK, 2004, CLIN EXP ALLERGY, V34, P1642, DOI 10.1111/j.1365-2222.2004.02077.x; Lessard A, 2008, CHEST, V134, P317, DOI 10.1378/chest.07-2959; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Ronmark E, 2005, EUR RESPIR J, V25, P282, DOI 10.1183/09031936.05.00054304; Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; World Health Organization Office of Health Communications and Public Relations, 2006, OB OV, P3; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang M, 2010, CLIN EXP ALLERGY, V40, P163, DOI 10.1111/j.1365-2222.2009.03393.x; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	34	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116540	10.1371/journal.pone.0116540	http://dx.doi.org/10.1371/journal.pone.0116540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658739	Green Submitted, Green Published, gold			2022-12-26	WOS:000349444900047
J	Mouden, C; de Tayrac, M; Dubourg, C; Rose, S; Carre, W; Hamdi-Roze, H; Babron, MC; Akloul, L; Heron-Longe, B; Odent, S; Dupe, V; Giet, R; David, V				Mouden, Charlotte; de Tayrac, Marie; Dubourg, Christele; Rose, Sophie; Carre, Wilfrid; Hamdi-Roze, Houda; Babron, Marie-Claude; Akloul, Linda; Heron-Longe, Benedicte; Odent, Sylvie; Dupe, Valerie; Giet, Regis; David, Veronique			Homozygous STIL Mutation Causes Holoprosencephaly and Microcephaly in Two Siblings	PLOS ONE			English	Article							MEIER-GORLIN SYNDROME; CHICK-EMBRYOS; HUMAN-CELLS; GENE; CENTRIOLE; PROTEIN; SIL; SHH; AMPLIFICATION; PHENOTYPE	Holoprosencephaly (HPE) is a frequent congenital malformation of the brain characterized by impaired forebrain cleavage and midline facial anomalies. Heterozygous mutations in 14 genes have been identified in HPE patients that account for only 30% of HPE cases, suggesting the existence of other HPE genes. Data from homozygosity mapping and whole-exome sequencing in a consanguineous Turkish family were combined to identify a homozygous missense mutation (c.2150G>A; p.Gly717Glu) in STIL, common to the two affected children. STIL has a role in centriole formation and has previously been described in rare cases of microcephaly. Rescue experiments in U2OS cells showed that the STIL p.Gly717Glu mutation was not able to fully restore the centriole duplication failure following depletion of endogenous STIL protein indicating the deleterious role of the mutation. In situ hybridization experiments using chick embryos demonstrated that expression of Stil was in accordance with a function during early patterning of the forebrain. It is only the second time that a STIL homozygous mutation causing a recessive form of HPE was reported. This result also supports the genetic heterogeneity of HPE and increases the panel of genes to be tested for HPE diagnosis.	[Mouden, Charlotte; de Tayrac, Marie; Dubourg, Christele; Rose, Sophie; Hamdi-Roze, Houda; Odent, Sylvie; Dupe, Valerie; David, Veronique] Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Genet Pathol Liees Dev, F-35043 Rennes, France; [Giet, Regis] Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Cytosquelette & Proliferat Cellulaire, F-35043 Rennes, France; [Dubourg, Christele; Carre, Wilfrid; Hamdi-Roze, Houda; David, Veronique] CHU Pontchaillou, Lab Genet Mol & Genom, F-35033 Rennes, France; [Babron, Marie-Claude] Univ Paris Diderot, INSERM, Variabil Genet & Malad Humaines U946, F-75010 Paris, France; [Akloul, Linda; Odent, Sylvie] Hop Sud, Serv Genet Clin, F-35200 Rennes, France; [Heron-Longe, Benedicte] Hop Jean Verdier, APHP, Serv Pediat, F-93140 Bondy, France; [de Tayrac, Marie] Univ Rennes 1, F-35033 Rennes, France	Universite de Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Jean-Verdier - APHP; Universite de Rennes	David, V (corresponding author), Univ Rennes 1, Fac Med, Inst Genet & Dev Rennes, Equipe Genet Pathol Liees Dev, F-35043 Rennes, France.	veronique.david@univ-rennes1.fr	de Tayrac, Marie/AAG-7800-2020; Dupe, Valerie/CJQ-0939-2022; Dupe, Valerie/P-2140-2018	Dupe, Valerie/0000-0003-4859-0612; Dupe, Valerie/0000-0003-4859-0612; Babron, Marie-Claude/0000-0002-4100-0299; Hamdi-Roze, Houda/0000-0003-2175-9190	Agence de la Biomedecine; Agence Nationale de la Recherche [ANR-12-BSV1-0007-01]	Agence de la Biomedecine; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence de la Biomedecine (to V. David) and the Agence Nationale de la Recherche (grant no. ANR-12-BSV1-0007-01 (to V. Dupe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglyamova GV, 2007, DEV DYNAM, V236, P1363, DOI 10.1002/dvdy.21146; Arquint C, 2014, CURR BIOL, V24, P351, DOI 10.1016/j.cub.2013.12.016; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Bendavid C, 2010, AM J MED GENET C, V154C, P86, DOI 10.1002/ajmg.c.30250; Bennett H, 2014, PEDIATR NEUROL, DOI [10.1016/j.pediatrneurol.2014.11.008, DOI 10.1016/J.PEDIATRNEUR0L.2014.11.008]; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; de Munnik SA, 2012, AM J MED GENET A, V158A, P2733, DOI 10.1002/ajmg.a.35681; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Dupe V, 2011, HUM MOL GENET, V20, P1122, DOI 10.1093/hmg/ddq556; Franck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014600; Gazal S, 2014, BIOINFORMATICS, V30, P1940, DOI 10.1093/bioinformatics/btu149; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Kakar N, 2014, HUM GENET, DOI [10.1007/s00439-014-1519-0, DOI 10.1007/S00439-014-1519-0]; Karkera JD, 2002, CYTOGENET GENOME RES, V97, P62, DOI 10.1159/000064057; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lacruz RS, 2011, J DENT RES, V90, P1228, DOI 10.1177/0022034511418231; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Mercier S, 2013, DIS MODEL MECH, V6, P537, DOI 10.1242/dmm.010132; Mercier S, 2011, J MED GENET, V48, P752, DOI 10.1136/jmedgenet-2011-100339; Papari E, 2013, CLIN GENET, V83, P488, DOI 10.1111/j.1399-0004.2012.01949.x; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Solomon BD, 1993, GENEREVIEWS R; Sun L, 2014, BIOCHEM BIOPH RES CO, V449, P444, DOI 10.1016/j.bbrc.2014.05.048; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	35	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117418	10.1371/journal.pone.0117418	http://dx.doi.org/10.1371/journal.pone.0117418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658757	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900146
J	Philp, LK; Heilbronn, LK; Janovska, A; Wittert, GA				Philp, Lisa K.; Heilbronn, Leonie K.; Janovska, Alena; Wittert, Gary A.			Dietary Enrichment with Fish Oil Prevents High Fat-Induced Metabolic Dysfunction in Skeletal Muscle in Mice	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; FIBER-TYPE; UP-REGULATION; UNCOUPLING PROTEIN-3; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; ACID OXIDATION; SOLEUS MUSCLE; VISCERAL FAT; BODY-WEIGHT	High saturated fat (HF-S) diets increase intramyocellular lipid, an effect ameliorated by omega-3 fatty acids in vitro and in vivo, though little is known about sex-and muscle fiber type-specific effects. We compared effects of standard chow, HF-S, and 7.5% HF-S replaced with fish oil (HF-FO) diets on the metabolic profile and lipid metabolism gene and protein content in red (soleus) and white (extensor digitorum longus) muscles of male and female C57BL/6 mice (n = 9-12/group). Weight gain was similar in HF-S- and HF-FO-fed groups. HF-S feeding increased mesenteric fat mass and lipid marker, Oil Red O, in red and mixed muscle; HF-FO increased interscapular brown fat mass. Compared to chow, HF-S and HF-FO increased expression of genes regulating triacylglycerol synthesis and fatty acid transport, HF-S suppressed genes and proteins regulating fatty acid oxidation, whereas HF-FO increased oxidative genes, proteins and enzymes and lipolytic gene content, whilst suppressing lipogenic genes. In comparison to HF-S, HF-FO further increased fat transporters, markers of fatty acid oxidation and mitochondrial content, and reduced lipogenic genes. No diet-by-sex interactions were observed. Neither diet influenced fiber type composition. However, some interactions between muscle type and diet were observed. HF-S induced changes in triacylglycerol synthesis and lipogenic genes in red, but not white, muscle, and mitochondrial biogenesis and oxidative genes were suppressed by HF-S and increased by HF-FO in red muscle only. In conclusion, HF-S feeding promotes lipid storage in red muscle, an effect abrogated by the fish oil, which increases mediators of lipolysis, oxidation and thermogenesis while inhibiting lipogenic genes. Greater storage and synthesis, and lower oxidative genes in red, but not white, muscle likely contribute to lipid accretion encountered in red muscle. Despite several gender-dimorphic genes, both sexes exhibited a similar HF-S-induced metabolic and gene expression profile; likewise fish oil was similarly protective in both sexes.	[Philp, Lisa K.; Heilbronn, Leonie K.; Janovska, Alena; Wittert, Gary A.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	University of Adelaide	Philp, LK (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	lisa.philp@qut.edu.au	wittert, gary/AAE-2398-2019; Heilbronn, Leonie/H-1874-2013	Philp, Lisa/0000-0001-8365-295X; Wittert, Gary/0000-0001-6818-6065; Heilbronn, Leonie/0000-0003-2106-7303	Australian Post-graduate Award	Australian Post-graduate Award(Australian Government)	This work was funded by an Australian Post-graduate Award (http://education.gov.au/australian-postgraduate-awards) - LKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bertrand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078874; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Biscione F, 2007, CURR VASC PHARMACOL, V5, P163, DOI 10.2174/157016107780368334; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Catala-Niell A, 2008, CELL PHYSIOL BIOCHEM, V22, P327, DOI 10.1159/000149811; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; Doh KO, 2005, LIFE SCI, V77, P435, DOI 10.1016/j.lfs.2004.11.032; DREON DM, 1988, AM J CLIN NUTR, V47, P995, DOI 10.1093/ajcn/47.6.995; Feillet-Coudray C, 2013, BRIT J NUTR, V110, P1789, DOI 10.1017/S0007114513001311; Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132; FRYER LGD, 1995, EUR J BIOCHEM, V229, P741, DOI 10.1111/j.1432-1033.1995.tb20522.x; Guillerm-Regost C, 2006, OBESITY, V14, P1700, DOI 10.1038/oby.2006.195; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; HINTZ CS, 1980, AM J PHYSIOL, V239, pC58, DOI 10.1152/ajpcell.1980.239.3.C58; Hoeks J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027274; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; Janczyk W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-85; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kaneko S, 2011, ANAT REC, V294, P1904, DOI 10.1002/ar.21472; Kim CH, 2003, METABOLISM, V52, P1586, DOI 10.1016/S0026-0495(03)00328-7; Kim JY, 2000, AM J PHYSIOL-REG I, V279, pR2057, DOI 10.1152/ajpregu.2000.279.6.R2057; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Lam YY, 2011, BBA-MOL CELL BIOL L, V1811, P468, DOI 10.1016/j.bbalip.2011.04.011; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; PARRISH CC, 1990, METABOLISM, V39, P217, DOI 10.1016/0026-0495(90)90038-E; Perez-Echarri N, 2009, J NUTR BIOCHEM, V20, P705, DOI 10.1016/j.jnutbio.2008.06.013; Piers LS, 2003, BRIT J NUTR, V90, P717, DOI 10.1079/BJN2003948; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Samec S, 2002, PFLUG ARCH EUR J PHY, V445, P80, DOI 10.1007/s00424-002-0879-9; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 1997, AM J CLIN NUTR, V66, P276, DOI 10.1093/ajcn/66.2.276; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; THOMAS CD, 1992, AM J CLIN NUTR, V55, P934, DOI 10.1093/ajcn/55.5.934; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Turvey EA, 2005, J APPL PHYSIOL, V98, P350, DOI [10.1152/japplphysiol.00604.2004, 10.1152/japplphysiol.00604.2005]; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382; Yu YH, 2011, J NUTR BIOCHEM, V22, P179, DOI 10.1016/j.jnutbio.2010.01.006; Zderic TW, 2004, AM J PHYSIOL-ENDOC M, V286, pE217, DOI 10.1152/ajpendo.00159.2003	63	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117494	10.1371/journal.pone.0117494	http://dx.doi.org/10.1371/journal.pone.0117494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658742	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900164
J	Shave, S; Blackburn, EA; Adie, J; Houston, DR; Auer, M; Webster, SP; Taylor, P; Walkinshaw, MD				Shave, Steven; Blackburn, Elizabeth A.; Adie, Jillian; Houston, Douglas R.; Auer, Manfred; Webster, Scott P.; Taylor, Paul; Walkinshaw, Malcolm D.			UFSRAT: Ultra-Fast Shape Recognition with Atom Types -The Discovery of Novel Bioactive Small Molecular Scaffolds for FKBP12 and 11 beta HSD1	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DRUG-LIKE COMPOUNDS; LIGAND DISCOVERY; PROGRAM LIDAEUS; INHIBITORS; IDENTIFICATION; PROTEIN; DESCRIPTORS; DATABASES; BINDING	Motivation Using molecular similarity to discover bioactive small molecules with novel chemical scaffolds can be computationally demanding. We describe Ultra-fast Shape Recognition with Atom Types (UFSRAT), an efficient algorithm that considers both the 3D distribution (shape) and electrostatics of atoms to score and retrieve molecules capable of making similar interactions to those of the supplied query. Results Computational optimization and pre-calculation of molecular descriptors enables a query molecule to be run against a database containing 3.8 million molecules and results returned in under 10 seconds on modest hardware. UFSRAT has been used in pipelines to identify bioactive molecules for two clinically relevant drug targets; FK506-Binding Protein 12 and 11 beta-hydroxysteroid dehydrogenase type 1. In the case of FK506-Binding Protein 12, UFSRAT was used as the first step in a structure-based virtual screening pipeline, yielding many actives, of which the most active shows a K-D, (app) of 281 mu M and contains a substructure present in the query compound. Success was also achieved running solely the UFSRAT technique to identify new actives for 11 beta-hydroxysteroid dehydrogenase type 1, for which the most active displays an IC50 of 67 nM in a cell based assay and contains a substructure radically different to the query. This demonstrates the valuable ability of the UFSRAT algorithm to perform scaffold hops. Availability and Implementation A web-based implementation of the algorithm is freely available at http://opus.bch.ed.ac.uk/ufsrat/.	[Shave, Steven; Blackburn, Elizabeth A.; Adie, Jillian; Houston, Douglas R.; Auer, Manfred; Taylor, Paul; Walkinshaw, Malcolm D.] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland; [Webster, Scott P.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Walkinshaw, MD (corresponding author), Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	Shave, Steven/0000-0001-6996-3663; Houston, Douglas/0000-0002-3469-1546; Auer, Manfred/0000-0001-8920-3522; Webster, Scott/0000-0003-4656-4744; Adie, Jillian/0000-0002-5048-9583; Blackburn, Elizabeth A/0000-0003-1325-9575; walkinshaw, malcolm/0000-0001-5955-9325; Taylor, Paul/0000-0002-8213-0380	Wellcome Trust [101527/Z/13/Z]; studentships from Biotechnology and Biological Sciences Research Council; Medical Research Council [MC_G0802522] Funding Source: researchfish; MRC [MC_G0802522] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); studentships from Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Experiments were carried out in the Centre for Translational and Chemical Biology (CTCB) and the Edinburgh Protein Production Facility (EPPF). The CTCB and the EPPF were funded by the Wellcome Trust http://www.wellcome.ac.uk/ (Grant number 101527/Z/13/Z). JA, EAB and SS were funded by studentships from the Biotechnology and Biological Sciences Research Council (http:w//www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie J, 2010, THESIS U EDINBURGH; Arampatzis S, 2005, J NEUROIMMUNOL, V157, P126; Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Ballester PJ, 2007, P R SOC A, V463, P1307, DOI 10.1098/rspa.2007.1823; Ballester PJ, 2012, J R SOC INTERFACE, V9, P3196, DOI 10.1098/rsif.2012.0569; Ballester PJ, 2010, J R SOC INTERFACE, V7, P335, DOI 10.1098/rsif.2009.0170; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Brown RD, 1997, J CHEM INF COMP SCI, V37, P1, DOI 10.1021/ci960373c; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Fulton KF, 2003, BIOCHEMISTRY-US, V42, P2364, DOI 10.1021/bi020564a; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Hsin KY, 2011, NUCLEIC ACIDS RES, V39, pD1042, DOI 10.1093/nar/gkq878; Landrum g, 2006, RDKIT OPEN SOURCE CH; Li HL, 2009, J MED CHEM, V52, P4936, DOI 10.1021/jm801622x; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mundt S, 2005, ASSAY DRUG DEV TECHN, V3, P367, DOI 10.1089/adt.2005.3.367; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Patil SP, 2014, J COMPUT AID MOL DES, V28, P89, DOI 10.1007/s10822-014-9732-4; Patterson DE, 1996, J MED CHEM, V39, P3049, DOI 10.1021/jm960290n; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schreyer AM, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-27; Shave SR, 2008, IBM J RES DEV, V52, P57, DOI 10.1147/rd.521.0057; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Sheridan RP, 2002, J CHEM INF COMP SCI, V42, P103, DOI 10.1021/ci0100806; Sheridan RP, 2003, J CHEM INF COMP SCI, V43, P1037, DOI [10.1021/ci030004y, 10.1021/ci03(9)04y]; Stebbins JL, 2007, J MED CHEM, V50, P6607, DOI 10.1021/jm0707424; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; Taylor P, 2008, BRIT J PHARMACOL, V153, pS55, DOI 10.1038/sj.bjp.0707532; Tjernberg A, 2004, ANAL CHEM, V76, P4325, DOI 10.1021/ac0497914; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Valentine H, 2007, EUR UROL, V51, P1724, DOI 10.1016/j.eururo.2006.11.026; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Wear MA, 2007, PROTEIN EXPRES PURIF, V51, P80, DOI 10.1016/j.pep.2006.06.019; Webster SP, 2007, EXPERT OPIN THER PAT, V17, P1407, DOI 10.1517/13543776.17.12.1407; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab	46	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116570	10.1371/journal.pone.0116570	http://dx.doi.org/10.1371/journal.pone.0116570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659145	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900051
J	de Oliveira, ML; Santos, LMP; da Silva, EN				de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes			Direct Healthcare Cost of Obesity in Brazil: An Application of the Cost-of-Illness Method from the Perspective of the Public Health System in 2011	PLOS ONE			English	Article							BODY-MASS INDEX; ECONOMIC BURDEN; OVERWEIGHT; CANCER; MORTALITY; CONSEQUENCES; METAANALYSIS; WEIGHT; IMPACT; RISK	Background Obesity is a global public health problem and a risk factor for several diseases that financially impact healthcare systems. Objective To estimate the direct costs attributable to obesity (body mass index {BMI} >= 30 kg/m(2)) and morbid obesity (BMI >= 40 kg/m(2)) in adults aged >= 20 incurred by the Brazilian public health system in 2011. Settings Public hospitals and outpatient care. Methods A cost-of-illness method was adopted using a top-down approach based on prevalence. The proportion of the cost of each obesity-associated comorbidity was calculated and obesity prevalence was used to calculate attributable risk. Direct healthcare cost data (inpatient care, bariatric surgery, outpatient care, medications and diagnostic procedures) were extracted from the Ministry of Health information systems, available on the web. Results Direct costs attributable to obesity totaled US$ 269.6 million (1.86% of all expenditures on medium-and high-complexity health care). The cost of morbid obesity accounted for 23.8% (US$ 64.2 million) of all obesity-related costs despite being 18 times less prevalent than obesity. Bariatric surgery costs in Brazil totaled US$ 17.4 million in 2011. The cost of morbid obesity in women was five times higher than it was in men. Conclusion The cost of morbid obesity was found to be proportionally higher than the cost of obesity. If the current epidemic were not reversed, the prevalence of obesity in Brazil will increase gradually in the coming years, as well as its costs, having serious implications for the financial sustainability of the Brazilian public health system.	[de Oliveira, Michele Lessa; Pacheco Santos, Leonor Maria; da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia	da Silva, EN (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	evertonsilva@unb.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185				Access Economics, 2006, EC COSTS OB REP ACC; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; [Anonymous], 2000, WHO TECH REP SER, P894; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bachman KH, 2007, DIS MANAGE, V10, P129, DOI 10.1089/dis.2007.103643; Bahia L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-440; Barrett A, 2008, ISPOR 13 ANN INT M; Branca F, 2007, CHALLENGE OBESITY WH, P11; Brasil, PROD AMB PROC MENT H; Brasil. Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20, P130; Brasil. Ministerio da Saude, 2008, AR EC SAUD DES AV EC, P104, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cordeiro Ricardo, 2005, Rev. bras. epidemiol., V8, P111; Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Ezzati M, 2004, COMP QUANTIFICATION, V1, P497; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hensrud DD, 2006, MAYO CLIN PROC, V81, pS5; International Association for the Study of Obesity International Obesity Taskforce, EST REL RISKS BMI CA; Lehnert T, 2013, BEST PRACT RES CL EN, V27, P105, DOI 10.1016/j.beem.2013.01.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Oliveira IV, 2007, THESIS U BRASILIA BR; Santos LMP, 2010, OBES SURG, V20, P943, DOI 10.1007/s11695-008-9570-3; Pereira J, 1999, CUSTOS OBESIDADE POR; Pereira MG, 2001, EPIDEMIOLOGIA TEORIA, P412; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sarno F, 2007, REV SAUDE PUBL, V41, P788, DOI 10.1590/S0034-89102007000500013; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025; Sussenbach SP, 2012, OBES SURG, V22, P266, DOI 10.1007/s11695-011-0558-z; Sussenbach SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099976; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Wagner M.B., 1998, J PEDIAT, V74, P247; Wang GJ, 2002, AM J PREV MED, V23, P1, DOI 10.1016/S0749-3797(02)00448-8; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012; Yang P, 2009, EUR J CANCER, V45, P2867, DOI 10.1016/j.ejca.2009.04.019	51	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121160	10.1371/journal.pone.0121160	http://dx.doi.org/10.1371/journal.pone.0121160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25658694	Green Published, gold, Green Submitted			2022-12-26	WOS:000352135600061
J	Benzaquem, DC; Oliveira, C; Batista, JD; Zuanon, J; Porto, JIR				Benzaquem, Denise Correa; Oliveira, Claudio; Batista, Jaqueline da Silva; Zuanon, Jansen; Rebelo Porto, Jorge Ivan			DNA Barcoding in Pencilfishes (Lebiasinidae: Nannostomus) Reveals Cryptic Diversity across the Brazilian Amazon	PLOS ONE			English	Article							FRESH-WATER FISHES; INDO-WEST PACIFIC; CHARACIFORMES CHARACIDAE; TAXONOMY; NOV	Nannostomus is comprised of 20 species. Popularly known as pencilfishes the vast majority of these species lives in the flooded forests of the Amazon basin and are popular in the ornamental trade. Among the lebiasinids, it is the only genus to have undergone more than one taxonomic revision. Even so, it still possesses poorly defined species. Here, we report the results of an application of DNA barcoding to the identification of pencilfishes and highlight the deeply divergent clades within four nominal species. We surveyed the sequence variation in the mtDNA cytochrome c oxidase subunit I gene among 110 individuals representing 14 nominal species that were collected from several rivers along the Amazon basin. The mean Kimura-2-parameter distances within species and genus were 2% and 19,0%, respectively. The deep lineage divergences detected in N. digrammus, N. trifasciatus, N. unifasciatus and N. eques suggest the existence of hidden diversity in Nannostomus species. For N. digrammus and N. trifasciatus, in particular, the estimated divergences in some lineages were so high that doubt about their conspecific status is raised.	[Benzaquem, Denise Correa; Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, BR-69067375 Manaus, Amazonas, Brazil; [Oliveira, Claudio] UNESP, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [Batista, Jaqueline da Silva] Inst Nacl de Pesquisas da Amazonia, Lab Temat Biol Mol, Lab Fisiol Comportamental & Evolucao, BR-69067375 Manaus, Amazonas, Brazil; [Zuanon, Jansen] Inst Nacl de Pesquisas da Amazonia, Lab Sistemat & Ecol Peixes, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Estadual Paulista; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Porto, JIR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim, Av Andre Araujo 2-936, BR-69067375 Manaus, Amazonas, Brazil.	jirporto@inpa.gov.br	Porto, Jorge/T-4694-2019; Oliveira, Claudio/D-7713-2012; Porto, Jorge/K-1441-2014; da Silva Batista, Jacqueline/AAD-4349-2020; Zuanon, Jansen A. S./E-5791-2013	Oliveira, Claudio/0000-0002-7010-8880; Porto, Jorge/0000-0003-1393-6492; da Silva Batista, Jacqueline/0000-0002-6649-6200; Zuanon, Jansen A. S./0000-0001-8354-2750; santos, leonor maria pacheco/0000-0002-6739-6260; Silva, Everton/0000-0001-8747-4185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL) [564953/2010-5]; FAPEAM/CNPq/PRONEX [003/2009]; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM) [563348/2010-0]; Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEAM/CNPq/PRONEX; CNPq/FAPEAM (INCT CENBAM); CNPq/FAPEAM (SISBIOTA Rede BIOPHAM); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Rede BrBOL #564953/2010-5); FAPEAM/CNPq/PRONEX (Call 003/2009), CNPq/FAPEAM (INCT CENBAM), CNPq/FAPEAM (SISBIOTA Rede BIOPHAM #563348/2010-0). Fundacao de Amparo a Pesquisa do Estado do Amazonas and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided PhD fellowship to DCB. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided fellowship to CO and JZ. DNA sequencing core facility was provided by Instituto Nacional de Pesquisas da Amazonia (INPA) and Universidade Estadual de Sao Paulo (UNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Allen Gerald R., 2013, Journal of the Ocean Science Foundation, V6, P33; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Borsa P, 2013, CR BIOL, V336, P82, DOI 10.1016/j.crvi.2013.01.004; Carvalho LN, 2007, TROPICAL BIOL CONSER, P1, DOI [10.1007/s12033-007-0062-9, DOI 10.1007/S12033-007-0062-9]; Clare EL, 2011, PLOS ONE; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Froese R., 2021, FISHBASE WORLD WIDE; Galimberti A, 2012, MOL ECOL RESOUR, V12, P403, DOI 10.1111/j.1755-0998.2011.03110.x; Gery J, 1877, CHARACOIDS WORLD, P672; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson NF, 2011, INVERTEBR SYST, V25, P471, DOI 10.1071/IS11052; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lundberg John G., 1998, P13; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paepke Hans-Joachim, 2001, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V2, P143; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Roxo FF, 2012, ZOOTAXA, P1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J., 2001, MOL CLONING LAB MANU; Silva GSC, 2013, J FISH BIOL, V82, P1613, DOI 10.1111/jfb.12094; Sistrom MJ, 2009, J ZOOL, V278, P287, DOI 10.1111/j.1469-7998.2009.00576.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terencio ML, 2012, J FISH BIOL, V81, P110, DOI 10.1111/j.1095-8649.2012.03320.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Victor BC, 2010, ZOOL STUD, V49, P865; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weitzman H, 1982, BIOL DIVERSIFICATION; WEITZMAN S H, 1978, Smithsonian Contributions to Zoology, P1; Weitzman SH, 1975, SMITHSONIAN CONTRIBU, V186, P1; Weitzman SH, 2003, CHECK LIST FRESHWATE; WEITZMAN STANLEY H., 1966, PROC U S NAT MUS, V119, P1; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zarske A, 2013, VERTEBR ZOOL, V63, P125; Zarske A, 2011, VERTEBR ZOOL, V61, P283; Zarske Axel, 2009, Vertebrate Zoology, V59, P11; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	65	117	121	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0112217	10.1371/journal.pone.0112217	http://dx.doi.org/10.1371/journal.pone.0112217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658694	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900002
